PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Xu, FW; Zhao, F; Zhao, XX; Zhang, D; Liu, XM; Hu, SQ; Mei, S; Fan, ZL; Huang, Y; Sun, H; Wei, L; Wu, C; Li, QJ; Wang, JW; Cen, S; Liang, C; Guo, F				Xu, Fengwen; Zhao, Fei; Zhao, Xiaoxiao; Zhang, Di; Liu, Xiaoman; Hu, Siqi; Mei, Shan; Fan, Zhangling; Huang, Yu; Sun, Hong; Wei, Liang; Wu, Chao; Li, Quanjie; Wang, Jianwei; Cen, Shan; Liang, Chen; Guo, Fei			Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); inhibition mechanism; infection; host-pathogen interaction; myxovirus resistance 2 (MX2); myxovirus resistance protein B (MxB); nuclear export signal (NES); virus capsid; viral infection; protein oligomerization	VIRAL DETERMINANTS; SAMHD1 RESTRICTS; INTERFERON; INFECTION; PROTEIN; VIRUS; REPLICATION; RESISTANCE; SERINC5; HOST	Interferon-regulated myxovirus resistance protein B (MxB) is an interferon-induced GTPase belonging to the dynamin superfamily. It inhibits infection with a wide range of different viruses, including HIV-1, by impairing viral DNA entry into the nucleus. Unlike the related antiviral GTPase MxA, MxB possesses an N-terminal region that contains a nuclear localization signal and is crucial for inhibiting HIV-1. Because MxB previously has been shown to reside in both the nuclear envelope and the cytoplasm, here we used bioinformatics and biochemical approaches to identify a nuclear export signal (NES) responsible for MxB's cytoplasmic location. Using the online computational tool LocNES (Locating Nuclear Export Signals or NESs), we identified five putative NES candidates in MxB and investigated whether their deletion caused nuclear localization of MxB. Our results revealed that none of the five deletion variants relocates to the nucleus, suggesting that these five predicted NES sequences do not confer NES activity. Interestingly, deletion of one sequence, encompassing amino acids 505?527, abrogated the anti-HIV-1 activity of MxB. Further mutation experiments disclosed that amino acids 515?519, and Pro-515 in particular, regulate MxB oligomerization and its binding to HIV-1 capsid, thereby playing an important role in MxB-mediated restriction of HIV-1 infection. In summary, our results indicate that none of the five predicted NES sequences in MxB appears to be required for its nuclear export. Our findings also reveal several residues in MxB, including Pro-515, critical for its oligomerization and anti-HIV-1 function.	[Xu, Fengwen; Zhao, Fei; Zhao, Xiaoxiao; Zhang, Di; Liu, Xiaoman; Hu, Siqi; Mei, Shan; Fan, Zhangling; Huang, Yu; Sun, Hong; Wei, Liang; Wu, Chao; Wang, Jianwei; Guo, Fei] Chinese Acad Med Sci & Peking Union Med Coll, NHC Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Xu, Fengwen; Zhao, Fei; Zhao, Xiaoxiao; Zhang, Di; Liu, Xiaoman; Hu, Siqi; Mei, Shan; Fan, Zhangling; Huang, Yu; Sun, Hong; Wei, Liang; Guo, Fei] Chinese Acad Med Sci & Peking Union Med Coll, Ctr AIDS Res, Beijing 100730, Peoples R China; [Li, Quanjie; Cen, Shan] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Beijing 100050, Peoples R China; [Liang, Chen] McGill Univ, AIDS Ctr, Lady Davis Inst, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Peking Union Medical College; Lady Davis Institute; McGill University	Guo, F (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Ctr AIDS Res, Beijing 100730, Peoples R China.; Guo, F (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.; Guo, F (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Pathogen Biol, Ctr AIDS Res, Beijing 100730, Peoples R China.	guofei@ipb.pumc.edu.cn		Wang, Jianwei/0000-0002-1116-4559	National Key Plan for Scientific Research and Development of China [2016YFD0500307]; Ministry of Science and Technology of China [2018ZX10301408-003, 2018ZX10731101-001-018]; CAMS Innovation Fund for Medical Sciences (CIFMS) [CIFMS 2017-I2M-1-014, CIFMS 2018-I2M-3-004]; National Natural Science Foundation of China [81401673, 81528012, 81601771, 81702451, 81371808]; Canadian Institutes of Health Research Grant [CCI-132561]; CAMS general fund [2019-RC-HL-012]; PUMC Youth Fund/Fundamental Research Funds for the Central Universities [3332018202, 3332019157]	National Key Plan for Scientific Research and Development of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); CAMS Innovation Fund for Medical Sciences (CIFMS); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); CAMS general fund; PUMC Youth Fund/Fundamental Research Funds for the Central Universities	This work was supported by National Key Plan for Scientific Research and Development of China Grant 2016YFD0500307; Ministry of Science and Technology of China Grants 2018ZX10301408-003 and 2018ZX10731101-001-018; CAMS Innovation Fund for Medical Sciences (CIFMS) Grants CIFMS 2017-I2M-1-014 and CIFMS 2018-I2M-3-004; National Natural Science Foundation of China Grants 81401673, 81528012, 81601771, 81702451, and 81371808; Canadian Institutes of Health Research Grant CCI-132561; CAMS general fund Grant 2019-RC-HL-012; and PUMC Youth Fund/Fundamental Research Funds for the Central Universities Grants 3332018202 and 3332019157. The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez FJD, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701264; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Buffone C, 2015, J VIROL, V89, P3285, DOI 10.1128/JVI.03730-14; Busnadiego I, 2014, J VIROL, V88, P7738, DOI 10.1128/JVI.00214-14; Crameri M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04379-2; Dicks MDJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007408; Dicks MDJ, 2016, J VIROL, V90, P22, DOI 10.1128/JVI.02247-15; Fackler OT, 2015, VIRUSES-BASEL, V7, P6730, DOI 10.3390/v7122970; Fribourgh JL, 2014, CELL HOST MICROBE, V16, P627, DOI 10.1016/j.chom.2014.09.021; Fricke T, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0068-x; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2015, J VIROL, V89, P4676, DOI 10.1128/JVI.00169-15; Goujon C, 2014, J VIROL, V88, P9017, DOI 10.1128/JVI.01269-14; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Holler O, 2009, REV SCI TECH OIE, V28, P219, DOI 10.20506/rst.28.1.1867; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; Kane M, 2018, ELIFE, V7, DOI 10.7554/eLife.35738; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lee SH, 2002, GENOME RES, V12, P527, DOI 10.1101/gr.20102; Li J, 2015, BIOCHEM J, V468, P303, DOI 10.1042/BJ20141331; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Matreyek KA, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0090-z; Melen K, 1996, J BIOL CHEM, V271, P23478, DOI 10.1074/jbc.271.38.23478; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Peltekian C, 2005, J HEPATOL, V43, P965, DOI 10.1016/j.jhep.2005.06.019; Reichelt M, 2004, TRAFFIC, V5, P772, DOI 10.1111/j.1600-0854.2004.00219.x; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Schilling M, 2018, J VIROL, V92, DOI 10.1128/JVI.01056-18; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schulte B, 2015, J VIROL, V89, P8599, DOI 10.1128/JVI.00753-15; Shah VB, 2011, JOVE-J VIS EXP, DOI 10.3791/3384; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Staeheli P, 2018, J VIROL, V92, DOI 10.1128/JVI.00709-18; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Van Hoeven N, 2009, J VIROL, V83, P2851, DOI 10.1128/JVI.02174-08; Wei W, 2016, EBIOMEDICINE, V8, P230, DOI 10.1016/j.ebiom.2016.04.020; Xu DR, 2015, BIOINFORMATICS, V31, P1357, DOI 10.1093/bioinformatics/btu826; Yi DR, 2019, J VIROL, V93, DOI 10.1128/JVI.01285-18; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	51	2	2	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6447	6456		10.1074/jbc.RA119.012439	http://dx.doi.org/10.1074/jbc.RA119.012439			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32217692	hybrid, Green Published			2022-12-26	WOS:000537685000016
J	Buajitti, E; Frank, J; Watson, T; Kornas, K; Rosella, LC				Buajitti, Emmalin; Frank, John; Watson, Tristan; Kornas, Kathy; Rosella, Laura C.			Changing relative and absolute socioeconomic health inequalities in Ontario, Canada: A population-based cohort study of adult premature mortality, 1992 to 2017	PLOS ONE			English	Article							AVOIDABLE MORTALITY; INCOME; GRADIENTS; OUTCOMES; DISEASE; ACCESS; INDEX	Background This study aimed to characterize trends in absolute and relative socioeconomic inequalities in adult premature mortality between 1992 and 2017, in the context of declining population-wide mortality rates. We conducted a population-based cohort study of all adult premature deaths in Ontario, Canada using provincial vital statistics data linked to census-based, area-level deprivation indices for socioeconomic status. Methods The cohort included all individuals eligible for Ontario's single-payer health insurance system at any time between January 1, 1992 and December 31, 2017 with a recorded Ontario place of residence and valid socioeconomic status information (N = 820,370). Deaths between ages 18 and 74 were used to calculate adult premature mortality rates per 1000, stratified by provincial quintile of material deprivation. Relative inequalities were measured using Relative Index of Inequality (RII) measures. Absolute inequalities were estimated using Slope Index of Inequality (SII) measures. All outcome measures were calculated as sex-specific, annual measures for each year from 1992 to 2017. Results Premature mortality rates declined in all socioeconomic groups between 1992 and 2017. Relative inequalities in premature mortality increased over the same period. Absolute inequalities were mostly stable between 1992 and 2007, but increased dramatically between 2008 and 2017, with larger increases to absolute inequalities seen in females than in males. Conclusions As in other developed countries, long-term downward trends in all-cause premature mortality in Ontario, Canada have shifted to a plateau pattern in recent years, especially in lower-socioeconomic status subpopulations. Determinants of this may differ by setting. Regular monitoring of mortality by socioeconomic status is the only way that this phenomenon can be detected sensitively and early, for public health attention and possible corrective action.	[Buajitti, Emmalin; Kornas, Kathy; Rosella, Laura C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Buajitti, Emmalin; Watson, Tristan; Rosella, Laura C.] ICES, Toronto, ON, Canada; [Frank, John] Univ Edinburgh, Coll Med & Vet Med, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland	University of Toronto; University of Toronto; University of Edinburgh	Rosella, LC (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Rosella, LC (corresponding author), ICES, Toronto, ON, Canada.	laura.rosella@utoronto.ca		Watson, Tristan/0000-0001-8257-4216	Canadian Institutes for Health Research [FRN-142498]; Canada Research Chair in Population Health Analytics [CRC-950-23072]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Population Health Analytics	This study was funded by the Canadian Institutes for Health Research (www.cihr-irsc.gc.ca) Operating Grant (FRN-142498) held by LCR. CLR is supported by a Canada Research Chair in Population Health Analytics (CRC-950-23072). The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blakely T, 2017, EPIDEMIOLOGY, V28, P594, DOI [10.1097/EDE.0000000000000671, 10.1097/ede.0000000000000671]; Bor J, 2017, LANCET, V389, P1475, DOI 10.1016/S0140-6736(17)30571-8; Buajitti E, 2018, ONTARIO ATLAS ADULT; Buajitti E, 2020, SSM-POPUL HLTH, V10, DOI 10.1016/j.ssmph.2020.100553; Canada Statistics, POST CODEOM CONV FIL; Canadian Institute for Health Information, 2012, HLTH IND 2012; Case A, 2017, BROOKINGS PAP ECO AC, P397; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Chiu M, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0375-3; Dorling D, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3697; Frank JW, 2018, NEW FORMS DATA UNDER, V8; Fransham M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1946; Giles-Corti B, 2002, PREV MED, V35, P601, DOI 10.1006/pmed.2002.1115; Green M, 2017, HEALTH PLACE, V44, P77, DOI 10.1016/j.healthplace.2017.02.002; Hajizadeh M, 2016, HEALTH POLICY, V120, P1040, DOI 10.1016/j.healthpol.2016.07.019; Health Quality Ontario, 2015, QUAL MATT REAL EXC C; Hemeon J., 2016, HIST DATA LINKAGE QU; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; Hosseinpoor AR, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0229-9; Hosseinpoor AR, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0307-y; Juhn YJ, 2011, J URBAN HEALTH, V88, P933, DOI 10.1007/s11524-011-9572-7; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kaufman JS, 2017, AM J LAW MED, V43, P193, DOI 10.1177/0098858817723659; Khan AM, 2017, J EPIDEMIOL COMMUN H, V71, P625, DOI 10.1136/jech-2016-208525; King NB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5774; Krieger N, 2008, PLOS MED, V5, P227, DOI 10.1371/journal.pmed.0050046; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1732; Mackenbach JP, 2015, J EPIDEMIOL COMMUN H, V69, P207, DOI 10.1136/jech-2014-204319; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; MARMOT M, 2019, BMJ-BRIT MED J, V365, DOI DOI 10.1136/BMJ.L2278; Matheson FI, 2017, 2011 ONTARIO MARGINA; Matheson FI., 2012, ONTARIO MARGINALIZAT; Matheson FI, 2012, CAN J PUBLIC HEALTH, V103, pS12, DOI 10.1007/BF03403823; Moreno-Betancur M, 2015, EPIDEMIOLOGY, V26, P518, DOI 10.1097/EDE.0000000000000311; National Center for Health Statistics, 2018, HLTH US 2017 SPEC FE; Newacheck PW, 1996, PEDIATRICS, V97, P26; Page A., 2006, AUSTR NZ ATLAS AVOID; Pathirana TI, 2018, AUST NZ J PUBL HEAL, V42, P186, DOI 10.1111/1753-6405.12762; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Scottish Government, 2017, LONG TERM MON HLTH I; Shumany R., 2018, MORTALITY OVERVIEW 2; Southern DA, 2005, MED CARE, V43, P1116, DOI 10.1097/01.mlr.0000182517.57235.6d; Statistics Canada, 2018, CANSIM TABL 051 0005; Thomas B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3639; Tjepkema Michael, 2011, Health Rep, V22, P25; Tobias M, 2001, AUST NZ J PUBL HEAL, V25, P12, DOI 10.1111/j.1467-842X.2001.tb00543.x; United Nations, 2015, SUST DEV GOALS; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511	49	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230684	10.1371/journal.pone.0230684	http://dx.doi.org/10.1371/journal.pone.0230684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8KJ	32240183	Green Submitted, Green Published, gold			2022-12-26	WOS:000535945000035
J	Guilloteau, A; Binquet, C; Bourredjem, A; Fournel, I; Lalanne-Mistrih, ML; Nacher, M; Rochemont, D; Cabie, A; Mimeau, E; Mislin-Tritsch, C; Joux, J; Lannuzel, A; Bonithon-Kopp, C; Bejot, Y; Devilliers, H				Guilloteau, Adrien; Binquet, Christine; Bourredjem, Abderrahmane; Fournel, Isabelle; Lalanne-Mistrih, Marie Laure; Nacher, Mathieu; Rochemont, Devi; Cabie, Andre; Mimeau, Emmanuelle; Mislin-Tritsch, Caroline; Joux, Julien; Lannuzel, Annie; Bonithon-Kopp, Claire; Bejot, Yannick; Devilliers, Herve		INDIA Study Grp	Social deprivation among socio-economic contrasted french areas: Using item response theory analysis to assess differential item functioning of the EPICES questionnaire in stroke patients	PLOS ONE			English	Article							HEALTH; INDEX; SCORE	Background Multiple approaches have been proposed to measure low socio-economic status. In France the concept of precariousness, akin to social deprivation, was developed and is widely used. EPICES is a short questionnaire that was developed to measure this concept. This study aimed to evaluate Differential Item Functioning (DIF) in the EPICES questionnaire between contrasted areas: mainland France, French West Indies (FWI) and French Guiana (FG). Methods The population was taken from the INDIA study, which aimed to evaluate the impact of social inequalities on stroke characteristics and prognosis. Eligible people were patients referred to neurology or emergency departments for a suspicion of stroke. We assessed the DIF using hybrid ordinal logistic regression method, derived from item response theory. Results We analysed 1 553 stroke patients, including 768 from FWI (49.5%), 289 from FG (18.6%) and 496 from mainland (31.9%). We identified five items with a moderate to large DIF in area comparisons: "meeting with a social worker", "complementary health insurance", "home-owning", "financial difficulties" and "sport activities". Correlation between EPICES score and the latent variable was strong (r = 0.84). Conclusion This is the first attempt to assess the DIF of the EPICES score between different French populations. We found several items with DIF, which can be explained by individual interpretation or local context. However, the DIFs did not lead to a large difference between the latent variable and the EPICES score, which indicates that it can be used to assess precariousness and social deprivation between contrasted areas.	[Guilloteau, Adrien; Binquet, Christine; Bourredjem, Abderrahmane; Fournel, Isabelle; Bonithon-Kopp, Claire; Devilliers, Herve] Bourgogne Franche Comte Univ, Univ Hosp Dijon, Clin Epidemiol Unit, Epidemiol & Infect Control Unit,INSERM,CIC 1432, Dijon, France; [Lalanne-Mistrih, Marie Laure] Univ West Indies Pointe A Pitre, INSERM, CIC 1424, Clin Epidemiol Unit Pointe A Pitre,Univ Hosp Poin, Pointe A Pitre, Guadeloupe, France; [Nacher, Mathieu; Rochemont, Devi] Univ French Guiana Cayenne, Hosp Andree Rosemon, Clin Epidemiol Unit, INSERM,CIC 1424, Guyane, France; [Cabie, Andre] Univ West Indies, INSERM, CIC 1424,EA4537 Ft De France, Clin Epidemiol Unit Ft De France,Univ Hosp Martin, Fort De France, Martinique, France; [Mimeau, Emmanuelle] Hosp Andree Rosemon Cayenne, Guyane, France; [Mislin-Tritsch, Caroline] Western Guyana Hosp St Laurent Du Maroni, Guyane, France; [Joux, Julien] Univ Hosp Martinique Ft De France, Fort De France, Martinique, France; [Lannuzel, Annie] Univ West Indies Pointe A Pitre, INSERM, CIC 1424,Inst Brain & Spinal Cord Disorders,ICM,U, Clin Epidemiol Unit Pointe A Pitre,Univ Hosp Poin, Paris, France; [Bejot, Yannick] Univ Hosp Dijon, Neurol Dept, Dijon, France; [Bejot, Yannick] Univ Hosp Dijon, Dijon Stroke Registry, Dijon, France	CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Martinique; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne	Guilloteau, A (corresponding author), Bourgogne Franche Comte Univ, Univ Hosp Dijon, Clin Epidemiol Unit, Epidemiol & Infect Control Unit,INSERM,CIC 1432, Dijon, France.	adrien.guilloteau@chu-dijon.fr	nacher, mathieu/AAH-4796-2021; lannuzel, annie/AAB-6253-2021; Binquet, Christine/E-8953-2018	nacher, mathieu/0000-0001-9397-3204; Binquet, Christine/0000-0002-9417-5754; caroline, MISSLIN-TRITSCH/0000-0002-4732-8180; Bejot, Yannick/0000-0001-7848-7072; Cabie, Andre/0000-0003-0117-3061; Guilloteau, Adrien/0000-0003-1161-297X	French Ministry of Health [PHRC 2010/07/05]	French Ministry of Health	This study was supported by a grant from the French Ministry of Health (National PHRC 2010/07/05, Claire Bonithon-Kopp) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], REV FRANCOPH PSYCHOO; Barbier J. C., 2002, 19 CEE, V19; Bejot Y, 2017, EUR J NEUROL; Bertin M, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-22; Blanpain N., 2016, INSEE PREM; Bongue B, 2016, J FRALITY AGING, V5, P168, DOI 10.14283/jfa.2016.96; Butel P., 2014, HIST ANTILLES FRANCA; Carde E, 2012, ANTHROPOL SANTE, V5, DOI 10.4000/anthropologiesante.1003; Chauvin P, 2013, ACTUAL DOSS SANTE PU, V73, P8; Chavent M., 2014, ARXIV14114911, P14114911; Choi SW, 2011, J STAT SOFTW, V39, P1; Cosson E, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007120; Desse M., 2007, ETUDES CARIBEENNES, P8; Empana JP, 2016, HEART, V102, P1890, DOI 10.1136/heartjnl-2016-309502; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Haut Comite de la sante publique, 1998, PROGR PREC FRANC SES; Jaffiol C, 2013, DIABETES METAB, V39, P56, DOI 10.1016/j.diabet.2012.09.002; Jaluzot L, 2015, INSEE PREMIERE, V1589, P1; Krieger N, 2007, EPIDEMIOLOGY, V18, P658, DOI 10.1097/EDE.0b013e318156bfcd; Labbe E, 2015, EUR J PUBLIC HEALTH, V25, P604, DOI 10.1093/eurpub/cku231; Martin D, 2000, ENVIRON PLANN A, V32, P735, DOI 10.1068/a32130; Michel C, 2010, INSEE PREM, P1; Moulin JJ, 2006, B EPIDEMIOLOGIQUE HE, V14, P93; Naulin A., 2017, PARCOURS RESIDENTIEL, P4; OECD, 2015, IT TOG WHY LESS IN B; Opatowski M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009511; Pierret Regis, 2013, NOUVELLE REV SCI SOC, V2, P307; Robert S., 2013, CONSTRUCTION VALIDAT; Sass C, SANTE PUBLIQUE, V18, P513; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; Townsend P., 1979, POVERTY UK; Treyens P-E, 2015, INSEE ANAL GUYANE, P1; Vaucher P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000692; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; Wresinski J., 1987, GRANDE PAUVRETE PREC; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230661	10.1371/journal.pone.0230661	http://dx.doi.org/10.1371/journal.pone.0230661			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8KJ	32240217	gold, Green Published			2022-12-26	WOS:000535945000034
J	Kim, NR; Jardi, F; Khalil, R; Antonio, L; Schollaert, D; Deboel, L; van Lenthe, GH; Decallonne, B; Carmeliet, G; Gustafsson, JA; Claessens, F; Ohlsson, C; Lagerquist, MK; Dubois, V; Vanderschueren, D				Kim, Na Ri; Jardi, Ferran; Khalil, Rougin; Antonio, Leen; Schollaert, Dieter; Deboel, Ludo; van Lenthe, G. Harry; Decallonne, Brigitte; Carmeliet, Geert; Gustafsson, Jan-Ake; Claessens, Frank; Ohlsson, Claes; Lagerquist, Marie K.; Dubois, Vanessa; Vanderschueren, Dirk			Estrogen receptor alpha signaling in extrahypothalamic neurons during late puberty decreases bone size and strength in female but not in male mice	FASEB JOURNAL			English	Article						GH; IGF-1; neuroendocrine bone axis; puberty; sex steroids; skeletal sexual dimorphism	GROWTH-HORMONE-SECRETION; SEXUAL-DIMORPHISM; ER-ALPHA; ANDROGENS; GENE; BETA; HYPOTHALAMUS; INACTIVATION; INNERVATION; DEFICIENCY	Sexually dimorphic bone structure emerges largely during puberty. Sex steroids are critical for peak bone mass acquisition in both genders. In particular, the biphasic effects of estrogens mediate the skeletal sexual dimorphism. However, so far the stimulatory vs inhibitory actions of estrogens on bone mass are not fully explained by direct effects on bone cells. Recently, it has become evident that there is possible neuroendocrine action of estrogen receptor alpha (ER alpha) on the skeleton. Based on these considerations, we hypothesized that neuronal ER alpha-signaling may contribute to the skeletal growth during puberty. Here, we generated mice with tamoxifen-inducible Thy1-Cre mediated ER alpha inactivation during late puberty specifically in extrahypothalamic neurons (N-ER alpha KO). Inactivation of neuronal ER alpha did not alter the body weight in males, whereas N-ER alpha KO females exhibited a higher body weight and increased body and bone length compared to their control littermates at 16 weeks of age. Ex vivo microCT analysis showed increased radial bone expansion of the midshaft femur in female N-ER alpha KO along with higher serum levels of insulin-like growth factor (IGF)-1 as well as IGF-binding protein (IGFBP)-3. Furthermore, the 3-point bending test revealed increased bone strength in female N-ER alpha KO. In contrast, inactivation of neuronal ER alpha had no major effect on bone growth in males. In conclusion, we demonstrate that central ER alpha-signaling limits longitudinal bone growth and radial bone expansion specifically in females potentially by interacting with the GH/IGF-1 axis.	[Kim, Na Ri; Jardi, Ferran; Khalil, Rougin; Antonio, Leen; Schollaert, Dieter; Deboel, Ludo; Decallonne, Brigitte; Carmeliet, Geert; Dubois, Vanessa; Vanderschueren, Dirk] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing CHROMETA, Clin & Expt Endocrinol, Herestr 49 Box 902, B-3000 Leuven, Belgium; [van Lenthe, G. Harry] Katholieke Univ Leuven, Biomech Sect, Dept Mech Engn, Leuven, Belgium; [Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Dept Biol & Biochem, Houston, TX USA; [Claessens, Frank] Katholieke Univ Leuven, Mol Endocrinol Lab, Dept Cellular & Mol Med, Leuven, Belgium; [Ohlsson, Claes; Lagerquist, Marie K.] Univ Gothenburg, Sahlgrenska Acad, Ctr Bone & Arthrit Res, Inst Med, Gothenburg, Sweden	KU Leuven; KU Leuven; University of Houston System; University of Houston; KU Leuven; University of Gothenburg	Vanderschueren, D (corresponding author), Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing CHROMETA, Clin & Expt Endocrinol, Herestr 49 Box 902, B-3000 Leuven, Belgium.	dirk.vanderschueren@uzleuven.be	Antonio, Leen/T-1206-2018; Lagerquist, Marie/A-9531-2010; van Lenthe, Harry (GH)/C-1030-2008; Dubois, Vanessa/ABF-9551-2021; Ohlsson, Claes/AGP-3544-2022; Claessens, Frank/M-8565-2016	Antonio, Leen/0000-0002-1079-2860; Lagerquist, Marie/0000-0002-9089-8605; van Lenthe, Harry (GH)/0000-0001-8303-4959; Dubois, Vanessa/0000-0001-8894-2980; Ohlsson, Claes/0000-0002-9633-2805; DEBOEL, LUDO/0000-0002-2303-513X; Jardi, Ferran/0000-0003-4468-6123; vanderschueren, dirk/0000-0003-1395-0104; Claessens, Frank/0000-0002-8676-7709	Flemish Fund for Scientific Research (FWO) [P192/2016]; Eunice Kennedy Shriver NICHD/NIH (NCTRI) [P50-HD28934]	Flemish Fund for Scientific Research (FWO)(FWO); Eunice Kennedy Shriver NICHD/NIH (NCTRI)	This work was funded by a research grant from the Flemish Fund for Scientific Research (FWO; P192/2016). The authors thank Erik Van Herck for his excellent technical assistance and prof. Julie Bakker and prof. Charlotte Cornil (Research Group in Behavioral Neuroendocrinology, University of Liege) for helpful discussions. The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core (Charlottesville, VA, USA) is supported by the Eunice Kennedy Shriver NICHD/NIH (NCTRI) Grant P50-HD28934.	Addison ML, 2012, ENDOCRINOLOGY, V153, P1898, DOI 10.1210/en.2011-1982; Ahlborg HG, 2003, NEW ENGL J MED, V349, P327, DOI 10.1056/NEJMoa022464; Akingbemi BT, 2003, ENDOCRINOLOGY, V144, P84, DOI 10.1210/en.2002-220292; Almeida M, 2017, PHYSIOL REV, V97, P135, DOI 10.1152/physrev.00033.2015; Almeida M, 2013, J CLIN INVEST, V123, P394, DOI 10.1172/JCI65910; Antonson P, 2012, BIOCHEM BIOPH RES CO, V424, P710, DOI 10.1016/j.bbrc.2012.07.016; Borjesson AE, 2010, J BONE MINER RES, V25, P2414, DOI 10.1002/jbmr.156; Burghardt AJ, 2010, J BONE MINER RES, V25, P983, DOI 10.1359/jbmr.091104; Callewaert F, 2010, J BONE MINER RES, V25, P617, DOI 10.1359/jbmr.090828; Callewaert F, 2009, FASEB J, V23, P232, DOI 10.1096/fj.08-113456; Chagin AS, 2004, J BONE MINER RES, V19, P72, DOI 10.1359/JBMR.0301203; Farman HH, 2016, ENDOCRINOLOGY, V157, P3242, DOI 10.1210/en.2016-1181; Herber CB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08046-4; JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128; Jardi F, 2017, MOL CELL ENDOCRINOL, V452, P57, DOI 10.1016/j.mce.2017.05.012; Juul A, 2001, HUM REPROD UPDATE, V7, P303, DOI 10.1093/humupd/7.3.303; KERRIGAN JR, 1992, ENDOCR REV, V13, P281, DOI 10.1210/er.13.2.281; Kondoh S, 2014, BONE, V60, P68, DOI 10.1016/j.bone.2013.12.005; Laperre K, 2011, BONE, V49, P613, DOI 10.1016/j.bone.2011.06.031; Laurent M, 2014, ASIAN J ANDROL, V16, P213, DOI 10.4103/1008-682X.122356; Lindberg MK, 2003, MOL ENDOCRINOL, V17, P203, DOI 10.1210/me.2002-0206; Lindberg MK, 2001, J ENDOCRINOL, V171, P229, DOI 10.1677/joe.0.1710229; Maatta JA, 2013, FASEB J, V27, P478, DOI 10.1096/fj.12-213587; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Melville KM, 2014, J BONE MINER RES, V29, P370, DOI 10.1002/jbmr.2082; Mitra SW, 2003, ENDOCRINOLOGY, V144, P2055, DOI 10.1210/en.2002-221069; Nicks KM, 2012, J BONE MINER RES, V27, P637, DOI 10.1002/jbmr.1468; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; Ohlsson C, 2012, P NATL ACAD SCI USA, V109, P983, DOI 10.1073/pnas.1111436109; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8; Serre CM, 1999, BONE, V25, P623, DOI 10.1016/S8756-3282(99)00215-X; Sims NA, 2006, AM J PHYSIOL-ENDOC M, V290, pE456, DOI 10.1152/ajpendo.00311.2005; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Steyn FJ, 2013, ENDOCRINOLOGY, V154, P4939, DOI 10.1210/en.2013-1502; Sundh D, 2015, J BONE MINER RES, V30, P1692, DOI 10.1002/jbmr.2509; TURNER RT, 1990, J ORTHOPAED RES, V8, P612, DOI 10.1002/jor.1100080418; Vanderschueren D, 2000, J CLIN ENDOCR METAB, V85, P3024, DOI 10.1210/jc.85.9.3024; Vanderschueren D, 2014, ENDOCR REV, V35, P906, DOI 10.1210/er.2014-1024; Veldhuis JD, 2000, J CLIN ENDOCR METAB, V85, P2385, DOI 10.1210/jc.85.7.2385; VERHAEGHE J, 1990, DIABETES, V39, P477, DOI 10.2337/diabetes.39.4.477; Vidal O, 1999, BIOCHEM BIOPH RES CO, V265, P569, DOI 10.1006/bbrc.1999.1711; Windahl SH, 2013, P NATL ACAD SCI USA, V110, P2294, DOI 10.1073/pnas.1220811110; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118	45	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					7118	7126		10.1096/fj.202000272R	http://dx.doi.org/10.1096/fj.202000272R		APR 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32239553	hybrid, Green Published			2022-12-26	WOS:000523590400001
J	Lee, J; Park, HK; Kwon, MJ; Ham, SY; Kim, JM; Lim, SY; Song, JU				Lee, Jonghoo; Park, Hye Kyeong; Kwon, Min-Jung; Ham, Soo-Youn; Kim, Joon Mo; Lim, Si-Young; Song, Jae-Uk			Decreased lung function is associated with elevated ferritin but not iron or transferrin saturation in 42,927 healthy Korean men: A cross-sectional study	PLOS ONE			English	Article							SERUM FERRITIN; INSULIN-RESISTANCE; HOMEOSTASIS; DISEASE; RISK; INTERLEUKIN-8; OBESITY; STORES; CELL	Objectives Though elevated ferritin level and decreased lung function both predispose people to cardio-metabolic disease, few reports have investigated the association between them. Furthermore, it remains unclear whether the association reflects a change in iron stores or an epiphenomenon reflecting metabolic stress. Therefore, we looked for possible associations between ferritin, iron, and transferrin saturation (TSAT) and lung function to clarify the role of iron-related parameters in healthy men. Methods We conducted a cohort study of 42,927 healthy Korean men (mean age: 38.6 years). Percent predicted forced expiratory volume in one second (FEV1%) and forced vital capacity (FVC%) were categorized into quartiles. Adjusted odds ratios (aORs) and 95% confidence intervals (using the highest quartile as reference) were calculated for hyperferritinemia, high iron, and high TSAT after controlling for potential confounders. Results The median ferritin level was 199.8 (141.5-275.6) ng/mL. The prevalence of hyperferritinemia (defined as > 300 ng/mL) was 19.3%. Subjects with hyperferritinemia had lower FEV1% and FVC% than those with normal ferritin level with a slight difference, but those were statistically significant (99.22% vs.99.61% for FEV1%, p = 0.015 and 98.43% vs. 98.87% for FVC, p = 0.001). However, FEV1/FVC ratio was not significantly different between groups (P = 0.797). Compared with the highest quartile, the aORs for hyperferritinemia across decreasing quartiles were 1.081 (1.005-1.163), 1.100 (1.007-1.200), and 1.140 (1.053-1.233) for FEV1% (p for trend = 0.007) and 1.094 (1.018-1.176), 1.101 (1.021-1.188), and 1.150 (1.056-1.252) for FVC% (p for trend = 0.001). However, neither FEV1% nor FVC% was associated with iron or TSAT. Conclusions Hyperferritinemia was associated with decreased lung function in healthy Korean men, but iron and TSAT were not. Longitudinal follow-up studies are required to validate our findings.	[Lee, Jonghoo] Jeju Natl Univ, Jeju Natl Univ Hosp, Sch Med, Dept Internal Med, Jeju, South Korea; [Park, Hye Kyeong] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Internal Med,Div Pulm & Crit Care Med, Ilsan, South Korea; [Kwon, Min-Jung] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Lab Med, Seoul, South Korea; [Ham, Soo-Youn] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Radiol, Seoul, South Korea; [Kim, Joon Mo] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Ophthalmol, Seoul, South Korea; [Lim, Si-Young; Song, Jae-Uk] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Internal Med,Div Pulm & Crit Care Med, Seoul, South Korea	Jeju National University; Inje University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Song, JU (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Internal Med,Div Pulm & Crit Care Med, Seoul, South Korea.	khfever76@gmail.com			Jeju National University	Jeju National University	The 2020 scientific promotion program funded by Jeju National University.	Adams PC, 2011, J HEPATOL, V55, P453, DOI 10.1016/j.jhep.2011.02.010; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; [Anonymous], 2005, P AM THORAC SOC, V2, P5; Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Ball BR, 2000, INHAL TOXICOL, V12, P209, DOI 10.1080/089583700750019576; Brigham EP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117545; Choi HS, 2008, J CLIN ENDOCR METAB, V96, P643, DOI DOI 10.1210/JC.2010-2133; Choi HS, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e304; Curjuric I, 2014, EUR RESPIR J, V43, P1278, DOI 10.1183/09031936.00055813; Engstrom G, 2003, J INTERN MED, V253, P574, DOI 10.1046/j.1365-2796.2003.01138.x; ERGER RA, 1995, AM J PHYSIOL-LUNG C, V268, pL117, DOI 10.1152/ajplung.1995.268.1.L117; Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5; Frantz S, 2014, RESP MED, V108, P114, DOI 10.1016/j.rmed.2013.08.041; Ghio AJ, 2017, INT J CHRONIC OBSTR, V12, P2075, DOI 10.2147/COPD.S138457; Ghio AJ, 2008, AM J RESP CRIT CARE, V178, P1130, DOI 10.1164/rccm.200802-334OC; Gye HJ, 2016, BRIT J OPHTHALMOL, V100, P1703, DOI 10.1136/bjophthalmol-2015-307678; Heunks LMA, 2000, THORAX, V55, P704, DOI 10.1136/thorax.55.8.704; Hole DJ, 1996, BRIT MED J, V313, P711; Holgate ST, 2019, RESPIROLOGY, V24, P1138, DOI 10.1111/resp.13690; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jung CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075250; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Kell DB, 2014, METALLOMICS, V6, P748, DOI 10.1039/c3mt00347g; Kuang YB, 2019, CANCER LETT, V464, P56, DOI 10.1016/j.canlet.2019.08.007; Lee CH, 2016, INT J CHRONIC OBSTR, V11, P3001, DOI 10.2147/COPD.S116982; LEGGETT BA, 1990, CLIN CHEM, V36, P1350; Liu JM, 2003, AM J CLIN NUTR, V78, P1160, DOI 10.1093/ajcn/78.6.1160; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McKeever TM, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-67; MORRISON HI, 1994, EPIDEMIOLOGY, V5, P243, DOI 10.1097/00001648-199403000-00015; North CM, 2019, RESPIROLOGY, V24, P484, DOI 10.1111/resp.13531; Pan Y, 2008, AM J HUM BIOL, V20, P406, DOI 10.1002/ajhb.20745; Park JH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011032; Park SK, 2014, ENDOCR J, V61, P215, DOI 10.1507/endocrj.EJ13-0173; Park SK, 2012, DIABETES CARE, V35, P2521, DOI 10.2337/dc12-0543; Pittet JF, 1997, AM J RESP CRIT CARE, V155, P1187, DOI 10.1164/ajrccm.155.4.9105054; Podmore C, 2016, DIABETES CARE, V39, P572, DOI 10.2337/dc15-0257; SALONEN JT, 1992, CIRCULATION, V86, P803, DOI 10.1161/01.CIR.86.3.803; Seong JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177722; Shaaban R, 2006, RESP MED, V100, P2112, DOI 10.1016/j.rmed.2006.03.027; Song JU, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208736; Song JU, 2017, MOD RHEUMATOL, V27, P1057, DOI 10.1080/14397595.2017.1285981; Sung KC, 2012, ARTERIOSCL THROM VAS, V32, P2525, DOI 10.1161/ATVBAHA.112.253088; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; WALTERS GO, 1973, J CLIN PATHOL, V26, P770, DOI 10.1136/jcp.26.10.770; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; West JB, 2013, AM J RESP CRIT CARE, V188, P1366, DOI 10.1164/rccm.201304-0743LE; Worwood M, 1997, CLIN CHIM ACTA, V259, P3, DOI 10.1016/S0009-8981(96)06488-1; Yeap BB, 2015, CLIN ENDOCRINOL, V82, P525, DOI 10.1111/cen.12529; Zhang WZ, 2019, FREE RADICAL BIO MED, V133, P238, DOI 10.1016/j.freeradbiomed.2018.07.024	51	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0231057	10.1371/journal.pone.0231057	http://dx.doi.org/10.1371/journal.pone.0231057			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240239	Green Published, gold			2022-12-26	WOS:000535945000088
J	Yamaguchi, M; Yamada, K; Iseki, M; Karasawa, Y; Murakami, Y; Enomoto, T; Kikuchi, N; Chiba, S; Hara, A; Yamaguchi, K; Inada, E				Yamaguchi, Masahiro; Yamada, Keiko; Iseki, Masako; Karasawa, Yusuke; Murakami, Yasuko; Enomoto, Tatsuya; Kikuchi, Nobuko; Chiba, Satoko; Hara, Atsuko; Yamaguchi, Keisuke; Inada, Eiichi			Insomnia and caregiver burden in chronic pain patients: A cross-sectional clinical study	PLOS ONE			English	Article							FAMILY CAREGIVERS; GENERAL-POPULATION; ELDER ABUSE; PREVALENCE; IMPACT; CLASSIFICATION; VALIDATION; VALIDITY; QUALITY; ADULTS	Insomnia is a major comorbid symptom of chronic pain and is likely to affect caregiver burden. This cross-sectional study investigated the association between insomnia in chronic pain patients and family caregiver burden. Participants were 60 patients with chronic pain of >= 3 months duration. Demographic and clinical information were collected using the Athens Insomnia Scale (AIS), the Pain Disability Assessment Scale (PDAS), the Hospital Anxiety and Depression Scale (HADS), and a pain intensity numerical rating scale (NRS). Family members who accompanied chronic pain patients to hospital completed the Zarit Burden Interview (ZBI). Univariate regression analysis and multiple regression analysis were conducted to clarify the associations between ZBI scores and total/subscale AIS scores. Covariates were age; sex; pain duration; and scores on the PDAS, HADS anxiety subscale, HADS depression subscale, and NRS. Insomnia was independently associated with ZBI scores [beta: 0.27, 95% confidence interval (CI): 0.07-0.52, p = 0.001]. Scores on the AIS subscale of physical and mental functioning during the day were significantly associated with ZBI scores (beta: 0.32, 95% CI: 0.05-0.59, p = 0.007). In conclusion, the findings suggest that in chronic pain patients, comorbid insomnia and physical and mental daytime functioning is associated with family caregiver burden independently of pain duration, pain-related disability, and pain intensity.	[Yamaguchi, Masahiro; Iseki, Masako; Karasawa, Yusuke; Inada, Eiichi] Juntendo Univ, Grad Sch Med, Dept Pain Med, Bunkyo Ku, Tokyo, Japan; [Yamaguchi, Masahiro; Karasawa, Yusuke] Pfizer Japan, Med Affairs, Shibuya Ku, Tokyo, Japan; [Yamada, Keiko; Iseki, Masako; Murakami, Yasuko; Enomoto, Tatsuya; Kikuchi, Nobuko; Chiba, Satoko; Hara, Atsuko; Yamaguchi, Keisuke; Inada, Eiichi] Juntendo Univ, Fac Med, Dept Anesthesiol & Pain Med, Bunkyo Ku, Tokyo, Japan; [Yamada, Keiko] McGill Univ, Dept Psychol, Montreal, PQ, Canada	Juntendo University; Pfizer; Juntendo University; McGill University	Yamaguchi, M (corresponding author), Juntendo Univ, Grad Sch Med, Dept Pain Med, Bunkyo Ku, Tokyo, Japan.; Yamaguchi, M (corresponding author), Pfizer Japan, Med Affairs, Shibuya Ku, Tokyo, Japan.	yamaguchi2711@outlook.jp		Karasawa, Yusuke/0000-0002-8086-1366; Yamaguchi, Masahiro/0000-0001-9855-6602	Juntendo University	Juntendo University	The principal author and one coauthor have been employed by a pharmaceutical company (Pfizer Japan). However, the present study has no financial or other relationships with that company as it was entirely sponsored by and performed within Juntendo University using anonymous patient data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pfizer provided support in the form of salaries for authors MY and YK, but did not have any additional role in the study design, data collection and analysis, or publication or preparation of the manuscript. The specific roles of these authors (MY and YK) are articulated in the "Author contributions" section.	BRATTBERG G, 1989, PAIN, V37, P215, DOI 10.1016/0304-3959(89)90133-4; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Coffman Ian, 2017, Mhealth, V3, P36, DOI 10.21037/mhealth.2017.08.01; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Enomoto K, 2018, J PAIN RES, V11, P793, DOI 10.2147/JPR.S154852; Gater A, 2015, PATIENT, V8, P507, DOI 10.1007/s40271-015-0114-3; Grov EK, 2006, SOC SCI MED, V63, P2429, DOI 10.1016/j.socscimed.2006.06.008; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Hagell P, 2017, J PAIN SYMPTOM MANAG, V53, P272, DOI 10.1016/j.jpainsymman.2016.09.007; Higginson IJ, 2010, J CLIN EPIDEMIOL, V63, P535, DOI 10.1016/j.jclinepi.2009.06.014; Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100; Kim HH, 2016, PALLIAT SUPPORT CARE, V14, P5, DOI 10.1017/S1478951515000073; Lee MH, 2005, J ELDER ABUSE NEGL, V17, P61, DOI 10.1300/J084v17n01_04; Louie GH, 2011, ARTHRIT CARE RES, V63, P247, DOI 10.1002/acr.20362; McCracken Lance M, 2002, Pain Res Manag, V7, P75; McCracken LM, 2011, PAIN MED, V12, P904, DOI 10.1111/j.1526-4637.2011.01115.x; Ministry of Health Labour and Welfare, 2001, COMPR SURV LIV COND; Ministry of Health Labour and Welfare, 2010, COMPR SURV LIV COND; Morin CM, 2011, CAN J PSYCHIAT, V56, P540, DOI 10.1177/070674371105600905; Ohayon MM, 2010, SLEEP MED, V11, P1010, DOI 10.1016/j.sleep.2010.02.018; Ohayon MM, 2009, SLEEP MED, V10, P952, DOI 10.1016/j.sleep.2009.07.008; Ohayon MM, 2005, J PSYCHIAT RES, V39, P151, DOI 10.1016/j.jpsychires.2004.07.001; Okajima I, 2013, PSYCHIAT CLIN NEUROS, V67, P420, DOI 10.1111/pcn.12073; Rofail D, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0951-1; Schiamberg LB, 2000, INT J AGING HUM DEV, V50, P329, DOI 10.2190/DXAX-8TJ9-RG5K-MPU5; Schulz R, 2003, NEW ENGL J MED, V349, P1936, DOI 10.1056/NEJMsa035373; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Sivertsen B, 2009, J PSYCHOSOM RES, V67, P109, DOI 10.1016/j.jpsychores.2009.05.001; Smith BH, 2001, FAM PRACT, V18, P292, DOI 10.1093/fampra/18.3.292; Smith MT, 2000, J BEHAV MED, V23, P1, DOI 10.1023/A:1005444719169; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Soldatos CR, 2003, J PSYCHOSOM RES, V55, P263, DOI 10.1016/S0022-3999(02)00604-9; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Tang NKY, 2007, J SLEEP RES, V16, P85, DOI 10.1111/j.1365-2869.2007.00571.x; Treede RD, 2015, PAIN, V156, P1003, DOI 10.1097/j.pain.0000000000000160; Verhaak PFM, 1998, PAIN, V77, P231, DOI 10.1016/S0304-3959(98)00117-1; Yamashiro K, 2011, CLIN J PAIN, V27, P338, DOI 10.1097/AJP.0b013e318204858a; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; Zhang JH, 2012, SLEEP MED, V13, P455, DOI 10.1016/j.sleep.2011.11.015; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230933	10.1371/journal.pone.0230933	http://dx.doi.org/10.1371/journal.pone.0230933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8KJ	32240225	Green Published, gold, Green Submitted			2022-12-26	WOS:000535945000061
J	Chen, NN; Zhou, PX; Liu, XZ; Li, JC; Wan, Y; Liu, SY; Wei, FX				Chen, Ningning; Zhou, Pengxiang; Liu, Xizhe; Li, Jiachun; Wan, Yong; Liu, Shaoyu; Wei, Fuxin			Overexpression of Rictor in the injured spinal cord promotes functional recovery in a rat model of spinal cord injury	FASEB JOURNAL			English	Article						functional recovery; neurogenesis; Rictor; spinal cord injury	NEURAL STEM-CELLS; INFLAMMATORY RESPONSE; REGENERATION; PHENOTYPE; AUTOPHAGY; RAPAMYCIN; PROLIFERATION; POLARIZATION; MACROPHAGES; HYPOTHERMIA	Rictor is an essential component that directly activates the mammalian target of rapamycin (mTOR) activity, which contributes to the intrinsic axon growth capacity of adult sensory neurons after injury. However, whether its action also applies to regeneration after spinal cord injury (SCI) remains unknown. In this study, rats were given spinal cord contusion at the T9-10 level to establish the SCI model and were subsequently treated with intraspinal cord injection of a Rictor overexpression lentiviral vector to locally upregulate the Rictor expression in the injured spinal cord. Thereafter, we investigated the therapeutic effects of Rictor overexpression in the injured spinal cords of SCI rats. Rictor overexpression not only significantly attenuated the acute inflammatory response and cell death after SCI but also markedly increased the shift in macrophages around the lesion from the M1 to M2 phenotype compared to those of the control lentiviral vector injection-treated group. Furthermore, Rictor overexpression dramatically increased neurogenesis in the lesion epicenter, subsequently promoting the tissue repair and functional recovery in SCI rats. Interestingly, the mechanism underlying the beneficial effects of Rictor overexpression on SCI may be associated with the Rictor overexpression playing a role in the anti-inflammatory response and driving macrophage polarization toward the M2 phenotype, which benefits resident neuronal and oligodendrocyte survival. Our findings demonstrate that Rictor is an effective target that affects the generation of molecules that inhibit spinal cord regeneration. In conclusion, localized Rictor overexpression represents a promising potential strategy for the repair of SCI.	[Chen, Ningning; Li, Jiachun; Liu, Shaoyu; Wei, Fuxin] Sun Yat Sen Univ, Affiliated Hosp 7, Dept Orthoped, 628 Zhenyuan Rd, Shenzhen 518107, Peoples R China; [Zhou, Pengxiang] Daqing Longnan Hosp, Dept Phys Diagnost, Daqing, Peoples R China; [Liu, Xizhe; Wan, Yong] Sun Yat Sen Univ, Dept Spine Surg, Affiliated Hosp 1, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Liu, SY; Wei, FX (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 7, Dept Orthoped, 628 Zhenyuan Rd, Shenzhen 518107, Peoples R China.; Wan, Y (corresponding author), Sun Yat Sen Univ, Dept Spine Surg, Affiliated Hosp 1, Guangzhou, Peoples R China.	yongwanphd@163.com; gzshaoyuliu@163.com; fuxinweiphd@163.com			National Natural Science Foundation of China Youth Found [81801907]; Shenzhen Committee of Science and Technology, China [JCYJ20180307 145215811]; Sun Yat-sen University Youth Teacher Training Project Foundation, China [19ykpy11]; Sanming Project of Medicine in Shenzhen [SZSM201911002]	National Natural Science Foundation of China Youth Found; Shenzhen Committee of Science and Technology, China; Sun Yat-sen University Youth Teacher Training Project Foundation, China; Sanming Project of Medicine in Shenzhen	This work was supported by grant funds from the National Natural Science Foundation of China Youth Found (No. 81801907), Shenzhen Committee of Science and Technology, China (No. JCYJ20180307 145215811), Sun Yat-sen University Youth Teacher Training Project Foundation, China (No. 19ykpy11), and the Sanming Project of Medicine in Shenzhen (No. SZSM201911002)	Alkabie S, 2016, WORLD NEUROSURG, V86, P432, DOI 10.1016/j.wneu.2015.09.079; Tran AP, 2018, PHYSIOL REV, V98, P881, DOI 10.1152/physrev.00017.2017; Benavides-Serrato A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176599; Bhattacharya I, 2013, ARTERIOSCL THROM VAS, V33, P2105, DOI 10.1161/ATVBAHA.112.301001; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Chen HC, 2013, J SURG RES, V179, pE203, DOI 10.1016/j.jss.2012.02.023; Chen NN, 2016, CRIT CARE MED, V44, pE146, DOI 10.1097/CCM.0000000000001351; Chen WT, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0358-16.2016; Clarke AJ, 2019, NAT REV IMMUNOL, V19, P170, DOI 10.1038/s41577-018-0095-2; Esposito E, 2011, TRENDS PHARMACOL SCI, V32, P107, DOI 10.1016/j.tips.2010.11.009; Gaudet AD, 2016, J NEUROSCI, V36, P8516, DOI 10.1523/JNEUROSCI.0735-16.2016; Gensel JC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40144; Goldshmit Y, 2015, MOL CELL NEUROSCI, V68, P82, DOI 10.1016/j.mcn.2015.04.006; Haan N, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0327-3; Hallowell RW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14208; Hesp ZC, 2015, J NEUROSCI, V35, P1274, DOI 10.1523/JNEUROSCI.2568-14.2015; Ji XC, 2015, CELL MOL NEUROBIOL, V35, P881, DOI 10.1007/s10571-015-0182-x; Ji YF, 2013, GLIA, V61, P1959, DOI 10.1002/glia.22566; Kim JH, 2017, EXP NEUROBIOL, V26, P278, DOI 10.5607/en.2017.26.5.278; Kobashi S, 2019, MOL THER; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Liu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.527; Ma SF, 2015, BRAIN BEHAV IMMUN, V45, P157, DOI 10.1016/j.bbi.2014.11.007; Maybhate A, 2012, CRIT CARE MED, V40, P573, DOI 10.1097/CCM.0b013e318232d97e; Menezes K, 2010, FASEB J, V24, P4513, DOI 10.1096/fj.10-157628; Nesic O, 2001, J NEUROTRAUM, V18, P947, DOI 10.1089/089771501750451857; New PW, 2019, SPINAL CORD, V57, P183, DOI 10.1038/s41393-018-0209-5; Ni SF, 2019, MOL THER, V27, P2134, DOI 10.1016/j.ymthe.2019.08.009; Oh MH, 2017, CELL REP, V20, P2439, DOI 10.1016/j.celrep.2017.08.046; Ohri SS, 2018, J NEUROSCI, V38, P5900, DOI 10.1523/JNEUROSCI.0679-17.2018; Park J, 2018, MOL THER, V26, P1756, DOI 10.1016/j.ymthe.2018.04.022; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Ren JF, 2017, J PATHOL, V242, P488, DOI 10.1002/path.4921; Sekiguchi A, 2012, J NEUROTRAUM, V29, P946, DOI 10.1089/neu.2011.1919; Shibutani ST, 2015, NAT IMMUNOL, V16, P1014, DOI 10.1038/ni.3273; Shrivastava R, 2019, CYTOKINE, V118, P130, DOI 10.1016/j.cyto.2018.03.032; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Stenudd M, 2015, JAMA NEUROL, V72, P235, DOI 10.1001/jamaneurol.2014.2927; Thomanetz V, 2013, J CELL BIOL, V201, P293, DOI 10.1083/jcb.201205030; Wang C, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1630-1; Wu HF, 2013, BIOMATERIALS, V34, P1686, DOI 10.1016/j.biomaterials.2012.11.013; Yao AH, 2014, NEUROTHERAPEUTICS, V11, P636, DOI 10.1007/s13311-013-0254-x; Zhou T, 2019, NAT NEUROSCI, V22, P421, DOI 10.1038/s41593-018-0324-9	43	8	8	5	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6984	6998		10.1096/fj.201903171R	http://dx.doi.org/10.1096/fj.201903171R		MAR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32232913	hybrid			2022-12-26	WOS:000522882500001
J	Griese, F; Latus, S; Schluter, M; Graeser, M; Lutz, M; Schlaefer, A; Knopp, T				Griese, Florian; Latus, Sarah; Schlueter, Matthias; Graeser, Matthias; Lutz, Matthias; Schlaefer, Alexander; Knopp, Tobias			In-Vitro MPI-guided IVOCT catheter tracking in real time for motion artifact compensation	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; CO-REGISTRATION; RECONSTRUCTION; ANGIOGRAPHY; RISK	Purpose Using 4D magnetic particle imaging (MPI), intravascular optical coherence tomography (IVOCT) catheters are tracked in real time in order to compensate for image artifacts related to relative motion. Our approach demonstrates the feasibility for bimodal IVOCT and MPI in-vitro experiments. Material and methods During IVOCT imaging of a stenosis phantom the catheter is tracked using MPI. A 4D trajectory of the catheter tip is determined from the MPI data using center of mass sub-voxel strategies. A custom built IVOCT imaging adapter is used to perform different catheter motion profiles: no motion artifacts, motion artifacts due to catheter bending, and heart beat motion artifacts. Two IVOCT volume reconstruction methods are compared qualitatively and quantitatively using the DICE metric and the known stenosis length. Results The MPI-tracked trajectory of the IVOCT catheter is validated in multiple repeated measurements calculating the absolute mean error and standard deviation. Both volume reconstruction methods are compared and analyzed whether they are capable of compensating the motion artifacts. The novel approach of MPI-guided catheter tracking corrects motion artifacts leading to a DICE coefficient with a minimum of 86% in comparison to 58% for a standard reconstruction approach. Conclusions IVOCT catheter tracking with MPI in real time is an auspicious method for radiation free MPI-guided IVOCT interventions. The combination of MPI and IVOCT can help to reduce motion artifacts due to catheter bending and heart beat for optimized IVOCT volume reconstructions.	[Griese, Florian; Graeser, Matthias; Knopp, Tobias] Hamburg Univ Technol, Inst Biomed Imaging, Hamburg, Germany; [Griese, Florian; Graeser, Matthias; Knopp, Tobias] Univ Med Ctr Hamburg Eppendorf, Sect Biomed Imaging, Hamburg, Germany; [Latus, Sarah; Schlueter, Matthias; Schlaefer, Alexander] Hamburg Univ Technol, Inst Med Technol, Hamburg, Germany; [Lutz, Matthias] Univ Med Ctr Schleswig Holstein, Dept Internal Med, Kiel, Germany	Hamburg University of Technology; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hamburg University of Technology; University of Kiel; Schleswig Holstein University Hospital	Griese, F (corresponding author), Hamburg Univ Technol, Inst Biomed Imaging, Hamburg, Germany.; Griese, F (corresponding author), Univ Med Ctr Hamburg Eppendorf, Sect Biomed Imaging, Hamburg, Germany.	florian.griese@tuhh.de		Graser, Matthias/0000-0003-1472-5988; Griese, Florian/0000-0003-3309-9783; Latus, Sarah/0000-0002-9796-7001; Schluter, Matthias/0000-0002-2019-1102	German Research Foundation (DFG) [SCHL 1844/2-1/2, KN 1108/2-1]; Federal Ministry of Education and Research (BMBF) [05M16GKA]; Hamburg University of Technology (TUHH)	German Research Foundation (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Hamburg University of Technology (TUHH)	F.G., M.G. and T.K. thankfully acknowledge the financial support by the German Research Foundation (DFG, grant number KN 1108/2-1) and the Federal Ministry of Education and Research (BMBF, grant number 05M16GKA). A.S. acknowledges partial support by the German Research Foundation (DFG, grant number SCHL 1844/2-1/2). We acknowledge support for the Open Access fees by Hamburg University of Technology (TUHH) in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou L, 2017, IEEE J BIOMED HEALTH, P1; Bohnert J, 2010, IFMBE PROC, V25, P249; Bohnert J, 2008, SPRINGER IFMBE SERIE, V22, P2332; Bruker Biospin MRI GmbH Ettlingen, 2014, MPI PRECL BROCH; De Cock D, 2014, CURR CARDIOVASC IMAG, V7, DOI 10.1007/s12410-014-9290-0; Drexler W, 2008, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-540-77550-8; Drexler W., 2013 C LAS EL EUR IN; Gessert N, 2019, IEEE T MED IMAGING, V38, P426, DOI 10.1109/TMI.2018.2865659; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Graeser M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06992-5; Griese F, 2017, INT J MAGNETIC PARTI, V3; Ha J, 2012, INT J CARDIOVAS IMAG, V28, P1299, DOI 10.1007/s10554-011-9953-8; Haegele J, 2016, IEEE T MED IMAGING, V35, P2312, DOI 10.1109/TMI.2016.2559538; Haegele J, 2016, PHYS MED BIOL, V61, pN415, DOI 10.1088/0031-9155/61/16/N415; Haegele J, 2013, MAGN RESON MED, V69, P1761, DOI 10.1002/mrm.24421; Haegele J, 2012, RADIOLOGY, V265, P933, DOI 10.1148/radiol.12120424; Hebsgaard L, 2015, INT J CARDIOL, V182, P272, DOI 10.1016/j.ijcard.2014.12.088; Herz S, 2019, J ENDOVASC THER, V26, P512, DOI 10.1177/1526602819851202; Herz S, 2018, CARDIOVASC INTER RAD, V41, P1100, DOI 10.1007/s00270-018-1955-7; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Katzberg RW, 2006, KIDNEY INT, V69, pS3, DOI 10.1038/sj.ki.5000366; Knopp T, 2017, PHYS MED BIOL, V62, pR124, DOI 10.1088/1361-6560/aa6c99; Knopp T, 2016, PHYS MED BIOL, V61, pN257, DOI 10.1088/0031-9155/61/11/N257; Knopp T, 2010, PHYS MED BIOL, V55, P1577, DOI 10.1088/0031-9155/55/6/003; Knopp T., 2019, INT J MAGN PART IMAG, V5, P1; Knopp T., 2019, J OPEN SOURCE SOFTW, V4, P1331, DOI [10.21105/joss.01331, DOI 10.21105/JOSS.01331]; Kunio M, 2018, INT J CARDIOVAS IMAG, V34, P673, DOI 10.1007/s10554-017-1275-z; Latus S, 2019, IEEE ENG MED BIO, P6004, DOI 10.1109/EMBC.2019.8857712; Latus S, 2019, MED PHYS, V46, P1371, DOI 10.1002/mp.13388; Latus S, 2018, PROC SPIE, V10573, DOI 10.1117/12.2293497; Lu M, 2010, AM J HEMATOL, V85, P315, DOI 10.1002/ajh.21656; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; Neuwelt EA, 2009, KIDNEY INT, V75, P465, DOI 10.1038/ki.2008.496; Papafaklis MI, 2015, EUROINTERVENTION, V11, P407, DOI 10.4244/EIJY14M06_11; Peng J, 2019, IEEE T BIO-MED ENG, V66, P802, DOI 10.1109/TBME.2018.2856930; Rahmer J, 2015, PHYS MED BIOL, V60, P1775, DOI 10.1088/0031-9155/60/5/1775; Rahmer J, 2017, IEEE T MED IMAGING, V36, P1449, DOI 10.1109/TMI.2017.2679099; Salamon J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156899; Saritas EU, 2013, IEEE T MED IMAGING, V32, P1600, DOI 10.1109/TMI.2013.2260764; Schmale I, 2015, IEEE T MAGN, V51, DOI 10.1109/TMAG.2014.2322940; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Vaalma S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168902; van Ditzhuijzen NS, 2014, INT J CARDIOVAS IMAG, V30, P1013, DOI 10.1007/s10554-014-0447-3; Wang TS, 2015, BIOMED OPT EXPRESS, V6, P5021, DOI 10.1364/BOE.6.005021; Weber A, 2016, PHYS MED BIOL, V61, P475, DOI 10.1088/0031-9155/61/2/475; Weizenecker J, 2009, PHYS MED BIOL, V54, pL1, DOI 10.1088/0031-9155/54/5/L01	47	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230821	10.1371/journal.pone.0230821	http://dx.doi.org/10.1371/journal.pone.0230821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HO	32231378	Green Submitted, Green Published, gold			2022-12-26	WOS:000535937400020
J	Pfaehler, E; Burggraaff, C; Kramer, G; Zijlstra, J; Hoekstra, OS; Jalving, M; Noordzij, W; Brouwers, AH; Stevenson, MG; de Jong, J; Boellaard, R				Pfaehler, Elisabeth; Burggraaff, Coreline; Kramer, Gem; Zijlstra, Josee; Hoekstra, Otto S.; Jalving, Mathilde; Noordzij, Walter; Brouwers, Adrienne H.; Stevenson, Marc G.; de Jong, Johan; Boellaard, Ronald			PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability	PLOS ONE			English	Article							CELL LUNG-CANCER; FDG-PET; VOLUME; DELINEATION; REPEATABILITY; RADIOTHERAPY; IMPACT; RADIOMICS; ACCURACY; FEATURES	Background PET-based tumor delineation is an error prone and labor intensive part of image analysis. Especially for patients with advanced disease showing bulky tumor FDG load, segmentations are challenging. Reducing the amount of user-interaction in the segmentation might help to facilitate segmentation tasks especially when labeling bulky and complex tumors. Therefore, this study reports on segmentation workflows/strategies that may reduce the inter-observer variability for large tumors with complex shapes with different levels of userinteraction. Methods Twenty PET images of bulky tumors were delineated independently by six observers using four strategies: (I) manual, (II) interactive threshold-based, (III) interactive threshold-based segmentation with the additional presentation of the PET-gradient image and (IV) the selection of the most reasonable result out of four established semi-automatic segmentation algorithms (Select-the-best approach). The segmentations were compared using Jaccard coefficients (JC) and percentage volume differences. To obtain a reference standard, a majority vote (MV) segmentation was calculated including all segmentations of experienced observers. Performed and MV segmentations were compared regarding positive predictive value (PPV), sensitivity (SE), and percentage volume differences. Results The results show that with decreasing user-interaction the inter-observer variability decreases. JC values and percentage volume differences of Select-the-best and a workflow including gradient information were significantly better than the measurements of the other segmentation strategies (p-value<0.01). Interactive threshold-based and manual segmentations also result in significant lower and more variable PPV/SE values when compared with the MV segmentation. Conclusions FDG PET segmentations of bulky tumors using strategies with lower user-interaction showed less inter-observer variability. None of the methods led to good results in all cases, but use of either the gradient or the Select-the-best workflow did outperform the other strategies tested and may be a good candidate for fast and reliable labeling of bulky and heterogeneous tumors.	[Pfaehler, Elisabeth; Noordzij, Walter; Brouwers, Adrienne H.; de Jong, Johan; Boellaard, Ronald] Univ Groningen, Univ Med Ctr Groningen, Nucl Med & Mol Imaging, Groningen, Netherlands; [Burggraaff, Coreline; Kramer, Gem; Zijlstra, Josee; Boellaard, Ronald] Canc Ctr Amsterdam, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Hoekstra, Otto S.; Jalving, Mathilde] Univ Groningen, Univ Med Ctr Groningen, Dept Oncol Med, Groningen, Netherlands; [Stevenson, Marc G.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg Oncol, Groningen, Netherlands	University of Groningen; University of Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; University of Groningen	Pfaehler, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Nucl Med & Mol Imaging, Groningen, Netherlands.	e.a.g.pfaehler@umcg.nl		Pfaehler, Elisabeth/0000-0002-6160-3011; Hoekstra, Otto S/0000-0003-0767-2734; Brouwers, Adrienne/0000-0003-2698-1516	Netherlands Organization for Scientific Research (NWO) [14929]; Dutch Cancer Society, POINTING project [10034]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society, POINTING project	EP, RB: research program STRaTeGy with project number 14929, which is (partly) financed by the Netherlands Organization for Scientific Research (NWO) RB:Dutch Cancer Society, POINTING project, grant 10034.	Avril NE, 2005, RADIOL CLIN N AM, V43, P189, DOI 10.1016/j.rcl.2004.09.006; Boellaard R., 2018, QUANTITATIVE ONCOLOG; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Caldwell CB, 2001, INT J RADIAT ONCOL, V51, P923, DOI 10.1016/S0360-3016(01)01722-9; Cottereau AS, 2017, J NUCL MED, V58, P276, DOI 10.2967/jnumed.116.180406; Erasmus JJ, 2003, J CLIN ONCOL, V21, P2574, DOI 10.1200/JCO.2003.01.144; Erdi YE, 1997, CANCER, V80, P2505, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2505::AID-CNCR24>3.3.CO;2-B; Foster B, 2014, COMPUT BIOL MED, V50, P76, DOI 10.1016/j.compbiomed.2014.04.014; Frings V, 2014, RADIOLOGY, V273, P539, DOI 10.1148/radiol.14132807; Giraud P, 2002, RADIOTHER ONCOL, V62, P27, DOI 10.1016/S0167-8140(01)00444-3; Graham MM, 2015, J NUCL MED, V56, P955, DOI 10.2967/jnumed.115.158402; Hatt M, 2018, MED IMAGE ANAL, V44, P177, DOI 10.1016/j.media.2017.12.007; Hatt M, 2017, MED PHYS, V44, pE1, DOI 10.1002/mp.12124; Havaei M, 2017, MED IMAGE ANAL, V35, P18, DOI 10.1016/j.media.2016.05.004; Heye T, 2013, RADIOLOGY, V266, P812, DOI 10.1148/radiol.12120255; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ilyas H, 2018, EUR J NUCL MED MOL I, V45, P1142, DOI 10.1007/s00259-018-3953-z; Jentzen W, 2007, J NUCL MED, V48, P108; Kolinger GD, 2019, EJNMMI RES, V9, DOI 10.1186/s13550-019-0481-1; Kramer GM, 2016, J NUCL MED, V57, P1343, DOI 10.2967/jnumed.115.170225; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Lam L, 1997, IEEE T SYST MAN CY A, V27, P553, DOI 10.1109/3468.618255; Leijenaar R., 2015, EUR J CANCER, V48, P441, DOI DOI 10.1016/J.EJCA.2011.11.036.RADI0MICS; Nehmeh SA, 2009, MED PHYS, V36, P4803, DOI 10.1118/1.3222732; Nestle U, 2005, J NUCL MED, V46, P1342; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Paulino AC, 2004, INT J RADIAT ONCOL, V59, P4, DOI 10.1016/j.ijrobp.2003.10.045; Schaefer A, 2016, EUR J NUCL MED MOL I, V43, P911, DOI 10.1007/s00259-015-3239-7; Schinagl DAX, 2009, RADIOTHER ONCOL, V91, P95, DOI 10.1016/j.radonc.2009.02.007; Schoder H, 2009, J NUCL MED, V50, p74S, DOI 10.2967/jnumed.108.057208; Shepherd T, 2012, IEEE T MED IMAGING, V31, P2006, DOI 10.1109/TMI.2012.2202322; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Stevanovic M, 2018, J THEOR SOC BEHAV, V48, P369, DOI 10.1111/jtsb.12175; Stevenson MG, 2018, EJNMMI RES, V8, DOI 10.1186/s13550-018-0397-1; Teramoto A, 2016, MED PHYS, V43, P2821, DOI 10.1118/1.4948498; Vallieres M, 2015, PHYS MED BIOL, V60, P5471, DOI 10.1088/0031-9155/60/14/5471; Van Baardwijk A, 2007, INT J RADIAT ONCOL, V68, P771, DOI 10.1016/j.ijrobp.2006.12.067; van Velden FHP, 2016, MOL IMAGING BIOL, V18, P788, DOI 10.1007/s11307-016-0940-2; Vanhove Karolien, 2018, Cancer Treat Res Commun, V15, P7, DOI 10.1016/j.ctarc.2017.11.005; Vees H, 2009, EUR J NUCL MED MOL I, V36, P182, DOI 10.1007/s00259-008-0943-6; Weber WA, 2000, NUCL MED BIOL, V27, P683, DOI 10.1016/S0969-8051(00)00141-4; Zhao XM, 2019, PHYS MED BIOL, V64, DOI 10.1088/1361-6560/aaf44b	42	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230901	10.1371/journal.pone.0230901	http://dx.doi.org/10.1371/journal.pone.0230901			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HE	32226030	gold, Green Published			2022-12-26	WOS:000535936400025
J	Wang, Y; Bai, YY; Liu, YX; Noel, SW; Yan, QS; Thi, HP; Sun, XG; Wei, W; Ma, J; Zheng, F				Wang, Yang; Bai, Yingyu; Liu, Yixin; Noel, Sam Wilfried; Yan, Qiushuang; Huyen Pham Thi; Sun, Xuguo; Wei, Wei; Ma, Jun; Zheng, Fang			Plasma exosomal miRNAs involved in endothelial injury in microscopic polyangiitis patients	FASEB JOURNAL			English	Article						high-throughput sequencing; microRNA profile; plasma exosomes	ANCA-ASSOCIATED VASCULITIS; CELLS; EXPRESSION	Microscopic polyangiitis (MPA) is a systemic autoimmune disease that primarily affects the small and medium blood vessels. Endothelial injury is one of the pathological hallmarks of MPA. However, the pathogenesis for this has not yet been fully elucidated. Exosomal microRNAs (miRNAs) have recently emerged as a new molecular pattern involved in the endothelial injury in other diseases. Hence, we speculated that MPA plasma-derived exosomes (MPA-exo) could induce the endothelial injury, which was likely to be aroused by the dysregulated exosomal miRNAs in MPA. In the present study, plasma-derived exosomes were isolated and identified. MPA-exo could be internalized by human renal glomerular endothelial cells (HRGECs) in vitro and induced HRGECs injury. Subsequently, a series of differentially expressed miRNAs in MPA-exo were identified by high-throughput sequencing analysis. Further bioinformatics analysis for the target genes of these differentially expressed miRNAs showed a potential mechanism for their possible role in MPA endothelial injury. Notably, we revealed a considerable correlation between miR-185-3p, miR-125a-3p, and clinical parameters. In conclusion, the current study revealed that differentially expressed miRNAs in MPA-exo are associated with the endothelial injury. Our results suggested that these miRNAs and their target genes might be involved in the inflammation process of MPA.	[Wang, Yang; Bai, Yingyu; Noel, Sam Wilfried; Yan, Qiushuang; Huyen Pham Thi; Sun, Xuguo; Zheng, Fang] Tianjin Med Univ, Sch Med Lab, Dept Clin Immunol, Tianjin 300203, Peoples R China; [Liu, Yixin] Fudan Univ, Donghua Hosp, Dept Clin Lab, Shanghai, Peoples R China; [Wei, Wei] Tianjin Med Univ, Gen Hosp, Dept Rheumatol, Tianjin 300052, Peoples R China; [Ma, Jun] Tianjin Med Univ, Coll Publ Hlth, Dept Hlth Stat, Tianjin 300070, Peoples R China	Tianjin Medical University; Fudan University; Tianjin Medical University; Tianjin Medical University	Zheng, F (corresponding author), Tianjin Med Univ, Sch Med Lab, Dept Clin Immunol, Tianjin 300203, Peoples R China.; Wei, W (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Rheumatol, Tianjin 300052, Peoples R China.; Ma, J (corresponding author), Tianjin Med Univ, Coll Publ Hlth, Dept Hlth Stat, Tianjin 300070, Peoples R China.	tjweiwei2003@163.com; majun@tmu.edu.cn; fangzheng@tmu.edu.cn			Tianjin Medical University (TMU) [2017XK030605]; Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation) [19JCTPJC 57200]	Tianjin Medical University (TMU); Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation)	Tianjin Medical University (TMU), Grant/Award Number: 2017XK030605; Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation), Grant/Award Number: 19JCTPJC 57200	Bertram A, 2015, J AM SOC NEPHROL, V26, P2860, DOI 10.1681/ASN.2014050477; Braudeau C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00102; Chang DY, 2019, SEMIN ARTHRITIS RHEU, V48, P701, DOI 10.1016/j.semarthrit.2018.05.003; Csernok E, 2018, BEST PRACT RES CL RH, V32, P52, DOI 10.1016/j.berh.2018.07.005; Hou ZX, 2019, CIRC RES, V124, P1386, DOI 10.1161/CIRCRESAHA.118.314635; Jarrot PA, 2016, AUTOIMMUN REV, V15, P704, DOI 10.1016/j.autrev.2016.03.007; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kettritz R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019411.36000.06; Krebs CF, 2013, J AM SOC NEPHROL, V24, P1955, DOI 10.1681/ASN.2013020130; Kuschnerus K, 2019, DIABETES, V68, P349, DOI 10.2337/db18-0084; Li XZ, 2019, FASEB J, V33, P12704, DOI 10.1096/fj.201901548R; Ma D, 2019, INFLAMM BOWEL DIS, V25, P862, DOI 10.1093/ibd/izy381; Mavropoulos A, 2013, AUTOIMMUN REV, V12, P580, DOI 10.1016/j.autrev.2012.10.019; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Merkel PA, 2011, J RHEUMATOL, V38, P1480, DOI 10.3899/jrheum.110276; Miao D, 2019, RHEUMATOLOGY OXFORD; Morris RK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4342; Mun D, 2019, FASEB J, V33, P5979, DOI 10.1096/fj.201801758R; Nagao T, 2011, NEPHROL DIAL TRANSPL, V26, P2752, DOI 10.1093/ndt/gfr032; Nolan SL, 2008, J AM SOC NEPHROL, V19, P973, DOI 10.1681/ASN.2007111166; Page AV, 2013, VIRULENCE, V4, P507, DOI 10.4161/viru.24530; Raimondi L, 2019, CARCINOGENESIS; Rees MD, 2012, FREE RADICAL BIO MED, V53, P2344, DOI 10.1016/j.freeradbiomed.2012.10.002; Shah D, 2019, AM J RESP CELL MOL, V60, P465, DOI 10.1165/rcmb.2018-0194OC; Sinico RA, 2013, AUTOIMMUN REV, V12, P477, DOI 10.1016/j.autrev.2012.08.006; Sun XJ, 2018, J CELL MOL MED, V22, P4550, DOI 10.1111/jcmm.13736; Tadema H, 2011, RHEUMATOLOGY, V50, P689, DOI 10.1093/rheumatology/keq375; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Treiber T, 2019, NAT REV MOL CELL BIO, V20, P5, DOI 10.1038/s41580-018-0059-1; Wang LY, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1949-5; Westerterp M, 2016, ARTERIOSCL THROM VAS, V36, P1328, DOI 10.1161/ATVBAHA.115.306670; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xiao H, 2005, AM J PATHOL, V167, P39, DOI 10.1016/S0002-9440(10)62951-3; Zhang W, 2019, ARTIF CELL NANOMED B, V47, P2791, DOI 10.1080/21691401.2019.1636806; Zheng B, 2017, MOL THER, V25, P1279, DOI 10.1016/j.ymthe.2017.03.031	36	6	6	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6215	6228		10.1096/fj.201902964R	http://dx.doi.org/10.1096/fj.201902964R		MAR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32232900	Bronze			2022-12-26	WOS:000522546800001
J	Rodgers, JB; Ryu, WS				Rodgers, Jarlath Byrne; Ryu, William S.			Targeted thermal stimulation and high-content phenotyping reveal that the C. elegans escape response integrates current behavioral state and past experience	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; AVOIDANCE-BEHAVIOR; TOUCH; NEUROBIOLOGY; HABITUATION; NOCICEPTION; MODULATE	The ability to avoid harmful or potentially harmful stimuli can help an organism escape predators and injury, and certain avoidance mechanisms are conserved across the animal kingdom. However, how the need to avoid an imminent threat is balanced with current behavior and modified by past experience is not well understood. In this work we focused on rapidly increasing temperature, a signal that triggers an escape response in a variety of animals, including the nematode Caenorhabditis elegans. We have developed a noxious thermal response assay using an infrared laser that can be automatically controlled and targeted in order to investigate how C. elegans responds to noxious heat over long timescales and to repeated stimuli in various behavioral and sensory contexts. High-content phenotyping of behavior in individual animals revealed that the C. elegans escape response is multidimensional, with some features that extend for several minutes, and can be modulated by (i) stimulus amplitude; (ii) other sensory inputs, such as food context; (iii) long and short-term thermal experience; and (iv) the animal's current behavioral state.	[Rodgers, Jarlath Byrne; Ryu, William S.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Rodgers, Jarlath Byrne; Ryu, William S.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Ryu, William S.] Univ Toronto, Dept Phys, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Ryu, WS (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.; Ryu, WS (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON, Canada.; Ryu, WS (corresponding author), Univ Toronto, Dept Phys, Toronto, ON, Canada.	willryu@gmail.com		Ryu, William/0000-0002-0350-7507				Aoki I, 2015, CURR OPIN NEUROBIOL, V34, P117, DOI 10.1016/j.conb.2015.03.011; Ardiel EL, 2017, NPJ SCI LEARN, V2, DOI 10.1038/s41539-017-0011-8; Ardiel E, 2008, J NEUROGENET, V22, P239, DOI 10.1080/01677060802298509; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bath DE, 2014, NAT METHODS, V11, P756, DOI [10.1038/nmeth.2973, 10.1038/NMETH.2973]; BRENNER S, 1974, GENETICS, V77, P71; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Broekmans OD, 2016, ELIFE, V5, DOI 10.7554/eLife.17227; Brown AEX, 2013, P NATL ACAD SCI USA, V110, P791, DOI 10.1073/pnas.1211447110; Cande J, 2018, ELIFE, V7, DOI 10.7554/eLife.34275; Card G, 2008, J EXP BIOL, V211, P341, DOI 10.1242/jeb.012682; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Chew YL, 2018, NEURON, V99, P1233, DOI 10.1016/j.neuron.2018.08.003; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; Colwill RM, 2011, REV NEUROSCIENCE, V22, P63, DOI 10.1515/RNS.2011.008; CROLL NA, 1975, J ZOOL, V176, P159, DOI 10.1111/j.1469-7998.1975.tb03191.x; Daniels BC, 2019, P NATL ACAD SCI USA, V116, P7226, DOI 10.1073/pnas.1816531116; Donnelly JL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001529; Edwards DH, 1999, TRENDS NEUROSCI, V22, P153, DOI 10.1016/S0166-2236(98)01340-X; ELHARAKANY AA, 1984, J ELECTROANAL CHEM, V162, P285, DOI 10.1016/S0022-0728(84)80171-0; Ezcurra M, 2016, J NEUROSCI, V36, P3157, DOI 10.1523/JNEUROSCI.1128-15.2016; Garcia D, 2011, EXP FLUIDS, V50, P1247, DOI 10.1007/s00348-010-0985-y; Garcia D, 2010, COMPUT STAT DATA AN, V54, P1167, DOI 10.1016/j.csda.2009.09.020; Ghosh R, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-85; Glauser DA, 2011, GENETICS, V188, P91, DOI 10.1534/genetics.111.127100; Goodman MB, 2019, GENETICS, V212, P25, DOI 10.1534/genetics.118.300241; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Han JY, 2010, CHEM REV, V110, P2709, DOI 10.1021/cr900249z; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hori S, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007477; Katz PS, 1998, ANN NY ACAD SCI, V860, P181, DOI 10.1111/j.1749-6632.1998.tb09048.x; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Kotera I, 2016, ELIFE, V5, DOI 10.7554/eLife.19021; Leung K, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005262; Leybaert L, 1998, BIOPHYS J, V75, P2025, DOI 10.1016/S0006-3495(98)77644-1; Liu M, 2018, ELIFE, V7, DOI 10.7554/eLife.36419; Liu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032360; Lopez-Cruz A, 2019, NEURON, V102, P407, DOI 10.1016/j.neuron.2019.01.053; Maguire SM, 2011, CURR BIOL, V21, P1326, DOI 10.1016/j.cub.2011.06.063; McClanahan PD, 2017, INTEGR BIOL-UK, V9, P800, DOI 10.1039/c7ib00120g; McDiarmid TA, 2018, GENES BRAIN BEHAV, V17, DOI 10.1111/gbb.12437; Mohammadi A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-66; O'Hagan R, 2005, INT REV NEUROBIOL, V69, P169, DOI 10.1016/S0074-7742(05)69006-X; Parida L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111342; Petzold BC, 2013, INTEGR BIOL-UK, V5, P853, DOI [10.1039/c3ib20293c, 10.1039/c3b20293c]; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Pirri JK, 2012, CURR OPIN NEUROBIOL, V22, P187, DOI 10.1016/j.conb.2011.12.007; Pirri JK, 2009, NEURON, V62, P526, DOI 10.1016/j.neuron.2009.04.013; RANKIN CH, 1992, BEHAV NEUROSCI, V106, P239, DOI 10.1037/0735-7044.106.2.239; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schild LC, 2014, NEURON, V84, P983, DOI 10.1016/j.neuron.2014.10.039; Sethian JA, 1999, CAMBRIDGE MONOGRAPHS; Stegeman GW, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0510-z; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Summers PJ, 2015, J NEUROSCI, V35, P10331, DOI 10.1523/JNEUROSCI.0225-15.2015; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wittenburg N, 1999, P NATL ACAD SCI USA, V96, P10477, DOI 10.1073/pnas.96.18.10477; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020; Yemini E, 2013, NAT METHODS, V10, P877, DOI [10.1038/NMETH.2560, 10.1038/nmeth.2560]; You YJ, 2012, ANIM CELLS SYST, V16, P351, DOI 10.1080/19768354.2012.716791; Yu JY, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0282-16.2017; Zhao BB, 2003, J NEUROSCI, V23, P5319; Zhen M, 2015, CURR OPIN NEUROBIOL, V33, P117, DOI 10.1016/j.conb.2015.03.009; Zhou Y, 2017, GENETICS, V206, P1469, DOI 10.1534/genetics.116.197293	67	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0229399	10.1371/journal.pone.0229399	http://dx.doi.org/10.1371/journal.pone.0229399			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218560	gold, Green Published			2022-12-26	WOS:000535935400004
J	Cepeda, A; Nowotny, KM; Frankeberger, J; Ramirez, E; Rodriguez, VE; Perdue, T; Valdez, A				Cepeda, Alice; Nowotny, Kathryn M.; Frankeberger, Jessica; Ramirez, Esmeralda; Rodriguez, Victoria E.; Perdue, Tasha; Valdez, Avelardo			Examination of multilevel domains of minority stress: Implications for drug use and mental and physical health among Latina women who have sex with women and men	PLOS ONE			English	Article							DEPENDENCE SCALE SDS; SEXUALLY-TRANSMITTED INFECTIONS; INTIMATE PARTNER VIOLENCE; SUBSTANCE USE; STRUCTURAL RACISM; SEVERITY; VALIDITY; ORIENTATION; RELIABILITY; POPULATION	There has recently been growing attention and concern in the U.S. on the detrimental drug use and related health conditions impacting diverse sexual minority populations. While some evidence indicates that bisexual women are at increased risk of substance use, little attention has been given to disadvantaged and racial/ethnic minority bisexual women, who are particularly vulnerable to a complexity of stressors and risk. Using data from a 15-year longitudinal study in San Antonio, Texas, the current study examines drug use, incarceration histories, stressful life events, and infections among 206 young adult Mexican-American women who report engaging in sex with both men and women (WSWM) (n = 61) and those indicating having exclusively male sex partners (WSM) (n = 145). A bivariate analysis finds that WSWM experienced more frequent (p = 0.001) and longer total time incarcerated (p = 0.001), as well as exposure to more stressful life events (p = 0.003). WSWM also have higher rates of past 30 day injection drug use (p = 0.026) and related Hepatitis C Virus (HCV) infection (p = 0.001), as well as greater symptomatology associated with depression (p = 0.014), PTSD (p = 0.005), and suicidal ideation (p = 0.036). Findings indicate a significantly elevated risk profile for socio-economically marginalized WSWM. This knowledge is timely and central to policy discourse to develop interventions and health campaigns aimed at reducing and/or preventing further health disparities among this highly susceptible population of minority women.	[Cepeda, Alice; Ramirez, Esmeralda; Perdue, Tasha; Valdez, Avelardo] Univ Southern Calif, Suzanne Dworak Peck Sch Social Work, Los Angeles, CA 90007 USA; [Nowotny, Kathryn M.] Univ Miami, Dept Sociol, Miami, FL USA; [Frankeberger, Jessica] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA USA; [Rodriguez, Victoria E.] Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Program Publ Hlth, Irvine, CA USA	University of Southern California; University of Miami; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Irvine	Cepeda, A (corresponding author), Univ Southern Calif, Suzanne Dworak Peck Sch Social Work, Los Angeles, CA 90007 USA.	alicecep@usc.edu	Frankeberger, Jessica/U-9626-2019	Frankeberger, Jessica/0000-0002-8590-1304; Rodriguez, Victoria Elizabeth/0000-0001-5645-1378	National Institutes of Health, National Institute on Drug Abuse (NIDA) [R01DA039269]	National Institutes of Health, National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This study was funded by the National Institutes of Health, National Institute on Drug Abuse (NIDA) under grant R01DA039269 awarded to AC and AV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenor M, 2017, PREV MED, V95, P74, DOI 10.1016/j.ypmed.2016.11.023; American Psychological Association, 2012, APA DICT PSYCHOL; Ard KL, 2011, J GEN INTERN MED, V26, P930, DOI 10.1007/s11606-011-1697-6; Armenta A, 2017, SOCIOL RACE ETHNIC, V3, P82, DOI 10.1177/2332649216648714; Asad AL, 2018, SOC SCI MED, V199, P19, DOI 10.1016/j.socscimed.2017.03.010; Baguley T, 2009, BRIT J PSYCHOL, V100, P603, DOI 10.1348/000712608X377117; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Bauer GR, 2008, WOMEN HEALTH, V48, P383, DOI 10.1080/03630240802575120; Belknap J., 2006, FEM CRIMINOL, V1, P48, DOI DOI 10.1177/1557085105282897; Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bloomfield K, 2011, SUBST ABUS, V32, P210, DOI 10.1080/08897077.2011.598404; Bostwick WB, 2015, LGBT HEALTH, V2, P121, DOI 10.1089/lgbt.2014.0074; Breiding MatthewJ., 2015, INTIMATE PARTNER VIO; Bronfenbrenner U., 1998, HDB CHILD PSYCHOL, P993, DOI DOI 10.1002/9780470147658; Conron KJ, 2010, AM J PUBLIC HEALTH, V100, P1953, DOI 10.2105/AJPH.2009.174169; Conybeare D, 2012, J CLIN PSYCHOL, V68, P699, DOI 10.1002/jclp.21845; Copen CE, 2016, 21648344 NAT SURV FA; CUELLAR I, 1995, HISPANIC J BEHAV SCI, V17, P275, DOI 10.1177/07399863950173001; Everett BG, 2017, PERSPECT SEX REPRO H, V49, P157, DOI 10.1363/psrh.12032; Ferri CP, 2000, DRUG ALCOHOL REV, V19, P451, DOI 10.1080/713659418; Fethers K, 2000, SEX TRANSM INFECT, V76, P345, DOI 10.1136/sti.76.5.345; Fredriksen-Goldsen Karen I, 2012, Am J Public Health, V102, pe16, DOI 10.2105/AJPH.2011.300379; Fredriksen-Goldsen KI, 2010, AM J PUBLIC HEALTH, V100, P2255, DOI 10.2105/AJPH.2009.177329; Garcia J, 2016, SOCIOL COMPASS, V10, P3, DOI 10.1111/soc4.12337; German D, 2015, AIDS BEHAV, V19, P1361, DOI 10.1007/s10461-014-0972-z; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Gonzalez-Saiz F, 2009, EUR ADDICT RES, V15, P87, DOI 10.1159/000189787; Goodman LA, 1998, J TRAUMA STRESS, V11, P521, DOI 10.1023/A:1024456713321; GOSSOP M, 1995, ADDICTION, V90, P607, DOI 10.1111/j.1360-0443.1995.tb02199.x; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Inst Med, 2011, HEALTH OF LESBIAN, GAY, BISEXUAL, AND TRANSGENDER PEOPLE: BUILDING A FOUNDATION FOR BETTER UNDERSTANDING, P1; Castillo II, 2010, ACTAS ESP PSIQUIATRI, V38, P270; Kaye S, 2002, ADDICTION, V97, P727, DOI 10.1046/j.1360-0443.2002.00121.x; Kerr D, 2015, SUBST USE MISUSE, V50, P340, DOI 10.3109/10826084.2014.980954; Kim Hyun-Jun, 2012, Am J Public Health, V102, pe9, DOI 10.2105/AJPH.2011.300378; Krehely J, 2009, CLOSE LGBT HLTH DISP; Liu H, 2017, SOCIOL PERSPECT, V60, P620, DOI 10.1177/0731121416663685; Logie CH, 2015, SEX TRANSM INFECT, V91, P278, DOI 10.1136/sextrans-2014-051745; Lyons T, 2016, ARCH SEX BEHAV, V45, P1403, DOI 10.1007/s10508-015-0508-2; Martin G, 2006, DRUG ALCOHOL DEPEN, V83, P90, DOI 10.1016/j.drugalcdep.2005.10.014; Massoglia M, 2008, J HEALTH SOC BEHAV, V49, P56, DOI 10.1177/002214650804900105; Matthews A, 2014, SUBST USE MISUSE, V49, P1888, DOI 10.3109/10826084.2014.913632; Mays VM, 2001, AM J PUBLIC HEALTH, V91, P1869, DOI 10.2105/AJPH.91.11.1869; McCauley HL, 2015, J WOMENS HEALTH, V24, P621, DOI 10.1089/jwh.2014.5032; MELCHIOR LA, 1993, EDUC PSYCHOL MEAS, V53, P1117, DOI 10.1177/0013164493053004024; Meyer IH, 2017, AM J PUBLIC HEALTH, V107, P267, DOI 10.2105/AJPH.2016.303576; Meyer JP, 2011, J WOMENS HEALTH, V20, P991, DOI 10.1089/jwh.2010.2328; Nowotny KM, 2014, WOMEN HEALTH, V54, P781, DOI 10.1080/03630242.2014.932892; Nowotny KM, 2019, CRIMINAL JUSTICE CON; Purdie-Vaughns V, 2008, SEX ROLES, V59, P377, DOI 10.1007/s11199-008-9424-4; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Richie B., 2012, ARRESTED JUSTICE; Scheer S, 2002, AM J PUBLIC HEALTH, V92, P1110, DOI 10.2105/AJPH.92.7.1110; Scher CD, 2004, CHILD ABUSE NEGLECT, V28, P167, DOI 10.1016/j.chiabu.2003.09.012; Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Straus Murray A, 2004, Violence Vict, V19, P507; Talley AE, 2016, LGBT HEALTH, V3, P266, DOI 10.1089/lgbt.2015.0073; Topp L, 1997, ADDICTION, V92, P839, DOI 10.1046/j.1360-0443.1997.9278397.x; Valdez A, 2007, MEXICAN AMERICAN GIRLS AND GANG VIOLENCE: BEYOND RISK, P1, DOI 10.1057/9780230601833; Walters M.L., 2013, NATL INTIMATE PARTNE; Williams SL, 2017, J SOC ISSUES, V73, P450, DOI 10.1111/josi.12225	63	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230437	10.1371/journal.pone.0230437	http://dx.doi.org/10.1371/journal.pone.0230437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8GI	32214323	gold, Green Published			2022-12-26	WOS:000535934200026
J	Chun, S; Phan, MTT; Hong, S; Yang, J; Yoon, Y; Han, S; Kang, J; Yazer, MH; Kim, J; Cho, D				Chun, Sejong; Phan, Minh-Trang Thi; Hong, Saetbyul; Yang, Jehoon; Yoon, Yeup; Han, Sangbin; Kang, Jungwon; Yazer, Mark H.; Kim, Jaehyun; Cho, Duck			Double-filtered leukoreduction as a method for risk reduction of transfusion-associated graft-versus-host disease	PLOS ONE			English	Article							MICROSCOPIC CELL COUNTER; RESIDUAL LEUKOCYTES; GAMMA-IRRADIATION; CARDIAC-ARREST; BLOOD-CELLS; HYPERKALEMIA; HEMOVIGILANCE; PREVENTION; HEMOLYSIS; IMPACT	Background Transfusion-associated graft-versus-host disease (TA-GvHD) is caused by leukocytes, specifically T cells within a transfused blood product. Currently, the prevention of transfusion-associated graft-versus-host disease is performed by irradiation of blood products. With a sufficient reduction of leukocytes, the risk for TA-GvHD can be decreased. With consistent advances in current state-of-the-art blood filters, we herein propose that double filtration can sufficiently reduce leukocytes to reduce the risk for TA-GvHD. Materials Thirty RBC concentrates were filtered with leukocyte filters, followed by storage at 1-6 degrees C for 72 hours, and then a second filtration was performed. Residual leukocytes in the double-filtered RBC units (n = 30) were assessed with flow cytometric methods, and an additional assay with isolated peripheral blood mononuclear cells (PBMCs) (n = 6) was done by both flow cytometric methods and an automated hematology analyzer. Quality of the RBCs after filtration was evaluated by hematological and biochemical tests. In vitro T cell expansion was performed using anti-CD3/CD28-coated Dynabeads or anti-CD3 (OKT3). In vivo experiment for GvHD was performed by using NOD.Cg-Prkdc(scid) Il2rg(tm1Wjl)/SzJ (NSG) mice. Results Double-filtered blood products showed residual leukocyte levels below detection limits, which calculated to be below 1200-2500 cells per blood unit. In vitro expansion rate of T cells showed that 6x10(3) and 1x10(3) cell-seeded specimens showed 60.8 +/- 10.6 fold and 10.2 +/- 9.7-fold expansion, respectively. Cell expansion was not sufficiently observed in wells planted with 1x10(2) or 10 cells. In vivo experiments showed that mice injected with 1x10(5) or more cells cause fatal GvHD. GvHD induced inflammation was observed in mice injected with 1x10(4) or more cells. No evidence of GvHD was found in mice injected with 10(3) cells. Conclusions Our study suggests that additional removal of contaminating lymphocytes by a second leukodepletion step may further reduce the risk for TA-GvHD.	[Chun, Sejong] Chonnam Natl Univ Med Sch & Hosp, Dept Lab Med, Gwangju, South Korea; [Phan, Minh-Trang Thi; Cho, Duck] Sungkyunwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea; [Hong, Saetbyul; Yang, Jehoon; Yoon, Yeup] Samsung Med Ctr, Anim Res & Mol Imaging Ctr, Seoul, South Korea; [Yoon, Yeup; Cho, Duck] Sungkyunwan Univ, Sch Med, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea; [Han, Sangbin] Sungkyunwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Kang, Jungwon; Kim, Jaehyun] Korean Red Cross, Blood Transfus Res Inst, Wonju, South Korea; [Yazer, Mark H.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Chonnam National University; Chonnam National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cho, D (corresponding author), Sungkyunwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea.; Cho, D (corresponding author), Sungkyunwan Univ, Sch Med, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea.; Kim, J (corresponding author), Korean Red Cross, Blood Transfus Res Inst, Wonju, South Korea.	kimjh@redcross.or.kr; duck.cho@skku.edu		Chun, Sejong/0000-0001-7462-5802	Blood Transfusion Research Institute, Korean Red Cross [2016-I02]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2015R1D1A1A09058740, 2018R1A2B6006200]	Blood Transfusion Research Institute, Korean Red Cross; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by a grant provided by the Blood Transfusion Research Institute, Korean Red Cross (2016-I02), as an inside research project, and in part by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2015R1D1A1A09058740 and 2018R1A2B6006200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/968302; Bae SY, 2007, VOX SANG, V92, P64, DOI 10.1111/j.1423-0410.2006.00854.x; Baz EMK, 2002, TRANSFUSION MED, V12, P383, DOI 10.1046/j.1365-3148.2002.00402.x; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Buoro S, 2018, INT J LAB HEMATOL, V40, P26, DOI 10.1111/ijlh.12723; CARSON TH, 1994, TRANSFUSION, V34, P86, DOI 10.1046/j.1537-2995.1994.34194098616.x; Castro G, 2018, TRANSFUSION, V58, P1506, DOI 10.1111/trf.14589; Cho YU, 2015, INT J LAB HEMATOL, V37, P346, DOI 10.1111/ijlh.12292; Chun S, 2017, TRANSFUS APHER SCI, V56, P427, DOI 10.1016/j.transci.2017.03.017; Fast LD, 2013, TRANSFUSION, V53, P373, DOI 10.1111/j.1537-2995.2012.03715.x; Fast LD, 2011, TRANSFUSION, V51, P1397, DOI 10.1111/j.1537-2995.2010.02984.x; Fujii H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133216; Fujii Y, 2016, EXPERT REV MED DEVIC, V13, P5, DOI 10.1586/17434440.2016.1126179; Fujita H, 2018, TRANSFUSION, V58, P2383, DOI 10.1111/trf.14897; Fukuoka Y, 1999, Masui, V48, P192; Hauck-Dlimi B, 2016, CLIN LAB, V62, P1295, DOI 10.7754/Clin.Lab.2015.151127; Healthcare G., 2010, ISOLATION MONONUCLEA; HOFFMANNFEZER G, 1993, BLOOD, V81, P3440; Jang YK, 2014, CYTOTHERAPY, V16, P298, DOI 10.1016/j.jcyt.2013.10.012; KIM DO WAN, 2015, Acute and Critical Care, V30, P132; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; Kleinman S, 2018, TRANSFUSION, V58, P2545, DOI 10.1111/trf.14930; Lockridge JL, 2013, BIOL BLOOD MARROW TR, V19, P1310, DOI 10.1016/j.bbmt.2013.06.007; Miyao H, 2000, Masui, V49, P383; Muller SM, 1999, BONE MARROW TRANSPL, V24, P575, DOI 10.1038/sj.bmt.1701970; Orlin J B, 1997, Curr Opin Hematol, V4, P442; PELSZYNSKI MM, 1994, BLOOD, V83, P1683; Pohler P, 2015, TRANSFUSION, V55, P337, DOI 10.1111/trf.12836; Przepiorka D, 1996, AM J CLIN PATHOL, V106, P6; Reverberi Roberto, 2007, Ann Ist Super Sanita, V43, P176; SCHMIDT WF, 1982, JAMA-J AM MED ASSOC, V248, P1629; Serrano K, 2014, VOX SANG, V106, P379, DOI 10.1111/vox.12112; Singh Shikha, 2009, Biotechnology Journal, V4, P1140, DOI 10.1002/biot.200800182; Sohn HM, 2012, KOREAN J ANESTHESIOL, V62, P281, DOI 10.4097/kjae.2012.62.3.281; Stainsby D, 2006, TRANSFUS MED REV, V20, P273, DOI 10.1016/j.tmrv.2006.05.002; Strauss RG, 2010, TRANSFUSION, V50, P1862, DOI 10.1111/j.1537-2995.2010.02789.x; Vraets A, 2011, TRANSFUS MED REV, V25, P184, DOI 10.1016/j.tmrv.2011.01.006; Williamson LM, 2007, TRANSFUSION, V47, P1455, DOI 10.1111/j.1537-2995.2007.01281.x; Wiltshire M, 2010, TRANSFUSION, V50, P970, DOI 10.1111/j.1537-2995.2009.02500.x	39	6	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0229724	10.1371/journal.pone.0229724	http://dx.doi.org/10.1371/journal.pone.0229724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214402	Green Published, gold			2022-12-26	WOS:000535934200012
J	Stumpf, C; Wimmer, T; Lorenz, B; Stieger, K				Stumpf, Constanze; Wimmer, Tobias; Lorenz, Birgit; Stieger, Knut			Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TRANSFER BRET; FLUORESCENT PROTEIN; REAL-TIME; RECEPTOR; BINDING; CELLS; QUANTIFICATION; LUCIFERASE; DISTANCE	In age-related macular degeneration (AMD) or diabetic retinopathy (DR), hypoxia and inflammatory processes lead to an upregulation of the vascular endothelial growth factor (VEGF) expression and thereby to pathological neovascularisation with incorrectly formed vessels prone to damage, thus increasing the vascular permeability and the risk of bleeding and oedema in the retina. State of the art treatment is the repeated intraocular injection of anti-VEGF molecules. For developing improved individualized treatment approaches, a minimally invasive, repeatable method for in vivo quantification of VEGF in the eye is necessary. Therefore, we designed single molecule eBRET2 VEGF biosensors by directly fusing a Renilla luciferase mutant (Rluc8) N-terminal and a green fluorescent protein (GFP2) C-terminal to a VEGF binding domain. In total, 10 different VEGF biosensors (Re01- Re10) were generated based on either single domains or full length of VEGF receptor 1 or 2 extracellular regions as VEGF binding domains. Full length expression of the biosensors in HEK293-T cells was verified via Western Blot employing an anti-Rluc8-IgG. Expression of alternative splice variants was eliminated through the deletion of the donor splice site by introduction of a silent point mutation. In all ten biosensors the energy transfer from the Rluc8 to the GFP2 occurs and generates a measurable eBRET2 ratio. Four biosensors show a relevant change of the BRET ratio (Delta BR) after VEGF binding. Furthermore, each biosensor shows a unique detection range for VEGF quantification and especially Re06 and Re07 have a high sensitivity in the range of in vivo VEGF concentrations in the eye, previously measured by invasive methods. In conclusion, we generated several eBRET2 biosensors that are suitable for VEGF quantification in vitro and could identify two eBRET2 biosensors, which may be suitable for non-invasive in vivo VEGF quantification with an implantable device.	[Stumpf, Constanze; Wimmer, Tobias; Lorenz, Birgit; Stieger, Knut] Justus Liebig Univ Giessen, Dept Ophthalmol, Giessen, Germany	Justus Liebig University Giessen	Wimmer, T (corresponding author), Justus Liebig Univ Giessen, Dept Ophthalmol, Giessen, Germany.	Tobias.Wimmer@augen.med.uni-giessen.de		Wimmer, Tobias/0000-0001-8176-4747	Justus-Liebig-University Giessen	Justus-Liebig-University Giessen	This study was funded in part by a graduate scholarship from the Justus-Liebig-University Giessen awarded to CS. No additional external funding was received for this study.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Aper SJA, 2016, ACS CHEM BIOL, V11, P2854, DOI 10.1021/acschembio.6b00453; Bahrami B, 2017, ASIA-PAC J OPHTHALMO, V6, P535, DOI 10.22608/APO.2017350; Balaratnasingam C, 2015, CLIN OPHTHALMOL, V9, P2355, DOI 10.2147/OPTH.S80040; Molinas MDB, 2014, CYTOTECHNOLOGY, V66, P493, DOI 10.1007/s10616-013-9601-3; Bhuckory S, 2019, BIOSENSORS-BASEL, V9, DOI 10.3390/bios9020076; Borroto-Escuela DO, 2013, METHOD CELL BIOL, V117, P141, DOI 10.1016/B978-0-12-408143-7.00008-6; Bourne RRA, 2017, LANCET GLOB HEALTH, V5, pE888, DOI 10.1016/S2214-109X(17)30293-0; Brozzo MS, 2012, BLOOD, V119, P1781, DOI 10.1182/blood-2011-11-390922; Campochiaro PA, 2015, PROG RETIN EYE RES, V49, P67, DOI 10.1016/j.preteyeres.2015.06.002; Couturier Cyril, 2012, Front Endocrinol (Lausanne), V3, P100, DOI 10.3389/fendo.2012.00100; Dacres H, 2013, BIOSENS BIOELECTRON, V41, P459, DOI 10.1016/j.bios.2012.09.004; Dacres H, 2012, BIOCHEM BIOPH RES CO, V425, P625, DOI 10.1016/j.bbrc.2012.07.133; De A, 2007, CANCER RES, V67, P7175, DOI 10.1158/0008-5472.CAN-06-4623; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dimri S, 2016, METHODS MOL BIOL, V1443, P57, DOI 10.1007/978-1-4939-3724-0_5; Dragulescu-Andrasi A, 2011, P NATL ACAD SCI USA, V108, P12060, DOI 10.1073/pnas.1100923108; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2016, NAT REV DRUG DISCOV, V15, P385, DOI 10.1038/nrd.2015.17; Fiszer-Kierzkowska A, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-27; Fuh G, 1998, J BIOL CHEM, V273, P11197, DOI 10.1074/jbc.273.18.11197; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Hu QJ, 2015, RETINA-J RET VIT DIS, V35, P435, DOI 10.1097/IAE.0000000000000329; Kamkaew A, 2016, CHEM COMMUN, V52, P6997, DOI 10.1039/c6cc02764d; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Le NCH, 2014, BIOSENS BIOELECTRON, V62, P177, DOI 10.1016/j.bios.2014.06.032; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Loening AM, 2007, J MOL BIOL, V374, P1017, DOI 10.1016/j.jmb.2007.09.078; Muether PS, 2013, AM J OPHTHALMOL, V156, P989, DOI 10.1016/j.ajo.2013.06.020; Muether PS, 2013, RETINA-J RET VIT DIS, V33, P1809, DOI 10.1097/IAE.0b013e318285cd9e; Muether PS, 2012, OPHTHALMOLOGY, V119, P2082, DOI 10.1016/j.ophtha.2012.07.041; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Patil AS, 2012, J CELL PHYSIOL, V227, P1298, DOI 10.1002/jcp.22846; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Robers MB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10091; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; Wimmer T, 2016, BIOSENS BIOELECTRON, V86, P609, DOI 10.1016/j.bios.2016.07.058; Wimmer T., 2018, ENTWICKLUNG SYSTEMS; Yao J, 2011, P NATL ACAD SCI USA, V108, P11590, DOI 10.1073/pnas.1109029108; Yoshida T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39618	43	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230344	10.1371/journal.pone.0230344	http://dx.doi.org/10.1371/journal.pone.0230344			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214330	Green Published, gold			2022-12-26	WOS:000535934200025
J	Tseng, LC; Yu, PY; Hwang, JS				Tseng, Li-Chun; Yu, Pin-Yi; Hwang, Jiang-Shiou			Distribution and sexual dimorphism of the crab Xenograpsus testudinatus from the hydrothermal vent field of Kueishan Island, northeastern Taiwan	PLOS ONE			English	Article							RHITHROPANOPEUS-HARRISII; HABITAT SELECTION; MUD CRAB; BRACHYURA; DECAPODA; SIZE; COMMUNITIES; CRUSTACEA; WEIGHT; LENGTH	The sulphur-rich and acidic vent waters of a shallow hydrothermal vent field next to Kueishan Island in Taiwan provide a specific and generally toxic environment. Among only a few aquatic organisms able to survive there, the grapsoid crab Xenograpsus testudinatus is the dominant species with a high population density in the vent area. Here we study the gender-specific distribution, morphological traits, and relationship of wet weight vs. carapace width of this crab. A total of 1120 individuals including 831 male and 289 female (included 15 ovigerous) were examined during August and September in 2011 and May and September in 2012. Except in August 2011, there are no significant differences in the distribution of X. testudinatus in the hydrothermal vent area from the vent spout during most months. Among crabs, the weight of male (6.87 +/- 2.90 g) was significantly heavier than that of females (4.17 +/- 1.25 g) (p < 0.001, Student's t-test). As for the wet weight of crabs, significant differences were noted in both the length of chela and the width of carapace between males and females. Sexual dimorphism of X. testudinatus is evident in three morphological traits. Pearson's correlation showed a significant and positive correlation (p < 0.001) of wet weight, width of carapace and length of chela of the two sexes. Ovigerous crabs (shortest carapace width: 1.93 cm) were present in the specimen collected from August 2011 and May 2012. The ovigerous crabs were not found in the samples collected from September in both years 2011 and 2012, indicating that reproduction may have ceased during the period of sampling. The present results suggested that the reproductive period of X. testudinatus was before September. The distribution pattern and sexual dimorphism of X. testudinatus provided a better understanding of the idiobiology of this dominant metazoan in the hydrothermal vent area.	[Tseng, Li-Chun; Yu, Pin-Yi; Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Inst Marine Biol, Coll Life Sci, Keelung, Taiwan; [Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan	National Taiwan Ocean University; National Taiwan Ocean University	Hwang, JS (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Biol, Coll Life Sci, Keelung, Taiwan.; Hwang, JS (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan.	jshwang@mail.ntou.edu.tw		Tseng, Li-Chun/0000-0003-0251-565X	Ministry of Science and Technology (MOST) of Taiwan [MOST 106-2811-M019-004, MOST 107-2811-M-019-004, MOST 108-2811-M-019-504, MOST 106-2621-M-019-001, MOST 1072621-M-019-001, MOST 108-2621-M-019-003]	Ministry of Science and Technology (MOST) of Taiwan(Ministry of Science and Technology, Taiwan)	Financial support from the Ministry of Science and Technology (MOST) of Taiwan is acknowledged through grants MOST 106-2811-M019-004, MOST 107-2811-M-019-004 and MOST 108-2811-M-019-504 to L.-C. Tseng, as well as the grants MOST 106-2621-M-019-001, MOST 1072621-M-019-001 and MOST 108-2621-M-019-003 to J.-S. Hwang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pinheiro MAA, 2006, BRAZ ARCH BIOL TECHN, V49, P813, DOI 10.1590/S1516-89132006000600016; Baeza JA, 2012, J SHELLFISH RES, V31, P909, DOI 10.2983/035.031.0401; Azevedo DS, 2017, THALASSAS, V33, P1, DOI 10.1007/s41208-015-0008-0; BILDSTEIN KL, 1989, ANIM BEHAV, V37, P133, DOI 10.1016/0003-3472(89)90013-4; César II., 2007, Braz. J. Biol., V67, P749, DOI 10.1590/S1519-69842007000400023; Chan BKK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148675; Chang C. I, 2006, THESIS; Chang NN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204753; Chen C, 2018, MAR BIODIVERS, V48, P709, DOI 10.1007/s12526-017-0804-2; Chen CTA, 2005, CHEM GEOL, V224, P69, DOI 10.1016/j.chemgeo.2005.07.022; Chen CTA, 2005, ACTA OCEANOL SIN, V24, P125; Chen KS, 2012, TOTAL QUAL MANAG BUS, V23, P309, DOI 10.1080/14783363.2011.593851; Chen T-Y, 2004, THESIS; Chen YJ, 2015, BIOGEOSCIENCES, V12, P2631, DOI 10.5194/bg-12-2631-2015; Chen YG, 2001, QUATERNARY SCI REV, V20, P869, DOI 10.1016/S0277-3791(00)00047-0; Chiu CL, 2010, TERR ATMOS OCEAN SCI, V21, P575, DOI 10.3319/TAO.2010.02.22.02(TH); Czerniejewski P, 2006, OCEANOLOGIA, V48, P275; Dahms HU, 2018, HYDROBIOLOGIA, V818, P1, DOI 10.1007/s10750-018-3598-8; Dahms HU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182649; Dahms HU, 2013, J MAR SCI TECH-TAIW, V21, P297, DOI 10.6119/JMST-013-1223-6; Dahms HU, 2014, J MAR SCI TECH-TAIW, V22, P82, DOI 10.6119/JMST-013-0312-2; Hartnoll R.G., 1982, P111; Hartnoll RG, 2006, HYDROBIOLOGIA, V557, P31, DOI 10.1007/s10750-005-9305-6; Hegele-Drywa J, 2014, OCEANOLOGIA, V56, P805, DOI 10.5697/oc.56-4.805; Ho PH, 2000, RAFFLES B ZOOL, V48, P111; Ho TW, 2015, MAR BIOL, V162, P1787, DOI 10.1007/s00227-015-2711-z; Hu MYA, 2012, AQUAT BIOL, V15, P11, DOI 10.3354/ab00396; Hung JJ, 2018, MAR CHEM, V198, P88, DOI 10.1016/j.marchem.2017.12.004; Hung JJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211516; Hung JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207774; Jeng MS, 2004, NATURE, V432, P969, DOI 10.1038/432969a; Kuo F-W, 2001, THESIS; Lebrato M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53314-y; Lee SY, 1995, J EXP MAR BIOL ECOL, V193, P161, DOI 10.1016/0022-0981(95)00116-6; Lin CH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34596-0; Morris DW, 2011, P ROY SOC B-BIOL SCI, V278, P2401, DOI 10.1098/rspb.2011.0604; MORRIS DW, 1988, EVOL ECOL, V2, P253, DOI 10.1007/BF02214286; Ng N.K., 2000, National Taiwan Museum Special Publication Series, V10, P191; Nordhaus I, 2009, J EXP MAR BIOL ECOL, V374, P104, DOI 10.1016/j.jembe.2009.04.002; Patil K. M., 2012, J EXP SCI, V3, P13; Peng SH, 2011, MAR POLLUT BULL, V63, P396, DOI 10.1016/j.marpolbul.2011.05.013; RICKER WE, 1973, J FISH RES BOARD CAN, V30, P409, DOI 10.1139/f73-072; Riipinen K, 2017, AQUAT INVASIONS, V12, P191, DOI 10.3391/ai.2017.12.2.07; Rodenhouse NL, 1997, ECOLOGY, V78, P2025, DOI 10.2307/2265942; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Rufino M, 2004, ITAL J ZOOL, V71, P79, DOI 10.1080/11250000409356554; SCHOENER TW, 1980, ANN ENTOMOL SOC AM, V73, P106, DOI 10.1093/aesa/73.1.106; Simpson LA, 2016, J CRUSTACEAN BIOL, V36, P792, DOI 10.1163/1937240X-00002486; SONG S.-R., 2013, TAIWAN NATURAL SCI, V32, P74; SVARDSON G, 1949, OIKOS, V1, P157, DOI 10.2307/3564710; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Tseng LC, 2018, CRUSTACEANA, V91, P879, DOI 10.1163/15685403-00003800; Tseng LC, 2013, HELGOLAND MAR RES, V67, P507, DOI 10.1007/s10152-012-0339-7; Waiho K, 2016, MAR BIOL RES, V12, P726, DOI 10.1080/17451000.2016.1200726; Wang L, 2017, MICROB ECOL, V73, P571, DOI 10.1007/s00248-016-0898-2; Wang TW, 2014, MAR BIOL, V161, P2447, DOI 10.1007/s00227-014-2479-6; Warner GF, 1977, BIOL CRABS; Yu P-Y, 2013, THESIS	58	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230742	10.1371/journal.pone.0230742	http://dx.doi.org/10.1371/journal.pone.0230742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214356	gold, Green Published			2022-12-26	WOS:000535934200052
J	Gupta, V; Guleri, R; Gupta, M; Kaur, N; Kaur, K; Kumar, P; Anand, M; Kaur, G; Pati, PK				Gupta, Vasudha; Guleri, Rupam; Gupta, Muskan; Kaur, Navdeep; Kaur, Kuldeep; Kumar, Paramdeep; Anand, Manju; Kaur, Gurcharan; Pati, Pratap Kumar			Anti-neuroinflammatory potential of Tylophora indica (Burm. f) Merrill and development of an efficient in vitro propagation system for its clinical use	PLOS ONE			English	Article							NF-KAPPA-B; GENETIC STABILITY; MICROGLIA; CALLUS; MICROPROPAGATION; ESTABLISHMENT; REGENERATION; ACTIVATION; MECHANISMS; EXPRESSION	Neuroinflammation is a major risk factor associated with the pathogenesis of neurodegenerative diseases. Conventional non-steroidal anti-inflammatory drugs are prescribed but their long term use is associated with adverse effects. Thus, herbal based medicines are attracting major attraction worldwide as potential therapeutic candidates. Tylophora indica (Burm. f) Merrill is a valuable medicinal plant well known in Ayurvedic practices for its immunomodulatory, anti-oxidant, anti-asthmatic and antirheumatic activities. The present study aimed to elucidate the anti-neuroinflammatory potential of water and hydroalcoholic leaf extracts of micropropagated plants of T. indica using BV-2 microglia activated with lipopolysaccharide as an in vitro model system and development of an efficient reproducible protocol for its in vitro cloning. Non cytotoxic doses of the water and hydroalcoholic extracts (0.2 mu g/ml and 20 mu g/ml, respectively) were selected using MTT assay. alpha-Tubulin, Iba-1 and inflammatory cascade proteins like NF kappa B, AP1 expression was studied using immunostaining to ascertain the anti-neuroinflammatory potential of these extracts. Further, anti-migratory activity was also analyzed by Wound Scratch Assay. Both extracts effectively attenuated lipopolysaccharide induced microglial activation, migration and the production of nitrite via regulation of the expression of NF kappa B and AP1 as the possible underlying target molecules. An efficient and reproducible protocol for in vitro cloning of T. indica through multiple shoot proliferation from nodal segments was established on both solid and liquid Murashige and Skoog's (MS) media supplemented with 15 mu M and 10 mu M of Benzyl Amino Purine respectively. Regenerated shoots were rooted on both solid and liquid MS media supplemented with Indole-3-butyric acid (5-15 mu M) and the rooted plantlets were successfully acclimatized and transferred to open field conditions showing 90% survivability. The present study suggests that T. indica may prove to be a potential anti-neuroinflammatory agent and may be further explored as a potential therapeutic candidate for the management of neurodegenerative diseases. Further, the current study will expedite the conservation of T. indica ensuring ample supply of this threatened medicinal plant to fulfill its increasing demand in herbal industry.	[Gupta, Vasudha; Guleri, Rupam; Gupta, Muskan; Kaur, Navdeep; Kaur, Kuldeep; Kumar, Paramdeep; Kaur, Gurcharan; Pati, Pratap Kumar] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India; [Anand, Manju] Amity Univ, Amity Inst Biotechnol, Gurgaon, Haryana, India	Guru Nanak Dev University	Kaur, G; Pati, PK (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.	kgurcharan.neuro@yahoo.com; pkpati@yahoo.com	KAUR, NAVDEEP/GPK-0563-2022	KAUR, NAVDEEP/0000-0002-4399-2797; pati, pratap/0000-0001-9017-7608				Aid S, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-17; Ajmone-Cat MA, 2010, PHARMACEUTICALS, V3, P1949, DOI 10.3390/ph3061949; Anand M, 2012, MICROPROPAGATION SYS, V41; Aruna Bhatia, 2013, Journal of Natural Product and Plant Resources, V3, P1; Bach DH, 2019, CURR MED CHEM, V26, P4709, DOI [10.2174/10929867325666180726123339, 10.2174/0929867325666180726123339]; BERA TK, 1993, BOT BULL ACAD SINICA, V34, P83; Bhardwaj AK, 2018, PLANT CELL TISS ORG, V135, P499, DOI 10.1007/s11240-018-1482-x; Bhatia A, 2015, INT J CHEM PHARM ANA, V2, P88; BHUTANI KK, 1984, PHYTOCHEMISTRY, V23, P1765, DOI 10.1016/S0031-9422(00)83487-1; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Butiuc-Keul A, GENETIC STABILITY AS, V1, P61; Chaudhuri KN, 2004, PLANT CELL REP, V22, P731, DOI 10.1007/s00299-003-0753-z; Choi DK, 2011, MOLECULES, V16, P1021, DOI 10.3390/molecules16021021; Faisal M, 2005, IN VITRO CELL DEV-PL, V41, P511, DOI 10.1079/IVP2005674; Faisal M, 2003, PLANT CELL TISS ORG, V75, P125, DOI 10.1023/A:1025084203958; Faisal M, 2007, PLANT BIOTECHNOL REP, V1, P155, DOI 10.1007/s11816-007-0025-4; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Ganguly T, 2001, PHYTOMEDICINE, V8, P348, DOI 10.1078/0944-7113-00055; Gantait S, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0865-8; GOPALAKRISHNAN C, 1980, INDIAN J MED RES, V71, P940; Gottschalk RA, 2016, CELL SYST, V2, P378, DOI 10.1016/j.cels.2016.04.016; Gupta M, 2010, J PHARM SCI RES, V2, P401; Gupta M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0650-3; Harmanjit Kaur, 2011, International Journal of Medicinal and Aromatic Plants, V1, P83; JOSHI SG, 2000, MED PLANTS; Kang G, 2004, J PHARMACOL SCI, V94, P325, DOI 10.1254/jphs.94.325; Karlstetter M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-125; Kaur H, 2011, INT J BIOTECHNOLOGY, V2, P297; Kaur H, 2011, AFR J BIOTECHNOL, V10, P6928; Kaur H, 2011, J MED PLANTS RES, V5, P729; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kharrazi M., 2011, Journal of Biological & Environmental Sciences, V4, P1; Krishna H, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0389-7; Kunene EN, 2018, ADV MED PLANT RES, V6, P26; Lakshmanan V, 2007, ELECTRON J BIOTECHN, V10, P106, DOI 10.2225/vol10-issue1-fulltext-12; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Lively S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-75; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Maroon Joseph C, 2010, Surg Neurol Int, V1, P80, DOI 10.4103/2152-7806.73804; Martins M, 2004, PLANT CELL REP, V23, P492, DOI 10.1007/s00299-004-0870-3; Minano HS, 2009, SCI HORTIC-AMSTERDAM, V122, P238, DOI 10.1016/j.scienta.2009.05.001; MULCHANDANI N B, 1971, Chemistry and Industry, V19, P505; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Oh JH, 2008, EUR J PHARMACOL, V599, P11, DOI 10.1016/j.ejphar.2008.09.017; Ohsawa K, 2000, J CELL SCI, V113, P3073; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Palhares RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127866; Raj C. D., 2006, Journal of Pharmacology and Toxicology, V1, P490; RAO KV, 1971, J PHARM SCI, V60, P1725, DOI 10.1002/jps.2600601133; Rao SN, 2013, J AM SCI, V4, P127; Renaud J, 2014, CURR PHARM BIOTECHNO, V15, P318, DOI 10.2174/1389201015666140617101332; Rock RB, 2006, J NEUROIMMUNE PHARM, V1, P117, DOI 10.1007/s11481-006-9012-8; Ruzic DV, 2008, HORTIC SCI, V35, P12, DOI 10.17221/646-HORTSCI; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Shehu U. I., 2016, African Journal of Agricultural Research, V11, P898; Sidhu Y., 2011, PLYMOUTH STUD SCI, V4, P432; Takayama S., 2005, LIQUID CULTURE SYSTE, P61; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thomas TD, 2005, IN VITRO CELL DEV-PL, V41, P124, DOI 10.1079/IVP2004575; Waldie T, 2018, PLANT PHYSIOL, V177, P803, DOI 10.1104/pp.17.01691; Wang CC, 2014, KAOHSIUNG J MED SCI, V30, P73, DOI 10.1016/j.kjms.2013.09.012; Yang CW, 2006, MOL PHARMACOL, V69, P749, DOI 10.1124/mol.105.017764	62	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230142	10.1371/journal.pone.0230142	http://dx.doi.org/10.1371/journal.pone.0230142			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210464	Green Published, gold			2022-12-26	WOS:000535307600017
J	Zhao, WN; Liang, HL; Fu, Y; Liu, YB; Yang, C; Zhang, T; Wang, TY; Rong, LY; Zhang, S; Wu, ZX; Sun, WT				Zhao, Wanning; Liang, Hanling; Fu, Yu; Liu, Yubo; Yang, Chen; Zhang, Tian; Wang, Tianyu; Rong, Liyan; Zhang, Shuang; Wu, Zhaoxia; Sun, Wentao			Effects of different fertilization modes on rice yield and quality under a rice-crab culture system	PLOS ONE			English	Article							PHYSICOCHEMICAL PROPERTIES; NITROGEN-FERTILIZER; GRAIN QUALITY; STARCH; CHINA; CHALKINESS; COCULTURE	Rice-crab culture is the characteristic rice ecological breeding model used in the Panjin area of Liaohe River Basin, China, and it can improve the ecological environment and create increased economic benefits. From a food perspective, both rice yield and quality, which are closely related to the fertilization mode, should be considered. However, the effect of different fertilization modes on rice quality has not been comprehensively investigated in this coculture system. This study investigated the effects of three fertilization modes(FP1, FP2, and OPT) divided according to different fertilization types and methods on rice yield and quality, and set up a non-fertilized control group. In the rice-crab culture system, FP2 used fewer fertilizers and had a lower economic cost, and the yield was only slightly less than that of OPT(highest yield) but there was no statistical difference. FP2 elicited the best appearance quality and better cooking and eating quality among all treatment modes. Compared with CK, three fertilization modes significantly increased the protein content in rice and decreased the amylose content, which would lead to the deterioration of rice eating quality. However FP2 had the least protein increase and the least amylose reduction. There was no significant change in crude fat and starch content. Therefore, the FP2 fertilization mode was the best choice for the rice-crab culture system, as it significantly improved rice yield and increased rice quality at a relatively low cost.	[Zhao, Wanning; Liang, Hanling; Fu, Yu; Liu, Yubo; Yang, Chen; Zhang, Tian; Wang, Tianyu; Rong, Liyan; Zhang, Shuang; Wu, Zhaoxia] Shenyang Agr Univ, Coll Food, Shenyang, Liaoning, Peoples R China; [Sun, Wentao] Liaoning Acad Agr Sci, Inst Plant Nutr & Environm Resources, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University	Wu, ZX (corresponding author), Shenyang Agr Univ, Coll Food, Shenyang, Liaoning, Peoples R China.; Sun, WT (corresponding author), Liaoning Acad Agr Sci, Inst Plant Nutr & Environm Resources, Shenyang, Liaoning, Peoples R China.	wuzxsau@163.com; wentaosw@163.com		zhao, wanning/0000-0002-5558-5531	National Key Research and Development Program of China [2018YFD0200203]; Science and Technology Innovation Talents Training Project of Liaoning Province [XLYC1802044]	National Key Research and Development Program of China; Science and Technology Innovation Talents Training Project of Liaoning Province	WZX,ZWN,LHL,FY,LYB,YC,ZT,WTY,RLY, ZS received award of this work. This work was supported by grants from the National Key Research and Development Program of China (grant no. 2018YFD0200203) and Science and Technology Innovation Talents Training Project of Liaoning Province (grant no. XLYC1802044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An H., 2012, ACTA AGRIC NUCL SIN, V26, P5081; Asghar S., 2012, PAKISTAN J FOOD SCI, V22, P128; Ashim Chakravorty, 2014, Journal of Central European Agriculture, V15, P213, DOI 10.5513/JCEA01/15.4.1532; Baxter G, 2014, J CEREAL SCI, V60, P414, DOI 10.1016/j.jcs.2014.05.002; Cai YX, 2011, J SCI FOOD AGR, V91, P1977, DOI 10.1002/jsfa.4404; Chen Y., 2018, LIAONING AGR SCI, V3, P30; Cheng C, 2019, J CEREAL SCI, V87, P39, DOI 10.1016/j.jcs.2019.02.009; Deng F, 2018, AGR FOREST METEOROL, V263, P49, DOI 10.1016/j.agrformet.2018.08.006; Deng ZD, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep42999; Ding WC, 2018, FIELD CROP RES, V227, P11, DOI 10.1016/j.fcr.2018.08.001; Hao HL, 2007, RICE SCI, V14, P289, DOI 10.1016/S1672-6308(08)60007-4; [侯云鹏 Hou Yunpeng], 2015, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V21, P836; Jia D., 2016, ASIAN AGR RES, V8, P33, DOI [10.22004/ag.econ.241299, DOI 10.22004/AG.ECON.241299]; JIN ZX, 2001, PLANT NUTR FERTILIZE, V7, P31; Kramer AW, 2002, AGR ECOSYST ENVIRON, V91, P233, DOI 10.1016/S0167-8809(01)00226-2; Li HY, 2018, CARBOHYD POLYM, V195, P9, DOI 10.1016/j.carbpol.2018.04.065; Li HY, 2016, FOOD CHEM, V196, P702, DOI 10.1016/j.foodchem.2015.09.112; Li MY, 2017, AGR SCI TECH, V18, P1416; Li XD, 2007, AQUACULTURE, V273, P487, DOI 10.1016/j.aquaculture.2007.10.028; Lisle AJ, 2000, CEREAL CHEM, V77, P627, DOI 10.1094/CCHEM.2000.77.5.627; Liu MingDa, 2012, Journal of Shenyang Agricultural University, V43, P306; Liu QH, 2019, CHIL J AGR RES, V79, P202, DOI 10.4067/S0718-58392019000200202; Liu X, 2019, AGR WATER MANAGE, V221, P34, DOI 10.1016/j.agwat.2019.04.009; Lu RK, 2000, SOIL AGR CHEM ANAL M; Martin M, 2002, J CEREAL SCI, V36, P285, DOI 10.1006/jcrs.2001.0465; Meng ShunLong, 2018, Agricultural Biotechnology, V7, P129; Qiao JF, 2011, PLANT SOIL, V349, P191, DOI 10.1007/s11104-011-0861-4; Tang S, 2019, FOOD CHEM, V277, P455, DOI 10.1016/j.foodchem.2018.10.137; Walia M. K., 2014, Journal of Plant Science Research, V30, P33; Wang A., 2018, MIGRATION TRANSFORMA; Wang Ang, 2019, Aquaculture and Fisheries, V4, P134, DOI 10.1016/j.aaf.2018.12.006; Wang Hui, 2018, China Rice, V24, P16, DOI 10.3969/j.issn.1006-8082.2018.04.004; Wei HY, 2018, J INTEGR AGR, V17, P2222, DOI [10.1016/s2095-3119(18)62052-0, 10.1016/S2095-3119(18)62052-0]; Xi M, 2014, PLANT PROD SCI, V17, P285, DOI 10.1626/pps.17.285; [徐敏 Xu Min], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P1828; Xu Q, 2019, J CLEAN PROD, V208, P188, DOI 10.1016/j.jclepro.2018.10.092; Yan Y, 2014, J INTEGR AGR, V13, P641, DOI 10.1016/S2095-3119(13)60722-4; Zeng YH, 2019, J CEREAL SCI, V87, P111, DOI 10.1016/j.jcs.2019.03.015; Zheng HB, 2017, SUSTAIN SCI, V12, P155, DOI 10.1007/s11625-016-0399-8; Zhou LJ, 2015, FIELD CROP RES, V172, P1, DOI 10.1016/j.fcr.2014.12.004; Zhu DW, 2017, J INTEGR AGR, V16, P1018, DOI [10.1016/S2095-3119(16)61577-0, 10.1016/s2095-3119(16)61577-0]	42	5	6	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230600	10.1371/journal.pone.0230600	http://dx.doi.org/10.1371/journal.pone.0230600			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210447	gold, Green Published			2022-12-26	WOS:000535307600034
J	Ding, J; Shi, CF; Bowes, J; Eyre, S; Orozco, G				Ding, James; Shi, Chenfu; Bowes, John; Eyre, Stephen; Orozco, Gisela			Exploring the overlap between rheumatoid arthritis susceptibility loci and long non-coding RNA annotations	PLOS ONE			English	Article							ASSOCIATION; DISCOVERY; ENHANCERS; ATLAS	Whilst susceptibility variants for many complex diseases, such as rheumatoid arthritis (RA), have been well characterised, the mechanism by which risk is mediated is still unclear for many loci. This is especially true for the majority of variants that do not affect protein-coding regions. lncRNA represent a group of molecules that have been shown to be enriched amongst variants associated with RA and other complex diseases, compared to random variants. In order to establish to what degree direct disruption of lncRNA may represent a potential mechanism for mediating RA susceptibility, we chose to further explore this overlap. By testing the ability of annotated features to improve a model of disease susceptibility, we were able to demonstrate a local enrichment of enhancers from immune-relevant cell types amongst RA susceptibility variants (log(2) enrichment 3.40). This was not possible for lncRNA annotations in general, however a small, but significant enrichment was observed for immune-enriched lncRNA (log(2) enrichment 0.867002). This enrichment was no longer apparent when the model was conditioned on immune-relevant enhancers (log(2) enrichment -0.372734), suggesting that direct disruption of lncRNA sequence, independent of enhancer disruption, does not represent a major mechanism by which susceptibility to complex diseases is mediated. Furthermore, we demonstrated that, in keeping with general lncRNA characteristics, immune-enriched lncRNA are expressed at low levels that may not be amenable to functional characterisation.	[Ding, James; Shi, Chenfu; Bowes, John; Eyre, Stephen; Orozco, Gisela] Univ Manchester, Div Musculoskeletal & Dermatol Sci, Ctr Genet & Genom Versus Arthrit, Sch Biol Sci,Fac Biol Med & Hlth, Manchester, Lancs, England; [Bowes, John; Eyre, Stephen; Orozco, Gisela] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England	University of Manchester; University of Manchester	Ding, J (corresponding author), Univ Manchester, Div Musculoskeletal & Dermatol Sci, Ctr Genet & Genom Versus Arthrit, Sch Biol Sci,Fac Biol Med & Hlth, Manchester, Lancs, England.	james.ding@manchester.ac.uk	Orozco, Gisela/E-1856-2015	Orozco, Gisela/0000-0002-3479-0448; Shi, Chenfu/0000-0002-3083-8416; Ding, James/0000-0001-7273-9646	Wellcome Trust [207491/Z/17/Z, 215207/Z/19/Z]; Versus Arthritis [21754, 21348]; NIHR Manchester Biomedical Research Centre	Wellcome Trust(Wellcome TrustEuropean Commission); Versus Arthritis(Versus Arthritis); NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR))	This research was funded by the Wellcome Trust and Versus Arthritis and supported by the NIHR Manchester Biomedical Research Centre. JD, CS and GO are funded by the Wellcome Trust (JD and GO, 207491/Z/17/Z; CS, 215207/Z/19/Z) and by Versus Arthritis (21754 and 21348). JB and SE are funded by Versus Arthritis (JB, 21754; SE, 21754 and 21348). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Hon CC, 2017, NATURE, V543, P199, DOI 10.1038/nature21374; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jarroux J, 2017, ADV EXP MED BIOL, V1008, P1, DOI 10.1007/978-981-10-5203-3_1; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Messemaker TC, 2016, GENES IMMUN, V17, P85, DOI 10.1038/gene.2015.54; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Volders PJ, 2019, NUCLEIC ACIDS RES, V47, pD135, DOI 10.1093/nar/gky1031	16	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0223939	10.1371/journal.pone.0223939	http://dx.doi.org/10.1371/journal.pone.0223939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196497	Green Published, gold, Green Submitted			2022-12-26	WOS:000535303100003
J	Gi, YM; Jung, BY; Kim, KW; Cho, JH; Ha, IH				Gi, Yu-mi; Jung, Boyoung; Kim, Koh-Woon; Cho, Jae-Heung; Ha, In-Hyuk			Low handgrip strength is closely associated with anemia among adults: A cross-sectional study using Korea National Health and Nutrition Examination Survey (KNHANES)	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; GRIP STRENGTH; OLDER PERSONS; HEMOGLOBIN CONCENTRATION; OXIDATIVE STRESS; WOMENS-HEALTH; CUT POINTS; MORTALITY; MOBILITY; DECLINE	Background Anemia, which is a major public health problem worldwide, represents a decline in the oxygenation function, and can therefore be related to low strength. However, hemoglobin cannot repair muscles directly, but is beneficial only in a supportive role. Previous studies on the relationship between handgrip strength and anemia have been controversial. Thus, we aimed to analyze the association between handgrip strength and anemia in Korean adults. Methods This cross-sectional study used the 2013-2017 data from the 6th and 7th Korean National Health and Nutrition Examination Survey (KNHANES) that included 16,638 Korean adults, aged >= 19 years, who met the inclusion or exclusion criteria. Differences in sociodemographic factors (sex, age, education, income, and employment), lifestyle factors (alcohol consumption, smoking, and physical activity), and illness and health factors [body mass index (BMI), vitamin intake, iron intake, comorbid illnesses, and handgrip strength] by existence of anemia, were analyzed using the Chi square test. Binary logistic regression analysis was used to measure the association between handgrip strength and anemia, while adjusting for other possible confounders. Subgroup analysis, stratified by sex and age, was performed. Results Among Korean adults aged >= 19 years, 745,296 (7.7%) had anemia. A higher odds ratio, adjusted for other covariates/factors (OR) of anemia occurred in the weak handgrip strength group than in the strong handgrip strength group (OR = 1.92, 95% CI: 1.58-2.33). The subgroup analysis showed a higher OR adjusted for other covariates/factors of anemia in the weak handgrip strength group than in the strong handgrip strength group, regardless of sex or age. However, the association was greater for males (OR = 2.13, 95% CI: 1.35-3.34) and for those aged >= 65 years (OR = 1.92, 95% CI: 1.42-2.58). Conclusion This study showed a strong association between handgrip strength and anemia that was particularly strong for males and those aged >= 65 years.	[Gi, Yu-mi] Jaseng Hosp Korean Med, Seoul, South Korea; [Jung, Boyoung] Hanyang Womens Univ, Dept Hlth Adm, Seoul, South Korea; [Kim, Koh-Woon; Cho, Jae-Heung] Kyung Hee Univ, Coll Korean Med, Dept Korean Rehabil Med, Seoul, South Korea; [Ha, In-Hyuk] Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea	Kyung Hee University	Jung, BY (corresponding author), Hanyang Womens Univ, Dept Hlth Adm, Seoul, South Korea.; Ha, IH (corresponding author), Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea.	happiness630@hanmail.net; hanihata@gmail.com	Kim, Koh-Woon/A-2234-2017	HA, IN-HYUK/0000-0002-5020-6723; Kim, Koh-Woon/0000-0002-0353-6041				Adamu AL, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0128-2; Ahn S., 2005, THESIS; Al-Mekhlafi HM, 2014, NUTRIENTS, V6, P190, DOI 10.3390/nu6010190; Alley DE, 2014, J GERONTOL A-BIOL, V69, P559, DOI 10.1093/gerona/glu011; [Anonymous], 2017, STATE FOOD SECURITY; Antwi-Bafour Samuel, 2016, J Med Case Rep, V10, P110, DOI 10.1186/s13256-016-0889-4; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Chaves PHM, 2002, J AM GERIATR SOC, V50, P1257, DOI 10.1046/j.1532-5415.2002.50313.x; Chaves PHM, 2005, J GERONTOL A-BIOL, V60, P729, DOI 10.1093/gerona/60.6.729; Cho S-B, 2013, WBC HEMOGLOBIN ELDER, V22, P1075; Chung H., 1991, KOREAN J NUTR, V24, P450; COOK JD, 1976, AM J CLIN NUTR, V29, P859, DOI 10.1093/ajcn/29.8.859; den Elzen WPJ, 2009, CAN MED ASSOC J, V181, P151, DOI 10.1503/cmaj.090040; Eisenstaedt R, 2006, BLOOD REV, V20, P213, DOI 10.1016/j.blre.2005.12.002; Ferrucci L, 1997, J GERONTOL A-BIOL, V52, pM275, DOI 10.1093/gerona/52A.5.M275; Fukushima T, 2019, INTEGR CANCER THER, V18, DOI 10.1177/1534735419842196; Gaskell Helen, 2008, BMC Geriatr, V8, P1, DOI 10.1186/1471-2318-8-1; GIULIVI C, 1990, J BIOL CHEM, V265, P19453; Gordon SR, 1994, AM J GASTROENTEROLOG, V89; Grune T, 2000, BIOGERONTOLOGY, V1, P31, DOI 10.1023/A:1010037908060; Haslam A, 2012, J AM GERIATR SOC, V60, P2362, DOI 10.1111/jgs.12009; Hicks GE, 2012, J GERONTOL A-BIOL, V67, P66, DOI 10.1093/gerona/glr055; Hirani V, 2016, J GERONTOL A-BIOL, V71, P1667, DOI 10.1093/gerona/glw055; Hong CH, 2013, NEUROLOGY, V81, P528, DOI 10.1212/WNL.0b013e31829e701d; JACOBS A, 1971, J CLIN PATHOL, V24, P694, DOI 10.1136/jcp.24.8.694; Joosten E, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0326-y; Kim Y, 2014, EPIDEMIOLOGY HLTH, V36; Kim YJ, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6930-y; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Lee J, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1858-2; Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513; Lucca U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001920; Manini TM, 2007, J AM GERIATR SOC, V55, P451, DOI 10.1111/j.1532-5415.2007.01087.x; Manini TM, 2012, J GERONTOL A-BIOL, V67, P28, DOI 10.1093/gerona/glr010; Masukume G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122729; Mugisha JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078394; Organization WH, 2001, GUID PROGR MAN, P47; Park JY, 2017, PLOS ONE, V12; Park YN, 2017, REGIONAL DISPARITIES; Pate RR, 2013, JAMA PEDIATR, V167, P221, DOI 10.1001/jamapediatrics.2013.1464; Payne CF, 2018, J EPIDEMIOL COMMUN H, V72, P796, DOI 10.1136/jech-2018-210449; Penninx BWJH, 2004, J AM GERIATR SOC, V52, P719, DOI 10.1111/j.1532-5415.2004.52208.x; Penninx BWJH, 2003, AM J MED, V115, P104, DOI 10.1016/S0002-9343(03)00263-8; Rammohan A, 2011, ISRN PUBLIC HLTH; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Rijk JM, 2016, GERIATR GERONTOL INT, V16, P5, DOI 10.1111/ggi.12508; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; SALIVE ME, 1992, J AM GERIATR SOC, V40, P489, DOI 10.1111/j.1532-5415.1992.tb02017.x; Sallinen J, 2010, J AM GERIATR SOC, V58, P1721, DOI 10.1111/j.1532-5415.2010.03035.x; Shavelle RM, 2012, INT J HEMATOL, V95, P248, DOI 10.1007/s12185-012-1007-z; Santos PHS, 2019, PUBLIC HEALTH NURS, V36, P178, DOI 10.1111/phn.12579; Society MoHaWTKN, 2010, DIET REF INT KOR 201; Society MoHaWTKN, 2015, DIET REF INT KOR 201; Thein M, 2009, MEDICINE, V88, P107, DOI 10.1097/MD.0b013e31819d89d5; Vulser H, 2016, ACTA PSYCHIAT SCAND, V134, P150, DOI 10.1111/acps.12595; WHO Scientific Group on Nutritional Anaemias & World Health Organization, 1968, NUTR AN REP WHO SCI; Yoo JI, 2017, J KOREAN MED SCI, V32, P868, DOI 10.3346/jkms.2017.32.5.868; Yoo JI, 2016, J KOREAN MED SCI, V31, P1479, DOI 10.3346/jkms.2016.31.9.1479; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214; Zakai NA, 2013, AM J HEMATOL, V88, P5, DOI 10.1002/ajh.23336	61	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0218058	10.1371/journal.pone.0218058	http://dx.doi.org/10.1371/journal.pone.0218058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9FU	32196502	Green Published, Green Submitted, gold			2022-12-26	WOS:000535303100001
J	Hu, K; Xiang, J; Yu, YX; Tang, L; Xiang, Q; Li, JM; Tang, YH; Chen, YJ; Zhang, Y				Hu, Ke; Xiang, Ju; Yu, Yun-Xia; Tang, Liang; Xiang, Qin; Li, Jian-Ming; Tang, Yong-Hong; Chen, Yong-Jun; Zhang, Yan			Significance-based multi-scale method for network community detection and its application in disease-gene prediction	PLOS ONE			English	Article							COMPLEX NETWORKS; ALGORITHM; CLUSTERINGS; MODULARITY	Community detection in complex networks is an important issue in network science. Several statistical measures have been proposed and widely applied to detecting the communities in various complex networks. However, due to the lack of flexibility resolution, some of them have to encounter the resolution limit and thus are not compatible with multi-scale structures of complex networks. In this paper, we investigated a statistical measure of interest for community detection, Significance [Sci. Rep. 3 (2013) 2930], and analyzed its critical behaviors based on the theoretical derivation of critical number of communities and the phase diagram in community-partition transition. It was revealed that Significance exhibits far higher resolution than the traditional Modularity when the intra- and inter-link densities of communities are obviously different. Following the critical analysis, we developed a multi-resolution version of Significance for identifying communities in the multi-scale networks. Experimental tests in several typical networks have been performed and confirmed that the generalized Significance can be competent for the multi-scale communities detection. Moreover, it can effectively relax the first- and second-type resolution limits. Finally, we displayed an important potential application of the multi-scale Significance in computational biology: disease-gene identification, showing that extracting information from the perspective of multi-scale module mining is helpful for disease gene prediction.	[Hu, Ke; Yu, Yun-Xia] Xiangtan Univ, Sch Phys & Optoelect Engn, Xiangtan, Hunan, Peoples R China; [Xiang, Ju; Zhang, Yan] Cent South Univ, Sch Comp Sci & Engn, Changsha, Hunan, Peoples R China; [Xiang, Ju; Tang, Liang; Xiang, Qin; Li, Jian-Ming; Zhang, Yan] Changsha Med Univ, Sch Basic Med Sci, Changsha, Hunan, Peoples R China; [Li, Jian-Ming] Cent South Univ, Xiang Ya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Li, Jian-Ming] Xiangya Boai Rehabil Hosp, Dept Rehabil, Changsha, Hunan, Peoples R China; [Li, Jian-Ming; Tang, Yong-Hong; Chen, Yong-Jun] Univ South China, Nanhua Affiliated Hosp, Dept Neurol, Hengyang, Hunan, Peoples R China	Xiangtan University; Central South University; Changsha Medical University; Central South University; University of South China	Yu, YX (corresponding author), Xiangtan Univ, Sch Phys & Optoelect Engn, Xiangtan, Hunan, Peoples R China.; Xiang, J (corresponding author), Cent South Univ, Sch Comp Sci & Engn, Changsha, Hunan, Peoples R China.; Xiang, J (corresponding author), Changsha Med Univ, Sch Basic Med Sci, Changsha, Hunan, Peoples R China.	xiang.ju@foxmail.com; yunxiayu@xtu.edu.cn		yunxia, yu/0000-0003-2539-490X	National Natural Science Foundation of China [61702054, 81873780]; Hunan Provincial Natural Science Foundation of China [2018JJ3568, 2019JJ50697]; Training Program for Excellent Young Innovators of Changsha [kq1905045, kq1905047]; Scientific Research Fund of Education Department of Hunan Province [17A024, 18B539, 19B072]; Hunan Key Laboratory Cultivation Base of the Research and Development of Novel Pharmaceutical Preparations [2016TP1029]; Hunan Provincial Innovation Platform and Talents Program [2018RS3105]; Hunan Provincial Science and Technology Department [[2018]85]; Human Provincial Health and Family Planning Commission [[2018]85]; Hunan Provincial Commission of Health and Family Planning [[2017]144]; Hunan Provincial Science and Technology Department Clinical Medical Technology Innovation GuideProject [2018SK50711]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Training Program for Excellent Young Innovators of Changsha; Scientific Research Fund of Education Department of Hunan Province; Hunan Key Laboratory Cultivation Base of the Research and Development of Novel Pharmaceutical Preparations; Hunan Provincial Innovation Platform and Talents Program; Hunan Provincial Science and Technology Department; Human Provincial Health and Family Planning Commission; Hunan Provincial Commission of Health and Family Planning; Hunan Provincial Science and Technology Department Clinical Medical Technology Innovation GuideProject	The following grants provided support for this study: National Natural Science Foundation of China (Grant No. 61702054(JX), 81873780(JML)); Hunan Provincial Natural Science Foundation of China (Grant No. 2018JJ3568(JX) and 2019JJ50697(LT)); Training Program for Excellent Young Innovators of Changsha (Grant No. kq1905045(JX) and kq1905047(LT)); Scientific Research Fund of Education Department of Hunan Province (Grant No. 17A024(JX),18B539(YZ), 19B072(QX)); Hunan Key Laboratory Cultivation Base of the Research and Development of Novel Pharmaceutical Preparations (No. 2016TP1029) (JML); Hunan Provincial Innovation Platform and Talents Program (No. 2018RS3105)(JML); Hunan Provincial Science and Technology Department and Human Provincial Health and Family Planning Commission (Grant No.[2018]85)(YHT); Key Project of Hunan Provincial Commission of Health and Family Planning (Grant No.[2017]144)(YHT); Hunan Provincial Science and Technology Department Clinical Medical Technology Innovation GuideProject(2018SK50711)(YJC).	Agarwal G, 2008, EUR PHYS J B, V66, P409, DOI 10.1140/epjb/e2008-00425-1; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; [Anonymous], IMPROVED MUTUAL INFO; Arenas A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.114102; Arenas A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053039; Barber MJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026129; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Botta F, 2016, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2016/12/123402; Cao J, 2016, PHYSICA A, V462, P386, DOI 10.1016/j.physa.2016.06.113; Chen JR, 2017, CHINESE PHYS B, V26, DOI 10.1088/1674-1056/26/1/018901; Chen JR, 2016, PHYSICA A, V447, P482, DOI 10.1016/j.physa.2015.12.006; Chen P, 2010, J INFORMETR, V4, P278, DOI 10.1016/j.joi.2010.01.001; Cheng JJ, 2016, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2016/03/033403; Cheng XQ, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/04/P04024; Choobdar S, 2019, NAT METHODS, V16, P843, DOI 10.1038/s41592-019-0509-5; Decelle A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.065701; Delvenne JC, 2010, P NATL ACAD SCI USA, V107, P12755, DOI 10.1073/pnas.0903215107; Eustace J, 2015, PHYSICA A, V436, P665, DOI 10.1016/j.physa.2015.05.044; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gagneur J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r57; Ghiassian SD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004120; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goh KI, 2012, BRIEF FUNCT GENOMICS, V11, P533, DOI 10.1093/bfgp/els032; He DX, 2016, PHYSICA A, V461, P602, DOI 10.1016/j.physa.2016.06.033; Hu K, 2018, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/aae02b; Huang JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023829; Jin D, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/05/P05031; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Lai DR, 2016, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2016/05/053301; Lai DR, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.066118; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Le Martelot Erwan, 2013, International Journal of Web Based Communities, V9, P323; Li HJ, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48005; Liang ZW, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/9/098902; Lin GQ, 2014, INT J MOD PHYS C, V25, DOI 10.1142/S0129183114400051; Liu W, 2016, J BIOMED INFORM, V61, P10, DOI 10.1016/j.jbi.2016.03.012; Ma JL, 2016, PHYSICA A, V456, P281, DOI 10.1016/j.physa.2016.03.092; Ma JL, 2016, INT J MOD PHYS C, V27, DOI 10.1142/S0129183116500443; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Nadakuditi RR, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.188701; Nam Y, 2019, BIOINFORMATICS, V35, P1923, DOI 10.1093/bioinformatics/bty882; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nicolini C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19250; Reichardt J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.078701; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Ronhovde P, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046114; Ronhovde P, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016109; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Shang RH, 2016, PHYSICA A, V453, P203, DOI 10.1016/j.physa.2016.02.020; Traag VA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02930; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Vinh NX, 2010, J MACH LEARN RES, V11, P2837; Wu JS, 2015, PHYSICA A, V433, P218, DOI 10.1016/j.physa.2015.03.044; Wu ZX, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.012802; Xiang J, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30301-2; Xiang J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32582-0; Xiang J, 2016, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2016/03/033405; Xiang J, 2016, PHYSICA A, V443, P451, DOI 10.1016/j.physa.2015.09.093; Xiang J, 2015, EPL-EUROPHYS LETT, V111, DOI 10.1209/0295-5075/111/48003; Xiang J, 2015, PHYSICA A, V432, P127, DOI 10.1016/j.physa.2015.03.006; Xiang J, 2012, PHYSICA A, V391, P4995, DOI 10.1016/j.physa.2012.05.006; Xin Y, 2016, PHYSICA A, V450, P241, DOI 10.1016/j.physa.2016.01.025; Yan S, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/08/P08010; Yang Z, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.052311; You T, 2016, PHYSICA A, V464, P221, DOI 10.1016/j.physa.2016.07.025; Zhang J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/113003; Zhang SH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S10; Zhang ZY, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062803	72	2	2	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0227244	10.1371/journal.pone.0227244	http://dx.doi.org/10.1371/journal.pone.0227244			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196490	Green Published, gold			2022-12-26	WOS:000535303100005
J	Borowik, T; Ratkiewicz, M; Maslanko, W; Duda, N; Kowalczyk, R				Borowik, Tomasz; Ratkiewicz, Miroslaw; Maslanko, Weronika; Duda, Norbert; Kowalczyk, Rafal			The level of habitat patchiness influences movement strategy of moose in Eastern Poland	PLOS ONE			English	Article							PARTIAL MIGRATION; NORTHERN UNGULATE; PREDATION RISK; RED DEER; EVOLUTION; PATTERNS; RANGE; PHENOLOGY; GRADIENT; BENEFITS	Spatio-temporal variation in resource availability leads to a variety of animal movement strategies. In the case of ungulates, temporally unpredictable landscapes are associated with nomadism, while high predictability in the resource distribution favours migratory or sedentary behaviours depending on the spatial and temporal scale of landscape dynamics. As most of the surveys on moose (Alces alces) movement behaviours in Europe have been conducted on Scandinavian populations, little is known about the movement strategies of moose at the southern edge of the species' range. We expected that decreasing habitat patchiness in central Europe would be associated with the prevalence of migratory behaviours. To verify this hypothesis, we analysed 32 moose fitted with GPS collars from two study areas in eastern Poland which differed in a level of habitat patchiness. We classified moose movements using the net squared displacement method. As presumed, lower patchiness in the Biebrza study site was associated with the predominance of individuals migrating short-distance, while in more patchy landscape of Polesie, resident moose dominated. At the individual level, the propensity of moose to migrate decreased with increasing abundance of forest habitats in their summer ranges. In addition, the parameters (migration distance, timing and duration) for migratory individuals varied substantially between individuals and years. Yet, in spring individual moose expressed a consistent migration timing across years. There was little synchronization of migration timing between individuals from the same population both in spring and autumn, which may have been related to mild weather conditions. We observed that moose postponed their migrations and started movement toward summer ranges at a similar time window in years when spring was delayed due to harsh weather. Hence, in light of global warming, we presume further changes in animal movements will arise.	[Borowik, Tomasz; Kowalczyk, Rafal] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Ratkiewicz, Miroslaw; Duda, Norbert] Univ Bialystok, Inst Biol, Bialystok, Poland; [Maslanko, Weronika] Univ Life Sci Lublin, Dept Anim Ethol & Wildlife Management, Lublin, Poland; [Duda, Norbert] Zespol Szkol Ogolnoksztalcacych Nr 2 Bialymstoku, Bialystok, Poland	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; University of Bialystok; University of Life Sciences in Lublin	Borowik, T (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.	tborowik@ibs.bialowieza.pl	Ratkiewicz, Mirosław/AAI-9035-2020; Borowik, Tomasz/W-4008-2018; Maslanko, Weronika/T-9105-2018	Ratkiewicz, Mirosław/0000-0003-2929-3612; Kowalczyk, Rafal/0000-0001-7264-2158; Borowik, Tomasz/0000-0003-0321-8200; Maslanko, Weronika/0000-0003-4021-4348	Polish Ministry of Science and Higher Education of Poland [NN3042809940]	Polish Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland)	The Polish Ministry of Science and Higher Education of Poland, project No. NN3042809940 (National Science Centre, NCN; Poland) granted to M. Ratkiewicz	Aikens EO, 2017, ECOL LETT, V20, P741, DOI 10.1111/ele.12772; ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; Apollonio M, 2017, MAMMAL RES, V62, P209, DOI 10.1007/s13364-017-0321-5; Arnemo Jon M., 2003, Alces, V39, P243; Avgar T, 2013, J ANIM ECOL, V82, P96, DOI 10.1111/j.1365-2656.2012.02035.x; Ball JP, 2001, WILDLIFE BIOL, V7, P39, DOI 10.2981/wlb.2001.007; BALLARD WB, 1991, WILDLIFE MONOGR, P1; Bauer S, 2009, BIOL LETTERS, V5, P433, DOI 10.1098/rsbl.2009.0324; Bischof R, 2012, AM NAT, V180, P407, DOI 10.1086/667590; Borowik T, 2018, BASIC APPL ECOL, V30, P87, DOI 10.1016/j.baae.2018.05.003; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cagnacci F, 2016, J ANIM ECOL, V85, P54, DOI 10.1111/1365-2656.12449; Cagnacci F, 2011, OIKOS, V120, P1790, DOI 10.1111/j.1600-0706.2011.19441.x; CEDERLUND G, 1987, J WILDLIFE MANAGE, V51, P342, DOI 10.2307/3801014; Chapman BB, 2011, OIKOS, DOI [10.1890/12-0245.1, DOI 10.1890/12-0245.1]; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Culp LA, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1565; Debeffe L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42639-3; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Eggeman SL, 2016, J ANIM ECOL, V85, P785, DOI 10.1111/1365-2656.12495; Fortuniak K, 2016, ATLAS PARAMETROW MET; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; Gazda L., 2009, REZERWAT BIOSFERY PO, P29; GEBCZYNSKA Z, 1989, ACTA THERIOL, V34, P195; Gebczynska Z, 1984, ACTA ZOOL FENN, V172, P93; Gurarie E, 2017, J ANIM ECOL, V86, P943, DOI 10.1111/1365-2656.12674; Harasimiuk M, 2009, REZERWAT BIOSFERY PO, P37; Hays GC, 2013, FUNCT ECOL, V27, P748, DOI 10.1111/1365-2435.12073; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Hein AM, 2012, ECOL LETT, V15, P104, DOI 10.1111/j.1461-0248.2011.01714.x; Heino M, 2001, AM NAT, V157, P495, DOI 10.1086/319927; Hofman-Kaminska E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190723; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Hurley MA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0196; KAITALA A, 1993, AM NAT, V142, P59, DOI 10.1086/285529; Kaszewski BM, 2005, REZERWAT BIOSFERY PO, P36; Lack David, 1943, BRIT BIRDS, V37, P122; Loe LE, 2005, J ANIM ECOL, V74, P579, DOI 10.1111/j.1365-2656.2005.00987.x; Martin J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25777-y; Merkle JA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0456; Mueller T, 2011, GLOBAL ECOL BIOGEOGR, V20, P683, DOI 10.1111/j.1466-8238.2010.00638.x; Mysterud A, 1999, J ZOOL, V247, P479, DOI 10.1111/j.1469-7998.1999.tb01011.x; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; Naidoo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036527; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Peters W, 2017, ECOL MONOGR, V87, P297, DOI 10.1002/ecm.1250; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2007, ECOLOGY, V88, P381, DOI 10.1890/06-0875; Piasecki D., 2009, REZERWAT BIOSFERY PO, P64; R Development Core Team, 2016, R LANG ENV STAT COMP; Rivrud IM, 2016, ECOLOGY, V97, P1058, DOI 10.1890/15-1191.1; Rolandsen CM, 2017, OIKOS, V126, P547, DOI 10.1111/oik.02996; Sawyer H, 2011, J ANIM ECOL, V80, P1078, DOI 10.1111/j.1365-2656.2011.01845.x; Shaw AK, 2013, AM NAT, V181, P114, DOI 10.1086/668600; Singh NJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149594; Singh NJ, 2012, ECOL APPL, V22, P2007, DOI 10.1890/12-0245.1; Skov C, 2011, P ROY SOC B-BIOL SCI, V278, P1414, DOI 10.1098/rspb.2010.2035; Sokolowski AW, 2006, LASY PRIME LNOCNO WS; Spitz DB, 2017, ECOGRAPHY, V40, P788, DOI 10.1111/ecog.02587; SWEANOR PY, 1989, J APPL ECOL, V26, P25, DOI 10.2307/2403648; Turchin Peter, 1998; Urban G, 2009, SUSTAINABLE DEVELOPMENT AND BIOCLIMATE: REVIEWED CONFERENCE PROCEEDINGS, P60; urek S., 2005, PRZYRODA BIEBRZA SKI, P19; van Moorter B, 2013, J ANIM ECOL, V82, P770, DOI 10.1111/1365-2656.12045; Wawrzyniak Piotr, 2010, P223; White KS, 2014, ECOLOGY, V95, P225, DOI 10.1890/13-0054.1; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Wood SN, 2016, J AM STAT ASSOC, V111, P1548, DOI 10.1080/01621459.2016.1180986	69	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230521	10.1371/journal.pone.0230521	http://dx.doi.org/10.1371/journal.pone.0230521			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191742	Green Published, gold			2022-12-26	WOS:000535302300054
J	Quinteiro, J; Rodriguez-Castro, J; Rey-Mendez, M; Gonzalez-Henriquez, N				Quinteiro, Javier; Rodriguez-Castro, Jorge; Rey-Mendez, Manuel; Gonzalez-Henriquez, Nieves			Phylogeography of the insular populations of common octopus, Octopus vulgaris Cuvier, 1797, in the Atlantic Macaronesia	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; GENETIC-STRUCTURE; DNA; CEPHALOPODA; MOLLUSCA; PACIFIC; GROWTH; OCEAN; OCTOPODIDAE; DIVERGENCE	Exploited, understudied populations of the common octopus, Octopus vulgaris Cuvier, 1797, occur in the northeastern Atlantic (NEA) throughout Macaronesia, comprising the Azores, Madeira and Canaries, and also the Cabo Verde archipelago. This octopus species, found from the intertidal to shallow continental-shelf waters, is largely sedentary, and the subject of intense, frequently unregulated fishing effort. We infer connectivity among insular populations of this octopus. Mitochondrial control region and COX1 sequence datasets reveal two highly divergent haplogroups (alpha and beta) at similar frequencies, with opposing clinal distributions along the sampled latitudinal range. Haplogroups have different demographic and phylogeographic patterns, with origins related to the two last glacial maxima. F-ST values suggest a significant differentiation for most pairwise comparisons, including insular and continental samples, from the Galicia and Morocco coasts, with the exception of pairwise comparisons for samples from Madeira and the Canaries populations. Results indicate the existence of genetically differentiated octopus populations throughout the NEA. This emphasizes the importance of regulations by autonomous regional governments of the Azores, Madeira and the Canaries, for appropriate management of insular octopus stocks.	[Quinteiro, Javier; Rodriguez-Castro, Jorge; Rey-Mendez, Manuel] Univ Santiago de Compostela, Dept Biochem & Mol Biol, Mol Systemat Lab, La Coruna, Galicia, Spain; [Gonzalez-Henriquez, Nieves] Univ Las Palmas Gran Canaria, Dept Biol, BIOMOL Lab, Las Palmas Gran Canaria, Spain	Universidade de Santiago de Compostela; Universidad de Las Palmas de Gran Canaria	Quinteiro, J (corresponding author), Univ Santiago de Compostela, Dept Biochem & Mol Biol, Mol Systemat Lab, La Coruna, Galicia, Spain.	javier.quinteiro@gmail.com	Castro, Jorge Rodríguez/E-5345-2018; Quinteiro, Javier/C-4410-2011	Castro, Jorge Rodríguez/0000-0003-2912-9601; Quinteiro, Javier/0000-0002-8683-9522	BANCOMAC (European Community Initiative INTERREG IIIB); BANGEN projects (MAC Interreg Territorial Cooperation Programme "Madeira, Azores and Canary Islands")	BANCOMAC (European Community Initiative INTERREG IIIB); BANGEN projects (MAC Interreg Territorial Cooperation Programme "Madeira, Azores and Canary Islands")	This work was supported by the BANCOMAC (European Community Initiative INTERREG IIIB) and BANGEN projects (MAC Interreg Territorial Cooperation Programme "Madeira, Azores and Canary Islands"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACd, 1999, INST DYN SUBTR JET A, V29, P837, DOI [10.1175/1520-0485, DOI 10.1175/1520-0485]; Allcock AL, 2011, DEEP-SEA RES PT II, V58, P242, DOI 10.1016/j.dsr2.2010.05.016; Amor MD, 2017, ZOOL SCR, V46, P275, DOI 10.1111/zsc.12207; Avila SP, 2019, BIOL REV, V94, P1116, DOI 10.1111/brv.12492; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barry PD, 2013, J MOLLUS STUD, V79, P133, DOI 10.1093/mollus/eyt006; Berger A, 2016, REV GEOPHYS, V54, P162, DOI 10.1002/2015RG000482; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Cabranes C, 2008, ICES J MAR SCI, V65, P12, DOI 10.1093/icesjms/fsm178; Camus MF, 2017, MOL BIOL EVOL, V34, P2600, DOI 10.1093/molbev/msx184; Cuccu D, 2013, J MAR BIOL ASSOC UK, V93, P843, DOI 10.1017/S0025315412000203; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Luca D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149496; De Luca D, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00055; Sales JBD, 2013, J SHELLFISH RES, V32, P325, DOI 10.2983/035.032.0211; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fadhlaoui-Zid K, 2012, CR BIOL, V335, P625, DOI 10.1016/j.crvi.2012.10.004; FAO, 2018, REP FAO CECAF WORK G; Goodall-Copestake WP, 2012, HEREDITY, V109, P50, DOI 10.1038/hdy.2012.12; Greatorex EC, 2000, MOL ECOL, V9, P641, DOI 10.1046/j.1365-294x.2000.00882-7.x; Guillot G, 2005, MOL ECOL NOTES, V5, P3; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hanski I, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P186; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hernandez-Lopez JL, 2001, FISH B-NOAA, V99, P679; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Huber C, 2006, EARTH PLANET SC LETT, V243, P504, DOI 10.1016/j.epsl.2006.01.002; Ibanez CM, 2011, MAR ECOL PROG SER, V431, P163, DOI 10.3354/meps09133; Jenkins TL, 2018, PEERJ, V6, DOI 10.7717/peerj.5684; Juarez OE, 2012, CIENC MAR, V38, P563, DOI 10.7773/cm.v38i3.1962; JUKES T H, 1969, P21; KEIGWIN L, 1982, SCIENCE, V217, P350, DOI 10.1126/science.217.4557.350; KEIGWIN LD, 1978, GEOLOGY, V6, P630, DOI 10.1130/0091-7613(1978)6<630:PCOTIO>2.0.CO;2; Keskin E, 2011, BIOCHEM SYST ECOL, V39, P277, DOI 10.1016/j.bse.2011.08.015; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Leite TS, 2008, J MOLLUS STUD, V74, P63, DOI 10.1093/mollus/eym050; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Mangold K., 1983, P335; Fernandez-Palacios JM, 2011, J BIOGEOGR, V38, P226, DOI 10.1111/j.1365-2699.2010.02427.x; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Meckler AN, 2013, NATURE, V495, P495, DOI 10.1038/nature12006; Morri C, 2000, ARQUIPELAGO-LIFE AND MARINE SCIENCES, SUPPLEMENT 2, PART A, 2000, PROCEEDINGS, P157; Norman M.D., 2016, CEPHALOPODS WORLD AN, V3, P36; O Foighil D, 2001, MAR ECOL PROG SER, V213, P165, DOI 10.3354/meps213165; Perez-Losada M, 2007, MOL ECOL, V16, P2667, DOI 10.1111/j.1365-294X.2007.03333.x; Pham CK, 2013, ICES J MAR SCI, V70, P564, DOI 10.1093/icesjms/fst024; Pliego-Cardenas R, 2014, J SHELLFISH RES, V33, P293, DOI 10.2983/035.033.0128; Pusz AE, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA001950; Quinteiro J, 2007, MAR BIOL, V153, P47, DOI 10.1007/s00227-007-0783-0; Quinteiro J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124707; Quinteiro J, 2011, MOLLUSCAN RES, V31, P15; Quinteiro J, 2011, J MAR BIOL ASSOC UK, V91, P1537, DOI 10.1017/S0025315411000166; Raya CP, 1998, S AFR J MARINE SCI, V20, P135; Ruddiman W., 1976, MEM GEOL SOC AM, V145, P111, DOI [DOI 10.1130/MEM145-P111, 10.1130/MEM145-p111]; Sa-Pinto A, 2008, MOL ECOL, V17, P519, DOI 10.1111/j.1365-294X.2007.03563.x; Sanchez G, 2016, FISH RES, V175, P1, DOI 10.1016/j.fishres.2015.11.005; Sasson N, 2012, MAR ECOL PROG SER, V459, P99, DOI 10.3354/meps09735; Schmidt DN, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P427; SMALE MJ, 1981, MAR BIOL, V65, P1, DOI 10.1007/BF00397061; Sonderblohm CP, 2014, ICES J MAR SCI, V71, P2231, DOI 10.1093/icesjms/fst189; Strugnell JM, 2017, ECOL EVOL, V7, P8087, DOI 10.1002/ece3.3327; Teske PR, 2007, MAR BIOL, V151, P2119, DOI 10.1007/s00227-007-0644-x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van den Broeck H, 2008, MAR BIOL, V153, P421, DOI 10.1007/s00227-007-0820-z; Van Nieuwenhove AHM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214748; Vangriesheim A, 2003, OCEANOL ACTA, V26, P149, DOI 10.1016/S0399-1784(02)00002-6; Warnke K, 2004, J ZOOL SYST EVOL RES, V42, P306, DOI 10.1111/j.1439-0469.2004.00277.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Wilke T, 2003, ZOOL J LINN SOC-LOND, V137, P319, DOI 10.1046/j.1096-3642.2003.00049.x; Winkelmann I, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0273	74	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230294	10.1371/journal.pone.0230294	http://dx.doi.org/10.1371/journal.pone.0230294			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191765	Green Published, gold			2022-12-26	WOS:000535302300035
J	White, SL; Begum, SI; Vieira, MC; Seed, P; Lawlor, DL; Sattar, N; Nelson, SM; Welsh, P; Pasupathy, D; Poston, L				White, Sara L.; Begum, Shah Ina; Vieira, Matias C.; Seed, Paul; Lawlor, Deborah L.; Sattar, Naveed; Nelson, Scott M.; Welsh, Paul; Pasupathy, Dharmintra; Poston, Lucille		UPBEAT Consortium	Metabolic phenotyping by treatment modality in obese women with gestational diabetes suggests diverse pathophysiology: An exploratory study	PLOS ONE			English	Article							INSULIN-RESISTANCE; HYPERGLYCEMIA; PREGNANCY; SECRETION; SENSITIVITY; ACIDS	Background and purpose Excess insulin resistance is considered the predominant pathophysiological mechanism in obese women who develop gestational diabetes (GDM). We hypothesised that obese women requiring differing treatment modalities for GDM may have diverse underlying metabolic pathways. Methods In this secondary analysis of the UK pregnancies Better Eating and Activity Trial (UPBEAT) we studied women from the control arm with complete biochemical data at three gestational time points; at 15-18+6 and 27-28+6 weeks (before treatment), and 34-36+0 weeks (after treatment). A total of 89 analytes were measured (plasma/serum) using a targeted nuclear magnetic resonance (NMR) platform and conventional assays. We used linear regression with appropriate adjustment to model metabolite concentration, stratified by treatment group. Main findings 300 women (median BMI 35kg/m(2); inter quartile range 32.8-38.2) were studied. 71 developed GDM; 28 received dietary treatment only, 20 metformin, and 23 received insulin. Prior to the initiation of treatment, multiple metabolites differed (p<0.05) between the diet and insulin-treated groups, especially very large density lipoprotein (VLDL) and high density lipoprotein (HDL) subclasses and constituents, with some differences maintained at 34-36 weeks' gestation despite treatment. Gestational lipid profiles of the diet treatment group were indicative of a lower insulin resistance profile, when compared to both insulin-treated women and those without GDM. At 28 weeks' the diet treatment group had lower plasma fasting glucose and insulin than women treated with insulin, yet similar to those without GDM, consistent with a glycaemic mechanism independent of insulin resistance. Conclusions/Interpretation This exploratory study suggests that GDM pathophysiological processes may differ amongst obese women who require different treatment modalities to achieve glucose control and can be revealed using metabolic profiling.	[White, Sara L.; Begum, Shah Ina; Vieira, Matias C.; Seed, Paul; Pasupathy, Dharmintra; Poston, Lucille] Kings Coll London, Sch Life Course Sci, Dept Women & Childrens Hlth, London, England; [Lawlor, Deborah L.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Lawlor, Deborah L.] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Lawlor, Deborah L.] Univ Hosp Bristol NHS Fdn Trust, NIHR Bristol Biomed Res Ctr, Bristol, Avon, England; [Lawlor, Deborah L.] Univ Bristol, Bristol, Avon, England; [Sattar, Naveed; Welsh, Paul] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Nelson, Scott M.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland	University of London; King's College London; University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of Glasgow; University of Glasgow	White, SL (corresponding author), Kings Coll London, Sch Life Course Sci, Dept Women & Childrens Hlth, London, England.	sara.white@kcl.ac.uk	Welsh, Paul/H-5249-2019; Seed, Paul T/C-4435-2008	Welsh, Paul/0000-0002-7970-3643; Begum, Shahina/0000-0002-3521-8865; Seed, Paul T/0000-0001-7904-7933; Poston, Lucilla/0000-0003-1100-2821; Singh, Claire/0000-0003-1681-8467; White, Sara Louise/0000-0001-7979-0508; /0000-0002-8076-4275	National Institute of Health Research [RP-PG-0407-10452]; Medical Research Council UK [MR/L002477/1]; Chief Scientist Office, Scottish Government Health Directorates (Edinburgh) [CZB/A/680]; Biomedical Research Centre at Guys & St Thomas NHS Foundation Trust & King's College London; NIHR Bristol Biomedical Research Centre; Tommy's Charity, UK [SC039280]; Diabetes UK [14/0004849]; Tommy's Charity; CAPES-Brazil [BEX 9571/13-2]; European Union's Seventh Framework Programme, ERC grant agreement [FP7/20072013, 669545]; US National Institute of Health [R01 DK10324]; National Institute for Health [NF-SI-0166-10196]; Emeritus National Institute for Health [NI-SI-0512-10104]; MRC [MC_UU_00011/6, MR/L002477/1] Funding Source: UKRI	National Institute of Health Research(National Institute for Health Research (NIHR)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office, Scottish Government Health Directorates (Edinburgh); Biomedical Research Centre at Guys & St Thomas NHS Foundation Trust & King's College London; NIHR Bristol Biomedical Research Centre; Tommy's Charity, UK; Diabetes UK(Diabetes UK); Tommy's Charity; CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); European Union's Seventh Framework Programme, ERC grant agreement; US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health; Emeritus National Institute for Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study received funding from the National Institute of Health Research (www.nihr.ac.uk) (RP-PG-0407-10452), Medical Research Council UK (www.mrc.ac.uk) (MR/L002477/1), Chief Scientist Office, Scottish Government Health Directorates (Edinburgh) (www.cso.scot.nhs.uk) (CZB/A/680), Biomedical Research Centre at Guys & St Thomas NHS Foundation Trust & King's College London (www.guysandstthomasbrc.nihr.ac.uk) and the NIHR Bristol Biomedical Research Centre (www.bristolbrc.nihr.ac.uk), Tommy's Charity, UK (www.tommys.org) (SC039280). SLW was supported by a fellowship from Diabetes UK (www.diabetes.org.uk) (14/0004849). DP was funded by Tommy's Charity. MCV was supported by a fellowship from CAPES-Brazil (www.iie.org/programs/CAPES) (BEX 9571/13-2). DAL's contribution to this work was supported by the European Union's Seventh Framework Programme (www.ec.europa.eu/research/fp7) (FP7/20072013), ERC grant agreement (www.erc.europa.eu) (No 669545, DevelopObese) and the US National Institute of Health (www.nih.gov) (R01 DK10324) and is a National Institute for Health research Senior Investigator (NF-SI-0166-10196) and LP is an Emeritus National Institute for Health Research Senior Investigator (NI-SI-0512-10104). The study sponsor or funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Festa A, 1999, DIABETES CARE, V22, P1688, DOI 10.2337/diacare.22.10.1688; Fischer K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001606; Hoofnagle AN, 2010, CURR DIABETES REP, V10, P78, DOI 10.1007/s11892-009-0085-7; KautzkyWiller A, 1997, DIABETES CARE, V20, P1717, DOI 10.2337/diacare.20.11.1717; LabCorp, UND NMR LIPOPROFILE; Lindsay RS, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0925-2; Little R.J.A., 2002, STAT ANAL MISSING DA; Mahendran Y, 2013, DIABETES CARE, V36, P3732, DOI 10.2337/dc13-0800; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Mills HL, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1248-7; Poston L, 2015, LANCET DIABETES ENDO, V3, P767, DOI 10.1016/S2213-8587(15)00227-2; Powe CE, 2016, DIABETES CARE, V39, P1052, DOI 10.2337/dc15-2672; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Wang Q, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0733-0; WARD WK, 1985, J CLIN ENDOCR METAB, V61, P1039, DOI 10.1210/jcem-61-6-1039; White SL, 2017, DIABETOLOGIA, V60, P1903, DOI 10.1007/s00125-017-4380-6; Wurtz P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001765; Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895; Wurtz P, 2012, DIABETES, V61, P1372, DOI 10.2337/db11-1355	22	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230658	10.1371/journal.pone.0230658	http://dx.doi.org/10.1371/journal.pone.0230658			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240196	Green Published, gold, Green Accepted			2022-12-26	WOS:000535945000033
J	Gyasi, RM; Obeng, B; Yeboah, JY				Gyasi, Razak M.; Obeng, Bernard; Yeboah, Joseph Y.			Impact of food insecurity with hunger on mental distress among community-dwelling older adults	PLOS ONE			English	Article							SOCIAL SUPPORT; PSYCHOLOGICAL DISTRESS; DEPRESSION; HEALTH; ANXIETY; ASSOCIATION; NUTRITION; IDEATION; GENDER	Background Hunger frequently and persistently occur in older populations in low-income countries especially in sub-Sahara Africa. The aim of this study was to examine the associations between food insecurity with hunger and psychological distress among older people in Ghana. Methods A total of 1200 individuals aged.50 years were recruited during 2016/2017 Ageing, Health, Psychological Well-being and Health-seeking Behavior Study. Associations between psychological distress (assessed with the Kessler Psychological Distress Scale) and hunger (assessed with a 30-day subjective scale) were evaluated using linear regression modeling. Results The overall prevalence of food insecurity was 36% with approximately 27% and 9% respectively for moderate and severe levels of hunger whilst the mean score of psychological distress was 9.5 (+/- 4.10). Persons experiencing moderate hunger (beta = 0.71, SE = 0.160, p < 0.001) and severe hunger (beta = 1.81, SE = 0.280, p < 0.001) significantly reported increased psychological distress outcome compared to those without hunger. These associations varied between women (beta = 1.59, SE = 0.359 p < 0.001) and men (beta = 2.33, SE = 0.474, p < 0.001) as well as 50-64 age group (beta = 1.48, SE = 0.368, p < 0.005) and 65+ age group (beta = 2.51, SE = 0.467, p < 0.001). Conclusions The results suggest that experiencing hunger is associated with psychological distress and the effect may be aggravated with advancing age and in men. These findings may inform social policy initiatives and health programmatic interventions for older people exposed to food insecurity.	[Gyasi, Razak M.] African Populat & Hlth Res Ctr APHRC, Nairobi, Kenya; [Obeng, Bernard] Kwame Nkrumah Univ Sci & Technol, Dept Sociol & Social Work, Kumasi, Ghana; [Yeboah, Joseph Y.] Kwame Nkrumah Univ Sci & Technol, Dept Geog & Rural Dev, Kumasi, Ghana	African Population & Health Research Centre; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Gyasi, RM (corresponding author), African Populat & Hlth Res Ctr APHRC, Nairobi, Kenya.	RGyasi@aphrc.org	Gyasi, Razak M/V-2309-2018	Gyasi, Razak M/0000-0002-6733-1539	Lingnan University, Hong Kong [RPG 1129310]	Lingnan University, Hong Kong	This work was supported by Lingnan University, Hong Kong [RPG 1129310] to RMG (https://www.ln.edu.hk/about-lu/introducinglingnan).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff RR, 2016, PREV MED, V92, P106, DOI 10.1016/j.ypmed.2016.08.012; [Anonymous], 2018, THESIS; [Anonymous], [No title captured]; Biritwum R, 2013, STUDY GLOBAL AGEING; Canavan ME, 2013, INT J MENT HEALTH SY, V7, DOI 10.1186/1752-4458-7-9; Carter KN, 2011, SOC SCI MED, V72, P1463, DOI 10.1016/j.socscimed.2011.03.009; Davison KM, 2015, SOC PSYCH PSYCH EPID, V50, P963, DOI 10.1007/s00127-015-1018-1; Dean WR, 2011, SOC SCI MED, V72, P1454, DOI 10.1016/j.socscimed.2011.03.015; Frith E, 2018, CLIN NUTR, V37, P1765, DOI 10.1016/j.clnu.2017.07.001; Ghana Statistical Service, 2012, POP HOUS CENS SUMM F; Guerrero Natalie, 2014, WMJ, V113, P133; Gurung RAR, 2003, PSYCHOL AGING, V18, P487, DOI 10.1037/0882-7974.18.3.487; Gyasi R., 2020, J AFFECTIVE DISORDER; Gyasi RM, 2019, J AFFECT DISORDERS, V259, P154, DOI 10.1016/j.jad.2019.08.024; Gyasi RM, 2020, GERONTOLOGIST, V60, P416, DOI 10.1093/geront/gnz052; Gyasi RM, 2019, WOMEN HEALTH, V59, P1089, DOI 10.1080/03630242.2019.1587666; Gyasi RM, 2019, ARCH GERONTOL GERIAT, V81, P142, DOI 10.1016/j.archger.2018.11.016; Gyasi RM, 2020, J AGING HEALTH, V32, P227, DOI 10.1177/0898264318816217; Gyasi RM, 2019, INT PSYCHOGERIATR, V31, P1047, DOI 10.1017/S1041610218001539; Hadley C, 2008, J EPIDEMIOL COMMUN H, V62, P980, DOI 10.1136/jech.2007.068460; Hadley C, 2006, AM J HUM BIOL, V18, P359, DOI 10.1002/ajhb.20505; Jones AD, 2017, AM J PREV MED, V53, P264, DOI 10.1016/j.amepre.2017.04.008; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Koyanagi A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040749; Koyanagi A, 2019, J AFFECT DISORDERS, V248, P91, DOI 10.1016/j.jad.2019.01.033; Laraia BA, 2006, J NUTR, V136, P177, DOI 10.1093/jn/136.1.177; Leung CW, 2015, J NUTR, V145, P622, DOI 10.3945/jn.114.199414; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; McDonough P, 2001, SOC SCI MED, V52, P547, DOI 10.1016/S0277-9536(00)00159-3; McIntyre L, 2013, J AFFECT DISORDERS, V150, P123, DOI 10.1016/j.jad.2012.11.029; McKinnon B, 2016, B WORLD HEALTH ORGAN, V94, P340, DOI 10.2471/BLT.15.163295; Milajerdi A, 2019, PUBLIC HEALTH, V167, P152, DOI 10.1016/j.puhe.2018.05.020; Organization WH, 2015, SUMM WORLD REP AG HL; Perez-Escamilla Rafael, 2017, Curr Dev Nutr, V1, pe000513, DOI 10.3945/cdn.117.000513; Pilgrim A, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.125476; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; United Nations DESA, 2017, WORLD POP PROSP POP; United States Department of Agriculture, 2016, FOOD SEC US 2015 RET; Ustun T., 2005, QUALITY ASSURANCE SU; Wang KP, 2019, FOOD SECUR, V11, P929, DOI 10.1007/s12571-019-00945-8; Weaver LJ, 2009, ECOL FOOD NUTR, V48, P263, DOI 10.1080/03670240903001167; Whitaker RC, 2006, PEDIATRICS, V118, pE859, DOI 10.1542/peds.2006-0239; WHO, 2019, NUTR OLD PERS; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Ziliak J., 2016, STATE SENIOR HUNGER	45	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0229840	10.1371/journal.pone.0229840	http://dx.doi.org/10.1371/journal.pone.0229840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8HO	32231372	gold, Green Published			2022-12-26	WOS:000535937400004
J	Calderon-Loor, M; Cuesta, F; Pinto, E; Gosling, WD				Calderon-Loor, Marco; Cuesta, Francisco; Pinto, Esteban; Gosling, William D.			Carbon sequestration rates indicate ecosystem recovery following human disturbance in the equatorial Andes	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; ELEVATIONAL TRANSECT; ABOVEGROUND BIOMASS; FOREST TRANSITION; TUSSOCK GRASS; PARAMO; STORAGE; STOCKS; BIODIVERSITY; ALLOMETRY	Few studies exist that document how high-elevation Andean ecosystems recover naturally after the cessation of human activities and this can limit the implementation of cost-effective restoration actions. We assessed Andean forest (Polylepis stands) and paramo grassland recovery along an elevation gradient (3,600-4,350 m.a.s.l.) in the Yanacocha Reserve (Ecuador) where natural recovery has been allowed since 1995. Within the Yanacocha Reserve in 2012 and 2014 the aboveground biomass (AGB), aboveground necromass (AGN) and belowground biomass (BGB) carbon (C) stocks were measured and C sequestration rates calculated as proxy of ecosystem recovery. The soil organic carbon (SOC) stock to 36-cm depth was also quantified during the 2012 survey. To explore potential drivers of spatiotemporal variation of the forest and paramo C stocks they were related to abiotic and biotic variables. Andean forest C stocks were influenced mainly by disturbance history and tree-species composition. Paramo C stocks spatial variation were related to the elevation gradient; we found a positive significant trend in paramo AGB-C stocks with elevation, whereas we found a significant negative trend in AGN-C stocks. Likewise, significant temporal changes were found for AGB-C and AGN-C stocks. Net increases in AGB-C stocks were the largest in the Andean forest and pa ' ramo, 2.5 Mg C ha(-1) year(-1) and 1.5 Mg C ha(-1) year(-1) respectively. Carbon sequestration rates were partly explained by environmental variables. In the Andean forest, plots with low dominance of Baccharis padifolia were observed to present higher AGB-C and lower BGB-C sequestration rates. In the pa ' ramo, higher sequestration rates for AGB-C were found at higher elevations and associated with higher levels of growth-forms diversity. Temporal changes in BGB-C stocks on the contrary were non-significant. Our results indicated that terrestrial aboveground C sequestration rates might be an appropriate indicator for assessing Andean forest and pa ' ramo recovery after human disturbance.	[Calderon-Loor, Marco] Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Melbourne, Vic, Australia; [Cuesta, Francisco] Univ Amer UDLA, Grp Invest Biodiversidad Medio Ambiente & Salud B, Quito, Ecuador; [Cuesta, Francisco; Gosling, William D.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam IBED, Dept Ecosyst & Landscape Dynam, Amsterdam, Netherlands; [Pinto, Esteban] Consorcio Desarrollo Sostenible Ecorreg Andina CO, Biodivers Dept, Quito, Ecuador	Deakin University; Universidad de Las Americas - Ecuador; University of Amsterdam	Calderon-Loor, M (corresponding author), Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Melbourne, Vic, Australia.; Cuesta, F (corresponding author), Univ Amer UDLA, Grp Invest Biodiversidad Medio Ambiente & Salud B, Quito, Ecuador.; Cuesta, F (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam IBED, Dept Ecosyst & Landscape Dynam, Amsterdam, Netherlands.	mcalderonloor@deakin.edu.au; francisco.cuesta@udla.edu.ec	Gosling, William/D-2459-2009; Gosling, William/AAB-2761-2020	Gosling, William/0000-0001-9903-8401; Gosling, William/0000-0001-9903-8401; Calderon Loor, Marco Rodrigo/0000-0003-1011-4389; Cuesta, Francisco/0000-0002-5150-073X	Global Environmental Fund [4750]; Swiss Agency for Development and Cooperation (SDC) through the CIMA [PA0042-C011-0031]; Andean Forest Programs [81028631]; EcoAndes Project	Global Environmental Fund(Smithsonian Institution); Swiss Agency for Development and Cooperation (SDC) through the CIMA; Andean Forest Programs; EcoAndes Project	This paper has been developed thanks to the financial support of: The EcoAndes Project conducted by CONDESAN and UN-Environment, funded by the Global Environmental Fund (GEF < http://www.thegef.org >).Grant number: 4750 The Swiss Agency for Development and Cooperation (SDC, < www.eda.admin.ch/sdc >) through the CIMA (Gran number PA0042-C011-0031) and Andean Forest Programs (Grant number 81028631). FC, MCL, EP The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu Z, 2009, RESTOR ECOL, V17, P619, DOI 10.1111/j.1526-100X.2008.00406.x; Adler PB, 1999, J RANGE MANAGE, V52, P471, DOI 10.2307/4003774; Aronson J., 1993, Restoration Ecology, V1, P8, DOI 10.1111/j.1526-100X.1993.tb00004.x; Biswas SR, 2010, ECOLOGY, V91, P28, DOI 10.1890/08-0887.1; BuYez, 2013, MONITOREO CONTENIDOS; Buytaert W, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011755; Buytaert W, 2002, SOIL USE MANAGE, V18, P94, DOI [10.1111/j.1475-2743.2002.tb00226.x, 10.1079/SUM2001107]; Buytaert W, 2006, EARTH-SCI REV, V79, P53, DOI 10.1016/j.earscirev.2006.06.002; Buytaert W, 2011, GLOBAL ECOL BIOGEOGR, V20, P19, DOI 10.1111/j.1466-8238.2010.00585.x; CARTER MR, 1990, CAN J SOIL SCI, V70, P425, DOI 10.4141/cjss90-042; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J., 2006, MANUAL CAMPO; Chazdon RL, 2017, CONSERV LETT, V10, P125, DOI 10.1111/conl.12220; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Cuesta F, 2017, ECOGRAPHY, V40, P1381, DOI 10.1111/ecog.02567; Cuni-Sanchez A, 2017, FOREST ECOL MANAG, V399, P235, DOI 10.1016/j.foreco.2017.05.030; Eynden Mvd, 2011, EFFECTS FIRE HIST SP; Farley KA, 2007, ANN ASSOC AM GEOGR, V97, P755, DOI 10.1111/j.1467-8306.2007.00581.x; Farley KA, 2013, CONSERV LETT, V6, P21, DOI 10.1111/j.1755-263X.2012.00267.x; Fehse J, 2002, FOREST ECOL MANAG, V163, P9, DOI 10.1016/S0378-1127(01)00535-7; Feldpausch TR, 2011, BIOGEOSCIENCES, V8, P1081, DOI 10.5194/bg-8-1081-2011; Feldpausch TR, 2012, BIOGEOSCIENCES DISCU, V9; Garcia-Aristizabal A, 2007, J VOLCANOL GEOTH RES, V161, P333, DOI 10.1016/j.jvolgeores.2006.12.007; Gentry AH, 1995, BIODIVERSITY AND CONSERVATION OF NEOTROPICAL MONTANE FORESTS, P103; Gibbon A, 2010, ECOSYSTEMS, V13, P1097, DOI 10.1007/s10021-010-9376-8; Girardin CAJ, 2013, GLOBAL BIOGEOCHEM CY, V27, P252, DOI 10.1029/2011GB004082; Girardin CAJ, 2010, GLOBAL CHANGE BIOL, V16, P3176, DOI 10.1111/j.1365-2486.2010.02235.x; Graefe S, 2008, BIOTROPICA, V40, P536, DOI 10.1111/j.1744-7429.2008.00419.x; Hemp A, 2017, BIODIVERS CONSERV, V26, P103, DOI 10.1007/s10531-016-1226-3; HOFSTEDE RGM, 1995, LAND DEGRAD REHABIL, V6, P133, DOI 10.1002/ldr.3400060302; HOFSTEDE RGM, 1995, ARCTIC ALPINE RES, V27, P1, DOI 10.2307/1552062; HOFSTEDE RGM, 1995, ARCTIC ALPINE RES, V27, P13, DOI 10.2307/1552063; HOFSTEDE RGM, 1995, VEGETATIO, V119, P53; Horn Sally P., 2009, P505, DOI 10.1007/978-3-540-77381-8_18; IPCC, 2006, ENERGY, V2; Jain TB, 1997, SOIL SCI SOC AM J, V61, P1190, DOI 10.2136/sssaj1997.03615995006100040026x; JORGENSEN PM, 1994, AAU REPORTS, V34, P1; Keating PL, 2007, J LAT AM GEOGR, V6, P43, DOI 10.1353/lag.2007.0003; Keating PL, 2000, J TORREY BOT SOC, V127, P162, DOI 10.2307/3088693; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Lal R, 2008, ENERG ENVIRON SCI, V1, P86, DOI 10.1039/b809492f; Leuschner C, 2007, BASIC APPL ECOL, V8, P219, DOI 10.1016/j.baae.2006.02.004; Malhi Y, 2010, GLOBAL CHANGE BIOL, V16, P5; Marengo JA, 2011, CLIMATE CHANGE EVIDE; MARGALEF R, 1963, AM NAT, V97, P357, DOI 10.1086/282286; Marthews T, 2012, MANUAL GLOBAL ECOSYS; Martin PA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2236; McCune B, 2002, ANAL ECOLOGICAL COMM; Metcalfe D., 2007, MANUAL CAMPO; Minaya V, 2016, J PLANT ECOL, V9, P553, DOI 10.1093/jpe/rtv073; Monteiro JAF, 2011, FLORA, V206, P387, DOI 10.1016/j.flora.2011.01.001; Moser G., 2008, V198, P229; Moser G, 2011, GLOBAL CHANGE BIOL, V17, P2211, DOI 10.1111/j.1365-2486.2010.02367.x; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Oliveras I, 2014, AUSTRAL ECOL, V39, P408, DOI 10.1111/aec.12098; Palace M, 2012, TROPICAL FORESTS, P215; Pauli H, 2015, GLORIA FIELD MANUAL, V5th; Pearson T, 2005, SOURCEBOOK LAN USE L; Pearson T.R.H., 2007, GEN TECHNICAL REPORT, V18, P42; Pena E., 2011, PLANET EARTH 2011 GL, P123, DOI [10.5772/23515, DOI 10.5772/23515]; Pena MA, 2018, PLANT ECOL, V219, P1481, DOI 10.1007/s11258-018-0895-2; Pena MA, 2013, FOREST ECOL MANAG, V302, P54, DOI 10.1016/j.foreco.2013.03.025; Picard N., 2012, Manual for building tree volume and biomass allometric equations: from field measurement to prediction; Podwojewski P, 2002, OVERGRAZING EFFECTS; Poorter L, 2017, GLOBAL ECOL BIOGEOGR, V26, P1423, DOI 10.1111/geb.12668; Poulenard J, 2001, CATENA, V45, P185, DOI 10.1016/S0341-8162(01)00148-5; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsay P, 1997, PLANT ECOL, V131, P20; Ramsay PM, 1996, VEGETATIO, V124, P129; Ramsay PM, 2001, MT RES DEV, V21, P161, DOI 10.1659/0276-4741(2001)021[0161:AAOANP]2.0.CO;2; Rhoades C, 2000, ECOLOGICAL APLICATIO, P9; Roman-Cuesta RM, 2011, FOREST ECOL MANAG, V261, P1987, DOI 10.1016/j.foreco.2011.02.025; Roman-Cuesta RM, 2014, FOREST ECOL MANAG, DOI [10.1016/j.foreco.2014.07.032, DOI 10.1016/J.FORECO.2014.07.032]; Silver WL, 2000, RESTOR ECOL, V8, P394, DOI 10.1046/j.1526-100x.2000.80054.x; Sklenar P, 2007, FLORA, V202, P50, DOI 10.1016/j.flora.2006.03.002; Sklenar Petr, 2001, Diversity and Distributions, V7, P113, DOI 10.1046/j.1472-4642.2001.00101.x; Sklenar P, 2014, J BIOGEOGR, V41, P287, DOI 10.1111/jbi.12212; Sokal R. R., 1981, BIOMETRY PRINCIPLES; Spracklen DV, 2014, BIOGEOSCIENCES, V11, P2741, DOI 10.5194/bg-11-2741-2014; Spracklen DV, 2016, FOREST ECOL MANAG, V364, P139, DOI 10.1016/j.foreco.2016.01.001; Suarez E, 2001, ARCT ANTARCT ALP RES, V33, P158; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tilman D., 2014, ANN REV ECOLOGY EVOL, V45; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Tonneijck F, 2010, EUROPEAN J SOIL SCI, V61, P15; Tonneijck F, 2009, CARBON STOCKS STABIL; Tonneijck FH, 2008, GEODERMA, V144, P231, DOI 10.1016/j.geoderma.2007.11.009; Vanacker V, 2003, GEOMORPHOLOGY, V52, P299, DOI 10.1016/S0169-555X(02)00263-5; Vasquez E, 2014, ALPINE BOT, V124, P71, DOI 10.1007/s00035-014-0126-y; Venter M, 2017, GLOBAL CHANGE BIOL, V23, P4873, DOI 10.1111/gcb.13741; Waksman SA, 1930, SOIL SCI, V30, P97, DOI 10.1097/00010694-193008000-00002; Zimmermann M, 2009, EUR J SOIL SCI, V60, P895, DOI 10.1111/j.1365-2389.2009.01175.x; Zimmermann M, 2009, CRIT CARE, V13, DOI 10.1186/cc7703	93	5	5	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230612	10.1371/journal.pone.0230612	http://dx.doi.org/10.1371/journal.pone.0230612			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HE	32226044	Green Published, gold			2022-12-26	WOS:000535936400009
J	Alemayehu, AM; Dagne, H; Dagnew, B				Alemayehu, Abiy Maru; Dagne, Henok; Dagnew, Baye			Knowledge and associated factors towards diabetes mellitus among adult non-diabetic community members of Gondar city, Ethiopia 2019	PLOS ONE			English	Article								Introduction Diabetes mellitus is a metabolic disorder resulting from either loss of insulin producing cells, insufficient insulin action, or both. Knowledge can play an important role in preventing diabetes mellitus and its complications. There is limited information regarding knowledge and related factors regarding diabetes mellitus among non-diabetic adult community members in the study area. Therefore, the current study aimed to determine knowledge and associated factors towards diabetes mellitus among non-diabetes community members of Gondar city. Methods Community-based cross-sectional study was conducted on non-diabetic community members from July 1-29, 2019 in Gondar city. The participants were selected randomly from each households. A structured questionnaire was used to collect the data. EpiData version 3.1 was used for data entry and SPSS version 20 was used for data processing and analysis. Descriptive statistics were calculated for most variables. Multivariable logistic regression was used to identify the associated factors. A variable was considered significantly associated at p-value<0.05. Result A total of 633 study subjects participated in this study with a mean age of 36.12 (+/- 12.87) years. Of these study participants, 572 had awareness about diabetes mellitus and 51.4% (95% CI: 47.4%, 55.8%) had good knowledge. Being male [Adjusted odds ratio = 1.62 (95% CI: 1.05, 2.48)], monthly income of 3000-5000 birr [Adjusted odds ratio = 1.88 (95% CI: 1.03, 3.41)], monthly income of >= 5001 birr [Adjusted odds ratio = 2.37 (95% CI: 1.17, 4.78)], previous training on diabetes mellitus [Adjusted odds ratio = 4.37 (95% CI; 3.04, 7.37)], being grade 9-12 [Adjusted odds ratio = 3.1 (95% CI: 1.09, 8.66)], having college and above educational qualification [Adjusted odds ratio = 3.70 (95% CI: 1.26, 10.85)] were significantly associated with good knowledge towards diabetes mellitus. Conclusion The level of knowledge regarding diabetes mellitus was low among study participants which indicates a need for health education intervention. Previous training on diabetes mellitus, educational status and average monthly income and being male were the factors associated with good knowledge of participants about diabetes mellitus.	[Alemayehu, Abiy Maru] Univ Gondar, Dept Optometry, Coll Med & Hlth Sci, Gondar, Ethiopia; [Dagne, Henok] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Environm & Occupat Hlth & Safety, Gondar, Ethiopia; [Dagnew, Baye] Univ Gondar, Dept Human Physiol, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Alemayehu, AM (corresponding author), Univ Gondar, Dept Optometry, Coll Med & Hlth Sci, Gondar, Ethiopia.	atinkutmar@gmail.com	Dagnew, Baye/AAS-3964-2021; Dagne, Henok/AAM-6529-2021; Dagnew, Baye/AAL-9572-2020	Dagnew, Baye/0000-0002-2397-5930; Dagnew, Baye/0000-0002-2397-5930; Derso, Henok Dagne/0000-0001-7161-0904; Maru, Abiy/0000-0002-6032-8978				Aguiree F, 2013, INT DIAB FED DIAB AT; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Asmamaw A, 2015, SCI J PUBLIC HLTH, V3, P199, DOI DOI 10.11648/J.SJPH.20150302.17; Balla SA, 2014, AM J HLTH RES, V2, P356, DOI DOI 10.11648/j.ajhr.20140206.16; Bani IA, 2015, J DIABETES MELLITUS, V5, P115, DOI [10.4236/jdm.2015.52014, DOI 10.4236/JDM.2015.52014]; Berhe KK, 2014, J DIABETES METAB, V5, DOI 10.4172/2155-6156.1000378; Central Statistical Agency and ICF, 2016, ETH DEM HLTH SURV; Daniel W. W., 2018, BIOSTATISTICS FDN AN; Fatema K, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4285-9; Gebregeorgis MY, 2016, AFR EDUC RE, V13, P119, DOI 10.1080/18146627.2016.1224579; Gillani AH, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091906; Gondar Finance and Economy directory, 2017, POP CENS PROJ 2017; Green LW, 2012, FAM PRACT, V29, pi13, DOI 10.1093/fampra/cmr126; Hartayu Titien Siwi, 2012, BMC Res Notes, V5, P315, DOI 10.1186/1756-0500-5-315; Herath HMM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4459-5; ICF international, 2012, ATL GEND HLTH IND DA; Islam FMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110368; Kassahun CW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170040; Maina WK, 2010, PAN AFR MED J, V7; Masood I, 2016, PRIM CARE DIABETES, V10, P3, DOI 10.1016/j.pcd.2015.06.004; Memon MS, 2015, PAK J MED SCI, V31, P183, DOI 10.12669/pjms.311.6317; Organization WH, 2016, GLOB REP DIAB, DOI [10.2337/db15-0956, DOI 10.2337/DB15-0956]; Rani PK, 2008, RURAL REMOTE HEALTH, V8; Rathod GB., 2014, INT J CURR RES REV, V6, P63; Sristi S, 2015, INT J DIABETES DEV C, V35, P33, DOI 10.1007/s13410-014-0219-6; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wolde Mistire, 2017, BMC Res Notes, V10, P551, DOI 10.1186/s13104-017-2871-7; World Health Organization, 2005, PREV BLINDN DIAB MEL; Zuhaid Muhammad, 2012, J Ayub Med Coll Abbottabad, V24, P105	29	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230880	10.1371/journal.pone.0230880	http://dx.doi.org/10.1371/journal.pone.0230880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214398	gold, Green Published			2022-12-26	WOS:000535934200072
J	Behar, E; Bagnulo, R; Knight, K; Santos, GM; Coffin, PO				Behar, Emily; Bagnulo, Rita; Knight, Kelly; Santos, Glenn-Milo; Coffin, Phillip O.			"Chasing the pain relief, not the high": Experiences managing pain after opioid reductions among patients with HIV and a history of substance use	PLOS ONE			English	Article							MISUSE; RISK	Background Opioid overdose mortality continues to increase in the United States despite significant investments to reverse the epidemic. The national response to-date has focused primarily on reducing opioid prescribing, yet reductions in prescribing have been associated with patients reporting uncontrolled pain, psychological distress, and transition to illicit substances. The aim of this study is to qualitatively explore chronic pain management experiences among PLWH with a history of illicit substance use after long-term opioid therapy reductions or discontinuations. Methods We analyzed 18 interviews, stopping upon reaching thematic saturation, with HIV-positive participants with a history of substance use who were enrolled in a longitudinal cohort study to assess the impact of prescribing changes among patients with chronic pain. Participants in this nested qualitative study had been reduced/discontinued from opioid pain relievers (OPRs) within the 12 months prior to interview. Interviews were audio-recorded and transcribed verbatim. Two analysts coded all interviews, interrater reliability was measured, and coding discrepancies discussed. The study took place in San Francisco, California in 2018. Results Eleven participants were male with a mean age of 55; 8 were African American and 8 were White. All participants were HIV-positive, actively engaged in primary care, and had a lifetime history of illicit substance use. Twelve reported using illicit substances within the past year, including non-prescription opioids/heroin (10), and stimulant use (10). After being reduced/discontinued from their long-term opioid therapy, patients reported developing complex multimodal pain management systems that often included both nonpharmacological approaches and illicit substance use. Participants encountered a range of barriers to nonpharmacological therapies including issues related to accessibility and availability. Participants often reported attempts to replicate their prior OPR prescription by seeking out the same medication and dose from illicit sources and reported transitioning to heroin after exhausting other options. Conclusion After being reduced/discontinued from OPRs, HIV-positive patients with a history of substance use reported experimenting with a range of pain management modalities including nonpharmacological therapies and illicit substance use to manage symptoms of opioid withdrawal and pain. Providers should consider that any change to a patients' long-term opioid therapy may result in experimentation with pain management outside of the medical setting and may want to employ patient-centered, holistic approaches when managing patients' opioid prescriptions and chronic pain.	[Behar, Emily; Bagnulo, Rita; Santos, Glenn-Milo; Coffin, Phillip O.] San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA; [Behar, Emily; Knight, Kelly; Santos, Glenn-Milo; Coffin, Phillip O.] Univ Calif San Francisco, San Francisco, CA 94143 USA	San Francisco Department of Public Health; University of California System; University of California San Francisco	Behar, E (corresponding author), San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA.; Behar, E (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	Emily.Behar@sfdph.org	; Coffin, Phillip/G-3286-2012	Santos, Glenn-Milo/0000-0003-1009-5317; Coffin, Phillip/0000-0002-3891-6570	National Institutes of Health; University of California, San Francisco; Center for AIDS Prevention Studies [P30MH062246]; National Institute on Drug Abuse at the National Institutes of Health [1R01DA040189]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco(University of California System); Center for AIDS Prevention Studies; National Institute on Drug Abuse at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This research was supported by a grant from the National Institutes of Health, University of California, San Francisco, Center for AIDS Prevention Studies, #P30MH062246 (ML, https://globalhealthsciences.ucsf.edu/internationaltraineeships-aids-prevention-studies-itaps) and a grant from the National Institute on Drug Abuse at the National Institutes of Health, #1R01DA040189 (PC, https://www.drugabuse.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker WC, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0608-2; Blanco C, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.18m12174; Bruns E, 2019, J ALTERN COMPLEMENT; Compton WM, 2016, NEW ENGL J MED, V374, P154, DOI 10.1056/NEJMra1508490; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Dowell D, 2019, N ENGL J MED; Dowell D, 2017, ANN INTERN MED, V167, P208, DOI 10.7326/M17-1402; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr6501e1, 10.1001/jama.2016.1464, 10.15585/mmwr.rr7103a1]; Glaser B. G., 2009, DISCOVERY GROUNDED T; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jeevanjee S, 2014, AIDS BEHAV, V18, P1352, DOI 10.1007/s10461-013-0619-5; Kertesz SG, 2019, J SUBST ABUSE TREAT; Kim H, 2017, RES NURS HEALTH, V40, P23, DOI 10.1002/nur.21768; Krebs EE, 2018, JAMA-J AM MED ASSOC, V319, P872, DOI 10.1001/jama.2018.0899; Larochelle MR, 2019, ANN INTERN MED, V171, P129, DOI 10.7326/M19-1394; Manhapra A, 2018, NAT RX DRUG AB HER S; Manhapra A, 2018, SUBST ABUS, V39, P152, DOI 10.1080/08897077.2017.1381663; Marcus KS, 2000, PAIN MED, V1, P260, DOI 10.1046/j.1526-4637.2000.00033.x; Morasco BJ, 2013, DRUG ALCOHOL DEPEN, V127, P193, DOI 10.1016/j.drugalcdep.2012.06.032; Oliva EM, 2017, J AM PHARM ASSOC, V57; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Phillips JK, 2017, TRENDS OPIOID USE HA; Pope C, 2006, QUALITATIVE RES HLTH; SAMHSA, 2010, SUBST ABUSE TREAT AD, V9, P1; SAMHSA's Center for the Application of Prevention Technologies, 2016, PREV PRESCR DRUG MIS; Skelly AC, 2018, NONINVASIVE NONPHARM, V18-EHC013-EF; Spitz A, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-35; Sullivan MD, 2010, PAIN, V150, P332, DOI 10.1016/j.pain.2010.05.020; Throckmorton M.D, 2019, COMMUNICATION; Traylor C, 2019, MED STRATEGIES NONOP, DOI [10.15585/mmwr.mm6610a1, DOI 10.15585/MMWR.MM6610A1]; U.S. Food and Drug Administration, 2019, FDA ID HARM REP SUDD; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Vijayaraghavan M, 2012, PAIN MED, V13, P1141, DOI 10.1111/j.1526-4637.2012.01443.x	33	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230408	10.1371/journal.pone.0230408	http://dx.doi.org/10.1371/journal.pone.0230408			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9HN	32210442	Green Published, gold			2022-12-26	WOS:000535307600024
J	Esposito, M; Sherr, GL; Esposito, A; Kaluski, G; Ellington, F; Shen, CH				Esposito, Michelle; Sherr, Goldie Libby; Esposito, Anthony; Kaluski, George; Ellington, Farris; Shen, Chang-Hui			Accumulation of unacetylatable Snf2p at the INO1 promoter is detrimental to remodeler recycling supply for CUP1 induction	PLOS ONE			English	Article							DEPENDENT RECRUITMENT; GENE-EXPRESSION; CHROMATIN; SWI/SNF; ACETYLATION; REQUIRES; COMPLEX; ELEMENT; INO80P	Chromatin structure plays a decisive role in gene regulation through the actions of transcriptional activators, coactivators, and epigenetic machinery. These trans-acting factors contribute to gene expression through their interactions with chromatin structure. In yeast INO1 activation, transcriptional activators and coactivators have been defined through intense study but the mechanistic links within these trans-acting factors and their functional implications are not yet fully understood. In this study, we examined the crosstalk within transcriptional coactivators with regard to the implications of Snf2p acetylation during INO1 activation. Through various biochemical analysis, we demonstrated that both Snf2p and Ino80p chromatin remodelers accumulate at the INO1 promoter in the absence of Snf2p acetylation during induction. Furthermore, nucleosome density and histone acetylation patterns remained unaffected by Snf2p acetylation status. We also showed that cells experience increased sensitivity to copper toxicity when remodelers accumulate at the INO1 promoter due to the decreased CUP1 expression. Therefore, our data provide evidence for crosstalk within transcriptional co-activators during INO1 activation. In light of these findings, we propose a model in which acetylation-driven chromatin remodeler recycling allows for efficient regulation of genes that are dependent upon limited co-activators.	[Esposito, Michelle; Sherr, Goldie Libby; Kaluski, George; Ellington, Farris; Shen, Chang-Hui] CUNY Coll Staten Isl, Dept Biol, Staten Isl, NY 10314 USA; [Esposito, Michelle; Sherr, Goldie Libby; Shen, Chang-Hui] CUNY, Grad Ctr, PhD Program Biol, New York, NY 10016 USA; [Esposito, Anthony] New Jersey City Univ, Dept Biol, Jersey City, NJ USA; [Shen, Chang-Hui] CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10016 USA; [Shen, Chang-Hui] CUNY, Inst Macromol Assemblies, Staten Isl, NY 10314 USA; [Esposito, Michelle] Georgian Court Univ, Dept Biol, Lakewood, NJ USA; [Sherr, Goldie Libby] CUNY, Bronx Community Coll, Dept Biol Sci, Bronx, NY USA	City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System	Shen, CH (corresponding author), CUNY Coll Staten Isl, Dept Biol, Staten Isl, NY 10314 USA.; Shen, CH (corresponding author), CUNY, Grad Ctr, PhD Program Biol, New York, NY 10016 USA.; Shen, CH (corresponding author), CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10016 USA.; Shen, CH (corresponding author), CUNY, Inst Macromol Assemblies, Staten Isl, NY 10314 USA.	changhui.shen@csi.cuny.edu		SHEN, CHANG-HUI/0000-0001-8510-448X	North Atlantic Treaty Organization (NATO) [SPS G5266]; National Science Foundation (NSF) [MCB 0919218]; Professional Staff Congress-City University of New York (PSCCUNY) awards	North Atlantic Treaty Organization (NATO)(NATO (North Atlantic Treaty Organisation)); National Science Foundation (NSF)(National Science Foundation (NSF)); Professional Staff Congress-City University of New York (PSCCUNY) awards	We would like to declare that CHS received funding from North Atlantic Treaty Organization (NATO) SPS G5266, National Science Foundation (NSF) MCB 0919218, Professional Staff Congress-City University of New York (PSCCUNY) awards for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS E, 1986, MOL CELL BIOL, V6, P3643, DOI 10.1128/MCB.6.11.3643; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Bartholomew B, 2014, ANNU REV BIOCHEM, V83, P671, DOI 10.1146/annurev-biochem-051810-093157; Charles GM, 2011, P NATL ACAD SCI USA, V108, P10620, DOI 10.1073/pnas.1019735108; Cheng X, 2018, P NATL ACAD SCI USA, V115, P10028, DOI 10.1073/pnas.1806513115; Clapier CR, 2017, NAT REV MOL CELL BIO, V18, P407, DOI 10.1038/nrm.2017.26; Davie JK, 2000, MOL CELL BIOL, V20, P5960, DOI 10.1128/MCB.20.16.5960-5973.2000; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Echtenkamp FJ, 2016, MOL CELL, V64, P888, DOI 10.1016/j.molcel.2016.09.040; Esposito M, 2010, BIOCHEM BIOPH RES CO, V391, P1285, DOI 10.1016/j.bbrc.2009.12.063; Ferreira R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-73; Ford J, 2008, BIOCHEM BIOPH RES CO, V373, P602, DOI 10.1016/j.bbrc.2008.06.079; Ford J, 2007, BIOCHEM BIOPH RES CO, V361, P974, DOI 10.1016/j.bbrc.2007.07.109; Gardocki ME, 2005, EUKARYOT CELL, V4, P604, DOI 10.1128/EC.4.3.604-614.2005; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kim JH, 2010, GENE DEV, V24, P2766, DOI 10.1101/gad.1979710; Konarzewska P, 2012, BIOCHEM BIOPH RES CO, V418, P483, DOI 10.1016/j.bbrc.2012.01.044; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; NEIGEBORN L, 1984, GENETICS, V108, P845; Pacheco D, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00038-18; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; SCHOLER A, 1994, MOL CELL BIOL, V14, P3613, DOI 10.1128/MCB.14.6.3613; SCHWANK S, 1995, NUCLEIC ACIDS RES, V23, P230, DOI 10.1093/nar/23.2.230; Shaldubina A, 2002, MOL PSYCHIATR, V7, P174, DOI 10.1038/sj.mp.4000965; Shetty A, 2010, EUKARYOT CELL, V9, P1845, DOI 10.1128/EC.00144-10; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wimalarathna RN, 2014, BIOCHEM CELL BIOL, V92, P69, DOI 10.1139/bcb-2013-0097	30	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230572	10.1371/journal.pone.0230572	http://dx.doi.org/10.1371/journal.pone.0230572			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210477	Green Published, gold			2022-12-26	WOS:000535307600033
J	Morales-Rios, O; Cicero-Oneto, C; Garcia-Ruiz, C; Villanueva-Garcia, D; Hernandez-Hernandez, M; Olivar-Lopez, V; Jimenez-Juarez, RN; Jasso-Gutierrez, L				Morales-Rios, Olga; Cicero-Oneto, Carlo; Garcia-Ruiz, Carlos; Villanueva-Garcia, Dina; Hernandez-Hernandez, Maribelle; Olivar-Lopez, Victor; Norberto Jimenez-Juarez, Rodolfo; Jasso-Gutierrez, Luis			Descriptive study of adverse drug reactions in a tertiary care pediatric hospital in Me'xico from 2014 to 2017	PLOS ONE			English	Article							TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON SYNDROME; RISK-FACTORS; CHILDREN; EPIDEMIOLOGY; PREVENTABILITY; SURVEILLANCE; POLYPHARMACY; NEUTROPENIA; CHILDHOOD	Introduction In Pediatrics, adverse drug reactions (ADRs) affect morbidity and mortality. In Mexico, the characteristics of ADRs and suspect drugs have not been described in hospitalized children. Objective To estimate the frequency of ADRs and describe them, as well as suspect drugs, in a tertiary care pediatric hospital in Mexico. Methods A total of 1,649 Hospital Infantil de Mexico Federico Gomez ADR reports were analyzed. Completeness of the information was assessed, and ADRs severity and seriousness were assigned based on NOM-220-SSA1-2012, with causality being established according to the Naranjo algorithm. ADRs were classified with WHO Adverse Drug Reaction Terminology (WHO-ART). The drugs involved in ADRs were categorized according to the Anatomical Therapeutic Chemical (ATC) classification. Descriptive analysis was performed using the SPSS 20 statistical package. Results Of all the reports, 5.8% lacked sufficient information for the analysis (grade 0). ADRs frequency ranged from 2.12% to 8.07%. ADRs occurred most commonly in children (56.9%), in the female gender (52%), in subjects with normal BMI Z-score (46.6%) and malnutrition (35.3%), diagnosed with neoplasms (72.2%) and in the Emergency Department (70.0%). ADRs were severe in 14.4% of cases, in 81.0% they were serious and 2.1% were classified as definite. Most common serious ADR was febrile neutropenia (44.5%). The 0.7% of patients recovering with sequelae; 1.1% died (with the medication being associated) and 70.3% were admitted to the hospital as a result of an ADR. Antineoplastic and immunomodulating agents were more commonly associated with serious ADRs. Conclusion ADRs affected morbidity and mortality, which is why strengthening pharmacovigilance programs in Mexican pediatric hospitals is necessary.	[Morales-Rios, Olga; Garcia-Ruiz, Carlos; Jasso-Gutierrez, Luis] Hosp Infantil Mexico Dr Federico Gomez, Clin Res Dept, Ciudad De Mexico, Mexico; [Cicero-Oneto, Carlo] Hosp Infantil Mexico Dr Federico Gomez, Hematol Oncol Dept, Ciudad De Mexico, Mexico; [Villanueva-Garcia, Dina] Hosp Infantil Mexico Dr Federico Gomez, Neonatol Dept, Ciudad De Mexico, Mexico; [Hernandez-Hernandez, Maribelle] Hosp Infantil Mexico Dr Federico Gomez, Intens Therapy Dept, Ciudad De Mexico, Mexico; [Olivar-Lopez, Victor] Hosp Infantil Mexico Dr Federico Gomez, Emergency Dept, Ciudad De Mexico, Mexico; [Norberto Jimenez-Juarez, Rodolfo] Hosp Infantil Mexico Dr Federico Gomez, Infect Dis Dept, Ciudad De Mexico, Mexico; [Norberto Jimenez-Juarez, Rodolfo] Inst Mexicano Seguro Social, Infect Dis Hosp, Ctr Med Nacl La Raza, Dept Pediat, Ciudad De Mexico, Mexico	Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Instituto Mexicano del Seguro Social	Morales-Rios, O (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, Clin Res Dept, Ciudad De Mexico, Mexico.	magdalaqfb@yahoo.com.mx		Jimenez-Juarez, Rodolfo N/0000-0001-5086-3363	 [HIM 2018-003 SSA 1470]		OMR received "Federal Funding" for this work (Grant Number: HIM 2018-003 SSA 1470). The funding entity had no participation in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aagaard L, 2012, DRUG SAFETY, V35, P1171, DOI 10.2165/11631940-000000000-00000; Aagaard L, 2010, BRIT J CLIN PHARMACO, V70, P481, DOI 10.1111/j.1365-2125.2010.03682.x; Agbabiaka TB, 2008, DRUG SAFETY, V31, P21, DOI 10.2165/00002018-200831010-00003; Jimenez-Triana CA, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001413; [Anonymous], 1994, INT C HARMONISATION; Behera SK, 2018, INT J CLIN PHARM-NET, V40, P903, DOI 10.1007/s11096-018-0694-9; Castelan-Martinez OD, 2016, J PEDIAT HEMATOL ONC, V38, P191, DOI 10.1097/MPH.0000000000000515; Castelan-Martinez OD, 2014, INT J PEDIATR OTORHI, V78, P1456, DOI 10.1016/j.ijporl.2014.06.007; Clavenna A, 2009, ARCH DIS CHILD, V94, P724, DOI 10.1136/adc.2008.154377; Cliff-Eribo KO, 2016, EXPERT OPIN DRUG SAF, V15, P1321, DOI 10.1080/14740338.2016.1221921; Cohen E, 2007, J CLIN EPIDEMIOL, V60, P118, DOI 10.1016/j.jclinepi.2006.03.015; Dai DW, 2016, PEDIATR CRIT CARE ME, V17, pE218, DOI 10.1097/PCC.0000000000000684; de las Salas R, 2016, COLOMB MEDICA, V47, P142; Feudtner C, 2012, ARCH PEDIAT ADOL MED, V166, P9, DOI 10.1001/archpediatrics.2011.161; Finkelstein Y, 2011, PEDIATRICS, V128, P723, DOI 10.1542/peds.2010-3322; Gallagher RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050127; Gautier I, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0395-4; Gomez Olivan LM, 2005, REV MEXICANA CIENCIA, V36, P5; HARTWIG SC, 1992, AM J HOSP PHARM, V49, P2229, DOI 10.1093/ajhp/49.9.2229; Hospital Infantil de Mexico Federico Gomez, AN EST HIMFG; Impicciatore P, 2001, BRIT J CLIN PHARMACO, V52, P77, DOI 10.1046/j.0306-5251.2001.01407.x; Israels T, 2009, PEDIATR BLOOD CANCER, V53, P47, DOI 10.1002/pbc.22032; Jasso-Gutierrez L, 2009, B MED HOSP INFANT M, V66, P51; Jiménez López Giset, 2014, Rev Cubana Salud Pública, V40, P263; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Khan LM, 2013, EUR J CLIN PHARMACOL, V69, P1985, DOI 10.1007/s00228-013-1563-z; Kobayashi S, 2013, PEDIATR INT, V55, P65, DOI 10.1111/ped.12025; Le J, 2006, PEDIATRICS, V118, P555, DOI 10.1542/peds.2005-2429; Lindell-Osuagwu L, 2009, J CLIN PHARM THER, V34, P277, DOI 10.1111/j.1365-2710.2008.01005.x; Rios OM, 2016, INT J CLIN PHARM-NET, V38, P80, DOI 10.1007/s11096-015-0209-x; Moreau JF, 2014, PEDIATR DERMATOL, V31, P163, DOI 10.1111/pde.12158; Mueller EL, 2015, PEDIATR BLOOD CANCER, V62, P490, DOI 10.1002/pbc.25288; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Oshikoya KA, 2011, SAO PAULO MED J, V129, P153, DOI 10.1590/S1516-31802011000300006; PONTO LLB, 1990, CLIN PHARMACOKINET, V18, P381; Rashed AN, 2012, DRUG SAFETY, V35, P481, DOI 10.2165/11597920-000000000-00000; Rashed AN, 2012, EUR J CLIN PHARMACOL, V68, P801, DOI 10.1007/s00228-011-1183-4; Rosli R, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00030; Sanchez-Sanchez B, 2012, DRUG SAFETY, V35, P837, DOI 10.2165/11631810-000000000-00000; Shi QP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-73; Smyth RMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024061; Speranza N, 2008, REV MED URUG, V24, P161; Star K, 2011, DRUG SAFETY, V34, P415, DOI 10.2165/11587540-000000000-00000; Temple ME, 2004, DRUG SAFETY, V27, P819, DOI 10.2165/00002018-200427110-00005; Thiesen S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-237; Varallo FR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171470; Vargas-Neri Jessica Liliana, 2016, Rev Med Inst Mex Seguro Soc, V54, P404; Veroniki AA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017248	48	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230576	10.1371/journal.pone.0230576	http://dx.doi.org/10.1371/journal.pone.0230576			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208451	Green Published, gold			2022-12-26	WOS:000535305100024
J	Pichot, H; Pereira, B; Magnat, E; Hennequin, M; Tubert-Jeannin, S				Pichot, Helene; Pereira, Bruno; Magnat, Elodie; Hennequin, Martine; Tubert-Jeannin, Stephanie			Implementation and impact of a dental preventive intervention conducted within a health promotion program on health inequalities: A retrospective study	PLOS ONE			English	Article							SEALANT RETENTION; FISSURE SEALANTS; PIT; PREVALENCE; CHILDREN	Background The objective of this retrospective survey was to evaluate after one year, the conditions and impacts of a dental sealant intervention conducted in New Caledonia, within a health promotion program. A greater or at least equivalent quality and impact of the intervention was expected for children living in socially deprived regions with the greatest health needs. Methods The study population was the schoolchildren, aged 6 years in 2016, who benefited from the dental sealant program (n = 2532). The study sample was randomly selected in 2017 from that population (n = 550). The children's dental status was evaluated at school in 2017 and compared with that recorded in 2016 during the sealant intervention allowing the calculation of the retention rates and one-year carious increment on first permanent molars. Sociodemographic variables (gender, public/private school) and conditions of sealant placement (school/dental office, presence of a dental assistant) were recorded. The carious increment was explained using a mixed multiple random-effects regression. A mediation analysis was conducted to assess the respective contributions of the retention rates and the region of origin on caries increment. Results The participation rate was very high (89%) and on average, children had 83% of their dental sealants present after one year, 31% fully and 52% partially present. Caries increment varied depending on the sealant retention rate as well as on the region (North, South, Islands). The mediation analysis showed that living in a deprived area (The Islands) was a strong determinant for high caries increment particularly when the retention rates were low. Conclusions This study showed a high participation rate and acceptable effectiveness as measured with the one-year retention rates, for a fissure sealant intervention conducted in real-life conditions and integrated in a large health promotion program. Nevertheless, the intervention was not effective enough to totally balance the influence of health determinants, especially in socially deprived sectors characterized by greater dental needs.	[Pichot, Helene; Hennequin, Martine; Tubert-Jeannin, Stephanie] Univ Clermont Auvergne, CROC, Clermont Ferrand, France; [Pichot, Helene; Magnat, Elodie] Hlth & Social Agcy New Caledonia, Noumea, New Caledonia; [Pereira, Bruno] CHU Clermont Ferrand, Delegat Rech Clin & Innovat, Clermont Ferrand, France; [Hennequin, Martine; Tubert-Jeannin, Stephanie] CHU Clermont Ferrand, Serv Odontol, Clermont Ferrand, France	Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; CHU Clermont Ferrand	Pichot, H; Tubert-Jeannin, S (corresponding author), Univ Clermont Auvergne, CROC, Clermont Ferrand, France.; Pichot, H (corresponding author), Hlth & Social Agcy New Caledonia, Noumea, New Caledonia.; Tubert-Jeannin, S (corresponding author), CHU Clermont Ferrand, Serv Odontol, Clermont Ferrand, France.	helene.pichot@ass.nc; stephanie.tubert@uca.fr	Hennequin, Martine/AAB-3004-2021	Hennequin, Martine/0000-0001-8173-2606; Tubert-jeannin, stephanie/0000-0002-8360-8948				Ahovuo-Saloranta A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001830.pub5; Bleijenberg N, 2018, INT J NURS STUD, V79, P86, DOI 10.1016/j.ijnurstu.2017.12.001; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Silva AM, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009837.pub2; Dorantes C, 2005, PEDIATR DENT, V27, P212; Fonnebo V, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-7; Francis R, 2008, COMMUNITY DENT HLTH, V25, P211, DOI 10.1922/CDH_2168Mascarenhas05; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Fry D, 2017, HEALTH PROMOT INT, V32, P901, DOI 10.1093/heapro/daw022; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Gouvernement de la Nouvelle Caledonie, 2018, PLAN KAM 86 ACT; Gugnani Neeraj, 2013, Evid Based Dent, V14, P71, DOI 10.1038/sj.ebd.6400946; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Heifetz Stanley B, 2004, J Clin Dent, V15, P1; Hox JJ, 2010, MULTILEVEL ANAL TECH, V2nd; Imai K, 2011, AM POLIT SCI REV, V105, P765, DOI 10.1017/S0003055411000414; INSEE Premiere, 2015, 1572 INSEE PREM; ISMAIL AI, 1989, J PUBLIC HEALTH DENT, V49, P206, DOI 10.1111/j.1752-7325.1989.tb02070.x; Keshavarz N, 2010, SOC SCI MED, V70, P1467, DOI 10.1016/j.socscimed.2010.01.034; Langford R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1360-y; Lorenc T, 2013, J EPIDEMIOL COMMUN H, V67, P190, DOI 10.1136/jech-2012-201257; Macpherson LMD, 2010, BRIT DENT J, V209, P73, DOI 10.1038/sj.bdj.2010.628; Marmot MG, 2003, PERSPECT BIOL MED, V46, pS9, DOI 10.1353/pbm.2003.0056; Mazevet ME, 2018, HEALTH POLICY, V122, P1273, DOI 10.1016/j.healthpol.2018.10.001; Muller-Bolla M, 2006, COMMUNITY DENT ORAL, V34, P321, DOI 10.1111/j.1600-0528.2006.00319.x; Muller-Bolla M, 2013, COMMUNITY DENT ORAL, V41, P232, DOI 10.1111/cdoe.12011; Pegon-Machat E, 2016, BRIT DENT J, V220, P197, DOI 10.1038/sj.bdj.2016.138; Pichot H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112452; RIPA LW, 1991, J PUBLIC HEALTH DENT, V51, P78, DOI 10.1111/j.1752-7325.1991.tb02185.x; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Siegal MD, 2010, J PUBLIC HEALTH DENT, V70, P140, DOI 10.1111/j.1752-7325.2009.00155.x; Simonsen RJ, 2011, AUST DENT J, V56, P45, DOI 10.1111/j.1834-7819.2010.01295.x; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Tlanviwat S, 2008, COMMUNITY DENT HLTH, V25, P216, DOI 10.1922/CDH_2135Tianviwat05; Tubert-Jeannin S, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4996-y; Venker DJ, 2004, J PUBLIC HEALTH DENT, V64, P191; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Watt RG, 2012, COMMUNITY DENT ORAL, V40, P289, DOI 10.1111/j.1600-0528.2012.00680.x; Williams R, 2018, INT J DENT HYG, V16, pE65, DOI 10.1111/idh.12303; Winter J, 2018, CLIN ORAL INVEST, V22, P2241, DOI 10.1007/s00784-017-2318-5; World Health Organization, 2013, WHO OR HLTH SURV BAS	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230639	10.1371/journal.pone.0230639	http://dx.doi.org/10.1371/journal.pone.0230639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9GO	32208466	gold, Green Published			2022-12-26	WOS:000535305100029
J	Hoffing, RAC; Lauharatanahirun, N; Forster, DE; Garcia, JO; Vettel, JM; Thurman, SM				Hoffing, Russell A. Cohen; Lauharatanahirun, Nina; Forster, Daniel E.; Garcia, Javier O.; Vettel, Jean M.; Thurman, Steven M.			Dissociable mappings of tonic and phasic pupillary features onto cognitive processes involved in mental arithmetic	PLOS ONE			English	Article							LOCUS-COERULEUS; ATTENTION; VIGILANCE; STATE; FLUCTUATIONS; PUPILLOMETRY; PERFORMANCE; DIAMETER; TRACKING; AROUSAL	Pupil size modulations have been used for decades as a window into the mind, and several pupillary features have been implicated in a variety of cognitive processes. Thus, a general challenge facing the field of pupillometry has been understanding which pupil features should be most relevant for explaining behavior in a given task domain. In the present study, a longitudinal design was employed where participants completed 8 biweekly sessions of a classic mental arithmetic task for the purposes of teasing apart the relationships between tonic/phasic pupil features (baseline, peak amplitude, peak latency) and two task-related cognitive processes including mental processing load (indexed by math question difficulty) and decision making (indexed by response times). We used multi-level modeling to account for individual variation while identifying pupil-to-behavior relationships at the single-trial and between-session levels. We show a dissociation between phasic and tonic features with peak amplitude and latency (but not baseline) driven by ongoing task-related processing, whereas baseline was driven by state-level effects that changed over a longer time period (i.e. weeks). Finally, we report a dissociation between peak amplitude and latency whereby amplitude reflected surprise and processing load, and latency reflected decision making times.	[Hoffing, Russell A. Cohen; Lauharatanahirun, Nina; Forster, Daniel E.; Garcia, Javier O.; Vettel, Jean M.; Thurman, Steven M.] US Combat Capabil Dev Command Army Res Lab, Human Res & Engn Div, Aberdeen Proving Ground, MD 21005 USA; [Lauharatanahirun, Nina] Univ Penn, Annenberg Sch Commun, Philadelphia, PA 19104 USA; [Garcia, Javier O.; Vettel, Jean M.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Vettel, Jean M.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA	University of Pennsylvania; University of Pennsylvania; University of California System; University of California Santa Barbara	Hoffing, RAC (corresponding author), US Combat Capabil Dev Command Army Res Lab, Human Res & Engn Div, Aberdeen Proving Ground, MD 21005 USA.	russell.a.cohenhoffing.civ@mail.mil		Cohen Hoffing, Russell/0000-0002-3478-8196				[Anonymous], 2013, SIMPLE WAY RECONSTRU; [Anonymous], 2005, SR RES EYELINK USER; Aston-Jones G, 2005, SLEEP MED, V6, pS3, DOI 10.1016/S1389-9457(05)80002-4; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Braem S, 2015, COGN AFFECT BEHAV NE, V15, P374, DOI 10.3758/s13415-014-0333-4; Breton-Provencher V, 2019, NAT NEUROSCI, V22, P218, DOI 10.1038/s41593-018-0305-z; Cavanagh JF, 2014, J EXP PSYCHOL GEN, V143, P1476, DOI 10.1037/a0035813; Cieslak M., 2016, THESIS; de Gee JW, 2017, ELIFE, V6, DOI 10.7554/eLife.23232; de Gee JW, 2014, P NATL ACAD SCI USA, V111, pE618, DOI 10.1073/pnas.1317557111; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Einhauser W, 2008, P NATL ACAD SCI USA, V105, P1704, DOI 10.1073/pnas.0707727105; Einhauser Wolfgang, 2010, Front Hum Neurosci, V4, P18, DOI 10.3389/fnhum.2010.00018; Franklin MS, 2013, Q J EXP PSYCHOL, V66, P2289, DOI 10.1080/17470218.2013.858170; Geva R, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00145; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Granholm EE, 2004, INT J PSYCHOPHYSIOLO; Graw P, 2004, PHYSIOL BEHAV, V80, P695, DOI 10.1016/j.physbeh.2003.12.004; Hopstaken JF, 2015, BIOL PSYCHOL, V110, P100, DOI 10.1016/j.biopsycho.2015.06.013; Hupe JM, 2009, J VISION, V9, DOI 10.1167/9.7.10; Joshi S, 2016, NEURON, V89, P221, DOI 10.1016/j.neuron.2015.11.028; KAHNEMAN D, 1967, SCIENCE, V157, P218, DOI 10.1126/science.157.3785.218; Klingner J, 2011, PSYCHOPHYSIOLOGY, V48, P323, DOI 10.1111/j.1469-8986.2010.01069.x; Konishi M, 2017, COGNITION, V168, P16, DOI 10.1016/j.cognition.2017.06.006; Kristjansson SD, 2009, APPL ERGON, V40, P978, DOI 10.1016/j.apergo.2009.04.007; L?decke D., 2018, SJSTATS STAT FUNCTIO; Larsen RS, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00021; Mattarella-Micke A, 2011, EMOTION, V11, P1000, DOI 10.1037/a0023224; Murphy PR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003854; Murphy PR, 2014, HUM BRAIN MAPP, V35, P4140, DOI 10.1002/hbm.22466; Murphy PR, 2011, PSYCHOPHYSIOLOGY, V48, P1531, DOI 10.1111/j.1469-8986.2011.01226.x; Nieuwenhuis S, 2011, PSYCHOPHYSIOLOGY, V48, P162, DOI 10.1111/j.1469-8986.2010.01057.x; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Reimer J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13289; Sirois S, 2014, WIRES COGN SCI, V5, P679, DOI 10.1002/wcs.1323; Stephen R., 2002, HIERARCHICAL LINEAR; Thurman SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191883; Unsworth N, 2018, COGN AFFECT BEHAV NE, V18, P638, DOI 10.3758/s13415-018-0594-4; Unsworth N, 2016, COGN AFFECT BEHAV NE, V16, P601, DOI 10.3758/s13415-016-0417-4; van den Brink RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165274; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Zenon A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41484	45	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230517	10.1371/journal.pone.0230517	http://dx.doi.org/10.1371/journal.pone.0230517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9GC	32203562	Green Published, gold			2022-12-26	WOS:000535303900024
J	Schulz, C; Buchele, G; Peter, RS; Rothenbacher, D; Roigk, P; Rapp, K; Reber, KC; Konig, HH				Schulz, Claudia; Buechele, Gisela; Peter, Raphael Simon; Rothenbacher, Dietrich; Roigk, Patrick; Rapp, Kilian; Reber, Katrin Christiane; Koenig, Hans-Helmut			Regional variation of care dependency after hip fracture in Germany: A retrospective cohort study using health insurance claims data	PLOS ONE			English	Article							FUNCTIONAL STATUS; EXPENDITURES; SERVICES; MOBILITY; OUTCOMES; ADULTS; RISK; HOME	Objective To investigate variation of care dependency after hip fracture across German regions based on the assessment by the German statutory long-term care insurance. Data sources/study setting Patient-level statutory health and long-term care insurance claims data from 2009-2011 and official statistical data from Germany. Study design We performed a retrospective cohort study. Investigated multinomial outcome categories were increase in care dependency (new onset or a higher care dependency than pre-fracture), no change as reference and death as competing risk in the quarterly period following hip fracture (follow-up 3 months). Regional variation was operationalized with the variance of regional-level random intercepts based on generalized linear mixed models. We adjusted for patient and regional characteristics. Principal findings The study included 122,887 hip fracture patients in 95 German postal code regions. Crude outcomes were 30.87% increase in care dependency and 14.35% death. Results indicated modest variation on regional level. Male sex, increasing age, increasing comorbidity, pertrochanteric and subtrochanteric fracture site compared to femoral neck, time from hospital admission to surgery of 3 or more days, as well as increasing inpatient length of stay, non-participation in rehabilitation and regions with lower hospital density were positively associated with an increase in care dependency. Conclusions Several characteristics on patient and regional level associated with the outcome were identified. Variation in the increase in care dependency after hip fracture appeared to be attributable primarily to patient characteristics. Variation on regional level was only modest.	[Schulz, Claudia; Reber, Katrin Christiane; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany; [Buechele, Gisela; Peter, Raphael Simon; Rothenbacher, Dietrich] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany; [Roigk, Patrick; Rapp, Kilian] Robert Bosch Krankenhaus, Dept Clin Gerontol, Stuttgart, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; Bosch; Robert Bosch Krankenhaus	Schulz, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany.	c.schulz@uke.de	Peter, Raphael/J-3101-2019	Peter, Raphael/0000-0003-4310-9500	German Federal Ministry of Education and Research [01EC1404E]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (grant 01EC1404E) within the project "Prevention and Rehabilitation of Osteoporotic Fractures in Disadvantaged Populations 2" (PROFinD2) which all authors are involved in. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Nebreda ML, 2008, BONE, V42, P278, DOI 10.1016/j.bone.2007.10.001; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), 2015, S2E LEITL 012 001 SC; Barbier S, 2009, OSTEOPOROSIS INT, V20, P371, DOI 10.1007/s00198-008-0687-y; Becker C, 1998, FACT RES INTERV GER, P55; Becker C, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2630; Bell A., 2019, QUAL QUANT, V53, P1051, DOI [10.1007/s11135-018-0802-x, DOI 10.1007/S11135-018-0802-X]; Bentler SE, 2009, AM J EPIDEMIOL, V170, P1290, DOI 10.1093/aje/kwp266; Blackburn J, 2016, OSTEOPOROSIS INT, V27, P953, DOI 10.1007/s00198-015-3327-3; Brennan SL, 2010, J EPIDEMIOL COMMUN H, V64, P656, DOI 10.1136/jech.2008.085738; Bundesministerium fur Gesundheit, 2018, ZAHL FAKT PFLEG; Cary MP, 2016, ARCH PHYS MED REHAB, V97, P760, DOI 10.1016/j.apmr.2016.01.012; Cheng SY, 2011, OSTEOPOROSIS INT, V22, P2575, DOI 10.1007/s00198-011-1596-z; Defer A, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0195-y; Deutsches Institut fur Medizinische Dokumentation und Information, 2017, INT STAT KLASS KRANK; Dyer SM, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0332-0; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Federal Statistical Office Germany, 2011, KRANK; Federal Statistical Office Germany, 2012, POSTL REG ZUG NACH F; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Gardiner JC, 2009, STAT MED, V28, P221, DOI 10.1002/sim.3478; Gilbert R, 2010, J PUBLIC HEALTH-UK, V32, P117, DOI 10.1093/pubmed/fdp077; Hacker J, 2012, HEALTH ECON, V21, P1427, DOI 10.1002/hec.1805; Hoffmann F, 2012, GESUNDHEITSWESEN, V74, P291, DOI 10.1055/s-0031-1275711; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Huber CA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1030; Huber CA, 2013, J CLIN EPIDEMIOL, V66, P1118, DOI 10.1016/j.jclinepi.2013.04.011; Icks A, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0140-5; JACOBSEN SJ, 1990, JAMA-J AM MED ASSOC, V264, P500, DOI 10.1001/jama.264.4.500; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Lin Pi-Chu, 2004, J Nurs Res, V12, P72; Magaziner J, 2000, J GERONTOL A-BIOL, V55, pM498, DOI 10.1093/gerona/55.9.M498; MUNDLAK Y, 1978, ECONOMETRICA, V46, P69, DOI 10.2307/1913646; Neuhaus JM, 1998, BIOMETRICS, V54, P638, DOI 10.2307/3109770; Pitzul KB, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1524-1; Ruths S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2087-5; Schnee M, 2008, GESUNDHEITSMONITOR, P88; Schulz C, 2019, J AM MED DIR ASSOC, V20, P451, DOI 10.1016/j.jamda.2018.09.029; Statistisches Bundesamt Deutschland, 2013, TIEFG DIAGN KRANK PA; Teppala S, 2017, J GERONTOL A-BIOL, V72, P1376, DOI 10.1093/gerona/glw249; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Wildner M, 2001, OSTEOPOROSIS INT, V12, P136, DOI 10.1007/s001980170146	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230648	10.1371/journal.pone.0230648	http://dx.doi.org/10.1371/journal.pone.0230648			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9GC	32203564	gold, Green Published			2022-12-26	WOS:000535303900033
J	Jiao, WT; Fan, YF; Blackmore, NJ; Parker, EJ				Jiao, Wanting; Fan, Yifei; Blackmore, Nicola J.; Parker, Emily J.			A single amino acid substitution uncouples catalysis and allostery in an essential biosynthetic enzyme in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; molecular dynamics; protein sequence; enzyme mutation; enzyme inhibitor; enzyme structure; aromatic amino acid biosynthesis; DAH7PS; shikimate pathway; statistical coupling analysis; tuberculosis	3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE; SYNERGISTIC ALLOSTERY; CHORISMATE MUTASE; SCATTERING; COMPLEXES; DYNAMICS; EFFICIENCY; REVEALS; PROVIDE; SYSTEM	Allostery exploits the conformational dynamics of enzymes by triggering a shift in population ensembles toward functionally distinct conformational or dynamic states. Allostery extensively regulates the activities of key enzymes within biosynthetic pathways to meet metabolic demand for their end products. Here, we have examined a critical enzyme, 3-deoxy-d-arabino-heptulosonate 7-phosphate synthase (DAH7PS), at the gateway to aromatic amino acid biosynthesis in Mycobacterium tuberculosis, which shows extremely complex dynamic allostery: three distinct aromatic amino acids jointly communicate occupancy to the active site via subtle changes in dynamics, enabling exquisite fine-tuning of delivery of these essential metabolites. Furthermore, this allosteric mechanism is co-opted by pathway branchpoint enzyme chorismate mutase upon complex formation. In this study, using statistical coupling analysis, site-directed mutagenesis, isothermal calorimetry, small-angle X-ray scattering, and X-ray crystallography analyses, we have pinpointed a critical node within the complex dynamic communication network responsible for this sophisticated allosteric machinery. Through a facile Gly to Pro substitution, we have altered backbone dynamics, completely severing the allosteric signal yet remarkably, generating a nonallosteric enzyme that retains full catalytic activity. We also identified a second residue of prime importance to the inter-enzyme communication with chorismate mutase. Our results reveal that highly complex dynamic allostery is surprisingly vulnerable and provide further insights into the intimate link between catalysis and allostery.	[Jiao, Wanting; Fan, Yifei; Blackmore, Nicola J.; Parker, Emily J.] Univ Canterbury, Maurice Wilkins Ctr Mol Biodiscovery, Biomol Interact Ctr, Christchurch 8041, New Zealand; [Jiao, Wanting; Fan, Yifei; Parker, Emily J.] Victoria Univ Wellington, Ferrier Res Inst, Wellington 6012, New Zealand	University of Canterbury; Victoria University Wellington	Parker, EJ (corresponding author), Victoria Univ Wellington, Ferrier Res Inst, Wellington 6012, New Zealand.	emily.parker@vuw.ac.nz		Jiao, Wanting/0000-0002-0234-7206; Fan, Yifei/0000-0002-4131-5573; Parker, Emily/0000-0002-9571-9987	New Zealand Marsden Fund [UOC-1105]; Maurice Wilkins Centre for Molecular Biodiscovery	New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Maurice Wilkins Centre for Molecular Biodiscovery	This work was supported by New Zealand Marsden Fund Grant UOC-1105 and The Maurice Wilkins Centre for Molecular Biodiscovery. The authors declare that they have no conflicts of interest with the contents of this article.	Ahuja LG, 2019, P NATL ACAD SCI USA, V116, P15052, DOI 10.1073/pnas.1900163116; Bahar I, 2007, CURR OPIN STRUC BIOL, V17, P633, DOI 10.1016/j.sbi.2007.09.011; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Blackmore NJ, 2015, J BIOL CHEM, V290, P18187, DOI 10.1074/jbc.M115.638700; Blackmore NJ, 2013, J MOL BIOL, V425, P1582, DOI 10.1016/j.jmb.2012.12.019; Burschowsky D, 2018, BIOCHEMISTRY-US, V57, P557, DOI 10.1021/acs.biochem.7b01018; Chinthalapudi K, 2017, ELIFE, V6, DOI 10.7554/eLife.32742; Choy MS, 2017, MOL CELL, V65, P644, DOI 10.1016/j.molcel.2017.01.014; Cross PJ, 2011, J BIOL CHEM, V286, P10216, DOI 10.1074/jbc.M110.209924; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hartmann M, 2003, P NATL ACAD SCI USA, V100, P862, DOI 10.1073/pnas.0337566100; Holliday MJ, 2017, STRUCTURE, V25, P276, DOI 10.1016/j.str.2016.12.003; Jiao WT, 2019, BIOPHYS J, V116, P1887, DOI 10.1016/j.bpj.2019.03.040; Jiao W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180052; Jiao WT, 2012, J MOL BIOL, V415, P716, DOI 10.1016/j.jmb.2011.11.037; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kim J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600663; Kirby N, 2016, ACTA CRYSTALLOGR D, V72, P1254, DOI 10.1107/S2059798316017174; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konig V, 2004, J MOL BIOL, V337, P675, DOI 10.1016/j.jmb.2004.01.055; Lang EJM, 2016, J AM CHEM SOC, V138, P2036, DOI 10.1021/jacs.5b13134; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Modi T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123808; Munack S, 2016, J MOL BIOL, V428, P1237, DOI 10.1016/j.jmb.2016.01.001; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nazmi AR, 2016, J BIOL CHEM, V291, P21836, DOI 10.1074/jbc.M116.741637; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Reichau S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152723; Rivoire O, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004817; Rosensweig C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03503-6; Saavedra HG, 2018, NATURE, V558, P324, DOI 10.1038/s41586-018-0183-2; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Shumilin IA, 1999, STRUCTURE, V7, P865, DOI 10.1016/S0969-2126(99)80109-9; Shumilin IA, 2003, BIOCHEMISTRY-US, V42, P3766, DOI 10.1021/bi027257p; Stacklies W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000574; Sterritt OW, 2018, BIOCHEMISTRY-US, V57, P2667, DOI 10.1021/acs.biochem.8b00082; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Tesileanu T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004091; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Wagner T, 2000, J MOL BIOL, V301, P389, DOI 10.1006/jmbi.2000.3957; Walker GE, 1996, MICROBIOL-SGM, V142, P1973, DOI 10.1099/13500872-142-8-1973; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Webby CJ, 2005, ACTA CRYSTALLOGR F, V61, P403, DOI 10.1107/S1744309105007931	52	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6252	6262		10.1074/jbc.RA120.012605	http://dx.doi.org/10.1074/jbc.RA120.012605			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32217694	hybrid, Green Published			2022-12-26	WOS:000537685000001
J	Ghodke, PP; Guengerich, FP				Ghodke, Pratibha P.; Guengerich, F. Peter			Impact of 1,N-6-ethenoadenosine, a damaged ribonucleotide in DNA, on translesion synthesis and repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; DNA enzyme; RNA modification; RNA processing; reverse transcription; 1; N6-ethenoadenosine (1; N6-?rA); DNA adducts; genome integrity; polymerase eta; translesion synthesis (TLS); DNA alkylation	POLYMERASE-ETA; KINETIC-ANALYSIS; VINYL-CHLORIDE; ERRONEOUS INCORPORATION; REVERSE TRANSCRIPTION; SOMATIC HYPERMUTATION; METABOLITES INVITRO; ESCHERICHIA-COLI; OXIDATIVE DAMAGE; RIBOSOMAL-RNA	Incorporation of ribonucleotides into DNA can severely diminish genome integrity. However, how ribonucleotides instigate DNA damage is poorly understood. In DNA, they can promote replication stress and genomic instability and have been implicated in several diseases. We report here the impact of the ribonucleotide rATP and of its naturally occurring damaged analog 1,N-6-ethenoadenosine (1,N-6-?rA) on translesion synthesis (TLS), mediated by human DNA polymerase ? (hpol ?), and on RNase H2?mediated incision. Mass spectral analysis revealed that 1,N-6-?rA in DNA generates extensive frameshifts during TLS, which can lead to genomic instability. Moreover, steady-state kinetic analysis of the TLS process indicated that deoxypurines (i.e. dATP and dGTP) are inserted predominantly opposite 1,N-6-?rA. We also show that hpol ? acts as a reverse transcriptase in the presence of damaged ribonucleotide 1,N-6-?rA but has poor RNA primer extension activities. Steady-state kinetic analysis of reverse transcription and RNA primer extension showed that hpol ? favors the addition of dATP and dGTP opposite 1,N-6-?rA. We also found that RNase H2 recognizes 1,N-6-?rA but has limited incision activity across from this lesion, which can lead to the persistence of this detrimental DNA adduct. We conclude that the damaged and unrepaired ribonucleotide 1,N-6-?rA in DNA exhibits mutagenic potential and can also alter the reading frame in an mRNA transcript because 1,N-6-?rA is incompletely incised by RNase H2.	[Ghodke, Pratibha P.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37323 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Ghodke, Pratibha P./0000-0002-8402-3933	National Institutes of Health [R01 ES026955]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01 ES026955 (to F. P. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya N, 2019, CURR GENET, V65, P649, DOI 10.1007/s00294-018-0918-5; Alenko A, 2017, BIOCHEMISTRY-US, V56, P5053, DOI 10.1021/acs.biochem.7b00730; [Anonymous], [No title captured]; Barnes RP, 2017, DNA REPAIR, V57, P1, DOI 10.1016/j.dnarep.2017.05.006; Beckman JW, 2008, J BIOL CHEM, V283, P36711, DOI 10.1074/jbc.M806785200; Berglund AK, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006628; BERGMAN K, 1982, ARCH TOXICOL, V49, P117, DOI 10.1007/BF00332359; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Betous R, 2009, MOL CARCINOGEN, V48, P369, DOI 10.1002/mc.20509; BIERNAT J, 1978, NUCLEIC ACIDS RES, V5, P789, DOI 10.1093/nar/5.3.789; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Calabretta A, 2013, BIOCHEMISTRY-US, V52, P1990, DOI 10.1021/bi400116y; Caldecott KW, 2014, SCIENCE, V343, P260, DOI 10.1126/science.1248234; Cerritelli SM, 2019, DNA REPAIR, V84, DOI 10.1016/j.dnarep.2019.102736; Cerritelli SM, 2016, TRENDS BIOCHEM SCI, V41, P434, DOI 10.1016/j.tibs.2016.02.005; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Che Y, 2010, J PSYCHIATR NEUROSCI, V35, P296, DOI 10.1503/jpn.090083; Chowdhury Goutam, 2011, Curr Protoc Nucleic Acid Chem, VChapter 7, DOI 10.1002/0471142700.nc0716s47; Clausen AR, 2013, DNA REPAIR, V12, P121, DOI 10.1016/j.dnarep.2012.11.006; Colussi C, 2002, CURR BIOL, V12, P912, DOI 10.1016/S0960-9822(02)00863-1; Conover HN, 2015, GENETICS, V201, P951, DOI 10.1534/genetics.115.181149; Crespan E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10805; Cronan GE, 2019, P NATL ACAD SCI USA, V116, P1251, DOI 10.1073/pnas.1814512116; Defoiche J, 2009, CLIN CHEM, V55, P1824, DOI 10.1373/clinchem.2008.119446; DeRose EF, 2012, BIOCHEMISTRY-US, V51, P2407, DOI 10.1021/bi201710q; ELGHISSASSI F, 1995, CHEM RES TOXICOL, V8, P278, DOI 10.1021/tx00044a013; Evich M, 2016, CHEMBIOCHEM, V17, P1968, DOI 10.1002/cbic.201600385; Fiala KA, 2007, J MOL BIOL, V365, P590, DOI 10.1016/j.jmb.2006.10.008; Forslund JME, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007315; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Franklin A, 2004, IMMUNOL CELL BIOL, V82, P219, DOI 10.1046/j.0818-9641.2004.01221.x; Fu IW, 2019, DNA REPAIR, V73, P155, DOI 10.1016/j.dnarep.2018.11.012; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Gali VK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12915-1; Garcia-Exposito L, 2016, CELL REP, V17, P1858, DOI 10.1016/j.celrep.2016.10.048; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; GUENGERICH FP, 1992, J AM CHEM SOC, V114, P1074, DOI 10.1021/ja00029a041; GUENGERICH FP, 1979, BIOCHEM PHARMACOL, V28, P589, DOI 10.1016/0006-2952(79)90140-0; Heider MR, 2017, J BIOL CHEM, V292, P8835, DOI 10.1074/jbc.M117.783472; Hofer T, 2005, BIOL CHEM, V386, P333, DOI 10.1515/bc.2005.040; Hwang HS, 2004, BIOCHEMISTRY-US, V43, P14612, DOI 10.1021/bi0489558; Hyjek M, 2019, DNA REPAIR, V84, DOI 10.1016/j.dnarep.2019.102672; Johnson KA, 2019, BEILSTEIN J ORG CHEM, V15, P16, DOI 10.3762/bjoc.15.2; Johnson MK, 2019, NUCLEIC ACIDS RES, V47, P10693, DOI 10.1093/nar/gkz792; Katafuchi A, 2010, NUCLEIC ACIDS RES, V38, P859, DOI 10.1093/nar/gkp1095; Kellner V, 2020, EMBO J, V39, DOI 10.15252/embj.2019102309; Kennedy EM, 2012, J BIOL CHEM, V287, P14280, DOI 10.1074/jbc.M112.348482; Kim N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003924; Kreisel K, 2019, NUCLEIC ACIDS RES, V47, P2425, DOI 10.1093/nar/gky1291; LAIB RJ, 1977, TOXICOLOGY, V8, P185, DOI 10.1016/0300-483X(77)90007-5; Levine RL, 2001, J BIOL CHEM, V276, P18717, DOI 10.1074/jbc.M102158200; Li ZW, 2006, IUBMB LIFE, V58, P581, DOI 10.1080/15216540600946456; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Liu M, 2012, BIOL CHEM, V393, P123, DOI 10.1515/hsz-2011-0247; Malfatti MC, 2019, J BIOL CHEM, V294, P13061, DOI 10.1074/jbc.RA119.009493; Markkanen E, 2017, DNA REPAIR, V59, P82, DOI 10.1016/j.dnarep.2017.09.007; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Mentegari E, 2017, NUCLEIC ACIDS RES, V45, P2600, DOI 10.1093/nar/gkw1275; Meroni A, 2019, NUCLEIC ACIDS RES, V47, P4612, DOI 10.1093/nar/gkz165; Moss CF, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx1009; Nawrot B, 2011, CELL MOL LIFE SCI, V68, P4023, DOI 10.1007/s00018-011-0773-8; O'Flaherty Derek K, 2014, Curr Protoc Nucleic Acid Chem, V59, DOI 10.1002/0471142700.nc0721s59; OTTENWALDER H, 1979, ARCH TOXICOL, V41, P279, DOI 10.1007/BF00296897; Pai CC, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020057; Patra A, 2015, J BIOL CHEM, V290, P8028, DOI 10.1074/jbc.M115.637561; Patra A, 2016, J BIOL CHEM, V291, P14134, DOI 10.1074/jbc.M116.732487; Potenski CJ, 2014, NUCLEIC ACIDS RES, V42, P10226, DOI 10.1093/nar/gku773; Poulsen HE, 2012, FREE RADICAL BIO MED, V52, P1353, DOI 10.1016/j.freeradbiomed.2012.01.009; Pryor JM, 2018, SCIENCE, V361, P1126, DOI 10.1126/science.aat2477; Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062; RANDERATH K, 1992, MUTAT RES, V275, P355, DOI 10.1016/0921-8734(92)90038-Q; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Ren MT, 2019, CHEM RES TOXICOL, V32, P926, DOI 10.1021/acs.chemrestox.9b00059; Rey L, 2009, MOL CELL BIOL, V29, P3344, DOI 10.1128/MCB.00115-09; RIBOVICH ML, 1982, CARCINOGENESIS, V3, P539, DOI 10.1093/carcin/3.5.539; Sassa A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50421-8; Sassa A, 2019, GENES ENVIRON, V41, DOI 10.1186/s41021-019-0118-7; Sassa A, 2016, J BIOL CHEM, V291, P24314, DOI 10.1074/jbc.M116.738732; Sastre-Moreno G, 2014, NUCLEIC ACIDS RES, V42, P9821, DOI 10.1093/nar/gku711; SCHULMAN LH, 1976, BIOCHEMISTRY-US, V15, P5769, DOI 10.1021/bi00671a013; SECRIST JA, 1972, BIOCHEMISTRY-US, V11, P3499, DOI 10.1021/bi00769a001; Seiffert S, 2011, ANAL BIOCHEM, V414, P47, DOI 10.1016/j.ab.2011.02.040; Shah S, 2008, NAT PROTOC, V3, P351, DOI 10.1038/nprot.2007.535; Shimizu M, 2007, BIOCHEMISTRY-US, V46, P5515, DOI 10.1021/bi062238r; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; SPENGLER S, 1981, NUCLEIC ACIDS RES, V9, P365, DOI 10.1093/nar/9.2.365; Storici F, 2007, NATURE, V447, P338, DOI 10.1038/nature05720; Su Y, 2019, J BIOL CHEM, V294, P6073, DOI 10.1074/jbc.RA119.007925; Su Y, 2017, J BIOL CHEM, V292, P18044, DOI 10.1074/jbc.M117.809723; Su Yan, 2016, Curr Protoc Nucleic Acid Chem, V65, DOI 10.1002/cpnc.2; Su Y, 2016, J BIOL CHEM, V291, P3747, DOI 10.1074/jbc.M115.706226; Su Y, 2015, J BIOL CHEM, V290, P15921, DOI 10.1074/jbc.M115.653691; Suo ZC, 1998, J BIOL CHEM, V273, P27259, DOI 10.1074/jbc.273.42.27259; Thapar R, 2019, BIOCHEMISTRY-US, V58, P312, DOI 10.1021/acs.biochem.8b00949; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Uehara R, 2018, CELL REP, V25, P1135, DOI 10.1016/j.celrep.2018.10.019; Vaisman A, 2018, CRIT REV BIOCHEM MOL, V53, P382, DOI 10.1080/10409238.2018.1483889; Vaisman A, 2017, CRIT REV BIOCHEM MOL, V52, P274, DOI 10.1080/10409238.2017.1291576; Wanrooij PH, 2019, FEBS LETT, V593, P1554, DOI 10.1002/1873-3468.13440; Willi J, 2018, NUCLEIC ACIDS RES, V46, P1945, DOI 10.1093/nar/gkx1308; Williams JS, 2014, DNA REPAIR, V19, P27, DOI 10.1016/j.dnarep.2014.03.029; Wurtmann EJ, 2009, CRIT REV BIOCHEM MOL, V44, P34, DOI [10.1080/10409230802594043, 10.1080/10409230802594043 ]; Yan LWL, 2019, J BIOL CHEM, V294, P15158, DOI 10.1074/jbc.REV119.006513; Yang W, 2018, ANNU REV BIOCHEM, V87, P239, DOI 10.1146/annurev-biochem-062917-012405; Yao NY, 2013, P NATL ACAD SCI USA, V110, P12942, DOI 10.1073/pnas.1309506110; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhao Y, 2013, P NATL ACAD SCI USA, V110, P8146, DOI 10.1073/pnas.1303126110	107	6	6	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6092	6107		10.1074/jbc.RA120.012829	http://dx.doi.org/10.1074/jbc.RA120.012829			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32213600	Green Published, hybrid			2022-12-26	WOS:000531417300020
J	Ishikawa, A; Wada, T; Nishimura, S; Ito, T; Okekawa, A; Onogi, Y; Watanabe, E; Sameshima, A; Tanaka, T; Tsuneki, H; Saito, S; Sasaoka, T				Ishikawa, Akari; Wada, Tsutomu; Nishimura, Sanshiro; Ito, Tetsuo; Okekawa, Akira; Onogi, Yasuhiro; Watanabe, Eri; Sameshima, Azusa; Tanaka, Tomoko; Tsuneki, Hiroshi; Saito, Shigeru; Sasaoka, Toshiyasu			Estrogen regulates sex-specific localization of regulatory T cells in adipose tissue of obese female mice	PLOS ONE			English	Article							HIGH-FAT; INSULIN-RESISTANCE; INFLAMMATION; ACCUMULATION; METABOLISM; ESTRADIOL; MIGRATION; HOMEOSTASIS; ACTIVATION; EXPRESSION	Regulatory T cells (Treg) play essential roles in maintaining immune homeostasis. Resident Treg in visceral adipose tissue (VAT-Treg) decrease in male obese mice, which leads to the development of obesity-associated chronic inflammations and insulin resistance. Although gender differences in immune responses have been reported, the effects of the difference in metabolic environment on VAT-Treg are unclear. We investigated the localization of VAT-Treg in female mice in comparison with that in male mice. On a high-fat diet (HFD), VAT-Treg decreased in male mice but increased in female mice. The increase was abolished in ovariectomized and HFD-fed mice, but was restored by estrogen supplementation. The IL33 receptor ST2, which is important for the localization and maturation of VAT-Treg in males, was reduced in CD4(+)CD25(+) T cells isolated from gonadal fat of obese mice of both genders, suggesting that a different system exists for VAT-Treg localization in females. Extensive analysis of chemokine expression in gonadal fat and adipose CD4(+)CD25(+)T cells revealed several chemokine signals related to female-specific VAT-Treg accumulation such as CCL24, CCR6, and CXCR3. Taken together, the current study demonstrated sexual dimorphism in VAT-Treg localization in obese mice. Estrogen may attenuate obesity-associated chronic inflammation partly through altering chemokine-related VAT-Treg localization in females.	[Ishikawa, Akari; Wada, Tsutomu; Nishimura, Sanshiro; Ito, Tetsuo; Okekawa, Akira; Onogi, Yasuhiro; Watanabe, Eri; Tsuneki, Hiroshi; Sasaoka, Toshiyasu] Univ Toyama, Dept Clin Pharmacol, Toyama, Japan; [Sameshima, Azusa; Tanaka, Tomoko; Saito, Shigeru] Univ Toyama, Dept Obstet & Gynecol, Toyama, Japan	University of Toyama; University of Toyama	Wada, T; Sasaoka, T (corresponding author), Univ Toyama, Dept Clin Pharmacol, Toyama, Japan.	twada@pha.u-toyama.ac.jp; tsasaoka@pha.u-toyama.ac.jp	Onogi, Yasuhiro/AAD-9305-2022; Wada, Tsutomu/AAY-4450-2020	Wada, Tsutomu/0000-0001-5819-8556; Onogi, Yasuhiro/0000-0002-7950-8952	Japan Society for the Promotion of Science (JSPS KAKENHI) [JP15K09410]; Mitsubishi Tanabe Pharma Corporation	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation)	This study was funded by the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number JP15K09410) to TW and a research grant from Mitsubishi Tanabe Pharma Corporation to TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; Amengual-Cladera E, 2012, METABOLISM, V61, P1108, DOI 10.1016/j.metabol.2011.12.016; Araujo-Pires AC, 2015, J BONE MINER RES, V30, P400, DOI 10.1002/jbmr.2376; Asarian L, 2002, HORM BEHAV, V42, P461, DOI 10.1006/hbeh.2002.1835; Becker M, 2017, EUR J IMMUNOL, V47, P1867, DOI 10.1002/eji.201646739; Benezech C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00171; Campbell DJ, 2015, J IMMUNOL, V195, P2507, DOI 10.4049/jimmunol.1500801; Cephus JY, 2017, CELL REP, V21, P2487, DOI 10.1016/j.celrep.2017.10.110; Chaudhry A, 2013, J CLIN INVEST, V123, P939, DOI 10.1172/JCI57175; Chow Z, 2015, IMMUNOL CELL BIOL, V93, P355, DOI 10.1038/icb.2014.117; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; D'Eon TM, 2005, J BIOL CHEM, V280, P35983, DOI 10.1074/jbc.M507339200; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Eller K, 2011, DIABETES, V60, P2954, DOI 10.2337/db11-0358; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Han JM, 2013, J IMMUNOL, V191, P527, DOI 10.4049/jimmunol.1301035; Ho MF, 2016, MOL ENDOCRINOL, V30, P382, DOI 10.1210/me.2015-1267; Karvonen-Gutierrez CA, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0714-x; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Laffont S, 2017, J EXP MED, V214, P1581, DOI 10.1084/jem.20161807; Li CR, 2018, CELL, V174, P285, DOI 10.1016/j.cell.2018.05.004; Nagira K, 2006, ENDOCRINOLOGY, V147, P1020, DOI 10.1210/en.2005-0825; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ohkura N, 2016, IMMUNITY, V16, P295, DOI [10.1038/nri.2016.36, DOI 10.1038/NRI.2016.36]; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Poehlein CH, 2009, EUR J IMMUNOL, V39, P3121, DOI 10.1002/eji.200939453; Polanczyk MJ, 2005, J NEUROIMMUNOL, V170, P85, DOI 10.1016/j.jneuroim.2005.08.023; Rocha VZ, 2014, ARTERIOSCL THROM VAS, V34, P1374, DOI 10.1161/ATVBAHA.113.303133; Sameshima A, 2015, J ENDOCRINOL, V227, P25, DOI 10.1530/JOE-15-0239; Torres MJ, 2018, CELL METAB, V27, P167, DOI 10.1016/j.cmet.2017.10.003; Travers RL, 2015, INT J OBESITY, V39, P762, DOI 10.1038/ijo.2014.195; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Wada T, 2010, ENDOCRINOLOGY, V151, P2040, DOI 10.1210/en.2009-0869; Wei S, 2006, BLOOD, V108, P426, DOI 10.1182/blood-2006-01-0177; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wolowczuk I, 2012, AM J PHYSIOL-REG I, V303, pR135, DOI 10.1152/ajpregu.00373.2011; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009; Yamada Y, 2012, DIABETOLOGIA, V55, P2238, DOI 10.1007/s00125-012-2547-8; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yonezawa R, 2012, AM J PHYSIOL-ENDOC M, V303, pE445, DOI 10.1152/ajpendo.00638.2011; Zeng Q, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02075; Zeyda M, 2011, OBESITY, V19, P743, DOI 10.1038/oby.2010.123	45	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230885	10.1371/journal.pone.0230885	http://dx.doi.org/10.1371/journal.pone.0230885			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240221	gold, Green Published			2022-12-26	WOS:000535945000055
J	Lee, J; Lee, AL; Park, JH; Moon, JE; Park, JM; Kim, SJ; Chang, KH				Lee, Jungbin; Lee, A. Leum; Park, Jeong-Ho; Moon, Ji Eun; Park, Jung-Mi; Kim, Sang Joon; Chang, Kee-Hyun			The clinical application of nigrosome 1 detection on high-resolution susceptibility-weighted imaging in the evaluation of suspected Parkinsonism: The real-world performance and pitfalls	PLOS ONE			English	Article							SWALLOW TAIL SIGN; SUBSTANTIA-NIGRA; DIAGNOSIS; DISEASE; MRI; HYPERINTENSITY; VISUALIZATION; NEUROMELANIN; ACCURACY; PATTERNS	Purpose To evaluate the real-world diagnostic performance of high-resolution susceptibility-weighted imaging (HR-SWI) and investigate whether the reader's predictions can be used to find cases where HR-SWI finding and final clinical diagnosis matched. Methods This retrospective study enrolled patients with suspected Parkinsonism (n = 48) or volunteers with other intracranial pathologies (n = 31) who underwent brain magnetic resonance imaging (MRI) including HR-SWI, which was used to evaluate nigrosome 1 (NG1). All patients with suspected Parkinsonism underwent N-3-fluoropropyl-2-carbomethoxy-3-4-iodophenyl nortropane (FP-CIT) positron emission tomography and a clinical diagnosis was made by a neurologist. The HR-SWI data were qualitatively analyzed by two independent reviewers. A consensus reading was performed and a diagnostic confidence score was assigned. According to final clinical diagnosis, diagnostic sensitivity, specificity, and accuracy were calculated. Receiver operating characteristic (ROC) curve analysis was used to examine whether the diagnostic confidence score could be used to identify HR-SWI finding-final clinical diagnosis matched cases. Results Of the 48 patients with suspected Parkinsonism, 31 were diagnosed with idiopathic Parkinson's disease, and three with multiple system atrophy. The remaining 14 patients were included in the disease control group. Of the 31 volunteers, 10 subjects were excluded due to possibility of nigrostriatal degeneration and finally 21 subjects were enrolled as controls with non-Parkinsonism pathology (non-PD control). After consensus reading, 25 subjects were classified as true positive and 28 as true negative, according to HR-SWI findings. The calculated diagnostic sensitivity, specificity, and accuracy were 73.5%, 80.0%, and 76.8%, respectively. With using diagnostic concordance score, the area under the ROC curve for the detection of concordance case was 0.83 (95% CI: 0.72-0.91, p < 0.05). Conclusion The diagnostic performance of NG1 detection using HR-SWI with 3T MRI was within acceptable range. Using the reader's diagnostic confidence could be helpful to find cases which HR-SWI finding and final clinical conclusion match. So HR-SWI may be of added value in the evaluation of suspected Parkinsonism.	[Lee, Jungbin; Lee, A. Leum] Soonchunhyang Univ, Dept Radiol, Bucheon Hosp, Bucheon, South Korea; [Park, Jeong-Ho] Soonchunhyang Univ, Dept Neurol, Bucheon Hosp, Bucheon, South Korea; [Moon, Ji Eun] Soonchunhyang Univ, Clin Trial Ctr, Dept Biostat, Bucheon Hosp, Bucheon, South Korea; [Park, Jung-Mi] Soonchunhyang Univ, Dept Nucl Med, Bucheon Hosp, Bucheon, South Korea; [Kim, Sang Joon] Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Chang, Kee-Hyun] Human Med Imaging & Intervent Ctr, Dept Radiol, Seoul, South Korea	Soonchunhyang University; Soonchunhyang University; Soonchunhyang University; Soonchunhyang University; University of Ulsan; Asan Medical Center	Lee, AL (corresponding author), Soonchunhyang Univ, Dept Radiol, Bucheon Hosp, Bucheon, South Korea.	armailbox@hanmail.net		Lee, A Leum/0000-0001-7662-4264; Lee, Jungbin/0000-0002-6240-8277	National Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF-2019R1G1A1099493]; Soonchunhyang University Research Fund	National Research Foundation of Korea (NRF) - Korea government (MSIT); Soonchunhyang University Research Fund	This work was partially supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (grant no. NRF-2019R1G1A1099493) and Soonchunhyang University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlMatter M, 2020, CLIN NEURORADIOL, V30, P835, DOI 10.1007/s00062-019-00846-5; Bae YJ, 2018, RADIOLOGY, V287, P285, DOI 10.1148/radiol.2017162486; Bae YJ, 2016, MOVEMENT DISORD, V31, P684, DOI 10.1002/mds.26584; Benamer HTS, 2009, EUR NEUROL, V61, P11, DOI 10.1159/000165343; Blazejewska AI, 2013, NEUROLOGY, V81, P534, DOI 10.1212/WNL.0b013e31829e6fd2; Cheng ZH, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102103; Cosottini M, 2014, RADIOLOGY, V271, P831, DOI 10.1148/radiol.14131448; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Gerlach M, 2003, NEUROTOX RES, V5, P35, DOI 10.1007/BF03033371; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Gramsch C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185489; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kim EY, 2019, BRIT J RADIOL, V92, DOI 10.1259/bjr.20180842; Kim EY, 2018, J CLIN NEUROL, V14, P90, DOI 10.3988/jcn.2018.14.1.90; Marras C, 2018, NPJ PARKINSON DIS, V4, DOI 10.1038/s41531-018-0058-0; MILTON WJ, 1991, RADIOLOGY, V181, P715, DOI 10.1148/radiology.181.3.1947087; Nam Y, 2017, J MAGN RESON IMAGING, V46, P528, DOI 10.1002/jmri.25553; Noh Y, 2015, AM J NEURORADIOL, V36, P2010, DOI 10.3174/ajnr.A4412; Oh SW, 2016, AM J ROENTGENOL, V207, P1089, DOI 10.2214/AJR.16.16092; Oustwani CS, 2017, CLIN IMAG, V44, P66, DOI 10.1016/j.clinimag.2017.04.005; Reiter E, 2015, MOVEMENT DISORD, V30, P1068, DOI 10.1002/mds.26171; Schwarz ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093814; Shams S, 2017, AM J NEURORADIOL, V38, P1737, DOI 10.3174/ajnr.A5274; Stezin A, 2018, EUR RADIOL, V28, P718, DOI 10.1007/s00330-017-4950-5; Sung YH, 2019, PARKINSONISM RELAT D, V62, P171, DOI 10.1016/j.parkreldis.2018.12.019; Sung YH, 2016, RADIOLOGY, V279, P849, DOI 10.1148/radiol.2015151466; Thenganatt MA, 2012, EXPERT REV NEUROTHER, V12, P687, DOI [10.1586/ern.12.49, 10.1586/ERN.12.49]; Zecca L, 2008, J NEUROCHEM, V106, P1866, DOI 10.1111/j.1471-4159.2008.05541.x	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0231010	10.1371/journal.pone.0231010	http://dx.doi.org/10.1371/journal.pone.0231010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240236	Green Published, gold			2022-12-26	WOS:000535945000077
J	Tschirhart, N; Jiraporncharoen, W; Angkurawaranon, C; Hashmi, A; Nosten, S; McGready, R; Ottersen, T				Tschirhart, Naomi; Jiraporncharoen, Wichuda; Angkurawaranon, Chaisiri; Hashmi, Ahmar; Nosten, Suphak; McGready, Rose; Ottersen, Trygve			Choosing where to give birth: Factors influencing migrant women's decision making in two regions of Thailand	PLOS ONE			English	Article							MATERNITY CARE	Background Choosing where to give birth can be a matter of life and death for both mother and child. Migrants, registered or unregistered, may face different choices and challenges than non-migrants. Despite this, previous research on the factors migrant women consider when deciding where to give birth is very limited. This paper addresses this gap by examining women's decision making in a respective border and urban locale in Thailand. Methods We held focus group discussions [13] with 72 non-Thai pregnant migrant women at non-government clinics in a rural border area and at two hospitals in Chiang Mai, a large city in Northern Thailand in 2018. We asked women where they will go to give birth and to explain the factors that influenced their decision. Results Women identified getting the relevant documentation necessary to register their child's birth, safe birth and medical advice/quality care, as the top three factors that influenced their care seeking decision making. Language of service, free or low cost care, language of services, proximity to home, and limited alternate options for care were also identified as important considerations. Conclusion Understanding factors that migrant women value when choosing where to deliver can help health care providers to create services that are responsive to migrants' preferences and encourage provision of relevant information which may influence patient decision making. The desire to obtain birth documentation for their child appears to be important for migrants who understand the importance of personal documentation for the lives of their children. Healthcare institutions may wish to introduce processes to facilitate obtaining documentation for pregnant migrant women and their newborns.	[Tschirhart, Naomi; Ottersen, Trygve] Univ Oslo, Dept Community Med & Global Hlth, Oslo, Norway; [Tschirhart, Naomi; Ottersen, Trygve] Univ Oslo, Fac Med, Ctr Global Hlth, Inst Hlth & Soc,Oslo Grp Global Hlth Policy, Oslo, Norway; [Jiraporncharoen, Wichuda; Angkurawaranon, Chaisiri; Hashmi, Ahmar] Chiang Mai Univ, Dept Family Med, Chiang Mai, Thailand; [Nosten, Suphak] Borderland Hlth Fdn, Mae Sot, Thailand; [McGready, Rose] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Ottersen, Trygve] Norwegian Inst Publ Hlth, Div Hlth Serv, Oslo, Norway	University of Oslo; University of Oslo; Chiang Mai University; University of Oxford; Norwegian Institute of Public Health (NIPH)	Tschirhart, N (corresponding author), Univ Oslo, Dept Community Med & Global Hlth, Oslo, Norway.; Tschirhart, N (corresponding author), Univ Oslo, Fac Med, Ctr Global Hlth, Inst Hlth & Soc,Oslo Grp Global Hlth Policy, Oslo, Norway.; Jiraporncharoen, W (corresponding author), Chiang Mai Univ, Dept Family Med, Chiang Mai, Thailand.	ntschirhart@gmail.com; wichudaj131@gmail.com	Angkurawaranon, Chaisiri/I-6140-2015; Hashmi, Ahmar/X-7128-2019; McGready, Rose/A-3290-2014	Angkurawaranon, Chaisiri/0000-0003-4206-9164; Hashmi, Ahmar/0000-0002-1592-0606; McGready, Rose/0000-0003-1621-3257; Jiraporncharoen, Wichuda/0000-0002-8131-6474	Faculty of Medicine, Department of Family Medicine, Chiang Mai University; Life Sciences Internationalization Fund at the University of Oslo; European Union [609020]	Faculty of Medicine, Department of Family Medicine, Chiang Mai University; Life Sciences Internationalization Fund at the University of Oslo; European Union(European Commission)	We acknowledge the funding which made this research possible. We received funds from the Faculty of Medicine, Department of Family Medicine, Chiang Mai University, the Life Sciences Internationalization Fund at the University of Oslo and the European Union Seventh Framework Programme (FP7-PEOPLE-2013-COFUND) under grant agreement n degrees 609020 -Scientia Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrahim S, 2017, EUR J PUBLIC HEALTH, V27; Almeida L, 2013, MATERN CHILD HLTH J, V17, P1346, DOI 10.1007/s10995-012-1149-x; [Anonymous], 2019, MIGR FUND; [Anonymous], 2017, GOOD PRACT PAP ACT 7; Butt L, 2017, ASIAN POPUL STUD, V13, P223, DOI 10.1080/17441730.2016.1239431; Coxon K, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1279-7; Gilder ME, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218138; Gruss I, 2017, SOJOURN, V32, P1, DOI 10.1355/sj32-1a; Harkins Benjamin., 2019, THAILAND MIGRATION R; Hashmi AH, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1473104; Hoang H, 2014, WOMEN BIRTH, V27, P233, DOI 10.1016/j.wombi.2014.06.005; Koblinsky M, 2016, LANCET, V388, P2307, DOI 10.1016/S0140-6736(16)31333-2; Mae Tao Clinic, 2019, STAT REG; Mala Dumrongkiat, 2018, BANGKOK POST; Pilkington H, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-35; Pudpong N, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142581; Seo BK, 2017, MED ANTHROPOL Q, V31, P481, DOI 10.1111/maq.12342; Suphanchaimat R, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16061016; Tschirhart N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160222; Tschirhart N, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0391-z; Tuangratananon T, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030430; van den Akker T, 2016, BEST PRACT RES CL OB, V32, P26, DOI 10.1016/j.bpobgyn.2015.08.016; Zhao JF, 2016, ENVIRON PROG SUSTAIN, V35, P263, DOI 10.1002/ep.12196	23	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230407	10.1371/journal.pone.0230407	http://dx.doi.org/10.1371/journal.pone.0230407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240176	Green Published, gold			2022-12-26	WOS:000535945000024
J	Wylegala, A; Mazur, R; Bolek, B; Wylegala, E				Wylegala, Adam; Mazur, Robert; Bolek, Bartlomiej; Wylegala, Edward			Reproducibility, and repeatability of corneal topography measured by Revo NX, Galilei G6 and Casia 2 in normal eyes	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; ORBSCAN II; SCHEIMPFLUG; AGREEMENT; PENTACAM; OCT	Purpose To test the repeatability and reproducibility of the topography module in posterior segment spectral domain optical coherence tomography with Revo NX (new device) and to compare keratometry values obtained by a Scheimpflug tomography (Galilei G6) and a swept source OCT (Casia 2). Methods In this prospective study, healthy subjects with nonoperated eyes had their central corneal thickness (CCT), anterior and posterior K1/K2 corneal power measured with the new device. Two operators made 6 measurements on the new device to check intraobserver repeatability and reproducibility, and measurement on Casia 2 and Galilei G6. Bland-Altman plots were used to assess the agreement between the devices for each analyzed variable. Results 94 eyes (94 patients) were studied. All devices produced significantly different mean CCT, the highest for Galilei 569.13 +/- 37.58 mu m followed by Casia 545.00 +/- 36.15 mu m and Revo 537.39 +/- 35.92 mu m. The mean anterior K1 was 43.21 +/- 1.37 for Casia 2 43.21 +/- 1.55 for Revo NX and 43.19 +/- 1.39 for Galilei G6, and the differences were insignificant p = 0.617. The posterior K1 for Revo NX was -5.77 +/- 0.25 whereas for Casia 2 it was -5.98 +/- 0.22 and for Galilei G6-6.09 +/- 0.28 D p < 0.0001. The Revo NX showed intraclass correlation coefficient ranging from 0.975 for the posterior K2 surface, and 0.994 for anterior K1 and 0.998 for CCT. Conclusions Revo NX is independent of the user and offers a high level of repeatability for the anterior and posterior cornea. The wide range of differences between the devices suggests they should not be used interchangeably.	[Wylegala, Adam; Mazur, Robert; Bolek, Bartlomiej; Wylegala, Edward] Railway Hosp, Ophthalmol Dept, Katowice, Poland; [Wylegala, Adam; Mazur, Robert; Bolek, Bartlomiej; Wylegala, Edward] Zabrze Med Univ Silesia, Sch Med, Div Dent, Katowice, Poland	Medical University Silesia	Wylegala, A (corresponding author), Railway Hosp, Ophthalmol Dept, Katowice, Poland.; Wylegala, A (corresponding author), Zabrze Med Univ Silesia, Sch Med, Div Dent, Katowice, Poland.	Adam.wylegala@gmail.com	Wylęgała, Edward Aleksander/AGL-6056-2022; Wylęgała, Adam/AAK-5951-2020; Bolek, Bartlomiej/AAO-4178-2020	Wylęgała, Edward Aleksander/0000-0002-6707-5790; Bolek, Bartlomiej/0000-0002-3205-6864; Wylegala, Adam/0000-0001-7295-4936	Optopol Technology Ltd.	Optopol Technology Ltd.	Optopol Technology Ltd. provided the Revo NX equipment with corneal topography module used in this study. AW received a speaker's honorarium form Carl Zeiss and works as a consultant for Carl Zeiss Meditec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang M, 2018, PROG RETIN EYE RES, V66, P132, DOI 10.1016/j.preteyeres.2018.04.002; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Crawford AZ, 2013, AM J OPHTHALMOL, V156, P53, DOI 10.1016/j.ajo.2013.01.029; Eppig T., 2018, CURR EYE RES, V43, P1, DOI [10.1080/02713683.2017.1377258, DOI 10.1080/02713683.2017.1377258]; Eppig T., 2018, CLIN APPL OCT OPHTHA, V1, P133, DOI [10.5772/intechopen.78293, DOI 10.5772/INTECHOPEN.78293]; Goebels S, 2015, J CATARACT REFR SURG, V41, P2387, DOI 10.1016/j.jcrs.2015.05.028; Goebels S, 2015, AM J OPHTHALMOL, V159, P733, DOI 10.1016/j.ajo.2015.01.014; Kanellopoulos AJ, 2013, CLIN OPHTHALMOL, V7, P2239, DOI 10.2147/OPTH.S53718; Kannengiesser M, 2012, Z MED PHYS, V22, P215, DOI 10.1016/j.zemedi.2012.04.002; Karnowski K, 2011, BIOMED OPT EXPRESS, V2, P2709, DOI 10.1364/BOE.2.002709; Kiraly L, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/6181405; Li H, 2008, OPHTHALMOLOGY, V115, P796, DOI 10.1016/j.ophtha.2007.07.006; Meyer JJ, 2017, AM J OPHTHALMOL, V175, P122, DOI 10.1016/j.ajo.2016.12.003; Piotrowiak I, 2012, ISRN OPHTHALMOLOGY, V2012, P1; Salouti R, 2009, CLIN EXP OPTOM, V92, P429, DOI 10.1111/j.1444-0938.2009.00407.x; Savini G, 2009, J REFRACT SURG, V25, P534, DOI 10.3928/1081597X-20090512-07; Shin MC, 2016, OPTOMETRY VISION SCI, V93, P259, DOI 10.1097/OPX.0000000000000799; Szalai E, 2012, J CATARACT REFR SURG, V38, P485, DOI 10.1016/j.jcrs.2011.10.027; Wylegala A, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0911-x; Wylegala E, 2009, EUR J OPHTHALMOL, V19, P723; Wylegala E, 2009, J CATARACT REFR SURG, V35, P1410, DOI 10.1016/j.jcrs.2009.03.034	22	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230589	10.1371/journal.pone.0230589	http://dx.doi.org/10.1371/journal.pone.0230589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240192	gold, Green Published			2022-12-26	WOS:000535945000030
J	Mossner, S; Phan, HT; Triller, S; Moll, JM; Conrad, U; Scheller, J				Mossner, Sofie; Phan, Hoang T.; Triller, Saskia; Moll, Jens M.; Conrad, Udo; Scheller, Juergen			Multimerization strategies for efficient production and purification of highly active synthetic cytokine receptor ligands	PLOS ONE			English	Article							ANTIBODIES; GP130	Cytokine signaling is transmitted by cell surface receptors which act as natural biological switches to control cellular functions such as immune reactions. Recently, we have designed synthetic cytokine receptors (SyCyRs) consisting of green fluorescent protein (GFP)- and mCherry-nanobodies fused to the transmembrane and intracellular domains of cytokine receptors. Following stimulation with homo- and heterodimeric GFP-mCherry fusion proteins, the resulting receptors phenocopied signaling induced by physiologically occurring cytokines. GFP and mCherry fusion proteins were produced in E. coli or CHO-K1 cells, but the overall yield and stability was low. Therefore, we applied two alternative multi-merization strategies and achieved immunoglobulin Fc-mediated dimeric and coiled-coil GCN4pII-mediated trimeric assemblies. GFP- and/or mCherry-Fc homodimers activated synthetic gp130 cytokine receptors, which naturally respond to Interleukin 6 family cytokines. Activation of these synthetic gp130 receptors resulted in STAT3 and ERK phosphorylation and subsequent proliferation of Ba/F3-gp130 cells. Half-maximal effective concentrations (EC50) of 8.1 ng/ml and 0.64 ng/ml were determined for dimeric GFP-Fc and mCherry-Fc, respectively. This is well within the expected EC50 range of the native cytokines. Moreover, we generated tetrameric and hexameric GFP-mCherry-Fc fusion proteins, which were also biologically active. This highlighted the importance of close juxtaposition of two cytokine receptors for efficient receptor activation. Finally, we used a trimeric GCN4pII motif to generate homo-trimeric GFP and mCherry complexes. These synthetic cytokines showed improved EC50 values (GFP(3) : 0.58 ng/ml; mCherrry(3) : 0.37 ng/ml), over dimeric Fc fused variants. In conclusion, we successfully generated highly effective and stable multimeric synthetic cytokine receptor ligands for activation of synthetic cytokine receptors.	[Mossner, Sofie; Moll, Jens M.; Scheller, Juergen] Heinrich Heine Univ, Med Fac, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Phan, Hoang T.; Triller, Saskia; Conrad, Udo] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany	Heinrich Heine University Dusseldorf; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Scheller, J (corresponding author), Heinrich Heine Univ, Med Fac, Inst Biochem & Mol Biol 2, Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Scheller, Jürgen/K-5290-2015	Phan, Hoang Trong/0000-0001-7580-5776	Deutsche Forschungsgemeinschaft [SFB1116]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by a grant from the Deutsche Forschungsgemeinschaft (SFB1116).	Atanasova M, 2012, CRIT REV BIOCHEM MOL, V47, P502, DOI 10.3109/10409238.2012.729561; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Croxford AL, 2012, EUR J IMMUNOL, V42, P2263, DOI 10.1002/eji.201242598; Engelowski E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04454-8; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Floss DM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15173-3; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Phan HT, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00115; Phan HT, 2016, METHODS MOL BIOL, V1349, P35, DOI 10.1007/978-1-4939-3008-1_3; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kubala MH, 2010, PROTEIN SCI, V19, P2389, DOI 10.1002/pro.519; Phan HT, 2013, PLANT BIOTECHNOL J, V11, P582, DOI 10.1111/pbi.12049; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Scheller J, 2019, TRENDS IMMUNOLOGY, V40; Si W, 2018, SYN SYST BIOTECHNO, V3, P179, DOI 10.1016/j.synbio.2018.08.001; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7	18	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230804	10.1371/journal.pone.0230804	http://dx.doi.org/10.1371/journal.pone.0230804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236103	Green Published, gold			2022-12-26	WOS:000535938700032
J	Quintero, J; Pulido, NR; Logan, J; Ant, T; Bruce, J; Carrasquilla, G				Quintero, Juliana; Pulido, Nicolas Ronderos; Logan, James; Ant, Thomas; Bruce, Jane; Carrasquilla, Gabriel			Effectiveness of an intervention for Aedes aegypti control scaled-up under an inter-sectoral approach in a Colombian city hyper-endemic for dengue virus	PLOS ONE			English	Article							WATER CONTAINER COVERS; INSECTICIDE-TREATED CURTAINS; VECTOR CONTROL INTERVENTIONS; ECONOMIC BURDEN; LATIN-AMERICA; DISEASE; HEALTH; TRANSMISSION; PREVENTION; DYNAMICS	Aedes aegypti transmitted arboviral diseases are of significant importance in Colombia, particularly since the 2014/2015 introduction of chikungunya and Zika in the Americas and the increasing spread of dengue. In response, the Colombian government initiated the scaling-up of a community-based intervention under inter and multi-sector partnerships in two out of four sectors in Girardot, one of the most hyper-endemic dengue cities in the country. Using a quasi-experimental research design a scaled-up community-led Aedes control intervention was assessed for its capacity to reduce dengue from January 2010 to August 2017 in Girardot, Colombia. Reported dengue cases, and associated factors were analysed from available data sets from the Colombian disease surveillance systems. We estimated the reduction in dengue cases before and after the intervention using, Propensity Score Matching and an Autoregressive Moving Average model for robustness. In addition, the differences in dengue incidence among scaling-up phases (pre-implementation vs sustainability) and between treatment groups (intervention and control areas) were modelled. Evidence was found in favour of the intervention, although to maximise impact the scaling-up of the intervention should continue until it covers the remaining sectors. It is expected that a greater impact of the intervention can be documented in the next outbreak of dengue in Girardot.	[Quintero, Juliana; Logan, James; Carrasquilla, Gabriel] Fdn Santa Fe Bogota, Eje Salud Poblac, Bogota, Colombia; [Quintero, Juliana; Pulido, Nicolas Ronderos] Univ Santo Tomas, Bogota, Colombia; [Logan, James; Ant, Thomas; Bruce, Jane] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London, England	Universidad Santo Tomas USTA; University of London; London School of Hygiene & Tropical Medicine	Quintero, J (corresponding author), Fdn Santa Fe Bogota, Eje Salud Poblac, Bogota, Colombia.; Quintero, J (corresponding author), Univ Santo Tomas, Bogota, Colombia.	juliana.quintero@lshtm.ac.uk		Quintero Espinosa, Juliana/0000-0003-3005-4184	Administrative Department of Science, Technology and Innovation of Colombia (Colciencias) [622172553374]; International Development Research Center of Canada (IDRC) Project [107843-001]	Administrative Department of Science, Technology and Innovation of Colombia (Colciencias)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); International Development Research Center of Canada (IDRC) Project	The study was supported financially by a grant from the following institutions: Administrative Department of Science, Technology and Innovation of Colombia (Colciencias) Project 622172553374 and by the International Development Research Center of Canada (IDRC) Project 107843-001. The nets employed in this study were donated by the Ministry of Health of Colombia. Colciencias URL: https://www.colciencias.gov.co/IDRC URL: https://www.idrc.ca/The funders had no role in the e study design, data collection and analysis, decision to publish, or preparation of the manuscript. JQ and GC received boths awards.	Alcala L, 2015, BIOMEDICA, V35, P258, DOI [10.1590/S0120-41572015000200014, 10.7705/biomedica.v35i2.2567]; Alfonso-Sierra E, 2016, PATHOG GLOB HEALTH, V110, P14, DOI 10.1080/20477724.2016.1142057; Alvarado-Castro V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4290-z; Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499; Arunachalam N, 2012, PATHOG GLOB HEALTH, V106, P488, DOI 10.1179/2047773212Y.0000000056; Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892; Aunger R, 2016, HEALTH PSYCHOL REV, V10, P425, DOI 10.1080/17437199.2016.1219673; Ballenger-Browning KK, 2009, TROP MED INT HEALTH, V14, P1542, DOI 10.1111/j.1365-3156.2009.02396.x; Barker PM, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0374-x; Bernal R, 2011, GUIA PRACTICA EVALUA, DOI [10.7440/j.ctt1b3t82z, DOI 10.7440/J.CTT1B3T82Z]; Bouzid M, PUBLIC HLTH INTERVEN; Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551; Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Buttenheim Alison, 2018, SOCARXIV, P1; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Carrasco LR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001426; Rodriguez RC, 2016, AM J TROP MED HYG, V94, P1065, DOI 10.4269/ajtmh.15-0280; Coelho GE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004705; Cromwell EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005429; Eisenstein M, 2016, NATURE, V531, pS61, DOI 10.1038/531S61a; Enduri MK, 2018, SPAT SPATIO-TEMPORAL, V25, P57, DOI 10.1016/j.sste.2018.03.001; Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006; Fabián, 2015, Physis, V25, P571, DOI 10.1590/S0103-73312015000200013; Fuentes-Vallejo M, 2015, CAD SAUDE PUBLICA, V31, P517, DOI 10.1590/0102-311X00057214; Garcia-Betancourt T, 2014, ECOHEALTH, V11, P434, DOI 10.1007/s10393-014-0953-8; Gomez-Dantes H, 2009, CAD SAUDE PUBLICA, V25, pS19, DOI 10.1590/S0102-311X2009001300003; Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157; Henna Hasson, 2010, IEEE INT C COMM CAP, P1, DOI [10.1186/1748-5908-5-1, DOI 10.1186/1748-5908-5-1]; Hernandez-Suarez CM, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.28026; Horstick O, 2018, LANCET INFECT DIS, V18, pE147, DOI 10.1016/S1473-3099(17)30422-X; Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027; INDIG D, 2017, BMC PUBLIC HEALTH, V18, DOI DOI 10.1186/S12889-017-4524-0; Instituto Nacional de Salud, 2012, DENG SURV PROT, DOI [10.1111/j.1467-6419.2007.00527.x, DOI 10.1111/J.1467-6419.2007.00527.X]; Instituto Nacional de Salud, 2015, B EP SEM SEM EP NUM; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; Liyanage P, 2019, LANCET PLANET HEALTH, V3, pE211, DOI 10.1016/S2542-5196(19)30057-9; Lotufo PA, 2016, SAO PAULO MED J, V134, P95, DOI 10.1590/1516-3180.2016.13421602; Maria Turchi Martelli C, 2015, EC IMPACT DENGUE MUL; Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020; Messina JP, 2014, GLOBAL COMPENDIUM HU; Milat AJ, 2013, HEALTH PROMOT INT, V28, P285, DOI 10.1093/heapro/dar097; Moore GF, 2017, SSM-POPUL HLTH, V3, P132, DOI 10.1016/j.ssmph.2016.12.005; Mulligan K, 2015, PATHOG GLOB HEALTH, V109, P10, DOI 10.1179/2047773214Y.0000000168; Nishikawa AM, 2016, VALUE HEALTH, V19, pA216, DOI 10.1016/j.jval.2016.03.1217; Ooi EE, 2001, LANCET, V357, P685, DOI 10.1016/S0140-6736(00)04137-4; Overgaard HJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2295-1; Padilla J.C., 2012, DENGUE COLOMBIA EPID; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Quintero J, 2015, T ROY SOC TROP MED H, V109, P116, DOI 10.1093/trstmh/tru208; Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38; Quintero J, 2009, CAD SAUDE PUBLICA, V25, pS93, DOI 10.1590/S0102-311X2009001300009; Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003; Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283; Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384; San Martin JL, 2007, REV PANAM SALUD PUBL, V21, P55, DOI 10.1590/S1020-49892007000100011; Sarti E, 2016, INT J INFECT DIS, V44, P44, DOI 10.1016/j.ijid.2016.01.015; Schmunis G A, 2000, Cad Saude Publica, V16 Suppl 2, P117, DOI 10.1590/S0102-311X2000000800016; Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8; Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026; Sommerfeld J, 2015, T ROY SOC TROP MED H, V109, P85, DOI 10.1093/trstmh/tru176; Sommerfeld J, 2012, PATHOG GLOB HEALTH, V106, P428, DOI 10.1179/2047773212Y.0000000055; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Torres JR, 2007, CAD SAUDE PUBLICA, V23, pS23, DOI 10.1590/S0102-311X2007001300004; Vanlerberghe V, 2011, TROP MED INT HEALTH, V16, P72; Vanlerberghe V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000994; Wilson AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003228; World Health Organization. WHO, 2018, GLOB VECT CONTR RESP	71	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230486	10.1371/journal.pone.0230486	http://dx.doi.org/10.1371/journal.pone.0230486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236142	Green Published, gold			2022-12-26	WOS:000535938700020
J	Koike, Y; Li, B; Lee, CR; Alganabi, M; Zhu, HT; Chusilp, S; Lee, DR; Cheng, SG; Li, Q; Pierro, A				Koike, Yuhki; Li, Bo; Lee, Carol; Alganabi, Mashriq; Zhu, Haitao; Chusilp, Sinobol; Lee, Dorothy; Cheng, Shigang; Li, Qi; Pierro, Agostino			The intestinal injury caused by ischemia-reperfusion is attenuated by amniotic fluid stem cells via the release of tumor necrosis factor-stimulated gene 6 protein	FASEB JOURNAL			English	Article						amniotic fluid stem cell (AFSC); intestinal injury; ischemia; reperfusion (I; R); tumor necrosis factor-stimulated gene 6 protein (TSG-6)	MODERATE HYPOTHERMIA; TSG-6; METABOLISM; RECOVERY; EFFICACY; THERAPY; HEART; MODEL; MICE; LUNG	Ischemia/reperfusion (I/R) is implicated in the pathogenesis of various acute intestinal injuries. Amniotic fluid stem cells (AFSC) are beneficial in experimental intestinal diseases. Tumor necrosis factor-induced protein 6 (TSG-6) has been shown to exert anti-inflammatory effects. We aimed to investigate if AFSC secreted TSG-6 reduces inflammation and rescues intestinal I/R injury. The superior mesenteric artery of 3-week-old rats was occluded for 90 minutes and green fluorescent protein-labeled AFSC or recombinant TSG-6 was injected intravenously upon reperfusion. AFSC distribution was evaluated at 24, 48, and 72 hours after I/R. AFSC and TSG-6 effects on the intestine were assessed 48 hours postsurgery. Intestinal organoids were used to study the effects of TSG-6 after hypoxia-induced epithelial damage. After I/R-induced intestinal injury, AFSC migrated preferentially to the ileum, the primary site of injury, through blood circulation. Engrafted AFSC reduced ileum injury, inflammation, and oxidative stress. These AFSC-mediated beneficial effects were dependent on secretion of TSG-6. Administration of TSG-6 protected against hypoxia-induced epithelial damage in intestinal organoids. Finally, TSG-6 attenuated intestinal damage during I/R by suppressing genes involved in wound and injury pathways. This study indicates that AFSC or TSG-6 have the potential of rescuing the intestine from the damage caused by I/R.	[Koike, Yuhki; Li, Bo; Lee, Carol; Alganabi, Mashriq; Zhu, Haitao; Chusilp, Sinobol; Lee, Dorothy; Cheng, Shigang; Li, Qi; Pierro, Agostino] Hosp Sick Children, Div Gen & Thorac Surg, Translat Med, Toronto, ON, Canada; [Koike, Yuhki] Mie Univ, Grad Sch Med, Dept Gastrointestinal & Paediat Surg, Tsu, Mie, Japan	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Mie University	Pierro, A (corresponding author), Univ Toronto, Hosp Sick Children, Div Gen & Thorac Surg, Translat Med, 1526-555 Univ Ave, Toronto, ON M5G 1X8, Canada.	agostino.pierro@sickkids.ca	zhu, HAITAO/GVL-0589-2022; Li, Bo/AAP-6556-2020; Alganabi, Mashriq/AAR-3656-2020	Li, Bo/0000-0002-8298-8344; Alganabi, Mashriq/0000-0001-9835-9609; Chusilp, Sinobol/0000-0001-6473-0385	Canadian Institutes of Health Research (CIHR) [353857]; Restracomp Fellowship, The Hospital for Sick Children	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Restracomp Fellowship, The Hospital for Sick Children	AP is supported by a Canadian Institutes of Health Research (CIHR) Foundation Grant 353857 and is the Robert M. Filler Chair of Surgery for The Hospital for Sick Children. BL is the recipient of Restracomp Fellowship, The Hospital for Sick Children. The funders were not involved in the study design, the collection, analysis, interpretation of data, writing of the report or the decision to submit the paper for publication	Angelini A, 2011, J HEART LUNG TRANSPL, V30, P1281, DOI 10.1016/j.healun.2011.07.017; Ben Shahar Y, 2016, EUR J PEDIATR SURG, V26, P47, DOI 10.1055/s-0035-1559886; Bryan C, 2019, PEDIATR RES, V85, P390, DOI 10.1038/s41390-018-0250-2; Caracuel L, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00118; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; da Cunha MGMCM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136145; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Crosignani V, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116023; Da Sacco S, 2011, CURR OPIN ORGAN TRAN, V16, P101, DOI 10.1097/MOT.0b013e3283424f6e; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Hu Y, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7239181; Idrovo JP, 2014, MOL MED, V20, P676, DOI 10.2119/molmed.2014.00134; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Lee C, 2018, PEDIATR SURG INT, V34, P155, DOI 10.1007/s00383-017-4183-3; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesage F, 2017, HERNIA, V21, P973, DOI 10.1007/s10029-017-1635-6; Li B, 2019, PEDIATR SURG INT, V35, P3, DOI 10.1007/s00383-018-4369-3; Li B, 2017, SCI REP-UK, V7, DOI 10.1038/srep46616; Li B, 2016, J PEDIATR SURG, V51, P775, DOI 10.1016/j.jpedsurg.2016.02.019; Martin J, 2016, J BIOL CHEM, V291, P13789, DOI 10.1074/jbc.M115.670521; Martinez-Revelles S, 2012, BRIT J PHARMACOL, V165, P937, DOI 10.1111/j.1476-5381.2011.01617.x; McCulloh CJ, 2017, J SURG RES, V214, P278, DOI 10.1016/j.jss.2017.03.026; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2005, BIOCHEM BIOPH RES CO, V330, P737, DOI 10.1016/j.bbrc.2005.03.040; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Piccoli M, 2012, STEM CELLS, V30, P1675, DOI 10.1002/stem.1134; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Rehni AK, 2007, BEHAV BRAIN RES, V183, P95, DOI 10.1016/j.bbr.2007.05.028; Sala E, 2015, GASTROENTEROLOGY, V149, P163, DOI 10.1053/j.gastro.2015.03.013; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SCHOENBERG MH, 1993, CRIT CARE MED, V21, P1376, DOI 10.1097/00003246-199309000-00023; SONG WJ, 2018, STEM CELL RES THER, V9; Song WJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04766-7; Stefanutti G, 2008, CRIT CARE MED, V36, P1564, DOI 10.1097/CCM.0b013e3181709e9f; Stefanutti G, 2007, PEDIATR RES, V62, P43, DOI 10.1203/PDR.0b013e31806790c0; Sukhotnik I, 2007, DIGEST DIS SCI, V52, P1497, DOI 10.1007/s10620-006-9629-8; Sukhotnik I, 2019, EUR J PEDIATR SURG, V29, P188, DOI 10.1055/s-0037-1618593; Sukhotnik I, 2011, J PEDIATR SURG, V46, P1353, DOI 10.1016/j.jpedsurg.2010.09.051; Toiyama Y, 2010, J GASTROENTEROL, V45, P544, DOI 10.1007/s00535-009-0187-7; Vejchapipat P, 2002, J PEDIATR SURG, V37, P786, DOI 10.1053/jpsu.2002.32288; Vejchapipat P, 2000, J PEDIATR SURG, V35, P759, DOI 10.1053/jpsu.2000.6062; Wang Y, 2016, MOL MED REP, V14, P234, DOI 10.3892/mmr.2016.5212; Watkins DJ, 2013, J PEDIATR SURG, V48, P1323, DOI 10.1016/j.jpedsurg.2013.03.032; Zani A, 2014, GUT, V63, P300, DOI 10.1136/gutjnl-2012-303735; Zhang SQ, 2018, J CELL BIOCHEM, V119, P1627, DOI 10.1002/jcb.26322	49	9	10	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6824	6836		10.1096/fj.201902892RR	http://dx.doi.org/10.1096/fj.201902892RR		MAR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32223023	Bronze			2022-12-26	WOS:000522486500001
J	Arinaminpathy, N; Gomez, GB; Sachdeva, KS; Rao, R; Parmar, M; Nair, SA; Rade, K; Kumta, S; Hermann, D; Hanson, C; Chin, DP; Dewan, P				Arinaminpathy, Nimalan; Gomez, Gabriela B.; Sachdeva, Kuldeep S.; Rao, Raghuram; Parmar, Malik; Nair, Sreenivas A.; Rade, Kiran; Kumta, Sameer; Hermann, David; Hanson, Christy; Chin, Daniel P.; Dewan, Puneet			The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RIFAMPIN; RISK	There is increasing interest in future, highly-potent 'pan-TB' regimens against tuberculosis (TB), that may be equally effective in both drug-susceptible and rifampicin-resistant (RR) forms of TB. Taking the example of India, the country with the world's largest burden of TB, we show that adoption of these regimens could be: (i) epidemiologically impactful, and (ii) cost-saving to the national TB programme, even if the regimen itself is more costly than current TB treatment. Mathematical modelling suggests that deployment of a pan-TB regimen in 2022 would reduce the annual incidence of TB in 2030 by 23.9% [95% Bayesian credible intervals [CrI] 17.6-30.8%] if used to treat all TB cases, and by 2.30% [95% CrI 1.57-3.48%] if used to treat only RR-TB. Notably, with a regimen costing less than USD 359 (95% CrI 287-441), treating all diagnosed TB cases with the pan-TB regimen yielded greater cost-savings than treating just those diagnosed with RR-TB. One limitation of our approach is that it does not capture the risk of resistance to the new regimen. We discuss ways in which this risk could be mitigated using modern adherence support mechanisms, as well as drug sensitivity testing at the point of TB diagnosis, to prevent new resistant forms from becoming established. A combination of such approaches would be important for maximising the useful lifetime of any future regimen.	[Arinaminpathy, Nimalan] Imperial Coll London, Fac Med, MRC Ctr Global Infect Dis Anal, London, England; [Gomez, Gabriela B.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Sachdeva, Kuldeep S.; Rao, Raghuram] Govt India, Cent TB Div, New Delhi, India; [Parmar, Malik; Rade, Kiran] WHO, India Country Off, New Delhi, India; [Nair, Sreenivas A.] Stop TB Partnership, Geneva, Switzerland; [Kumta, Sameer] Bill & Melinda Gates Fdn, India Country Off, New Delhi, India; [Hermann, David; Hanson, Christy; Chin, Daniel P.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Dewan, Puneet] Global Good, Intellectual Ventures, Seattle, WA USA	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Bill & Melinda Gates Foundation; Intellectual Ventures	Arinaminpathy, N (corresponding author), Imperial Coll London, Fac Med, MRC Ctr Global Infect Dis Anal, London, England.	nim.pathy@imperial.ac.uk	Rade, Kiran/AAU-9564-2020	Rade, Kiran/0000-0001-7601-0780; Nair, Sreenivas/0000-0002-2586-6797; Arinaminpathy, Nimalan/0000-0002-0412-150X	Bill and Melinda Gates Foundation (BMGF) [OPP1095710]; MRC [MR/R015600/1] Funding Source: UKRI	Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NA received a grant from the Bill and Melinda Gates Foundation (BMGF), number OPP1095710. SK, DH, CH and DPC are current employees and PD was a former employee of BMGF. All contributed to model validation and to the final manuscript draft. The funder otherwise had no role in the study.	Alkema L, 2008, SEX TRANSM INFECT, V84, pI11, DOI 10.1136/sti.2008.029991; [Anonymous], 2017, NAT STRAT PLAN TUB E; Arinaminpathy N, 2016, LANCET INFECT DIS, V16; Central TB Division India, REP JOINT MON MISS; Chadha VK, 2013, INT J TUBERC LUNG D, V17, P312, DOI 10.5588/ijtld.12.0330; Conradie F., 2018, NIX TB TRIAL PRETOMA; Dheda K, 2018, LANCET RESP MED, V6, P240, DOI 10.1016/S2213-2600(18)30097-3; Dorman SE, 2018, LANCET INFECT DIS, V18, P76, DOI [10.1016/S1473-3099(17)30691-6, 10.1016/s1473-3099(17)30691-6]; Evans CA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001064; Global Drug Facility, 2018, BIV 2018 MED CAT; Imperial MZ, 2018, NAT MED, V24, P1708, DOI 10.1038/s41591-018-0224-2; Iseman MD, 2002, EUR RESPIR J, V20, p87S, DOI 10.1183/09031936.02.00309102; Kendall EA, 2018, LANCET RESP MED, V6, P486, DOI 10.1016/S2213-2600(18)30197-8; Kendall EA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002202; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Lienhardt C, 2011, JAMA-J AM MED ASSOC, V305, P1415, DOI 10.1001/jama.2011.436; MENZIES D, 2009, PLOS MED, V6, P1, DOI DOI 10.1371/journal.pmed.0060001; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Murray S, 2016, INT J TUBERC LUNG D, V20, pS38, DOI 10.5588/ijtld.16.0069; Nikam C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051121; Pai M, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001805; Pandey S, 2017, INT J TUBERC LUNG D, V21, P366, DOI 10.5588/ijtld.16.0182; Revised National Tuberculosis Control Programme, 2016, REP 1 NAT ANT TB DRU; Ridzon R, 1998, AM J RESP CRIT CARE, V157, P1881, DOI 10.1164/ajrccm.157.6.9712009; Rupert S, 2017, INT J TUBERC LUNG D, V21, P375, DOI 10.5588/ijtld.16.0496; Sachdeva KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131438; Satyanarayana S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024160; Schnippel K, 2018, LANCET RESP MED, V6, P699, DOI 10.1016/S2213-2600(18)30235-2; Subbaraman R, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001018; VALLSPINOSA A, 1970, NEW ENGL J MED, V283, P616, DOI 10.1056/NEJM197009172831202; Wallis RS, 2018, LANCET RESP MED, V6, P239, DOI 10.1016/S2213-2600(18)30096-1; WHO, 2015, WORLD HEAL ORGAN, V58, P7250; Working Group for New TB Drugs, STOP TB PARTNERSHIP; World Health Organization, 2016, TARG REG PROF TB TRE; World Health Organization, 2018, GLOB TUB REP 2018; Zumla A, 2015, LANCET RESP MED, V3, P220, DOI 10.1016/S2213-2600(15)00063-6; Zurcher K, 2019, LANCET INFECT DIS, V19, P298, DOI 10.1016/S1473-3099(18)30673-X	37	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0230808	10.1371/journal.pone.0230808	http://dx.doi.org/10.1371/journal.pone.0230808			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218585	Green Published, gold			2022-12-26	WOS:000535935400025
J	Kang, J; Jeong, SH; Lee, K; Park, N; Jung, H; Lee, K; Ju, JH				Kang, Jaewoo; Jeong, Sang Hoon; Lee, Kijun; Park, Narae; Jung, Hyerin; Lee, Kyuhong; Ju, Ji Hyeon			Exacerbation of symptomatic arthritis by cigarette smoke in experimental arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; AUTOIMMUNITY; PROGRESSION; DISEASE; AUTOANTIBODIES; CITRULLINATION; INFLAMMATION; ASSOCIATION; VIMENTIN	Introduction Epidemiologically, cigarette smoking is a well-known risk factor for the pathogenesis of rheumatoid arthritis (RA). However, there has been few plausible explanations why cigarette smoking aggravated RA. We investigated the causal effect of smoking in experimental model of arthritis development. Methods During induction of experimental arthritis with collagen challenge, mice were exposed to a smoking environment with 3R4F cigarettes. Generated smoke was delivered to mice through a nose-only exposure chamber (ISO standard 3308). Human cartilage pellet was challenged by cigarette smoke extract to identify citrullinating potential in vitro. Results Cigarette smoke exacerbated arthritis in a collagen-induced arthritis (CIA) model. Exposure to smoke accelerated the onset of arthritis by 2 weeks compared to the conventional model without smoke. Citrullination of lung tissue as well as tarsal joints were revealed in smoke-aggravated CIA mice. Interestingly, tracheal cartilage was a core organ regarding intensity and area size of citrullination. The trachea might be an interesting organ in viewpoint of sharing cartilage with joint and direct smoke exposure. Anti-CCP antibodies were barely detected in the serum of CIA mice, they were significantly elevated in cigarette smoke group. Citrullinated antigens were increased in the serum of smoke-exposed mice. Lastly, a cigarette smoke extract enhanced human cartilage citrullination in vitro. Conclusions Missing link of arthritic mechanism between smoke and RA could be partially explained by tracheal citrullination. To control tracheal cartilage citrullination may be beneficial for preventing arthritis development or aggravation if cigarette smoke is becoming a risk factor to pre-arthritic individual.	[Kang, Jaewoo; Jeong, Sang Hoon; Lee, Kijun; Park, Narae; Jung, Hyerin; Ju, Ji Hyeon] Catholic Univ Korea, Coll Med, Catholic Induced Pluripotent Stem Cell iPSC Res C, CiSTEM Lab, Seoul, South Korea; [Kang, Jaewoo; Lee, Kijun; Park, Narae; Jung, Hyerin; Ju, Ji Hyeon] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea; [Lee, Kyuhong] Korea Inst Toxicol, Jeonbuk Dept Inhalat Res, Jeongeup, Jeollabuk Do, South Korea; [Ju, Ji Hyeon] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Rheumatol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT); Catholic University of Korea; Seoul St. Mary's Hospital	Ju, JH (corresponding author), Catholic Univ Korea, Coll Med, Catholic Induced Pluripotent Stem Cell iPSC Res C, CiSTEM Lab, Seoul, South Korea.; Ju, JH (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea.; Ju, JH (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Rheumatol, Seoul, South Korea.	juji@catholic.ac.kr		Ju, Ji Hyeon/0000-0002-1381-5466	Korea Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [HI14C3417]	Korea Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This work was supported by a grant of the Korea Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea. (HI14C3417), Ji Hyeon Ju	Apel F, 2018, NAT REV RHEUMATOL, V14, P467, DOI 10.1038/s41584-018-0039-z; Bae S, 2012, J IMMUNOL, V189, P365, DOI 10.4049/jimmunol.1102073; Boissier MC, 2012, J AUTOIMMUN, V39, P222, DOI 10.1016/j.jaut.2012.05.021; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Burkhardt H, 2005, EUR J IMMUNOL, V35, P1643, DOI 10.1002/eji.200526000; Chang K, 2014, INT J MOL SCI, V15, P22279, DOI 10.3390/ijms151222279; Chang X, 2005, RHEUMATOLOGY, V44, P1374, DOI 10.1093/rheumatology/kei023; Chen L, 2014, EUR RESPIR J, V44, P634, DOI 10.1183/09031936.00171313; Costenbader KH, 2006, AM J MED, V119, P503, DOI 10.1016/j.amjmed.2005.09.053; Daijo H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34424; Darrah E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005370; Di Giuseppe D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4498; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Foulquier C, 2007, ARTHRITIS RHEUM-US, V56, P3541, DOI 10.1002/art.22983; Ge CR, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93688; Hasler P, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14352; Huckel M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1869; Kearney PL, 2005, BIOCHEMISTRY-US, V44, P10570, DOI 10.1021/bi050292m; Kim EJ, 2009, CHEST, V136, P1397, DOI 10.1378/chest.09-0444; Kim Y, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.24; Koushik S, 2017, EXPERT OPIN THER TAR, V21, P433, DOI 10.1080/14728222.2017.1294160; Lee J, 2017, RHEUMATOLOGY, V56, P644, DOI 10.1093/rheumatology/kew449; Li FJ, 2017, J IMMUNOL, V199, P1596, DOI 10.4049/jimmunol.1700473; Makrygiannakis D, 2008, ANN RHEUM DIS, V67, P1488, DOI 10.1136/ard.2007.075192; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Miglino N, 2012, EUR RESPIR J, V39, P705, DOI 10.1183/09031936.00174310; Nam Y, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0477-6; Nguyen Nam Trung, 2015, J Exp Pharmacol, V7, P29, DOI 10.2147/JEP.S63549; O'Neil LJ, 2019, TRENDS MOL MED, V25, P215, DOI 10.1016/j.molmed.2018.12.008; Pratesi F, 2014, ANN RHEUM DIS, V73, P1414, DOI 10.1136/annrheumdis-2012-202765; Rim YA, 2018, J TISSUE ENG REGEN M, V12, pE1531, DOI 10.1002/term.2578; Saevarsdottir S, 2015, ANN RHEUM DIS, V74, P1509, DOI 10.1136/annrheumdis-2013-204601; Samara KD, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0692-9; Schurgers E, 2012, EUR J IMMUNOL, V42, P3223, DOI 10.1002/eji.201242573; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Sugiyama D, 2010, ANN RHEUM DIS, V69, P70, DOI 10.1136/ard.2008.096487; Szodoray P, 2010, AUTOIMMUN REV, V9, P140, DOI 10.1016/j.autrev.2009.04.006; Talbot J, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1609-9; Tilleman K, 2008, RHEUMATOLOGY, V47, P597, DOI 10.1093/rheumatology/ken077; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P709, DOI 10.1002/art.20044; van Venrooij WJ, 2008, ANN NY ACAD SCI, V1143, P268, DOI 10.1196/annals.1443.013; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x; Young A, 2007, RHEUMATOLOGY, V46, P350, DOI 10.1093/rheumatology/kel253	44	8	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0230719	10.1371/journal.pone.0230719	http://dx.doi.org/10.1371/journal.pone.0230719			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218599	Green Published, gold			2022-12-26	WOS:000535935400020
J	Nielson, KG; Woodman, SG; Rood, SB				Nielson, Kayleigh G.; Woodman, Samuel G.; Rood, Stewart B.			Prospective impacts of oil spills on floodplain vegetation: Both crude oil and diluted bitumen increase foliar temperatures, senescence and abscission in three cottonwood (Populus) species	PLOS ONE			English	Article							RIPARIAN COTTONWOODS; WATER RELATIONS; GAS-EXCHANGE; TOXICITY; SANDS; RIVER; THERMOGRAPHY; MIXTURES; SOUTHERN; ALBERTA	Oil pipelines are vulnerable at river crossings since floods can expose and rupture pipes, releasing oil that floats and coats floodplain vegetation. This study investigated the consequences of oil coatings on leaves of cottonwoods (riparian poplars), the predominant trees in floodplain woodlands around the Northern Hemisphere. The study compared conventional crude oil (CO) versus diluted bitumen (dilbit, DB), heavy oil originating from the Alberta oil sands; with petroleum jelly (PJ) as a reference. The treatments increased leaf surface temperatures (T-leaf) in narrowleaf and plains cottonwoods (Populus angustifolia, P. deltoides) and balsam poplars (P. balsamifera) (Control = 21.8 degrees C, PJ = 23.7 degrees C; CO = 26.2 degrees C; DB = 28.1 degrees C; T-air = 25 degrees C). The leaf warming followed stomatal occlusion from the foliar coating, which would reduce transpiration and evaporative cooling, combined with increased solar warming with the darker oils. T-leaf varied across the three cottonwood species, with cooler, narrow, narrowleaf cottonwood leaves; intermediate plains cottonwood leaves; and warmer, darker, balsam poplar leaves (average T-leaf: narrowleaf = 23.8 degrees C, plains = 24.3 degrees C, and balsam = 26.7 degrees C), with similar warming in each species following the different treatments. Across species and treatments, T-leaf was tightly correlated with foliar condition, which assessed turgor versus wilting of leaf blades and petioles, along with leaf necrosis and senescence (r(2) = 0.980, narrowleaf; 0.998, plains; 0.852, balsam). This tight association indicates validity of both T-leaf and foliar condition as diagnostic measures. Crude oil and dilbit had similar foliar impacts, and for both, leaf abscission occurred within 2 to 3 weeks. Consequently, following an oil spill, remediation should commence quickly but extending vegetation removal beyond a few weeks would have limited benefit since the contaminated leaves would have abscised.	[Nielson, Kayleigh G.; Woodman, Samuel G.; Rood, Stewart B.] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB, Canada	University of Lethbridge	Rood, SB (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB, Canada.	rood@uleth.ca		Woodman, Samuel/0000-0001-9725-5867	Alberta Environment and Parks; Alberta Innovates [AI 2612]; Natural Sciences and Engineering Research Council Canada [2019-05384]	Alberta Environment and Parks; Alberta Innovates; Natural Sciences and Engineering Research Council Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding to SBR was provided by Alberta Environment and Parks (https://www.alberta.ca/environment-and-parks.aspx) following a Creative Sentencing Order after the 2012 Red Deer River pipeline rupture; Alberta Innovates (AI 2612; https://albertainnovates.ca/); and Natural Sciences and Engineering Research Council Canada (Discovery Grant 2019-05384; http://www.nserccrsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YJ, 2004, B ENVIRON CONTAM TOX, V72, P1006, DOI 10.1007/s00128-004-0343-y; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Baek KH, 2004, J ENVIRON SCI HEAL A, V39, P2465, DOI 10.1081/lesa-200026309; Bajons P, 2005, INFRARED PHYS TECHN, V46, P429, DOI 10.1016/j.infrared.2004.09.001; BAKER J. M., 1970, Environmental Pollution, V1, P27, DOI 10.1016/0013-9327(70)90004-2; BARR DA, 1976, INT J BIOMETEOROL, V20, P1, DOI 10.1007/BF01553165; BEMENT R. E., 1961, JOUR RANGE MANAGEMENT, V14, P102, DOI 10.2307/3894725; BRADFORD KJ, 1982, PLANT PHYSIOL, V70, P1508, DOI 10.1104/pp.70.5.1508; Dew WA, 2015, J APPL TOXICOL, V35, P1219, DOI 10.1002/jat.3196; Flanagan LB, 2017, AGR FOREST METEOROL, V232, P332, DOI 10.1016/j.agrformet.2016.08.024; FREEDMAN W, 1976, CAN J BOT, V54, P2219, DOI 10.1139/b76-238; FREELAND RO, 1948, PLANT PHYSIOL, V23, P595, DOI 10.1104/pp.23.4.595; Ghannam MT, 2012, J PETROL SCI ENG, V81, P122, DOI 10.1016/j.petrol.2011.12.024; Girgin S, 2016, J LOSS PREVENT PROC, V40, P578, DOI 10.1016/j.jlp.2016.02.008; Hein F.J., 2006, NONRENEWABLE RESOUR, V15, P85, DOI [10.1007/s11053-006-9015-4, DOI 10.1007/S11053-006-9015-4]; Hester MW, 2016, ENVIRON POLLUT, V216, P361, DOI 10.1016/j.envpol.2016.05.065; Hoberg G, 2013, CAN PUBLIC POL, V39, P371, DOI 10.3138/CPP.39.3.371; Hughes JD, 2016, CAN CTR POLICY ALTER; HUTCHINSON TC, 1978, CAN J BOT, V56, P2424, DOI 10.1139/b78-294; Jones HG, 2002, J EXP BOT, V53, P2249, DOI 10.1093/jxb/erf083; Kaluthota S, 2015, TREE PHYSIOL, V35, P936, DOI 10.1093/treephys/tpv069; Kelly EN, 2009, P NATL ACAD SCI USA, V106, P22346, DOI 10.1073/pnas.0912050106; Leigh A, 2017, PLANT CELL ENVIRON, V40, P237, DOI 10.1111/pce.12857; Liebsch D, 2016, NEW PHYTOL, V212, P563, DOI 10.1111/nph.14217; MACKAY D, 1973, CAN J CHEM ENG, V51, P434, DOI 10.1002/cjce.5450510407; Malcolm C, 1981, RANGELAND J, V3, P106, DOI [10.1071/RJ9810106, DOI 10.1071/RJ9810106]; Martinez-Palou R, 2011, J PETROL SCI ENG, V75, P274, DOI 10.1016/j.petrol.2010.11.020; MENDELSSOHN IA, 1990, OIL CHEM POLLUT, V7, P1, DOI 10.1016/S0269-8579(05)80031-0; Costa JM, 2013, J EXP BOT, V64, P3937, DOI 10.1093/jxb/ert029; NASH BL, 1992, CAN J FOREST RES, V22, P1770, DOI 10.1139/x92-231; Nielson KG, 2019, BIOL INVASIONS, V21, P2963, DOI 10.1007/s10530-019-02025-6; ODonnell H.W., 2005, PIP DIV SPEC C 2005, DOI [10.1061/40800(180)35, DOI 10.1061/40800(180)35]; Parker SR, 1995, PLANT PATHOL, V44, P856, DOI 10.1111/j.1365-3059.1995.tb02745.x; Pearce DW, 2006, TREE PHYSIOL, V26, P211, DOI 10.1093/treephys/26.2.211; Pezeshki SR, 2001, ENVIRON POLLUT, V112, P483, DOI 10.1016/S0269-7491(00)00133-0; PEZESHKI SR, 1993, WATER AIR SOIL POLL, V68, P461, DOI 10.1007/BF00478469; Pezeshki SR, 2000, ENVIRON POLLUT, V108, P129, DOI 10.1016/S0269-7491(99)00244-4; Philibert DA, 2016, ENVIRON SCI TECHNOL, V50, P6091, DOI 10.1021/acs.est.6b00949; Philipsen LJ, 2018, DENDROCHRONOLOGIA, V51, P82, DOI 10.1016/j.dendro.2018.08.002; RACINE CH, 1994, CAN J BOT, V72, P1171, DOI 10.1139/b94-143; RODEN JS, 1993, PLANT CELL ENVIRON, V16, P571, DOI 10.1111/j.1365-3040.1993.tb00905.x; Rood S, 2013, OIL SPILL COOPERATIV, V2; Rood SB, 2003, TREE PHYSIOL, V23, P1113, DOI 10.1093/treephys/23.16.1113; ROOD SB, 1986, CAN J BOT, V64, P1382, DOI 10.1139/b86-189; Rood SB, 2011, OECOLOGIA, V165, P31, DOI 10.1007/s00442-010-1758-2; Rood SB, 2010, PHOTOSYNTH RES, V104, P31, DOI 10.1007/s11120-009-9511-6; Tsaprailis H, 2014, PUBLICATION ALBERTA; Walker AH, 2016, J MAR SCI ENG, V4, DOI 10.3390/jmse4010023; WEIN RW, 1973, J APPL ECOL, V10, P671, DOI 10.2307/2401861; Yang C, 2011, ENVIRON FORENSICS, V12, P173, DOI 10.1080/15275922.2011.574312; Zanewich KP, 2018, TREE PHYSIOL, V38, P789, DOI 10.1093/treephys/tpy019	52	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0230630	10.1371/journal.pone.0230630	http://dx.doi.org/10.1371/journal.pone.0230630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218607	Green Published, gold			2022-12-26	WOS:000535935400017
J	Datta, A; Yang, CR; Limbutara, K; Chou, CL; Rinschen, MM; Raghuram, V; Knepper, MA				Datta, Arnab; Yang, Chin-Rang; Limbutara, Kavee; Chou, Chung-Lin; Rinschen, Markus M.; Raghuram, Viswanathan; Knepper, Mark A.			PKA-independent vasopressin signaling in renal collecting duct	FASEB JOURNAL			English	Article						AMPK; AQP2; cAMP; mpkCCD; phosphoproteomics; PRM-MS	ACTIVATED PROTEIN-KINASE; SYSTEMS-LEVEL ANALYSIS; AQP2 GENE-EXPRESSION; LUMEN POLARITY; NITRIC-OXIDE; PHOSPHORYLATION SITES; AQUAPORIN 2; KIDNEY; CELLS; RECEPTOR	Vasopressin regulates renal water excretion by binding to a G(alpha)s-coupled receptor (V2R) in collecting duct cells, resulting in increased water permeability through regulation of the aquaporin-2 (AQP2) water channel. This action is widely accepted to be associated with cAMP-mediated activation of protein kinase A (PKA). Here, we use phosphoproteomics in collecting duct cells in which PKA has been deleted (CRISPR-Cas9) to identify PKA-independent responses to vasopressin. The results show that V2R-mediated vasopressin signaling is predominantly, but not entirely, PKA-dependent. Upregulated sites in PKA-null cells include Ser256 of AQP2, which is critical to regulation of AQP2 trafficking. In addition, phosphorylation changes in the protein kinases Stk39 (SPAK) and Prkci (an atypical PKC) are consistent with PKA-independent regulation of these protein kinases. Target motif analysis of the phosphopeptides increased in PKA-null cells indicates that vasopressin activates one or more members of the AMPK/SNF1-subfamily of basophilic protein kinases. In vitro phosphorylation assays using recombinant, purified SNF1-subfamily kinases confirmed postulated target specificities. Of interest, measured IBMX-dependent cAMP levels were an order of magnitude higher in PKA-null than in PKA-intact cells, indicative of a PKA-dependent feedback mechanism. Overall, the findings support the conclusion that V2-receptor mediated signaling in collecting duct cells is in part PKA-independent.	[Datta, Arnab; Yang, Chin-Rang; Limbutara, Kavee; Chou, Chung-Lin; Raghuram, Viswanathan; Knepper, Mark A.] NHLBI, Epithelial Syst Biol Lab, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Datta, Arnab] Yenepoya Deemed Be Univ, Yenepoya Res Ctr, Mangalore, India; [Rinschen, Markus M.] Scripps Res Inst, Dept Chem, Ctr Metabol & Mass Spectrometry, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Yenepoya (Deemed to be University); Scripps Research Institute	Knepper, MA (corresponding author), NHLBI, Epithelial Syst Biol Lab, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	knep@helix.nih.gov	Datta, Arnab/H-2755-2013	Datta, Arnab/0000-0002-9220-7812; Limbutara, Kavee/0000-0003-0889-5833	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [ZIA-HL-006129, ZIA-HL-001285]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI)	HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: ZIA-HL-001285; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: ZIA-HL-006129	Al-bataineh MM, 2016, AM J PHYSIOL-RENAL, V311, pF890, DOI 10.1152/ajprenal.00308.2016; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Bouley R, 2000, J CLIN INVEST, V106, P1115, DOI 10.1172/JCI9594; Bradford D, 2014, AM J PHYSIOL-CELL PH, V307, pC123, DOI 10.1152/ajpcell.00377.2012; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; CHAMPIGNEULLE A, 1993, AM J PHYSIOL, V265, pF35, DOI 10.1152/ajprenal.1993.265.1.F35; Chen LH, 2017, P NATL ACAD SCI USA, V114, pE9989, DOI 10.1073/pnas.1710964114; Chou CL, 2000, J BIOL CHEM, V275, P36839, DOI 10.1074/jbc.M005552200; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; Cohen D, 2003, METHODS, V30, P269, DOI 10.1016/S1046-2023(03)00033-1; Cohen D, 2007, MOL BIOL CELL, V18, P2203, DOI 10.1091/mbc.E07-02-0095; Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677; Deshmukh AS, 2010, DIABETOLOGIA, V53, P1142, DOI 10.1007/s00125-010-1716-x; Donsmark M, 2004, BIOCHEM BIOPH RES CO, V316, P867, DOI 10.1016/j.bbrc.2004.02.140; Douglass J, 2012, AM J PHYSIOL-CELL PH, V303, pC715, DOI 10.1152/ajpcell.00166.2012; Ducharme NA, 2006, MOL BIOL CELL, V17, P3625, DOI 10.1091/mbc.E05-08-0736; Elbert M, 2006, MOL BIOL CELL, V17, P3345, DOI 10.1091/mbc.E06-03-0193; Fu D, 2011, P NATL ACAD SCI USA, V108, P1403, DOI 10.1073/pnas.1018376108; Gagnon KB, 2010, AM J PHYSIOL-CELL PH, V299, pC614, DOI 10.1152/ajpcell.00074.2010; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hasler U, 2009, AM J PHYSIOL-RENAL, V297, pF10, DOI 10.1152/ajprenal.00053.2009; Isobe K, 2017, P NATL ACAD SCI USA, V114, pE8875, DOI 10.1073/pnas.1709123114; Katsura T, 1997, AM J PHYSIOL-RENAL, V272, pF816; Kim JH, 2011, PLOS ONE, V6; Klein JD, 2016, AM J PHYSIOL-RENAL, V310, pF1008, DOI 10.1152/ajprenal.00102.2016; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Kortenoeven MLA, 2012, AM J PHYSIOL-RENAL, V302, pF1395, DOI 10.1152/ajprenal.00376.2011; Lapierre LA, 2017, MOL BIOL CELL, V28, P1088, DOI 10.1091/mbc.E16-04-0214; Lapierre LA, 2012, MOL BIOL CELL, V23, P2302, DOI 10.1091/mbc.E11-08-0681; Lazaro-Dieguez F, 2013, J CELL BIOL, V203, P251, DOI 10.1083/jcb.201303013; Liwang JK, 2019, AM J PHYSIOL-RENAL, V316, pF253, DOI 10.1152/ajprenal.00491.2017; Loo CS, 2013, P NATL ACAD SCI USA, V110, P17119, DOI 10.1073/pnas.1309219110; Lorenz R, 2017, HANDB EXP PHARMACOL, V238, P105, DOI 10.1007/164_2015_36; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; Mohammadi A, 2001, J LIPID RES, V42, P1062; Murphy BA, 2009, AM J PHYSIOL-CELL PH, V297, pC750, DOI 10.1152/ajpcell.00127.2009; Naruse M, 1992, Nihon Jinzo Gakkai Shi, V34, P337; Nickols HH, 2004, J BIOL CHEM, V279, P46969, DOI 10.1074/jbc.M407351200; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Nishimoto G, 1999, AM J PHYSIOL-RENAL, V276, pF254, DOI 10.1152/ajprenal.1999.276.2.F254; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Olesen ETB, 2016, AM J PHYSIOL-RENAL, V311, pF935, DOI 10.1152/ajprenal.00559.2015; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; Prats C, 2009, J BIOL CHEM, V284, P15692, DOI 10.1074/jbc.M900845200; Procino G, 2003, FASEB J, V17, P1886, DOI 10.1096/fj.02-0870fje; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Saethang T, 2019, BIOINFORMATICS, V35, P5313, DOI 10.1093/bioinformatics/btz568; Sandi MJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan3286; Sandoval PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34863; Saritas T, 2013, J AM SOC NEPHROL, V24, P407, DOI 10.1681/ASN.2012040404; Schenk LK, 2012, J AM SOC NEPHROL, V23, P1008, DOI 10.1681/ASN.2011070738; STAR RA, 1988, J CLIN INVEST, V81, P1879, DOI 10.1172/JCI113534; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; UCHIDA S, 1994, J BIOL CHEM, V269, P23451; Walls PLL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14531-5; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yip KP, 2006, AM J PHYSIOL-RENAL, V291, pF882, DOI 10.1152/ajprenal.00411.2005; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106; Zeaiter Z, 2008, CELL MICROBIOL, V10, P781, DOI 10.1111/j.1462-5822.2007.01084.x; Zwartkruis FJT, 1999, EXP CELL RES, V253, P157, DOI 10.1006/excr.1999.4695	62	18	18	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6129	6146		10.1096/fj.201902982R	http://dx.doi.org/10.1096/fj.201902982R		MAR 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32219907	Bronze, Green Accepted			2022-12-26	WOS:000522483000001
J	Takasumi, M; Omori, T; Machida, T; Ishida, Y; Hayashi, M; Suzuki, T; Homma, Y; Endo, Y; Takahashi, M; Ohira, H; Fujita, T; Sekine, H				Takasumi, Mika; Omori, Tomoko; Machida, Takeshi; Ishida, Yumi; Hayashi, Manabu; Suzuki, Toshiyuki; Homma, Yoshimi; Endo, Yuichi; Takahashi, Minoru; Ohira, Hiromasa; Fujita, Teizo; Sekine, Hideharu			A novel complement inhibitor sMAP-FH targeting both the lectin and alternative complement pathways	FASEB JOURNAL			English	Article						alternative complement pathway; factor H; lectin complement pathway; MAp44; small mannose-binding lectin-associated protein	MANNOSE-BINDING LECTIN; PATTERN-RECOGNITION MOLECULES; SERINE-PROTEASE (MASP)-1; FACTOR-H; REPERFUSION INJURY; ACTIVATION; SYSTEM; IMMUNOLOGY; DOMAINS; FUSION	Inhibition of the complement activation has emerged as an option for treatment of a range of diseases. Activation of the lectin and alternative pathways (LP and AP, respectively) contribute to the deterioration of conditions in certain diseases such as ischemia-reperfusion injuries and age-related macular degeneration (AMD). In the current study, we generated dual complement inhibitors of the pathways MAp44-FH and sMAP-FH by fusing full-length MAp44 or small mannose-binding lectin-associated protein (sMAP), LP regulators, with the N-terminal five short consensus repeat (SCR) domains of complement factor H (SCR1/5-FH), an AP regulator. The murine forms of both fusion proteins formed a complex with endogenous mannose-binding lectin (MBL) or ficolin A in the circulation when administered in mice intraperitoneally. Multiple complement activation assays revealed that sMAP-FH had significantly higher inhibitory effects on activation of the LP and AP in vivo as well as in vitro compared to MAp44-FH. Human form of sMAP-FH also showed dual inhibitory effects on LP and AP activation in human sera. Our results indicate that the novel fusion protein sMAP-FH inhibits both the LP and AP activation in mice and in human sera, and could be an effective therapeutic agent for diseases in which both the LP and AP activation are significantly involved.	[Takasumi, Mika; Omori, Tomoko; Machida, Takeshi; Ishida, Yumi; Hayashi, Manabu; Endo, Yuichi; Takahashi, Minoru; Sekine, Hideharu] Fukushima Med Univ, Dept Immunol, Sch Med, Fukushima, Japan; [Takasumi, Mika; Hayashi, Manabu; Ohira, Hiromasa] Fukushima Med Univ, Dept Gastroenterol, Sch Med, Fukushima, Japan; [Suzuki, Toshiyuki; Homma, Yoshimi] Fukushima Med Univ, Dept Biomol Sci, Sch Med, Fukushima, Japan; [Fujita, Teizo] Fukushima Prefectural Gen Hyg Inst, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University; Fukushima Medical University	Machida, T (corresponding author), Fukushima Med Univ, Dept Immunol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan.	be204093@fmu.ac.jp			Japan Agency for Medical Research and Development (AMED) [JP17lm0203002]; MEXT | Japan Society for the Promotion of Science (JSPS) [26670478, 19K17440]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Curadim Pharma Co., Ltd.; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP17lm0203002; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 26670478 and 19K17440	Chan RK, 2006, J IMMUNOL, V177, P8080, DOI 10.4049/jimmunol.177.11.8080; Cicardi M, 2005, SPRINGER SEMIN IMMUN, V27, P286, DOI 10.1007/s00281-005-0001-4; Daha MR, 2016, J NEPHROL, V29, P1, DOI 10.1007/s40620-015-0245-6; Degn SE, 2014, P NATL ACAD SCI USA, V111, P13445, DOI 10.1073/pnas.1406849111; Degn SE, 2013, J IMMUNOL, V191, P1334, DOI 10.4049/jimmunol.1300780; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; Fridkis-Hareli M, 2011, BLOOD, V118, P4705, DOI 10.1182/blood-2011-06-359646; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; FUJITA T, 1983, J EXP MED, V157, P1239, DOI 10.1084/jem.157.4.1239; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; Hayashi M, 2019, J IMMUNOL, V203, P1411, DOI 10.4049/jimmunol.1900605; Holers VM, 2016, SEMIN IMMUNOL, V28, P260, DOI 10.1016/j.smim.2016.05.007; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; Iwaki D, 2005, J ENDOTOXIN RES, V11, P47, DOI 10.1179/096805105225006704; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Jordan JE, 2001, CIRCULATION, V104, P1413, DOI 10.1161/hc3601.095578; Joseph K, 2013, J BIOL CHEM, V288, P12753, DOI 10.1074/jbc.M112.421891; KAWASAKI T, 1978, BIOCHEM BIOPH RES CO, V81, P1018, DOI 10.1016/0006-291X(78)91452-3; Kuraya M, 2003, INT IMMUNOL, V15, P109, DOI 10.1093/intimm/dxg008; Merinero HM, 2018, KIDNEY INT, V93, P470, DOI 10.1016/j.kint.2017.07.015; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Matsushita M, 2000, J IMMUNOL, V165, P2637, DOI 10.4049/jimmunol.165.5.2637; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Morrison H, 2011, CURR NEUROVASC RES, V8, P52, DOI 10.2174/156720211794520260; Nordmaj MA, 2015, FASEB J, V29, P4945, DOI 10.1096/fj.15-277103; Orsini F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0684-6; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Risitano AM, 2012, BLOOD, V119, P6307, DOI 10.1182/blood-2011-12-398792; Rohrer B, 2012, J OCUL PHARMACOL TH, V28, P402, DOI 10.1089/jop.2011.0212; Rohrer Barbel, 2011, Mol Immunol, V48, pe1, DOI 10.1016/j.molimm.2010.12.016; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; Sekine H, 2011, ARTHRITIS RHEUM-US, V63, P1076, DOI 10.1002/art.30222; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Troldborg A, 2017, CLIN EXP IMMUNOL, V188, P138, DOI 10.1111/cei.12909; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506	41	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6598	6612		10.1096/fj.201902475R	http://dx.doi.org/10.1096/fj.201902475R		MAR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32219899	Bronze, Green Published			2022-12-26	WOS:000522483300001
J	Wu, FY; Li, CI; Liao, LN; Liu, CS; Lin, WY; Lin, CH; Yang, CW; Li, TC; Lin, CC				Wu, Fang-Yang; Li, Chia-Ing; Liao, Li-Na; Liu, Chiu-Shong; Lin, Wen-Yuan; Lin, Chih-Hsueh; Yang, Chuan-Wei; Li, Tsai-Chung; Lin, Cheng-Chieh			Evaluation of single nucleotide polymorphisms in 6 candidate genes and carotid intima-media thickness in community-dwelling residents	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; ARTERIAL-WALL THICKNESS; RISK-FACTORS; ATHEROSCLEROSIS RISK; PLASMA-FIBRINOGEN; CRP GENE; ENVIRONMENTAL CONTRIBUTIONS; ASSOCIATION; HERITABILITY	Evidence suggests the existence of association between a large panel of modifiable biomarkers representing inflammation, coagulation, paraoxonase, and endothelial activation pathways and carotid atherosclerosis. Thus, this study investigated whether CRP, FGA, FGB, FGG, PON1, and EDNRA gene variants affected plasma hs-CRP, fibrinogen levels, and thickness of carotid intima media thickness (IMT). Nineteen single-nucleotide polymorphisms of CRP, FGA, FGB, FGG, PON1, and EDNRA genes were examined in 480 participants from 160 families. Carotid IMT was measured by ultrasound. Generalized linear models with generalized estimating equation were utilized to consider the dependence of subjects within families. In the recessive model, homozygotes for the minor alleles of rs1800789, rs1800790 and rs4220 SNPs in FGB gene indicated a reduced risk of IMT (Exp. beta = 0.89, 0.89, 0.88), which remained significant after adjustment for confounding factors. Significant interaction effects between CRP SNP rs1130864 and rs3093059 and gender for IMT were observed with a significant association in men only. Men carrying minor-minor genotype of CRP SNP rs1130864 and rs3093059 had 0.70- and 0.78-fold lower IMT than men carrying minor-major/major-major genotype. We also observed that the interaction of CRP SNP rs1130864 and rs3093059 with obesity on IMT, hs-CRP and fibrinogen levels. These results support the hypothesis that inflammatory genes are involved in atherosclerosis, most likely via complex gene-gender and gene-obesity interactions.	[Wu, Fang-Yang; Liao, Li-Na; Li, Tsai-Chung] China Med Univ, Dept Publ Hlth, Coll Publ Hlth, Taichung, Taiwan; [Li, Chia-Ing; Liu, Chiu-Shong; Lin, Wen-Yuan; Lin, Chih-Hsueh; Lin, Cheng-Chieh] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Li, Chia-Ing; Liu, Chiu-Shong; Yang, Chuan-Wei; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Liu, Chiu-Shong; Lin, Wen-Yuan; Lin, Chih-Hsueh; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Dept Healthcare Adm, Coll Med & Hlth Sci, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Li, TC (corresponding author), China Med Univ, Dept Publ Hlth, Coll Publ Hlth, Taichung, Taiwan.; Lin, CC (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung, Taiwan.; Lin, CC (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.; Lin, CC (corresponding author), China Med Univ Hosp, Dept Family Med, Taichung, Taiwan.; Li, TC (corresponding author), Asia Univ, Dept Healthcare Adm, Coll Med & Hlth Sci, Taichung, Taiwan.	tcli@mail.cmu.edu.tw; cclin@mail.cmuh.org.tw	Li, Tsai-Chung/P-2052-2015; Lin, Cheng-Chieh/P-2564-2015	Li, Tsai-Chung/0000-0002-3346-7462; Lin, Cheng-Chieh/0000-0002-9625-6216	Ministry of Science and Technology, Taiwan [MOST 104-2314-B-039-016, MOST 105-2314-B-039-021-MY3, MOST 105-2314-B-039025-MY3, MOST 107-2314-B-039-049, MOST 108-2314-B-039-039, MOST 108-2314-B-039035-MY3, MOST 108-2314-B-039-031-MY2]; China Medical University Hospital [DMR-107-200]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital	Ministry of Science and Technology, Taiwan - MOST 104-2314-B-039-016, MOST 105-2314-B-039-021-MY3, MOST 105-2314-B-039025-MY3, MOST 107-2314-B-039-049, MOST 108-2314-B-039-039, MOST 108-2314-B-039035-MY3 and MOST 108-2314-B-039-031-MY2 China Medical University Hospital - DMR-107-200 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldassarre D, 2012, J AM COLL CARDIOL, V60, P1489, DOI 10.1016/j.jacc.2012.06.034; Bensen JT, 1999, GENET EPIDEMIOL, V16, P165, DOI 10.1002/(SICI)1098-2272(1999)16:2<165::AID-GEPI4>3.0.CO;2-H; Boekholdt SM, 2001, CIRCULATION, V104, P3063, DOI 10.1161/hc5001.100793; Brites F, 2017, BBA CLIN, V8, P66, DOI 10.1016/j.bbacli.2017.07.002; Brull DJ, 2003, ARTERIOSCL THROM VAS, V23, P2063, DOI 10.1161/01.ATV.0000084640.21712.9C; Cao JJ, 2003, CIRCULATION, V108, P166, DOI 10.1161/01.CIR.0000079160.07364.6A; Cece H, 2011, CLIN INVEST MED, V34, pE225, DOI 10.25011/cim.v34i4.15364; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; de Maat MPM, 1998, ARTERIOSCL THROM VAS, V18, P265, DOI 10.1161/01.ATV.18.2.265; Dursun B, 2008, NEPHROL DIAL TRANSPL, V23, P1697, DOI 10.1093/ndt/gfm906; Fan JL, 2000, ANN NY ACAD SCI, V902, P84; Folsom AR, 2001, AM J CARDIOL, V88, P112, DOI 10.1016/S0002-9149(01)01603-4; Folsom AR, 2001, ANN EPIDEMIOL, V11, P166, DOI 10.1016/S1047-2797(00)00203-9; Fox CS, 2003, STROKE, V34, P397, DOI 10.1161/01.STR.0000048214.56981.6F; Hafizi S, 1999, ATHEROSCLEROSIS, V146, P351, DOI 10.1016/S0021-9150(99)00178-1; Harangi M, 2008, CEREBROVASC DIS, V25, P122, DOI 10.1159/000112322; Howard G, 1997, STROKE, V28, P1693, DOI 10.1161/01.STR.28.9.1693; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Jarvisalo MJ, 2002, ARTERIOSCL THROM VAS, V22, P1323, DOI 10.1161/01.ATV.0000024222.06463.21; Juo SHH, 2004, STROKE, V35, P2243, DOI 10.1161/01.STR.0000142132.20442.d8; Kaplan M, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-7; Karvonen J, 2004, EUR J CARDIOV PREV R, V11, P511, DOI 10.1097/00149831-200412000-00011; Labib HA, 2011, J CLIN PATHOL, V64, P528, DOI 10.1136/jcp.2011.090209corr1; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; Lefkowitz RJ, 2001, JAMA-J AM MED ASSOC, V285, P581, DOI 10.1001/jama.285.5.581; Leus FR, 2000, ATHEROSCLEROSIS, V149, P371, DOI 10.1016/S0021-9150(99)00324-X; Li CW, 2015, GENE, V562, P226, DOI 10.1016/j.gene.2015.02.078; Li TC, 2015, BIOMEDICINE-TAIWAN, V5, P8, DOI 10.7603/s40681-015-0008-7; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lin CC, 2014, EXP GERONTOL, V57, P141, DOI 10.1016/j.exger.2014.05.012; Lopez-Mejias R, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/756279; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; Martinez-Vila E, 2003, CEREBROVASC DIS, V16, P356, DOI 10.1159/000072557; Moskau S, 2005, STROKE, V36, P5, DOI 10.1161/01.STR.0000149936.33498.83; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; O'Leary DH, 2002, AM J CARDIOL, V90, p18L, DOI 10.1016/S0002-9149(02)02957-0; Ottman R, 1996, PREV MED, V25, P764, DOI 10.1006/pmed.1996.0117; Paramo JA, 2004, HAEMATOLOGICA, V89, P1226; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rallidis LS, 2010, THROMB RES, V125, P34, DOI 10.1016/j.thromres.2009.02.017; Scherrer DZ, 2015, ARQ BRAS CARDIOL, V105, P45, DOI 10.5935/abc.20150053; Siegerink B, 2009, J THROMB HAEMOST, V7, P385, DOI 10.1111/j.1538-7836.2008.03266.x; Simmonds RE, 2001, THROMB HAEMOSTASIS, V86, P374, DOI 10.1055/s-0037-1616235; Srinivasan SR, 2004, ATHEROSCLEROSIS, V177, P167, DOI 10.1016/j.atherosclerosis.2004.06.013; Suk HJ, 2005, ATHEROSCLEROSIS, V178, P139, DOI 10.1016/j.atherosclerosis.2004.07.033; Theodoraki EV, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-28; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P2167, DOI 10.1161/01.ATV.17.10.2167; van der Bom JG, 1998, ARTERIOSCL THROM VAS, V18, P621, DOI 10.1161/01.ATV.18.4.621; Vasankari T, 2001, ATHEROSCLEROSIS, V155, P403, DOI 10.1016/S0021-9150(00)00573-6; VELLER MG, 1993, J VASC SURG, V17, P719, DOI 10.1016/0741-5214(93)90116-4; Voetsch B, 2004, ARTERIOSCL THROM VAS, V24, P216, DOI 10.1161/01.ATV.0000107402.79771.fc; Wang MS, 2012, DNA CELL BIOL, V31, P975, DOI 10.1089/dna.2011.1478; Wang TJ, 2002, ARTERIOSCL THROM VAS, V22, P1662, DOI 10.1161/01.ATV.0000034543.78801.69; Xiang AH, 2002, ARTERIOSCL THROM VAS, V22, P843, DOI 10.1161/01.ATV.0000015329.15481.E8; Yasuda H, 2007, J HUM HYPERTENS, V21, P883, DOI 10.1038/sj.jhh.1002234; YU JCM, 1995, BRIT J PHARMACOL, V116, P2441, DOI 10.1111/j.1476-5381.1995.tb15093.x; Zeng Y, 2012, J CLIN NEUROSCI, V19, P753, DOI 10.1016/j.jocn.2011.09.019; Zhao Y, 2012, MOL GENET METAB, V105, P141, DOI 10.1016/j.ymgme.2011.09.018	60	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230715	10.1371/journal.pone.0230715	http://dx.doi.org/10.1371/journal.pone.0230715			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214403	Green Published, gold			2022-12-26	WOS:000535934200044
J	Zhang, JP; Ying, Y; Li, XB; Yao, XH				Zhang, Jinping; Ying, Yue; Li, Xuebin; Yao, Xiaohua			Changes in tannin and saponin components during co-composting of Camellia oleifera Abel shell and seed cake	PLOS ONE			English	Article							COLONIC MICROFLORA; POMEGRANATE JUICE; METABOLITES	This study investigated the co-compost product of the shell and seed cake of Camellia oleifera Abel, which is a small evergreen tree in the family Theaceae. Tannin and saponin contents in compost samples at different time-points and their compositional changes, as well as their relationships with nutrients and compost maturity, were analyzed using an UPLC-triple-TOF/MS system. Our results showed that tannins in the compost samples mainly consisted of 11 phenolic acid compounds, of which four small-molecule phenolic acid compounds were found in low contents. Saponins mainly consisted of five saponin aglycones (A, B, C, D, E) and four of their derivatives in C. oleifera. Microbially secreted enzymes converted the large-molecule phenolic acid compounds into small-molecule compounds and their derivatives, while saponins were decomposed into saponin aglycones. Contents of tannin and saponin had correlations with the C/N ratio, germination index (GI), and the Solvita maturity index. After composting, the content of tannin was reduced to less than 1%, and the content of saponin was not more than 2%. And compost products were safe.	[Zhang, Jinping; Ying, Yue; Li, Xuebin; Yao, Xiaohua] Chinese Acad Forestry, Res Inst Subtrop Forestry, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Zhang, JP (corresponding author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Hangzhou, Zhejiang, Peoples R China.	jinpingzhang@126.com		zhang, jinping/0000-0002-1496-659X	Provincial Department of Science and Technology of Zhejiang, China [2017C02022]	Provincial Department of Science and Technology of Zhejiang, China	This work was financially supported by the Provincial Department of Science and Technology of Zhejiang, China, Grant NO.2017C02022	Ai Q H, 2011, PERIODICAL OCEAN U C, V41, P33, DOI DOI 10.16441/J.CNKI.HDXB.2011.Z1.005; Albertse EH, 2002, CLONING EXPRESSION C; Arivalagan M, 2013, INDIAN J PHARM SCI, V75, P110, DOI 10.4103/0250-474X.113542; Cerda B, 2004, EUR J NUTR, V43, P205, DOI 10.1007/s00394-004-0461-7; Deng G. L., 2005, SICHUAN FOOD FERMENT, V3, P41; [董敬娜 Dong Jingna], 2011, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V33, P185; HAO WN, 2010, AGROCHEMICALS, V49, P90, DOI DOI 10.16820/J.CNKI.1006-0413.2010.02.004; Hu JH, 2012, J WUHAN POLYTECHNIC, V2, P20; Hu W. B., 2015, JIANXI SCI, V33, P85, DOI DOI 10.13990/J.ISSN1001-3679.2015.01.021; Huang GF, 2004, WASTE MANAGE, V24, P805, DOI 10.1016/j.wasman.2004.03.011; Larrosa M, 2006, J AGR FOOD CHEM, V54, P1611, DOI 10.1021/jf0527403; Li Z., 2006, THESIS; Lin J, 2018, CHINA BREWING, V37, P45; Ma L, 2009, CHINESE AGR SCI B, V25, P82; Mahendran B, 2006, APPL MICROBIOL BIOT, V70, P444, DOI 10.1007/s00253-005-0082-y; Manjit, 2008, WORLD J MICROB BIOT, V24, P3023, DOI 10.1007/s11274-008-9847-7; McSweeney CS, 2001, ANIM FEED SCI TECH, V91, P83, DOI 10.1016/S0377-8401(01)00232-2; Meng XY, 2018, BIORESOURCE TECHNOL, V251, P22, DOI 10.1016/j.biortech.2017.09.077; Mertens-Talcott SU, 2006, J AGR FOOD CHEM, V54, P8956, DOI 10.1021/jf061674h; Morel JL, 1985, COMPOSTING AGR OTHER; Rashad FM, 2010, BIORESOURCE TECHNOL, V101, P5952, DOI 10.1016/j.biortech.2010.02.103; SAVOLAINEN H, 1992, J APPL TOXICOL, V12, P191, DOI 10.1002/jat.2550120307; Seeram NP, 2006, J NUTR, V136, P2481, DOI 10.1093/jn/136.10.2481; Zhang JP, 2019, BIORESOURCES, V14, P1603, DOI 10.15376/biores.14.1.1603-1617; Zhang JP, 2018, BIORESOURCES, V13, P7508, DOI 10.15376/biores.13.4.7508-7518; Zhuang R., 2008, CAMELLIA OLEIFERA CH, P3; 沈善登, 2012, [中国油脂, China Oils and Fats], V37, P67	27	5	5	9	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230602	10.1371/journal.pone.0230602	http://dx.doi.org/10.1371/journal.pone.0230602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210466	Green Published, gold, Green Submitted			2022-12-26	WOS:000535307600035
J	Hale, LP; Neff, J; Cheatham, L; Cardona, D; Markert, ML; Kurtzberg, J				Hale, Laura P.; Neff, Jadee; Cheatham, Lynn; Cardona, Diana; Markert, M. Louise; Kurtzberg, Joanne			Histopathologic assessment of cultured human thymus	PLOS ONE			English	Article							COMPLETE DIGEORGE-SYNDROME; TRANSPLANTATION; MICROENVIRONMENT; IDENTIFICATION; POPULATION; REPERTOIRE; BIPOTENT; CELLS	The maintenance and propagation of complex mixtures of cells in vitro in the form of native organs or engineered organoids has contributed to understanding mechanisms of cell and organ development and function which can be translated into therapeutic benefits. For example, allogeneic cultured postnatal human thymus tissue has been shown to support production of naive recipient T cells when transplanted into patients with complete DiGeorge anomaly and other genetic defects that result in congenital lack of a thymus. Patients receiving such transplants typically exhibit reversal of their immunodeficiency and normalization of their peripheral blood T cell receptor V-beta repertoire, with long-term survival. This study was designed to assess the histopathologic changes that occur in postnatal human thymus slices when cultured according to protocols used for transplanted tissues. Results showed that as thymic organ cultures progressed from days 0 through 21, slices developed increasing amounts of necrosis, increasing condensation of thymic epithelium, and decreasing numbers of residual T cells. The architecture of the thymic epithelial network remained generally well-preserved throughout the 21 days of culture, with focal expression of cytokeratin 14, a putative biomarker of thymic epithelial cells with long-term organ-repopulating potential. All organ slices derived from the same donor thymus closely resembled one another, with minor differences in size, shape, and relative content of cortex versus medulla. Similarly, slices derived from different donors showed similar histopathologic characteristics when examined at the same culture time point. Taken together, these results demonstrate that diagnostic criteria based on structural features of the tissue identifiable via hematoxylin and eosin staining and cytokeratin immunohistochemistry can be used to evaluate the quality of slices transplanted into patients with congenital athymia.	[Hale, Laura P.; Neff, Jadee; Cardona, Diana] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA; [Cheatham, Lynn; Kurtzberg, Joanne] Duke Univ, Sch Med, Marcus Ctr Cellular Cures, Durham, NC USA; [Markert, M. Louise; Kurtzberg, Joanne] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA	Duke University; Duke University; Duke University	Hale, LP (corresponding author), Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA.	laura.hale@duke.edu	; Kurtzberg, Joanne/M-4733-2014	Cardona, Diana/0000-0002-6877-2280; Kurtzberg, Joanne/0000-0002-3370-0703	National Institutes of Health [P01-AG052359, 5U01-HG007672-05, 5 R01AI047040]; Robertson Foundation; Hartwell Foundation; Duke University Medical Center (Duke Chancellor's Discovery Grant)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robertson Foundation; Hartwell Foundation; Duke University Medical Center (Duke Chancellor's Discovery Grant)	The authors gratefully acknowledge the receipt of salary support or consultant fees for this study provided to Duke through a contract with Enzyvant Therapeutics GmbH (to LPH, MLM, JK, JN) and via National Institutes of Health (to LPH via P01-AG052359 to J. Nikolich-Zigich). Additional funding to support the development of methodology for culture and evaluation of postnatal human thymus and its transplantation was obtained from the National Institutes of Health (5U01-HG007672-05 to V. Shashi; 5 R01AI047040 to MLM), the Robertson Foundation, the Hartwell Foundation (to MLM), and Duke University Medical Center (Duke Chancellor's Discovery Grant to MLM). None of these funding sources had a role in the decision to publish or in determining the content of this publication.	Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Davies EG, 2017, J ALLERGY CLIN IMMUN, V140, P1660, DOI 10.1016/j.jaci.2017.03.020; Davis CM, 1997, J CLIN IMMUNOL, V17, P167, DOI 10.1023/A:1027382600143; Hale LP, 2004, J IMMUNOL, V172, P617, DOI 10.4049/jimmunol.172.1.617; Hong R, 1996, TRANSPLANTATION, V61, P444, DOI 10.1097/00007890-199602150-00023; Hun M, 2017, BIOMATERIALS, V118, P1, DOI 10.1016/j.biomaterials.2016.11.054; Lee EN, 2011, ANAT CELL BIOL, V44, P14, DOI 10.5115/acb.2011.44.1.14; Li B, 2011, CLIN IMMUNOL, V140, P244, DOI 10.1016/j.clim.2011.04.004; Markert ML, 2008, J IMMUNOL, V180, P6354, DOI 10.4049/jimmunol.180.9.6354; Markert ML, 2007, BLOOD, V109, P4539, DOI 10.1182/blood-2006-10-048652; Markert ML, 2011, BLOOD, V117, P688, DOI 10.1182/blood-2010-06-292490; Markert ML, 2010, CLIN IMMUNOL, V135, P236, DOI 10.1016/j.clim.2010.02.007; Markert ML, 1997, CLIN IMMUNOL IMMUNOP, V82, P26, DOI 10.1006/clin.1996.4266; Markert ML, 2004, BLOOD, V104, P2574, DOI 10.1182/blood-2003-08-2984; Markert ML, 1999, NEW ENGL J MED, V341, P1180, DOI 10.1056/NEJM199910143411603; Markert ML, 2003, BLOOD, V102, P1121, DOI 10.1182/blood-2002-08-2545; Markert ML, 1997, J IMMUNOL, V158, P998; Markert ML, 2008, CLIN IMMUNOLOGY, P1253; Rice HE, 2004, J PEDIATR SURG, V39, P1607, DOI 10.1016/j.jpedsurg.2004.07.020; Ucar A, 2014, IMMUNITY, V41, P257, DOI 10.1016/j.immuni.2014.07.005; Ulyanchenko S, 2016, CELL REP, V14, P2819, DOI 10.1016/j.celrep.2016.02.080; Wong K, 2014, CELL REP, V8, P1198, DOI 10.1016/j.celrep.2014.07.029; Yu XM, 2014, J ALLERGY CLIN IMMUN, V133, P1109, DOI 10.1016/j.jaci.2013.11.018	23	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230668	10.1371/journal.pone.0230668	http://dx.doi.org/10.1371/journal.pone.0230668			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208448	gold, Green Published			2022-12-26	WOS:000535305100036
J	Setiawan, D; Andrijono; Hadinegoro, SR; Meyta, H; Sitohang, RV; Tandy, G; Perwitasari, DA; Postma, MJ				Setiawan, Didik; Andrijono; Hadinegoro, Sri Rezeki; Meyta, Hashta; Sitohang, R. Vensya; Tandy, Gertrudis; Perwitasari, Dyah Aryani; Postma, Maarten J.			Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; CROSS-PROTECTIVE EFFICACY; MIDDLE-INCOME COUNTRIES; AS04-ADJUVANTED VACCINE; HPV VACCINATION; DOUBLE-BLIND; INFECTION	Introduction The clinical and economic impact of cervical cancer consistently become a serious burden for all countries, including Indonesia. The implementation of HPV vaccination policy for a big country such as Indonesia requires a strong commitment from several decision-makers. The aim of this study was to provide a comprehensive description on cost-effectiveness and the budget-impact of HPV vaccination policy in Indonesia. Method A cohort Markov model was used to evaluate the cost and the clinical impact of HPV vaccination for 10 years old girls in Indonesia. The researchers consider two doses of all three available HPV vaccines adjusted with the HPV infection profile with 95% vaccination coverage to estimate the national cervical cancer incidence and mortality. The Budget impact analysis explores three different scenarios covering (1) Two districts per year expansion, (2) oneprovince per year expansion and (3) achieving the National Immunization Program in 2024. Results Upon fully vaccinating almost 2.3 million 10-year-old girls, 34,723; 43,414; and 51,522 cervical cancer cases were prevented by Quadrivalent, Bivalent and Nonavalent vaccines, consecutively. Furthermore, the highest (591 cases) and lowest (399 cases) mortality were prevented by Nonavalent and Quadrivalent vaccines, respectively. Most of the vaccines were considerably cost-effective and only the Bivalent vaccine with the GAVI/UNICEF price which will be considered a cost-saving strategy. To provide national coverage of HPV vaccination in Indonesia, the government has to provide an annual budget of about US$49 million and US$22 million using the government contract price and GAVI/UNICEF price, respectively. Conclusion HPV vaccination shows a cost-effective strategy and the budget required to provide this policy is considerably affordable for Indonesia.	[Setiawan, Didik] Univ Muhammadiyah Purwokerto, Fac Pharm, Banyumas, Indonesia; [Setiawan, Didik] Univ Muhammadiyah Purwokerto, Ctr Hlth Econ Studies, Banyumas, Indonesia; [Andrijono] Cipto Mangunkumo Hosp, Dept Obstetr & Gynecol, Div Oncol, Jakarta, Indonesia; [Andrijono] Univ Indonesia, Fac Med, Jakarta, Indonesia; [Hadinegoro, Sri Rezeki] Univ Indonesia, Fac Med, Dept Child Hlth, Jakarta, Indonesia; [Hadinegoro, Sri Rezeki] Indonesian Immunizat Tech Advisory Grp Indonesia, Jakarta, Indonesia; [Meyta, Hashta; Sitohang, R. Vensya; Tandy, Gertrudis] Minist Hlth, Directorate Gen Dis Prevent & Control P2P, Jakarta, Indonesia; [Perwitasari, Dyah Aryani] Univ Ahmad Dahlan, Fac Pharm, Yogyakarta, Indonesia; [Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit Pharmacoepidemil & Pharmacoecon PE2, Groningen, Netherlands	Universitas Muhammadiyah Purwokerto; Universitas Muhammadiyah Purwokerto; University of Indonesia; University of Indonesia; Ministry of Health - Indonesia; Universitas Ahmad Dahlan; University of Groningen	Setiawan, D (corresponding author), Univ Muhammadiyah Purwokerto, Fac Pharm, Banyumas, Indonesia.; Setiawan, D (corresponding author), Univ Muhammadiyah Purwokerto, Ctr Hlth Econ Studies, Banyumas, Indonesia.	d.didiksetiawan@gmail.com	Perwitasari, Dyah Aryani/ABD-4396-2021	Perwitasari, Dyah Aryani/0000-0002-2638-6664; Postma, Maarten/0000-0002-6306-3653; Setiawan, Didik/0000-0001-9104-548X	Ministry of Research, Technology, and higher education, Republic of Indonesia	Ministry of Research, Technology, and higher education, Republic of Indonesia	Didik Setiawan (DS) and Dyah Aryani Perwitasari (DAP) Received funding from Ministry of Research, Technology, and higher education, Republic of Indonesia. The sponsor does not play any role in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	[Anonymous], 2010, B NY; Bogaards JA, 2011, EPIDEMIOLOGY, V22, P505, DOI 10.1097/EDE.0b013e31821d107b; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruni L, 2014, HPV CTR, piii; Central Bureau of Statistics, PROYEKS PEND IND UM; Chesson HW, 2015, SEX TRANSM INFECT, V91, pA61, DOI 10.1136/sextrans-2015-052270.168; David MP, 2009, GYNECOL ONCOL, V115, pS1, DOI 10.1016/j.ygyno.2009.01.011; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Esposito S, 2011, IMMUNOGENICITY SAFET, V30, P49; Ezat SWP, 2010, ASIAN PAC J CANCER P, V11, P943; Ferlay J, 2018, GLOBAL CANC OBSERVAT; GAVI, 2018, DET PROD PEOF; Haeussler K, 2014, VALUE HEALTH, V17, pA674, DOI 10.1016/j.jval.2014.08.2500; Indonesian Health Technology Assessment Committee, 2017, HLTH TECHN ASS HTA G; Jit M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0446-9; Kementerian Kesehatan RI, 2014, PERATURAN MENTERI KE, P1; Kementrian Kesehatan Republik Indonesia, 2012, 143000000000 DAN JAM; Kim YM, 2013, J OBSTET GYNAECOL RE, V39, P1190, DOI 10.1111/jog.12052; Lee VJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-203; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Menteri Kesehatan Republik Indonesia, 2015, PEN KANK PAYUD KANK; Newall AT, 2014, PHARMACOECONOMICS, V32, P525, DOI 10.1007/s40273-014-0162-x; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Purba FD, 2018, QUALITY LIFE INDONES, P1; Sachs JD, 2001, MACR HLTH INV HLTH E, V8; Seitz H, 2015, CANCER PREV RES, V8, P932, DOI 10.1158/1940-6207.CAPR-15-0164; Setiawan D, 2018, VALUE HEAL REG ISSUE, V15; Setiawan D, 2017, EXPERT REV VACCINES, V16, P933, DOI 10.1080/14760584.2017.1357472; Setiawan Didik, 2016, Value Health Reg Issues, V9, P84, DOI 10.1016/j.vhri.2015.10.010; Setiawan D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160707; Setiawan D, 2015, EXPERT REV VACCINES, V14, P589, DOI 10.1586/14760584.2014.990386; Silas OA, 2018, EXPERT REV VACCINES, V17, P91, DOI 10.1080/14760584.2018.1411195; Thomas DB, 2001, AM J EPIDEMIOL, V153, P732, DOI 10.1093/aje/153.8.732; Vet JNI, 2012, BRIT J CANCER, V107, P772, DOI 10.1038/bjc.2012.334; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X	35	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230359	10.1371/journal.pone.0230359	http://dx.doi.org/10.1371/journal.pone.0230359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GC	32203527	gold, Green Published			2022-12-26	WOS:000535303900015
J	Cheng, SH; McKinnon, MC; Masuda, YJ; Garside, R; Jones, KW; Miller, DC; Pullin, AS; Sutherland, WJ; Augustin, C; Gill, DA; Wongbusarakum, S; Wilkie, D				Cheng, Samantha H.; McKinnon, Madeleine C.; Masuda, Yuta J.; Garside, Ruth; Jones, Kelly W.; Miller, Daniel C.; Pullin, Andrew S.; Sutherland, William J.; Augustin, Caitlin; Gill, David A.; Wongbusarakum, Supin; Wilkie, David			Strengthen causal models for better conservation outcomes for human well-being	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; ENVIRONMENTAL ASSESSMENT; ASSIGNED VALUES; SUSTAINABILITY; LIVELIHOODS; KNOWLEDGE; PROGRAM; IMPACT	Background Understanding how the conservation of nature can lead to improvement in human conditions is a research area with significant growth and attention. Progress towards effective conservation requires understanding mechanisms for achieving impact within complex social-ecological systems. Causal models are useful tools for defining plausible pathways from conservation actions to impacts on nature and people. Evaluating the potential of different strategies for delivering co-benefits for nature and people will require the use and testing of clear causal models that explicitly define the logic and assumptions behind cause and effect relationships. Objectives and methods In this study, we outline criteria for credible causal models and systematically evaluated their use in a broad base of literature (similar to 1,000 peer-reviewed and grey literature articles from a published systematic evidence map) on links between nature-based conservation actions and human well-being impacts. Results Out of 1,027 publications identified, only similar to 20% of articles used any type of causal models to guide their work, and only 14 total articles fulfilled all criteria for credibility. Articles rarely tested the validity of models with empirical data.	[Cheng, Samantha H.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Cheng, Samantha H.] Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA; [McKinnon, Madeleine C.] Bright Impact, San Francisco, CA USA; [Masuda, Yuta J.] Nature Conservancy, Global Sci, Seattle, WA USA; [Garside, Ruth] European Ctr Environm & Human Hlth, Truro, England; [Jones, Kelly W.] Colorado State Univ, Ft Collins, CO 80523 USA; [Miller, Daniel C.] Univ Illinois, Urbana, IL USA; [Pullin, Andrew S.] Bangor Univ, Ctr Evidence Based Conservat, Bangor, Gwynedd, Wales; [Sutherland, William J.] Univ Cambridge, Dept Zool, Cambridge, England; [Augustin, Caitlin] DataKind, New York, NY USA; [Gill, David A.] Moore Ctr Sci, Conservat Int, Arlington, VA USA; [Gill, David A.] George Mason Univ, Environm Sci & Policy, Fairfax, VA 22030 USA; [Gill, David A.] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Wongbusarakum, Supin] NOAA, Honolulu, HI USA; [Wilkie, David] Wildlife Conservat Soc, Bronx, NY USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; American Museum of Natural History (AMNH); Nature Conservancy; Colorado State University; University of Illinois System; University of Illinois Urbana-Champaign; Bangor University; University of Cambridge; Conservation International; George Mason University; Duke University; National Oceanic Atmospheric Admin (NOAA) - USA; Wildlife Conservation Society	Cheng, SH (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.; Cheng, SH (corresponding author), Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA.	scheng@amnh.org		Cheng, Samantha/0000-0003-1799-6310; Garside, Ruth/0000-0003-1649-4773; Pullin, Andrew/0000-0001-5299-8042; Jones, Kelly/0000-0001-9664-7615	Science for Nature and People Partnership (SNAPP); Nature Conservancy; Wildlife Conservation Society; National Center for Ecological Analysis and Synthesis (NCEAS) at the University of California, Santa Barbara; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula (PenCLAHRC)	Science for Nature and People Partnership (SNAPP); Nature Conservancy; Wildlife Conservation Society; National Center for Ecological Analysis and Synthesis (NCEAS) at the University of California, Santa Barbara; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula (PenCLAHRC)(National Institute for Health Research (NIHR))	All authors are funded by the Science for Nature and People Partnership (SNAPP), a partnership of The Nature Conservancy, the Wildlife Conservation Society and the National Center for Ecological Analysis and Synthesis (NCEAS) at the University of California, Santa Barbara, for providing funding for the EvidenceBased Conservation working group (https://snappartnership.net/).RG is partially supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula (PenCLAHRC) (https://www.nihr.ac.uk/about-us/how-we-are-managed/our-structure/infrastructure/collaborations-for-leadership-inapplied-health-research-and-care.htm).WJS is funded by Arcadia (https://www.arcadiafund.org.uk/).The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Agrawal Arun, 2006, WCS Working Paper, P1; Arakaki FA, 2015, EVOLUTION DUBLIN COR, V2015, P3; Bayas JCL, 2011, P NATL ACAD SCI USA, V108, P18612, DOI 10.1073/pnas.1013516108; Berinato Scott, 2016, GOOD CHARTS HBR GUID; Berkes F, 2006, HUM ECOL, V34, P479, DOI 10.1007/s10745-006-9008-2; Bottrill M, 2014, WHAT ARE IMPACTS NAT, P1; Braumoeller BF, 2003, POLIT ANAL, V11, P209, DOI 10.1093/pan/mpg012; Conservation Measures Partnership, 2013, OP STAND PRACT CONS; Costedoat S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119881; Danielsen F, 2005, SCIENCE, V310, P643, DOI 10.1126/science.1118387; Development USAfI, 2016, US RES CHAINS DEP TH, P1; Doick KJ, 2014, SCI TOTAL ENVIRON, V493, P662, DOI 10.1016/j.scitotenv.2014.06.048; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Foundation K. W.K, 2004, DEVELOPMENT, P72; Foundations of Success, 2009, US CONC MOD DOC SIT; Funnell S.C., 2011, PURPOSEFUL PROGRAM T, V31; Greene WH., 2003, ECONOMETRIC ANAL; Greenheck FM, 2009, ENV CONSERVATIONS SU; Grol MJ, 2007, J NEUROSCI, V27, P11877, DOI 10.1523/JNEUROSCI.3923-07.2007; Halpern JY, 2016, REV SYMB LOGIC, V9, P76, DOI 10.1017/S1755020315000246; International C, 2013, CONSTR THEOR CHANG E, P23; James KL, 2016, ENVIRON EVID, V5, DOI 10.1186/s13750-016-0059-6; Jiang GQ, 2016, J BIOMED SEMANT, V7, DOI 10.1186/s13326-016-0053-5; Kareiva P, 2014, J APPL ECOL, V51, P1137, DOI 10.1111/1365-2664.12259; LARKIN JH, 1987, COGNITIVE SCI, V11, P65, DOI 10.1016/S0364-0213(87)80026-5; Li W, 2015, ENVIRON IMPACT ASSES, V50, P158, DOI 10.1016/j.eiar.2014.09.012; Liang YC, 2012, ECOL ECON, V75, P152, DOI 10.1016/j.ecolecon.2012.01.019; Mahajan SL, 2019, CONSERVATION SCI PRA, DOI [10.1002/csp2.11, DOI 10.1002/CSP2.11]; Mahdi, 2009, ENVIRON MANAGE, V43, P84, DOI 10.1007/s00267-008-9142-2; Margoluis R, 2013, ECOL SOC, V18, DOI 10.5751/ES-05610-180322; Margoluis R, 2009, EVAL PROGRAM PLANN, V32, P138, DOI 10.1016/j.evalprogplan.2008.09.007; McKinnon MC, 2016, ENVIRON EVID, V5, DOI 10.1186/s13750-016-0058-7; McKinnon MC, 2015, NATURE, V528, P185, DOI 10.1038/528185a; McKinnon MC, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0282; Miller BW, 2012, CONSERV BIOL, V26, P218, DOI 10.1111/j.1523-1739.2012.01823.x; Nesbit JC, 2006, REV EDUC RES, V76, P413, DOI 10.3102/00346543076003413; Norton SB, 2017, FRESHW SCI, V36, P231, DOI 10.1086/690296; Nowak D.J., 2010, AIR QUALITY EFFECTS; Otten JJ, 2015, HEALTH AFFAIR, V34, P1901, DOI 10.1377/hlthaff.2015.0642; Palmer MA, 2012, BIOSCIENCE, V62, P5, DOI 10.1525/bio.2012.62.1.2; Pegas Fernanda de Vasconcellos, 2013, Journal of Ecotourism, V12, P90, DOI 10.1080/14724049.2013.831099; Qiu JX, 2018, BIOSCIENCE, V68, P182, DOI 10.1093/biosci/bix167; Rogers P., 2008, EVALUATION-US, V14, P29, DOI [DOI 10.1177/1356389007084674, 10.1177/1356389007084674]; Salafsky N, 2000, WORLD DEV, V28, P1421, DOI 10.1016/S0305-750X(00)00031-0; Salafsky N, 2001, CONSERV BIOL, V15, P1585, DOI 10.1046/j.1523-1739.2001.00220.x; Salafsky N, 2008, CONSERV BIOL, V22, P897, DOI 10.1111/j.1523-1739.2008.00937.x; Sawitri DR, 2015, PROCEDIA ENVIRON SCI, V23, P27, DOI 10.1016/j.proenv.2015.01.005; Scacchi W, 2002, PROCESS MODELS SOFTW; Scoones I, 1998, SUSTAINABLE LIVELIHO; Seymour E, 2010, AUSTRALAS J ENV MAN, V17, P142, DOI 10.1080/14486563.2010.9725261; Sokolow SH, 2015, P NATL ACAD SCI USA, V112, P9650, DOI 10.1073/pnas.1502651112; Stem C, 2005, CONSERV BIOL, V19, P295, DOI 10.1111/j.1523-1739.2005.00594.x; Sutherland WJ, 2017, NATURE ECOLOGY EVOLU; Taplin DH, 2013, THEORY CHANGE TECHNI, P23; Team RC, 2017, R LANG ENV STAT COMP; Ha TTP, 2013, AQUACULT ECON MANAG, V17, P1, DOI 10.1080/13657305.2013.747224; UN General Assembly, 2015, ARES7012015; United States Environmental Protection Agency, 2012, EPA100K12012; Vogel I., 2010, AM J EVAL, V24, P501; West Mark, 2017, CONSERV BIOL, P1; Westgate MJ, 2018, NAT ECOL EVOL, V2, P588, DOI 10.1038/s41559-018-0502-x; Wood SLR, 2015, FRONT ECOL ENVIRON, V13, P123, DOI 10.1890/1540-9295-13.3.123	63	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0230495	10.1371/journal.pone.0230495	http://dx.doi.org/10.1371/journal.pone.0230495			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9FU	32196534	Green Published, gold			2022-12-26	WOS:000535303100033
J	Hebeisen, M; Micheroli, R; Scherer, A; Baraliakos, X; de Hooge, M; van der Heijde, D; Landewe, R; Burki, K; Nissen, MJ; Moller, B; Zufferey, P; Exer, P; Ciurea, A				Hebeisen, Monika; Micheroli, Raphael; Scherer, Almut; Baraliakos, Xenofon; de Hooge, Manouk; van der Heijde, Desiree; Landewe, Robert; Buerki, Kristina; Nissen, Michael J.; Moeller, Burkhard; Zufferey, Pascal; Exer, Pascale; Ciurea, Adrian			Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort	PLOS ONE			English	Article							CHRONIC BACK-PAIN; ANKYLOSING-SPONDYLITIS; BONE-FORMATION; SACROILIAC JOINTS; STRUCTURAL LESIONS; CRITERIA; VALIDITY; DAMAGE; PART; MRI	Objective To investigate whether spinal radiographic progression relates to structural damage at the sacroiliac level in axial spondyloarthritis (axSpA). Methods Patients classified as nonradiographic (nr-) and radiographic (r-) axSpA in the Swiss Clinical Quality Management cohort with radiographs performed every 2 years, scored according to the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS), were included. The relationship between classification status and spinal progression during 2 years was investigated using binomial generalized estimating equations models with adjustment for sex, ankylosing spondylitis disease activity score (ASDAS) and tumour necrosis factor inhibitor treatment. Baseline spinal damage was considered an intermediate variable and included in sensitivity analyses. Results In total, 88 nr-axSpA and 418 r-axSpA patients contributed to data for 725 radiographic intervals. R-axSpA patients were more frequently male, had a longer disease duration and higher structural damage at baseline. Mean (SD) mSASSS change over 2 years was 0.16 (0.62) units in nr-axSpA and 0.92 (2.78) units in r-axSpA, p = 0.01. Nr-axSpA was associated with a significantly lower progression in 2 years (defined as an increase in >= 2 mSASSS units) in adjusted analyses (OR 0.33, 95%CI 0.13; 0.83), confirmed with progression defined as the formation of >= 1 syndesmophyte. Mediation analyses revealed that sacroiliitis exerted its effect on spinal progression indirectly by being associated with the appearance of a first syndesmophyte (OR 0.09, 95%CI 0.02; 0.36 for nr-axSpA vs r-axSpA). Baseline syndesmophytes were predictors of further progression. Conclusion Spinal structural damage is mainly restricted to patients with r-axSpA, leading to relevant prognostic and therapeutic implications.	[Hebeisen, Monika; Micheroli, Raphael; Buerki, Kristina; Ciurea, Adrian] Zurich Univ Hosp, Dept Rheumatol, Zurich, Switzerland; [Hebeisen, Monika; Scherer, Almut] Swiss Clin Qual Management Fdn, Stat Grp, Zurich, Switzerland; [Baraliakos, Xenofon] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet Herne, Bochum, Germany; [de Hooge, Manouk] Univ Ghent, VIB Inflammat Res Ctr, Ghent, Belgium; [de Hooge, Manouk; van der Heijde, Desiree] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands; [Landewe, Robert] Amsterdam Rheumatol & Clin Immunol Ctr, Amsterdam, Netherlands; [Landewe, Robert] Zuyderland Med Ctr, Heerlen, Netherlands; [Nissen, Michael J.] Univ Hosp, Dept Rheumatol, Geneva, Switzerland; [Moeller, Burkhard] Inselspital Bern, Dept Rheumatol Allergol & Clin Immunol, Bern, Switzerland; [Zufferey, Pascal] CHU Vaudois, Dept Rheumatol, Lausanne, Switzerland; [Exer, Pascale] Rheumatol Practice, Basel, Switzerland	University of Zurich; University Zurich Hospital; Rheumazentrum Ruhrgebiet; Ruhr University Bochum; Flanders Institute for Biotechnology (VIB); Ghent University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Geneva; University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Ciurea, A (corresponding author), Zurich Univ Hosp, Dept Rheumatol, Zurich, Switzerland.	adrian.ciurea@usz.ch	van der Heijde, Désirée/I-6774-2019; Baraliakos, Xenofon/AAF-7346-2019; LANDEWE, ROBERT B.M./ABD-7388-2021	van der Heijde, Désirée/0000-0002-5781-158X; Baraliakos, Xenofon/0000-0002-9475-9362; LANDEWE, ROBERT B.M./0000-0002-0577-6620; Micheroli, Raphael/0000-0002-8918-7304	Swiss Society of Rheumatology; AbbVie; Celgene; Lilly; Merck Sharp Dohme; Novartis; Pfizer; Roche; Samsung; Sandoz; Sanofi; UCB; Arco Foundation, Switzerland; Swiss Balgrist Society, Switzerland; Stiftung fur Rheumaforschung, Zurich, Switzerland; Merck Sharp Dohme Corp.	Swiss Society of Rheumatology; AbbVie(AbbVie); Celgene(Bristol-Myers SquibbCelgene Corporation); Lilly(Eli Lilly); Merck Sharp Dohme(Merck & Company); Novartis(Novartis); Pfizer(Pfizer); Roche(Roche Holding); Samsung(Samsung); Sandoz(Novartis); Sanofi; UCB(UCB Pharma SA); Arco Foundation, Switzerland; Swiss Balgrist Society, Switzerland; Stiftung fur Rheumaforschung, Zurich, Switzerland; Merck Sharp Dohme Corp.(Merck & Company)	The Swiss Clinical Quality Management (SCQM) registries for rheumatic diseases are run by the SCQM Foundation which is supported by by the Swiss Society of Rheumatology and by AbbVie, Celgene, Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Roche, Samsung, Sandoz, Sanofi, UCB, and has received project-based financial supports from the Arco Foundation, Switzerland, as well as from the Swiss Balgrist Society, Switzerland. This study was supported by the Stiftung fur Rheumaforschung, Zurich, Switzerland, and by a commercial funder, Merck Sharp & Dohme Corp., through a research grant from the InvestigatorInitiated Studies Program to SCQM. This does not alter our adherence to PLOS ONE policies on sharing data and materials. With this funding, SCQM provided support in the form of salaries for specific roles of authors MH (statistical analysis) and AS (project administration and statistical supervision) as well as XB and MdH (scoring of spinal radiographs). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The complete roles of these authors are articulated in the "author contributions" section.	Baeten D, 2013, ARTHRITIS RHEUM-US, V65, P12, DOI 10.1002/art.37829; Bakker PA, 2018, RHEUMATOLOGY, V57, P1186, DOI 10.1093/rheumatology/kex532; Bakker PAC, 2017, ANN RHEUM DIS, V76, P392, DOI 10.1136/annrheumdis-2016-209405; Baraliakos X, 2007, ANN RHEUM DIS, V66, P910, DOI 10.1136/ard.2006.066415; Baraliakos X, 2014, ANN RHEUM DIS, V73, P710, DOI 10.1136/annrheumdis-2012-202698; Baraliakos X, 2009, J RHEUMATOL, V36, P997, DOI 10.3899/jrheum.080871; Boel A, 2019, ANN RHEUM DIS, V78, P1545, DOI 10.1136/annrheumdis-2019-215707; Boonen A, 2015, SEMIN ARTHRITIS RHEU, V44, P556, DOI 10.1016/j.semarthrit.2014.10.009; Ciurea A, 2013, ARTHRITIS RHEUM-US, V65, P3096, DOI 10.1002/art.38140; Creemers MCW, 2005, ANN RHEUM DIS, V64, P127, DOI 10.1136/ard.2004.020503; de Bruin F, 2018, ANN RHEUM DIS, V77, P371, DOI 10.1136/annrheumdis-2017-212553; de Hooge M, 2016, ANN RHEUM DIS, V75, P1308, DOI 10.1136/annrheumdis-2015-207823; de Koning A, 2018, ANN RHEUM DIS, V77, P293, DOI 10.1136/annrheumdis-2017-211989; de Winter J, 2018, ARTHRITIS RHEUMATOL, V70, P1042, DOI 10.1002/art.40475; Deodhar A, 2014, ARTHRITIS RHEUMATOL, V66, P2649, DOI 10.1002/art.38776; Haroon N, 2013, ARTHRITIS RHEUM-US, V65, P2645, DOI 10.1002/art.38070; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Jacques P, 2014, ANN RHEUM DIS, V73, P437, DOI 10.1136/annrheumdis-2013-203643; Kiltz U, 2012, ARTHRIT CARE RES, V64, P1415, DOI 10.1002/acr.21688; Landewe R, 2004, ARTHRITIS RHEUM, V50, P699, DOI 10.1002/art.20204; Lockwood MM, 2017, BEST PRACT RES CL RH, V31, P816, DOI 10.1016/j.berh.2018.08.008; Lories RJ, 2017, BEST PRACT RES CL RH, V31, P877, DOI 10.1016/j.berh.2018.07.007; Maas F, 2017, ARTHRIT CARE RES, V69, P1011, DOI 10.1002/acr.23097; Machado P, 2011, ANN RHEUM DIS, V70, P1758, DOI 10.1136/ard.2011.150037; Mease PJ, 2018, ARTHRIT CARE RES, V70, P1661, DOI 10.1002/acr.23534; Molnar C, 2018, ANN RHEUM DIS, V77, P63, DOI 10.1136/annrheumdis-2017-211544; Molto A, 2015, ANN RHEUM DIS, V74, P746, DOI 10.1136/annrheumdis-2013-204262; Poddubnyy D, 2018, RHEUMATOLOGY, V57, P703, DOI 10.1093/rheumatology/kex475; Poddubnyy D, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0681-5; Poddubnyy D, 2012, ARTHRITIS RHEUM-US, V64, P1388, DOI 10.1002/art.33465; Protopopov M, 2018, EXPERT REV CLIN IMMU, V14, P525, DOI 10.1080/1744666X.2018.1477591; Protopopov M, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1453-3; Ramiro S, 2019, ARTHRIT CARE RES, V71, P1678, DOI 10.1002/acr.23796; Ramiro S, 2015, ANN RHEUM DIS, V74, P52, DOI 10.1136/annrheumdis-2013-204055; Ramiro S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4144; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Rudwaleit M, 2009, ARTHRITIS RHEUM-US, V60, P717, DOI 10.1002/art.24483; Sepriano A, 2016, ANN RHEUM DIS, V75, P1034, DOI 10.1136/annrheumdis-2015-208730; Sieper J, 2013, ARTHRITIS RHEUM-US, V65, P543, DOI 10.1002/art.37803; van den Berg R, 2014, ARTHRITIS RHEUMATOL, V66, P2403, DOI 10.1002/art.38738; van den Berg R, 2013, RHEUMATOLOGY, V52, P1492, DOI 10.1093/rheumatology/ket164; van der Heijde D, 2018, ANN RHEUM DIS, V77, P699, DOI 10.1136/annrheumdis-2017-212377; van der Heijde D, 2017, ANN RHEUM DIS, V76, P978, DOI 10.1136/annrheumdis-2016-210770; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wallis D, 2013, J RHEUMATOL, V40, P2038, DOI 10.3899/jrheum.130588; Wanders A, 2004, ANN RHEUM DIS, V63, P1601, DOI 10.1136/ard.2004.022038; Weber U, 2018, ARTHRITIS RHEUMATOL, V70, P736, DOI 10.1002/art.40429	47	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0230268	10.1371/journal.pone.0230268	http://dx.doi.org/10.1371/journal.pone.0230268			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196530	Green Published, gold, Green Accepted			2022-12-26	WOS:000535303100024
J	Rose, JJ; Bocian, KA; Xu, QZ; Wang, L; DeMartino, AW; Chen, XK; Corey, CG; Guimaraes, DA; Azarov, I; Huang, XYN; Tong, Q; Guo, LP; Nouraie, M; McTiernan, CF; O'Donnell, CP; Tejero, J; Shiva, S; Gladwin, MT				Rose, Jason J.; Bocian, Kaitlin A.; Xu, Qinzi; Wang, Ling; DeMartino, Anthony W.; Chen, Xiukai; Corey, Catherine G.; Guimaraes, Danielle A.; Azarov, Ivan; Huang, Xueyin N.; Tong, Qin; Guo, Lanping; Nouraie, Mehdi; McTiernan, Charles F.; O'Donnell, Christopher P.; Tejero, Jesus; Shiva, Sruti; Gladwin, Mark T.			A neuroglobin-based high-affinity ligand trap reverses carbon monoxide?induced mitochondrial poisoning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbon monoxide; nitric oxide; mitochondria; mitochondrial disease; mitochondrial respiratory chain complex; hypoxia; hypoxia-inducible factor (HIF); antidotes; CO poisoning; hemoglobin; medical toxicology; neuroglobin	CYTOCHROME-C-OXIDASE; LONG-TERM MORTALITY; NITRIC-OXIDE; OXIDATIVE STRESS; COMPLEX-I; RESPIRATORY-CHAIN; ENERGY-METABOLISM; OXYGEN; INHIBITION; HYPOXIA	Carbon monoxide (CO) remains the most common cause of human poisoning. The consequences of CO poisoning include cardiac dysfunction, brain injury, and death. CO causes toxicity by binding to hemoglobin and by inhibiting mitochondrial cytochrome c oxidase (CcO), thereby decreasing oxygen delivery and inhibiting oxidative phosphorylation. We have recently developed a CO antidote based on human neuroglobin (Ngb-H64Q-CCC). This molecule enhances clearance of CO from red blood cells in vitro and in vivo. Herein, we tested whether Ngb-H64Q-CCC can also scavenge CO from CcO and attenuate CO-induced inhibition of mitochondrial respiration. Heart tissue from mice exposed to 3% CO exhibited a 42 ? 19% reduction in tissue respiration rate and a 33 ? 38% reduction in CcO activity compared with unexposed mice. Intravenous infusion of Ngb-H64Q-CCC restored respiration rates to that of control mice correlating with higher electron transport chain CcO activity in Ngb-H64Q-CCC?treated compared with PBS-treated, CO-poisoned mice. Further, using a Clark-type oxygen electrode, we measured isolated rat liver mitochondrial respiration in the presence and absence of saturating solutions of CO (160 ?m) and nitric oxide (100 ?m). Both CO and NO inhibited respiration, and treatment with Ngb-H64Q-CCC (100 and 50 ?m, respectively) significantly reversed this inhibition. These results suggest that Ngb-H64Q-CCC mitigates CO toxicity by scavenging CO from carboxyhemoglobin, improving systemic oxygen delivery and reversing the inhibitory effects of CO on mitochondria. We conclude that Ngb-H64Q-CCC or other CO scavengers demonstrate potential as antidotes that reverse the clinical and molecular effects of CO poisoning.	[Rose, Jason J.; Bocian, Kaitlin A.; Xu, Qinzi; Wang, Ling; DeMartino, Anthony W.; Chen, Xiukai; Corey, Catherine G.; Guimaraes, Danielle A.; Azarov, Ivan; Huang, Xueyin N.; Tong, Qin; Guo, Lanping; Nouraie, Mehdi; McTiernan, Charles F.; O'Donnell, Christopher P.; Tejero, Jesus; Shiva, Sruti; Gladwin, Mark T.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Corey, Catherine G.; Guimaraes, Danielle A.; Tejero, Jesus; Shiva, Sruti] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Rose, Jason J.; Tejero, Jesus; Gladwin, Mark T.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rose, JJ (corresponding author), Univ Pittsburgh, Med Ctr, 3459 Fifth Ave, Pittsburgh, PA 15213 USA.	rosejj@upmc.edu	Guimaraes, Danielle/AAX-3556-2020; Tejero, Jesus/G-3953-2017; Rose, Jason/AAY-8921-2021; Nouraie, Seyed Mehdi/O-4071-2018	Guimaraes, Danielle/0000-0002-5187-2090; Tejero, Jesus/0000-0003-3245-9978; Nouraie, Seyed Mehdi/0000-0001-7465-0581; DeMartino, Anthony/0000-0001-5303-5758; Rose, Jason/0000-0003-1347-9148; Wang, Ling/0000-0003-4333-3158	National Institutes of Health [F32 HL132418, K08 HL136857, R01 HL111706, R01 HL125886, R01 HL098032, P01 HL103455, T32 HL110849, T32 HL007563, R01 GM113816, R21 ES027390]; National Institutes of Health, NHLBI SMARTT (Science Moving towArd Research Translation and Therapy) Program; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; Parker B. Francis Foundation; Bayer Pharmaceuticals	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NHLBI SMARTT (Science Moving towArd Research Translation and Therapy) Program; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; Parker B. Francis Foundation; Bayer Pharmaceuticals(Bayer AG)	This work was supported in part by National Institutes of Health Grants F32 HL132418 and K08 HL136857 (to J. J. R.), R01 HL111706 (to C. P. O.), R01 HL125886 (to J. T. and M. T. G.), R01 HL098032, P01 HL103455, T32 HL110849, and T32 HL007563 (to M. T. G.), R01 GM113816 (to S. S.) and R21 ES027390 (to J. T.). This work was also supported by the National Institutes of Health, NHLBI SMARTT (Science Moving towArd Research Translation and Therapy) Program, the Institute for Transfusion Medicine, the Hemophilia Center of Western Pennsylvania (to M. T. G.), and Parker B. Francis Foundation (to J. J. R.). J. J. R., L. W., C. F. M., J. T., and M. T. G. are shareholders in Globin Solutions. J. J. R., Q. X., A. W. D., J. T., and M. T. G. are coinventors of provisional, pending, and granted patents for the use of recombinant neuroglobin and other heme-based molecules as antidotes for carbon monoxide poisoning. J. J. R. and J. T. are officers and directors of Globin Solutions, Inc. M. T. G. is a director and advisor of Globin Solutions, Inc., which has licensed this technology and had an option to technology directed at using hydroxycobalamin for carbon monoxide poisoning from Virginia Commonwealth University that has expired. M. T. G. is a coinventor on patents directed to the use of nitrite salts in cardiovascular diseases licensed and exclusively optioned to Globin Solutions, Inc., which has a sponsored research agreement with the University of Pittsburgh aimed at developing carbon monoxide poisoning antidotes into therapeutics that did not support the research contained in this grant that partially supports the efforts of M. T. G., J. T., Q. X., X. C., Q. T., and X. N. H., M. T. G. is a coinvestigator in a research collaboration with Bayer Pharmaceuticals to evaluate riociguate as a treatment for patients with sickle cell disease. The financial conflicts of interest of J. J. R., J. T., Q. X., L. W., A. W. D., C. F. M., and M. T. G. were managed by the University of Pittsburgh Conflict of Interest Committee and a data stewardship committee. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Hasan YM, 2013, REPROD SCI, V20, P299, DOI 10.1177/1933719112453509; Alonso JR, 2003, PHARMACOL TOXICOL, V93, P142, DOI 10.1034/j.1600-0773.2003.930306.x; Azarov I, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aah6571; Bai YD, 2004, ANN NY ACAD SCI, V1011, P272, DOI 10.1196/annals.1293.026; Bernard C., 1857, LEONS EFFETS SUBSTAN; Brookes PS, 2003, J BIOL CHEM, V278, P31603, DOI 10.1074/jbc.M211784200; Brookes PS, 2002, METHOD ENZYMOL, V359, P305; Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; Brown S D, 1989, Adv Exp Med Biol, V248, P747; BROWN SD, 1990, J APPL PHYSIOL, V68, P604, DOI 10.1152/jappl.1990.68.2.604; BROWN SD, 1992, J CLIN INVEST, V89, P666, DOI 10.1172/JCI115633; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P21, DOI 10.1016/S0968-0004(00)01698-4; Cai B, 2011, EXP NEUROL, V227, P224, DOI 10.1016/j.expneurol.2010.11.009; Chambers CA, 2008, BRAIN INJURY, V22, P387, DOI 10.1080/02699050802008075; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; COBURN RF, 1973, ANNU REV MED, V24, P241, DOI 10.1146/annurev.me.24.020173.001325; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dziewierz A, 2013, J EMERG MED, V45, P831, DOI 10.1016/j.jemermed.2013.05.061; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Fischer GW, 2010, SEMIN THORAC CARDIOV, V22, P140, DOI 10.1053/j.semtcvs.2010.09.007; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; Gao L, 2008, VET CLIN N AM-SMALL, V38, P137, DOI 10.1016/j.cvsm.2007.10.004; Gellerich FN, 1999, SHOCK, V11, P336, DOI 10.1097/00024382-199905000-00006; Gnaiger E, 1998, J EXP BIOL, V201, P1129; GOLDBAUM L R, 1976, Annals of Clinical and Laboratory Science, V6, P372; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Hall JE, 2020, GUYTON HALL TXB MED; Hampson NB, 2008, CRIT CARE MED, V36, P2523, DOI 10.1097/CCM.0b013e31818419d8; Hampson NB, 2016, ANN AM THORAC SOC, V13, P1768, DOI 10.1513/AnnalsATS.201604-318OC; Hampson NB, 2012, AM J RESP CRIT CARE, V186, P1095, DOI 10.1164/rccm.201207-1284CI; Hampson NB, 2012, UNDERSEA HYPERBAR M, V39, P657; Hampson NB, 2009, CRIT CARE MED, V37, P1941, DOI 10.1097/CCM.0b013e3181a0064f; Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123; Henry CR, 2006, JAMA-J AM MED ASSOC, V295, P398, DOI 10.1001/jama.295.4.398; Hernansanz-Agustin P, 2017, REDOX BIOL, V12, P1040, DOI 10.1016/j.redox.2017.04.025; Hopkins RO, 2008, UNDERSEA HYPERBAR M, V35, P258; Hsiao Cheng-Lung, 2004, Acta Neurol Taiwan, V13, P64; Huang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105503; Iheagwara KN, 2007, BBA-MOL BASIS DIS, V1772, P1112, DOI 10.1016/j.bbadis.2007.06.002; Jang DH, 2018, INTENS CARE MED EXP, V6, DOI 10.1186/s40635-018-0169-2; Merino JJ, 2014, INT J MOL SCI, V15, P2475, DOI 10.3390/ijms15022475; Kamga C, 2012, NITRIC OXIDE-BIOL CH, V26, P251, DOI 10.1016/j.niox.2012.03.005; Ketteler M, 1998, KIDNEY INT, pS27; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Lippi G, 2012, CLIN BIOCHEM, V45, P1278, DOI 10.1016/j.clinbiochem.2012.06.004; Lo Iacono L, 2011, FREE RADICAL BIO MED, V50, P1556, DOI 10.1016/j.freeradbiomed.2011.02.033; MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013; Mimura K, 1999, Seishin Shinkeigaku Zasshi, V101, P592; Miro O, 1998, PHARMACOL TOXICOL, V82, P199, DOI 10.1111/j.1600-0773.1998.tb01425.x; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Pannala VR, 2016, J APPL PHYSIOL, V121, P1196, DOI 10.1152/japplphysiol.00524.2016; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; Piantadosi CA, 2006, FREE RADICAL BIO MED, V40, P1332, DOI 10.1016/j.freeradbiomed.2005.11.020; Piantadosi CA, 2008, FREE RADICAL BIO MED, V45, P562, DOI 10.1016/j.freeradbiomed.2008.05.013; Plotnikov EY, 2009, BBA-MOL BASIS DIS, V1792, P796, DOI 10.1016/j.bbadis.2009.06.005; Powell CS, 2003, AM J PHYSIOL-LUNG C, V285, pL189, DOI 10.1152/ajplung.00253.2002; Protti A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0762-7; Roderique JD, 2015, TOXICOLOGY, V334, P45, DOI 10.1016/j.tox.2015.05.004; Rose JJ, 2017, AM J RESP CRIT CARE, V195, P596, DOI 10.1164/rccm.201606-1275CI; Sarti P, 2003, IUBMB LIFE, V55, P605, DOI 10.1080/15216540310001628726; Sarti P, 2012, BBA-BIOENERGETICS, V1817, P610, DOI 10.1016/j.bbabio.2011.09.002; SCHEWE T, 1983, BIOMED BIOCHIM ACTA, V42, P789; SCHWERZMANN K, 1986, J CELL BIOL, V102, P97, DOI 10.1083/jcb.102.1.97; Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Smithline HA, 2003, RESUSCITATION, V56, P97, DOI 10.1016/S0300-9572(02)00272-1; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Tejero J, 2014, BIOL CHEM, V395, P631, DOI 10.1515/hsz-2013-0289; Thom SR, 1997, CHEM RES TOXICOL, V10, P1023, DOI 10.1021/tx970041h; THOM SR, 1994, TOXICOL APPL PHARM, V128, P105, DOI 10.1006/taap.1994.1186; Thom SR, 2008, PHYSL MED HYPERBARIC, V321, P347; Thom SR, 2006, AM J RESP CRIT CARE, V174, P1239, DOI 10.1164/rccm.200604-557OC; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Tsai AL, 2012, BIOCHEMISTRY-US, V51, P172, DOI 10.1021/bi2015629; Turner M, 1999, J ACCID EMERG MED, V16, P92; WALD G, 1957, J GEN PHYSIOL, V40, P593, DOI 10.1085/jgp.40.4.593; Weaver LK, 2009, NEW ENGL J MED, V360, P1217, DOI 10.1056/NEJMcp0808891; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Weaver LK, 2008, UNDERSEA HYPERBAR M, P258; Wen JJ, 2010, ANTIOXID REDOX SIGN, V12, P27, DOI [10.1089/ars.2008.2418, 10.1089/ARS.2008.2418]; Wilson DF, 2014, J APPL PHYSIOL, V117, P1431, DOI 10.1152/japplphysiol.00737.2014; WINTER PM, 1976, JAMA-J AM MED ASSOC, V236, P1502, DOI 10.1001/jama.236.13.1502; Yang XD, 1997, J BIOL CHEM, V272, P9683; Yu Z, 2009, NEUROSCIENCE, V162, P396, DOI 10.1016/j.neuroscience.2009.04.055; ZHANG J, 1992, J CLIN INVEST, V90, P1193, DOI 10.1172/JCI115980	92	16	18	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6357	6371		10.1074/jbc.RA119.010593	http://dx.doi.org/10.1074/jbc.RA119.010593			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32205448	hybrid, Green Published			2022-12-26	WOS:000537685000010
J	Borrachero-Conejo, AI; Adams, WR; Saracino, E; Mola, MG; Wang, MQ; Posati, T; Formaggio, F; De Bellis, M; Frigeri, A; Caprini, M; Hutchinson, MR; Muccini, M; Zamboni, R; Nicchia, GP; Mahadevan-Jansen, A; Benfenati, V				Borrachero-Conejo, Ana, I; Adams, Wilson R.; Saracino, Emanuela; Mola, Maria Grazia; Wang, Manqing; Posati, Tamara; Formaggio, Francesco; De Bellis, Manuela; Frigeri, Antonio; Caprini, Marco; Hutchinson, Mark R.; Muccini, Michele; Zamboni, Roberto; Nicchia, Grazia Paola; Mahadevan-Jansen, Anita; Benfenati, Valentina			Stimulation of water and calcium dynamics in astrocytes with pulsed infrared light	FASEB JOURNAL			English	Article						AQP4; astrocytes; infrared stimulation; TRPV4; water dynamics	SENSITIZES TRPV4 CHANNEL; CELL-VOLUME; OPTICAL STIMULATION; CA2+; AQUAPORIN-4; AQP4; PHOTOSTIMULATION; CONDUCTANCE; ACTIVATION; EXPRESSION	Astrocytes are non-neuronal cells that govern the homeostatic regulation of the brain through ions and water transport, and Ca2+-mediated signaling. As they are tightly integrated into neural networks, label-free tools that can modulate cell function are needed to evaluate the role of astrocytes in brain physiology and dysfunction. Using live-cell fluorescence imaging, pharmacology, electrophysiology, and genetic manipulation, we show that pulsed infrared light can modulate astrocyte function through changes in intracellular Ca2+ and water dynamics, providing unique mechanistic insight into the effect of pulsed infrared laser light on astroglial cells. Water transport is activated and, IP3R, TRPA1, TRPV4, and Aquaporin-4 are all involved in shaping the dynamics of infrared pulse-evoked intracellular calcium signal. These results demonstrate that astrocyte function can be modulated with infrared light. We expect that targeted control over calcium dynamics and water transport will help to study the crucial role of astrocytes in edema, ischemia, glioma progression, stroke, and epilepsy.	[Borrachero-Conejo, Ana, I; Caprini, Marco; Muccini, Michele] CNR, Ist Studio Mat Nanostrutturati, Bologna, Italy; [Adams, Wilson R.; Mahadevan-Jansen, Anita] Vanderbilt Univ, Dept Biomed Engn, 5824 Stevenson Ctr, Nashville, TN 37235 USA; [Adams, Wilson R.; Wang, Manqing; Mahadevan-Jansen, Anita] Vanderbilt Univ, Vanderbilt Biophoton Ctr, Nashville, TN 37232 USA; [Saracino, Emanuela; Posati, Tamara; Zamboni, Roberto; Nicchia, Grazia Paola; Benfenati, Valentina] CNR, Ist Sintesi Organ & Fotoreatt, Via Gobetti 101, I-40129 Bologna, Italy; [Mola, Maria Grazia; De Bellis, Manuela; Nicchia, Grazia Paola] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut & Ctr Exce, Bari, Italy; [Wang, Manqing] Chongqing Univ, Bioengn Coll, Chongqing, Peoples R China; [Formaggio, Francesco; Caprini, Marco] Univ Bologna, Dipartimento Farm & Biotecnol, Bologna, Italy; [Frigeri, Antonio] Univ Bari Aldo Moro, Sch Med, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Frigeri, Antonio; Nicchia, Grazia Paola] Yeshiva Univ, Albert Einstein Coll Med, Dept Neurosci, New York, NY 10033 USA; [Hutchinson, Mark R.] Univ Adelaide, Australian Res Council Ctr Excellence Nanoscale B, Adelaide Med Sch, Adelaide, SA, Australia; [Mahadevan-Jansen, Anita] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio dei Materiali Nanostrutturati (ISMN-CNR); Vanderbilt University; Vanderbilt University; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR); Universita degli Studi di Bari Aldo Moro; Chongqing University; University of Bologna; Universita degli Studi di Bari Aldo Moro; Yeshiva University; University of Adelaide; Vanderbilt University	Mahadevan-Jansen, A (corresponding author), Vanderbilt Univ, Dept Biomed Engn, 5824 Stevenson Ctr, Nashville, TN 37235 USA.; Benfenati, V (corresponding author), CNR, Ist Sintesi Organ & Fotoreatt, Via Gobetti 101, I-40129 Bologna, Italy.	anita.mahadevan-jansen@vanderbilt.edu; valentina.benfenati@isof.cnr.it	frigeri, Antonio/AAC-6336-2022; Borrachero-Conejo, Ana I./AAA-6590-2021; Hutchinson, Mark/N-1815-2019; Saracino, Emanuela/Q-4385-2018; Benfenati, Valentina/D-4579-2016	Borrachero-Conejo, Ana I./0000-0002-0479-5598; Hutchinson, Mark/0000-0003-2154-5950; Benfenati, Valentina/0000-0002-2858-8497; Formaggio, Francesco/0000-0002-7504-6607	NIDDK NIH HHS [U24 DK059637] Funding Source: Medline; NIH HHS [DK20593, CA68485, DK58404, EY08126] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Barrett JN, 2018, J NEUROPHYSIOL, V120, P509, DOI 10.1152/jn.00740.2017; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Benfenati V, 2010, NEUROSCIENCE, V168, P926, DOI 10.1016/j.neuroscience.2009.12.017; Benfenati V, 2014, ADV HEALTHC MATER, V3, P392, DOI 10.1002/adhm.201300179; Benfenati V, 2013, NAT MATER, V12, P672, DOI [10.1038/NMAT3630, 10.1038/nmat3630]; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; Benfenati V, 2009, CHANNELS, V3, P323, DOI 10.4161/chan.3.5.9568; Bindocci E, 2017, SCIENCE, V356, DOI 10.1126/science.aai8185; Borrachero-Conejo AI, 2019, ADV HEALTHC MATER, V8, DOI 10.1002/adhm.201801139; Butenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039959; Cayce JM, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.1.015007; Cayce JM, 2010, IEEE J SEL TOP QUANT, V16, P565, DOI 10.1109/JSTQE.2009.2032424; Cayce JM, 2014, CELL CALCIUM, V55, P183, DOI 10.1016/j.ceca.2014.01.004; Cho WH, 2016, EXP NEUROBIOL, V25, P197, DOI 10.5607/en.2016.25.5.197; Choi M, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600774; Dunn KM, 2013, P NATL ACAD SCI USA, V110, P6157, DOI 10.1073/pnas.1216514110; Ebtehaj Z, 2018, J PHYS CHEM B, V122, P7319, DOI 10.1021/acs.jpcb.8b02616; Eom K, 2017, J BIOPHOTONICS, V10, P486, DOI 10.1002/jbio.201600280; Ermakova YG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15362; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Formaggio F, 2019, FASEB J, V33, P101, DOI 10.1096/fj.201701397RR; Fujita F, 2018, J PHYSIOL SCI, V68, P431, DOI 10.1007/s12576-017-0545-9; Garcia-Elias A, 2008, J BIOL CHEM, V283, P31284, DOI 10.1074/jbc.C800184200; Garcia-Elias A, 2013, P NATL ACAD SCI USA, V110, P9553, DOI 10.1073/pnas.1220231110; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; Jo AO, 2015, J NEUROSCI, V35, P13525, DOI 10.1523/JNEUROSCI.1987-15.2015; Lumbreras V, 2014, J NEUROPHYSIOL, V112, P1246, DOI 10.1152/jn.00253.2014; Maya-Vetencourt JF, 2017, NAT MATER, V16, P681, DOI [10.1038/NMAT4874, 10.1038/nmat4874]; Mederos S, 2019, GLIA, V67, P915, DOI 10.1002/glia.23580; Mola MG, 2016, GLIA, V64, P139, DOI 10.1002/glia.22921; Moreau D, 2018, J BIOPHOTONICS, V11, DOI 10.1002/jbio.201700020; Nicchia GP, 2004, NEUROSCIENCE, V129, P935, DOI 10.1016/j.neuroscience.2004.07.055; Nicchia GP, 2000, GLIA, V31, P29, DOI 10.1002/(SICI)1098-1136(200007)31:1<29::AID-GLIA30>3.0.CO;2-3; Nicchia GP, 2016, EXP EYE RES, V146, P259, DOI 10.1016/j.exer.2016.03.019; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Noell S, 2012, CELL TISSUE RES, V347, P429, DOI 10.1007/s00441-011-1321-4; Owen SF, 2019, NAT NEUROSCI, V22, P1061, DOI 10.1038/s41593-019-0422-3; Paris L, 2017, BIOMED OPT EXPRESS, V8, P4568, DOI 10.1364/BOE.8.004568; Plaksin M, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.011043; Posati T, 2016, SCI REP-UK, V6, DOI 10.1038/srep31226; Santello M, 2019, NAT NEUROSCI, V22, P154, DOI 10.1038/s41593-018-0325-8; Scemes E, 2000, MOL NEUROBIOL, V22, P167, DOI 10.1385/MN:22:1-3:167; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shapiro MG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1742; Sherwood MW, 2017, GLIA, V65, P502, DOI 10.1002/glia.23107; Shigetomi E, 2013, J NEUROSCI, V33, P10143, DOI 10.1523/JNEUROSCI.5779-12.2013; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Startek JB, 2019, ELIFE, V8, DOI 10.7554/eLife.46084; Startek JB, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020371; Thompson Alexander C, 2014, Curr Mol Imaging, V3, P162; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Tolstykh GP, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.2.025001; Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016; Vincent F, 2009, BIOCHEM BIOPH RES CO, V389, P490, DOI 10.1016/j.bbrc.2009.09.007; Walsh AJ, 2017, SPIE BIOS SAN FRANC; Wells J, 2005, OPT LETT, V30, P504, DOI 10.1364/OL.30.000504; Wells J, 2007, BIOPHYS J, V93, P2567, DOI 10.1529/biophysj.107.104786; Yool AJ, 2010, CLIN EXP PHARMACOL P, V37, P403, DOI 10.1111/j.1440-1681.2009.05244.x; Zhao Y, 2009, OPT EXPRESS, V17, P1291, DOI 10.1364/OE.17.001291	59	11	11	6	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6539	6553		10.1096/fj.201903049R	http://dx.doi.org/10.1096/fj.201903049R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32202681	Bronze			2022-12-26	WOS:000531325500038
J	Singh, V; Xu, L; Boyko, S; Surewicz, K; Surewicz, WK				Singh, Virender; Xu, Ling; Boyko, Solomiia; Surewicz, Krystyna; Surewicz, Witold K.			Zinc promotes liquid?liquid phase separation of tau protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tau protein (tau); tauopathy; zinc; neurodegeneration; metal homeostasis; amyloid; Alzheimer disease; divalent transition metal; liquid-liquid phase separation; amyloid plaques; divalent transition metal	MEDIATED NEURODEGENERATION; ALZHEIMERS-DISEASE; AGGREGATION; STRESS; TRANSITION; TOXICITY; HEALTH; IONS; BETA	Tau is a microtubule-associated protein that plays a major role in Alzheimer's disease (AD) and other tauopathies. Recent reports indicate that, in the presence of crowding agents, tau can undergo liquid?liquid phase separation (LLPS), forming highly dynamic liquid droplets. Here, using recombinantly expressed proteins, turbidimetry, fluorescence microscopy imaging, and fluorescence recovery after photobleaching (FRAP) assays, we show that the divalent transition metal zinc strongly promotes this process, shifting the equilibrium phase boundary to lower protein or crowding agent concentrations. We observed no tau LLPS-promoting effect for any other divalent transition metal ions tested, including Mn2+, Fe2+, Co2+, Ni2+, and Cu2+. We also demonstrate that multiple zinc-binding sites on tau are involved in the LLPS-promoting effect and provide insights into the mechanism of this process. Zinc concentration is highly elevated in AD brains, and this metal ion is believed to be an important player in the pathogenesis of this disease. Thus, the present findings bring a new dimension to understanding the relationship between zinc homeostasis and the pathogenic process in AD and related neurodegenerative disorders.	[Singh, Virender; Xu, Ling; Boyko, Solomiia; Surewicz, Krystyna; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	witold.surewicz@case.edu	Singh, Virender/AAB-5190-2019	Singh, Virender/0000-0002-6720-8784	National Institutes of Health [RF1 AG061797]; Department of Physiology and Biophysics, Case Western Reserve University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Physiology and Biophysics, Case Western Reserve University	This work was supported by National Institutes of Health Grant RF1 AG061797 (to W. K. S.) and the Department of Physiology and Biophysics, Case Western Reserve University, Pilot Project Grant (to W. K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambadipudi S, 2019, CHEM SCI, V10, P6503, DOI 10.1039/c9sc00531e; Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; Babinchak WM, 2019, J BIOL CHEM, V294, P6306, DOI 10.1074/jbc.RA118.007222; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Boyko S, 2019, J BIOL CHEM, V294, P11054, DOI 10.1074/jbc.AC119.009198; Breydo L, 2011, METALLOMICS, V3, P1163, DOI 10.1039/c1mt00106j; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Cuajungco MP, 1997, BRAIN RES REV, V23, P219, DOI 10.1016/S0165-0173(97)00002-7; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Elbaum-Garfinkle S, 2019, J BIOL CHEM, V294, P7160, DOI 10.1074/jbc.REV118.001188; Faller P, 2014, ACCOUNTS CHEM RES, V47, P2252, DOI 10.1021/ar400293h; Fichou Y, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0682-x; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hernandez-Vega A, 2017, CELL REP, V20, P2304, DOI 10.1016/j.celrep.2017.08.042; Hu JY, 2017, BBA-MOL BASIS DIS, V1863, P414, DOI 10.1016/j.bbadis.2016.11.022; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Huang YP, 2014, CELL REP, V8, P831, DOI 10.1016/j.celrep.2014.06.047; Jiji AC, 2017, CHEM-EUR J, V23, P16976, DOI 10.1002/chem.201704555; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Morris S, 2017, FIT FOR THE PRESIDENCY?: WINNERS, LOSERS, WHAT-IFS, AND ALSO-RANS, P303; Nedelsky NB, 2019, NAT REV NEUROL, V15, P272, DOI 10.1038/s41582-019-0157-5; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Peskett TR, 2018, MOL CELL, V70, P588, DOI 10.1016/j.molcel.2018.04.007; Portbury SD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122506; Rayman JB, 2018, CELL REP, V22, P59, DOI 10.1016/j.celrep.2017.12.036; Religa D, 2006, NEUROLOGY, V67, P69, DOI 10.1212/01.wnl.0000223644.08653.b5; Roman AY, 2019, J MOL BIOL, V431, P687, DOI 10.1016/j.jmb.2018.12.008; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; Szewczyk B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00033; Tonnies E, 2017, J ALZHEIMERS DIS, V57, P1105, DOI 10.3233/JAD-161088; Vanderweyde T, 2016, CELL REP, V15, P1455, DOI 10.1016/j.celrep.2016.04.045; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Zhang XM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002183	40	42	42	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5850	5856		10.1074/jbc.AC120.013166	http://dx.doi.org/10.1074/jbc.AC120.013166			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32229582	hybrid, Green Published			2022-12-26	WOS:000531417300002
J	Charmet, G; Tran, LG; Auzanneau, J; Rincent, R; Bouchet, S				Charmet, Gilles; Tran, Louis-Gautier; Auzanneau, Jerome; Rincent, Renaud; Bouchet, Sophie			BWGS: A R package for genomic selection and its application to a wheat breeding programme	PLOS ONE			English	Review							MARKER-ASSISTED SELECTION; GENETIC VALUES; QUANTITATIVE TRAITS; ENABLED PREDICTION; CALIBRATION SET; PLANT; REGRESSION; EFFICIENCY; ACCURACY; REGULARIZATION	We developed an integrated R library called BWGS to enable easy computation of Genomic Estimates of Breeding values (GEBV) for genomic selection. BWGS, for BreedWheat Genomic selection, was developed in the framework of a cooperative private-public partnership project called Breedwheat (https://breedwheat.fr) and relies on existing R-libraries, all freely available from CRAN servers. The two main functions enable to run 1) replicated random cross validations within a training set of genotyped and phenotyped lines and 2) GEBV prediction, for a set of genotyped-only lines. Options are available for 1) missing data imputation, 2) markers and training set selection and 3) genomic prediction with 15 different methods, either parametric or semi-parametric. The usefulness and efficiency of BWGS are illustrated using a population of wheat lines from a real breeding programme. Adjusted yield data from historical trials (highly unbalanced design) were used for testing the options of BWGS. On the whole, 760 candidate lines with adjusted phenotypes and genotypes for 47 839 robust SNP were used. With a simple desktop computer, we obtained results which compared with previously published results on wheat genomic selection. As predicted by the theory, factors that are most influencing predictive ability, for a given trait of moderate heritability, are the size of the training population and a minimum number of markers for capturing every QTL information. Missing data up to 40%, if randomly distributed, do not degrade predictive ability once imputed, and up to 80% randomly distributed missing data are still acceptable once imputed with Expectation-Maximization method of package rrBLUP. It is worth noticing that selecting markers that are most associated to the trait do improve predictive ability, compared with the whole set of markers, but only when marker selection is made on the whole population. When marker selection is made only on the sampled training set, this advantage nearly disappeared, since it was clearly due to overfitting. Few differences are observed between the 15 prediction models with this dataset. Although non-parametric methods that are supposed to capture non-additive effects have slightly better predictive accuracy, differences remain small. Finally, the GEBV from the 15 prediction models are all highly correlated to each other. These results are encouraging for an efficient use of genomic selection in applied breeding programmes and BWGS is a simple and powerful toolbox to apply in breeding programmes or training activities.	[Charmet, Gilles; Tran, Louis-Gautier; Rincent, Renaud; Bouchet, Sophie] INRAE UCA, UMR GDEC, Clermont Ferrand, France; [Auzanneau, Jerome] Agriobtentions, Ferme De Gauvilliers, Orsonville, France	INRAE	Charmet, G (corresponding author), INRAE UCA, UMR GDEC, Clermont Ferrand, France.	gilles.charmet@inra.fr	Van Giang TRAN, Louis Gautier/AAW-2776-2020	Charmet, Gilles/0000-0001-8927-5040; Rincent, Renaud/0000-0003-0885-0969	BreedWheat project from the French Government [ANR-10-BTBR-03]; France AgriMer; French Fund	BreedWheat project from the French Government; France AgriMer; French Fund	This work was supported by the BreedWheat project thanks to funding from the French Government managed by the National Research Agency (ANR) in the framework of Investments for the Future (ANR-10-BTBR-03), France AgriMer and the French Fund to support Plant Breeding (FSOV). https://breedwheat.fr/.	Akdemir D, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0116-6; Bassi FM, 2016, PLANT SCI, V242, P23, DOI 10.1016/j.plantsci.2015.08.021; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Bernardo R, 2006, CROP SCI, V46, P1972, DOI 10.2135/cropsci2006.01-0057; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Cericola F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169606; Chang LY, 2018, BMC GENET, V19, DOI 10.1186/s12863-017-0595-2; Crossa J, 2017, TRENDS PLANT SCI, V22, P961, DOI 10.1016/j.tplants.2017.08.011; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; Daetwyler HD, 2013, GENETICS, V193, P347, DOI 10.1534/genetics.112.147983; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; de los Campos G, 2010, GENET RES, V92, P295, DOI 10.1017/S0016672310000285; Desta ZA, 2014, TRENDS PLANT SCI, V19, P592, DOI 10.1016/j.tplants.2014.05.006; Endelman JB, 2012, G3-GENES GENOM GENET, V2, P1405, DOI 10.1534/g3.112.004259; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Estaghvirou SBO, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-860; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285; Gianola D, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-87; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Gonzalez-Camacho JM, 2012, THEOR APPL GENET, V125, P759, DOI 10.1007/s00122-012-1868-9; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; He S, 2016, THEOR APPL GENET, V129, P641, DOI 10.1007/s00122-015-2655-1; Heffner EL, 2011, PLANT GENOME-US, V4, P65, DOI [10.3835/plantgenome2010.12.0029, 10.3835/plantgenome.2010.12.0029]; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Heslot N, 2015, CROP SCI, V55, P1, DOI 10.2135/cropsci2014.03.0249; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Hospital F, 1997, THEOR APPL GENET, V95, P1181, DOI 10.1007/s001220050679; Isidro J, 2015, THEOR APPL GENET, V128, P145, DOI 10.1007/s00122-014-2418-4; Iwata H, 2011, CROP SCI, V51, P1915, DOI 10.2135/cropsci2010.12.0732; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Jiang Y, 2015, GENETICS, V201, P759, DOI 10.1534/genetics.115.177907; Kang HM, 2017, FRONT AGRIC SCI ENG, V4, P268, DOI 10.15302/J-FASE-2017164; LANDE R, 1990, GENETICS, V124, P743; Li B, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00237; Liu X, 2018, CHINESE J AERONAUT, V31, P117, DOI 10.1016/j.cja.2017.08.018; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Ma C., 2017, PACKAGE G2P GENOMIC; Ma WL, 2018, PLANTA, V248, P1307, DOI 10.1007/s00425-018-2976-9; Ma YS, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0504-9; Meuwissen THE, 2001, GENETICS, V157, P1819; Michel S, 2018, THEOR APPL GENET, V131, P477, DOI 10.1007/s00122-017-2998-x; Michel S, 2016, THEOR APPL GENET, V129, P1179, DOI 10.1007/s00122-016-2694-2; Moreau L, 1998, GENETICS, V148, P1353; Oury F.X., 2015, WINTER WHEAT TRITICU, DOI [10.15454/1.4489666216568333E12, DOI 10.15454/1.4489666216568333E12]; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; R Core Team, 2021, R LANGUAGE ENV STAT; Rimbert H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0186329; Rincent R, 2017, THEOR APPL GENET, V130, P2231, DOI 10.1007/s00122-017-2956-7; Rincent R, 2012, GENETICS, V192, P715, DOI 10.1534/genetics.112.141473; Schaeffer LR, 2006, J ANIM BREED GENET, V123, P218, DOI 10.1111/j.1439-0388.2006.00595.x; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schulz-Streeck Torben, 2011, BMC Proc, V5 Suppl 3, pS12, DOI 10.1186/1753-6561-5-S3-S12; Song JY, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0715-8; Spindel JE, 2016, NEW PHYTOL, V212, P814, DOI 10.1111/nph.14174; Wang D, 2012, HEREDITY, V109, P313, DOI 10.1038/hdy.2012.44; Wang X, 2018, INT CONF MANIP MANU, P201, DOI 10.1109/3M-NANO.2018.8552241; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Wimmer V, 2012, BIOINFORMATICS, V28, P2086, DOI 10.1093/bioinformatics/bts335; Zhou Y, 2017, BRIEF BIOINFORM, V18, P744, DOI 10.1093/bib/bbw064; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	66	14	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0222733	10.1371/journal.pone.0222733	http://dx.doi.org/10.1371/journal.pone.0222733			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240182	Green Published, Green Submitted, gold			2022-12-26	WOS:000535945000002
J	Ge, YJ; Zhang, S; Wang, JL; Xia, FB; Wan, JB; Lu, JJ; Ye, RD				Ge, Yunjun; Zhang, Shuo; Wang, Junlin; Xia, Fangbo; Wan, Jian-Bo; Lu, Jinjian; Ye, Richard D.			Dual modulation of formyl peptide receptor 2 by aspirin-triggered lipoxin contributes to its anti-inflammatory activity	FASEB JOURNAL			English	Article						biased signaling; G protein-coupled receptor; inflammation; inverse agonism	PROTEIN-COUPLED RECEPTOR; BETA-ARRESTIN; ACTIVATES NEUTROPHILS; ALLOSTERIC MODULATION; A(4) RECEPTORS; STABLE ANALOGS; LIGAND; 7-TRANSMEMBRANE; FPR2/ALX; AGONIST	The eicosanoid lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) (ATL) are potent anti-inflammatory agents. How their anti-inflammatory effects are mediated by receptors such as the formyl peptide receptor 2 (FPR2/ALX) remains incompletely understood. In the present study, fluorescent biosensors of FPR2/ALX were prepared and ATL-induced conformational changes were recorded. A biphasic dose curve consisting of a descending phase and an ascending phase was observed, with the descending phase corresponding to diminished FPR2 response such as Ca2+ mobilization induced by the potent synthetic agonist WKYMVm. Preincubation of FPR2-expressing cells with 100 pM of ATL also lowered the threshold for WKYMVm to induce beta-arrestin-2 membrane translocation, and inhibited WKYMVm-induced interleukin 8 secretion, suggesting signaling bias favoring anti-inflammatory activities. At 100 pM and above, ATL-induced receptor conformational changes resembling that of the WKYMVm along with a weak but measurable inhibition of forskolin-induced cAMP accumulation. However, no Ca2+ mobilization was induced by ATL until its concentration reached 1 mu M. Taken together, these results suggest a dual regulatory mechanism by which ATL exerts anti-inflammatory effects through FPR2/ALX.	[Ge, Yunjun; Wang, Junlin; Xia, Fangbo; Wan, Jian-Bo; Lu, Jinjian; Ye, Richard D.] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Zhuhai, Macau Special A, Peoples R China; [Zhang, Shuo] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China; [Ye, Richard D.] Chinese Univ Hong Kong, Sch Life & Hlth Sci, Kobilka Inst Innovat Drug Discovery, Shenzhen, Peoples R China	University of Macau; Shanghai Jiao Tong University; Chinese University of Hong Kong, Shenzhen	Ye, RD (corresponding author), Chinese Univ Hong Kong, Sch Life & Hlth Sci, Kobilka Inst Innovat Drug Discovery, Shenzhen, Peoples R China.	richardye@cuhk.edu.cn	Lu, Jinjian/X-2083-2019; Ye, Richard/ABF-2413-2020; Wan, Jian-Bo/D-8368-2014	Lu, Jinjian/0000-0001-6703-3120; Ye, Richard/0000-0002-2164-5620; Wan, Jian-Bo/0000-0002-6750-2617	University of Macau [MYRG2016-00152-ICMS-QRCM, MYRG2016-00246-ICMS-QRCM]	University of Macau	University of Macau, Grant/Award Number: MYRG2016-00152-ICMS-QRCM and MYRG2016-00246-ICMS-QRCM	Bae YS, 2003, MOL PHARMACOL, V64, P721, DOI 10.1124/mol.64.3.721; Cattaneo F, 2013, INT J MOL SCI, V14, P7193, DOI 10.3390/ijms14047193; Chen T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15009-1; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Christophe T, 2002, SCAND J IMMUNOL, V56, P470, DOI 10.1046/j.1365-3083.2002.01149.x; Civciristov S, 2019, BRIT J PHARMACOL, V176, P2382, DOI 10.1111/bph.14636; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; Clish CB, 1999, P NATL ACAD SCI USA, V96, P8247, DOI 10.1073/pnas.96.14.8247; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; Dahlgren C, 2016, BIOCHEM PHARMACOL, V114, P22, DOI 10.1016/j.bcp.2016.04.014; Dogan B, 2015, MED SCI MONITOR, V21, P2485, DOI 10.12659/MSM.895115; Dorward DA, 2015, AM J PATHOL, V185, P1172, DOI 10.1016/j.ajpath.2015.01.020; Du Y, 2019, CELL, V177, P1232, DOI 10.1016/j.cell.2019.04.022; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; FIORE S, 1994, J EXP MED, V180, P253, DOI 10.1084/jem.180.1.253; Fiorucci S, 2003, BRIT J PHARMACOL, V139, P1351, DOI 10.1038/sj.bjp.0705356; Forsman H, 2011, SCAND J IMMUNOL, V74, P227, DOI 10.1111/j.1365-3083.2011.02570.x; Forsman H, 2009, SCAND J IMMUNOL, V70, P396, DOI 10.1111/j.1365-3083.2009.02311.x; Gabl M, 2017, BIOCHEM PHARMACOL, V145, P114, DOI 10.1016/j.bcp.2017.08.018; Gewirtz AT, 1998, J CLIN INVEST, V101, P1860, DOI 10.1172/JCI1339; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gregory KJ, 2018, ACS PHARMACOL TRANSL, V1, P96, DOI 10.1021/acsptsci.8b00021; Guo ZD, 2016, STROKE, V47, P490, DOI 10.1161/STROKEAHA.115.011223; Hanson J, 2013, BIOCHEM PHARMACOL, V85, P1795, DOI 10.1016/j.bcp.2013.04.019; He HQ, 2017, MOLECULES, V22, DOI 10.3390/molecules22030455; He HQ, 2014, J BIOL CHEM, V289, P2295, DOI 10.1074/jbc.M113.509216; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Hodges RR, 2017, MUCOSAL IMMUNOL, V10, P46, DOI 10.1038/mi.2016.33; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hoffmann C, 2010, NAT PROTOC, V5, P1666, DOI 10.1038/nprot.2010.129; Holdfeldt A, 2019, ACS OMEGA, V4, P5968, DOI 10.1021/acsomega.9b00098; Huet E, 2007, CELL SIGNAL, V19, P1939, DOI 10.1016/j.cellsig.2007.05.006; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Le YY, 1999, J IMMUNOL, V163, P6777; Le YY, 2002, INT IMMUNOPHARMACOL, V2, P1, DOI 10.1016/S1567-5769(01)00150-3; Li LZ, 2016, J LEUKOCYTE BIOL, V99, P425, DOI 10.1189/jlb.2RI0815-354RR; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Maddox JF, 1997, J BIOL CHEM, V272, P6972, DOI 10.1074/jbc.272.11.6972; Maderna P, 2010, FASEB J, V24, P4240, DOI 10.1096/fj.10-159913; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Nanamori M, 2004, MOL PHARMACOL, V66, P1213, DOI 10.1124/mol.104.004309; Paul-Clark MJ, 2004, J EXP MED, V200, P69, DOI 10.1084/jem.20040566; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Qin CX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14232; Ranjan R, 2017, TRENDS CELL BIOL, V27, P861, DOI 10.1016/j.tcb.2017.05.008; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Shimizu S, 2013, ANN OTO RHINOL LARYN, V122, P683, DOI 10.1177/000348941312201104; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Takano T, 1997, J EXP MED, V185, P1693, DOI 10.1084/jem.185.9.1693; Thompson D, 2014, J BIOL CHEM, V289, P36166, DOI 10.1074/jbc.M114.612630; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Yu D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142848; Zhuang YW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14728-9	62	28	28	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6920	6933		10.1096/fj.201903206R	http://dx.doi.org/10.1096/fj.201903206R		APR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32239559				2022-12-26	WOS:000522968700001
J	McKelvey, KJ; Hudson, AL; Kumar, RP; Wilmott, JS; Attrill, GH; Long, GV; Scolyer, RA; Clarke, SJ; Wheeler, HR; Diakos, CI; Howell, VM				McKelvey, Kelly J.; Hudson, Amanda L.; Kumar, Ramyashree Prasanna; Wilmott, James S.; Attrill, Grace H.; Long, Georgina, V; Scolyer, Richard A.; Clarke, Stephen J.; Wheeler, Helen R.; Diakos, Connie, I; Howell, Viive M.			Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model	PLOS ONE			English	Article							EXPERIMENTAL BRAIN-TUMORS; REGULATORY T-CELLS; IN-VIVO MODELS; MOUSE MODELS; MECHANISMS; EXPRESSION; MICROGLIA; ANTI-PD-1; GROWTH	Glioblastoma, the most aggressive form of glioma, has a 5-year survival rate of <5%. While radiation and immunotherapies are routinely studied in the murine Gl261 glioma model, little is known about its inherent immune response. This study quantifies the temporal and spatial localization of immune cell populations and mediators during glioma development. Eightweek old male C57Bl/6 mice were orthotopically inoculated with 1x10(6) Gl261 cells and tumor morphology, local and systemic immune cell populations, and plasma cytokines/chemokines assessed at day 0, 1, 3, 7, 14, and 21 post-inoculation by magnetic resonance imaging, chromogenic immunohistochemistry, multiplex immunofluorescent immunohistochemistry, flow cytometry and multiplex immunoassay respectively. From day 3 tumors were distinguishable with >30% Ki67 and increased tissue vascularization (p<0.05). Increasing tumor proliferation/malignancy and vascularization were associated with significant temporal changes in immune cell populations within the tumor (p< 0.05) and systemic compartments (p = 0.02 to p< 0.0001). Of note, at day 14 16/24 plasma cytokine/chemokines levels decreased coinciding with an increase in tumor cytotoxic T cells, natural killer and natural killer/T cells. Data derived provide baseline characterization of the local and systemic immune response during glioma development. They reveal that type II macrophages and myeloid-derived suppressor cells are more prevalent in tumors than regulatory T cells, highlighting these cell types for further therapeutic exploration.	[McKelvey, Kelly J.; Hudson, Amanda L.; Kumar, Ramyashree Prasanna; Clarke, Stephen J.; Wheeler, Helen R.; Diakos, Connie, I; Howell, Viive M.] Univ Sydney, Northern Clin Sch, Kolling Inst, Bill Walsh Translat Canc Res Lab, St Leonards, NSW, Australia; [McKelvey, Kelly J.; Hudson, Amanda L.; Kumar, Ramyashree Prasanna; Clarke, Stephen J.; Wheeler, Helen R.; Diakos, Connie, I; Howell, Viive M.] Northern Sydney Local Hlth Dist, St Leonards, NSW, Australia; [McKelvey, Kelly J.; Hudson, Amanda L.; Kumar, Ramyashree Prasanna; Clarke, Stephen J.; Wheeler, Helen R.; Diakos, Connie, I; Howell, Viive M.] Royal North Shore Hosp, Sydney Vital Translat Res Ctr, St Leonards, NSW, Australia; [McKelvey, Kelly J.; Hudson, Amanda L.; Wheeler, Helen R.; Howell, Viive M.] Brain Canc Grp, St Leonards, NSW, Australia; [Wilmott, James S.; Attrill, Grace H.; Long, Georgina, V; Scolyer, Richard A.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia; [Wilmott, James S.; Attrill, Grace H.; Long, Georgina, V; Scolyer, Richard A.] Univ Sydney, Charles Perkins Ctr, Camperdown, NSW, Australia; [Long, Georgina, V; Clarke, Stephen J.; Wheeler, Helen R.; Diakos, Connie, I] Royal North Shore Hosp, Northern Sydney Canc Ctr, St Leonards, NSW, Australia; [Long, Georgina, V] Mater Hosp, Sydney, NSW, Australia; [Scolyer, Richard A.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Scolyer, Richard A.] New South Wales Hlth Pathol, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; Melanoma Institute Australia; University of Sydney; University of Sydney; Royal North Shore Hospital; University of Sydney	McKelvey, KJ (corresponding author), Univ Sydney, Northern Clin Sch, Kolling Inst, Bill Walsh Translat Canc Res Lab, St Leonards, NSW, Australia.; McKelvey, KJ (corresponding author), Northern Sydney Local Hlth Dist, St Leonards, NSW, Australia.; McKelvey, KJ (corresponding author), Royal North Shore Hosp, Sydney Vital Translat Res Ctr, St Leonards, NSW, Australia.; McKelvey, KJ (corresponding author), Brain Canc Grp, St Leonards, NSW, Australia.	kelly.mckelvey@sydney.edu.au	Wilmott, James/AGA-8227-2022; Scolyer, Richard/AAE-8511-2019; Long, Georgina/C-1771-2013	Wilmott, James/0000-0002-6750-5244; Prasanna Kumar, Ramyashree/0000-0003-0495-0225; Clarke, Stephen/0000-0001-5817-1222; Scolyer, Richard/0000-0002-8991-0013; Attrill, Grace/0000-0001-8926-6582; Long, Georgina/0000-0001-8894-3545; McKelvey, Kelly/0000-0002-4923-791X	Matt Callander `Beanie for Brain Cancer' HMRI Fellowship - Mark Hughes Foundation; Brain Cancer Group Fellowship; Mark Hughes Foundation; Brain Cancer Group; Sydney Vital Translational Research Centre; James N Kirby Foundation; Goodridge Foundation	Matt Callander `Beanie for Brain Cancer' HMRI Fellowship - Mark Hughes Foundation; Brain Cancer Group Fellowship; Mark Hughes Foundation; Brain Cancer Group; Sydney Vital Translational Research Centre; James N Kirby Foundation; Goodridge Foundation	KM is supported by the Matt Callander `Beanie for Brain Cancer' HMRI Fellowship funded by the Mark Hughes Foundation (https://markhughesfoundation.com.au/)and AH by The Brain Cancer Group Fellowship (https://braincancergroup.com.au/).The project was supported by project grants from The Mark Hughes Foundation, The Brain Cancer Group, and Sydney Vital Translational Research Centre (https://www.sydneyvital.org.au/).Purchase of the VECTRA3 microscope was supported by The James N Kirby Foundation (https://www.kirbyfoundation.com.au/) and The Goodridge Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, R LANG ENV STAT COMP; Australian Institute of Health and Welfare (AIHW), 2017, BRAIN OTH CENTR NERV; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bhatia A, 2011, CANCER MICROENVIRON, V4, P209, DOI 10.1007/s12307-011-0065-8; Brown NF, 2018, BRIT J CANCER, V119, P1171, DOI 10.1038/s41416-018-0258-8; Bruger P., 2002, SURG PATHOLOGY NERVO, P405; Chandramohan V., 2017, TRANSLATIONAL IMMUNO, P111; Chang AL, 2016, CANCER RES, V76, P5671, DOI 10.1158/0008-5472.CAN-16-0144; Chen L, 2013, BBA-REV CANCER, V1836, P158, DOI 10.1016/j.bbcan.2013.04.003; Chen ZH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01004; Cho A, 2018, MAMM GENOME, V29, P806, DOI 10.1007/s00335-018-9761-8; Chongsathidkiet P, 2018, NAT MED, V24, P1459, DOI 10.1038/s41591-018-0135-2; Cuoco JA, 2018, WORLD NEUROSURG, V120, P302, DOI 10.1016/j.wneu.2018.08.202; DEANE BR, 1981, J NEUROL SCI, V49, P55, DOI 10.1016/0022-510X(81)90188-X; Doblas S, 2010, J MAGN RESON IMAGING, V32, P267, DOI 10.1002/jmri.22263; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Galban S, 2017, TOMOGRAPHY, V3, P9, DOI 10.18383/j.tom.2017.00112; Han Seunggu J, 2015, Neurosurgery, V62 Suppl 1, P160, DOI 10.1227/NEU.0000000000000801; Herting CJ, 2017, GLIA, V65, P1914, DOI 10.1002/glia.23203; Hudson AL, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00314; Huszthy PC, 2012, NEURO-ONCOLOGY, V14, P979, DOI 10.1093/neuonc/nos135; Karachi A, 2018, NEURO-ONCOLOGY, V20, P1566, DOI 10.1093/neuonc/noy072; Kim JE, 2017, CLIN CANCER RES, V23, P124, DOI 10.1158/1078-0432.CCR-15-1535; Kucheryavykh LY, 2012, BIOTECHNIQUES, V53, P305, DOI 10.2144/000113940; Ladomersky E, 2018, CLIN CANCER RES, V24, P2559, DOI 10.1158/1078-0432.CCR-17-3573; Lee CR, 2016, CELL REP, V17, P3219, DOI 10.1016/j.celrep.2016.11.062; Liau LM, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1507-6; Martikainen M, 2019, CANCERS, V11, DOI 10.3390/cancers11020186; Mathivet T, 2017, EMBO MOL MED, V9, P1629, DOI 10.15252/emmm.201607445; McKelvey KJ, 2018, MAMM GENOME, V29, P843, DOI 10.1007/s00335-018-9777-0; Newcomb EW, 2009, CNS CANC MODELS MARK, V12, P227, DOI DOI 10.1007/978-1-60327-553-8; Parker NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep22477; Reyes-Aldasoro CC, 2011, J MICROSC-OXFORD, V242, P262, DOI 10.1111/j.1365-2818.2010.03464.x; Rhle PF, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00296; Satoh J, 2016, NEUROPATHOLOGY, V36, P39, DOI 10.1111/neup.12235; SHAPIRO WR, 1970, CANCER RES, V30, P2401; Shurin GV, 2013, CANCER MICROENVIRON, V6, P159, DOI 10.1007/s12307-013-0133-3; Simeonova I, 2014, CELL MOL LIFE SCI, V71, P4007, DOI 10.1007/s00018-014-1675-3; Skuljec J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02458; Szatmari T, 2006, CANCER SCI, V97, P546, DOI 10.1111/j.1349-7006.2006.00208.x; Wick W, 2014, NAT REV NEUROL, V10, P372, DOI 10.1038/nrneurol.2014.100; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zagzag D, 2003, BRAIN PATHOL, V13, P34; Zagzag D, 2000, LAB INVEST, V80, P837, DOI 10.1038/labinvest.3780088; Zagzag D, 2008, AM J PATHOL, V173, P545, DOI 10.2353/ajpath.2008.071197; Zeng J, 2013, INT J RADIAT ONCOL, V86, P343, DOI 10.1016/j.ijrobp.2012.12.025; Zhang J, 2007, AAPS PHARMSCITECH, V8	47	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0226444	10.1371/journal.pone.0226444	http://dx.doi.org/10.1371/journal.pone.0226444			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240177	Green Submitted, gold, Green Published			2022-12-26	WOS:000535945000007
J	Morillon, AC; Williamson, RD; Baker, PN; Kell, DB; Kenny, LC; English, JA; McCarthy, FP; McCarthy, C				Morillon, Aude-Claire; Williamson, Rachel D.; Baker, Philip N.; Kell, Douglas B.; Kenny, Louise C.; English, Jane A.; McCarthy, Fergus P.; McCarthy, Cathal			Effect of L-Ergothioneine on the metabolic plasma profile of the RUPP rat model of pre-eclampsia	PLOS ONE			English	Article							REDUCED UTERINE PERFUSION; OXIDATIVE STRESS; DYSFUNCTION; DISCOVERY; DISEASE; DAMAGE; URINE; LIVER; SERUM	Introduction Pre-eclampsia is a major cause of maternal and fetal mortality and morbidity worldwide. Its pathophysiology remains unclear, but mitochondrial dysfunction and oxidative stress have been implicated. L-Ergothioneine is a naturally occurring, water-soluble betaine, that has demonstrated antioxidant properties. Using the reduced uterine perfusion pressure (RUPP) rat model of pre-eclampsia, this study aimed to define the plasma metabolic profile following treatment with L-Ergothioneine. Methods The effect of L-Ergothioneine (ET) treatment was explored using in vivo treatment in rats: Sham control (SC, n = 5), RUPP control (RC, n = 5), Sham +ET (ST, n = 5), RUPP +ET (RT, n = 5). Differential expression of plasma metabolites were obtained using untargeted liquid chromatography coupled to mass spectrometry. Statistical analysis was performed on normalised data comparing RC to SC, RT to RC, and RT to ST. Metabolites significantly altered (FDR < 0.05) were identified through database search. Results We report significantly lower levels of L-palmitoylcarnitine in RC compared to SC, a fatty acyl substrate involved in beta-oxidation in the mitochondria. We report that a metabolite that has been associated with oxidative stress (Glutamylcysteine) was detected at significantly higher levels in RT vs RC and RT vs ST. Five metabolites associated with inflammation were significantly lower in RT vs RC and three metabolites in RT vs ST, demonstrating the anti-inflammatory effects of ET in the RUPP rat model of pre-eclampsia. Conclusions L-Ergothioneine may help preserve mitochondrial function by increasing antioxidant levels, and reducing inflammatory responses associated with pre-eclampsia. This study shows the potential of L-Ergothioneine as a treatment for pre-eclampsia.	[Morillon, Aude-Claire; Williamson, Rachel D.; English, Jane A.; McCarthy, Fergus P.] INFANT Res Ctr, Cork, Ireland; [Morillon, Aude-Claire; McCarthy, Fergus P.] Univ Coll Cork, Dept Obstet & Gynecol, Cork, Ireland; [Baker, Philip N.] Univ Leicester, Coll Life Sci, Leicester, Leics, England; [Kell, Douglas B.] Univ Liverpool, Fac Hlth & Life Sci, Inst Integrat Biol, Dept Biochem, Crown St, Liverpool, Merseyside, England; [Kell, Douglas B.] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, Lyngby, Denmark; [Kenny, Louise C.] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England; [English, Jane A.] Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland; [McCarthy, Cathal] Univ Coll Cork, Dept Pharmacol & Therapeut, Cork, Ireland	University College Cork; University of Leicester; University of Liverpool; Novo Nordisk Foundation; Technical University of Denmark; University of Liverpool; University College Cork; University College Cork	Morillon, AC (corresponding author), INFANT Res Ctr, Cork, Ireland.; Morillon, AC (corresponding author), Univ Coll Cork, Dept Obstet & Gynecol, Cork, Ireland.	morillon.ac@gmail.com	; Kenny, Louise/G-1112-2011	Morillon, Aude-Claire/0000-0002-9692-9396; Kenny, Louise/0000-0002-9011-759X	Science Foundation Ireland [12/RC/2272]; Health Research Board Ireland [HRA-POR-2015-1240, HRB EIA-2017-023]; BBSRC; Novo Nordisk Foundation [NNF10CC1016517]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board Ireland; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	ACM was funded by a Science Foundation IrelanDd (https://www.sfi.ie/) (12/RC/2272), and CM and RDW are funded through Health Research Board Ireland (https://www.hrb.ie/), (HRA-POR-2015-1240). JAE is funded by Health Research Board Ireland HRB EIA-2017-023. DBK thanks the BBSRC and the Novo Nordisk Foundation (https://novonordiskfonden.dk/en/) grant NNF10CC1016517) for financial support. Waters Corporation provided access to mass spectrometry instrumentation (https://www.waters.com/nextgen/us/en.html?locale=en_GB).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EJ, 2016, PROG LIPID RES, V64, P30, DOI 10.1016/j.plipres.2016.07.002; Bateman RH, 2002, J AM SOC MASS SPECTR, V13, P792, DOI 10.1016/S1044-0305(02)00420-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Borodina I KL, 2019, NUTR RES REV; Broadhurst D, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1367-3; Brown JM, 2015, ANNU REV MED, V66, P343, DOI 10.1146/annurev-med-060513-093205; Brown MA, 2018, PREGNANCY HYPERTENS, V13, P291, DOI 10.1016/j.preghy.2018.05.004; Cai H, 2012, CURR ALZHEIMER RES, V9, P5, DOI 10.2174/156720512799015064; Cheah IK, 2017, ANTIOXID REDOX SIGN, V26, P193, DOI 10.1089/ars.2016.6778; Cheah IK, 2016, FREE RADICAL RES, V50, P14, DOI 10.3109/10715762.2015.1099642; Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017; Deiana M, 2004, CLIN NUTR, V23, P183, DOI 10.1016/S0261-5614(03)00108-0; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Forster R, 2015, FOOD CHEM TOXICOL, V80, P85, DOI 10.1016/j.fct.2015.02.019; Frolkis A, 2010, NUCLEIC ACIDS RES, V38, pD480, DOI 10.1093/nar/gkp1002; Funke C, 2013, NEUROCHEM INT, V62, P637, DOI 10.1016/j.neuint.2012.11.015; Graham SF, 2017, J PERINATOL, V37, P91, DOI 10.1038/jp.2016.139; Granger JP, 2006, METH MOLEC MED, V122, P383; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; Halliwell B, 2018, FEBS LETT, V592, P3357, DOI 10.1002/1873-3468.13123; Horgan RP, 2011, J PROTEOME RES, V10, P3660, DOI 10.1021/pr2002897; KAWANO H, 1982, CHEM PHARM BULL, V30, P1760; Kell DB, 2016, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00060; Kenny LC, 2018, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00239; Matsubara K, 2015, INT J MOL SCI, V16, P4600, DOI 10.3390/ijms16034600; McCarthy C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32683; McCarthy FP, 2011, HYPERTENSION, V58, P280, DOI 10.1161/HYPERTENSIONAHA.111.172627; Moher D., 2009, ANN INTERN MED, V6, DOI [DOI 10.18632/aging.103000, 10.1371/journal.pmed.100009]; Picca A, 2019, EXP GERONTOL, V126, DOI 10.1016/j.exger.2019.110692; R Core Team, 2021, R LANGUAGE ENV STAT; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Redman CWG, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.003; Sakrak O, 2008, J SURG RES, V144, P36, DOI 10.1016/j.jss.2007.04.020; Salek RM, 2013, GIGASCIENCE, V2, DOI [10.1186/2047-217X-2-13, 10.1186/2047-217X-2-8]; Sanchez-Aranguren LC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00372; Schloerke B., 2011, GGALLY EXTENSION GGP; Schonfeld P, 2010, BBA-BIOENERGETICS, V1797, P929, DOI 10.1016/j.bbabio.2010.01.010; Sedeek M, 2008, AM J HYPERTENS, V21, P1152, DOI 10.1038/ajh.2008.239; Shaw W, 2010, NUTR NEUROSCI, V13, P135, DOI 10.1179/147683010X12611460763968; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Smith E, 2019, HEART; Tang RMY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20021-z; Tanret C, 1909, CR HEBD ACAD SCI, V149, P222; Underwood BR, 2006, BRAIN, V129, P877, DOI 10.1093/brain/awl027; Vaka VR, 2018, HYPERTENSION, V72, P703, DOI 10.1161/HYPERTENSIONAHA.118.11290; VAVICH JM, 1970, CLIN CHEM, V16, P702; Wickham H, 2011, WIRES COMPUT STAT, V3, P180, DOI 10.1002/wics.147; Williamson RD, 2020, HYPERTENSION, V75, P561, DOI 10.1161/HYPERTENSIONAHA.119.13929; Williamson RD, 2018, PREGNANCY HYPERTENS, V13, P248, DOI 10.1016/j.preghy.2018.06.012; Williamson RD, 2017, OXIDATIVE STRESS PRE; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Wishart DS, 2016, NAT REV DRUG DISCOV, V15, P473, DOI 10.1038/nrd.2016.32; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489	54	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230977	10.1371/journal.pone.0230977	http://dx.doi.org/10.1371/journal.pone.0230977			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HO	32231385	Green Published, gold			2022-12-26	WOS:000535937400023
J	Gheibi, N; Ghorbani, M; Shariatifar, H; Farasat, A				Gheibi, Nematollah; Ghorbani, Mohamad; Shariatifar, Hanifeh; Farasat, Alireza			Effects of unsaturated fatty acids (Arachidonic/Oleic Acids) on stability and structural properties of Calprotectin using molecular docking and molecular dynamics simulation approach	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; BINDING PROTEIN; S100 PROTEINS; ASSOCIATION; CALCIUM	Calprotectin is a heterodimeric protein complex with two subunits called S100A8/A9. The protein has an essential role in inflammation process and various human diseases. It has the ability to bind to unsaturated fatty acids including Arachidonic acid, Oleic acid and etc., which could be considered as a major carrier for fatty acids. In this study we aimed to appraise the thermodynamics and structural changes of Calprotectin in presence of Arachidonic acid/Oleic acid) using docking and molecular dynami simulation method. To create the best conformation of Calprotectin-Oleic acid/Arachidonic acid complexes, the docking process was performed. The complexes with the best binding energy were selected as the models for molecular dynamics simulation process. Furthermore, the structural and thermodynamics properties of the complexes were evaluated too. The Root Mean Square Deviation and Root Mean Square Fluctuation results showed that the binding of Arachidonic acid/Oleic acid to Calprotectin can cause the protein structural changes which was confirmed by Define Secondary Structure of Proteins results. Accordingly, the binding free energy results verified that binding of Oleic acid to Calprotectin leads to instability of S100A8/A9 subunits in the protein. Moreover, the electrostatic energy contribution of the complexes (Calprotectin-Oleic acid/Arachidonic acid) was remarkably higher than van der Waals energy. Thus, the outcome of this study confirm that Oleic acid has a stronger interaction with Calprotectin in comparison with Arachidonic acid. Our findings indicated that binding of unsaturated fatty acids to Calprotectin leads to structural changes of the S100A8/A9 subunits which could be beneficial to play a biological role in inflammation process.	[Gheibi, Nematollah; Farasat, Alireza] Qazvin Univ Med Sci, Res Inst Prevent Non Communicable Dis, Cellular & Mol Res Ctr, Qazvin, Iran; [Ghorbani, Mohamad] Tarbiat Modares Univ, Fac Biol Sci, Dept Nanobiotechnol Biophys, Tehran, Iran; [Shariatifar, Hanifeh] Islamic Azad Univ, Young Researchers & Elite Club, Tehran Med Sci, Tehran, Iran	Qazvin University of Medical Sciences (QUMS); Tarbiat Modares University; Islamic Azad University	Farasat, A (corresponding author), Qazvin Univ Med Sci, Res Inst Prevent Non Communicable Dis, Cellular & Mol Res Ctr, Qazvin, Iran.	a.farasat@qums.ac.ir	Farasat, Alireza/AGO-3954-2022		Research Council of Qazvin University of Medical Sciences	Research Council of Qazvin University of Medical Sciences	The authors appreciate the Research Council of Qazvin University of Medical Sciences.	Akya A, 2019, INFECT GENET EVOL, V75, DOI 10.1016/j.meegid.2019.103953; Asghari H, 2016, INT J BIOL MACROMOL, V84, P35, DOI 10.1016/j.ijbiomac.2015.11.065; Bagherzadeh K, 2015, J BIOMOL STRUCT DYN, V33, P487, DOI 10.1080/07391102.2014.893203; Baker TM, 2017, CHEM SCI, V8, P1369, DOI 10.1039/c6sc03487j; Batoulis H, 2016, SCI REP-UK, V6, DOI 10.1038/srep24131; Bu WM, 2012, FASEB J, V26, P2394, DOI 10.1096/fj.11-198853; Capaldi S, 2006, PROTEINS, V64, P79, DOI 10.1002/prot.20961; Champaiboon C, 2009, J BIOL CHEM, V284, P7078, DOI 10.1074/jbc.M806605200; Chang CC, 2016, BBA-PROTEINS PROTEOM, V1864, P1558, DOI 10.1016/j.bbapap.2016.08.008; Chen JZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36900; Dhas DBB, 2012, CURRENT PEDIAT RES, V16; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Farasat A, 2017, J BIOMOL STRUCT DYN, V35, P1710, DOI 10.1080/07391102.2016.1192065; Fukunaga S, 2018, INT J MOL MED, V41, P107, DOI 10.3892/ijmm.2017.3244; Reis RAG, 2014, J BIOL INORG CHEM, V19, P1113, DOI 10.1007/s00775-014-1149-y; Heilmann RM, 2018, J VET INTERN MED, V32, P679, DOI 10.1111/jvim.15065; Herrera Oscar R, 2016, J Pediatr Pharmacol Ther, V21, P308; Kerkhoff C, 1999, J BIOL CHEM, V274, P32672, DOI 10.1074/jbc.274.46.32672; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Kufareva Irina, 2012, Methods Mol Biol, V857, P231, DOI 10.1007/978-1-61779-588-6_10; Kumar A, 2019, J BIOMOL STRUCT DYN, V37, P275, DOI 10.1080/07391102.2018.1426043; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lim SY, 2009, J LEUKOCYTE BIOL, V86, P577, DOI 10.1189/jlb.1008608; Lin HL, 2016, BMC STRUCT BIOL, V16, DOI 10.1186/s12900-016-0058-4; Mahapatra MK, 2018, J BIOMOL STRUCT DYN, V36, P1195, DOI 10.1080/07391102.2017.1317026; Mallamace D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123825; Manolakis AC, 2011, DIGEST DIS SCI, V56, P1601, DOI 10.1007/s10620-010-1494-9; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mudedla SK, 2015, PHYS CHEM CHEM PHYS, V17, P30307, DOI 10.1039/c5cp05034k; Ochoa R, 2018, PHYS CHEM CHEM PHYS, V20, P25901, DOI 10.1039/c8cp03826k; Ometto F, 2017, EXP BIOL MED, V242, P859, DOI 10.1177/1535370216681551; Pepper RJ, 2015, AM J PATHOL, V185, P1264, DOI 10.1016/j.ajpath.2015.01.015; Robb CT, 2016, SEMIN IMMUNOPATHOL, V38, P425, DOI 10.1007/s00281-016-0560-6; Ruse M, 2003, J INVEST DERMATOL, V121, P132, DOI 10.1046/j.1523-1747.2003.12309.x; Shabani F, 2018, INFLAMM RES, V67, P801, DOI 10.1007/s00011-018-1173-4; Shen ML, 2012, J BIOMOL STRUCT DYN, V30, P652, DOI 10.1080/07391102.2012.689698; Shirley SH, 2014, J SKIN CANCER, V2014, DOI 10.1155/2014/846249; Simopoulos AP, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030128; Tardif MR, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/296149; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Van Hoovels L, 2017, J LAB PRECISION MED, V2; Verma S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149014; Wang TQ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153683; Wu SJ, 2016, TOXINS, V8, DOI 10.3390/toxins8070176; Yousefi R, 2007, ACTA BIOCH BIOPH SIN, V39, P795, DOI 10.1111/j.1745-7270.2007.00343.x; Zhu QL, 2017, ONCOTARGET, V8, P37342, DOI 10.18632/oncotarget.16954	47	7	9	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230780	10.1371/journal.pone.0230780	http://dx.doi.org/10.1371/journal.pone.0230780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214349	Green Published, gold, Green Accepted			2022-12-26	WOS:000535934200058
J	Yilgwan, CS; Pam, VC; Ige, OO; Golit, WN; Anzaku, S; Imade, GE; Yilgwan, G; Mutihir, JT; Sagay, AS; Odili, A; Zoakah, AI; Bode-Thomas, F; Simon, MA				Yilgwan, Christopher S.; Pam, Victor C.; Ige, Olukemi O.; Golit, Williams N.; Anzaku, Stephen; Imade, Godwin E.; Yilgwan, Gavou; Mutihir, Josiah T.; Sagay, Atiene S.; Odili, Augustine; Zoakah, Ayuba I.; Bode-Thomas, Fidelia; Simon, Melissa A.			Profile of congenital heart disease in infants born following exposure to preeclampsia	PLOS ONE			English	Article							ANGIOGENIC IMBALANCE; GROWTH STANDARDS; GLOBAL BURDEN; DEFECTS; FETAL; ASSOCIATION; CHILD	Background Events in pregnancy play an important role in predisposing the newborn to the risk of developing CHD. This study evaluated the association between maternal preeclampsia and her offspring risk of CHD. Methods This is a cohort study of 90 sex-matched neonates (45 each born to women with preeclampsia and normal pregnancy) in Jos, Nigeria. Anthropometry was taken shortly after delivery using standard protocols. Echocardiography was performed within 24 hours of life and repeated 7 and 28 days later. SPSS version 25 was used in all analyses. Statistical significance was set at p<0.05. Results Congenital heart disease (CHD) was observed in 27 (30.0%) of newborns of women with preeclampsia compared with 11 (12.1%) of newborns without preeclampsia (p<0.001) at the end of 7 days and in 19 (21.1%) of newborns of women with preeclampsia and 3 (3.3%) of newborns of women without preeclampsia by the end of the 4th week of life (p<0.001). Overall, ASD (4 newborns), PDA (21 newborns), patent foramen ovale (14 newborns) and VSD (2 newborns) were the prevalent lesions found among all the newborns studied in the first week of life. Isolated atrial and ventricular septal defects were seen in 4 (4.4%) of the newborns of women with preeclampsia. Being the infant of a woman with preeclampsia was associated with about 8-fold increased risk of having CHD (OR = 7.9, 95% CI = 2.5-24.9, p<0.001). Conclusion CHD may be more common in newborns of women with preeclampsia underscoring the need for fetal and newborn screening for CHD in women with preeclampsia so as to improve their infant's well being.	[Yilgwan, Christopher S.; Ige, Olukemi O.; Bode-Thomas, Fidelia] Univ Jos, Dept Paediat, Jos, Nigeria; [Pam, Victor C.; Imade, Godwin E.; Mutihir, Josiah T.; Sagay, Atiene S.] Univ Jos, Dept Obstet & Gynaecol, Jos, Nigeria; [Golit, Williams N.] Plateau Specialist Hosp, Dept Obstet & Gynaecol, Jos, Nigeria; [Anzaku, Stephen] Bingham Univ, Dept Obstet & Gynaecol, Karu Lga, Nigeria; [Yilgwan, Gavou] Univ Jos, Dept Human Physiol, Jos, Nigeria; [Odili, Augustine; Zoakah, Ayuba I.] Univ Abuja, Dept Internal Med, Abuja, Nigeria; [Simon, Melissa A.] Univ Jos, Dept Community Med, Jos, Nigeria; [Simon, Melissa A.] Northwestern Univ, Dept Obstet & Gynecol, Chicago, IL 60611 USA	University of Jos; University of Jos; University of Jos; University of Jos; Northwestern University	Yilgwan, CS (corresponding author), Univ Jos, Dept Paediat, Jos, Nigeria.	yilgwan@hotmail.com	Yilgwan, Christopher/DJC-9032-2022	Yilgwan, Christopher/0000-0003-4741-7009; Odili, Augustine/0000-0002-4564-1587; Zoakah, Ayuba/0000-0003-1856-7753	STAMINA grant [D43TW010130]	STAMINA grant	CSY, VCP and OOI received mentorship training grant from STAMINA D43TW010130 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger N, 2016, CAN J CARDIOL, V32, DOI 10.1016/j.cjca.2015.12.011; Auger N, 2015, JAMA-J AM MED ASSOC, V314, P1588, DOI 10.1001/jama.2015.12505; Auger N, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-67; Botto LD., 2015, MOSS ADAMSHEART DIS, V1, P28; Boyd HA, 2017, CIRCULATION, V136, P39, DOI 10.1161/CIRCULATIONAHA.116.024600; Brodwall K, 2016, PAEDIATR PERINAT EP, V30, P76, DOI 10.1111/ppe.12252; Cheitlin MD, 2003, ACC AHA ASE 2003 GUI; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; George D., 2020, IBM SPSS STAT 25 STE, V16th Edn, DOI 10.4324/9780429056765; Ismail LC, 2013, BJOG-INT J OBSTET GY, V120, P42, DOI 10.1111/1471-0528.12125; Liu SL, 2013, CIRCULATION, V128, P583, DOI 10.1161/CIRCULATIONAHA.112.001054; Llurba E, 2014, EUR HEART J, V35, P701, DOI 10.1093/eurheartj/eht389; MOHER D, 2009, LANCET, V339, DOI DOI 10.1136/BMJ.B2535; Musa NL, 2017, CARDIOL YOUNG, V27, pS3, DOI 10.1017/S1047951117002530; Myatt L, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0595-4; Oster ME, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4573; Sabzevari Sakinne, 2016, Int J Community Based Nurs Midwifery, V4, P374; Sanchez O, 2016, FETAL DIAGN THER, V40, P21, DOI 10.1159/000441356; Shih T, 2016, AM J PERINAT, V33, P329, DOI 10.1055/s-0035-1564881; Simeone RM, 2015, MMWR-MORBID MORTAL W, V64, P1104, DOI 10.15585/mmwr.mm6439a3; Sircar M, 2015, CURR OPIN NEPHROL HY, V24, P131, DOI 10.1097/MNH.0000000000000105; Sliwa K, 2014, EUR HEART J, V35, P680, DOI 10.1093/eurheartj/eht485; Ying W, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009382; Zimmerman M, 2017, CIRCULATION, V136	24	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0229987	10.1371/journal.pone.0229987	http://dx.doi.org/10.1371/journal.pone.0229987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214332	Green Published, gold			2022-12-26	WOS:000535934200014
J	Buranello, PAA; Barbosa-Lorenzi, VC; Pinto, MR; Pereira-da-Silva, G; Barreira, MCRA; Jamur, MC; Oliver, C				Buranello, Patricia A. A.; Barbosa-Lorenzi, Valeria C.; Pinto, Marcelo R.; Pereira-da-Silva, Gabriela; Barreira, Maria Cristina R. A.; Jamur, Maria Celia; Oliver, Constance			The lectin ArtinM activates RBL-2H3 mast cells without inducing degranulation	PLOS ONE			English	Article							NF-KAPPA-B; PARACOCCIDIOIDES-BRASILIENSIS INFECTION; MONOCLONAL-ANTIBODY AA4; FC-EPSILON-RI; ARTOCARPUS-INTEGRIFOLIA; LEUKEMIA-CELLS; CYTOKINE PRODUCTION; HIGH-AFFINITY; TNF-ALPHA; IGE	Mast cells are connective tissue resident cells with morphological and functional characteristics that contribute to their role in allergic and inflammatory processes, host defense and maintenance of tissue homeostasis. Mast cell activation results in the release of pro-inflammatory mediators which are largely responsible for the physiological functions of mast cells. The lectin ArtinM, extracted from Artocarpus heterophyllus (jackfruit), binds to D-manose, thus inducing degranulation of mast cells. ArtinM has several immunomodulatory properties including acceleration of wound healing, and induction of cytokine release. The aim of the present study was to investigate the role of ArtinM in the activation and proliferation of mast cells. The rat mast cell line RBL-2H3 was used throughout this study. At a low concentration (0.25 mu g/mL), ArtinM induced mast cell activation and the release of IL-6 without stimulating the release of pre-formed or newly formed mediators. Additionally, when the cells were activated by ArtinM protein tyrosine phosphorylation was stimulated. The low concentration of ArtinM also activated the transcription factor NFkB, but not NFAT. ArtinM also affected the cell cycle and stimulated cell proliferation. Therefore, ArtinM may have therapeutic applications by modulating immune responses due to its ability to activate mast cells and promote the release of newly synthesized mediators. Additionally, ArtinM could have beneficial effects at low concentrations without degranulating mast cells and inducing allergic reactions.	[Buranello, Patricia A. A.; Barbosa-Lorenzi, Valeria C.; Pinto, Marcelo R.; Barreira, Maria Cristina R. A.; Jamur, Maria Celia; Oliver, Constance] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol & Pathogen Bioagents, Ribeirao Preto, SP, Brazil; [Pereira-da-Silva, Gabriela] Univ Sao Paulo, Dept Maternal Infant Nursing & Publ Hlth, Escola Enfermagem Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Buranello, Patricia A. A.] Univ Fed Triangulo Mineiro, Dept Biol Sci, Uberaba, MG, Brazil; [Pinto, Marcelo R.] Univ Uberaba, Lab Biopathol & Mol Biol, Uberaba, MG, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Triangulo Mineiro; Universidade de Uberaba (Uniube)	Oliver, C (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol & Pathogen Bioagents, Ribeirao Preto, SP, Brazil.	coliver@fmrp.usp.br	Buranello, Patrícia/AAY-9749-2020; Pinto, Marcelo Rodrigues/P-5898-2019; Oliver, Constance/L-9904-2017	Buranello, Patrícia/0000-0002-0963-9607; Pinto, Marcelo Rodrigues/0000-0003-4545-1369; Oliver, Constance/0000-0002-8633-4612	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2006/60642-2, 2009/54013-0, 2010/10034-1, 2013/04088-0, 2017/18618-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [305682/2011-3, 304740/2015-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2006/60642-2 to COc 2009/54013-0 to MCJ, CO, 2010/10034-1 to PAAB, 2013/04088-0 MCRB, MCJ, CO; 2017/18618-1 to CO); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (305682/2011-3 to CO; 304740/2015-2 to CO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Maximiano WMA, 2017, J HISTOCHEM CYTOCHEM, V65, P723, DOI 10.1369/0022155417734174; Artuc M, 1999, EXP DERMATOL, V8, P1, DOI 10.1111/j.1600-0625.1999.tb00342.x; Azzolina A, 2003, BBA-MOL CELL RES, V1643, P75, DOI 10.1016/j.bbamcr.2003.09.003; Barbosa-Lorenzi VC, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0161-0; Barbosa-Lorenzi VC, 2011, BIOCHEM BIOPH RES CO, V416, P318, DOI 10.1016/j.bbrc.2011.11.033; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Carvalho EVMM, 2018, LIFE SCI, V207, P152, DOI 10.1016/j.lfs.2018.06.003; Carvalho FC, 2014, BIOSENSORS-BASEL, V4, P358, DOI 10.3390/bios4040358; Chahud F, 2009, INT J EXP PATHOL, V90, P166, DOI 10.1111/j.1365-2613.2008.00626.x; Coltri KC, 2008, AM J PATHOL, V173, P423, DOI 10.2353/ajpath.2008.080126; Coltri KC, 2010, MED MYCOL, V48, P792, DOI 10.3109/13693780903501671; da Silva TA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071400; da Silva TA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07397-0; da Silva TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149721; de Almeida Buranello Patricia Andressa, 2010, PLoS One, V5, pe9776, DOI 10.1371/journal.pone.0009776; de Castro RO, 2012, J BIOL CHEM, V287, P8194, DOI 10.1074/jbc.M111.326850; de Souza LPF, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00164; Freitas EG, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9160540; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gilfillan AM, 2011, CRIT REV IMMUNOL, V31, P475, DOI 10.1615/CritRevImmunol.v31.i6.30; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gonzalez-Espinosa C, 2003, J EXP MED, V197, P1453, DOI 10.1084/jem.20021806; Grodzki ACG, 2009, MOL IMMUNOL, V46, P2539, DOI 10.1016/j.molimm.2009.05.013; Joyce D, 2001, CYTOKINE GROWTH F R, V12, P73, DOI 10.1016/S1359-6101(00)00018-6; Juremalm M, 2005, CHEM IMMUNOL ALLERGY, V87, P130, DOI 10.1159/000087640; Kim YJ, 2013, WOUND REPAIR REGEN, V21, P456, DOI 10.1111/wrr.12041; Klemm S, 2006, IMMUNOBIOLOGY, V211, P815, DOI 10.1016/j.imbio.2006.07.001; Komi DEA, 2020, CLIN REV ALLERG IMMU, V58, P298, DOI 10.1007/s12016-019-08729-w; Kulinski JM, 2016, EUR J PHARMACOL, V778, P56, DOI 10.1016/j.ejphar.2015.02.058; Lavanya V, 2016, GLYCOCONJUGATE J, V33, P877, DOI 10.1007/s10719-016-9725-8; LealBerumen I, 1996, J IMMUNOL, V156, P316; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; da Silva EZM, 2014, J HISTOCHEM CYTOCHEM, V62, P698, DOI 10.1369/0022155414545334; Mariano VS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098512; Marquardt DL, 2000, J ALLERGY CLIN IMMUN, V105, P500, DOI 10.1067/mai.2000.104942; Oliveira-Brito PKM, 2018, MOLECULES, V23, DOI 10.3390/molecules23092339; Matsushima H, 2004, J IMMUNOL, V173, P531, DOI 10.4049/jimmunol.173.1.531; METZGER H, 1986, ANNU REV IMMUNOL, V4, P419, DOI 10.1146/annurev.iy.04.040186.002223; MISQUITH S, 1994, J BIOL CHEM, V269, P30393; Moon TC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00569; Moreno AN, 2003, INT ARCH ALLERGY IMM, V132, P221, DOI 10.1159/000074303; Morita H, 2016, SEMIN IMMUNOPATHOL, V38, P623, DOI 10.1007/s00281-016-0566-0; Mukai K, 2018, IMMUNOL REV, V282, P121, DOI 10.1111/imr.12634; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Ng MFY, 2010, INT WOUND J, V7, P55, DOI 10.1111/j.1742-481X.2009.00651.x; Oliveira AF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184010; OLIVER C, 1992, J CELL BIOL, V116, P635, DOI 10.1083/jcb.116.3.635; Panunto-Castelo A, 2001, GLYCOBIOLOGY, V11, P1035, DOI 10.1093/glycob/11.12.1035; Patel S, 2016, J WOUND CARE, V25, P46, DOI 10.12968/jowc.2016.25.1.46; Peng YD, 2005, J LEUKOCYTE BIOL, V77, P975, DOI 10.1189/jlb.0204115; Pereira-Da-Silva G, 2008, IMMUNOL LETT, V119, P114, DOI 10.1016/j.imlet.2008.06.002; PFEIFFER JR, 1985, J CELL BIOL, V101, P2145, DOI 10.1083/jcb.101.6.2145; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Ricci-Azevedo R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004609; Rivera J, 2006, TRENDS IMMUNOL, V27, P251, DOI 10.1016/j.it.2006.04.001; Rosa JC, 1999, PROTEIN SCI, V8, P13; Ruas LP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00867; SANTOSDEOLIVEIRA R, 1994, J IMMUNOL, V153, P1798; Souza MA, 2013, GLYCOCONJUGATE J, V30, P641, DOI 10.1007/s10719-012-9464-4; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; SWAIM WD, 1994, J BIOL CHEM, V269, P19466; Teixeira CR, 2006, VACCINE, V24, P3001, DOI 10.1016/j.vaccine.2005.11.067; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x; Theoharides TC, 2019, EXPERT REV CLIN IMMU, V15, P639, DOI 10.1080/1744666X.2019.1596800; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Toledo KA, 2009, IMMUNOL LETT, V123, P14, DOI 10.1016/j.imlet.2009.01.009; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Yu YX, 2016, EUR J PHARMACOL, V778, P33, DOI 10.1016/j.ejphar.2015.07.017	70	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230633	10.1371/journal.pone.0230633	http://dx.doi.org/10.1371/journal.pone.0230633			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208440	Green Published, Green Submitted, gold			2022-12-26	WOS:000535305100028
J	Zou, YX; Tang, F; Talbert, JC; Ng, CM				Zou, Yixuan; Tang, Fei; Talbert, Jeffery C.; Ng, Chee M.			Using medical claims database to develop a population disease progression model for leuprorelin-treated subjects with hormone-sensitive prostate cancer	PLOS ONE			English	Article							ANDROGEN DEPRIVATION THERAPY; PROGNOSTIC-FACTORS; CLINICAL-TRIALS; ANTIGEN; INTERMITTENT; SURVIVAL; TESTOSTERONE; SUPPRESSION; RECOMMENDATIONS; CHEMOTHERAPY	Androgen deprivation therapy (ADT) is a widely used treatment for patients with hormone-sensitive prostate cancer (PCa). However, duration of treatment response varies, and most patients eventually experience disease progression despite treatment. Leuprorelin is a luteinizing hormone-releasing hormone (LHRH) agonist, a commonly used form of ADT. Prostate-specific antigen (PSA) is a biomarker for monitoring disease progression and predicting treatment response and survival in PCa. However, time-dependent profile of tumor regression and growth in patients with hormone-sensitive PCa on ADT has never been fully characterized. In this analysis, nationwide medical claims database provided by Humana from 2007 to 2011 was used to construct a population-based disease progression model for patients with hormone-sensitive PCa on leuprorelin. Data were analyzed by nonlinear mixed effects modeling utilizing Monte Carlo Parametric Expectation Maximization (MCPEM) method in NONMEM. Covariate selection was performed using a modified Wald's approximation method with backward elimination (WAM-BE) proposed by our group. 1113 PSA observations from 264 subjects with malignant PCa were used for model development. PSA kinetics were well described by the final covariate model. Model parameters were well estimated, but large between-patient variability was observed. Hemoglobin significantly affected proportion of drug-resistant cells in the original tumor, while baseline PSA and anti-androgen use significantly affected treatment effect on drug-sensitive PCa cells (Ds). Population estimate of Ds was 3.78 x 10(-2) day(-1). Population estimates of growth rates for drug-sensitive (Gs) and drug-resistant PCa cells (G(R)) were 1.96 x 10(-3) and 6.54 x 10(-4) day(-1), corresponding to a PSA doubling time of 354 and 1060 days, respectively. Proportion of the original PCa cells inherently resistant to treatment was estimated to be 1.94%. Application of population-based disease progression model to clinical data allowed characterization of tumor resistant patterns and growth/regression rates that enhances our understanding of how PCa responds to ADT.	[Zou, Yixuan; Tang, Fei; Ng, Chee M.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40506 USA; [Zou, Yixuan] Univ Kentucky, Dept Stat, Lexington, KY USA; [Talbert, Jeffery C.] Univ Kentucky, Coll Pharm, Dept Pharm Practice & Sci, Lexington, KY USA; [Ng, Chee M.] NewRound Pharmaceut Consulting LLC, Foster City, CA 94404 USA	University of Kentucky; University of Kentucky; University of Kentucky	Ng, CM (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40506 USA.; Ng, CM (corresponding author), NewRound Pharmaceut Consulting LLC, Foster City, CA 94404 USA.	cheemng@gmail.com	Tang, Fei/AAD-2400-2020	Tang, Fei/0000-0002-4517-7569; Talbert, Jeffery/0000-0002-4304-5167				Ahmed M, 2013, INT J UROL, V20, P362, DOI 10.1111/iju.12005; Armstrong AJ, 2007, CLIN CANCER RES, V13, P6396, DOI 10.1158/1078-0432.CCR-07-1036; Bauer RJ, 2004, MONTE CARLO PARAMETR; Bauer RJ, 2007, AAPS J, V9, pE60, DOI 10.1208/aapsj0901007; Beal SL, 2001, J PHARMACOKINET PHAR, V28, P481, DOI 10.1023/A:1012299115260; Bergstrand M, 2011, AAPS J, V13, P143, DOI 10.1208/s12248-011-9255-z; Bloem BR, 2018, J PARKINSON DIS, V8, P45, DOI 10.3233/JPD-171277; Boccon-Gibod L, 2007, EUR UROL SUPPL, V6, P829, DOI 10.1016/j.eursup.2007.06.004; Chang SL, 2009, J UROLOGY, V182, P61, DOI [10.1016/j.juro, DOI 10.1016/J.JURO]; Chang SL, 2009, J UROLOGY, V182, P255, DOI 10.1016/j.juro.2009.02.141; CHEN CR, 2014, INT J PHOTOENERGY, V2014, P9, DOI DOI 10.1155/2014/925370.925370; Cook Sarah F, 2016, Curr Pharmacol Rep, V2, P221, DOI 10.1007/s40495-016-0066-x; Crook JM, 2012, NEW ENGL J MED, V367, P895, DOI 10.1056/NEJMoa1201546; Silva FC, 2014, EUR UROL, V66, P232, DOI 10.1016/j.eururo.2013.03.055; Daskivich TJ, 2007, UROLOGY, V70, P527, DOI 10.1016/j.urology.2007.04.035; Dimakakos A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/890697; EMRICH LJ, 1985, CANCER RES, V45, P5173; Fizazi K, 2015, ANN ONCOL, V26, P1660, DOI 10.1093/annonc/mdv245; Gillessen S, 2017, EUR UROL, P002; Giltinan D, 1995, MONOGRAPHS STAT APPL; Halabi S, 2014, J CLIN ONCOL, V32, P671, DOI 10.1200/JCO.2013.52.3696; Han KS, 2015, YONSEI MED J, V56, P368, DOI 10.3349/ymj.2015.56.2.368; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hussain M, 2013, NEW ENGL J MED, V368, P1314, DOI 10.1056/NEJMoa1212299; Ji GJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007823; KELLY WK, 1993, J CLIN ONCOL, V11, P607, DOI 10.1200/JCO.1993.11.4.607; Kongseang C, 2017, PROSTATE INT, V5, P35, DOI 10.1016/j.prnil.2017.01.004; Kowalski KG, 2001, J PHARMACOKINET PHAR, V28, P253, DOI 10.1023/A:1011579109640; Lesko LJ, 2007, CLIN PHARMACOL THER, V81, P807, DOI 10.1038/sj.clpt.6100204; Lilja H, 2008, NAT REV CANCER, V8, P268, DOI 10.1038/nrc2351; Loblaw DA, 2007, J CLIN ONCOL, V25, P1596, DOI 10.1200/JCO.2006.10.1949; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Motheral BR, 1997, CLIN THER, V19, P346, DOI 10.1016/S0149-2918(97)80122-1; Ng CM, 2011, CANCER CHEMOTH PHARM, V67, P985, DOI 10.1007/s00280-010-1393-y; Ng CM, 2010, CANCER CHEMOTH PHARM, V65, P207, DOI 10.1007/s00280-009-1023-8; Ng CM, 2005, J CLIN PHARMACOL, V45, P792, DOI 10.1177/0091270005277075; Ng CM, 2005, PHARM RES-DORDR, V22, P1088, DOI 10.1007/s11095-005-5642-4; PETRYLAK DP, 1992, CANCER, V70, P2870; Pietro Giuliano Di, 2016, Int Neurourol J, V20, pS112; Regis L, 2017, PROSTATE, V77, P114, DOI 10.1002/pros.23256; Scher HI, 1999, J NATL CANCER I, V91, P244, DOI 10.1093/jnci/91.3.244; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Scher HI, 2016, J CLIN ONCOL, V34, P1402, DOI 10.1200/JCO.2015.64.2702; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; Sharifi N, 2013, ENDOCRINOLOGY, V154, P4010, DOI 10.1210/en.2013-1466; Sharifi N, 2010, ENDOCR-RELAT CANCER, V17, pR305, DOI 10.1677/ERC-10-0187; SHEINER LB, 1977, J PHARMACOKINET BIOP, V5, P445, DOI 10.1007/BF01061728; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shevach J, 2019, EUR UROL FOCUS, V5, P125, DOI 10.1016/j.euf.2019.02.006; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smaletz O, 2002, J CLIN ONCOL, V20, P3972, DOI 10.1200/JCO.2002.11.021; Smith MR, 2011, CANCER-AM CANCER SOC, V117, P2077, DOI 10.1002/cncr.25762; Sturgeon CM, 2008, CLIN CHEM, V54, pE11, DOI 10.1373/clinchem.2008.105601; Takizawa I, 2010, PROSTATE, V70, P1395, DOI 10.1002/pros.21174; Tyree PT, 2006, AM J MED QUAL, V21, P269, DOI 10.1177/1062860606288774; Varenhorst E, 2016, CANCER MED-US, V5, P407, DOI 10.1002/cam4.594; Venuto CS, 2016, MOVEMENT DISORD, V31, P947, DOI 10.1002/mds.26644; Vollmer RT, 1999, CLIN CANCER RES, V5, P831; Voth AM, 2017, MATH BIOSCI ENG, V14, P777, DOI 10.3934/mbe.2017043; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; Wallis CJD, 2017, EUR UROL, P055; Wilke D, 2018, PHARMACOTHERAPY, V38, P327, DOI 10.1002/phar.2084; Wilkerson J, 2017, LANCET ONCOL, V18, P143, DOI 10.1016/S1470-2045(16)30633-7; Williams VL, 2018, CANCER MED-US, V7, P2160, DOI 10.1002/cam4.1451; YOUNG CYF, 1992, BIOCHEMISTRY-US, V31, P818, DOI 10.1021/bi00118a026; ZOU YX, 2017, J PHARMACOKINET P S1, V44, pS75	66	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230571	10.1371/journal.pone.0230571	http://dx.doi.org/10.1371/journal.pone.0230571			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208461	Green Published, gold			2022-12-26	WOS:000535305100023
J	Lanner, L; Lindstrom, AK				Lanner, Lars; Lindstrom, Annika Kristina			Incidence of HPV and HPV related dysplasia in elderly women in Sweden	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; NATURAL-HISTORY; CERVICAL-CANCER	Background About one-third of the cervical cancer cases in Sweden occur in women over the age of 60. The primary aim of this study was to analyze the incidence of HPV, and HPV related dysplasia, in elderly women who had an HPV negative test at the age of 60 years or older. Methods From October 2004 to June 2019, 1784 women aged 60-90 years were sampled for an HPV test when attending an outpatient gynecology clinic. Of these women, 827 HPV-negative women had two or more HPV tests at intervals of three months to eleven years (mean 3.2 years). The women with positive results had a repeat HPV test and cytology after 2.5 months on average. Those with a positive repeat HPV test were examined by colposcopy and biopsy. Findings The overall prevalence of HPV was 5.4%, (95%CI 4.4-6.6, 96/1784). The incidence of HPV in the 827 women, who were HPV negative in their first test, was 2.4% (95%CI 1.5-3.8, n = 20). At the repeat test 1.2% remained positive (95%CI 0.6-2.3, n = 10). HPV-related dysplasia diagnosed by histology was found in 1.2% (95%CI 0.6-2.3, n = 10) of the 827 women. CIN2+ was found in 0.5% (95%CI 0.2-1.3, n = 4). In the repeat HPV test 52.6% 10/19) were HPV positive. The time between an HPV negative test and an HPV positive test and CIN2+ was on average 45.5 months (range 10-85 months). The positive predictive value (PPV) for CIN2+ was 20.0% in the first positive HPV test and 40.0% in the repeat HPV test. The women with CIN2+ had normal cytology. No cancer or glandular dysplasia was detected. Interpretation In this study older HPV-negative women were at risk of becoming HPV positive. Among the women who were HPV positive in a repeat test, there was a high risk of dysplasia.	[Lanner, Lars; Lindstrom, Annika Kristina] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Lindstrom, Annika Kristina] Orebro Univ, Fac Med & Hlth, Clin Res Ctr, Orebro, Sweden	Uppsala University; Orebro University	Lindstrom, AK (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.; Lindstrom, AK (corresponding author), Orebro Univ, Fac Med & Hlth, Clin Res Ctr, Orebro, Sweden.	annika.lindstrom@kbh.uu.se	Lindstrom, Annika K./ABB-7829-2020	Lindstrom, Annika K./0000-0002-7407-9642				Aarnio Riina, 2019, Eur J Obstet Gynecol Reprod Biol X, V3, P100042, DOI 10.1016/j.eurox.2019.100042; Beckman N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a279; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; Carpenter AB, 1999, CANCER CYTOPATHOL, V87, P105, DOI 10.1002/(SICI)1097-0142(19990625)87:3<105::AID-CNCR2>3.0.CO;2-Z; Commission E, 2015, HLTH GLANC EUR 2014; Darlin L, 2014, ANTICANCER RES, V34, P5147; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Ernstson A, 2019, ANTICANCER RES, V39, P381, DOI 10.21873/anticanres.13123; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Gilani SM, 2013, ACTA CYTOL, V57, P575, DOI 10.1159/000353769; Gustavsson I, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1216-7; Gustavsson I, 2009, J CLIN VIROL, V46, P112, DOI 10.1016/j.jcv.2009.06.021; Gustavsson I, 2009, J CLIN VIROL, V45, P85, DOI 10.1016/j.jcv.2009.04.012; Heideman DAM, 2011, J CLIN MICROBIOL, V49, P3983, DOI 10.1128/JCM.05552-11; Hermansson RS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189300; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Korostil IA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-312; Kulmala SM, 2004, J CLIN MICROBIOL, V42, P2470, DOI 10.1128/JCM.42.6.2470-2475.2004; Lindstrom AK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207714; Richart R M, 1973, Pathol Annu, V8, P301; Rissel C, 2014, SEX HEALTH, V11, P416, DOI 10.1071/SH14105; Socialstyrelsen, 2015, STAND INF PREV REPR, P1; SOLOMAN D, 1989, DIAGN CYTOPATHOL, V5, P331, DOI [10.1002/dc.2840050318, DOI 10.1002/DC.2840050318, DOI 10.1002/dc.2840050318]; Strander B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7361; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; The Board of Health and Welfare CfE, 2013, CAUS OF DEATH, P277; The Board of Health and Welfare CfE, 2014, CANC INC SWED; Tranbaloc P, 2008, GYNECOL OBSTET FERTI, V36, P650, DOI 10.1016/j.gyobfe.2008.03.016; von Karsa L, 2015, PAPILLOMAVIRUS RES, V1, P22, DOI 10.1016/j.pvr.2015.06.006	29	5	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0229758	10.1371/journal.pone.0229758	http://dx.doi.org/10.1371/journal.pone.0229758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196503	Green Published, gold			2022-12-26	WOS:000535303100012
J	Schahab, N; Kavsur, R; Mahn, T; Schaefer, C; Kania, A; Fimmers, R; Nickenig, G; Zimmer, S				Schahab, Nadjib; Kavsur, Refik; Mahn, Thorsten; Schaefer, Christian; Kania, Alexander; Fimmers, Rolf; Nickenig, Georg; Zimmer, Sebastian			Endovascular management of femoral access-site and access-related vascular complications following percutaneous coronary interventions (PCI)	PLOS ONE			English	Article							ARTERIOVENOUS-FISTULAS; ARTERY; IMPLANTATION; ANGIOPLASTY; INJECTION; REPAIR	Background Major vascular complications (VCs) of ilio-femoral arterial access after percutaneous coronary interventions are infrequent, but are associated with increased mortality and morbidity. Routine endovascular repair of VCs is becoming the treatment of choice, especially for patients who cannot tolerate vascular surgery due to advanced cardiovascular disease or are in a bailout situation. Here, we review the different types of vascular access site complications associated with percutaneous coronary interventions (PCIs) and assess the safety and efficacy of endovascular treatment. Methods Data were retrospectively analysed from patients who experienced VCs after transfemoral PCIs, from December 2014 to May 2018. During this period, out of 2833 patients who underwent femoral coronary interventions, 53 (1.9%) experienced major VCs. Results In total, 40/53 (75.5%) cases with major VCs led to unplanned endovascular repair and 13/53 (24.5%) cases required surgical repair. VCs included 17 (32.1%) retroperitoneal bleeding events (BARC-2, 3a,b), 20 (37.7%) intimal dissections, and 16 (30.2%) femoral pseudoaneurysms. Overall, 32 (60.4%) patients received a covered stent, two (3.8%) received a nitinol stent, five (9.4%) patients with dissections were treated with prolonged balloon angioplasty alone, and one patient with femoral pseudoaneurysm underwent thrombin injection with simultaneous balloon occlusion. The mean hospital stay for patients after endovascular treatment was 11.06 +/- 5.2 days, while for patients after surgical repair it was 17 +/- 8.2 days. Endovascularly treated patients were transfused with red blood cells (13/40 32.5% vs. 2/13 15.4%) significantly more often than patients treated surgically, although surgically treated patients received more red blood cell concentrates per unit than endovascularly treated patients (1 +/- 0.47 vs. 2 +/- 0.93). During the one-year follow-up, no intermittent claudication was reported, and no patient required secondary endovascular or surgical repair. Conclusions For patients who cannot tolerate vascular surgery due to advanced cardiovascular disease or are in a bailout situation, endovascular management of VCs following PCIs seems to be a feasible and safe treatment option, and represents an alternative to surgical repair in life-threatening situations. Endovascular treatment was associated with significantly fewer red blood cell concentrates per patient and fewer days in hospital than surgical treatment.	[Schahab, Nadjib; Kavsur, Refik; Mahn, Thorsten; Schaefer, Christian; Nickenig, Georg; Zimmer, Sebastian] Univ Hosp Bonn, Dept Internal Med Cardiol Pulmonol & Angiol 2, Bonn, Germany; [Kania, Alexander] Univ Hosp Bonn, Dept Gen Visceral Thorac & Vasc Surg, Bonn, Germany; [Fimmers, Rolf] Univ Hosp Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Schahab, N (corresponding author), Univ Hosp Bonn, Dept Internal Med Cardiol Pulmonol & Angiol 2, Bonn, Germany.	Nadjib.Schahab@ukbonn.de	Kania, Alexander/AAR-3648-2021					Alonzo A, 2016, CATHETER CARDIO INTE, V87, P849, DOI 10.1002/ccd.26076; Applegate RJ, 2008, JACC-CARDIOVASC INTE, V1, P317, DOI 10.1016/j.jcin.2008.03.013; BABU SC, 1989, J VASC SURG, V10, P113, DOI 10.1067/mva.1989.0100113; Baltacioglu F, 2003, CARDIOVASC INTER RAD, V26, P434; Bonvini RF, 2013, J VASC INTERV RADIOL, V24, P175, DOI 10.1016/j.jvir.2012.10.020; Dzijan-Horn M, 2014, CIRC-CARDIOVASC INTE, V7, P207, DOI 10.1161/CIRCINTERVENTIONS.113.000836; FRANCO CD, 1993, SURGERY, V113, P419; GLASER RL, 1989, ARCH SURG-CHICAGO, V124, P1313; Kwok CS, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.117.005866; Loose HW, 1998, BRIT J RADIOL, V71, P1255, DOI 10.1259/bjr.71.852.10318997; LUMSDEN AB, 1994, AM SURGEON, V60, P132; Muradin GSR, 2001, RADIOLOGY, V221, P137, DOI 10.1148/radiol.2211010039; OMOIGUI NA, 1995, J AM COLL CARDIOL, V26, P922, DOI 10.1016/0735-1097(95)00263-4; Onal B, 2005, ACTA RADIOL, V46, P359, DOI 10.1080/02841850510021166; Sedaghat A, 2019, INT J CARDIOL, V281, P42, DOI 10.1016/j.ijcard.2018.12.053; Sedaghat A, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.003834; Thalhammer C, 2000, RADIOLOGY, V214, P127, DOI 10.1148/radiology.214.1.r00ja04127; Tsetis D, 2010, CARDIOVASC INTER RAD, V33, P457, DOI 10.1007/s00270-010-9820-3	18	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230535	10.1371/journal.pone.0230535	http://dx.doi.org/10.1371/journal.pone.0230535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191751	Green Published, gold			2022-12-26	WOS:000535302300058
J	Yamada, TG; Hiki, Y; Hiroi, NF; Shagimardanova, E; Gusev, O; Cornette, R; Kikawada, T; Funahashi, A				Yamada, Takahiro G.; Hiki, Yusuke; Hiroi, Noriko F.; Shagimardanova, Elena; Gusev, Oleg; Cornette, Richard; Kikawada, Takahiro; Funahashi, Akira			Identification of a master transcription factor and a regulatory mechanism for desiccation tolerance in the anhydrobiotic cell line Pv11	PLOS ONE			English	Article							POLYPEDILUM-VANDERPLANKI; EXPRESSION; BINDING; CRYPTOBIOSIS; TREHALOSE; PROFILES; DATABASE; MODELS; MOTIFS; GENOME	Water is essential for living organisms. Terrestrial organisms are incessantly exposed to the stress of losing water, desiccation stress. Avoiding the mortality caused by desiccation stress, many organisms acquired molecular mechanisms to tolerate desiccation. Larvae of the African midge, Polypedilum vanderplanki, and its embryonic cell line Pv11 tolerate desiccation stress by entering an ametabolic state, anhydrobiosis, and return to active life after rehydration. The genes related to desiccation tolerance have been comprehensively analyzed, but transcriptional regulatory mechanisms to induce these genes after desiccation or rehydration remain unclear. Here, we comprehensively analyzed the gene regulatory network in Pv11 cells and compared it with that of Drosophila melanogaster, a desiccation sensitive species. We demonstrated that nuclear transcription factor Y subunit gamma-like, which is important for drought stress tolerance in plants, and its transcriptional regulation of downstream positive feedback loops have a pivotal role in regulating various anhydrobiosis-related genes. This study provides an initial insight into the systemic mechanism of desiccation tolerance.	[Yamada, Takahiro G.; Hiki, Yusuke; Funahashi, Akira] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa, Japan; [Hiroi, Noriko F.] Sanyo Onoda City Univ, Fac Pharmaceut Sci, Yamaguchi, Japan; [Shagimardanova, Elena; Gusev, Oleg] Kazan Fed Univ, Kazan, Russia; [Gusev, Oleg] RIKEN, RIKEN Cluster Sci Technol & Innovat Hub, Yokohama, Kanagawa, Japan; [Cornette, Richard; Kikawada, Takahiro] Natl Agr & Food Res Org NARO, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Kikawada, Takahiro] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	Keio University; Kazan Federal University; RIKEN; National Agriculture & Food Research Organization - Japan; University of Tokyo	Funahashi, A (corresponding author), Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa, Japan.; Kikawada, T (corresponding author), Natl Agr & Food Res Org NARO, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.; Kikawada, T (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.	kikawada@affrc.go.jp; funa@bio.keio.ac.jp	Kikawada, Takahiro/A-1289-2010; Shagimardanova, Elena I/H-3699-2012; Hiroi, Noriko/AAE-2657-2019; Gusev, Oleg/D-9383-2011; Funahashi, Akira/C-4923-2014	Kikawada, Takahiro/0000-0002-2329-9282; Shagimardanova, Elena I/0000-0003-2339-261X; Hiroi, Noriko/0000-0002-0214-373X; Gusev, Oleg/0000-0002-6203-9758; Funahashi, Akira/0000-0003-0605-239X; Yamada, Takahiro/0000-0002-1665-1778; Hiki, Yusuke/0000-0001-6955-3867	JSPS KAKENHI [22128001, 18H02217, 17H01511]; European Union [734434]; MSCA-RISE "DRYNET" [734434, 17-44-07002]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); European Union(European Commission); MSCA-RISE "DRYNET"	Takahiro Kikawada received JSPS KAKENHI (Grant Number: 22128001, https://kaken.nii.ac.jp/en/grant/KAKENHI-ORGANIZER-22128001/), the European Union Horizon 2020 Research and Innovation Program, MSCA-RISE "DRYNET" (Grant Number 734434, https://cordis.europa.eu/project/id/734434), and a pilot program of international collaborative research (Collaborative research based on a joint call with Russia) under "Commissioned projects for promotion of strategic international collaborative research" (https://www.affrc.maff.go.jp/kokusaikenkyu/attach/pdf/joint_call_for_ international_research-28.pdf) for sequencing of RNA-seq datasets used in this study. Elena Shagimardanova received Russian Science Foundation Joint Research Groups Grant 17-44-07002(https://rscf.ru/en/contests/search-projects/17-44-07002/) for preparation of RNA-seq libraries used in this study. Oleg Gusev received JSPS KAKENHI (Grant Number: 18H02217, https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT18H02217/) for preparation of RNA-seq libraries used in this study. Takahiro Kikawada and Akira Funahashi received JSPS KAKENHI (Grant Number: 17H01511, https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-17H01511/) for computational resources for all computational analyses in this study, i.e., DEG analysis, network inference, etc. and preparation of the manuscript, i.e., English proofreading.	Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Andrews S., 2010, FASTQC QUALITY CONTR; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chen H., 2018, VENNDIAGRAM GENERATE; Chen M, 2014, PLANT BIOTECHNOL J, V12, P447, DOI [10.1111/pbi.12151, 10.1111/pbi.12270]; Clegg JS, 2001, COMP BIOCHEM PHYS B, V128, P613, DOI 10.1016/S1096-4959(01)00300-1; Cornette R, 2010, J BIOL CHEM, V285, P35889, DOI 10.1074/jbc.M110.150623; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Davidson EH, 2001, COMMUN STAT THEORY M; Deviatiiarov R, 2017, MITOCHONDRIAL DNA A, V28, P218, DOI 10.3109/19401736.2015.1115849; ERDOS P, 1960, B INT STATIST INST, V38, P343; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gaidatzis D, 2015, BIOINFORMATICS, V31, P1130, DOI 10.1093/bioinformatics/btu781; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Gusev O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5784; Hatanaka R, 2015, PLANTA, V242, P451, DOI 10.1007/s00425-015-2284-6; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kikawada T, 2005, INTEGR COMP BIOL, V45, P710, DOI 10.1093/icb/45.5.710; Kikawada T, 2008, BBA-BIOMEMBRANES, V1778, P514, DOI 10.1016/j.bbamem.2007.11.009; Kikawada T, 2006, BIOCHEM BIOPH RES CO, V348, P56, DOI 10.1016/j.bbrc.2006.07.003; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kummerfeld SK, 2006, NUCLEIC ACIDS RES, V34, pD74, DOI 10.1093/nar/gkj131; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lapinski J, 2003, FEBS LETT, V553, P387, DOI 10.1016/S0014-5793(03)01062-7; Ligges U., 2003, J STAT SOFTW, V8, P1, DOI [DOI 10.18637/JSS.V008.I11, 10.18637/jss.v008.i11]; Lo CC, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0366-2; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maeda YT, 2006, J MOL BIOL, V359, P1107, DOI 10.1016/j.jmb.2006.03.064; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Mazin PV, 2018, P NATL ACAD SCI USA, V115, pE2477, DOI 10.1073/pnas.1719493115; McSorley R, 2003, FLA ENTOMOL, V86, P138, DOI 10.1653/0015-4040(2003)086[0138:AONTEE]2.0.CO;2; Nakahara Y, 2010, CRYOBIOLOGY, V60, P138, DOI 10.1016/j.cryobiol.2009.10.004; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Park S, 2018, BMC SYST BIOL, V12, DOI 10.1186/s12918-018-0547-0; Pfaff B, 2008, J STAT SOFTW, V27, P1; R Core Team, 2013, R LANG ENV STAT COMP; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Shannon P, 2018, MOTIFDB ANNOTATED CO; Sogame Y, 2017, EXTREMOPHILES, V21, P65, DOI 10.1007/s00792-016-0880-4; Tokumoto S, 2019, CRYOBIOLOGY CRYOTECH, V64, P67; Watanabe K, 2016, CRYOBIOLOGY, V73, P93, DOI 10.1016/j.cryobiol.2016.05.006; Watanabe M, 2003, J EXP BIOL, V206, P2281, DOI 10.1242/jeb.00418; Watanabe M, 2007, J INSECT PHYSIOL, V53, P573, DOI 10.1016/j.jinsphys.2007.02.008; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Welnicz W, 2011, J INSECT PHYSIOL, V57, P577, DOI 10.1016/j.jinsphys.2011.03.019; Wiese R, 2004, MATH VIS, P173; Yamada TG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36124-6; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Zhu LHJ, 2011, NUCLEIC ACIDS RES, V39, pD111, DOI 10.1093/nar/gkq858	56	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230218	10.1371/journal.pone.0230218	http://dx.doi.org/10.1371/journal.pone.0230218			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191739	gold, Green Published			2022-12-26	WOS:000535302300030
J	Knights, AJ; Yang, L; Shah, M; Norton, LJ; Green, GS; Stout, ES; Vohralik, EJ; Crossley, M; Quinlan, KGR				Knights, Alexander J.; Yang, Lu; Shah, Manan; Norton, Laura J.; Green, Gamran S.; Stout, Elizabeth S.; Vohralik, Emily J.; Crossley, Merlin; Quinlan, Kate G. R.			Kr?ppel-like factor 3 (KLF3) suppresses NF-?B?driven inflammation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; endotoxin; NF-kappa B (NF-KB); NF-kB transcription factor; gene regulation; macrophage; lipopolysaccharide (LPS); transcription; Kr?ppel-like factor 3 (KLF3)	KRUPPEL-LIKE FACTORS; KAPPA-B ACTIVATION; BINDING-PROTEIN; TARGETED DISRUPTION; GENE-EXPRESSION; DNA-BINDING; KLF3/BKLF; LIPOPOLYSACCHARIDE; MACROPHAGE; REVEALS	Bacterial products such as lipopolysaccharides (or endotoxin) cause systemic inflammation, resulting in a substantial global health burden. The onset, progression, and resolution of the inflammatory response to endotoxin are usually tightly controlled to avoid chronic inflammation. Members of the NF-?B family of transcription factors are key drivers of inflammation that activate sets of genes in response to inflammatory signals. Such responses are typically short-lived and can be suppressed by proteins that act post-translationally, such as the SOCS (suppressor of cytokine signaling) family. Less is known about direct transcriptional regulation of these responses, however. Here, using a combination of in vitro approaches and in vivo animal models, we show that endotoxin treatment induced expression of the well-characterized transcriptional repressor Kr?ppel-like factor 3 (KLF3), which, in turn, directly repressed the expression of the NF-?B family member RELA/p65. We also observed that KLF3-deficient mice were hypersensitive to endotoxin and exhibited elevated levels of circulating Ly6C(+) monocytes and macrophage-derived inflammatory cytokines. These findings reveal that KLF3 is a fundamental suppressor that operates as a feedback inhibitor of RELA/p65 and may be important in facilitating the resolution of inflammation.	[Knights, Alexander J.; Yang, Lu; Shah, Manan; Norton, Laura J.; Green, Gamran S.; Stout, Elizabeth S.; Vohralik, Emily J.; Crossley, Merlin; Quinlan, Kate G. R.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Quinlan, KGR (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	kate.quinlan@unsw.edu.au	Knights, Alexander/AAL-1769-2021; Crossley, Merlin/D-7888-2011	Shah, Manan/0000-0003-1390-5450; Stout, Elizabeth/0000-0003-4957-5019; Crossley, Merlin/0000-0003-2057-3642; Knights, Alexander/0000-0001-8402-2212	Australian National Health and Medical Research Council (NHMRC) [APP1025873, APP1025877]; Australian Postgraduate Awards; University of New South Wales Sydney Scientia Fellowship; University of New South Wales Sydney Scientia Scholarship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Awards(Australian Government); University of New South Wales Sydney Scientia Fellowship; University of New South Wales Sydney Scientia Scholarship	This work was supported by Australian National Health and Medical Research Council (NHMRC) Grants APP1025873 and APP1025877 (to M. C.), Australian Postgraduate Awards (to A. J. K., L. J. N., M. S., and E. S. S.), a University of New South Wales Sydney Scientia Fellowship (to K. G. R. Q.), and a University of New South Wales Sydney Scientia Scholarship (to E. J. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; Bell-Anderson KS, 2013, DIABETES, V62, P2728, DOI 10.2337/db12-1745; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Burdach J, 2014, NUCLEIC ACIDS RES, V42, P276, DOI 10.1093/nar/gkt895; Crossley M, 1996, MOL CELL BIOL, V16, P1695; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Date D, 2014, J BIOL CHEM, V289, P10318, DOI 10.1074/jbc.M113.526749; Dewi V, 2015, J BIOL CHEM, V290, P8591, DOI 10.1074/jbc.M115.638338; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Fan YB, 2012, ARTERIOSCL THROM VAS, V32, P2981, DOI 10.1161/ATVBAHA.112.300349; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Funnell APW, 2013, MOL CELL BIOL, V33, P2976, DOI 10.1128/MCB.00074-13; Funnell APW, 2012, MOL CELL BIOL, V32, P3281, DOI 10.1128/MCB.00173-12; Gadjeva M, 2004, J IMMUNOL, V173, P5786, DOI 10.4049/jimmunol.173.9.5786; Gajendran M, 2018, DM-DIS MON, V64, P20, DOI 10.1016/j.disamonth.2017.07.001; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geng S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13436; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jain MK, 2014, ARTERIOSCL THROM VAS, V34, P499, DOI 10.1161/ATVBAHA.113.301925; Kauppinen A, 2016, CELL MOL LIFE SCI, V73, P1765, DOI 10.1007/s00018-016-2147-8; Kim GD, 2016, J BIOL CHEM, V291, P21271, DOI 10.1074/jbc.M116.738617; Knights AJ, 2016, J BIOL CHEM, V291, P16048, DOI 10.1074/jbc.M116.715748; Kulakovskiy IV, 2018, NUCLEIC ACIDS RES, V46, pD252, DOI 10.1093/nar/gkx1106; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lingrel JB, 2012, CIRC RES, V110, P1294, DOI 10.1161/CIRCRESAHA.112.267310; LIPTAY S, 1994, MOL CELL BIOL, V14, P7695, DOI 10.1128/MCB.14.12.7695; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mao LF, 2017, DIABETES, V66, P407, DOI 10.2337/db16-0343; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mori N, 1996, BLOOD, V87, P3410, DOI 10.1182/blood.V87.8.3410.bloodjournal8783410; OETTGEN HF, 1980, RECENT RES CANCER, V75, P207; Perez-Cerda F., 2016, MULT SCLER DEMYELINA, V1, P9, DOI [10.1186/s40893-016-0012-0, DOI 10.1186/S40893-016-0012-0]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Steiner AA, 2011, J PHYSIOL-LONDON, V589, P2415, DOI 10.1113/jphysiol.2010.202465; Straub RH, 2016, EVOL MED PUBLIC HLTH, P37, DOI 10.1093/emph/eow001; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Sweet DR, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00006; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Vu TT, 2011, J IMMUNOL, V187, P5032, DOI 10.4049/jimmunol.1101450; Vasseur S, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-25; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	54	9	9	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6080	6091		10.1074/jbc.RA120.013114	http://dx.doi.org/10.1074/jbc.RA120.013114			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32213596	Green Published, hybrid			2022-12-26	WOS:000531417300019
J	Manska, S; Octaviano, R; Rossetto, CC				Manska, Salom; Octaviano, Rionna; Rossetto, Cyprian C.			5-Ethynyl-2?-deoxycytidine and 5-ethynyl-2?-deoxyuridine are differentially incorporated in cells infected with HSV-1, HCMV, and KSHV viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nucleoside; nucleotide analogue; nucleoside; nucleotide metabolism; herpesvirus; DNA replication; viral replication; 5-ethynyl-2?-deoxycytidine (EdC); 5-ethynyl-2?-deoxyuridine (EdU); thymidine kinase; pulse labeling; cell proliferation; non-radioactive labeling; thymidine kinase; fluorescent reporter	URACIL-DNA GLYCOSYLASE; HERPES-SIMPLEX-VIRUS; HUMAN CYTOMEGALOVIRUS; PROTEIN-KINASE; ENDOTHELIAL ORIGIN; REPLICATION FORKS; THYMIDINE KINASE; DUTPASE; EDU; PHOSPHORYLATION	Nucleoside analogues are a valuable experimental tool. Incorporation of these molecules into newly synthesized DNA (i.e. pulse-labeling) is used to monitor cell proliferation or to isolate nascent DNA. Some of the most common nucleoside analogues used for pulse-labeling of DNA in cells are the deoxypyrimidine analogues 5-ethynyl-2?-deoxyuridine (EdU) and 5-ethynyl-2?-deoxycytidine (EdC). Click chemistry enables conjugation of an azide molecule tagged with a fluorescent dye or biotin to the alkyne of the analog, which can then be used to detect incorporation of EdU and EdC into DNA. The use of EdC is often recommended because of the potential cytotoxicity associated with EdU during longer incubations. Here, by comparing the relative incorporation efficiencies of EdU and EdC during short 30-min pulses, we demonstrate significantly lower incorporation of EdC than of EdU in noninfected human fibroblast cells or in cells infected with either human cytomegalovirus or Kaposi's sarcoma-associated herpesvirus. Interestingly, cells infected with herpes simplex virus type-1 (HSV-1) incorporated EdC and EdU at similar levels during short pulses. Of note, exogenous expression of HSV-1 thymidine kinase increased the incorporation efficiency of EdC. These results highlight the limitations when using substituted pyrimidine analogues in pulse-labeling and suggest that EdU is the preferable nucleoside analogue for short pulse-labeling experiments, resulting in increased recovery and sensitivity for downstream applications. This is an important discovery that may help to better characterize the biochemical properties of different nucleoside analogues with a given kinase, ultimately leading to significant differences in labeling efficiency of nascent DNA.	[Manska, Salom; Octaviano, Rionna; Rossetto, Cyprian C.] Univ Nevada, Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Rossetto, CC (corresponding author), Univ Nevada, Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA.	crossetto@med.unr.edu		Octaviano, Rionna/0000-0001-7236-8240; Manska, Salome/0000-0002-6345-0880; Rossetto, Cyprian/0000-0002-4415-0196	National Institutes of Health [R01 AI045096, R56 AI106737]; University of Nevada, Reno (UNR) IDeA Network of Biomedical Research Excellence (INBRE) [P20 GM103440]; UNR startup funds	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nevada, Reno (UNR) IDeA Network of Biomedical Research Excellence (INBRE); UNR startup funds	This work was supported by National Institutes of Health Grants R01 AI045096 and R56 AI106737 (to C. C. R.); University of Nevada, Reno (UNR) IDeA Network of Biomedical Research Excellence (INBRE) Grant P20 GM103440; and UNR startup funds (to C. C. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BARR PJ, 1981, J MED CHEM, V24, P1385, DOI 10.1021/jm00144a003; BJURSELL KG, 1972, EUR J BIOCHEM, V29, P348, DOI 10.1111/j.1432-1033.1972.tb01995.x; Brulois KF, 2012, J VIROL, V86, P9708, DOI 10.1128/JVI.01019-12; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Cannon JS, 1999, J VIROL, V73, P4786, DOI 10.1128/JVI.73.6.4786-4793.1999; Chen RX, 2002, J GEN VIROL, V83, P2339, DOI 10.1099/0022-1317-83-10-2339; Courcelle CT, 2001, J VIROL, V75, P7592, DOI 10.1128/JVI.75.16.7592-7601.2001; Cristofoli WA, 2007, J MED CHEM, V50, P2851, DOI 10.1021/jm0701472; Davison AJ, 2005, J VIROL, V79, P12880, DOI 10.1128/JVI.79.20.12880-12892.2005; DECLERCQ E, 1982, MOL PHARMACOL, V21, P217; DECLERCQ E, 1984, PHARMACOL THERAPEUT, V26, P1, DOI 10.1016/0163-7258(84)90049-4; DECLERCQ E, 1979, P NATL ACAD SCI USA, V76, P2947, DOI 10.1073/pnas.76.6.2947; Dembowski JA, 2017, JOVE-J VIS EXP, DOI 10.3791/56374; Dembowski JA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006166; Dembowski JA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004939; Diermeier-Daucher S, 2009, CYTOM PART A, V75A, P535, DOI 10.1002/cyto.a.20712; Ding P, 2010, CHEM-EUR J, V16, P14385, DOI 10.1002/chem.201001572; Dong QW, 2018, MBIO, V9, DOI 10.1128/mBio.01831-18; GRATZNER HG, 1975, EXP CELL RES, V95, P88, DOI 10.1016/0014-4827(75)90612-6; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; GREENBERG GR, 1962, P NATL ACAD SCI USA, V48, P247, DOI 10.1073/pnas.48.2.247; Guan LR, 2011, CHEMBIOCHEM, V12, P2184, DOI 10.1002/cbic.201100353; Guo HB, 2005, J AM CHEM SOC, V127, P3191, DOI 10.1021/ja0439625; GUPTA PK, 1981, CANCER RES, V41, P3133; Gustafson EA, 2000, J VIROL, V74, P684, DOI 10.1128/JVI.74.2.684-692.2000; Hocek M, 2014, J ORG CHEM, V79, P9914, DOI 10.1021/jo5020799; Jager S, 2005, J AM CHEM SOC, V127, P15071, DOI 10.1021/ja051725b; JAMIESON AT, 1974, J GEN VIROL, V24, P465, DOI 10.1099/0022-1317-24-3-465; JAMIESON AT, 1974, J GEN VIROL, V24, P481, DOI 10.1099/0022-1317-24-3-481; JONES AS, 1981, J MED CHEM, V24, P759, DOI 10.1021/jm00138a024; Kato A, 2014, J VIROL, V88, P2775, DOI 10.1128/JVI.03300-13; Kohlmeier F, 2013, CHROMOSOME RES, V21, P87, DOI 10.1007/s10577-013-9340-5; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Leung KHT, 2013, BIOTECHNIQUES, V55, P204, DOI 10.2144/000114089; Ligasova A, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150172; Ligasova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117459; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; LITTLER E, 1992, NATURE, V358, P160, DOI 10.1038/358160a0; Lu CC, 2007, J VIROL, V81, P1195, DOI 10.1128/JVI.01518-06; MAUDGAL PC, 1980, ANTIMICROB AGENTS CH, V17, P8, DOI 10.1128/AAC.17.1.8; MESSIER B, 1958, EXP CELL RES, V14, P224, DOI 10.1016/0014-4827(58)90235-0; Michel D, 2004, BBA-PROTEINS PROTEOM, V1697, P169, DOI 10.1016/j.bbapap.2003.11.022; Michel D, 1996, J VIROL, V70, P6340, DOI 10.1128/JVI.70.9.6340-6346.1996; Minkah N, 2015, J VIROL, V89, P3366, DOI 10.1128/JVI.03111-14; Myoung J, 2011, J VIROL METHODS, V174, P12, DOI 10.1016/j.jviromet.2011.03.012; Neef AB, 2012, CHEMBIOCHEM, V13, P1750, DOI 10.1002/cbic.201200253; Park J, 2000, J GEN VIROL, V81, P1067, DOI 10.1099/0022-1317-81-4-1067; Prichard MN, 1996, J VIROL, V70, P3018, DOI 10.1128/JVI.70.5.3018-3025.1996; PYLES RB, 1992, J VIROL, V66, P6706, DOI 10.1128/JVI.66.11.6706-6713.1992; Qu DZ, 2011, ANAL BIOCHEM, V417, P112, DOI 10.1016/j.ab.2011.05.037; Reyes ED, 2017, MOL CELL PROTEOMICS, V16, P2079, DOI 10.1074/mcp.M117.067116; RICHARDS RG, 1984, ADV ENZYME REGUL, V22, P157, DOI 10.1016/0065-2571(84)90013-X; Ross HH, 2011, J NEURO-ONCOL, V105, P485, DOI 10.1007/s11060-011-0621-6; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; SCHECK AC, 1987, INTERVIROLOGY, V27, P121, DOI 10.1159/000149730; Schmidt N, 2015, J VIROL, V89, P11107, DOI 10.1128/JVI.01950-15; Schormann N, 2014, PROTEIN SCI, V23, P1667, DOI 10.1002/pro.2554; Senkevich TG, 2017, J VIROL, V91, DOI 10.1128/JVI.01015-17; Sirbu BM, 2012, NAT PROTOC, V7, P594, DOI 10.1038/nprot.2012.010; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Strahan R, 2018, J VIROL, V92, DOI 10.1128/JVI.00739-18; Sturzl M, 2013, INT J CANCER, V132, P1954, DOI 10.1002/ijc.27849; SULLIVAN V, 1992, NATURE, V358, P162, DOI 10.1038/358162a0; TAYLOR JH, 1957, P NATL ACAD SCI USA, V43, P122, DOI 10.1073/pnas.43.1.122; TOMILIN NV, 1989, INT REV CYTOL, V114, P125; Walker R. T., 1981, NUCL ACIDS S SER, P21; Wang IH, 2013, CELL HOST MICROBE, V14, P468, DOI 10.1016/j.chom.2013.09.004; Wiest NE, 2017, METHOD ENZYMOL, V591, P1, DOI 10.1016/bs.mie.2017.03.001; Wu ZLL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023172; XEROS N, 1962, NATURE, V194, P682, DOI 10.1038/194682a0; Zhao H, 2013, CYTOM PART A, V83, P979, DOI 10.1002/cyto.a.22396	72	8	8	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5871	5890		10.1074/jbc.RA119.012378	http://dx.doi.org/10.1074/jbc.RA119.012378			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32205447	Green Published, hybrid			2022-12-26	WOS:000531417300004
J	Carregaro, RL; Tottoli, CR; Rodrigues, DD; Bosmans, JE; da Silva, EN; van Tulder, M				Carregaro, Rodrigo Luiz; Tottoli, Caroline Ribeiro; Rodrigues, Daniela da Silva; Bosmans, Judith E.; da Silva, Everton Nunes; van Tulder, Maurits			Low back pain should be considered a health and research priority in Brazil: Lost productivity and healthcare costs between 2012 to 2016	PLOS ONE			English	Article							MUSCULOSKELETAL DISORDERS; HELP-SEEKING; WORK; PREVALENCE; ILLNESS; BEHAVIOR; ABSENCE; BURDEN; CLAIMS; HARM	Background Low Back Pain (LBP) is associated with an increase in disability-adjusted life years, and increased risk of disability retirement and greater absenteeism in Brazil. Hence, evidence on healthcare and lost productivity costs due to LBP is of utmost importance to inform decision-makers. Methods Cost-of-illness study with top-down approach, and societal perspective. We extracted data from National databases, considering the period 2012-2016. Outpatient expenses included clinical, surgical, diagnosis, orthosis/prosthetics, and complementary actions. Inpatient care expenses included hospital and professional services, intensive care unit, and companion stay. For productivity losses, duration of work absence and associated information (work-related and non-work-related; value of the sickness absence benefit; age; gender; and economic activity) were analyzed. Lost productivity costs were calculated multiplying the absence from work (days) by the daily-benefit. Results The societal costs amounted to US$ 2.2 billion, and productivity losses represented 79% of the costs. Total healthcare expenses were estimated to US$ 460 million. We found more than 880,000 diagnostic images. Individuals with LBP were in total 59 million days absent from work between 2012-2016. The mean lost days absent from work per person, for each year investigated was, respectively, 88; 84; 83; 87; and 100. Men were more days absent from work than women. In addition, rural workers presented greater absence from work compared to other professional activities. Conclusion Healthcare expenses and lost productivity costs due to LBP were substantial, hence, there is a need for improvement of health services and policies to deal with this increasing burden of illness. We found an extensive use of diagnostic imaging, which is rather discouraged by clinical guidelines. We assume that men were experiencing high levels of back pain disability compared with women, as they presented greater absenteeism and higher lost productivity costs.	[Carregaro, Rodrigo Luiz; Tottoli, Caroline Ribeiro] Univ Brasilia UnB, Sch Phys Therapy, Master Rehabil Sci, Campus UnB Ceilandia, Brasilia, DF, Brazil; [Carregaro, Rodrigo Luiz; Tottoli, Caroline Ribeiro; da Silva, Everton Nunes] Univ Brasilia UnB, Nucleo Evidencias & Tecnol Saude NETecS, Campus UnB Ceilandia, Brasilia, DF, Brazil; [Rodrigues, Daniela da Silva] Univ Brasilia UnB, Sch Occupat Therapy, Campus UnB Ceilandia, Brasilia, DF, Brazil; [Bosmans, Judith E.; van Tulder, Maurits] Vrije Univ Amsterdam, Fac Sci, Dept Hlth Sci, Amsterdam, Netherlands; [da Silva, Everton Nunes] Univ Brasilia UnB, Sch Collect Hlth, Campus UnB Ceilandia, Brasilia, DF, Brazil; [van Tulder, Maurits] Aarhus Univ Hosp, Dept Physiotherapy & Occupat Therapy, Aarhus, Denmark	Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia; Vrije Universiteit Amsterdam; Universidade de Brasilia; Aarhus University	Carregaro, RL (corresponding author), Univ Brasilia UnB, Sch Phys Therapy, Master Rehabil Sci, Campus UnB Ceilandia, Brasilia, DF, Brazil.; Carregaro, RL (corresponding author), Univ Brasilia UnB, Nucleo Evidencias & Tecnol Saude NETecS, Campus UnB Ceilandia, Brasilia, DF, Brazil.	rodrigocarregaro@unb.br	van Tulder, Maurits/AAB-9785-2022; da Silva Rodrigues, Daniela/ABZ-4936-2022; Carregaro, Rodrigo Luiz/K-3263-2012	van Tulder, Maurits/0000-0002-7589-8471; da Silva Rodrigues, Daniela/0000-0001-7391-1794; Carregaro, Rodrigo Luiz/0000-0002-2382-0787; Silva, Everton/0000-0001-8747-4185	CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate Education): Postdoctoral Research Abroad scholarship [88881.120102/2016-01]	CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate Education): Postdoctoral Research Abroad scholarship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	RLC. CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate Education): Postdoctoral Research Abroad scholarship, process n. 88881.120102/2016-01. http://www.capes.gov.br/.The funding sources has no role in the design and implementation of the study or in the data analysis and presentation of the results.	Barber Julie, 2004, J Health Serv Res Policy, V9, P197, DOI 10.1258/1355819042250249; Barbosa-Branco A, 2011, AM J IND MED, V54, P858, DOI 10.1002/ajim.20974; Takahashi MABC, 2008, CAD SAUDE PUBLICA, V24, P2661, DOI 10.1590/S0102-311X2008001100021; Benzaquem DC, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0121160, 10.1371/journal.pone.0112217]; Buchbinder R, 2018, LANCET, V391, P2384, DOI 10.1016/S0140-6736(18)30488-4; Carregaro RL, 2019, INT J PUBLIC HEALTH, V64, P965, DOI 10.1007/s00038-019-01211-6; Araujo MYC, 2017, J OCCUP ENVIRON MED, V59, P313, DOI [10.1097/JOM.0000000000000951, 10.1097/jom.0000000000000951]; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Darlow B, 2017, BRIT J SPORT MED, V51, P414, DOI 10.1136/bjsports-2016-096741; DATASUS, 2017, DEP INF SUS; de Oliveira MM, 2015, EPIDEMIOL SERV SAUDE, V24, P287, DOI 10.5123/S1679-49742015000200011; Dean SG, 2011, J OCCUP REHABIL, V21, P395, DOI 10.1007/s10926-010-9275-z; Downie A, 2020, BRIT J SPORT MED, V54, P642, DOI 10.1136/bjsports-2018-100087; Ekman M, 2005, SPINE, V30, P1777, DOI 10.1097/01.brs.0000171911.99348.90; Flynn TW, 2011, J ORTHOP SPORT PHYS, V41, P838, DOI 10.2519/jospt.2011.3618; Foster NE, 2018, LANCET, V391, P2368, DOI 10.1016/S0140-6736(18)30489-6; Fritz JM, 2012, SPINE, V37, P2114, DOI 10.1097/BRS.0b013e31825d32f5; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Garcia JBS, 2014, PAIN PHYSICIAN, V17, P379; Geneen L, 2017, COCHRANE DB SYST REV, V4, DOI [DOI 10.1002/14651858.CD011279.PUB3, 10.1002/14651858]; Goren A, 2014, PAIN MED, V15, P1880, DOI 10.1111/pme.12542; Gouveia Miguel, 2011, Rev. Port. Sau. Pub., V29, P100; Hayden JA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000335.pub2; Henschke N, 2015, MAYO CLIN PROC, V90, P139, DOI 10.1016/j.mayocp.2014.09.010; Hurwitz EL, 2018, EUR SPINE J, V27, P796, DOI 10.1007/s00586-017-5432-9; Jenkins HJ, 2018, SPINE J, V18, P2266, DOI 10.1016/j.spinee.2018.05.004; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kigozi J, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4257-0; Kresal F, 2015, INT J OCCUP SAF ERGO, V21, P166, DOI 10.1080/10803548.2015.1029289; Krol M, 2014, PHARMACOECONOMICS, V32, P335, DOI 10.1007/s40273-014-0132-3; Krol M, 2013, PHARMACOECONOMICS, V31, P537, DOI 10.1007/s40273-013-0056-3; Lambeek LC, 2011, SPINE, V36, P1050, DOI 10.1097/BRS.0b013e3181e70488; Larg A, 2011, PHARMACOECONOMICS, V29, P653, DOI 10.2165/11588380-000000000-00000; Lopez F, 2017, NOTA TECNICA; Malta Deborah Carvalho, 2017, Rev. Saúde Pública, V51, p11s, DOI [10.1590/s1518-8787.2017051000090, 10.1590/s1518-8787.2017051000006]; Malta Deborah Carvalho, 2015, Rev. bras. epidemiol., V18, P3, DOI 10.1590/1980-5497201500060002; Marinho F, 2018, LANCET, V392, P760, DOI 10.1016/S0140-6736(18)31221-2; Meucci Rodrigo Dalke, 2014, Rev. bras. saúde ocup., V39, P6, DOI 10.1590/0303-7657000079113; Meucci RD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005874; Meziat N, 2011, REV SAUDE PUBL, V45, P494, DOI 10.1590/S0034-89102011000300007; National Institute for Health and Clinical Excellence (NICE), 2016, LOW BACK PAIN SCIATI; Olafsson G, 2018, EUR SPINE J, V27, P2875, DOI 10.1007/s00586-018-5742-6; Leopoldino AAO, 2016, REV BRAS REUMATOL, V56, P258, DOI 10.1016/j.rbre.2016.03.011; Pinheiro Rejane Sobrino, 2002, Ciênc. saúde coletiva, V7, P687; Depintor JDP, 2016, SAO PAULO MED J, V134, P375, DOI 10.1590/1516-3180.2016.0091310516; Punnett L, 2005, AM J IND MED, V48, P459, DOI 10.1002/ajim.20232; Reed SJ, 2014, IMAGING NONSPECIFIC; Rutten GM, 2010, PHYS THER, V90, P1111, DOI 10.2522/ptj.20090173; Salathe CR, 2012, OCCUP MED-OXFORD, V62, P273, DOI 10.1093/occmed/kqs024; Santana VS, 2012, INJURY PREV, V18, P221, DOI 10.1136/injuryprev-2011-040113; SANTOS LUIZA GOMES, 2017, Coluna/Columna, V16, P198, DOI 10.1590/s1808-185120171603165890; Schwertner DS, 2020, J BACK MUSCULOSKELET, V33, P233, DOI 10.3233/BMR-170821; Silva Marcia Regina da, 2017, Saúde debate, V41, P183, DOI 10.1590/0103-1104201711215; Smith JA, 2006, MED J AUSTRALIA, V184, P81, DOI 10.5694/j.1326-5377.2006.tb00124.x; Souza NS, 2008, REV SAUDE PUBL, V42, P630, DOI 10.1590/S0034-89102008000400008; Stochkendahl MJ, 2018, EUR SPINE J, V27, P60, DOI 10.1007/s00586-017-5099-2; Vargas C, 2018, PAIN REP, V3, DOI 10.1097/PR9.0000000000000656; Vieira EA, 2011, ESTAC CIENT-UNIFAP, V1, P1; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Wang YXJ, 2018, J ORTHOP TRANSL, V15, P21, DOI 10.1016/j.jot.2018.07.009; WB, 2019, WORLD BANK PPP CONV; Wynne-Jones G, 2014, OCCUP ENVIRON MED, V71, P448, DOI 10.1136/oemed-2013-101571	64	16	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230902	10.1371/journal.pone.0230902	http://dx.doi.org/10.1371/journal.pone.0230902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8IA	32236113	Green Published, gold			2022-12-26	WOS:000535938700036
J	Kim, Y; Jang, YN; Kim, JY; Kim, N; Noh, S; Kim, H; Queenan, BN; Bellmore, R; Mun, JY; Park, H; Rah, JC; Pak, DTS; Lee, KJ				Kim, Yoonju; Jang, You-Na; Kim, Ji-Young; Kim, Nari; Noh, Seulgi; Kim, Hyeyeon; Queenan, Bridget N.; Bellmore, Ryan; Mun, Ji Young; Park, Hyungju; Rah, Jong Cheol; Pak, Daniel T. S.; Lee, Kea Joo			Microtubule-associated protein 2 mediates induction of long-term potentiation in hippocampal neurons	FASEB JOURNAL			English	Article						dendritic spine; electron microscopy; MAP2; synaptic plasticity	DENDRITIC SPINE MORPHOLOGY; AMPA RECEPTORS; NMDA RECEPTORS; STRUCTURAL PLASTICITY; BIDIRECTIONAL CONTROL; MAP2 PHOSPHORYLATION; SIGNALING PATHWAY; ACTIN; ACTIVATION; KINASE	Microtubule-associated protein (MAP) 2 has been perceived as a static cytoskeletal protein enriched in neuronal dendritic shafts. Emerging evidence indicates dynamic functions for various MAPs in activity-dependent synaptic plasticity. However, it is unclear how MAP2 is associated with synaptic plasticity mechanisms. Here, we demonstrate that specific silencing of high-molecular-weight MAP2 in vivo abolished induction of long-term potentiation (LTP) in the Schaffer collateral pathway of CA1 pyramidal neurons and in vitro blocked LTP-induced surface delivery of AMPA receptors and spine enlargement. In mature hippocampal neurons, we observed rapid translocation of a subpopulation of MAP2, present in dendritic shafts, to spines following LTP stimulation. Time-lapse confocal imaging showed that spine translocation of MAP2 was coupled with LTP-induced spine enlargement. Consistently, immunogold electron microscopy revealed that LTP stimulation of the Schaffer collateral pathway promoted MAP2 labeling in spine heads of CA1 neurons. This translocation depended on NMDA receptor activation and Ras-MAPK signaling. Furthermore, LTP stimulation led to an increase in surface-expressed AMPA receptors specifically in the neurons with MAP2 spine translocation. Altogether, this study indicates a novel role for MAP2 in LTP mechanisms and suggests that MAP2 participates in activity-dependent synaptic plasticity in mature hippocampal networks.	[Kim, Yoonju; Jang, You-Na; Noh, Seulgi; Mun, Ji Young; Lee, Kea Joo] Korea Brain Res Inst, Neural Circuits Res Grp, 61 Cheomdan Ro, Daegu 41062, South Korea; [Kim, Ji-Young; Kim, Hyeyeon; Park, Hyungju] Korea Brain Res Inst, Neurovasc Unit Res Grp, Daegu, South Korea; [Kim, Nari; Rah, Jong Cheol; Lee, Kea Joo] Korea Brain Res Inst, Ctr Cort Proc, Daegu, South Korea; [Queenan, Bridget N.; Bellmore, Ryan; Pak, Daniel T. S.] Georgetown Univ, Med Ctr, Dept Pharmacol & Physiol, Interdisciplinary Program Neurosci, Med Dent Bldg C405,3900 Reservoir Rd NW, Washington, DC 20057 USA; [Park, Hyungju; Rah, Jong Cheol; Lee, Kea Joo] DGIST, Dept Brain & Cognit Sci, Daegu, South Korea	Korea Brain Research Institute (KBRI); Korea Brain Research Institute (KBRI); Korea Brain Research Institute (KBRI); Georgetown University; Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Lee, KJ (corresponding author), Korea Brain Res Inst, Neural Circuits Res Grp, 61 Cheomdan Ro, Daegu 41062, South Korea.; Pak, DTS (corresponding author), Georgetown Univ, Med Ctr, Dept Pharmacol & Physiol, Interdisciplinary Program Neurosci, Med Dent Bldg C405,3900 Reservoir Rd NW, Washington, DC 20057 USA.	Daniel.Pak@georgetown.edu; relaylee@kbri.re.kr		Kim, Yoonju/0000-0003-2657-2923; Rah, Jong-Cheol/0000-0003-3780-0522	Ministry of Science and ICT [20-BR-01-08, 20-BR-04-01, NRF-2017M3C7A1048086]; Ministry of Education [NRF-2015R1D1A1A01058889]; GUMC Pilot Project Grant	Ministry of Science and ICT(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education; GUMC Pilot Project Grant	the KBRI Basic Research Programs funded by the Ministry of Science and ICT, Grant/Award Number: 20-BR-01-08 and 20-BR-04-01; the Korean NRF Basic Science Research Programs funded by the Ministry of Science and ICT, Grant/Award Number: NRF-2017M3C7A1048086; the Korean NRF Basic Science Research Programs funded by the Ministry of Education, Grant/Award Number: NRF-2015R1D1A1A01058889; the GUMC Pilot Project Grant	Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; CACERES A, 1983, P NATL ACAD SCI-BIOL, V80, P1738, DOI 10.1073/pnas.80.6.1738; CACERES A, 1984, J NEUROSCI, V4, P394; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; DYE RB, 1993, J BIOL CHEM, V268, P6847; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fink CC, 2002, CURR OPIN NEUROBIOL, V12, P293, DOI 10.1016/S0959-4388(02)00327-6; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GARNER CC, 1988, J CELL BIOL, V106, P779, DOI 10.1083/jcb.106.3.779; Gelinas JN, 2008, LEARN MEMORY, V15, P403, DOI 10.1101/lm.830008; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Gu JP, 2008, J NEUROSCI, V28, P12120, DOI 10.1523/JNEUROSCI.2509-08.2008; HALPAIN S, 1990, NEURON, V5, P237, DOI 10.1016/0896-6273(90)90161-8; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; Hu HL, 2008, J NEUROSCI, V28, P7847, DOI 10.1523/JNEUROSCI.1496-08.2008; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Jin SX, 2013, J BIOL CHEM, V288, P21703, DOI 10.1074/jbc.M113.471904; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; Kaech S, 1997, J NEUROSCI, V17, P9565; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kim Y, 2015, J BIOL CHEM, V290, P7323, DOI 10.1074/jbc.M114.634527; KINDLER S, 1990, J BIOL CHEM, V265, P19679; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee KJ, 2013, NEURON, V77, P99, DOI 10.1016/j.neuron.2012.10.033; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Loveland KL, 1999, J BIOL CHEM, V274, P19261, DOI 10.1074/jbc.274.27.19261; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marsden KM, 1996, J NEUROSCI, V16, P3265; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; MORALES M, 1989, CELL TISSUE RES, V256, P447; Muly EC, 2004, CEREB CORTEX, V14, P1398, DOI 10.1093/cercor/bhh101; MURTHY ASN, 1983, EUR J BIOCHEM, V137, P37, DOI 10.1111/j.1432-1033.1983.tb07792.x; Orban PC, 1999, TRENDS NEUROSCI, V22, P38, DOI 10.1016/S0166-2236(98)01306-X; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Park H, 2014, NEURON, V84, P1009, DOI 10.1016/j.neuron.2014.10.045; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Peris L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05869-z; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Quinlan EM, 1996, NEURON, V16, P357, DOI 10.1016/S0896-6273(00)80053-7; Quinlan EM, 1996, J NEUROSCI, V16, P7627; Racz B, 2004, J NEUROSCI, V24, P10310, DOI 10.1523/JNEUROSCI.2080-04.2004; SATTILARO RF, 1986, BIOCHEMISTRY-US, V25, P2003, DOI 10.1021/bi00356a025; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; Tao-Cheng JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118750; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	63	18	19	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6965	6983		10.1096/fj.201902122RR	http://dx.doi.org/10.1096/fj.201902122RR		APR 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32237183	hybrid			2022-12-26	WOS:000522967700001
J	Bouzid, N; Jamilloux, Y; Chapurlat, R; Pradat, P; De Parisot, A; Kodjikian, L; Seve, P				Bouzid, Nabil; Jamilloux, Yvan; Chapurlat, Roland; Pradat, Pierre; De Parisot, Audrey; Kodjikian, Laurent; Seve, Pascal			Impact of systemic treatments on the course of HLA-B27-associated uveitis: A retrospective study of 101 patients	PLOS ONE			English	Article							ACUTE ANTERIOR UVEITIS; SOCIETY CLASSIFICATION CRITERIA; ANKYLOSING-SPONDYLITIS; SPONDYLOARTHRITIS; SULFASALAZINE; EFFICACY; FLARES; SPONDYLARTHROPATHY; RECOMMENDATIONS; GOLIMUMAB	Purpose To investigate the efficacy and tolerance of systemic treatments for the prevention of HLA-B27-associated acute uveitis (AU) recurrence. Methods Retrospective review of patients with HLA-B27-associated uveitis followed in our tertiary center over a 15-year period. Systemic treatments were prescribed to patients with frequent (more than 2 flares per year) or severe uveitis, according to a step-up strategy Results 101 patients (51.5% of men, 88.1% of white Europeans) with a median age of 37 years. AU was mostly recurrent (68.3%) and associated with spondyloarthritis (60.4%). After a median follow-up duration of 22 months (3-73), 37.6% of the patients have received systemic treatment. 88.5% of the patients have been treated with sulfasalazine (SSZ) for ophthalmologic purposes (23/26). Methotrexate (MTX) and anti-TNFa agents have been initiated for a rheumatologic indication in 81.8% (9/11) and 100% of the patients (13/13), respectively. The annual uveitis relapse rate significantly decreased on SSZ (0.37 recurrences/year versus baseline 2.46 recurrences/year; p< 0.001) and MTX (1.54 recurrences/year versus 4.17/year; p = 0.008). Patients under ADA for ophthalmologic purposes (n = 2) did not experience any recurrence. Conclusion We report an open-label strategy to prevent the recurrences of HLA-B27-associated AU. First-line sulfasalazine reduced uveitis relapses. The use of anti-TNF alpha agents for ophthalmologic purposes was unnecessary with rare exceptions.	[Bouzid, Nabil; Jamilloux, Yvan; De Parisot, Audrey; Seve, Pascal] Univ Claude Bernard Lyon 1, Serv Med Interne, Hop Croix Rousse, Hosp Civils Lyon, Lyon, France; [Chapurlat, Roland] Univ Lyon, Hosp Civils Lyon, Serv Rhumatol, Hop Edouard Herriot,INSERM UMR 1033, Lyon, France; [Pradat, Pierre] Univ Claude Bernard Lyon 1, Ctr Rech Clin, Hop Croix Rousse, Hosp Civils Lyon, Lyon, France; [Kodjikian, Laurent] Univ Claude Bernard Lyon 1, Serv Ophtalmol, Hop Croix Rousse, Hosp Civils Lyon, Lyon, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Seve, P (corresponding author), Univ Claude Bernard Lyon 1, Serv Med Interne, Hop Croix Rousse, Hosp Civils Lyon, Lyon, France.	pascal.seve@chu-lyon.fr	CHAPURLAT, ROLAND/AAU-1165-2021; Jamilloux, Yvan/F-6601-2019	Jamilloux, Yvan/0000-0001-5249-3650; Bouzid, Nabil/0000-0001-8407-3749				Benitez-Del-Castillo JM, 2000, EYE, V14, P340, DOI 10.1038/eye.2000.84; Braun J, 2005, ARTHRITIS RHEUM, V52, P2447, DOI 10.1002/art.21197; BREWERTON DA, 1973, LANCET, V2, P994, DOI 10.1016/S0140-6736(73)91090-8; BREWERTON DA, 1973, LANCET, V1, P904; Brown PM, 2016, NAT REV RHEUMATOL, V12, P731, DOI 10.1038/nrrheum.2016.175; Calvo-Rio V, 2016, SEMIN ARTHRITIS RHEU, V46, P95, DOI 10.1016/j.semarthrit.2016.03.002; Chang JH, 2005, SURV OPHTHALMOL, V50, P364, DOI 10.1016/j.survophthal.2005.04.003; Chen JM, 2006, J RHEUMATOL, V33, P722; Dick AD, 2018, OPHTHALMOLOGY, V125, P757, DOI 10.1016/j.ophtha.2017.11.017; DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218, DOI 10.1002/art.1780341003; DOUGADOS M, 1993, REV RHUM, V60, P81; Dunn James P, 2004, Curr Opin Ophthalmol, V15, P293, DOI 10.1097/00055735-200408000-00003; DUNNE JA, 1985, BRIT J OPHTHALMOL, V69, P120, DOI 10.1136/bjo.69.2.120; Gaudio PA, 2004, OCUL IMMUNOL INFLAMM, V12, P169, DOI 10.1080/092739490500192; Guignard S, 2006, ANN RHEUM DIS, V65, P1631, DOI 10.1136/ard.2006.052092; Jabs DA, 2000, AM J OPHTHALMOL, V130, P492, DOI 10.1016/S0002-9394(00)00659-0; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Jakob E, 2009, J RHEUMATOL, V36, P127, DOI 10.3899/jrheum.080102; Jamilloux Y, 2018, OPHTHALMOLOGY, V125, pE53, DOI 10.1016/j.ophtha.2018.03.005; Kim M, 2016, AM J OPHTHALMOL, V170, P32, DOI 10.1016/j.ajo.2016.07.016; McCannel CA, 1996, AM J OPHTHALMOL, V121, P35, DOI 10.1016/S0002-9394(14)70532-X; Monnet D, 2004, OPHTHALMOLOGY, V111, P802, DOI 10.1016/j.ophtha.2003.07.011; Munoz-Fernandez S, 2003, J RHEUMATOL, V30, P1277; Munoz-Fernandez S, 2009, EYE, V23, P1130, DOI 10.1038/eye.2008.198; Qiu Q, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006337; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P696, DOI 10.1136/ard.2008.092585; Suhler Eric B, 2003, Curr Opin Ophthalmol, V14, P378, DOI 10.1097/00055735-200312000-00010; van der Heijde D, 2017, ANN RHEUM DIS, V76, P978, DOI 10.1136/annrheumdis-2016-210770; Wach J, 2015, GRAEF ARCH CLIN EXP, V253, P115, DOI 10.1007/s00417-014-2772-6; Ward MM, 2016, ARTHRITIS RHEUMATOL, V68, P282, DOI 10.1002/art.39298; Wendling D, 2014, CURR MED RES OPIN, V30, P2515, DOI 10.1185/03007995.2014.969368; Wendling D, 2011, SEMIN ARTHRITIS RHEU, V41, P503, DOI 10.1016/j.semarthrit.2011.05.005; Yazgan S, 2017, INT OPHTHALMOL, V37, P139, DOI 10.1007/s10792-016-0239-y; Zeboulon N, 2008, ANN RHEUM DIS, V67, P955, DOI 10.1136/ard.2007.075754; Zochling J, 2015, COCHRANE DB SYST REV, V18; zu Hoerste MM, 2018, GRAEF ARCH CLIN EXP, V256, P1985, DOI 10.1007/s00417-018-4082-x	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230560	10.1371/journal.pone.0230560	http://dx.doi.org/10.1371/journal.pone.0230560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HO	32231384	Green Published, gold			2022-12-26	WOS:000535937400010
J	Al-Kuhlani, M; Lambert, G; Pal, S; de la Maza, L; Ojcius, DM				Al-Kuhlani, Mufadhal; Lambert, Graham; Pal, Sukumar; de la Maza, Luis; Ojcius, David M.			Immune response against Chlamydia trachomatis via toll-like receptors is negatively regulated by SIGIRR	PLOS ONE			English	Article							INFECTION; INFLAMMATION; IL-1R8; CELLS; INTERLEUKIN-8; ACTIVATION; EXPRESSION; RESISTANCE; SECRETION; SEPSIS	Chlamydia trachomatis is the most common bacterial sexually-transmitted infection and the major cause of preventable blindness worldwide. The asymptomatic nature of many infections along with uncontrolled inflammation leads to irreversible damage in the upper genital tract and the tarsal conjunctivae, with the major complications of infertility and chronic pelvic pain, and blindness, respectively. Inflammation must, therefore, be tightly regulated to avoid an unrestrained immune response. The genetic factors that regulate inflammation through Toll-like receptor (TLR) signaling pathways during C. trachomatis infection have not been fully characterized. SIGIRR (also known as IL-1R8 or TIR8) can regulate inflammation in response to various pathogens and diseases. However, nothing is known about its role during C. trachomatis infection. Expression of the pro-inflammatory chemokine, IL-8, was measured in epithelial cells infected with C. trachomatis. The effect of SIGIRR was determined by depleting SIGIRR or over-expressing SIGIRR in the epithelial cells before infection. Our results indicate that, in the absence of SIGIRR, epithelial cells induce higher levels of the pro-inflammatory chemokine, IL-8, in response to C. trachomatis infection. In addition, SIGIRR associates with MyD88 in both infected and uninfected infected cells. Collectively, our data demonstrate that SIGIRR functions as a negative regulator of the immune response to C. trachomatis infection. This finding provides insights into the immuno-pathogenesis of C. trachomatis that can be used to treat and identify individuals at risk of uncontrolled inflammation during infection.	[Al-Kuhlani, Mufadhal] Fresno City Coll, Dept Life Sci, Fresno, CA USA; [Al-Kuhlani, Mufadhal; Ojcius, David M.] Univ Pacific, Dept Biomed Sci, Arthur Dugoni Sch Dent, San Francisco, CA 94103 USA; [Lambert, Graham] Touro Univ Nevada, Coll Osteopath Med, Henderson, NV USA; [Pal, Sukumar; de la Maza, Luis] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA	University of the Pacific; University of California System; University of California Irvine	Ojcius, DM (corresponding author), Univ Pacific, Dept Biomed Sci, Arthur Dugoni Sch Dent, San Francisco, CA 94103 USA.	dojcius@pacific.edu	Ojcius, David/ABE-6557-2020	Pal, Sukumar/0000-0001-5170-5121; Ojcius, David/0000-0003-1461-4495	National Institute of Health [R56 AI078419]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the National Institute of Health (R56 AI078419) (DMO and LdM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2010, MICROBES INFECT, V12, P652, DOI 10.1016/j.micinf.2010.04.008; Al-Kuhlani M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093939; Batliwalla FM, 2005, MOL MED, V11, P21, DOI 10.2119/2006-00003.Gulko; Blok DC, 2014, J INNATE IMMUN, V6, P542, DOI 10.1159/000358239; Bozza S, 2008, J IMMUNOL, V180, P4022, DOI 10.4049/jimmunol.180.6.4022; Buchholz KR, 2006, CELL MICROBIOL, V8, P1768, DOI 10.1111/j.1462-5822.2006.00747.x; Bulek K, 2009, J IMMUNOL, V182, P2601, DOI 10.4049/jimmunol.0802729; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dessus-Babus S, 2002, INFECT IMMUN, V70, P3234, DOI 10.1128/IAI.70.6.3234-3248.2002; Drexler SK, 2010, SCAND J IMMUNOL, V71, P393, DOI 10.1111/j.1365-3083.2010.02392.x; Garlanda C, 2004, P NATL ACAD SCI USA, V101, P3522, DOI 10.1073/pnas.0308680101; Garlanda C, 2007, J IMMUNOL, V179, P3119, DOI 10.4049/jimmunol.179.5.3119; Gong J, 2010, J STRUCT BIOL, V169, P323, DOI 10.1016/j.jsb.2009.12.007; Guven-Maiorov E, 2015, BIOPHYS J, V109, P1214, DOI 10.1016/j.bpj.2015.06.048; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Horne DJ, 2012, J INFECT DIS, V205, P586, DOI 10.1093/infdis/jir785; Huang X, 2006, J IMMUNOL, V177, P548, DOI 10.4049/jimmunol.177.1.548; Lech M, 2008, J EXP MED, V205, P1879, DOI 10.1084/jem.20072646; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Molgora M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00149; MOLLER BR, 1979, BRIT J VENER DIS, V55, P422; Nold-Petry CA, 2015, NAT IMMUNOL, V16, P354, DOI 10.1038/ni.3103; Noris M, 2009, J IMMUNOL, V183, P4249, DOI 10.4049/jimmunol.0803549; O'Connell CM, 2006, J BIOL CHEM, V281, P1652, DOI 10.1074/jbc.M510182200; Perfettini JL, 2003, J BIOL CHEM, V278, P9496, DOI 10.1074/jbc.M211275200; Pettengill MA, 2016, BIOMED J, V39, P306, DOI 10.1016/j.bj.2016.07.001; Pioli PA, 2004, INFECT IMMUN, V72, P5799, DOI 10.1128/IAI.72.10.5799-5806.2004; Qin JZ, 2005, J BIOL CHEM, V280, P25233, DOI 10.1074/jbc.M501363200; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; Roan NR, 2008, CELL MICROBIOL, V10, P9, DOI 10.1111/j.1462-5822.2007.01069.x; Rodriguez TV, 2012, INFECT IMMUN, V80, P100, DOI 10.1128/IAI.05695-11; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Urbonas V, 2012, J PEDIAT HEMATOL ONC, V34, P122, DOI 10.1097/MPH.0b013e3182446a60; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Zhang C, 2011, MOL BIOL REP, V38, P601, DOI 10.1007/s11033-010-0146-7	36	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230718	10.1371/journal.pone.0230718	http://dx.doi.org/10.1371/journal.pone.0230718			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210474	Green Submitted, Green Published, gold			2022-12-26	WOS:000535307600043
J	Farhana, L; Sarkar, S; Nangia-Makker, P; Yu, YJ; Khosla, P; Levi, E; Azmi, A; Majumdar, APN				Farhana, Lulu; Sarkar, Sarah; Nangia-Makker, Pratima; Yu, Yingjie; Khosla, Pramod; Levi, Edi; Azmi, Asfar; Majumdar, Adhip P. N.			Natural agents inhibit colon cancer cell proliferation and alter microbial diversity in mice	PLOS ONE			English	Article							GAMMA-TOCOTRIENOL; GUT MICROBIOTA; VITAMIN-E; SIGNALING PATHWAY; GOLDEN SPICE; CURCUMIN; BIOAVAILABILITY; POLYPHENOLS; METABOLITES; APOPTOSIS	The current study was undertaken to investigate the effect of differentially formulated polyphenolic compound Essential Turmeric Oil-Curcumin (ETO-Cur), and Tocotrienol-rich fraction (TRF) of vitamin E isomers on colorectal cancer (CRC) cells that produce aggressive tumors. Combinations of ETO-Cur and TRF were used to determine the combinatorial effects of ETO-Cur and TRF-mediated inhibition of growth of CRC cells in vitro and HCT116 cells xenograft in SCID mice. 16S rRNA gene sequence profiling was performed to determine the outcome of gut microbial communities in mice feces between control and ETO-Cur-TRF groups. Bacterial identifications were validated by performing SYBR-based Real Time (RT) PCR. For metagenomics analysis to characterize the microbial communities, multiple software/tools were used, including Quantitative Insights into Microbial Ecology (QIIME) processing tool. We found ETO-Cur and TRF to synergize and that the combination of ETO-Cur-TRF significantly inhibited growth of HCT-116 xenografts in SCID mice. This was associated with a marked alteration in microbial communities and increased microbial OTU (operation taxonomic unit) number. The relative abundance of taxa was increased and the level of microbial diversity after 34 days of combinatorial treatment was found to be 44% higher over the control. Shifting of microbial family composition was observed in ETO-Cur-TRF treated mice as evidenced by marked reductions in Bacteroidaceae, Ruminococcaceae, Clostridiales, Firmicutes and Parabacteroids families, compared to controls. Interestingly, during the inhibition of tumor growth in ETO-Cur treated mice, probiotic Lactobacillaceae and Bifidobacteriaceae were increased by 20-fold and 6-fold, respectively. The relative abundance of anti-inflammatory Clostridium XIVa was also increased in ETO-Cur-TRF treated mice when compared with the control. Our data suggest that ETO-Cur-TRF show synergistic effects in inhibiting colorectal cancer cell proliferation in vitro and in mouse xenografts in vivo, and might induce changes in microbial diversity in mice.	[Farhana, Lulu; Sarkar, Sarah; Nangia-Makker, Pratima; Yu, Yingjie; Levi, Edi; Majumdar, Adhip P. N.] John Dingell Vet Affairs Med Ctr, Detroit, MI 48201 USA; [Farhana, Lulu; Nangia-Makker, Pratima; Yu, Yingjie; Azmi, Asfar; Majumdar, Adhip P. N.] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA; [Nangia-Makker, Pratima; Azmi, Asfar; Majumdar, Adhip P. N.] Karmanos Canc Inst, Detroit, MI 48201 USA; [Khosla, Pramod] Wayne State Univ, Dept Nutr & Food Sci, Detroit, MI USA; [Levi, Edi] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University	Majumdar, APN (corresponding author), John Dingell Vet Affairs Med Ctr, Detroit, MI 48201 USA.; Majumdar, APN (corresponding author), Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA.; Majumdar, APN (corresponding author), Karmanos Canc Inst, Detroit, MI 48201 USA.	majumdar@med.wayne.edu		Majumdar, Adhip/0000-0002-6413-5102	National Institute of Health, USA (NIH) [1R21CA175916]; Department of Veteran Affairs, USA [I101BX001927]; Metropolitan Detroit Research and Education Fund, Detroit, Michigan, USA (MDREF)	National Institute of Health, USA (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran Affairs, USA(US Department of Veterans Affairs); Metropolitan Detroit Research and Education Fund, Detroit, Michigan, USA (MDREF)	This study was funded by grants to Dr. Adhip Majumdar from the National Institute of Health, USA (NIH) (1R21CA175916), the Department of Veteran Affairs, USA (I101BX001927) and the Metropolitan Detroit Research and Education Fund, Detroit, Michigan, USA (MDREF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar IB, 2015, NAT PROD RES, V29, P2137, DOI 10.1080/14786419.2014.991927; Aggarwal BB, 2010, BIOCHEM PHARMACOL, V80, P1613, DOI 10.1016/j.bcp.2010.07.043; Ahn KS, 2007, J BIOL CHEM, V282, P809, DOI 10.1074/jbc.M610028200; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Antony B, 2008, INDIAN J PHARM SCI, V70, P445, DOI 10.4103/0250-474X.44591; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Bachawal SV, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-84; Baxter NT, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-20; Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001; Espin JC, 2017, BIOCHEM PHARMACOL, V139, P82, DOI 10.1016/j.bcp.2017.04.033; Cerda B, 2005, J AGR FOOD CHEM, V53, P227, DOI 10.1021/jf049144d; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Duineveld LAM, 2016, ANN FAM MED, V14, P215, DOI 10.1370/afm.1919; Dulal S, 2014, CANCER J, V20, P225, DOI 10.1097/PPO.0000000000000050; Evans HM, 1922, SCIENCE, V56, P650, DOI 10.1126/science.56.1458.650; Farhana Lulu, 2018, World J Gastrointest Pathophysiol, V9, P47, DOI 10.4291/wjgp.v9.i2.47; Farhana L, 2012, J ONCOL, V2012, DOI 10.1155/2012/796729; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gross G, 2010, J AGR FOOD CHEM, V58, P10236, DOI 10.1021/jf101475m; Gupta SC, 2012, CLIN EXP PHARMACOL P, V39, P283, DOI 10.1111/j.1440-1681.2011.05648.x; Jeffery M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002200.pub2; Kaileh M, 2010, J AM COLL NUTR, V29, p334S, DOI 10.1080/07315724.2010.10719848; Keku TO, 2013, TRENDS MICROBIOL, V21, P506, DOI 10.1016/j.tim.2013.08.004; Li H, 2019, BIOTECHNOLOGY ADV; Lim SW, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-469; Lim SW, 2014, BIOMED PHARMACOTHER, V68, P1105, DOI 10.1016/j.biopha.2014.10.006; Majumdar APN, 2009, NUTR CANCER, V61, P544, DOI 10.1080/01635580902752262; Mantzorou M, 2018, PHYTOTHER RES, V32, P957, DOI 10.1002/ptr.6037; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; Mocchegiani E, 2014, AGEING RES REV, V14, P81, DOI 10.1016/j.arr.2014.01.001; Nangia-Makker P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084369; Nautiyal Jyoti, 2011, J Mol Signal, V6, P7, DOI 10.1186/1750-2187-6-7; Ohno M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185999; Prasad S, 2014, BIOTECHNOL ADV, V32, P1053, DOI 10.1016/j.biotechadv.2014.04.004; Rajendran P, 2011, BRIT J PHARMACOL, V163, P283, DOI 10.1111/j.1476-5381.2010.01187.x; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Sargent DJ, 2005, J CLIN ONCOL, V23, P2020, DOI 10.1200/JCO.2005.01.112; Sen CK, 2004, ANN NY ACAD SCI, V1031, P127, DOI 10.1196/annals.1331.013; Sharma S, 2006, CLIN EXP PHARMACOL P, V33, P940, DOI 10.1111/j.1440-1681.2006.04468.x; Shishu, 2008, AAPS PHARMSCITECH, V9, P810, DOI 10.1208/s12249-008-9096-y; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Toden S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00812-6; van Gestel YRBM, 2014, CANCER EPIDEMIOL, V38, P448, DOI 10.1016/j.canep.2014.04.004; Wang LL, 2018, EUR REV MED PHARMACO, V22, P7257, DOI 10.26355/eurrev_201811_16260; Yan QL, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00381; Yang ZH, 2010, INT J CANCER, V126, P852, DOI 10.1002/ijc.24766; Yu YJ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0372-7; Yu YJ, 2009, TRANSL ONCOL, V2, P321, DOI 10.1593/tlo.09193; Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13; Zam W, 2018, J NUTR METAB, V2018, DOI 10.1155/2018/1367984	50	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0229823	10.1371/journal.pone.0229823	http://dx.doi.org/10.1371/journal.pone.0229823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196510	Green Published, gold			2022-12-26	WOS:000535303100014
J	You, I; Kim, EB				You, Inhwan; Kim, Eun Bae			Genome-based species-specific primers for rapid identification of six species of Lactobacillus acidophilus group using multiplex PCR	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; 16S RIBOSOMAL-RNA; ACETOACETATE DECARBOXYLASE GENE; REGION; PURIFICATION; CLONING; STRAIN; SAFETY	Many Lactobacillus species are frequently isolated from dairy products, animal guts, and the vaginas of healthy women. However, sequencing-based identification of isolated Lactobacillus strain is time/cost-consuming and lobor-intensive. In this study, we developed a multiplex PCR method to distinguish six closely related species in the Lactobacillus acidophilus group (L. gasseri, L. acidophilus, L. helveticus, L. jensenii, L. crispatus, and L. gallinarum), which is based on species-specific primer sets. Altogether, 86 genomes of 9 Lactobacillus species from the National Center of Biotechnology Information (NCBI) database were compared to detect species-specific genes and design six species-specific primer sets. The PCR conditions of the individual primer sets were optimized via gradient PCR methods. A final multiplex PCR condition was also optimized for a mixture of all six primer sets mixed. When identifying a single strain, the optimized multiplex PCR method can specifically detect one of the six species, but no band was amplified at least from the other Lactobacillus and Enterococcus species. These results indicated that species-specific primer sets designed from the genome comparison could identify one strain within the six Lactobacillus species by a single PCR reaction. Using the method described here, we will be able to save time, cost, and labor during species identification and screening of commercially important probiotic lactobacilli.	[You, Inhwan; Kim, Eun Bae] Kangwon Natl Univ, Coll Anim Life Sci, Dept Anim Life Sci, Chunchon, South Korea; [Kim, Eun Bae] Kangwon Natl Univ, Inst Anim Resources, Chunchon, South Korea	Kangwon National University; Kangwon National University	Kim, EB (corresponding author), Kangwon Natl Univ, Coll Anim Life Sci, Dept Anim Life Sci, Chunchon, South Korea.; Kim, EB (corresponding author), Kangwon Natl Univ, Inst Anim Resources, Chunchon, South Korea.	itanimal@kangwon.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2016R1C1B2016246]; Brain Korea 21 Plus Project	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Brain Korea 21 Plus Project	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016R1C1B2016246) and Brain Korea 21 Plus Project.	Arthur CJ, 2006, CHEM BIOL, V13, P587, DOI 10.1016/j.chembiol.2006.03.010; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bae Kim Eun, 2016, PLOSONE, V11; Berger B, 2007, J BACTERIOL, V189, P1311, DOI 10.1128/JB.01393-06; Berthoud H, 2017, INT DAIRY J, V70, P65, DOI 10.1016/j.idairyj.2016.10.005; Cousin FJ, 2018, INT J FOOD MICROBIOL; De Vuyst L, 2007, J MOL MICROB BIOTECH, V13, P194, DOI 10.1159/000104752; Dicks LMT, 2010, BENEF MICROBES, V1, P11, DOI 10.3920/BM2009.0012; Dubernet S, 2002, FEMS MICROBIOL LETT, V214, P271, DOI [10.1111/j.1574-6968.2002.tb11358.x, 10.1016/S0378-1097(02)00895-9]; Frolkova P, 2012, FOLIA MICROBIOL, V57, P439, DOI 10.1007/s12223-012-0115-8; FUJISAWA T, 1992, INT J SYST BACTERIOL, V42, P487, DOI 10.1099/00207713-42-3-487; GERISCHER U, 1990, J BACTERIOL, V172, P6907, DOI 10.1128/jb.172.12.6907-6918.1990; Han KS, 2005, BIOTECHNOL LETT, V27, P1183, DOI 10.1007/s10529-005-0014-z; ISOLAURI E, 1991, PEDIATRICS, V88, P90; JOHNSON JL, 1980, INT J SYST BACTERIOL, V30, P53, DOI 10.1099/00207713-30-1-53; Kim EB, 2014, APPL ENVIRON MICROB, V80, P154, DOI 10.1128/AEM.03108-13; Kopit LM, 2014, APPL ENVIRON MICROB, V80, P1899, DOI 10.1128/AEM.03859-13; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kwon HS, 2004, FEMS MICROBIOL LETT, V239, P267, DOI 10.1016/j.femsle.2004.08.049; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; Lin XL, 2017, MED SCI MONITOR, V23, DOI 10.12659/MSM.902237; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; Misra A, 2009, MOL BIOSYST, V5, P651, DOI 10.1039/b820420a; Moser A, 2017, INT DAIRY J, V68, P52, DOI 10.1016/j.idairyj.2016.12.007; Naser SM, 2007, INT J SYST EVOL MICR, V57, P2777, DOI 10.1099/ijs.0.64711-0; Nissen L, 2009, INT J FOOD MICROBIOL, V135, P288, DOI 10.1016/j.ijfoodmicro.2009.08.027; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Park J, 2017, CURR MICROBIOL, V74, P476, DOI 10.1007/s00284-017-1210-5; Perdigon G, 2001, Curr Issues Intest Microbiol, V2, P27; PETERSEN DJ, 1990, APPL ENVIRON MICROB, V56, P3491, DOI 10.1128/AEM.56.11.3491-3498.1990; Rajoka MSR, 2017, APPL MICROBIOL BIOT, V101, P35, DOI 10.1007/s00253-016-8005-7; Rizk G, 2010, BIOINFORMATICS, V26, P2534, DOI 10.1093/bioinformatics/btq485; RUCH FE, 1973, J BIOL CHEM, V248, P8086; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Sun ZH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9322; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wang RF, 1996, APPL ENVIRON MICROB, V62, P1242, DOI 10.1128/AEM.62.4.1242-1247.1996	39	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0230550	10.1371/journal.pone.0230550	http://dx.doi.org/10.1371/journal.pone.0230550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196527	Green Submitted, gold, Green Published			2022-12-26	WOS:000535303100037
J	Chang, PH; Lin, CR; Lee, YH; Liu, YL; Chang, GC; Hoogland, AI; Lai, YH				Chang, Pi-Hua; Lin, Ching-Rong; Lee, Yun-Hsiang; Liu, Yi-Lin; Chang, Gee-Chen; Hoogland, Aasha, I; Lai, Yeur-Hur			Exercise experiences in patients with metastatic lung cancer: A qualitative approach	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OF-LIFE; FUNCTIONAL-CAPACITY; NARRATIVE INQUIRY; SYMPTOM BURDEN; STAGE CANCER; REHABILITATION; METHODOLOGY; INTERVENTION; PREFERENCES	Background Patients with metastatic lung cancer can have severe cancer-related symptoms and treatment-induced side effects. Exercise is beneficial for patients with metastatic lung cancer; however, little information is available on guiding patients how to perform exercise during hospitalization. The purpose of this qualitative study was to understand exercise experiences in patients with metastatic lung cancer. Methods Patients with metastatic lung cancer (n = 24) participated in face-to-face in-depth interviews at an inpatient ward of a medical center in central Taiwan. Interview transcripts were evaluated using narrative analysis to extract and validate themes. Results Three primary themes were identified: (1) modifying exercise to maximize physical functions; (2) living with symptoms and frustration, but still exercising; and (3) doing exercise to sustain hopes, inner power, and life. Secondary findings included: (1) adopting walking as their main form of exercise because of its convenience; and (2) among patients with severe symptoms, adjusting exercise towards shorter time durations and shorter distances, slower speeds, and higher frequencies. Conclusions The study found physically active lung cancer patients, although with metastatic condition, adjusted their exercise activities to balance disease and treatment-induced deteriorations and boost themselves to feel hope and fight for cancer. However, the results may not be applicable to physically inactive patients. Future research to explore experiences from those with even worse physical conditions and further helping them to take some mild exercise to enhance the positive side of cancer experiences are suggested.	[Chang, Pi-Hua; Liu, Yi-Lin] Taichung Vet Gen Hosp, Dept Nursing, Taichung, Taiwan; [Chang, Pi-Hua; Lee, Yun-Hsiang; Lai, Yeur-Hur] Natl Taiwan Univ, Coll Med, Sch Nursing, Taipei, Taiwan; [Lin, Ching-Rong] Chang Gung Univ, Coll Med, Sch Nursing, Taoyuan, Taiwan; [Lin, Ching-Rong] Chang Gung Mem Hosp, Proton & Radiat Therapy Ctr, Dept Radiat Oncol, Taoyuan, Taiwan; [Chang, Gee-Chen] Taichung Vet Gen Hosp, Div Chest Med, Taichung, Taiwan; [Chang, Gee-Chen] Taichung Vet Gen Hosp, Comprehens Canc Ctr, Dept Internal Med, Taichung, Taiwan; [Chang, Gee-Chen] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan; [Hoogland, Aasha, I] H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL USA; [Lai, Yeur-Hur] Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan	Taichung Veterans General Hospital; National Taiwan University; Chang Gung University; Chang Gung Memorial Hospital; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; H Lee Moffitt Cancer Center & Research Institute; National Taiwan University	Lai, YH (corresponding author), Natl Taiwan Univ, Coll Med, Sch Nursing, Taipei, Taiwan.; Lai, YH (corresponding author), Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan.	laiyhwk@ntu.edu.tw		LAI, YEUR-HUR/0000-0003-0313-2634; Hoogland, Aasha/0000-0002-8691-8132	Taichung Veterans General Hospital Research Program in Taiwan [TCVGH-997415B]	Taichung Veterans General Hospital Research Program in Taiwan	This study was funded by the Taichung Veterans General Hospital Research Program (TCVGH-997415B) in Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aarts H, 1997, HEALTH EDUC RES, V12, P363, DOI 10.1093/her/12.3.363; Aboagye E, 2017, PAIN THER, V6, P85, DOI 10.1007/s40122-017-0067-4; Adamsen L, 2012, SCAND J MED SCI SPOR, V22, P804, DOI 10.1111/j.1600-0838.2011.01323.x; Albrecht TA, 2012, CLIN J ONCOL NURS, V16, P293, DOI 10.1188/12.CJON.293-300; Ament W, 2009, SPORTS MED, V39, P389, DOI 10.2165/00007256-200939050-00005; Bade BC, 2018, INTEGR CANCER THER, V17, P921, DOI 10.1177/1534735418781739; Bade BC, 2015, J THORAC ONCOL, V10, P861, DOI 10.1097/JTO.0000000000000536; Betof AS, 2013, BRAIN BEHAV IMMUN, V30, pS75, DOI 10.1016/j.bbi.2012.05.001; Booth S, 2014, MANAGING BREATHLESSN, P143; Buccheri G, 1996, EUR J CANCER, V32A, P1135, DOI 10.1016/0959-8049(95)00664-8; Buchan D. S., 2012, Journal of Obesity, V2012, P546459; Buman MP, 2010, PSYCHOL SPORT EXERC, V11, P223, DOI 10.1016/j.psychsport.2010.02.002; Chasen M, 2014, CAN MED ASSOC J, V186, P1071, DOI 10.1503/cmaj.131402; Cheng TYD, 2016, J THORAC ONCOL, V11, P1653, DOI 10.1016/j.jtho.2016.05.021; Cheville AL, 2013, J PAIN SYMPTOM MANAG, V45, P811, DOI 10.1016/j.jpainsymman.2012.05.006; Cheville AL, 2012, J PAIN SYMPTOM MANAG, V44, P84, DOI 10.1016/j.jpainsymman.2011.08.009; Clifford BK, 2018, SUPPORT CARE CANCER, V26, P685, DOI 10.1007/s00520-017-3964-5; Delaney LJ, 2018, COLLEGIAN, V25, P119, DOI 10.1016/j.colegn.2017.02.005; Denehy L, 2013, J THORAC ONCOL, V8, P1545, DOI 10.1097/JTO.0000000000000032; Dhillon HM, 2017, ANN ONCOL, V28, P1889, DOI 10.1093/annonc/mdx205; Edbrooke L, 2019, SUPPORT CARE CANCER; Edbrooke L, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091288; Edbrooke L, 2019, THORAX, V74, P787, DOI 10.1136/thoraxjnl-2018-212996; Edbrooke L, 2020, SUPPORT CARE CANCER, V28, P99, DOI 10.1007/s00520-019-04783-4; Eliott JA, 2007, SOC SCI MED, V64, P138, DOI 10.1016/j.socscimed.2006.08.029; Floersch J., 2010, QUAL SOC WORK, V9, P407, DOI [10.1177/1473325010362330, DOI 10.1177/1473325010362330]; Giovannucci EL, 2012, JNCI-J NATL CANCER I, V104, P797, DOI 10.1093/jnci/djs229; Granger CL, 2011, LUNG CANCER, V72, P139, DOI 10.1016/j.lungcan.2011.01.006; Granger CL, 2019, EUR J CANCER CARE, V28, DOI 10.1111/ecc.12946; Granger CL, 2017, SUPPORT CARE CANCER, V25, P983, DOI 10.1007/s00520-016-3484-8; Gysels M, 2008, J PAIN SYMPTOM MANAG, V35, P347, DOI 10.1016/j.jpainsymman.2007.05.012; Hannum SM, 2016, J AGING STUD, V36, P17, DOI 10.1016/j.jaging.2015.12.006; Haydon G, 2018, COLLEGIAN, V25, P125, DOI 10.1016/j.colegn.2017.03.001; Hayes SC, 2019, J SCI MED SPORT, V22, P1175, DOI 10.1016/j.jsams.2019.05.003; Health Promotion Administration, 2018, TAIW CANC REG ANN RE; Henke CC, 2014, SUPPORT CARE CANCER, V22, P95, DOI 10.1007/s00520-013-1925-1; Hwang CL, 2012, SUPPORT CARE CANCER, V20, P3169, DOI 10.1007/s00520-012-1452-5; Iyer S, 2013, LUNG CANCER, V81, P288, DOI 10.1016/j.lungcan.2013.03.008; Jones LW, 2012, LUNG CANCER, V76, P248, DOI 10.1016/j.lungcan.2011.10.009; Kartolo A, 2016, SUPPORT CARE CANCER, V24, P129, DOI 10.1007/s00520-015-2767-9; Kim KHC, 2004, PUBLIC HEALTH NUTR, V7, P773, DOI 10.1079/PHN2004601; Lakoski SG, 2012, NAT REV CLIN ONCOL, V9, P288, DOI 10.1038/nrclinonc.2012.27; Liao YC, 2014, ONCOL NURS FORUM, V41, pE44, DOI 10.1188/14.ONF.E44-E55; Marshall B, 2013, J COMPUT INFORM SYST, V54, P11, DOI 10.1080/08874417.2013.11645667; McClement SE, 2008, EUR J CANCER, V44, P1169, DOI 10.1016/j.ejca.2008.02.031; McTiernan A, 2004, CANCER INVEST, V22, P68, DOI 10.1081/CNV-120027581; Midtgaard J, 2015, ACTA ONCOL, V54, P609, DOI 10.3109/0284186X.2014.995777; Mikkelsen MK, 2019, EUR J ONCOL NURS, V41, P16, DOI 10.1016/j.ejon.2019.04.005; Miller KD, 2019, CA-CANCER J CLIN, V69, P363, DOI 10.3322/caac.21565; Moen T., 2006, INT J QUALITATIVE ME, V5, P56, DOI [10.1177/160940690600500405, DOI 10.1177/160940690600500405]; Olivier C, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4102-6; Overcash JA, 2003, CRIT REV ONCOL HEMAT, V48, P179, DOI 10.1016/j.critrevonc.2003.04.006; OWEN WF, 1984, Q J SPEECH, V70, P274, DOI 10.1080/00335638409383697; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Quist M, 2015, INTEGR CANCER THER, V14, P341, DOI 10.1177/1534735415572887; Quist M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-477; Riley T, 2005, HEALTH EDUC RES, V20, P226, DOI 10.1093/her/cyg122; Sheilds L, 2015, INT J NURS STUD, V52, P207, DOI 10.1016/j.ijnurstu.2014.10.008; Sheill G, 2018, PM&R, V10, P843, DOI 10.1016/j.pmrj.2018.02.006; Silver JK, 2013, CA-CANCER J CLIN, V63, P295, DOI 10.3322/caac.21186; Sung MR, 2017, CLIN LUNG CANCER, V18, P274, DOI 10.1016/j.cllc.2016.12.010; Tanaka K, 2002, J PAIN SYMPTOM MANAG, V23, P417, DOI 10.1016/S0885-3924(02)00376-7; Temel JS, 2009, J THORAC ONCOL, V4, P595, DOI 10.1097/JTO.0b013e31819d18e5; Tsai E, 2018, PSYCHO-ONCOLOGY, V27, P563, DOI 10.1002/pon.4519; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799; Turner RR, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010192.pub3; Walters S, 2013, THORAX, V68, P551, DOI 10.1136/thoraxjnl-2012-202297; Wang CC, 2015, Int J Nurs Sci, V2, P195, DOI 10.1016/j.ijnss.2015.04.014; Wang JW, 2015, SUPPORT CARE CANCER, V23, P1383, DOI 10.1007/s00520-014-2494-7; Woike BA, 2008, SOC PERSONAL PSYCHOL, V2, P434, DOI 10.1111/j.1751-9004.2007.00070.x	70	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230188	10.1371/journal.pone.0230188	http://dx.doi.org/10.1371/journal.pone.0230188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8KJ	32240205	Green Published, gold			2022-12-26	WOS:000535945000019
J	Hashida, Y; Withey, J; Lewis, DJ; Newman, T; Kline, JD				Hashida, Yukiko; Withey, John; Lewis, David J.; Newman, Tara; Kline, Jeffrey D.			Anticipating changes in wildlife habitat induced by private forest owners' adaptation to climate change and carbon policy	PLOS ONE			English	Article							LAND-USE CHANGE; ECOSYSTEM SERVICES; CHANGE IMPACTS; BIODIVERSITY; CONSERVATION; SEQUESTRATION; VULNERABILITY; STRATEGIES; NORTHWEST	Conserving forests to provide ecosystem services and biodiversity will be a key environmental challenge as society strives to adapt to climate change. The ecosystem services and biodiversity that forests provide will be influenced by the behaviors of numerous individual private landowners as they alter their use of forests in response to climate change and any future carbon pricing policies that emerge. We evaluated the impact of forest landowners' likely adaptation behaviors on potential habitat for 35 terrestrial, forest-dependent vertebrates across three U.S. Pacific states. In particular, we couple a previously estimated empirical-economic model of forest management with spatially explicit species' range and habitat associations to quantify the effects of adaptation to climate change and carbon pricing on potential habitat for our focal species (amphibians, birds and mammals) drawn from state agency lists of species of conservation concern. We show that both climate change and carbon pricing policies would likely encourage adaptation away from currently prevalent coniferous forest types, such as Douglas-fir, largely through harvest and planting decisions. This would reduce potential habitat for a majority of the focal species we studied across all three vertebrate taxa. The total anticipated habitat loss for amphibians, birds and mammals considered species of state concern would exceed total habitat gained, and the net loss in habitat per decade would accelerate over time. Carbon payments to forest landowners likely would lead to unintended localized habitat losses especially in Douglas-fir dominant forest types, and encourage more hardwoods on private forest lands. Our study highlights potential tradeoffs that could arise from pricing one ecosystem service (e.g., carbon) while leaving others (e.g., wildlife habitat) unpriced. Our study demonstrates the importance of anticipating potential changes in ecosystem services and biodiversity resulting from forest landowners' climate adaptation behavior and accounting for a broader set of environmental benefits and costs when designing policies to address climate change.	[Hashida, Yukiko] Univ Georgia, Dept Agr & Appl Econ, Athens, GA 30602 USA; [Withey, John; Newman, Tara] Evergreen State Coll, Grad Program Environm, Olympia, WA 98505 USA; [Lewis, David J.] Oregon State Univ, Dept Appl Econ, Corvallis, OR 97331 USA; [Kline, Jeffrey D.] US Forest Serv, USDA, Pacific Northwest Res Stn, Corvallis, OR USA	University System of Georgia; University of Georgia; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service	Hashida, Y (corresponding author), Univ Georgia, Dept Agr & Appl Econ, Athens, GA 30602 USA.	yhashida@uga.edu	Lewis, David/AFQ-9010-2022; Lewis, David/AAH-4137-2022; Lewis, David J/I-5700-2013	Lewis, David/0000-0002-2161-4189; Lewis, David/0000-0002-2161-4189; Lewis, David J/0000-0002-2161-4189; Hashida, Yukiko/0000-0001-8546-1532	USDA National Institute for Food and Agriculture [201767023-26275, 201767011-26079]; USDA Forest Service Pacific Northwest Research Station [14-JV-11261955-059]; Evergreen State College	USDA National Institute for Food and Agriculture; USDA Forest Service Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Evergreen State College	YH received funding from the USDA National Institute for Food and Agriculture (201767011-26079); DL received funding from the USDA Forest Service Pacific Northwest Research Station (14-JV-11261955-059) and the USDA National Institute for Food and Agriculture (201767023-26275).; JW received a Sponsored Research Grant from the Evergreen State College. A forest economist from the USDA Forest Service, Jeffrey Kline, is one of the authors and played a role in preparing the manuscript.	Abatzoglou JT, 2016, P NATL ACAD SCI USA, V113, P11770, DOI 10.1073/pnas.1607171113; [Anonymous], 2016, PROT AR DAT US PAD U; [Anonymous], ARCGIS DESKT 10 7; Bateman I, 2016, J ENVIRON MANAGE, V181, P172, DOI 10.1016/j.jenvman.2016.06.020; Bryan BA, 2016, GLOBAL ENVIRON CHANG, V38, P130, DOI 10.1016/j.gloenvcha.2016.03.002; Burger JA, 2009, FOREST ECOL MANAG, V258, P2335, DOI 10.1016/j.foreco.2009.03.015; California Department of Fish and Wildlife, 2005, STAT RAR THREAT END; Chen GS, 2017, EARTH SYST SCI DATA, V9, P545, DOI 10.5194/essd-9-545-2017; Christensen GA, 2016, PNWGTR913 USDA FOR S; Coops NC, 2010, CAN J FOREST RES, V40, P511, DOI 10.1139/X09-201; Crookston NL, 2010, FOREST ECOL MANAG, V260, P1198, DOI 10.1016/j.foreco.2010.07.013; Curtis PG, 2018, SCIENCE, V361, P1108, DOI 10.1126/science.aau3445; Diaz S, SUMMARY POLICYMAKERS, V45; Fezzi C, 2015, NAT CLIM CHANGE, V5, P255, DOI [10.1038/nclimate2525, 10.1038/NCLIMATE2525]; Food and Agriculture Organsiation of the United Nations, 2015, GLOBAL FOREST RESOUR; Forest Service U.S. Department of Agriculture, 2006, COOP ACR BOUND PARTN; Gray AN, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1224; Guo C, 2013, J ENVIRON ECON MANAG, V65, P452, DOI 10.1016/j.jeem.2012.12.003; Hashida Y, 2019, J ASSOC ENVIRON RESO, V6, P893, DOI 10.1086/704517; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Irwin LL, 2018, FOREST ECOL MANAG, V424, P288, DOI 10.1016/j.foreco.2018.05.007; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Kremen C, 2018, SCIENCE, V362, DOI 10.1126/science.aau6020; Krutilla JV, 1967, AM ECON REV, V57, P777; Latta GS, 2016, FOREST POLICY ECON, V65, P1, DOI 10.1016/j.forpol.2016.01.004; Lawler JJ, 2014, P NATL ACAD SCI USA, V111, P7492, DOI 10.1073/pnas.1405557111; Lawler JJ, 2009, ANN NY ACAD SCI, V1162, P79, DOI 10.1111/j.1749-6632.2009.04147.x; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lewis DJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220260; Lewis DJ, 2018, J ENVIRON ECON MANAG, V92, P20, DOI 10.1016/j.jeem.2018.08.014; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lubowski RN, 2006, J ENVIRON ECON MANAG, V51, P135, DOI 10.1016/j.jeem.2005.08.001; Massetti E, 2018, REV ENV ECON POLICY, V12, P324, DOI 10.1093/reep/rey007; McKenney DW, 2015, CAN J FOREST RES, V45, P1248, DOI 10.1139/cjfr-2015-0051; Mendenhall CD, 2016, P NATL ACAD SCI USA, V113, P14544, DOI 10.1073/pnas.1604981113; Midgley GF, 2002, GLOBAL ECOL BIOGEOGR, V11, P445, DOI 10.1046/j.1466-822X.2002.00307.x; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Nelson E, 2008, P NATL ACAD SCI USA, V105, P9471, DOI 10.1073/pnas.0706178105; Nordhaus William D., 2013, CLIM CASINO; Office of the Chief Financial Officer U.S. Department of Agriculture, STRAT PLAN FY 2014 2; Oregon Department of Fish and Wildlife, 2016, OR CONS STRAT 2016; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Phelps J, 2012, NAT CLIM CHANGE, V2, P497, DOI [10.1038/NCLIMATE1462, 10.1038/nclimate1462]; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Polasky S, 2019, P NATL ACAD SCI USA, V116, P5233, DOI 10.1073/pnas.1901616116; Rehfeldt GE, 2006, INT J PLANT SCI, V167, P1123, DOI 10.1086/507711; Restaino CM, 2016, P NATL ACAD SCI USA, V113, P9557, DOI 10.1073/pnas.1602384113; Salzman J, 2018, NAT SUSTAIN, V1, P136, DOI 10.1038/s41893-018-0033-0; Sanford T, 2014, NAT CLIM CHANGE, V4, P164, DOI 10.1038/nclimate2148; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; Sohngen B, 2016, FOREST POLICY ECON, V72, P18, DOI 10.1016/j.forpol.2016.06.011; Spies TA, 2010, LANDSCAPE ECOL, V25, P1185, DOI 10.1007/s10980-010-9483-0; Strassburg BBN, 2010, CONSERV LETT, V3, P98, DOI 10.1111/j.1755-263X.2009.00092.x; Todd Morgan., 2017, PNWGTR958 USDA FOR S, V130, P958; Train KE, 2009, DISCRETE CHOICE METHODS WITH SIMULATION, 2ND EDITION, P1, DOI 10.1017/CBO9780511805271; U.S.GeologicalSurvey, 2017, NAT GAP AN PROGR USG; van Kooten GC, 2015, EC FOREST CARBON SEQ; VANKOOTEN GC, 1995, AM J AGR ECON, V77, P365, DOI 10.2307/1243546; Washington Department of Fish & Wildlife, 2016, PRIOR HAB SPEC PHS L; Weiskittel A. R., 2012, Schweizerische Zeitschrift fur Forstwesen, V163, P70, DOI 10.3188/szf.2012.0070; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037	62	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230525	10.1371/journal.pone.0230525	http://dx.doi.org/10.1371/journal.pone.0230525			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8KJ	32240191	Green Published, Green Submitted, gold			2022-12-26	WOS:000535945000029
J	Shinohara, S; Amemiya, A; Takizawa, M				Shinohara, Satoshi; Amemiya, Atsuhito; Takizawa, Motoi			Evaluation of weight retention four weeks after delivery as a risk factor for gestational diabetes mellitus in a subsequent pregnancy	PLOS ONE			English	Article							OBESITY; ASSOCIATION; PREVALENCE; WOMEN	Aim We aimed to assess the association between postpartum weight retention (PPWR) in the fourth week after delivery and the risk of gestational diabetes mellitus (GDM) in a subsequent pregnancy. Methods We performed a retrospective cohort study of the obstetric records of women who gave birth to their second singleton between 32 and 41 weeks of gestation at the National Hospital Organization Kofu National Hospital between January 2013 and September 2019. The exclusion criteria were missing data, twin pregnancy, diabetes in pregnancy, and delivery before 22 weeks in the first pregnancy. We calculated PPWR as the BMI 4 weeks after the first birth minus the BMI before the first pregnancy and grouped the subjects into the stable PPWR (gain of <1 BMI unit) and non-stable PPWR groups (gain of >= 1 BMI units). We used the chi(2) test and multivariable logistic regression analysis to investigate the association between weight retention at the postpartum checkup and GDM. Results We included 566 women in this study (mean age, 31.7 +/- 4.8 years; mean maternal pre-pregnancy BMI, 21.3 +/- 3.5 kg/m(2); term delivery, n = 544 [96.1%]). The overall prevalence of GDM during the second pregnancy was 7.4% (42/566), and 33.9% (192/566) of women had stable PPWR. Non-stable PPWR was not significantly associated with GDM in the second pregnancy (adjusted odds ratio, 1.93; 95% confidence interval, 0.84-4.46) after controlling for each variable. Conclusion PPWR measured in the fourth week after delivery was not associated with an increased risk of GDM in the second pregnancy.	[Shinohara, Satoshi; Amemiya, Atsuhito; Takizawa, Motoi] Natl Hosp Org Kofu Natl Hosp, Dept Obstet & Gynecol, Kofu, Yamanashi, Japan		Shinohara, S (corresponding author), Natl Hosp Org Kofu Natl Hosp, Dept Obstet & Gynecol, Kofu, Yamanashi, Japan.	shinohara617@gmail.com						BEHBOUDIGANDEVANI, 2019, DIABETOL METAB SYNDR, V11, DOI DOI 10.1186/S13098-019-0406-1; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bryson CL, 2003, AM J EPIDEMIOL, V158, P1148, DOI 10.1093/aje/kwg273; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Nguyen CL, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/6536974; Cunningham F, 1997, WILLIAMS OBSTET, P533; Di Cianni G, 2003, DIABETES RES CLIN PR, V62, P131, DOI 10.1016/j.diabres.2003.07.004; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; da Silva LLGD, 2017, PREGNANCY HYPERTENS, V10, P196, DOI 10.1016/j.preghy.2017.08.006; Gore SA, 2003, ANN BEHAV MED, V26, P149, DOI 10.1207/S15324796ABM2602_07; Gunderson EP, 2009, OBSTET GYN CLIN N AM, V36, P317, DOI 10.1016/j.ogc.2009.04.001; Hedderson MM, 2010, PAEDIATR PERINAT EP, V24, P441, DOI 10.1111/j.1365-3016.2010.01140.x; Herring SJ, 2008, OBESITY, V16, P1296, DOI 10.1038/oby.2008.71; Kamana KC, 2015, ANN NUTR METAB, V66, P14, DOI 10.1159/000371628; Kodama Y, 2013, J OBSTET GYNAECOL RE, V39, P1242, DOI 10.1111/jog.12055; Kramer CK, 2019, DIABETOLOGIA, V62, P905, DOI 10.1007/s00125-019-4840-2; Lee KW, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2131-4; Liu J, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2423-3; Minakami H, 2014, J OBSTET GYNAECOL RE, V40, P1469, DOI 10.1111/jog.12419; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moons KGM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001744; Morikawa M, 2010, DIABETES RES CLIN PR, V90, P339, DOI 10.1016/j.diabres.2010.08.023; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Sorbye LM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002367; Wendland EM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-23; World Health Organization, 1998, BAS NEWB RES PRACT G; Xiong X, 2001, INT J GYNECOL OBSTET, V75, P221, DOI 10.1016/S0020-7292(01)00496-9; Yu HF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004863	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0231018	10.1371/journal.pone.0231018	http://dx.doi.org/10.1371/journal.pone.0231018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240241	Green Published, gold			2022-12-26	WOS:000535945000079
J	Yang, CL; Shen, SN; Zheng, XL; Ye, K; Ge, H; Sun, YN; Lu, YF				Yang, Chengliang; Shen, Sining; Zheng, Xiaoli; Ye, Ke; Ge, Hong; Sun, Yanan; Lu, Yufei			Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4	FASEB JOURNAL			English	Article						autophagy; chemoresistance; esophageal squamous cell carcinoma; long non-coding RNA LINC00337; targeting protein for Xenopus kinesin-like protein 2	CANCER; PROLIFERATION; APOPTOSIS; INHIBITION; PROMOTES; GROWTH; STAGE	Esophageal cancer represents the eighth most frequently occurring cancer, as well as the sixth most widespread cause of cancer-related deaths. In recent years, accumulating evidence has implicated long non-coding RNAs in the progression of esophageal squamous cell carcinoma (ESCC). The aim of the present study was to investigate the potential involvement and underlying mechanisms of LINC00337 in ESCC. Expression patterns of LINC00337 and targeting protein for Xenopus kinesin-like protein 2 (TPX2) in ESCC tissues and cells were detected using RT-qPCR and immunohistochemical staining. Next, the interactions among LINC00337, E2F4, and TPX2 were identified using chromatin immunoprecipitation, dual-luciferase reporter, and RNA-binding protein immunoprecipitation assays, suggesting that LINC00337 could recruit E2F4 to enhance the transcription of TPX2. Thereafter, the regulatory roles of LINC00337 and TPX2 in ESCC were analyzed by altering the expression of LINC00337 or TPX2 in ESCC cells following treatment with cisplatin (DDP). The levels of autophagy-related proteins Beclin1 and LC3II/LC3I, viability, autophagy, apoptosis, and chemoresistance of ESCC cells to DDP were measured following transfection treatment with different plasmids. Additionally, the role of the LINC00337/E2F4/TPX2 axis was assessed in vivo by measuring tumor formation in nude mice. The results demonstrated that LINC00337 upregulated TPX2, consequently leading to elevated levels of Beclin1 and LC3II/LC3I, promoted cell viability and autophagy, while inhibiting apoptosis and chemosensitivity to DDP in ESCC. In sum, the current study evidenced that the overexpression of LINC00337 could potentially enhance ESCC cell autophagy and chemoresistance to DDP via the upregulation of TPX2 by recruiting E2F4. Thus, LINC00337 may serve as a potential candidate for the treatment of ESCC.	[Yang, Chengliang; Zheng, Xiaoli; Ye, Ke; Ge, Hong; Sun, Yanan; Lu, Yufei] Zhengzhou Univ, Dept Radiat Oncol, Affiliated Canc Hosp, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China; [Shen, Sining] Zhengzhou Univ, Dept Thorac Surg, Affiliated Canc Hosp, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University	Ge, H (corresponding author), Zhengzhou Univ, Dept Radiat Oncol, Affiliated Canc Hosp, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China.	proge_hong@163.com	YANG, CHENGLIANG/AAP-4080-2020					Cao HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106007; Chen H, 2018, AM J CANCER RES, V8, P291; Chen YS, 2013, PATHOL RES PRACT, V209, P562, DOI 10.1016/j.prp.2013.06.006; Gao B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178760; Hsu PK, 2014, J GASTROENTEROL, V49, P1231, DOI 10.1007/s00535-013-0870-6; Hu B, 2019, AM J TRANSL RES, V11, P3238; Jia SL, 2019, INFECT GENET EVOL, V67, P88, DOI 10.1016/j.meegid.2018.10.027; Kim JA, 2017, CHIN CLIN ONCOL, V6, DOI 10.21037/cco.2017.09.05; Kondo Y, 2017, CANCER SCI, V108, P1927, DOI 10.1111/cas.13342; Lee BK, 2011, NUCLEIC ACIDS RES, V39, P3558, DOI 10.1093/nar/gkq1313; Li J, 2006, J SURG RES, V132, P112, DOI 10.1016/j.jss.2005.10.005; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Liu HC, 2014, BIOMED PHARMACOTHER, V68, P833, DOI 10.1016/j.biopha.2014.08.008; Liu HC, 2013, BIOMED PHARMACOTHER, V67, P751, DOI 10.1016/j.biopha.2013.04.004; Liu JB, 2011, WORLD J GASTROENTERO, V17, P4917, DOI 10.3748/wjg.v17.i44.4917; Nakajima M, 2013, EXPERT OPIN PHARMACO, V14, P1345, DOI 10.1517/14656566.2013.801454; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; Okuda M, 2017, ONCOTARGET, V8, P34670, DOI 10.18632/oncotarget.16668; Pu Q, 2016, THORAC CANCER, V7, P348, DOI 10.1111/1759-7714.12317; Shi WH, 2015, TUMOR BIOL, V36, P2501, DOI 10.1007/s13277-014-2863-3; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Tang QS, 2013, CANCER LETT, V336, P325, DOI 10.1016/j.canlet.2013.03.023; Toshimitsu H, 2004, CANCER LETT, V211, P69, DOI 10.1016/j.canlet.2004.01.038; Wang CM, 2014, DIGEST DIS SCI, V59, P591, DOI 10.1007/s10620-013-2956-7; Wang XH, 2016, J TOXICOL ENV HEAL A, V79, P407, DOI 10.1080/15287394.2016.1176617; Wang YJ, 2016, TUMOR BIOL, V37, P925, DOI 10.1007/s13277-015-3890-4; Zang WQ, 2016, ONCOTARGET, V7, P19960, DOI 10.18632/oncotarget.6963; Zhang X, 2019, OSA CONTINUUM, V2, P1, DOI 10.1364/OSAC.2.000001	28	21	21	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6055	6069		10.1096/fj.201900731RR	http://dx.doi.org/10.1096/fj.201900731RR		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32239565				2022-12-26	WOS:000522969200001
J	Harrison, KS; Zhu, LQ; Thunuguntla, P; Jones, C				Harrison, Kelly S.; Zhu, Liqian; Thunuguntla, Prasanth; Jones, Clinton			Herpes simplex virus 1 regulates beta-catenin expression in TG neurons during the latency-reactivation cycle	PLOS ONE			English	Article							1ST 1.5 KILOBASES; 2 SMALL RNAS; TYPE-1 LATENCY; TRANSCRIPT GENE; PRODUCTIVE INFECTION; INHIBITS APOPTOSIS; SENSORY NEURONS; PHENOTYPE; GANGLIA; CELLS	When herpes simplex virus 1 (HSV-1) infection is initiated in the ocular, nasal, or oral cavity, sensory neurons within trigeminal ganglia (TG) become infected. Following a burst of viral transcription in TG neurons, lytic cycle viral genes are suppressed and latency is established. The latency-associated transcript (LAT) is the only viral gene abundantly expressed during latency, and LAT expression is important for the latency-reactivation cycle. Reactivation from latency is required for virus transmission and recurrent disease, including encephalitis. The Wnt/beta-catenin signaling pathway is differentially expressed in TG during the bovine herpesvirus 1 latency-reactivation cycle. Hence, we hypothesized HSV-1 regulates the Wnt/beta-catenin pathway and promotes maintenance of latency because this pathway enhances neuronal survival and axonal repair. New studies revealed beta-catenin was expressed in significantly more TG neurons during latency compared to TG from uninfected mice or mice latently infected with a LAT(-/-) mutant virus. When TG explants were incubated with media containing dexamethasone to stimulate reactivation, significantly fewer beta-catenin+ TG neurons were detected. Conversely, TG explants from uninfected mice or mice latently infected with a LAT(-/-) mutant increased the number of beta-catenin+ TG neurons in the presence of DEX relative to samples not treated with DEX. Impairing Wnt signaling with small molecule antagonists reduced virus shedding during explant-induced reactivation. These studies suggested beta-catenin was differentially expressed during the latency-reactivation cycle, in part due to LAT expression.	[Harrison, Kelly S.; Zhu, Liqian; Thunuguntla, Prasanth; Jones, Clinton] Oklahoma State Univ, Coll Vet Med, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [Zhu, Liqian] Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China; [Zhu, Liqian] Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Zhu, Liqian] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA	Oklahoma State University System; Oklahoma State University - Stillwater; Yangzhou University; Yangzhou University; University of Wisconsin System; University of Wisconsin Madison	Jones, C (corresponding author), Oklahoma State Univ, Coll Vet Med, Dept Vet Pathobiol, Stillwater, OK 74078 USA.	clint.jones10@okstate.edu		Harrison, Kelly/0000-0003-0211-8769; Jones, Clinton/0000-0002-6656-4971	National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R21NS102290]; USDA-NIFA Competitive Grants Program [16-09370, 2018-06668]; Sitlington Endowment; Oklahoma Center for Respiratory and Infectious Diseases (National Institutes of Health Centers for Biomedical Research Excellence Grant) [P20GM103648]; OSU CVM Research Advisory Council; Chinese National Science Foundation [31472172, 31772743]; National Key Research Program [2016YFD0500704]	National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); USDA-NIFA Competitive Grants Program; Sitlington Endowment; Oklahoma Center for Respiratory and Infectious Diseases (National Institutes of Health Centers for Biomedical Research Excellence Grant); OSU CVM Research Advisory Council; Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Research Program	This research was supported by grants from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R21NS102290 (CJ), USDA-NIFA Competitive Grants Program (16-09370 and 2018-06668) (CJ), the Sitlington Endowment (CJ), support from the Oklahoma Center for Respiratory and Infectious Diseases (National Institutes of Health Centers for Biomedical Research Excellence Grant #P20GM103648), and funds from the OSU CVM Research Advisory Council (KH). These studies were also partially supported by the Chinese National Science Foundation Grant (No. 31472172 and No. 31772743) (LZ) and National Key Research Program (No. 2016YFD0500704) (LZ).	Ahmed M, 2002, J VIROL, V76, P717, DOI 10.1128/JVI.76.2.717-729.2002; Allen SJ, 2011, J VIROL, V85, P4184, DOI 10.1128/JVI.02290-10; Berwick DC, 2012, BIOCHEM SOC T, V40, P1123, DOI 10.1042/BST20120122; BIECHELE TL, 2012, SCI SIGNAL, V5, DOI DOI 10.1083/JCB.152.1.87; Branco FJ, 2005, J VIROL, V79, P9019, DOI 10.1128/JVI.79.14.9019-9025.2005; Carpenter D, 2015, J NEUROVIROL, V21, P568, DOI 10.1007/s13365-015-0361-z; Cha PH, 2016, NAT CHEM BIOL, V12, P593, DOI [10.1038/NCHEMBIO.2103, 10.1038/nchembio.2103]; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Drayman N, 2019, ELIFE, V8, DOI 10.7554/eLife.46339; FRASER NW, 1981, P NATL ACAD SCI-BIOL, V78, P6461, DOI 10.1073/pnas.78.10.6461; Gao G, 2009, CELL RES, V19, P665, DOI 10.1038/cr.2009.45; Garcia AL, 2018, NEURAL REGEN RES, V13, P43, DOI 10.4103/1673-5374.224359; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Harrison KS, 2019, J VIROL, V93, DOI 10.1128/JVI.00418-19; Inman M, 2001, J VIROL, V75, P3636, DOI 10.1128/JVI.75.8.3636-3646.2001; Jiang XZ, 2015, J NEUROVIROL, V21, P199, DOI 10.1007/s13365-015-0319-1; Jiang XZ, 2011, J VIROL, V85, P2325, DOI 10.1128/JVI.01791-10; Jin L, 2005, J VIROL, V79, P12286, DOI 10.1128/JVI.79.19.12286-12295.2005; Jin L, 2008, J NEUROVIROL, V14, P389, DOI 10.1080/13550280802216510; Jones Clinton, 2013, J Cell Death, V6, P1, DOI 10.4137/JCD.S10803; Kawanon Y, 2003, J CELL SCI, V116, P2677, DOI DOI 10.1242/JCS.00470; Kondo T, 2011, STEM CELLS, V29, P836, DOI 10.1002/stem.624; Kook I, 2015, J NEUROVIROL, V21, P585, DOI 10.1007/s13365-015-0339-x; Kook I, 2015, VIROLOGY, V484, P377, DOI 10.1016/j.virol.2015.06.010; KRAMER MF, 1995, J VIROL, V69, P1389, DOI 10.1128/JVI.69.3.1389-1399.1995; Lambert C, 2016, MOL NEUROBIOL, V53, P2297, DOI 10.1007/s12035-015-9138-x; Lewandowski G, 2002, ARCH VIROL, V147, P167, DOI 10.1007/s705-002-8309-9; Li SM, 2010, J GEN VIROL, V91, P858, DOI 10.1099/vir.0.015719-0; Liu YL, 2016, J VIROL, V90, P3148, DOI 10.1128/JVI.02971-15; Lovato L, 2003, J VIROL, V77, P4848, DOI 10.1128/JVI.77.8.4848-4857.2003; Mott KR, 2003, J GEN VIROL, V84, P2975, DOI 10.1099/vir.0.19421-0; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Peng W, 2008, J NEUROVIROL, V14, P41, DOI 10.1080/13550280701793957; Perng GC, 2000, SCIENCE, V287, P1500, DOI 10.1126/science.287.5457.1500; Perng GC, 2002, J VIROL, V76, P1224, DOI 10.1128/JVI.76.3.1224-1235.2002; Perng GC, 2000, J VIROL, V74, P1885, DOI 10.1128/JVI.74.4.1885-1891.2000; PERNG GC, 1994, J VIROL, V68, P8045, DOI 10.1128/JVI.68.12.8045-8055.1994; Perng GC, 1996, J VIROL, V70, P976, DOI 10.1128/JVI.70.2.976-984.1996; Perng Guey-Chuen, 2010, Interdiscip Perspect Infect Dis, V2010, P262415, DOI 10.1155/2010/262415; Phelan D, 2017, J NEUROIMMUNOL, V308, P65, DOI 10.1016/j.jneuroim.2017.03.002; Polakis P., 2012, COLD SPRING HARB PER; Purro SA, 2014, J MOL CELL BIOL, V6, P75, DOI 10.1093/jmcb/mjt049; Raja P, 2016, MBIO, V7, DOI [10.1128/mBio.00633-16, 10.1128/mBio.02007-15]; Rosso SB, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00103; Salinas PC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008003; Sawtell NM, 1997, J VIROL, V71, P5423, DOI 10.1128/JVI.71.7.5423-5431.1997; Shen WW, 2009, J VIROL, V83, P9131, DOI 10.1128/JVI.00871-09; Simonetti M, 2014, NEURON, V83, P104, DOI 10.1016/j.neuron.2014.05.037; Tang S, 2009, J VIROL, V83, P1433, DOI 10.1128/JVI.01723-08; Teo Chuin Hau, 2018, Neurosignals, V26, P31, DOI 10.1159/000487764; Thompson RL, 2001, J VIROL, V75, P6660, DOI 10.1128/JVI.75.14.6660-6675.2001; Umbach JL, 2009, J VIROL, V83, P10677, DOI 10.1128/JVI.01185-09; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Workman A, 2018, J VIROL, V92, DOI 10.1128/JVI.01937-17; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zhu L, 2017, J VIROL, V91; Zhu LQ, 2018, VIRUS RES, V256, P29, DOI 10.1016/j.virusres.2018.07.020	58	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230870	10.1371/journal.pone.0230870	http://dx.doi.org/10.1371/journal.pone.0230870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HE	32226020	Green Published, gold			2022-12-26	WOS:000535936400022
J	Milenkov, AR; Felini, M; Baker, E; Acharya, R; Diese, EL; Onsa, S; Fernando, S; Chor, H				Milenkov, Amy Raines; Felini, Martha; Baker, Eva; Acharya, Rushil; Diese, Elvis Longanga; Onsa, Sara; Fernando, Shane; Chor, Holy			Uptake of cancer screenings among a multiethnic refugee population in North Texas, 2014-2018	PLOS ONE			English	Article							CERVICAL-CANCER; PREVENTIVE HEALTH; IMMIGRANT WOMEN; EPIDEMIOLOGIC TRANSITION; BREAST; DISPARITIES; PERSPECTIVES; KNOWLEDGE; AMERICAN; BEHAVIOR	Background Refugees are less likely than US born populations to receive cancer screenings. Building Bridges is a community health worker prevention program designed to increase refugee's cancer screening uptake. The purpose of this cross sectional analysis was to assess differences in uptake of cervical, breast, liver, and colorectal screens across six cultural groups. Methods Data was abstracted in 2018 for this analysis. Participants were categorized into six cultural groups (Myanmar, Central Africa, Bhutan, Somalia, Arabic Speaking Countries, and Other) to assess differences in sociodemographic measures and screening uptake. Uptake proportions were calculated for each cancer type (cervical, breast, liver, and colon) among eligible participants, by gender and cultural group. Differences in uptake across groups were assessed using stratified analysis and logistic regression. Prevalence odds ratios (POR) and 95% confidence intervals (CIs) were calculated for each group to assess the association between screening completion and cultural group. Findings 874 refugees were asked about cancer screening history. The majority of participants were either 'never had been screened' or 'not up-to-date' for every cancer screening. Among age eligible, 82% had no prior pap exam within the past 3 years, 81% had no prior mammogram within the past year, 69% didn't know their Hepatitis B status and 87% never had a colon cancer screening. Overall, higher uptake of all types of cancer screenings was observed in Myanmar and Bhutanese groups, except colon cancer screening which was higher among Central African Region and Arabic Speaking participants. Conclusion Screening uptake varied by ethnic group and screening type. The program reached an under and never screened population, however, the proportion of refugees who received a cancer screening remained low compared to the US population. Diversity within refugee communities requires adaptation to specific cultural and linguistic needs to include new Americans in cancer elimination efforts.	[Milenkov, Amy Raines; Felini, Martha; Baker, Eva; Acharya, Rushil; Diese, Elvis Longanga; Onsa, Sara; Fernando, Shane] Univ North Texas, Hlth Sci Ctr, Dept Pediat & Womens Hlth, Ft Worth, TX 76107 USA; [Chor, Holy] Univ North Texas, Hlth Sci Ctr, Texas Coll Osteopath Med, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Milenkov, AR (corresponding author), Univ North Texas, Hlth Sci Ctr, Dept Pediat & Womens Hlth, Ft Worth, TX 76107 USA.	Amy.Raines-Milenkov@unthsc.edu	Acharya, Rushil/HHZ-5564-2022	Acharya, Rushil/0000-0003-1546-7335; Raines Milenkov, Amy/0000-0002-8178-0779; Longanga Diese, Elvis/0000-0002-7840-9864	Cancer Prevention and Research Institute of Texas (CPRIT) [PP170012, PP130074]	Cancer Prevention and Research Institute of Texas (CPRIT)	This research was supported by the Cancer Prevention and Research Institute of Texas (CPRIT), Evidence-Based Cancer Prevention Services, PP170012 and PP130074 (ARM). https://www.cprit.state.tx.us/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyemiju TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048834; Anaman JA, 2018, J CANCER EDUC, V33, P716, DOI 10.1007/s13187-016-1126-y; Apitzsch H, 1996, NORD J PSYCHIAT, V50, P333, DOI 10.3109/08039489609078175; Batalova BBaJ, 2019, REFUGEES ASYLEES US; Ben Morrison T, 2012, J IMMIGR MINOR HEALT, V14, P968, DOI 10.1007/s10903-012-9632-4; Bishehsari F, 2014, WORLD J GASTROENTERO, V20, P6055, DOI 10.3748/wjg.v20.i20.6055; CDC, 2012, GUID PRED POST MED S; Colvin HM, 2010, HEPATITIS AND LIVER CANCER: A NATIONAL STRATEGY FOR PREVENTION AND CONTROL OF HEPATITIS B AND C, P1; Dallo FJ, 2015, WOMEN HEALTH ISS, V25, P56, DOI 10.1016/j.whi.2014.10.002; Darwish-Yassine May, 2005, Ethn Dis, V15, pS1; Department USS, 2017, FACT SHEET FISC YEAR; Department USS, REF ADM BUR POP REF; Endeshaw M, 2018, J LOW GENIT TRACT DI, V22, P280, DOI 10.1097/LGT.0000000000000422; Force TUSPST. Published Recommendations, 2019, FORC TUSPST; Forney-Gorman A, 2016, J IMMIGR MINOR HEALT, V18, P1371, DOI 10.1007/s10903-015-0267-0; Franceschi S, 2013, MOL ONCOL, V7, P1, DOI 10.1016/j.molonc.2012.10.010; Ginsburg O, 2017, LANCET, V389, P847, DOI [10.1016/S0140-6736(16)31392-7, 10.1]; Gondek M, 2015, J CANCER EDUC, V30, P593, DOI 10.1007/s13187-014-0751-6; Hall IJ, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.170465; Harcourt N, 2014, J IMMIGR MINOR HEALT, V16, P450, DOI 10.1007/s10903-012-9766-4; Haworth RJ, 2014, J COMMUN HEALTH, V39, P872, DOI 10.1007/s10900-014-9906-y; Kue J, 2017, J COMMUN HEALTH, V42, P1079, DOI 10.1007/s10900-017-0355-2; Miyamoto Robin ES, 2019, Hawaii J Med Public Health, V78, P78; (ODPHP) OoDPaHP, 2008, HLTH PEOPL 2020 OBJ; Padela AI, 2014, J LOW GENIT TRACT DI, V18, P326, DOI 10.1097/LGT.0000000000000026; Ratha D, 2016, MIGR REM FACTB; Saadi A, 2015, WOMEN HEALTH ISS, V25, P501, DOI 10.1016/j.whi.2015.06.005; Saadi A, 2012, J IMMIGR MINOR HEALT, V14, P633, DOI 10.1007/s10903-011-9520-3; Salman KF, 2012, HEALTH CARE WOMEN IN, V33, P45, DOI 10.1080/07399332.2011.610536; Samuel PS, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-30; Schuster RC, 2018, J NATL MED ASS; Sewali B, 2015, CANCER MED-US, V4, P620, DOI 10.1002/cam4.429; Texas CPaRIo (CPRIT), 2018, 2018 TEXAS CANC PLAN; USA for UNHCR-The UN Refugee Agency, 2019, WHAT IS REF DEF MEAN; Vahabi M, 2016, CANCER MED-US, V5, P1670, DOI 10.1002/cam4.700; Wang A, 2018, J IMMIGR MINOR HEALT, P1, DOI [10.1007/s10903-017-0556-x, DOI 10.1007/S10903-017-0556-X]; World Health Organization, 2012, ADDR CHALL WOM HLTH; Zhang Y, 2017, J COMMUN HEALTH, V42, P583, DOI 10.1007/s10900-016-0292-5	38	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230675	10.1371/journal.pone.0230675	http://dx.doi.org/10.1371/journal.pone.0230675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8HE	32226017	gold, Green Published			2022-12-26	WOS:000535936400011
J	Ricci, G; Castelpietra, E; Romano, F; Di Lorenzo, G; Zito, G; Ronfani, L; Biffi, S; Monasta, L				Ricci, Giuseppe; Castelpietra, Elena; Romano, Federico; Di Lorenzo, Giovanni; Zito, Gabriella; Ronfani, Luca; Biffi, Stefania; Monasta, Lorenzo			Case-control study to develop and validate a questionnaire for the secondary prevention of endometriosis	PLOS ONE			English	Article							SEVERE TEENAGE ACNE; RED HAIR COLOR; PRESURGICAL DIAGNOSIS; PIGMENTARY TRAITS; RISK; WOMEN; ASSOCIATION; PATHOGENESIS; POPULATION; PREVALENCE	Background Endometriosis is a debilitating gynecologic disease characterized by the implantation of endometrial tissue in ectopic locations, with signs of severe and chronic inflammation. The new knowledge on endometriosis has highlighted the value of secondary prevention through the early diagnosis and treatment of lesions to reduce serious consequences, first of all, infertility and chronic pelvic pain. The purpose of this study is to assess the reliability and validity of the questionnaire, as a tool to precociously identify women with endometriosis, to prevent the progression of symptoms. Method We reviewed the literature and selected risk factors, symptoms, and phenotypic traits of the women affected by endometriosis to create the questionnaire divided into 8 modules, with 47 questions. A total of 151 women completed the questionnaires: 51 patients who have endometriosis (the cases) and 100 matched women without endometriosis (the controls). After data collection, bivariate and multivariate analyses were conducted. Results We retained four of the significant variables from a step-down logistic regression, namely chronic pelvic pain, dyspareunia with VAS >= 3, painful defecation, and acne, to develop a final "predictive" logistic model achieving 90.2% sensitivity and 75% specificity. Conclusion Our pilot study demonstrated that the questionnaire provides a powerful tool for the secondary prevention of endometriosis.	[Ricci, Giuseppe; Castelpietra, Elena; Romano, Federico; Di Lorenzo, Giovanni; Zito, Gabriella; Ronfani, Luca; Biffi, Stefania; Monasta, Lorenzo] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Ricci, Giuseppe] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy	IRCCS Burlo Garofolo; University of Trieste	Biffi, S (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.	stefania.biffi@burlo.trieste.it	romano, federico/K-2667-2018; Ricci, Giuseppe/AAC-3332-2022; Castelpietra, Elena/AAC-9621-2022; Monasta, Lorenzo/B-1388-2012; Biffi, Stefania/C-6652-2015	Ricci, Giuseppe/0000-0002-8031-1102; Monasta, Lorenzo/0000-0001-7774-548X; Biffi, Stefania/0000-0003-2257-2053; Di Lorenzo, Giovanni/0000-0002-8845-1206; Castelpietra, Elena/0000-0001-6761-6633				Abrao MS, 2007, HUM REPROD, V22, P3092, DOI 10.1093/humrep/dem187; Aguiar FM, 2009, CLIN EXP OBSTET GYN, V36, P23; Barra F, 2018, HUM REPROD UPDATE, V24, P710, DOI 10.1093/humupd/dmy027; Barra F, 2018, EXPERT OPIN INV DRUG, V27, P445, DOI 10.1080/13543784.2018.1471135; Borghese B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/618964; Bungum HF, 2014, EUR J OBSTET GYN R B, V179, P209, DOI 10.1016/j.ejogrb.2014.04.025; Chapron C, 2005, HUM REPROD, V20, P507, DOI 10.1093/humrep/deh627; Chapron C, 2012, HUM REPROD, V27, P702, DOI 10.1093/humrep/der462; Chapron C, 2011, FERTIL STERIL, V95, P877, DOI 10.1016/j.fertnstert.2010.10.027; CRAMER DW, 1986, JAMA-J AM MED ASSOC, V255, P1904; Dancet EAF, 2012, HUM REPROD, V27, P3168, DOI 10.1093/humrep/des299; Ek M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0213-2; Fauconnier A, 2018, J GYNECOL OBSTET HUM, V47, P69, DOI 10.1016/j.jogoh.2017.11.003; Fedele L, 2007, HUM REPROD, V22, P2698, DOI 10.1093/humrep/dem236; Ferrero S, 2005, HUM REPROD, V20, P3514, DOI 10.1093/humrep/dei263; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Hediger ML, 2005, FERTIL STERIL, V84, P1366, DOI 10.1016/j.fertnstert.2005.05.029; Hickey M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1752; Kashima K, 2004, INT J GYNECOL OBSTET, V84, P61, DOI 10.1016/S0020-7292(03)00340-0; Kvaskoff M, 2015, HUM REPROD UPDATE, V21, P500, DOI 10.1093/humupd/dmv013; Kvaskoff M, 2014, INT J EPIDEMIOL, V43, P255, DOI 10.1093/ije/dyt235; Kvaskoff M, 2009, INT J EPIDEMIOL, V38, P1143, DOI 10.1093/ije/dyp175; Lagana AS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225615; Lagana AS, 2017, MED HYPOTHESES, V103, P10, DOI 10.1016/j.mehy.2017.03.032; LAMB K, 1986, AM J PREV MED, V2, P324; Luisi S, 2009, GYNECOL ENDOCRINOL, V25, P734, DOI 10.3109/09513590903159664; Maggiore ULR, 2017, EUR UROL, V71, P790, DOI 10.1016/j.eururo.2016.12.015; Matalliotakis I, 2012, J OBSTET GYNAECOL, V32, P291, DOI 10.3109/01443615.2011.644358; Missmer SA, 2006, FERTIL STERIL, V85, P866, DOI 10.1016/j.fertnstert.2005.12.008; MORADI M, 2019, BMC WOMENS HEALTH, V19, DOI DOI 10.1186/S12905-019-076272; Morassutto C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154227; Nielsen NM, 2011, HUM REPROD, V26, P1555, DOI 10.1093/humrep/der105; Nnoaham KE, 2012, FERTIL STERIL, V98, P692, DOI 10.1016/j.fertnstert.2012.04.022; Paulson John D, 2007, JSLS, V11, P175; Pellegrini C, 2012, FERTIL STERIL, V98, P1200, DOI 10.1016/j.fertnstert.2012.06.056; Pillet MCL, 2012, HUM REPROD, V27, P265, DOI 10.1093/humrep/der346; Ragab A, 2015, INT J HEALTH SCI-IJH, V9, P273; Riazi H, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0196-z; Santoro L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/236821; Schliep KC, 2015, HUM REPROD, V30, P2427, DOI 10.1093/humrep/dev147; Shah DK, 2010, ACTA OBSTET GYN SCAN, V89, P646, DOI 10.3109/00016341003657900; Somigliana E, 2010, HUM REPROD, V25, P728, DOI 10.1093/humrep/dep453; Stephansson O, 2011, HUM REPROD, V26, P2896, DOI 10.1093/humrep/der263; Tietjen GE, 2007, HEADACHE, V47, P1069, DOI 10.1111/j.1526-4610.2007.00784.x; TRELOAR SA, 2010, AM J OBSTET GYNECOL, V202, DOI DOI 10.1016/IAJ0G.2009.10.85'7; Van den Bosch T, 2018, BEST PRACT RES CL OB, V51, P16, DOI 10.1016/j.bpobgyn.2018.01.013; Vercellini P, 2014, HUM REPROD, V29, P2171, DOI 10.1093/humrep/deu169; Vigano P, 2004, BEST PRACT RES CL OB, V18, P177, DOI 10.1016/j.bpobgyn.2004.01.007; WOODWORTH SH, 1995, FERTIL STERIL, V64, P651, DOI 10.1016/S0015-0282(16)57809-1; Wu CY, 2015, INT J COLORECTAL DIS, V30, P907, DOI 10.1007/s00384-015-2218-6; Wyshak G, 2000, INT J DERMATOL, V39, P798, DOI 10.1046/j.1365-4362.2000.00051-2.x; Xie J, 2014, HUM REPROD, V29, P2592, DOI 10.1093/humrep/deu207; Yang MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033941; Zhang MF, 2014, HUM GENET, V133, P259, DOI 10.1007/s00439-013-1374-4; Zito G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/191967	55	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230828	10.1371/journal.pone.0230828	http://dx.doi.org/10.1371/journal.pone.0230828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HE	32226031	Green Published, gold			2022-12-26	WOS:000535936400018
J	Jahanzad, E; Holtz, BA; Zuber, CA; Doll, D; Brewer, KM; Hogan, S; Gaudin, ACM				Jahanzad, Emad; Holtz, Brent A.; Zuber, Cameron A.; Doll, David; Brewer, Kelsey M.; Hogan, Sean; Gaudin, Amelie C. M.			Orchard recycling improves climate change adaptation and mitigation potential of almond production systems	PLOS ONE			English	Article							HYDRAULIC CONDUCTIVITY; DEFICIT IRRIGATION; ORGANIC-MATTER; CARBON STOCKS; SOIL; WATER; NITROGEN; CONSERVATION; COMPACTION; MANAGEMENT	There is an urgent need to develop climate smart agroecosystems capable of mitigating climate change and adapting to its effects. In California, high commodity prices and increased frequency of drought have encouraged orchard turnover, providing an opportunity to recycle tree biomass in situ prior to replanting an orchard. Whole orchard recycling (WOR) has potential as a carbon (C) negative cultural practice to build soil C storage, soil health, and orchard productivity. We tested the potential of this practice for long term C sequestration and hypothesized that associated co-benefits to soil health will enhance sustainability and resiliency of almond orchards to water-deficit conditions. We measured soil health metrics and productivity of an almond orchard following grinding and incorporation of woody biomass vs. burning of old orchard biomass 9 years after implementation. We also conducted a deficit irrigation trial with control and deficit irrigation (-20%) treatments to quantify shifts in tree water status and resilience. Biomass recycling led to higher yields and substantial improvement in soil functioning, including nutrient content, aggregation, porosity, and water retention. This practice also sequestered significantly higher levels of C in the topsoil (+5 t ha(-1)) compared to burning. We measured a 20% increase in irrigation water use efficiency and improved soil and tree water status under stress, suggesting that in situ biomass recycling can be considered as a climate smart practice in California irrigated almond systems.	[Jahanzad, Emad; Brewer, Kelsey M.; Gaudin, Amelie C. M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Holtz, Brent A.; Zuber, Cameron A.; Doll, David; Hogan, Sean] Univ Calif Davis, Agr & Nat Recourses, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Gaudin, ACM (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	agaudin@ucdavis.edu			California Department of Food and Agriculture [SCB16043]	California Department of Food and Agriculture	ACMG SCB16043 California Department of Food and Agriculture https://www.cdfa.ca.gov/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Ardo J, 2003, J ARID ENVIRON, V54, P633, DOI 10.1006/jare.2002.1105; BAVEL C. H. M. VAN., 1950, Proceedings. Soil Science Society of America, 1949, V14, P20; Bell CW, 2013, JOVE-J VIS EXP, DOI 10.3791/50961; Blake G. R., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P377; Bonanomi G, 2011, APPL SOIL ECOL, V47, P184, DOI 10.1016/j.apsoil.2010.12.007; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; CDFA, 2018, CAL DEP FOOD AGR 201, V8; Cheesman S, 2016, SOIL TILL RES, V156, P99, DOI 10.1016/j.still.2015.09.018; Chung HG, 2007, GLOBAL CHANGE BIOL, V13, P980, DOI 10.1111/j.1365-2486.2007.01313.x; Doll D., 2010, IRRIGATION MODULE CA, P16; Donato DC, 2012, J ENVIRON MANAGE, V97, P89, DOI 10.1016/j.jenvman.2011.12.004; DURNER W, 1994, WATER RESOUR RES, V30, P211, DOI 10.1029/93WR02676; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Fonte SJ, 2010, GEODERMA, V155, P320, DOI 10.1016/j.geoderma.2009.12.016; Frank S, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8c83; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P197, DOI 10.1016/S0167-1987(02)00027-2; Ghimire R, 2012, PADDY WATER ENVIRON, V10, P95, DOI 10.1007/s10333-011-0268-0; Goldhamer DA, 2004, J HORTIC SCI BIOTECH, V79, P538, DOI 10.1080/14620316.2004.11511802; Hamza MA, 2005, SOIL TILL RES, V82, P121, DOI 10.1016/j.still.2004.08.009; Haney R., 2015, INTEGRATED APPROACH; Haney RL., 2012, OPEN J SOIL SCI, V2, P269, DOI [10.4236/ojss.2012.23032, DOI 10.4236/OJSS.2012.23032]; Hofer S., 2003, QUIK CHEM METHOD; Holtz BA, 2016, ACTA HORTIC, V1112, P315, DOI 10.17660/ActaHortic.2016.1112.42; Holtz B.A., 2009, ORCHARD CARBON RECYC; Holtza B., 2018, Acta Horticulturae, P265; Horneck DA, 1998, HANDBOOK OF REFERENCE METHODS FOR PLANT ANALYSIS, P75; Horwath W.R., 1996, METHODS SOIL ANAL PA, P753; Institute SAS, 1995, JMP STAT GRAPH GUID; Johnson B, 2013, 1301 BSU CGISS; Karami A, 2012, AGR ECOSYST ENVIRON, V148, P22, DOI 10.1016/j.agee.2011.10.021; Kendall A, 2015, J IND ECOL, V19, P1008, DOI 10.1111/jiec.12332; Kerr A, 2018, CLIMATIC CHANGE, V148, P419, DOI 10.1007/s10584-017-2011-3; Lal R, 2015, SUSTAINABILITY-BASEL, V7, P5875, DOI 10.3390/su7055875; Lal R, 2014, J SOIL WATER CONSERV, V69, p186A, DOI 10.2489/jswc.69.6.186A; Lampinen BD, 2012, HORTTECHNOLOGY, V22, P237, DOI 10.21273/HORTTECH.22.2.237; Lipiec J, 2003, GEODERMA, V116, P107, DOI 10.1016/S0016-7061(03)00097-1; Littel RC, 2006, SAS MIXED MODELS, P834; LIU ZL, 2017, PLOS ONE, V12, DOI DOI 10.1371/JOURNAL.PONE.0179079; Meyer G.A., 1992, INDUCTIVELY COUPLED, V2, P473; Minasny B, 2017, GEODERMA, V292, P59, DOI 10.1016/j.geoderma.2017.01.002; Mitchell JP, 2017, SOIL TILL RES, V165, P325, DOI 10.1016/j.still.2016.09.001; Nar H, 2009, PHOTOSYNTHETICA, V47, P429, DOI 10.1007/s11099-009-0066-8; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Neves CSVJ, 2003, SOIL TILL RES, V71, P109, DOI 10.1016/S0167-1987(03)00023-0; Olander L, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/011002; Peters A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR007136; Rhoades JD, 1982, AGRONOMY, V9, P167, DOI DOI 10.2134/AGR0NM0N0GR9.2.2ED.C10; Rible J.M., 1960, METHOD S 190 CATION; Richards L. A., 1954, DIAGN IMPR SAL ALK S, P102; Rumpel C, 2018, NATURE; SALIENDRA NZ, 1995, PLANTA, V196, P357, DOI 10.1007/BF00201396; Sanden B., 2007, FALL IRRIGATION MANA; SAS Institute, 2009, SAS US GUID STAT VER; Schindler U, 2010, J PLANT NUTR SOIL SC, V173, P563, DOI 10.1002/jpln.200900201; Sheldrick B.H., 1993, SOIL SAMPLING METHOD, P499; Singhania RR, 2013, BIORESOURCE TECHNOL, V127, P500, DOI 10.1016/j.biortech.2012.09.012; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Song K, 2016, SCI REP-UK, V6, DOI 10.1038/srep36602; Spinelli GM, 2016, AGR WATER MANAGE, V168, P11, DOI 10.1016/j.agwat.2016.01.005; Teviotdale BL, 2001, PLANT DIS, V85, P399, DOI [10.1094/PDIS.2001.85.4.399, 10.1094/PDIS.2001.85.5.558B]; Throckmorton HM, 2012, ECOL LETT, V15, P1257, DOI 10.1111/j.1461-0248.2012.01848.x; Tripathy R, 2004, J PLANT NUTR SOIL SC, V167, P216, DOI 10.1002/jpln.200321175; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Weil RR, 2003, ESTIMATING ACTIVE CA	65	11	11	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0229588	10.1371/journal.pone.0229588	http://dx.doi.org/10.1371/journal.pone.0229588			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218562	Green Published, gold			2022-12-26	WOS:000535935400005
J	Eraso, JM; Kachroo, P; Olsen, RJ; Beres, SB; Zhu, LC; Badu, T; Shannon, S; Cantu, CC; Saavedra, MO; Kubiak, SL; Porter, AR; Deleo, FR; Musser, JM				Eraso, Jesus M.; Kachroo, Priyanka; Olsen, Randall J.; Beres, Stephen B.; Zhu, Luchang; Badu, Traci; Shannon, Sydney; Cantu, Concepcion C.; Saavedra, Matthew Ojeda; Kubiak, Samantha L.; Porter, Adeline R.; Deleo, Frank R.; Musser, James M.			Genetic heterogeneity of the Spy1336/R28-Spy1337 virulence axis in Streptococcus pyogenes and effect on gene transcript levels and pathogenesis	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; ALPHA-C-PROTEIN; GROUP-B STREPTOCOCCI; SURFACE-PROTEINS; PHASE VARIATION; PUERPERAL SEPSIS; TANDEM REPEATS; ANTIGEN GENE; DNA REPEATS; R-ANTIGEN	Streptococcus pyogenes is a strict human pathogen responsible for more than 700 million infections annually worldwide. Strains of serotype M28 S. pyogenes are typically among the five more abundant types causing invasive infections and pharyngitis in adults and children. Type M28 strains also have an unusual propensity to cause puerperal sepsis and neonatal disease. We recently discovered that a one-nucleotide indel in an intergenic homopolymeric tract located between genes Spy1336/R28 and Spy1337 altered virulence in a mouse model of infection. In the present study, we analyzed size variation in this homopolymeric tract and determined the extent of heterogeneity in the number of tandemly-repeated 79-amino acid domains in the coding region of Spy1336/R28 in large samples of strains recovered from humans with invasive infections. Both repeat sequence elements are highly polymorphic in natural populations of M28 strains. Variation in the homopolymeric tract results in (i) changes in transcript levels of Spy1336/R28 and Spy1337 in vitro, (ii) differences in virulence in a mouse model of necrotizing myositis, and (iii) global transcriptome changes as shown by RNAseq analysis of isogenic mutant strains. Variation in the number of tandem repeats in the coding sequence of Spy1336/R28 is responsible for size variation of R28 protein in natural populations. Isogenic mutant strains in which genes encoding R28 or transcriptional regulator Spy1337 are inactivated are significantly less virulent in a nonhuman primate model of necrotizing myositis. Our findings provide impetus for additional studies addressing the role of R28 and Spy1337 variation in pathogen-host interactions.	[Eraso, Jesus M.; Kachroo, Priyanka; Olsen, Randall J.; Beres, Stephen B.; Zhu, Luchang; Badu, Traci; Shannon, Sydney; Cantu, Concepcion C.; Saavedra, Matthew Ojeda; Kubiak, Samantha L.; Musser, James M.] Houston Methodist Res Inst, Ctr Mol & Translat Human Infect Dis Res, Dept Pathol & Genom Med, Houston, TX 77030 USA; [Eraso, Jesus M.; Kachroo, Priyanka; Olsen, Randall J.; Beres, Stephen B.; Zhu, Luchang; Badu, Traci; Shannon, Sydney; Cantu, Concepcion C.; Saavedra, Matthew Ojeda; Kubiak, Samantha L.; Musser, James M.] Houston Methodist Hosp, Houston, TX 77030 USA; [Olsen, Randall J.; Musser, James M.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Olsen, Randall J.; Musser, James M.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Porter, Adeline R.; Deleo, Frank R.] NIAID, Bacteriol Lab, Rocky Mt Labs, NIH, Hamilton, MT USA; [Badu, Traci] Macalester Coll, Dept Neurosci, St Paul, MN 55105 USA; [Shannon, Sydney] Univ Rochester, Dept Biomed Engn, Rochester, NY USA; [Kubiak, Samantha L.] Univ North Texas, Hlth Sci Ctr, Sch Hlth Profess, Ft Worth, TX USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Macalester College; University of Rochester; University of North Texas System; University of North Texas Denton	Musser, JM (corresponding author), Houston Methodist Res Inst, Ctr Mol & Translat Human Infect Dis Res, Dept Pathol & Genom Med, Houston, TX 77030 USA.; Musser, JM (corresponding author), Houston Methodist Hosp, Houston, TX 77030 USA.; Musser, JM (corresponding author), Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA.; Musser, JM (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.	jmmusser@houstonmethodist.org	; Zhu, Luchang/C-9784-2017	Eraso, Jesus/0000-0003-1383-8702; Zhu, Luchang/0000-0002-4064-5781; Shannon, Sydney/0000-0003-0474-0869	Fondren Foundation; Houston Methodist Hospital and Research Institute; National Institutes of Health [AI139369-01A1]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health	Fondren Foundation; Houston Methodist Hospital and Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by the Fondren Foundation, Houston Methodist Hospital and Research Institute and National Institutes of Health grant AI139369-01A1 (to J.M.M.), and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (to F.R.D.). Fondren Foundation URL: https://fconline.foundationcenter.org/fdo-grantmaker-profile/?key=FOND00 NIH URL: https://www.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2002, NUCLEIC ACIDS RES, V30, P2987, DOI 10.1093/nar/gkf391; Bae T, 2003, J BACTERIOL, V185, P2910, DOI 10.1128/JB.185.9.2910-2919.2003; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barnett TC, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268818002285; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Beaudoin A, 2015, MMWR-MORBID MORTAL W, V64, P555; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; Ben Zakour NL, 2012, J CLIN MICROBIOL, V50, P2224, DOI 10.1128/JCM.00675-12; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Beres SB, 2016, MBIO, V7, DOI 10.1128/mBio.00403-16; Bi X, 1996, J MOL BIOL, V256, P849, DOI 10.1006/jmbi.1996.0131; Bolduc GR, 2002, CELL MICROBIOL, V4, P751, DOI 10.1046/j.1462-5822.2002.00227.x; Carapetis JR, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2015.84; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; Chuang I, 2002, CLIN INFECT DIS, V35, P665, DOI 10.1086/342062; COLMAN G, 1993, J MED MICROBIOL, V39, P165, DOI 10.1099/00222615-39-3-165; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; Creti R, 2004, J CLIN MICROBIOL, V42, P1326, DOI 10.1128/JCM.42.3.1326-1329.2004; Egan SM, 2002, J BACTERIOL, V184, P5529, DOI 10.1128/JB.184.20.5529-5532.2002; Eraso JM, 2008, J BACTERIOL, V190, P4831, DOI 10.1128/JB.00301-08; Eraso JM, 2016, INFECT IMMUN, V84, P3268, DOI 10.1128/IAI.00608-16; Ferretti JJ., 2016, STREPTOCOCCUS PYOGEN; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; Flores AR, 2019, J PEDIAT INF DIS SOC, V8, P244, DOI 10.1093/jpids/piy053; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; GAWORZEWSKA E, 1988, EPIDEMIOL INFECT, V100, P257, DOI 10.1017/S095026880006739X; Gerlach RG, 2007, CELL MICROBIOL, V9, P1834, DOI 10.1111/j.1462-5822.2007.00919.x; Gherardi G, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00059; Gorrell RJ, 2013, CELL MICROBIOL, V15, P554, DOI 10.1111/cmi.12055; Gravekamp C, 1996, INFECT IMMUN, V64, P3576, DOI 10.1128/IAI.64.9.3576-3583.1996; Gravekamp C, 1997, INFECT IMMUN, V65, P5216, DOI 10.1128/IAI.65.12.5216-5221.1997; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; JONES KF, 1988, P NATL ACAD SCI USA, V85, P8271, DOI 10.1073/pnas.85.21.8271; Kachroo P, 2019, NAT GENET, V51, P548, DOI 10.1038/s41588-018-0343-1; Kassai-Jager E, 2008, GENE, V410, P18, DOI 10.1016/j.gene.2007.11.006; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Kobayashi SD, 2002, P NATL ACAD SCI USA, V99, P6901, DOI 10.1073/pnas.092148299; Kvam AI, 2011, CLIN VACCINE IMMUNOL, V18, P1365, DOI 10.1128/CVI.05005-11; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lachenauer CS, 2000, P NATL ACAD SCI USA, V97, P9630, DOI 10.1073/pnas.97.17.9630; LaFoya B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020449; LANCEFIELD RC, 1952, J EXP MED, V96, P83, DOI 10.1084/jem.96.1.83; LANCEFIELD RC, 1957, J EXP MED, V106, P525, DOI 10.1084/jem.106.4.525; Lancefield RC, 1943, J EXP MED, V78, P465, DOI 10.1084/jem.78.6.465; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li J, 1997, P NATL ACAD SCI USA, V94, P13251, DOI 10.1073/pnas.94.24.13251; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; Madoff LC, 1996, P NATL ACAD SCI USA, V93, P4131, DOI 10.1073/pnas.93.9.4131; Maeland JA, 2015, CLIN VACCINE IMMUNOL, V22, P153, DOI 10.1128/CVI.00643-14; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Martinez-Laguna Y, 1999, MOL MICROBIOL, V33, P153, DOI 10.1046/j.1365-2958.1999.01460.x; MICHEL JL, 1991, INFECT IMMUN, V59, P2023, DOI 10.1128/IAI.59.6.2023-2028.1991; MICHEL JL, 1992, P NATL ACAD SCI USA, V89, P10060, DOI 10.1073/pnas.89.21.10060; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Morin N, 2010, FEMS IMMUNOL MED MIC, V58, P344, DOI [10.1111/j.1574-695X.2009.00645.x, 10.1111/j.1574-695X.2010.00645.x]; Munson GP, 2000, MOL MICROBIOL, V36, P1391, DOI 10.1046/j.1365-2958.2000.01957.x; Naseer U, 2016, EUR J CLIN MICROBIOL, V35, P1639, DOI 10.1007/s10096-016-2704-y; Nasser W, 2014, P NATL ACAD SCI USA, V111, pE1768, DOI 10.1073/pnas.1403138111; Nelson GE, 2016, CLIN INFECT DIS, V63, P478, DOI 10.1093/cid/ciw248; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Olsen RJ, 2010, P NATL ACAD SCI USA, V107, P888, DOI 10.1073/pnas.0911811107; Orsi RH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-102; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Plainvert C, 2012, CLIN MICROBIOL INFEC, V18, P702, DOI 10.1111/j.1469-0691.2011.03624.x; Porter ME, 2004, MOL MICROBIOL, V54, P1117, DOI 10.1111/j.1365-2958.2004.04333.x; Puopolo KM, 2003, MOL MICROBIOL, V50, P977, DOI 10.1046/j.1365-2958.2003.03745.x; Puopolo KM, 2001, INFECT IMMUN, V69, P5037, DOI 10.1128/IAI.69.8.5037-5045.2001; Ramirez-Pena E, 2010, MOL MICROBIOL, V78, P1332, DOI 10.1111/j.1365-2958.2010.07427.x; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Raymond J, 2005, INFECT CONT HOSP EP, V26, P455, DOI 10.1086/502567; Richard GF, 2000, EMBO REP, V1, P122, DOI 10.1093/embo-reports/kvd031; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Rocha EPC, 2003, GENOME RES, V13, P1123, DOI 10.1101/gr.966203; Rodriguez-Iturbe B., 2016, STREPTOCOCCUS PYOGEN; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Santiago AE, 2016, MOL MICROBIOL, V101, P314, DOI 10.1111/mmi.13392; Shea PR, 2011, EMERG INFECT DIS, V17, P2010, DOI 10.3201/eid1711.110159; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; Sitkiewicz I, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-65; Smit PW, 2015, EUR J CLIN MICROBIOL, V34, P2131, DOI 10.1007/s10096-015-2462-2; Stalhammar-Carlemalm M, 1999, MOL MICROBIOL, V33, P208, DOI 10.1046/j.1365-2958.1999.01470.x; Stalhammar-Carlemalm M, 2000, J INFECT DIS, V182, P142, DOI 10.1086/315693; STALHAMMARCARLEMALM M, 1993, J EXP MED, V177, P1593, DOI 10.1084/jem.177.6.1593; Stevens DL, 2016, STREPTOCOCCUS PYOGEN; Stockbauer KE, 1999, P NATL ACAD SCI USA, V96, P242, DOI 10.1073/pnas.96.1.242; Tegtmeyer N, 2010, J BIOL CHEM, V285, P23513, DOI 10.1074/jbc.M109.096214; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; van der Ende A, 2000, INFECT IMMUN, V68, P6685, DOI 10.1128/IAI.68.12.6685-6690.2000; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; VANHAM SM, 1993, CELL, V73, P1187, DOI 10.1016/0092-8674(93)90647-9; Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13; Wastfelt M, 1996, J BIOL CHEM, V271, P18892, DOI 10.1074/jbc.271.31.18892; Weckel A, 2018, J BIOL CHEM, V293, P16006, DOI 10.1074/jbc.RA118.004134; Withey JH, 2005, J BACTERIOL, V187, P7890, DOI 10.1128/JB.187.23.7890-7900.2005; Yang J, 2011, TRENDS MICROBIOL, V19, P128, DOI 10.1016/j.tim.2010.12.001; Yu RR, 1999, J BACTERIOL, V181, P2584, DOI 10.1128/JB.181.8.2584-2592.1999; Zhou K, 2014, FEMS MICROBIOL REV, V38, P119, DOI 10.1111/1574-6976.12036; Zhu L, 2015, J CLIN INVEST; Zhu L, 2019, J CLIN INVEST, V129, P887, DOI 10.1172/JCI124994; Zhu LC, 2015, MBIO, V6, DOI 10.1128/mBio.01378-15	104	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0229064	10.1371/journal.pone.0229064	http://dx.doi.org/10.1371/journal.pone.0229064			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214338	Green Published, Green Submitted, gold			2022-12-26	WOS:000535934200007
J	Foolad, F; Khodagholi, F; Nabavi, SM; Javan, M				Foolad, Forough; Khodagholi, Fariba; Nabavi, Seyed Massood; Javan, Mohammad			Changes in mitochondrial function in patients with neuromyelitis optica; correlations with motor and cognitive disabilities	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; CYTOCHROME-C; SPINAL-CORD; T-CELLS; APOPTOSIS; LESIONS; MARKER; BRAIN; SIRT1; NMO	Background Neuromyelitis Optica (NMO) is an inflammatory demyelinating disease that mainly affects optic nerves and spinal cord. Besides, loss of motor and cognitive function has been reported as important symptoms of disease. Objective Here we investigated the mitochondrial dysfunction and metabolic alterations in NMO patients and evaluate their correlation with disease progress, disability and cognitive impairment. Methods The individuals (12 controls and 12 NMO) were assessed for disease severity by expanded disease status scale (EDSS), cognitive function via symbol digit modalities test (SDMT) and fine motor disability by 9-hole peg test (9-HPT). We have measured Sirtuin 1 (SIRT1), SIRT3, mitochondrial complex I, complex IV, aconitase and a-ketoglutarate dehydrogenase (alpha-KGD) activity in peripheral blood mononuclear cells (PBMCs). Furthermore, SIRT1, pyruvate, lactate and cytochrome c (Cyt c) were determined in plasma. Results Our results exhibited increased 9-HPT time in NMO patients. 9-HPT results correlated with EDSS; and SDMT negatively correlated with disease duration and number of attacks in patients. Investigation of PBMCs of NMO patients exhibited a decrease of mitochondrial complex I and IV activity that was significant for complex IV. Besides, complex I activity was negatively correlated with 9-HPT time in NMO group. In the plasma samples, a correlation between pyruvate to lactate ratio and EDSS in NMO patients was found and a negative correlation between Cyt c concentration and SDMT was detected. Conclusion Our data support the hypothesis that mitochondrial dysfunction occurred in the CNS and the peripheral blood may contribute to disease progress, disability level and the cognitive impairment in NMO patients.	[Foolad, Forough; Javan, Mohammad] Tarbiat Modares Univ, Dept Physiol, Fac Med Sci, Tehran, Iran; [Khodagholi, Fariba] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Nabavi, Seyed Massood] ACECR, Dept Regenerat Biomed, Cell Sci Res Ctr, Royan Inst Stem Cell Biol & Technol, Tehran, Iran; [Nabavi, Seyed Massood; Javan, Mohammad] ACECR, Dept Brain & Cognit Sci, Cell Sci Res Ctr, Royan Inst Stem Cell Biol & Technol, Tehran, Iran	Tarbiat Modares University; Shahid Beheshti University Medical Sciences; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR)	Javan, M (corresponding author), Tarbiat Modares Univ, Dept Physiol, Fac Med Sci, Tehran, Iran.; Javan, M (corresponding author), ACECR, Dept Brain & Cognit Sci, Cell Sci Res Ctr, Royan Inst Stem Cell Biol & Technol, Tehran, Iran.	mjavan@modares.ac.ir	Khodagholi, Fariba/AAZ-4436-2020; Foolad, Forough/AAR-5384-2020; Javan, Mohammad/C-6758-2008	Foolad, Forough/0000-0002-9787-5721; Javan, Mohammad/0000-0003-2045-6171	Tarbiat Modares University [IG-39803, Med-95-2259]; Iranian Council for Cognitive Sciences and Technologies	Tarbiat Modares University; Iranian Council for Cognitive Sciences and Technologies	This study was supported by grants grants Med-95-2259 and IG-39803 from Tarbiat Modares University to MJ (www.modares.ac.ir) and Iranian Council for Cognitive Sciences and Technologies to FF (www.cogc.ir).	Aarbakke J, 1997, TRENDS PHARMACOL SCI, V18, P3, DOI 10.1016/S0165-6147(96)01007-3; Ahlemeyer B, 2002, BRAIN RES, V934, P107, DOI 10.1016/S0006-8993(02)02365-X; Barczyk K, 2005, INT J CANCER, V116, P167, DOI 10.1002/ijc.21037; Blanc F, 2008, ARCH NEUROL-CHICAGO, V65, P84, DOI 10.1001/archneurol.2007.16; Blanc F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033878; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Calabrese M, 2012, NEUROLOGY, V79, P1671, DOI 10.1212/WNL.0b013e31826e9a96; Chen CM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112480; Choi J, 2014, ANN CLIN TRANSL NEUR, V1, P589, DOI 10.1002/acn3.86; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Duan YY, 2017, ACTA RADIOL, V58, P1132, DOI 10.1177/0284185116683575; Duan YY, 2012, EUR J RADIOL, V81, pE110, DOI 10.1016/j.ejrad.2011.01.065; Foolad F, 2019, MULT SCLER RELAT DIS, V34, P47, DOI 10.1016/j.msard.2019.06.004; Fulton B, 1996, DRUGS, V51, P278, DOI 10.2165/00003495-199651020-00007; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GIBSON GE, 1988, ARCH NEUROL-CHICAGO, V45, P836, DOI 10.1001/archneur.1988.00520320022009; Gonzalo H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00938; Huang W, 2012, ACTA PHARMACOL SIN, V33, P668, DOI 10.1038/aps.2011.189; Kim HH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181758; Kim SM, 2011, J NEUROL, V258, P2176, DOI 10.1007/s00415-011-6086-x; Kinoshita M, 2009, NEUROREPORT, V20, P508, DOI 10.1097/WNR.0b013e32832776f4; Kruse O, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-74; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; La Rocca C, 2017, METABOLISM, V77, P39, DOI 10.1016/j.metabol.2017.08.011; Lei M, 2012, EUR J PHARMACOL, V674, P73, DOI 10.1016/j.ejphar.2011.10.015; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li R, 2017, J NEUROIMMUNOL, V313, P56, DOI 10.1016/j.jneuroim.2017.10.013; Liu Y, 2018, EUR RADIOL, V28, P96, DOI 10.1007/s00330-017-4921-x; Liu YO, 2015, NEUROLOGY, V84, P1465, DOI 10.1212/WNL.0000000000001441; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; MARBACH EP, 1967, CLIN CHEM, V13, P314; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Meng H, 2017, J NEUROL, V264, P1549, DOI 10.1007/s00415-016-8345-3; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Papadopoulou A, 2019, J NEUROL NEUROSUR PS, V90, P1156, DOI 10.1136/jnnp-2018-320249; Pennisi G, 2011, BIOCHEM PHARMACOL, V82, P1490, DOI 10.1016/j.bcp.2011.07.092; Pierron D, 2012, BBA-BIOENERGETICS, V1817, P590, DOI 10.1016/j.bbabio.2011.07.007; Preyat N, 2013, J LEUKOCYTE BIOL, V93, P669, DOI 10.1189/jlb.1112557; Renz A, 2001, BLOOD, V98, P1542, DOI 10.1182/blood.V98.5.1542; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Sanchez-Catasus CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066271; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23; Sheridan LK, 2006, ARCH CLIN NEUROPSYCH, V21, P23, DOI 10.1016/j.acn.2005.07.003; Smith A., 1982, SYMBOL DIGIT MODALIT; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Takano R, 2010, NEUROLOGY, V75, P208, DOI 10.1212/WNL.0b013e3181e2414b; Tannahill GM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00106; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Uzawa A, 2010, MULT SCLER J, V16, P1443, DOI 10.1177/1352458510379247; Varrin-Doyer M, 2012, ANN NEUROL, V72, P53, DOI 10.1002/ana.23651; Vasquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064; WILLIAMS JN, 1964, ARCH BIOCHEM BIOPHYS, V107, P537, DOI 10.1016/0003-9861(64)90313-3; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Yang YJ, 2010, J BIOL CHEM, V285, P7417, DOI 10.1074/jbc.M109.053421; Zambonin JL, 2011, BRAIN, V134, P1901, DOI 10.1093/brain/awr110	59	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230691	10.1371/journal.pone.0230691	http://dx.doi.org/10.1371/journal.pone.0230691			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214385	Green Submitted, Green Published, gold			2022-12-26	WOS:000535934200041
J	Dworzanski, J; Strycharz-Dudziak, M; Kliszczewska, E; Kielczykowska, M; Dworzanska, A; Drop, B; Polz-Dacewicz, M				Dworzanski, Jakub; Strycharz-Dudziak, Malgorzata; Kliszczewska, Ewa; Kielczykowska, Malgorzata; Dworzanska, Anna; Drop, Bartlomiej; Polz-Dacewicz, Malgorzata			Glutathione peroxidase (GPx) and superoxide dismutase (SOD) activity in patients with diabetes mellitus type 2 infected with Epstein-Barr virus	PLOS ONE			English	Article							OXIDATIVE STRESS; ANTIOXIDANT; PREVALENCE; ATLAS	Oxidative stress is suggested to be the crucial factor in diabetes mellitus type 2 (DM2) pathogenesis and in the development of diabetic complications. Patients with DM2 may be more susceptible to infections due to hyperglycaemia-induced virulence of various microorganisms. Several studies pointed that Epstein-Barr virus (EBV) infection is associated with reactive oxygen species (ROS) production and/or activation of signalling pathways connected with ROS. The present study analyzed serum activity of glutathione peroxidase (GPx) and superoxide dismutase (SOD) in DM2 patients with and without EBV infection. Blood and saliva were collected from 120 patients with DM2. EBV DNA was detected in the saliva using nested-PCR technique. Spectrophotometric methods were implemented to determine serum GPx and SOD activity with the use of diagnostic kits produced by Randox Laboratories. GPx and SOD activity was decreased in diabetic patients, with the lowest values in DM2 EBV-positive patients. There was correlation between GPx and SOD activity-with increased value of GPx, SOD activity was also rised. In patients with DM2 history longer than 10 years as well as in DM2 patients with obesity, antioxidant enzymes activity was decreased. Determination of examined parameters may be useful in diabetic patients with EBV infection and could be important prognostic factor.	[Dworzanski, Jakub; Dworzanska, Anna] Masovian Specialist Hosp, Radom, Poland; [Strycharz-Dudziak, Malgorzata] Med Univ Lublin, Chair & Dept Conservat Dent Endodont, Lublin, Poland; [Kliszczewska, Ewa; Polz-Dacewicz, Malgorzata] Med Univ Lublin, Dept Virol, Lublin, Poland; [Kielczykowska, Malgorzata] Med Univ Lublin, Dept Med Chem, Lublin, Poland; [Drop, Bartlomiej] Med Univ Lublin, Dept Informat Technol & Med Stat, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Kliszczewska, E (corresponding author), Med Univ Lublin, Dept Virol, Lublin, Poland.	ewakliszczewska@gmail.com	Polz-Dacewicz, Malgorzata Anna/ABI-3021-2020; Drop, Bartlomiej/AAB-4532-2021	Polz-Dacewicz, Malgorzata Anna/0000-0002-3222-184X; Drop, Bartlomiej/0000-0001-7044-3657; Strycharz-Dudziak, Malgorzata/0000-0003-0560-7322; Stepien, Ewa/0000-0002-9024-8602; Kielczykowska, Malgorzata/0000-0002-3637-2856	Medical University of Lublin, Lublin, Poland [DS 233]	Medical University of Lublin, Lublin, Poland	This study was supported by a Research Grant from the Medical University of Lublin, Lublin, Poland (DS 233)	Al Hroob AM, 2019, BIOMED PHARMACOTHER, V109, P2155, DOI 10.1016/j.biopha.2018.11.086; Al-Rawi NH, 2011, DIABETES VASC DIS RE, V8, P22, DOI 10.1177/1479164110390243; [Anonymous], 2015, INTEGR OBES DIABETES; Aouacheri O, 2015, CAN J DIABETES, V39, P44, DOI 10.1016/j.jcjd.2014.03.002; ARTHUR JR, 1985, LIFE SCI, V36, P1569, DOI 10.1016/0024-3205(85)90381-9; Arvey A, 2012, CELL HOST MICROBE, V12, P233, DOI 10.1016/j.chom.2012.06.008; Bandeira SD, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/819310; Bikkad MD, 2014, BIOMED RES-INDIA, V25, P84; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briggs ON, 2016, INT J SCI RES, V5, P2319; Burgos-Moron E, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091385; Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253; Dworzanski J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222607; Foltyn S, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0141-x; Gargouri B, 2011, BIOL TRACE ELEM RES, V144, P1449, DOI 10.1007/s12011-011-9135-5; Gawlik K, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2352361; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Handley SA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0287-y; Hisalkar PJ, 2012, BIOL MED, V4, P65; Houghton D, 2018, DIABETOLOGIA, V61, P1700, DOI 10.1007/s00125-018-4632-0; Hu JM, 2017, INT J CANCER, V141, P1722, DOI 10.1002/ijc.30816; Kumawat M., 2009, OPEN ENDOCRINOL J, V3, P12, DOI DOI 10.2174/1874216500903010012; Lassoued S, 2008, MOL CELL BIOCHEM, V313, P179, DOI 10.1007/s11010-008-9755-z; Ma XL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00782; Manasaveena V., 2014, INT J PHARM PHARM SC, V6, P52; Manoharan S, 2005, INDIAN J MED RES, V122, P529; Moussa S.A., 2008, ROM J BIOPHYS, V18, P225; Nikolich-Zugich J, 2017, CURR OPIN IMMUNOL, V48, P23, DOI 10.1016/j.coi.2017.07.011; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Parker Michael T., 2016, Yale Journal of Biology and Medicine, V89, P339; Polz-Dacewicz M, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0093-6; Ramakrishna V, 2008, ACTA DIABETOL, V45, P41, DOI 10.1007/s00592-007-0018-3; Singh, 2015, INT J CONT MED RES, V2, P20; Singh AK, 2016, J POSTGRAD MED, V62, P96, DOI 10.4103/0022-3859.180555; Strycharz-Dudziak M, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/5832410	38	32	33	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230374	10.1371/journal.pone.0230374	http://dx.doi.org/10.1371/journal.pone.0230374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210468	Green Published, gold			2022-12-26	WOS:000535307600023
J	Hughes, AT; Hamilton, RJ; Choat, JH; Rhodes, KL				Hughes, A. T.; Hamilton, R. J.; Choat, J. H.; Rhodes, K. L.			Declining grouper spawning aggregations in Western Province, Solomon Islands, signal the need for a modified management approach	PLOS ONE			English	Article							CORALGROUPER PLECTROPOMUS-AREOLATUS; BROWN-MARBLED GROUPER; EPINEPHELUS-FUSCOGUTTATUS; CAMOUFLAGE GROUPER; GLOBAL CHANGE; REEF; FISHERIES; POHNPEI; VULNERABILITY; DYNAMICS	Globally, groupers (Epinephelidae) that form fish spawning aggregations (FSAs) are highly vulnerable to overfishing and often require site-specific approaches to management. Over 5-years (2009-2013), we conducted underwater visual censuses (UVC) at a well-known spawning site at Njari Island, Gizo, Western Province, Solomon Islands, that supports aggregations of squaretail coralgrouper (Plectropomus areolatus), camouflage grouper (Epinephelus polyphekadion) and brown-marbled grouper (E. fuscoguttatus). Findings show that while there were species-specific variations in the duration and timing of the spawning season, aggregation densities peaked from March to June, representing the main spawning season for all three species. For P. areolatus, gonad analysis from samples taken from 2008 to 2011 confirmed reproductive activity in support of density trends observed through UVC. Over the 5-year UVC monitoring period, FSA densities declined for P. areolatus and E. polyphekadion. Conversely, following the first year of monitoring, E. fuscoguttatus densities increased. These inter-specific differences may reflect variable responses to fishing as shown elsewhere, or for example, differences in recruitment success. In response to known declines in FSAs of these species, in 2018 the Solomon Islands government placed a nationwide ban on these species' harvest and sale between October and January. As this study shows, this ban does not encompass the peak aggregation period at Njari and will offer limited protection to other FSAs of these species that are known to vary in reproductive seasonality across the Solomon Islands. A more biologically meaningful and practical management strategy would be to implement a nationwide ban on the harvest and sale of these groupers each month between full and new moons when these FSAs form consistently throughout the country. Since effective management of FSAs typically requires a combined approach, spatial management that protects both spawning sites and reproductive migratory corridors is warranted.	[Hughes, A. T.] Wildlife Conservat Soc, Munda, Western Provinc, Solomon Islands; [Hamilton, R. J.] Nature Conservancy, Asia Pacific Resource Ctr, South Brisbane, Qld, Australia; [Hamilton, R. J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Choat, J. H.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Rhodes, K. L.] MarAlliance, Grass Valley, CA 94107 USA	Nature Conservancy; James Cook University; James Cook University	Rhodes, KL (corresponding author), MarAlliance, Grass Valley, CA 94107 USA.	klrhodes_grouper@yahoo.com		Hamilton, Richard/0000-0002-0076-4276; Rhodes, Kevin/0000-0003-2085-5527	David and Lucile Packard Foundation; James Cook University; Australian Leadership Award; USAID Coral Triangle Support Partnership; Postgraduate Research Grant	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); James Cook University; Australian Leadership Award; USAID Coral Triangle Support Partnership(United States Agency for International Development (USAID)); Postgraduate Research Grant	David and Lucile Packard Foundation (www.packard.org), James Cook University (www.jcu.edu.au) Postgraduate Research Grant, Australian Leadership Award (www.australiaawards.gov.au), USAID Coral Triangle Support Partnership (www.usaid.gov).	Aguilar-Perera A, 2006, MAR ECOL PROG SER, V327, P289, DOI 10.3354/meps327289; Bell, 2011, VULNERABILITY TROPIC; Bennett G, AA201415 CGIAR RES P; Bijoux J, 2013, ENDANGER SPECIES RES, V22, P145, DOI 10.3354/esr00534; Brewer T. D., 2011, CORAL REEF FISH VALU; Choat JH, 2012, FISH FISH SER, V35, P85, DOI 10.1007/978-94-007-1980-4_4; Cinner JE, 2006, ENVIRON CONSERV, V33, P73, DOI 10.1017/S0376892906002748; Colin PL, 2013, ESTUAR COAST SHELF S, V123, P1, DOI 10.1016/j.ecss.2011.10.011; Cuetos-Bueno J, 2018, FISH RES, V199, P263, DOI 10.1016/j.fishres.2017.10.010; de Mitcheson YS, 2012, FISH FISH SER, V35, P225, DOI 10.1007/978-94-007-1980-4_8; Domeier ML, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4_1; Erisman BE, 2013, FISH RES, V106, P279; Erisman B, 2017, FISH FISH, V18, P128, DOI 10.1111/faf.12132; Erisman BE, 2011, CAN J FISH AQUAT SCI, V68, P1705, DOI 10.1139/F2011-090; Gillett R, 2006, FAO FISHCODE REV; Graham RT, 2008, CORAL REEFS, V27, P311, DOI 10.1007/s00338-007-0329-4; Hamilton RJ, 2012, BIOL CONSERV, V145, P246, DOI 10.1016/j.biocon.2011.11.020; Hamilton RJ, 2011, BIOL CONSERV, V144, P1850, DOI 10.1016/j.biocon.2011.03.024; Hamilton R. J., 2006, SPC LIVE REEF FISH I, V16, P13; Hamilton RE, 2004, 404 TNC; Hamilton RJ, 2016, CORAL REEFS, V35, P751, DOI 10.1007/s00338-016-1441-0; Hughes A.T, 2017, THESIS, DOI [10.4225/28/5731812CA07A3, DOI 10.4225/28/5731812CA07A3]; Johannes RE, 1999, MARINE CONSERVATION, P144; Johannes RE, 1999, SPC LIVE REEF FISH I, V5, P8; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Ministry of Fisheries and Marine Resources, 2019, SOL ISL NAT FISH POL; de Mitcheson YS, 2013, FISH FISH, V14, P119, DOI 10.1111/j.1467-2979.2011.00455.x; NHMRC, 2013, AUSTR COD CAR US AN, V8th; Pears RJ, 2006, MAR ECOL PROG SER, V307, P259, DOI 10.3354/meps307259; Pet JS, 2005, ENVIRON BIOL FISH, V74, P209, DOI 10.1007/s10641-005-8528-8; Rhodes K, 2018, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2018-2.RLTS.T44673A100468078.en, DOI 10.2305/IUCN.UK.2018-2.RLTS.T44673A100468078.EN]; Rhodes K, 2018, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2018-2.RLTS.T61339A100553967.en, DOI 10.2305/IUCN.UK.2018-2.RLTS.T61339A100553967.EN]; Rhodes KL, 2014, CORAL REEFS, V33, P765, DOI 10.1007/s00338-014-1172-z; Rhodes KL, 2013, J FISH BIOL, V82, P1333, DOI 10.1111/jfb.12076; Rhodes KL, 2012, CORAL REEFS, V31, P443, DOI 10.1007/s00338-012-0875-2; Rhodes KL, 2008, FISH B-NOAA, V106, P194; Rhodes KL, 2019, REG STUD MAR SCI, V32, DOI 10.1016/j.rsma.2019.100807; Rhodes KL, 2018, FISH RES, V204, P156, DOI 10.1016/j.fishres.2018.02.017; Rhodes KL, 2011, MAR ECOL PROG SER, V421, P183, DOI 10.3354/meps08904; Rhodes KL, 2002, ENVIRON BIOL FISH, V63, P27, DOI 10.1023/A:1013840621820; Rhodes KL, 2018, PLECTROPOMUS AREOLAT, DOI [10.2305/IUCN.UK.2018-2.RLT-S.T64411A100466794.en, DOI 10.2305/IUCN.UK.2018-2.RLT-S.T64411A100466794.EN]; Robinson J, 2015, CORAL REEFS, V34, P371, DOI 10.1007/s00338-014-1243-1; SABETIAN A, 2006, SPC TRADITIONAL MARI, V20, P3, DOI DOI 10.HTTPS://C0ASTFISH.SPC.INT/EN/PUBLICATI0NS/BULLETINS/TRADITI0NAL-MANAGEMENT/202-TRADITI0NAL-; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Sadovy Y, 2005, CORAL REEFS, V24, P254, DOI 10.1007/s00338-005-0474-6; Sadovy Y, 2018, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2018-2.RTLS.T7862A46909843.en, DOI 10.2305/IUCN.UK.2018-2.RTLS.T7862A46909843.EN]; Sadovy Y. J., 2003, STOCKS LAST LIVE REE; Stump K, 2017, B MAR SCI, V93, P375, DOI 10.5343/bms.2016.1042; Tacon AGJ, 2010, REV FISH SCI, V18, P94, DOI 10.1080/10641260903325680; Waldie PA, 2016, ROY SOC OPEN SCI, V3, P1; Warren-Rhodes K, 2003, AMBIO, V32, P481, DOI 10.1639/0044-7447(2003)032[0481:MEAITI]2.0.CO;2; Wilkinson CR, 1996, GLOB CHANGE BIOL, V2, P547, DOI 10.1111/j.1365-2486.1996.tb00066.x; Wilson Joanne, 2010, SPC Live Reef Fish Information Bulletin, V19, P7	53	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230485	10.1371/journal.pone.0230485	http://dx.doi.org/10.1371/journal.pone.0230485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210459	gold, Green Accepted, Green Published			2022-12-26	WOS:000535307600028
J	Li, M; Ferreira, S; Smith, TA				Li, Mengyao; Ferreira, Susana; Smith, Travis A.			Temperature and self-reported mental health in the United States	PLOS ONE			English	Article							SEASONAL AFFECTIVE-DISORDER; CLIMATE-CHANGE; MORTALITY; PRECIPITATION; FLUCTUATIONS; ADAPTATION; HAPPINESS; SUICIDE; WEATHER; OUTPUT	This study estimates the association between temperature and self-reported mental health. We match individual-level mental health data for over three million Americans between 1993 and 2010 to historical daily weather information. We exploit the random fluctuations in temperature over time within counties to identify its effect on a 30-day measure of self-reported mental health. Compared to the temperature range of 60-70 degrees F, cooler days in the past month reduce the probability of reporting days of bad mental health while hotter days increase this probability. We also find a salience effect: cooler days have an immediate effect, whereas hotter days tend to matter most after about 10 days. Using our estimates, we calculate the willingness to pay to avoid an additional hot day in terms of its impact on self-reported mental health.	[Li, Mengyao; Ferreira, Susana; Smith, Travis A.] Univ Georgia, Dept Agr & Appl Econ, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Li, M (corresponding author), Univ Georgia, Dept Agr & Appl Econ, Athens, GA 30602 USA.	sphere1991apply@gmail.com		Ferreira, Susana/0000-0002-9049-4408; Li, Mengyao/0000-0002-3744-9499				ANDERSON JL, 1994, J PSYCHOSOM RES, V38, P323, DOI 10.1016/0022-3999(94)90037-X; [Anonymous], 2012, N AM LAND DAT ASS SY; [Anonymous], 2017, SUST DEV KNOWL PLATF; [Anonymous], WORKING PAPERS; Auffhammer M, 2013, REV ENV ECON POLICY, V7, P181, DOI 10.1093/reep/ret016; Barreca A, 2016, J POLIT ECON, V124, P105, DOI 10.1086/684582; Barreca AI, 2012, J ENVIRON ECON MANAG, V63, P19, DOI 10.1016/j.jeem.2011.07.004; Basu R, 2018, AM J EPIDEMIOL, V187, P2306, DOI 10.1093/aje/kwy116; Baylis  P., 2015, TEMPERATURE TEMPERAM; Baylis P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195750; Bridges FS, 2005, PERCEPT MOTOR SKILL, V100, P920, DOI 10.2466/pms.100.3c.920-924; Burke M, 2018, NAT CLIM CHANGE, V8, P723, DOI 10.1038/s41558-018-0222-x; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Deschenes O, 2007, AM ECON REV, V97, P354, DOI 10.1257/aer.97.1.354; Deschenes O, 2014, ENERG ECON, V46, P606, DOI 10.1016/j.eneco.2013.10.013; Deschenes O, 2011, AM ECON J-APPL ECON, V3, P152, DOI 10.1257/app.3.4.152; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Ferreira S, 2010, ENVIRON RESOUR ECON, V46, P249, DOI 10.1007/s10640-009-9339-8; Frey BS, 2010, ANNU REV RESOUR ECON, V2, P139, DOI 10.1146/annurev.resource.012809.103926; Frey BS, 2002, J ECON LIT, V40, P402, DOI 10.1257/002205102320161320; Grace K, 2015, GLOBAL ENVIRON CHANG, V35, P125, DOI 10.1016/j.gloenvcha.2015.06.010; Grossman M, 2000, HANDB ECON, V17, P347; Harmon K., 2019, DOES HEAT WAVE AFFEC; Heal G, 2016, REV ENV ECON POLICY, V10, P347, DOI 10.1093/reep/rew007; HENNESSY CH, 1994, PUBLIC HEALTH REP, V109, P665; HEUTEL G., 2017, 23271 NBER, DOI DOI 10.3386/W23271; Humble MB, 2010, J PHOTOCH PHOTOBIO B, V101, P142, DOI 10.1016/j.jphotobiol.2010.08.003; Jin L, 2017, WORKING PAPER; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; Meesters Y, 2016, PSYCHOL RES BEHAV MA, V9, P317, DOI 10.2147/PRBM.S114906; Morey E, 2007, J MENT HEALTH POLICY, V10, P73; Obradovich N, 2018, P NATL ACAD SCI USA, V115, P10953, DOI 10.1073/pnas.1801528115; Obradovich N, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601555; Oswald AJ, 2010, SCIENCE, V327, P576, DOI 10.1126/science.1180606; Short ME, 2009, J OCCUP ENVIRON MED, V51, P786, DOI 10.1097/JOM.0b013e3181a86671; Yardley J, 2011, GLOBAL ENVIRON CHANG, V21, P670, DOI 10.1016/j.gloenvcha.2010.11.010; Zhang X, 2017, J ENVIRON ECON MANAG, V85, P81, DOI 10.1016/j.jeem.2017.04.001; Zivin JG, 2014, J LABOR ECON, V32, P1, DOI 10.1086/671766; Zou E, 2017, WORKING PAPER	39	8	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230316	10.1371/journal.pone.0230316	http://dx.doi.org/10.1371/journal.pone.0230316			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9HN	32210473	gold, Green Published			2022-12-26	WOS:000535307600020
J	Ismail, AA; Donia, HM; Ghatesh, HM; Farid, CI				Ismail, Aisha A.; Donia, Hanaa M.; Ghatesh, Hafsa M.; Farid, Carmen, I			CD200/CD200 receptor axis in psoriasis vulgaris	PLOS ONE			English	Article							REGULATORY T-CELLS; EXPRESSION; CD200; DISEASE; CYTOKINES; SEVERITY; GENE; TH17	Background Psoriasis is a chronic inflammatory multisystem disease with imbalance between the Th17 and T regulatory sub-populations. CD200/CD200R is an anti-inflammatory/immune-suppressive axis that might contribute to its pathogenesis given its relation to the Tregs induction. The current study aimed to investigate the status of the CD200/CD200R axis in the blood of psoriasis vulgaris patients versus healthy controls. Methods In this comparative cross sectional study, the blood levels of sCD200 and CD200R levels were measured in 25 psoriasis vulgaris patients and an age and sex matched 25 healthy controls using ELISA and flow-cytometry respectively. Their levels were tested for correlation to disease severity. Results sCD200 was significantly higher while CD200R was significantly lower in psoriasis vulgaris patients than in controls. They did not correlate to each other or to psoriasis severity although they differed significantly among cases of different severities. Conclusion Aberrant expression of CD200/CD200R might play a role in psoriasis vulgaris pathophysiology and disease severity. It might constitute a future target of therapy, but cannot be used as a marker of disease severity.	[Ismail, Aisha A.; Ghatesh, Hafsa M.; Farid, Carmen, I] Alexandria Univ, Fac Med, Dept Dermatol Venereol & Androl, Alexandria, Egypt; [Donia, Hanaa M.] Alexandria Univ, Fac Med, Dept Clin & Chem Pathol, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University	Farid, CI (corresponding author), Alexandria Univ, Fac Med, Dept Dermatol Venereol & Androl, Alexandria, Egypt.	carmen271173@yahoo.com	Farid, carmen/G-9102-2018	Farid, carmen/0000-0003-2195-0227				Akman-Karakas A, 2013, MED SCI MONITOR, V19, P888, DOI 10.12659/MSM.889624; Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Baliwag J, 2015, CYTOKINE, V73, P342, DOI 10.1016/j.cyto.2014.12.014; Baran W, 2005, ACTA DERMATOVEN ALP, V14, P79; Borska L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112238; Elshal MF, 2016, CLIN LAB, V62, P1521, DOI 10.7754/Clin.Lab.2016.151231; Gao S, 2014, INFLAMM RES, V63, P441, DOI 10.1007/s00011-014-0716-6; Holmannova Drahomira, 2012, Acta Medica (Hradec Kralove), V55, P12; Jenmalm MC, 2006, J IMMUNOL, V176, P191, DOI 10.4049/jimmunol.176.1.191; Kanelleas A, 2011, CLIN EXP DERMATOL, V36, P845, DOI 10.1111/j.1365-2230.2011.04131.x; Karamehic Jasenko, 2014, Med Arch, V68, P236, DOI 10.5455/medarh.2014.68.236-238; Lei H, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00184; Li DP, 2020, INT IMMUNOPHARMACOL, V78, DOI 10.1016/j.intimp.2019.106046; Li Y, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3853; Lippens C, 2016, J AUTOIMMUN, V75, P39, DOI 10.1016/j.jaut.2016.07.004; Ramamoorthy S, 2013, MOL CELL BIOL, V33, P1711, DOI 10.1128/MCB.01151-12; Reich K, 2012, J EUR ACAD DERMATOL, V26, P3, DOI 10.1111/j.1468-3083.2011.04410.x; Ren J, 2017, ADV PROTEIN CHEM STR, V107, P155, DOI 10.1016/bs.apcsb.2016.10.002; Ren Y, 2015, RHEUMATOLOGY, V54, P712, DOI 10.1093/rheumatology/keu362; Rosenblum MD, 2004, BLOOD, V103, P2691, DOI 10.1182/blood-2003-09-3184; Saito C, 2009, J DERMATOL SCI, V53, P231, DOI 10.1016/j.jdermsci.2008.09.011; Schmitt J, 2005, DERMATOLOGY, V210, P194, DOI 10.1159/000083509; Shah K, 2017, J AM ACAD DERMATOL, V77, P287, DOI 10.1016/j.jaad.2017.03.037; Sugiyama H, 2005, J IMMUNOL, V174, P164, DOI 10.4049/jimmunol.174.1.164; Walker DG, 2009, EXP NEUROL, V215, P5, DOI 10.1016/j.expneurol.2008.09.003; Yan KX, 2010, BRIT J DERMATOL, V163, P48, DOI 10.1111/j.1365-2133.2010.09742.x	26	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230621	10.1371/journal.pone.0230621	http://dx.doi.org/10.1371/journal.pone.0230621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GC	32203537	gold, Green Published			2022-12-26	WOS:000535303900028
J	Pera, MC; Coratti, G; Berti, B; D'Amico, A; Sframeli, M; Albamonte, E; de Sanctis, R; Messina, S; Catteruccia, M; Brigati, G; Antonaci, L; Lucibello, S; Bruno, C; Sansone, VA; Bertini, E; Tiziano, D; Pane, M; Mercuri, E				Pera, Maria Carmela; Coratti, Giorgia; Berti, Beatrice; D'Amico, Adele; Sframeli, Maria; Albamonte, Emilio; de Sanctis, Roberto; Messina, Sonia; Catteruccia, Michela; Brigati, Giorgia; Antonaci, Laura; Lucibello, Simona; Bruno, Claudio; Sansone, Valeria A.; Bertini, Enrico; Tiziano, Danilo; Pane, Marika; Mercuri, Eugenio			Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey?	PLOS ONE			English	Article							NATURAL-HISTORY; CLINICAL-TRIAL; SMA; MANAGEMENT; TYPE-1; CHILDHOOD	Background The advent of new therapies has increased the need to achieve early diagnosis in Spinal Muscular Atrophy (SMA). The aim of the present study was to define the age of diagnosis in the three main types of SMA with pediatric-onset and the timing between the recognition of clinical signs and confirmed genetic diagnosis. Methods All patients with a confirmed diagnosis of type I, II, III SMA followed in 5 Italian centers were included in this study, assessing age at symptoms onset, presenting sign or symptom, age at diagnosis, interval between clinical onset and diagnosis and type of medical investigations conducted in order to obtain the diagnosis. Results The cohort included 480 patients, 191 affected by SMA type I, 210 by type II and 79 by type III. The mean age at diagnosis was 4.70 months (SD +/- 2.82) in type I, 15.6 months (SD +/- 5.88) in type II, and 4.34 years (SD +/- 4.01) in type III. The mean time between symptom onset and diagnosis was 1.94 months (SD +/- 1.84) in type I, 5.28 months (SD +/- 4.68) in type II and 16.8 months (SD +/- 18.72) in type III. Conclusions Our results suggest that despite improved care recommendations there is still a marked diagnostic delay, especially in type III. At the time new therapies are becoming available more attention should be devoted to reducing such delay as there is consistent evidence of the benefit of early treatment.	[Pera, Maria Carmela; Coratti, Giorgia; Antonaci, Laura; Lucibello, Simona; Mercuri, Eugenio] Univ Cattolica Sacro Cuore, Pediat Neurol, Rome, Italy; [Berti, Beatrice; de Sanctis, Roberto; Pane, Marika; Mercuri, Eugenio] Fdn Policlin Univ Agostino Gemelli IRCCS, Ctr Clin Nemo, Rome, Italy; [D'Amico, Adele; Catteruccia, Michela; Bertini, Enrico] IRCCS Bambino Gesu Childrens Hosp, Dept Neurosci, Unit Neuromuscular & Neurodegenerat Disorders, Rome, Italy; [Sframeli, Maria; Messina, Sonia] Univ Messina, Ctr Clin Nemo Sud, Dept Neurosci, Messina, Italy; [Albamonte, Emilio; Sansone, Valeria A.] Univ Milan, Niguarda Hosp, Neuromuscular Omnictr Clin Ctr, Neurorehabil Unit, Milan, Italy; [Brigati, Giorgia; Bruno, Claudio] IRCCS Ist Giannina Gaslini, Ctr Expt & Translat Myol, Genoa, Italy; [Tiziano, Danilo] Policlin Univ Agostino Gemelli IRCCS, Univ Cattolica Sacro Cuore Fdn, Inst Genom Med, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Bambino Gesu; University of Messina; University of Milan; University of Genoa; IRCCS Istituto Giannina Gaslini; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Mercuri, E (corresponding author), Univ Cattolica Sacro Cuore, Pediat Neurol, Rome, Italy.; Mercuri, E (corresponding author), Fdn Policlin Univ Agostino Gemelli IRCCS, Ctr Clin Nemo, Rome, Italy.	eugeniomaria.mercuri@unicatt.it	Coratti, Giorgia/Y-6292-2019; Antonaci, Laura/AAC-3274-2022; Berti, Beatrice/AAC-7216-2022; Lucibello, Simona/AAB-6848-2022; Coratti, Giorgia/AAV-3224-2021; Bertini, Enrico/ABG-1278-2020; Pera, Maria Carmela/J-6068-2018; Bertini, Enrico/A-2284-2014	Coratti, Giorgia/0000-0001-6666-5628; Berti, Beatrice/0000-0002-5698-9415; Lucibello, Simona/0000-0003-0970-5755; Coratti, Giorgia/0000-0001-6666-5628; ALBAMONTE, EMILIO/0000-0002-8465-4460; Antonaci, Laura/0000-0003-4753-8441; Pera, Maria Carmela/0000-0001-6777-1721; Brigati, Giorgia/0000-0002-8040-5950; Bertini, Enrico/0000-0001-9276-4590	Famiglie SMA/Telethon Italy	Famiglie SMA/Telethon Italy	The project was funded by Famiglie SMA/Telethon Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach JR, 2002, PEDIATR PULM, V34, P16, DOI 10.1002/ppul.10110; Crawford TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033572; D'Amico A, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-71; De Sanctis R, 2018, NEUROMUSCULAR DISORD, V28, P24, DOI 10.1016/j.nmd.2017.09.015; De Vivo DC, 2019, NEUROMUSCULAR DISORD, V29, P842, DOI 10.1016/j.nmd.2019.09.007; Dubowitz V, 1991, Neuromuscul Disord, V1, P77, DOI 10.1016/0960-8966(91)90051-S; Farrar MA, 2013, J PEDIATR-US, V162, P155, DOI 10.1016/j.jpeds.2012.05.067; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Finkel R, 2015, NEUROMUSCULAR DISORD, V25, P593, DOI 10.1016/j.nmd.2015.04.009; Finkel RS, 2018, NEUROMUSCULAR DISORD, V28, P197, DOI 10.1016/j.nmd.2017.11.004; Finkel RS, 2014, NEUROLOGY, V83, P810, DOI 10.1212/WNL.0000000000000741; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; Lawton S, 2015, EUR J HUM GENET, V23, P575, DOI 10.1038/ejhg.2014.147; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LEWIN B, 1995, CELL, V80, P1, DOI 10.1016/0092-8674(95)90442-5; Lin CW, 2015, PEDIATR NEUROL, V53, P293, DOI 10.1016/j.pediatrneurol.2015.06.002; Melki J, 1994, SCIENCE; Mendell J, 2017, NEUROMUSCULAR DISORD, V27, pS208, DOI 10.1016/j.nmd.2017.06.412; Mercuri E, 2018, NEW ENGL J MED, V378, P625, DOI 10.1056/NEJMoa1710504; Mercuri Eugenio, 2012, Lancet Neurol, V11, P443, DOI 10.1016/S1474-4422(12)70061-3; Mercuri E, 2018, NEUROMUSCULAR DISORD, V28, P103, DOI 10.1016/j.nmd.2017.11.005; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Munsat TL., 1991, NEUROMUSCUL DISORD, V1, P81, DOI [10.1016/0960-8966(91)90052-t, DOI 10.1016/0960-8966(91)90052-T]; Oskoui M, 2007, NEUROLOGY, V69, P1931, DOI 10.1212/01.wnl.0000290830.40544.b9; PEARN J, 1980, LANCET, V1, P919; Shell R, 2017, AM J RESP CRIT CARE, V195; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025; Zerres K, 1997, J NEUROL SCI, V146, P67, DOI 10.1016/S0022-510X(96)00284-5	30	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230677	10.1371/journal.pone.0230677	http://dx.doi.org/10.1371/journal.pone.0230677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GC	32203538	Green Published, gold			2022-12-26	WOS:000535303900035
J	Arima, M; Akiyama, M; Fujiwara, K; Mori, Y; Inoue, H; Seki, E; Nakama, T; Tsukamoto, S; Ochiai, M; Ohga, S; Sonoda, KH				Arima, Mitsuru; Akiyama, Masato; Fujiwara, Kohta; Mori, Yujiro; Inoue, Hirosuke; Seki, Eiko; Nakama, Takahito; Tsukamoto, Shoko; Ochiai, Masayuki; Ohga, Shouichi; Sonoda, Koh-Hei			Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PSYCHOLOGICAL-DEVELOPMENT; KYOTO SCALE; CHILDREN; LASER	Purpose The purpose of this study was to evaluate neurodevelopmental outcomes in 18-month old (corrected age) preterm infants who received an intravitreal bevacizumab (IVB) injection for the treatment of type 1 retinopathy of prematurity (ROP). Methods In this ten-year retrospective study, we reviewed the medical records of patients who underwent ROP screening at Kyushu University Hospital. Among the patients who received IVB or laser photocoagulation (LPC) for the treatment of type 1 ROP, we included infants whose neurodevelopmental examination (the Kyoto Scale of Psychological Development [KSPD]) results at 18 months corrected age were available. Then, the effect of IVB on the developmental quotient (DQ) in each KSPD domain (Postural-Movement, Cognitive-Adaptive, or Language-Social domain) or the overall DQ was investigated by performing linear regression analysis. Results Out of the 513 patients reviewed, 53 were included in the study. IVB and LPC were performed for 14 and 39 patients, respectively. Administration of IVB was significantly associated with neurodevelopmental delay in the Language-Social domain (p = 0.01). The observed association remained even after adjusting for gestational age and birth weight (p = 0.03). Conclusions Administration of IVB may introduce a risk of developmental impairment of interpersonal relationships, socializations, and/or verbal abilities of preterm children. We recommended that preterm infants who received IVB undergo a neurodevelopmental reassessment during their school years or in adulthood.	[Arima, Mitsuru; Akiyama, Masato; Fujiwara, Kohta; Mori, Yujiro; Seki, Eiko; Nakama, Takahito; Tsukamoto, Shoko; Sonoda, Koh-Hei] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Japan; [Inoue, Hirosuke; Ochiai, Masayuki; Ohga, Shouichi] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka, Japan	Kyushu University; Kyushu University	Arima, M (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Japan.	m-arima@eye.med.kyushu-u.ac.jp	Akiyama, Masato/AHC-2589-2022		JSPS KAKENHI [JP19K18846]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by a JSPS KAKENHI Grant Number JP19K18846 for M.Arima (https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT19K18846/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki S, 2016, BRAIN DEV-JPN, V38, P481, DOI 10.1016/j.braindev.2015.11.001; Blencowe H, 2013, PEDIATR RES, V74, P35, DOI 10.1038/pr.2013.205; Dhingra D, 2019, OPHTHAL EPIDEMIOL, V26, P169, DOI 10.1080/09286586.2018.1562082; Eichmann Anne, 2013, Cold Spring Harb Perspect Med, V3, pa006551, DOI 10.1101/cshperspect.a006551; Fierson WM, 2013, PEDIATRICS, V131, P189, DOI 10.1542/peds.2012-2996; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good William V, 2004, Trans Am Ophthalmol Soc, V102, P233; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Hwang CK, 2015, OPHTHALMOLOGY, V122, P1008, DOI 10.1016/j.ophtha.2014.12.017; Kanai Yoshihide, 2018, J Phys Ther Sci, V30, P1019, DOI 10.1589/jpts.30.1019; Koyama T, 2009, PSYCHIAT CLIN NEUROS, V63, P241, DOI 10.1111/j.1440-1819.2009.01931.x; Lepore D, 2014, OPHTHALMOLOGY, V121, P2212, DOI 10.1016/j.ophtha.2014.05.015; Lien RY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148019; Linsell L, 2015, JAMA PEDIATR, V169, P1162, DOI 10.1001/jamapediatrics.2015.2175; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Morin J, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3218; Quinn GE, 2016, OPHTHALMOLOGY, V123, P1595, DOI 10.1016/j.ophtha.2016.03.026; Rodriguez SH, 2019, OSLI RETINA, V50, P337, DOI 10.3928/23258160-20190605-01; Rosenstein JM, 2010, ORGANOGENESIS, V6, P107, DOI 10.4161/org.6.2.11687; Sato T, 2012, AM J OPHTHALMOL, V153, P327, DOI 10.1016/j.ajo.2011.07.005; Stahl A, 2019, LANCET, V394, P1551, DOI 10.1016/S0140-6736(19)31344-3; Stoll BJ, 2015, JAMA-J AM MED ASSOC, V314, P1039, DOI 10.1001/jama.2015.10244; VanderVeen DK, 2017, OPHTHALMOLOGY, V124, P619, DOI 10.1016/j.ophtha.2016.12.025; Wu WC, 2017, RETINA-J RET VIT DIS, V37, P694, DOI 10.1097/IAE.0000000000001209	24	23	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0230678	10.1371/journal.pone.0230678	http://dx.doi.org/10.1371/journal.pone.0230678			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196539	Green Published, gold			2022-12-26	WOS:000535303100043
J	Stafford, P; Johnston, SA; Kantarci, OH; Zare-Shahabadi, A; Warrington, A; Rodriguez, M				Stafford, Phillip; Johnston, Stephen Albert; Kantarci, Orhun H.; Zare-Shahabadi, Ameneh; Warrington, Arthur; Rodriguez, Moses			Antibody characterization using immunosignatures	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; PEPTIDE; REMYELINATION; AUTOANTIBODY	Therapeutic monoclonal antibodies have the potential to work as biological therapeutics. OKT3, Herceptin, Keytruda and others have positively impacted healthcare. Antibodies evolved naturally to provide high specificity and high affinity once mature. These characteristics can make them useful as therapeutics. However, we may be missing characteristics that are not obvious. We present a means of measuring antibodies in an unbiased manner that may highlight therapeutic activity. We propose using a microarray of random peptides to assess antibody properties. We tested twenty-four different commercial antibodies to gain some perspective about how much information can be derived from binding antibodies to random peptide libraries. Some monoclonals preferred to bind shorter peptides, some longer, some preferred motifs closer to the C-term, some nearer the N-term. We tested some antibodies with clinical activity but whose function was blinded to us at the time. We were provided with twenty-one different monoclonal antibodies, thirteen mouse and eight human IgM. These antibodies produced a variety of binding patterns on the random peptide arrays. When unblinded, the antibodies with polyspecific binding were the ones with the greatest therapeutic activity. The protein target to these therapeutic monoclonals is still unknown but using common sequence motifs from the peptides we predicted several human and mouse proteins. The same five highest proteins appeared in both mouse and human lists.	[Stafford, Phillip] Caris Life Sci, Dept Bioinformat, Phoenix, AZ USA; [Johnston, Stephen Albert] Arizona State Univ, Ctr Innovat Med, Biodesign Inst, Tempe, AZ USA; [Kantarci, Orhun H.; Zare-Shahabadi, Ameneh; Warrington, Arthur; Rodriguez, Moses] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA	Arizona State University; Arizona State University-Tempe; Mayo Clinic	Kantarci, OH (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	kantarci.orhun@mayo.edu		Stafford, Phillip/0000-0001-7989-9036; Rodriguez, Moses/0000-0001-6328-6497	Du Pre Grant from MS International Federation (MSIF)	Du Pre Grant from MS International Federation (MSIF)	Ameneh Zare was supported by a Du Pre Grant from MS International Federation (MSIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura K, 1995, MOL BRAIN RES, V34, P283, DOI 10.1016/0169-328X(95)00190-4; Asakura K, 1998, J NEUROSCI, V18, P7700; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Boltz KW, 2009, ANALYST, V134, P650, DOI 10.1039/b823156g; Brown JR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-349; Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800; CAPDEVILA J, 2010, MOL CELLULAR PROTEOM, V28; Halperin RF, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-1; Hecker M, 2016, MOL CELL PROTEOMICS, V15, P1360, DOI 10.1074/mcp.M115.051664; Huang J, 2012, NUCLEIC ACIDS RES, V40, pD271, DOI 10.1093/nar/gkr922; Legutki JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5785; MILLER DJ, 1995, J IMMUNOL, V154, P2460; Navalkar KA, 2015, J IMMUNOL METHODS, V417, P10, DOI 10.1016/j.jim.2014.12.002; O'Donnell B, 2015, CANCER INFORM, V14, P219, DOI [10.4137/CIN.S17285, 10.4137/CIn.s17285]; Richer J, 2015, MOL CELL PROTEOMICS, V14, P136, DOI 10.1074/mcp.M114.043513; RODRIGUEZ M, 1987, J NEUROPATH EXP NEUR, V46, P84, DOI 10.1097/00005072-198701000-00008; Rowe M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005882; Singh S, 2018, MOL NEUROBIOL, V55, P633, DOI 10.1007/s12035-016-0334-0; Stafford P, 2016, MOL CELL PROTEOMICS, V15, P1610, DOI 10.1074/mcp.M115.054601; Stafford P, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011593; Wang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18469-6	21	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0229080	10.1371/journal.pone.0229080	http://dx.doi.org/10.1371/journal.pone.0229080			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196507	Green Published, gold			2022-12-26	WOS:000535303100009
J	Yao, X; Yasmeen, R; Padda, IU; Shah, WU; Kamal, MA				Yao, Xing; Yasmeen, Rizwana; Padda, Ihtsham Ul Haq; Shah, Wasi Ul Hassan; Kamal, Muhammad Abdul			Inequalities by energy sources: An assessment of environmental quality	PLOS ONE			English	Article							ECONOMIC-GROWTH; TRADE OPENNESS; CO2 EMISSIONS; CARBON EMISSIONS; OECD COUNTRIES; KUZNETS CURVE; PANEL-DATA; CONSUMPTION; CAUSALITY; INCOME	Energy demand is rising day by day, driven mainly by the development of countries. At the same time, uneven economic growth in countries is the prime cause of inequality in energy consumption. Keeping in view the worth of energy in the growth process, this study quantifies the impact of energy inequalities and trade on environmental quality over the period 1995-2018 for 57 countries. The Theil approach is used to quantify inter-and intra-regional disparities in five energy sources; oil, coal, natural gas hydroelectricity, and renewable energy. The results show that North America has the highest oil consumption inequality between the regions while East Asia & Pacific has the highest index value within the regions. Coal consumption inequality is declining in North America, but not in East Asia and the Pacific. Europe & Central Asia, and North America have the highest inequalities in natural gas consumption between the regions. Inequality is shrinking in hydropower consumption between the regions, however, such trend has not loomed within the regions. Europe & Central Asia and East Asia & Pacific have major renewable consumption inequalities within the regions. Generally, there is a decreasing temporal trend in energy consumption inequalities of all energy sources. The GMM technique is applied to investigate the impact of energy inequalities and trade openness on environmental quality. The results reveal that energy inequalities degrade environmental quality. Moreover, trade has a positive impact on environmental quality. However, democratic countries can be advantageous to improve the environmental quality. The study implies that countries should take actions to reduce energy inequalities within and between the regions. Specialization in production through trade can also be an option for improvement in the environment.	[Yao, Xing; Yasmeen, Rizwana] Southwestern Univ Finance & Econ, Sch Int Business, Chengdu, Peoples R China; [Padda, Ihtsham Ul Haq] Fed Urdu Univ Arts Sci & Technol, Dept Econ, Islamabad, Pakistan; [Shah, Wasi Ul Hassan] Southwestern Univ Finance & Econ, Sch Stat, Chengdu, Peoples R China; [Kamal, Muhammad Abdul] Dept Econ AWKUM, Mardan, Pakistan	Southwestern University of Finance & Economics - China; Federal Urdu University of Arts Science & Technology; Southwestern University of Finance & Economics - China	Padda, IU (corresponding author), Fed Urdu Univ Arts Sci & Technol, Dept Econ, Islamabad, Pakistan.	ihtsham91@yahoo.com	yasmeen, rizwana/ADX-1747-2022; Shah, Wasi Ul Hassan/ADC-4237-2022; Padda, Ihtsham Ul Haq/AAC-2495-2022; Kamal, Muhammad Abdul/ABU-8922-2022; Kamal, Muhammad Abdul/AAE-9420-2019	yasmeen, rizwana/0000-0002-8590-7773; Shah, Wasi Ul Hassan/0000-0003-1470-4861; Padda, Ihtsham Ul Haq/0000-0003-4482-1938; Kamal, Muhammad Abdul/0000-0003-3419-7879	Humanities and Social Sciences Projects of Ministry of Ministry of Education of China [19XJA79003]; Fundamental Research Funds for Central Universities [JBK 2003003]; Sichuan Institute for Free Trade Zone Research, Southwestern University of Finance and Economics	Humanities and Social Sciences Projects of Ministry of Ministry of Education of China; Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); Sichuan Institute for Free Trade Zone Research, Southwestern University of Finance and Economics	This study is sponsored by the Humanities and Social Sciences Projects of Ministry of Ministry of Education of China (19XJA79003) to XY, The Fundamental Research Funds for Central Universities (JBK 2003003) to XY, and Sichuan Institute for Free Trade Zone Research, Southwestern University of Finance and Economics.	Akin C.S., 2014, INT J ENERGY EC POLI, V4, P465; Antweiler W., 2001, REV ECON STAT, V80, P15; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; Armeanu D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195708; Battig MB, 2009, INT ORGAN, V63, P281, DOI 10.1017/S0020818309090092; Blundell R, 1998, J ECONOMETRICS, V87, P115, DOI 10.1016/S0304-4076(98)00009-8; Cao GY., 2017, RES WORLD EC, V8, P59; Chebbi HE, 2011, MIDDLE EAST DEV J, V3, P29, DOI 10.1142/S1793812011000314; Cole MA, 2006, ECON LETT, V92, P108, DOI 10.1016/j.econlet.2006.01.018; Dedeoglu D, 2013, ENERG POLICY, V57, P469, DOI 10.1016/j.enpol.2013.02.016; Dong KY, 2018, J CLEAN PROD, V196, P51, DOI 10.1016/j.jclepro.2018.05.271; Dorling D., 2017, IS INEQUALITY BAD EN; Ghoshray A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205671; Gozgor G, 2018, ENERGY, V153, P27, DOI 10.1016/j.energy.2018.03.158; Gozgor G, 2017, ENVIRON SCI POLLUT R, V24, P27813, DOI 10.1007/s11356-017-0361-z; Hafeez M, 2019, ENERGIES, V12, DOI 10.3390/en12071358; Hasson A., 2017, ENERGY CONSUMPTION T; Hossain S., 2012, LOW CARBON EC, V3, P92, DOI DOI 10.4236/LCE.2012.323013; Ibrahim MH, 2016, S AFR J ECON, V84, P323, DOI 10.1111/saje.12095; Intergovernmental Panel on Climate Change, 2001, 3 ASS REP WORK GROUP; IPCC, 2014, CLIMATE CHANGE 2014, DOI 10.1016/S0022-0248(00)00575-3; Iwata H, 2011, APPL ENERG, V88, P1986, DOI 10.1016/j.apenergy.2010.11.005; Johnson P., 1998, ENV NAFTA UNDERSTAND; Kahouli B, 2017, ENERG ECON, V68, P19, DOI 10.1016/j.eneco.2017.09.013; Kohler M, 2013, ENERG POLICY, V63, P1042, DOI 10.1016/j.enpol.2013.09.022; Korves N., 2011, CLIMATE CHANGE SOCIO; LIU H, 2019, PLOS ONE, V14; Managi S., 2008, DISCUSSION PAPERS, V8013; Meyerson FAB, 1998, POPUL DEV REV, V24, P115, DOI 10.2307/2808124; Novotny J, 2007, ANN REGIONAL SCI, V41, P563, DOI 10.1007/s00168-007-0113-y; Pachuri S., 2014, ENERGY INEQUALITY PO; Padda IUH, 2019, ENVIRON SCI POLLUT R, V26, P1733, DOI 10.1007/s11356-018-3717-0; Saez MP, 2018, REV ECON MUND, P149; PODOBNIK B, 2002, J WORLD SYSTEMS RES, V8, P252; Povitkina M, 2018, ENVIRON POLIT, V27, P411, DOI 10.1080/09644016.2018.1444723; Rafindadi AA, 2019, J ENVIRON MANAGE, V244, P265, DOI 10.1016/j.jenvman.2019.05.048; Roodman D, 2009, STATA J, V9, P86, DOI 10.1177/1536867X0900900106; Sadraoui T., 2019, INT J EC FINANCIAL M, V7, P20, DOI [10.12691/ijefm-7-1-3, DOI 10.12691/IJEFM-7-1-3]; Shafiei S, 2014, ENERG POLICY, V66, P547, DOI 10.1016/j.enpol.2013.10.064; Shah WU, 2019, ENVIRON SCI POLLUT R, V26, P21437, DOI 10.1007/s11356-019-05450-1; Shahbaz M, 2014, ENERG POLICY, V70, P126, DOI 10.1016/j.enpol.2014.03.029; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sun HP, 2019, ENERG POLICY, V135, DOI 10.1016/j.enpol.2019.111002; Sun HP, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11092682; Tang CF, 2015, ENERGY, V79, P447, DOI 10.1016/j.energy.2014.11.033; Theil H., 1967, EC INFORM THEORY; Tiwari AK, 2013, RENEW SUST ENERG REV, V18, P519, DOI 10.1016/j.rser.2012.10.031; Wang S.P., 2015, PLOS ONE, V10; World Energy Council, 2000, EN TOM WORLD; Wu LW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171707; Yao X, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11030597; Yasmeen R, 2019, ENVIRON SCI POLLUT R, V26, P5221, DOI 10.1007/s11356-018-3956-0; Yasmeen R, 2018, ENVIRON SCI POLLUT R, V25, P34360, DOI 10.1007/s11356-018-3390-3	53	22	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0230503	10.1371/journal.pone.0230503	http://dx.doi.org/10.1371/journal.pone.0230503			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9FU	32196532	Green Published, gold			2022-12-26	WOS:000535303100035
J	Pedro-Zapater, A; Segarra, J; Tejero, RG; Vinals, V; Rodriguez, C				Pedro-Zapater, Alba; Segarra, Juan; Gran Tejero, Ruben; Vinals, Victor; Rodriguez, Clemente			Reducing the WCET and analysis time of systems with simple lockable instruction caches	PLOS ONE			English	Article							EFFICIENT	One of the key challenges in real-time systems is the analysis of the memory hierarchy. Many Worst-Case Execution Time (WCET) analysis methods supporting an instruction cache are based on iterative or convergence algorithms, which are rather slow. Our goal in this paper is to reduce the WCET analysis time on systems with a simple lockable instruction cache, focusing on the Lock-MS method. First, we propose an algorithm to obtain a structure-based representation of the Control Flow Graph (CFG). It organizes the whole WCET problem as nested subproblems, which takes advantage of common branch-and-bound algorithms of Integer Linear Programming (ILP) solvers. Second, we add support for multiple locking points per task, each one with specific cache contents, instead of a given locked content for the whole task execution. Locking points are set heuristically before outer loops. Such simple heuristics adds no complexity, and reduces the WCET by taking profit of the temporal reuse found in loops. Since loops can be processed as isolated regions, the optimal contents to lock into cache for each region can be obtained, and the WCET analysis time is further reduced. With these two improvements, our WCET analysis is around 10 times faster than other approaches. Also, our results show that the WCET is reduced, and the hit ratio achieved for the lockable instruction cache is similar to that of a real execution with an LRU instruction cache. Finally, we analyze the WCET sensitivity to compiler optimization, showing for each benchmark the right choices and pointing out that O0 is always the worst option.	[Pedro-Zapater, Alba; Segarra, Juan; Gran Tejero, Ruben; Vinals, Victor] Univ Zaragoza, Inst Invest Ingn Aragon I3A, Dept Informat & Ingn Sistemas, Zaragoza, Spain; [Rodriguez, Clemente] Univ Basque Country, Dept Arquitectura & Tecnol Comp, Pais Vasco, Spain; [Pedro-Zapater, Alba; Segarra, Juan; Gran Tejero, Ruben; Vinals, Victor; Rodriguez, Clemente] HiPEAC, Zaragoza, Spain	University of Zaragoza; University of Basque Country	Pedro-Zapater, A (corresponding author), Univ Zaragoza, Inst Invest Ingn Aragon I3A, Dept Informat & Ingn Sistemas, Zaragoza, Spain.; Pedro-Zapater, A (corresponding author), HiPEAC, Zaragoza, Spain.	albapz@unizar.es		Gran Tejero, Ruben/0000-0002-4031-5651; Segarra, Juan/0000-0003-1550-735X	AEI/ERDF, UE [FPU14/02463, TIN2016-76635-C2-1-R]; Aragon Gov. [gaZ: T58\_17R]; European ESF [gaZ: T58\_17R]	AEI/ERDF, UE; Aragon Gov.; European ESF	This work was supported in part by grants FPU14/02463, TIN2016-76635-C2-1-R (AEI/ERDF, UE), and gaZ: T58\_17R research group (Aragon Gov. and European ESF)	[Anonymous], 16 INT WORKSH WORST; Aparicio LC, 2008, RTCSA 2008: 14TH IEEE INTERNATIONAL CONFERENCE ON EMBEDDED AND REAL-TIME COMPUTING SYSTEMS AND APPLICATIONS - PROCEEDINGS, P393, DOI 10.1109/RTCSA.2008.10; Aparicio LC, 2011, J SYST ARCHITECT, V57, P695, DOI 10.1016/j.sysarc.2010.08.008; Aparicio LC, 2010, IEEE INT CONF EMBED, P319, DOI 10.1109/RTCSA.2010.8; Arnaud A., 2006, P 14 INT C REAL TIM; Binkert Nathan, 2011, Computer Architecture News, V39, P1, DOI 10.1145/2024716.2024718; Bonenfant A., 2008, P WORKSH RES AN; Bygde S, 2009, IEEE INT CONF EMBED, P13, DOI 10.1109/RTCSA.2009.9; Campoy AM, 2005, LECT NOTES COMPUT SC, V3820, P150; Colin A, 2000, REAL-TIME SYST, V18, P249, DOI 10.1023/A:1008149332687; Cousot P., 1977, S PRINC PROGR LANG P, P238, DOI [10.1145/512950.512973, DOI 10.1145/512950.512973]; Ding HP, 2013, DES AUT CON; Ferdinand C, 1999, REAL-TIME SYST, V17, P131, DOI 10.1023/A:1008186323068; Gran R, 2013, J SYST ARCHITECT, V59, P667, DOI 10.1016/j.sysarc.2013.07.012; Gustafsson Jan, 2010, WCET2010, P137; Li YTS, 1996, REAL TIM SYST SYMP P, P254, DOI 10.1109/REAL.1996.563722; Marti Campoy A, 2003, CAN C EL COMP ENG; Marti Campoy A, 2001, IEEE REAL TIM EMB SY; Mittal S, 2016, ACM T DES AUTOMAT EL, V21, DOI 10.1145/2858792; Puaut I, 2002, P IEEE REAL TIM SYST; Puaut I, 2006, EUROMICRO, P217, DOI 10.1109/ECRTS.2006.32; Reineke J, 2007, REAL-TIME SYST, V37, P99, DOI 10.1007/s11241-007-9032-3; Segarra J, 2015, ACM T EMBED COMPUT S, V14, DOI 10.1145/2677093; Segarra J, 2012, IEEE REAL TIME, P45, DOI 10.1109/RTAS.2012.11; Vestal S, 2007, RTSS 2007: 28TH IEEE INTERNATIONAL REAL-TIME SYSTEMS SYMPOSIUM, PROCEEDINGS, P239, DOI 10.1109/RTSS.2007.47; Wilhelm R, 2008, ACM T EMBED COMPUT S, V7, DOI 10.1145/1347375.1347389; Xu L, 2008, PROCEEDINGS OF 2008 INTERNATIONAL SEMINAR ON EDUCATION MANAGEMENT AND ENGINEERING, P8; Zheng WG, 2017, ACM T ARCHIT CODE OP, V14, DOI 10.1145/3046683	28	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0229980	10.1371/journal.pone.0229980	http://dx.doi.org/10.1371/journal.pone.0229980			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191731	Green Published, gold			2022-12-26	WOS:000535302300021
J	Li, WJ; Dai, Y; Shi, BY; Yue, F; Zou, J; Xu, GB; Jiang, XH; Wang, F; Zhou, XK; Liu, LY				Li, Wenjiao; Dai, Yuan; Shi, Boyun; Yue, Fei; Zou, Jing; Xu, Guibin; Jiang, Xianhan; Wang, Fen; Zhou, Xinke; Liu, Leyuan			LRPPRC sustains Yap-P27-mediated cell ploidy and P62-HDAC6-mediated autophagy maturation and suppresses genome instability and hepatocellular carcinomas	ONCOGENE			English	Article							MITOCHONDRIAL; PROTEIN; TUMORIGENESIS; MICROTUBULE; PATHWAY; RASSF1; LIVER; ASSOCIATION; ACTIVATION; ANEUPLOIDY	Mutants in the gene encoding mitochondrion-associated protein LRPPRC were found to be associated with French Canadian Type Leigh syndrome, a human disorder characterized with neurodegeneration and cytochrome c oxidase deficiency. LRPPRC interacts with one of microtubule-associated protein family MAP1S that promotes autophagy initiation and maturation to suppress genomic instability and tumorigenesis. Previously, although various studies have attributed LRPPRC nuclear acid-associated functions, we characterized that LRPPRC acted as an inhibitor of autophagy in human cancer cells. Here we show that liver-specific deletion of LRPPRC causes liver-specific increases of YAP and P27 and decreases of P62, leading to an increase of cell polyploidy and an impairment of autophagy maturation. The blockade of autophagy maturation and promotion of polyploidy caused by LRPPRC depletion synergistically enhances diethylnitrosamine-induced DNA damage, genome instability, and further tumorigenesis so that LRPPRC knockout mice develop more and larger hepatocellular carcinomas and survive a shorter lifespan. Therefore, LRPPRC suppresses genome instability and hepatocellular carcinomas and promotes survivals in mice by sustaining Yap-P27-mediated cell ploidy and P62-HDAC6-controlled autophagy maturation.	[Li, Wenjiao; Shi, Boyun; Xu, Guibin; Jiang, Xianhan; Zhou, Xinke; Liu, Leyuan] Guangzhou Med Univ, Affiliated Hosp 5, 621 Gangwan Rd, Guangzhou 710700, Guangdong, Peoples R China; [Li, Wenjiao; Dai, Yuan; Shi, Boyun; Yue, Fei; Zou, Jing; Xu, Guibin; Jiang, Xianhan; Wang, Fen; Liu, Leyuan] Texas A&M Univ, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA; [Liu, Leyuan] Texas A&M Univ, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Guangzhou Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station	Liu, LY (corresponding author), Guangzhou Med Univ, Affiliated Hosp 5, 621 Gangwan Rd, Guangzhou 710700, Guangdong, Peoples R China.; Liu, LY (corresponding author), Texas A&M Univ, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.; Liu, LY (corresponding author), Texas A&M Univ, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA.	liuleyuan@hotmail.com	Yue, Fei/N-1891-2018	Li, Wenjiao/0000-0003-1308-8489; Zou, Jing/0000-0002-0976-7078	National Natural Science Foundation of China [81772931]; NCI [R01CA142862]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Nils-Goran Larsson, Department of Mitochondrial Genetics, Max Planck Institute for Biology of Ageing, Cologne, Germany, for providing LRPPRCloxP/loxP mice to us as a gift. This work was supported by National Natural Science Foundation of China (81772931) and NCI R01CA142862 to Leyuan Liu.	Chen Q, 2015, J BIOL CHEM, V290, P26051, DOI 10.1074/jbc.M115.653568; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; Chourasia AH, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0130-8; Cuillerier A, 2017, HUM MOL GENET, V26, P3186, DOI 10.1093/hmg/ddx202; Hergovich A, 2012, BIOCHEM SOC T, V40, P124, DOI 10.1042/BST20110619; Jiang XH, 2018, PROSTATE, V78, P426, DOI 10.1002/pros.23487; Jiang XH, 2015, MOL CARCINOGEN, V54, P1194, DOI 10.1002/mc.22193; Jiang XH, 2014, CANCER-AM CANCER SOC, V120, P1228, DOI 10.1002/cncr.28551; Jimenez-Martinez M, 2019, CANCERS, V11, DOI 10.3390/cancers11111767; Johansen T, 2020, J MOL BIOL, V432, P80, DOI 10.1016/j.jmb.2019.07.016; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lee YA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07338-z; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Li WJ, 2019, CELL DEATH DIFFER, V26, P1379, DOI 10.1038/s41418-018-0211-7; Li WJ, 2016, AGING CELL, V15, P370, DOI 10.1111/acel.12441; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liu LY, 2012, AUTOPHAGY, V8, P278, DOI 10.4161/auto.8.2.18939; Liu LJ, 2011, J BIOL CHEM, V286, P41253, DOI 10.1074/jbc.M111.276121; Liu LY, 2005, BIOCHEM BIOPH RES CO, V332, P670, DOI 10.1016/j.bbrc.2005.05.006; Liu LY, 2005, CANCER RES, V65, P4191, DOI 10.1158/0008-5472.CAN-04-3865; Liu LY, 2005, CANCER RES, V65, P1830, DOI 10.1158/0008-5472.CAN-04-3896; Liu LY, 2002, IN VITRO CELL DEV-AN, V38, P582; Liu LY, 2002, GENOMICS, V79, P124, DOI 10.1006/geno.2001.6679; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mishra PK, 2009, FREE RADICAL RES, V43, P718, DOI 10.1080/10715760903037699; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Nam M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01879-x; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Refolo G, 2019, HEPATOLOGY, V69, P34, DOI 10.1002/hep.30149; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Ryter Stefan W, 2014, Int J Cell Biol, V2014, P502676, DOI 10.1155/2014/502676; Schweitzer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040537; Siira SJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01221-z; Singh S, 2014, NAT REV GASTRO HEPAT, V11, P45, DOI 10.1038/nrgastro.2013.143; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Terman A, 2006, CHEM-BIOL INTERACT, V163, P29, DOI 10.1016/j.cbi.2006.04.013; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vandin F, 2012, BIOCOMPUT-PAC SYM, P55; Xie R, 2011, CANCER RES, V71, P7537, DOI 10.1158/0008-5472.CAN-11-2170; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; Xu FH, 2012, BIOCHEM J, V441, P275, DOI 10.1042/BJ20110985; Xu GB, 2016, ONCOTARGET, V7, P6255, DOI 10.18632/oncotarget.6669; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Yue F, 2017, CANCER RES, V77, P2938, DOI 10.1158/0008-5472.CAN-16-3462; Yue F, 2015, AGING-US, V7, P839, DOI 10.18632/aging.100818; Zhang SH, 2017, CANCER CELL, V31, P669, DOI 10.1016/j.ccell.2017.04.004; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094903; Zou J, 2013, BIOCHEM J, V454, P447, DOI 10.1042/BJ20130306	56	10	10	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	19					3879	3892		10.1038/s41388-020-1257-9	http://dx.doi.org/10.1038/s41388-020-1257-9		MAR 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LK4OF	32203162				2022-12-26	WOS:000519841000001
J	Wang, YQ; Sun, ZQ; Bianco, PR; Lyubchenko, YL				Wang, Yaqing; Sun, Zhiqiang; Bianco, Piero R.; Lyubchenko, Yuri L.			Atomic force microscopy?based characterization of the interaction of PriA helicase with stalled DNA replication forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atomic force microscopy (AFM); DNA replication; single-molecule biophysics; protein translocation; protein?DNA interaction; DNA helicase	ESCHERICHIA-COLI-SSB; BINDING-PROTEIN; 2 MODES; PRIMOSOME; RECG; RECOMBINATION; ASSOCIATION; SPECIFICITY; MECHANISMS; MUTANTS	In bacteria, the restart of stalled DNA replication forks requires the DNA helicase PriA. PriA can recognize and remodel abandoned DNA replication forks, unwind DNA in the 3?-to-5? direction, and facilitate the loading of the helicase DnaB onto the DNA to restart replication. Single-stranded DNA?binding protein (SSB) is typically present at the abandoned forks, but it is unclear how SSB and PriA interact, although it has been shown that the two proteins interact both physically and functionally. Here, we used atomic force microscopy to visualize the interaction of PriA with DNA substrates with or without SSB. These experiments were done in the absence of ATP to delineate the substrate recognition pattern of PriA before its ATP-catalyzed DNA-unwinding reaction. These analyses revealed that in the absence of SSB, PriA binds preferentially to a fork substrate with a gap in the leading strand. Such a preference has not been observed for 5?- and 3?-tailed duplexes, suggesting that it is the fork structure that plays an essential role in PriA's selection of DNA substrates. Furthermore, we found that in the absence of SSB, PriA binds exclusively to the fork regions of the DNA substrates. In contrast, fork-bound SSB loads PriA onto the duplex DNA arms of forks, suggesting a remodeling of PriA by SSB. We also demonstrate that the remodeling of PriA requires a functional C-terminal domain of SSB. In summary, our atomic force microscopy analyses reveal key details in the interactions between PriA and stalled DNA replication forks with or without SSB.	[Wang, Yaqing; Sun, Zhiqiang; Lyubchenko, Yuri L.] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA; [Bianco, Piero R.] SUNY Buffalo, Ctr Single Mol Biophys, Buffalo, NY 14214 USA	University of Nebraska System; University of Nebraska Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lyubchenko, YL (corresponding author), Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA.	ylyubchenko@unmc.edu		Wang, Yaqing/0000-0002-5797-3992; Lyubchenko, Yuri/0000-0001-9721-8302	NIGMS, National Institutes of Health [R01 GM118006, R01 GM100156]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants R01 GM118006 (to Y. L. L.) and R01 GM100156 (to P. R. B. and Y. L. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLEN GC, 1993, J BIOL CHEM, V268, P19204; ARAI KI, 1981, P NATL ACAD SCI-BIOL, V78, P707, DOI 10.1073/pnas.78.2.707; Bagchi D, 2018, NUCLEIC ACIDS RES, V46, P8500, DOI 10.1093/nar/gky647; Bell JC, 2015, ELIFE, V4, DOI 10.7554/eLife.08646; Bhattacharyya B, 2014, P NATL ACAD SCI USA, V111, P1373, DOI 10.1073/pnas.1318001111; Bianco PR, 2017, PROG BIOPHYS MOL BIO, V127, P111, DOI 10.1016/j.pbiomolbio.2016.11.001; Bianco PR, 2017, PROTEIN SCI, V26, P638, DOI 10.1002/pro.3114; Bianco PR, 2017, PROTEIN SCI, V26, P227, DOI 10.1002/pro.3072; Cadman CJ, 2005, J BIOL CHEM, V280, P39693, DOI 10.1074/jbc.M508521200; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Chen HW, 2004, J BIOL CHEM, V279, P38503, DOI 10.1074/jbc.M404769200; Costes A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001238; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Ding WF, 2020, PROTEIN SCI, V29, P1211, DOI 10.1002/pro.3855; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Jones JM, 2001, J MOL BIOL, V312, P935, DOI 10.1006/jmbi.2001.4930; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kozlov AG, 2010, BIOCHEMISTRY-US, V49, P3555, DOI 10.1021/bi100069s; Liu J, 2011, PROTEIN SCI, V20, P1005, DOI 10.1002/pro.633; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Marians KJ, 2000, TRENDS BIOCHEM SCI, V25, P185, DOI 10.1016/S0968-0004(00)01565-6; MASAI H, 1994, EMBO J, V13, P5338, DOI 10.1002/j.1460-2075.1994.tb06868.x; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00013-18; Mills M, 2017, NUCLEIC ACIDS RES, V45, P11878, DOI 10.1093/nar/gkx939; Nurse P, 1999, J BIOL CHEM, V274, P25026, DOI 10.1074/jbc.274.35.25026; OUZOUNIS CA, 1991, NUCLEIC ACIDS RES, V19, P6953, DOI 10.1093/nar/19.24.6953; Sandler SJ, 2000, J BACTERIOL, V182, P9, DOI 10.1128/JB.182.1.9-13.2000; Sasaki K, 2007, EMBO J, V26, P2584, DOI 10.1038/sj.emboj.7601697; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Shlyakhtenko Luda S, 2013, Methods Mol Biol, V931, P295, DOI 10.1007/978-1-62703-056-4_14; Shlyakhtenko LS, 2012, BIOCHEMISTRY-US, V51, P6432, DOI 10.1021/bi300733d; Shlyakhtenko LS, 2012, BIOCHEMISTRY-US, V51, P1500, DOI 10.1021/bi201863z; Sun ZQ, 2018, BIOCHEMISTRY-US, V57, P1967, DOI 10.1021/acs.biochem.7b01235; Sun ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09625; Tan HY, 2017, PROTEIN SCI, V26, P700, DOI 10.1002/pro.3115; Tanaka T, 2003, GENES CELLS, V8, P251, DOI 10.1046/j.1365-2443.2003.00630.x; Tanaka T, 2002, J BIOL CHEM, V277, P38062, DOI 10.1074/jbc.M204397200; Tanaka T, 2007, J BIOL CHEM, V282, P19917, DOI 10.1074/jbc.M701848200; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P3342, DOI 10.1073/pnas.72.9.3342; Windgassen TA, 2019, J BIOL CHEM, V294, P2801, DOI 10.1074/jbc.RA118.006870; Windgassen TA, 2018, P NATL ACAD SCI USA, V115, pE9075, DOI 10.1073/pnas.1809842115; Windgassen TA, 2018, NUCLEIC ACIDS RES, V46, P504, DOI 10.1093/nar/gkx1203; Yu C, 2016, GENES CELLS, V21, P163, DOI 10.1111/gtc.12334; ZAVITZ KH, 1991, MOL MICROBIOL, V5, P2869, DOI 10.1111/j.1365-2958.1991.tb01846.x; ZAVITZ KH, 1992, J BIOL CHEM, V267, P6933	51	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6043	6052		10.1074/jbc.RA120.013013	http://dx.doi.org/10.1074/jbc.RA120.013013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32209655	hybrid, Green Published			2022-12-26	WOS:000531417300016
J	Itoi, M; Kitazawa, K; Yokota, I; Wakimasu, K; Cho, Y; Nakamura, Y; Hieda, O; Teramukai, S; Kinoshita, S; Sotozono, C				Itoi, Motohiro; Kitazawa, Koji; Yokota, Isao; Wakimasu, Koichi; Cho, Yuko; Nakamura, Yo; Hieda, Osamu; Teramukai, Satoshi; Kinoshita, Shigeru; Sotozono, Chie			Anterior and posterior ratio of corneal surface areas: A novel index for detecting early stage keratoconus	PLOS ONE			English	Article							FORME-FRUSTE KERATOCONUS; IN-SITU KERATOMILEUSIS; ELEVATION; ECTASIA; EYES	Purpose To evaluate the diagnostic ability of the ratio of anterior and posterior corneal surface areas (As/Ps) comparing with other keratoconus screening indices in distinguishing forme fruste keratoconus (FFKC) from normal eyes. Methods In this comparative study, 13 eyes of 13 patients with FFKC, 29 eyes of 29 patients with keratoconus (KC) and 88 eyes of 88 patients with normal subjects were involved. The As/Ps measured by the anterior segment optical coherence tomography (AS-OCT) and other indices measured by AS-OCT and rotating Scheimpflug-based corneal tomography were evaluated. The area under receiver-operating-characteristics (AU-ROC) was calculated to assess the diagnostic ability in discriminating FFKC from normal eyes. Results The As/Ps, the Belin/Ambrosio display enhanced ectasia total derivation value (BAD-D) and posterior and anterior elevation values showed the AU-ROC 0.9 or more in differentiating FFKC from normal eyes (0.980, 0.951, 0.924 and 0.903, respectively). The sensitivity and specificity were 0.92 and 0.96 for the As/Ps, 1.00 and 0.90 for BAD-D, 0.85 and 0.86 for posterior elevation value, and 0.85 and 0.96 for anterior elevation value, respectively. Conclusions Among the several indices for keratoconus screening which we evaluated, the As/Ps obtained by AS-OCT had the large AU-ROC with high sensitivity and specificity in detecting FFKC, which was comparable with BAD-D obtained by rotating Scheimpflug-based corneal tomography. The As/Ps may provide information for improving the diagnostic accuracy of KC, even in the initial stage of the disease.	[Itoi, Motohiro; Kitazawa, Koji; Cho, Yuko; Nakamura, Yo; Hieda, Osamu; Sotozono, Chie] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Kitazawa, Koji; Wakimasu, Koichi] Baptist Eye Inst, Dept Ophthalmol, Kyoto, Japan; [Yokota, Isao; Teramukai, Satoshi] Kyoto Prefectural Univ Med, Dept Biostat, Kyoto, Japan; [Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Frontier Med Sci & Technol Ophthalmol, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Kitazawa, K (corresponding author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan.; Kitazawa, K (corresponding author), Baptist Eye Inst, Dept Ophthalmol, Kyoto, Japan.	kkitazaw@koto.kpu-m.ac.jp	Teramukai, Satoshi/I-2249-2019; Yokota, Isao/AAB-2910-2021	Teramukai, Satoshi/0000-0003-2184-0597; Yokota, Isao/0000-0001-6254-2225				Ambrosio R., 2013, CURR OPHTHALMOL REP, V1, P28; Arbelaez MC, 2012, OPHTHALMOLOGY, V119, P2231, DOI 10.1016/j.ophtha.2012.06.005; Awad EA, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0584-2; Cavas-Martinez F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184569; Cavas-Martinez F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110249; de Sanctis U, 2008, OPHTHALMOLOGY, V115, P1534, DOI 10.1016/j.ophtha.2008.02.020; Fam HB, 2006, J CATARACT REFR SURG, V32, P1281, DOI 10.1016/j.jcrs.2006.02.060; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Gomes JAP, 2015, CORNEA, V34, P359, DOI 10.1097/ICO.0000000000000408; Habibzadeh F, 2016, BIOCHEM MEDICA, V26, P297, DOI 10.11613/BM.2016.034; KENNEDY RH, 1986, AM J OPHTHALMOL, V101, P267, DOI 10.1016/0002-9394(86)90817-2; Kitazawa K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33490-z; Kitazawa K, 2016, CORNEA, V35, P1229, DOI 10.1097/ICO.0000000000000963; Klein SR, 2006, CORNEA, V25, P388, DOI 10.1097/01.ico.0000222479.68242.77; Kozobolis V, 2012, EUR J OPHTHALMOL, V22, P920, DOI 10.5301/ejo.5000184; Li XH, 2004, OPHTHALMOLOGY, V111, P440, DOI 10.1016/j.ophtha.2003.06.020; MAEDA N, 1995, ARCH OPHTHALMOL-CHIC, V113, P870, DOI 10.1001/archopht.1995.01100070044023; MAEDA N, 1994, INVEST OPHTH VIS SCI, V35, P2749; Muftuoglu O, 2013, J CATARACT REFR SURG, V39, P1348, DOI 10.1016/j.jcrs.2013.03.023; Naderan M, 2018, INT OPHTHALMOL, V38, P1565, DOI 10.1007/s10792-017-0620-5; Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039; Randleman JB, 2006, CURR OPIN OPHTHALMOL, V17, P406, DOI 10.1097/01.icu.0000233963.26628.f0; Rao SN, 2002, OPHTHALMOLOGY, V109, P1642, DOI 10.1016/S0161-6420(02)01121-1; Saad A, 2010, INVEST OPHTH VIS SCI, V51, P5546, DOI 10.1167/iovs.10-5369; Schweitzer C, 2010, INVEST OPHTH VIS SCI, V51, P2403, DOI 10.1167/iovs.09-3689; Wang YM, 2017, J REFRACT SURG, V33, P632, DOI 10.3928/1081597X-20170621-09; Yousefi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205998; Zadnik K, 1996, CORNEA, V15, P139, DOI 10.1097/00003226-199603000-00006	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0231074	10.1371/journal.pone.0231074	http://dx.doi.org/10.1371/journal.pone.0231074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240243	gold, Green Published			2022-12-26	WOS:000535945000089
J	Xia, AN; Liu, J; Kang, DC; Zhang, HG; Zhang, RH; Liu, YG				Xia, Ao-Nan; Liu, Jun; Kang, Da-Cheng; Zhang, Hai-Guang; Zhang, Ru-Hua; Liu, Yun-Guo			Assessment of endophytic bacterial diversity in rose by high-throughput sequencing analysis	PLOS ONE			English	Article							MICROBIAL DIVERSITY; BIOCONTROL AGENTS; ESSENTIAL OIL; PLANT; COMMUNITIES; WATER; WILD; LEAVES; SOUTH; SOIL	The endophytic bacterial diversity of rose was analyzed by high-throughput sequencing of 16S rDNA and functional prediction of the bacterial community. The number of bacterial sequence reads obtained from 18 rose samples ranged from 63,951 to 114,833, and reads were allocated to 1982 OTUs based on sequences of the V3-V4 region. The highest Shannon Index was found in Luogang rose (1.93), while the lowest was found in Grasse rose (0.35). The bacterial sequence reads were grouped into three different phyla: Firmicutes, Proteobacteria, and Actinobacteria. At the genus level, Bacillus and Staphylococcus had the highest abundance across all 18 samples; Bacillus was particularly abundant in Daguo rose (99.09%), Rosa damascena (99.65%), and Fenghua rose (99.58%). Unclassified OTUs were also found in all samples. PICRUSt gene prediction revealed that each endophyte sample contained multiple KEGG functional modules related to human metabolism and health. A high abundance of functional genes were involved in (1) Amino Acid Metabolism, (2) Carbohydrate Metabolism, (3) Cellular Processes and Signaling, (4) Energy Metabolism, and (5) Membrane Transport, indicating that the endophytic community comprised a wide variety of microorganisms and genes that could be used for further studies. The rose endophytic bacterial community is rich in diversity; community composition varies among roses and contains functional information related to human health.	[Xia, Ao-Nan; Liu, Jun] Xinjiang Univ, Coll Life Sci & Technol, Urumqi, Peoples R China; [Xia, Ao-Nan; Kang, Da-Cheng; Zhang, Hai-Guang; Zhang, Ru-Hua; Liu, Yun-Guo] Linyi Univ, Coll Life Sci, Linyi, Shandong, Peoples R China	Xinjiang University; Linyi University	Liu, YG (corresponding author), Linyi Univ, Coll Life Sci, Linyi, Shandong, Peoples R China.	yguoliu@163.com		Xia, Aonan/0000-0001-8446-4969	High-level talent introduction project of Linyi University [LYDX2018BS032]	High-level talent introduction project of Linyi University	This work was supported by grant from the High-level talent introduction project of Linyi University (LYDX2018BS032).	Abia ALK, 2018, SCI TOTAL ENVIRON, V616, P326, DOI 10.1016/j.scitotenv.2017.10.322; [Anonymous], 2017, COMP FUNCTION ROSE I, V47, P366, DOI [10.3760/cma.j.issn.0255-7053.2017.06.009, DOI 10.3760/CMA.J.ISSN.0255-7053.2017.06.009]; Aregbe AY, 2019, FOOD CHEM, V290, P125, DOI 10.1016/j.foodchem.2019.03.100; Ashitha A, 2019, MICROB PATHOGENESIS, V135, DOI 10.1016/j.micpath.2019.103624; Barzanti R, 2007, MICROB ECOL, V53, P306, DOI 10.1007/s00248-006-9164-3; Baydar H, 2005, IND CROP PROD, V21, P251, DOI 10.1016/j.indcrop.2004.04.004; Beneduzi A, 2013, APPL SOIL ECOL, V63, P94, DOI 10.1016/j.apsoil.2012.08.010; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Chen HM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030672; D'Angiolillo F, 2018, NOT BOT HORTI AGROBO, V46, P402, DOI 10.15835/nbha46211061; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Eljounaidi K, 2016, BIOL CONTROL, V103, P62, DOI 10.1016/j.biocontrol.2016.07.013; Ercolini D, 2012, APPL ENVIRON MICROB, V78, P8142, DOI 10.1128/AEM.02218-12; Etesami H, 2016, BIOL CONTROL, V94, P11, DOI 10.1016/j.biocontrol.2015.12.003; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Hung PQ, 2007, BIOL FERT SOILS, V44, P155, DOI 10.1007/s00374-007-0189-7; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; Islam MN, 2019, FOODBORNE PATHOG DIS, V16, P661, DOI 10.1089/fpd.2018.2496; Jiang XT, 2013, MICROB ECOL, V66, P96, DOI 10.1007/s00248-013-0238-8; Jin H, 2013, ANTON LEEUW INT J G, V104, P949, DOI 10.1007/s10482-013-0014-2; Klose S, 2006, SOIL BIOL BIOCHEM, V38, P1243, DOI 10.1016/j.soilbio.2005.09.025; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lin YH, 2015, PEDOBIOLOGIA, V58, P177, DOI 10.1016/j.pedobi.2015.09.001; Liu WR, 2017, BIORESOURCE TECHNOL, V231, P45, DOI 10.1016/j.biortech.2017.01.050; Liu Y, 2017, PLANT GROWTH REGUL, V81, P317, DOI 10.1007/s10725-016-0208-5; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Maggini V, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1890-z; Mago R, 2011, THEOR APPL GENET, V122, P735, DOI 10.1007/s00122-010-1482-7; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Nadpal JD, 2018, FOOD CHEM, V241, P290, DOI 10.1016/j.foodchem.2017.08.111; Pan D, 2015, MYCOTOXIN RES, V31, P137, DOI 10.1007/s12550-015-0224-8; Patel S, 2017, TRENDS FOOD SCI TECH, V63, P29, DOI 10.1016/j.tifs.2017.03.001; Rybakova D, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0310-6; Verma RS, 2016, J ESSENT OIL RES, V28, P332, DOI 10.1080/10412905.2016.1144543; Wang F, 2018, AMB EXPRESS, V8, DOI 10.1186/s13568-018-0713-1; Wang HX, 2008, ENVIRON MICROBIOL, V10, P2684, DOI 10.1111/j.1462-2920.2008.01689.x; Wang KY, 2016, SCI REP-UK, V6, DOI 10.1038/srep37490; Werlemark G, 2010, DOGROSES BOT HORTICU; Zhao MQ, 2007, APPL MICROBIOL BIOT, V73, P1435, DOI 10.1007/s00253-006-0625-x	41	4	5	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230924	10.1371/journal.pone.0230924	http://dx.doi.org/10.1371/journal.pone.0230924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240208	Green Published, gold			2022-12-26	WOS:000535945000059
J	Yada, H; Abe, H; Odachi, R; Adachi, K				Yada, Hironori; Abe, Hiroshi; Odachi, Ryo; Adachi, Keiichiro			Exploration of the factors related to self-efficacy among psychiatric nurses	PLOS ONE			English	Article							SCALE	The average length of hospital stay in the psychiatric ward is longer, and the risk of patient-to-nurse violence is higher than that in other departments. Therefore, psychiatric nurses' work environment may differ from that of other nurses. The factors related to psychiatric nurses' self-efficacy may also differ from those of general workers or other nurses. Mental health care that considers the characteristics of psychiatric nurses requires exploration of self-efficacy unique to psychiatric nurses. This cross-sectional study aimed to explore the distinct factors related to psychiatric nurses' self-efficacy. The developed 24 items related to improvement in self-efficacy and 25 items related to decrease in self-efficacy were examined. The Generalized Self-Efficacy Scale was used to measure the validity of the factors. To extract the factors of self-efficacy, data from 132 nurses and assistant nurses who provided informed consent were analyzed, and the reliability and validity of the factors were calculated. The factors associated with improvement in self-efficacy were "Positive reactions by patients," "Ability to positively change nurse-patient relationship," and "Practicability of appropriate nursing." The factors associated with decrease in self-efficacy were "Uncertainty in psychiatric nursing" and "Nurses' role loss." The Cronbach's a for all factors exceeded.70. Of the five factors, four had significant weak-to-moderate correlations with the Japanese version of the Generalized Self-Efficacy Scale; therefore, the validity was quantitatively confirmed with four factors. Interventions based on these four factors may improve psychiatric nurses' self-efficacy. Additionally, it is possible that this tool assesses the unique facets of self-efficacy rather than psychiatric nurses' general self-efficacy. Interventions to improve psychiatric nurses' self-efficacy based on the characteristics of psychiatry are needed.	[Yada, Hironori; Odachi, Ryo] Yamaguchi Univ, Dept Clin Nursing, Grad Sch Med, Yamaguchi, Japan; [Abe, Hiroshi] Hlth Sci Univ Hokkaido, Dept Clin Psychol, Tobetsu, Hokkaido, Japan; [Adachi, Keiichiro] Yamaguchi Univ, Dept Fundamental Nursing, Grad Sch Med, Yamaguchi, Japan	Yamaguchi University; Health Sciences University of Hokkaido; Yamaguchi University	Yada, H (corresponding author), Yamaguchi Univ, Dept Clin Nursing, Grad Sch Med, Yamaguchi, Japan.	yadahiro@yamaguchi-u.ac.jp		Odachi, Ryo/0000-0003-2927-0541	JSPS KAKENHI [19K19498]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI(https://www.jsps.go.jp/j-grantsinaid/) [grant number 19K19498]. The supporting source had no involvements for this study design (collection, analysis, and interpretation of data), writing the report and the decision to submit the report for publication.	Asako Miura, 2007, J JAPANESE SOC ARTIF, V21, P620; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Bandura A., 1997, SELF EFFICACY EXERCI, P201, DOI [10.1007/s00420-010-0540-4, DOI 10.1007/S00420-010-0540-4]; Boswell JF, 2014, J CLIN PSYCHOL, V69, DOI [10.1002/jclp, DOI 10.1002/JCLP]; Cranley L, 2009, WORLDV EVID-BASED NU, V6, P3, DOI 10.1111/j.1741-6787.2008.00138.x; De Simone S, 2018, APPL NURS RES, V39, P130, DOI 10.1016/j.apnr.2017.11.004; Fida R, 2018, HEALTH CARE MANAGE R, V43, P21, DOI 10.1097/HMR.0000000000000126; Hsieh HF, 2018, J ADV NURS, V74, P425, DOI 10.1111/jan.13451; Hulin C, 2001, J CONSUM PSYCHOL, V10, P55, DOI 10.1207/S15327663JCP1001&2_05; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kanehara A, 2015, PSYCHIAT CLIN NEUROS, V69, P523, DOI 10.1111/pcn.12267; Kim Jeong-Hee, 2012, [Korean Journal of Occupational Health Nursing, 한국직업건강간호학회지], V21, P134; Kimura K, 2012, JAPANESE J NURSING R, V35, P87, DOI [10.15065/jjsnr.20121011009, DOI 10.15065/JJSNR.20121011009]; King BM, 2019, J PSYCHOSOC NURS MEN, V57, P29, DOI 10.3928/02793695-20190225-01; Koopmans PC, 2011, INT ARCH OCC ENV HEA, V84, P193, DOI 10.1007/s00420-010-0540-4; Kunnan A. J., 1998, LANG TEST, V15, P295, DOI DOI 10.1177/026553229801500302; Lunenburg F C, 2011, INT J MANAGEMENT BUS, V14, P1; Ministry of Health. Labor and Welfare, 2017, OV MED FAC SURV HOSP; Myers N, 2011, RES Q EXERCISE SPORT, V82, P79, DOI 10.1080/02701367.2011.10599724; NARITA K, 1995, JPN J EDUC PSYCHOL, V43, P306, DOI 10.5926/jjep1953.43.3_306; Organisation for Economic Cooperation and Development, 2014, OECD HLTH STAT FREQ; Sakai Toshiko, 2017, J JAPAN HLTH MED ASS, V26, P65; SHERER M, 1982, PSYCHOL REP, V51, P663, DOI 10.2466/pr0.1982.51.2.663; SHERER M, 1983, PSYCHOL REP, V53, P899, DOI 10.2466/pr0.1983.53.3.899; Stewart D, 2015, INT J MENT HEALTH NU, V24, P82, DOI 10.1111/inm.12107; Yada Hironori, 2017, Journal of UOEH, V39, P229, DOI 10.7888/juoeh.39.229; Yada H, 2011, PSYCHIAT CLIN NEUROS, V65, P567, DOI 10.1111/j.1440-1819.2011.02258.x; Yang J, 2018, PSYCHIAT DANUB, V30, P189, DOI 10.24869/psyd.2018.189; Yoshizawa K, 2016, ARCH ENVIRON OCCUP H, V71, P10, DOI 10.1080/19338244.2014.927345	29	3	3	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230740	10.1371/journal.pone.0230740	http://dx.doi.org/10.1371/journal.pone.0230740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8KJ	32240210	Green Published, gold			2022-12-26	WOS:000535945000039
J	Yu, SZ; Wang, Y; Hou, J; Li, WY; Wang, X; Xiang, LCL; Tan, DL; Wang, WJ; Jiang, LL; Claret, FX; Jiao, M; Guo, H				Yu, SiZhe; Wang, Yu; Hou, Jia; Li, WenYuan; Wang, Xiao; Xiang, LuoChengLing; Tan, DeLi; Wang, WenJuan; Jiang, LiLi; Claret, Francois X.; Jiao, Min; Guo, Hui			Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival	PLOS ONE			English	Article							CTLA-4 BLOCKADE; T-CELLS; LANDSCAPE; MICROENVIRONMENT; IMMUNOTHERAPY; MACROPHAGES; EXPRESSION; BIOMARKERS	Systematic interrogation of tumor-infiltrating immune cells (TIICs) is key to the prediction of clinical outcome and development of immunotherapies. However, little is known about the TIICs of hepatocellular carcinoma (HCC) and its impact on the prognosis of patients and potential for immunotherapy. We applied CIBERSORT of 1090 tumors to infer the infiltration of 22 subsets of TIICs using gene expression data. Unsupervised clustering analysis by 22 TIICs revealed 4 clusters of tumors, mainly defined by macrophages and T cells, with distinct prognosis and associations with immune checkpoint molecules, including PD-1, CD274, CTLA-4, LAG-3 and IFNG. We found tumors with decreased number of M1 macrophages or increased regulatory T cells were associated with poor prognosis. Based on the multivariate Cox analysis, a nomogram was also established for clinical application. In conclusion, composition of the TIICs in HCC was quite different, which is an important determinant of prognosis with great potential to identify candidates for immunotherapy.	[Yu, SiZhe; Wang, Yu; Hou, Jia; Li, WenYuan; Wang, Xiao; Xiang, LuoChengLing; Tan, DeLi; Wang, WenJuan; Jiang, LiLi; Jiao, Min; Guo, Hui] Xi An Jiao Tong Univ, Dept Med Oncol, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Wang, Yu] Xi An Jiao Tong Univ, Dept Respirol, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China; [Claret, Francois X.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Guo, Hui] Xi An Jiao Tong Univ, Key Lab Environm & Genes Related Dis, Minist Educ China, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; University of Texas System; UTMD Anderson Cancer Center; Ministry of Education, China; Xi'an Jiaotong University	Jiao, M; Guo, H (corresponding author), Xi An Jiao Tong Univ, Dept Med Oncol, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China.; Guo, H (corresponding author), Xi An Jiao Tong Univ, Key Lab Environm & Genes Related Dis, Minist Educ China, Xian, Shaanxi, Peoples R China.	jiaomin3650000@163.com; guohuihappy97@163.com			National Natural Science Foundation of China [81672432]; China Postdoctoral Science Foundation [2018M640999, 2019T120920]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the National Natural Science Foundation of China (81672432) and the China Postdoctoral Science Foundation (2018M640999 and 2019T120920) to Hui Guo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao JY, 2017, MOL CANCER THER, V16, P1544, DOI 10.1158/1535-7163.MCT-16-0866; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Cariani E, 2019, LIVER INT, V39, P1608, DOI 10.1111/liv.14192; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Chen J, 2019, MED SCI MONITOR, V25, P6204, DOI 10.12659/MSM.915408; Ghazal K, 2019, CLIN RES HEPATOL GAS, V43, P273, DOI 10.1016/j.clinre.2018.10.005; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; Greten TF, 2010, J IMMUNOTHER, V33, P211, DOI 10.1097/CJI.0b013e3181bb499f; Harding JJ, 2019, DIGEST DIS SCI, V64, P918, DOI 10.1007/s10620-019-05517-6; Huang QC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026168; Ikeda M, 2017, JPN J CLIN ONCOL, V47, P512, DOI 10.1093/jjco/hyx038; Kindlund B, 2017, GASTRIC CANCER, V20, P116, DOI 10.1007/s10120-015-0591-z; Kurebayashi Y, 2018, HEPATOLOGY, V68, P1025, DOI 10.1002/hep.29904; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Li ZX, 2019, CANCER LETT, V458, P86, DOI 10.1016/j.canlet.2019.05.019; Lim CJ, 2019, GUT, V68, P916, DOI 10.1136/gutjnl-2018-316510; Liu CQ, 2018, BRIT J CANCER, V119, P80, DOI 10.1038/s41416-018-0144-4; Liu XF, 2019, ONCOLOGIST, V24, pS3, DOI 10.1634/theoncologist.2019-IO-S1-s01; Liu Y, 2018, TRENDS IMMUNOL, V39, P953, DOI 10.1016/j.it.2018.10.009; Lu C, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1047-6; Ma LJ, 2018, THERANOSTICS, V8, P5690, DOI 10.7150/thno.28742; Meng G, 2019, MOL THER-ONCOLYTICS, V13, P22, DOI 10.1016/j.omto.2019.03.004; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Phan GQ, 2008, ANN SURG ONCOL, V15, P3014, DOI 10.1245/s10434-008-0104-y; Prieto J, 2015, NAT REV GASTRO HEPAT, V12, P681, DOI 10.1038/nrgastro.2015.173; Reghupaty SC, 2019, CANCERS, V11, DOI 10.3390/cancers11091265; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rohr-Udilova N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24437-5; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Shindo Y, 2019, CANCERS, V11, DOI 10.3390/cancers11091223; Sia D, 2017, GASTROENTEROLOGY, V153, P812, DOI 10.1053/j.gastro.2017.06.007; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Sun HY, 2019, HEPATOLOGY, V70, P168, DOI 10.1002/hep.30347; Teng FF, 2018, CANCER LETT, V414, P166, DOI 10.1016/j.canlet.2017.11.014; Tian MX, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1341-6; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tovoli F, 2019, DIGEST LIVER DIS, V51, P1067, DOI 10.1016/j.dld.2019.05.006; Wang Y, 2016, CELL PHYSIOL BIOCHEM, V38, P306, DOI 10.1159/000438631; Xu LX, 2019, ANN ONCOL, V30, P990, DOI 10.1093/annonc/mdz103; Xu X, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.9292; Xue TC, 2015, TUMOR BIOL, V36, P5891, DOI 10.1007/s13277-015-3261-1; YANG HY, 2019, FRONTIERS ONCOLOGY, V9, DOI DOI 10.3389/FONC.2019; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y; Yuan XL, 2010, CLIN IMMUNOL, V134, P277, DOI 10.1016/j.clim.2009.10.005; Zhao HQ, 2014, WORLD J GASTROENTERO, V20, P7971, DOI 10.3748/wjg.v20.i24.7971; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035	48	25	27	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0231003	10.1371/journal.pone.0231003	http://dx.doi.org/10.1371/journal.pone.0231003			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240238	Green Published, gold			2022-12-26	WOS:000535945000074
J	Simunovic, K; Sahin, O; Kovac, J; Shen, ZQ; Klancnik, A; Zhang, QJ; Mozina, SS				Simunovic, Katarina; Sahin, Orhan; Kovac, Jasna; Shen, Zhangqi; Klancnik, Anja; Zhang, Qijing; Mozina, Sonja Smole			(-)-alpha-Pinene reduces quorum sensing and Campylobacter jejuni colonization in broiler chickens	PLOS ONE			English	Article							IN-VIVO; RESISTANT CAMPYLOBACTER; BIOFILM FORMATION; ALPHA-PINENE; PERFORMANCE; INFECTION; VIRULENCE; MOTILITY; VITRO; LUXS	Campylobacter jejuni is one of the most prevalent causes of bacterial gastroenteritis worldwide, and it is largely associated with consumption of contaminated poultry. Current Campylobacter control measures at the poultry production level remain insufficient, and hence there is the need for alternative control strategies. We evaluated the potential of the monoterpene (-)-alpha-pinene for control of C. jejuni in poultry. The antibacterial and resistance-modulatory activities of (-)-alpha-pinene were also determined against 57 C. jejuni strains. In addition, the anti-quorum-sensing activity of (-)-alpha-pinene against C. jejuni NCTC 11168 was determined for three subinhibitory concentrations (125, 62.5, 31.25 mg/L) over three incubation times using an autoinducer-2 bioassay based on Vibrio harveyi BB170 bioluminescence measurements. The effects of a subinhibitory concentration of (-)-alpha-pinene (250 mg/L) on survival of C. jejuni, and in combination with enrofloxacin on fluoroquinolone resistance development in C. jejuni, were determined in a broiler chicken model, by addition of (-)-alpha-pinene to the broiler water supply. The reduction of C. jejuni numbers by (-)-alpha-pinene was further determined in broiler chickens that were colonized with either fluoroquinolone-susceptible or -resistant strains, by direct gavage treatment. We observed weak in vitro antimicrobial activity for (-)-alpha-pinene alone (MIC >500 mg/L), but strong potentiating effects on antibiotics erythromycin and ciprofloxacin against different Campylobacter strains (>512 fold change). After 24 h of treatment of C. jejuni with (-)-alpha-pinene, its quorum-sensing signaling was reduced by >80% compared to the untreated control. When given in the drinking water, (-)-alpha-pinene did not show any significant inhibitory effects on the level of C. jejuni in the colonized chickens, and did not reduce fluoroquinolone resistance development in combination with enrofloxacin. Conversely, when (-)-alpha-pinene was administered by direct gavage, it significantly reduced the number of fluoroquinolone susceptible C. jejuni in the colonized broiler chickens. These results demonstrate that (-)-alpha-pinene modulates quorum-sensing in Campylobacter, potentiates antibiotics against different Campylobacter strains, and reduces Campylobacter colonization in broiler chickens.	[Simunovic, Katarina; Klancnik, Anja; Mozina, Sonja Smole] Univ Ljubljana, Biotech Fac, Dept Food Sci & Technol, Ljubljana, Slovenia; [Sahin, Orhan; Shen, Zhangqi; Zhang, Qijing] Iowa State Univ, Coll Vet Med, Ames, IA USA; [Kovac, Jasna] Penn State Univ, Dept Food Sci, University Pk, PA 16802 USA; [Shen, Zhangqi] China Agr Univ, Coll Vet Med, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China	University of Ljubljana; Iowa State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; China Agricultural University	Mozina, SS (corresponding author), Univ Ljubljana, Biotech Fac, Dept Food Sci & Technol, Ljubljana, Slovenia.	sonja.smole-mozina@bf.uni-lj.si	Shen, Zhangqi/HCI-5736-2022	Shen, Zhangqi/0000-0003-4789-7540	Slovenian Research Agency (ARRS) [P4-0116]; USDA National Institute of Food and Hatch Appropriations [PEN04646, 1015787]; Slovenian-American bilateral project BI-SLO-USA 2014/2015; Slovenian-American bilateral project BI-SLO-USA 2018/19	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); USDA National Institute of Food and Hatch Appropriations; Slovenian-American bilateral project BI-SLO-USA 2014/2015; Slovenian-American bilateral project BI-SLO-USA 2018/19	This study was financed by the Slovenian-American bilateral projects BI-SLO-USA 2014/2015 and 2018/19 and P4-0116 funded by the Slovenian Research Agency (ARRS) awarded to SSM. http://www.arrs.si/en/index.asp JK was supported by the USDA National Institute of Food and Hatch Appropriations under Project #PEN04646 and Accession #1015787. https://nifa.usda.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alali WQ, 2013, POULTRY SCI, V92, P836, DOI 10.3382/ps.2012-02783; [Anonymous], 2018, EFSA J; Aydin E, 2013, BIOLOGIA, V68, P1004, DOI 10.2478/s11756-013-0230-2; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Bezek K, 2016, PHYTOTHER RES, V30, P1527, DOI 10.1002/ptr.5658; BIOHAZ, 2011, EFSA J, V9, DOI [10.2903/j.efsa.2011.2105, DOI 10.2903/J.EFSA.2011.2105]; Bouzenna H, 2017, BIOMED PHARMACOTHER, V93, P961, DOI 10.1016/j.biopha.2017.06.031; Brackman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016084; Castillo S, 2015, FOLIA MICROBIOL, V60, P89, DOI 10.1007/s12223-014-0344-0; Dittoe DK, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00216; Elvers KT, 2002, MICROBIOL-SGM, V148, P1475, DOI 10.1099/00221287-148-5-1475; European Food Safety Authority, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5182; Golden NJ, 2002, INFECT IMMUN, V70, P1761, DOI 10.1128/IAI.70.4.1761-1771.2002; Grilli E, 2013, J APPL MICROBIOL, V114, P308, DOI 10.1111/jam.12053; Harjai K, 2010, FEMS IMMUNOL MED MIC, V58, P161, DOI 10.1111/j.1574-695X.2009.00614.x; Hoffmann N, 2007, ANTIMICROB AGENTS CH, V51, P3677, DOI 10.1128/AAC.01011-06; Holmgren K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-73; Jeon B, 2003, MICROBIOL IMMUNOL, V47, P833, DOI 10.1111/j.1348-0421.2003.tb03449.x; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Kelly C, 2017, FOODBORNE PATHOG DIS, V14, P341, DOI 10.1089/fpd.2016.2265; Kovac J, 2018, ZOONOSES PUBLIC HLTH, V65, P51, DOI 10.1111/zph.12366; Kovac J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122871; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Lin J, 2003, INFECT IMMUN, V71, P4250, DOI 10.1128/IAI.71.8.4250-4259.2003; Luangtongkum T, 2006, APPL ENVIRON MICROB, V72, P3600, DOI 10.1128/AEM.72.5.3600-3607.2006; Luo ND, 2005, P NATL ACAD SCI USA, V102, P541, DOI 10.1073/pnas.0408966102; Marder EP, 2018, MMWR-MORBID MORTAL W, V67, P324, DOI 10.15585/mmwr.mm6711a3; Meunier M, 2016, J APPL MICROBIOL, V120, P1139, DOI 10.1111/jam.12986; Oh E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01129; Plummer P, 2012, INFECT IMMUN, V80, P585, DOI 10.1128/IAI.05766-11; Plummer PJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00022; Quinn T, 2007, J ANTIMICROB CHEMOTH, V59, P1230, DOI 10.1093/jac/dkl470; Quinones B, 2009, APPL ENVIRON MICROB, V75, P281, DOI 10.1128/AEM.01803-08; Reuter K, 2016, PERSPECT MED CHEM, V8, DOI 10.4137/PMC.S13209; Reyer H, 2017, J AGR FOOD CHEM, V65, P6821, DOI 10.1021/acs.jafc.7b01925; Riedel CT, 2009, J FOOD PROTECT, V72, P1173, DOI 10.4315/0362-028X-72.6.1173; da Silva ACR, 2012, MOLECULES, V17, P6305, DOI 10.3390/molecules17066305; Robyn J, 2015, COMPR REV FOOD SCI F, V14, P81, DOI 10.1111/1541-4337.12124; Sahin O, 2015, AVIAN DIS, V59, P185, DOI 10.1637/11072-032315-Review; Schwarz S, 2010, J ANTIMICROB CHEMOTH, V65, P601, DOI 10.1093/jac/dkq037; Tiihonen K, 2010, BRIT POULTRY SCI, V51, P381, DOI 10.1080/00071668.2010.496446	41	8	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230423	10.1371/journal.pone.0230423	http://dx.doi.org/10.1371/journal.pone.0230423			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236115	gold, Green Published			2022-12-26	WOS:000535938700018
J	Kamsan, SS; Singh, DKA; Tan, MP; Kumar, S				Kamsan, Siti Salwana; Singh, Devinder Kaur Ajit; Tan, Maw Pin; Kumar, Saravana			The knowledge and self-management educational needs of older adults with knee osteoarthritis: A qualitative study	PLOS ONE			English	Article							OF-LIFE; GLOBAL BURDEN; HIP; RECOMMENDATIONS; PROGRAM; STRATEGIES; EXERCISE; CRITERIA; DISEASE; ILLNESS	Knee osteoarthritis (KOA) is closely related with ageing, physical disability and functional dependency. The course of KOA is considered progressive and irreversible. Engagement with self-management may, however, minimize the impact of KOA. To be fully engaged with self-management activities, knowledge about KOA is a prerequisite. There is limited empirical data on older adults' understanding on KOA and their information needs about KOA. Therefore, the aims of this study were to explore older adults' knowledge about KOA and their perspectives on the information required to enable self-management. Three focus groups were conducted with 16 older adults with KOA. The sample consisted of three men and thirteen women with the mean age 73.2 years (range from 61 to 89). Thematic content analysis revealed two themes which were understanding about KOA and information needed about KOA. Participants' knowledge about KOA varied between individuals with many expressing that they needed more information about KOA. A targeted strategy is needed to educate older adults about KOA in order to support and prepare them for selfmanagement.	[Kamsan, Siti Salwana; Singh, Devinder Kaur Ajit] Univ Kebangsaan Malaysia, Fac Hlth Sci, Physiotherapy Program, Kuala Lumpur, Malaysia; [Kamsan, Siti Salwana; Singh, Devinder Kaur Ajit] Univ Kebangsaan Malaysia, Fac Hlth Sci, Ctr Hlth Ageing & Wellness, Kuala Lumpur, Malaysia; [Kamsan, Siti Salwana] Int Islamic Univ Malaysia, Fac Allied Hlth Sci, Dept Phys Rehabil Sci, Selayang, Pahang, Malaysia; [Tan, Maw Pin] Univ Malaya, Fac Med, Dept Med, Div Geriatr Med, Kuala Lumpur, Malaysia; [Tan, Maw Pin] Sunway Univ, Fac Healthcare & Med Sci, Dept Med Sci, Bandar Sunway, Malaysia; [Kumar, Saravana] Univ South Australia, Sch Hlth Sci, City East Campus, Adelaide, SA, Australia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; International Islamic University Malaysia; Universiti Malaya; Sunway University; University of South Australia	Singh, DKA (corresponding author), Univ Kebangsaan Malaysia, Fac Hlth Sci, Physiotherapy Program, Kuala Lumpur, Malaysia.; Singh, DKA (corresponding author), Univ Kebangsaan Malaysia, Fac Hlth Sci, Ctr Hlth Ageing & Wellness, Kuala Lumpur, Malaysia.	devinder@ukm.edu.my	Kumar, Saravana/B-8876-2009; Singh, Devinder Kaur Ajit/W-5552-2018; Tan, Maw Pin/G-6917-2011	Kumar, Saravana/0000-0002-4003-4411; Singh, Devinder Kaur Ajit/0000-0002-6551-0437; Tan, Maw Pin/0000-0002-3400-8540; Kamsan, Siti Salwana/0000-0002-5624-3883				Abu Hassan MF, 2015, J TEKNOL, V77, P19; Aksekili M.A.E., 2016, ACTA MED ANATOLIA, V4, P1, DOI [10.5505/actamedica.2016.41636, DOI 10.5505/ACTAMEDICA.2016.41636]; Al-Taiar Abdullah, 2013, BMC Res Notes, V6, P406, DOI 10.1186/1756-0500-6-406; Alami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019634; Ali SA, 2018, J PAIN RES, V11, P417, DOI 10.2147/JPR.S150578; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Araujo Ivan Luis Andrade, 2016, Knee Surg Relat Res, V28, P219, DOI 10.5792/ksrr.2016.28.3.219; Bakirhan S, 2017, ACTA ORTOP BRAS, V25, P248, DOI 10.1590/1413-785220172506144577; Berkman ND, 2011, EVIDENCE REPORT TECH, V1, P941; Bindawas SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196150; Brady T, 2012, ORTHOP NURS, V31, P124, DOI 10.1097/NOR.0b013e31824fcf47; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Buckwalter JA, 2013, CARTILAGE, V4, P286, DOI 10.1177/1947603513495889; Cameron M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002947.pub2; Carmona-Teres V, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1584-3; Chan KKW, 2011, RHEUMATOL REP, V3, P9, DOI 10.4081/rr.2011.e3; Chia YC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011925; Chokkhanchitchai S, 2010, CLIN RHEUMATOL, V29, P39, DOI 10.1007/s10067-009-1295-8; Chou L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195489; Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Daily JW, 2016, J MED FOOD, V19, P717, DOI 10.1089/jmf.2016.3705; Darlow B, 2018, BMC RHEUMATOL, V2, DOI 10.1186/s41927-018-0023-x; Dedeli O, 2013, HLTH PSYCHOL RES, V1; Etikan I., 2016, AM J THEORETICAL APP, V5, P1, DOI [10.11648/j.ajtas.20160501.11, DOI 10.11648/J.AJTAS.20160501.11]; Fernandes L, 2013, ANN RHEUM DIS, V72, P1125, DOI 10.1136/annrheumdis-2012-202745; Foo C.N., 2017, MALAYS J MED HLTH SC, V13, P7; Grady PA, 2014, AM J PUBLIC HEALTH, V104, pE25, DOI 10.2105/AJPH.2014.302041; Hamad WH, 2018, ANN PHYS REHABIL MED, V61, pe128; Hansson EE, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-244; Hauk L, 2014, AM FAM PHYSICIAN, V89, P918; Herbolsheimer F, 2018, INNOVATION AGING S1, V2, P268; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hurley MV, 2007, ARTHRIT RHEUM-ARTHR, V57, P1211, DOI 10.1002/art.22995; Ibrahim WH, 2018, CHRON RESP DIS, V16, DOI 10.1177/1479972318767719; Iijima Hirotaka, 2018, BMC Psychol, V6, P19, DOI 10.1186/s40359-018-0234-3; Jantan I., 2006, JURNAL SAINS KESIHAT, V4; Jessep SA, 2009, PHYSIOTHERAPY, V95, P94, DOI 10.1016/j.physio.2009.01.005; Kallio H, 2016, J ADV NURS, V72, P2954, DOI 10.1111/jan.13031; Kao MJ, 2012, ARCH GERONTOL GERIAT, V54, P317, DOI 10.1016/j.archger.2011.05.018; Kawano MM, 2015, ACTA ORTOP BRAS, V23, P307, DOI 10.1590/1413-785220152306150596; Kiadaliri AA, 2018, ACTA ORTHOP, V89, P177, DOI 10.1080/17453674.2017.1404791; Kwok EYT, 2016, CLIN GERONTOLOGIST, V39, P428, DOI 10.1080/07317115.2016.1171818; Lembrer D, 2015, MATH EDU SOC, P188; Lespasio M. J., 2017, PERMANENTE J, V21; Loeser RF, 2010, CLIN GERIATR MED, V26, P371, DOI 10.1016/j.cger.2010.03.002; Loke YK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040210; MacKay C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006006; Marconcin P, 2018, CLIN REHABIL, V32, P223, DOI 10.1177/0269215517718892; Moser A, 2017, EUR J GEN PRACT, V24, DOI [10.1080/13814788.2017.1375091, 10.1080/13814788.2017.1375092]; Moura MD, 2017, PHYTOTHER RES, V31, P1676, DOI 10.1002/ptr.5910; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; Nguyen T.V., 2014, INT J CLIN RHEUMATOL, V9, P405; Nyumba TO, 2018, METHODS ECOL EVOL, V9, P20, DOI 10.1111/2041-210X.12860; Nyvang J, 2016, INT J QUAL STUD HEAL, V11, DOI 10.3402/qhw.v11.30193; Ong BN, 2011, INT J QUAL STUD HEAL, V6, DOI 10.3402/qhw.v6i3.7035; Paskins Z, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-46; Pellegrini CA, 2018, DISABIL REHABIL, V40, P2004, DOI 10.1080/09638288.2017.1323026; Pellinen T, 2016, J ADV NURS, V72, P2857, DOI 10.1111/jan.13053; Ponvel P, 2019, JURNAL SAINS KESIHAT, V17; Pouli N, 2014, DISABIL REHABIL, V36, P600, DOI 10.3109/09638288.2013.805257; Prion S, 2014, CLIN SIMUL NURS, V10, pE107, DOI 10.1016/j.ecns.2013.05.003; Roger KS, 2018, J RELIG SPIRITUAL SO, V37, P24, DOI 10.1080/15426432.2017.1386151; Roopsawang I, 2015, PAC RIM INT J NURS R, V19, P187; Salehi-Abrari I., 2016, AUTOIMMUNE DIS THERA, V3, P1; Sathiyamoorthy T, 2018, J COMMUN HEALTH, V43, P816, DOI 10.1007/s10900-018-0470-8; Saulescu I, 2016, ANN RHEUM DIS, V75, P1163, DOI 10.1136/annrheumdis-2016-eular.2443; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Shaik SFV, 2018, J YOUNG PHARM, V10, P322, DOI 10.5530/jyp.2018.10.71; Sharma A, 2016, OPEN ACCESS RHEUMATO, V8, P103, DOI 10.2147/OARRR.S93516; SINGH DKA, 2018, J SAINS KESIHAT MALA, V16, P187, DOI DOI 10.17576/JSKM-2018-25; Son HM, 2013, ACUPUNCT MED, V31, P39, DOI 10.1136/acupmed-2012-010224; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tuncer T, 2012, TURK J RHEUMATOL, V27, P1, DOI 10.5606/tjr.2012.001; Wise BL, 2010, OSTEOARTHR CARTILAGE, V18, P883, DOI 10.1016/j.joca.2009.11.016; Yang M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189884; Zamanzadeh Vahid, 2017, J Caring Sci, V6, P81, DOI 10.15171/jcs.2017.009; Zhu L, 2015, EVIDENCE BASED COMPL, V2015	78	4	4	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230318	10.1371/journal.pone.0230318	http://dx.doi.org/10.1371/journal.pone.0230318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8HE	32226047	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000535936400004
J	Barbe, MF; Hilliard, BA; Amin, M; Harris, MY; Hobson, LJ; Cruz, GE; Popoff, SN				Barbe, Mary F.; Hilliard, Brendan A.; Amin, Mamta; Harris, Michele Y.; Hobson, Lucas J.; Cruz, Geneva E.; Popoff, Steven N.			Blocking CTGF/CCN2 reduces established skeletal muscle fibrosis in a rat model of overuse injury	FASEB JOURNAL			English	Article						CCN2; extracellular matrix; overuse injury; TGF-beta; work-related musculoskeletal disorders	TISSUE GROWTH-FACTOR; SENSORIMOTOR DECLINES; HEPATIC-FIBROSIS; HIGH-REPETITION; SUBSTANCE-P; CCN FAMILY; TGF-BETA; EXPRESSION; CTGF; PROTEIN	Tissue fibrosis is a hallmark of overuse musculoskeletal injuries and contributes to functional declines. We tested whether inhibition of CCN2 (cellular communication network factor 2, previously known as connective tissue growth factor, CTGF) using a specific antibody (termed FG-3019 or pamrevlumab) reduces established overuse-induced muscle fibrosis in a clinically relevant rodent model of upper extremity overuse injury. Young adult rats performed a high repetition high force (HRHF) reaching and lever-pulling task for 18 weeks, after first being shaped for 6 weeks to learn this operant task. Rats were then euthanized (HRHF-Untreated), or rested and treated for 6 weeks with FG-3019 (HRHF-Rest/FG-3019) or a human IgG as a vehicle control (HRHF-Rest/IgG). HRHF-Untreated and HRHF-Rest/IgG rats had higher muscle levels of several fibrosis-related proteins (TGF beta 1, CCN2, collagen types I and III, and FGF2), and higher muscle numbers of alpha SMA and pERK immunopositive cells, compared to control rats. Each of these fibrogenic changes was restored to control levels by the blocking of CCN2 signaling in HRHF-Rest/FG-3019 rats, as were HRHF task-induced increases in serum CCN2 and pro-collagen I intact N-terminal protein. Levels of cleaved CCN3, an antifibrotic protein, were lowered in HRHF-Untreated and HRHF-Rest/IgG rats, compared to control rats, yet elevated back to control levels in HRHF-Rest/FG-3019 rats. Significant grip strength declines observed in HRHF-Untreated and HRHF-Rest/IgG rats, were restored to control levels in HRHF-Rest/FG-3019 rats. These results are highly encouraging for use of FG-3019 for therapeutic treatment of persistent skeletal muscle fibrosis, such as those induced with chronic overuse.	[Barbe, Mary F.; Hilliard, Brendan A.; Amin, Mamta; Harris, Michele Y.; Hobson, Lucas J.; Cruz, Geneva E.; Popoff, Steven N.] Temple Univ, Lewis Katz Sch Med, Dept Anat & Cell Biol, 3500 North Broad St, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Barbe, MF (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Anat & Cell Biol, 3500 North Broad St, Philadelphia, PA 19140 USA.	mary.barbe@temple.edu		Barbe, Mary/0000-0002-5235-9803	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH) [AR056019]	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH) under Award Number AR056019. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Abdelmagid SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038359; Barbe MF, 2019, J MUSCULOSKEL NEURON, V19, P396; Barbe MF, 2019, J ORTHOP RES, V37, P2004, DOI 10.1002/jor.24337; Barbe MF, 2018, BONE, V110, P267, DOI 10.1016/j.bone.2018.02.014; Barbe MF, 2013, J AM ACAD ORTHOP SUR, V21, P644, DOI 10.5435/JAAOS-21-10-644; Barr AE, 2002, PHYS THER, V82, P173, DOI 10.1093/ptj/82.2.173; Bartel F, 2012, INT J GYNECOL PATHOL, V31, P405, DOI 10.1097/PGP.0b013e31824d1891; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bickelhaupt S, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw339; Bove GM, 2019, PAIN, V160, P632, DOI 10.1097/j.pain.0000000000001443; Bove GM, 2016, J NEUROL SCI, V361, P168, DOI 10.1016/j.jns.2015.12.029; Brenner MC, 2016, PHARM RES-DORDR, V33, P1833, DOI 10.1007/s11095-016-1918-0; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Choi J, 2013, J BIOL CHEM, V288, P23075, DOI 10.1074/jbc.M113.475418; Clark BD, 2004, J ORTHOP SPORT PHYS, V34, P244, DOI 10.2519/jospt.2004.34.5.244; Driscoll M, 2011, J BODYW MOV THER, V15, P335, DOI 10.1016/j.jbmt.2010.05.002; Fisher PW, 2015, J CELL COMMUN SIGNAL, V9, P37, DOI 10.1007/s12079-015-0263-0; Foglia B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112700; Frara N, 2018, CONNECT TISSUE RES, V59, P30, DOI 10.1080/03008207.2017.1297809; Morales MG, 2013, HUM MOL GENET, V22, P4938, DOI 10.1093/hmg/ddt352; Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952; George J, 2007, GENE THER, V14, P790, DOI 10.1038/sj.gt.3302929; Gonzalez D, 2018, HUM MOL GENET, V27, P2913, DOI 10.1093/hmg/ddy204; Iannarone Victoria J., 2019, Journal of Biological Methods, V6, pe117, DOI 10.14440/jbm.2019.289; Ito Y, 2010, AM J PHYSIOL-RENAL, V299, pF545, DOI 10.1152/ajprenal.00120.2009; Jain NX, 2014, J MUSCULOSKEL NEURON, V14, P78; Kaasboll OJ, 2018, J BIOL CHEM, V293, P17953, DOI 10.1074/jbc.RA118.004559; Kietrys DM, 2011, J MOTOR BEHAV, V43, P465, DOI 10.1080/00222895.2011.627897; Kivela R, 2007, J APPL PHYSIOL, V103, P1395, DOI 10.1152/japplphysiol.00531.2007; Klinkhammer BM, 2017, ADV CHRONIC KIDNEY D, V24, P117, DOI 10.1053/j.ackd.2016.11.002; Kyurkchiev Stanimir, 2004, Cell Commun Signal, V2, P9, DOI 10.1186/1478-811X-2-9; Leask A, 2015, J CELL COMMUN SIGNAL, V9, P97, DOI 10.1007/s12079-015-0281-y; Lin N, 2011, AM J PHYSIOL-CELL PH, V301, pC469, DOI 10.1152/ajpcell.00452.2010; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Mahdy MAA, 2019, CELL TISSUE RES, V375, P575, DOI 10.1007/s00441-018-2955-2; Makino K, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1356-3; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Nakama LH, 2006, J ORTHOP RES, V24, P393, DOI 10.1002/jor.20053; NIOSH, 2011, NAT MAN AG JUN 2010; Ohara Yuuki, 2018, Oncotarget, V9, P18494, DOI 10.18632/oncotarget.24892; Pedersen BK, 2001, EXERC IMMUNOL REV, V7, P18; Pendurthi UR, 2005, CANCER RES, V65, P9705, DOI 10.1158/0008-5472.CAN-05-0982; Peng L, 2019, NEUROPEPTIDES, V76, DOI 10.1016/j.npep.2019.101941; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Perbal B, 2019, J CELL COMMUN SIGNAL, V13, P1, DOI 10.1007/s12079-019-00506-w; Perbal B, 2018, J CELL COMMUN SIGNAL, V12, P1, DOI 10.1007/s12079-018-0460-8; PICOZZI VJ, 2017, J CANC CLIN TRIALS, V2, P1; Rani S, 2010, J CELL PHYSIOL, V225, P152, DOI 10.1002/jcp.22208; Richeldi L, 2020, LANCET RESP MED, V8, P25, DOI 10.1016/S2213-2600(19)30262-0; Riser BL, 2015, J CELL COMMUN SIGNAL, V9, P327, DOI 10.1007/s12079-015-0309-3; Riser BL, 2009, AM J PATHOL, V174, P1725, DOI 10.2353/ajpath.2009.080241; Sakai N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05624-2; Sato S, 2000, J RHEUMATOL, V27, P149; Schild C, 2004, BBA-MOL CELL RES, V1691, P33, DOI 10.1016/j.bbamcr.2003.12.001; Sisco M, 2008, WOUND REPAIR REGEN, V16, P661, DOI 10.1111/j.1524-475X.2008.00416.x; Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850; Stauber WT, 1996, MUSCLE NERVE, V19, P423, DOI 10.1002/mus.880190402; Stauber WT, 2000, MUSCLE NERVE, V23, P1819, DOI 10.1002/1097-4598(200012)23:12<1819::AID-MUS4>3.0.CO;2-2; Su BY, 2001, J CLIN PATHOL-MOL PA, V54, P184, DOI 10.1136/mp.54.3.184; Tamura I, 2001, AM J PHYSIOL-CELL PH, V281, pC1524, DOI 10.1152/ajpcell.2001.281.5.C1524; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Wells AU, 2020, LANCET RESP MED, V8, P2, DOI 10.1016/S2213-2600(19)30339-X; Xin DL, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0354-3; Yang HW, 2010, ACTA OPHTHALMOL, V88, P652, DOI 10.1111/j.1755-3768.2009.01641.x; Zhang FQ, 2015, J BIOL CHEM, V290, P8232, DOI 10.1074/jbc.M114.623074; Zhao Z, 2015, IN VITRO CELL DEV-AN, V51, P941, DOI 10.1007/s11626-015-9914-y; Zoheiry Mona M, 2015, Electron Physician, V7, P1626, DOI 10.19082/1626; Zugel M, 2018, BRIT J SPORT MED, V52, P1497, DOI 10.1136/bjsports-2018-099308	68	25	25	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6554	6569		10.1096/fj.202000240RR	http://dx.doi.org/10.1096/fj.202000240RR		MAR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32227398	hybrid, Green Published			2022-12-26	WOS:000522484900001
J	Medolago, CAB; Costa, MC; Silveira, LF; Francisco, MR				Medolago, Cesar A. B.; Costa, Mariellen C.; Silveira, Luis F.; Francisco, Mercival R.			Hybridization between two recently diverged Neotropical passerines: The Pearly-bellied Seedeater Sporophila pileata, and the Copper Seedeater S. bouvreuil (Aves, Passeriformes, Thraupidae)	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; COMPUTER-PROGRAM; HYBRID ZONE; DNA; RADIATION; INTROGRESSION; SUBSTITUTIONS; SPECIATION; EVOLUTION; SOFTWARE	The small Neotropical finches called capuchinos are outstanding because they have experienced one of the most recent and explosive avian radiations ever documented for birds. Despite very low morphological and niche divergence among species, many of them are reproductively isolated when in sympatry due to strong sexual selection in plumage traits. However, a specific pair of mostly parapatric species, the Pearly-bellied, Sporophila pileata, and the Copper Seedeaters, S. bouvreuil, has confounded taxonomists because individuals with intermediate color patterns can be found. By analyzing diagnostic COI mtDNA sequences and adult male plumage we provide evidence for hybridization. Paternity tests using microsatellites also indicated that representatives with intermediate plumage pattern can be fertile. Our findings are consistent with the classification of S. bouvreuil and S. pileata as distinct taxa, but we demonstrate that the sexual selection mechanisms involved in the isolation of other reproductively sympatric capuchinos are not applicable to this pair of species, likely because of reduced barriers to mate recognition.	[Medolago, Cesar A. B.; Costa, Mariellen C.; Francisco, Mercival R.] Univ Fed Sao Carlos, Programa Pos Grad Ecol & Recursos Nat, Sao Carlos, SP, Brazil; [Silveira, Luis F.] Univ Sao Paulo, Secao Aves, Museu Zool, Sao Paulo, SP, Brazil; [Francisco, Mercival R.] Univ Fed Sao Carlos, Dept Ciencias Ambientais, Sorocaba, SP, Brazil	Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade Federal de Sao Carlos	Francisco, MR (corresponding author), Univ Fed Sao Carlos, Programa Pos Grad Ecol & Recursos Nat, Sao Carlos, SP, Brazil.; Francisco, MR (corresponding author), Univ Fed Sao Carlos, Dept Ciencias Ambientais, Sorocaba, SP, Brazil.	mercival@ufscar.br	Costa, Mariellen C/H-6608-2017; Silveira, Luis Fabio/F-8337-2012	Costa, Mariellen C/0000-0001-7501-7606; Silveira, Luis Fabio/0000-0003-2576-7657; Francisco, Mercival/0000-0003-2083-7812	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded in part by fellowships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq to CABM, MCC, LFS, and MRF. No additional external funding was received for this study.	Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Areta JI, 2017, EMU, V117, P40, DOI 10.1080/01584197.2016.1266447; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrera-Guzman AO, 2018, P NATL ACAD SCI USA, V115, pE218, DOI 10.1073/pnas.1717319115; Benites P, 2015, J AVIAN BIOL, V46, P55, DOI 10.1111/jav.00447; Biagolini C, 2016, ZOOLOGIA-CURITIBA, V33, DOI 10.1590/S1984-4689zool-20160068; Campagna L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199113; Campagna L, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602404; Campagna L, 2013, AUK, V130, P645, DOI 10.1525/auk.2013.13064; Campagna L, 2012, P ROY SOC B-BIOL SCI, V279, P1847, DOI 10.1098/rspb.2011.2170; Campagna L, 2010, MOL ECOL RESOUR, V10, P449, DOI 10.1111/j.1755-0998.2009.02799.x; Coster SS, 2018, ECOL EVOL, V8, P9870, DOI 10.1002/ece3.4472; da Silva JMC, 1999, STUD AVIAN BIOL, P272; Davidson BS, 2013, ECOL EVOL, V3, P2485, DOI 10.1002/ece3.604; Durigan G, 2004, VIABILIDADE CONSERVA; Fleischer RC, 1996, MOL ZOOLOGY ADV STRA; Francisco MR, 2006, WILSON J ORNITHOL, V118, P85, DOI 10.1676/1559-4491(2006)118[0085:BBOTDS]2.0.CO;2; Freitas MS, 2018, WILSON J ORNITHOL, V130, P823, DOI 10.1676/17-102.1; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Harris RB, 2018, MOL PHYLOGENET EVOL, V120, P183, DOI 10.1016/j.ympev.2017.11.020; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hogner S, 2012, ECOL EVOL, V2, P2974, DOI 10.1002/ece3.398; Areta JI, 2012, WILSON J ORNITHOL, V124, P688, DOI 10.1676/1559-4491-124.4.688; Areta JI, 2011, CONDOR, V113, P678, DOI 10.1525/cond.2011.100059; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kopuchian, 2016, NUESTRAS AVES, V61, P3; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Leafloor JO, 2013, AUK, V130, P487, DOI 10.1525/auk.2013.12196; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lijtmaer DA, 2004, MOL PHYLOGENET EVOL, V33, P562, DOI 10.1016/j.ympev.2004.07.011; Liu IA, 2015, J EVOLUTION BIOL, V28, P1156, DOI 10.1111/jeb.12644; Machado E, 2011, ZOOTAXA, P49, DOI 10.11646/zootaxa.2781.1.4; Machado Érika, 2010, Pap. Avulsos Zool. (São Paulo), V50, P517, DOI 10.1590/S0031-10492010003200001; Medolago CAB, 2018, MOL BIOL REP, V45, P2815, DOI 10.1007/s11033-018-4377-3; Megna LC, 2014, J AVIAN BIOL, V45, P410, DOI 10.1111/jav.00421; Miller MJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0227-7; Mitrus J, 2014, AVIAN BIOL RES, V7, P111, DOI 10.3184/175815514X13948188185179; Moulton LL, 2017, CONSERV GENET, V18, P1481, DOI 10.1007/s10592-017-0989-8; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ridgely R.S., 1994, BIRDS S AM, VII; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Seneviratne SS, 2012, J AVIAN BIOL, V43, P119, DOI 10.1111/j.1600-048X.2012.05516.x; Sick H, 2001, ORNITOLOGIA BRASILEI; Sonsthagen SA, 2016, MOL PHYLOGENET EVOL, V103, P41, DOI 10.1016/j.ympev.2016.06.008; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Taylor SA, 2014, CURR BIOL, V24, P671, DOI 10.1016/j.cub.2014.01.069; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toews DPL, 2016, CURR BIOL, V26, P2313, DOI 10.1016/j.cub.2016.06.034; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vijay N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13195; Webb WC, 2011, MOL ECOL, V20, P2390, DOI 10.1111/j.1365-294X.2011.05095.x; Westneat DF, 2005, MOL ECOL, V14, P2155, DOI 10.1111/j.1365-294X.2005.02562.x	56	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0229714	10.1371/journal.pone.0229714	http://dx.doi.org/10.1371/journal.pone.0229714			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218563	Green Published, gold			2022-12-26	WOS:000535935400006
J	Ceccaroni, L; Piera, J; Wernand, MR; Zielinski, O; Busch, JA; Van der Woerd, HJ; Bardaji, R; Friedrichs, A; Novoa, S; Thijsse, P; Velickovski, F; Blaas, M; Dubsky, K				Ceccaroni, Luigi; Piera, Jaume; Wernand, Marcel R.; Zielinski, Oliver; Busch, Julia A.; Van der Woerd, Hendrik Jan; Bardaji, Raul; Friedrichs, Anna; Novoa, Stefani; Thijsse, Peter; Velickovski, Filip; Blaas, Meinte; Dubsky, Karin			Citclops: A next-generation sensor system for the monitoring of natural waters and a citizens' observatory for the assessment of ecosystems' status	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; COLOR; MODIS	The European-Commission-funded project 'Citclops' (Citizens' observatory for coast and ocean optical monitoring) developed methods, tools and sensors, which can be used by citizens to monitor natural waters, with a strong focus on long-term data series related to environmental sciences. The new sensors, based on optical technologies, respond to a number of scientific, technical and societal objectives, ranging from more precise monitoring of key environmental descriptors of the aquatic environment (water colour, transparency and fluorescence) to an improved management of data collected with citizen participation. The sensors were tested, calibrated, integrated on several platforms, scientifically validated and demonstrated in the field. The new methods and tools were tested in a citizen-science context. The general conclusion is that citizens are valuable contributors in quality and quantity to the objective of collecting, integrating and analysing fragmented and diverse environmental data. An integration of these data into data-analysis tools has a large potential to support authoritative monitoring and decision-making. In this paper, the project's objectives, results, technical achievements and lessons learned are presented.	[Ceccaroni, Luigi; Novoa, Stefani] Earthwatch, Oxford, England; [Piera, Jaume] CSIC, ICM, Barcelona, Spain; [Wernand, Marcel R.] Royal Netherlands Inst Sea Res, Den Hoorn, Netherlands; [Zielinski, Oliver; Busch, Julia A.; Friedrichs, Anna] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Oldenburg, Germany; [Zielinski, Oliver; Busch, Julia A.] German Res Ctr Artificial Intelligence, Marine Percept Res Grp, Oldenburg, Germany; [Busch, Julia A.] Common Wadden Sea Secretariat, Wilhelmshaven, Germany; [Van der Woerd, Hendrik Jan] Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands; [Bardaji, Raul] CSIC, Marine Technol Unit, Barcelona, Spain; [Friedrichs, Anna] Fed Maritime & Hydrog Agcy, Hamburg, Germany; [Thijsse, Peter] MARIS BV, Nootdorp, Netherlands; [Velickovski, Filip] Quantium, Sydney, NSW, Australia; [Blaas, Meinte] Rijkswaterstaat Water Transport & Environm, Lelystad, Netherlands; [Dubsky, Karin] Univ Dublin Trinity Coll, Dept Civil Struct & Environm Engn, Dublin, Ireland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Carl von Ossietzky Universitat Oldenburg; German Research Center for Artificial Intelligence (DFKI); Vrije Universiteit Amsterdam; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Unidad de Tecnologia Marina (UTM); Trinity College Dublin	Ceccaroni, L (corresponding author), Earthwatch, Oxford, England.	lceccaroni@earthwatch.org.uk	Piera, Jaume/AAP-4663-2021; Piera, Jaume/I-1152-2015; van der Woerd, Hans J/K-9812-2013	Piera, Jaume/0000-0001-5818-9836; Piera, Jaume/0000-0001-5818-9836; van der Woerd, Hans J/0000-0002-8901-7567; Zielinski, Oliver/0000-0002-6018-5030; Ceccaroni, Luigi/0000-0002-3116-0811	European Union [308469, 824711, 824580]	European Union(European Commission)	The funders of this study provided support in the form of salaries for authors LC, JP, MRW, OZ, JAB, HVDW, RB, AF, SN, PT, FV, MB, KD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. More specifically, all authors (LC, JP, MRW, OZ, JAB, HVDW, RB, AF, SN, PT, FV, MB, KD) received funding from the European Union's FP7 research and innovation programme under grant agreement No 308469 'Citclops'. LC received funding from the European Union's Horizon 2020 research and innovation programme under grant agreements No 824711 'MICS' and No 824580 'EU-Citizen.Science'. The opinions expressed in this study are those of the authors and are not necessarily those of the Citclops, MICS or EU-Citizen.Science partners, or the European Commission.	Arar E.J., 1997, 4450 US ENV PROT AG; Bardaji R, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16030373; Behrenfeld MJ, 2009, BIOGEOSCIENCES, V6, P779, DOI 10.5194/bg-6-779-2009; Brunet C., 2011, PHYTOPLANKTON PIGMEN; Busch JA, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8110879; Busch JA, 2016, INT J APPL EARTH OBS, V47, P40, DOI 10.1016/j.jag.2015.11.017; Ceccaroni L, 2017, ADV KNOWL ACQUISITIO, P1, DOI 10.4018/978-1-5225-0962-2.ch001; Coble P.G., 2013, SUBSEA OPTICS IMAGIN, P98; Eblen R. A., 1994, ENCY ENV; French V., 2017, ADV CITIZEN SCI COAS, DOI [10.25607/OBP-29, DOI 10.25607/OBP-29]; Friebe A, 2017, OCEANS-IEEE; Friedrichs A, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040678; Fritz S, 2019, NAT SUSTAIN, V2, P922, DOI 10.1038/s41893-019-0390-3; Garaba SP, 2015, INT J ENV RES PUB HE, V12, P16096, DOI 10.3390/ijerph121215044; Hadj-Hammou J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188507; Huot Y, 2005, LIMNOL OCEANOGR-METH, V3, P108, DOI 10.4319/lom.2005.3.108; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Loiselle SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162684; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mobley C.D.., 1994, LIGHT WATER RAD TRAN; Moore C, 2009, OCEAN SCI, V5, P661, DOI 10.5194/os-5-661-2009; Novoa S, 2013, J EUROPEAN OPTICAL S, V8, DOI [10.2971/jeos.2013.13077, DOI 10.2971/JEOS.2013.13077]; Novoa S, 2014, J EUROPEAN OPTICAL S, V9; Novoa S, 2015, LIMNOL OCEANOGR-METH, V13, P697, DOI 10.1002/lom3.10059; Pearlman J, 2017, SEA TECHNOL, V58, P30; Sarthyendranath S., 2000, REMOTE SENSING OCEAN; Thiel M, 2014, OCEANOGR MAR BIOL, V52, P257; van der Woerd HJ, 2015, SENSORS-BASEL, V15, P25663, DOI 10.3390/s151025663; Van der Woerd HJ, 2013, D2 4 KEY SCI ASPECTS, DOI [10.5281/zenodo.3668738, DOI 10.5281/ZENODO.3668738]; Wernand M, 2014, HIST OCEANOGRAPHY YB, V19, P61; Wernand MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063766; Wernand MR, 2010, J EUROPEAN OPTICAL S, V5; Wollschlager J, 2016, IEEE J OCEANIC ENG, V41, P753, DOI 10.1109/JOE.2016.2557466; Zielinski O, 2009, OCEAN SCI, V5, P329, DOI 10.5194/os-5-329-2009	34	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230084	10.1371/journal.pone.0230084	http://dx.doi.org/10.1371/journal.pone.0230084			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214341	Green Published, gold			2022-12-26	WOS:000535934200017
J	Fong, FLY; Lam, KY; Lau, CS; Ho, KH; Kan, YH; Poon, MY; El-Nezami, H; Sze, ETP				Fong, Fiona Long Yan; Lam, Ka Yam; Lau, Chun San; Ho, Kin Hei; Kan, Yeuk Hei; Poon, Mui Yee; El-Nezami, Hani; Sze, Eric Tung Po			Reduction in biogenic amines in douchi fermented by probiotic bacteria	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; SQUAMOUS-CELL CARCINOMA; NASOPHARYNGEAL CARCINOMA; PRESERVED FOODS; RISK; POPULATION; PREVENTION; SUFU	Ecology studies showed that esophageal and gastric cancers are directly correlated with the consumption of processed foods. The carcinogenicity of traditional Chinese fermented foods such as douchi (fermented black beans or fermented black soybeans) is due to the presence of carcinogenic N-nitroso compounds, which are derived from biogenic amines. Among the various biogenic amines that can act as precursors of N-nitroso compounds, histamine and tyramine are considered to be the most toxic and are of public health concern when present in food. We have examined some douchi products on the market, and significant amounts of histamine and tyramine were found. The use of fermentation starters generated by subculturing fermented products with unknown microbiota would induce the risk of biogenic amines. As the microbiota used in fermentation is a crucial factor in determining the biogenic amines of fermented food, it is hypothesized that the possible harmful effects of douchi can be minimized through the use of fermentation starters composed of probiotic bacteria. This is the first study to investigate the potential of using probiotic bacteria in manufacturing douchi. Lactobacillus rhamnosus GG (LGG), Lactobacillus casei Shirota (LcS) and Escherichia coli Nissle 1917 (EcN) were used to ferment black beans in this study, and no tyramine was detected in black bean samples incubated with these three strains anaerobically at 37 degrees C or 20 degrees C. The starter culture strains, temperature and presence of oxygen during the incubation period were found to be critical to the generation of biogenic amines. The findings of this study can provide evidence-based insights and warrant further investigations on the potential of reducing the harmful compounds in food fermented with probiotic bacteria as well as the sensory evaluation of douchi fermented with probiotic bacteria.	[Fong, Fiona Long Yan] Educ Univ Hong Kong, Dept Sci & Environm Studies, Hong Kong, Peoples R China; [Lam, Ka Yam; Lau, Chun San; Ho, Kin Hei; Kan, Yeuk Hei; Poon, Mui Yee; Sze, Eric Tung Po] Open Univ Hong Kong, Sch Sci & Technol, Hong Kong, Peoples R China; [El-Nezami, Hani] Univ Hong Kong, Sch Biol Sci, Hong Kong, Peoples R China	Education University of Hong Kong (EdUHK); Hong Kong Metropolitan University; University of Hong Kong	Sze, ETP (corresponding author), Open Univ Hong Kong, Sch Sci & Technol, Hong Kong, Peoples R China.	esze@ouhk.edu.hk	Sze, Eric/AAW-8946-2021; Lam, Thomas Ka Yam/C-5705-2017	Lam, Thomas Ka Yam/0000-0002-0728-0266	Faculty Development Scheme of the Hong Kong Research Grant Council (RGC) [UGC/FDS16/M07/18]; Institute for Research in Innovative Technology & Sustainability (IRITS); School of Science and Technology, the Open University of Hong Kong	Faculty Development Scheme of the Hong Kong Research Grant Council (RGC); Institute for Research in Innovative Technology & Sustainability (IRITS); School of Science and Technology, the Open University of Hong Kong	This work was funded by the Faculty Development Scheme of the Hong Kong Research Grant Council (RGC) (Project Reference Number UGC/FDS16/M07/18). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Institute for Research in Innovative Technology & Sustainability (IRITS) and the School of Science and Technology, the Open University of Hong Kong.	BLACKWELL B, 1963, LANCET, V2, P849; Chen YS, 2006, LETT APPL MICROBIOL, V43, P229, DOI 10.1111/j.1472-765X.2006.01922.x; Chu Jian-Jun, 1994, Zhonghua Yufang Yixue Zazhi, V28, P202; Collins JD, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2393; Costa MP, 2018, FOOD QUALITY BALANCI; Curiel JA, 2011, MEAT SCI, V88, P368, DOI 10.1016/j.meatsci.2011.01.011; FDA U. S, 2018, GRAS NOT INV; [Food and Agriculture Organization of the United Nations/World Health Organization Nations F.a.A.O.o.t.U.], 2001, REP JOINT FAO WHO EX; Food and Agriculture Organization of the United Nations/World Health Organization, 2012, JOINT FAO WHO EXP M; Food and Agriculture Organization of the United Nations/World Health Organization, 2018, JOINT FAO WHO LIT RE; Guan RF, 2013, FOOD CONTROL, V31, P345, DOI 10.1016/j.foodcont.2012.10.033; Guo XC, 2009, INT J CANCER, V124, P2942, DOI 10.1002/ijc.24293; Han BZ, 2004, FOOD CONTROL, V15, P265, DOI 10.1016/S0956-7135(03)00066-5; Han BZ, 2001, INT J FOOD MICROBIOL, V65, P1, DOI 10.1016/S0168-1605(00)00523-7; HANINGTON E, 1967, BMJ-BRIT MED J, V2, P550; Harada R, 2018, J BIOSCI BIOENG, V125, P688, DOI 10.1016/j.jbiosc.2017.12.004; Hildesheim A, 2002, J NATL CANCER I, V94, P1780, DOI 10.1093/jnci/94.23.1780; Hu YJ, 2010, J SCI FOOD AGR, V90, P1194, DOI 10.1002/jsfa.3947; Jairath G, 2015, J FOOD SCI TECH MYS, V52, P6835, DOI 10.1007/s13197-015-1860-x; Jung AR, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1394-4; Karami S, 2017, INT J PHARM INVESTIG, V7, P137, DOI 10.4103/jphi.JPHI_8_17; Key T, 2004, PUBLIC HEALTH NUTR, V7, P187, DOI 10.1079/PHN2003588; Ladero V, 2010, CURR NUTR FOOD SCI, V6, P145, DOI 10.2174/157340110791233256; Li L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30456-z; Liu CJ, 2012, J ZHEJIANG UNIV-SC B, V13, P298, DOI 10.1631/jzus.B1100221; LUH BS, 1995, J IND MICROBIOL, V14, P467, DOI 10.1007/BF01573959; McCredie M, 1999, BRIT J CANCER, V79, P1277, DOI 10.1038/sj.bjc.6690205; Mitacek EJ, 1999, FOOD CHEM TOXICOL, V37, P297, DOI 10.1016/S0278-6915(99)00017-4; Song QK, 2013, ASIAN PAC J CANCER P, V14, P659, DOI 10.7314/APJCP.2013.14.2.659; Song QK, 2012, CANCER SCI, V103, P2007, DOI 10.1111/j.1349-7006.2012.02387.x; Sugiyama S., 1984, Food Microbiology, V1, P339, DOI 10.1016/0740-0020(84)90067-4; Suzzi G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00472; Tang T, 2011, FOOD CONTROL, V22, P1203, DOI 10.1016/j.foodcont.2011.01.018; Tsai YH, 2007, FOOD CHEM, V103, P1305, DOI 10.1016/j.foodchem.2006.10.036; Wang F., 1998, KLUW S ANAL CIRC SIG; World Health Organization, 2018, 2018 GLOB HLTH OBS; Yang HL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226965; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; YU MC, 1988, CANCER RES, V48, P1954; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E; Zhang JH, 2006, FOOD CHEM, V98, P551, DOI 10.1016/j.foodchem.2005.06.024; Zukiewicz-Sobczak W, 2014, CENT EUR J IMMUNOL, V39, P104, DOI 10.5114/ceji.2014.42134	42	7	8	9	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230916	10.1371/journal.pone.0230916	http://dx.doi.org/10.1371/journal.pone.0230916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214369	Green Published, gold			2022-12-26	WOS:000535934200073
J	Hirota, M; Yada, K; Morimoto, T; Endo, T; Miyoshi, T; Miyagawa, S; Hirohara, Y; Yamaguchi, T; Saika, M; Fujikado, T				Hirota, Masakazu; Yada, Kozue; Morimoto, Takeshi; Endo, Takao; Miyoshi, Tomomitsu; Miyagawa, Suguru; Hirohara, Yoko; Yamaguchi, Tatsuo; Saika, Makoto; Fujikado, Takashi			Objective evaluation of visual fatigue in patients with intermittent exotropia	PLOS ONE			English	Article							STRABISMUS; ACCOMMODATION	Purpose The purpose of this study was to evaluate the degree of visual fatigue in patients with intermittent exotropia (IXT) using the binocular fusion maintenance (BFM) test. Methods Fourteen patients with IXT (32.1 +/- 16.4 years) and 15 age-matched healthy volunteers (31.2 +/- 9.3 years) participated in the study. BFM was assessed by measuring the transmittance of liquid crystals placed in front of the subject's nondominant eye at the instance when binocular fusion was broken and vergence eye movement was induced. A questionnaire on subjective symptoms was administered to the subjects before and after the visual task. The visual task consisted of a reciprocal movement between 67 and 40 cm. Results The change [post-pre] of BFM was significantly lower in the IXT group (-0.185 +/- 0.187) than in the control group (-0.030 +/- 0.070) (P = 0.010). The change of total subjective eye symptom score was significantly greater in the IXT group (2.28 +/- 1.43) than in the control group (0.93 +/- 1.27) (P = 0.018). The reduction in BFM rate with increasing total subjective eye symptom score was significantly greater in the IXT group (-0.106 +/- 0.017) than in the control group (-0.030 +/- 0.013) (P = 0.006). Conclusion The present findings objectively showed that patients with IXT are at a greater risk of visual fatigue in comparison with healthy individuals.	[Hirota, Masakazu; Morimoto, Takeshi; Miyagawa, Suguru; Hirohara, Yoko; Fujikado, Takashi] Osaka Univ, Dept Appl Visual Sci, Grad Sch Med, Suita, Osaka, Japan; [Hirota, Masakazu] Teikyo Univ, Dept Orthopt, Fac Med Technol, Itabashi Ku, Tokyo, Japan; [Yada, Kozue; Endo, Takao] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka, Japan; [Morimoto, Takeshi] Osaka Univ, Dept Adv Visual Neurosci, Grad Sch Med, Suita, Osaka, Japan; [Miyoshi, Tomomitsu] Osaka Univ, Dept Integrat Physiol, Grad Sch Med, Suita, Osaka, Japan; [Miyagawa, Suguru; Hirohara, Yoko; Fujikado, Takashi] Osaka Univ, Special Res Promot Grp, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Miyagawa, Suguru; Hirohara, Yoko; Yamaguchi, Tatsuo; Saika, Makoto] Topcon Corp, Tokyo, Japan	Osaka University; Teikyo University; Osaka University; Osaka University; Osaka University; Osaka University; Topcon Corporation	Fujikado, T (corresponding author), Osaka Univ, Dept Appl Visual Sci, Grad Sch Med, Suita, Osaka, Japan.; Fujikado, T (corresponding author), Osaka Univ, Special Res Promot Grp, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	fujikado@ophthal.med.osaka-u.ac.jp	Hirota, Masakazu/ABE-3358-2020	Hirota, Masakazu/0000-0003-1420-9844	Asian CORE Program; Japan Society for the Promotion of Science (JSPS); Advanced Nano Photonics Research and Education Center in Asia; JSPS [17J01295]; Ministry of Education, Culture, Sports, Science and Technology Japan [J16H05487]	Asian CORE Program; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Advanced Nano Photonics Research and Education Center in Asia; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Topcon Corporation provided support in the form of salaries for Suguru Miyagawa, Yoko Hirohara, Tatsuo Yamaguchi, and Makoto Saika but did not have any role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Authors" section. This does not alter our adherence to the policies of PlosOne on sharing data and materials. Takashi Fujikado received research funding from Topcon Corporation. This study is supported by grants from an Asian CORE Program, Japan Society for the Promotion of Science (JSPS), Advanced Nano Photonics Research and Education Center in Asia (TF); the JSPS Core-to-Core Program, A, Advanced Research Networks (TF); the Ministry of Education, Culture, Sports, Science and Technology Japan, Grant-in-Aid for Scientific Research B, J16H05487 (TF); Research Fellowship for Young Scientists, JSPS, 17J01295 (MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrishami M., 2014, IRAN J OPHTHALMOL, V26, P199; Berens C, 1926, Trans Am Ophthalmol Soc, V24, P262; Burian H M, 1970, Trans Am Ophthalmol Soc, V68, P56; BURIAN HM, 1966, AM J OPHTHALMOL, V62, P1161, DOI 10.1016/0002-9394(66)92570-0; Chia A, 2007, BRIT J OPHTHALMOL, V91, DOI 10.1136/bjo.2007.116905; FINCHAM EF, 1957, J PHYSIOL-LONDON, V137, P488, DOI 10.1113/jphysiol.1957.sp005829; Hirota M, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.2.9; Hoffman DM, 2008, J VISION, V8, DOI 10.1167/8.3.33; Hrynchak PK, 2010, OPHTHAL PHYSL OPT, V30, P304, DOI 10.1111/j.1475-1313.2010.00723.x; Jeng WD, 2014, APPL OPTICS, V53, pH76, DOI 10.1364/AO.53.000H76; Kim J, 2014, VISION RES, V105, P159, DOI 10.1016/j.visres.2014.10.021; Kobayashi M, 2008, APPL OPTICS, V47, P4619, DOI 10.1364/AO.47.004619; Koh S, 2016, CORNEA, V35, pS83, DOI 10.1097/ICO.0000000000000998; Kwon KA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0227; Maeda F, 2011, JPN J OPHTHALMOL, V55, P175, DOI 10.1007/s10384-011-0011-9; Maples WC, 2007, OPTOMETRY VISION SCI, V84, P224, DOI 10.1097/OPX.0b013e3180339f44; Matsuo T, 2005, OPHTHAL EPIDEMIOL, V12, P31, DOI 10.1080/09286580490907805; Mohney BG, 2003, OPHTHALMOLOGY, V110, P2093, DOI 10.1016/j.ophtha.2003.04.001; Nakazawa T, 2002, AM J IND MED, V42, P421, DOI 10.1002/ajim.10133; Rosenfield M, 2011, OPHTHAL PHYSL OPT, V31, P502, DOI 10.1111/j.1475-1313.2011.00834.x; Seaber J H, 1966, Am Orthopt J, V16, P67; Sheard C., 1930, AM J OPTOM, V7, P9, DOI [10.1097/00006324-193001000-00001, DOI 10.1097/00006324-193001000-00001]; Sheedy J, 2002, OPTOMETRY VISION SCI, V79, P306, DOI 10.1097/00006324-200205000-00010; Von Noorden G. K., 2002, BINOCULAR VISION OCU, V6th; WEALE RA, 1954, BRIT J OPHTHALMOL, V38, P248, DOI 10.1136/bjo.38.4.248; Westman M, 2012, J OPTOM, V5, P62; Yuge K., 1963, STARABISMUS AMBLYOPI, P79	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230788	10.1371/journal.pone.0230788	http://dx.doi.org/10.1371/journal.pone.0230788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214343	Green Published, gold			2022-12-26	WOS:000535934200059
J	Kim, H; Caulfield, LE; Rebholz, CM; Ramsing, R; Nachman, KE				Kim, Hyunju; Caulfield, Laura E.; Rebholz, Casey M.; Ramsing, Rebecca; Nachman, Keeve E.			Trends in types of protein in US adolescents and children: Results from the National Health and Nutrition Examination Survey 1999-2010	PLOS ONE			English	Article							DIETARY ASSESSMENT METHODS; MEAT CONSUMPTION; ENERGY-INTAKE; PATTERNS; CHILDHOOD; QUALITY; VALIDITY; TRACKING; PROGRAM; WOMEN	Background It is unclear if the intakes of different types of protein have changed over time. Objective We delineated trends in types of protein (beef, pork, lamb or goat, chicken, turkey, fish, dairy, eggs, legumes, and nuts and seeds) in US children (2-<12 years) and adolescents (12-19 years) from 1999 to 2010. Methods We used 6 repeated cross-sectional surveys (National Health and Nutrition Examination Survey 1999-2010, n >= 1,665 for children; n >= 1,156 for adolescents) to test for linear trends in the intake of types of protein (grams per kilogram of body weight) among children and adolescents, and according to sociodemographic groups and participation in food assistance programs. Results Among children, pork intake (0.76 to 0.51 g/kg) decreased, but chicken (0.98 to 1.28 g/kg), all poultry (1.18 to 1.55 g/kg), egg (0.63 to 0.69 g/kg), and legume (0.35 to 0.54 g/kg) intake increased (all P<0.05). Among adolescents, beef intake decreased (0.92 to 0.67 g/kg) whereas chicken (0.59 to 0.74 g/kg) and all poultry (0.72 to 0.86 g/kg) intake increased from 1999 to 2010 (all P<0.01). Participants of the Women, Infants, and Children (WIC) increased the intake of chicken and dairy (all P<0.05) over time whereas no significant trend was observed for income-eligible non-participants. Fish intake did not change in any age group, and recommended types of protein (poultry, fish, nuts and seeds) declined among children of lower socioeconomic status. Conclusions Intake of recommended types of protein increased among children, adolescents and WIC participants. However, subgroup analyses suggest socioeconomic disparities.	[Kim, Hyunju; Caulfield, Laura E.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, Baltimore, MD USA; [Kim, Hyunju; Rebholz, Casey M.] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Kim, Hyunju; Ramsing, Rebecca; Nachman, Keeve E.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Livable Future, Baltimore, MD 21205 USA; [Rebholz, Casey M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ramsing, Rebecca; Nachman, Keeve E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD 21205 USA; [Nachman, Keeve E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Nachman, KE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Livable Future, Baltimore, MD 21205 USA.; Nachman, KE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD 21205 USA.; Nachman, KE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA.	knachman@jhu.edu		Kim, Hyunju/0000-0002-1707-7018; Rebholz, Casey/0000-0002-5442-8745; Nachman, Keeve/0000-0003-4925-4151	Johns Hopkins Center for a Livable Future; National Institute of Diabetes and Digestive and Kidney Diseases [K01 DK107782]; National Heart, Lung, and Blood Institute [R21 HL143089]	Johns Hopkins Center for a Livable Future; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	HK, RR, and KEN were supported by a directed research grant from the Johns Hopkins Center for a Livable Future. CMR was supported by a mentored research scientist development award from the National Institute of Diabetes and Digestive and Kidney Diseases (K01 DK107782) and a grant from the National Heart, Lung, and Blood Institute (R21 HL143089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyeva T, 2015, AM J PREV MED, V49, P594, DOI 10.1016/j.amepre.2015.04.035; Berryman CE, 2018, AM J CLIN NUTR, V108, P405, DOI 10.1093/ajcn/nqy088; Bowman SA., 2003, FAM EC NUTR REV, V15, P29; Burrows TL, 2010, J AM DIET ASSOC, V110, P1501, DOI 10.1016/j.jada.2010.07.008; Daniel CR, 2011, PUBLIC HEALTH NUTR, V14, P575, DOI 10.1017/S1368980010002077; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; DRAKE MA, 1992, PUBLIC HEALTH REP, V107, P312; Food and Nutrition Service (FNS) USDA, 2012, Fed Regist, V77, P4088; Gidding SS, 2006, PEDIATRICS, V117, P544, DOI [10.1542/peds.2005-2374, 10.1542/peds.2005-2565]; Gu X, 2017, AM J CLIN NUTR, V105, P194, DOI 10.3945/ajcn.116.135095; Hornell A., 2013, FOOD NUTR RES, V57; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Joint Institute for Food Safety and Applied Nutrition, 2010, FOOD COMM INT DAT WH; Kim H, 2019, PUBLIC HEALTH NUTR, V22, P191, DOI 10.1017/S1368980018003348; Krebs-Smith SM, 2010, AM J PREV MED, V38, P472, DOI 10.1016/j.amepre.2010.01.016; Mancino L, FOOD AWAY HOME AFFEC, V32; Mikkila V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418; Natinoal Center for Health Statistics, NHANES DIET DAT OV; National Cancer Institute, 2017, REC POT APPR DIET AS; Northstone K, 2008, BRIT J NUTR, V100, P1069, DOI 10.1017/S0007114508968264; Odoms-Young AM, 2014, PUBLIC HEALTH NUTR, V17, P83, DOI 10.1017/S1368980013000761; Ritchie LD, 2018, PEDIATR OBES, V13, P14, DOI 10.1111/ijpo.12440; Singer MR, 1995, AM J PUBLIC HEALTH, V85, P1673, DOI 10.2105/AJPH.85.12.1673; Tester JM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3557; U.S. Department of Agriculture Food and Nutrition Service OoR, 2007, NUTR AN SCH NUTR DIE, VII; *US DEP HHS US DEP, 2005, DIET GUID AM 2005; US Department of Health and Human Services & US Department of Agriculture, 2010, DIET GUID AM 2010; US Department of Health and Human Services & US Department of Agriculture, 2000, DIET GUID AM 2000; US Department of Health and Human Services & US Department of Agriculture, 2015, DIET GUID AM 2015; Vernarelli JA, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090924; Walker JL, 2018, EUR J CLIN NUTR, V72, P185, DOI 10.1038/s41430-017-0029-2; Wang DD, 2014, JAMA INTERN MED, V174, P1587, DOI 10.1001/jamainternmed.2014.3422; Wang Y, 2011, J EPIDEMIOL COMMUN H, V65, P177, DOI 10.1136/jech.2009.095901; Wang YF, 2002, J NUTR, V132, P430, DOI 10.1093/jn/132.3.430; Wang YF, 2010, PUBLIC HEALTH NUTR, V13, P1333, DOI 10.1017/S1368980010000224; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Zhang F., 2018, ACM T MULTIM COMPUT, V14, P1, DOI [10.1145/3176646, DOI 10.1145/3176646, DOI 10.1001/JAMANETW0RK0PEN.2018.0237]; Zipf G, 2013, VITAL HLTH STAT, V56, P1	38	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230686	10.1371/journal.pone.0230686	http://dx.doi.org/10.1371/journal.pone.0230686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8GI	32214368	Green Published, gold			2022-12-26	WOS:000535934200039
J	Ye, JR; Hao, MQ; Xing, H; Wang, YC; Wang, J; Feng, Y; Xin, RL; Zeng, J; Zhao, S; Hao, YX; Chen, J; Ruan, YH; Li, X; Shao, YM; Lu, HY				Ye, Jingrong; Hao, Mingqiang; Xing, Hui; Wang, Yuncong; Wang, Juan; Feng, Yi; Xin, Ruolei; Zeng, Ji; Zhao, Shuai; Hao, Yinxiao; Chen, Jing; Ruan, Yuhua; Li, Xue; Shao, Yiming; Lu, Hongyan			Characterization of subtypes and transmitted drug resistance strains of HIV among Beijing residents between 2001-2016	PLOS ONE			English	Article							PREVALENCE; MUTATIONS; MEN; SEX	Background Beijing is a national and international hub potentially containing a broad diversity of HIV variants. Previous studies on molecular epidemiology of HIV in Beijing pooled together samples from residents and non-residents. Pooling residents and non-residents has potentially introduced bias and undermined a good assessment and the intervention among the autochthonous population. Here, we aimed to define HIV subtype diversity and investigate the TDR in Beijing residents exclusively. Methods We analyzed the demographic, clinical, and virological data collected between 2001 and 2016 from residents in Beijing. A population-based sequencing of the HIV pol gene was carried out using plasma specimens. Phylogenetic analysis was performed in order to classify sequences into their corresponding subtypes using an automated subtyping tool, the Context-Based Modeling for Expeditious Typing (COMET). Furthermore, the drug resistance mutations were determined using the World Health Organization list for surveillance of TDR mutations. Results Data on TDR were available for 92% of 2,315 individuals with HIV infection, of whom 7.1% were women. The bioinformatic analysis of HIV strains from this study revealed that a combined 17 subtypes were circulating in Beijing, China between 2001 and 2016. The most common ones were CRF01_AE, CRF07_BC, and subtype B in Beijing during this period. The overall prevalence of TDR was 4.5% (95% confidence intervals[CI]: 3.6%-5.4%), with a declining trend over the period of spanning 2001 through 2016. In-depth class-specific analysis revealed that the prevalence of TDR for the nucleoside reverse-transcriptase inhibitors (NRTIs) was 1.0% (95% CI: 0.6-1.5), 0.9% (95% CI:0.6-1.4) for non-NRTIs and 2.8% (95% CI:2.1-3.5) for protease inhibitors. The prevalence of TDR was lower in individuals infected with the CRF07_BC HIV strain than those infected with CRF01_AE. Conclusions Our data showed that the HIV epidemic in Beijing displayed a high genetic heterogeneity and a low and declining prevalence of TDR. In sharp contrast to Europe and North America, the declining trend of TDR between 2001 through 2016 was noticed while there was a widespread distribution of antiretroviral treatment in Beijing, China.	[Ye, Jingrong; Hao, Mingqiang; Wang, Yuncong; Wang, Juan; Xin, Ruolei; Zeng, Ji; Hao, Yinxiao; Chen, Jing; Li, Xue; Lu, Hongyan] Beijing Ctr Dis Prevent & Control, Inst HIV AIDS & STD Prevent & Control, Beijing, Peoples R China; [Ye, Jingrong; Hao, Mingqiang; Wang, Yuncong; Wang, Juan; Xin, Ruolei; Zeng, Ji; Hao, Yinxiao; Chen, Jing; Li, Xue; Lu, Hongyan] Beijing Res Ctr Prevent Med, Beijing, Peoples R China; [Xing, Hui; Feng, Yi; Zhao, Shuai; Ruan, Yuhua; Shao, Yiming] China Ctr Dis Prevent & Control, Div Virol & Immunol, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Xing, Hui; Feng, Yi; Zhao, Shuai; Ruan, Yuhua; Shao, Yiming] China Ctr Dis Prevent & Control, Natl Ctr AIDS STD Prevent & Control NCAIDS, Beijing, Peoples R China		Lu, HY (corresponding author), Beijing Ctr Dis Prevent & Control, Inst HIV AIDS & STD Prevent & Control, Beijing, Peoples R China.; Lu, HY (corresponding author), Beijing Res Ctr Prevent Med, Beijing, Peoples R China.; Shao, YM (corresponding author), China Ctr Dis Prevent & Control, Div Virol & Immunol, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.; Shao, YM (corresponding author), China Ctr Dis Prevent & Control, Natl Ctr AIDS STD Prevent & Control NCAIDS, Beijing, Peoples R China.	yshao@bjmu.edu.cn; hongyan_lu@sina.com			Beijing Natural Science Foundation [D161100000416002, 7202074]	Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by Beijing Natural Science Foundation (D161100000416002 to Hongyan Lu and 7202074 to Ruolei Xin). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila-Rios S, 2016, LANCET HIV, V3, pE579, DOI 10.1016/S2352-3018(16)30119-9; Beijing Health and Family Planning Commission, EP SIT BEIJ 2016; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Chen M, 2018, EPIDEMIOL INFECT, V146, P775, DOI 10.1017/S0950268818000389; Dunn D, 2014, AIDS, V28, P773, DOI 10.1097/QAD.0000000000000119; Hao MQ, 2017, AIDS RES HUM RETROV, V33, P970, DOI [10.1089/aid.2017.0053, 10.1089/AID.2017.0053]; Lu XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171481; National Health and Family Planning Commission, GEN OFF NAT HLTH FAM; Panichsillapakit T, 2016, JAIDS-J ACQ IMM DEF, V71, P228, DOI 10.1097/QAI.0000000000000831; RIBERA J, 2017, PLOS ONE, V12, DOI DOI 10.1371/JOURNAL.PONE.0185644; Robert I., 2016, KABACOFF R ACTION DA; Song YX, 2018, EPIDEMIOL INFECT, V146, P339, DOI 10.1017/S0950268817003016; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; WHO`, MOST COUNTR AD HIV P; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Yang WL, 2015, J INFECT DIS, V212, P28, DOI 10.1093/infdis/jiv012; Ye JR, 2012, AIDS RES HUM RETROV, V28, P418, DOI 10.1089/aid.2011.0097; Ye JR, 2020, AIDS, V34, P609, DOI 10.1097/QAD.0000000000002468; Zhang FD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165110; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; Zhang XY, 2007, AIDS, V21, pS59, DOI 10.1097/01.aids.0000304698.47261.b1; Zhao B, 2015, JAIDS-J ACQ IMM DEF, V68, P250, DOI 10.1097/QAI.0000000000000467; Zhao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109821	23	4	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230779	10.1371/journal.pone.0230779	http://dx.doi.org/10.1371/journal.pone.0230779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214358	gold, Green Published			2022-12-26	WOS:000535934200057
J	Rezaee, ME; Lynch, KE; Li, ZZ; MacKenzie, TA; Seigne, JD; Robertson, DJ; Sirovich, B; Goodney, PP; Schroeck, FR				Rezaee, Michael E.; Lynch, Kristine E.; Li, Zhongze; MacKenzie, Todd A.; Seigne, John D.; Robertson, Douglas J.; Sirovich, Brenda; Goodney, Philip P.; Schroeck, Florian R.			The impact of low- versus high-intensity surveillance cystoscopy on surgical care and cancer outcomes in patients with high-risk non-muscle-invasive bladder cancer (NMIBC)	PLOS ONE			English	Article							TRANSURETHRAL RESECTION; GUIDELINES	Purpose To assess the association of low- vs. guideline-recommended high-intensity cystoscopic surveillance with outcomes among patients with high-risk non-muscle invasive bladder cancer (NMIBC). Materials & methods A retrospective cohort study of Veterans Affairs patients diagnosed with high-risk NMIBC between 2005 and 2011 with follow-up through 2014. Patients were categorized by number of surveillance cystoscopies over two years following diagnosis: low- (1-5) vs. high-intensity (6 or more) surveillance. Propensity score adjusted regression models were used to assess the association of low-intensity cystoscopic surveillance with frequency of transurethral resections, and risk of progression to invasive disease and bladder cancer death. Results Among 1,542 patients, 520 (33.7%) underwent low-intensity cystoscopic surveillance. Patients undergoing low-intensity surveillance had fewer transurethral resections (37 vs. 99 per 100 person-years; p< 0.001). Risk of death from bladder cancer did not differ significantly by low (cumulative incidence [CIn] 8.4% [95% CI 6.5-10.9) at 5 years) vs. high-intensity surveillance (CIn 9.1% [95% CI 7.4-11.2) at 5 years, p = 0.61). Low vs. high-intensity surveillance was not associated with increased risk of bladder cancer death among patients with Ta (CIn 5.7% vs. 8.2% at 5 years p = 0.24) or T1 disease at diagnosis (CIn 10.2% vs. 9.1% at 5 years, p = 0.58). Among patients with Ta disease, low-intensity surveillance was associated with decreased risk of progression to invasive disease (T1 or T2) or bladder cancer death (CIn 19.3% vs. 31.3% at 5 years, p = 0.002). Conclusions Patients with high-risk NMIBC undergoing low- vs. high-intensity cystoscopic surveillance underwent fewer transurethral resections, but did not experience an increased risk of progression or bladder cancer death. These findings provide a strong rationale for a clinical trial to determine whether low-intensity surveillance is comparable to high-intensity surveillance for cancer control in high-risk NMIBC.	[Rezaee, Michael E.; Seigne, John D.; Robertson, Douglas J.; Sirovich, Brenda; Goodney, Philip P.; Schroeck, Florian R.] White River Junct VA Med Ctr, White River Jct, VT 05009 USA; [Rezaee, Michael E.; Schroeck, Florian R.] Dartmouth Hitchcock Med Ctr, Sect Urol, Lebanon, NH 03766 USA; [Lynch, Kristine E.] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Lynch, Kristine E.] Univ Utah, Salt Lake City, UT USA; [Li, Zhongze; MacKenzie, Todd A.] Dartmouth Coll, Biomed Data Sci Dept, Geisel Sch Med, 1 Med Ctr Dr, Lebanon, NH 03756 USA; [MacKenzie, Todd A.; Robertson, Douglas J.; Sirovich, Brenda; Goodney, Philip P.; Schroeck, Florian R.] Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, Geisel Sch Med, 1 Med Ctr Dr, Lebanon, NH 03756 USA; [Seigne, John D.; Schroeck, Florian R.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA	Dartmouth College; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Schroeck, FR (corresponding author), White River Junct VA Med Ctr, White River Jct, VT 05009 USA.; Schroeck, FR (corresponding author), Dartmouth Hitchcock Med Ctr, Sect Urol, Lebanon, NH 03766 USA.; Schroeck, FR (corresponding author), Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, Geisel Sch Med, 1 Med Ctr Dr, Lebanon, NH 03756 USA.; Schroeck, FR (corresponding author), Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA.	Florian.R.Schroeck@dartmouth.edu	Schroeck, Florian R./I-5342-2019	Schroeck, Florian R./0000-0002-1860-2611	Conquer Cancer Foundation Career Development Award; Dow-Crichlow Award of the Department of Surgery at the Dartmouth-Hitchcock Medical Center; Department of Veterans Affairs Health Services Research Development [IIR 15-085, 1I01HX001880-01A2]	Conquer Cancer Foundation Career Development Award; Dow-Crichlow Award of the Department of Surgery at the Dartmouth-Hitchcock Medical Center; Department of Veterans Affairs Health Services Research Development(US Department of Veterans Affairs)	FRS is supported by a Conquer Cancer Foundation Career Development Award and by the Dow-Crichlow Award of the Department of Surgery at the Dartmouth-Hitchcock Medical Center. PPG is supported by the Department of Veterans Affairs Health Services Research & Development (IIR 15-085, 1I01HX001880-01A2). The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Agha Z, 2000, ARCH INTERN MED, V160, P3252, DOI 10.1001/archinte.160.21.3252; American Urological Association. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Joint Guidline, 2016, DIAGN TREATM NONM IN; Babjuk M, 2017, EUR UROL, V71, P447, DOI 10.1016/j.eururo.2016.05.041; Chamie K, 2011, CANCER-AM CANCER SOC, V117, P5392, DOI 10.1002/cncr.26198; Chang SS, 2016, J UROLOGY, V196, P1021, DOI 10.1016/j.juro.2016.06.049; Gregg JR, 2016, CAN J UROL, V23, P8198; Han DS, 2018, PATIENT FACLITY FACT; Hollenbeck BK, 2006, CANCER-AM CANCER SOC, V106, P1527, DOI 10.1002/cncr.21765; Hollenbeck BK, 2009, JNCI-J NATL CANCER I, V101, P571, DOI 10.1093/jnci/djp039; Merkow RP, 2018, JAMA SURG, V153, P850, DOI 10.1001/jamasurg.2018.0492; National Cancer Institute, 2018, CANC STAT FACTS BLAD; National Comprehensive Cancer Network, 2018, BLADDER CANC; Noone AM, 2018, SEER CANC STAT REV 1; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Schrag D, 2003, J NATL CANCER I, V95, P588, DOI 10.1093/jnci/95.8.588; Schroeck FR, 2019, CANCER-AM CANCER SOC, V125, P3147, DOI 10.1002/cncr.32185; Schroeck FR, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.3442; Schroeck FR, 2018, UROL ONCOL-SEMIN ORI, V36, P257, DOI 10.1016/j.urolonc.2017.12.016; Schroeck FR, 2017, UROLOGY, V110, P84, DOI 10.1016/j.urology.2017.07.056; Schroeck FR, 2017, BMC UROL, V17, DOI 10.1186/s12894-017-0271-x; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; US Departments of Veterans Affairs and Defense, 2017, VA DOD CPG MAN PTSD; Wagner TH, 2016, HEALTH SERV RES, V51, P2002, DOI 10.1111/1475-6773.12454; Warren JL, 2002, MED CARE, V40, P3; Woldu SL, 2017, BJU INT, V119, P371, DOI 10.1111/bju.13760	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230417	10.1371/journal.pone.0230417	http://dx.doi.org/10.1371/journal.pone.0230417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GC	32203532	Green Published, gold			2022-12-26	WOS:000535303900021
J	Peterson, LR; O'Grady, S; Keegan, M; Fisher, A; Zelencik, S; Kufner, B; Shah, M; Lim, R; Schora, D; Das, S; Singh, K				Peterson, Lance R.; O'Grady, Sean; Keegan, Mary; Fisher, Adrienne; Zelencik, Shane; Kufner, Bridget; Shah, Mona; Lim, Rachel; Schora, Donna; Das, Sanchita; Singh, Kamaljit			Reduced Clostridioides difficile infection in a pragmatic stepped-wedge initiative using admission surveillance to detect colonization	PLOS ONE			English	Article							CARE; AUREUS; EPIDEMIOLOGY; ACQUISITION; SPORES; IMPACT; HANDS; TIME	Background Clostridioides difficile Infection (CDI) is a persistent healthcare issue. In the US, CDI is the most common infectious cause of hospital-onset (HO) diarrhea. Objective Assess the impact of admission testing for toxigenic C. difficile colonization on the incidence of HO-CDI. Design Pragmatic stepped-wedge Infection Control initiative. Setting NorthShore University HealthSystem is a four-hospital system near Chicago, IL. Patients All patients admitted to the four hospitals during the initiative. Interventions From September 2017 through August 2018 we conducted a quality improvement program where admitted patients had a peri-rectal swab tested for toxigenic C. difficile. All colonized patients were placed into contact precautions. Measurements We tested admissions who: i) had been hospitalized within two months, ii) had a past C. difficile positive test, and/or iii) were in a long-term care facility within six months. We measured compliance with all other practices to reduce the incidence of HO-CDI. Results 30% of admissions were tested and 8.3% were positive. In the year prior to the initiative (Period 1) there were 63,057 admitted patients when HO-CDI incidence was 5.96 cases/10,000 patient days. During the 12-month initiative (Period 2) there were 62,760 admissions and the HO-CDI incidence was 4.23 cases/10,000 patient days (p = 0.02). There were no other practice or antibiotic use changes. Continuing admission surveillance provided a HOCDI incidence of 2.9 cases/10,000 patient days during the final 9 months of 2018 (p<0.0001 compared to Period 1), equaling < 1 case/1,000 admissions. Limitations This was not a randomized controlled trial, and multiple prevention practices were in place at the time of the admission surveillance initiative. Conclusion Admission C. difficile surveillance testing is an important tool for preventing hospital-onset C. difficile infection. Registration This quality improvement initiative is registered at ClinicalTrials.gov. The unique registration identifier number is NCT04014608.	[Peterson, Lance R.; Singh, Kamaljit] NorthShore Univ HealthSyst, Dept Med, Div Infect Dis, Evanston, IL 60201 USA; [Peterson, Lance R.; Schora, Donna; Das, Sanchita; Singh, Kamaljit] NorthShore Univ HealthSyst, Dept Pathol & Lab Med, Div Microbiol, Evanston, IL 60201 USA; [Peterson, Lance R.; Fisher, Adrienne; Zelencik, Shane; Kufner, Bridget; Shah, Mona; Lim, Rachel; Das, Sanchita; Singh, Kamaljit] NorthShore Univ HealthSyst, Dept Infect Control, Evanston, IL 60201 USA; [O'Grady, Sean] NorthShore Univ HealthSyst, Evanston, IL USA; [Keegan, Mary] NorthShore Univ HealthSyst, Dept Nursing, Evanston, IL USA	NorthShore University Health System; NorthShore University Health System; NorthShore University Health System; NorthShore University Health System; NorthShore University Health System	Peterson, LR (corresponding author), NorthShore Univ HealthSyst, Dept Med, Div Infect Dis, Evanston, IL 60201 USA.; Peterson, LR (corresponding author), NorthShore Univ HealthSyst, Dept Pathol & Lab Med, Div Microbiol, Evanston, IL 60201 USA.; Peterson, LR (corresponding author), NorthShore Univ HealthSyst, Dept Infect Control, Evanston, IL 60201 USA.	lpeterson@northshore.org						Abou Chakra CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098400; Anderson DJ, 2018, LANCET INFECT DIS, V18, P845, DOI 10.1016/S1473-3099(18)30278-0; Anderson DJ, 2017, LANCET, V389, P805, DOI [10.1016/S0140-6736(16)31588-4, 10.1016/s0140-6736(16)31588-4]; Balm Michelle N D, 2013, BMC Infect Dis, V13, P491, DOI 10.1186/1471-2334-13-491; Baron SW, 2020, INFECT CONT HOSP EP, V41, P149, DOI 10.1017/ice.2019.309; Bartsch SM, 2012, EUR J CLIN MICROBIOL, V31, P3163, DOI 10.1007/s10096-012-1681-z; Bolon M, 2011, INFECT DIS CLIN N AM, V25, P21, DOI 10.1016/j.idc.2010.11.001; Caroff DA, 2017, CLIN INFECT DIS, V65, P1232, DOI 10.1093/cid/cix456; Centers for Disease Control and Prevention, 2018, STRAT PREV CLOSTR DI; Centers for Disease Control and Prevention, 2016, CLOSTR DIFF INF CDI; Centers for Disease Control and Prevention, 2015, ANN REP EM INF PROGR; Centers for Medicare and Medicaid Services, 2018, HOSP ACQ COND HOSP ACQ COND; Chang HT, 2007, INFECT CONT HOSP EP, V28, P926, DOI 10.1086/519178; Chang S, 2009, CLIN INFECT DIS, V48, P1423, DOI 10.1086/598505; Curry SR, 2011, J CLIN MICROBIOL, V49, P3788, DOI 10.1128/JCM.00679-11; Donskey CJ, 2018, INFECT CONT HOSP EP, V39, P909, DOI 10.1017/ice.2018.106; Fang FC, 2017, J CLIN MICROBIOL, V55, P670, DOI 10.1128/JCM.02463-16; Gerding DN, 2015, INFECT DIS CLIN N AM, V29, P37, DOI 10.1016/j.idc.2014.11.004; Guerrero DM, 2012, AM J INFECT CONTROL, V40, P556, DOI 10.1016/j.ajic.2011.08.002; Guh AY, 2018, ANN INTERN MED, V169, pITC49, DOI 10.7326/AITC201810020; Kumar N, 2019, NAT GENET, V51, P1315, DOI 10.1038/s41588-019-0478-8; Kundrapu S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1514-2; Kundrapu S, 2014, INFECT CONT HOSP EP, V35, P204, DOI 10.1086/674859; Kutty PK, 2019, INFECT CONT HOSP EP, V40, P801, DOI 10.1017/ice.2019.109; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Linsenmeyer K, 2018, CLIN INFECT DIS, V67, P1912, DOI 10.1093/cid/ciy455; Longtin Y, 2016, JAMA INTERN MED, V176, P796, DOI [10.1001/jamainternmed.2016.0177, 10.1001/jama]; Magill SS, 2018, NEW ENGL J MED, V379, P1732, DOI 10.1056/NEJMoa1801550; Mawer DPC, 2017, CLIN INFECT DIS, V64, P1163, DOI 10.1093/cid/cix079; McDonald LC, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00782-18; McDonald LC, 2018, CLIN INFECT DIS, V66, pE1, DOI [10.1093/cid/cix1085, 10.1093/cid/ciy149]; McDonald LC, 2019, CLOSTRIDIOIDES FORME; Meltzer E, 2019, CLIN MICROBIOL INFEC, V25, P1127, DOI 10.1016/j.cmi.2019.02.002; NorthShore University HealthSystem Research Institute Quality Improvement (QI) Checklist, 2011, NORTHSH U HLTH SYST; Patel PA, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01553-17, 10.1128/jcm.01553-17]; Peterson LR, 2016, AM J INFECT CONTROL, V44, P1622, DOI 10.1016/j.ajic.2016.04.251; Peterson LR, 2016, J CLIN MICROBIOL, V54, P2647, DOI 10.1128/JCM.00698-16; Ridgway JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079716; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Robicsek A, 2011, INFECT CONT HOSP EP, V32, P9, DOI 10.1086/657631; Shardell M, 2007, CLIN INFECT DIS, V45, P901, DOI 10.1086/521255; Tripepi G, 2011, NEPHRON CLIN PRACT, V118, pC399, DOI 10.1159/000324049; Weaver FM, 2017, INFECT CONT HOSP EP, V38, P1351, DOI 10.1017/ice.2017.208	43	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230475	10.1371/journal.pone.0230475	http://dx.doi.org/10.1371/journal.pone.0230475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191763	Green Published, gold, Green Submitted			2022-12-26	WOS:000535302300052
J	Yang, JL; LeBlanc, ME; Cano, I; Saez-Torres, KL; Saint-Geniez, M; Ng, YS; D'Amore, PA				Yang, Jinling; LeBlanc, Michelle E.; Cano, Issahy; Saez-Torres, Kahira L.; Saint-Geniez, Magali; Ng, Yin-Shan; D'Amore, Patricia A.			ADAM10 and ADAM17 proteases mediate proinflammatory cytokine-induced and constitutive cleavage of endomucin from the endothelial surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; endothelial cell; proteolytic enzyme; leukocyte; glycoprotein; endothelium; matrix metalloproteinase (MMP); endomucin; glycocalyx	NECROSIS-FACTOR-ALPHA; ADHESION MOLECULE; REGULATED RELEASE; CELL-ADHESION; GLYCOCALYX; ECTODOMAIN; INFLAMMATION; DISINTEGRIN; PERMEABILITY; FRACTALKINE	Contact between inflammatory cells and endothelial cells (ECs) is a crucial step in vascular inflammation. Recently, we demonstrated that the cell-surface level of endomucin (EMCN), a heavily O-glycosylated single-transmembrane sialomucin, interferes with the interactions between inflammatory cells and ECs. We have also shown that, in response to an inflammatory stimulus, EMCN is cleared from the cell surface by an unknown mechanism. In this study, using adenovirus-mediated overexpression of a tagged EMCN in human umbilical vein ECs, we found that treatment with tumor necrosis factor ? (TNF-?) or the strong oxidant pervanadate leads to loss of cell-surface EMCN and increases the levels of the C-terminal fragment of EMCN 3- to 4-fold. Furthermore, treatment with the broad-spectrum matrix metalloproteinase inhibitor batimastat (BB94) or inhibition of ADAM metallopeptidase domain 10 (ADAM10) and ADAM17 with two small-molecule inhibitors, GW280264X and GI254023X, or with siRNA significantly reduced basal and TNF?-induced cell-surface EMCN cleavage. Release of the C-terminal fragment of EMCN by TNF-? treatment was blocked by chemical inhibition of ADAM10 alone or in combination with ADAM17. These results indicate that cell-surface EMCN undergoes constitutive cleavage and that TNF-? treatment dramatically increases this cleavage, which is mediated predominantly by ADAM10 and ADAM17. As endothelial cell-surface EMCN attenuates leukocyte?EC interactions during inflammation, we propose that EMCN is a potential therapeutic target to manage vascular inflammation.	[Yang, Jinling; LeBlanc, Michelle E.; Cano, Issahy; Saez-Torres, Kahira L.; Saint-Geniez, Magali; Ng, Yin-Shan; D'Amore, Patricia A.] Massachusetts Eye & Ear, Schepens Eye Res Inst, Boston, MA 02115 USA; [Yang, Jinling; LeBlanc, Michelle E.; Cano, Issahy; Saez-Torres, Kahira L.; Saint-Geniez, Magali; Ng, Yin-Shan; D'Amore, Patricia A.] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA; [D'Amore, Patricia A.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Yang, Jinling] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	D'Amore, PA (corresponding author), Massachusetts Eye & Ear, Schepens Eye Res Inst, Boston, MA 02115 USA.; D'Amore, PA (corresponding author), Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA.; D'Amore, PA (corresponding author), Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA.	patricia_damore@meei.harvard.edu	Ng, Wing Yin/HHN-1743-2022	Yang, Jinling/0000-0003-2748-2161; Cano, Issahy/0000-0001-9994-149X	National Institutes of Health [P30 EY03790, R01EY26539, F32 EY028405]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants P30 EY03790 and R01EY26539 (to P. A. D.) and F32 EY028405 (to M. E. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains Figs. S1-S6.	BAZIL V, 1993, P NATL ACAD SCI USA, V90, P3792, DOI 10.1073/pnas.90.9.3792; Dreymueller D, 2012, EMBO MOL MED, V4, P412, DOI 10.1002/emmm.201200217; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; Essick E, 2008, MOL CELL BIOCHEM, V314, P151, DOI 10.1007/s11010-008-9776-7; GARDLUND B, 1995, J INFECT DIS, V172, P296, DOI 10.1093/infdis/172.1.296; Garton KJ, 2003, J BIOL CHEM, V278, P37459, DOI 10.1074/jbc.M305877200; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Gotte M, 2002, INVEST OPHTH VIS SCI, V43, P1135; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; Hikita A, 2009, BIOCHEM CELL BIOL, V87, P581, DOI [10.1139/O09-015, 10.1139/o09-015]; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Kanki Y, 2011, EMBO J, V30, P2582, DOI 10.1038/emboj.2011.173; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Koenen RR, 2009, BLOOD, V113, P4799, DOI 10.1182/blood-2008-04-152330; Kreuger J, 2016, NAT REV DRUG DISCOV, V15, P125, DOI 10.1038/nrd.2015.2; Kuhn A, 2002, J INVEST DERMATOL, V119, P1388, DOI 10.1046/j.1523-1747.2002.19647.x; Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lipowsky HH, 2011, AM J PHYSIOL-HEART C, V301, pH2235, DOI 10.1152/ajpheart.00803.2011; Masouleh BK, 2009, J IMMUNOL, V182, P4985, DOI 10.4049/jimmunol.0800574; Morgan SM, 1999, BLOOD, V93, P165, DOI 10.1182/blood.V93.1.165.401k25_165_175; Mulivor AW, 2009, MICROCIRCULATION, V16, P657, DOI 10.3109/10739680903133714; Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; Muller WA, 2002, LAB INVEST, V82, P521, DOI 10.1038/labinvest.3780446; Pruessmeyer J, 2014, BLOOD, V123, P4077, DOI 10.1182/blood-2013-09-511543; Pruessmeyer J, 2010, J BIOL CHEM, V285, P555, DOI 10.1074/jbc.M109.059394; Ramnath R, 2014, FASEB J, V28, P4686, DOI 10.1096/fj.14-252221; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Reiland J, 1996, BIOCHEM J, V319, P39, DOI 10.1042/bj3190039; RIEU P, 1992, EUR J IMMUNOL, V22, P3021, DOI 10.1002/eji.1830221138; Scholz F, 2007, J INVEST DERMATOL, V127, P1444, DOI 10.1038/sj.jid.5700751; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Silveira RC, 2003, J PEDIATR-US, V143, P625, DOI 10.1067/S0022-3476(03)00531-6; Tsakadze NL, 2006, J BIOL CHEM, V281, P3157, DOI 10.1074/jbc.M510797200; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Wachtel M, 1999, J CELL SCI, V112, P4347; Zahr A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10363; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	43	7	7	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6641	6651		10.1074/jbc.RA119.011192	http://dx.doi.org/10.1074/jbc.RA119.011192			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32193206	Green Published, hybrid			2022-12-26	WOS:000537685000030
J	Przygrodzka, E; Sokolowska, G; Myszczynski, K; Krawczynski, K; Kaczmarek, MM				Przygrodzka, Emilia; Sokolowska, Gabriela; Myszczynski, Kamil; Krawczynski, Kamil; Kaczmarek, Monika M.			Clustered microRNAs: The molecular mechanism supporting the maintenance of luteal function during early pregnancy	FASEB JOURNAL			English	Article						estradiol; luteolysis; progesterone; prostaglandins	CORPUS-LUTEUM; TRANSCRIPTIONAL ACTIVATION; ESTROUS-CYCLE; EXPRESSION; GENES; PROGESTERONE; NUR77; PROSTAGLANDIN-F2-ALPHA; RECOGNITION; INVOLVEMENT	MicroRNAs (miRNAs) are recognized as the important regulators of ovarian function. However, little is known about the hormonal regulation of miRNA expression and the role of the specific miRNA-mRNA interactions in corpus luteum. Therefore, the present study was undertaken to determine: (a) the expression of miRNAs in the corpus luteum in early pregnancy vs regression; (b) the effect of conceptus and uterine signals in the expression of selected miRNAs; and (c) the role of specific miRNA-mRNA interactions in the molecular changes and secretory function of the corpus luteum in the pig. The results showed that the majority of miRNAs differentially expressed in the corpus luteum in early pregnancy vs regression belong to independent clusters (eg, miR-99b, miR-532), which are highly conserved among different animal species. The main conceptus signal in the pig (17 beta-estradiol) elevated the luteal expression of the miR-99b cluster and lowered the expression of NR4A1 and AKR1C1, the genes involved in corpus luteum regression. Furthermore, the delivery of miR-99b cluster mimics to luteal tissue concomitantly decreased NR4A1 and AKR1C1 expression and enhanced progesterone secretion. The present study demonstrated that conceptus signals can support the maintenance of luteal function during pregnancy by clustered miRNA-stimulated pathways, governing the expression of genes involved in luteal regression.	[Przygrodzka, Emilia; Sokolowska, Gabriela; Krawczynski, Kamil; Kaczmarek, Monika M.] Polish Acad Sci, Dept Hormonal Act Mech, Inst Anim Reprod & Food Res, Olsztyn, Poland; [Myszczynski, Kamil; Kaczmarek, Monika M.] Polish Acad Sci, Mol Biol Lab, Inst Anim Reprod & Food Res, Olsztyn, Poland; [Przygrodzka, Emilia] Univ Nebraska Med Ctr, Olson Ctr Womens Hlth, Dept Obstet & Gynecol, Omaha, NE USA; [Sokolowska, Gabriela] Med Univ Bialystok, Clin Res Ctr, Bialystok, Poland; [Krawczynski, Kamil] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurochem, Warsaw, Poland	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; University of Nebraska System; University of Nebraska Medical Center; Medical University of Bialystok; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Przygrodzka, E; Kaczmarek, MM (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Tuwima 10 Str, PL-10748 Olsztyn, Poland.	e.bolzan@pan.olsztyn.pl; m.kaczmarek@pan.olsztyn.pl	KACZMAREK, Monika Marzena/AAS-2271-2020; PRZYGRODZKA, Emilia/H-7239-2017	KACZMAREK, Monika Marzena/0000-0002-8213-4381; PRZYGRODZKA, Emilia/0000-0003-4018-9023; Krawczynski, Kamil/0000-0001-5336-7525; Myszczynski, Kamil/0000-0002-3118-0900	Institute of Animal Reproduction and Food Research; Polish Academy of Science [GW10/2015]	Institute of Animal Reproduction and Food Research; Polish Academy of Science	The authors are grateful to K. Gromadzka-Hliwa, M. Romaniewicz, and P. Golder from the Institute of Animal Reproduction and Food Research, Polish Academy of Science for their excellent technical assistance in the laboratory. This research was supported by the statutory funds of the Institute of Animal Reproduction and Food Research, Polish Academy of Science (grant number-GW10/2015) and grant funded by KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal-Safe Food" (decision of Ministry of Science and Higher Education No. 05-1/KNOW2/2015; grant number-KNOW/2016/IRZiBZ/ESR3/01/4).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Atli MO, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094870; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bazer F. W., 1982, Control of pig reproduction, P227; BAZER FW, 1977, PROSTAGLANDINS, V14, P397, DOI 10.1016/0090-6980(77)90185-X; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Davis JS, 2002, FRONT BIOSCI-LANDMRK, V7, pD1949, DOI 10.2741/davis1; Duren RP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150450; Farberov S, 2018, BIOL REPROD, V98, P366, DOI 10.1093/biolre/iox167; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; FORD SP, 1982, J ANIM SCI, V55, P657, DOI 10.2527/jas1982.553657x; Geisert R D, 1990, J Reprod Fertil Suppl, V40, P293; Godoi PHC, 2016, J BIOL CHEM, V291, P14072, DOI 10.1074/jbc.M116.715235; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; GUTHRIE HD, 1972, ENDOCRINOLOGY, V91, P675, DOI 10.1210/endo-91-3-675; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hong XM, 2008, ENDOCRINOLOGY, V149, P6207, DOI 10.1210/en.2008-0294; Hughes CK, 2019, BIOL REPROD, V100, P1581, DOI 10.1093/biolre/ioz037; Kim D, 2016, NAT GENET, V48, P1517, DOI 10.1038/ng.3694; Krawczynski K, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123588; Krzymowski T, 2004, VET J, V168, P285, DOI 10.1016/j.tvjl.2003.10.010; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lai X., 2013, ENCY SYSTEMBIOL, P77; Lee SY, 2012, MOL CELL ENDOCRINOL, V362, P91, DOI 10.1016/j.mce.2012.05.015; Ma TH, 2011, J APPL GENET, V52, P481, DOI 10.1007/s13353-011-0055-z; Maalouf SW, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135053; Maalouf SW, 2014, MOL CELL ENDOCRINOL, V398, P78, DOI 10.1016/j.mce.2014.10.005; McBride D, 2012, REPRODUCTION, V144, P221, DOI 10.1530/REP-12-0025; Mohammed BT, 2017, J CLIN ENDOCR METAB, V102, P2188, DOI 10.1210/jc.2017-00259; Oliveros J.C., 2007, INTERACTIVE TOOL COM; Otsuka M, 2008, J CLIN INVEST, V118, P1944, DOI 10.1172/JCI33680; Palomba S, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0205-8; Przygrodzka E, 2016, REPRODUCTION, V151, P135, DOI 10.1530/REP-15-0332; Przygrodzka E, 2015, THERIOGENOLOGY, V83, P535, DOI 10.1016/j.theriogenology.2014.10.016; Przygrodzka E., 2017, LIFE CYCLE CORPUS LU, P227, DOI [10.1007/978-3-319-43238-0, DOI 10.1007/978-3-319-43238-0, DOI 10.1007/978-3-319-43238-0_12]; Przygrodzka E, 2014, REPROD BIOL, V14, P243, DOI 10.1016/j.repbio.2014.04.001; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Spencer TE, 2002, FRONT BIOSCI-LANDMRK, V7, pD1879, DOI 10.2741/spencer; Stefanczyk-Krzymowska S, 2006, PROSTAG OTH LIPID M, V81, P71, DOI 10.1016/j.prostaglandins.2006.07.004; Stocco CO, 2002, J BIOL CHEM, V277, P3293, DOI 10.1074/jbc.M110936200; Stocco CO, 2000, J BIOL CHEM, V275, P37202, DOI 10.1074/jbc.M006016200; Talbott H, 2017, MOL CELL ENDOCRINOL, V452, P93, DOI 10.1016/j.mce.2017.05.018; Waclawik A, 2007, J ENDOCRINOL, V194, P499, DOI 10.1677/JOE-07-0155; WILSON TE, 1993, MOL CELL BIOL, V13, P861, DOI 10.1128/MCB.13.2.861; Wiltbank Milo C, 2003, Reprod Biol Endocrinol, V1, P91, DOI 10.1186/1477-7827-1-91; YOON JK, 1994, MOL CELL BIOL, V14, P7731, DOI 10.1128/MCB.14.12.7731; Zhang PL, 1997, MOL ENDOCRINOL, V11, P891, DOI 10.1210/me.11.7.891; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	53	3	4	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6582	6597		10.1096/fj.201903007RR	http://dx.doi.org/10.1096/fj.201903007RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32202349				2022-12-26	WOS:000531325500041
J	Rudich, P; Watkins, S; Lamitina, T				Rudich, Paige; Watkins, Simon; Lamitina, Todd			PolyQ-independent toxicity associated with novel translational products from CAG repeat expansions	PLOS ONE			English	Article							MEMBRANE-PROTEINS; RNA INTERFERENCE; STOP-TRANSFER; POLYGLUTAMINE; FLUORESCENT; POLYLEUCINE; NEURONS; REGENERATION; PATHOGENESIS; AGGREGATION	Expanded CAG nucleotide repeats are the underlying genetic cause of at least 14 incurable diseases, including Huntington's disease (HD). The toxicity associated with many CAG repeat expansions is thought to be due to the translation of the CAG repeat to create a polyQ protein, which forms toxic oligomers and aggregates. However, recent studies show that HD CAG repeats undergo a non-canonical form of translation called Repeat-associated non-AUG dependent (RAN) translation. RAN translation of the CAG sense and CUG antisense RNAs produces six distinct repeat peptides: polyalanine (polyAla, from both CAG and CUG repeats), polyserine (polySer), polyleucine (polyLeu), polycysteine (polyCys), and polyglutamine (polyGln). The toxic potential of individual CAG-derived RAN polypeptides is not well understood. We developed pure C. elegans protein models for each CAG RAN polypeptide using codon-varied expression constructs that preserve RAN protein sequence but eliminate repetitive CAG/CUG RNA. While all RAN polypeptides formed aggregates, only polyLeu was consistently toxic across multiple cell types. In GABAergic neurons, which exhibit significant neurodegeneration in HD patients, codon-varied (Leu)38, but not (Gln)38, caused substantial neurodegeneration and motility defects. Our studies provide the first in vivo evaluation of CAG-derived RAN polypeptides in a multicellular model organism and suggest that polyQ-independent mechanisms, such as RAN-translated polyLeu peptides, may have a significant pathological role in CAG repeat expansion disorders.	[Rudich, Paige; Lamitina, Todd] Univ Pittsburgh, Med Ctr, Grad Program Cell Biol & Mol Physiol, Pittsburgh, PA 15260 USA; [Rudich, Paige; Watkins, Simon; Lamitina, Todd] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA; [Watkins, Simon] Univ Pittsburgh, Ctr Biol Imaging, Sch Med, Pittsburgh, PA USA; [Lamitina, Todd] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Div Child Neurol,Med Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lamitina, T (corresponding author), Univ Pittsburgh, Med Ctr, Grad Program Cell Biol & Mol Physiol, Pittsburgh, PA 15260 USA.; Lamitina, T (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.; Lamitina, T (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Div Child Neurol,Med Ctr, Pittsburgh, PA 15213 USA.	stl52@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552; Lamitina, Todd/0000-0001-7332-9075	Children's Hospital of Pittsburgh Research Advisory Council - NIH Office of Research Infrastructure Programs [NIH NS 1R21NS107797];  [P40 OD010440]	Children's Hospital of Pittsburgh Research Advisory Council - NIH Office of Research Infrastructure Programs; 	This work was funded by a grant to T.L. (NIH NS 1R21NS107797) and a Children's Hospital of Pittsburgh Research Advisory Council grant (P. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	Albrecht AN, 2004, HUM MOL GENET, V13, P2351, DOI 10.1093/hmg/ddh277; Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; Aronson DE, 2011, TRAFFIC, V12, P543, DOI 10.1111/j.1600-0854.2011.01168.x; Ashkenazi A, 2017, NATURE, V545, P108, DOI 10.1038/nature22078; Ayhan F, 2018, EMBO J, V37, DOI 10.15252/embj.201899023; Banez-Coronel M, 2019, LAB INVEST, V99, P929, DOI 10.1038/s41374-019-0241-x; Banez-Coronel M, 2015, NEURON, V88, P667, DOI 10.1016/j.neuron.2015.10.038; Berendzen KM, 2016, CELL, V166, P1553, DOI 10.1016/j.cell.2016.08.042; Brignull HR, 2006, METHOD ENZYMOL, V412, P256, DOI 10.1016/S0076-6879(06)12016-9; Cascarina SM, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006256; CHEN HF, 1995, J BIOL CHEM, V270, P14115, DOI 10.1074/jbc.270.23.14115; Cheng WW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02495-z; Diez-Ardanuy C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00036-8; Dorsman JC, 2002, HUM MOL GENET, V11, P1487, DOI 10.1093/hmg/11.13.1487; Earls LR, 2010, P NATL ACAD SCI USA, V107, P14460, DOI 10.1073/pnas.0910630107; Faber PW, 1999, P NATL ACAD SCI USA, V96, P179, DOI 10.1073/pnas.96.1.179; Faber PW, 2002, P NATL ACAD SCI USA, V99, P17131, DOI 10.1073/pnas.262544899; FENG JX, 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0023525; Garcia SM, 2007, GENE DEV, V21, P3006, DOI 10.1101/gad.1575307; Gonzalez-Hunt CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114459; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Green KM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02200-0; Gurezka R, 1999, J BIOL CHEM, V274, P9265, DOI 10.1074/jbc.274.14.9265; Hsu RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016417; Jain RK, 2001, BIOCHEM J, V360, P645, DOI 10.1042/0264-6021:3600645; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; Kumar AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166854; KUROIWA T, 1991, J BIOL CHEM, V266, P9251; Lee AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173644; Lee JM, 2019, CELL, V178, P887, DOI 10.1016/j.cell.2019.06.036; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Nemes JP, 2000, HUM MOL GENET, V9, P1543, DOI 10.1093/hmg/9.10.1543; Nix P, 2014, J NEUROSCI, V34, P629, DOI 10.1523/JNEUROSCI.3859-13.2014; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Oma Y, 2005, BBA-PROTEINS PROTEOM, V1748, P174, DOI 10.1016/j.bbapap.2004.12.017; Oma Y, 2007, PROTEIN SCI, V16, P2195, DOI 10.1110/ps.072955307; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Parslow AC, 2014, JOVE-J VIS EXP, DOI 10.3791/51086; Paulson Henry, 2018, Handb Clin Neurol, V147, P105, DOI 10.1016/B978-0-444-63233-3.00009-9; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pelassa I, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00345; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; Rudich P, 2017, HUM MOL GENET, V26, P4916, DOI 10.1093/hmg/ddx372; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schuske K, 2004, TRENDS NEUROSCI, V27, P407, DOI 10.1016/j.tins.2004.05.005; Scior A, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-87; Segev Y, 2013, NEUROBIOL AGING, V34, P863, DOI 10.1016/j.neurobiolaging.2012.06.020; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Tabet R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02643-5; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Vaccaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031321; van Eyk CL, 2012, HUM MOL GENET, V21, P536, DOI 10.1093/hmg/ddr487; Wang Z, 2018, 2018 1ST WORKSHOP ON WIDE BANDGAP POWER DEVICES AND APPLICATIONS IN ASIA (WIPDA ASIA), P12, DOI 10.1109/WiPDAAsia.2018.8734582; Westergard T, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809423; Whitley P, 1996, J BIOL CHEM, V271, P7583, DOI 10.1074/jbc.271.13.7583; Wright GEB, 2019, AM J HUM GENET, V104, P1116, DOI 10.1016/j.ajhg.2019.04.007; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	65	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0227464	10.1371/journal.pone.0227464	http://dx.doi.org/10.1371/journal.pone.0227464			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240172	Green Submitted, Green Published, gold			2022-12-26	WOS:000535945000012
J	Samiea, A; Yoon, JSJ; Cheung, ST; Chamberlain, TC; Mui, ALF				Samiea, Abrar; Yoon, Jeff S. J.; Cheung, Sylvia T.; Chamberlain, Thomas C.; Mui, Alice L-F			Interleukin-10 contributes to PGE(2) signalling through upregulation of EP4 via SHIP1 and STAT3	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MACROPHAGE; IL-10; EXPRESSION; PROTEIN; CELLS; MICE; ACTIVATION; RECEPTORS; INDUCTION	Macrophage cells form part of our first line defense against pathogens. Macrophages become activated by microbial products such as lipopolysaccharide (LPS) to produce inflammatory mediators, such as TNF alpha and other cytokines, which orchestrate the host defense against the pathogen. Once the pathogen has been eradicated, the activated macrophage must be appropriately deactivated or inflammatory diseases result. Interleukin-10 (IL10) is a key anti-inflammatory cytokine which deactivates the activated macrophage. The IL10 receptor (IL10R) signals through the Jak1/Tyk2 tyrosine kinases, STAT3 transcription factor and the SHIP1 inositol phosphatase. However, IL10 has also been described to induce the activation of the cyclic adenosine monophosphate (cAMP) regulated protein kinase A (PKA). We now report that IL10R signalling leads to STAT3/SHIP1 dependent expression of the EP4 receptor for prostaglandin E-2 (PGE(2)). In macrophages, EP4 is a G(alpha s)-protein coupled receptor that stimulates adenylate cyclase (AC) production of cAMP, leading to downstream activation of protein kinase A (PKA) and phosphorylation of the CREB transcription factor. IL10 induction of phospho-CREB and inhibition of LPS-induced phosphorylation of p85 PI3K and p70 S6 kinase required the presence of EP4. These data suggest that IL10R activation of STAT3/SHIP1 enhances EP4 expression, and that it is EP4 which activates cAMP-dependent signalling. The coordination between IL10R and EP4 signalling also provides an explanation for why cAMP elevating agents synergize with IL10 to elicit anti-inflammatory responses.	[Samiea, Abrar; Yoon, Jeff S. J.; Cheung, Sylvia T.; Chamberlain, Thomas C.; Mui, Alice L-F] Vancouver Coastal Hlth Res Inst, Immun & Infect Res Ctr, Vancouver, BC, Canada; [Samiea, Abrar; Yoon, Jeff S. J.; Cheung, Sylvia T.; Chamberlain, Thomas C.; Mui, Alice L-F] Univ British Columbia, Dept Surg, Vancouver, BC, Canada; [Yoon, Jeff S. J.; Cheung, Sylvia T.; Chamberlain, Thomas C.; Mui, Alice L-F] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada	Vancouver Coastal Health Research Institute; University of British Columbia; University of British Columbia	Mui, ALF (corresponding author), Vancouver Coastal Hlth Res Inst, Immun & Infect Res Ctr, Vancouver, BC, Canada.; Mui, ALF (corresponding author), Univ British Columbia, Dept Surg, Vancouver, BC, Canada.; Mui, ALF (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada.	alice.mui@ubc.ca		Chamberlain, Thomas/0000-0002-3030-6065	Canadian Institutes of Health Research [MOP-133415]; Natural Science and Engineering Research Council [RGPIN-2014-05662]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	These studies were supported by operating grants from the Canadian Institutes of Health Research (MOP-133415) and the Natural Science and Engineering Research Council (RGPIN-2014-05662). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrios-Rodiles M, 1999, J IMMUNOL, V163, P963; Birrell MA, 2015, THORAX, V70, P740, DOI 10.1136/thoraxjnl-2014-206592; Bryn T, 2008, INT IMMUNOL, V20, P235, DOI 10.1093/intimm/dxm134; Cao J, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw660; Chan CS, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.348599; Cheung ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071336; Corraliza IM, 1997, BBA-GEN SUBJECTS, V1334, P123, DOI 10.1016/S0304-4165(96)00081-5; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Engelhardt KR, 2014, CURR TOP MICROBIOL, V380, P1, DOI 10.1007/978-3-662-43492-5_1; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; Fujino H, 2005, MOL PHARMACOL, V68, P251, DOI 10.1124/mol.105.011833; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Glas J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052873; Glocker EO, 2011, ANN NY ACAD SCI, V1246, P102, DOI 10.1111/j.1749-6632.2011.06339.x; Glocker EO, 2010, LANCET, V376, P1272, DOI 10.1016/S0140-6736(10)61008-2; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Iyer SS, 2010, J IMMUNOL, V185, P6599, DOI 10.4049/jimmunol.1002041; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kashmiry A, 2018, BBA-MOL CELL BIOL L, V1863, P1297, DOI 10.1016/j.bbalip.2018.07.003; Katsuyama M, 1998, BIOCHEM BIOPH RES CO, V251, P727, DOI 10.1006/bbrc.1998.9540; Kim S, 2001, J BIOL CHEM, V276, P12864, DOI 10.1074/jbc.M001492200; Kotlarz D, 2012, GASTROENTEROLOGY, V143, P347, DOI 10.1053/j.gastro.2012.04.045; Krystal G, 2000, SEMIN IMMUNOL, V12, P397, DOI 10.1006/smim.2000.0222; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Latiano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022688; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MacKenzie KF, 2013, MOL CELL BIOL, V33, P1456, DOI 10.1128/MCB.01690-12; Minami M, 2008, J BIOL CHEM, V283, P9692, DOI 10.1074/jbc.M709663200; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakase H, 2010, INFLAMM BOWEL DIS, V16, P731, DOI 10.1002/ibd.21080; Nitta M, 2002, SCAND J IMMUNOL, V56, P66, DOI 10.1046/j.1365-3083.2002.01096.x; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Ovchinnikov DA, 2008, GENESIS, V46, P447, DOI 10.1002/dvg.20417; Pauls SD, 2017, EUR J IMMUNOL, V47, P932, DOI 10.1002/eji.201646795; Pengal RA, 2006, MOL IMMUNOL, V43, P1557, DOI 10.1016/j.molimm.2005.09.022; Portelli MA, 2015, CLIN EXP ALLERGY, V45, P21, DOI 10.1111/cea.12327; Quiros M, 2017, J CLIN INVEST, V127, P3516, DOI 10.1172/JCI90229; Rauh MJ, 2004, BIOCHEM SOC T, V32, P785, DOI 10.1042/BST0320785; Rennick DM, 1997, J LEUKOCYTE BIOL, V61, P389, DOI 10.1002/jlb.61.4.389; Seldon Paul M., 1998, Cell Biochemistry and Biophysics, V29, P179, DOI 10.1007/BF02737835; Shouval DS, 2014, ADV IMMUNOL, V122, P177, DOI 10.1016/B978-0-12-800267-4.00005-5; STRASSMANN G, 1994, J EXP MED, V180, P2365, DOI 10.1084/jem.180.6.2365; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Chu VT, 2016, P NATL ACAD SCI USA, V113, P12514, DOI 10.1073/pnas.1613884113; WAAL MR, 1991, J EXP MED, V174, P1209, DOI DOI 10.1084/JEM.174.5.1209; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; WeberNordt RM, 1996, J BIOL CHEM, V271, P27954, DOI 10.1074/jbc.271.44.27954; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567; Xu K, 2001, J IMMUNOL, V166, P6358, DOI 10.4049/jimmunol.166.10.6358	59	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230427	10.1371/journal.pone.0230427	http://dx.doi.org/10.1371/journal.pone.0230427			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240179	Green Published, Green Submitted, gold			2022-12-26	WOS:000535945000025
J	Gibson, E; Stacey, N; Sunderland, TCH; Adhuri, DS				Gibson, Emily; Stacey, Natasha; Sunderland, Terry C. H.; Adhuri, Dedi S.			Dietary diversity and fish consumption of mothers and their children in fisher households in Komodo District, eastern Indonesia	PLOS ONE			English	Article							FOOD-BASED STRATEGIES; SMALL-SCALE FISHERIES; VITAMIN-A; CAPTURE FISHERIES; SECURITY; NUTRITION; AQUACULTURE; WOMEN; AVAILABILITY; BANGLADESH	Small-scale coastal fisheries contribute directly and indirectly to the food and nutrition security of marine-dependent households. Fishers can apportion part of their catch for household consumption or use the income earned to purchase staples and other desired foods. Fish are an important animal-source food rich in micronutrients essential for cognitive development of children and for adult health, and a valuable addition to rice-based diets. Furthermore, the engagement of women in fisheries value chains and increased control over income may facilitate decision-making which improves nutrition outcomes for women and their children. Despite these contributions, food insecurity remains prevalent in many low and middle income fish-producing countries. This paper reports findings from an exploration of the interplaying factors leading to food and nutrition insecurity in three marine-dependent coastal communities in eastern Indonesia, focusing on the consumption pathway, that is, the contribution of fish to the diets and nutrition of women and children. The research was undertaken as a mixed-methods case study. The study found that over 50% of mother-child pairs failed to meet the minimum recommended dietary diversity, and, while fish was the main animal-source food in diets, the introduction of fish to infant and young child diets was delayed due to fears of allergies and illnesses. Moreover, access to nutrient-dense foods was affected by variable and insufficient income from fisheries-based livelihoods, isolation from markets, and the broader food environment. Given the shift towards 'nutrition-sensitive interventions' to improve the livelihoods and well-being of fisher households, these results highlight the need for analysis of the intra-household sharing of fish within fisher households, culturally-appropriate strategies to improve the quality of family and especially complementary foods, and efforts to increase physical access to nutrient-dense foods.	[Gibson, Emily; Stacey, Natasha] Charles Darwin Univ, Res Inst Environm & Livelihoods, Casuarina, NT, Australia; [Sunderland, Terry C. H.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC, Canada; [Adhuri, Dedi S.] Indonesian Inst Sci, Res Ctr Soc & Culture, Jakarta, Indonesia; [Gibson, Emily] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT, Australia	Charles Darwin University; University of British Columbia; Indonesian Institute of Sciences; Charles Darwin University	Gibson, E (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Casuarina, NT, Australia.; Gibson, E (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT, Australia.	emily.gibson@cdu.edu.au	Sunderland, Terence/AAS-5080-2021	Stacey, Natasha/0000-0002-2262-9817; Sunderland, Terence/0000-0002-1985-9849; Adhuri, Dedi/0000-0002-6784-1774; , Emily/0000-0002-7249-9010	Australian Government Research Training Scholarship; Charles Darwin University's College of Engineering, Information Technology and Environment; Australian Center for International Agricultural Research Small Research Grant [FIS/2014/104]	Australian Government Research Training Scholarship(Australian Government); Charles Darwin University's College of Engineering, Information Technology and Environment; Australian Center for International Agricultural Research Small Research Grant	EG is in receipt of an Australian Government Research Training Scholarship and also received funding from Charles Darwin University's College of Engineering, Information Technology and Environment (www.cdu.edu.au) and an Australian Center for International Agricultural Research Small Research Grant FIS/2014/104 (www.aciar.gov.au).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva S, 2016, POPUL ENVIRON, V37, P341, DOI 10.1007/s11111-015-0240-9; [Anonymous], 2017, ESTIMATION POTENTIAL; [Anonymous], 2003, 131 IFPRI; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Bandoh DA, 2017, BMC NUTR, V3, P1; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bene C, 2016, WORLD DEV, V79, P177, DOI 10.1016/j.worlddev.2015.11.007; Bene C, 2015, FOOD SECUR, V7, P261, DOI 10.1007/s12571-015-0427-z; Bhagowalia P, 2012, 01192 POV HLTH NUTR; Bogard JR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175098; Bogard JR, 2015, FOOD NUTR BULL, V36, P276, DOI 10.1177/0379572115598885; Bogard JR, 2015, J FOOD COMPOS ANAL, V42, P120, DOI 10.1016/j.jfca.2015.03.002; Burchi F, 2016, FOOD POLICY, V60, P10, DOI 10.1016/j.foodpol.2015.03.008; Burke L, 2012, REEFS RISK REVISITED; Campbell AA, 2009, NUTR RES, V29, P75, DOI 10.1016/j.nutres.2008.12.004; CHAPMAN MD, 1987, HUM ECOL, V15, P267, DOI 10.1007/BF00888026; Charlton KE, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2953-9; Cinner JE, 2010, MAR POLICY, V34, P22, DOI 10.1016/j.marpol.2009.04.003; Cisneros-Montemayor AM, 2016, PLOS ONE, V11, P16; Cross CL, 2013, BIOSTATISICS FDN ANA, V10; Darling ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113614; Dewey KG, 2007, FOOD NUTR BULL, V28, pS595, DOI 10.1177/15648265070284S412; Dewey KG, 2013, J NUTR, V143, P2050, DOI 10.3945/jn.113.182527; Dey MM, 2007, AQUACULT ECON MANAG, V9, P98; Fabinyi M, 2017, HUM ECOL, V45, P177, DOI 10.1007/s10745-016-9874-1; Fanzo J, 2018, GLOBAL NUTR REPORT S; FAO, 2016, CONTRIBUTING FOOD SE; FAO and FHI 360, 2016, MIN DIET DIV WOM GUI; FAO IFAD UNICEF WFP WHO, 2018, STAT FOOD SEC NUTR W; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Foale S, 2013, MAR POLICY, V38, P174, DOI 10.1016/j.marpol.2012.05.033; Food and Agriculture Organization of the United Nations (FAO), 2018, STAT WORLF FISH AQ 2; Ghattas H., 2014, FOOD SECURITY NUTR C; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Halim A, 2019, MAR POLICY, V100, P238, DOI 10.1016/j.marpol.2018.11.044; Harper S, 2013, MAR POLICY, V39, P56, DOI 10.1016/j.marpol.2012.10.018; Herforth A, 2015, FOOD SECUR, V7, P505, DOI 10.1007/s12571-015-0455-8; HLPE, 2020, FOOD SEC NUTR BUILD; HLPE, 2017, NUTR FOOD SYST; Hotz C, 2005, EUR J CLIN NUTR, V59, P226, DOI 10.1038/sj.ejcn.1602063; Kawarazuka N, 2010, FOOD SECUR, V2, P343, DOI 10.1007/s12571-010-0079-y; Kementerian Kelautan dan Perikanan, 2018, PROD PER; Kleiber D, 2014, CAN J FISH AQUAT SCI, V71, P656, DOI 10.1139/cjfas-2013-0177; Komatsu H, 2018, FOOD POLICY, V79, P256, DOI 10.1016/j.foodpol.2018.07.002; Komodo National Park Authority, 2000, 25 YEAR MAST PLAN MA; Konyole S. O., 2012, Journal of Food Research, V1, P111; Malapit HJL, 2015, FOOD POLICY, V52, P54, DOI 10.1016/j.foodpol.2015.02.003; Martin-Pr?vel Y., 2015, MOVING FORWARD CHOOS; Michaelsen KF, 2009, FOOD NUTR BULL, V30, pS343, DOI 10.1177/15648265090303S303; Miller DD, 2013, FOOD POLICY, V42, P115, DOI 10.1016/j.foodpol.2013.06.008; Mills DJ, 2011, SMALL-SCALE FISHERIES MANAGEMENT: FRAMEWORKS AND APPROACHES FOR THE DEVELOPING WORLD, P1, DOI 10.1079/9781845936075.0001; National Secretariat of CTI-CFF Indonesia, 2009, FISH FOOD SEC; Needham S, 2014, CONTRACT RAP PUBLICA; Pachon H, 2007, FOOD NUTR BULL, V28, P215, DOI 10.1177/156482650702800211; Pemerintah Provinsi Nusa Tenggara Timur Dewan Ketahanan Pangan Kementerian Pertanian World Food Programme, 2015, PET KET KER PANG NUS; Pollnac RB, 2000, 2226 COAST RES CTR C; Quisumbing A. R., 1995, Women: the key to food security.; Roos N, 2002, INT J FOOD SCI NUTR, V53, P425, DOI 10.1080/0963748021000044778; Roos N, 2007, J NUTR, V137, P1106, DOI 10.1093/jn/137.4.1106; SEAMEO RECFON, 2016, EV 2012 2015 MAT CHI; Steenbergen DJ, 2017, MAR POLICY, V82, P181, DOI 10.1016/j.marpol.2017.04.012; Stephenson J, 2018, LANCET, V391, P1830, DOI [10.1016/S0140-6736(18)30311-8, 10.1016/s0140-6736(18)30311-8]; Thilsted S. H., 2012, Sustainable Diets and Biodiversity: Directions and Solutions for Policy, Research and Action. International Scientific Symposium, Biodiversity and Sustainable Diets United Against Hunger, FAO Headquarters, Rome, Italy, 3-5 November 2010, P176; Thilsted SH, 2016, FOOD POLICY, V61, P126, DOI 10.1016/j.foodpol.2016.02.005; Thorne-Lyman AL, 2017, FOOD NUTR BULL, V38, P354, DOI 10.1177/0379572117709417; Torheim LE, 2010, J NUTR, V140, p2051S, DOI 10.3945/jn.110.123463; UNICEF, 1990, UNICEF POL REV; United Nations, 1986, WEIGH MEAS CHILDR AS; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WFP SEAMEO TROPMED, 2010, NUTR SEC FOOD SEC 7; WHO, 2010, MEASUR 2; WHO, 2006, WHO CHILD GROWTH STA; Word Health Organization, 2018, INF YOUNG CHILD FEED	73	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230777	10.1371/journal.pone.0230777	http://dx.doi.org/10.1371/journal.pone.0230777			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8IA	32236144	gold, Green Submitted, Green Published			2022-12-26	WOS:000535938700029
J	Margiotta, E; Miragoli, F; Callegari, ML; Vettoretti, S; Caldiroli, L; Meneghini, M; Zanoni, F; Messa, P				Margiotta, Elisabetta; Miragoli, Francesco; Callegari, Maria Luisa; Vettoretti, Simone; Caldiroli, Lara; Meneghini, Maria; Zanoni, Francesca; Messa, Piergiorgio			Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease	PLOS ONE			English	Article							UREMIC TOXINS; INFLAMMATION; HEALTH; MORTALITY; BACTERIA; ADULTS	Background Frailty is common in older patients affected by chronic kidney disease (CKD). Since gut microbiota (gMB) may contribute to frailty, we explored possible associations between gMB and frailty in CKD. Methods We studied 64 CKD patients (stage 3b-4), categorized as frail (F, 38) and not frail (NF, 26) according to Fried criteria, and 15 controls (C), all older than 65 years. In CKD we assessed serum C-reactive protein, blood neutrophil/lymphocyte ratio, Malnutrition-inflammation Score (MIS); gMB was studied by denaturing gel gradient electrophoresis (DGGE), highthroughput sequencing (16S r-RNA gene), and quantitative real-time PCR (RT-PCR). Results No differences in alpha diversity between CKD and C and between F and NF patients emerged, but high-throughput sequencing showed significantly higher abundance of potentially noxious bacteria (Citrobacter, Coprobacillus, etc) and lower abundance of saccharolytic and butyrate-producing bacteria (Prevotella spp., Faecalibacterium prausnitzii, Roseburia spp.), in CKD respect to C. Mogibacteriaceae family and Oscillospira genus abundance was positively related to inflammatory indices in the whole CKD cohort, while that of Akkermansia, Ruminococcus and Eubacterium genera was negatively related. Compared with NF, in F there was a higher abundance of some bacteria (Mogibacteriacee, Coriobacteriacee, Eggerthella, etc), many of which have been described as more abundant in other diseases. Conclusions These results suggest that inflammation and frailty could be associated to gMB modifications in CKD.	[Margiotta, Elisabetta; Vettoretti, Simone; Caldiroli, Lara; Meneghini, Maria; Zanoni, Francesca; Messa, Piergiorgio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Nephrol Dialysis & Renal Transplantat, Milan, Italy; [Miragoli, Francesco; Callegari, Maria Luisa] Univ Cattolica Sacro Cuore, Ctr Ric Biotecnol, Cremona, Italy; [Messa, Piergiorgio] Univ Milan, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; Catholic University of the Sacred Heart; University of Milan	Vettoretti, S (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Nephrol Dialysis & Renal Transplantat, Milan, Italy.	simone.vettoretti@policlinico.mi.it	Zanoni, Francesca/AAH-1738-2019; Luisa, Callegari Maria/AAB-3153-2021	Luisa, Callegari Maria/0000-0002-7811-5305; Meneghini, Maria/0000-0001-7307-923X; zanoni, francesca/0000-0001-9567-6713; vettoretti, simone/0000-0002-1040-4952; MIRAGOLI, Francesco/0000-0003-4174-9571	clinical research funds of Unit of Nephrology, Dialysis and Kidney Transplantation, Fondazione Ca' Granda IRCCS Ospedale Maggiore - Policlinico Milano, Italy	clinical research funds of Unit of Nephrology, Dialysis and Kidney Transplantation, Fondazione Ca' Granda IRCCS Ospedale Maggiore - Policlinico Milano, Italy	This research was supported by the clinical research funds of Unit of Nephrology, Dialysis and Kidney Transplantation, Fondazione Ca' Granda IRCCS Ospedale Maggiore - Policlinico Milano, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros AF, 2015, FUTURE MICROBIOL, V10, P517, DOI [10.2217/FMB.14.140, 10.2217/fmb.14.140]; Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Cho GS, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00658; Chowdhury R, 2017, ARCH GERONTOL GERIAT, V68, P135, DOI 10.1016/j.archger.2016.10.007; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Deng B, 2012, J I BREWING, V118, P120, DOI 10.1002/jib.2; Evenepoel P, 2009, KIDNEY INT, V76, pS12, DOI 10.1038/ki.2009.402; Farrington K, 2016, NEPHROL DIAL TRANSPL, V31, P1, DOI 10.1093/ndt/gfw356; Franceschi C., 2014, J GERONTOL A BIOL S1, V69, P4, DOI [DOI 10.1093/GER0NA/GLU057, 10.1093/gerona/glu057, DOI 10.1093/GERONA/GLU057]; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fukuuchi F., 2002, CLIN EXP NEPHROL, V6, P99, DOI [10.1007/s101570200016, DOI 10.1007/S101570200016]; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gryp T, 2017, TOXINS, V9, DOI 10.3390/toxins9020052; Hida M, 1996, NEPHRON, V74, P349, DOI 10.1159/000189334; Jackson M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0262-7; Jeffery IB, 2016, ISME J, V10, P170, DOI 10.1038/ismej.2015.88; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1251, DOI 10.1053/ajkd.2001.29222; Kim JC, 2013, J AM SOC NEPHROL, V24, P337, DOI 10.1681/ASN.2012010047; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lau WL, 2015, NEPHRON, V130, P92, DOI 10.1159/000381990; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; Lin CJ, 2012, ARCH MED RES, V43, P451, DOI 10.1016/j.arcmed.2012.08.002; Liu XF, 2013, CURR MICROBIOL, V67, P170, DOI 10.1007/s00284-013-0338-1; Maffei VJ, 2017, J GERONTOL A-BIOL, V72, P1474, DOI 10.1093/gerona/glx042; Miragoli F, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fiw230; Nagpal R, 2016, BENEF MICROBES, V7, P181, DOI [10.3920/bm2015.0062, 10.3920/BM2015.0062]; Nakabayashi I, 2011, NEPHROL DIAL TRANSPL, V26, P1094, DOI 10.1093/ndt/gfq624; Patel, 2011, J BIOTECHNOL BIOSCI, V1; Roager HM, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.93, 10.1038/NMICROBIOL.2016.93]; Rossi M, 2015, J RENAL NUTR, V25, P399, DOI 10.1053/j.jrn.2015.01.017; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Ticinesi A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121303; Ticinesi A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10734-y; van Tongeren SP, 2005, APPL ENVIRON MICROB, V71, P6438, DOI 10.1128/AEM.71.10.6438-6442.2005; Vaziri ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114881; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Wang FQ, 2012, NEPHROLOGY, V17, P733, DOI 10.1111/j.1440-1797.2012.01647.x; Wang I-K, 2011, REAL TIME PCR ANAL I, DOI [10.1128/AEM.05605-11, DOI 10.1128/AEM.05605-11]; Zhang YJ, 2015, INT J MOL SCI, V16, P7493, DOI 10.3390/ijms16047493; Zinkernagel MS, 2017, SCI REP-UK, V7, DOI 10.1038/srep40826; Zybailov BL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0199274	45	18	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0228530	10.1371/journal.pone.0228530	http://dx.doi.org/10.1371/journal.pone.0228530			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236095	Green Published, gold			2022-12-26	WOS:000535938700004
J	Lee, YN; Reyes-Alcaraz, A; Yun, S; Lee, CS; Hwang, JI; Seong, JY				Lee, Yoo-Na; Reyes-Alcaraz, Arfaxad; Yun, Seongsik; Lee, Cheol Soon; Hwang, Jong-Ik; Seong, Jae Young			Exploring the molecular structures that confer ligand selectivity for galanin type II and III receptors	PLOS ONE			English	Article							EVOLUTIONARILY CONSERVED RESIDUES; CRYSTAL-STRUCTURE; BIASED AGONISM; NEUROPEPTIDE; BINDING; SPEXIN; CONFORMATION; RELEASE; ACIDS; SITE	Galanin receptors (GALRs) belong to the superfamily of G-protein coupled receptors. The three GALR subtypes (GALR1, GALR2, and GALR3) are activated by their endogenous ligands: spexin (SPX) and galanin (GAL). The synthetic SPX-based GALR2-specific agonist, SG2A, plays a dual role in the regulation of appetite and depression-like behaviors. Little is known, however, about the molecular interaction between GALR2 and SG2A. Using site-directed mutagenesis and domain swapping between GALR2 and GALR3, we identified residues in GALR2 that promote interaction with SG2A and residues in GALR3 that inhibit interaction with SG2A. In particular, Phe(103), Phe(106), and His(110) in the transmembrane helix 3 (TM3) domain; Val(193), Phe(194), and Ser(195) in the TM5 domain; and Leu(273) in the extracellular loop 3 (ECL3) domain of GALR2 provide favorable interactions with the Asn(5), Ala(7), Phe(11), and Pro(13) residues of SG2A. Our results explain how SG2A achieves selective interaction with GALR2 and inhibits interaction with GALR3. The results described here can be used broadly for in silico virtual screening of small molecules for the development of GALR subtype-specific agonists and/or antagonists.	[Lee, Yoo-Na; Reyes-Alcaraz, Arfaxad; Yun, Seongsik; Hwang, Jong-Ik; Seong, Jae Young] Korea Univ, Grad Sch Biomed Sci, GPCR Lab, Coll Med, Seoul, South Korea; [Reyes-Alcaraz, Arfaxad] Univ Houston, Coll Pharm, Houston, TX 77030 USA; [Lee, Cheol Soon] Korea Univ, Grad Sch Biomed Sci, Coll Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); University of Houston System; University of Houston; Korea University; Korea University Medicine (KU Medicine)	Seong, JY (corresponding author), Korea Univ, Grad Sch Biomed Sci, GPCR Lab, Coll Med, Seoul, South Korea.	jyseong@korea.ac.kr		Hwang, Jong-Ik/0000-0002-0729-1782	National Research Foundation - Ministry of Science, ICT and Future Planning, Korea [NRF-2015M3A9E7029172]	National Research Foundation - Ministry of Science, ICT and Future Planning, Korea	This work was supported by the Research Program (NRF-2015M3A9E7029172) of the National Research Foundation (https://ernd.nrf.re.kr/index.do) funded by the Ministry of Science, ICT and Future Planning, Korea. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acharjee S, 2004, J BIOL CHEM, V279, P54445, DOI 10.1074/jbc.M408909200; Bailey KR, 2007, PHARMACOL BIOCHEM BE, V86, P8, DOI 10.1016/j.pbb.2006.11.024; Baranowska B, 1997, METABOLISM, V46, P1384, DOI 10.1016/S0026-0495(97)90136-0; Blackshear A, 2007, PEPTIDES, V28, P1120, DOI 10.1016/j.peptides.2007.01.015; Carpenter KA, 1999, BIOCHEMISTRY-US, V38, P15295, DOI 10.1021/bi991081i; Castellano JM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1281, DOI 10.1152/ajpendo.00130.2006; Church WB, 2002, PROTEIN ENG, V15, P313, DOI 10.1093/protein/15.4.313; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Gearing KL, 2003, PROTEIN ENG, V16, P365, DOI 10.1093/protein/gzg045; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kim DK, 2014, ENDOCRINOLOGY, V155, P1864, DOI 10.1210/en.2013-2106; Kooistra AJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28288; Kuteeva E, 2008, NEUROPSYCHOPHARMACOL, V33, P2573, DOI 10.1038/sj.npp.1301660; Liu Y, 2013, MOL CELL ENDOCRINOL, V374, P65, DOI 10.1016/j.mce.2013.04.008; Lundstrom L, 2005, NEUROPEPTIDES, V39, P169, DOI 10.1016/j.npep.2004.12.029; Lundstrom L, 2007, J NEUROCHEM, V103, P1774, DOI 10.1111/j.1471-4159.2007.04959.x; Moon MJ, 2015, J BIOL CHEM, V290, P5696, DOI 10.1074/jbc.M114.612606; Moon MJ, 2012, J BIOL CHEM, V287, P3873, DOI 10.1074/jbc.M111.276808; Oh DY, 2008, J BIOL CHEM, V283, P21054, DOI 10.1074/jbc.M708908200; Oh-Hashi Kentaro, 2017, Biochem Biophys Rep, V12, P40, DOI 10.1016/j.bbrep.2017.08.002; Park CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065420; Rajagopal S, 2013, J BIOL CHEM, V288, P35039, DOI 10.1074/jbc.M113.479113; Reyes-Alcaraz A, 2019, JOVE-J VIS EXP, DOI 10.3791/59994; Reyes-Alcaraz A, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0134-3; Reyes-Alcaraz A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21453; Runesson J, 2010, NEUROCHEM INT, V57, P804, DOI 10.1016/j.neuint.2010.08.018; Sriram K, 2018, MOL PHARMACOL, V93, P251, DOI 10.1124/mol.117.111062; Swanson CJ, 2005, P NATL ACAD SCI USA, V102, P17489, DOI 10.1073/pnas.0508970102; Thompson GL, 2015, MOL PHARMACOL, V88, P335, DOI 10.1124/mol.115.098848; Wacker D, 2017, CELL, V170, P414, DOI 10.1016/j.cell.2017.07.009; Walewski JL, 2014, OBESITY, V22, P1643, DOI 10.1002/oby.20725; Webling Kristin E B, 2012, Front Endocrinol (Lausanne), V3, P146, DOI 10.3389/fendo.2012.00146; Weiss DR, 2013, ACS CHEM BIOL, V8, P1018, DOI 10.1021/cb400103f; WENNERBERG ABA, 1990, BIOCHEM BIOPH RES CO, V166, P1102, DOI 10.1016/0006-291X(90)90980-2; Yun S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00391; Yun S, 2015, MOL BIOL EVOL, V32, P2803, DOI 10.1093/molbev/msv179	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230872	10.1371/journal.pone.0230872	http://dx.doi.org/10.1371/journal.pone.0230872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HO	32231393	Green Published, gold			2022-12-26	WOS:000535937400022
J	Tarumi, W; Shinohara, K				Tarumi, Wataru; Shinohara, Kazuyuki			Women's body odour during the ovulatory phase modulates testosterone and cortisol levels in men	PLOS ONE			English	Article							BREAST-MILK ODOR; BEHAVIOR; ATTRACTIVENESS; STIMULATION; PHEROMONES; RESPONSES; HORMONE; SCENT; CUE	A growing body of evidence suggests that men may perceive women's bodily odour to be more attractive during the high-fertility ovulatory phase than during other phases in the menstrual cycle. In particular, women's bodily odour may influence important aspects of male mating behaviour, but the precise nature of this phenomena remains to be elucidated. Twenty-six men and five women participated in the study. Each woman wore a cotton T-shirt during the night for 3 days during the ovulatory phase, after which the regions of the T-shirt that had been in contact with the woman's chest, armpits, and back, were cut out of the garment. We evaluated the changes in testosterone and cortisol levels in the saliva of men who smelled these cloth pieces. The odour emitted from the backs of women in the ovulatory phase was found to increase testosterone secretion in men, whereas the odour emitted from the chests of women in the ovulatory phase reduced cortisol secretion in men. These results suggest that the odour of specific body parts of women modulate unconscious physiological reactions in men.	[Tarumi, Wataru; Shinohara, Kazuyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Neurobiol & Behav, Div Adv Prevent Med Sci, Nagasaki, Nagasaki, Japan	Nagasaki University	Shinohara, K (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Neurobiol & Behav, Div Adv Prevent Med Sci, Nagasaki, Nagasaki, Japan.	kazuyuki@nagasaki-u.ac.jp			JSPS KAKENHI [18K13116]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by JSPS KAKENHI Grant Number 18K13116 to WT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiee Z, 2013, PEDIATR NEONATOL, V54, P322, DOI 10.1016/j.pedneo.2013.04.004; Bensafi A, 2004, BEHAV BRAIN RES, V152, P11, DOI 10.1016/j.bbr.2003.09.009; Cerda-Molina AL, 2006, HORM BEHAV, V49, P81, DOI 10.1016/j.yhbeh.2005.04.014; Cerda-Molina Ana Lilia, 2013, Front Endocrinol (Lausanne), V4, P159, DOI 10.3389/fendo.2013.00159; CERNOCH JM, 1985, CHILD DEV, V56, P1593, DOI 10.1111/j.1467-8624.1985.tb00224.x; Cornwell RE, 2004, P ROY SOC B-BIOL SCI, V271, P635, DOI 10.1098/rspb.2003.2649; COWLEY JJ, 1991, J STEROID BIOCHEM, V39, P647, DOI 10.1016/0960-0760(91)90264-6; Cutler WB, 1998, ARCH SEX BEHAV, V27, P1, DOI 10.1023/A:1018637907321; DOTY RL, 1975, SCIENCE, V190, P1316, DOI 10.1126/science.1239080; Faigl V, 2012, ACTA VET HUNG, V60, P115, DOI 10.1556/AVet.2012.010; Gelstein S, 2011, SCIENCE, V331, P226, DOI 10.1126/science.1198331; Gildersleeve KA, 2012, HORM BEHAV, V61, P157, DOI 10.1016/j.yhbeh.2011.11.005; Grosser BI, 2000, PSYCHONEUROENDOCRINO, V25, P289, DOI 10.1016/S0306-4530(99)00056-6; Havlicek J, 2006, ETHOLOGY, V112, P81, DOI 10.1111/j.1439-0310.2006.01125.x; Holstege G, 2003, INT REV NEUROBIOL, V56, P213, DOI 10.1016/S0074-7742(03)56006-8; KALOGERAKIS MG, 1963, PSYCHOSOM MED, V25, P420, DOI 10.1097/00006842-196309000-00002; Liening SH, 2010, SOC PERSONAL PSYCHOL, V4, P982, DOI 10.1111/j.1751-9004.2010.00316.x; Macfarlane A, 1975, Ciba Found Symp, P103; MAKIN JW, 1989, CHILD DEV, V60, P803, DOI 10.2307/1131020; Miller SL, 2010, PSYCHOL SCI, V21, P276, DOI 10.1177/0956797609357733; Monti-Bloch L, 1998, J STEROID BIOCHEM, V65, P237, DOI 10.1016/S0960-0760(98)00025-9; Nishitani S, 2009, NEUROSCI RES, V63, P66, DOI 10.1016/j.neures.2008.10.007; Oren C, 2019, SOC COGN AFFECT NEUR, V14, P719, DOI 10.1093/scan/nsz051; Oren C, 2019, PSYCHONEUROENDOCRINO, V101, P50, DOI 10.1016/j.psyneuen.2018.10.028; Petrulis A, 2013, HORM BEHAV, V63, P723, DOI 10.1016/j.yhbeh.2013.03.011; Rantala MJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1696; ROSE JD, 1978, EXP NEUROL, V60, P499, DOI 10.1016/0014-4886(78)90006-7; SCHAAL B, 1980, REPROD NUTR DEV, V20, P843, DOI 10.1051/rnd:19800510; Scordato ES, 2007, CHEM SENSES, V32, P493, DOI 10.1093/chemse/bjm018; Shinohara K, 2000, CHEM SENSES, V25, P465, DOI 10.1093/chemse/25.4.465; Singh D, 2001, P ROY SOC B-BIOL SCI, V268, P797, DOI 10.1098/rspb.2001.1589; SLIMP JC, 1977, PHYSIOL BEHAV, V18, P1027, DOI 10.1016/0031-9384(77)90007-5; Sobel N, 1999, BRAIN, V122, P209, DOI 10.1093/brain/122.2.209; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; Sullivan RM, 1998, BIOL NEONATE, V74, P402, DOI 10.1159/000014061; Thiboutot D, 2004, J INVEST DERMATOL, V123, P1, DOI 10.1111/j.1523-1747.2004.t01-2-.x; Tsukahara S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00299; van Anders SM, 2012, ARCH SEX BEHAV, V41, P1471, DOI 10.1007/s10508-012-9946-2; VARENDI H, 1994, LANCET, V344, P989, DOI 10.1016/S0140-6736(94)91645-4; Varendi H, 2001, ACTA PAEDIATR, V90, P372, DOI 10.1080/080352501750126131; Zhou W, 2014, CURR BIOL, V24, P1091, DOI 10.1016/j.cub.2014.03.035; Ziegler TE, 2005, HORM BEHAV, V47, P56, DOI 10.1016/j.yhbeh.2004.08.009	42	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230838	10.1371/journal.pone.0230838	http://dx.doi.org/10.1371/journal.pone.0230838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8HO	32231386	Green Published, gold			2022-12-26	WOS:000535937400021
J	Caplan, JM; Kennedy, LW; Neudecker, CH				Caplan, Joel M.; Kennedy, Leslie W.; Neudecker, Christine H.			Cholera deaths in Soho, London, 1854: Risk Terrain Modeling for epidemiological investigations	PLOS ONE			English	Article								Risk Terrain Modeling (RTM) is a spatial analysis technique used to diagnose environmental conditions that lead to hazardous outcomes. Originally developed for applications to violent crime analysis, RTM is utilized here to analyze Dr. John Snow's data from the 1854 cholera outbreak in London to demonstrate its potential value to contemporary epidemiological investigations. Dr. Snow saved countless lives when he traced the source of the cholera outbreak to a specific water pump through inductive reasoning, which he communicated through maps and spatial evidence. His methods have since inspired several fields of scientific inquiry. Informed by the extant research on RTM, we speculated that it could have helped test Dr. Snow's hypothesis about cholera and empirically identified the sole source of contaminated well water. We learned that it could and, although it was not available to Dr. Snow in the 1800s, we discuss RTM's implications for present-day research and practice as it relates to the analysis, prevention and treatment of cholera and other public health threats around the world.	[Caplan, Joel M.; Kennedy, Leslie W.; Neudecker, Christine H.] Rutgers Univ Newark, Rutgers Sch Criminal Justice, Newark, NJ 07102 USA	Rutgers State University Newark	Caplan, JM (corresponding author), Rutgers Univ Newark, Rutgers Sch Criminal Justice, Newark, NJ 07102 USA.	jcaplan@rutgers.edu		Neudecker, Christine/0000-0001-8017-3240					0	2	2	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230725	10.1371/journal.pone.0230725	http://dx.doi.org/10.1371/journal.pone.0230725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HE	32226024	Green Published, gold			2022-12-26	WOS:000535936400015
J	Martin-Vicente, M; Gonzalez-Riano, C; Barbas, C; Jimenez-Sousa, MA; Brochado-Kith, O; Resino, S; Martinez, I				Martin-Vicente, Maria; Gonzalez-Riano, Carolina; Barbas, Coral; Angeles Jimenez-Sousa, Maria; Brochado-Kith, Oscar; Resino, Salvador; Martinez, Isidoro			Metabolic changes during respiratory syncytial virus infection of epithelial cells	PLOS ONE			English	Article							GENE NETWORKS; ACTIVATION	Viral infections induce substantial metabolic changes in infected cells to optimize viral production while cells develop countermeasures to restrict that infection. Human respiratory syncytial virus (HRSV) is an infectious pathogen that causes severe lower respiratory tract infections (LRTI) in infants, the elderly, and immunocompromised adults for which no effective treatment or vaccine is currently available. In this study, variations in metabolite levels at different time points post-HRSV infection of epithelial cells were studied by untargeted metabolomics using liquid chromatography/mass spectrometry analysis of methanol cell extracts. Numerous metabolites were significantly upregulated after 18 hours post-infection, including nucleotides, amino acids, amino and nucleotide sugars, and metabolites of the central carbon pathway. In contrast, most lipid classes were downregulated. Additionally, increased levels of oxidized glutathione and polyamines were associated with oxidative stress in infected cells. These results show how HRSV infection influences cell metabolism to produce the energy and building blocks necessary for virus reproduction, suggesting potential therapeutic interventions against this virus.	[Martin-Vicente, Maria; Angeles Jimenez-Sousa, Maria; Brochado-Kith, Oscar; Resino, Salvador; Martinez, Isidoro] Inst Salud Carlos III, Unidad Infecc Viral & Inmunidad, Ctr Nacl Microbiol, Madrid, Spain; [Gonzalez-Riano, Carolina; Barbas, Coral] Univ CEU San Pablo, Fac Farm, Ctr Metabol & Bioanal CEMBIO, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); San Pablo CEU University	Resino, S; Martinez, I (corresponding author), Inst Salud Carlos III, Unidad Infecc Viral & Inmunidad, Ctr Nacl Microbiol, Madrid, Spain.	sresino@isciii.es; imago@isciii.es	Riaño, Carolina González/K-2784-2015; Jiménez-Sousa, Maria A./I-8725-2012; Brochado, Óscar/AAL-2474-2021; Vicente, María Martín/AAC-8266-2021; Resino, Salvador/B-2430-2008; Barbas, Coral/K-3871-2014; Martínez, Isidoro/J-3032-2012	Riaño, Carolina González/0000-0001-7026-8684; Jiménez-Sousa, Maria A./0000-0002-1945-6169; Brochado, Óscar/0000-0001-8372-2604; Resino, Salvador/0000-0001-8783-0450; Barbas, Coral/0000-0003-4722-491X; Martínez, Isidoro/0000-0002-9949-9264	Instituto de Salud Carlos III [PI15CIII/0024]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the Instituto de Salud Carlos III, grant number PI15CIII/0024 to IM. URL: https://www.isciii.es/Paginas/Inicio.aspx The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamko DJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1709-6; Amarasinghe GK, 2019, ARCH VIROL, V164, P1967, DOI 10.1007/s00705-019-04247-4; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; ARUMUGHAM RG, 1989, J BIOL CHEM, V264, P10339; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Barlotta A, 2019, J INFECT DIS, V219, P1216, DOI 10.1093/infdis/jiy659; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Collins PL, 2013, FIELDS VIROLOGY, V1, P1087; DeVito SR, 2014, P NATL ACAD SCI USA, V111, P18019, DOI 10.1073/pnas.1415864111; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fontaine KA, 2014, J VIROL, V88, P4366, DOI 10.1128/JVI.03134-13; Fritsch SD, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00630; Garofalo RP, 2013, ANTIOXID REDOX SIGN, V18, P186, DOI 10.1089/ars.2011.4307; Gerresheim GK, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111410; de la Fuente AG, 2018, J PHARMACEUT BIOMED, V154, P138, DOI 10.1016/j.jpba.2018.02.046; Gil-de-la-Fuente A, 2019, J PROTEOME RES, V18, P797, DOI 10.1021/acs.jproteome.8b00720; Goodwin CM, 2015, TRENDS MICROBIOL, V23, P789, DOI 10.1016/j.tim.2015.08.007; Armitage EG, 2015, ELECTROPHORESIS, V36, P3050, DOI 10.1002/elps.201500352; Gualdoni GA, 2018, P NATL ACAD SCI USA, V115, pE7158, DOI 10.1073/pnas.1800525115; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hillyer P, 2018, J VIROL, V92, DOI 10.1128/JVI.02202-17; Hosakote YM, 2009, AM J RESP CELL MOL, V41, P348, DOI 10.1165/rcmb.2008-0330OC; Hu M, 2019, ELIFE, V8; Huang Yuh-Chin T, 2008, Genomic Med, V2, P113, DOI 10.1007/s11568-009-9080-y; Jaishy B, 2016, J LIPID RES, V57, P1619, DOI 10.1194/jlr.R067520; Jarc E, 2019, YALE J BIOL MED, V92, P435; Jordan TX, 2017, J VIROL, V91, DOI 10.1128/JVI.02020-16; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Li M, 2018, J VIROL, V92, DOI 10.1128/JVI.02193-17; Longo N, 2016, BBA-MOL CELL RES, V1863, P2422, DOI 10.1016/j.bbamcr.2016.01.023; Martinez I, 2007, J GEN VIROL, V88, P570, DOI 10.1099/vir.0.82187-0; Martinez I, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00276; Martinez I, 2016, VIRULENCE, V7, P427, DOI 10.1080/21505594.2016.1144001; Mata M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069670; Mata M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048037; Mayer KA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01533; MBIGUINO A, 1991, J VIROL METHODS, V31, P161, DOI 10.1016/0166-0934(91)90154-R; Mohapatra SS, 2008, CLIN MICROBIOL REV, V21, P495, DOI 10.1128/CMR.00054-07; Mounce BC, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00029-17; Munday DC, 2010, PROTEOMICS, V10, P4320, DOI 10.1002/pmic.201000228; Munday DC, 2010, MOL CELL PROTEOMICS, V9, P2438, DOI 10.1074/mcp.M110.001859; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Ohol YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144648; Cala MP, 2018, J CACHEXIA SARCOPENI, V9, P348, DOI 10.1002/jcsm.12270; Podwojski K, 2009, BIOINFORMATICS, V25, P758, DOI 10.1093/bioinformatics/btp052; Prusinkiewicz MA, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020141; Ramaswamy M, 2009, COPD, V6, P64, DOI 10.1080/15412550902724024; Sanchez EL, 2015, VIROLOGY, V479, P609, DOI 10.1016/j.virol.2015.02.038; Sarkar I, 2019, J PROTEOME RES, V18, P1145, DOI 10.1021/acs.jproteome.8b00806; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Stewart CJ, 2019, PEDIAT ALLERG IMM-UK, V30, P848, DOI 10.1111/pai.13101; Stewart CJ, 2018, J INFECT DIS, V217, P1160, DOI 10.1093/infdis/jix680; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; Telving R, 2016, FORENSIC SCI INT, V266, P453, DOI 10.1016/j.forsciint.2016.07.004; Tian B, 2002, J VIROL, V76, P6800, DOI 10.1128/JVI.76.13.6800-6814.2002; Turi KN, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1431-z; van Diepen A, 2010, J PROTEOMICS, V73, P1680, DOI 10.1016/j.jprot.2010.04.008; Vastag L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002124; Walsh EE, 2017, CLIN CHEST MED, V38, P29, DOI 10.1016/j.ccm.2016.11.010; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Zhang YH, 2001, J VIROL, V75, P9044, DOI 10.1128/JVI.75.19.9044-9058.2001	65	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230844	10.1371/journal.pone.0230844	http://dx.doi.org/10.1371/journal.pone.0230844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LA1QR	32214395	gold, Green Published, Green Submitted			2022-12-26	WOS:000523730000001
J	Zhang, F; Zhu, Y; Wu, SH; Hou, GD; Wu, NX; Qian, LR; Yang, D				Zhang, Fei; Zhu, Yu; Wu, Shuhua; Hou, Guodong; Wu, Nianxiang; Qian, Lirun; Yang, Dong			MLK3 is a newly identified microRNA-520b target that regulates liver cancer cell migration	PLOS ONE			English	Article							SUPPRESSES PROLIFERATION; INVASION; CARCINOMA; PHOSPHORYLATION; KINASE	The roles of microRNAs (miRNAs) in liver cancer have attracted much attention in recent years. In this study, we demonstrate that miR-520b is downregulated in MHCC-97H cells, a liver cancer cell line with high potential of metastasis, compared with MHCC-97L cells which has a low potential of metastasis. Furthermore, the enhanced expression of miR-520b could inhibit liver cancer cell migration, while silencing its expression resulted in increased migration. Mixed lineage kinase 3 (MLK3) was identified as a direct and functional new target of miR-520b. This regulation was also confirmed by luciferase reporter assays. In addition, our results showed that overexpression of the MLK3 expression partially reversed the effect of miR-520b on liver cancer cell migration, indicating that MLK3 contributes to the migration in liver cancer. The newly identified miR-520b/MLK3 axis partially elucidates the molecular mechanism of liver cancer cell migration and represents a new potential therapeutic target for liver cancer treatment.	[Zhang, Fei; Hou, Guodong; Wu, Nianxiang; Qian, Lirun] Anhui Vocat Coll Def Technol, Luan, Anhui, Peoples R China; [Zhu, Yu] Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China; [Wu, Shuhua] Anhui Prov Childrens Hosp, Hefei, Anhui, Peoples R China; [Yang, Dong] Zhuji Peoples Hosp Zhejiang Prov, Dept Hepatobiliary Surg, Zhuji, Zhejiang, Peoples R China	Xi'an Jiaotong University	Yang, D (corresponding author), Zhuji Peoples Hosp Zhejiang Prov, Dept Hepatobiliary Surg, Zhuji, Zhejiang, Peoples R China.	dongyang112019@163.com			Natural science research projects in Universities in Anhui [KJ2017A777]; Key Program in the Youth Elite Support Plan in Universities of Anhui Province [gxyqZD2016463]; Open Research Project of Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Ministry of Education	Natural science research projects in Universities in Anhui; Key Program in the Youth Elite Support Plan in Universities of Anhui Province; Open Research Project of Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Ministry of Education	This work was supported by Natural science research projects in Universities in Anhui (No. KJ2017A777) and The Key Program in the Youth Elite Support Plan in Universities of Anhui Province (No. gxyqZD2016463). The study is also supported by Open Research Project of Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Ministry of Education.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen J, 2012, CANCER RES, V72, P4130, DOI 10.1158/0008-5472.CAN-12-0655; Cui ST, 2017, AM J CANCER RES, V7, P1528; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; GALLO KA, 1994, J BIOL CHEM, V269, P15092; Guan R, 2017, ONCOL LETT, V14, P3155, DOI 10.3892/ol.2017.6552; Guo YT, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-37; Hartkamp J, 1999, CANCER RES, V59, P2195; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Jin K, 2018, THORAC CANCER, V9, P1249, DOI 10.1111/1759-7714.12825; Kwak MS, 2012, DIGEST DIS SCI, V57, P813, DOI 10.1007/s10620-011-1995-1; Li S, 2016, CELL PHYSIOL BIOCHEM, V40, P1303, DOI 10.1159/000453183; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Lu YC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02058-8; Qin XR, 2007, TRANSL RES, V150, P281, DOI 10.1016/j.trsl.2007.06.005; Rattanasinchai C, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.44; Ren W, 2018, BIOMED PHARMACOTHER, V108, P467, DOI 10.1016/j.biopha.2018.09.019; Rhoo KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108487; Schroyer AL, 2018, ONCOGENE, V37, P1031, DOI 10.1038/onc.2017.396; Song T, 2015, AM J TRANSL RES, V7, P2786; Wang GH, 2015, DIGEST DIS SCI, V60, P3044, DOI 10.1007/s10620-015-3706-9; Wang J, 2017, ONCOL RES, V25, P1297, DOI 10.3727/096504017X14873430389189; Xiao J, 2018, ONCOL RES, V26, P593, DOI 10.3727/096504017X14920318811712; You JC, 2009, ENDOCRINOLOGY, V150, P1607, DOI 10.1210/en.2008-0616; Zeng H, 2019, DRUG DES DEV THER, V13, P435, DOI 10.2147/DDDT.S186352; Zhang J, 2014, CLIN EXP DERMATOL, V39, P376, DOI 10.1111/ced.12286; Zhang LL, 2018, EXP THER MED, V16, P3987, DOI 10.3892/etm.2018.6732; Zhang WY, 2015, BIOCHEM BIOPH RES CO, V460, P793, DOI 10.1016/j.bbrc.2015.03.108; Zhang WY, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-128; Zhang WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031450	30	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230716	10.1371/journal.pone.0230716	http://dx.doi.org/10.1371/journal.pone.0230716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214367	Green Submitted, gold, Green Published			2022-12-26	WOS:000535934200045
J	Yang, XT; Hu, F; Liu, JA; Yu, S; Cheung, MPL; Liu, XL; Ng, IOL; Guan, XY; Wong, KKW; Sharma, R; Lung, HL; Jiao, YF; Lee, LTO; Cheung, M				Yang, Xintao; Hu, Feng; Liu, Jessica Aijia; Yu, Shan; Cheung, May Pui Lai; Liu, Xuelai; Ng, Irene Oi-Lin; Guan, Xin-Yuan; Wong, Kelvin K. W.; Sharma, Rakesh; Lung, Hong Lok; Jiao, Yufei; Lee, Leo Tsz On; Cheung, Martin			Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma	ONCOGENE			English	Article							TUMOR-SUPPRESSOR PROTEIN; NEURAL CREST; TRANSCRIPTIONAL CONTROL; METASTASIS SUPPRESSOR; CELL INVASION; CANCER; PROMOTES; LIVER; GENE; PROLIFERATION	A Rho GTPase-activating protein (RhoGAP), deleted in liver cancer 1 (DLC1), is known to function as a tumor suppressor in various cancer types; however, whether DLC1 is a tumor-suppressor gene or an oncogene in melanoma remains to be clarified. Here we revealed that high DLC1 expression was detected in most of the melanoma tissues where it was localized in both the nuclei and the cytoplasm. Functional studies unveiled that DLC1 was both required and sufficient for melanoma growth and metastasis. These tumorigenic events were mediated by nuclear-localized DLC1 in a RhoGAP-independent manner. Mechanistically, mass spectrometry analysis identified a DLC1-associated protein, FOXK1 transcription factor, which mediated oncogenic events in melanoma by translocating and retaining DLC1 into the nucleus. RNA-sequencing profiling studies further revealed MMP9 as a direct target of FOXK1 through DLC1-regulated promoter occupancy for cooperative activation of MMP9 expression to promote melanoma invasion and metastasis. Concerted action of DLC1-FOXK1 in MMP9 gene regulation was further supported by their highly correlated expression in melanoma patients' samples and cell lines. Together, our results not only unravel a mechanism by which nuclear DLC1 functions as an oncogene in melanoma but also suggest an unexpected role of RhoGAP protein in transcriptional regulation.	[Yang, Xintao; Hu, Feng; Cheung, May Pui Lai; Cheung, Martin] Univ Hong Kong, Shenzhen Inst Res & Innovat HKU SIRI, Shenzhen, Peoples R China; [Yang, Xintao; Hu, Feng; Cheung, May Pui Lai; Cheung, Martin] Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Fac Med, Hong Kong, Peoples R China; [Liu, Jessica Aijia] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anaesthesiol, Hong Kong, Peoples R China; [Yu, Shan; Lee, Leo Tsz On] Univ Macau, Canc Ctr, Fac Hlth Sci, Taipa, Macau, Peoples R China; [Liu, Xuelai] Hebei Med Univ, Dept Pediat Surg, Hosp 2, Shijiazhuang, Hebei, Peoples R China; [Ng, Irene Oi-Lin] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Liver Res, Hong Kong, Peoples R China; [Ng, Irene Oi-Lin] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Peoples R China; [Guan, Xin-Yuan] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Peoples R China; [Wong, Kelvin K. W.; Sharma, Rakesh] Univ Hong Kong, Li Ka Shing Fac Med, Ctr PanorOm Sci, Prote & Metab Core Facil, Hong Kong, Peoples R China; [Lung, Hong Lok] Hong Kong Baptist Univ, Dept Biol, Fac Sci, Hong Kong, Peoples R China; [Jiao, Yufei] Harbin Med Univ, Dept Pathol, Affiliated Hosp 2, Harbin, Peoples R China; [Lee, Leo Tsz On] Univ Macau, Ctr Reprod Dev & Aging, Fac Hlth Sci, Taipa, Macau, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Macau; Hebei Medical University; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Hong Kong Baptist University; Harbin Medical University; University of Macau	Cheung, M (corresponding author), Univ Hong Kong, Shenzhen Inst Res & Innovat HKU SIRI, Shenzhen, Peoples R China.; Cheung, M (corresponding author), Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Fac Med, Hong Kong, Peoples R China.	mcheung9@hku.hk	Lee, Leo T.O./AAB-1581-2021; Cheung, Martin Chi Hang/C-4235-2009	Sharma, Rakesh/0000-0002-5306-3457; Yang, Xintao/0000-0003-0364-9377; Ng, Irene Oi-lin/0000-0001-7532-2029; Liu, Jessica Aijia/0000-0002-9307-2235; Cheung, Martin Chi Hang/0000-0002-3471-8534; Hu, Feng/0000-0001-9605-7594	Research Grants Council of Hong Kong [GRF_17110715, GRF_17123016, GRF_17114817]; University Grants Council of Hong Kong [GRF_17110715, GRF_17123016, GRF_17114817]; National Natural Science Foundation of China [81972588]; University of Hong Kong [201409176166, 201611159243]; Government Matching Grant Scheme (6th Phase)	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); University Grants Council of Hong Kong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Hong Kong(University of Hong Kong); Government Matching Grant Scheme (6th Phase)	This work was supported by grants from the Research Grants Council and University Grants Council of Hong Kong (GRF_17110715, GRF_17123016, GRF_17114817), National Natural Science Foundation of China (81972588) as well as Small Project Fund (201409176166), Seed Fund for Basic Research (201611159243) from the University of Hong Kong, and Government Matching Grant Scheme (6th Phase).	Bailey CM, 2012, PIGM CELL MELANOMA R, V25, P573, DOI 10.1111/j.1755-148X.2012.01025.x; Barras D, 2014, CANCER METAST REV, V33, P87, DOI 10.1007/s10555-013-9458-0; Chan LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025547; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; Cronin JC, 2013, CANCER RES, V73, P5709, DOI 10.1158/0008-5472.CAN-12-4620; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Goodison S, 2005, CANCER RES, V65, P6042, DOI 10.1158/0008-5472.CAN-04-3043; Graf SA, 2014, J INVEST DERMATOL, V134, P2212, DOI 10.1038/jid.2014.128; Harris ML, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003644; Hill VK, 2013, ANNU REV GENOM HUM G, V14, P257, DOI 10.1146/annurev-genom-091212-153429; Huang XT, 2018, CELL PHYSIOL BIOCHEM, V47, P590, DOI 10.1159/000490015; Kaufman CK, 2016, SCIENCE, V351, DOI 10.1126/science.aad2197; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD1284, DOI 10.1093/nar/gkx1188; Kim T, 2009, CANCER METAST REV, V28, P77, DOI 10.1007/s10555-008-9167-2; Kulesa PM, 2013, CELLS TISSUES ORGANS, V198, P12, DOI 10.1159/000348418; Lahoz A, 2008, GENE DEV, V22, P1724, DOI 10.1101/gad.1691408; Liao YC, 2008, INT J BIOCHEM CELL B, V40, P843, DOI 10.1016/j.biocel.2007.04.008; Liu JA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01107-0; Liu JA, 2016, DEV BIOL, V419, P199, DOI 10.1016/j.ydbio.2016.09.006; Low JSW, 2011, ONCOGENE, V30, P1923, DOI 10.1038/onc.2010.576; Monsonego-Ornan E, 2012, DEV BIOL, V364, P162, DOI 10.1016/j.ydbio.2012.01.028; Park H, 2015, P NATL ACAD SCI USA, V112, P12492, DOI 10.1073/pnas.1507491112; Peng Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.225; Pohl BS, 2004, DEV GENES EVOL, V214, P200, DOI 10.1007/s00427-004-0391-7; Popescu NC, 2014, MOL DIAGN THER, V18, P293, DOI 10.1007/s40291-014-0086-3; Potterf SB, 2001, DEV BIOL, V237, P245, DOI 10.1006/dbio.2001.0372; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; Shakhova O, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004877; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; Shi H, 2014, MELANOMA RES, V24, P99, DOI 10.1097/CMR.0000000000000043; Sjoestroem C, 2014, MODERN PATHOL, V27, P1203, DOI 10.1038/modpathol.2013.223; Tang ZY, 2013, CELL BIOL INT, V37, P849, DOI 10.1002/cbin.10107; Torres-Collado AX, 2018, CANCERS, V10, DOI 10.3390/cancers10060157; Tripathi BK, 2017, J CELL BIOL, V216, P4255, DOI 10.1083/jcb.201703105; Tripathi V, 2014, ONCOGENE, V33, P724, DOI 10.1038/onc.2013.7; Tripathi V, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-27; Wang DR, 2016, ONCOTARGET, V7, P45144, DOI 10.18632/oncotarget.9266; Wang WQ, 2015, DEV CELL, V32, P707, DOI 10.1016/j.devcel.2015.01.031; Wang YF, 2014, J CLIN INVEST, V124, P1646, DOI 10.1172/JCI71812; Wong CM, 2003, CANCER RES, V63, P7646; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Wu M, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.68; Xu HT, 2018, EXP THER MED, V15, P3108, DOI 10.3892/etm.2018.5732; Yang XT, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-018-0998-6; Yuan BZ, 2007, EXP CELL RES, V313, P3868, DOI 10.1016/j.yexcr.2007.08.009	46	7	8	3	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	20					4061	4076		10.1038/s41388-020-1274-8	http://dx.doi.org/10.1038/s41388-020-1274-8		MAR 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LN3GC	32214200	Green Published, hybrid			2022-12-26	WOS:000521526300001
J	Banas, AM; Bocian-Ostrzycka, KM; Plichta, M; Dunin-Horkawicz, S; Ludwiczak, J; Placzkiewicz, J; Jagusztyn-Krynicka, EK				Banas, Anna Marta; Bocian-Ostrzycka, Katarzyna Marta; Plichta, Maciej; Dunin-Horkawicz, Stanislaw; Ludwiczak, Jan; Placzkiewicz, Jagoda; Jagusztyn-Krynicka, Elzbieta Katarzyna			C8J_1298, a bifunctional thiol oxidoreductase of Campylobacter jejuni, affects Dsb (disulfide bond) network functioning	PLOS ONE			English	Article							ISOMERASE DSBC; ESCHERICHIA-COLI; HELICOBACTER-PYLORI; CRYSTAL-STRUCTURE; IN-VIVO; OXIDATIVE STRESS; GENOME SEQUENCE; OXIDASE DSBA; PROTEIN; MUTANTS	Posttranslational generation of disulfide bonds catalyzed by bacterial Dsb (disulfide bond) enzymes is essential for the oxidative folding of many proteins. Although we now have a good understanding of the Escherichia coli disulfide bond formation system, there are significant gaps in our knowledge concerning the Dsb systems of other bacteria, including Campylobacter jejuni, a food-borne, zoonotic pathogen. We attempted to gain a more complete understanding of the process by thorough analysis of C8J_1298 functioning in vitro and in vivo. C8J_1298 is a homodimeric thiol-oxidoreductase present in wild type (wt) cells, in both reduced and oxidized forms. The protein was previously described as a homolog of DsbC, and thus potentially should be active in rearrangement of disulfides. Indeed, biochemical studies with purified protein revealed that C8J_1298 shares many properties with EcDsbC. However, its activity in vivo is dependent on the genetic background, namely, the set of other Dsb proteins present in the periplasm that determine the redox conditions. In wt C. jejuni cells, C8J_1298 potentially works as a DsbG involved in the control of the cysteine sulfenylation level and protecting single cysteine residues from oxidation to sulfenic acid. A strain lacking only C8J_1298 is indistinguishable from the wild type strain by several assays recognized as the criteria to determine isomerization or oxidative Dsb pathways. Remarkably, in C. jejuni strain lacking DsbA1, the protein involved in generation of disulfides, C8J_1298 acts as an oxidase, similar to the homodimeric oxidoreductase of Helicobater pylori, HP0231. In E. coli, C8J_1298 acts as a bifunctional protein, also resembling HP0231. These findings are strongly supported by phylogenetic data. We also showed that CjDsbD (C8J_0565) is a C8J_1298 redox partner.	[Banas, Anna Marta; Bocian-Ostrzycka, Katarzyna Marta; Plichta, Maciej; Jagusztyn-Krynicka, Elzbieta Katarzyna] Univ Warsaw, Fac Biol, Inst Microbiol, Dept Bacterial Genet, Warsaw, Poland; [Dunin-Horkawicz, Stanislaw; Ludwiczak, Jan] Univ Warsaw, Ctr New Technol, Lab Struct Bioinformat, Warsaw, Poland; [Ludwiczak, Jan] Nencki Inst Expt Biol, Lab Bioinformat, Warsaw, Poland; [Placzkiewicz, Jagoda] Univ Warsaw, Fac Biol, Inst Microbiol, Dept Virol, Warsaw, Poland; [Plichta, Maciej] Polish Acad Sci, Inst Biochem & Biophys, Dept Biopys, Warsaw, Poland	University of Warsaw; University of Warsaw; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Jagusztyn-Krynicka, EK (corresponding author), Univ Warsaw, Fac Biol, Inst Microbiol, Dept Bacterial Genet, Warsaw, Poland.	kjkryn@biol.uw.edu.pl	; Ludwiczak, Jan/B-7591-2019	Dunin-Horkawicz, Stanislaw/0000-0002-4581-1558; Banas, Anna Marta/0000-0002-6043-2169; Placzkiewicz, Jagoda/0000-0002-8017-8647; Plichta, Maciej/0000-0001-6363-5247; Bocian-Ostrzycka, Katarzyna Marta/0000-0003-3271-0325; Ludwiczak, Jan/0000-0002-3487-5433	National Science Centre, Poland [2015/17/B/NZ1/00230]; Ministry of Science and Higher Education through the Faculty of Biology, University of Warsaw [501-D114-86-0115000-02, 501-D114-86-0117602, 501-D114-86-0117604, DSM2019 KMB-O 501-D114-01-1140400]; 'Etiuda' scholarship from the National Science Centre, Poland [2019/32/T/NZ1/00323]	National Science Centre, Poland(National Science Centre, Poland); Ministry of Science and Higher Education through the Faculty of Biology, University of Warsaw; 'Etiuda' scholarship from the National Science Centre, Poland	This study was funded by the National Science Centre, Poland awarded to EKJ-K (grant no 2015/17/B/NZ1/00230) and by the Ministry of Science and Higher Education through the Faculty of Biology, University of Warsaw intramural grants (DSM2017 AMB no 501-D114-86-0115000-02, DSM2018 AMB no 501-D114-86-0117602, DSM2018 KMB-O no 501-D114-86-0117604 and DSM2019 KMB-O 501-D114-01-1140400). J. L. was supported by the 'Etiuda' scholarship from the National Science Centre, Poland (2019/32/T/NZ1/00323).yy	Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Arredondo S, 2008, J BIOL CHEM, V283, P31469, DOI 10.1074/jbc.M803346200; Atack JM, 2008, MICROBIOL-SGM, V154, P2219, DOI 10.1099/mic.0.2008/019711-0; Atack JM, 2009, FUTURE MICROBIOL, V4, P677, DOI 10.2217/FMB.09.44; Bader MW, 2001, EMBO J, V20, P1555, DOI 10.1093/emboj/20.7.1555; Banaszak K, 2004, ACTA CRYSTALLOGR D, V60, P1747, DOI 10.1107/S0907444904018359; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Berkmen M, 2005, J BIOL CHEM, V280, P11387, DOI 10.1074/jbc.M411774200; Berkmen M, 2012, PROTEIN EXPRES PURIF, V82, P240, DOI 10.1016/j.pep.2011.10.009; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Bessette PH, 2001, J BACTERIOL, V183, P980, DOI 10.1128/JB.183.3.980-988.2001; Bocian-Ostrzycka KM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01158; Bocian-Ostrzycka KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01065; Bocian-Ostrzycka KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00570; Burnham PM, 2018, NAT REV MICROBIOL, V16, P551, DOI 10.1038/s41579-018-0037-9; Chatelle C, 2015, ANTIOXID REDOX SIGN, V23, P945, DOI 10.1089/ars.2014.6235; Cho SH, 2014, CELL, V159, P1652, DOI 10.1016/j.cell.2014.11.045; Cho SH, 2013, ANTIOXID REDOX SIGN, V18, P1690, DOI 10.1089/ars.2012.4962; Collet JF, 2003, J BIOL CHEM, V278, P45325, DOI 10.1074/jbc.M307818200; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; de Vries SPW, 2015, MICROBIOL-SGM, V161, P2316, DOI 10.1099/mic.0.000184; Denoncin K, 2014, J BIOL CHEM, V289, P12356, DOI 10.1074/jbc.M114.554055; Denoncin K, 2013, ANTIOXID REDOX SIGN, V19, P63, DOI 10.1089/ars.2012.4864; Denoncin Katleen, 2013, Methods Mol Biol, V966, P325, DOI 10.1007/978-1-62703-245-2_20; Denoncin K, 2010, J BIOL CHEM, V285, P29425, DOI 10.1074/jbc.M110.119321; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Esson D, 2016, SCI REP-UK, V6, DOI 10.1038/srep38303; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Furlong EJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16065; Gaasbeek EJ, 2009, J BACTERIOL, V191, P3785, DOI 10.1128/JB.01817-08; Gao BL, 2014, MBIO, V5, DOI 10.1128/mBio.01349-14; Grabowska AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106247; Gundogdu O, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02117; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Handley RA, 2015, MICROBIOL-SGM, V161, P1524, DOI 10.1099/mic.0.000109; Hatahet F, 2014, BBA-PROTEINS PROTEOM, V1844, P1402, DOI 10.1016/j.bbapap.2014.02.014; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Hermann B, 2015, NATURE, V520, P706, DOI 10.1038/nature14109; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Hiniker A, 2007, P NATL ACAD SCI USA, V104, P11670, DOI 10.1073/pnas.0704692104; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Holmes K, 2005, MICROBIOL-SGM, V151, P243, DOI 10.1099/mic.0.27412-0; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; JANDER G, 1994, EMBO J, V13, P5121, DOI 10.1002/j.1460-2075.1994.tb06841.x; Jiao L, 2013, J STRUCT BIOL, V183, P1, DOI 10.1016/j.jsb.2013.05.013; Kaakoush NO, 2008, FEBS J, V275, P5021, DOI 10.1111/j.1742-4658.2008.06636.x; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Kim JC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00751; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Kpadeh ZZ, 2015, MOL MICROBIOL, V95, P1054, DOI 10.1111/mmi.12914; Kpadeh ZZ, 2013, J BACTERIOL, V195, P1825, DOI 10.1128/JB.01949-12; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kwiatek A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00712; LABIGNEROUSSEL A, 1987, J BACTERIOL, V169, P5320, DOI 10.1128/jb.169.11.5320-5323.1987; Landeta C, 2018, NAT MICROBIOL, V3, P270, DOI 10.1038/s41564-017-0106-2; Landeta C, 2017, J BIOL CHEM, V292, P6529, DOI 10.1074/jbc.M116.770891; Lester J, 2015, MOL MICROBIOL, V96, P110, DOI 10.1111/mmi.12923; Leverrier P, 2011, J BIOL CHEM, V286, P16734, DOI 10.1074/jbc.M111.224865; Liu YW, 2015, MOL MICROBIOL, V96, P1298, DOI 10.1111/mmi.13008; Manning G, 2001, APPL ENVIRON MICROB, V67, P1185, DOI 10.1128/AEM.67.3.1185-1189.2001; Manta Bruno, 2019, EcoSal Plus, V8, DOI 10.1128/ecosalplus.ESP-0012-2018; Mariano G, 2018, CELL REP, V22, P774, DOI 10.1016/j.celrep.2017.12.075; MAYER MP, 1995, GENE, V163, P41, DOI 10.1016/0378-1119(95)00389-N; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; McMahon RM, 2014, BBA-PROTEINS PROTEOM, V1844, P1391, DOI 10.1016/j.bbapap.2014.01.013; Messens J, 2007, J BIOL CHEM, V282, P31302, DOI 10.1074/jbc.M705236200; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Mohawk KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088043; Olejnik K, 2005, BBA-PROTEINS PROTEOM, V1752, P133, DOI 10.1016/j.bbapap.2005.07.021; PALMER SR, 1983, LANCET, V1, P287, DOI 10.1016/S0140-6736(83)91698-7; Pan JL, 2008, J MOL BIOL, V377, P1433, DOI 10.1016/j.jmb.2008.01.058; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pascoe B, 2019, MICROB GENOMICS, V5, DOI 10.1099/mgen.0.000279; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Raczko AM, 2005, MICROBIOL-SGM, V151, P219, DOI 10.1099/mic.0.27483-0; Ren GP, 2011, ANTIOXID REDOX SIGN, V14, P2399, DOI 10.1089/ars.2010.3782; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Roszczenko P, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0471-z; Roszczenko P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046563; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Sambrook J., 2001, MOL CLONING LAB MANU; Segatori L, 2006, J BIOL CHEM, V281, P4911, DOI 10.1074/jbc.M505453200; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svensson SL, 2015, MOL MICROBIOL, V96, P189, DOI 10.1111/mmi.12927; Vertommen D, 2008, MOL MICROBIOL, V67, P336, DOI 10.1111/j.1365-2958.2007.06030.x; Wosten MMSM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00174; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Yao RJ, 1996, J BACTERIOL, V178, P3335, DOI 10.1128/jb.178.11.3335-3338.1996; Yoon BY, 2014, BIOCHEM BIOPH RES CO, V446, P971, DOI 10.1016/j.bbrc.2014.03.043; Yoon JY, 2011, FEBS LETT, V585, P3862, DOI 10.1016/j.febslet.2011.10.042; Zhang M, 2004, ACTA CRYSTALLOGR D, V60, P1512, DOI 10.1107/S0907444904014S93	102	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230366	10.1371/journal.pone.0230366	http://dx.doi.org/10.1371/journal.pone.0230366			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GC	32203539	Green Published, gold			2022-12-26	WOS:000535303900016
J	Arroyo-Loranca, RG; Hernandez-Saavedra, NY; Hernandez-Adame, L; Rivera-Perez, C				Arroyo-Loranca, Raquel G.; Hernandez-Saavedra, Norma Y.; Hernandez-Adame, Luis; Rivera-Perez, Crisalejandra			Ps19, a novel chitin binding protein from Pteria sterna capable to mineralize aragonite plates in vitro	PLOS ONE			English	Article							NACREOUS LAYER FORMATION; MATRIX PROTEIN; ORGANIC MATRIX; POLYACRYLAMIDE-GELS; CARBONIC-ANHYDRASE; PEARL OYSTER; SHELL; BIOMINERALIZATION; CRYSTALLIZATION; PURIFICATION	Mollusk shell is composed of two CaCO3 polymorphs (calcite and aragonite) and an organic matrix that consists of acetic acid- or ethylenediaminetetraacetic acid (EDTA)-soluble and insoluble proteins and other biomolecules (polysaccharides, beta-chitin). However, the shell matrix proteins involved in nacre formation are not fully known. Thus, the aim of this study was to identify and characterize a novel protein from the acetic acid-insoluble fraction from the shell of Pteria sterna, named in this study as Ps19, to have a better understanding of the biomineralization process. Ps19 biochemical characterization showed that it is a glycoprotein that exhibits calcium- and chitin-binding capabilities. Additionally, it is capable of inducing aragonite plate crystallization in vitro. Ps19 partial peptide sequence showed similarity with other known shell matrix proteins, but it displayed similarity with proteins from Crassostrea gigas, Mizuhopecten yessoensis, Biomphalaria glabrata, Alpysia californica, Lottia gigantea and Elysia chlorotica. The results obtained indicated that Ps19 might play an important role in nacre growth of mollusk shells.	[Arroyo-Loranca, Raquel G.; Hernandez-Saavedra, Norma Y.] Ctr Invest Biol Noroeste CIBNOR, Mol Genet Lab, La Paz, Baja California, Mexico; [Hernandez-Adame, Luis; Rivera-Perez, Crisalejandra] Ctr Invest Biol Noroeste CIBNOR, CONACYT, La Paz, Baja California, Mexico	CIBNOR - Centro de Investigaciones Biologicas del Noroeste; CIBNOR - Centro de Investigaciones Biologicas del Noroeste	Rivera-Perez, C (corresponding author), Ctr Invest Biol Noroeste CIBNOR, CONACYT, La Paz, Baja California, Mexico.	crivera@cibnor.mx	Rivera-Perez, Crisalejandra/AAM-1269-2021; Hernandez Saavedra, Norma Yolanda/ABB-4249-2021; Hernandez-Adame, Luis/G-4451-2015	Hernandez Saavedra, Norma Yolanda/0000-0002-7004-299X; Hernandez-Adame, Luis/0000-0002-0188-7526; Rivera Perez, Crisalejandra/0000-0002-9746-3225	CONACyT [358437]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors are grateful to Ariel Cruz head of the Electronic Microscopy Laboratory at CIBNOR for his technical support with SEM images; Delia Rojas Posadas for technical assistance; Jose ' Luis Rodriguez Lo ' pez and Beatriz A. Rivera for their technical support with Raman measurements at (LINAN)-IPICYT; Diana Fischer for editorial services, and to CONACyT for the fellowship (358437).	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; Bahn SY, 2015, CRYST GROWTH DES, V15, P3666, DOI 10.1021/acs.cgd.5b00275; Baqueiro E, 1995, AV PERSPECT, V14, P231; Barthelat F, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/3/035001; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Chen Y, 2018, J BIOL CHEM, V293, P17803, DOI 10.1074/jbc.RA118.005281; De La Pierre M, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4871900; Du JZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21797-w; Evans JS, 2008, CHEM REV, V108, P4455, DOI 10.1021/cr078251e; Feng DD, 2017, SCI REP-UK, V7, DOI 10.1038/srep45754; Fricke M, 2007, TOP CURR CHEM, V270, P1, DOI 10.1007/128_063; Froes AM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01790; Gao P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133913; GREEN MR, 1973, ANAL BIOCHEM, V56, P43, DOI 10.1016/0003-2697(73)90167-X; HILLNER PE, 1992, GEOLOGY, V20, P359, DOI 10.1130/0091-7613(1992)020<0359:ASIOCG>2.3.CO;2; Jin C, 2019, INT J BIOL MACROMOL, V135, P745, DOI 10.1016/j.ijbiomac.2019.05.205; Keckesova Z, 2017, NATURE, V543, P681, DOI 10.1038/nature21408; Keene EC, 2010, CRYST GROWTH DES, V10, P5169, DOI 10.1021/cg1009303; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lens I., 2010, TSINGHUA SCI TECHNOL, V37, P1, DOI DOI 10.1016/S1007-0214(05)70107-3; Levi Y, 1998, CHEM-EUR J, V4, P389, DOI 10.1002/(SICI)1521-3765(19980310)4:3<389::AID-CHEM389>3.0.CO;2-X; Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372; Liao Z, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219699; Ma YF, 2013, MAT SCI ENG C-MATER, V33, P1521, DOI 10.1016/j.msec.2012.12.057; Mann K, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-28; Marie B, 2016, J R SOC INTERFACE, V14, P1; Marie B., 2015, KEY ENG MATER, V672, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.672.158; Marie B, 2008, CHEMBIOCHEM, V9, P2515, DOI 10.1002/cbic.200800159; Marie B, 2007, FEBS J, V274, P2933, DOI 10.1111/j.1742-4658.2007.05825.x; Marie B, 2010, CHEMBIOCHEM, V11, P2138, DOI 10.1002/cbic.201000276; Marin F., 2013, RECENTS ADV PEARL RE, V149; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marin Frederic, 2012, Front Biosci (Schol Ed), V4, P1099; Matsushiro A, 2003, MAR BIOTECHNOL, V5, P37, DOI 10.1007/s10126-002-0048-3; Miyashita T, 2000, MAR BIOTECHNOL, V2, P409; Montagnani C, 2011, CHEMBIOCHEM, V12, P2033, DOI 10.1002/cbic.201100216; Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217; Nudelman F, 2015, SEMIN CELL DEV BIOL, V46, P2, DOI 10.1016/j.semcdb.2015.07.004; RABILLOUD T, 1994, CELL MOL BIOL, V40, P57; RIGHETTI PG, 1978, J CHROMATOGR, V157, P243, DOI 10.1016/S0021-9673(00)92339-2; Rousseau M, 2009, J STRUCT BIOL, V165, P190, DOI 10.1016/j.jsb.2008.11.011; RUTT HN, 1974, J PHYS C SOLID STATE, V7, P4522, DOI 10.1088/0022-3719/7/24/015; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; SAMATA T, 1990, VELIGER, V33, P190; Sato Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052372; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Tushtev K, 2008, MAT SCI ENG C-BIO S, V28, P1164, DOI 10.1016/j.msec.2007.10.039; URMOS J, 1991, AM MINERAL, V76, P641; Wang SN, 2013, J STRUCT BIOL, V183, P404, DOI 10.1016/j.jsb.2013.07.013; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; Yang D, 2019, J BIOL CHEM, V294, P8371, DOI 10.1074/jbc.RA118.007338; ZACHARIUS RM, 1969, ANAL BIOCHEM, V30, P148, DOI 10.1016/0003-2697(69)90383-2; Zeng M, 2018, P NATL ACAD SCI; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179; Zhang R, 2019, BIOMINERALIZATION ME, V1, DOI [10.1007/978-981-13-1459-9, DOI 10.1007/978-981-13-1459-9]	59	6	6	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230431	10.1371/journal.pone.0230431	http://dx.doi.org/10.1371/journal.pone.0230431			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191756	gold, Green Published			2022-12-26	WOS:000535302300046
J	Zhou, XT; Strezov, V; Jiang, YJ; Yang, XX; Kan, T; Evans, T				Zhou, Xiaoteng; Strezov, Vladimir; Jiang, Yijiao; Yang, Xiaoxia; Kan, Tao; Evans, Tim			Contamination identification, source apportionment and health risk assessment of trace elements at different fractions of atmospheric particles at iron and steelmaking areas in China	PLOS ONE			English	Article							AIRBORNE PARTICULATE MATTER; HEAVY-METALS; SIZE DISTRIBUTIONS; MAIN COMPONENTS; AIR-QUALITY; URBAN; INHALATION; POLLUTION; VICINITY; BIOACCESSIBILITY	China has the largest share of global iron and steel production, which is considered to play a significant contribution to air pollution. This study aims to investigate trace element contamination at different fractions of particulate matter (PM) at industrial areas in China. Three PM fractions, PM2.1-9.0, PM1.1-2.1 and PM1.1, were collected from areas surrounding iron and steelmaking plants at Kunming, Wuhan, Nanjing and Ningbo in China. Multiple trace elements and their bioavailability, as well as Pb isotopic compositions, were analysed for identification of contaminants, health risk assessment and source apportionment. Results showed that PM particles in the sites near industrial areas were associated with a range of toxic trace elements, specifically As, Cr(VI), Cd and Mn, and posed significant health risks to humans. The isotopic Pb compositions identified that coal and high temperature metallurgical processes in the steelmaking process were the dominant contributors to local air pollution in these sites. In addition to iron and steelmaking activities, traffic emissions and remote pollution also played a contributing role in PM contamination, confirmed by the differences of Pb isotopic compositions at each PM fraction and statistical results from Preference Ranking Organization Method for Enrichment Evaluations (PROMETHEE) and Geometrical Analysis for Interactive Aid (GAIA). The results presented in this study provide a comprehensive understanding of PM emissions at iron and steelmaking areas, which helps to guide subsequent updates of air pollution control guidelines to efficiently minimise environmental footprint and ensure long term sustainability of the industries.	[Zhou, Xiaoteng; Strezov, Vladimir; Jiang, Yijiao; Yang, Xiaoxia; Kan, Tao; Evans, Tim] Macquarie Univ, ARC Res Hub Computat Particle Technol, Sydney, NSW, Australia; [Zhou, Xiaoteng; Strezov, Vladimir; Kan, Tao; Evans, Tim] Macquarie Univ, Dept Earth & Environm Sci, Sydney, NSW, Australia; [Jiang, Yijiao; Yang, Xiaoxia] Macquarie Univ, Sch Engn, Sydney, NSW, Australia	Macquarie University; Macquarie University; Macquarie University	Zhou, XT (corresponding author), Macquarie Univ, ARC Res Hub Computat Particle Technol, Sydney, NSW, Australia.; Zhou, XT (corresponding author), Macquarie Univ, Dept Earth & Environm Sci, Sydney, NSW, Australia.	xiaoteng.zhou@mq.edu.au	Kan, Tao/AGY-8209-2022; Strezov, Vladimir/J-4827-2019	Kan, Tao/0000-0002-8468-4475; Strezov, Vladimir/0000-0002-9129-9284; Zhou, Xiaoteng/0000-0002-1900-6037; Jiang, Yijiao/0000-0002-6191-9825	Australian Research Council Industrial Transformation Research Hub for Computational Particle Technology, Australia [IH140100035]	Australian Research Council Industrial Transformation Research Hub for Computational Particle Technology, Australia(Australian Research Council)	This project is founded by the Australian Research Council Industrial Transformation Research Hub for Computational Particle Technology (IH140100035), Australia.	Allen AG, 2001, ATMOS ENVIRON, V35, P4581, DOI 10.1016/S1352-2310(01)00190-X; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Dall'Osto M, 2008, AEROSOL SCI TECH, V42, P981, DOI 10.1080/02786820802339587; Deng Q., 2019, AIR QUALITY TOP 20 S; der Heiden P, 2011, COPENHAGEN J ASIAN S, V29, P110, DOI DOI 10.22439/CJAS.V29I2.4029; Espinasse B, 1997, EUR J OPER RES, V103, P389, DOI 10.1016/S0377-2217(97)00127-6; Fang WX, 2013, ENVIRON SCI TECHNOL, V47, P12469, DOI 10.1021/es4026613; Galindo N, 2018, CHEMOSPHERE, V201, P243, DOI 10.1016/j.chemosphere.2018.02.162; Geller VD, 2005, ENVIRON SCI TECHNOL, V39, P8653, DOI 10.1021/es050360s; Gunawardana C, 2015, CHEMOSPHERE, V119, P1391, DOI 10.1016/j.chemosphere.2014.02.048; Gunawardena J, 2013, ATMOS ENVIRON, V68, P235, DOI 10.1016/j.atmosenv.2012.11.062; Hemon W.C.L., 1960, JAPCA-INT J AIR POLL, V10, P208; Hernandez-Pellon A, 2018, ENVIRON RES, V165, P140, DOI 10.1016/j.envres.2018.04.014; Herngren L, 2006, ANAL CHIM ACTA, V571, P270, DOI 10.1016/j.aca.2006.04.064; Hieu NT, 2010, ATMOS RES, V98, P526, DOI 10.1016/j.atmosres.2010.08.019; Ilic I, 2011, ATMOS RES, V101, P450, DOI 10.1016/j.atmosres.2011.04.002; Jha MK, 2001, RESOUR CONSERV RECY, V33, P1, DOI 10.1016/S0921-3449(00)00095-1; Jiun-Homg T, 2007, J HAZARD MATER, V147, P111, DOI 10.1016/j.jhazmat.2006.12.054; Jobby R, 2018, CHEMOSPHERE, V207, P255, DOI 10.1016/j.chemosphere.2018.05.050; Kot A, 2000, TRAC-TREND ANAL CHEM, V19, P69, DOI 10.1016/S0165-9936(99)00195-8; Li M, 2017, NATL SCI REV, V4, P834, DOI 10.1093/nsr/nwx150; Li SW, 2016, ENVIRON INT, V94, P69, DOI 10.1016/j.envint.2016.05.010; Lin CC, 2005, ENVIRON SCI TECHNOL, V39, P8113, DOI 10.1021/es048182a; Liu L, 2016, SCI TOTAL ENVIRON, V563, P190, DOI 10.1016/j.scitotenv.2016.04.114; Liu QY, 2020, SCI TOTAL ENVIRON, V701, DOI 10.1016/j.scitotenv.2019.134844; Liu WJ, 2019, ENVIRON POLLUT, V254, DOI 10.1016/j.envpol.2019.113046; Loxham M, 2013, ENVIRON SCI TECHNOL, V47, P3614, DOI 10.1021/es304481m; Ma HW, 2007, ENVIRON INT, V33, P206, DOI 10.1016/j.envint.2006.09.011; Mahbub P, 2010, ENVIRON SCI TECHNOL, V44, P8904, DOI 10.1021/es1012565; Mateos AC, 2018, ENVIRON RES, V161, P370, DOI 10.1016/j.envres.2017.11.035; Maytaal A., 2018, WORLDSTEEL RAISES FO; Megido L, 2017, CHEMOSPHERE, V177, P284, DOI 10.1016/j.chemosphere.2017.03.009; National Bureau of Statistics, 2018, DUST SOOT EM TONS; Nikolic D, 2009, J ENVIRON MANAGE, V91, P509, DOI 10.1016/j.jenvman.2009.09.019; NYIRENDA RL, 1991, MINER ENG, V4, P1003, DOI 10.1016/0892-6875(91)90080-F; Ogundele LT, 2017, ENVIRON RES, V156, P320, DOI 10.1016/j.envres.2017.03.051; Pena-Fernandez A, 2014, ENVIRON INT, V72, P176, DOI 10.1016/j.envint.2014.04.007; Rovira J, 2018, ENVIRON RES, V165, P201, DOI 10.1016/j.envres.2018.04.010; Rovira J, 2018, SCI TOTAL ENVIRON, V630, P34, DOI 10.1016/j.scitotenv.2018.02.175; Rovira J, 2016, ARCH ENVIRON CON TOX, V71, P473, DOI 10.1007/s00244-016-0308-2; Rovira J, 2015, WASTE MANAGE, V43, P168, DOI 10.1016/j.wasman.2015.05.039; Sanchez-Soberon F, 2019, ENVIRON RES, V175, P287, DOI 10.1016/j.envres.2019.05.035; Sanchez-Soberon F, 2015, ATMOS ENVIRON, V120, P109, DOI 10.1016/j.atmosenv.2015.08.020; Sasi BMJ., 2013, INT J MIN METAL MECH, V1, P219; Taiwo AM, 2014, SCI TOTAL ENVIRON, V490, P488, DOI 10.1016/j.scitotenv.2014.04.118; Tan MG, 2006, ANAL CHEM, V78, P8044, DOI 10.1021/ac061365q; Thorpe A, 2008, SCI TOTAL ENVIRON, V400, P270, DOI 10.1016/j.scitotenv.2008.06.007; U.S. EPA, 1986, RISK ASS CARC EFF; U.S. EPA, 2002, SUPPL GUID DEV SOIL, P187; US EPA, 2019, REG SCREEN LEV RSLS; WHO, 2007, HLTH RISKS HEAVY MET, P144; WHO, 2006, HLTH RISKS PART MATT, P113; WHO, 2018, ARSENIC; Worldsteel Association, 2019, FACT SHEET STEEL RAW, P3; Worldsteel Association, 2019, GLOB CRUD STEEL OUTP; Yang XX, 2019, SCI TOTAL ENVIRON, V694, DOI 10.1016/j.scitotenv.2019.07.340; Zhao J, 2014, TRANSPORT RES REC, P71, DOI 10.3141/2439-07; Zhu BQ, 2001, APPL GEOCHEM, V16, P409	58	6	6	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230983	10.1371/journal.pone.0230983	http://dx.doi.org/10.1371/journal.pone.0230983			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240214	Green Published, gold			2022-12-26	WOS:000535945000071
J	Valdez-Lopez, JC; Gulati, S; Ortiz, EA; Palczewski, K; Robinson, PR				Valdez-Lopez, Juan C.; Gulati, Sahil; Ortiz, Elelbin A.; Palczewski, Krzysztof; Robinson, Phyllis R.			Melanopsin Carboxy-terminus phosphorylation plasticity and bulk negative charge, not strict site specificity, achieves phototransduction deactivation	PLOS ONE			English	Article							MASS-SPECTROMETRIC ANALYSIS; GANGLION-CELLS; CRYSTAL-STRUCTURE; RHODOPSIN; ARRESTIN; IDENTIFICATION; EXPRESSION; KINETICS; OPSIN; TAIL	Melanopsin is a visual pigment expressed in a small subset of ganglion cells in the mammalian retina known as intrinsically photosensitive retinal ganglion cells (ipRGCs) and is implicated in regulating non-image forming functions such as circadian photoentrainment and pupil constriction and contrast sensitivity in image formation. Mouse melanopsin's Carboxyterminus (C-terminus) possesses 38 serine and threonine residues, which can potentially serve as phosphorylation sites for a G-protein Receptor Kinase (GRK) and be involved in the deactivation of signal transduction. Previous studies suggest that S388, T389, S391, S392, S394, S395 on the proximal region of the C-terminus of mouse melanopsin are necessary for melanopsin deactivation. We expressed a series of mouse melanopsin C-terminal mutants in HEK293 cells and using calcium imaging, and we found that the necessary cluster of six serine and threonine residues, while being critical, are insufficient for proper melanopsin deactivation. Interestingly, the additional six serine and threonine residues adjacent to the required six sites, in either proximal or distal direction, are capable of restoring wild-type deactivation of melanopsin. These findings suggest an element of plasticity in the molecular basis of melanopsin phosphorylation and deactivation. In addition, C-terminal chimeric mutants and molecular modeling studies support the idea that the initial steps of deactivation and beta- arrestin binding are centered around these critical phosphorylation sites (S388-S395). The degree of functional versatility described in this study, along with ipRGC biophysical heterogeneity and the possible use of multiple signal transduction cascades, might contribute to the diverse ipRGC light responses for use in non-image and image forming behaviors, even though all six sub types of ipRGCs express the same melanopsin gene OPN4.	[Valdez-Lopez, Juan C.; Ortiz, Elelbin A.; Robinson, Phyllis R.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA; [Gulati, Sahil; Palczewski, Krzysztof] Univ Calif Irvine, Gavin Herbert Eye Inst, Dept Ophthalmol, Irvine, CA USA; [Gulati, Sahil] Gatan Inc, Pleasanton, CA USA; [Ortiz, Elelbin A.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University System of Maryland; University of Maryland Baltimore County; University of California System; University of California Irvine; University of Pennsylvania; Pennsylvania Medicine	Robinson, PR (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA.	probinso@umbc.edu		Robinson, Phyllis/0000-0002-3828-8826; Ortiz, Elelbin/0000-0003-2214-7428; Valdez-Lopez, Juan/0000-0003-3617-171X; Gulati, Sahil/0000-0002-8255-479X	NIH [T32 GM066706, R01 EY027202-01A1, 1S10OD023436-01]; Alcon Research Institute; Research to Prevent Blindness	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alcon Research Institute(Novartis); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	NIH Training Grant T32 GM066706 awarded to J.C.V.L.,NIH R01 EY027202-01A1 awarded to P.R.R., NIH shared instrument grant 1S10OD023436-01 (purchase of the Fusion Lumos tribrid mass spectrometer system), and the and the Alcon Research Institute (ARI; to K.P.) and Research to Prevent Blindness to The Department of Ophthalmology at UCI. K.P. is the Leopold Chair of Ophthalmology at the University of California, Irvine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Gatan Inc. is the current location for author SG, and data collection was done while affiliated with the University of California, Irvine. Gatan Inc. currently supports in the form of salaries for author SG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "Author Contributions" section.	Ablonczy Z, 2002, PHOTOCHEM PHOTOBIOL, V75, P316, DOI 10.1562/0031-8655(2002)075<0316:MSAOPR>2.0.CO;2; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Azevedo AW, 2015, ELIFE, V4, DOI 10.7554/eLife.05981; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Berg D, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0022-19.2019; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Blasic JR, 2014, BIOCHEMISTRY-US, V53, P2644, DOI 10.1021/bi401724r; Blasic JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045387; Blasic JR, 2012, CELL MOL LIFE SCI, V69, P1551, DOI 10.1007/s00018-011-0891-3; Bray L, 2014, J BIOL CHEM, V289, P33754, DOI 10.1074/jbc.M114.612614; Cameron EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113138; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Emanuel AJ, 2017, CELL REP, V21, P1048, DOI 10.1016/j.celrep.2017.09.095; Emanuel AJ, 2015, NEURON, V85, P1043, DOI 10.1016/j.neuron.2015.02.011; Fahrenkrug J, 2014, J BIOL CHEM, V289, P35482, DOI 10.1074/jbc.M114.586529; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gao Shujuan, 2014, J Mol Signal, V9, P3, DOI 10.1186/1750-2187-9-3; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hughes S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034531; Hurley JB, 1998, VISION RES, V38, P1341, DOI 10.1016/S0042-6989(97)00459-8; Jiang Z, 2018, CELL, V175, P652, DOI 10.1016/j.cell.2018.08.055; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; Lee KA, 2002, PROTEIN SCI, V11, P862, DOI 10.1110/ps.3870102; Milner ES, 2017, CELL, V171, P865, DOI 10.1016/j.cell.2017.09.005; Mure LS, 2018, CELL REP, V25, P2497, DOI 10.1016/j.celrep.2018.11.008; Mure LS, 2016, NEURON, V90, P1016, DOI 10.1016/j.neuron.2016.04.016; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Pandy-Szekeres G, 2018, NUCLEIC ACIDS RES, V46, pD440, DOI 10.1093/nar/gkx1109; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Rupp AC, 2019, ELIFE, V8, DOI 10.7554/eLife.44358; Sexton TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128690; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimamura T, 2008, J BIOL CHEM, V283, P17753, DOI 10.1074/jbc.C800040200; Shirzad-Waser N, 2016, PROG RETIN EYE RES, V52, P1, DOI 10.1016/j.preteyeres.2016.02.001; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Somasundaram P, 2017, P NATL ACAD SCI USA, V114, P2741, DOI 10.1073/pnas.1611893114; Sonoda T, 2018, NEURON, V99, P754, DOI 10.1016/j.neuron.2018.06.032; Tsukamoto H, 2015, J BIOL CHEM, V290, P27176, DOI 10.1074/jbc.M115.666305; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wong KY, 2012, J NEUROSCI, V32, P11478, DOI 10.1523/JNEUROSCI.1423-12.2012; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002; Zvonok N, 2010, J PROTEOME RES, V9, P1746, DOI 10.1021/pr900870p	53	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0228121	10.1371/journal.pone.0228121	http://dx.doi.org/10.1371/journal.pone.0228121			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236094	Green Submitted, Green Published, gold			2022-12-26	WOS:000535938700003
J	Lerch, S; Rey-Cadilhac, L; Cariou, R; Faulconnier, Y; Jondreville, C; Roux, D; Dervilly-Pinel, G; Le Bizec, B; Jurjanz, S; Ferlay, A				Lerch, Sylvain; Rey-Cadilhac, Lucille; Cariou, Ronan; Faulconnier, Yannick; Jondreville, Catherine; Roux, Denis; Dervilly-Pinel, Gaud; Le Bizec, Bruno; Jurjanz, Stefan; Ferlay, Anne			Undernutrition combined with dietary mineral oil hastens depuration of stored dioxin and polychlorinated biphenyls in ewes. 2. Tissue distribution, mass balance and body burden	PLOS ONE			English	Article							DIBENZO-P-DIOXINS; ADIPOSE TISSUES; FEEDING LEVEL; PCBS; FOOD; FAT; METABOLISM; PREDICTION; RAPESEED; MUSCLE	Food safety crises involving persistent organic pollutants (POPs) lead to systematic slaughter of livestock to prevent contaminants from entering the food chain. Therefore, there is a need to develop strategies to depurate livestock moderately contaminated with POPs to reduce economic and social damage. This study aimed to test undernutrition (37% of energy requirements) combined with mineral oil (10% in total dry matter intake) in nine non-lactating ewes contaminated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and polychlorinated biphenyls (PCBs) 126 and 153 as a strategy to enhance the depuration of POPs through faecal excretion. To better understand the underlying mechanisms of the depuration process, lipophilic POPs and lipid fluxes were co-monitored in various body and excretion compartments. Body compartments (adipose tissues, muscle, liver and blood) and the total empty body were analyzed for lipids and POPs concentrations and burdens at slaughter, as well as excretion compartments (faeces and wool) collected during the depuration period. Decreases in empty body total and lipid weights were 6-fold higher in underfed and supplemented ewes compared to control ewes. In addition, over the depuration period undernutrition and supplementation treatment increased faecal TCDD, PCBs 126 and 153 excretions by 1.4- to 2.1-fold but tended to decrease wool PCB 153 excretion by 1.4-fold. This induced 2- to 3-fold higher decreases in the empty body POPs burdens for underfed and supplemented ewes. Nonetheless, when expressed relative to the calculated initial empty body burdens, burdens at slaughter decreased only slightly from 97%, 103% and 98% for control ewes to 92%, 97% and 94% for underfed and supplemented ones, for TCDD, PCBs 126 and 153, respectively. Fine descriptions at once of POPs kinetic (companion paper 1) and mass balance (companion paper 2), and of body lipid dynamics were very useful in improving our understanding of the fate of POPs in the ruminants.	[Lerch, Sylvain; Rey-Cadilhac, Lucille; Jondreville, Catherine; Jurjanz, Stefan] Univ Lorraine, INRAE, UR AFPA, Nancy, France; [Lerch, Sylvain] Agroscope, Ruminant Res Unit, Posieux, Switzerland; [Rey-Cadilhac, Lucille; Faulconnier, Yannick; Ferlay, Anne] Univ Clermont Auvergne, UMR Herbivores, VetAgro Sup, INRAE, St Genes Champanelle, France; [Cariou, Ronan; Dervilly-Pinel, Gaud; Le Bizec, Bruno] INRAE, Oniris, LABERCA, Nantes, France; [Roux, Denis] INRAE, UE Herbipole, St Genes Champanelle, France	INRAE; Universite de Lorraine; Swiss Federal Research Station Agroscope; INRAE; Universite Clermont Auvergne (UCA); VetAgro Sup; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Nantes Universite; INRAE	Lerch, S (corresponding author), Univ Lorraine, INRAE, UR AFPA, Nancy, France.; Lerch, S (corresponding author), Agroscope, Ruminant Res Unit, Posieux, Switzerland.	sylvain.lerch@agroscope.admin.ch	Dervilly-Pinel, Gaud/B-5060-2016; Lerch, Sylvain/AAD-5727-2021; Cariou, Ronan/M-5549-2014	Dervilly-Pinel, Gaud/0000-0002-1867-0008; Lerch, Sylvain/0000-0003-0957-8012; Cariou, Ronan/0000-0002-4669-1834	"Conseil Regional de Lorraine" (Nancy, France); "Centre National Interprofessionnel de l'Economie Laitiere" (CNIEL, Paris, France)	"Conseil Regional de Lorraine" (Nancy, France)(Region Grand-Est); "Centre National Interprofessionnel de l'Economie Laitiere" (CNIEL, Paris, France)	This work was supported by the "Conseil Regional de Lorraine" (Nancy, France) under Grant "Universite/EPST-Region 2014" and by the "Centre National Interprofessionnel de l'Economie Laitiere" (CNIEL, Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antignac JP, 2006, ANAL BIOANAL CHEM, V384, P271, DOI 10.1007/s00216-005-0129-z; Atti N, 1999, ANN ZOOTECH, V48, P189, DOI 10.1051/animres:19990304; Bas P, 2001, PROD ANIM, V14, P311; Cariou R, 2010, ENVIRON POLLUT, V158, P941, DOI 10.1016/j.envpol.2009.09.010; Chilliard Y., 1987, B TECH CRZV THEIX IN, V70, P117; Delavaud C, 2007, BRIT J NUTR, V98, P106, DOI 10.1017/S0007114507704968; ECOBICHON DJ, 1969, TOXICOL APPL PHARM, V15, P420, DOI 10.1016/0041-008X(69)90040-4; Faulconnier Y, 1999, PROD ANIM, V12, P287; Feil VJ, 2000, J AGR FOOD CHEM, V48, P6163, DOI 10.1021/jf0003092; FINDLAY GM, 1971, NATURE, V229, P63, DOI 10.1038/229063a0; FOLCH J, 1957, J BIOL CHEM, V226, P497; GAGLIOSTRO G, 1991, J DAIRY SCI, V74, P1893, DOI 10.3168/jds.S0022-0302(91)78355-0; GILL IJ, 1992, AUST VET J, V69, P155, DOI 10.1111/j.1751-0813.1992.tb07499.x; HERDT TH, 1988, J ANIM SCI, V66, P1997; Hoogenboom R, 2015, FOOD CONTROL, V50, P670, DOI 10.1016/j.foodcont.2014.10.010; Hoogenboom RLAP, 2015, CHEMOSPHERE, V122, P137, DOI 10.1016/j.chemosphere.2014.11.030; Huwe JK, 2005, J AGR FOOD CHEM, V53, P2362, DOI 10.1021/jf0480997; Inui H, 2014, INT J MOL SCI, V15, P14044, DOI 10.3390/ijms150814044; Jandacek RJ, 2005, AM J PHYSIOL-GASTR L, V288, pG292, DOI 10.1152/ajpgi.00285.2004; Jandacek RJ, 2007, J NUTR BIOCHEM, V18, P163, DOI 10.1016/j.jnutbio.2006.12.001; Lerch S, 2012, J DAIRY SCI, V95, P1956, DOI 10.3168/jds.2011-4575; Lerch S, 2016, J AGR FOOD CHEM, V64, P1212, DOI 10.1021/acs.jafc.5b05817; Nakao T, 2002, CHEMOSPHERE, V48, P885, DOI 10.1016/S0045-6535(02)00156-X; POLIN D, 1989, POULTRY SCI, V68, P885, DOI 10.3382/ps.0680885; Poulin P, 2012, J PHARM SCI-US, V101, P2250, DOI 10.1002/jps.23090; Rey-Cadilhac L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230629; Richter W, 2001, J AGR FOOD CHEM, V49, P5857, DOI 10.1021/jf010859f; ROBELIN J, 1981, J LIPID RES, V22, P452; ROZMAN K, 1984, B ENVIRON CONTAM TOX, V32, P27, DOI 10.1007/BF01607461; ROZMAN K, 1982, J AGR FOOD CHEM, V30, P98, DOI 10.1021/jf00109a022; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Thomas GO, 1999, ENVIRON SCI TECHNOL, V33, P104, DOI 10.1021/es980322r; UNEP, 2001, FIN ACT PLEN STOCKH, P445; VANKEULEN J, 1977, J ANIM SCI, V44, P282	34	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230628	10.1371/journal.pone.0230628	http://dx.doi.org/10.1371/journal.pone.0230628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HO	32231383	Green Published, gold			2022-12-26	WOS:000535937400014
J	Liu, YW; Lin, CC; Yong, CEC; Wang, CC; Chen, CL; Wang, JH; Yen, YH				Liu, Yueh-Wei; Lin, Chih-Che; Yong, Chee-Chien; Wang, Chih-Chi; Chen, Chao-Long; Wang, Jing-Houng; Yen, Yi-Hao			Prognosis after resection of single large hepatocellular carcinoma: Results from an Asian high-volume liver surgery center	PLOS ONE			English	Article							STAGE B; SUBCLASSIFICATION; FIBROSIS	Background & aims In 2012, the Barcelona Clinic Liver Cancer (BCLC) system designated a single large hepatocellular carcinoma (SLHCC) (> 5 cm) as BCLC stage A rather than stage B. However, a recent study from western countries reported that prognosis following liver resection (LR) among patients with SLHCC was similar to that among patients with BCLC stage B. We aim to evaluate the prognosis following LR among patients with SLHCC from an Asian high-volume liver surgery center. Methods Patients who underwent curative-intent LR for histologically proven HCC between 2011 and 2017 were enrolled using an HCC registry database. Overall survival (OS) among patients with BCLC stages 0, A, and B was examined. Patients with a SLHCC were classified as BCLC stage A1. Results Among 543 patients, 89 (16.4%) were BCLC stage 0, 289 (53.2%) were BCLC stage A, 92 (16.9%) were BCLC stage A1, and 73 (13.4%) were BCLC stage B. The median follow-up was 38 months. The five-year OS rates among patients with BCLC stages 0, A, A1, and B were 83.5%, 83.7%, 77.4%, and 55.4%, respectively (p<0.001). No difference in OS was noted for patients with BCLC stage A versus A1 (p = 0.11), even after adjusting for competing factors (hazard ratio = 0.97, 95% confidence interval = 0.53-1.79; p = 0.93). Conclusion Prognosis following LR among patients with SLHCC was similar to that among patients with BCLC stage A. The prognosis for SLHCC should thus be considered comparable to that for BCLC stage A.	[Liu, Yueh-Wei; Lin, Chih-Che; Yong, Chee-Chien; Wang, Chih-Chi; Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Ctr, Kaohsiung, Taiwan; [Liu, Yueh-Wei; Lin, Chih-Che; Yong, Chee-Chien; Wang, Chih-Chi; Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Wang, Jing-Houng; Yen, Yi-Hao] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Wang, Jing-Houng; Yen, Yi-Hao] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Yen, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.; Yen, YH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	cassellyen@yahoo.com.tw			Kaohsiung Chang Gung Memorial Hospital, Taiwan [CMRPG8J1281]	Kaohsiung Chang Gung Memorial Hospital, Taiwan	This study was supported by Grant CMRPG8J1281 from the Kaohsiung Chang Gung Memorial Hospital, Taiwan. Grant Recipient is YiHao Yen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolondi L, 2012, SEMIN LIVER DIS, V32, P348, DOI 10.1055/s-0032-1329906; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chiang CJ, 2015, HEPATOLOGY, V61, P1154, DOI 10.1002/hep.27630; Cho Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165722; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Ertle J, 2011, INT J CANCER, V128, P2436, DOI 10.1002/ijc.25797; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, 2019, J Hepatol, V70, P817, DOI 10.1016/j.jhep.2019.01.020; Everhart JE, 2010, HEPATOLOGY, V51, P585, DOI 10.1002/hep.23315; Gawrieh S, 2019, ALIMENT PHARM THER, V50, P809, DOI 10.1111/apt.15464; Ha Y, 2014, J GASTROEN HEPATOL, V29, P787, DOI 10.1111/jgh.12452; Ishii M, 2014, WORLD J GASTROENTERO, V20, P3335, DOI 10.3748/wjg.v20.i12.3335; Jung YK, 2016, J GASTROEN HEPATOL, V31, P467, DOI 10.1111/jgh.13152; Liu PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155588; Marrero JA, 2018, HEPATOLOGY, V68, P723, DOI 10.1002/hep.29913; Marubashi S, 2015, BRIT J SURG, V102, P776, DOI 10.1002/bjs.9815; Moris D, 2018, EJSO-EUR J SURG ONC, V44, P927, DOI 10.1016/j.ejso.2018.04.018; Okamura Y, 2014, J GASTROINTEST SURG, V18, P1994, DOI 10.1007/s11605-014-2646-6; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734; Piscaglia F, 2016, HEPATOLOGY, V63, P827, DOI 10.1002/hep.28368; Ramesh H, 2014, J CLIN EXP HEPATOL, V4, pS90, DOI 10.1016/j.jceh.2014.07.002; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Tsilimigras DI, 2019, ANN SURG ONCOL, V26, P3693, DOI 10.1245/s10434-019-07580-9; Vitale A, 2015, J HEPATOL, V62, P617, DOI 10.1016/j.jhep.2014.10.037; Yamakado K, 2014, JPN J RADIOL, V32, P644, DOI 10.1007/s11604-014-0358-1	25	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0230897	10.1371/journal.pone.0230897	http://dx.doi.org/10.1371/journal.pone.0230897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218593	Green Published, gold			2022-12-26	WOS:000535935400030
J	Rezvan, M; Shekarpour, S; Alshargi, F; Thirunarayan, K; Shalin, VL; Sheth, A				Rezvan, Mohammadreza; Shekarpour, Saeedeh; Alshargi, Faisal; Thirunarayan, Krishnaprasad; Shalin, Valerie L.; Sheth, Amit			Analyzing and learning the language for different types of harassment	PLOS ONE			English	Article								THIS ARTICLE USES WORDS OR LANGUAGE THAT IS CONSIDERED PROFANE, VULGAR, OR OFFENSIVE BY SOME READERS. The presence of a significant amount of harassment in user-generated content and its negative impact calls for robust automatic detection approaches. This requires the identification of different types of harassment. Earlier work has classified harassing language in terms of hurtfulness, abusiveness, sentiment, and profanity. However, to identify and understand harassment more accurately, it is essential to determine the contextual type that captures the interrelated conditions in which harassing language occurs. In this paper we introduce the notion of contextual type in harassment by distinguishing between five contextual types: (i) sexual, (ii) racial, (iii) appearance-related, (iv) intellectual and (v) political. We utilize an annotated corpus from Twitter distinguishing these types of harassment. We study the context of each kind to shed light on the linguistic meaning, interpretation, and distribution, with results from two lines of investigation: an extensive linguistic analysis, and the statistical distribution of uni-grams. We then build type- aware classifiers to automate the identification of type-specific harassment. Our experiments demonstrate that these classifiers provide competitive accuracy for identifying and analyzing harassment on social media. We present extensive discussion and significant observations about the effectiveness of type-aware classifiers using a detailed comparison setup, providing insight into the role of type-dependent features.	[Rezvan, Mohammadreza] Univ Wisconsin, Madison, WI 53706 USA; [Shekarpour, Saeedeh] Univ Dayton, Dayton, OH 45469 USA; [Thirunarayan, Krishnaprasad; Shalin, Valerie L.] Wright State Univ, Knoesis Ctr, Dayton, OH 45435 USA; [Alshargi, Faisal] Univ Leipzig, Leipzig, Germany; [Sheth, Amit] Univ South Carolina, AI Inst, Columbia, SC 29208 USA	University of Wisconsin System; University of Wisconsin Madison; University of Dayton; University System of Ohio; Wright State University Dayton; Leipzig University; University of South Carolina System; University of South Carolina Columbia	Rezvan, M (corresponding author), Univ Wisconsin, Madison, WI 53706 USA.; Shekarpour, S (corresponding author), Univ Dayton, Dayton, OH 45469 USA.	mohammadrezarezvan94@gmail.com; sshekarpour1@udayton.edu	Sheth, Amit/ABC-4600-2020	Sheth, Amit/0000-0002-0021-5293	National Science Foundation (NSF) [CNS 1513721]; Context-Aware Harassment Detection on Social Media	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Context-Aware Harassment Detection on Social Media	We acknowledge support from the National Science Foundation (NSF, https://www.nsf.gov) award CNS 1513721: Context-Aware Harassment Detection on Social Media. Dr. Amit Sheth, Dr. Krishnaprasad Thirunarayan, and Dr. Valerie Shalin received this award. Any opinions, findings, and conclusions, recommendations expressed in this material are those of the author (s) and do not necessarily reflect the views of the NSF. And the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berne S, 2014, BODY IMAGE, V11, P527, DOI 10.1016/j.bodyim.2014.08.006; Chatzakou D, P 2017 ACM WEB SCI C; Chen Y, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P71, DOI 10.1109/SocialCom-PASSAT.2012.55; Cheng L, P 12 ACM INT C WEB S; Coe R., 2002, BRIT ED RES ASS ANN, P1214; Davidson Thomas, 2017, P INT AAAI C WEB SOC, V11, P512; Dinakar K., 2011, 5 INT AAAI C WEBL SO, P11; Duggan Maeve, 2017, ONLINE HARASSMENT 20; Edupuganti V., 2017, THESIS; ElSherief Mai, 2018, ICWSM; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Founta Antigoni-Maria, 2018, ARXIV180200393; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Golbeck J, P 2017 ACM WEB SCI C; Goldhahn ETQ D., 2012, P LREC 2012, P759, DOI [10.1016/j.dcan.2017.10.002, DOI 10.1016/J.DCAN.2017.10.002]; Ho Chung Wu, 2008, ACM Transactions on Information Systems, V26; Hong L., 2009, P CONTENT ANAL WEB, V2, P1; Hosseinmardi H, 2016, PROCEEDINGS OF THE 2016 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING ASONAM 2016, P186, DOI 10.1109/ASONAM.2016.7752233; Hosseinmardi Homa, 2015, ARXIV150303909; Hub B, 2010, GUID DEAL POL HAR WO; Jurafsky Dan, 2014, SPEECH LANGUAGE PROC, V3; Kandakatla R., 2016, THESIS; Mahdavinejad MS, 2018, DIGIT COMMUN NETW, V4, P161, DOI 10.1016/j.dcan.2017.10.002; Mangaonkar A, 2015, INT CONF ELECTRO INF, P611, DOI 10.1109/EIT.2015.7293405; Marshall TC, 2015, PERS INDIV DIFFER, V85, P35, DOI 10.1016/j.paid.2015.04.039; Marwa T., 2018, P PAIS 2018 INT C PA, DOI [10.1109/PAIS.2018.8598530, DOI 10.1109/PAIS.2018.8598530]; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Mishne G., 2005, P ACM SIGIR 2005 WOR, P321; Mohammadreza Rezvan SS, 2018, HARASSMENT CORPUS; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nandhini BS, 2015, PROCEDIA COMPUT SCI, V45, P485, DOI 10.1016/j.procs.2015.03.085; Nobata C, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16), P145, DOI 10.1145/2872427.2883062; Pennebaker J. W., 2015, DEV PSYCHOMETRIC PRO, DOI DOI 10.15781/T29G6Z; Perez-Rosas Veronica, 2017, ARXIV170807104; Ptaszynski M, 2010, 36 AISB, P7; Raisi E., 2016, ARXIV160608084; Raisi E, P 2017 IEEE ACM INT; Raisi E, 2018, 2018 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P479; Rezvan M, 2018, WEBSCI'18: PROCEEDINGS OF THE 10TH ACM CONFERENCE ON WEB SCIENCE, P33, DOI 10.1145/3201064.3201103; Sanchez H., 2011, SER NSDI, V12, P15; Suk JC., 2012, CONTENT CONTEXT HATE, P144, DOI [10.1017/CBO9781139042871.013, DOI 10.1017/CBO9781139042871.013]; Talukder S, 2018, 12 INT AAAI C WEB SO, P385; Tokuhisa R., 2008, P 22 INT C COMP LING, V1, P881, DOI DOI 10.3115/1599081.1599192; Wang WB, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P587, DOI 10.1109/SocialCom-PASSAT.2012.119; Younus A, 2015, 2015 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE AND INTELLIGENT AGENT TECHNOLOGY (WI-IAT), VOL 1, P511, DOI 10.1109/WI-IAT.2015.27; Zois DS, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P2017	49	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0227330	10.1371/journal.pone.0227330	http://dx.doi.org/10.1371/journal.pone.0227330			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218569	Green Published, Green Submitted, gold			2022-12-26	WOS:000535935400002
J	Costa, NCS; Piccoli, JP; Santos, NA; Clementino, LC; Fusco-Almeida, AM; De Annunzio, SR; Fontana, CR; Verga, JBM; Eto, SF; Pizauro, JM; Graminha, MAS; Cilli, EM				Costa, Natalia C. S.; Piccoli, Julia P.; Santos-Filho, Norival A.; Clementino, Leandro C.; Fusco-Almeida, Ana M.; De Annunzio, Sarah R.; Fontana, Carla R.; Verga, Juliane B. M.; Eto, Silas F.; Pizauro-Junior, Joao M.; Graminha, Marcia A. S.; Cilli, Eduardo M.			Antimicrobial activity of RP-1 peptide conjugate with ferrocene group	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; IN-VITRO; ESCHERICHIA-COLI; AMPHOTERICIN-B; RESISTANCE; BACTERIAL; LEISHMANIASIS; ANTIBACTERIAL; EFFICACY	Parasitic diseases are a neglected and serious problem, especially in underdeveloped countries. Among the major parasitic diseases, Leishmaniasis figures as an urgent challenge due to its high incidence and severity. At the same time, the indiscriminate use of antibiotics by the population is increasing together with resistance to medicines. To address this problem, new antibiotic-like molecules that directly kill or inhibit the growth of microorganisms are necessary, where antimicrobial peptides (AMPs) can be of great help. In this work, the ferrocene molecule, one active compound with low levels of in vivo toxicity, was coupled to the N-terminus of the RP1 peptide (derived from the human chemokine CXCL4), aiming to evaluate how this change modifies the structure, biological activity, and toxicity of the peptide. The peptide and the conjugate were synthesized using the solid phase peptide synthesis (SPPS). Circular dichroism assays in PBS showed that the RP1 peptide and its conjugate had a typical spectrum for disordered structures. The Fc-RP1 presented anti-amastigote activity against Leishmania amazonensis (IC50 = 0.25 mu mol L-1). In comparison with amphotericin B, a second-line drug approved for leishmaniasis treatment, (IC50 = 0.63 mu mol L-1), Fc-RP1 was more active and showed a 2.5-fold higher selectivity index. The RP1 peptide presented a MIC of 4.3 mu mol L-1 against S. agalactiae, whilst Fc-RP1 was four times more active (MIC = 0.96 mu mol L-1), indicating that ferrocene improved the antimicrobial activity against Gram-positive bacteria. The Fc-RP1 peptide also decreased the minimum inhibitory concentration (MIC) in the assays against E. faecalis (MIC = 7.9 mu mol L-1), E. coli (MIC = 3.9 mu mol L-1) and S. aureus (MIC = 3.9 mu mol L-1). The cytotoxicity of the compounds was tested against HaCaT cells, and no significant activity at the highest concentration tested (500 mu g. mL(-1)) was observed, showing the high potential of this new compound as a possible new drug. The coupling of ferrocene also increased the vesicle permeabilization of the peptide, showing a direct relation between high peptide concentration and high carboxy-fluorescein release, which indicates the action mechanism by pore formation on the vesicles. Several studies have shown that ferrocene destabilizes cell membranes through lipid peroxidation, leading to cell lysis. It is noteworthy that the Fc-RP1 peptide synthesized here is a prototype of a bioconjugation strategy, but it still is a compound with great biological activity against neglected and fish diseases.	[Costa, Natalia C. S.; Piccoli, Julia P.; Santos-Filho, Norival A.; Cilli, Eduardo M.] Sao Paulo State Univ UNESP, Inst Chem, Dept Biochem & Technol Chem, Araraquara, SP, Brazil; [Costa, Natalia C. S.; Clementino, Leandro C.; Fusco-Almeida, Ana M.; De Annunzio, Sarah R.; Fontana, Carla R.; Verga, Juliane B. M.; Graminha, Marcia A. S.] Sao Paulo State Univ UNESP, Sch Pharmaceut Sci, Dept Clin Anal, Araraquara, SP, Brazil; [Eto, Silas F.; Pizauro-Junior, Joao M.] Sao Paulo State Univ UNESP, Fac Agr & Vet Sci, Araraquara, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Cilli, EM (corresponding author), Sao Paulo State Univ UNESP, Inst Chem, Dept Biochem & Technol Chem, Araraquara, SP, Brazil.; Graminha, MAS (corresponding author), Sao Paulo State Univ UNESP, Sch Pharmaceut Sci, Dept Clin Anal, Araraquara, SP, Brazil.	marcia.graminha@unesp.br; eduardo.cilli@unesp.br	Mendonça, Carla Raquel Fontana/ABF-6409-2020; Fontana, Carla/AAY-7578-2020; Santos-Filho, Norival Alves/G-1812-2012; Cilli, Eduardo Maffud/B-9130-2012; Graminha, Marcia/D-7951-2013; Clementino, Leandro C/P-7912-2017; Pizauro, Joao/D-3171-2012	Mendonça, Carla Raquel Fontana/0000-0002-9135-3690; Santos-Filho, Norival Alves/0000-0002-0344-6900; Cilli, Eduardo Maffud/0000-0002-4767-0904; Graminha, Marcia/0000-0001-7280-3775; Clementino, Leandro C/0000-0001-5196-6372; Buzzon Meneghesso Verga, Juliane/0000-0001-7006-7663; INCT de Optica Basica e Aplicada as Ciencias da Vida (CNPq), CePOF (FAPESP)/0000-0002-6403-4037; De Annunzio, Sarah Raquel/0000-0001-5477-2135; Pizauro, Joao/0000-0002-0911-5053; Eto, Silas Fernandes/0000-0003-4796-9727	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) [18/11384-8, 2013/07600-3]; CNPq [01/2016-CNPQ-(420405/2016notsign 0)]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We are grateful to Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) (18/11384-8, 2013/07600-3) and CNPq (Universal Project 01/2016-CNPQ-(420405/2016notsign 0) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for financial support.	Abbassi F, 2008, PEPTIDES, V29, P1526, DOI 10.1016/j.peptides.2008.05.008; af Geijersstam AR, 2007, ORAL MICROBIOL IMMUN, V22, P87, DOI 10.1111/j.1399-302X.2007.00327.x; Agarwal S, 2016, MED PRIN PRACT, V25, P301, DOI 10.1159/000443479; Aoki W, 2013, PHARMACEUTICALS-BASE, V6, P1055, DOI 10.3390/ph6081055; Velasquez AMA, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00688-17; Velasquez AMA, 2014, BIOORG MED CHEM LETT, V24, P1707, DOI 10.1016/j.bmcl.2014.02.046; Auvynet C, 2009, FEBS J, V276, P6497, DOI 10.1111/j.1742-4658.2009.07360.x; Beceiro A, 2013, CLIN MICROBIOL REV, V26, P185, DOI 10.1128/CMR.00059-12; Bourbigot S, 2009, BIOPOLYMERS, V91, P1, DOI 10.1002/bip.21071; Bromley EHC, 2011, PROG MOL BIOL TRANSL, V103, P231, DOI 10.1016/B978-0-12-415906-8.00001-7; Brown ED, 2016, NATURE, V529, P336, DOI 10.1038/nature17042; Casallanovo F, 2006, BIOPOLYMERS, V84, P169, DOI 10.1002/bip.20374; Chang SK, 2015, J VET MED SCI, V77, P59, DOI 10.1292/jvms.13-0281; Chavez-Fumagalli MA, 2015, REV SOC BRAS MED TRO, V48, P235, DOI 10.1590/0037-8682-0138-2015; Chohan ZH, 2009, J ENZYM INHIB MED CH, V24, P169, DOI [10.1080/14756360801948766, 10.1080/14756360801948766 ]; Cilli EM, 2007, TOXICON, V50, P1201, DOI 10.1016/j.toxicon.2007.07.013; Clementino LD, 2018, REV BRAS FARMACOGN, V28, P673, DOI 10.1016/j.bjp.2018.07.008; Coqueiro A, 2014, J BRAZIL CHEM SOC, V25, P1839, DOI 10.5935/0103-5053.20140138; Crusca E, 2011, BIOPOLYMERS, V96, P41, DOI 10.1002/bip.21454; Cunha MA, 2015, AM J TROP MED HYG, V93, P1214, DOI 10.4269/ajtmh.15-0033; DA SILVA L. H. P., 1953, Folia Clinica et Biologica, V20, P191; de Almeida L, 2017, J BIOMED NANOTECHNOL, V13, P117, DOI 10.1166/jbn.2017.2349; Deshayes S, 2017, BIOCONJUGATE CHEM, V28, P793, DOI 10.1021/acs.bioconjchem.6b00725; Domarle O, 1998, ANTIMICROB AGENTS CH, V42, P540, DOI 10.1128/AAC.42.3.540; dos Santos VAFFM, 2013, MOLECULES, V18, P1053, DOI 10.3390/molecules18011053; Dutra LA, 2014, ANTIMICROB AGENTS CH, V58, P4837, DOI 10.1128/AAC.00052-14; Ebbensgaard A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144611; Erfe MCB, 2012, ANTIMICROB AGENTS CH, V56, P658, DOI 10.1128/AAC.05349-11; Eto SF, 2018, FISH SHELLFISH IMMUN, V76, P153, DOI 10.1016/j.fsi.2018.02.048; Falkenberg M, 2019, J APPL PHYCOL, V31, P797, DOI 10.1007/s10811-018-1572-5; Florek OB, 2018, ACTA CRYSTALLOGR D, V74, P1233, DOI 10.1107/S2059798318009440; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Frieri M, 2017, J INFECT PUBLIC HEAL, V10, P369, DOI 10.1016/j.jiph.2016.08.007; Gangcuangco LM, 2015, INT J INFECT DIS, V34, P55, DOI 10.1016/j.ijid.2015.02.022; Gow NAR, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0035-2016; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gross A, 2011, DALTON T, V40, P1382, DOI 10.1039/c0dt01113d; Guilhelmelli F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00353; Hamblin MR, 2016, CURR OPIN MICROBIOL, V33, P67, DOI 10.1016/j.mib.2016.06.008; Kishi RNI, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203451; Jaouen G, 2015, CHEM SOC REV, V44, P8802, DOI 10.1039/c5cs00486a; Kulkarni MM, 2006, MOL MICROBIOL, V62, P1484, DOI 10.1111/j.1365-2958.2006.05459.x; Kumar P, 2017, 3 BIOTECH, V8, DOI 10.1007/s13205-017-1049-2; LaRock CN, 2015, BBA-BIOMEMBRANES, V1848, P3047, DOI 10.1016/j.bbamem.2015.02.010; Lauridsen TK, 2011, SCAND J INFECT DIS, V43, P545, DOI 10.3109/00365548.2011.554432; Leprohon P, 2015, INT J PARASITOL-DRUG, V5, P26, DOI 10.1016/j.ijpddr.2014.09.005; Li BY, 2018, J ORTHOP RES, V36, P22, DOI 10.1002/jor.23656; Lippert R, 2017, J INORG BIOCHEM, V171, P76, DOI 10.1016/j.jinorgbio.2017.03.002; Lorenzon EN, 2013, AMINO ACIDS, V44, P1521, DOI 10.1007/s00726-013-1475-3; Lorenzon EN, 2014, AMINO ACIDS, V46, P2627, DOI 10.1007/s00726-014-1832-x; Lu DL, 2018, FISH SHELLFISH IMMUN; Malanovic N, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9030059; Marquette A, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020018; Medina-Alarcon KP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01048; MERRIFIELD RB, 1964, BIOCHEMISTRY-US, V3, P1385, DOI 10.1021/bi00897a032; Miklan Z, 2007, BIOPOLYMERS, V88, P108, DOI 10.1002/bip.20696; Monte-Neto R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003476; Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Oryan A, 2016, ASIAN PAC J TROP MED, V9, P901, DOI 10.1016/j.apjtm.2016.06.021; Paganelli FL, 2012, TRENDS MICROBIOL, V20, P40, DOI 10.1016/j.tim.2011.11.001; Passalacqua TG, 2015, BIOORG MED CHEM LETT, V25, P3342, DOI 10.1016/j.bmcl.2015.05.072; Pech-Canul Angel de la Cruz, 2017, J Parasitol Res, V2017, P3751403, DOI 10.1155/2017/3751403; Piccoli JP, 2016, BIOPOLYMERS, V106, P357, DOI 10.1002/bip.22815; Pigott DM, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.36; Pinto MC, 2011, J MED ENTOMOL, V48, P39, DOI 10.1603/ME10081; Pinto MC, 2005, MEM I OSWALDO CRUZ, V100, P733, DOI 10.1590/S0074-02762005000700009; Rai Jaswant, 2013, Int J Appl Basic Med Res, V3, P3, DOI 10.4103/2229-516X.112229; Raja Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174024; Rauf MK, 2016, ARCH PHARM, V349, P50, DOI 10.1002/ardp.201500312; Reinhardt A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050701; Luque-Ortega JR, 2008, FASEB J, V22, P1817, DOI 10.1096/fj.07-096081; Russell AL, 2010, CHEM PHYS LIPIDS, V163, P488, DOI 10.1016/j.chemphyslip.2010.03.009; Saleem M, 2015, ANAL CHIM ACTA, V876, P9, DOI 10.1016/j.aca.2015.01.012; Santos MM, 2017, MINI-REV MED CHEM, V17, P771, DOI 10.2174/1389557516666161031141620; Santos VAFFM, 2012, J NAT PROD, V75, P991, DOI 10.1021/np300077r; Singh A, 2019, DALTON T, V48, P3146, DOI 10.1039/c9dt90027f; Singh A, 2019, DALTON T, V48, P2840, DOI 10.1039/c8dt03440k; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Tiwari KN, 2012, DALTON T, V41, P6451, DOI 10.1039/c2dt12180h; Torrent M, 2012, CURR DRUG TARGETS, V13, P1138, DOI 10.2174/138945012802002393; Ubeda JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r115; United Nations DoEaSA Population Division, 2017, ESAPWP248 UN DOEASA; Van Tyne D, 2013, TOXINS, V5, P895, DOI 10.3390/toxins5050895; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Velasquez AMA, 2016, J BRAZIL CHEM SOC, V27, P1032, DOI 10.5935/0103-5053.20150360; Vera J, 2011, DALTON T, V40, P9557, DOI 10.1039/c1dt10995b; Vicente EF, 2017, J PHYS CHEM B, V121, P11085, DOI 10.1021/acs.jpcb.7b09642; Vicente EF, 2015, PROTEIN PEPTIDE LETT, V22, P119, DOI 10.2174/0929866521666140508125215; Vouga M, 2016, CLIN MICROBIOL INFEC, V22, P12, DOI 10.1016/j.cmi.2015.10.010; Wang Y, 2015, ANGEW CHEM INT EDIT, V54, P10230, DOI 10.1002/anie.201503048; Wenzel M, 2013, ACS CHEM BIOL, V8, P1442, DOI 10.1021/cb4000844; Yang H, 2016, MAR DRUGS, V14, DOI 10.3390/md14050096; Zhang LJ, 2016, CURR BIOL, V26, pR14, DOI 10.1016/j.cub.2015.11.017	95	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0228740	10.1371/journal.pone.0228740	http://dx.doi.org/10.1371/journal.pone.0228740			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214347	Green Published, gold			2022-12-26	WOS:000535934200006
J	Schmidt-Sane, MM; Nielsen, JO; Chikombero, M; Lubowa, D; Lwanga, M; Gamusi, J; Kabanda, R; Kaawa-Mafigiri, D				Schmidt-Sane, Megan M.; Nielsen, Jannie O.; Chikombero, Mandi; Lubowa, Douglas; Lwanga, Miriam; Gamusi, Jonathan; Kabanda, Richard; Kaawa-Mafigiri, David			Challenges to Ebola preparedness during an ongoing outbreak: An analysis of borderland livelihoods and trust in Uganda	PLOS ONE			English	Article								Ebola Virus Disease in the Democratic Republic of Congo (DRC) was declared a public health emergency of international concern on July 17, 2019. The first case to cross the border into Uganda in June 2019 demonstrates the importance of better understanding border dynamics in a context of Ebola. This paper adopts a political economy approach to contextualize epidemic response programs conducted in moderate- and high-risk border districts in Uganda, through a qualitative study with 287 participants. To that end, our aim was to describe the historical underpinnings of the borderlands context; the role of livelihood strategies in constraining risk avoidance decisions; and the dynamics of trust in authority figures, including health workers. This paper reports that border communities are highly connected, for a variety of social and economic reasons. These daily realities are in direct opposition to guidance to limit travel during an active Ebola epidemic. We argue that an ability to limit movement is constrained by the economic need to seek livelihood strategies wherever that may be. Moreover, border regions are populated by communities with long-standing distrust in authority figures, particularly in fishing areas. This distrust spills over with consequences for Ebola prevention and control activities. This research indexes the importance of tailoring Ebola programming and policies to consider the political and economic dynamics of borderlands.	[Schmidt-Sane, Megan M.; Kaawa-Mafigiri, David] Makerere Univ, Dept Social Work & Social Adm, Sch Social Sci, Kampala, Uganda; [Schmidt-Sane, Megan M.; Nielsen, Jannie O.; Kaawa-Mafigiri, David] Makerere Univ, Ctr Social Sci Res AIDS, Sch Social Sci, Kampala, Uganda; [Schmidt-Sane, Megan M.; Kaawa-Mafigiri, David] Case Western Reserve Univ, Dept Anthropol, Cleveland, OH 44106 USA; [Chikombero, Mandi; Lubowa, Douglas; Lwanga, Miriam; Gamusi, Jonathan] UNICEF Uganda, Kampala, Uganda; [Kabanda, Richard] Uganda Minist Hlth, Kampala, Uganda	Makerere University; Makerere University; Case Western Reserve University	Schmidt-Sane, MM (corresponding author), Makerere Univ, Dept Social Work & Social Adm, Sch Social Sci, Kampala, Uganda.; Schmidt-Sane, MM (corresponding author), Makerere Univ, Ctr Social Sci Res AIDS, Sch Social Sci, Kampala, Uganda.; Schmidt-Sane, MM (corresponding author), Case Western Reserve Univ, Dept Anthropol, Cleveland, OH 44106 USA.	mms44@case.edu		Schmidt-Sane, Megan/0000-0003-3669-7527	UNICEF Uganda	UNICEF Uganda	DKM received funding from UNICEF Uganda (https://www.unicef.org/uganda/) to conduct this work. The funders did not play a role in study design, data collection, analysis. The funders did approve the publication of this study and contributed to the preparation of the manuscript.	Abramowitz S, 2017, ANNU REV ANTHROPOL, V46, P421, DOI 10.1146/annurev-anthro-102116-041616; Abramowitz SA, 2015, LANCET, V385, P330, DOI 10.1016/S0140-6736(15)60119-2; [Anonymous], 2011, RES METHODS ANTHR; [Anonymous], 2018, UG NAT EB VIR DIS CO; [Anonymous], 2019, 542016 WHO REG OFF A; [Anonymous], 2019, EB VIR DIS UG SIT RE; [Anonymous], 2019, RAD TACKL RUM MIS DR; [Anonymous], 2019, EB VIR DIS DEM REP C; Martin AIC, 2016, INT HEALTH, V8, P227, DOI 10.1093/inthealth/ihw018; Chandler C, 2015, LANCET, V385, P1275, DOI 10.1016/S0140-6736(14)62382-5; Doyal L, 1979, POLITICAL EC HLTH; Doyle S, 2009, J EAST AFR STUD, V3, P284, DOI 10.1080/17531050902972782; Espeland RH, 2006, POLITICS LAND RIGHTS; Farmer P, 2004, CURR ANTHROPOL, V45, P305, DOI 10.1086/382250; Faye S. L, 2015, ANTHR SANTE, V11; GALTUNG J, 1990, J PEACE RES, V27, P291, DOI 10.1177/0022343390027003005; Gartrell B., 1983, AFR STUD REV, V26, P1; Gatiso T, 2018, PLOS NEGLECT TROP D, V12, P1; GINI Index, 2016, WORLD BANK EST; Han C, 2018, ANNU REV ANTHROPOL, V47, P331, DOI 10.1146/annurev-anthro-102116-041644; Hewlett BS, 2007, EBOLA CULTURE POLITI; Irani J, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007344; Kibanja GM, 2012, INT CULT PSYCHOL, P403, DOI 10.1007/978-1-4614-0448-4_16; Maconachie R, 2018, J RURAL STUD, V61, P110, DOI 10.1016/j.jrurstud.2018.03.009; Mesch GS, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02016; Moran MH, 2017, ANTHROPOL QUART, V90, P399, DOI 10.1353/anq.2017.0024; Odokonyero T, 2017, UNIVERSAL HLTH COVER; Okuonzi SA, 2004, LANCET, V364, P1632, DOI 10.1016/S0140-6736(04)17320-0; Omidian Patricia., 2014, MED ANTHR STUDY EBOL; Packard R.M., 1989, WHITE PLAGUE BLACK L; Rhodes T, 2012, RETHINKING SOCIAL EPIDEMIOLOGY: TOWARDS A SCIENCE OF CHANGE, P205, DOI 10.1007/978-94-007-2138-8_10; Rohner D, 2013, J ECON GROWTH, V18, P217, DOI 10.1007/s10887-013-9093-1; Roseberry William, 1989, ANTHR HIST ESSAYS CU; Ryan MJ, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001272; SCHENSUL STEPHEN L., 1999, ESSENTIAL ETHNOGRAPH, V2; STARR H, 1983, COMP POLIT STUD, V16, P92, DOI 10.1177/0010414083016001004; Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5; Wigmore R., 2015, EBOLA RESPONSE ANTHR, V4; Wilkinson A, 2015, AFR AFFAIRS, V114, P136, DOI 10.1093/afraf/adu080; Young G, 2019, URBAN FORUM, V30, P407, DOI 10.1007/s12132-019-09372-6	41	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230683	10.1371/journal.pone.0230683	http://dx.doi.org/10.1371/journal.pone.0230683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8GI	32214381	Green Published, gold			2022-12-26	WOS:000535934200038
J	Derish, I; Lee, JKH; Wong-King-Cheong, M; Babayeva, S; Caplan, J; Leung, V; Shahinian, C; Gravel, M; Deans, MR; Gros, P; Torban, E				Derish, Ida; Lee, Jeremy K. H.; Wong-King-Cheong, Melanie; Babayeva, Sima; Caplan, Jillian; Leung, Vicki; Shahinian, Chloe; Gravel, Michel; Deans, Michael R.; Gros, Philippe; Torban, Elena			Differential role of planar cell polarity gene Vangl2 in embryonic and adult mammalian kidneys	PLOS ONE			English	Article							APICAL CONSTRICTION; CONVERGENT EXTENSION; MORPHOGENESIS; PROTEIN; GROWTH; CELSR1; RAB11; MICE	Planar cell polarity (PCP) pathway is crucial for tissue morphogenesis. Mutations in PCP genes cause multi-organ anomalies including dysplastic kidneys. Defective PCP signaling was postulated to contribute to cystogenesis in polycystic kidney disease. This work was undertaken to elucidate the role of the key PCP gene, Vangl2, in embryonic and postnatal renal tubules and ascertain whether its loss contributes to cyst formation and defective tubular function in mature animals. We generated mice with ubiquitous and collecting ductrestricted excision of Vangl2. We analyzed renal tubules in mutant and control mice at embryonic day E17.5 and postnatal days P1, P7, P30, P90, 6- and 9-month old animals. The collecting duct functions were analyzed in young and adult mutant and control mice. Loss of Vangl2 leads to profound tubular dilatation and microcysts in embryonic kidneys. Mechanistically, these abnormalities are caused by defective convergent extension (larger tubular cross-sectional area) and apical constriction (cuboidal cell shape and a reduction of activated actomyosin at the luminal surface). However, the embryonic tubule defects were rapidly resolved by Vangl2-independent mechanisms after birth. Normal collecting duct architecture and functions were found in young and mature animals. During embryogenesis, Vangl2 controls tubular size via convergent extension and apical constriction. However, rapidly after birth, PCP-dependent control of tubular size is switched to a PCP-independent regulatory mechanism. We conclude that loss of the Vangl2 gene is dispensable for tubular elongation and maintenance postnatally. It does not lead to cyst formation and is unlikely to contribute to polycystic kidney disease.	[Derish, Ida; Lee, Jeremy K. H.; Wong-King-Cheong, Melanie; Babayeva, Sima; Caplan, Jillian; Shahinian, Chloe; Torban, Elena] McGill Univ, Dept Med, Montreal, PQ, Canada; [Derish, Ida; Lee, Jeremy K. H.; Wong-King-Cheong, Melanie; Babayeva, Sima; Caplan, Jillian; Shahinian, Chloe; Torban, Elena] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada; [Leung, Vicki; Gravel, Michel; Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Deans, Michael R.] Univ Utah, Sch Med, Dept Surg, Div Otolaryngol, Salt Lake City, UT USA	McGill University; McGill University; McGill University; Utah System of Higher Education; University of Utah	Torban, E (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.; Torban, E (corresponding author), McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada.	elena.torban@mcgill.ca	Derish, Ida/AAB-9134-2022	Lee, Jeremy/0000-0001-5672-6933	Kidney Foundation of Canada [KFOC1518, KFOC1719]; Canadian Institute of Health Research [CIHR230929]	Kidney Foundation of Canada; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the grants to E.T. from the Kidney Foundation of Canada (https://kidney.ca) grants #KFOC1518 & KFOC1719 and from the Canadian Institute of Health Research (https://cihr-irsc.gc.ca) grant #CIHR230929. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babayeva S, 2013, J BIOL CHEM, V288, P24035, DOI 10.1074/jbc.M113.452904; Brzoska HL, 2016, KIDNEY INT, V90, P1274, DOI 10.1016/j.kint.2016.07.011; Carroll TJ, 2012, CURR TOP DEV BIOL, V101, P185, DOI 10.1016/B978-0-12-394592-1.00011-9; Copley CO, 2013, J NEUROSCI, V33, P14001, DOI 10.1523/JNEUROSCI.1307-13.2013; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Henderson DJ, 2006, TRENDS CARDIOVAS MED, V16, P38, DOI 10.1016/j.tcm.2005.11.005; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kunimoto K, 2017, CURR BIOL, V27, P3120, DOI 10.1016/j.cub.2017.09.011; Lienkamp SS, 2012, NAT GENET, V44, P1382, DOI 10.1038/ng.2452; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Menezes LF, 2009, METHOD CELL BIOL, V94, P273, DOI 10.1016/S0091-679X(08)94014-0; Nicolaou N, 2015, NAT REV NEPHROL, V11, P720, DOI 10.1038/nrneph.2015.140; Nishio S, 2010, J AM SOC NEPHROL, V21, P295, DOI 10.1681/ASN.2009060603; Ohata S, 2015, J NEUROSCI, V35, P11153, DOI 10.1523/JNEUROSCI.0686-15.2015; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Ossipova O, 2015, DEVELOPMENT, V142, P99, DOI 10.1242/dev.111161; Ossipova O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4734; Palmer BF, 2015, CLIN J AM SOC NEPHRO, V10, P1050, DOI 10.2215/CJN.08580813; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Queisser-Luft A., 2002, Archives of Gynecology and Obstetrics, V266, P163, DOI 10.1007/s00404-001-0265-4; Rocque BL, 2015, J AM SOC NEPHROL, V26, P576, DOI 10.1681/ASN.2014040340; Rodriguez MM, 2014, FETAL PEDIATR PATHOL, V33, P293, DOI 10.3109/15513815.2014.959678; Sai XR, 2014, DEV BIOL, V394, P206, DOI 10.1016/j.ydbio.2014.08.022; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Smith P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43444-8; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; Torban E, 2007, GENE EXPR PATTERNS, V7, P346, DOI 10.1016/j.modgep.2006.07.007; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Yates LL, 2010, HUM MOL GENET, V19, P4663, DOI 10.1093/hmg/ddq397; Yates LL, 2010, HUM MOL GENET, V19, P2251, DOI 10.1093/hmg/ddq104; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhang Z, 2010, J AM SOC NEPHROL, V21, P573, DOI 10.1681/ASN.2009070719; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230586	10.1371/journal.pone.0230586	http://dx.doi.org/10.1371/journal.pone.0230586			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GC	32203543	Green Published, gold, Green Submitted			2022-12-26	WOS:000535303900027
J	Seabright, AP; Fine, NHF; Barlow, JP; Lord, SO; Musa, I; Gray, A; Bryant, JA; Banzhaf, M; Lavery, GG; Hardie, DG; Hodson, DJ; Philp, A; Lai, YC				Seabright, Alex P.; Fine, Nicholas H. F.; Barlow, Jonathan P.; Lord, Samuel O.; Musa, Ibrahim; Gray, Alexander; Bryant, Jack A.; Banzhaf, Manuel; Lavery, Gareth G.; Hardie, D. Grahame; Hodson, David J.; Philp, Andrew; Lai, Yu-Chiang			AMPK activation induces mitophagy and promotes mitochondrial fission while activating TBK1 in a PINK1-Parkin independent manner	FASEB JOURNAL			English	Article						endogenous; mitophagy; skeletal muscle; tandem ubiquitin-binding entity (TUBE); ubiquitin	PINK1-DEPENDENT PHOSPHORYLATION; PARKIN; UBIQUITIN; PINK1; ULK1; MECHANISM; AUTOPHAGY; BINDING; IDENTIFICATION; TRANSLOCATION	Mitophagy is a key process regulating mitochondrial quality control. Several mechanisms have been proposed to regulate mitophagy, but these have mostly been studied using stably expressed non-native proteins in immortalized cell lines. In skeletal muscle, mitophagy and its molecular mechanisms require more thorough investigation. To measure mitophagy directly, we generated a stable skeletal muscle C2C12 cell line, expressing a mitophagy reporter construct (mCherry-green fluorescence protein-mtFIS1(101-152)). Here, we report that both carbonyl cyanide m-chlorophenyl hydrazone (CCCP) treatment and adenosine monophosphate activated protein kinase (AMPK) activation by 991 promote mitochondrial fission via phosphorylation of MFF and induce mitophagy by similar to 20%. Upon CCCP treatment, but not 991, ubiquitin phosphorylation, a read-out of PTEN-induced kinase 1 (PINK1) activity, and Parkin E3 ligase activity toward CDGSH iron sulfur domain 1 (CISD1) were increased. Although the PINK1-Parkin signaling pathway is active in response to CCCP treatment, we observed no change in markers of mitochondrial protein content. Interestingly, our data shows that TANK-binding kinase 1 (TBK1) phosphorylation is increased after both CCCP and 991 treatments, suggesting TBK1 activation to be independent of both PINK1 and Parkin. Finally, we confirmed in non-muscle cell lines that TBK1 phosphorylation occurs in the absence of PINK1 and is regulated by AMPK-dependent signaling. Thus, AMPK activation promotes mitophagy by enhancing mitochondrial fission (via MFF phosphorylation) and autophagosomal engulfment (via TBK1 activation) in a PINK1-Parkin independent manner.	[Seabright, Alex P.; Lord, Samuel O.; Musa, Ibrahim; Lai, Yu-Chiang] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham B15 2TT, W Midlands, England; [Fine, Nicholas H. F.; Lavery, Gareth G.; Hodson, David J.; Lai, Yu-Chiang] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England; [Barlow, Jonathan P.; Lai, Yu-Chiang] Univ Birmingham, Mitochondrial Profiling Ctr, Birmingham, W Midlands, England; [Gray, Alexander; Hardie, D. Grahame] Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Dundee, Scotland; [Bryant, Jack A.; Banzhaf, Manuel] Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Lavery, Gareth G.; Hodson, David J.] Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England; [Lavery, Gareth G.; Lai, Yu-Chiang] Univ Birmingham, MRC Versus Arthrit Ctr Musculoskeletal Ageing Res, Birmingham, W Midlands, England; [Hodson, David J.] Univ Birmingham, Ctr Membrane Prot & Receptors, Birmingham, W Midlands, England; [Philp, Andrew] Garvan Inst Med Res, Diabet & Metab Div, Sydney, NSW, Australia; [Philp, Andrew] UNSW Sydney, St Vincents Clin Sch, UNSW Med, Sydney, NSW, Australia	University of Birmingham; University of Birmingham; University of Birmingham; University of Dundee; University of Birmingham; University of Birmingham; University of Birmingham; Garvan Institute of Medical Research; University of New South Wales Sydney	Lai, YC (corresponding author), Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham B15 2TT, W Midlands, England.	y.lai.1@bham.ac.uk	Musa, Ibrahim/GYJ-0462-2022; Lai, Yu-Chiang/AAR-8005-2021	Bryant, Jack/0000-0002-7912-2144; Fine, Nicholas/0000-0003-2343-8534; Lai, Yu-Chiang/0000-0002-8254-3732; Lord, Samuel/0000-0002-6241-7966; Banzhaf, Manuel/0000-0002-4682-1037; Philp, Andrew/0000-0003-3860-4136; Gray, Alexander/0000-0001-9227-0363	BBSRC; MRC Versus Arthritis Centre for Musculoskeletal Ageing Research; Wellcome Trust [204766/Z/16/Z, 104612/Z/14/Z]; MRC [MR/N00275X/1, MR/S025618/1]; Diabetes UK [17/0005681]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [715884]; MRC [1854365] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC Versus Arthritis Centre for Musculoskeletal Ageing Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors gratefully acknowledge Dr Ian Ganley (MRC protein phosphorylation and ubiquitylation unit, University of Dundee) for providing the mito-QC mitophagy reporter construct; Professor Richard Youle (National Institute of Health, Bethesda, USA) for providing the PINK1 knockout cell line; Professor Miratul Muqit for providing the PINK1 antibody; MRC PPU Reagents and Services for providing HALO-UBA<SUP>UBQLN1</SUP> TUBE construct for bacterial expression. The authors also acknowledge use of the Mitochondrial Profiling Centre, a core resource supported by the University of Birmingham. This study was supported by the BBSRC funded Midlands Integrative Biosciences Doctoral Training Partnership (MIBTP) and MRC Versus Arthritis Centre for Musculoskeletal Ageing Research. GGL was supported by a Wellcome Trust Senior Fellowship (104612/Z/14/Z). DGH was supported by an Investigator Award from the Wellcome Trust (204766/Z/16/Z). DJH was supported by MRC (MR/N00275X/1 and MR/S025618/1) and Diabetes UK (17/0005681) Project Grants. This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (Starting Grant 715884 to DJH).	Affourtit C, 2009, METHOD ENZYMOL, V457, P405, DOI 10.1016/S0076-6879(09)05023-X; Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894; Bultot L, 2016, AM J PHYSIOL-ENDOC M, V311, pE706, DOI 10.1152/ajpendo.00237.2016; Burchell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034748; Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106; Carter HN, 2018, J PHYSIOL-LONDON, V596, P3567, DOI 10.1113/JP275998; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen CCW, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0157-y; Chu CT, 2019, NEUROBIOL DIS, V122, P23, DOI 10.1016/j.nbd.2018.07.015; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Ducommun S, 2015, CELL SIGNAL, V27, P978, DOI 10.1016/j.cellsig.2015.02.008; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Emmerich CH, 2015, BIOCHEM BIOPH RES CO, V466, P1, DOI 10.1016/j.bbrc.2015.08.109; Fogarty S, 2016, MOL CANCER RES, V14, P683, DOI 10.1158/1541-7786.MCR-15-0479; Fonseca TB, 2019, NATURE, V570, pE34, DOI 10.1038/s41586-019-1296-y; Heo JM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aav0443; Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; Hood DA, 2019, ANNU REV PHYSIOL, V81, P19, DOI 10.1146/annurev-physiol-020518-114310; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kazlauskaite A, 2015, EMBO REP, V16, P939, DOI 10.15252/embr.201540352; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lai YC, 2015, EMBO J, V34, P2840, DOI 10.15252/embj.201591593; Lai YC, 2014, BIOCHEM J, V460, P363, DOI 10.1042/BJ20131673; Laker RC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00520-9; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Liu R, 2015, MOL BIOL CELL, V26, P4466, DOI 10.1091/mbc.E15-08-0591; Matsumoto G, 2015, HUM MOL GENET, V24, P4429, DOI 10.1093/hmg/ddv179; McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008; McWilliams TG, 2017, CURR OPIN CELL BIOL, V45, P83, DOI 10.1016/j.ceb.2017.03.013; McWilliams TG, 2016, J CELL BIOL, V214, P333, DOI 10.1083/jcb.201603039; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009; Tian WL, 2015, FEBS LETT, V589, P1847, DOI 10.1016/j.febslet.2015.05.020; Toyama EQ, SCIENCE NEW YORK NY, V351, P275; Van Humbeeck C, 2011, J NEUROSCI, V31, P10249, DOI 10.1523/JNEUROSCI.1917-11.2011; Vargas JNS, 2019, MOL CELL, V74, P347, DOI 10.1016/j.molcel.2019.02.010; Villa E, 2018, TRENDS CELL BIOL, V28, P882, DOI 10.1016/j.tcb.2018.07.004; Villa E, 2017, CELL REP, V20, P2846, DOI 10.1016/j.celrep.2017.08.087; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wild P, SCIENCE NEW YORK NY, V333, P228; Wilson RJ, 2019, MITOCHONDRION, V44, P20, DOI 10.1016/j.mito.2017.12.008; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Zhao P, 2018, CELL, V172, P731, DOI 10.1016/j.cell.2018.01.007	56	54	54	3	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6284	6301		10.1096/fj.201903051R	http://dx.doi.org/10.1096/fj.201903051R		MAR 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32201986	Green Published, Green Accepted			2022-12-26	WOS:000521563300001
J	Gao, QZ; Zhou, R; Meng, Y; Duan, RF; Wu, L; Li, R; Deng, FL; Lin, C; Zhao, L				Gao, Qingzu; Zhou, Rui; Meng, Yuan; Duan, Rongfei; Wu, Ling; Li, Rui; Deng, Fengliu; Lin, Chuang; Zhao, Liang			Long noncoding RNA CMPK2 promotes colorectal cancer progression by activating the FUBP3-c-Myc axis	ONCOGENE			English	Article							FAR UPSTREAM ELEMENT; C-MYC; TRANSCRIPTION; PROTEINS; LNCRNA; LIM	Long noncoding RNAs (lncRNAs) have been shown to play crucial roles in cancer long noncoding RNAs (lncRNAs) have been known to play crucial roles in cancer development and progression by regulating chromatin dynamics and gene expression. However, only a few lncRNAs with annotated functions in the progression of colorectal cancer (CRC) have been identified to date. In the present study, the expression of lncCMPK2 was upregulated in CRC tissues and positively correlated with clinical stages and lymphatic metastasis. The overexpression of lncCMPK2 promoted the proliferation and cell cycle transition of CRC cells. Conversely, the silencing of lncCMPK2 restricted cell proliferation both in vitro and in vivo. lncCMPK2 was localized to the nucleus of CRC cells, bound to far upstream element binding protein 3 (FUBP3), and guided FUBP3 to the far upstream element (FUSE) of the c-Myc gene to activate transcription. lncCMPK2 also stabilized FUBP3. These results provide novel insights into the functional mechanism of lncCMPK2 in CRC progression and highlight its potential as a biomarker of advanced CRC and therapeutic target.	[Gao, Qingzu; Zhou, Rui; Meng, Yuan; Wu, Ling; Li, Rui; Deng, Fengliu; Lin, Chuang; Zhao, Liang] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Peoples R China; [Gao, Qingzu] Xinxiang Med Univ, Dept Pathol, Affiliated Hosp 1, Xinxiang, Henan, Peoples R China; [Gao, Qingzu; Zhou, Rui; Wu, Ling; Li, Rui; Deng, Fengliu; Zhao, Liang] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Peoples R China; [Meng, Yuan] Second Peoples Hosp Longgang Dist, Dept Pathol, Shenzhen, Peoples R China; [Duan, Rongfei] Xinxiang Med Univ, Dept Endocrinol, Affiliated Hosp 1, Guangzhou, Peoples R China	Southern Medical University - China; Xinxiang Medical University; Southern Medical University - China; Xinxiang Medical University	Zhao, L (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Peoples R China.; Zhao, L (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Peoples R China.	liangsmu@foxmail.com			National Natural Science Foundation of China [81572813, 81773082, 81702903, 81872423]; Guangdong Natural Science Foundation [2016A030313626, 2017A030310038, 2018B030311036]; Fork Ying Tung Education Foundation [161035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Fork Ying Tung Education Foundation	This work was supported by the National Natural Science Foundation of China (nos. 81572813, 81773082, 81702903, and 81872423), Guangdong Natural Science Foundation (2016A030313626, 2017A030310038, 2018B030311036), and Fork Ying Tung Education Foundation (161035).	Arab K, 2014, MOL CELL, V55, P604, DOI 10.1016/j.molcel.2014.06.031; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; AVIGAN MI, 1990, J BIOL CHEM, V265, P18538; Beckedorff FC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003705; Bhan A, 2014, CHEMMEDCHEM, V9, P1932, DOI 10.1002/cmdc.201300534; Chen Q, 2018, CLIN CANCER RES, V24, P684, DOI 10.1158/1078-0432.CCR-17-0605; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; DavisSmyth T, 1996, J BIOL CHEM, V271, P31679, DOI 10.1074/jbc.271.49.31679; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Gu J, 2018, CELL PHYSIOL BIOCHEM, V48, P194, DOI 10.1159/000491718; Hajjari M, 2015, CANCER BIOL MED, V12, P1, DOI 10.7497/j.issn.2095-3941.2015.0006; Han QR, 2019, ONCOGENE, V38, P3019, DOI 10.1038/s41388-018-0614-4; Huang HI, 2016, PROTEOMICS, V16, P2351, DOI 10.1002/pmic.201600098; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Kambara H, 2014, NUCLEIC ACIDS RES, V42, P10668, DOI 10.1093/nar/gku713; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013; Ling H, 2013, GENOME RES, V23, P1446, DOI 10.1101/gr.152942.112; Liu JH, 2017, FRONT BIOSCI-LANDMRK, V22, P66, DOI 10.2741/4472; Liu TY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0873-2; Ma YL, 2016, GUT, V65, P1494, DOI 10.1136/gutjnl-2014-308392; Malakar P, 2019, CANCER RES, V79, P2480, DOI 10.1158/0008-5472.CAN-18-1432; Mariotti B, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00100; Munschauer M, 2018, NATURE, V561, P132, DOI 10.1038/s41586-018-0453-z; Naxerova K, 2017, SCIENCE, V357, P55, DOI 10.1126/science.aai8515; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Quinn LM, 2017, TRANSCR-AUSTIN, V8, P185, DOI 10.1080/21541264.2017.1293595; Ren J, 2018, THERANOSTICS, V8, P3932, DOI 10.7150/thno.25541; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Silva JM, 2011, RNA BIOL, V8, P496, DOI 10.4161/rna.8.3.14800; Wang H, 2014, CLIN CANCER RES, V20, P5835, DOI 10.1158/1078-0432.CCR-14-0485; Wang ZH, 2018, CANCER CELL, V33, P706, DOI 10.1016/j.ccell.2018.03.006; Weber A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-369; Zhao LA, 2010, GUT, V59, P1226, DOI 10.1136/gut.2009.202739; Zheng P, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0216-3; Zubaidah RM, 2008, PROTEOMICS, V8, P5086, DOI 10.1002/pmic.200800322	41	27	27	0	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	19					3926	3938		10.1038/s41388-020-1266-8	http://dx.doi.org/10.1038/s41388-020-1266-8		MAR 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LK4OF	32203166				2022-12-26	WOS:000520826900001
J	Wenzel, J; Rose, K; Haghighi, EB; Lamprecht, C; Rauen, G; Freihen, V; Kesselring, R; Boerries, M; Hecht, A				Wenzel, Janna; Rose, Katja; Haghighi, Elham Bavafaye; Lamprecht, Constanze; Rauen, Gilles; Freihen, Vivien; Kesselring, Rebecca; Boerries, Melanie; Hecht, Andreas			Loss of the nuclear Wnt pathway effector TCF7L2 promotes migration and invasion of human colorectal cancer cells	ONCOGENE			English	Article							WNT/BETA-CATENIN PATHWAY; EPHB3 TUMOR-SUPPRESSOR; BETA-CATENIN; HUMAN COLON; COMPETITIVE DISPLACEMENT; ACTIVATION DOMAIN; FEEDBACK LOOP; HUMAN BREAST; STEM-CELLS; TRANSCRIPTION	The transcription factor TCF7L2 is indispensable for intestinal tissue homeostasis where it transmits mitogenic Wnt/beta-Catenin signals in stem and progenitor cells, from which intestinal tumors arise. Yet, TCF7L2 belongs to the most frequently mutated genes in colorectal cancer (CRC), and tumor-suppressive functions of TCF7L2 were proposed. This apparent paradox warrants to clarify the role of TCF7L2 in colorectal carcinogenesis. Here, we investigated TCF7L2 dependence/independence of CRC cells and the cellular and molecular consequences of TCF7L2 loss-of-function. By genome editing we achieved complete TCF7L2 inactivation in several CRC cell lines without loss of viability, showing that CRC cells have widely lost the strict requirement for TCF7L2. TCF7L2 deficiency impaired G1/S progression, reminiscent of the physiological role of TCF7L2. In addition, TCF7L2-negative cells exhibited morphological changes, enhanced migration, invasion, and collagen adhesion, albeit the severity of the phenotypic alterations manifested in a cell-line-specific fashion. To provide a molecular framework for the observed cellular changes, we performed global transcriptome profiling and identified gene-regulatory networks in which TCF7L2 positively regulates the proto-oncogene MYC, while repressing the cell cycle inhibitors CDKN2C/CDKN2D. Consistent with its function in curbing cell motility and invasion, TCF7L2 directly suppresses the pro-metastatic transcription factor RUNX2 and impinges on the expression of cell adhesion molecules. Altogether, we conclude that the proliferation-stimulating activity of TCF7L2 persists in CRC cells. In addition, TCF7L2 acts as invasion suppressor. Despite its negative impact on cell cycle progression, TCF7L2 loss-of-function may thereby increase malignancy, which could explain why TCF7L2 is mutated in a sizeable fraction of colorectal tumors.	[Wenzel, Janna; Rose, Katja; Freihen, Vivien; Hecht, Andreas] Univ Freiburg, Fac Med, Inst Mol Med & Cell Res, Stefan Meier Str 17, D-79104 Freiburg, Germany; [Wenzel, Janna; Rauen, Gilles; Hecht, Andreas] Univ Freiburg, Fac Biol, Schanzlestr 1, D-79104 Freiburg, Germany; [Haghighi, Elham Bavafaye; Boerries, Melanie] Univ Freiburg, Inst Med Bioinformat & Syst Med, Med Ctr, Fac Med, Breisacherstr 153, D-79104 Freiburg, Germany; [Lamprecht, Constanze] Univ Freiburg, Inst Phys, Hermann Herder Str 3a, D-79104 Freiburg, Germany; [Lamprecht, Constanze; Rauen, Gilles; Hecht, Andreas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Schanzlestr 18, D-79104 Freiburg, Germany; [Lamprecht, Constanze] Univ Freiburg, Freiburg Ctr Interact Mat & Bioinspired Technol F, Georges Kohler Allee 105, D-79110 Freiburg, Germany; [Kesselring, Rebecca] Univ Freiburg, Dept Gen & Visceral Surg, Ctr Surg, Med Ctr,Fac Med, Hugstetter Str 55, D-79106 Freiburg, Germany; [Boerries, Melanie] German Canc Consortium DKTK, Hugstetter Str 55, D-79106 Freiburg, Germany; [Boerries, Melanie] German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Hecht, A (corresponding author), Univ Freiburg, Fac Med, Inst Mol Med & Cell Res, Stefan Meier Str 17, D-79104 Freiburg, Germany.; Hecht, A (corresponding author), Univ Freiburg, Fac Biol, Schanzlestr 1, D-79104 Freiburg, Germany.; Hecht, A (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Schanzlestr 18, D-79104 Freiburg, Germany.	andreas.hecht@mol-med.uni-freiburg.de	Boerries, Melanie/AAM-2602-2021	Lamprecht, Constanze/0000-0002-6005-6239	Deutsche Forschungsgemeinschaft (DFG) [DFG HE2004/11-1, CRC-850, KE2164/2-1, 322977937/GRK2344]; German Federal Ministry of Education and Research (BMBF) [FKZ 01ZX1708F]; Carl-Zeiss-Foundation [Az. 0563-2.8/685/4]; Deutsche Forschungsgemeinschaft Research Training Group GRK2344 "MeInBio-BioInMe"; Projekt DEAL	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Carl-Zeiss-Foundation; Deutsche Forschungsgemeinschaft Research Training Group GRK2344 "MeInBio-BioInMe"(German Research Foundation (DFG)); Projekt DEAL	The authors express their gratitude to K. Geiger, D. Herchenbach, J. Bodinek, and A. Schmitt for exquisite technical assistance, and to the team of the Genomics and Proteomics Core Facility, German Cancer Research Center/DKFZ, Heidelberg, Germany, for sequencing services. The studies reported herein were financially supported by the Deutsche Forschungsgemeinschaft (DFG) (DFG HE2004/11-1 to AH; CRC-850 subprojects B5 to AH, C11 to RK [KE2164/2-1] and Z1 to MB; 322977937/GRK2344 subprojects B02 to MB and B03 to AH), and by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept CoNfirm (FKZ 01ZX1708F to MB). CL received a fellowship from the Carl-Zeiss-Foundation (Postdoc Program 2017, Az. 0563-2.8/685/4). JW was additionally supported by the Deutsche Forschungsgemeinschaft Research Training Group GRK2344 "MeInBio-BioInMe". Open access funding provided by Projekt DEAL.	Albers J, 2015, J CLIN INVEST, V125, P1603, DOI 10.1172/JCI79743; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Angus-Hill ML, 2011, P NATL ACAD SCI USA, V108, P4914, DOI 10.1073/pnas.1102300108; Arrigoni L, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1495; Atcha FA, 2003, J BIOL CHEM, V278, P16169, DOI 10.1074/jbc.M213218200; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Berg KCG, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0691-y; Beumer J, 2016, DEVELOPMENT, V143, P3639, DOI 10.1242/dev.133132; Beyes S, 2019, ONCOGENE, V38, P6647, DOI 10.1038/s41388-019-0905-4; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bormann F, 2018, CELL REP, V23, P3407, DOI 10.1016/j.celrep.2018.05.045; Cadigan KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007906; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chai J, 2018, AM J CANCER RES, V8, P538; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; de Lau W, 2007, FRONT BIOSCI-LANDMRK, V12, P471, DOI 10.2741/2076; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fox J., 2018, R COMPANION APPL REG, VThird; Freihen V, 2020, INT J CANCER, V146, P2229, DOI 10.1002/ijc.32644; Frietze S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r52; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geoghegan G, 2019, MOL METAB, V24, P44, DOI 10.1016/j.molmet.2019.03.003; Giakountis A, 2016, CELL REP, V15, P2588, DOI 10.1016/j.celrep.2016.05.038; Guo ZJ, 2016, ONCOTARGET, V7, P20999, DOI 10.18632/oncotarget.8236; Hecht A, 2003, J BIOL CHEM, V278, P3776, DOI 10.1074/jbc.M210081200; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Hoverter NP, 2014, NUCLEIC ACIDS RES, V42, P13615, DOI 10.1093/nar/gku1186; Hrckulak D, 2018, GENES-BASEL, V9, DOI 10.3390/genes9090439; Hrckulak D, 2016, CANCERS, V8, DOI 10.3390/cancers8070070; Jagle S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007109; Jagle S, 2014, P NATL ACAD SCI USA, V111, P4886, DOI 10.1073/pnas.1314523111; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kadem LF, 2016, ADV MATER, V28, P1799, DOI 10.1002/adma.201504394; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Koshizuka K, 2017, CANCER SCI, V108, P1681, DOI 10.1111/cas.13298; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Li XQ, 2015, CANCER RES, V75, P3302, DOI 10.1158/0008-5472.CAN-15-0240; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Lv HQ, 2016, ONCOL RES, V23, P283, DOI 10.3727/096504016X14562725373833; Mokry M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015092; Mouradov D, 2014, CANCER RES, V74, P3238, DOI 10.1158/0008-5472.CAN-14-0013; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Neri P, 2011, BLOOD, V117, P6202, DOI 10.1182/blood-2010-06-292243; Ramovs V, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1146-8; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Ronsch K, 2015, MOL ONCOL, V9, P335, DOI 10.1016/j.molonc.2014.08.016; Ronsch K, 2011, EPIGENETICS-US, V6, P610, DOI 10.4161/epi.6.5.15300; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schnappauf O, 2016, BBA-GENE REGUL MECH, V1859, P1353, DOI 10.1016/j.bbagrm.2016.08.002; Schuijers J, 2015, CELL STEM CELL, V16, P158, DOI 10.1016/j.stem.2014.12.006; Seebauer CT, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1242543; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tang W, 2014, BRIT J CANCER, V110, P450, DOI 10.1038/bjc.2013.724; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2012, MOL CELL BIOL, V32, P1918, DOI 10.1128/MCB.06288-11; Varnat F, 2010, EMBO MOL MED, V2, P440, DOI 10.1002/emmm.201000098; Wen DC, 2017, BIOMED PHARMACOTHER, V95, P1314, DOI 10.1016/j.biopha.2017.09.044; Wickham H, 2009, GGPLOT2; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xiang JF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0367-6; Yochum GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018966; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08; Zhang Y, 2012, J BIOL CHEM, V287, P32494, DOI 10.1074/jbc.M112.368282	79	24	24	2	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	19					3893	3909		10.1038/s41388-020-1259-7	http://dx.doi.org/10.1038/s41388-020-1259-7		MAR 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LK4OF	32203164	Green Published, hybrid			2022-12-26	WOS:000520614000003
J	Bhagdikar, D; Grundy, FJ; Henkin, TM				Bhagdikar, Divyaa; Grundy, Frank J.; Henkin, Tina M.			Transcriptional and translational S-box riboswitches differ in ligand-binding properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA structure; translation regulation; transcription regulation; aptamer; S-adenosylmethionine (SAM); gene regulation; ligand binding; riboswitch; SAM riboswitch; transcriptional S-box riboswitch; translational S-box riboswitch	MEDIATED GENE-REGULATION; SAM-I RIBOSWITCH; MESSENGER-RNA; TERMINATION CONTROL; ESCHERICHIA-COLI; SINGLE-MOLECULE; MK BOX; ADENOSYLMETHIONINE; EXPRESSION; MECHANISM	There are a number of riboswitches that utilize the same ligand-binding domain to regulate transcription or translation. S-box (SAM-I) riboswitches, including the riboswitch present in the Bacillus subtilis metI gene, which encodes cystathionine ?-synthase, regulate the expression of genes involved in methionine metabolism in response to SAM, primarily at the level of transcriptional attenuation. A rarer class of S-box riboswitches is predicted to regulate translation initiation. Here we identified and characterized a translational S-box riboswitch in the metI gene from Desulfurispirillum indicum. The regulatory mechanisms of riboswitches are influenced by the kinetics of ligand interaction. The half-life of the translational D. indicum metI RNA?SAM complex is significantly shorter than that of the transcriptional B. subtilis metI RNA. This finding suggests that, unlike the transcriptional RNA, the translational metI riboswitch can make multiple reversible regulatory decisions. Comparison of both RNAs revealed that the second internal loop of helix P3 in the transcriptional RNA usually contains an A residue, whereas the translational RNA contains a C residue that is conserved in other S-box RNAs that are predicted to regulate translation. Mutational analysis indicated that the presence of an A or C residue correlates with RNA?SAM complex stability. Biochemical analyses indicate that the internal loop sequence critically determines the stability of the RNA?SAM complex by influencing the flexibility of residues involved in SAM binding and thereby affects the molecular mechanism of riboswitch function.	[Bhagdikar, Divyaa; Grundy, Frank J.; Henkin, Tina M.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Bhagdikar, Divyaa; Grundy, Frank J.; Henkin, Tina M.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Henkin, TM (corresponding author), Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA.	henkin.3@osu.edu	Bhagdikar, Divyaa/AAT-2107-2021		National Institutes of Health [R01GM063615]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01GM063615 (to T. M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antunes D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40875-1; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Batey RT, 2011, WIRES RNA, V2, P299, DOI 10.1002/wrna.63; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Breaker RR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003566; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chen HY, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145794; Coppins RL, 2007, CURR OPIN MICROBIOL, V10, P176, DOI 10.1016/j.mib.2007.03.006; Fredrick K, 2002, MOL CELL, V9, P1125, DOI 10.1016/S1097-2765(02)00523-3; Fuchs RT, 2007, P NATL ACAD SCI USA, V104, P4876, DOI 10.1073/pnas.0609956104; Garst AD, 2009, BBA-GENE REGUL MECH, V1789, P584, DOI 10.1016/j.bbagrm.2009.06.004; Gong S, 2016, J PHYS CHEM B, V120, P12305, DOI 10.1021/acs.jpcb.6b09698; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Grundy FJ, 1998, MOL MICROBIOL, V30, P737, DOI 10.1046/j.1365-2958.1998.01105.x; Guedich S, 2016, RNA BIOL, V13, P373, DOI 10.1080/15476286.2016.1142040; Hall KB, 2009, METHOD ENZYMOL, V469, P269, DOI 10.1016/S0076-6879(09)69013-3; Henkin TM, 2006, COLD SPRING HARB SYM, V71, P231, DOI 10.1101/sqb.2006.71.020; Hennelly SP, 2013, NUCLEIC ACIDS RES, V41, P1922, DOI 10.1093/nar/gks978; Karabiber F, 2013, RNA, V19, P63, DOI 10.1261/rna.036327.112; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Lu CR, 2010, J MOL BIOL, V404, P803, DOI 10.1016/j.jmb.2010.09.059; Lutz B, 2014, NUCLEIC ACIDS RES, V42, P2687, DOI 10.1093/nar/gkt1213; MANOR H, 1969, J MOL BIOL, V39, P1, DOI 10.1016/0022-2836(69)90329-5; McCown PJ, 2017, RNA, V23, P995, DOI 10.1261/rna.061234.117; McDaniel BA, 2005, MOL MICROBIOL, V57, P1008, DOI 10.1111/j.1365-2958.2005.04740.x; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; McGinnis JL, 2009, METHOD ENZYMOL, V468, P67, DOI 10.1016/S0076-6879(09)68004-6; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Neupane K, 2011, NUCLEIC ACIDS RES, V39, P7677, DOI 10.1093/nar/gkr305; Palmgren M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175422; Pavlova N, 2019, GENE, V708, P38, DOI 10.1016/j.gene.2019.05.036; Pradhan V., 2012, THESIS; Rauschenbach I, 2012, FEMS MICROBIOL ECOL, V81, P156, DOI 10.1111/j.1574-6941.2012.01351.x; Rauschenbach I, 2011, INT J SYST EVOL MICR, V61, P654, DOI 10.1099/ijs.0.022392-0; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Ringquist S, 1998, METH MOL B, V77, P283; Rode AB, 2015, ANGEW CHEM INT EDIT, V54, P905, DOI 10.1002/anie.201407385; ROSE JK, 1970, J MOL BIOL, V51, P541, DOI 10.1016/0022-2836(70)90007-0; Savinov A, 2014, BBA-GENE REGUL MECH, V1839, P1030, DOI 10.1016/j.bbagrm.2014.04.005; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Sherwood AV, 2016, ANNU REV MICROBIOL, V70, P361, DOI 10.1146/annurev-micro-091014-104306; Sherwood AV, 2015, P NATL ACAD SCI USA, V112, P1113, DOI 10.1073/pnas.1424175112; Smith AM, 2010, MOL MICROBIOL, V78, P1393, DOI 10.1111/j.1365-2958.2010.07410.x; Stoddard CD, 2013, J MOL BIOL, V425, P1596, DOI 10.1016/j.jmb.2013.02.023; Stoddard CD, 2010, STRUCTURE, V18, P787, DOI 10.1016/j.str.2010.04.006; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; Suddala KC, 2013, NUCLEIC ACIDS RES, V41, P10462, DOI 10.1093/nar/gkt798; Tomsic J, 2008, J BACTERIOL, V190, P823, DOI 10.1128/JB.01034-07; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wilson RC, 2011, J MOL BIOL, V405, P926, DOI 10.1016/j.jmb.2010.10.056; Wostenberg C, 2015, J MOL BIOL, V427, P3473, DOI 10.1016/j.jmb.2015.07.027; Zhang J, 2010, BIOCHEMISTRY-US, V49, P9123, DOI 10.1021/bi1012645	57	2	2	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6849	6860		10.1074/jbc.RA120.012853	http://dx.doi.org/10.1074/jbc.RA120.012853			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32209653	hybrid, Green Published			2022-12-26	WOS:000536212600007
J	Kapoor, A; Chen, CRG; Iozzo, RV				Kapoor, Aastha; Chen, Carolyn G.; Iozzo, Renato V.			Endorepellin evokes an angiostatic stress signaling cascade in endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiogenesis; stress response; proteoglycan; endothelial cell; signal transduction; angiogenesis; eIF2; GADD45; PERK; stress signaling	UNFOLDED PROTEIN RESPONSE; SKELETAL-MUSCLE; RECEPTOR 2; SULFATE PROTEOGLYCAN; GENE-EXPRESSION; ER STRESS; PERLECAN; GROWTH; ANGIOGENESIS; AUTOPHAGY	Endorepellin, the C-terminal fragment of the heparan sulfate proteoglycan perlecan, influences various signaling pathways in endothelial cells by binding to VEGFR2. In this study, we discovered that soluble endorepellin activates the canonical stress signaling pathway consisting of PERK, eIF2?, ATF4, and GADD45?. Specifically, endorepellin evoked transient activation of VEGFR2, which, in turn, phosphorylated PERK at Thr(980). Subsequently, PERK phosphorylated eIF2? at Ser(51), upregulating its downstream effector proteins ATF4 and GADD45?. RNAi-mediated knockdown of PERK or eIF2? abrogated the endorepellin-mediated up-regulation of GADD45?, the ultimate effector protein of this stress signaling cascade. To functionally validate these findings, we utilized an ex vivo model of angiogenesis. Exposure of the aortic rings embedded in 3D fibrillar collagen to recombinant endorepellin for 2?4 h activated PERK and induced GADD45? vis ? vis vehicle-treated counterparts. Similar effects were obtained with the established cellular stress inducer tunicamycin. Notably, chronic exposure of aortic rings to endorepellin for 7?9 days markedly suppressed vessel sprouting, an angiostatic effect that was rescued by blocking PERK kinase activity. Our findings unravel a mechanism by which an extracellular matrix protein evokes stress signaling in endothelial cells, which leads to angiostasis.	[Kapoor, Aastha; Chen, Carolyn G.; Iozzo, Renato V.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Kapoor, Aastha; Chen, Carolyn G.; Iozzo, Renato V.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Kimmel Canc Ctr, Canc Cell Biol & Signaling Program, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	renato.iozzo@jefferson.edu	Iozzo, Renato/AAS-1980-2020	Kapoor, Aastha/0000-0002-7954-9113; Chen, Carolyn/0000-0003-4933-6544	National Institutes of Health [CA039481, RO1 CA047282, T32 AR052273]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants RO1 stresses such as exposure to UV light, nutrient deprivation, CA039481 and RO1 CA047282 (to R. V. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported in part by National Institutes of Health Training Grant T32 AR052273.	Adams CM, 2017, CURR OPIN CLIN NUTR, V20, P164, DOI 10.1097/MCO.0000000000000362; ALVAREZ RJ, 1992, KIDNEY INT, V41, P14, DOI 10.1038/ki.1992.3; Arab K, 2019, NAT GENET, V51, P217, DOI 10.1038/s41588-018-0306-6; Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Axten JM, 2013, ACS MED CHEM LETT, V4, P964, DOI 10.1021/ml400228e; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Benton RL, 2008, J COMP NEUROL, V507, P1031, DOI 10.1002/cne.21570; Binet F, 2015, CELL METAB, V22, P560, DOI 10.1016/j.cmet.2015.07.010; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2006, J NATL CANCER I, V98, P1634, DOI 10.1093/jnci/djj441; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Bretz CL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197069; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Chen C, 2019, METHODS MOL BIOL, V1952, P157, DOI 10.1007/978-1-4939-9133-4_14; Chen CG, 2020, MATRIX BIOL, V90, P1, DOI 10.1016/j.matbio.2020.02.001; COHEN IR, 1993, P NATL ACAD SCI USA, V90, P10404, DOI 10.1073/pnas.90.21.10404; COHEN IR, 1994, CANCER RES, V54, P5771; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Ebert SM, 2020, J BIOL CHEM, V295, P2787, DOI 10.1074/jbc.RA119.012095; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Ernst C, 2006, J NEUROSCI METH, V150, P138, DOI 10.1016/j.jneumeth.2005.06.018; Farach-Carson MC, 2007, GLYCOBIOLOGY, V17, P897, DOI 10.1093/glycob/cwm043; Farach-Carson MC, 2014, MATRIX BIOL, V34, P64, DOI 10.1016/j.matbio.2013.08.004; Fong TAT, 1999, CANCER RES, V59, P99; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Gao M, 2013, NUCLEIC ACIDS RES, V41, P5210, DOI 10.1093/nar/gkt223; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Goyal A, 2016, J BIOL CHEM, V291, P19245, DOI 10.1074/jbc.M116.740266; Goyal A, 2012, J BIOL CHEM, V287, P43543, DOI 10.1074/jbc.M112.401786; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Gubbiotti MA, 2017, MATRIX BIOL, V57-58, P285, DOI 10.1016/j.matbio.2016.09.003; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008008; Handler M, 1997, DEV DYNAM, V210, P130, DOI 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Holczer M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168359; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Iqbal F, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0631-1; Ito N, 1999, Angiogenesis, V3, P159, DOI 10.1023/A:1009008926710; Kapoor Aastha, 2020, Matrix Biol Plus, V6-7, P100025, DOI 10.1016/j.mbplus.2020.100025; Karali E, 2014, MOL CELL, V54, P559, DOI 10.1016/j.molcel.2014.03.022; Karamanos NK, 2018, CHEM REV, V118, P9152, DOI 10.1021/acs.chemrev.8b00354; Kovalsky O, 2001, J BIOL CHEM, V276, P39330, DOI 10.1074/jbc.M105115200; Liebermann Dan A., 2011, Critical Reviews in Oncogenesis, V16, P129; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Livezey M, 2018, CELL DEATH DIFFER, V25, P1796, DOI 10.1038/s41418-018-0143-2; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Neill T, 2018, J BIOL CHEM, V293, P12137, DOI 10.1074/jbc.RA118.002934; Neill T, 2015, BIOCHEMISTRY-US, V54, P4583, DOI 10.1021/acs.biochem.5b00653; Nicosia RF, 2009, J CELL MOL MED, V13, P4113, DOI 10.1111/j.1582-4934.2009.00891.x; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Poluzzi C, 2016, ADV DRUG DELIVER REV, V97, P156, DOI 10.1016/j.addr.2015.10.012; Poluzzi C, 2014, J BIOL CHEM, V289, P16114, DOI 10.1074/jbc.M114.556530; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Schaefer L, 2017, FEBS J, V284, P10, DOI 10.1111/febs.13963; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Smith AL, 2015, J MED CHEM, V58, P1426, DOI 10.1021/jm5017494; Sparro G, 1997, PROTEIN EXPRES PURIF, V10, P169, DOI 10.1006/prep.1997.0726; Su Q, 2008, J BIOL CHEM, V283, P469, DOI 10.1074/jbc.M704612200; Tameire F, 2015, SEMIN CANCER BIOL, V33, P3, DOI 10.1016/j.semcancer.2015.04.002; Theocharis AD, 2015, BBA-REV CANCER, V1855, P276, DOI 10.1016/j.bbcan.2015.03.006; Torres A, 2017, J BIOL CHEM, V292, P5055, DOI 10.1074/jbc.M116.753632; Van Valckenborgh E, 2002, BRIT J CANCER, V86, P796, DOI 10.1038/sj.bjc.6600137; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Weigel Paul H, 2015, Int J Cell Biol, V2015, P367579, DOI 10.1155/2015/367579; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Willis CD, 2013, FEBS J, V280, P2271, DOI 10.1111/febs.12164; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yang F, 2013, J BIOL CHEM, V288, P6552, DOI 10.1074/jbc.M112.418335; Yang P, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0465-3; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022	79	10	10	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6344	6356		10.1074/jbc.RA120.012525	http://dx.doi.org/10.1074/jbc.RA120.012525			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32205445	Green Published, hybrid			2022-12-26	WOS:000537685000009
J	Deeba, F; Sanz-Leon, P; Robinson, PA				Deeba, F.; Sanz-Leon, P.; Robinson, P. A.			Effects of physiological parameter evolution on the dynamics of tonic-clonic seizures	PLOS ONE			English	Article							CORTICALLY GENERATED SEIZURES; SPIKE-WAVE COMPLEXES; FAST COMPONENTS; ALPHA-RHYTHMS; EPILEPSY; MODEL; MECHANISMS; SYNCHRONIZATION; NETWORKS	The temporal and spectral characteristics of tonic-clonic seizures are investigated using a neural field model of the corticothalamic system in the presence of a temporally varying connection strength between the cerebral cortex and thalamus. Increasing connection strength drives the system into similar to 10 Hz seizure oscillations once a threshold is passed and a subcritical Hopf bifurcation occurs. In this study, the spectral and temporal characteristics of tonic-clonic seizures are explored as functions of the relevant properties of physiological connection strengths, such as maximum strength, time above threshold, and the ramp rate at which the strength increases or decreases. Analysis shows that the seizure onset time decreases with the maximum connection strength and time above threshold, but increases with the ramp rate. Seizure duration and offset time increase with maximum connection strength, time above threshold, and rate of change. Spectral analysis reveals that the power of nonlinear harmonics and the duration of the oscillations increase as the maximum connection strength and the time above threshold increase. A secondary limit cycle at similar to 18 Hz, termed a saddle-cycle, is also seen during seizure onset and becomes more prominent and robust with increasing ramp rate. If the time above the threshold is too small, the system does not reach the 10 Hz limit cycle, and only exhibits 18 Hz saddle-cycle oscillations. It is also seen that the time to reach the saturated large amplitude limit-cycle seizure oscillation from both the instability threshold and from the end of the saddle-cycle oscillations is inversely proportional to the square root of the ramp rate.	[Deeba, F.; Sanz-Leon, P.; Robinson, P. A.] Univ Sydney, Sch Phys, Sydney, NSW, Australia; [Deeba, F.; Sanz-Leon, P.; Robinson, P. A.] Univ Sydney, Ctr Integrat Brain Funct, Sydney, NSW, Australia; [Deeba, F.] Dhaka Univ Engn & Technol, Dept Phys, Gazipur, Bangladesh	University of Sydney; University of Sydney; Dhaka University of Engineering & Technology (DUET)	Deeba, F (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW, Australia.; Deeba, F (corresponding author), Univ Sydney, Ctr Integrat Brain Funct, Sydney, NSW, Australia.; Deeba, F (corresponding author), Dhaka Univ Engn & Technol, Dept Phys, Gazipur, Bangladesh.	farah.deeba@sydney.edu.au	Deeba, Farah/ABB-1678-2021	Deeba, Farah/0000-0002-4250-6582	Australian Research Council Center of Excellence for Integrative Brain Function (ARC Center of Excellence Grant) [CE140100007]; Australian Research Council Laureate Fellowship [FL140100025]	Australian Research Council Center of Excellence for Integrative Brain Function (ARC Center of Excellence Grant)(Australian Research Council); Australian Research Council Laureate Fellowship(Australian Research Council)	This work was supported by the Australian Research Council Center of Excellence for Integrative Brain Function (ARC Center of Excellence Grant CE140100007) and by an Australian Research Council Laureate Fellowship (Grant FL140100025).	Abeysuriya RG, 2015, J NEUROSCI METH, V253, P55, DOI 10.1016/j.jneumeth.2015.06.002; Abeysuriya RG, 2014, J THEOR BIOL, V344, P70, DOI 10.1016/j.jtbi.2013.11.013; AMINOFF MJ, 1984, BRAIN, V107, P569, DOI 10.1093/brain/107.2.569; ANDREW RD, 1991, J NEUROL SCI, V101, P7, DOI 10.1016/0022-510X(91)90013-W; Baier G., 2018, COMPLEXITY SYNERGETI, P333, DOI [10.1111/j.1528-1167.2009.02087.x, DOI 10.1111/J.1528-1167.2009.02087.X]; BAUER J, 1992, EUR ARCH PSY CLIN N, V241, P365, DOI 10.1007/BF02191962; Blumenfeld H, 2009, BRAIN, V132, P999, DOI 10.1093/brain/awp028; Braitenberg V, 2013, SPRINGER SCI BUS MED; Breakspear M, 2006, CEREB CORTEX, V16, P1296, DOI 10.1093/cercor/bhj072; Breakspear M, 2003, NETWORK-COMP NEURAL, V14, P703, DOI 10.1088/0954-898X/14/4/305; Browne T., 2000, HDB OF EPILEPSY; COHEN L, 1989, P IEEE, V77, P941, DOI 10.1109/5.30749; DAM AM, 1980, EPILEPSIA, V21, P617, DOI 10.1111/j.1528-1157.1980.tb04315.x; daSilva FHL, 1997, INT J PSYCHOPHYSIOL, V26, P237; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; Deeba E, 2018, J THEOR BIOL, V454, P11, DOI 10.1016/j.jtbi.2018.05.029; Deeba F, 2019, PHYS REV E, V100, DOI 10.1103/PhysRevE.100.022407; DODRILL CB, 1986, EPILEPSIA, V27, P399, DOI 10.1111/j.1528-1157.1986.tb03559.x; ENGEL J, 1997, EPILEPSY COMPREHENSI, V1; Freeman WJ, 1975, MASS ACTION NERVOUS; GLOOR P, 1988, TRENDS NEUROSCI, V11, P63, DOI 10.1016/0166-2236(88)90166-X; Hall D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071369; Jirsa VK, 2014, BRAIN, V137, P2210, DOI 10.1093/brain/awu133; Jirsa VK, 1996, PHYS REV LETT, V77, P960, DOI 10.1103/PhysRevLett.77.960; Jiruska P, 2013, J PHYSIOL-LONDON, V591, P787, DOI 10.1113/jphysiol.2012.239590; Kim JW, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031907; Kim JW, 2009, J THEOR BIOL, V257, P527, DOI 10.1016/j.jtbi.2008.12.009; Koppert M, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S0129065712500323; Kramer MA, 2012, P NATL ACAD SCI USA, V109, P21116, DOI 10.1073/pnas.1210047110; Kufluoglu H, 2014, ACM J EMERG TECH COM, V10, DOI 10.1145/2517648; Liley DTJ, 1999, NEUROCOMPUTING, V26-7, P795, DOI 10.1016/S0925-2312(98)00149-0; Lytton WW, 2005, EPILEPSY BEHAV, V7, P336, DOI 10.1016/j.yebeh.2005.06.011; Marten F, 2009, PHILOS T R SOC A, V367, P1145, DOI 10.1098/rsta.2008.0255; NUNEZ P L, 1974, Mathematical Biosciences, V21, P279, DOI 10.1016/0025-5564(74)90020-0; Pinotsis DA, 2012, NEUROIMAGE, V59, P1261, DOI [10.1016/j.neuroimage.2011.08.020, 10.1016/j.neuroimage.2010.12.039]; Rennie CJ, 2002, BIOL CYBERN, V86, P457, DOI 10.1007/s00422-002-0310-9; Roberts JA, 2008, J THEOR BIOL, V253, P189, DOI 10.1016/j.jtbi.2008.03.005; Robinson PA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021922; Robinson PA, 2004, HUM BRAIN MAPP, V23, P53, DOI 10.1002/hbm.20032; Robinson PA, 1997, PHYS REV E, V56, P826, DOI 10.1103/PhysRevE.56.826; Robinson PA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041924; Rodrigues S, 2009, J COMPUT NEUROSCI, V27, P507, DOI 10.1007/s10827-009-0166-2; Sanz-Leon P, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006387; SCHIFF SJ, 1994, OPT ENG, V33, P2162, DOI 10.1117/12.172248; Schiff SJ, 2000, CLIN NEUROPHYSIOL, V111, P953, DOI 10.1016/S1388-2457(00)00259-5; Soltesz, 2011, COMPUTATIONAL NEUROS; Staley K, 2015, NAT NEUROSCI, V18, P367, DOI 10.1038/nn.3947; Steriade M, 1998, J NEUROPHYSIOL, V80, P1456, DOI 10.1152/jn.1998.80.3.1456; Steriade M, 1998, J NEUROPHYSIOL, V80, P1439, DOI 10.1152/jn.1998.80.3.1439; Suffczynski P, 2006, IEEE T BIO-MED ENG, V53, P524, DOI 10.1109/TBME.2005.869800; Suffczynski P, 2005, J CLIN NEUROPHYSIOL, V22, P288; Suffczynski P, 2004, NEUROSCIENCE, V126, P467, DOI 10.1016/j.neuroscience.2004.03.014; Suffczynski P, 2001, INT J PSYCHOPHYSIOL, V43, P25, DOI 10.1016/S0167-8760(01)00177-5; Tzallas AT, 2009, IEEE T INF TECHNOL B, V13, P703, DOI 10.1109/TITB.2009.2017939; van Albada SJ, 2010, CLIN NEUROPHYSIOL, V121, P21, DOI 10.1016/j.clinph.2009.09.021; Velazquez JLP, 2006, PROC SPIE, V5975, DOI 10.1117/12.675581; Voss LJ, 2009, EPILEPSIA, V50, P1971, DOI 10.1111/j.1528-1167.2009.02087.x; WILLIAMS D, 1953, BRAIN, V76, P50, DOI 10.1093/brain/76.1.50; Yang DP, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.042410	59	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230510	10.1371/journal.pone.0230510	http://dx.doi.org/10.1371/journal.pone.0230510			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240175	Green Published, gold, Green Submitted			2022-12-26	WOS:000535945000028
J	Cebula, A; Tyka, AK; Tyka, A; Palka, T; Pilch, W; Luty, L; Mucha, D				Cebula, Agata; Tyka, Anna Katarzyna; Tyka, Aleksander; Palka, Tomasz; Pilch, Wanda; Luty, Lidia; Mucha, Dariusz			Physiological response and cardiorespiratory adaptation after a 6-week Nordic Walking training targeted at lipid oxidation in a group of post-menopausal women	PLOS ONE			English	Article							BODY-COMPOSITION; BLOOD-PRESSURE; AEROBIC EXERCISE; ARTERIAL STIFFNESS; INTENSITY; PARAMETERS; FAT; HYPERTENSION; MUSCLE	This study examined the effects of a 6-week Nordic Walking (NW) training, at the intensity corresponding to the dominance of lipid metabolism, on the levels of selected physiological indices, the haemodynamic indices of the cardiovascular system and physical fitness in sedentary women older than 55 years of age. In addition, the physiological response of the female body to the walking effort on treadmill with poles (NW) and without poles (W) was compared and the influence of training on this response was determined. A single group study with a pre-test/post-test study design was conducted. Eighteen women performed NW controlled intensity training 3 times a week for 6 weeks. Body composition, resting blood pressure (BP), heart rate (HR), maximum oxygen uptake (VO(2)max) as well as circulatory and respiratory indices in two graded walking efforts on mechanical treadmill NW and W were measured before and after training period. The intensity of workouts, which considered the dominance of lipid metabolism, was determined individually, based on the dynamics of changes in the level of physiological indices during the graded intensity NW. After the course of training, body mass, fat mass, resting BP and HR decreased significantly (p < 0.05). HR and respiratory exchange ratio recorded during NW and W at 1.75 m.s(-1) walking speed decreased, while the oxygen pulse increased (p < 0.05). VO(2)max increased significantly (p < 0.05). Before and after the training period HR, oxygen uptake per minute, and energy expenditure during NW were significantly higher than in W(p < 0.05). The study showed that 6-week NW training at the intensity corresponding to the dominance of lipid metabolism can provide improvement in body composition, cardiovascular function and physical performance in previously sedentary women. NW compared to the regular walk with the same speed revealed higher energy expenditure.	[Cebula, Agata; Mucha, Dariusz] Univ Phys Educ, Fac Phys Educ & Sport, Dept Biol Regenerat & Posture Correct, Krakow, Poland; [Tyka, Anna Katarzyna] Univ Phys Educ, Fac Tourism & Leisure, Dept Recreat & Biol Regenerat, Krakow, Poland; [Tyka, Aleksander; Palka, Tomasz] Univ Phys Educ, Fac Phys Educ & Sport, Dept Physiol & Biochem, Krakow, Poland; [Pilch, Wanda] Univ Phys Educ, Fac Cosmetol, Dept Biochem & Basic Cosmetol, Krakow, Poland; [Luty, Lidia] Univ Agr, Dept Stat & Econometr, Krakow, Poland	Agricultural University Krakow	Cebula, A (corresponding author), Univ Phys Educ, Fac Phys Educ & Sport, Dept Biol Regenerat & Posture Correct, Krakow, Poland.	agata.cebula@awf.krakow.pl		Mucha, Dariusz/0000-0001-8361-8663; Palka, Tomasz/0000-0001-5225-9397; Pilch, Wanda/0000-0001-6689-0155; Luty, Lidia/0000-0001-8250-8331; Cebula, Agata/0000-0003-3125-8736; Tyka, Anna/0000-0002-2743-2618	Polish Minister of Science and Higher Education [12/MN/IFC/2011]; Minister of Science and Higher Education [022/RID/2018/19]	Polish Minister of Science and Higher Education(Ministry of Science and Higher Education, Poland); Minister of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was supported by Polish Minister of Science and Higher Education. Award Number: 12/MN/IFC/2011|Recipient: Agata Cebula. Open Access financed within the framework of the program of the Minister of Science and Higher Education under the name 'Regional Initiative for Perfection' within the years 2019-2022, project No. 022/RID/2018/19 in the total of 11,919,908 PLN.	American College of Sports Medicine, 2009, Med Sci Sports Exerc, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Ammar T, 2015, J EXERC REHABIL, V11, P145, DOI 10.12965/jer.150204; Antunes Marques P., 2019, CONSCIENTIAE SAUDE, V18, P105, DOI [10.5585/conssaude.v18n1.10814, DOI 10.5585/CONSSAUDE.V18N1.10814, 10.5585/ConsSaude.v18n14.10814, DOI 10.5585/CONSSAUDE.V18N14.10814]; Barnes JN, 2014, HYPERTENSION, V63, P303, DOI 10.1161/HYPERTENSIONAHA.113.02393; Biernat E., 2007, PHYS ED SPORT, V51, P47; Botero JP, 2014, CLIN PHYSIOL FUNCT I, V34, P138, DOI 10.1111/cpf.12076; Boutari C, 2017, ENDOCRINOL METAB, V32, P422, DOI 10.3803/EnM.2017.32.4.422; Braz NFT, 2012, INT J PREVENTIVE MED, V3, P652; Buzza G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165433; Cebula A, 2017, INT J OCCUP MED ENV, V30, P445, DOI 10.13075/ijomeh.1896.00860; Church TS, 2002, RES Q EXERCISE SPORT, V73, P296, DOI 10.1080/02701367.2002.10609023; Dechman G, 2012, EUR J SPORT SCI, V12, P36, DOI 10.1080/17461391.2010.551411; Deley G, 2009, HYPERTENSION, V53, P826, DOI 10.1161/HYPERTENSIONAHA.109.130039; Drapier E, 2018, INTEGR OBESITY DIABE, V4, P1; Dumortier M, 2003, DIABETES METAB, V29, P509, DOI 10.1016/S1262-3636(07)70065-4; Figard-Fabre H, 2011, INT J SPORTS MED, V32, P407, DOI 10.1055/s-0030-1268461; Figard-Fabre H, 2010, EUR J APPL PHYSIOL, V108, P1141, DOI 10.1007/s00421-009-1315-z; Figueroa A, 2011, MENOPAUSE, V18, P980, DOI 10.1097/gme.0b013e3182135442; Fleg JL, 2012, DISCOV MED, V13, P223; Franzoni Leandro Tolfo, 2018, Sports Med Int Open, V2, pE28, DOI 10.1055/s-0043-124757; Fujita E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208070; Gomenuka NA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211472; Hagberg JM, 2000, SPORTS MED, V30, P193, DOI 10.2165/00007256-200030030-00004; Hagner W, 2009, MENOPAUSE, V16, P1009, DOI 10.1097/gme.0b013e31819c0924; Huang YL, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-177; Kukkonen-Harjula K, 2007, SCAND J MED SCI SPOR, V17, P316, DOI 10.1111/j.1600-0838.2006.00585.x; Latosik E, 2014, J HUM KINET, V43, P185, DOI 10.2478/hukin-2014-0104; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Manetta J, 2002, MED SCI SPORT EXER, V34, P423, DOI 10.1097/00005768-200203000-00007; Mialich M.S., 2014, INT J CLIN NUTR, V2, P1, DOI DOI 10.12691/IJCN-2-1-1; Mikalacki M, 2012, HEALTHMED, V6, P476; Mikalacki M, 2011, COLLEGIUM ANTROPOL, V35, P889; Miller AP, 2016, J GERIATR CARDIOL, V13, P373, DOI 10.11909/j.issn.1671-5411.2016.05.001; Monteiro EP, 2017, SCAND J MED SCI SPOR, V27, P351, DOI 10.1111/sms.12652; Nasabian PJ, 2017, J ENDOCRINOL, V234, pR37, DOI 10.1530/JOE-16-0603; Njemanze H, 2016, ONCOTARGET, V7, P76390, DOI 10.18632/oncotarget.12403; OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494; Pellegrini B, 2017, GAIT POSTURE, V51, P234, DOI 10.1016/j.gaitpost.2016.10.010; Pellegrini B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138906; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Pilch W, 2017, J SPORT MED PHYS FIT, V57, P124, DOI 10.23736/S0022-4707.16.05964-X; Robergs R, 1999, FUNDAMENTAL PRINCIPL; RODGERS CD, 1995, MED SCI SPORT EXER, V27, P607; Song MS, 2013, ASIAN NURS RES, V7, P1, DOI 10.1016/j.anr.2012.11.001; St-Onge MP, 2010, NUTRITION, V26, P152, DOI 10.1016/j.nut.2009.07.004; Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011; Sun ZJ, 2015, HYPERTENSION, V65, P252, DOI 10.1161/HYPERTENSIONAHA.114.03617; Tan SJ, 2016, CLIN PHYSIOL FUNCT I, V36, P225, DOI 10.1111/cpf.12217; Tanaka H, 2000, CIRCULATION, V102, P1270, DOI 10.1161/01.CIR.102.11.1270; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Wang JX, 2015, J EXERC SCI FIT, V13, P111, DOI 10.1016/j.jesf.2015.08.003; Zaton M, 2010, PHYSIOLOGICAL TESTS; Zhou DH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27377-2	53	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230917	10.1371/journal.pone.0230917	http://dx.doi.org/10.1371/journal.pone.0230917			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236147	Green Published, gold			2022-12-26	WOS:000535938700040
J	Tian, Q; Yuan, P; Quan, CT; Li, MY; Xiao, JJ; Zhang, L; Lu, H; Ma, TF; Zou, L; Wang, F; Xue, PP; Ni, XF; Wang, W; Liu, L; Wang, Z; Zhu, F; Duan, QH				Tian, Qin; Yuan, Ping; Quan, Chuntao; Li, Mingyang; Xiao, Juanjuan; Zhang, Lu; Lu, Hui; Ma, Tengfei; Zou, Ling; Wang, Fei; Xue, Peipei; Ni, Xiaofang; Wang, Wei; Liu, Lin; Wang, Zhe; Zhu, Feng; Duan, Qiuhong			Phosphorylation of BCKDK of BCAA catabolism at Y246 by Src promotes metastasis of colorectal cancer	ONCOGENE			English	Article							AMINO-ACID-METABOLISM; HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; TYROSINE KINASES; FAMILY KINASES; TARGETING SRC; GROWTH; PROGRESSION; ACTIVATION	Branched-chain alpha-keto acid dehydrogenase kinase (BCKDK), the key enzyme of branched-chain amino acids (BCAAs) metabolism, has been reported to promote colorectal cancer (CRC) tumorigenesis by upregulating the MEK-ERK signaling pathway. However, the profile of BCKDK in metastatic colorectal cancer (mCRC) remains unknown. Here, we report a novel role of BCKDK in mCRC. BCKDK is upregulated in CRC tissues. Increased BCKDK expression was associated with metastasis and poor clinical prognosis in CRC patients. Knockdown of BCKDK decreased CRC cell migration and invasion ex vivo, and lung metastasis in vivo. BCKDK promoted the epithelial mesenchymal transition (EMT) program, by decreasing the expression of E-cadherin, epithelial marker, and increasing the expression of N-cadherin and Vimentin, which are mesenchymal markers. Moreover, BCKDK-knockdown experiments in combination with phosphoproteomics analysis revealed the potent role of BCKDK in modulating multiple signal transduction pathways, including EMT and metastasis. Src phosphorylated BCKDK at the tyrosine 246 (Y246) site in vitro and ex vivo. Knockdown and knockout of Src downregulated the phosphorylation of BCKDK. Importantly, phosphorylation of BCKDK by Src enhanced the activity and stability of BCKDK, thereby promoting the migration, invasion, and EMT of CRC cells. In summary, the identification of BCKDK as a novel prometastatic factor in human CRC will be beneficial for further diagnostic biomarker studies and suggests novel targeting opportunities.	[Tian, Qin; Yuan, Ping; Xiao, Juanjuan; Zhang, Lu; Lu, Hui; Ma, Tengfei; Zou, Ling; Wang, Fei; Ni, Xiaofang; Wang, Wei; Liu, Lin; Zhu, Feng; Duan, Qiuhong] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Biochem & Mol Biol, Wuhan 430030, Hubei, Peoples R China; [Quan, Chuntao] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Hubei, Peoples R China; [Li, Mingyang; Wang, Zhe] Fourth Mil Med Univ, Xijing Hosp, Dept Pathol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Li, Mingyang; Wang, Zhe] Fourth Mil Med Univ, Sch Basic Med, Xian 710032, Peoples R China; [Xiao, Juanjuan; Zhu, Feng] Guilin Med Univ, Affiliated Hosp, Canc Res Inst, Guilin 541000, Guangxi, Peoples R China; [Xue, Peipei] Populat & Family Planning Sci & Technol Res Inst, Key Lab Birth Defects & Reprod Hlth, Natl Hlth & Family Planning Commiss, Chongqing 400020, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Air Force Military Medical University; Air Force Military Medical University; Guilin Medical University	Zhu, F; Duan, QH (corresponding author), Huazhong Univ Sci & Technol, Sch Basic Med, Dept Biochem & Mol Biol, Wuhan 430030, Hubei, Peoples R China.; Wang, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Pathol, State Key Lab Canc Biol, Xian 710032, Peoples R China.; Wang, Z (corresponding author), Fourth Mil Med Univ, Sch Basic Med, Xian 710032, Peoples R China.; Zhu, F (corresponding author), Guilin Med Univ, Affiliated Hosp, Canc Res Inst, Guilin 541000, Guangxi, Peoples R China.	zhwang@fmmu.edu.cn; fengzhu@hust.edu.cn; duanqhwz@hust.edu.cn	Li, Mingyang/C-2324-2018	Li, Mingyang/0000-0003-1766-7867	National Natural Science Foundation of China [81972762, 81672936, 81672739, 81902849, 81503105]; Independent innovation project of Huazhong University of Science and Technology [2018KFYYXJJ084, 2016YXZD034]; Hubei Province Health and Family Planning Scientific Research Project [WJ2019M109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent innovation project of Huazhong University of Science and Technology; Hubei Province Health and Family Planning Scientific Research Project	This study was supported by the National Natural Science Foundation of China (Nos. 81972762, 81672936, 81672739, 81902849, and 81503105). The Independent innovation project of Huazhong University of Science and Technology (Nos. 2018KFYYXJJ084 and 2016YXZD034). Hubei Province Health and Family Planning Scientific Research Project (Nos. WJ2019M109).	Allgayer H, 2002, CANCER, V94, P344, DOI 10.1002/cncr.10221; Ananieva EA, 2018, CURR OPIN CLIN NUTR, V21, P64, DOI 10.1097/MCO.0000000000000430; Antoni S, 2016, B WORLD HEALTH ORGAN, V94, P174, DOI 10.2471/BLT.15.164384; Beaudet AL, 2012, SCIENCE, V338, P342, DOI 10.1126/science.1229178; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Burrage LC, 2014, HUM MOL GENET, V23, pR1, DOI 10.1093/hmg/ddu123; Cao H, 2015, PATHOL RES PRACT, V211, P557, DOI 10.1016/j.prp.2015.05.010; Montero JC, 2011, CLIN CANCER RES, V17, P5546, DOI 10.1158/1078-0432.CCR-10-2616; Cheon S, 2019, P NATL ACAD SCI USA, V116, P3662, DOI 10.1073/pnas.1818751116; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Dey P, 2017, NATURE, V542, P119, DOI 10.1038/nature21052; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris RA, 2005, J NUTR, V135, p1527S, DOI 10.1093/jn/135.6.1527S; Hattori A, 2017, NATURE, V545, P500, DOI 10.1038/nature22314; Katagiri R, 2018, GASTROENTEROLOGY, V155, P1474, DOI 10.1053/j.gastro.2018.07.033; Kim JY, 2013, P NATL ACAD SCI USA, V110, P12414, DOI 10.1073/pnas.1220674110; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lieu C, 2010, CLIN COLORECTAL CANC, V9, P89, DOI 10.3816/CCC.2010.n.012; Liu KA, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-6; Martinez-Perez J, 2017, HUM PATHOL, V67, P119, DOI 10.1016/j.humpath.2017.05.025; Matysiak M, 2017, ARCH GYNECOL OBSTET, V295, P817, DOI 10.1007/s00404-017-4304-1; Mayers JR, 2017, CANCER RES, V77, P3131, DOI 10.1158/0008-5472.CAN-17-0165; Mayers JR, 2016, SCIENCE, V353, P1161, DOI 10.1126/science.aaf5171; Mochel F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000647; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Olea-Flores M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101133; Panosyan EH, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3148-1; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Polonio-Vallon T, 2014, CELL CYCLE, V13, P115, DOI 10.4161/cc.26857; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Seeber A, 2016, ONCOL RES TREAT, V39, P796, DOI 10.1159/000453027; Shiozawa S, 2016, J NIPPON MED SCH, V83, P248, DOI 10.1272/jnms.83.248; Singh V, 2017, PROTEIN J, V36, P1, DOI 10.1007/s10930-017-9696-z; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tauriello DVF, 2017, MOL ONCOL, V11, P97, DOI 10.1002/1878-0261.12018; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; Tso SC, 2014, J BIOL CHEM, V289, P20583, DOI 10.1074/jbc.M114.569251; Varkaris A, 2014, CANCER METAST REV, V33, P595, DOI 10.1007/s10555-013-9481-1; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang ZQ, 2015, ONCOTARGET, V6, P31522, DOI 10.18632/oncotarget.5159; White PJ, 2018, CELL METAB, V27, P1281, DOI 10.1016/j.cmet.2018.04.015; Xue PP, 2017, EBIOMEDICINE, V20, P50, DOI 10.1016/j.ebiom.2017.05.001; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yi TF, 2014, P NATL ACAD SCI USA, V111, P11223, DOI 10.1073/pnas.1411381111; Yoo PS, 2006, CLIN COLORECTAL CANC, V6, P202, DOI 10.3816/CCC.2006.n.036; Zhang L, 2017, BIOCHEM BIOPH RES CO, V486, P224, DOI 10.1016/j.bbrc.2017.02.101; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zheng YH, 2016, LIVER INT, V36, P1836, DOI 10.1111/liv.13178	55	14	14	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	20					3980	3996		10.1038/s41388-020-1262-z	http://dx.doi.org/10.1038/s41388-020-1262-z		APR 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LN3GC	32238881	Green Published, hybrid			2022-12-26	WOS:000522804800001
J	Kim, JY; Kim, DY; Park, YJ; Jang, MJ				Kim, Jae Yoon; Kim, Dae Yeon; Park, Youn-Jin; Jang, Myoung-Jun			Transcriptome analysis of the edible mushroom Lentinula edodes in response to blue light	PLOS ONE			English	Article							NUCLEOSIDE-DIPHOSPHATE KINASE; FRUIT-BODY; GENE-EXPRESSION; ACTION SPECTRA; IN-VITRO; NEUROSPORA; PHOTORECEPTOR; MATURATION; PATHWAYS; CLONING	Lentinula edodes is one of the most popular edible mushrooms worldwide and contains important medicinal components such as lentinan, ergosterol, and eritadenine. Mushroom metabolism is regulated by the mycelia and fruit body using light; however, in mushrooms, the underlying molecular mechanisms controlling this process as well as light-induced gene expression remain unclear. Therefore, in this study, we compared morphological changes and gene expression in the fruit bodies of L. edodes cultivated under blue light and continuous darkness. Our results showed that blue light primarily induced pileus growth (diameter and thickness) compared to dark cultivation. Alternatively, stipe length development was promoted by dark cultivation. We also performed RNAseq on L. edodes under the blue light/dark cultivation conditions. A total of 12,051 genes were used for aligning the Illumina raw reads and 762 genes that showed fold change cut-offs of >vertical bar 2 vertical bar and significance p-values of < 0.05 were selected under blue light condition. Among the genes which showed two-fold changed genes, 221 were upregulated and 541 were downregulated. In order to identify blue light induced candidate genes, differentially expressed genes (DEGs) were selected according to 4-fold changes and validated by RT-PCR. We identified 8 upregulated genes under blue light condition, such as DDR48-heat shock protein, Fasciclin-domain-containing protein and carbohydrate esterase family 4 protein, FAD NAD-binding domain-containing protein that are involved in morphological development of primordium and embryonic muscle development, cell adhesion and affect the structure of cellulosic and non-cellulosic cell walls of fruit body development, and photoreceptor of blue light signaling for fruit body and pigment development, respectively. This study provides valuable insights into the molecular mechanisms underlying the role of blue light in mushroom growth and development and can thus contribute to breeding programs to improve mushroom cultivation.	[Kim, Jae Yoon; Park, Youn-Jin; Jang, Myoung-Jun] Kongju Natl Univ, Coll Ind Sci, Dept Plant Resources, Yesan, South Korea; [Kim, Dae Yeon] Korea Univ, Dept Biosyst & Biotechnol, Seoul, South Korea	Kongju National University; Korea University	Kim, JY; Jang, MJ (corresponding author), Kongju Natl Univ, Coll Ind Sci, Dept Plant Resources, Yesan, South Korea.	jaeyoonkim@kongju.ac.kr; plant119@konju.ac.kr			"Cooperative Research Program for Agriculture Science and Technology Development" Rural Development Administration, Republic of Korea [PJ013159012019]	"Cooperative Research Program for Agriculture Science and Technology Development" Rural Development Administration, Republic of Korea	This work was carried out with the support of "Cooperative Research Program for Agriculture Science and Technology Development (Project No. PJ013159012019)"Rural Development Administration, Republic of Korea.	Arevalo-Gardini E, 2019, TREE GENET GENOMES, V15, DOI 10.1007/s11295-019-1316-y; Arjona D, 2009, MYCOL RES, V113, P552, DOI 10.1016/j.mycres.2008.12.006; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; BARNETT HL, 1950, PHYTOPATHOLOGY, V40, P1; Chen LF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160336; Chum WWY, 2008, MYCOL RES, V112, P950, DOI 10.1016/j.mycres.2008.01.028; Corrochano LM, 2007, PHOTOCH PHOTOBIO SCI, V6, P725, DOI 10.1039/b702155k; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Postemsky PD, 2016, INT J MED MUSHROOMS, V18, P355, DOI 10.1615/IntJMedMushrooms.v18.i4.90; DURAND R, 1982, ARCH MICROBIOL, V132, P131, DOI 10.1007/BF00508717; DURAND R, 1983, PLANT CELL PHYSIOL, V24, P899, DOI 10.1093/oxfordjournals.pcp.a076593; DURAND R, 1985, PLANT CELL PHYSIOL, V26, P1175, DOI 10.1093/oxfordjournals.pcp.a077013; Ellis RJ, 1999, MYCOL RES, V103, P779, DOI 10.1017/S0953756298007722; Fu YP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08049-z; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hsu KH, 2011, INT J MED MUSHROOMS, V13, P513, DOI 10.1615/IntJMedMushr.v13.i6.30; Inatomi S, 2001, MUSHROOM SCI BIOTECH, V9, P21; IZUMIYA H, 1995, J BIOL CHEM, V270, P27859, DOI 10.1074/jbc.270.46.27859; Jang MJ, 2013, MYCOBIOLOGY, V41, P63, DOI 10.5941/MYCO.2013.41.1.63; Jee H, 2016, J EXERC REHABIL, V12, P255, DOI 10.12965/jer.1632642.321; jun Jang myoung, 2014, [Journal of Mushrooms, 한국버섯학회지], V12, P258, DOI 10.14480/JM.2014.12.4.258; Kamada T, 2010, FUNGAL GENET BIOL, V47, P917, DOI 10.1016/j.fgb.2010.05.003; KATAYOSE Y, 1990, NUCLEIC ACIDS RES, V18, P1395, DOI 10.1093/nar/18.6.1395; Kurahashi A, 2015, MYCOSCIENCE, V56, P177, DOI 10.1016/j.myc.2014.05.005; LEATHAM GF, 1987, T BRIT MYCOL SOC, V88, P9, DOI 10.1016/S0007-1536(87)80180-8; Liu XF, 2009, FEMS MICROBIOL LETT, V295, P50, DOI 10.1111/j.1574-6968.2009.01585.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; 김도희, 2012, 한국식품저장유통학회지, V19, P354; Nakano Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2160, DOI 10.1271/bbb.100565; Nakazawa T, 2008, FEMS MICROBIOL LETT, V289, P67, DOI 10.1111/j.1574-6968.2008.01364.x; Namba K, 2002, MUSHROOM SCI BIOTECH, V10, P141; Ng WL, 2000, FEMS MICROBIOL LETT, V185, P139, DOI 10.1111/j.1574-6968.2000.tb09052.x; Nikolaidis N, 2014, MOL BIOL EVOL, V31, P376, DOI 10.1093/molbev/mst206; Ogura Y, 2001, J BIOL CHEM, V276, P21228, DOI 10.1074/jbc.M011381200; Ohm RA, 2013, ENVIRON MICROBIOL, V15, P943, DOI 10.1111/j.1462-2920.2012.02878.x; Olmedo M, 2013, FUNGAL BIOL REV, V27, P10, DOI 10.1016/j.fbr.2013.02.004; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sakamoto Yuichi, 2004, Mycoscience, V45, P333, DOI 10.1007/s10267-004-0195-7; Sakamoto Y, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02990-16; Sano H, 2007, BIOSCI BIOTECH BIOCH, V71, P2206, DOI 10.1271/bbb.70170; Sano H, 2009, FUNGAL GENET BIOL, V46, P333, DOI 10.1016/j.fgb.2009.01.001; Savoie JM, AGR APPL, P3; Seifert GJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061628; Shiratori T, 1982, AGRIS, V2, P89; Song HY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27318-z; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; Tang LH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5837293; Tang LH, 2013, APPL MICROBIOL BIOT, V97, P4977, DOI 10.1007/s00253-013-4832-y; Terashima K, 2005, GENETICS, V171, P101, DOI 10.1534/genetics.104.040048; Tisch D, 2010, APPL MICROBIOL BIOT, V85, P1259, DOI 10.1007/s00253-009-2320-1; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Xiang QJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190226; Yoo SI, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5509-4	53	8	11	11	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0230680	10.1371/journal.pone.0230680	http://dx.doi.org/10.1371/journal.pone.0230680			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218597	Green Published, gold			2022-12-26	WOS:000535935400019
J	Wondergem, R; Pisters, MF; Heijmans, MW; Wouters, EJM; de Bie, RA; Veenhof, C; Visser-Meily, JMA				Wondergem, Roderick; Pisters, Martijn F.; Heijmans, Martijn W.; Wouters, Eveline J. M.; de Bie, Rob A.; Veenhof, Cindy; Visser-Meily, Johanna M. A.			Movement behavior remains stable in stroke survivors within the first two months after returning home	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; PHYSICAL-ACTIVITY; HOSPITAL ANXIETY; EXERCISE; SCALE; REHABILITATION; SENSITIVITY; PREVENTION; PEOPLE; TIME	Background and purpose The aim of this study is to investigate changes in movement behaviors, sedentary behavior and physical activity, and to identify potential movement behavior trajectory subgroups within the first two months after discharge from the hospital to the home setting in first-time stroke patients. Methods A total of 140 participants were included. Within three weeks after discharge, participants received an accelerometer, which they wore continuously for five weeks to objectively measure movement behavior outcomes. The movement behavior outcomes of interest were the mean time spent in sedentary behavior (SB), light physical activity (LPA) and moderate to vigorous physical activity (MVPA); the mean time spent in MVPA bouts. 10 minutes; and the weighted median sedentary bout. Generalized estimation equation analyses were performed to investigate overall changes in movement behavior outcomes. Latent class growth analyses were performed to identify patient subgroups of movement behavior outcome trajectories. Results In the first week, the participants spent an average, of 9.22 hours (67.03%) per day in SB, 3.87 hours (27.95%) per day in LPA and 0.70 hours (5.02%) per day in MVPA. Within the entire sample, a small but significant decrease in SB and increase in LPA were found in the first weeks in the home setting. For each movement behavior outcome variable, two or three distinctive subgroup trajectories were found. Although subgroup trajectories for each movement behavior outcome were identified, no relevant changes over time were found. Conclusion Overall, the majority of stroke survivors are highly sedentary and a substantial part is inactive in the period immediately after discharge from hospital care. Movement behavior outcomes remain fairly stable during this period, although distinctive subgroup trajectories were found for each movement behavior outcome. Future research should investigate whether movement behavior outcomes cluster in patterns.	[Wondergem, Roderick; Pisters, Martijn F.; Veenhof, Cindy] Julius Hlth Care Ctr, Ctr Phys Therapy Res & Innovat Primary Care, Utrecht, Netherlands; [Wondergem, Roderick; Pisters, Martijn F.; Veenhof, Cindy; Visser-Meily, Johanna M. A.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Rehabil Phys Therapy Sci & Sport, Brain Ctr, Utrecht, Netherlands; [Wondergem, Roderick; Pisters, Martijn F.; Wouters, Eveline J. M.] Fontys Univ Appl Sci, Dept Hlth Innovat & Technol, Eindhoven, Netherlands; [Heijmans, Martijn W.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands; [Wouters, Eveline J. M.] Tilburg Univ, Dept Tranzo, Sch Social & Behav Sci, Tilburg, Netherlands; [de Bie, Rob A.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; [de Bie, Rob A.] Maastricht Univ, Caphri Res Sch, Maastricht, Netherlands; [Veenhof, Cindy] Univ Appl Sci Utrecht, Expertise Ctr Hlth Urban Living, Res Grp Innovat Human Movement Care, Utrecht, Netherlands; [Visser-Meily, Johanna M. A.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Brain Ctr, Utrecht, Netherlands; [Visser-Meily, Johanna M. A.] De Hoogstr Rehabil, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Tilburg University; Maastricht University; Maastricht University; Utrecht University; Utrecht University Medical Center	Wondergem, R (corresponding author), Julius Hlth Care Ctr, Ctr Phys Therapy Res & Innovat Primary Care, Utrecht, Netherlands.; Wondergem, R (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Rehabil Phys Therapy Sci & Sport, Brain Ctr, Utrecht, Netherlands.; Wondergem, R (corresponding author), Fontys Univ Appl Sci, Dept Hlth Innovat & Technol, Eindhoven, Netherlands.	r.wondergem@fontys.nl		Veenhof, Cindy/0000-0003-0970-2896	Netherlands Organization for Scientific Research (NWO) [023.003.136]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was funded by the Netherlands Organization for Scientific Research (NWO), Doctoral grant for Teachers, 023.003.136 to RW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ae Lee J, 2018, STAT METHODS MED RES; Andruff H, 2009, TUTOR QUANT METHODS; Baert I, 2012, ARCH PHYS MED REHAB, V93, P669, DOI 10.1016/j.apmr.2011.09.022; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bellettiere J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180119; Bennie JA, 2018, INT J BEHAV NUTR PHY; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Byrom B, 2016, INT J OBESITY, V40, P1809, DOI 10.1038/ijo.2016.136; Chastin SFM, 2015, MEAS PHYS EDUC EXERC, V19, P138, DOI 10.1080/1091367X.2015.1050592; Chastin SFM, 2015, OBESITY, V23, P1800, DOI 10.1002/oby.21180; Collin C, 1988, Int Disabil Stud, V10, P61; Deijle IA, 2017, STROKE; Dhamoon MS, 2006, NEUROLOGY; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Ekelund U, 2019, BMJ; Elbers RG, 2012, QUAL LIFE RES, V21, P925, DOI 10.1007/s11136-011-0009-2; English C, 2018, INT J STROKE; English C, 2014, PHYS THER, V94, P185, DOI 10.2522/ptj.20130175; Evenson KR, 2015, INT J BEHAV NUTR PHY; Fanchamps MHJ, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18072167; Feigin VL, 2016, LANCET NEUROL; Gordon NF, 2004, CIRCULATION, V109, P2031, DOI 10.1161/01.CIR.0000126280.65777.A4; Hendrickx W, 2019, TOP STROKE REHABIL, V26, P327, DOI 10.1080/10749357.2019.1601419; HOLDEN MK, 1986, PHYS THER, V66, P1530, DOI 10.1093/ptj/66.10.1530; Holla JFM, 2014, ANN RHEUM DIS, V73, P1369, DOI 10.1136/annrheumdis-2012-202984; Huang HC, 2013, EUR J PHYS REHAB MED, V49, P463; IBM, 2017, IBM SPSS STAT SOFTW; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; King WC, 2015, OBESITY, V23, P1143, DOI 10.1002/oby.21106; Kringle EA, 2020, PM&R, V12, P186, DOI 10.1002/pmrj.12222; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lewis LK, 2016, AIMS PUBLIC HEALTH, V3, P503, DOI 10.3934/publichealth.2016.3.503; Mahendran N, 2016, GAIT POSTURE; Manns PJ, 2009, STROKE, V40, P864, DOI 10.1161/STROKEAHA.108.531590; Marzolini S, 2016, J STROKE CEREBROVASC; Miles J., 2001, APPL REGRESSION CORR; Minkman MMN, 2005, INT J INTEGR CARE; Mohan KM, 2011, STROKE; Muthen LK., 2011, ACTA PSYCHIAT SCAND, V123, P407, DOI [10.1111/j.1600-0447.2011.01711.x, DOI 10.1111/J.1600-0447.2011.01711.X]; Muthen LK, 2010, J AM GERIATRICS SOC; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nijsse B, 2017, NEUROPSYCHOL REHABIL, V27, P99, DOI 10.1080/09602011.2015.1065280; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; ODonnell MJ, 2016, LANCET; Olaiya MT, 2017, NEUROLOGY; Oomen J, 2019, TECHNOL SOC; Pedersen RA, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0872-9; Pijfers EM, 1985, UTRECHT COMMUNICATIO; Prior PL, 2018, STROKE VASC NEUROL, V3, P59, DOI 10.1136/svn-2018-000155; Rosendal H, 2002, INT J INTEGR CARE; Royston P, 2009, STATA J; Royston P, 2011, J STAT SOFTW; Sakakibara BM, 2017, INT J BEHAV MED; Salinas J, 2017, STROKE, V48, P1706, DOI 10.1161/STROKEAHA.117.015909; Saunders DH, 2014, STROKE, V45, P3742, DOI 10.1161/STROKEAHA.114.004311; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Thilarajah S, 2018, ARCH PHYS MED REHABI; Tieges Z, 2014, ARCH PHYS MED REHABI; Tieges Z, 2015, ARCH PHYS MED REHAB, V96, P15, DOI 10.1016/j.apmr.2014.08.015; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; Twisk J, 2011, APPL LONGITUDINAL DA, Vsecond; Ullrich A, 2018, SCAND J MED SCI SPOR, V28, P2702, DOI 10.1111/sms.13289; van Ballegooijen AJ, 2019, EUR REV AGING PHYS A, V16, DOI 10.1186/s11556-019-0210-9; van Bloemendaal M, 2012, DISABIL REHABIL, V34, P2207, DOI 10.3109/09638288.2012.680649; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Van der Staay FJ, 2002, GENES BRAIN BEHAV; van Mierlo M, 2018, DISABIL REHABIL; Veerbeek JM, 2014, KNGF, V121; Vellone E, 2015, J CARDIOVASC NURS; WHO, 2010, J CHEM INFORM MODELI; Wondergem R, 2018, EUR J PHYS REHABIL M; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	74	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0229587	10.1371/journal.pone.0229587	http://dx.doi.org/10.1371/journal.pone.0229587			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8GI	32214319	Green Published, gold			2022-12-26	WOS:000535934200010
J	Nalbert, T; Czopowicz, M; Szalus-Jordanow, O; Witkowski, L; Moroz, A; Mickiewicz, M; Markowska-Daniel, I; Sloniewska, D; Bagnicka, E; Kaba, J				Nalbert, Tomasz; Czopowicz, Michal; Szalus-Jordanow, Olga; Witkowski, Lucjan; Moroz, Agata; Mickiewicz, Marcin; Markowska-Daniel, Iwona; Sloniewska, Danuta; Bagnicka, Emilia; Kaba, Jaroslaw			The effect of the subclinical small ruminant lentivirus infection of female goats on the growth of kids	PLOS ONE			English	Article							CAPRINE ARTHRITIS-ENCEPHALITIS; VISNA VIRUS-INFECTION; BIRTH-WEIGHT; LITTER SIZE; SHEEP; PRODUCTIVITY; IMPACT; ELISA; TRANSMISSION; YIELD	A longitudinal observational study was carried out to evaluate the influence of prenatal exposure to small ruminant lentivirus(SRLV)-infected does on the body weight (BWT) of young kids. The study was carried out in years 2001-2017 in the research dairy goat herd. Goats in the herd were regularly serologically tested and individuals showing clinical signs of caprine arthritis-encephalitis (CAE) were promptly culled. As a result all goats enrolled in the study were asymptomatic. Moreover, kids were weaned immediately after birth, fed on bovine colostrum and kept in strict separation from mothers to prevent SRLV lactogenic transmission. Kids were weighed immediately after birth, and then 1-3 times within the first 3 months of life. In total 620 goat kids were weighed at least once, excluding weighing at birth, providing 992 BWT records. The mixed linear model including four variables fitted as random effects (doe, kid, the year of kid's birth and the exact age of a kid at weighing) and four potential confounders fitted as fixed effects (parity, kid's sex, litter size and birth body weight) was developed and showed that BWT was not significantly associated with SRLV serological status of a doe, regardless of the time for which does had been infected before the delivery of the kid (p = 0.242). This study provides strong evidence that kids born to SRLV-infected does grow equally well as kids from uninfected does, provided that the lactogenic viral transmission is prevented by maintaining strict separation between the offspring and mothers. This observation is important for choosing the most optimal strategy of CAE control in a goat herd.	[Nalbert, Tomasz; Czopowicz, Michal; Witkowski, Lucjan; Moroz, Agata; Mickiewicz, Marcin; Markowska-Daniel, Iwona; Kaba, Jaroslaw] Warsaw Univ Life Sci, Inst Vet Med, Div Vet Epidemiol & Econ, Warsaw, Poland; [Szalus-Jordanow, Olga] Warsaw Univ Life Sci, Inst Vet Med, Dept Small Anim Dis Clin, Div Infect Dis, Warsaw, Poland; [Sloniewska, Danuta; Bagnicka, Emilia] Polish Acad Sci, Inst Genet & Anim Breeding, Magdalenka, Poland	Warsaw University of Life Sciences; Warsaw University of Life Sciences; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences	Czopowicz, M (corresponding author), Warsaw Univ Life Sci, Inst Vet Med, Div Vet Epidemiol & Econ, Warsaw, Poland.	mczopowicz@gmail.com	Kaba, Jaroslaw/AFM-7891-2022; Mickiewicz, Marcin M.M./P-9486-2017; Czopowicz, Michał/U-5452-2018; Witkowski, Lucjan Adam/AAE-9239-2019; Mickiewicz, Marcin/GQA-5521-2022; Mickiewicz, Marcin/ABD-1619-2020	Czopowicz, Michał/0000-0002-4238-8360; Witkowski, Lucjan Adam/0000-0003-1069-3384; Mickiewicz, Marcin/0000-0001-9747-6803; Mickiewicz, Marcin/0000-0001-9747-6803; Markowska-Daniel, Iwona/0000-0003-2889-6745; Bagnicka, Emilia/0000-0001-7193-2006; Szalus-Jordanow, Olga/0000-0002-2532-3338; Kaba, Jaroslaw/0000-0002-7977-9875; Moroz-Fik, Agata/0000-0003-4172-7188	National Science Center [2013/09/B/NZ6/03514]	National Science Center(National Science Centre, Poland)	This work was financially supported by the National Science Center (grant number 2013/09/B/NZ6/03514).	Abu-Raya B, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00383; Alemu Fekadu Mazengia, 2015, Int J MCH AIDS, V3, P31; Arsenault J, 2003, PREV VET MED, V59, P125, DOI 10.1016/S0167-5877(03)00086-2; Caroline L, 2010, CURR HIV RES, V8, P94, DOI 10.2174/157016210790416415; CLAVIJO A, 1995, J IMMUNOASSAY, V16, P419, DOI 10.1080/15321819508013571; DOHOO IR, 1987, PREV VET MED, V4, P471, DOI 10.1016/0167-5877(87)90032-8; Dungu B, 2000, ONDERSTEPOORT J VET, V67, P87; Flynn PM, 2019, AIDS, V33, P597, DOI 10.1097/QAD.0000000000002092; GREENWOOD PL, 1995, PREV VET MED, V22, P71, DOI 10.1016/0167-5877(94)00399-4; Grego E, 2018, RES VET SCI, V118, P107, DOI 10.1016/j.rvsc.2018.01.008; Jarrige R., 1989, RUMINANT NUTR RECOMM; Jumare J, 2019, PEDIATR INFECT DIS J, V38, P280, DOI [10.1097/INF.0000000000002238, 10.1097/inf.0000000000002238]; Kaba J, 2012, J DAIRY SCI, V95, P1617, DOI 10.3168/jds.2011-4680; Kaba J, 2009, POL J VET SCI, V12, P183; Kaba J, 2011, CENT EUR J IMMUNOL, V36, P170; Keen JE, 1997, PREV VET MED, V30, P155, DOI 10.1016/S0167-5877(96)01101-4; Legrottaglie R, 1999, VET RES COMMUN, V23, P123, DOI 10.1023/A:1006258503071; Martinez-Navalon B, 2013, VET J, V197, P311, DOI 10.1016/j.tvjl.2012.12.020; Mellado M, 2011, ANIM PROD SCI, V51, P144, DOI 10.1071/AN10112; Michiels R, 2018, PREV VET MED, V151, P13, DOI 10.1016/j.prevetmed.2017.12.014; Mioc B, 2011, VET ARHIV, V81, P339; MOAEENUDDIN M, 2018, J ANIM SCI S3, V96, P451; Nalbert T, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9100822; Nalbert T, 2019, PREV VET MED, V165, P71, DOI 10.1016/j.prevetmed.2019.02.011; Nowicka D, 2014, POL J VET SCI, V17, P501, DOI 10.2478/pjvs-2014-0072; Nowicka D, 2015, J DAIRY RES, V82, P102, DOI 10.1017/S0022029914000727; Olech M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193892; Omoni AO, 2017, PEDIATR INFECT DIS J, V36, P869, DOI 10.1097/INF.0000000000001574; PEKELDER JJ, 1994, VET REC, V134, P348, DOI 10.1136/vr.134.14.348; PERRY LL, 1995, J INFECT DIS, V171, P328, DOI 10.1093/infdis/171.2.328; Peterhans E, 2004, VET RES, V35, P257, DOI 10.1051/vetres:2004014; Reczynska D, 2018, VET RES, V49, DOI 10.1186/s13567-018-0607-x; RIMSTAD E, 1993, AM J VET RES, V54, P1858; Rosala-Hallas A, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0828-6; SANCHEZ F, 1994, CAN J ANIM SCI, V74, P397, DOI 10.4141/cjas94-057; Shah C, 2004, J VIROL, V78, P7518, DOI 10.1128/JVI.78.14.7518-7522.2004; SNOWDER GD, 1990, J AM VET MED ASSOC, V197, P475; Sudfeld CR, 2016, JAIDS-J ACQ IMM DEF, V73, P182, DOI 10.1097/QAI.0000000000001034; Tavella A, 2018, VET REC, V182, DOI 10.1136/vr.104503; WOODARD JC, 1982, AM J VET RES, V43, P2085; ZANONI RG, 1994, J VET MED B, V41, P662, DOI 10.1111/j.1439-0450.1994.tb00277.x	41	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230617	10.1371/journal.pone.0230617	http://dx.doi.org/10.1371/journal.pone.0230617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208446	Green Published, gold			2022-12-26	WOS:000535305100026
J	Tafreshi, FA; Fatahi, Z; Ghasemi, SF; Taherian, A; Esfandiari, N				Tafreshi, Fatemeh Ashrafi; Fatahi, Zahra; Ghasemi, Seyedeh Fatemeh; Taherian, Amirali; Esfandiari, Neda			Ultrasensitive fluorescent detection of pesticides in real sample by using green carbon dots	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; ONE-STEP SYNTHESIS; ONE-POT SYNTHESIS; QUANTUM DOTS; ORGANOPHOSPHORUS PESTICIDES; HYDROTHERMAL TREATMENT; FACILE SYNTHESIS; GLYPHOSATE; SENSOR; PROBE	Pesticides, widely used in modern agriculture, could potentially cause environmental pollution and affect human lives. Hence, the development of a highly sensitive sensing element to detect pesticide residues is crucial for food safety and ecosystem protection. Optical methods based on fluorescence properties provide an ideal approach for screening and quantification of these compounds in different medias including water, plant, and nutritional products. The development of fluorescence emitting carbon dot-based sensors for monitoring pesticides has attracted great attention in recent years. In comparison to other fluorophores, carbon dots have more promising optical features, higher quantum yields and better biocompatibility. This article aims to present a novel fluorescent sensing method of diazinon, glyphosate, and amicarbazone using plant-based carbon dots. A comprehensive characterization of carbon dots obtained from cauliflower was performed by methods including UV-visible, FTIR spectroscopy, fluorometry, AFM, DLS, and zeta sizer. Following this step, carbon dots were used to detect pesticides. The fluorescence quenching property of carbon dots has been utilized to identify detection limit of 0.25, 0.5, and 2 ng ml(-1) for diazinon, amicarbazone, and glyphosate, respectively. Also, real sample study revealed that the detection of pesticides accompanied by our developed nano-sensor is repeatable and accurate. According to carbon dots specificity determination, the prepared nano sensor does not have the potential to identify "bromacil" and "dialen super" pesticides but the other three mentioned pesticides are detectable. The results confirm that synthesized green carbon dots are well qualified for application in food safety and environmental monitoring.	[Tafreshi, Fatemeh Ashrafi; Ghasemi, Seyedeh Fatemeh; Taherian, Amirali; Esfandiari, Neda] Shahid Beheshti Univ, Fac Life Sci & Biotechnol, Tehran, Iran; [Fatahi, Zahra] Shahid Beheshti Univ, Prot Res Ctr, Tehran, Iran	Shahid Beheshti University; Shahid Beheshti University	Esfandiari, N (corresponding author), Shahid Beheshti Univ, Fac Life Sci & Biotechnol, Tehran, Iran.	ne_esfandiari@sbu.ac.ir						Ahmed F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/963525; Azab HA, 2015, J LUMIN, V160, P181, DOI 10.1016/j.jlumin.2014.12.007; Bai SH, 2016, ENVIRON SCI POLLUT R, V23, P18988, DOI 10.1007/s11356-016-7425-3; Bandi R, 2018, J PHOTOCH PHOTOBIO B, V178, P330, DOI 10.1016/j.jphotobiol.2017.11.010; Bokina I. G., 2018, Entomological Review, V98, P663, DOI 10.1134/S0013873818060027; Bourlinos AB, 2008, SMALL, V4, P455, DOI 10.1002/smll.200700578; Buksek H, 2010, ACTA CHIM SLOV, V57, P700; Chandra S, 2012, RSC ADV, V2, P3602, DOI 10.1039/c2ra00030j; Chang JF, 2016, BIOSENS BIOELECTRON, V86, P971, DOI 10.1016/j.bios.2016.07.022; Chang MMF, 2017, SENSOR ACTUAT B-CHEM, V242, P1050, DOI 10.1016/j.snb.2016.09.147; Corbera M, 2005, ANAL CHIM ACTA, V540, P3, DOI 10.1016/j.aca.2004.12.028; Costas-Mora I, 2014, ANAL CHEM, V86, P4536, DOI 10.1021/ac500517h; Cui ZM, 2011, ANALYST, V136, P1351, DOI 10.1039/c0an00617c; Dayan FE, 2009, WEED SCI, V57, P579, DOI 10.1614/WS-09-099.1; Dinc S, 2016, SUGAR IND, V141, P560; Ding H, 2017, LANGMUIR, V33, P12635, DOI 10.1021/acs.langmuir.7b02385; Ding H, 2016, ACS NANO, V10, P484, DOI 10.1021/acsnano.5b05406; Ding H, 2014, NANOSCALE, V6, P13817, DOI 10.1039/c4nr04267k; Dong MF, 2015, ENVIRON SCI POLLUT R, V22, P17518, DOI 10.1007/s11356-015-4899-3; Duan HH, 2015, CHEM SOC REV, V44, P5778, DOI 10.1039/c4cs00363b; Dubey P, 2014, RSC ADV, V4, P5838, DOI 10.1039/c3ra45261a; Ensafi AA, 2018, SENSOR ACTUAT B-CHEM, V257, P889, DOI 10.1016/j.snb.2017.11.050; Fatahi Z, 2019, EXCLI J, V18, P454, DOI 10.17179/excli2019-1465; Gao XH, 2015, J MATER CHEM C, V3, P2302, DOI 10.1039/c4tc02582b; Gao Z, 2015, BIOSENS BIOELECTRON, V70, P232, DOI 10.1016/j.bios.2015.03.043; Giron-Perez MI, 2007, FISH SHELLFISH IMMUN, V23, P760, DOI 10.1016/j.fsi.2007.02.004; Goncalves HMR, 2010, BIOSENS BIOELECTRON, V26, P1302, DOI 10.1016/j.bios.2010.07.018; Gupta PK, 2018, VETERINARY TOXICOLOGY: BASIC AND CLINICAL PRINCIPLES, 3RD EDITION, P553, DOI 10.1016/B978-0-12-811410-0.00044-1; Hoo CM, 2008, J NANOPART RES, V10, P89, DOI 10.1007/s11051-008-9435-7; Hou JY, 2015, BIOSENS BIOELECTRON, V68, P20, DOI 10.1016/j.bios.2014.12.037; Hu SL, 2009, J MATER CHEM, V19, P484, DOI 10.1039/b812943f; Ko NR, 2017, RSC ADV, V7, P11420, DOI 10.1039/c6ra25949a; Li HT, 2016, CARBON, V104, P33, DOI 10.1016/j.carbon.2016.03.040; Li MX, 2017, J MATER CHEM C, V5, P6512, DOI 10.1039/c7tc01585b; Li N, 2015, 2D MATER, V2, DOI 10.1088/2053-1583/2/3/034018; Li XY, 2011, CHEM COMMUN, V47, P932, DOI 10.1039/c0cc03552a; Li XH, 2016, CHEM COMMUN, V52, P9406, DOI 10.1039/c6cc03080g; Lin BX, 2018, FOOD CHEM, V245, P1176, DOI 10.1016/j.foodchem.2017.11.038; Liu W, 2017, SENSOR ACTUAT B-CHEM, V241, P190, DOI 10.1016/j.snb.2016.10.068; LUNDGREN LN, 1986, J AGR FOOD CHEM, V34, P535, DOI 10.1021/jf00069a041; Manuweera G, 2012, CHEMICALS, ENVIRONMENT, HEALTH: A GLOBAL MANAGEMENT PERSPECTIVE, P187; Matouq MA, 2008, ULTRASON SONOCHEM, V15, P869, DOI 10.1016/j.ultsonch.2007.10.012; McGorrin RJ, 2011, ACS SYM SER, V1068, P3; Myers JP, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0117-0; Nemeth-Konda L, 2002, CHEMOSPHERE, V48, P545, DOI 10.1016/S0045-6535(02)00106-6; Nsibande SA, 2016, ANAL CHIM ACTA, V945, P9, DOI 10.1016/j.aca.2016.10.002; Pan DY, 2010, ADV MATER, V22, P734, DOI 10.1002/adma.200902825; Prasannan A, 2013, IND ENG CHEM RES, V52, P15673, DOI 10.1021/ie402421s; Qu KG, 2013, CHEM-EUR J, V19, P7243, DOI 10.1002/chem.201300042; Romero V, 2019, SENSOR ACTUAT B-CHEM, V280, P290, DOI 10.1016/j.snb.2018.10.064; Rubio F, 2003, J AGR FOOD CHEM, V51, P691, DOI 10.1021/jf020761g; Sahu S, 2012, CHEM COMMUN, V48, P8835, DOI 10.1039/c2cc33796g; Sahub C, 2018, SENSOR ACTUAT B-CHEM, V258, P88, DOI 10.1016/j.snb.2017.11.072; Salm P, 2009, J CHROMATOGR B, V877, P568, DOI 10.1016/j.jchromb.2008.12.066; Sharma V, 2017, J MATER CHEM B, V5, P8904, DOI 10.1039/c7tb02484c; Shi XB, 2019, TALANTA, V194, P809, DOI 10.1016/j.talanta.2018.11.005; Sohrabi MR, 2012, CHEMOMETR INTELL LAB, V110, P49, DOI 10.1016/j.chemolab.2011.09.009; Su YJ, 2014, RSC ADV, V4, P4839, DOI 10.1039/c3ra45453c; Tao HL, 2015, SPECTROCHIM ACTA A, V136, P1328, DOI 10.1016/j.saa.2014.10.020; Tyagi A, 2016, RSC ADV, V6, P72423, DOI 10.1039/c6ra10488f; Wang L, 2016, TALANTA, V160, P268, DOI 10.1016/j.talanta.2016.07.020; Wei L, 2017, J MATER CHEM B, V5, P3383, DOI 10.1039/c7tb00309a; Wu XL, 2017, BIOSENS BIOELECTRON, V94, P292, DOI 10.1016/j.bios.2017.03.010; Xiong MY, 2016, CHEM COMMUN, V52, P4679, DOI 10.1039/c6cc00192k; Yan X, 2017, NANOSCALE, V9, P2317, DOI 10.1039/c6nr08473g; Yang LM, 2019, ANAL LETT, V52, P729, DOI 10.1080/00032719.2018.1490311; Yang ZC, 2011, CHEM COMMUN, V47, P11615, DOI 10.1039/c1cc14860e; Yu J, 2016, NEW J CHEM, V40, P2083, DOI 10.1039/c5nj03252k; Yuan YS, 2017, SENSOR ACTUAT B-CHEM, V242, P545, DOI 10.1016/j.snb.2016.11.050; Zhai XY, 2012, CHEM COMMUN, V48, P7955, DOI 10.1039/c2cc33869f; Zhang JC, 2010, NEW J CHEM, V34, P591, DOI 10.1039/b9nj00662a; Zhang K, 2010, ANAL CHEM, V82, P9579, DOI 10.1021/ac102531z; Zhou JW, 2018, J AGR FOOD CHEM, V66, P1307, DOI 10.1021/acs.jafc.7b05119; Zhu AW, 2012, ANGEW CHEM INT EDIT, V51, P7185, DOI 10.1002/anie.201109089; Zhu Y, 2002, CHEMOSPHERE, V49, P669, DOI 10.1016/S0045-6535(02)00392-2; Zhu Y, 1999, J CHROMATOGR A, V850, P297, DOI 10.1016/S0021-9673(99)00558-0; Zuo PL, 2016, MICROCHIM ACTA, V183, P519, DOI 10.1007/s00604-015-1705-3	77	38	38	18	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230646	10.1371/journal.pone.0230646	http://dx.doi.org/10.1371/journal.pone.0230646			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208468	Green Published, gold			2022-12-26	WOS:000535305100031
J	Spiering, MJ				Spiering, Martin J.			Melding the best of two worlds: Cecil Pickett's work on cellular oxidative stress and in drug discovery and development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CONTROLLING INDUCIBLE EXPRESSION; ANTIOXIDANT RESPONSE ELEMENT; GLUTATHIONE S-TRANSFERASES; YA SUBUNIT GENE; NRF2; IDENTIFICATION; ACTIVATION; SEQUENCE					mspiering@asbmb.org		Spiering, Martin/0000-0002-9160-5296				Hawkins CL, 2019, J BIOL CHEM, V294, P19683, DOI 10.1074/jbc.REV119.006217; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; PAULSON KE, 1990, MOL CELL BIOL, V10, P1841, DOI 10.1128/MCB.10.5.1841; PICKETT CB, 1984, J BIOL CHEM, V259, P5182; Raghunath A, 2018, REDOX BIOL, V17, P297, DOI 10.1016/j.redox.2018.05.002; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; RUSHMORE TH, 1993, J BIOL CHEM, V268, P11475; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; RUSHMORE TH, 1990, P NATL ACAD SCI USA, V87, P3826, DOI 10.1073/pnas.87.10.3826	13	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3929	3931		10.1074/jbc.CL120.013048	http://dx.doi.org/10.1074/jbc.CL120.013048			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32198188	hybrid, Green Published			2022-12-26	WOS:000527704400017
J	Wybranski, C; Siedek, F; Damm, R; Gazis, A; Wenzel, O; Haneder, S; Persigehl, T; Steinhauser, S; Pech, M; Fischbach, F; Fischbach, K				Wybranski, Christian; Siedek, Florian; Damm, Robert; Gazis, Angelos; Wenzel, Ortrud; Haneder, Stefan; Persigehl, Thorsten; Steinhauser, Susanne; Pech, Maciej; Fischbach, Frank; Fischbach, Katharina			Respiratory motion artefacts in Gd-EOB-DTPA (Primovist/Eovist) and Gd-DOTA (Dotarem)-enhanced dynamic phase liver MRI after intensified and standard pre-scan patient preparation: A bi-institutional analysis	PLOS ONE			English	Article							HEPATIC ARTERIAL PHASE; TRANSIENT SEVERE MOTION; DISODIUM-ENHANCED MRI; BREATH-HOLD TECHNIQUE; GADOXETATE DISODIUM; REDUCING ARTIFACTS; PRIOR EPISODE; ACID; INFORMATION; ACQUISITION	Objective The objective of this study is to evaluate if intensified pre-scan patient preparation (IPPP) that comprises custom-made educational material on dynamic phase imaging and supervised pre-imaging breath-hold training in addition to standard informative conversation with verbal explanation of breath-hold commands (standard pre-scan patient preparationSPPP) might reduce the incidence of gadoxetate disodium (Gd-EOB-DTPA)-related transient severe respiratory motion (TSM) and severity of respiratory motion (RM) during dynamic phase liver MRI. Material and methods In this bi-institutional study 100 and 110 patients who received Gd-EOB-DTPA for dynamic phase liver MRI were allocated to either IPPP or SPPP at site A and B. The control group comprised 202 patients who received gadoterate meglumine (Gd-DOTA) of which each 101 patients were allocated to IPPP or SPPP at site B. RM artefacts were scored retrospectively in dynamic phase images (1: none-5: extensive) by five and two blinded readers at site A and B, respectively, and in the hepatobiliary phase of the Gd-EOB-DTPA-enhanced scans by two blinded readers at either site. Results The incidence of TSM was 15% at site A and 22.7% at site B (p = 0.157). IPPP did not reduce the incidence of TSM in comparison to SPPP: 16.7% vs. 21.6% (p = 0.366). This finding was consistent at site A: 12% vs. 18% (p = 0.401) and site B: 20.6% vs. 25% (p = 0.590). The TSM incidence in patients with IPPP and SPPP did not differ significantly between both sites (p = 0.227; p = 0.390). IPPP did not significantly mitigate RM in comparison to SPPP in any of the Gd-EOB-DTPA-enhanced dynamic phases and the hepatobiliary phase in patients without TSM (all p >= 0.072). In the Gd-DOTA control group on the other hand, IPPP significantly mitigated RM in all dynamic phases in comparison to SPPP (all p <= 0.031). Conclusions We conclude that Gd-EOB-DTPA-related TSM cannot be mitigated by education and training and that Gd-EOB-DTPA-related breath-hold difficulty does not only affect the subgroup of patients with TSM or exclusively the arterial phase as previously proposed.	[Wybranski, Christian; Siedek, Florian; Haneder, Stefan; Persigehl, Thorsten] Univ Cologne, Fac Med, Inst Diagnost & Intervent Radiol, Cologne, Germany; [Wybranski, Christian; Siedek, Florian; Haneder, Stefan; Persigehl, Thorsten] Univ Cologne, Univ Hosp Cologne, Cologne, Germany; [Damm, Robert; Gazis, Angelos; Wenzel, Ortrud; Pech, Maciej; Fischbach, Frank; Fischbach, Katharina] Univ Hosp Magdeburg, Dept Radiol & Nucl Med, Magdeburg, Germany; [Steinhauser, Susanne] Univ Hosp Cologne, Inst Med Stat & Computat Biol, Cologne, Germany	University of Cologne; University of Cologne; University Hospital Magdeburg; University of Cologne	Siedek, F (corresponding author), Univ Cologne, Fac Med, Inst Diagnost & Intervent Radiol, Cologne, Germany.; Siedek, F (corresponding author), Univ Cologne, Univ Hosp Cologne, Cologne, Germany.	florian.siedek@uk-koeln.de						Ali SH, 2013, AM J ROENTGENOL, V200, P630, DOI 10.2214/AJR.12.9015; Bashir MR, 2015, RADIOLOGY, V274, P141, DOI 10.1148/radiol.14140386; Bernardi L, 2001, J HYPERTENS, V19, P2221, DOI 10.1097/00004872-200112000-00016; Chandarana H, 2015, INVEST RADIOL, V50, P749, DOI 10.1097/RLI.0000000000000179; Davenport MS, 2017, AM J ROENTGENOL, V208, P328, DOI 10.2214/AJR.16.16860; Davenport MS, 2014, AM J ROENTGENOL, V203, P796, DOI 10.2214/AJR.13.11587; Davenport MS, 2014, RADIOLOGY, V272, P123, DOI 10.1148/radiol.14132269; Davenport MS, 2013, RADIOLOGY, V266, P452, DOI 10.1148/radiol.12120826; Fahlenkamp UL, 2016, INVEST RADIOL, V51, P33, DOI 10.1097/RLI.0000000000000203; Furlan A, 2017, CLIN RADIOL, V72, DOI 10.1016/j.crad.2016.08.005; Grazioli L, 2018, RADIOL MED, V123, P910, DOI 10.1007/s11547-018-0927-y; Gruber L, 2018, EUR RADIOL, V28, P2013, DOI 10.1007/s00330-017-5210-4; Gutzeit A, 2016, EUR RADIOL, V26, P2714, DOI 10.1007/s00330-015-4086-4; Hayashi T, 2015, RADIOLOGY, V276, P756, DOI 10.1148/radiol.2015141646; Im WH, 2017, ABDOM RADIOL, V42, P2393, DOI 10.1007/s00261-017-1145-0; Kim SY, 2015, AM J ROENTGENOL, V204, P1220, DOI 10.2214/AJR.14.13677; Kim YK, 2017, RADIOLOGY, V283, P429, DOI 10.1148/radiol.2016160241; Kromrey ML, 2020, EUR RADIOL, V30, P281, DOI 10.1007/s00330-019-06358-7; Luetkens JA, 2015, EUR RADIOL, V25, P3207, DOI 10.1007/s00330-015-3736-x; McClellan TR, 2017, RADIOLOGY, V282, P361, DOI 10.1148/radiol.2016160482; Motosugi U, 2016, RADIOLOGY, V279, P93, DOI 10.1148/radiol.2015150642; Namimoto T, 2018, CLIN IMAG, V52, P11, DOI 10.1016/j.clinimag.2018.01.020; Narkiewicz K, 2006, HYPERTENSION, V47, P51, DOI 10.1161/01.HYP.0000197613.47649.02; Park YS, 2016, INVEST RADIOL, V51, P127, DOI 10.1097/RLI.0000000000000211; Parkes MJ, 2006, EXP PHYSIOL, V91, P1, DOI 10.1113/expphysiol.2005.031625; Pietryga JA, 2014, RADIOLOGY, V271, P426, DOI 10.1148/radiol.13131988; Polanec SH, 2017, J MAGN RESON IMAGING, V46, P1107, DOI 10.1002/jmri.25657; Ringe KI, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200887; Ringe KI, 2018, ROFO-FORTSCHR RONTG, V190, P341, DOI 10.1055/s-0044-100727; Shah MR, 2017, CLIN IMAG, V41, P23, DOI 10.1016/j.clinimag.2016.09.004; Song JS, 2018, EUR RADIOL, V28, P1132, DOI 10.1007/s00330-017-5070-y; Tanaka M, 2016, ANN SURG ONCOL, V23, P3991, DOI 10.1245/s10434-016-5362-5; Tornqvist E, 2006, ACTA RADIOL, V47, P474, DOI 10.1080/02841850600690355; Weiss J, 2018, INVEST RADIOL, V53, P596, DOI 10.1097/RLI.0000000000000459; Well L, 2017, ROFO-FORTSCHR RONTG, V189, P651, DOI 10.1055/s-0043-102940; Yoo JL, 2016, INVEST RADIOL, V51, P440, DOI 10.1097/RLI.0000000000000249; Yoon JH, 2018, INVEST RADIOL, V53, P52, DOI 10.1097/RLI.0000000000000409; Yoon JH, 2017, INVEST RADIOL, V52, P596, DOI 10.1097/RLI.0000000000000385	38	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0230024	10.1371/journal.pone.0230024	http://dx.doi.org/10.1371/journal.pone.0230024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196535	Green Published, gold			2022-12-26	WOS:000535303100017
J	Bills, CB; Newberry, JA; Rao, GVR; Matheson, LW; Rao, S; Mahadevan, SV; Strehlow, MC				Bills, Corey B.; Newberry, Jennifer A.; Rao, G. V. Ramana; Matheson, Loretta W.; Rao, Srinivasa; Mahadevan, Swaminatha, V; Strehlow, Matthew C.			Acute respiratory illness among a prospective cohort of pediatric patients using emergency medical services in India: Demographic and prehospital clinical predictors of mortality	PLOS ONE			English	Article							CHILDREN; IMPLEMENTATION; PNEUMONIA; HYPOXEMIA; ACCURACY; EPIDEMIOLOGY; MANAGEMENT; INFECTION; IMPACT	Background In India, acute respiratory illnesses, including pneumonia, are the leading cause of early childhood death. Emergency medical services are a critical component of India's public health infrastructure; however, literature on the prehospital care of pediatric patients in low-and middle-income countries is minimal. The aim of this study is to describe the demographic and clinical characteristics associated with 30-day mortality among a cohort of pediatric patients transported via ambulance in India with an acute respiratory complaint. Methods Pediatric patients less than 18 years of age using ambulance services in one of seven states in India, with a chief complaint of "shortness of breath", or a "fever" with associated "difficulty breathing" or "cough", were enrolled prospectively. Patients were excluded if evidence of choking, trauma or fire-related injury, patient was absent on ambulance arrival, or refused transport. Primary exposures included demographic, environmental, and clinical indicators, including hypoxemia and respiratory distress. The primary outcome was 7 and 30-day mortality. Multivariable logistic regression, stratified by transport type, was constructed to estimate associations between demographic and clinical predictors of mortality. Results A total of 1443 patients were enrolled during the study period: 981 (68.5%) were transported from the field, and 452 (31.5%) were interfacility transports. Thirty-day response was 83.4% (N = 1222). The median age of all patients was 2 years (IQR: 0.17-10); 93.9% (N = 1347) of patients lived on family incomes below the poverty level; and 54.1% (N = 706) were male. Cumulative mortality at 2, 7, and 30-days was 5.2%, 7.1%, and 7.7%, respectively; with 94 deaths by 30 days. Thirty-day mortality was greatest among those 0-28 days (N = 38,17%); under-5 mortality was 9.8%. In multivariable modeling prehospital oxygen saturation <95% (OR: 3.18 CI: 1.77-5.71) and respiratory distress (OR: 3.72 CI: 2.17-6.36) were the strongest predictors of mortality at 30 days. Conclusions This is the first study to detail prehospital predictors of death among pediatric patients with shortness of breath in LMICs. The risk of death is particularly high among neonates and those with documented mild hypoxemia, or respiratory distress. Early recognition of critically ill children, targeted prehospital interventions, and diversion to higher level of care may help to mitigate the mortality burden in this population.	[Bills, Corey B.] Univ Colorado, Dept Emergency Med, Aurora, CO 80045 USA; [Newberry, Jennifer A.; Matheson, Loretta W.; Rao, Srinivasa; Mahadevan, Swaminatha, V; Strehlow, Matthew C.] Stanford Univ, Dept Emergency Med, Palo Alto, CA 94304 USA; [Rao, G. V. Ramana] GVK Emergency Management & Res Inst, Devar Yamzal, Telangana, India	University of Colorado System; University of Colorado Anschutz Medical Campus; Stanford University	Bills, CB (corresponding author), Univ Colorado, Dept Emergency Med, Aurora, CO 80045 USA.	corey.bills@cuanschutz.edu	Janagama, Srinivasa/GSE-5284-2022; Bills, Corey/AAJ-8200-2021	Janagama, Srinivasa/0000-0001-8009-2037; Bills, Corey/0000-0002-3456-6008; Matheson, Loretta/0000-0001-5647-7623; Strehlow, Matthew Charles/0000-0002-0049-9716				Acker P, 2019, J GLOBAL HLTH REPORT; Albert V, 2017, ANAESTHESIA, V72, P686, DOI 10.1111/anae.13838; American Academy of Pediatrics Taskforce on Interhospital Transport, 1993, GUID AIR GROUND TRAN, P74; [Anonymous], 2013, AMBULANCE SERVICE NA; Bills CB, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019937; BRITTO J, 1995, BRIT MED J, V311, P836, DOI 10.1136/bmj.311.7009.836; Burn SL, 2014, B WORLD HEALTH ORGAN, V92, P858, DOI 10.2471/BLT.14.137315; Department of Health & Family Welfare MoHFW Government of India, 2015, CHILD HLTH PROGR ANN; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; International Vaccine Access Center (IVAC) Johns Hopkins Bloomberg School of Public Health, 2016, PNEUM DIARRH PROGR R; Kim J, 2017, PLANT CELL REP, V36, P1215, DOI 10.1007/s00299-017-2147-7; Lazzerini M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136166; Lederer DJ, 2019, ANN AM THORAC SOC, V16, P22, DOI 10.1513/AnnalsATS.201808-564PS; Leowski J, 1986, World Health Stat Q, V39, P138; Lipnick MS, 2016, ANESTH ANALG, V123, P338, DOI 10.1213/ANE.0000000000001300; Lozano JM, 2001, INT J TUBERC LUNG D, V5, P496; McCollum ED, 2017, CLIN INFECT DIS, V65, P1560, DOI 10.1093/cid/cix543; Mohan P, 2011, J HEALTH POPUL NUTR, V29, P629; Muro F, 2015, TROP MED INT HEALTH, V20, P757, DOI 10.1111/tmi.12492; ONYANGO FE, 1993, BRIT MED J, V306, P612, DOI 10.1136/bmj.306.6878.612; Romito J, 2016, GUIDELINES AIR GROUN; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; SIMOES EAF, 1991, ARCH DIS CHILD, V66, P1199, DOI 10.1136/adc.66.10.1199; Smyth A, 1998, ANN TROP PAEDIATR, V18, P31, DOI 10.1080/02724936.1998.11747923; Sonego M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116380; Strehlow MC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011459; Transport of a Sick Neonate, NNF CLIN PRACT GUID, P303; Tschudy MMA, 2012, HARRIET LANE HDB MAN, V20th; United Nations Inter-agency Group for Child Mortality Estimation, 2014, LEV TRENDS CHILD MOR; Usen S, 1999, BMJ-BRIT MED J, V318, P86, DOI 10.1136/bmj.318.7176.86; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0; Wardlaw TM, 2006, PNEUMONIA FORGOTTEN; Warren J, 2004, CRIT CARE MED, V32, P256, DOI 10.1097/01.CCM.0000104917.39204.0A; WHO, 2005, HDB IMCI INT MAN CHI; WHO and The United Nations Children's Fund (UNICEF), 2013, END PERV CHILD DEATH; World Health Organization, PNEUM FACT SHEET; World Health Organization, GLOB DAT CHILD GROWT; World Health Organization, PARTN MAT NEWB CHILD; World Health Organization, 2013, POCK BOOK HOSP CAR C; Zhang L, 2011, INT J TUBERC LUNG D, V15, P317	41	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230911	10.1371/journal.pone.0230911	http://dx.doi.org/10.1371/journal.pone.0230911			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240227	gold, Green Published			2022-12-26	WOS:000535945000057
J	Geuens, N; Verheyen, H; Vlerick, P; Van Bogaert, P; Franck, E				Geuens, Nina; Verheyen, Helena; Vlerick, Peter; Van Bogaert, Peter; Franck, Erik			Exploring the influence of core-self evaluations, situational factors, and coping on nurse burnout: A cross-sectional survey study	PLOS ONE			English	Article							JOB DEMANDS; PRACTICE ENVIRONMENT; WORK ENGAGEMENT; MEDIATING ROLE; RESOURCES; PERSONALITY; CARE; SATISFACTION; RUMINATION; BEHAVIORS	Stress has become an inherent aspect of the nursing profession. Chronically experienced work stress can lead to burnout. Although situational stressors show a significant influence on burnout, their power to predict the complete syndrome is rather limited. After all, stressors only exist "in the eye of the beholder". This study aimed to explore how individual vulnerability factors such as core-self evaluations and coping, contribute to burnout in relation to situational stressors within a population of hospital nurses. Cross-sectional data was collected in 2014, using five validated self-report instruments: Dutch Core Self Evaluations Scale, Nursing Work Index Revised, Utrecht Coping List, Ruminative Response Scale, and Utrecht Burnout Scale. 219 of the 250 questionnaires were returned. Core-self evaluations, situational factors and coping each contributed significantly to the predictive capacity of the models of the separate burnout dimensions. Core-self evaluations was significantly related to emotional exhaustion. It was suggested that Core-self evaluations might be placed at the initiation of the loss cycle. However, further research is warranted.	[Geuens, Nina; Verheyen, Helena; Franck, Erik] Karel de Grote Univ Coll, Ctr Expertise Cycle Care, Antwerp, Belgium; [Vlerick, Peter] Univ Ghent, Dept Work Org & Soc, Ghent, Belgium; [Van Bogaert, Peter; Franck, Erik] Univ Antwerp, Fac Med & Hlth Sci, Ctr Res & Innovat Care, Dept Nursing & Midwifery Sci, Antwerp, Belgium	Ghent University; University of Antwerp	Geuens, N (corresponding author), Karel de Grote Univ Coll, Ctr Expertise Cycle Care, Antwerp, Belgium.	nina.geuens@kdg.be	Franck, Erik/ABD-5804-2020; Van Bogaert, Peter/R-8735-2016	Van Bogaert, Peter/0000-0001-6636-3793; Franck, Erik/0000-0001-7809-2265	Karel de Grote University College, Antwerp, Belgium	Karel de Grote University College, Antwerp, Belgium	NG received Scientific Research funding from the Karel de Grote University College, Antwerp, Belgium for this work. https://www.kdg.be/en/research-and-expertise The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken LH, 2001, HEALTH AFFAIR, V20, P43, DOI 10.1377/hlthaff.20.3.43; Aiken LH, 2000, NURS RES, V49, P146, DOI 10.1097/00006199-200005000-00006; Aiken Linda H, 2012, BMJ, V344, pe1717, DOI 10.1136/bmj.e1717; Alarcon G, 2009, WORK STRESS, V23, P244, DOI 10.1080/02678370903282600; [Anonymous], 5 EUR WORK COND SURV; Armon G, 2012, J PERS, V80, P403, DOI 10.1111/j.1467-6494.2011.00731.x; Awa WL, 2010, PATIENT EDUC COUNS, V78, P184, DOI 10.1016/j.pec.2009.04.008; Bakker A.B., 2007, J MANAGE PSYCHOL, V22 (3), P309, DOI [10.1108/02683940710733115, DOI 10.1108/02683940710733115]; Bakker AB, 2011, EUR J WORK ORGAN PSY, V20, P4, DOI 10.1080/1359432X.2010.485352; Best RG, 2005, J OCCUP HEALTH PSYCH, V10, P441, DOI 10.1037/1076-8998.10.4.441; Bono JE, 2003, EUR J PERSONALITY, V17, pS5, DOI 10.1002/per.481; Brinker JK, 2009, J CLIN PSYCHOL, V65, P1, DOI 10.1002/jclp.20542; Corp. I, 2013, IBM SPSS STAT WINDOW, V22.0; Cropley M., 2003, EUR J WORK ORGAN PSY, V12, P195, DOI [10.1080/13594320344000093, DOI 10.1080/13594320344000093]; de Jong G M, 2000, J Occup Health Psychol, V5, P309, DOI 10.1037/1076-8998.5.2.309; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Donahue EG, 2012, APPL PSYCHOL-HLTH WE, V4, P341, DOI 10.1111/j.1758-0854.2012.01078.x; Erickson RJ., 2008, ONLINE J ISSUES NURS, V13, P1; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; FREUDENBERGER HJ, 1974, J SOC ISSUES, V30, P159, DOI 10.1111/j.1540-4560.1974.tb00706.x; Garrosa E., 2008, INT J NURS STUD, V47, P205; Geuens N, 2019, CANDIAN J NURSING RE; Geuens N, 2017, J CLIN NURSING; Ingram RE., 2005, VULNERABILITY STRESS, P32, DOI DOI 10.4135/9781452231655.N2; Jenaro C, 2007, PROF PSYCHOL-RES PR, V38, P80, DOI 10.1037/0735-7028.38.1.80; Judge TA, 1997, RES ORGAN BEHAV, V19, P151; Judge TA, 2003, PERS PSYCHOL, V56, P303, DOI 10.1111/j.1744-6570.2003.tb00152.x; Kammeyer-Mueller JD, 2009, J APPL PSYCHOL, V94, P177, DOI 10.1037/a0013214; Kaschka WP, 2011, DTSCH ARZTEBL INT, V108, P781, DOI 10.3238/arztebl.2011.0781; Lazarus R. S., 1984, STRESS APPRAISAL COP; Leiter MP, 2009, J NURS MANAGE, V17, P331, DOI 10.1111/j.1365-2834.2009.01004.x; Llorens-Gumbau S., 2014, BURNOUT RES, V1, P3, DOI [10.1016/j.burn.2014.02.001, DOI 10.1016/J.BURN.2014.02.001]; Martin LL, 1996, SOME RUMINATIVE THOU; Maslach C, 1998, THEORIES OF ORGANIZATIONAL STRESS, P68; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 2003, CURR DIR PSYCHOL SCI, V12, P189, DOI 10.1111/1467-8721.01258; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C, 1996, MASLACH BURNOUT INVE; Maslach C.J.S., 1997, MASLACH BURNOUT INVE, V3rd; NOLENHOEKSEMA S, 1991, J PERS SOC PSYCHOL, V61, P115, DOI 10.1037/0022-3514.61.1.115; PARASURAMAN S, 1984, J VOCAT BEHAV, V24, P179, DOI 10.1016/0001-8791(84)90005-8; Peng JX, 2016, J HEALTH PSYCHOL, V21, P50, DOI 10.1177/1359105314521478; Purvanova RK, 2010, J VOCAT BEHAV, V77, P168, DOI 10.1016/j.jvb.2010.04.006; Raes F, 2012, RUMINATIVE RESPONSE; Salanova M, 2008, INT J HUM RESOUR MAN, V19, P116, DOI 10.1080/09585190701763982; Schaufeli W., 2003, UTRECHT WORK ENGAGEM; Schaufeli WB., 2000, HANDLEIDING UTRECHTS; Schaufeli WB, 2009, J ORGAN BEHAV, V30, P893, DOI 10.1002/job.595; Schoofs H, 2010, J PSYCHOPATHOL BEHAV, V32, P609, DOI 10.1007/s10862-010-9182-9; Schreurs PJG, 1993, UTRECTSE COPING LIJS; Shin H, 2014, PROF PSYCHOL-RES PR, V45, P44, DOI 10.1037/a0035220; Taycan O, 2014, ARCH ENVIRON OCCUP H, V69, P159, DOI 10.1080/19338244.2013.763758; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; Turner H, 2012, EUR EAT DISORD REV, V20, P339, DOI 10.1002/erv.2173; Van Bogaert P, 2018, ORG CONTEXT NURSING, P297; Van Bogaert P, 2018, ORG CONTEXT NURSING; Van Bogaert P, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3562-3; Van Bogaert P, 2013, INT J NURS STUD, V50, P1667, DOI 10.1016/j.ijnurstu.2013.05.010; Van Bogaert P, 2009, J ADV NURS, V65, P2175, DOI 10.1111/j.1365-2648.2009.05082.x; Van Bogaert P, 2009, INT J NURS STUD, V46, P55, DOI 10.1016/j.ijnurstu.2008.07.009; van Doorn RRA, 2015, EUR J WORK ORGAN PSY, V24, P76, DOI 10.1080/1359432X.2013.858700; Vandenbroeck S, 2012, ONDERZOEK NAAR BURN; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Westbrook MT, 1979, J CLIN PSYCHOL; Wright Kerri, 2014, Nurs Stand, V28, P37, DOI 10.7748/ns2014.01.28.20.37.e8391; Yagil D, 2008, INT J SERV IND MANAG, V19, P575, DOI 10.1108/09564230810903479	66	8	8	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230883	10.1371/journal.pone.0230883	http://dx.doi.org/10.1371/journal.pone.0230883			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8KJ	32240234	gold, Green Published			2022-12-26	WOS:000535945000054
J	Li, FF; Zhao, HP; Li, GW; Zhang, SJ; Wang, RL; Tao, Z; Zheng, YM; Han, ZP; Liu, P; Ma, QF; Luo, YM				Li, Fangfang; Zhao, Haiping; Li, Guangwen; Zhang, Sijia; Wang, Rongliang; Tao, Zhen; Zheng, Yangmin; Han, Ziping; Liu, Ping; Ma, Qingfeng; Luo, Yumin			Intravenous antagomiR-494 lessens brain-infiltrating neutrophils by increasing HDAC2-mediated repression of multiple MMPs in experimental stroke	FASEB JOURNAL			English	Article						antagomiR-494; HDAC2; MMP; neutrophils; stroke	ISCHEMIC-STROKE; INHIBITION; MIGRATION; INVASION; NEUROPROTECTION; TRANSCRIPTION; MODULATION; ACTIVATION; EXPRESSION; PROTECTS	Neutrophil infiltration and phenotypic transformation are believed to contribute to neuronal damage in ischemic stroke. Emerging evidence suggests that histone deacetylase 2 (HDAC2) is an epigenetic regulator of inflammatory cells. Here, we aimed to investigate whether microRNA-494 (miR-494) affects HDAC2-mediated neutrophil infiltration and phenotypic shift. MiR-494 levels in neutrophils from acute ischemic stroke (AIS) patients were detected by real-time PCR. Chromatin Immunoprecipitation (ChIP)-Seq was performed to clarify which genes are the binding targets of HDAC2. Endothelial cells and cortical neurons were subjected to oxygen-glucose deprivation (OGD), transwell assay was conducted to examine neutrophil migration through endothelial cells, and neuronal injury was examined after stimulating with supernatant from antagomiR-494-treated neutrophils. C57BL/6J mice were subjected to transient middle cerebral artery occlusion (MCAO) and antagomiR-494 was injected through tail vein immediately after reperfusion, and neutrophil infiltration and phenotypic shift was examined. We found that the expression of miR-494 in neutrophils was significantly increased in AIS patients. HDAC2 targeted multiple matrix metalloproteinases (MMPs) and Fc-gamma receptor III (CD16) genes in neutrophils of AIS patients. Furthermore, antagomiR-494 repressed expression of multiple MMPs genes, including MMP7, MMP10, MMP13, and MMP16, which reduced the number of brain-infiltrating neutrophils by regulating HDAC2. AntagomiR-494 could also exert its neuroprotective role through inhibiting the shift of neutrophils toward pro-inflammatory N1 phenotype in vivo and in vitro. Taken together, miR-494 may serve as an alternative predictive biomarker of the outcome of AIS patients, and antagomiR-494 treatment decreases the expression of multiple MMPs and the infiltration of neutrophils and inhibits the shift of neutrophils into N1 phenotype partly by targeting HDAC2.	[Li, Fangfang; Zhao, Haiping; Li, Guangwen; Zhang, Sijia; Wang, Rongliang; Tao, Zhen; Zheng, Yangmin; Han, Ziping; Liu, Ping; Ma, Qingfeng; Luo, Yumin] Capital Med Univ, Inst Cerebrovasc Dis Res, Xuanwu Hosp, 45 Changchun St, Beijing 100053, Peoples R China; [Li, Fangfang; Zhao, Haiping; Li, Guangwen; Zhang, Sijia; Wang, Rongliang; Tao, Zhen; Zheng, Yangmin; Han, Ziping; Liu, Ping; Ma, Qingfeng; Luo, Yumin] Capital Med Univ, Dept Neurol, Xuanwu Hosp, 45 Changchun St, Beijing 100053, Peoples R China; [Zhao, Haiping; Wang, Rongliang; Tao, Zhen; Zheng, Yangmin; Han, Ziping; Luo, Yumin] Beijing Geriatr Med Res Ctr, Beijing, Peoples R China; [Zhao, Haiping; Wang, Rongliang; Tao, Zhen; Zheng, Yangmin; Han, Ziping; Luo, Yumin] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Luo, Yumin] Capital Med Univ, Beijing Inst Brain Disorders, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Luo, YM (corresponding author), Capital Med Univ, Inst Cerebrovasc Dis Res, Xuanwu Hosp, 45 Changchun St, Beijing 100053, Peoples R China.; Luo, YM (corresponding author), Capital Med Univ, Dept Neurol, Xuanwu Hosp, 45 Changchun St, Beijing 100053, Peoples R China.	yumin111@ccmu.edu.cn	zhao, haiping/I-1306-2014	zhao, Haiping/0000-0002-3244-1527	National Natural Science Foundation of China (NSFC) [81771413,81771412,81971222]; Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) [KZ201810025041]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81771413,81771412,81971222; Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation), Grant/Award Number: KZ201810025041	Biswas MHU, 2016, STEM CELL REP, V7, P316, DOI 10.1016/j.stemcr.2016.08.006; Campbell BCV, 2019, LANCET, V394, P139, DOI 10.1016/S0140-6736(19)31053-0; Certo M, 2015, PHARMACOL RES, V102, P298, DOI 10.1016/j.phrs.2015.10.009; Crosson CE, 2010, INVEST OPHTH VIS SCI, V51, P3639, DOI 10.1167/iovs.09-4538; Dodds JA, 2019, NEUROLOGY, V92, pE2784, DOI 10.1212/WNL.0000000000007653; Feigenson M, 2017, J BONE MINER RES, V32, P2453, DOI 10.1002/jbmr.3236; Gao CZ, 2008, MOL BIOL CELL, V19, P3020, DOI 10.1091/mbc.E07-11-1203; Garcia-Culebras A, 2019, STROKE, V50, P2922, DOI 10.1161/STROKEAHA.119.025085; Gill SE, 2016, AM J RESP CELL MOL, V55, P243, DOI 10.1165/rcmb.2015-0193OC; Han ZP, 2018, AGING DIS, V9, P235, DOI 10.14336/AD.2017.0328; He XW, 2019, ATHEROSCLEROSIS, V289, P36, DOI 10.1016/j.atherosclerosis.2019.08.002; Huang L, 2018, EXP NEUROL, V300, P41, DOI 10.1016/j.expneurol.2017.10.024; Cuartero MI, 2013, STROKE, V44, P3498, DOI 10.1161/STROKEAHA.113.002470; Jickling GC, 2015, J CEREBR BLOOD F MET, V35, P888, DOI 10.1038/jcbfm.2015.45; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Lenglet S, 2014, THROMB HAEMOSTASIS, V112, P363, DOI 10.1160/TH14-01-0007; Li Y, 2018, NEOPLASIA, V20, P745, DOI 10.1016/j.neo.2018.03.008; Lin CY, 2015, ONCOTARGET, V6, P43081, DOI 10.18632/oncotarget.5638; Liu J, 2012, J CELL MOL MED, V16, P2379, DOI 10.1111/j.1582-4934.2012.01551.x; Ma FF, 2016, NEUROBIOL DIS, V91, P236, DOI 10.1016/j.nbd.2016.03.016; Ma H, 2014, INT J MOL SCI, V15, P10936, DOI 10.3390/ijms150610936; Mauler M, 2019, CIRCULATION, V139, P918, DOI 10.1161/CIRCULATIONAHA.118.033942; McCrary MR, 2019, FASEB J, V33, P10680, DOI 10.1096/fj.201900070R; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; Purroy A, 2018, ATHEROSCLEROSIS, V278, P124, DOI 10.1016/j.atherosclerosis.2018.09.022; Shi KB, 2019, LANCET NEUROL, V18, P1058, DOI 10.1016/S1474-4422(19)30078-X; Sonoda T, 2019, STROKE, V50, P1510, DOI 10.1161/STROKEAHA.118.023648; Swingler TE, 2010, BIOCHEM J, V427, P391, DOI 10.1042/BJ20091798; Tang CM, 2019, NANO LETT, V19, P4470, DOI 10.1021/acs.nanolett.9b01282; Venosa A, 2017, TOXICOL SCI, V157, P222, DOI 10.1093/toxsci/kfx032; Wang HZ, 2015, ONCOTARGETS THER, V8, P3211, DOI 10.2147/OTT.S79282; Wang H, 2019, CNS NEUROSCI THER, V25, P476, DOI 10.1111/cns.13074; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Xiong CX, 2019, FASEB J, V33, P8249, DOI 10.1096/fj.201801067RR; Zeidan-Chulia F, 2018, J PERIODONTAL RES, V53, P916, DOI 10.1111/jre.12583; Zhao HP, 2019, J CEREBR BLOOD F MET, V39, P2392, DOI 10.1177/0271678X19875201; Zhao HP, 2020, BRIT J PHARMACOL, V177, P128, DOI 10.1111/bph.14852; Zhao HW, 2021, J ASIAN NAT PROD RES, V23, P26, DOI 10.1080/10286020.2019.1700230	38	11	11	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6934	6949		10.1096/fj.201903127R	http://dx.doi.org/10.1096/fj.201903127R		APR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32239566	Green Submitted			2022-12-26	WOS:000522968100001
J	Garcia-Alaminos, A; Monsalve, F; Zafrilla, J; Cadarso, MA				Garcia-Alaminos, Angela; Monsalve, Fabio; Zafrilla, Jorge; Cadarso, Maria-Angeles			Unmasking social distant damage of developed regions' lifestyle: A decoupling analysis of the indecent labour footprint	PLOS ONE			English	Article							CONSUMPTION; IMPACT; TRADE; EMISSIONS; BOTTOM; ENERGY; CARBON; EU	A fair path to achieve a sustainable world would imply reducing the eventual negative effects linked to the production process while increasing economic output, which is referred to in the literature as impact decoupling. This article aims to assess whether global consumption chains are currently on the decoupling path or not, from a social point of view. Specifically, we address the working conditions which developed societies' lifestyle sparked at a distance in global factory countries, focusing on the most harmful consequences of an indecent work. Additionally, we determine the kind of decoupling observed through the new concept of social footprints' elasticities with respect to final demand for each region. We employ a Multi-Regional Input-Output model and an own elaboration database of social impacts concerning undignified working conditions. Results indicate that most countries achieved the goal of decoupling occupational injuries -both fatal and non-fatal- from production, while results for forced labour show a slower and sometimes uncertain process of decoupling. European Union and United States' footprints have been reduced overtime for the three impacts. However, more than half of these footprints are still generated by imports, mainly from developing regions.	[Garcia-Alaminos, Angela; Monsalve, Fabio; Zafrilla, Jorge; Cadarso, Maria-Angeles] Univ Castilla La Mancha, Dept Econ Anal & Finances, Global Energy & Environm Econ Anal Res Grp, Albacete, Spain; [Garcia-Alaminos, Angela; Monsalve, Fabio; Zafrilla, Jorge; Cadarso, Maria-Angeles] Univ Castilla La Mancha, Fac Econ & Business, Albacete, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha	Garcia-Alaminos, A (corresponding author), Univ Castilla La Mancha, Dept Econ Anal & Finances, Global Energy & Environm Econ Anal Res Grp, Albacete, Spain.; Garcia-Alaminos, A (corresponding author), Univ Castilla La Mancha, Fac Econ & Business, Albacete, Spain.	angela.garcia@uclm.es	Cadarso, Maria Angeles/AAB-5700-2019; Monsalve, Fabio/E-8610-2010; García-Alaminos, Ángela/B-5507-2019; Cadarso, Maria Angeles/F-4832-2016; Zafrilla, Jorge/I-2803-2015	Cadarso, Maria Angeles/0000-0002-5165-7729; Monsalve, Fabio/0000-0001-6595-2799; García-Alaminos, Ángela/0000-0002-2098-8525; Cadarso, Maria Angeles/0000-0002-5165-7729; Zafrilla, Jorge/0000-0001-7953-9006	Ministry of Economy and Competitiveness of Spain [ECO2012-33341]; European Social Fund through the Regional FPI program [PRE18]; University of Castilla-La Mancha through the Regional FPI program [PRE18]; "Plan Propio de Investigacion" from University of Castilla-La Mancha [2019-GRIN-27108]	Ministry of Economy and Competitiveness of Spain(Spanish Government); European Social Fund through the Regional FPI program; University of Castilla-La Mancha through the Regional FPI program; "Plan Propio de Investigacion" from University of Castilla-La Mancha	F.M., J.Z. and M.-A.C thank the Ministry of Economy and Competitiveness of Spain for funding the research project "ECO2012-33341 that led to this paper. A. G-A. also thanks the European Social Fund and University of Castilla-La Mancha support through the Regional FPI program (PRE18: Contratos predoctorales para la formacion de personal investigador en el marco del plan propio de I+D+i, susceptible de cofinanciacion por el Fondo Social Europeo). All the authors thank "Plan Propio de Investigacion" from University of Castilla-La Mancha (reference 2019-GRIN-27108) for funding this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizu-Gardoki O, 2018, J CLEAN PROD, V202, P1145, DOI 10.1016/j.jclepro.2018.08.235; Alli BO, 2008, FUNDAMENTAL PRINCIPL, Vxx; Alsamawi A, 2017, SOCIAL FOOTPRINT NAT; Alsamawi A, 2017, J CLEAN PROD, V147, P187, DOI 10.1016/j.jclepro.2016.12.110; Alsamawi A, 2014, J IND ECOL, V18, P59, DOI 10.1111/jiec.12104; Barrientos S, 2011, INT LABOUR REV, V150, P319, DOI 10.1111/j.1564-913X.2011.00119.x; Cadarso MA, 2012, ECOL ECON, V83, P221, DOI 10.1016/j.ecolecon.2012.05.009; Datta MN, 2013, HUM RIGHTS QUART, V35, P817, DOI 10.1353/hrq.2013.0051; Davies RB, 2013, J DEV ECON, V103, P1, DOI 10.1016/j.jdeveco.2013.01.003; Davis SJ, 2010, P NATL ACAD SCI USA, V107, P5687, DOI 10.1073/pnas.0906974107; EEA, 2014, PROGR RES EFF DEC EU; EMERSON CI, 2011, PRACTICAL ETHICS, V12, DOI DOI 10.1186/1472-6939-12-2; European Commission, 2003, THEM STRAT SUST US N; Fischer-Kowalski M., 2011, DECOUPLING NATURAL R; Garcia-Alaminos A., 2019, SOCIAL INDICATORS WO; Giuliani E, 2017, WORLD DEV, V96, P294, DOI 10.1016/j.worlddev.2017.03.013; Gomez-Paredes J, 2015, ECON SYST RES, V27, P415, DOI 10.1080/09535314.2014.998173; Gonz?lez E.R., 2009, OSH FIGURES STRESS W; Guo LH, 2014, INTERNATIONAL CONFERENCE ON EDUCATION AND SOCIAL DEVELOPMENT (ICESD 2014), P77; Hardadi G, 2017, J IND ECOL, V21, P1536, DOI 10.1111/jiec.12588; Hernandez D, 2015, EUR J POLIT ECON, V38, P118, DOI 10.1016/j.ejpoleco.2015.02.002; ILO, 2020, GLOB ALL FORC LAB GL, P16; ILO, 1998, INT LABOUR C 86 SESS, VII; IPCC, 2018, GLOB WARM 1 5C; Kareiva PM, 2015, P NATL ACAD SCI USA, V112, P7375, DOI 10.1073/pnas.1408120111; Kerrissey J, 2016, SOC FORCES, V95, P191, DOI 10.1093/sf/sow050; Korner T., 2009, QUALITY EMPLOYMENT; Loo BPY, 2016, J TRANSP GEOGR, V57, P134, DOI 10.1016/j.jtrangeo.2016.10.006; Matrix Insight, 2013, EC AN WORKPL MENT HL; Mazzanti M, 2005, ENV SCI, V2, P409, DOI DOI 10.1080/15693430500364707; Miller RE, 2009, INPUT OUTPUT ANAL FD, Vxxxii; MONSALVE A, 2018, ECON SYST RES, P1, DOI DOI 10.1080/09535314.2018.1491391; Monsalve F, 2016, ECOL ECON, V129, P62, DOI 10.1016/j.ecolecon.2016.06.006; Moreau V, 2018, APPL ENERG, V215, P54, DOI 10.1016/j.apenergy.2018.01.044; Mosley L, 2007, COMP POLIT STUD, V40, P923, DOI 10.1177/0010414006293442; Mudgal S, 2010, CONTRACT, V7; OECD, 2002, INDICATORS MEASURE D; Olney WW, 2013, J INT ECON, V91, P191, DOI 10.1016/j.jinteco.2013.08.003; Sanye-Mengual E, 2019, J CLEAN PROD, V236, DOI 10.1016/j.jclepro.2019.07.010; Scherer L, 2018, ENVIRON SCI POLICY, V90, P65, DOI 10.1016/j.envsci.2018.10.002; Simas M, 2017, ECOL INDIC, V76, P317, DOI 10.1016/j.ecolind.2017.01.026; Simas MS, 2014, SUSTAINABILITY-BASEL, V6, P7514, DOI 10.3390/su6117514; SINGLETON WT, 1982, J OCCUP ACCID, V4, P91, DOI 10.1016/0376-6349(82)90014-1; Skelton A, 2011, ENVIRON SCI TECHNOL, V45, P10516, DOI 10.1021/es202313e; Song Y, 2019, ECOL INDIC, V102, P230, DOI 10.1016/j.ecolind.2019.02.044; Srivastava R. S., 2005, BONDED LABOR INDIA I; Steen-Olsen K, 2012, ENVIRON SCI TECHNOL, V46, P10883, DOI 10.1021/es301949t; Stiglitz JE., 2010, REPORT COMMISSION ME; Tapio P, 2005, TRANSP POLICY, V12, P137, DOI 10.1016/j.tranpol.2005.01.001; Timmer M.P., 2016, GD162 GGDC U GRON; Timmer MP, 2015, REV INT ECON, V23, P575, DOI 10.1111/roie.12178; Tridico P, 2013, INT LABOUR REV, V152, P175, DOI 10.1111/j.1564-913X.2013.00176.x; UN, 2019, DEC WORK EC GROWTH W; United Nations, 2015, HDB MEAS QUAL EMPL S; USBILA, 2016, LIST GOODS PROD CHIL; Vargas R, 2015, EC DIE IMPACTS HUMAN; VEHMAS J, 2003, SERIES DISCUSSION WO, V7, P2003; Ward JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164733; Wiebe KS, 2018, J CLEAN PROD, V194, P243, DOI 10.1016/j.jclepro.2018.05.003; Wiedmann T, 2018, NAT GEOSCI, V11, P314, DOI 10.1038/s41561-018-0113-9; Wiedmann TO, 2015, P NATL ACAD SCI USA, V112, P6271, DOI 10.1073/pnas.1220362110; York R, 2003, ECOL ECON, V46, P351, DOI 10.1016/S0921-8009(03)00188-5	62	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0228649	10.1371/journal.pone.0228649	http://dx.doi.org/10.1371/journal.pone.0228649			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8IA	32236100	gold, Green Published			2022-12-26	WOS:000535938700006
J	Muyor, JM; Martin-Fuentes, I; Rodriguez-Ridao, D; Antequera-Vique, JA				Muyor, Jose M.; Martin-Fuentes, Isabel; Rodriguez-Ridao, David; Antequera-Vique, Jose A.			Electromyographic activity in the gluteus medius, gluteus maximus, biceps femoris, vastus lateralis, vastus medialis and rectus femoris during the Monopodal Squat, Forward Lunge and Lateral Step-Up exercises	PLOS ONE			English	Article							MUSCLE-ACTIVITY; THIGH MUSCLES; SURFACE ELECTROMYOGRAPHY; BACK SQUAT; HIP; STRENGTH; ACTIVATION; DEADLIFT; LOAD; PERFORMANCE	The Monopodal Squat, Forward Lunge and Lateral Step-Up exercises are commonly performed with one's own body weight for rehabilitation purposes. However, muscle activity evaluated using surface electromyography has never been analyzed among these three exercises. Therefore, the objectives of the present study were to evaluate the amplitude of the EMG activity of the gluteus medius, gluteus maximus, biceps femoris, vastus lateralis, vastus medialis and rectus femoris muscles in participants performing the Lateral Step-Up, Forward Lunge and Monopodal Squat exercises. A total of 20 physically active participants (10 men and 10 women) performed 5 repetitions at 60% (5 repetition maximum) in each of the evaluated exercises. The EMG amplitude was calculated in percentage of the maximum voluntary contraction. The Monopodal Squat exercise showed a higher EMG activity (p. 0.001) in relation to the Lateral Step-Up and Forward Lunge exercises in all of the evaluated muscles (d > 0.6) except for the rectus femoris. The three exercises showed significantly higher EMG activity in all of the muscles that were evaluated in the concentric phase in relation to the eccentric one. In the three evaluated exercises, vastus lateralis and vastus medialis showed the highest EMG activity, followed by gluteus medius and gluteus maximus. The Monopodal Squat, Forward Lunge and Lateral Step-Up exercises not only are recommended for their rehabilitation purposes but also should be recommended for performance objectives and strength improvement in the lower limbs.	[Muyor, Jose M.] Univ Almeria, Res Cent Serv, Lab Kinesiol Biomech & Ergon KIBIOMER Lab, Almeria, Spain; [Muyor, Jose M.; Martin-Fuentes, Isabel; Rodriguez-Ridao, David; Antequera-Vique, Jose A.] Univ Almeria, Hlth Res Ctr, Almeria, Spain; [Martin-Fuentes, Isabel] Univ Almeria, Fac Educ Sci, Edificio Cent, Almeria, Spain	Universidad de Almeria; Universidad de Almeria; Universidad de Almeria	Martin-Fuentes, I (corresponding author), Univ Almeria, Hlth Res Ctr, Almeria, Spain.; Martin-Fuentes, I (corresponding author), Univ Almeria, Fac Educ Sci, Edificio Cent, Almeria, Spain.	imf902@ual.es	Fuentes, Isabel Martín/AAC-8399-2019; Muyor, José M./M-7342-2015	Fuentes, Isabel Martín/0000-0003-4268-1935; Muyor, José M./0000-0003-2849-0323	Proyectos I+D +I Ministerio de Economia y Competitividad. Gobierno de Espana [DEP 2016-80296-R]	Proyectos I+D +I Ministerio de Economia y Competitividad. Gobierno de Espana	This work was supported by the Proyectos I+D +I Ministerio de Economia y Competitividad. Gobierno de Espana. Referencia: DEP 2016-80296-R (AEI/FEDER, UE).	Anders C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178957; Andersen LL, 2006, PHYS THER, V86, P683, DOI 10.1093/ptj/86.5.683; Andersen V, 2018, J STRENGTH COND RES, V32, P587, DOI 10.1519/JSC.0000000000001826; Andersen V, 2015, J STRENGTH COND RES, V29, P2932, DOI 10.1519/JSC.0000000000000950; Ankrum DR, 2000, P HUM FACTORS ERGON, V44, DOI [10.1177/00005768-200010000-00015, DOI 10.1177/00005768-200010000-00015]; Aspe RR, 2014, J STRENGTH COND RES, V28, P2827, DOI 10.1519/JSC.0000000000000462; Ayotte NW, 2007, J ORTHOP SPORT PHYS, V37, P48, DOI 10.2519/jospt.2007.2354; Bolgla LA, 2016, PHYSIOTHER THEOR PR, V32, P130, DOI 10.3109/09593985.2015.1092059; Bouillon LE, 2012, INT J SPORTS PHYS TH, V7, P595; Bourne MN, 2015, AM J SPORT MED, V43, P2663, DOI 10.1177/0363546515599633; Bussey MD, 2018, MUSCULOSKEL SCI PRAC, V34, P103, DOI 10.1016/j.msksp.2017.09.004; Camara KD, 2016, J STRENGTH COND RES, V30, P1183, DOI 10.1519/JSC.0000000000001352; DeFOREST Bradley A, 2014, Int J Exerc Sci, V7, P302; Earp JE, 2016, J STRENGTH COND RES, V30, P1585, DOI 10.1519/JSC.0000000000001405; Ebben WP, 2002, J STRENGTH COND RES, V16, P547, DOI 10.1519/00124278-200211000-00009; Ebenbichler GR, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00299; Eliassen W, 2018, INT J SPORTS PHYS TH, V13, P871, DOI 10.26603/ijspt20180871; Foley RCA, 2017, INT J SPORTS PHYS TH, V12, P550; Ford KR, 2015, OPEN ACCESS J SPORTS, V6, P291, DOI 10.2147/OAJSM.S72432; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gianola S, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1660-8; Giorgio P, 2009, J STRENGTH COND RES, V23, P652, DOI 10.1519/JSC.0b013e31818f0950; Hatfield GL, 2017, J STRENGTH COND RES, V31, P3444, DOI 10.1519/JSC.0000000000001756; Hegyi A, 2018, SCAND J MED SCI SPOR, V28, P992, DOI 10.1111/sms.13016; Jonhagen S, 2009, SCAND J MED SCI SPOR, V19, P561, DOI 10.1111/j.1600-0838.2007.00692.x; Komi PV, 2000, MED SCI SPORT EXER, V32, P1757, DOI 10.1097/00005768-200010000-00015; Kraemer WJ, 1997, J STRENGTH COND RES, V11, P131; Krause DA, 2018, INT J SPORTS PHYS TH, V13, P137, DOI 10.26603/ijspt20180137; Krause DA, 2009, J STRENGTH COND RES, V23, P2689, DOI 10.1519/JSC.0b013e3181bbe861; Teixeira CVL, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00643; Lanza MB, 2018, J STRENGTH COND RES, V32, pE58, DOI 10.1519/JSC.0000000000002953; Lehecka BJ, 2017, INT J SPORTS PHYS TH, V12, P543; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; MacAskill MJ, 2014, INT J SPORTS PHYS TH, V9, P907; Maia MF, 2014, J STRENGTH COND RES, V28, P2529, DOI 10.1519/JSC.0000000000000451; Marcolin G, 2018, PEERJ, V6, DOI 10.7717/peerj.5165; Matheson JW, 2001, MED SCI SPORT EXER, V33, P1713, DOI 10.1097/00005768-200110000-00016; McCurdy K, 2018, J STRENGTH COND RES, V32, P594, DOI 10.1519/JSC.0000000000001893; McCurdy K, 2010, J SPORT REHABIL, V19, P57, DOI 10.1123/jsr.19.1.57; Nijem RM, 2014, STRENGTH COND J, V36, P113, DOI 10.1519/SSC.0000000000000085; O'Sullivan K, 2010, BMC SPORTS SCI MED R, V2, DOI 10.1186/1758-2555-2-17; Oshikawa Tomoki, 2018, J Phys Ther Sci, V30, P434, DOI 10.1589/jpts.30.434; Paoli A, 2009, J STRENGTH COND RES, V23, P246, DOI 10.1519/JSC.0b013e3181876811; Peterson MD, 2010, AGEING RES REV, V9, P226, DOI 10.1016/j.arr.2010.03.004; Pincivero DM, 2006, J BIOMECH, V39, P246, DOI 10.1016/j.jbiomech.2004.11.023; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Reiman Michael P., 2012, Physiotherapy Theory and Practice, V28, P257, DOI 10.3109/09593985.2011.604981; Reiman MP, 2009, J SPORT REHABIL, V18, P33, DOI 10.1123/jsr.18.1.33; Renshaw Doug, 2010, Int J Exerc Sci, V3, P43; Schmitz RJ, 2002, J SPORT REHABIL, V11, P179, DOI 10.1123/jsr.11.3.179; Speirs DE, 2016, J STRENGTH COND RES, V30, P386, DOI 10.1519/JSC.0000000000001096; Stastny P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171632; Stastny P, 2015, ACTA GYMNICA, V45, P51, DOI 10.5507/ag.2015.011; Stastny P, 2015, J STRENGTH COND RES, V29, P3177, DOI 10.1519/JSC.0000000000000976; Stastny P, 2014, NEUROENDOCRINOL LETT, V35, P633; Vigotsky AD, 2018, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00985; Westcott WL, 2012, CURR SPORT MED REP, V11, P209, DOI 10.1249/JSR.0b013e31825dabb8; Yavuz HU, 2017, APPL BIONICS BIOMECH, V2017, DOI 10.1155/2017/9084725; Young WB, 1998, J STRENGTH COND RES, V12, P82, DOI 10.1519/1533-4287(1998)012<0082:AEOPPF>2.3.CO;2	59	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230841	10.1371/journal.pone.0230841	http://dx.doi.org/10.1371/journal.pone.0230841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236133	Green Published, gold			2022-12-26	WOS:000535938700033
J	Nakano, R; Kitanaka, T; Namba, S; Kitanaka, N; Sato, M; Shibukawa, Y; Masuhiro, Y; Kano, K; Matsumoto, T; Sugiya, H				Nakano, Rei; Kitanaka, Taku; Namba, Shinichi; Kitanaka, Nanako; Sato, Masaki; Shibukawa, Yoshiyuki; Masuhiro, Yoshikazu; Kano, Koichiro; Matsumoto, Taro; Sugiya, Hiroshi			All-trans retinoic acid induces reprogramming of canine dedifferentiated cells into neuron-like cells	PLOS ONE			English	Article							DIRECTED DIFFERENTIATION; FUNCTIONAL MATURATION; FAT-CELLS; INTERNEURONS; EXPRESSION; FIBROBLASTS; ACTIVATION; DRIVEN; MICE; JNK	The specification of cell identity depends on the exposure of cells to sequences of bioactive ligands. All-trans retinoic acid (ATRA) affects neuronal development in the early stage, and it is involved in neuronal lineage reprogramming. We previously established a fibroblast-like dedifferentiated fat cells (DFATs) derived from highly homogeneous mature adipocytes, which are more suitable for the study of cellular reprogramming. Canine cognitive dysfunction is similar to human cognitive dysfunction, suggesting that dogs could be a pathological and pharmacological model for human neuronal diseases. However, the effect of ATRA on neuronal reprogramming in dogs has remained unclear. Therefore, in this study, we investigated the effect of ATRA on the neuronal reprogramming of canine DFATs. ATRA induced the expression of neuronal marker mRNA/protein. The neuron-like cells showed Ca2+ influx with depolarization (50 mM KCl; 84.75 +/- 4.05%) and Na+ channel activation (50 mu M veratridine; 96.02 +/- 2.02%). Optical imaging of presynaptic terminal activity and detection of neurotransmitter release showed that the neuron-like cells exhibited the GABAergic neuronal property. Genome-wide RNA-sequencing analysis shows that the transcriptome profile of canine DFATs is effectively reprogrammed towards that of cortical interneuron lineage. Collectively, ATRA can produce functional GABAergic cortical interneuron-like cells from canine DFATs, exhibiting neuronal function with > 80% efficiency. We further demonstrated the contribution of JNK3 to ATRA-induced neuronal reprogramming in canine DFATs. In conclusion, the neuron-like cells from canine DFATs could be a powerful tool for translational research in cell transplantation therapy, in vitro disease modeling, and drug screening for neuronal diseases.	[Nakano, Rei] RIKEN Ctr Integrat Med Sci IMS, Lab Cellular Funct Convers Technol, Yokohama, Kanagawa, Japan; [Nakano, Rei; Kitanaka, Taku; Namba, Shinichi; Kitanaka, Nanako; Sugiya, Hiroshi] Nihon Univ, Coll Bioresource Sci, Lab Vet Biochem, Fujisawa, Kanagawa, Japan; [Sato, Masaki] Tokyo Dent Coll, Dept Biol, Tokyo, Japan; [Shibukawa, Yoshiyuki] Tokyo Dent Coll, Dept Physiol, Tokyo, Japan; [Masuhiro, Yoshikazu] Nihon Univ, Coll Bioresource Sci, Lab Mol & Cellular Physiol, Fujisawa, Kanagawa, Japan; [Kano, Koichiro] Nihon Univ, Coll Bioresource Sci, Lab Cell & Tissue Biol, Fujisawa, Kanagawa, Japan; [Matsumoto, Taro] Nihon Univ, Dept Funct Morphol, Div Cell Regenerat & Transplantat, Sch Med, Tokyo, Japan	RIKEN; Nihon University; Tokyo Dental College; Tokyo Dental College; Nihon University; Nihon University; Nihon University	Sugiya, H (corresponding author), Nihon Univ, Coll Bioresource Sci, Lab Vet Biochem, Fujisawa, Kanagawa, Japan.	sugiya.hiroshi@nihon-u.ac.jp		Namba, Shinichi/0000-0002-9182-3656; Nakano, Rei/0000-0003-0255-6347	Ministry of Education, Science, Sports, and Culture of Japan [18K14594]; Nihon University	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nihon University	This work was supported in part by a Grant-in-Aid for Scientific Research (#18K14594; RN) from the Ministry of Education, Science, Sports, and Culture of Japan (https://www.jsps.go.jp/j-grantsinaid/).This work was supported in part by a Nihon University Chairman of the Board of Trustees Grant (#2018-2020; TM) from Nihon University (http://www.nihon-u.ac.jp/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bissonnette CJ, 2011, STEM CELLS, V29, P802, DOI 10.1002/stem.626; Blumberg B, 1997, DEVELOPMENT, V124, P373; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Catts VS, 2008, EUR J NEUROSCI, V28, P883, DOI 10.1111/j.1460-9568.2008.06390.x; Chatzi C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000609; Chohan MO, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00064; Colditz MJ, 2010, EXP BRAIN RES, V200, P161, DOI 10.1007/s00221-009-1947-6; Cummings BJ, 1996, NEUROBIOL AGING, V17, P259, DOI 10.1016/0197-4580(95)02060-8; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Duncan T, 2017, STEM CELL REP, V9, P557, DOI 10.1016/j.stemcr.2017.07.008; Elmi M, 2007, MOL CELL NEUROSCI, V36, P248, DOI 10.1016/j.mcn.2007.07.001; Gao LF, 2017, STEM CELL REP, V8, P538, DOI 10.1016/j.stemcr.2017.01.014; Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Ichikawa H, 2012, J ENDODONT, V38, P1355, DOI 10.1016/j.joen.2012.06.015; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; KESSEL M, 1992, DEVELOPMENT, V115, P487; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Kim TG, 2014, STEM CELLS, V32, P1789, DOI 10.1002/stem.1704; Kitanaka N, 2019, PLOS ONE, V14; Kitanaka N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220262; Kitanaka N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208955; Kitanaka T, 2017, SCI REP-UK, V7, DOI 10.1038/srep39914; Konno T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166707; Kono S, 2014, VET J, V199, P88, DOI 10.1016/j.tvjl.2013.10.033; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; Lin PY, 2007, J NEUROSCI, V27, P12787, DOI 10.1523/JNEUROSCI.3302-07.2007; Liu Y, 2013, NAT PROTOC, V8, P1670, DOI 10.1038/nprot.2013.106; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0; Matsumoto T, 2011, J CELL PHYSL, V215, P210; Nakano R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26473-7; Nakano R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141581; Nakano R, 2015, J VET MED SCI, V77, P27, DOI 10.1292/jvms.14-0284; Nakano R, 2013, AM J VET RES, V74, P1311, DOI 10.2460/ajvr.74.10.1311; Namba S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182923; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Nobusue H, 2008, CELL TISSUE RES, V332, P435, DOI 10.1007/s00441-008-0593-9; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; Ono H, 2011, BIOCHEM BIOPH RES CO, V407, P562, DOI 10.1016/j.bbrc.2011.03.063; Saler M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122699; Salvin HE, 2011, VET J, V188, P331, DOI 10.1016/j.tvjl.2010.05.014; Shah M, 2016, ORGANOGENESIS, V12, P119, DOI 10.1080/15476278.2016.1197461; Shiotsugu J, 2004, DEVELOPMENT, V131, P2653, DOI 10.1242/dev.01129; SIVE HL, 1990, GENE DEV, V4, P932, DOI 10.1101/gad.4.6.932; Tonge PD, 2010, DIFFERENTIATION, V80, P20, DOI 10.1016/j.diff.2010.04.001; Tsuchiya H, 2015, VET IMMUNOL IMMUNOP, V168, P223, DOI 10.1016/j.vetimm.2015.10.003; Wilcox JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019768; Zhang L, 2015, CELL STEM CELL, V17, P735, DOI 10.1016/j.stem.2015.09.012; Zhang ML, 2016, CELL STEM CELL, V18, P653, DOI 10.1016/j.stem.2016.03.020	54	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0229892	10.1371/journal.pone.0229892	http://dx.doi.org/10.1371/journal.pone.0229892			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HO	32231396	Green Published, Green Submitted, gold			2022-12-26	WOS:000535937400005
J	Brandt, EJ; Ross, JS; Grady, JN; Ahmad, T; Pawar, S; Bernheim, SM; Desai, NR				Brandt, Eric J.; Ross, Joseph S.; Grady, Jacqueline N.; Ahmad, Tariq; Pawar, Sumeet; Bernheim, Susannah M.; Desai, Nihar R.			Impact of left ventricular assist devices and heart transplants on acute myocardial infarction and heart failure mortality and readmission measures	PLOS ONE			English	Article							PROFILING HOSPITAL PERFORMANCE; RATES	Background Concern has been raised about consequences of including patients with left ventricular assist device (LVAD) or heart transplantation in readmission and mortality measures. Methods We calculated unadjusted and hospital-specific 30-day risk-standardized mortality (RSMR) and readmission (RSRR) rates for all Medicare fee-for-service beneficiaries with a primary diagnosis of AMI or HF discharged between July 2010 and June 2013. Hospitals were compared before and after excluding LVAD and heart transplantation patients. LVAD indication was measured. Results In the AMI mortality (n = 506,543) and readmission (n = 526,309) cohorts, 1,166 and 1,016 patients received an LVAD while 3 and 2 had a heart transplantation, respectively. In the HF mortality (n = 1,015,335) and readmission (n = 1,254,124) cohorts, 789 and 931 received an LVAD, while 212 and 202 received a heart transplantation, respectively. Less than 2% of hospitals had either >= 6 patients who received an LVAD or, independently, had >= 1 heart transplantation. The AMI mortality and readmission cohorts used 1.8% and 2.8% of LVADs for semi-permanent/permanent indications, versus 73.8% and 78.0% for HF patients, respectively. The rest were for temporary/external indications. In the AMI cohort, RSMR for hospitals without LVAD patients versus hospitals with >= 6 LVADs was 14.8% and 14.3%, and RSRR was 17.8% and 18.3%, respectively; the HF cohort RSMR was 11.9% and 9.7% and RSRR was 22.6% and 23.4%, respectively. In the AMI cohort, RSMR for hospitals without versus with heart transplantation patients was 14.7% and 13.9% and RSRR was 17.8% and 17.7%, respectively; in the HF cohort, RSMR was 11.9% and 11.0%, and RSRR was 22.6% and 22.6%, respectively. Estimations changed <= 0.1% after excluding LVAD or heart transplantation patients. Conclusion Hospitals caring for >= 6 patients with LVAD or >= 1 heart transplantation typically had a trend toward lower RSMRs but higher RSRRs. Rates were insignificantly changed when these patients were excluded. LVADs were primarily for acute-care in the AMI cohort and chronic support in the HF cohort. LVAD and heart transplantation patients are a distinct group with differential care requirements and outcomes, thus should be considered separately from the rest of the HF cohort.	[Brandt, Eric J.; Ahmad, Tariq; Pawar, Sumeet; Desai, Nihar R.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Ross, Joseph S.; Grady, Jacqueline N.; Ahmad, Tariq; Bernheim, Susannah M.; Desai, Nihar R.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, Sect Gen Med, New Haven, CT 06510 USA; [Ross, Joseph S.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA	Yale University; Yale University; Yale University	Desai, NR (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA.; Desai, NR (corresponding author), Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA.	nihar.desai@yale.edu	; Ahamed, Tariq/E-8985-2016	Ross, Joseph/0000-0002-9218-3320; Ahamed, Tariq/0000-0002-4525-0738; Brandt, Eric/0000-0001-5463-4533	Centers for Medicare & Medicaid Services, an agency of the US Department of Health and Human Services [HHSM-500-2013-13018I, HHSM-500-T0001]	Centers for Medicare & Medicaid Services, an agency of the US Department of Health and Human Services	The analyses upon which this publication is based were performed under the Measure & Instrument Development and Support (MIDS) contract HHSM-500-2013-13018I, Task Order HHSM-500-T0001, entitled Development, Reevaluation, and Implementation of Outcome/Efficiency Measures for Hospital and Eligible Clinicians, funded by the Centers for Medicare & Medicaid Services, an agency of the US Department of Health and Human Services. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services nor does the mention of trade names, commercial products, or organizations imply endorsement by the US government. The authors assume full responsibility for the accuracy and completeness of the ideas presented	Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Centers for Medicare and Medicaid Services, 2017, HOSP VAL BAS PURCH; Centers for Medicare and Medicaid Services, 2013, MEAS UPD SPEC AC MYO; Centers for Medicare and Medicaid Services, 2016, COND SPEC MEAS UPD S; Centers for Medicare and Medicaid Services, 2013, MEAS UPD SPEC REP HO; Centers for Medicare and Medicaid Services, 2016, READM RED PROGR; Centers for Medicare and Medicaid Services, 2013, MEAS METH HEART FAIL; Everly Matthew J, 2008, Clin Transpl, P35; Grady JN, 2013, MEASURES UPDATES SPE; Iribarne A, 2014, ANN THORAC SURG, V98, P1274, DOI 10.1016/j.athoracsur.2014.06.059; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Khera R, 2015, JAMA INTERN MED, V175, P941, DOI 10.1001/jamainternmed.2014.7856; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Lampropulos JF, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000109; Lund LH, 2013, J HEART LUNG TRANSPL, V32, P951, DOI 10.1016/j.healun.2013.08.006; Stulak JM, 2014, CROAT MED J, V55, P596, DOI 10.3325/cmj.2014.55.596; YANCY CW, 2013, J AM COLL CARDIOL, V62, pE14, DOI DOI 10.1016/J.JACC.2013.05.019	17	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230734	10.1371/journal.pone.0230734	http://dx.doi.org/10.1371/journal.pone.0230734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214363	Green Published, gold, Green Submitted			2022-12-26	WOS:000535934200048
J	Evers, J; Grotenhuis, AJ; Aben, KKH; Kiemeney, LALM; Vrieling, A				Evers, Jelle; Grotenhuis, Anne J.; Aben, Katja K. H.; Kiemeney, Lambertus A. L. M.; Vrieling, Alina			No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression	PLOS ONE			English	Article							BODY-MASS; PREDICTING RECURRENCE; UROTHELIAL CARCINOMA; METFORMIN USE; RISK; OBESITY; IMPACT; SUSCEPTIBILITY; PROGNOSIS; OUTCOMES	Background Non-muscle invasive bladder cancer patients are at high risk for tumour recurrence and progression, hence an intensive follow-up procedure is recommended which is costly. Identification of factors that are associated with the risk of recurrence and progression may enable personalized follow-up schedules. Obesity and diabetes mellitus may be associated with a worse prognosis, but the evidence is limited and inconsistent. Our objective was to determine the associations of BMI and diabetes mellitus with risks of recurrence and progression among non-muscle invasive bladder cancer patients. Methods A population-based cohort of patients diagnosed with non-muscle invasive bladder cancer between 1995 and 2010 was retrospectively identified from the Netherlands Cancer Registry and invited to participate in the Nijmegen Bladder Cancer Study (n = 1,433). Average weight during adult life, height, and diabetes mellitus diagnosis were self-reported by use of a questionnaire. Clinical follow-up data were retrieved from medical files. Associations were quantified using proportional hazard analyses. For all analyses, minimal adjustment sets were selected using a Directed Acyclic Graph. Results Fourteen percent of the patients indicated to be diagnosed with diabetes mellitus, and more than half was overweight (45%) or obese (9%). Compared to healthy weight, overweight and obesity were not associated with risk of recurrence (adjusted hazard ratio (HR) = 1.02; 95% confidence interval (CI): 0.86-1.22, and HR = 1.02; 95% CI: 0.76-1.38, respectively) and overall progression (HR = 1.04; 95% CI: 0.74-1.44, and HR = 1.20; 95% CI: 0.69-2.09, respectively). Also, no clear associations of diabetes mellitus with risk of recurrence (HR = 1.22; 95% CI: 0.98-1.54) and overall progression (HR = 1.16; 95% CI: 0.76-1.76) were found. Conclusion Average BMI during adult life and diabetes mellitus were not clearly associated with risk of recurrence or progression in non-muscle invasive bladder cancer. Prospective cohort studies with detailed information on BMI and diabetes mellitus before and after diagnosis are needed to confirm these findings.	[Evers, Jelle; Grotenhuis, Anne J.; Aben, Katja K. H.; Kiemeney, Lambertus A. L. M.; Vrieling, Alina] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Hlth Evidence, Nijmegen, Netherlands; [Aben, Katja K. H.] Netherlands Comprehens Canc Org, Utrecht, Netherlands; [Kiemeney, Lambertus A. L. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Urol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Kiemeney, LALM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Hlth Evidence, Nijmegen, Netherlands.; Kiemeney, LALM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Urol, Nijmegen, Netherlands.	Bart.Kiemeney@radboudumc.nl	Vrieling, Alina/A-2725-2016; Aben, Katja KH/G-9686-2016	Vrieling, Alina/0000-0002-8178-2125; Aben, Katja KH/0000-0002-0214-2147; Evers, Jelle/0000-0003-0525-9786				Ahn JH, 2016, J KOREAN MED SCI, V31, P1464, DOI 10.3346/jkms.2016.31.9.1464; Babjuk M, 2017, EUR UROL, V71, P447, DOI 10.1016/j.eururo.2016.05.041; Barbosa ALA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194039; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cambier S, 2016, EUR UROL, V69, P60, DOI 10.1016/j.eururo.2015.06.045; Canadian Cancer Society, SURV STAT BLADD CANC; Eble JN, 2004, PATHOLOGY GENETICS T; Fernandez-Gomez J, 2009, J UROLOGY, V182, P2195, DOI 10.1016/j.juro.2009.07.016; Ferro M, 2019, WORLD J UROL, V37, P507, DOI 10.1007/s00345-018-2397-1; Gallagher EJ, 2013, CURR OPIN ENDOCRINOL, V20, P485, DOI 10.1097/01.med.0000433065.16918.83; Gallagher EJ, 2015, PHYSIOL REV, V95, P727, DOI 10.1152/physrev.00030.2014; Gild P, 2017, CURR OPIN UROL, V27, P409, DOI 10.1097/MOU.0000000000000425; Grotenhuis AJ, 2016, BLADDER CANCER, V2, P77, DOI 10.3233/BLC-150027; Hwang EC, 2011, INT J UROL, V18, P769, DOI 10.1111/j.1442-2042.2011.02845.x; International Diabetes Federation, 2017, DIABETES ATLAS; Johnson JA, 2012, DIABETOLOGIA, V55, P1607, DOI 10.1007/s00125-012-2525-1; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kluth LA, 2013, J UROLOGY, V190, P480, DOI 10.1016/j.juro.2013.01.089; Lamm D, 2014, J UROLOGY, V191, P20, DOI 10.1016/j.juro.2013.07.102; Marchetti GM, 2015, PACKAGE GGM; Mostofi FK, 1973, HISTOLOGICAL TYPING; Ploeg M, 2010, J UROLOGY, V183, P915, DOI 10.1016/j.juro.2009.11.018; Rafnar T, 2011, HUM MOL GENET, V20, P4268, DOI 10.1093/hmg/ddr303; Rieken M, 2013, BJU INT, V112, P1105, DOI 10.1111/bju.12448; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Suh S, 2011, DIABETES METAB J, V35, P193, DOI 10.4093/dmj.2011.35.3.193; Sun JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119313; Svatek RS, 2014, EUR UROL, V66, P253, DOI 10.1016/j.eururo.2014.01.006; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Textor J, 2015, DRAWING ANAL CAUSAL; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Westhoff E, 2018, BLADDER CANCER, V4, P91, DOI 10.3233/BLC-170147; World Health Organization, BOD MASS IND BMI; World Health Organization, OB OV; Wyszynski A, 2014, CANCER-AM CANCER SOC, V120, P408, DOI 10.1002/cncr.28394; Xu TY, 2015, INT UROL NEPHROL, V47, P1135, DOI 10.1007/s11255-015-1013-1; Zhu ZW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-310	37	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0229384	10.1371/journal.pone.0229384	http://dx.doi.org/10.1371/journal.pone.0229384			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210471	Green Published, gold			2022-12-26	WOS:000535307600008
J	Gorwa, J; Kabacinski, J; Murawa, M; Fryzowicz, A				Gorwa, Joanna; Kabacinski, Jaroslaw; Murawa, Michal; Fryzowicz, Anna			On the track of the ideal turnout: Electromyographic and kinematic analysis of the five classical ballet positions	PLOS ONE			English	Article							DANCERS; HIP; INJURY; CONTRIBUTORS; BIOMECHANICS; ROTATION; JUMP; KNEE; PLIE	The turnout of the lower extremities is the major component of the classical ballet positions (CPs) and correctly is initiated in the hips. The aim of this research was to determine the differences in the electromyographic and kinematic variables in the five CPs in ballet students with greater and lesser amount of passive hip external rotation (HER). A group of 14 female pre-professional ballet dancers 11-16 years of age participated in the study. Based on the amount of passive HER, participants with higher values made up greater rotation group (n = 7) whereas those with lesser values formed lesser rotation group (n = 7). Electromyographic activity of 14 muscles from right side of the trunk and right lower extremity was recorded with the surface electrodes while subjects were standing in all five CPs (CP1-CP5). The external rotation of the hips, knees and feet were recorded with the motion capture system. The kinematic differences between the groups were revealed in asymmetric positions CP4 and CP5 where foot progression angle was significantly lesser in forward than backward setting only in lesser rotation group. In lesser rotation group the ankle and back muscles were more engaged in CPs while abdominal and hip muscles less when compared with greater rotation group. This finding suggests that in the group with lesser passive HER the mechanism of forced turnout was employed. The most remarkable finding in our work was that various electromyographic patterns can be observed between groups in all CPs, while kinematic differences may be marked only in asymmetric positions.	[Gorwa, Joanna; Kabacinski, Jaroslaw; Murawa, Michal; Fryzowicz, Anna] Poznan Univ Phys Educ, Dept Biomech, Poznan, Poland		Gorwa, J (corresponding author), Poznan Univ Phys Educ, Dept Biomech, Poznan, Poland.	gorwa@awf.poznan.pl	Gorwa, Joanna/AAL-8010-2021	Gorwa, Joanna/0000-0003-2776-9197; Kabacinski, Jaroslaw/0000-0002-6478-6116; Fryzowicz, Anna/0000-0003-1163-3973; Murawa, Michal/0000-0003-4987-4131	Polish Ministry of Science and Higher Education [NN404515938]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Polish Ministry of Science and Higher Education under Grant NN404515938.	Amorim T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180639; Arnheim DD., 1991, DANCE INJURIES THEIR; Carter SL, 2019, J FOOT ANKLE RES, V12, DOI 10.1186/s13047-019-0318-1; Champion Lowry M, 2008, J Dance Med Sci, V12, P121; Coplan JA, 2002, J ORTHOP SPORT PHYS, V32, P579, DOI 10.2519/jospt.2002.32.11.579; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; DeMann L. E. Jr, 1997, Man Ther, V2, P2, DOI 10.1054/math.1997.0280; Gilbert CB, 1998, J ORTHOP SPORT PHYS, V27, P339, DOI 10.2519/jospt.1998.27.5.339; Gorwa J, 2019, ACTA BIOENG BIOMECH, V21, P111, DOI [10.37190/ABB-01429-2019-02, 10.5277/ABB-01429-2019-02]; Gorwa J, 2019, MED PROBL PERFORM AR, V34, P25, DOI 10.21091/mppa.2019.1006; Gorwa J, 2014, MED SCI MONITOR, V20, P1082, DOI 10.12659/MSM.890126; Gottschlich LM, 2011, CURR SPORT MED REP, V10, P40, DOI 10.1249/JSR.0b013e318205e08b; Grossman Gayanne, 2008, J Dance Med Sci, V12, P142; Hendry D, 2015, SCAND J MED SCI SPOR, V25, P888, DOI 10.1111/sms.12302; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Howse J, 2009, DANCE TECHNIQUE INJU; Jenkins JB, 2013, MED PROBL PERFORM AR, V28, P230; Krasnow D, 2012, MED PROBL PERFORM AR, V27, P143; Laugharne J, 1998, CNS DRUGS, V9, P1, DOI 10.2165/00023210-199809010-00001; Lee HH, 2012, J SPORT SCI, V30, P689, DOI 10.1080/02640414.2012.663097; Lin CF, 2016, J APPL BIOMECH, V32, P350, DOI 10.1123/jab.2014-0263; Negus V, 2005, J ORTHOP SPORT PHYS, V35, P307, DOI 10.2519/jospt.2005.35.5.307; Nowacki Relana M E, 2012, J Dance Med Sci, V16, P126; Quanbeck AE, 2017, J SPORT SCI, V35, P331, DOI 10.1080/02640414.2016.1164335; Sherman Astrid J, 2014, J Dance Med Sci, V18, P159, DOI 10.12678/1089-313X.18.4.159; Skwiot M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212188; Sutton-Traina K, 2015, MED PROBL PERFORM AR, V30, P78, DOI 10.21091/mppa.2015.2013; Tanabe H, 2017, MOTOR CONTROL, V21, P72, DOI 10.1123/mc.2015-0002; Torino P.D, 1999, J ELECTROMYOGR KINES, V9; TREPMAN E, 1994, MED SCI SPORT EXER, V26, P771, DOI 10.1249/00005768-199406000-00018; Trepman E, 1998, MED SCI SPORT EXER, V30, P1708, DOI 10.1097/00005768-199812000-00009; VAGANOVA A., 2015, BASIC PRINCIPLES CLA, V4th; Vaughan C.L., 1992, DYNAMICS HUMAN GAIT; Washington I, 2016, MED PROBL PERFORM AR, V31, P160, DOI 10.21091/mppa.2016.3029; WATKINS A, 1989, MED PROBL PERFORM AR, V4, P148; WOODHULLMCNEAL AP, 1990, MED PROBL PERFORM AR, V5, P151; Zaferiou AM, 2017, J BIOMECH, V52, P130, DOI 10.1016/j.jbiomech.2016.12.017	37	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230654	10.1371/journal.pone.0230654	http://dx.doi.org/10.1371/journal.pone.0230654			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210478	gold, Green Published			2022-12-26	WOS:000535307600040
J	Diringer, SE; Shimabuku, M; Cooley, H				Diringer, Sarah E.; Shimabuku, Morgan; Cooley, Heather			Economic evaluation of stormwater capture and its multiple benefits in California	PLOS ONE			English	Article								Urban stormwater is increasingly being considered a viable alternative water supply in California and throughout the southwestern U.S. However, current economic analyses of stormwater capture do not adequately examine differences in stormwater project types and do not evaluate co-benefits provided by the projects. As a result, urban stormwater capture is undervalued as a water supply option. To advance economic analyses of stormwater capture, we determined the levelized cost of water in U.S. dollar per acre-foot of water supply (AF; 1 AF = 1233.5 m(3)) for 50 proposed stormwater capture projects in California, characterizing the projects by water source, process, and water supply yield. In addition, we incorporated reported co-benefits of projects into the analysis to determine the net benefit of proposed projects. Proposed urban stormwater capture projects were more expensive than non-urban stormwater capture projects on a per-volume basis ($1,180 per AF and $531 per AF, respectively); however, this was primarily driven by the relatively large size of the non-urban stormwater capture projects examined. When incorporating the limited number of reported co-benefits of the projects, the expected levelized cost of water from urban stormwater capture projects decreased dramatically. For projects that reported even a limited number of additional benefits, the net levelized cost decreased from $1,030 per AF to $150 per AF, with some of the projects demonstrating a net benefit. Thus, scaling urban stormwater capture projects to capitalize on economies of scale and incorporating co-benefits of projects can dramatically improve the economic feasibility of these projects. This work demonstrates that stormwater capture can present a cost-effective water supply option in California, and that beyond California, fairer comparisons among projects and inclusion of co-benefits can provide decision makers with adequate information to maximize investments in water management.	[Diringer, Sarah E.; Shimabuku, Morgan; Cooley, Heather] Pacific Inst, Oakland, CA 94612 USA		Diringer, SE (corresponding author), Pacific Inst, Oakland, CA 94612 USA.	sdiringer@pacinst.org			David and Lucile Packard Foundation [2015-40634]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	SED, MS, and HC received funding from the David and Lucile Packard Foundation (Grant #2015-40634) (www.packard.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Rivers, 2010, PUTT GREEN WORK EC R; Arnold CL, 1996, J AM PLANN ASSOC, V62, P243, DOI 10.1080/01944369608975688; Board State, 2013, POL WAT QUAL CONTR R, P41; CA DWR, 2018, STORMW TARG GROUNDW, P64; California DWR, 2018, INTEGRATED REGIONAL; Cooley L, 2019, ROUT ST EUR FOR POL, P1; Dettinger MD, 2011, WATER-SUI, V3, P445, DOI 10.3390/w3020445; Garfin G., 2014, CLIMATE CHANGE IMPAC, P462, DOI [DOI 10.7930/J08G8HMN, 10.7930/J08G8HMN.]; Local Government Commission, 2016, NEW APPR STORMW MAN; Martin J, 2018, EARTH EC; NRDC Pacific Institute, 2014, UNT POT CAL WAT SUPP, P8; Odefey J., 2012, BANKING GREEN LOOK G; PERRONE D, 2016, SAN FRANC ESTUARY WA, V14, pNI318, DOI DOI 10.15447/sfews.2016v14iss2art4; Porse E, 2019, WATER RESOUR MANAG, V33, P713, DOI 10.1007/s11269-018-2134-y; Prudencio L, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaa81a; SCWC, 2012, STORMW CAPT OPP INCR; Shimabuku M, 2018, STORMWATER CAPTURE C, P33; Short W, 1995, RENEW ENERG, V95, P73; St Juliana Clements J, 2013, R1311C NRDC; State of California, BOND ACC PROP 1E, V1E; State of California, BOND ACC PROP, V84; Swain DL, 2018, NAT CLIM CHANGE, V8, P427, DOI 10.1038/s41558-018-0140-y; SWRCB STORMS, 2018, ENH URB RUN CAPT US; Williams AP, 2015, GEOPHYS RES LETT, V42, P6819, DOI 10.1002/2015GL064924	24	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230549	10.1371/journal.pone.0230549	http://dx.doi.org/10.1371/journal.pone.0230549			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208442	gold, Green Published			2022-12-26	WOS:000535305100021
J	Fjaellingsdal, TG; Schwenke, D; Ruigendijk, E; Scherbaum, S; Bleichner, MG				Fjaellingsdal, Tatiana Goregliad; Schwenke, Diana; Ruigendijk, Esther; Scherbaum, Stefan; Bleichner, Martin Georg			Studying brain activity during word-by-word interactions using wireless EEG	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SEMANTIC INTEGRATION; ERP; LANGUAGE; N400; POSITIVITY; PREDICTION; COMPONENT; REVEAL; SPEECH	We introduce here the word-by-word paradigm, a dynamic setting, in which two people take turns in producing a single sentence. This task requires a high degree of coordination between the partners and the simplicity of the task allows us to study with sufficient experimental control behavioral and neural processes that underlie this controlled interaction. For this study, 13 pairs of individuals engaged in a scripted word-by-word interaction, while we recorded the neural activity of both participants simultaneously using wireless EEG. To study expectation building, different semantic contexts were primed for each participant. Semantically unexpected continuations were introduced in 25% of all sentences. In line with the hypothesis, we observed amplitude differences for the P200-N400-P600 ERPs for unexpected compared to expected words. Moreover, we could successfully assess speech and reaction times. Our results show that it is possible to measure ERPs and RTs to semantically unexpected words in a dyadic interactive scenario.	[Fjaellingsdal, Tatiana Goregliad; Bleichner, Martin Georg] Carl von Ossietzky Univ Oldenburg, European Med Sch, Dept Psychol, Oldenburg, Germany; [Schwenke, Diana; Scherbaum, Stefan] Tech Univ Dresden, Dept Psychol, Dresden, Germany; [Ruigendijk, Esther; Bleichner, Martin Georg] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, Oldenburg, Germany; [Ruigendijk, Esther] Carl von Ossietzky Univ Oldenburg, Dept Dutch, Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Technische Universitat Dresden; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Fjaellingsdal, TG (corresponding author), Carl von Ossietzky Univ Oldenburg, European Med Sch, Dept Psychol, Oldenburg, Germany.	tatiana.goregliad1@uol.de	Bleichner, Martin G/AAA-1383-2021; Bleichner, Martin G/AAV-2585-2021	Bleichner, Martin G/0000-0001-6933-9238; Bleichner, Martin G/0000-0001-6933-9238; , Tatiana/0000-0002-1698-3529	Volkswagen Foundation; Task Group 7 "BCI for Hearing Aids", DFG Cluster of Excellence 1077 Hearing4all, Oldenburg, Germany	Volkswagen Foundation(Volkswagen); Task Group 7 "BCI for Hearing Aids", DFG Cluster of Excellence 1077 Hearing4all, Oldenburg, Germany	TGF, MGB, DS, SS = Volkswagen Foundation (European platform) MGB= Task Group 7 "BCI for Hearing Aids", DFG Cluster of Excellence 1077 Hearing4all, Oldenburg, Germany https://www.volkswagenstiftung.de/https://hearing4all.eu/EN/Research/C/Task-Group-7.php The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barraza P, 2019, METHODSX, V6, P428, DOI 10.1016/j.mex.2019.02.021; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bleichner MG, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00163; Blum S, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00141; Bogels S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145474; Bogels S, 2015, CEREB CORTEX, V25, P3219, DOI 10.1093/cercor/bhu116; Bogels S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12881; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Brookes M., 2018, VOICEBOX SPEECH PROC; Brouwer H, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01327; Casals M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112653; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Chang Chi-Yuan, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P1242, DOI 10.1109/EMBC.2018.8512547; Coch D, 2013, COGN AFFECT BEHAV NE, V13, P355, DOI 10.3758/s13415-012-0145-3; De Vos M, 2014, INT J PSYCHOPHYSIOL, V91, P46, DOI 10.1016/j.ijpsycho.2013.08.010; De Vos M, 2014, INT J PSYCHOPHYSIOL, V91, P1, DOI 10.1016/j.ijpsycho.2013.10.008; Debener S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16743; Debener S, 2012, PSYCHOPHYSIOLOGY, V49, P1617, DOI 10.1111/j.1469-8986.2012.01471.x; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; DeLong KA, 2014, NEUROPSYCHOLOGIA, V61, P150, DOI 10.1016/j.neuropsychologia.2014.06.016; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ditman T, 2007, PSYCHOPHYSIOLOGY, V44, P927, DOI 10.1111/j.1469-8986.2007.00593.x; DSHEMUCHADSE M, 2015, FRONT PSYCHOL, V6, P1; Evans KM, 2007, NEUROPSYCHOLOGIA, V45, P1777, DOI 10.1016/j.neuropsychologia.2006.12.014; Fjaellingsdal TG, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01854; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Guang OY, 2011, PSYCHOPHYSIOLOGY, V48, P1631, DOI 10.1111/j.1469-8986.2011.01269.x; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1518, DOI 10.1016/S0028-3932(00)00052-X; Hamilton LS, 2020, LANG COGN NEUROSCI, V35, P573, DOI 10.1080/23273798.2018.1499946; Hardcastle W. J., 2006, COARTICULATION THEOR; Himberg T, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00797; Hoffman A, 2008, MED EDUC, V42, P537, DOI 10.1111/j.1365-2923.2008.03077.x; Jackson F, 2015, EMOTION, V15, P12, DOI 10.1037/emo0000020; Jiang J, 2012, J NEUROSCI, V32, P16064, DOI 10.1523/JNEUROSCI.2926-12.2012; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kaan E, 2007, LANG LINGUIST COMPAS, V1, P571, DOI 10.1111/j.1749-818x.2007.00037.x; Kawasaki M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01692; Kos M, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00222; Kothe C., 2014, LAB STREAMING LAYER; Kuperberg GR, 2016, LANG COGN NEUROSCI, V31, P32, DOI 10.1080/23273798.2015.1102299; KUTAS M, 1983, MEM COGNITION, V11, P539, DOI 10.3758/BF03196991; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lee CY, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00285; Levinson SC, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00731; Lo S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01171; Moscatelli A, 2012, J VISION, V12, DOI 10.1167/12.11.26; Mullen T, 2013, IEEE ENG MED BIO, P2184, DOI 10.1109/EMBC.2013.6609968; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Nieuwland MS, 2006, J COGNITIVE NEUROSCI, V18, P1098, DOI 10.1162/jocn.2006.18.7.1098; Nieuwland MS, 2018, ELIFE, V7, DOI 10.7554/eLife.33468; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ouyang G, 2016, INT J PSYCHOPHYSIOL, V109, P9, DOI 10.1016/j.ijpsycho.2016.09.015; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; Pinheiro J., 2017, NLME LINEAR NONLINEA; Proverbio A. M., 2007, BMC NEUROSCI, V8, P1, DOI DOI 10.1186/1471-2202-8-24; R Core Team, 2021, R LANGUAGE ENV STAT; Randall RB, 2016, MECH SYST SIGNAL PR, V79, P3, DOI 10.1016/j.ymssp.2016.02.042; Ruigendijk E, 2016, SECOND LANG RES, V32, P197, DOI 10.1177/0267658315614614; Salvidegoitia MP, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13331; Sassenhagen J, 2014, BRAIN LANG, V137, P29, DOI 10.1016/j.bandl.2014.07.010; Sitnikova T, 2003, PSYCHOPHYSIOLOGY, V40, P160, DOI 10.1111/1469-8986.00016; Stuellein N, 2016, BRAIN RES, V1639, P88, DOI 10.1016/j.brainres.2016.02.029; Tanner D, 2016, J NEUROSCI METH, V266, P166, DOI 10.1016/j.jneumeth.2016.01.002; Tanner D, 2015, PSYCHOPHYSIOLOGY, V52, P997, DOI 10.1111/psyp.12437; Thornhill DE, 2012, INT J PSYCHOPHYSIOL, V83, P382, DOI 10.1016/j.ijpsycho.2011.12.007; Urbach TP, 2002, PSYCHOPHYSIOLOGY, V39, P791, DOI 10.1111/1469-8986.3960791; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; van de Meerendonk N, 2010, J COGNITIVE NEUROSCI, V22, P67, DOI 10.1162/jocn.2008.21170; Van Petten C, 2012, INT J PSYCHOPHYSIOL, V83, P176, DOI 10.1016/j.ijpsycho.2011.09.015; Wang L, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00187, 10.3389/fpsyg.2012.00438]; Wicha NYY, 2004, J COGNITIVE NEUROSCI, V16, P1272, DOI 10.1162/0898929041920487; Widmann A, 2015, J NEUROSCI METH, V250, P34, DOI 10.1016/j.jneumeth.2014.08.002; Wolff S, 2008, BRAIN LANG, V107, P133, DOI 10.1016/j.bandl.2008.06.003	77	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230280	10.1371/journal.pone.0230280	http://dx.doi.org/10.1371/journal.pone.0230280			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208429	gold, Green Published			2022-12-26	WOS:000535305100013
J	Lim, D; Lee, S; Choi, MS; Han, JY; Seong, Y; Na, D; Kwon, YS; Lee, YS				Lim, Do-Hwan; Lee, Seungjae; Choi, Min-Seok; Han, Jee Yun; Seong, Youngmo; Na, Dokyun; Kwon, Young-Soo; Lee, Young Sik			The conserved microRNA miR-8-3p coordinates the expression of V-ATPase subunits to regulate ecdysone biosynthesis for Drosophila metamorphosis	FASEB JOURNAL			English	Article						Ago1; CLIP-seq; ecdysone; metamorphosis; microRNA; V-ATPase	PROTHORACIC GLAND; H+-ATPASE; MESENCHYMAL TRANSITION; VACUOLAR ATPASE; MIR-200 FAMILY; INDUCIBLE GENE; EARLY PUFF; BODY-SIZE; ENCODES 2; RECEPTOR	The steroid hormone ecdysone is the central regulator of insect metamorphosis, during which a growing, immature larva is remodeled, through pupal stages, to a reproductive adult. However, the underlying mechanisms of ecdysone-mediated metamorphosis remain to be fully elucidated. Here, we identified metamorphosis-associated microRNAs (miRNAs) and their potential targets by cross-linking immunoprecipitation coupled with deep sequencing of endogenous Argonaute 1 protein in Drosophila. Interestingly, miR-8-3p targeted five Vha genes encoding distinct subunits of vacuolar H+-ATPase (V-ATPase), which has a vital role in the organellar acidification. The expression of ecdysone-responsive miR-8-3p is normally downregulated during Drosophila metamorphosis, but temporary overexpression of miR-8-3p in the whole body at the end of larval development led to defects in metamorphosis and survival, hallmarks of aberrant ecdysone signaling. In addition, miR-8-3p was expressed in the prothoracic gland (PG), which produces and releases ecdysone in response to prothoracicotropic hormone (PTTH). Notably, overexpression of miR-8-3p or knockdown of its Vha targets in the PG resulted in larger than normal, ecdysone-deficient larvae that failed to develop into the pupal stage but could be rescued by ecdysone feeding. Moreover, these animals showed defective PTTH signaling with a concomitant decrease in the expression of ecdysone biosynthetic genes. We also demonstrated that the regulatory network between the conserved miR-8-3p/miR-200 family and V-ATPase was functional in human cells. Consequently, our data indicate that the coordinated regulation of V-ATPase subunits by miR-8-3p is involved in Drosophila metamorphosis by controlling the ecdysone biosynthesis.	[Lim, Do-Hwan; Lee, Seungjae; Choi, Min-Seok; Han, Jee Yun; Lee, Young Sik] Korea Univ, Coll Life Sci & Biotechnol, Seoul 02841, South Korea; [Lim, Do-Hwan; Lee, Seungjae; Choi, Min-Seok; Lee, Young Sik] Korea Univ, Inst Anim Mol Biotechnol, Seoul, South Korea; [Seong, Youngmo; Kwon, Young-Soo] Sejong Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Na, Dokyun] Chung Ang Univ, Sch Integrat Engn, Seoul, South Korea; [Lim, Do-Hwan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Lee, Seungjae] Sloan Kettering Inst, Dept Dev Biol, New York, NY USA; [Han, Jee Yun] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA USA	Korea University; Korea University; Sejong University; Chung Ang University; University of California System; University of California San Diego; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles	Lee, YS (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Seoul 02841, South Korea.	ys-lee@korea.ac.kr	Lim, Dohwan/ABA-2685-2020	Lee, Seungjae/0000-0001-5626-9656; Lim, Do-Hwan/0000-0002-2054-1416; Lee, Seungjae/0000-0001-9081-2835	National Research Foundation of Korea (NRF) [NRF-2014R1A1A2058193]; Korea University (KU)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea University (KU)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2014R1A1A2058193; Korea University (KU)	Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cohen S, 2010, SEMIN CELL DEV BIOL, V21, P727, DOI 10.1016/j.semcdb.2010.07.004; DIBELLO PR, 1991, GENETICS, V129, P385; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Feng Xiangling, 2014, Cancer Lett, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fulga TA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8279; Gibbens YY, 2011, DEVELOPMENT, V138, P2693, DOI 10.1242/dev.063412; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Hermle T, 2013, EMBO J, V32, P245, DOI 10.1038/emboj.2012.323; Hong JS, 2015, VET RES, V46, DOI 10.1186/s13567-015-0172-5; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Jin H, 2012, GENE DEV, V26, P1427, DOI 10.1101/gad.192872.112; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; KING RC, 1966, Z ZELLFORSCH MIK ANA, V73, P272, DOI 10.1007/BF00334868; Kissing S, 2015, J BIOL CHEM, V290, P14166, DOI 10.1074/jbc.M114.628891; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kucherenko MM, 2012, EMBO J, V31, P4511, DOI 10.1038/emboj.2012.298; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim DH, 2019, INSECT MOL BIOL, V28, P444, DOI 10.1111/imb.12562; Lim DH, 2018, FASEB J, V32, P4519, DOI 10.1096/fj.201701185RR; Lim DH, 2013, J CELL BIOCHEM, V114, P418, DOI 10.1002/jcb.24379; Lorincz P, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6030022; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Martinez-Lopez N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3799; Maxson ME, 2014, J CELL SCI, V127, P4987, DOI 10.1242/jcs.158550; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mijaljica D, 2011, AUTOPHAGY, V7, P666, DOI 10.4161/auto.7.6.15812; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Moeller ME, 2013, DEVELOPMENT, V140, P4730, DOI 10.1242/dev.099739; Na D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1091; Niwa YS, 2014, GENES GENET SYST, V89, P27, DOI 10.1266/ggs.89.27; Ohhara Y, 2015, P NATL ACAD SCI USA, V112, P1452, DOI 10.1073/pnas.1414966112; Pamarthy S, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0811-3; Parvy JP, 2014, DEVELOPMENT, V141, P3955, DOI 10.1242/dev.102020; Perdigao-Henriques R, 2016, ONCOGENE, V35, P158, DOI 10.1038/onc.2015.69; Pignoni F, 1997, DEVELOPMENT, V124, P271; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Riddiford LM, 2001, VITAM HORM, V60, P1; RIDDIFORD LM, 1993, AM ZOOL, V33, P340; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; Sennoune SR, 2004, CELL BIOCHEM BIOPHYS, V40, P185, DOI 10.1385/CBB:40:2:185; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimada-Niwa Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6778; Tang HL, 2013, CLIN CANCER RES, V19, P5602, DOI 10.1158/1078-0432.CCR-13-1326; Texada MJ, 2019, DEV CELL, V48, P659, DOI 10.1016/j.devcel.2019.01.007; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Walkiewicz MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005072; Wang JX, 2012, IEEE T NANOBIOSCI, V11, P386, DOI 10.1109/TNB.2012.2210907; Wu YC, 2012, DEV CELL, V23, P202, DOI 10.1016/j.devcel.2012.05.013; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	71	6	6	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6449	6465		10.1096/fj.201901516R	http://dx.doi.org/10.1096/fj.201901516R		MAR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32196731				2022-12-26	WOS:000521550600001
J	Rolling, W; Lake, R; Dorrance, AE; McHale, LK				Rolling, William; Lake, Rhiannon; Dorrance, Anne E.; McHale, Leah K.			Genome-wide association analyses of quantitative disease resistance in diverse sets of soybean [Glycine max (L.) Merr.] plant introductions	PLOS ONE			English	Article							PHYTOPHTHORA ROOT-ROT; GENES CONFERRING RESISTANCE; MULTIPLE-HG TYPES; TRAIT LOCI; SCLEROTINIA-SCLEROTIORUM; POPULATION-STRUCTURE; HETERODERA-GLYCINES; FIELD-RESISTANCE; CYST-NEMATODE; STEM ROT	Phytophthora sojae is one of the costliest soybean pathogens in the US. Quantitative disease resistance (QDR) is a vital part of Phytophthora disease management. In this study, QDR was measured in 478 and 495 plant introductions (PIs) towards P. sojae isolates OH.121 and C2.S1, respectively, in genome-wide association (GWA) analyses to identify genetic markers linked to QDR loci (QDRL). Populations were generated by sampling PIs from the US, the Republic of Korea, and the full collection of PIs maintained by the USDA. Additionally, a meta-analysis of QDRL reported from bi-parental studies was done to compare past and present findings. Twenty-four significant marker-trait associations were identified from the 478 PIs phenotyped with OH.121, and an additional 24 marker-trait associations were identified from the 495 PIs phenotyped with C2.S1. In total, 48 significant markers were distributed across 16 chromosomes and based on linkage analysis, represent a total of 44 QDRL. The majority of QDRL were identified with only one of the two isolates, and only a region on chromosome 13 was consistently identified. Regions on chromosomes 3, 13, and 17 were identified in previous GWA-analyses and were re-identified in this study. Five QDRL co-localized with P. sojae meta-QDRL identified from QDRL reported in previous biparental mapping studies. The remaining regions represent novel QDRL, in the soybean P. sojae pathosystem and were primarily identified in germplasm from the Republic of Korea. Overall, the number of loci identified in this study highlights the complexity of QDR to P. sojae.	[Rolling, William; Dorrance, Anne E.; McHale, Leah K.] Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA; [Rolling, William; Dorrance, Anne E.; McHale, Leah K.] Ohio State Univ, Ctr Soybean Res, Columbus, OH 43210 USA; [Lake, Rhiannon; McHale, Leah K.] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA; [Dorrance, Anne E.] Ohio State Univ, Dept Plant Pathol, Wooster, OH USA; [Lake, Rhiannon] Corteva Agrisci, Napoleon, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	McHale, LK (corresponding author), Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA.; McHale, LK (corresponding author), Ohio State Univ, Ctr Soybean Res, Columbus, OH 43210 USA.; McHale, LK (corresponding author), Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA.	mchale.21@osu.edu		McHale, Leah/0000-0003-1028-2315; Rolling, William/0000-0001-6893-9872	United Soybean Board; Ohio Soybean Council; Center for Applied Plant Sciences; National Institute of Food and Agriculture, U.S. Department of Agriculture [OHO01303, OHO01279]	United Soybean Board; Ohio Soybean Council; Center for Applied Plant Sciences; National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported in part by an award from the United Soybean Board to AD, an award from the Ohio Soybean Council to LM, funds from the Center for Applied Plant Sciences to WR, AD & LM, state and federal funds appropriated to The Ohio State University, College of Food, Agricultural, and Environmental Sciences, and the National Institute of Food and Agriculture, U.S. Department of Agriculture Hatch projects for Development of Disease Management Strategies for Soybean Pathogens in Ohio OHO01303 to AD, and Genetic Analysis of Soybean Added-Value Traits and Soybean Variety Development for Ohio OHO01279 to LM.	Abeysekara NS, 2016, CROP SCI, V56, P2322, DOI 10.2135/cropsci2015.09.0578; Arahana VS, 2001, CROP SCI, V41, P180, DOI 10.2135/cropsci2001.411180x; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Bandillo N, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2015.04.0024; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bernard R. L., 1991, Soybean Genetics Newsletter, V18, P27; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Burnham KD, 2003, CROP SCI, V43, P1610, DOI 10.2135/cropsci2003.1610; Chang SJC, 1996, CROP SCI, V36, P1684, DOI 10.2135/cropsci1996.0011183X003600060044x; Cheng YB, 2017, THEOR APPL GENET, V130, P1041, DOI 10.1007/s00122-017-2869-5; Darvasi A, 1997, BEHAV GENET, V27, P125, DOI 10.1023/A:1025685324830; Demirbas A, 2001, CROP SCI, V41, P1220, DOI 10.2135/cropsci2001.4141220x; Dorrance AE, 2016, PLANT DIS, V100, P1429, DOI 10.1094/PDIS-08-15-0879-RE; Dorrance AE, 2009, PLANT DIS, V93, P875, DOI 10.1094/PDIS-93-9-0875; Dorrance AE, 2000, PLANT DIS, V84, P1303, DOI 10.1094/PDIS.2000.84.12.1303; Dorrance AE, 2003, PLANT DIS, V87, P308, DOI 10.1094/PDIS.2003.87.3.308; Dorrance AE, 2003, PLANT DIS, V87, P139, DOI 10.1094/PDIS.2003.87.2.139; Dorrance AE, 2001, PLANT DIS, V85, P1063, DOI 10.1094/PDIS.2001.85.10.1063; Dorrance AE, 2000, PHYTOPHTHORA DAMPING; DORRANCE AE, 2008, PLANT HLTH PROG, V10, P1094; Dorrance AE, 2018, CAN J PLANT PATHOL, V40, P210, DOI 10.1080/07060661.2018.1445127; Esgar R., 1987, CIRCULAR, P1280; [范爱颖 FAN Ai-Ying], 2009, [作物学报, Acta Agronomica Sinica], V35, P1844; Fournet S, 2013, PLANT PATHOL, V62, P184, DOI 10.1111/j.1365-3059.2012.02617.x; Fukuoka S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07773; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gordon SG, 2006, CROP SCI, V46, P168, DOI 10.2135/cropsci2004.04-0024; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Grau CR, SOYBEANS IMPROVEMENT, V16, P679; Guo XM, 2008, CROP SCI, V48, P1129, DOI 10.2135/cropsci2007.04.0198; Han YP, 2008, EUPHYTICA, V162, P231, DOI 10.1007/s10681-007-9558-4; Hnetkovsky N, 1996, CROP SCI, V36, P393, DOI 10.2135/cropsci1996.0011183X003600020030x; Jiao YQ, 2015, THEOR APPL GENET, V128, P15, DOI 10.1007/s00122-014-2409-5; Karhoff S, 2019, CROP SCI, V59, P968, DOI 10.2135/cropsci2018.08.0514; KAUFMANN MJ, 1958, PHYTOPATHOLOGY, V48, P201; Kou YJ, 2010, CURR OPIN PLANT BIOL, V13, P181, DOI 10.1016/j.pbi.2009.12.010; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Kugler KG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-728; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lee S, 2014, THEOR APPL GENET, V127, P429, DOI 10.1007/s00122-013-2229-z; Lee S, 2013, CROP SCI, V53, P1022, DOI 10.2135/cropsci2012.10.0578; Lee S, 2013, THEOR APPL GENET, V126, P1121, DOI 10.1007/s00122-013-2040-x; Li LH, 2016, MOL GENET GENOMICS, V291, P1095, DOI 10.1007/s00438-015-1164-x; Li XP, 2010, THEOR APPL GENET, V121, P651, DOI 10.1007/s00122-010-1337-2; Li ZK, 2006, P NATL ACAD SCI USA, V103, P7994, DOI 10.1073/pnas.0507492103; Lin F, 2013, THEOR APPL GENET, V126, P2177, DOI 10.1007/s00122-013-2127-4; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lohnes DG, 1997, CROP SCI, V37, P555, DOI 10.2135/cropsci1997.0011183X003700020040x; Ludke WH, 2019, CROP BREED APPL BIOT, V19, P31, DOI 10.1590/1984-70332019v19n1a05; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Mideros S, 2007, PHYTOPATHOLOGY, V97, P655, DOI 10.1094/PHYTO-97-5-0655; Moellers TC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03695-9; Morris PF, 1998, PLANT PHYSIOL, V117, P1171, DOI 10.1104/pp.117.4.1171; MORRIS PF, 1992, PHYSIOL MOL PLANT P, V40, P17, DOI 10.1016/0885-5765(92)90067-6; Mundt CC, 2014, INFECT GENET EVOL, V27, P446, DOI 10.1016/j.meegid.2014.01.011; Nelson R, 2018, NAT REV GENET, V19, P21, DOI 10.1038/nrg.2017.82; Nguyen VT, 2012, CROP SCI, V52, P2481, DOI 10.2135/cropsci2011.09.0466; Niks RE, 2015, ANNU REV PHYTOPATHOL, V53, P445, DOI 10.1146/annurev-phyto-080614-115928; Niu JP, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00538; Olhoft PM, 2006, METH MOL B, V343, P385; Palloix A, 2009, NEW PHYTOL, V183, P190, DOI 10.1111/j.1469-8137.2009.02827.x; Ping JQ, 2016, THEOR APPL GENET, V129, P445, DOI 10.1007/s00122-015-2638-2; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; R Core Team, 2021, R LANGUAGE ENV STAT; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Sahoo DK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169950; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; SCHMITTHENNER AF, 1985, PLANT DIS, V69, P362, DOI 10.1094/PD-69-362; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schneider R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2918-5; Schneider RN, 2015, GENOME WIDE ANAL PAR; Scott K, 2019, CROP SCI, V59, P605, DOI 10.2135/cropsci2018.09.0573; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Sneller CH, 2004, CROP SCI, V44, P689, DOI 10.2135/cropsci2004.689a; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Sosnowski O, 2012, BIOINFORMATICS, V28, P2082, DOI 10.1093/bioinformatics/bts313; Stasko AK, 2016, CROP SCI, V56, P2476, DOI 10.2135/cropsci2015.12.0749; Stewart S, 2016, PLANT DIS, V100, P367, DOI 10.1094/PDIS-04-15-0437-RE; StMartin SK, 1996, CROP SCI, V36, P814, DOI 10.2135/cropsci1996.0011183X003600030064x; Sun JT, 2014, J GENET, V93, P355, DOI 10.1007/s12041-014-0383-y; Sun JT, 2014, THEOR APPL GENET, V127, P913, DOI 10.1007/s00122-014-2266-2; Sun S, 2011, PLANT BREEDING, V130, P139, DOI 10.1111/j.1439-0523.2010.01794.x; Swaminathan S, 2016, THEOR APPL GENET, V129, P495, DOI 10.1007/s00122-015-2643-5; Tucker DM, 2010, CROP SCI, V50, P628, DOI 10.2135/cropsci2009.03.0161; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Vuong TD, 2011, EUPHYTICA, V181, P101, DOI 10.1007/s10681-011-0430-1; Wang HH, 2012, CROP SCI, V52, P609, DOI 10.2135/cropsci2011.06.0336; Wang HH, 2010, PLANT GENOME-US, V3, P23, DOI 10.3835/plantgenome2009.12.0029; Weng C, 2001, J HERED, V92, P442, DOI 10.1093/jhered/92.5.442; Wilcox JR, 1997, CROP SCI, V37, P1981, DOI 10.2135/cropsci1997.0011183X003700060060x; Wu XL, 2011, AGR SCI CHINA, V10, P1506, DOI 10.1016/S1671-2927(11)60145-4; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Yu AnLiang, 2010, Chinese Journal of Oil Crop Sciences, V32, P462; Yue P, 2001, THEOR APPL GENET, V102, P921, DOI 10.1007/s001220000453; Zhang J, 2013, J COMPUT, V8, P10, DOI 10.4304/jcp.8.1.10-17; Zhang JQ, 2013, THEOR APPL GENET, V126, P1555, DOI 10.1007/s00122-013-2073-1; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhong C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081809; Zhong C, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00044	106	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0227710	10.1371/journal.pone.0227710	http://dx.doi.org/10.1371/journal.pone.0227710			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196522	Green Published, gold			2022-12-26	WOS:000535303100007
J	Rodriguez-Pena, E; Verisimo, P; Fernandez, L; Gonzalez-Tizon, A; Barcena, C; Martinez-Lage, A				Rodriguez-Pena, Elba; Verisimo, Patricia; Fernandez, Luis; Gonzalez-Tizon, Ana; Barcena, Covadonga; Martinez-Lage, Andres			High incidence of heteroplasmy in the mtDNA of a natural population of the spider crab Maja brachydactyla	PLOS ONE			English	Article							PATERNAL MITOCHONDRIAL-DNA; RESTRICTION-SITE HETEROPLASMY; MATERNAL INHERITANCE; CALLINECTES-SAPIDUS; RAPID SEGREGATION; MOUSE MTDNA; RECOMBINATION; BRACHYURA; DECAPODA; LEAKAGE	Mitochondria are mostly inherited by maternal via, that is, only mitochondria from eggs are retained in the embryos. However, this general assumption of uniparentally transmitted, homoplasmic and non-recombining mitochondrial genomes is becoming more and more controversial. The presence of different sequences of mtDNA within a cell or individual, known as heteroplasmy, is increasingly reported in several taxon of animals, such as molluscs, arthropods and vertebrates. In this work, a considerable frequency of heteroplasmy were detected in the COI and 16S genes of the spider crab Maja brachydactyla, possibly associated to hybridisation with the congeneric species Maja squinado. This finding is a fact to keep in mind before addressing molecular analyses based on mitochondrial markers, since the assumption of maternal inheritance could lead to erroneous results. As M. brachydactyla is a commercial species, heteroplasmy is an important aspect to take into account for the fisheries management of this resource, since effective population size could be overestimated.	[Rodriguez-Pena, Elba; Verisimo, Patricia; Fernandez, Luis; Gonzalez-Tizon, Ana; Barcena, Covadonga; Martinez-Lage, Andres] Univ A Coruna, Fac Ciencias, Ctr Invest Cient Avazadas, Dept Biol, La Coruna, Spain	Universidade da Coruna	Martinez-Lage, A (corresponding author), Univ A Coruna, Fac Ciencias, Ctr Invest Cient Avazadas, Dept Biol, La Coruna, Spain.	andres@udc.es	; Martinez-Lage, Andres/A-4356-2015	Verisimo Amor, Patricia/0000-0002-3113-1949; Martinez-Lage, Andres/0000-0002-8218-7002	Ministerio de Economia y Competitividad of the Spanish Government [CTM2014-53838-R]; Conselleria de Educacio n e Ordenacion Universitaria of the Xunta de Galicia [ED431C2018/S7]; Axudas de apoio a etapa predoutoral from the Xunta de Galicia; European Social Fund	Ministerio de Economia y Competitividad of the Spanish Government(Spanish Government); Conselleria de Educacio n e Ordenacion Universitaria of the Xunta de Galicia; Axudas de apoio a etapa predoutoral from the Xunta de Galicia; European Social Fund(European Social Fund (ESF))	This work has been supported by the Ministerio de Economia y Competitividad (CTM2014-53838-R, awarded to AML and LF) of the Spanish Government and by the Conselleria de Educacio n e Ordenacion Universitaria of the Xunta de Galicia (ED431C2018/S7, https://www.xunta.gal/portada, awarded to AGT). The researcher ERP was supported by the Axudas de apoio a etapa predoutoral from the Xunta de Galicia, co-financed by the European Social Fund (https://ec.europa.eu/esf/home.jsp).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello Pere, 2014, Marine Biodiversity Records, V7, pe77, DOI 10.1017/S1755267214000827; Alexander M, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0561; Allen JF, 1996, J THEOR BIOL, V180, P135, DOI 10.1006/jtbi.1996.0089; Balss H., 1922, BEITRAGE KENNTNIS ME, P69; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; Bendall KE, 1996, AM J HUM GENET, V59, P1276; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bergstrom CT, 1998, GENETICS, V149, P2135; Bernardez Marti C, 2003, P 14 JORN PAR LEG MA, P133; Breton S, 2007, TRENDS GENET, V23, P465, DOI 10.1016/j.tig.2007.05.011; Breton S, 2015, GENOME, V58, P423, DOI 10.1139/gen-2015-0090; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Burgstaller JP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04797-2; Burt A, 2006, GENES CONFLICT BIOL; CLARK PF, 1986, J NAT HIST, V20, P825, DOI 10.1080/00222938600770591; Clark PF, 2001, J CRUSTACEAN BIOL, V21, P288, DOI 10.1651/0278-0372(2001)021[0288:AMAORV]2.0.CO;2; Conselleria do Mar da Xunta de Galicia, 2019, VEND NAS LONX PRIM V; Corgos A, 2011, J SEA RES, V66, P9, DOI 10.1016/j.seares.2011.04.011; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Crochet PA, 2000, MOL BIOL EVOL, V17, P1797, DOI 10.1093/oxfordjournals.molbev.a026280; dAcoz C., 1999, PATRIMOINES NATURELS, V40, P1; De Grave S, 2009, RAFFLES B ZOOLOGY S, P109; Dokianakis E, 2014, ECOL EVOL, V4, P2633, DOI 10.1002/ece3.1069; Doublet V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002938; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1974, GENETICS, V78, P737; FISHER C, 1990, P ROY SOC B-BIOL SCI, V242, P149, DOI 10.1098/rspb.1990.0118; Gandolfi A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170507; Gislason Oskar Sindri, 2013, Natturufraedingurinn, V83, P39; GOLD JR, 1990, ANIM GENET, V21, P313, DOI 10.1111/j.1365-2052.1990.tb03241.x; Gonzalez-Gurriaran E, 2002, J CRUSTACEAN BIOL, V22, P91, DOI 10.1651/0278-0372(2002)022[0091:MPOFSC]2.0.CO;2; Gordo I, 2000, GENETICS, V154, P1379; Guerao G, 2008, J NAT HIST, V42, P2257, DOI 10.1080/00222930802254755; Guerao G, 2011, SCI MAR, V75, P129, DOI 10.3989/scimar.2011.75n1129; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hauswirth W., 1985, ACHIEVEMENT PERSPECT, V2, P49; Herbst JFW, 1788, VERSUCH NATURGESCHIC; HINES AH, 1995, J MAR BIOL ASSOC UK, V75, P27, DOI 10.1017/S0025315400015174; HOWELL N, 1992, AM J HUM GENET, V50, P1333; HURST LD, 1992, P ROY SOC B-BIOL SCI, V247, P189, DOI 10.1098/rspb.1992.0027; Iglesias J., 2002, Boletin Instituto Espanol de Oceanografia, V18, P25; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; KONDO R, 1990, GENETICS, V126, P657; Kvist L, 2003, MOL BIOL EVOL, V20, P243, DOI 10.1093/molbev/msg025; Le Foll D., 1993, BIOL EXPLOITATION W; Loewe L, 2006, GENET RES, V87, P133, DOI 10.1017/S0016672306008123; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Machado TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133650; MAGOULAS A, 1993, MOL BIOL EVOL, V10, P319; Mitrofanov KY, 2018, RUSS J GENET+, V54, P121, DOI 10.1134/S1022795417100064; Morgan JAT, 2013, MITOCHONDRION, V13, P852, DOI 10.1016/j.mito.2013.06.002; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Neumann V, 1996, CRUSTACEANA, V69, P821, DOI 10.1163/156854096X00222; Neumann V, 1998, J NAT HIST, V32, P1667, DOI 10.1080/00222939800771191; Ng P. D., 2008, RAFFLES B ZOOL, V17, P286; Nunes MDS, 2013, MOL ECOL, V22, P2106, DOI 10.1111/mec.12256; Pardieck RA, 1999, MAR ECOL PROG SER, V186, P227, DOI 10.3354/meps186227; Pascual MS, 2001, J SHELLFISH RES, V20, P1003; Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435; Politi Y, 2014, DEV CELL, V29, P305, DOI 10.1016/j.devcel.2014.04.005; Radojicic JM, 2015, ECOL EVOL, V5, P4529, DOI 10.1002/ece3.1692; Rodriguez-Pena E, 2017, CONSERV GENET RESOUR, V9, P369, DOI 10.1007/s12686-017-0685-5; Rokas A, 2003, TRENDS ECOL EVOL, V18, P411, DOI 10.1016/S0169-5347(03)00125-3; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Santibanez-Koref M, 2019, MITOCHONDRION, V46, P302, DOI 10.1016/j.mito.2018.08.003; Sato K, 2017, J BIOCHEM, V162, P247, DOI 10.1093/jb/mvx052; Sato M, 2012, AUTOPHAGY, V8, P424, DOI 10.4161/auto.19243; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004; Sherengul W, 2006, GENES GENET SYST, V81, P399, DOI 10.1266/ggs.81.399; Shitara H, 1998, GENETICS, V148, P851; SOLIGNAC M, 1984, MOL GEN GENET, V197, P183, DOI 10.1007/BF00330961; Sotelo G, 2008, J CRUSTACEAN BIOL, V28, P76, DOI 10.1651/07-2875R.1; Sotelo G, 2009, MOL PHYLOGENET EVOL, V53, P314, DOI 10.1016/j.ympev.2009.05.009; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Theologidis L, 2007, GENETICS, V176, P1367, DOI 10.1534/genetics.106.069930; Tsaousis AD, 2005, MOL BIOL EVOL, V22, P925, DOI 10.1093/molbev/msi084; Vershinin VL, 2019, RUSS J GENET+, V55, P1041, DOI 10.1134/S1022795419080179; White DJ, 2008, MOL ECOL, V17, P4925, DOI 10.1111/j.1365-294X.2008.03982.x; Williams EP, 2017, J SHELLFISH RES, V36, P263, DOI 10.2983/035.036.0129; Wolff JN, 2016, SCI REP-UK, V6, DOI 10.1038/srep30016; Xu S, 2012, MOL BIOL EVOL, V29, P763, DOI 10.1093/molbev/msr243; ZOUROS E, 1992, NATURE, V359, P412, DOI 10.1038/359412a0; Zouros E, 2013, EVOL BIOL, V40, P1, DOI 10.1007/s11692-012-9195-2	89	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230243	10.1371/journal.pone.0230243	http://dx.doi.org/10.1371/journal.pone.0230243			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191743	Green Published, gold			2022-12-26	WOS:000535302300031
J	Weeks, MR; Lounsbury, DW; Li, JH; Hirsch, G; Berman, M; Green, HD; Rohena, L; Gonzalez, R; Montezuma-Rusca, JM; Jackson, S				Weeks, Margaret R.; Lounsbury, David W.; Li, Jianghong; Hirsch, Gary; Berman, Marcie; Green, Helena D.; Rohena, Lucy; Gonzalez, Rosely; Montezuma-Rusca, Jairo M.; Jackson, Seja			Simulating system dynamics of the HIV care continuum to achieve treatment as prevention	PLOS ONE			English	Article							PUBLIC-HEALTH; ANTIRETROVIRAL THERAPY; MODEL; ENGAGEMENT; IMPACT; VALIDATION; SCIENCE; POLICY; TRANSMISSION; PREVALENCE	The continuing HIV pandemic calls for broad, multi-sectoral responses that foster community control of local prevention and care services, with the goal of leveraging high quality treatment as a means of reducing HIV incidence. Service system improvements require stakeholder input from across the care continuum to identify gaps and to inform strategic plans that improve HIV service integration and delivery. System dynamics modeling offers a participatory research approach through which stakeholders learn about system complexity and about ways to achieve sustainable system-level improvements. Via an intensive group model building process with a task force of community stakeholders with diverse roles and responsibilities for HIV service implementation, delivery and surveillance, we designed and validated a multi-module system dynamics model of the HIV care continuum, in relation to local prevention and care service capacities. Multiple sources of data were used to calibrate the model for a three-county catchment area of central Connecticut. We feature a core module of the model for the purpose of illustrating its utility in understanding the dynamics of treatment as prevention at the community level. We also describe the methods used to validate the model and support its underlying assumptions to improve confidence in its use by stakeholders for systems understanding and decision making. The model's generalizability and implications of using it for future community-driven strategic planning and implementation efforts are discussed.	[Weeks, Margaret R.; Li, Jianghong; Berman, Marcie; Green, Helena D.; Rohena, Lucy; Gonzalez, Rosely] Inst Community Res, Hartford, CT 06106 USA; [Lounsbury, David W.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Hirsch, Gary] Creator Learning Environm, Wayland, MA USA; [Montezuma-Rusca, Jairo M.] Univ Connecticut, Ctr Hlth, Dept Internal Med, Farmington, CT USA; [Jackson, Seja] Burgdorf Hlth Ctr, St Francis Hosp, Hartford, CT USA; [Jackson, Seja] Burgdorf Hlth Ctr, Med Ctr, Hartford, CT USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Connecticut; Saint Francis Hospital & Medical Center	Weeks, MR (corresponding author), Inst Community Res, Hartford, CT 06106 USA.	mweeks@icrweb.org		Montaque, Helena/0000-0003-2806-0921; Weeks, Margaret R./0000-0001-7493-0276	U.S. National Institute of Mental Health of the National Institutes of Health [R01MH103176, R21MH110335]	U.S. National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	(MRW) Research reported in this publication was supported by the U.S. National Institute of Mental Health of the National Institutes of Health (https://www.nimh.nih.gov/index.shtml) under Award Numbers R01MH103176 and R21MH110335. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arquitt S, 2004, SYST DYNAM REV, V20, P179, DOI 10.1002/sdr.292; Atkinson JAM, 2015, PUBLIC HEALTH RES PR, V25, DOI 10.17061/phrp2531531; Barlas Y, 1996, SYST DYNAM REV, V12, P183, DOI 10.1002/(SICI)1099-1727(199623)12:3<183::AID-SDR103>3.0.CO;2-4; BARLAS Y, 1989, EUR J OPER RES, V42, P59, DOI 10.1016/0377-2217(89)90059-3; Castel AD, 2012, AIDS, V26, P345, DOI 10.1097/QAD.0b013e32834de5fe; Centers for Disease Control and Prevention, 2012, US VIR LOAD DAT MON; Centers for Disease Control & Prevention, 2013, BACKGR BRIEF PREV BE; Chen YY, 2013, CURR HIV-AIDS REP, V10, P79, DOI 10.1007/s11904-012-0144-6; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2012, HEALTH AFFAIR, V31, P1439, DOI 10.1377/hlthaff.2012.0250; Cohen MS, 2012, CLIN TRIALS, V9, P340, DOI 10.1177/1740774512443594; CT Department of Public Health, 2018, EST HIV PREV PERS AG; CT Department of Public Health, 2015, CONN HIV STAT 2014; CT Department of Public Health, 2018, EP PROF HIV CONN; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Department of Public Health SF, 2000, MED CARE, V38, P58, DOI [10.1097/00005650-200001000-00007, DOI 10.1097/00005650-200001000-00007]; Eisinger RW, 2019, JAMA J AM MED ASS; Fauci AS, 2019, JAMA-J AM MED ASSOC, V321, P844, DOI 10.1001/jama.2019.1343; Forrester J. W., 1980, TIMS STUDIES MANAGEM, V14, P201; Foster-Fishman PG, 2007, AM J COMMUN PSYCHOL, V39, P197, DOI 10.1007/s10464-007-9109-0; Foster-Fishman PG, 2007, AM J COMMUN PSYCHOL, V39, P191, DOI 10.1007/s10464-007-9104-5; Foster-Fishman PG, 2001, AM J COMMUN PSYCHOL, V29, P241, DOI 10.1023/A:1010378613583; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gillen EM, 2014, HEALTH EDUC BEHAV, V41, P63, DOI 10.1177/1090198113486804; Granich R, 2010, CURR OPIN HIV AIDS, V5, P298, DOI 10.1097/COH.0b013e32833a6c32; Hartford Department of Health and Human Services, 2016, RYAN WHIT PRIO UNPUB; Hirsch G, 2010, AM J PUBLIC HEALTH, V100, P616, DOI 10.2105/AJPH.2009.159434; Hirsch GB, 2007, AM J COMMUN PSYCHOL, V39, P239, DOI 10.1007/s10464-007-9114-3; Holtgrave DR, 2012, AIDS BEHAV, V16, P1085, DOI 10.1007/s10461-012-0186-1; Holtzman CW, 2015, DRUGS, V75, P445, DOI 10.1007/s40265-015-0373-2; Homer JB, 2006, AM J PUBLIC HEALTH, V96, P452, DOI 10.2105/AJPH.2005.062059; HOVMAND PETER S., 2014, COMMUNITY BASED SYST; Hull MW, 2012, CURR OPIN HIV AIDS, V7, P579, DOI 10.1097/COH.0b013e3283590617; Joint United Nations Programme on HIV/AIDS, 2010, GETT ZER 2011 2015 S; Kok S, 2015, HEALTH CARE MANAG SC, V18, P334, DOI 10.1007/s10729-014-9312-0; Leischow SJ, 2006, AM J PUBLIC HEALTH, V96, P403, DOI 10.2105/AJPH.2005.082842; Lounsbury DW, 2015, AIDS PATIENT CARE ST, V29, pS55, DOI 10.1089/apc.2014.0276; Lounsbury DW, 2014, QUAL LIFE RES, V23, P959, DOI 10.1007/s11136-013-0532-4; Luna-Reyes LF, 2006, SYST DYNAM REV, V22, P291, DOI 10.1002/sdr.349; Mabry PL, 2010, AM J PUBLIC HEALTH, V100, P1161, DOI 10.2105/AJPH.2010.198176; Macmillan A, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0098-z; Maglio PP, 2014, AM J PUBLIC HEALTH, V104, P1181, DOI 10.2105/AJPH.2014.301873; Marshall DA, 2015, VALUE HEALTH, V18, P5, DOI 10.1016/j.jval.2014.12.001; Martin EG, 2015, JAIDS-J ACQ IMM DEF, V68, pS59, DOI 10.1097/QAI.0000000000000395; Meadows D.H., 2008, THINKING SYSTEMS PRI; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Northridge ME, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0146-8; Oliva R, 2003, EUR J OPER RES, V151, P552, DOI 10.1016/S0377-2217(02)00622-7; Peterson S, 2019, SYST DYNAM REV, V35, P55, DOI 10.1002/sdr.1620; Qudrat-Ullah H, 2012, TELECOMMUN SYST, V51, P159, DOI 10.1007/s11235-011-9425-4; Qudrat-Ullah H, 2010, ENERG POLICY, V38, P2216, DOI 10.1016/j.enpol.2009.12.009; Richardson G. P., 1995, SYST DYNAM REV, V11, P1; Richardson G. P, 1999, FEEDBACK THOUGHT SOC; Richardson GP, 2011, SYST DYNAM REV, V27, P219, DOI 10.1002/sdr.462; Roussos ST, 2000, ANNU REV PUBL HEALTH, V21, P369, DOI 10.1146/annurev.publhealth.21.1.369; Schwarcz S, 2006, JAIDS-J ACQ IMM DEF, V43, P491, DOI 10.1097/01.qai.0000243114.37035.de; Scott RJ, 2013, SYST DYNAM REV, V29, P216, DOI 10.1002/sdr.1505; Song RG, 2017, JAIDS-J ACQ IMM DEF, V74, P3, DOI 10.1097/QAI.0000000000001151; Stave K., 2010, SUSTAINABILITY-BASEL, V2, P2762, DOI [DOI 10.3390/SU2092762, 10.3390/su2092762]; Stave KA, 2002, SYST DYNAM REV, V18, P139, DOI 10.1002/sdr.237; Sterman, 1984, DYNAMICA, V10, P51; Sterman J.D., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Sterman JD, 2002, SYST DYNAM REV, V18, P501, DOI 10.1002/sdr.261; STERMAN JD, 1994, SYST DYNAM REV, V10, P291, DOI 10.1002/sdr.4260100214; Terzian AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029679; The Joint United Nation Programme on HIV/AIDS, 2014, 90 90 90 AMB TREATM; Tozan Y, 2015, J URBAN HEALTH, V92, P490, DOI 10.1007/s11524-015-9963-2; Valdiserri R., HIV AIDS TREATMENT C; Van Olmen J, 2012, HLTH SYSTEM DYNAMICS; VANDENBELT M, 2004, MEDIATED MODELING SY; Vennix J.A., 1996, ENCY LIFE SUPPORT SY, V2, P97; Walensky RP, 2013, NEW ENGL J MED, V369, P1715, DOI 10.1056/NEJMsa1214720; Weeks MR, 2013, HEALTH EDUC RES, V28, P375, DOI 10.1093/her/cyt051; Weeks MR, 2017, AM J COMMUN PSYCHOL, V60, P584, DOI 10.1002/ajcp.12204; Zetola NM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-17; Zimmerman L, 2016, ADM POLICY MENT HLTH, V43, P834, DOI 10.1007/s10488-016-0754-1; Zolopa AR, 2010, ANTIVIR RES, V85, P241, DOI 10.1016/j.antiviral.2009.10.018	78	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230568	10.1371/journal.pone.0230568	http://dx.doi.org/10.1371/journal.pone.0230568			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9FM	32191771	gold, Green Published			2022-12-26	WOS:000535302300061
J	Teran, LC; Cuozzo, SA; Ficoseco, MCA; Fadda, S; Chaillou, S; Champomier-Verges, MC; Zagorec, M; Hebert, EM; Raya, RR				Teran, Lucrecia C.; Cuozzo, Sergio A.; Aristimuno Ficoseco, Maria C.; Fadda, Silvina; Chaillou, Stephane; Champomier-Verges, Marie-Christine; Zagorec, Monique; Hebert, Elvira M.; Raya, Raul R.			Nucleotide sequence and analysis of pRC12 and pRC18, two theta-replicating plasmids harbored by Lactobacillus curvatus CRL 705	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; LACTIC-ACID BACTERIA; MINIMAL REPLICON; COMPARATIVE GENOMICS; GENE-EXPRESSION; COPY-NUMBER; VECTORS; STRAINS; SAKE; TRANSFORMATION	The nucleotide sequences of plasmids pRC12 (12,342 bp; GC 43.99%) and pRC18 (18,664 bp; GC 34.33%), harbored by the bacteriocin-producer Lactobacillus curvatus CRL 705, were determined and analyzed. Plasmids pRC12 and pRC18 share a region with high DNA identity (> 83% identity between RepA, a Type II toxin-antitoxin system and a tyrosine integrase genes) and are stably maintained in their natural host L. curvatus CRL 705. Both plasmids are low copy number and belong to the theta-type replicating group. While pRC12 is a pUCL287-like plasmid that possesses iterons and the repA and repB genes for replication, pRC18 harbors a 168 amino acid replication protein affiliated to RepB, which was named RepB'. Plasmid pRC18 also possesses a pUCL287-like repA gene but it was disrupted by an 11 kb insertion element that contains RepB', several transposases/IS elements, and the lactocin Lac705 operon. An Escherichia coli / Lactobacillus shuttle vector, named plasmid p3B1, carrying the pRC18 replicon (i.e. repB' and replication origin), a chloramphenicol resistance gene and a pBluescript backbone, was constructed and used to define the host range of RepB'. Chloramphenicol-resistant transformants were obtained after electroporation of Lactobacillus plantarum CRL 691, Lactobacillus sakei 23K and a plasmid-cured derivative of L. curvatus CRL 705, but not of L. curvatus DSM 20019 or Lactococcus lactis NZ9000. Depending on the host, transformation efficiency ranged from 10(2) to 10(7) per mu g of DNA; in the new hosts, the plasmid was relatively stable as 29-53% of recombinants kept it after cell growth for 100 generations in the absence of selective pressure. Plasmid p3B1 could therefore be used for cloning and functional studies in several Lactobacillus species.	[Teran, Lucrecia C.; Aristimuno Ficoseco, Maria C.; Fadda, Silvina; Hebert, Elvira M.; Raya, Raul R.] Consejo Nacl Invest Cient & Tecn, Ctr Referencia Lactobacilos CERELA, San Miguel De Tucuman, Argentina; [Cuozzo, Sergio A.] Consejo Nacl Invest Cient & Tecn, Planta Piloto Proc & Ind Microbiol PROIMI, San Miguel De Tucuman, Argentina; [Chaillou, Stephane; Champomier-Verges, Marie-Christine] Univ Paris Saclay, INRAE, AgroParisTech, Micalis Inst, Jouy En Josas, France; [Zagorec, Monique] INRAE, UMR1014, Secalim, Oniris, Nantes, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Nantes Universite	Raya, RR (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Referencia Lactobacilos CERELA, San Miguel De Tucuman, Argentina.	rraya@cerela.org.ar	Teran, Lucrecia/ABB-3407-2021; Hebert, Elvira Maria/H-6635-2019	Teran, Lucrecia/0000-0002-7326-7190; Hebert, Elvira Maria/0000-0001-8288-9701; Zagorec, Monique/0000-0001-6439-983X	BecAR Program; Campus France Argentine; doctoral CONICET scholarship; FONCYT (Argentina) [PICT 02293, PICT 0175]; Agence Nationale pour la Recherche [ANR-10-INBS09, ANR-11-INBS-0013]	BecAR Program; Campus France Argentine; doctoral CONICET scholarship; FONCYT (Argentina)(FONCyT); Agence Nationale pour la Recherche(French National Research Agency (ANR))	LCT had a Ph.D fellowship of the BecAR Program and Campus France Argentine and a doctoral CONICET scholarship This work was supported by FONCYT (Argentina): Projects PICT 02293 and PICT 0175 (CERELOMICS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Lucrecia C. Teran had a Ph.D fellowship of the BecAR Program and Campus France Argentine and a doctoral CONICET scholarship. Daniel Vilte contributed with assistance during his training period. We thank Cecilia Haro and Marcela Medina for assistance and participation in discussion. The LABGeM (CEA/Genoscope & CNRS UMR8030), the France Genomique and French Bioinformatics Institute national infrastructures (funded as part of Investissement d'Avenir program managed by Agence Nationale pour la Recherche, contracts ANR-10-INBS09 and ANR-11-INBS-0013) are acknowledged for support within the MicroScope annotation platform.	Alpert CA, 2003, APPL ENVIRON MICROB, V69, P5574, DOI 10.1128/AEM.69.9.5574-5584.2003; ANDERSON DG, 1983, APPL ENVIRON MICROB, V46, P549, DOI 10.1128/AEM.46.3.549-552.1983; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; Benachour A, 1995, BIOCHIMIE, V77, P868, DOI 10.1016/0300-9084(95)90005-5; Benachour A, 1997, MOL GEN GENET, V255, P504, DOI 10.1007/s004380050523; Berthier F, 1996, MICROBIOL-UK, V142, P1273, DOI 10.1099/13500872-142-5-1273; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BRUAND C, 1993, P NATL ACAD SCI USA, V90, P11668, DOI 10.1073/pnas.90.24.11668; Chen ZJ, 2014, APPL MICROBIOL BIOT, V98, P5977, DOI 10.1007/s00253-014-5649-z; Chikindas ML, 2018, CURR OPIN BIOTECH, V49, P23, DOI 10.1016/j.copbio.2017.07.011; Coq AMCL, 2008, PLASMID, V60, P212, DOI 10.1016/j.plasmid.2008.08.002; Cui YH, 2015, INT J MOL SCI, V16, P13172, DOI 10.3390/ijms160613172; Cuozzo SA, 2000, FEMS MICROBIOL LETT, V185, P157, DOI 10.1111/j.1574-6968.2000.tb09055.x; Cuozzo SA, 2003, CURR MICROBIOL, V46, P180, DOI 10.1007/s00284-002-3844-0; da Costa RJ, 2019, J FOOD QUALITY, DOI 10.1155/2019/4726510; Danielsen M, 2002, PLASMID, V48, P98, DOI 10.1016/S0147-619X(02)00118-X; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Eisenbach L, 2018, INT J FOOD MICROBIOL, V286, P37, DOI 10.1016/j.ijfoodmicro.2018.06.025; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Ferrari A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44094-6; Hall AMJ, 2017, CURR OPIN MICROBIOL, V36, P102, DOI 10.1016/j.mib.2017.02.003; Harrison E, 2015, CURR BIOL, V25, P2034, DOI 10.1016/j.cub.2015.06.024; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; HAYES F, 1991, PLASMID, V25, P16, DOI 10.1016/0147-619X(91)90003-F; Holo H, 1995, Methods Mol Biol, V47, P195; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; Hulter N, 2017, CURR OPIN MICROBIOL, V38, P74, DOI 10.1016/j.mib.2017.05.001; KIEWIET R, 1993, APPL ENVIRON MICROB, V59, P358, DOI 10.1128/AEM.59.2.358-364.1993; Klaenhammer TR, 2012, NAT REV IMMUNOL, V12, P728, DOI 10.1038/nri3312; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Kyoui D, 2018, MICROBIOL RESOUR ANN, V7, DOI [10.1128/MRA.00823-18, 10.1128/mra.00823-18]; Lee CL, 2006, J MICROBIOL METH, V65, P258, DOI 10.1016/j.mimet.2005.07.019; Leloup L, 1997, APPL ENVIRON MICROB, V63, P2117, DOI 10.1128/AEM.63.6.2117-2123.1997; Lyhs U, 2008, FOOD MICROBIOL, V25, P529, DOI 10.1016/j.fm.2007.11.007; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Hebert EM, 2012, J BACTERIOL, V194, P538, DOI 10.1128/JB.06416-11; Panya M, 2012, APPL MICROBIOL BIOT, V93, P261, DOI 10.1007/s00253-011-3503-0; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; Poluektova EU, 2017, ARCH MICROBIOL, V199, P683, DOI 10.1007/s00203-017-1346-5; Rajewska M, 2012, FEMS MICROBIOL REV, V36, P408, DOI 10.1111/j.1574-6976.2011.00300.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Siedler S, 2019, CURR OPIN BIOTECH, V56, P138, DOI 10.1016/j.copbio.2018.11.015; Sorvig E, 2003, FEMS MICROBIOL LETT, V229, P119, DOI 10.1016/S0378-1097(03)00798-5; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Sun ZH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9322; Teran L. C., 2017, GENOME ANNOUNC, V5, DOI [10.1128/genomea.0058417, DOI 10.1128/GENOMEA.0058417]; Teran LC, 2019, LACTOBACILLUS GENOMICS AND METABOLIC ENGINEERING, P19, DOI 10.21775/9781910190890.02; Teran LC, 2018, GENOME BIOL EVOL, V10, P1516, DOI 10.1093/gbe/evy106; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Thompson JK, 1999, PLASMID, V42, P221, DOI 10.1006/plas.1999.1428; Torriani S, 1996, INT J SYST BACTERIOL, V46, P1158, DOI 10.1099/00207713-46-4-1158; Vallenet D, 2017, NUCLEIC ACIDS RES, V45, pD517, DOI 10.1093/nar/gkw1101; VIGNOLO GM, 1993, J APPL BACTERIOL, V75, P344, DOI 10.1111/j.1365-2672.1993.tb02786.x; Wang TT, 1997, CRIT REV BIOTECHNOL, V17, P227, DOI 10.3109/07388559709146615; Yang EJ, 2011, BIOTECHNOL LETT, V33, P599, DOI 10.1007/s10529-010-0467-6	57	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230857	10.1371/journal.pone.0230857	http://dx.doi.org/10.1371/journal.pone.0230857			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240216	Green Submitted, Green Published, gold			2022-12-26	WOS:000535945000049
J	Gupta, S; Barisal, S				Gupta, Shivani; Barisal, Sangeeta			Does a rise in BMI cause an increased risk of diabetes?: Evidence from India	PLOS ONE			English	Article							BODY-MASS INDEX; ALCOHOL-CONSUMPTION; FAST-FOOD; WEIGHT-GAIN; OBESITY; MELLITUS; GENETICS; IMPACT; LIFE	Background Overnutrition increases the risk of diabetes. Evidence on the causal impact of overnutrition on diabetes is scarce for India. Considering a representative sample from India, this study examines the causal effect of a rise in the Body Mass Index (BMI) of an individual on the likelihood of being diabetic while addressing the issue of unobserved endogeneity between overnutrition and diabetes. Methods The study considers individual level data from Demographic and Health Surveys (DHS) of India, namely, National Family Health Survey (NFHS) for the year 2015-16. The NFHS is a large-scale, multi-round survey conducted in a representative sample of households throughout India. The survey covers females having age 15-49 years and males having age 15-54 years. The instrument variable approach is used to address the potential endogeneity in the relationship between BMI and diabetes. We instrument BMI of an individual by BMI of a non-biologically related household member. Ordered Probit, Probit and IV-Probit models are estimated using two alternative definitions for measuring diabetes-self-reported diabetes status and blood glucose levels (ordinal measure). Results The coefficients obtained from the Ordered Probit and Probit models are much smaller than those estimated by an IV-Probit model. The latter estimates the causal impact of a rise in BMI on diabetes by taking into account the effect of the unobserved genetic and other related factors. The likelihood of being diabetic is twice or more among the overweight and obese individuals as compared to non-overweight individuals in all the specifications. With a unit increase in BMI the probability of being diabetic increases by about 1.5% among overweight and obese individuals and by 0.5% among the non-overweight individuals in the IV-Probit model. Similar results from the Ordered Probit model show that on average, the overweight and obese individuals experience about 0.2% increase in the probability of being diabetic and about 0.4% increase in the probability of being prediabetic. Conclusion Our study demonstrates that the likelihood of being both prediabetic and diabetic is higher among the overweight and obese individuals as compared to the non-overweight individuals. We also find that the level of risk of being prediabetic or diabetic differs across gender, wealth quintiles and regions and the effects are more severe among population in the urban areas, belonging to the richest wealth quintile and men. Our findings have significant implications for the policy formulation as diabetes has a substantial health and economic burden associated with it. Future studies may investigate the effect of abdominal obesity on diabetes.	[Gupta, Shivani; Barisal, Sangeeta] Jawaharlal Nehru Univ, Ctr Int Trade & Dev, Sch Int Studies, New Delhi, India	Jawaharlal Nehru University, New Delhi	Barisal, S (corresponding author), Jawaharlal Nehru Univ, Ctr Int Trade & Dev, Sch Int Studies, New Delhi, India.	sangeeta.bansal7@gmail.com						Astrup A, 2005, LANCET, V365, P4, DOI 10.1016/S0140-6736(04)17674-5; BECKER WE, 1992, ECONOMET THEOR, V8, P127, DOI 10.1017/S0266466600010781; Bener A, 2005, CROAT MED J, V46, P302; Bhattacharya J, 2011, J ECON PERSPECT, V25, P139, DOI 10.1257/jep.25.1.139; Boes S, 2006, ALLGEMEINES STAT ARC, P167, DOI [DOI 10.1007/S10182-006-0228-Y, 10.1007/s10182-006-0228-y]; Carlsson S, 2003, DIABETES CARE, V26, P2785, DOI 10.2337/diacare.26.10.2785; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Chang SA, 2012, DIABETES METAB J, V36, P399, DOI 10.4093/dmj.2012.36.6.399; Chiburis R, 2007, STATA J, V7, P167, DOI 10.1177/1536867X0700700202; Cobb LK, 2016, AM J EPIDEMIOL, V183, P435, DOI 10.1093/aje/kwv112; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Corneliben T., 2005, 320 U HANN I QUANT E; DFI, 2018, DIAB FDN IND; Dhana K, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002086; Fagard RH, 2009, PRIM CARE DIABETES, V3, P205, DOI 10.1016/j.pcd.2009.09.003; Falba TA, 2008, HEALTH SERV RES, V43, P96, DOI 10.1111/j.1475-6773.2007.00754.x; Fearon J. D., 2001, REGRESSION 5; Geiss LS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173428; Gray LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026464; Gulati S, 2014, NUTRIENTS, V6, P5955, DOI 10.3390/nu6125955; Hewitt JK, 1997, BEHAV GENET, V27, P353, DOI 10.1023/A:1025687930765; Howard AA, 2004, ANN INTERN MED, V140, P211, DOI 10.7326/0003-4819-140-6-200403160-00011; Huffman MD, 2011, J AM COLL CARDIOL, V57, P1765, DOI 10.1016/j.jacc.2010.09.083; IDF, 2017, INT DIAB FED IDF DIA; IDF, 2017, INT DIAB FED IDF SEA; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Katzmarzyk PT, 2002, INT J OBESITY, V26, P241, DOI 10.1038/sj.ijo.0801870; Kerr D, 2009, QJM-INT J MED, V102, P169, DOI 10.1093/qjmed/hcn163; Moebus S, 2011, EUR J EPIDEMIOL, V26, P719, DOI 10.1007/s10654-011-9608-z; Nelson MC, 2006, OBESITY, V14, P701, DOI 10.1038/oby.2006.80; NFHS, 2015, NAT FAM HLTH SURV; NHA, 2015, NAT HLTH ACC 2015 16; O'Malley G, 2010, DIABETOLOGIA, V53, P1199, DOI 10.1007/s00125-010-1693-0; Olinto MTA, 2017, ADIPOSITY EPIDEMIOLO; Patel S, 2001, J EPIDEMIOL COMMUN H, V55, P332, DOI 10.1136/jech.55.5.332; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Preston SH, 2011, AM J PUBLIC HEALTH, V101, P2137, DOI 10.2105/AJPH.2011.300219; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Ramachandran A, 2007, DIABETES CARE, V30, P2548, DOI 10.2337/dc07-0150; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Rowley WR, 2017, POPUL HEALTH MANAG, V20, P6, DOI 10.1089/pop.2015.0181; Sepp E, 2014, MICROB ECOL HEALTH D, V25, DOI 10.3402/mehd.v25.22857; Sikdar KC, 2010, QUAL LIFE RES, V19, P781, DOI 10.1007/s11136-010-9641-5; Teufel-Shone NI, 2015, ETHNIC HEALTH, V20, P327, DOI 10.1080/13557858.2014.921890; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Wooldridge J.M., 2006, INTRO ECONOMETRICS M; Yesudian CAK, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0080-x	47	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0229716	10.1371/journal.pone.0229716	http://dx.doi.org/10.1371/journal.pone.0229716			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8IA	32236106	Green Published, gold			2022-12-26	WOS:000535938700012
J	Neal, EFG; Nguyen, CD; Ratu, FT; Dunne, EM; Kama, M; Ortika, BD; Boelsen, LK; Kado, J; Tikoduadua, L; Devi, R; Tuivaga, E; Reyburnl, RC; Satzke, C; Rafai, E; Mulholland, K; Russell, FM				Neal, Eleanor F. G.; Nguyen, Cattram D.; Ratu, Felista T.; Dunne, Eileen M.; Kama, Mike; Ortika, Belinda D.; Boelsen, Laura K.; Kado, Joseph; Tikoduadua, Lisi; Devi, Rachel; Tuivaga, Evelyn; Reyburnl, Rita C.; Satzke, Catherine; Rafai, Eric; Mulholland, Kim; Russell, Fiona M.			Factors associated with pneumococcal carriage and density in children and adults in Fiji, using four cross-sectional surveys	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE COLONIZATION; CONJUGATE VACCINE; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; YOUNG-CHILDREN; STAPHYLOCOCCUS-AUREUS; SEROTYPE DISTRIBUTION; BACTERIAL CARRIAGE; VIRAL COINFECTION; DISEASE	This study describes predictors of pneumococcal nasopharyngeal carriage and density in Fiji. We used data from four annual (2012-2015) cross-sectional surveys, pre- and post-introduction of ten-valent pneumococcal conjugate vaccine (PCV10) in October 2012. Infants (5-8 weeks), toddlers (12-23 months), children (2-6 years), and their caregivers participated. Pneumococci were detected and quantified using lytA qPCR, with molecular serotyping by microarray. Logistic and quantile regression were used to determine predictors of pneumococcal carriage and density, respectively. There were 8,109 participants. Pneumococcal carriage was negatively associated with years post-PCV10 introduction (global P<0.001), and positively associated with indigenous iTaukei ethnicity (aOR 2.74 [95% CI 2.17-3.45] P<0.001); young age (infant, toddler, and child compared with caregiver participant groups) (global P<0.001); urban residence (aOR 1.45 [95% CI 1.30-2.57] P<0.001); living with >= 2 children < 5 years of age (aOR 1.42 [95% CI 1.27-1.59] P<0.001); low family income (aOR 1.44 [95% CI 1.28-1.62] P<0.001); and upper respiratory tract infection (URTI) symptoms (aOR 1.77 [95% CI 1.57-2.01] P<0.001). Predictors were similar for PCV10 and non-PCV10 carriage, except PCV10 carriage was negatively associated with PCV10 vaccination (0.58 [95% CI 0.41-0.82] P = 0.002) and positively associated with exposure to household cigarette smoke (aOR 1.21 [95% CI 1.02-1.43] P = 0.031), while there was no association between years post-PCV10 introduction and non-PCV10 carriage. Pneumococcal density was positively associated with URTI symptoms (adjusted median difference 0.28 [95% CI 0.16, 0.40] P<0.001) and toddler and child, compared with caregiver, participant groups (global P = 0.008). Predictors were similar for PCV10 and non-PCV10 density, except infant, toddler, and child participant groups were not associated with PCV10 density. PCV10 introduction was associated with reduced the odds of overall and PCV10 pneumococcal carriage in Fiji. However, after adjustment iTaukei ethnicity was positively associated with pneumococcal carriage compared with Fijians of Indian Descent, despite similar PCV10 coverage rates.	[Neal, Eleanor F. G.; Nguyen, Cattram D.; Dunne, Eileen M.; Ortika, Belinda D.; Boelsen, Laura K.; Reyburnl, Rita C.; Satzke, Catherine; Mulholland, Kim; Russell, Fiona M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Infect & Immun, Parkville, Vic, Australia; [Neal, Eleanor F. G.; Nguyen, Cattram D.; Dunne, Eileen M.; Satzke, Catherine; Mulholland, Kim; Russell, Fiona M.] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Ratu, Felista T.; Kama, Mike; Tikoduadua, Lisi; Devi, Rachel; Tuivaga, Evelyn; Rafai, Eric] Minist Hlth & Med Serv, Suva, Fiji; [Kado, Joseph] Univ Western Australia, Telethon Kids Inst, Crawley, WA, Australia; [Kado, Joseph] Fiji Natl Univ, Coll Med Nursing & Hlth Sci, Suva, Fiji; [Mulholland, Kim] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Telethon Kids Institute; University of Western Australia; Fiji National University (FNU); University of London; London School of Hygiene & Tropical Medicine	Neal, EFG (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Infect & Immun, Parkville, Vic, Australia.; Neal, EFG (corresponding author), Univ Melbourne, Dept Paediat, Parkville, Vic, Australia.	eleanor.neal@rch.org.au	Kado, Joseph Hiroshi Hisanasuke/CAA-1530-2022; Boelsen, Laura Kate/ABA-7442-2021; Neal, Eleanor/AAT-8411-2020; Kado, Joseph Hiroshi Hisanasuke/CAE-9501-2022	Kado, Joseph Hiroshi Hisanasuke/0000-0003-3121-4397; Boelsen, Laura Kate/0000-0002-2480-0753; Neal, Eleanor/0000-0001-7998-0942; Kado, Joseph Hiroshi Hisanasuke/0000-0003-3121-4397; Nguyen, Cattram/0000-0002-0599-8645	Bill & Melinda Gates Foundation [OPP1126272, OPP1084341]; Department of Foreign Affairs and Trade of the Australian Government; Fiji Health Sector Support Program; Victorian Government's Operational Infrastructure Support Program; NHMRC Early Career Fellowship; TRIP Fellowship; NHMRC Career Development Fellowship [1087957]; veski Inspiring Women Fellowship; Australian Government Research Training Scholarship	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Department of Foreign Affairs and Trade of the Australian Government(Australian Government); Fiji Health Sector Support Program; Victorian Government's Operational Infrastructure Support Program; NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); TRIP Fellowship; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); veski Inspiring Women Fellowship; Australian Government Research Training Scholarship(Australian Government)	This project was funded by the Bill & Melinda Gates Foundation (grant numbers OPP1126272 and OPP1084341), and the Department of Foreign Affairs and Trade of the Australian Government, the Fiji Health Sector Support Program (implemented by Abt JTA on behalf of the Australian Government), with support from the Victorian Government's Operational Infrastructure Support Program (https://www2.health.vic.gov.au/about/clinical-trials-and-research/operational-infrastructure-support).FMR was supported by a NHMRC Early Career and TRIP Fellowships (https://www.nhmrc.gov.au/).CS was supported by a NHMRC Career Development Fellowship (1087957) and a veski Inspiring Women Fellowship (https://www.veski.org.au/).EFGN holds an Australian Government Research Training Scholarship (https://www.education.gov.au/research-training-program).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030787; Adetifa IMO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030548; Baggett HC, 2017, CLIN INFECT DIS, V64, pS317, DOI 10.1093/cid/cix100; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Brandileone MCD, 2016, VACCINE, V34, P5604, DOI 10.1016/j.vaccine.2016.09.027; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Chan KCC, 2016, VACCINE, V34, P3867, DOI 10.1016/j.vaccine.2016.05.047; Christiansen TB, 2010, EPIDATA COMPREHENSIV; Davis SM, 2013, VACCINE, V32, P133, DOI 10.1016/j.vaccine.2013.05.005; Dunne EM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224392; Dunne EM, 2018, LANCET GLOB HEALTH, V6, pE1375, DOI 10.1016/S2214-109X(18)30383-8; Dunne EM, 2012, J CLIN MICROBIOL, V50, P1034, DOI 10.1128/JCM.06589-11; Fadlyana E, 2018, PNEUMONIA, V10, DOI 10.1186/s41479-018-0058-1; Fan RR, 2016, EMERG INFECT DIS, V22, P1996, DOI 10.3201/eid2211.160902; Farida H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087431; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Gebre T, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4040027; German EL, 2019, VACCINE, V37, P3953, DOI 10.1016/j.vaccine.2019.05.080; Government of Fiji FIBoS, 2017, 2017 POP HOUS CENS; Grant LR, 2016, PEDIATR INFECT DIS J, V35, P907, DOI 10.1097/INF.0000000000001207; Greenberg D, 2006, CLIN INFECT DIS, V42, P897, DOI 10.1086/500935; Hadinegoro SR, 2016, SE ASIAN J TROP MED, V47, P485; Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4; Heinsbroek E, 2018, VACCINE, V36, P7369, DOI 10.1016/j.vaccine.2018.10.021; Howard LM, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx161; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Lee GM, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0001; Lewnard JA, 2016, J INFECT DIS, V213, P1596, DOI 10.1093/infdis/jiv761; Ministry of Health and Medical Services, 2014, ALCHOHOL KAVA; Ministry of Health and Medical Services PoF, 2016, 762016 POF MIN HLTH; Ministry of Health PoF, 2013, MIN HLTH ANN REP 201; Moore MR, 2004, J INFECT DIS, V190, P2031, DOI 10.1086/425422; Narsey W, 2010, PRELIMINARY REPORT P; Navne JE, 2016, EPIDEMIOL INFECT, V144, P3226, DOI 10.1017/S0950268816001461; Neal EFG, 2020, VACCINE, V38, P202, DOI 10.1016/j.vaccine.2019.10.030; Neves FPG, 2017, VACCINE, V35, P2794, DOI 10.1016/j.vaccine.2017.04.019; Reisman J, 2014, J PEDIATR INFECT DIS, V3, P104, DOI 10.1093/jpids/pit069; Roca A, 2012, CLIN INFECT DIS, V55, P816, DOI 10.1093/cid/cis554; Rodrigues F, 2013, PEDIATR INFECT DIS J, V32, P227, DOI 10.1097/INF.0b013e31827687fc; Russell FM, 2006, ANN TROP PAEDIATR, V26, P187, DOI 10.1179/146532806X120273; Russell FM, 2010, PEDIATR INFECT DIS J, V29, P870, DOI 10.1097/INF.0b013e3181ec7ae2; Salter SJ, 2012, MICROBIOL-SGM, V158, P1560, DOI 10.1099/mic.0.056580-0; Satzke C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001903; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Savulescu C, 2017, LANCET RESP MED, V5, P648, DOI [10.1016/S2213-2600(17)30110-8, 10.1016/s2213-2600(17)30110-8]; Schaumburg F, 2013, T ROY SOC TROP MED H, V107, P105, DOI 10.1093/trstmh/trs018; Soewignjo S, 2001, CLIN INFECT DIS, V32, P1039, DOI 10.1086/319605; StataCorp, 2017, STATA STAT SOFTWARE; Tigoi CC, 2012, CLIN INFECT DIS, V55, P180, DOI 10.1093/cid/cis371; Usuf E, 2019, CLIN INFECT DIS, V68, P1512, DOI 10.1093/cid/ciy726; Valles X, 2006, TROP MED INT HEALTH, V11, P358, DOI 10.1111/j.1365-3156.2006.01565.x; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; WHO Publication, 2012, VACCINE, V30, P4717, DOI 10.1016/j.vaccine.2012.04.093; Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326; Wroe PC, 2012, PEDIATR INFECT DIS J, V31, P249, DOI 10.1097/INF.0b013e31824214ac	61	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0231041	10.1371/journal.pone.0231041	http://dx.doi.org/10.1371/journal.pone.0231041			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236150	gold, Green Published			2022-12-26	WOS:000535938700045
J	Park, HJ; Kim, JT; Chung, JE; Yang, JA; Bae, HJ; Sung, YW; Park, JE; Kim, SH; Cho, JY; Jung, KM; Bae, HK				Park, Hyo Jung; Kim, Jung Tae; Chung, Jee Eun; Yang, Jin A.; Bae, Hye Jung; Sung, Ye Won; Park, Ji Eun; Kim, Sun Hwa; Cho, Ji Yoon; Jung, Kyung Mi; Bae, Hee Kyung			Practice of parenteral nutrition in hospitalized adult patients in Korea: A retrospective multicenter cross-sectional study	PLOS ONE			English	Article							MALNUTRITION; STAY	There have been no studies on the characteristics of parenteral nutrition (PN) supply for adult inpatients in South Korea. The aim of this retrospective multicenter cross sectional study was to investigate the current practice and characteristics of PN support in hospitalized adult patients in South Korea for the first time. This study was conducted retrospectively for the adult patients who were hospitalized and received PN in nine hospitals on August 1st, 2017 to October 30th, 2017. We evaluated the type of PN formulation, PN administration period, administration route, calories supplied, amount of protein supplied, and laboratory results. Among the 11,580 inpatient admissions on that day, 1,439 patients received PN (12.4%). The majority of enrolled patients (96.5%) used the commercial PN, of which 86.2% were multi-chamber. 71.2% of them received PN peripherally. The average in hospital PN duration was 17.8 +/- 52.6 days. Patients received only 65.4 +/- 25.4% calories of their target calories. The in-hospital mortality of enrolled patients was 22%. In South Korea, commercial PN was usually administered to hospitalized adult patients and in-hospital mortality in adult patients using PN was higher in South Korea compared to other countries. This study provides the characteristics and the PN support status of hospitalized adult patients receiving PN in South Korea.	[Park, Hyo Jung] Samsung Med Ctr, Dept Pharmaceut Serv, Seoul, South Korea; [Kim, Jung Tae; Bae, Hee Kyung] Kyung Hee Univ Hosp Kangdong, Dept Pharm, Seoul, South Korea; [Chung, Jee Eun] Hanyang Univ, Coll Pharm, Ansan, Gyeonggi Do, South Korea; [Yang, Jin A.] Asan Med Ctr, Dept Pharm, Seoul, South Korea; [Bae, Hye Jung] Seoul Natl Univ Hosp, Dept Pharm, Seoul, South Korea; [Sung, Ye Won] Chungnam Natl Univ Hosp, Dept Pharm, Daejeon, South Korea; [Park, Ji Eun] Severance Hosp, Dept Pharm, Seoul, South Korea; [Kim, Sun Hwa] Chung Ang Univ Hosp, Dept Pharm, Seoul, South Korea; [Cho, Ji Yoon] Daegu Fatima Hosp, Dept Pharm, Daegu, South Korea; [Jung, Kyung Mi] Ulsan Univ Hosp, Dept Pharm, Ulsan, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Kyung Hee University; Hanyang University; University of Ulsan; Asan Medical Center; Seoul National University (SNU); Seoul National University Hospital; Chungnam National University; Chungnam National University Hospital; Yonsei University; Yonsei University Health System; Chung Ang University; Chung Ang University Hospital; Daegu Fatima Hospital; University of Ulsan; Ulsan University Hospital	Park, HJ (corresponding author), Samsung Med Ctr, Dept Pharmaceut Serv, Seoul, South Korea.	hyoj.park@samsung.com	Kim, Sun/GSN-4867-2022	Park, Hyo Jung/0000-0002-3875-0224; Kim, Jung Tae/0000-0003-0661-4735	Korean Society of Parenteral and Enteral Nutrition (KSPEN)	Korean Society of Parenteral and Enteral Nutrition (KSPEN)	Scientific grant support for this report is provided by Korean Society of Parenteral and Enteral Nutrition (KSPEN, www.kspen.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal E, 2013, CLIN NUTR, V32, P737, DOI 10.1016/j.clnu.2012.11.021; Arends J, 2017, CLIN NUTR, V36, P1187, DOI 10.1016/j.clnu.2017.06.017; Duncan A, 2012, AM J CLIN NUTR, V95, P64, DOI 10.3945/ajcn.111.023812; Dyson JK, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012663; Kang MC, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e10; Kim So Young, 2015, Asian Pac J Cancer Prev, V16, P1295; Lee JS, 2018, NUTR CLIN PRACT, V33, P633, DOI 10.1002/ncp.10093; Lim B, 2013, INTEGR MED RES, V2, P81, DOI 10.1016/j.imr.2013.06.004; Lim SL, 2012, CLIN NUTR, V31, P345, DOI 10.1016/j.clnu.2011.11.001; McClave SA, 2016, JPEN-PARENTER ENTER, V40, P159, DOI [10.1097/CCM.0000000000001525, 10.1177/0148607115621863]; Mogensen KM, 2019, NUTR CLIN PRACT; Petroff Barbara, 2016, Am J Health Syst Pharm, V73, P922, DOI 10.2146/ajhp151013; Petroff Barbara J, 2014, Am J Health Syst Pharm, V71, P325, DOI 10.2146/sp140004; Plauth M, 2019, CLIN NUTR, V38, P485, DOI 10.1016/j.clnu.2018.12.022; Ponta ML, 2018, CLIN NUTR ESPEN, V25, P87, DOI 10.1016/j.clnesp.2018.01.072; Saleh WA, 2018, CLIN NUTR, V37, P1976, DOI 10.1016/j.clnu.2017.09.001; Singer P, 2019, CLIN NUTR, V38, P48, DOI 10.1016/j.clnu.2018.08.037; Tuuminen T, 2019, CLIN NUTR ESPEN, V33, P283, DOI 10.1016/j.clnesp.2019.06.011; Volkert D, 2019, CLIN NUTR, V38, P10, DOI 10.1016/j.clnu.2018.05.024; Weimann A, 2017, CLIN NUTR, V36, P623, DOI 10.1016/j.clnu.2017.02.013; Wie GA, 2010, NUTRITION, V26, P263, DOI 10.1016/j.nut.2009.04.013; Wischmeyer PE, 2013, JPEN-PARENTER ENTER, V37, P56, DOI 10.1177/0148607112444448	22	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230922	10.1371/journal.pone.0230922	http://dx.doi.org/10.1371/journal.pone.0230922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236124	Green Published, gold			2022-12-26	WOS:000535938700041
J	Basu, A; Dvorina, N; Baldwin, WM; Mazumder, B				Basu, Abhijit; Dvorina, Nina; Baldwin, William M., III; Mazumder, Barsanjit			High-fat diet-induced GAIT element-mediated translational silencing of mRNAs encoding inflammatory proteins in macrophage protects against atherosclerosis	FASEB JOURNAL			English	Article						atherosclerosis; GAIT; inflammation; L13a; translational control	LOW-DENSITY-LIPOPROTEIN; GAMMA-INTERFERON; PROMOTES ATHEROSCLEROSIS; STRUCTURAL ALIGNMENT; INITIATION-FACTOR; L13A; POLARIZATION; TRANSCRIPT; CELLS; PROLIFERATION	Previously, we identified a mechanism of inflammation control directed by ribosomal protein L13a and "GAIT" (Gamma Activated Inhibitor of Translation) elements in target mRNAs and showed that its elimination in myeloid cell-specific L13a knockout mice (L13a KO) increased atherosclerosis susceptibility and severity. Here, we investigated the mechanistic basis of this endogenous defense against atherosclerosis. We compared molecular and cellular aspects of atherosclerosis in high-fat diet (HFD)-fed L13a KO and intact (control) mice. HFD treatment of control mice induced release of L13a from 60S ribosome, formation of RNA-binding complex, and subsequent GAIT element-mediated translational silencing. Atherosclerotic plaques from HFD-treated KO mice showed increased infiltration of M1 type inflammatory macrophages. Macrophages from KO mice showed increased phagocytic activity and elevated expression of LDL receptor and pro-inflammatory mediators. NanoString analysis of the plaques from KO mice showed upregulation of a number of mRNAs encoding inflammatory proteins. Bioinformatics analysis suggests the presence of the potential GAIT elements in the 3 ' UTRs of several of these mRNAs. Macrophage induces L13a/GAIT-dependent translational silencing of inflammatory genes in response to HFD as an endogenous defense against atherosclerosis in ApoE(-/-) model.	[Basu, Abhijit; Mazumder, Barsanjit] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Dept Biol Geol & Environm Sci, 2399 Euclid Ave,SR 261, Cleveland, OH 44115 USA; [Dvorina, Nina; Baldwin, William M., III] Cleveland Clin, Lerner Coll Med, Dept Inflammat & Immun, Cleveland, OH 44106 USA	University System of Ohio; Cleveland State University; Case Western Reserve University; Cleveland Clinic Foundation	Mazumder, B (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Dept Biol Geol & Environm Sci, 2399 Euclid Ave,SR 261, Cleveland, OH 44115 USA.	b.mazumder@csuohio.edu			National Heart, Lung, and Blood Institute (NHLBI) [HL79164]; National Institute of Allergy and Infectious Diseases (NIAID) [AI087586]; Cleveland State University, Center for Gene Regulation in Health and Disease	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cleveland State University, Center for Gene Regulation in Health and Disease	National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL79164; National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: AI087586; Cleveland State University, Center for Gene Regulation in Health and Disease	Aiello RJ, 1999, ARTERIOSCL THROM VAS, V19, P1518, DOI 10.1161/01.ATV.19.6.1518; Averill MM, 2012, ARTERIOSCL THROM VAS, V32, P223, DOI 10.1161/ATVBAHA.111.236927; Basu A, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx979; Basu A, 2014, ARTERIOSCL THROM VAS, V34, P533, DOI 10.1161/ATVBAHA.113.302573; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Doring Y, 2019, CIRCULATION, V139, P1338, DOI 10.1161/CIRCULATIONAHA.118.037953; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; ELLSWORTH JL, 1987, J BIOL CHEM, V262, P2316; Fava C, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00055; Gensel JC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40144; Goel Reema, 2008, Arterioscler Thromb Vasc Biol, V28, P1996, DOI 10.1161/ATVBAHA.108.172270; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Golledge J, 2013, ARTERIOSCL THROM VAS, V33, P670, DOI 10.1161/ATVBAHA.112.301004; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Havgaard JH, 2007, PLOS COMPUT BIOL, V3, P1896, DOI 10.1371/journal.pcbi.0030193; Havgaard JH, 2005, BIOINFORMATICS, V21, P1815, DOI 10.1093/bioinformatics/bti279; Ionita MG, 2010, ARTERIOSCL THROM VAS, V30, P1842, DOI 10.1161/ATVBAHA.110.209296; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kapasi P, 2007, MOL CELL, V25, P113, DOI 10.1016/j.molcel.2006.11.028; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Khyzha N, 2017, TRENDS MOL MED, V23, P332, DOI 10.1016/j.molmed.2017.02.004; KOO C, 1988, J CLIN INVEST, V81, P1332, DOI 10.1172/JCI113460; KOO C, 1986, J BIOL CHEM, V261, P1194; Kruth HS, 2002, J BIOL CHEM, V277, P34573, DOI 10.1074/jbc.M205059200; Leclercq A, 2007, J LEUKOCYTE BIOL, V82, P1420, DOI 10.1189/jlb.1106671; Leitinger N, 2013, ARTERIOSCL THROM VAS, V33, P1120, DOI 10.1161/ATVBAHA.112.300173; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lin J, 2013, CELL REP, V3, P200, DOI 10.1016/j.celrep.2012.12.012; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Mazumder B, 1999, MOL CELL BIOL, V19, P6898; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Mazumder B, 2001, MOL CELL BIOL, V21, P6440, DOI 10.1128/MCB.21.19.6440-6449.2001; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Moos MPW, 2005, ARTERIOSCL THROM VAS, V25, P2386, DOI 10.1161/01.ATV.0000187470.31662.fe; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nachtigal P, 2012, ATHEROSCLEROSIS, V224, P4, DOI 10.1016/j.atherosclerosis.2012.03.001; Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20; Nawaz A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00231-1; Oberoi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137924; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Poddar D, 2016, CELL MOL IMMUNOL, V13, P816, DOI 10.1038/cmi.2015.53; Poddar D, 2013, J IMMUNOL, V190, P3600, DOI 10.4049/jimmunol.1201933; Radhakrishnan A, 2016, J MOL BIOL, V428, P3558, DOI 10.1016/j.jmb.2016.05.025; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ramel D, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01276; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Robinet P, 2018, ARTERIOSCL THROM VAS, V38, P292, DOI 10.1161/ATVBAHA.117.309524; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; Schrijvers DM, 2007, CARDIOVASC RES, V73, P470, DOI 10.1016/j.cardiores.2006.09.005; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shi JY, 2018, METHODS MOL BIOL, V1784, P263, DOI 10.1007/978-1-4939-7837-3_24; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Surra JC, 2010, J ATHEROSCLER THROMB, V17, P712; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Torarinsson E, 2007, BIOINFORMATICS, V23, P926, DOI 10.1093/bioinformatics/btm049; Vyas K, 2009, MOL CELL BIOL, V29, P458, DOI 10.1128/MCB.00824-08; Wu MD, 2017, BLOOD, V129, P1415, DOI 10.1182/blood-2016-07-692673; Wu Q, ELIFE, V8, P45396; Ye Q, 2014, INFLAMMATION, V37, P555, DOI 10.1007/s10753-013-9769-x; Ye Q, 2009, INFLAMM RES, V58, P809, DOI 10.1007/s00011-009-0052-4; Yurdagul A, 2018, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00086; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391	76	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6888	6906		10.1096/fj.201903119R	http://dx.doi.org/10.1096/fj.201903119R		MAR 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32232901	Bronze, Green Accepted			2022-12-26	WOS:000522487000001
J	Papazian, T; El Osta, N; Hout, H; El Chammas, D; El Helou, N; Younes, H; Tayeh, GA; Khabbaz, LR				Papazian, Tatiana; El Osta, Nada; Hout, Hala; El Chammas, Daisy; El Helou, Nour; Younes, Hassan; Tayeh, Georges Abi; Khabbaz, Lydia Rabbaa			Pregnancy physical activity questionnaire (PPAQ): Translation and cross cultural adaption of an Arabic version	PLOS ONE			English	Article							EXERCISE; RELIABILITY; ADAPTATION; GUIDELINES; VALIDITY; WOMEN	Introduction Physical activity level during pregnancy is unknown in Middle Eastern and North African countries, since no valid tools assessing it exist in Arabic. The aim of this study is to culturally adapt and translate to Arabic an internationally validated instrument, the Pregnancy Physical Activity Questionnaire (PPAQ), and to measure the physical activity of pregnant women using the adapted PPAQ, Arabic version. This tool is time-sparing, self-administered and is the only one taking into account childcare and household chores. Methods After following the guidelines for translation and back-translation by certified translators, a committee composed of professionals in the field reviewed each item of the PPAQ, for its comprehensibility. This Arabic version of the PPAQ was tested on a sample of 179 pregnant Lebanese women, from different educational backgrounds, socioeconomic status and gestational ages. Results Cross-cultural adaptations were applied on the newly translated PPAQ in Arabic version, thus questions referring to some types of outdoor activities were excluded from the final format. Our results reported that 51% and 1.7% of women engage respectively in light and high intensity physical activity, while 18% had a sedentary lifestyle. Occupational type of activities were significantly more performed by women having a higher education (p value 0.001), as opposed to those who attended only high school, who were physically more active in household activities (p value 0.038). Second trimester was a period where pregnant women were active for household, caregiving (p value 0.031), whereas women in their third trimester were physically more active in occupational activities (p value 0.001). Sport-oriented activities were performed by women reporting a good physical status (p value 0.03). Age and crowding index were significantly correlated with occupational, household and caregiving activities (p values 0.004, 0.008 respectively). No significant correlations were observed with pre-gestational body mass index and the physical activity levels. Conclusion A valid tool will help researchers in Arab countries identify physical activity levels of pregnant women and consequently emit specific guidelines relative to the importance and the benefits of a daily active lifestyle throughout gestation.	[Papazian, Tatiana; Khabbaz, Lydia Rabbaa] St Joseph Univ Beirut, Fac Pharm, Lab Pharmacol Pharm Clin & Controle Qualite Medic, Beirut, Lebanon; [Papazian, Tatiana; Hout, Hala; El Chammas, Daisy; El Helou, Nour; Younes, Hassan] St Joseph Univ Beirut, Fac Pharm, Dept Nutr, Beirut, Lebanon; [El Osta, Nada] St Joseph Univ Beirut, Fac Dent Med, Dept Prosthodont, Beirut, Lebanon; [El Osta, Nada] St Joseph Univ Beirut, Unite Sante Orale, Lab Rech Craniofaciale, Fac Dent Med, Beirut, Lebanon; [El Osta, Nada] Clermont Univ, Univ Auvergne, Ctr Rech Odontol Clin, EA 4847, Clermont Ferrand, France; [Younes, Hassan] Inst Polytech LaSalle Beauvais, Dept Nutr & Hlth Sci, Beauvais, France; [Tayeh, Georges Abi] Hotel Dieu France Hosp, Dept Gynecol & Obstet, Beirut, Lebanon	Universite Clermont Auvergne (UCA); UniLaSalle	Khabbaz, LR (corresponding author), St Joseph Univ Beirut, Fac Pharm, Lab Pharmacol Pharm Clin & Controle Qualite Medic, Beirut, Lebanon.	lydia.khabbaz@usj.edu.lb	Helou, Nour El/AAH-6490-2021; Papazian, Tatiana/AAH-4745-2021; EL OSTA, Nada/GRS-4789-2022	Helou, Nour El/0000-0002-6012-0042; abi tayeh, Georges/0000-0002-2799-0222; Papazian, Tatiana/0000-0002-4355-3006				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, P1327, DOI 10.1097/00005768-200007000-00022; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Biernat E, 2018, INT J ENV RES PUBLIC, V15; Chandonnet N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038818; Chasan-Taber L, 2004, MED SCI SPORT EXER, V36, P1750, DOI 10.1249/01.MSS.0000142303.49306.0D; Chu AHY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136944; Cirak Y, 2015, J PHYS THER SCI, V27, P3703, DOI 10.1589/jpts.27.3703; Comm Obstet Practice, 2015, OBSTET GYNECOL, V126, pe135, DOI 10.1097/AOG.0000000000001214; de Oliveira CS, 2017, REV BRAS GINECOL OBS, V39, P424, DOI 10.1055/s-0037-1604180; Dempsey JC, 2004, AM J EPIDEMIOL, V159, P663, DOI 10.1093/aje/kwh091; Donnelly TT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199336; Duncombe D, 2009, MIDWIFERY, V25, P430, DOI 10.1016/j.midw.2007.03.002; Evenson KR, 2004, PAEDIATR PERINAT EP, V18, P400, DOI 10.1111/j.1365-3016.2004.00595.x; Fell DB, 2009, MATERN CHILD HLTH J, V13, P597, DOI 10.1007/s10995-008-0404-7; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Forczek W, 2017, OBSTET GYNECOL SURV, V72, P425, DOI 10.1097/OGX.0000000000000458; GALOBARDES B., 2004, J EPIDEMIOLOGY COMMU, V60, P7, DOI DOI 10.1136/J; Gjestland K, 2013, BRIT J SPORT MED, V47, P515, DOI 10.1136/bjsports-2012-091344; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hayman M, 2016, J SCI MED SPORT, V19, P664, DOI 10.1016/j.jsams.2015.09.004; Ko YL, 2016, EUR J SPORT SCI, V16, P374, DOI 10.1080/17461391.2015.1028468; Maslin Kate, 2016, Nurs Womens Health, V20, P447, DOI 10.1016/j.nwh.2016.08.009; Matsuzaki M, 2010, BIOSCI TRENDS, V4, P170; Mourady D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178181; Muktabhant B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007145.pub3; Nascimento SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128953; Owe KM, 2009, SCAND J MED SCI SPOR, V19, P637, DOI 10.1111/j.1600-0838.2008.00840.x; Perales M, 2017, JAMA-J AM MED ASSOC, V317, P1113, DOI 10.1001/jama.2017.0593; Rasmussen K.M., 2009, WEIGHT GAIN PREGNANC; Santos PC, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.22455; Sattler MC, 2018, SPORTS MED, V48, P2317, DOI 10.1007/s40279-018-0961-x; Schilling R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203525; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Silva F T, 2015, Ceska Gynekol, V80, P290; Tabachnik BG., USING MULTIVARIATE S, V4th; Xiang M, 2016, MATERN CHILD HLTH J, V20, P1940, DOI 10.1007/s10995-016-2008-y	36	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230420	10.1371/journal.pone.0230420	http://dx.doi.org/10.1371/journal.pone.0230420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HE	32226052	Green Published, gold			2022-12-26	WOS:000535936400007
J	Onusko, E; McDermott, MR; Robbins, N; Liu, GS; Kranias, EG; Rubinstein, J; Koch, SE				Onusko, Evan; McDermott, Michael R.; Robbins, Nathan; Liu, Guansheng; Kranias, Evangelia G.; Rubinstein, Jack; Koch, Sheryl E.			Probenecid treatment improves outcomes in a novel mouse model of peripartum cardiomyopathy	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; POSITIVE INOTROPE; HSP20; PREGNANCY; TRPV2; HYPERTROPHY; MORTALITY; CHANNELS; STRESS	Probenecid has been used for decades in the treatment of gout but recently has also been found to improve outcomes in patients with heart failure via stimulation of the transient receptor potential vanilloid 2 (TRPV2) channel in cardiomyocytes. This study tested the use of probenecid on a novel mouse model of peripartum cardiomyopathy (PPCM) as a potential treatment option. A human mutation of the human heat shock protein 20 (Hsp20-S10F) in mice has been recently shown to result in cardiomyopathy, when exposed to pregnancies. Treatment with either probenecid or control sucrose water was initiated after the first pregnancy in both wild type and Hsp20-S10F mice. Serial echocardiography was performed during subsequent pregnancies and hearts were collected after the third pregnancies for staining and molecular analysis. Hsp20-S10F mice treated with probenecid had decreased mortality, hypertrophy, TRPV2 expression and molecular parameters of heart failure. Probenecid treatment also decreased apoptosis as evidenced by an increase in the level of Bcl2/Bax. Probenecid improved survival in a novel mouse model of PPCM and may be an appropriate therapy for humans with PPCM as it has a proven safety and tolerability in patients with heart failure.	[Onusko, Evan; McDermott, Michael R.; Robbins, Nathan; Rubinstein, Jack; Koch, Sheryl E.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45221 USA; [Liu, Guansheng; Kranias, Evangelia G.] Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, Cincinnati, OH USA; [Onusko, Evan] Univ Cincinnati, Coll Med, Med Sch, Cincinnati, OH USA; [McDermott, Michael R.; Robbins, Nathan] Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Liu, Guansheng] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio University; University System of Ohio; University of Cincinnati	Koch, SE (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45221 USA.	sheryl.koch@uc.edu	McDermott, Michael Francis/GZM-5330-2022	Robbins, Nathan/0000-0002-9275-0778	National Institute of Environmental Health Sciences [ES-24744]	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the National Institute of Environmental Health Sciences Grant ES-24744 (To J. Rubinstein). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. www.niehs.nih.gov.	Arany Z, 2018, ANNU REV MED, V69, P165, DOI 10.1146/annurev-med-041316-090545; Bauersachs J, 2019, EUR J HEART FAIL, V21, P827, DOI 10.1002/ejhf.1493; Bouabdallaoui N, 2017, EUR HEART J-ACUTE CA, V6, P359, DOI 10.1177/2048872615612465; Brar SS, 2007, AM J CARDIOL, V100, P302, DOI 10.1016/j.amjcard.2007.02.092; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chung E, 2014, CARDIOVASC RES, V101, P561, DOI 10.1093/cvr/cvu013; Davis MB, 2020, J AM COLL CARDIOL, V75, P207, DOI 10.1016/j.jacc.2019.11.014; Dragun M, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55070380; Eghbali M, 2005, CIRC RES, V96, P1208, DOI 10.1161/01.RES.0000170652.71414.16; Elkayam U, 2005, CIRCULATION, V111, P2050, DOI 10.1161/01.CIR.0000162478.36652.7E; Estensen ME, 2013, ULTRASOUND OBST GYN, V41, P659, DOI 10.1002/uog.12296; Fan GC, 2005, TRENDS CARDIOVAS MED, V15, P138, DOI 10.1016/j.tcm.2005.05.004; Fan GC, 2005, CIRCULATION, V111, P1792, DOI 10.1161/01.CIR.0000160851.41872.C6; Fan GC, 2004, CIRC RES, V94, P1474, DOI 10.1161/01.RES.0000129179.66631.00; Fan GC, 2008, CIRC RES, V103, P1270, DOI 10.1161/CIRCRESAHA.108.182832; Fan GC, 2006, CIRC RES, V99, P1233, DOI 10.1161/01.RES.0000251074.19348.af; Fett JD, 2015, TRENDS CARDIOVAS MED, V25, P401, DOI 10.1016/j.tcm.2014.10.019; Fett JD, 2009, INT J GYNECOL OBSTET, V104, P125, DOI 10.1016/j.ijgo.2008.09.017; Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, DOI 10.17226/12910; Halkein J, 2013, J CLIN INVEST, V123, P2143, DOI 10.1172/JCI64365; Hayakawa Y, 2003, CIRCULATION, V108, P3036, DOI 10.1161/01.CIR.0000101920.72665.58; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; Hilfiker-Kleiner D, 2015, EUR HEART J, V36, P1090, DOI 10.1093/eurheartj/ehv009; Iwata Y, 2013, CARDIOVASC RES, V99, P760, DOI 10.1093/cvr/cvt163; Jones S, 2017, AGING CLIN EXP RES, V29, P863, DOI 10.1007/s40520-016-0663-x; Karaye KM, 2013, INT J CARDIOL, V164, P33, DOI 10.1016/j.ijcard.2011.11.069; Katanosaka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4932; Kim SC, 2018, J AM COLL CARDIOL, V71, P994, DOI 10.1016/j.jacc.2017.12.052; Koch SE, 2017, J HYPERTENS, V35, P602, DOI 10.1097/HJH.0000000000001213; Koch SE, 2013, J CARDIOVASC PHARM T, V18, P280, DOI 10.1177/1074248412469299; Koch SE, 2012, J MOL CELL CARDIOL, V53, P134, DOI 10.1016/j.yjmcc.2012.04.011; Konstam MA, 2011, JACC-CARDIOVASC IMAG, V4, P98, DOI 10.1016/j.jcmg.2010.10.008; Liu GS, 2018, J CELL MOL MED, V22, P3911, DOI 10.1111/jcmm.13665; Liu GS, 2018, AUTOPHAGY, V14, P80, DOI 10.1080/15548627.2017.1392420; McNamara DM, 2015, J AM COLL CARDIOL, V66, P905, DOI 10.1016/j.jacc.2015.06.1309; Morine KJ, 2016, CARDIOVASC PATHOL, V25, P478, DOI 10.1016/j.carpath.2016.08.004; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nicolaou P, 2008, J BIOL CHEM, V283, P33465, DOI 10.1074/jbc.M802307200; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; Poon IKH, 2014, NATURE, V507, P329, DOI 10.1038/nature13147; Qian J, 2011, CIRC RES, V108, P1429, DOI 10.1161/CIRCRESAHA.110.237644; Qian J, 2009, CIRC RES, V105, P1223, DOI 10.1161/CIRCRESAHA.109.200378; Robbins N, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007148; Robbins N, 2012, CARDIOVASC TOXICOL, V12, P1, DOI 10.1007/s12012-011-9145-8; SELEN A, 1982, J PHARM SCI, V71, P1238, DOI 10.1002/jps.2600711114; Sliwa K, 2018, EUR J HEART FAIL, V20, P951, DOI 10.1002/ejhf.1178; Sliwa K, 2010, CIRCULATION, V121, P1465, DOI 10.1161/CIRCULATIONAHA.109.901496; Vessey DA, 2011, MOL CELL BIOCHEM, V351, P77, DOI 10.1007/s11010-011-0713-9; Wong AYH, 2002, AM J PHYSL HEAR CIRC, V282	50	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0230386	10.1371/journal.pone.0230386	http://dx.doi.org/10.1371/journal.pone.0230386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218573	Green Submitted, Green Published, gold			2022-12-26	WOS:000535935400007
J	Iommi, D; Hummel, J; Figl, ML				Iommi, David; Hummel, Johann; Figl, Michael Lutz			Evaluation of 3D ultrasound for image guidance	PLOS ONE			English	Article							GUIDED INTERVENTION; CALIBRATION; ALIGNMENT; FUSION	Purpose In this paper we compared two different 3D ultrasound (US) modes (3D free-hand mode and 3D wobbler mode) to see which is more suitable to perform the 3D-US/3D-US registration for clinical guidance applications. The typical errors with respect to their impact on the final localization error were evaluated step by step. Methods Multi-point target and Hand-eye calibration methods were used for 3D US calibration together with a newly designed multi-cone phantom. Pointer based and image based methods were used for 2D US calibration. The calibration target error was computed by using a different multi-cone phantom. An egg-shaped phantom was used as ground truth to compare distortions for both 3D modes along with the measurements of the volume. Finally, we compared 3D ultrasound images acquired by 3D wobbler mode and 3D free-hand mode with respect to their 3D-US/3D-US registration accuracy using both, phantom and patient data. A theoretical step by step error analysis was performed and compared to empirical data. Results Target registration errors based on the calibration with the 3D Multi-point and 2D pointer/image method have been found to be comparable (*1mm). They both outperformed the 3D Hand-eye method (error > 2mm). Volume measurements with the 3D free-hand mode were closest to the ground truth (around 6% error compared to 9% with the 3D wobbler mode). Additional scans on phantoms showed a 3D-US/3D-US registration error below 1 mm for both, the 3D free-hand mode and the 3D wobbler mode, respectively. Results with patient data showed greater error with the 3D free-hand mode (6.50mm - 13.37mm) than with the 3D wobbler mode (2.99 +/- 1.54 mm). All the measured errors were found to be in accordance to their theoretical upper bounds. Conclusion While both 3D volume methods showed comparable results with respect to 3D-US/3D-US registration for phantom images, for patient data registrations the 3D wobbler mode is superior to the 3D free-hand mode. The effect of all error sources could be estimated by theoretical derivations.	[Iommi, David; Hummel, Johann; Figl, Michael Lutz] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria	Medical University of Vienna	Hummel, J (corresponding author), Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria.	johann.hummel@meduniwien.ac.at			 [764458]		D.I. ITN project 764458 European Commsion https://ec.europa.eu/info/fundingtenders/opportunities/portal/screen/home The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camps SM, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7569590; Comeau RM, 2000, MED PHYS, V27, P787, DOI 10.1118/1.598942; DETMER PR, 1994, ULTRASOUND MED BIOL, V20, P923, DOI 10.1016/0301-5629(94)90052-3; Douglas BR, 2001, RADIOL CLIN N AM, V39, P415, DOI 10.1016/S0033-8389(05)70289-X; Fagerquist Mats, 2017, ULTRASOUND, V156-165, P35; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fenster A, 2001, PHYS MED BIOL, V46, pR67, DOI 10.1088/0031-9155/46/5/201; Fenster Aaron, 2014, C P IEEE ENG MED BIO; Figl M, 2013, INT J COMPUT ASS RAD, V8, P849, DOI 10.1007/s11548-013-0819-5; Fitzpatrick JM, 1998, IEEE T MED IMAGING, V17; Fontanarosa, 2015, PHYS MED BIOL, P60; Gee A, 2003, PATTERN RECOGN LETT, V24, P757, DOI 10.1016/S0167-8655(02)00180-0; Hoffmann R, 2014, PHYS MED BIOL, V59, P5545, DOI 10.1088/0031-9155/59/18/5545; HORAUD R, 1995, INT J ROBOT RES, V14, P195, DOI 10.1177/027836499501400301; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Hummel J, 2006, PHYS MED BIOL, V51, pN205, DOI 10.1088/0031-9155/51/10/N01; Kaar M, 2013, MED PHYS, V40, DOI 10.1118/1.4795129; Kuiran Chen Thomas, 2008, P SPIE INT SOC OPTIC, P6918; Lasso A, 2014, IEEE T BIO-MED ENG, V61, P2527, DOI 10.1109/TBME.2014.2322864; Liang RH, 2008, J ZHEJIANG UNIV-SC A, V9, P1363, DOI 10.1631/jzus.A0820318; Liu Wenbo, 2009, IEEE EMBS; Mercier L, 2005, ULTRASOUND MED BIOL, V31, P449, DOI 10.1016/j.ultrasmedbio.2004.11.015; Mozaffari MH, 2017, ULTRASOUND MED BIOL, V43, P2099, DOI 10.1016/j.ultrasmedbio.2017.06.009; Onogi S, 2015, ADV BIOMED ENG, V4, P27, DOI 10.14326/abe.4.27; PARK FC, 1994, IEEE T ROBOTIC AUTOM, V10, P717, DOI 10.1109/70.326576; Po-Wei Hsu, 2009, ADV IMAGING BIOL MED; Prager RW, 2010, P I MECH ENG H, V224, P193, DOI 10.1243/09544119JEIM586; Schlosser J, 2013, PHYS MED BIOL, V58, P7481, DOI 10.1088/0031-9155/58/21/7481; TSAI RY, 1989, IEEE T ROBOTIC AUTOM, V5, P345, DOI 10.1109/70.34770; Uittenbogaard LB, 2010, ULTRASOUND OBST GYN, V35, P324, DOI 10.1002/uog.7561; Vasconcelos F, 2016, INT J COMPUT ASS RAD, V11, P1091, DOI 10.1007/s11548-016-1392-5; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Wen TX, 2017, ULTRASONIC IMAGING, V39, P240, DOI 10.1177/0161734616689464; Zettinig O, 2015, INT J COMPUT ASS RAD, V10, P1997, DOI 10.1007/s11548-015-1233-y; Zheng XJ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1962181	35	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0229441	10.1371/journal.pone.0229441	http://dx.doi.org/10.1371/journal.pone.0229441			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214326	Green Published, gold			2022-12-26	WOS:000535934200008
J	Sumampow, TCP; Shekelle, M; Beier, P; Walker, FM; Hepp, CM				Sumampow, Thalita Christiani Pingkan; Shekelle, Myron; Beier, Paul; Walker, Faith M.; Hepp, Crystal M.			Identifying genetic relationships among tarsier populations in the islands of Bunaken National Park and mainland Sulawesi	PLOS ONE			English	Article							HABITAT USE; DIANAE; HYBRIDIZATION; BIODIVERSITY; PLEISTOCENE; SPECIATION; DIVERSITY; TARSIIDAE; SOFTWARE; DENSITY	Eastern tarsiers (Tarsius tarsier complex) are small nocturnal primates endemic to Sulawesi Island and small adjacent islands of Indonesia. In 2004, the hybrid biogeography hypothesis predicted this species complex might contain 16 or more taxa, each corresponding to a region of endemism, based on: 1) geological evidence of the development of the archipelago, 2) biological evidence in the form of concordant distributions of monkeys and toads, and 3) the distribution of tarsier acoustic groups. Since then, 11 tarsier species have been recognized, potentially leaving more to be described. Efforts to identify these cryptic species are urgently needed so that habitat conversion, pet trade, and cultural activities will not render some species extinct before they are recognized. We gathered data to test the hypothesis of cryptic tarsier species on three volcanic islands in Bunaken National Park, North Sulawesi, namely Bunaken, Manadotua, and Mantehage, during May-August 2018. We sequenced individuals at 5 nuclear genes (ABCA1, ADORA3, AXIN1, RAG, and TTR) and made comparisons to existing genotypes at 14 mainland sites. Bayesian phylogenetic analyses revealed that island populations are genetically identical in all 5 genes, and formed a clade separated from the mainland ones. The eastern tarsiers first diverged from the western tarsiers approximately 2.5 MYA. The three island populations diverged from mainland tarsiers approximately 2,000-150,000 YA, due to either human activities or natural rafting. This study provides information for tarsier conservation, advances the understanding of biogeography of Sulawesi, and contributes to Indonesian awareness of biodiversity. Further quantitative genetics research on tarsiers, especially the island populations, will offer significant insights to establish more efficient and strategic tarsier conservation actions.	[Sumampow, Thalita Christiani Pingkan; Beier, Paul; Walker, Faith M.] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; [Shekelle, Myron] Western Washington Univ, Bellingham, WA 98225 USA; [Walker, Faith M.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ 86011 USA; [Hepp, Crystal M.] No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA	Northern Arizona University; Western Washington University; Northern Arizona University; Northern Arizona University	Sumampow, TCP (corresponding author), No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA.	tcs277@nau.edu		Shekelle, Myron/0000-0002-5755-3445	USAID; Brad McRae Fellowship; NAU Landscape Conservation Initiative; International Primatological Society; Margot Marsh Biodiversity Foundation	USAID(United States Agency for International Development (USAID)); Brad McRae Fellowship; NAU Landscape Conservation Initiative; International Primatological Society; Margot Marsh Biodiversity Foundation	TS received grants from USAID, Brad McRae Fellowship, NAU Landscape Conservation Initiative, and International Primatological Society. Participation by MS was facilitated by a grant from the Margot Marsh Biodiversity Foundation and a private donation by the Tjiasmanto Family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank USAID, Brad McRae Fellowship, NAU Landscape Conservation Initiative, and International Primatological Society for the financial support. We acknowledge Ministry of Environment and Forestry Republic of Indonesia, Bunaken National Park Agency, North Sulawesi Agency of Natural Resources Conservation (BKSDA), and Risat Sanger, S.IP (UNSRAT Alumni Association) for the administrative assistance. We thank Prof. Dr. Trina E. Tallei and Beivy Kolondam, MS (Sam Ratulangi University) for their assistance for the lab work. We also thank the local guide, our field assistants and volunteers: Noldi Kakauhe (local guide), Vandem Tundu and Felix Manderos (field assistants), Ida Naibaho (student field assistant), Amanda Nalang, S.Si, Yudi Candra, S.Si, Yohanes Venmard, ST, Riano Rembet, S.Si, Siti Nurrohma, Irene Esin, and Yordan Salindeho (volunteers). Participation by MS was facilitated by a grant from the Margot Marsh Biodiversity Foundation and a private donation by the Tjiasmanto Family.	Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; Aubert M, 2014, NATURE, V514, P223, DOI 10.1038/nature13422; Bearder SK, 1995, CREATURES OF THE DARK, P331; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bidochka MJ, 2001, APPL ENVIRON MICROB, V67, P1335, DOI 10.1128/AEM.67.3.1335-1342.2001; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; Brook BW, 2006, BIOTROPICA, V38, P302, DOI 10.1111/j.1744-7429.2006.00141.x; Brown RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104340; Burton JA, 2010, INT J PRIMATOL, V31, P1123, DOI 10.1007/s10764-010-9449-8; Carlton JT, 2017, SCIENCE, V357, P1402, DOI 10.1126/science.aao1498; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Costello MJ, 2012, SYST BIOL, V61, P871, DOI 10.1093/sysbio/syr080; Delic T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02938-z; Detroit F, 2019, NATURE, V568, P181, DOI 10.1038/s41586-019-1067-9; Driller C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141212; Espindola A, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1529; Evans BJ, 2003, EVOLUTION, V57, P1436; FEILER A, 1990, Zoologische Abhandlungen (Dresden), V46, P75; Fry BG, 2003, J TOXICOL-TOXIN REV, V22, P23, DOI 10.1081/TXR-120019018; Golding C, 2008, NEW ZEAL J ZOOL, V35, P189, DOI 10.1080/03014220809510113; Groves C, 2008, PRIMATES ORIENTAL NI, P112; Groves C.P., 2001, PRIMATE TAXONOMY; Groves C, 2010, INT J PRIMATOL, V31, P1071, DOI 10.1007/s10764-010-9443-1; Grow N, 2013, AM J PRIMATOL, V75, P464, DOI 10.1002/ajp.22123; Gursky S, 1998, FOLIA PRIMATOL, V69, P191, DOI 10.1159/000052713; Hall R, 2001, FAUNAL AND FLORAL MIGRATIONS AND EVOLUTION IN SE ASIA-AUSTRALASIA, P35; Hall R., 1996, TECTONIC EVOLUTION S, V106, P153; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; Ingicco T, 2018, NATURE, V557, P233, DOI 10.1038/s41586-018-0072-8; Kamagi DD, 2014, OPEN J GEN, V4, P332; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kementerian Lingkungan Hidup dan Kehutanan, 2015, SK 6 4 KKBHL 2015; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; MacKinnon J., 1980, International Journal of Primatology, V1, P361, DOI 10.1007/BF02692280; Mehta A., 1999, BUNAKEN NATL PARK NA; Merker S, 2005, ORYX, V39, P189, DOI 10.1017/S0030605305000438; Merker S, 2004, LAND USE NATURE CONS, P299; Merker S, 2008, PRIMATES, V49, P161, DOI 10.1007/s10329-007-0072-z; Merker S, 2006, INT J PRIMATOL, V27, P465, DOI 10.1007/s10764-006-9038-z; Merker S, 2010, INT J PRIMATOL, V31, P1107, DOI 10.1007/s10764-010-9452-0; Musser G.G., 1987, AM MUS NOVIT, V2867, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NIEMITZ C, 1991, FOLIA PRIMATOL, V56, P105, DOI 10.1159/000156534; Niemitz C., 1984, P1; Nietsch A, 1998, FOLIA PRIMATOL, V69, P371, DOI 10.1159/000052725; Nietsch A, 1992, INT J PRIMATOL SOC A, V318; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Rambaut A., FIGTREE V1 4 4 GRAPH; RAMBAUT A, 2018, SYST BIOL, V67, P901, DOI [10.1093/sysbio/syy032, DOI 10.1093/SYSBIO/SYY032, DOI 10.1093/SYSBI0/SYY032]; Roskov Y, SPECIES 2000 ITIS CA; Saroyo, 2017, BIOSCI RES, V14, P310; Schuler M., 2017, IMPROVING LIVES LIVE; Schwenk K, 2008, PHILOS T R SOC B, V363, P2805, DOI 10.1098/rstb.2008.0055; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Shekelle M, 2004, BIOTA, V9, P1; Shekelle M, 1997, SULAWESI PRIMATE NEW, V4, P4; Shekelle Myron, 2017, Primate Conservation, V31, P61; Shekelle M, 2010, INT J PRIMATOL, V31, P1083, DOI 10.1007/s10764-010-9457-8; Shekelle Myron, 2008, P71; Shekelle Myron, 2008, P35; Shekelle Myron, 2008, P51; Shekelle Myron, 2008, Primate Conservation, V23, P55, DOI 10.1896/052.023.0106; Shekelle M, 2009, ORYX, V43, P419, DOI 10.1017/S0030605309000337; United Nations Development Programme Bunaken National Park Management Advisory Board Indonesia, 2012, EQ IN CAS STUD SER; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Van den Bergh GD, 2016, NATURE, V529, P208, DOI 10.1038/nature16448; von Rintelen T, 2007, HYDROBIOLOGIA, V592, P11, DOI 10.1007/s10750-007-0765-8; Whitten T, 2002, ECOLOGY SULAWESI; Wuster W, 1996, ENVENOMINGS THEIR TR, P13	73	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230014	10.1371/journal.pone.0230014	http://dx.doi.org/10.1371/journal.pone.0230014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214331	Green Published, Green Submitted, gold			2022-12-26	WOS:000535934200015
J	Wen, HY; Qian, M; He, J; Li, MH; Yu, Q; Leng, ZW				Wen, Haiyan; Qian, Min; He, Jing; Li, Meihui; Yu, Qing; Leng, Zhengwei			Inhibiting of self-renewal, migration and invasion of ovarian cancer stem cells by blocking TGF-beta pathway	PLOS ONE			English	Article							EMT; METASTASIS; PROMOTES	Objective To investigate the effect and mechanism of SB525334 on self-renewal, migration and invasion of ovarian cancer stem cells. Methods ALDHhigh-expressing cancer stem cells (CSCs) were isolated from human ovarian cancer cell line SKOV-3 by flow cytometry and treated with 2 mu g/mL SB525334 for 6h. The sphere forming assay was used to detect the ability of self-renewal of CSCs and the colony formation assay was used to detect the tumorigenicity in vitro. Transwell migration and invasion assay were used to detect the migration and invasion ability of CSCs. To further explore the mechanism, real-time quantitative PCR and flow cytometry were used to detect the mRNA and protein expression of TGF-beta, Smad2, Smad3, phosphorylated Smad2, phosphorylated Smad3 and Smad4, respectively. Expressions of epithelial-mesenchymal transition (EMT)-related genes E-cadherin, Snail, Vimentin were also assessed. Results The self-renewal ability, tumorigenicity in vitro, migration and invasion ability of CSCs were significantly attenuated after SB525334 treatment. The expressions of TGF-beta, phosphorylated Smad2, phosphorylated Smad3, Snail, and Vimentin were decreased, while Smad4 and E-cadherin expressions were increased. Conclusion SB525334 may inhibit the self-renewal, invasion and migration of ovarian CSCs by blocking the TGF-beta/Smad/EMT pathway.	[Wen, Haiyan; Qian, Min; He, Jing; Li, Meihui; Yu, Qing] Hangzhou Womens Hosp, Dept Obstet, Hangzhou, Zhejiang, Peoples R China; [Leng, Zhengwei] North Sichuan Med Coll, Gen Surg Teaching & Res Off, Nanchong, Sichuan, Peoples R China	North Sichuan Medical University	Wen, HY (corresponding author), Hangzhou Womens Hosp, Dept Obstet, Hangzhou, Zhejiang, Peoples R China.; Leng, ZW (corresponding author), North Sichuan Med Coll, Gen Surg Teaching & Res Off, Nanchong, Sichuan, Peoples R China.	wenhy1991@163.com; lengzhengwei@163.com	yu, qing/HGC-4611-2022	Wen, Haiyan/0000-0001-8227-4248				Jia LY, 2018, MOLECULES, V23, DOI 10.3390/molecules23061469; Kaur A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01844; Kim D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0903-4; Leng ZW, 2017, EXP THER MED, V14, P2801, DOI 10.3892/etm.2017.4846; Li YY, 2018, BIOCHEM BIOPH RES CO, V495, P1081, DOI 10.1016/j.bbrc.2017.11.117; Li ZW, 2017, ONCOTARGET, V8, P67329, DOI 10.18632/oncotarget.18622; Mihanfar A, 2019, J CELL PHYSIOL, V234, P3238, DOI 10.1002/jcp.26768; Pieterse Z, 2019, INT J BIOCHEM CELL B, V106, P117, DOI 10.1016/j.biocel.2018.11.012; Prieto-Garcia E, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-0980-8; Risolino M, 2014, P NATL ACAD SCI USA, V111, pE3775, DOI 10.1073/pnas.1407074111; Roy L, 2018, CANCERS, V10, DOI 10.3390/cancers10080241; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Wang LQ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0889-7; Yang Y, 2017, INT J ONCOL, V51, P515, DOI 10.3892/ijo.2017.4044; Yue DL, 2015, EXP CELL RES, V336, P141, DOI 10.1016/j.yexcr.2015.06.007	15	8	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230230	10.1371/journal.pone.0230230	http://dx.doi.org/10.1371/journal.pone.0230230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214328	Green Published, gold			2022-12-26	WOS:000535934200022
J	Zhao, CH; Hu, YF; Chen, HH; Li, BY; Cao, LY; Xia, JL; Yin, YS				Zhao, Changhui; Hu, Yunfei; Chen, Huahai; Li, Baiyuan; Cao, Linyan; Xia, Jinlan; Yin, Yeshi			An in vitro evaluation of the effects of different statins on the structure and function of human gut bacterial community	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; PARKINSONS-DISEASE; MICROBIAL COMMUNITY; GENE-EXPRESSION; ROSUVASTATIN; DIVERSITY; OBESITY; SHAPE	Statins, a class of drugs that can effectively remove cholesterol from serum, are used to regulate plasma total cholesterol and reduce the risk of cardiovascular diseases, but it is still unclear whether the drug are modulated by gut microbiota or the structures of gut microbiota are shaped by statins. We investigated the interactions between statins and the human gut microbiota during the in vitro fermentation process by 16S rRNA gene sequencing, gas chromatography (GC), and high-performance liquid chromatography (HPLC) analyses. The presence of fluvastatin (FLU2) specifically promoted the growth of Escherichia/Shigella, Ruminococcaceae UCG 014, and Sutterella. However, the composition of the gut bacterial microbiota remained relatively static in samples treated with rosuvastatin (ROS), simvastatin (SIM), and atorvastatin (ATO). The PICRUSt program predicted moderate differences in the functional categories related to the biosynthesis of other secondary metabolites, cellular processes and signaling, and signal transduction in the FLU2 fermentation samples. Our study revealed substantial variation in the structure and function of microbiomes from the FLU2-treated samples. In addition, short-chain fatty acids (SCFAs) were also significantly decreased in FLU2-treated samples compared with the samples treated with other stains. Statins can be degraded by the human gut microbiota in vitro, and the degradation rate was approximately 7%-30% and 19%-48% after fermentation was allowed to proceed for 24 h and 48 h, respectively. Generally, FLU2 could largely shape the composition and function of human gut microbiota, which resulted in changes in the production of SCFAs. In turn, all statins could be degraded or modified by the gut microbiota. Our study paves the way for elucidating statin-gut microbiota interactions in vitro towards the improvement of the host health and personalized medicine.	[Zhao, Changhui; Xia, Jinlan] Cent South Univ, Key Lab Biomet, Minist Educ China, Sch Minerals Proc & Bioengn, Changsha, Hunan, Peoples R China; [Zhao, Changhui; Hu, Yunfei; Chen, Huahai; Li, Baiyuan; Cao, Linyan; Yin, Yeshi] Hunan Univ Sci & Engn, Key Lab Comprehens Utilizat Adv Plants Resources, Coll Chem & Bioengn, Yongzhou, Hunan, Peoples R China	Central South University; Ministry of Education, China	Xia, JL (corresponding author), Cent South Univ, Key Lab Biomet, Minist Educ China, Sch Minerals Proc & Bioengn, Changsha, Hunan, Peoples R China.; Yin, YS (corresponding author), Hunan Univ Sci & Engn, Key Lab Comprehens Utilizat Adv Plants Resources, Coll Chem & Bioengn, Yongzhou, Hunan, Peoples R China.	jlxia@csu.edu.cn; yinyeshi@126.com	Zhao, Changhui/N-2378-2019	Zhao, Changhui/0000-0002-1882-7490	National Natural Science Foundation of China [31741109]; Hunan Natural Science Foundation [2018JJ3200]; construct program of applied characteristic discipline in Hunan University of Science and Engineering	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Natural Science Foundation(Natural Science Foundation of Hunan Province); construct program of applied characteristic discipline in Hunan University of Science and Engineering	This work was supported by the National Natural Science Foundation of China (No. 31741109) to HC and the Hunan Natural Science Foundation (No. 2018JJ3200) to YY, and the construct program of applied characteristic discipline in Hunan University of Science and Engineering to YY.	Allen AP, 2017, SOC PERSONAL PSYCHOL, V11, DOI 10.1111/spc3.12309; Aura AM, 2011, MOL BIOSYST, V7, P437, DOI 10.1039/c0mb00023j; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bedarf JR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0428-y; Beltran D, 2019, FOOD FUNCT, V10, P1787, DOI [10.1039/c8fo02594k, 10.1039/C8FO02594K]; Bjorkhaug ST, 2019, GUT MICROBES, V10, P663, DOI 10.1080/19490976.2019.1580097; Caparros-Martin JA, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0312-4; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dennis KL, 2013, CANCER RES, V73, P5905, DOI 10.1158/0008-5472.CAN-13-1511; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fukiwake T, 2014, FOOD HYG SAFE SCI, V55, P94, DOI 10.3358/shokueishi.55.94; He XY, 2017, J PROTEOME RES, V16, P1900, DOI 10.1021/acs.jproteome.6b00984; Hennessy E, 2016, ANTIMICROB AGENTS CH, V60, P5111, DOI 10.1128/AAC.00192-16; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hu YF, 2019, JOVE-J VIS EXP, DOI 10.3791/59725; IRELAND A, 1990, CLIN SCI, V78, P105, DOI 10.1042/cs0780105; Istvan ES, 2002, AM HEART J, V144, pS27, DOI 10.1067/mhj.2002.130300; Jourova L, 2016, BIOMEDICAL PAPERS ME, V160; Khan TJ, 2018, OMICS, V22, P154, DOI 10.1089/omi.2017.0130; Ko HHT, 2017, PEERJ, V5, DOI 10.7717/peerj.3952; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Le Bastard Q, 2018, ALIMENT PHARM THER, V47, P332, DOI 10.1111/apt.14451; Lei F, 2012, APPL ENVIRON MICROB, V78, P5763, DOI 10.1128/AEM.00327-12; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lima WG, 2019, BIOMED PHARMACOTHER, V111, P270, DOI 10.1016/j.biopha.2018.12.076; Liu AM, 2019, PHARMACOL THERAPEUT, V195, P54, DOI 10.1016/j.pharmthera.2018.10.004; Liu GD, 2017, MOVEMENT DISORD, V32, P913, DOI 10.1002/mds.27006; Liu W, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224371; Liu YH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00530; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mach F, 2005, EUR J CLIN INVEST, V35, P476, DOI 10.1111/j.1365-2362.2005.01522.x; Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; Martinson JNV, 2019, ISME J, V13, P2306, DOI 10.1038/s41396-019-0435-7; Masadeh M, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-13; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Menni C, 2018, EUR HEART J, V39, P2390, DOI 10.1093/eurheartj/ehy226; Muscogiuri Giovanna, 2019, Int J Obes Suppl, V9, P10, DOI 10.1038/s41367-019-0011-7; Nenseter MS, 2014, SCAND J CLIN LAB INV, V74, P1, DOI 10.3109/00365513.2013.854926; Nolan JA, 2017, AM J PHYSIOL-GASTR L, V312, pG488, DOI 10.1152/ajpgi.00149.2016; Novakova L, 2009, TALANTA, V78, P834, DOI 10.1016/j.talanta.2008.12.057; O'Gorman CS, 2009, PEDIATR CARDIOL, V30, P482, DOI 10.1007/s00246-008-9364-3; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Pryor R, 2019, CELL, P1; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rycroft CE, 2001, LETT APPL MICROBIOL, V32, P156, DOI 10.1046/j.1472-765x.2001.00875.x; Saad R, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-16; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Strandberg TE, 1999, LANCET, V353, P118, DOI 10.1016/S0140-6736(05)76154-7; Sun BQ, 2018, J MICROBIOL, V56, P886, DOI 10.1007/s12275-018-8152-x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van de Guchte M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0466-8; Wang L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-42; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11; Yang LN, 2014, ASIAN AUSTRAL J ANIM, V27, P898, DOI 10.5713/ajas.2013.13621; Yin YS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08478-w; Yoo DH, 2014, DRUG METAB DISPOS, V42, P1508, DOI 10.1124/dmd.114.058354; Zhao SP, 2014, ATHEROSCLEROSIS, V233, P707, DOI 10.1016/j.atherosclerosis.2013.12.003; Zhu LX, 2014, PHYSIOL GENOMICS, V46, P679, DOI 10.1152/physiolgenomics.00082.2014; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	65	9	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230200	10.1371/journal.pone.0230200	http://dx.doi.org/10.1371/journal.pone.0230200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214324	gold, Green Published			2022-12-26	WOS:000535934200021
J	Woranam, K; Senawong, G; Utaiwat, S; Yunchalard, S; Sattayasai, J; Senawong, T				Woranam, Khanutsanan; Senawong, Gulsiri; Utaiwat, Suppawit; Yunchalard, Sirinda; Sattayasai, Jintana; Senawong, Thanaset			Anti-inflammatory activity of the dietary supplement Houttuynia cordata fermentation product in RAW264.7 cells and Wistar rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INFLAMMATION; EXPRESSION; ACID; POLYPHENOL; CANCER	Houttuynia cordata Thunb. has been used as a traditional medicine to treat a variety of ailments in Asian countries such as China, Japan, South Korea, and Thailand. In Thailand, H. cordata fermentation products (HCFPs) are commercially produced and popularly consumed throughout the country without experimental validation. Anti-inflammatory activity of H. cordata fresh leaves or aerial parts has previously been reported, however, the anti-inflammatory activity of the commercially available HCFPs produced by the industrialized process has not yet been investigated. The aim of this study was to evaluate in vitro and in vivo anti-inflammatory potential of the selected industrialized HCFP. LPS-induced RAW264.7 and carrageenan-induced paw edema models were used to evaluate the anti-inflammatory activity of HCFP. The phenolic acid components of HCFP aqueous and methanolic extracts were investigated using HPLC analysis. In RAW264.7 cells, the HCFP aqueous and methanolic extracts reduced NO production and suppressed LPS-stimulated expression of PGE(2), iNOS, IL-1 beta, TNF-alpha and IL-6 levels in a concentration-dependent manner, however, less effect on COX-2 level was observed. In Wistar rats, 3.08 and 6.16 mL/kg HCFP reduced paw edema after 2 h carrageenan stimulation, suggesting the second phase anti-edematous effect similar to diclofenac (150 mg/kg). Whereas, 6.16 mL/kg HCFP also reduced paw edema after 1 h carrageenan stimulation, suggesting the first phase anti-edematous effect. Quantitative HPLC revealed the active phenolic compounds including syringic, vanillic, p-hydroxybenzoic and ferulic acids, which possess anti-inflammatory activity. Our results demonstrated for the first time the anti-inflammatory activity of the industrialized HCFP both in vitro and in vivo, thus validating its promising anti-inflammation potential.	[Woranam, Khanutsanan; Senawong, Gulsiri; Utaiwat, Suppawit; Senawong, Thanaset] Khon Kaen Univ, Dept Biochem, Fac Sci, Khon Kaen, Thailand; [Yunchalard, Sirinda] Khon Kaen Univ, Fac Technol, Dept Biotechnol, Khon Kaen, Thailand; [Sattayasai, Jintana] Khon Kaen Univ, Dept Pharmacol, Fac Med, Khon Kaen, Thailand; [Senawong, Thanaset] Khon Kaen Univ, Nat Prod Res Unit, Fac Sci, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Senawong, T (corresponding author), Khon Kaen Univ, Dept Biochem, Fac Sci, Khon Kaen, Thailand.; Senawong, T (corresponding author), Khon Kaen Univ, Nat Prod Res Unit, Fac Sci, Khon Kaen, Thailand.	sthanaset@kku.ac.th	Senawong, Gulsiri/AAU-7950-2021; Senawong, Thanaset/GSE-3777-2022	Senawong, Gulsiri/0000-0002-0693-8812; 	Research and Researcher for Industry (RRi) project; Thailand Research Fund (TRF); Prolac (Thailand) Co., Ltd.; Lamphun Province, Thailand	Research and Researcher for Industry (RRi) project; Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Prolac (Thailand) Co., Ltd.; Lamphun Province, Thailand	This study was supported by the Research and Researcher for Industry (RRi) project, Thailand Research Fund (TRF), which was cooperated with the Prolac (Thailand) Co., Ltd., Lamphun Province, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the funders have been informed and agreed on publishing a manuscript, sharing data and materials.	Aaby K, 2005, J AGR FOOD CHEM, V53, P4032, DOI 10.1021/jf048001o; Adams RJ, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-70; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Allerton TD, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070921; Ben Lagha A, 2019, CYTOKINE, V115, P64, DOI 10.1016/j.cyto.2018.12.009; Cha H, 2018, FOOD CHEM TOXICOL, V121, P131, DOI 10.1016/j.fct.2018.08.060; Chaudhry H, 2013, IN VIVO, V27, P669; Chiang LC, 2003, AM J CHINESE MED, V31, P355, DOI 10.1142/S0192415X03001090; Chizzolini C, 2009, IMMUNOL CELL BIOL, V87, P510, DOI 10.1038/icb.2009.56; Dinarello CA, 1999, J INFECT DIS, V179, pS294, DOI 10.1086/513856; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Jee Y. C., 2010, CHONNAM MED J, V46, P140, DOI DOI 10.4068/CMJ.2010.46.3.140; Jung WK, 2008, LIFE SCI, V82, P797, DOI 10.1016/j.lfs.2008.01.014; Khaopha S., 2012, African Journal of Biotechnology, V11, P15923; Kumar Manish, 2014, Pharmacogn Rev, V8, P22, DOI 10.4103/0973-7847.125525; Kwon RH, 2012, TOXICOL RES-GER, V28, P117, DOI 10.5487/TR.2012.28.2.117; Legault J, 2010, J MED FOOD, V13, P460, DOI 10.1089/jmf.2009.0029; Leonard E, 2006, METAB ENG, V8, P172, DOI 10.1016/j.ymben.2005.11.001; Li J, 2015, EXP THER MED, V10, P3, DOI 10.3892/etm.2015.2467; Mackman N, 2003, ARTERIOSCL THROM VAS, V23, P1133, DOI 10.1161/01.ATV.0000080641.10662.4C; MARTEAU P, 1995, MICROB ECOL HEALTH D, V8, P151, DOI 10.3109/08910609509140093; Min HY, 2009, INT IMMUNOPHARMACOL, V9, P844, DOI 10.1016/j.intimp.2009.03.005; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; Nuengchamnong N, 2009, FOOD CHEM, V117, P750, DOI 10.1016/j.foodchem.2009.04.071; Oboh G, 2008, FOOD BIOTECHNOL, V22, P363, DOI 10.1080/08905430802463404; Park JW, 2012, INFLAMMATION, V35, P321, DOI 10.1007/s10753-011-9322-8; Posadas I, 2000, N-S ARCH PHARMACOL, V361, P98, DOI 10.1007/s002109900150; Pragasam SJ, 2013, INFLAMMATION, V36, P169, DOI 10.1007/s10753-012-9532-8; Sekita Y, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/2850947; Senawong T, 2014, SCIENCEASIA, V40, P420, DOI 10.2306/scienceasia1513-1874.2014.40.420; Shim SY, 2009, J MED FOOD, V12, P383, DOI 10.1089/jmf.2007.0684; Shin JY, 2017, MOL MED REP, V16, P5137, DOI 10.3892/mmr.2017.7297; Shin S, 2010, J VET SCI, V11, P273, DOI 10.4142/jvs.2010.11.3.273; Suzme S, 2014, INT J FOOD SCI TECH, V49, P819, DOI 10.1111/ijfs.12370; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; VINEGAR R, 1969, J PHARMACOL EXP THER, V166, P96; WILLOUGHBY DA, 1972, ANN RHEUM DIS, V31, P540, DOI 10.1136/ard.31.6.540; Wongrakpanich S, 2018, AGING DIS, V9, P143, DOI 10.14336/AD.2017.0306; Yoo SR, 2017, NAT PROD RES, V31, P2923, DOI 10.1080/14786419.2017.1300798	39	15	15	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230645	10.1371/journal.pone.0230645	http://dx.doi.org/10.1371/journal.pone.0230645			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210452	Green Published, gold			2022-12-26	WOS:000535307600038
J	Yanez-Montalvo, A; Gomez-Acata, S; Aguila, B; Hernandez-Arana, H; Falcon, LI				Yanez-Montalvo, Alfredo; Gomez-Acata, Selene; Aguila, Bernardo; Hernandez-Arana, Hector; Falcon, Luisa I.			The microbiome of modern microbialites in Bacalar Lagoon, Mexico	PLOS ONE			English	Article							FRESH-WATER MICROBIALITES; SULFATE-REDUCING BACTERIA; CUATRO CIENEGAS BASIN; QUINTANA-ROO; LAGUNA BACALAR; MARINE STROMATOLITES; COMMUNITY STRUCTURE; GLOBAL PATTERNS; R-PACKAGE; DIVERSITY	Microbialites are highly diverse microbial communities that represent modern examples of the oldest life forms, stromatolites (dated >3.7 Ga). Bacalar Lagoon, in Mexico, harbors the largest freshwater microbialite occurrences of the world; yet diverse anthropogenic activities are changing the oligotrophic conditions of the lagoon. The objective of this work was to perform a spatial exploration of the microbialites of Bacalar Lagoon, analyze their prokaryote diversity, following a high throughput sequencing approach of the V4 region of the 16S rDNA, and correlate to the environmental parameters that influence the structure of these communities. The results indicate the presence of microbialites throughout the periphery of the lagoon. The microbiome of the microbialites is composed primarily of Proteobacteria (40-80%), Cyanobacteria (1-11%), Bacteroidetes (7-8%), Chloroflexi (8-14%), Firmicutes (1-23%), Planctomycetes (1-8%), and Verrucomicrobia (1-4%). Phylogenetic distance analyses suggests two distinct groups of microbialites associated with regions in the lagoon that have differences in their environmental parameters, including soluble reactive silicate (in the north), bicarbonates and available forms of nitrogen (ammonium, nitrates and nitrites) (in the south). These microbialite groups had differences in their microbiome composition associated to strong anthropogenic pressure on water quality (agriculture, landfill leachate, lack of water treatment infrastructure and intensive tourism), which were related to a loss of microbial diversity.	[Yanez-Montalvo, Alfredo; Gomez-Acata, Selene; Aguila, Bernardo; Falcon, Luisa I.] UNAM, Inst Ecol, Parque Cient & Tecnol Yucatan, Sierra Papacal, Yucatan, Mexico; [Yanez-Montalvo, Alfredo; Hernandez-Arana, Hector] Colegio Frontera Sur, Unidad Chetumal, Chetmal, Quintana Roo, Mexico	Universidad Nacional Autonoma de Mexico; El Colegio de la Frontera Sur (ECOSUR)	Falcon, LI (corresponding author), UNAM, Inst Ecol, Parque Cient & Tecnol Yucatan, Sierra Papacal, Yucatan, Mexico.	falcon@ecologia.unam.mx	Hernandez-Arana, Hector A./AAL-2400-2020	Hernandez-Arana, Hector A./0000-0001-9769-3349; Falcon, Luisa I/0000-0002-7210-6483; Yanez-Montalvo, Alfredo/0000-0002-8344-5333; Aguila Salgado, Bernardo/0000-0002-5631-4549; Gomez Acata, Elizabeth Selene/0000-0003-0738-0483	CONACyT, Mexico; SEP-CONACyT [254962]; UNAM-DGAPA [207220]; UNAM DGAPA [000.000209003]	CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); SEP-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM-DGAPA(Universidad Nacional Autonoma de Mexico); UNAM DGAPA(Universidad Nacional Autonoma de Mexico)	Alfredo Yanez-Montalvo received a graduate studies scholarship from CONACyT, Mexico. Funding for this research came from SEP-CONACyT 254962 and UNAM-DGAPA 207220 (LIF). SGA received a postdoctoral scholarship from UNAM DGAPA 000.000209003. BA received a graduate studies scholarship from CONACyT, Mexico.	Akcaalan R, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-017-6314-7; Sanchez JA, 2016, TECNOL CIENC AGUA, V7, P75; Sanchez-Sanchez JA, 2015, REV MEX CIENC GEOL, V32, P62; Alvarez-Gongora C, 2006, MAR POLLUT BULL, V52, P48, DOI 10.1016/j.marpolbul.2005.08.006; Andersen JH, 2017, BIOL REV, V92, P135, DOI 10.1111/brv.12221; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; ArandaCirerol N, 2011, ENVIRON MONIT ASSESS, V172, P493, DOI 10.1007/s10661-010-1349-z; Archana A, 2018, WATER RES, V142, P459, DOI 10.1016/j.watres.2018.06.004; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baumgartner LK, 2006, SEDIMENT GEOL, V185, P131, DOI 10.1016/j.sedgeo.2005.12.008; Beltran Y, 2012, AQUAT MICROB ECOL, V67, P15, DOI 10.3354/ame01572; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bonilla-Rosso G, 2012, ASTROBIOLOGY, V12, P659, DOI 10.1089/ast.2011.0724; Braissant O, 2007, GEOBIOLOGY, V5, P401, DOI 10.1111/j.1472-4669.2007.00117.x; Budnick WR, 2019, GLOBAL ECOL BIOGEOGR, V28, P1597, DOI 10.1111/geb.12976; BURNE R V, 1987, Palaios, V2, P241, DOI 10.2307/3514674; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Camacho-Cruz KA, 2020, ENVIRON SCI POLLUT R, V27, P15967, DOI 10.1007/s11356-019-04757-3; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Carrillo L, 2009, ESTUAR COAST, V32, P906, DOI 10.1007/s12237-009-9196-2; Castanier S, 1999, SEDIMENT GEOL, V126, P9, DOI 10.1016/S0037-0738(99)00028-7; Castro-Contreras SI, 2014, PALAIOS, V29, P192, DOI 10.2110/palo.2013.063; Centeno CM, 2012, FEMS MICROBIOL ECOL, V82, P724, DOI 10.1111/j.1574-6941.2012.01447.x; Chagas AAP, 2016, EARTH-SCI REV, V162, P338, DOI 10.1016/j.earscirev.2016.09.012; Couradeau E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028767; De Anda V, 2018, CUATR CIEN BASIN, P85, DOI 10.1007/978-3-319-95855-2_7; Dixon J., 2001, ENV DEP WORKING PAPE, V80; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Elser JJ, 2005, FRESHWATER BIOL, V50, P1808, DOI 10.1111/j.1365-2427.2005.01451.x; Falcon LI, 2002, HYDROBIOLOGIA, V467, P71, DOI 10.1023/A:1014984629985; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Farias ME, 2014, EXTREMOPHILES, V18, P311, DOI 10.1007/s00792-013-0617-6; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer Noah, 2008, P95; FOURQUREAN JW, 1992, LIMNOL OCEANOGR, V37, P162, DOI 10.4319/lo.1992.37.1.0162; Gibbons SM, 2015, CURR OPIN GENET DEV, V35, P66, DOI 10.1016/j.gde.2015.10.003; Gischler E, 2011, ADV STROMATOLITE GEO, DOI DOI 10.1007/978-3-642-10415-2_13; Gischler E, 2008, SEDIMENTOLOGY, V55, P1293, DOI 10.1111/j.1365-3091.2007.00946.x; Gonzalez FUT, 2008, ESTUAR COAST SHELF S, V76, P418, DOI 10.1016/j.ecss.2007.07.025; Hanashiro FTT, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00743; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Hernandez-Arana HA, 2015, BIODIVERSITY AND CONSERVATION OF THE YUCATAN PENINSULA, P355, DOI 10.1007/978-3-319-06529-8_14; Hernandez-Terrones L, 2011, WATER AIR SOIL POLL, V218, P517, DOI 10.1007/s11270-010-0664-x; Herrera-Silveira JA, 2009, MAR POLLUT BULL, V59, P72, DOI 10.1016/j.marpolbul.2008.11.017; Hunt DE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01182; Johnson DB, 2018, GEOBIOLOGY, V16, P319, DOI 10.1111/gbi.12283; Kawaguchi T, 2002, J CRYST GROWTH, V240, P230, DOI 10.1016/S0022-0248(02)00918-1; Landeiro VL, 2018, DIVERS DISTRIB, V24, P966, DOI 10.1111/ddi.12734; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lebedeva EV, 2017, GEOGR NAT RESOUR, V38, P303, DOI [10.1134/S187537281703012X, 10.21782/GIPR0206-1619-2017-3(189-198)]; Legendre P, 2012, NUMERICAL ECOLOGY, DOI [10.1016/S0304-3800(00)00291-X, DOI 10.1016/S0304-3800(00)00291-X]; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Legendre P, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2728; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Lindsay MR, 2017, GEOBIOLOGY, V15, P131, DOI 10.1111/gbi.12201; Lizardi-Jimenez MA, 2015, DESALIN WATER TREAT, V54, P44, DOI 10.1080/19443994.2013.876670; Logue JB, 2012, ISME J, V6, P1127, DOI 10.1038/ismej.2011.184; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Magurran AE, 2013, MEASURING BIOL DIVER, DOI [10.2307/4126959, DOI 10.2307/4126959]; Martinez-Porchas M, 2017, REV AQUACULT, V9, P42, DOI 10.1111/raq.12102; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Metcalfe CD, 2011, ENVIRON POLLUT, V159, P991, DOI 10.1016/j.envpol.2010.11.031; Montecchia MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119426; Muller G, 1971, N JB MINER MH, V10, P466; Null KA, 2014, CONT SHELF RES, V82, P128, DOI 10.1016/j.csr.2014.04.008; Oakley BB, 2010, ISME J, V4, P488, DOI 10.1038/ismej.2009.146; Oliva-Rivera JJ, 2016, REV BIOL TROP, V64, P1643, DOI 10.15517/rbt.v64i4.22871; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; Ozturk E, 2015, ULTRASON SONOCHEM, V26, P422, DOI 10.1016/j.ultsonch.2015.02.012; Paul VG, 2016, ASTROBIOLOGY, V16, P282, DOI 10.1089/ast.2015.1326; Perez L, 2011, HYDROBIOLOGIA, V661, P407, DOI 10.1007/s10750-010-0552-9; Perry E, 2002, INT GEOL REV, V44, P191, DOI 10.2747/0020-6814.44.3.191; RASMUSSEN KA, 1993, GEOLOGY, V21, P199, DOI 10.1130/0091-7613(1993)021<0199:MSRFAB>2.3.CO;2; Reid RP, 2000, NATURE, V406, P989, DOI 10.1038/35023158; Reitner J., 2011, ENCY GEOBIOLOGY, P635, DOI [10.1007/978-1-4020-9212-1_196, DOI 10.1007/978-1-4020-9212-1_196]; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Roguet A, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0568-3; Saghai A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00797; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; Shiraishi F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12303-9; Simoes NR, 2015, HYDROBIOLOGIA, V758, P3, DOI 10.1007/s10750-015-2260-y; Spring S, 2016, ISME J, V10, P2801, DOI 10.1038/ismej.2016.84; Strickland J.D., 1972, J FISH RES BOARD CAN; Sun MY, 2012, MAR POLLUT BULL, V64, P1029, DOI 10.1016/j.marpolbul.2012.01.035; Velazquez NIT, 2019, MAR FRESHWATER RES, V70, P382, DOI 10.1071/MF18035; Valdespino-Castillo PM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00510; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Vieira RP, 2008, ENVIRON MICROBIOL, V10, P189, DOI 10.1111/j.1462-2920.2007.01443.x; Visscher PT, 1998, AM MINERAL, V83, P1482, DOI 10.2138/am-1998-11-1236; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; White RA, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01531; White RA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00966; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Wu HN, 2017, ENVIRON SCI POLLUT R, V24, P19795, DOI 10.1007/s11356-017-9602-4; Xie YW, 2016, ENVIRON POLLUT, V212, P348, DOI 10.1016/j.envpol.2016.01.031; Zapala MA, 2006, P NATL ACAD SCI USA, V103, P19430, DOI 10.1073/pnas.0609333103; Zeglin LH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00454; Zhu TT, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00004	104	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230071	10.1371/journal.pone.0230071	http://dx.doi.org/10.1371/journal.pone.0230071			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210450	gold, Green Published			2022-12-26	WOS:000535307600014
J	Yaron, A; Jankowski, MM; Badrieh, R; Nelken, I				Yaron, Amit X.; Jankowski, Maciej M.; Badrieh, Ruan; Nelken, Israel			Stimulus-specific adaptation to behaviorally-relevant sounds in awake rats	PLOS ONE			English	Article							RECEPTIVE-FIELD PLASTICITY; PRIMARY AUDITORY-CORTEX; INFERIOR COLLICULUS; FREQUENCY MAP; MEMORY; SENSITIVITY; NEURONS; SIGNALS; SPIKING	Stimulus-specific adaptation (SSA) is the reduction in responses to a common stimulus that does not generalize, or only partially generalizes, to other stimuli. SSA has been studied mainly with sounds that bear no behavioral meaning. We hypothesized that the acquisition of behavioral meaning by a sound should modify the amount of SSA evoked by that sound. To test this hypothesis, we used fear conditioning in rats, using two word-like stimuli, derived from the English words "danger" and "safety", as well as pure tones. One stimulus (CS+) was associated with a foot shock whereas the other stimulus (CS-) was presented without a concomitant foot shock. We recorded neural responses to the auditory stimuli telemetrically, using chronically implanted multi-electrode arrays in freely moving animals before and after conditioning. Consistent with our hypothesis, SSA changed in a way that depended on the behavioral role of the sound: the contrast between standard and deviant responses remained the same or decreased for CS+ stimuli but increased for CS- stimuli, showing that SSA is shaped by experience. In most cases the sensory responses underlying these changes in SSA increased following conditioning. Unexpectedly, the responses to CS+ word-like stimuli showed a specific, large decrease, which we interpret as evidence for substantial inhibitory plasticity.	[Yaron, Amit X.; Badrieh, Ruan; Nelken, Israel] Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, Jerusalem, Israel; [Yaron, Amit X.; Jankowski, Maciej M.; Nelken, Israel] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Nelken, I (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, Jerusalem, Israel.; Nelken, I (corresponding author), Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel.	israel.nelken@mail.huji.ac.il	Nelken, Israel/B-7753-2011; Jankowski, Maciej Michal/AGR-2179-2022	Nelken, Israel/0000-0002-6645-107X; yaron, amit/0000-0002-5360-5674; Jankowski, Maciej M./0000-0001-9589-3929	ERC [340063]; F.I.R.S.T grant from the Israel Science Foundation [1075/2013]; Israel Science Foundation [390/2013]; Gatsby Charitable Foundation	ERC(European Research Council (ERC)European Commission); F.I.R.S.T grant from the Israel Science Foundation; Israel Science Foundation(Israel Science Foundation); Gatsby Charitable Foundation	This research was supported by an advanced ERC grant (project RATLAND, no. 340063), by F.I.R.S.T grant no. 1075/2013 from the Israel Science Foundation, and by personal grant no. 390/2013 from the Israel Science Foundation to IN, as well as by a grant from the Gatsby Charitable Foundation.	Anderson LA, 2009, J NEUROSCI, V29, P7359, DOI 10.1523/JNEUROSCI.0793-09.2009; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Ayala YA, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00119; Bauerle P, 2011, J NEUROSCI, V31, P9708, DOI 10.1523/JNEUROSCI.5814-10.2011; BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; Burns SP, 2010, J NEUROSCI, V30, P13739, DOI 10.1523/JNEUROSCI.0743-10.2010; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; David SV, 2012, P NATL ACAD SCI USA, V109, P2144, DOI 10.1073/pnas.1117717109; Fishman YI, 2012, J NEUROSCI, V32, P15747, DOI 10.1523/JNEUROSCI.2835-12.2012; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Froemke RC, 2013, NAT NEUROSCI, V16, P79, DOI 10.1038/nn.3274; Gutfreund Y, 2012, BIOL CYBERN, V106, P657, DOI 10.1007/s00422-012-0497-3; Hershenhoren I, 2014, J NEUROSCI, V34, P3303, DOI 10.1523/JNEUROSCI.2166-13.2014; Kajikawa Y, 2011, NEURON, V72, P847, DOI 10.1016/j.neuron.2011.09.029; Kawahara H, 2008, INT CONF ACOUST SPEE, P3933, DOI 10.1109/ICASSP.2008.4518514; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Maor I, 2016, CEREB CORTEX, V26, P4242, DOI 10.1093/cercor/bhw266; Marblestone AH, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00137; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Medvedev AV, 2004, J NEUROPHYSIOL, V92, P52, DOI 10.1152/jn.01253.2003; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Nelken I, 2013, ADV EXP MED BIOL, V787, P411, DOI 10.1007/978-1-4614-1590-9_45; Netser S, 2011, J NEUROSCI, V31, P17811, DOI 10.1523/JNEUROSCI.4790-11.2011; Patel CR, 2012, HEARING RES, V286, P41, DOI 10.1016/j.heares.2012.02.007; Percaccio CR, 2005, J NEUROPHYSIOL, V94, P3590, DOI 10.1152/jn.00433.2005; Reches A, 2008, J NEUROSCI, V28, P1523, DOI 10.1523/JNEUROSCI.3785-07.2008; Reches A, 2010, J NEUROSCI, V30, P6991, DOI 10.1523/JNEUROSCI.5723-09.2010; Sakai M, 2001, P NATL ACAD SCI USA, V98, P3507, DOI 10.1073/pnas.061021698; Sakai M, 2002, P NATL ACAD SCI USA, V99, P7108, DOI 10.1073/pnas.102165399; Shen L, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00055; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; Taaseh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023369; Thomas JM, 2012, HEARING RES, V291, P34, DOI 10.1016/j.heares.2012.06.004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Weinberger NM, 2007, HEARING RES, V229, P54, DOI 10.1016/j.heares.2007.01.004; Yaron A, 2015, THESIS; Yaron A, 2012, NEURON, V76, P603, DOI 10.1016/j.neuron.2012.08.025; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373; Zhao L, 2011, NEUROSCIENCE, V181, P163, DOI 10.1016/j.neuroscience.2011.01.060	42	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0221541	10.1371/journal.pone.0221541	http://dx.doi.org/10.1371/journal.pone.0221541			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210448	Green Submitted, Green Published, gold			2022-12-26	WOS:000535307600001
J	Ali, E; Orfi, J; Najib, A				Ali, Emad; Orfi, Jamel; Najib, Abdullah			Developing and validating a dynamic model of water production by direct-contact membrane distillation	PLOS ONE			English	Article							MASS-TRANSFER; THERMAL EFFICIENCY; DESALINATION; PERFORMANCE; GAP; DESIGN; RECOVERY; DRIVEN; CFD	We consider the development and fitting of a dynamic model for desalinated water production by a direct-contact membrane distillation (DCMD) unit. Two types of dynamic-model structures, namely, lumped parameter and spatial, were evaluated. Both the models were validated using experimental response data generated by step testing the inlet hot stream temperature of a DCMD pilot plant. Both the model structures failed to follow the dynamic response adequately. However, a modification of the model by adding a heat loss term resulted in enhanced predictions for both model structures. The overall relative error in the model-plant mismatch was approximately 3%. This is reasonable considering the random uncertainties associated with the plant operation. This observation also improves our understanding of the importance of using better correlations for heat-transfer coefficients, to develop a more reliable and accurate predictive model for a wide range of operating conditions.	[Ali, Emad] King Saud Univ, Dept Chem Engn, Riyadh, Saudi Arabia; [Orfi, Jamel; Najib, Abdullah] King Saud Univ, Dept Mech Engn, Riyadh, Saudi Arabia	King Saud University; King Saud University	Ali, E (corresponding author), King Saud Univ, Dept Chem Engn, Riyadh, Saudi Arabia.	amkamal@ksu.edu.sa	Orfi, Jamel/AAT-4595-2020	Orfi, Jamel/0000-0001-8537-5810; Ali, Emadadeen/0000-0003-0657-2379	Deanship of Scientific Research, King Saud University [RG-VPP 091]	Deanship of Scientific Research, King Saud University(King Saud University)	The research is funded by the Deanship of Scientific Research, King Saud University through Research Group no (RG-VPP 091). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anezi A. A.-H., 2012, ISRN CHEM ENG, V2012, P1; Ali E., 2019, CHEM ENG SCI; Ali E, 2019, CHEM ENG PROCESS, V136, P17, DOI 10.1016/j.cep.2018.12.003; Ali E, 2018, DESALIN WATER TREAT, V116, P1, DOI 10.5004/dwt.2018.22471; Ali E, 2018, ARAB J SCI ENG, V43, P2413, DOI 10.1007/s13369-017-2831-5; Ali E, 2017, CHEM ENG RES DES, V125, P245, DOI 10.1016/j.cherd.2017.07.020; Alkhudhiri A, 2012, DESALINATION, V287, P2, DOI 10.1016/j.desal.2011.08.027; Alklaibi AM, 2005, DESALINATION, V171, P111, DOI 10.1016/j.desal.2004.03.024; Andrjesdottir O, 2013, INT J HEAT MASS TRAN, V66, P855, DOI 10.1016/j.ijheatmasstransfer.2013.07.051; Banat F, 2007, DESALINATION, V217, P29, DOI 10.1016/j.desal.2006.11.028; Bouguecha ST, 2015, CHEM ENG RES DES, V100, P331, DOI 10.1016/j.cherd.2015.05.044; Camacho LM, 2013, WATER-SUI, V5, P94, DOI 10.3390/w5010094; Charfi K, 2010, DESALINATION, V259, P84, DOI 10.1016/j.desal.2010.04.028; Chen TC, 2010, J MEMBRANE SCI, V358, P122, DOI 10.1016/j.memsci.2010.04.037; Chen TC, 2009, J MEMBRANE SCI, V330, P279, DOI 10.1016/j.memsci.2008.12.063; de Pinho MN, 2002, J MEMBRANE SCI, V206, P189, DOI 10.1016/S0376-7388(01)00761-X; Drioli E, 2015, DESALINATION, V356, P56, DOI 10.1016/j.desal.2014.10.028; Duong HC, 2015, DESALINATION, V374, P1, DOI 10.1016/j.desal.2015.07.009; Eleiwi F, 2016, DESALINATION, V384, P1, DOI 10.1016/j.desal.2016.01.004; Fard AK, 2015, DESALINATION, V360, P97, DOI 10.1016/j.desal.2015.01.016; Francis L, 2013, J MEMBRANE SCI, V448, P240, DOI 10.1016/j.memsci.2013.08.013; Geng HX, 2015, DESALINATION, V355, P178, DOI 10.1016/j.desal.2014.10.038; Ghadiri M, 2013, IND ENG CHEM RES, V52, P3490, DOI 10.1021/ie400188q; Guan GQ, 2015, DESALINATION, V366, P80, DOI 10.1016/j.desal.2015.01.013; Hassan AS, 2016, DESALIN WATER TREAT, V57, P23196, DOI 10.1080/19443994.2015.1099330; Karam AM, 2017, DESALINATION, V402, P50, DOI 10.1016/j.desal.2016.09.002; Khalifa AE, 2015, SEP PURIF TECHNOL, V141, P276, DOI 10.1016/j.seppur.2014.12.007; Khayet M, 2010, ENCY LIFE SUPPORT SY; Khayet M, 2011, ADV COLLOID INTERFAC, V164, P56, DOI 10.1016/j.cis.2010.09.005; Lawal D.U., 2014, INT J MAT MECH MANUF, V2, P302, DOI [10.7763/IJMMM.2014.V2.147, DOI 10.7763/IJMMM.2014.V2.147]; Lee JG, 2016, WATER RES, V107, P47, DOI 10.1016/j.watres.2016.10.059; Lee JG, 2015, J MEMBRANE SCI, V478, P85, DOI 10.1016/j.memsci.2014.12.053; Leinhard J., 2012, ANN REV HEAT TRANSF, V15, P363, DOI [10.1615/AnnualRevHeatTransfer.2012004659, DOI 10.1615/ANNUALREVHEATTRANSFER.2012004659]; Lokare OR, 2018, DESALINATION, V428, P250, DOI 10.1016/j.desal.2017.11.037; Lu YY, 2011, IND ENG CHEM RES, V50, P7345, DOI 10.1021/ie1016877; Najib A, 2017, DESALIN WATER TREAT, V76, P19, DOI 10.5004/dwt.2017.20303; Najib A, 2019, DESALINATION, V466, P52, DOI 10.1016/j.desal.2019.05.009; Nakoa K, 2015, DESALIN WATER TREAT, V56, P2618, DOI 10.1080/19443994.2014.972731; Orfi J, 2017, DESALIN WATER TREAT, V76, P40, DOI 10.5004/dwt.2017.11378; Pangarkar B.L., 2011, ISRN MAT SCI, V2011, P1; Qtaishat M, 2008, DESALINATION, V219, P272, DOI 10.1016/j.desal.2007.05.019; Stephanopoulos G., 1984, CHEM PROCESS CONTROL; Swaminathan J., 2006, APPL ENERG, V184, P491; Swaminathan J, 2016, J MEMBRANE SCI, V502, P171, DOI 10.1016/j.memsci.2015.12.017; Winter D, 2011, J MEMBRANE SCI, V375, P104, DOI 10.1016/j.memsci.2011.03.030; Yu H, 2012, J MEMBRANE SCI, V405, P38, DOI 10.1016/j.memsci.2012.02.035	46	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230207	10.1371/journal.pone.0230207	http://dx.doi.org/10.1371/journal.pone.0230207			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208423	Green Published, gold			2022-12-26	WOS:000535305100011
J	Mokotedi, L; Michel, FS; Mogane, C; Gomes, M; Woodiwiss, AJ; Norton, GR; Millen, AME				Mokotedi, Lebogang; Michel, Frederic S.; Mogane, Conrad; Gomes, Monica; Woodiwiss, Angela J.; Norton, Gavin R.; Millen, Aletta M. E.			Associations of inflammatory markers with impaired left ventricular diastolic and systolic function in collagen-induced arthritis	PLOS ONE			English	Article							HEART-FAILURE; RHEUMATOID-ARTHRITIS; EJECTION FRACTION; MYOCARDIAL-FUNCTION; DYSFUNCTION; ECHOCARDIOGRAPHY; RECOMMENDATIONS; HYPERTENSION; PREVALENCE; EXPRESSION	Background High-grade inflammation may play a pivotal role in the pathogenesis of left ventricular (LV) dysfunction. Evidence to support a role of systemic inflammation in mediating impaired LV function in experimental models of rheumatoid arthritis (RA) remains limited. The aim of the present study was to determine the effects of high-grade systemic inflammation on LV diastolic and systolic function in collagen-induced arthritis (CIA). Methods To induce CIA, bovine type-II collagen emulsified in incomplete Freund's adjuvant was injected at the base of the tail into 21 three-month old Sprague Dawley rats. Nine-weeks after the first immunisation, LV function was assessed by pulsed Doppler, tissue Doppler imaging and Speckle tracking echocardiography. Cardiac collagen content was determined by picrosirius red staining; circulating inflammatory markers were measured using ELISA. Results Compared to controls (n = 12), CIA rats had reduced myocardial relaxation as indexed by lateral e' (early diastolic mitral annular velocity) and e'/a' (early-to-late diastolic mitral annular velocity) and increased filling pressures as indexed by E/e'. No differences in ejection fraction and LV endocardial fractional shortening between the groups were recorded. LV global radial and circumferential strain and strain rate were reduced in CIA rats compared to controls. Higher concentrations of circulating inflammatory markers were associated with reduced lateral e', e'/a', radial and circumferential strain and strain rate. Greater collagen content was associated with increased concentrations of circulating inflammatory markers and E/e'. Conclusion High-grade inflammation is associated with impaired LV diastolic function and greater myocardial deformation independent of haemodynamic load in CIA rats.	[Mokotedi, Lebogang; Michel, Frederic S.; Mogane, Conrad; Gomes, Monica; Woodiwiss, Angela J.; Norton, Gavin R.; Millen, Aletta M. E.] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Cardiovasc Pathophysiol & Genom Res Unit, Johannesburg, South Africa	University of Witwatersrand	Mokotedi, L (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Cardiovasc Pathophysiol & Genom Res Unit, Johannesburg, South Africa.	Lebogang.mokotedi@wits.ac.za		Mokotedi, Lebogang/0000-0002-1520-7093; Millen, Aletta/0000-0002-4831-7336	Connective Tissue Diseases Research Fund; Faculty of Health Sciences Research Committee at the University of the Witwatersrand	Connective Tissue Diseases Research Fund; Faculty of Health Sciences Research Committee at the University of the Witwatersrand	This work was supported by the Connective Tissue Diseases Research Fund and the Faculty of Health Sciences Research Committee at the University of the Witwatersrand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeniran I, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00078; Alsamara M, 2014, EXPERT REV CARDIOVAS, V12, P743, DOI 10.1586/14779072.2014.911086; Aslam F, 2013, ARTHRIT CARE RES, V65, P534, DOI 10.1002/acr.21861; Baktir AO, 2015, HERZ, V40, P669, DOI 10.1007/s00059-014-4068-3; Baniaamam M, 2018, EXPERT OPIN BIOL TH, V18, P585, DOI 10.1080/14712598.2018.1462794; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Bravo PE, 2016, EUR HEART J-CARD IMG, V17, P293, DOI 10.1093/ehjci/jev154; Combes A, 2002, PFLUG ARCH EUR J PHY, V445, P246, DOI 10.1007/s00424-002-0921-y; Crowson CS, 2005, ARTHRITIS RHEUM-US, V52, P3039, DOI 10.1002/art.21349; Dai H, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007320; Deswal A, 2001, CIRCULATION, V103, P2055; Fine NM, 2014, ANN RHEUM DIS, V73, P1833, DOI 10.1136/annrheumdis-2013-203314; Franssen C, 2016, JACC-HEART FAIL, V4, P312, DOI 10.1016/j.jchf.2015.10.007; Hamdy RM, 2017, CLIN PRACT, V6, P37; Harvey A, 2016, CAN J CARDIOL, V32, P659, DOI 10.1016/j.cjca.2016.02.070; Iliesiu AM, 2018, ADV EXP MED BIOL, V1067, P67, DOI 10.1007/5584_2018_149; Jasemian Y., 2011, British Journal of Medicine and Medical Research, V1, P469; Kadappu KK, 2015, HEART LUNG CIRC, V24, P224, DOI 10.1016/j.hlc.2014.10.003; Kasner M, 2007, CIRCULATION, V116, P637, DOI 10.1161/CIRCULATIONAHA.106.661983; Kasner M, 2011, J AM COLL CARDIOL, V57, P977, DOI 10.1016/j.jacc.2010.10.024; Kim KR, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/709378; Kleijn SA, 2012, EUR HEART J-CARD IMG, V13, P159, DOI 10.1093/ejechocard/jer174; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Langeland S, 2005, CIRCULATION, V112, P2157, DOI 10.1161/CIRCULATIONAHA.105.554006; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Lewis GA, 2017, J AM COLL CARDIOL, V70, P2186, DOI 10.1016/j.jacc.2017.09.006; Liang KP, 2010, ANN RHEUM DIS, V69, P1665, DOI 10.1136/ard.2009.124362; Lo Gullo A, 2018, ATHEROSCLEROSIS, V271, P214, DOI 10.1016/j.atherosclerosis.2018.03.004; Logstrup BB, 2014, AM J CARDIOVASC DIS, V4, P79; McTiernan CF, 1997, CIRC RES, V81, P493, DOI 10.1161/01.RES.81.4.493; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Nicola PJ, 2005, ARTHRITIS RHEUM-US, V52, P412, DOI 10.1002/art.20855; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Pironti G, 2018, HEART; Reynolds SL, 2012, BRIT J PHARMACOL, V167, P505, DOI 10.1111/j.1476-5381.2012.01988.x; Rudominer RL, 2009, ARTHRITIS RHEUM-US, V60, P22, DOI 10.1002/art.24148; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Selby DE, 2011, J AM COLL CARDIOL, V58, P147, DOI 10.1016/j.jacc.2010.10.069; Shah AM, 2012, EUR HEART J, V33, P1716, DOI 10.1093/eurheartj/ehs124; Sitia S, 2012, INT J CARDIOL, V160, P8, DOI 10.1016/j.ijcard.2011.03.012; Suthahar Navin, 2017, Curr Heart Fail Rep, V14, P235, DOI 10.1007/s11897-017-0343-y; Tomas L, 2013, WIEN KLIN WOCHENSCHR, V125, P233, DOI 10.1007/s00508-013-0349-8; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Verhoeven F, 2017, CLIN EXP IMMUNOL, V188, P208, DOI 10.1111/cei.12938; Wan SH, 2014, J AM COLL CARDIOL, V63, P407, DOI 10.1016/j.jacc.2013.10.063; Westermann D, 2011, CIRC-HEART FAIL, V4, P44, DOI 10.1161/CIRCHEARTFAILURE.109.931451; Yalcin F, 2015, IJC HEART VASC, V7, P141, DOI 10.1016/j.ijcha.2015.04.003; Zile MR, 2015, CIRCULATION, V131, P1247, DOI 10.1161/CIRCULATIONAHA.114.013215	49	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230657	10.1371/journal.pone.0230657	http://dx.doi.org/10.1371/journal.pone.0230657			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208438	Green Published, gold			2022-12-26	WOS:000535305100033
J	Soliman, H				Soliman, Hatem			Deep learning based searching approach for RDF graphs	PLOS ONE			English	Article							KEYWORD SEARCH; FUZZY RDF; PREDICTION; EFFICIENT; ALGORITHMS; SEVERITY; PRIORITY; WEB	The Internet is a remarkably complex technical system. Its rapid growth has also brought technical issues such as problems to information retrieval. Search engines retrieve requested information based on the provided keywords. Consequently, it is difficult to accurately find the required information without understanding the syntax and semantics of the content. Multiple approaches are proposed to resolve this problem by employing the semantic web and linked data techniques. Such approaches serialize the content using the Resource Description Framework (RDF) and execute the queries using SPARQL to resolve the problem. However, an exact match between RDF content and query structure is required. Although, it improves the keyword-based search; however, it does not provide probabilistic reasoning to find the semantic relationship between the queries and their results. From this perspective, in this paper, we propose a deep learning-based approach for searching RDF graphs. The proposed approach treats document requests as a classification problem. First, we preprocess the RDF graphs to convert them into N-Triples format. Second, bag-of-words (BOW) and word2vec feature modeling techniques are combined for a novel deep representation of RDF graphs. The attention mechanism enables the proposed approach to understand the semantic between RDF graphs. Third, we train a convolutional neural network for the accurate retrieval of RDF graphs using the deep representation. We employ 10-fold cross-validation to evaluate the proposed approach. The results show that the proposed approach is accurate and surpasses the state-of-the-art. The average accuracy, precision, recall, and f-measure are up to 97.12%, 98.17%, 95.56%, and 96.85%, respectively.	[Soliman, Hatem] Nanjing Univ Aeronaut & Astronaut, Coll Comp Sci & Technol, Nanjing, Peoples R China	Nanjing University of Aeronautics & Astronautics	Soliman, H (corresponding author), Nanjing Univ Aeronaut & Astronaut, Coll Comp Sci & Technol, Nanjing, Peoples R China.	hatem@nuaa.edu.cn	Soliman, hatem/AAL-9110-2020	Soliman, hatem/0000-0002-7359-0123				Anvik J, 2011, ACM T SOFTW ENG METH, V20, DOI 10.1145/2000791.2000794; Arnaout H, 2018, J WEB SEMANT, V48, P66, DOI 10.1016/j.websem.2017.12.001; Besbes G, 2017, INTEGR COMPUT-AID E, V24, P87, DOI 10.3233/ICA-160525; Bizer C, 2009, LINKED DATA STORY SO; Bizer C, 2009, IEEE INTELL SYST, V24, P87, DOI 10.1109/MIS.2009.102; Casanova MA, 2019, LECT NOTES COMPUT SC, V11788, P7, DOI 10.1007/978-3-030-33223-5_2; de Virgilio M, 2014, RICIN TOXIN, P208; DeVirgilio R., 2012, P OTM CONF INT C MOV, V7566, P780; Dong F, 2015, FORMALIZATION VISUAL, P169; Elleuch N, 2011, P 11 INT WORKSH MULT; Gani A, 2015, KNOWLEDGE INFORM SYS, V46; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Gupta Y, 2015, EXPERT SYST APPL, V42, P1223, DOI 10.1016/j.eswa.2014.09.009; Hadi AS, 2013, 2013 IEEE 27TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS WORKSHOPS (WAINA), P613, DOI 10.1109/WAINA.2013.204; Hellerstein JL, 2000, SEVENTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-2001) / TWELFTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-2000), P596; Hindle A, 2012, PROC INT CONF SOFTW, P837, DOI 10.1109/ICSE.2012.6227135; Hinton G. E., 2012, COMPUT SCI, DOI DOI 10.9774/GLEAF.978-1-909493-38-4_2; Idreos S, 2015, SIGMOD'15: PROCEEDINGS OF THE 2015 ACM SIGMOD INTERNATIONAL CONFERENCE ON MANAGEMENT OF DATA, P277, DOI 10.1145/2723372.2731084; Izakian H, 2015, ENG APPL ARTIF INTEL, V39, P235, DOI 10.1016/j.engappai.2014.12.015; Gacto MJ, 2010, IEEE T FUZZY SYST, V18, P515, DOI 10.1109/TFUZZ.2010.2041008; Keras, FLATT LAYER; Komkhao M, 2013, INT J GEN SYST, V42, P41, DOI 10.1080/03081079.2012.710437; Kyu KM, 2019, 2019 INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION TECHNOLOGIES (ICAIT), P96, DOI 10.1109/AITC.2019.8920921; Lamkanfi Ahmed, 2010, Proceedings of the 2010 7th IEEE Working Conference on Mining Software Repositories (MSR 2010), P1, DOI 10.1109/MSR.2010.5463284; Lamkanfi A, 2011, EUR CON SFTWR MTNCE, P249, DOI 10.1109/CSMR.2011.31; Zhang L, 2013, PROC VLDB ENDOW, V6, P1642, DOI 10.14778/2556549.2556550; Li GF, 2019, FUZZY SET SYST, V376, P106, DOI 10.1016/j.fss.2019.02.021; Li W, 2008, EFFICIENT DATA MODEL, P58, DOI DOI 10.1145/1463434.1463503; Lughofer E, 2018, IEEE T FUZZY SYST, V26, P292, DOI 10.1109/TFUZZ.2017.2654504; Lv YH, 2008, IEEE INT CONF FUZZY, P1441; Ma ZM, 2018, INT J INTELL SYST, V33, P1534, DOI 10.1002/int.21996; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Nagarajan G, 2015, PROCEDIA COMPUT SCI, V48, P101, DOI 10.1016/j.procs.2015.04.157; Pancho DP, 2016, FUZZY SET SYST, V297, P1, DOI 10.1016/j.fss.2015.05.019; Purushotham S, 2012, COMM COM INF SC, V270, P680; Ramay WY, 2019, IEEE ACCESS, V7, P46846, DOI 10.1109/ACCESS.2019.2909746; Reh A, 2015, COMPUT GRAPH-UK, V53, P177, DOI 10.1016/j.cag.2015.04.001; Sak H, 2014, INTERSPEECH, P338; Singh V, 2016, IEEE T KNOWL DATA EN, V28, P741, DOI 10.1109/TKDE.2015.2492549; Sohrawardi SJ, 2014, 2014 NINTH INTERNATIONAL CONFERENCE ON DIGITAL INFORMATION MANAGEMENT (ICDIM), P242, DOI 10.1109/ICDIM.2014.6991434; Tian Y, 2012, APPL MECH MATER, V166-169, P215, DOI 10.4028/www.scientific.net/AMM.166-169.215; Tian Y, 2013, PROC IEEE INT CONF S, P200, DOI 10.1109/ICSM.2013.31; To ND, 2018, ADV INTELL SYST, V643, P418, DOI 10.1007/978-3-319-66827-7_38; Tran T, 2009, PROC INT CONF DATA, P405, DOI 10.1109/ICDE.2009.119; ULLAH R, 2015, HDB RES TRENDS FUTUR, P87, DOI DOI 10.4018/978-1-4666-8505-5.; Umer Q, 2019, J SYST SOFTWARE, V155, P57, DOI 10.1016/j.jss.2019.05.026; Umer Q, 2018, IEEE ACCESS, V6, P35743, DOI 10.1109/ACCESS.2018.2850910; Vaid S, 2017, 2017 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P2000, DOI 10.1109/ICACCI.2017.8126138; Wang BX, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL), VOL 1, P2311; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Yang G., 2017, P 32 ACM SIGAPP S AP, P1280; Yang M, 2014, PROC VLDB ENDOW, V7, P1809, DOI 10.14778/2733085.2733088; Zheng WG, 2016, PROC VLDB ENDOW, V9, P840, DOI 10.14778/2983200.2983201; Zhou L, 2011, COMPUT HUM BEHAV, V27, P1294, DOI 10.1016/j.chb.2010.07.024	54	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230500	10.1371/journal.pone.0230500	http://dx.doi.org/10.1371/journal.pone.0230500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GC	32203547	Green Published, gold			2022-12-26	WOS:000535303900023
J	Shiferaw, MB; Misganaw, AS				Shiferaw, Melashu Balew; Misganaw, Abay Sisay			Evaluation of continuous quality improvement of tuberculosis and HIV diagnostic services in Amhara Public Health Institute, Ethiopia	PLOS ONE			English	Article							SPECIMEN REJECTION	Background Unreliable laboratory results lead to unnecessary tests, procedures or treatments which may harm the patient. Continuous quality improvement (CQI) is a useful objective tool to improve processes and services. The use of quality indicators that meet requirements for effectiveness is an important quality improvement tool. However, the quality of critical aspects of pre-examination, examination, and post-examination processes have not been evaluated in Ethiopia including our setting. Hence, this study aimed to assess the performance of continuous quality improvement of TB and HIV laboratory tests in the Amhara Public Health Institute (APHI). Methods A cross-sectional study was conducted to evaluate the quality indicators of advanced TB and HIV related laboratory tests in APHI from 01 January to 30 September 2019. HIV viral load, exposed infant diagnosis (EID), GeneXpert and TB culture quality indicators data were used as a quality improvement tool and evaluated in comparison to established targets. Data were extracted from excel database and record review of patient information, and entered and analyzed using SPSS V20 software. Results A total of 26,487 samples were received from 01 January to 30 September 2019. The overall specimen rejection rate was 0.43% (115/26,487). Specifically, viral load and TB culture had 0.43% and 1.14% rejection rates, respectively. The highest monthly rejection was documented for TB culture (5.3%) and viral load (2.4%) in September 2019. Centrifugation problems (46.1% [53/115]) and the use of the wrong container (40.9% [47/115]) were the main reasons for the rejections. Moreover, EID test was interrupted for a total of 54 days and 22 days due to reagent stock out and equipment down time, respectively. Similarly, about 82% of viral load and 100% of the EID tests had long turnaround time (TAT) with an average of 24.1 and 29.3 days respectively in September 2019. Conclusions There were high rates of TB culture and viral load specimen rejection, and EID test interruptions. The TAT of viral load and EID tests were longer than the targeted goal (10 days) average TAT. Hence, training of sample collectors, functional equipment maintenance systems and supply chain management are recommended for continuous quality improvement.	[Shiferaw, Melashu Balew] Amhara Publ Hlth Inst, Res & Technol Transfer Directorate, Bahir Dar, Amhara, Ethiopia; [Misganaw, Abay Sisay] Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia	Addis Ababa University	Shiferaw, MB (corresponding author), Amhara Publ Hlth Inst, Res & Technol Transfer Directorate, Bahir Dar, Amhara, Ethiopia.	bmelashu@gmail.com	Shiferaw, Melashu/GPT-3320-2022					Addo SA, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3485-z; [Anonymous], 2012, 151892012 ISO; Cao L, 2016, CLIN CHIM ACTA, V458, P154, DOI 10.1016/j.cca.2016.05.003; CDC, ETH COUNTR PROF; College of Physicians and Surgeons of British Columbia, LAB MED PROF TEST AV; Da Rin G, 2010, J MED BIOCHEM, V29, P315, DOI 10.2478/v10011-010-0031-x; Dikmen ZG, 2015, BIOCHEM MEDICA, V25, P377, DOI 10.11613/BM.2015.037; Epner PL, 2013, BMJ QUAL SAF, V22, pii6, DOI 10.1136/bmjqs-2012-001621; Hammerling JA, 2012, LABMEDICINE, V43, P41, DOI 10.1309/LM6ER9WJR1IHQAUY; Jegede FE, 2015, OPEN J CLIN DIAGNOST, V5, P1, DOI DOI 10.4236/0JCD.2015.51001; Karcher DS, 2014, ARCH PATHOL LAB MED, V138, P1003, DOI 10.5858/arpa.2013-0331-CP; Kaushik Nitin, 2014, MLO Med Lab Obs, V46, P26; Krleza JL, 2019, BIOCHEM MEDICA, V29, DOI 10.11613/BM.2019.020502; Lee YJ, 2015, J KOREAN MED SCI, V30, P733, DOI 10.3346/jkms.2015.30.6.733; Mesfin Eyob Abera, 2017, EJIFCC, V28, P205; Minchella PA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173009; O'Connor John D, 2015, Clin Biochem Rev, V36, P7; PEPFAR VL/EID Community of Practice (COOP), 2019, VIR LOAD EARL INF DI; Petrose LG, 2016, AM J TROP MED HYG, V94, P1426, DOI 10.4269/ajtmh.15-0867; Plebani M, 2017, CLIN LAB MED, V37, P187, DOI 10.1016/j.cll.2016.09.015; Ridderhof JC, 2007, B WORLD HEALTH ORGAN, V85, P354, DOI 10.2471/BLT.06.039081; Rollins G, 2015, EXAMINING CONSEQUENC; Rooper L, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22060; Thiha S, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1395657; Walz SE, 2013, CLIN LAB MED, V33, P183, DOI 10.1016/j.cll.2012.10.001; Wexler C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181005; World Health Organization, 2019, GLOB TUB REP; Zinyowera S, EC EVALUATION VIRAL	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230532	10.1371/journal.pone.0230532	http://dx.doi.org/10.1371/journal.pone.0230532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191762	Green Published, gold			2022-12-26	WOS:000535302300057
J	Zeng, BP; Wang, SS; Li, Y; Xiao, ZJ; Zhou, M; Wang, SG; Zhang, DW				Zeng, Boping; Wang, Shasha; Li, Yan; Xiao, Zhongjiu; Zhou, Min; Wang, Shigui; Zhang, Daowei			Effect of long-term cold storage on trehalose metabolism of pre-wintering Harmonia axyridis adults and changes in morphological diversity before and after wintering	PLOS ONE			English	Article							MEMBRANE-BOUND TREHALASE; LADY BEETLE COLEOPTERA; GENE-EXPRESSION; PHENOTYPIC PLASTICITY; SEASONAL-VARIATION; MOLECULAR-CLONING; TOLERANCE; COCCINELLIDAE; HARDINESS; INSECT	Harmonia axyridis is a major bio-control agent of pests in agriculture and forest ecosystems. It is also a globally important invasive insect species. To test whether dark elytra colour is associated with greater cold hardiness, we compared the survival rate of prolonged cold exposure in both yellow and black colour morphs of female and male H. axyridis. We determined the trehalose and glycogen content, trehalase activity, and the dynamics of genes associated with the trehalose metabolic pathway. Yellow forms predominated before winter began, however black forms increased from 11.15 to 30.46% after overwintering. There was no significant difference in trehalose content between the females and males during overwintering. Glycogen content in over-wintering yellow females and black males increased significantly, while it decreased in black females. Soluble trehalase activity increased significantly in all the insects except black females. Membrane-bound trehalase activity increased in black males, and decreased in black females. Trehalose and glycogen content and trehalase activity were regulated by differential expression of TRE and TPS genes. Female beetles weighed more than males and survived in low temperatures for longer periods of time, regardless of elytra colour, suggesting that mass is a stronger predictor of overwintering survival rather than colour morph. Our results provide a guide for comparing cold resistance in insects and a theoretical basis for cold storage of H. axyridis for use as natural enemies of pests in biological control programs.	[Zeng, Boping; Xiao, Zhongjiu; Zhang, Daowei] Zunyi Normal Univ, Sch Biol & Agr Sci & Technol, Zunyi, Guizhou, Peoples R China; [Wang, Shasha; Li, Yan; Zhou, Min; Wang, Shigui] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University	Zhang, DW (corresponding author), Zunyi Normal Univ, Sch Biol & Agr Sci & Technol, Zunyi, Guizhou, Peoples R China.	zhangdw1000@163.com			National Natural Science Foundation of China [31672081]; Joint Project from Zunyi science and Technology Bureau; Zunyi Normal University Natural Science Foundation [ZSKH HZ(264)]; Guizhou Provincial Department of Education Foundation [QSZHZ[2012]146]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Joint Project from Zunyi science and Technology Bureau; Zunyi Normal University Natural Science Foundation; Guizhou Provincial Department of Education Foundation	This work was supported by the National Natural Science Foundation of China (Grant No. 31672081), the Joint Project from Zunyi science and Technology Bureau and Zunyi Normal University Natural Science Foundation (No. ZSKH HZ(264)), and the Guizhou Provincial Department of Education Foundation No. QSZHZ[2012]146.	[Anonymous], 2015, THESIS KUNMING U; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Benoit JB, 2007, J INSECT PHYSIOL, V53, P656, DOI 10.1016/j.jinsphys.2007.04.006; Benoit JB, 2009, COMP BIOCHEM PHYS A, V152, P518, DOI 10.1016/j.cbpa.2008.12.009; Berkvens N, 2012, J INSECT PHYSL, V56, P438, DOI [10.1016/j.jinsphys.2009.11, DOI 10.1016/J.JINSPHYS.2009.11]; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010133; Chen QW, 2018, B ENTOMOL RES, V108, P388, DOI [10.1017/S000748531700089X, 10.1017/s000748531700089x]; Dobzhansky T, 1933, AM NAT, V67, P97, DOI 10.1086/280472; Dong YC, 2014, INT J BIOL SCI, V10, P1051, DOI 10.7150/ijbs.9438; Du WenMei, 2014, Journal of Jilin Agricultural University, V36, P536; Dubovskiy IM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0584; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Gautier M, 2018, CURR BIOL, V28, P3296, DOI 10.1016/j.cub.2018.08.023; Ge LQ, 2011, PESTIC BIOCHEM PHYS, V100, P172, DOI 10.1016/j.pestbp.2011.03.007; HAYAKAWA Y, 1982, INSECT BIOCHEM, V12, P639, DOI 10.1016/0020-1790(82)90050-6; Heydari M, 2014, B ENTOMOL RES, V104, P592, DOI 10.1017/S0007485314000364; [景晓红 Ji Xiaohong], 2002, [生态学报, Acta Ecologica Sinica], V22, P2202; Koch R L, 2003, J Insect Sci, V3, P32; Koch RL, 2004, ENVIRON ENTOMOL, V33, P815, DOI 10.1603/0046-225X-33.4.815; Kostal V, 2014, J INSECT PHYSIOL, V63, P62, DOI 10.1016/j.jinsphys.2014.02.007; Kutch IC, 2014, J EXP BIOL, V217, P3664, DOI 10.1242/jeb.106294; Labrie G, 2008, ANN ENTOMOL SOC AM, V101, P860, DOI 10.1603/0013-8746(2008)101[860:OSOMAL]2.0.CO;2; Leather S. R., 1993, ECOLOGY INSECT OVERW; Liu JX, 2006, THESIS; Liu L, 2008, J MED PEST CONTROL, V24, P803; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma RY, 2006, ENVIRON ENTOMOL, V35, P881, DOI 10.1603/0046-225X-35.4.881; Matsuda H, 2015, J BIOL CHEM, V290, P1244, DOI 10.1074/jbc.M114.619411; Michie LJ, 2010, J EVOLUTION BIOL, V23, P1699, DOI 10.1111/j.1420-9101.2010.02043.x; Michie LJ, 2011, EVOL ECOL, V25, P1259, DOI 10.1007/s10682-011-9476-8; Mitsumasu K, 2005, INSECT MOL BIOL, V14, P501, DOI 10.1111/j.1365-2583.2005.00581.x; Mitsumasu K, 2010, FEBS J, V277, P4215, DOI 10.1111/j.1742-4658.2010.07811.x; Nomura M, 2001, APPL ENTOMOL ZOOL, V36, P443, DOI 10.1303/aez.2001.443; Parkash R, 2014, J EXP ZOOL PART A, V321, P13, DOI 10.1002/jez.1832; Parkash R, 2012, J COMP PHYSIOL B, V182, P625, DOI 10.1007/s00360-011-0641-8; Parkinson NM, 2003, COMP BIOCHEM PHYS C, V134, P513, DOI 10.1016/S1532-0456(03)00041-3; Purse BV, 2015, J BIOGEOGR, V42, P575, DOI 10.1111/jbi.12423; Qin Zi, 2012, Acta Entomologica Sinica, V55, P651; Rajpurohit Subhash, 2008, Entomological Research, V38, P49, DOI 10.1111/j.1748-5967.2008.00129.x; Ramniwas S, 2013, J EXP BIOL, V216, P1244, DOI 10.1242/jeb.076166; Ren Xiao-Yun, 2015, Huanjing Kunchong Xuebao, V37, P1195; Renault D, 2004, PHYSIOL ENTOMOL, V29, P139, DOI 10.1111/j.0307-6962.2004.00377.x; Roulin A, 2014, GLOBAL CHANGE BIOL, V20, P3344, DOI 10.1111/gcb.12594; Roy HE, 2016, BIOL INVASIONS, V18, P997, DOI 10.1007/s10530-016-1077-6; Ruan CC, 2012, BIOCONTROL, V57, P95, DOI 10.1007/s10526-011-9414-2; Sadeghi R, 2012, NEOTROP ENTOMOL, V41, P493, DOI 10.1007/s13744-012-0077-1; Santos R, 2012, ARCH INSECT BIOCHEM, V81, P199, DOI 10.1002/arch.21043; Shi ZK, 2017, BIOL OPEN, V6, P1096, DOI 10.1242/bio.025189; Shi ZK, 2016, COMP BIOCHEM PHYS B, V198, P10, DOI 10.1016/j.cbpb.2016.03.002; Shukla E, 2015, GLYCOBIOLOGY, V25, P357, DOI 10.1093/glycob/cwu125; TAKIGUCHI M, 1992, BIOCHEM J, V288, P19, DOI 10.1042/bj2880019; Tan CC, 1934, AM NAT, V68, P252, DOI 10.1086/280543; TAN CC, 1946, GENETICS, V31, P195; Tan XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep28245; Tang Bin, 2018, Scientia Agricultura Sinica, V51, P697; Tang B, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00030; Tang B, 2017, COMP BIOCHEM PHYS D, V22, P78, DOI 10.1016/j.cbd.2017.01.004; Tang Bin, 2014, Chinese Journal of Applied Entomology, V51, P1397, DOI 10.7679/j.issn.2095-1353.2014.164; Tang B, 2014, APPL ENTOMOL ZOOL, V49, P255, DOI 10.1007/s13355-014-0244-4; Tang Bin, 2012, Acta Entomologica Sinica, V55, P1315; Tang B, 2012, ARCH INSECT BIOCHEM, V80, P42, DOI 10.1002/arch.21027; Tang B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-51; Tatun N, 2008, INSECT BIOCHEM MOLEC, V38, P788, DOI 10.1016/j.ibmb.2008.05.003; Wang HS, 2006, CRYOBIOLOGY, V53, P206, DOI 10.1016/j.cryobiol.2006.06.003; Wang S, 2015, B ENTOMOL RES, V105, P245, DOI 10.1017/S0007485315000036; Wang S, 2011, BIOCONTROL, V56, P193, DOI 10.1007/s10526-010-9325-7; Wang S, 2009, ECOL ENTOMOL, V34, P483, DOI 10.1111/j.1365-2311.2008.01075.x; Xiao D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00033; Xu J, 2009, GLYCOBIOLOGY, V19, P250, DOI 10.1093/glycob/cwn127; Yang MM, 2017, PEST MANAG SCI, V73, P206, DOI 10.1002/ps.4287; Yoshinaga K, 1997, BIOSCI BIOTECH BIOCH, V61, P160, DOI 10.1271/bbb.61.160; Zhang L, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iex015; Zhao Jing, 2008, Acta Entomologica Sinica, V51, P1271; Zhao Jing, 2015, Chinese Journal of Applied Entomology, V52, P428, DOI 10.7679/j.issn.2095-1353.2015.047; Zhao Jing, 2010, Acta Entomologica Sinica, V53, P147; Zhao LN, 2016, SCI REP-UK, V6, DOI 10.1038/srep27841; Zvereva EL, 2019, SCI TOTAL ENVIRON, V673, P237, DOI 10.1016/j.scitotenv.2019.03.458	77	2	2	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230435	10.1371/journal.pone.0230435	http://dx.doi.org/10.1371/journal.pone.0230435			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191747	gold, Green Published			2022-12-26	WOS:000535302300048
J	Pillon, MC; Goslen, KH; Gordon, J; Wells, ML; Williams, JG; Stanley, RE				Pillon, Monica C.; Goslen, Kevin H.; Gordon, Jacob; Wells, Melissa L.; Williams, Jason G.; Stanley, Robin E.			It takes two (Las1 HEPN endoribonuclease domains) to cut RNA correctly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoribonuclease; ribosome assembly; RNA degradation; RNA processing; ribosomal RNA processing (rRNA processing); higher eukaryotes and prokaryotes nucleotide-binding (HEPN); Las1; Las1L; nuclease specificity; RNA cleavage; ribosome biogenesis factor; LAS1L; RNA processing	ASP CATALYTIC DYAD; POLYNUCLEOTIDE KINASE; STRUCTURAL BASIS; WILD-TYPE; REVEALS; YEAST; HISTIDINE; D121N	The ribosome biogenesis factor Las1 is an essential endoribonuclease that is well-conserved across eukaryotes and a newly established member of the higher eukaryotes and prokaryotes nucleotide-binding (HEPN) domain-containing nuclease family. HEPN nucleases participate in diverse RNA cleavage pathways and share a short HEPN nuclease motif (R?XXXH) important for RNA cleavage. Most HEPN nucleases participate in stress-activated RNA cleavage pathways; Las1 plays a fundamental role in processing pre-rRNA. Underscoring the significance of Las1 function in the cell, mutations in the human LAS1L (LAS1-like) gene have been associated with neurological dysfunction. Two juxtaposed HEPN nuclease motifs create Las1's composite nuclease active site, but the roles of the individual HEPN motif residues are poorly defined. Here using a combination of in vivo experiments in Saccharomyces cerevisiae and in vitro assays, we show that both HEPN nuclease motifs are required for Las1 nuclease activity and fidelity. Through in-depth sequence analysis and systematic mutagenesis, we determined the consensus HEPN motif in the Las1 subfamily and uncovered its canonical and specialized elements. Using reconstituted Las1 HEPN-HEPN? chimeras, we defined the molecular requirements for RNA cleavage. Intriguingly, both copies of the Las1 HEPN motif were important for nuclease function, revealing that both HEPN motifs participate in coordinating the RNA within the Las1 active site. We also established that conformational flexibility of the two HEPN domains is important for proper nuclease function. The results of our work reveal critical information about how dual HEPN domains come together to drive Las1-mediated RNA cleavage.	[Pillon, Monica C.; Goslen, Kevin H.; Gordon, Jacob; Wells, Melissa L.; Stanley, Robin E.] NIEHS, Signal Transduct Lab, NIH, US Dept HHS, POB 12233, Res Triangle Pk, NC 27709 USA; [Williams, Jason G.] NIEHS, Epigenet & Stem Cell Biol Lab, NIH, US Dept HHS, POB 12233, Res Triangle Pk, NC 27709 USA; [Goslen, Kevin H.] Wake Forest Sch Med, 475 Vine St, Winston Salem, NC 27101 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Wake Forest University	Stanley, RE (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	robin.stanley@nih.gov	Stanley, Robin/M-3008-2019	Stanley, Robin/0000-0002-2106-3102; Gordon, Jacob/0000-0001-7199-7416	National Institutes of Health Intramural Research Program; NIEHS, National Institutes of Health [ZIA ES103247]; Canadian Institutes of Health Research (CIHR) [146626]	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the National Institutes of Health Intramural Research Program and NIEHS, National Institutes of Health Grant ZIA ES103247 (to R. E. S.) and by the Canadian Institutes of Health Research (CIHR) Grant 146626 (to M. C. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Bassler J, 2019, ANNU REV BIOCHEM, V88, P281, DOI 10.1146/annurev-biochem-013118-110817; Butterfield RJ, 2014, NEUROLOGY, V82, P1322, DOI 10.1212/WNL.0000000000000305; Castle CD, 2013, NUCLEIC ACIDS RES, V41, P1135, DOI 10.1093/nar/gks1086; Castle CD, 2010, MOL CELL BIOL, V30, P4404, DOI 10.1128/MCB.00358-10; Cox DBT, 2017, SCIENCE, V358, P1019, DOI 10.1126/science.aaq0180; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Feldman HC, 2016, ACS CHEM BIOL, V11, P2195, DOI 10.1021/acschembio.5b00940; Fromm L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01786-9; Gasse L, 2015, MOL CELL, V60, P808, DOI 10.1016/j.molcel.2015.10.021; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179; Grynberg M, 2003, TRENDS BIOCHEM SCI, V28, P224, DOI 10.1016/S0968-0004(03)00060-4; Han YC, 2014, SCIENCE, V343, P1244, DOI 10.1126/science.1249845; Heindl K, 2010, EMBO J, V29, P4161, DOI 10.1038/emboj.2010.275; Hu H, 2016, MOL PSYCHIATR, V21, P133, DOI 10.1038/mp.2014.193; Huang H, 2014, MOL CELL, V53, P221, DOI 10.1016/j.molcel.2013.12.025; Jia XY, 2018, J BIOL CHEM, V293, P6812, DOI 10.1074/jbc.RA118.002421; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kim YK, 2013, PROTEINS, V81, P261, DOI 10.1002/prot.24183; Klinge S, 2019, NAT REV MOL CELL BIO, V20, P116, DOI 10.1038/s41580-018-0078-y; Knott GJ, 2017, NAT STRUCT MOL BIOL, V24, P825, DOI 10.1038/nsmb.3466; Konermann S, 2018, CELL, V173, P665, DOI 10.1016/j.cell.2018.02.033; Korennykh AV, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-47; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Liu L, 2017, CELL, V170, P714, DOI 10.1016/j.cell.2017.06.050; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Niewoehner O, 2017, NATURE, V548, P543, DOI 10.1038/nature23467; Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115; O'Connell MR, 2019, J MOL BIOL, V431, P66, DOI 10.1016/j.jmb.2018.06.029; Panov KI, 1996, FEBS LETT, V398, P57, DOI 10.1016/S0014-5793(96)01173-8; Pilion MC, 2019, NAT STRUCT MOL BIOL, V26, P830, DOI 10.1038/s41594-019-0289-8; Pillon MC, 2018, RNA, V24, P721, DOI 10.1261/rna.065037.117; Pillon MC, 2018, CURR GENET, V64, P183, DOI 10.1007/s00294-017-0749-9; Pillon MC, 2017, P NATL ACAD SCI USA, V114, pE5530, DOI 10.1073/pnas.1703133114; Quirk DJ, 1998, BIOCHEMISTRY-US, V37, P17958, DOI 10.1021/bi981688j; Quirk DJ, 1999, BIOPHYS J, V76, P1571, DOI 10.1016/S0006-3495(99)77316-9; Schillewaert S, 2012, MOL CELL BIOL, V32, P430, DOI 10.1128/MCB.06019-11; Slaymaker IM, 2019, CELL REP, V26, P3741, DOI 10.1016/j.celrep.2019.02.094; Terns MP, 2018, MOL CELL, V72, P404, DOI 10.1016/j.molcel.2018.09.018; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Tomecki R, 2017, FEBS LETT, V591, P1801, DOI 10.1002/1873-3468.12682; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10507-3; Zhang B, 2018, CELL RES, V28, P1198, DOI 10.1038/s41422-018-0109-4; Zhang C, 2018, CELL, V175, P212, DOI 10.1016/j.cell.2018.09.001	51	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5857	5870		10.1074/jbc.RA119.011193	http://dx.doi.org/10.1074/jbc.RA119.011193			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32220933	hybrid, Green Published			2022-12-26	WOS:000531417300003
J	Islam, S; Namilae, S; Prazenica, R; Liu, DH				Islam, Sabique; Namilae, Sirish; Prazenica, Richard; Liu, Dahai			Fuel shortages during hurricanes: Epidemiological modeling and optimal control	PLOS ONE			English	Article							PARAMETER-ESTIMATION; MANEUVERS; FILTERS; STATE	Hurricanes are powerful agents of destruction with significant socioeconomic impacts. A persistent problem due to the large-scale evacuations during hurricanes in the southeastern United States is the fuel shortages during the evacuation. Computational models can aid in emergency preparedness and help mitigate the impacts of hurricanes. In this paper, we model the hurricane fuel shortages using the SIR epidemic model. We utilize the crowd-sourced data corresponding to Hurricane Irma and Florence to parametrize the model. An estimation technique based on Unscented Kalman filter (UKF) is employed to evaluate the SIR dynamic parameters. Finally, an optimal control approach for refueling based on a vaccination analogue is presented to effectively reduce the fuel shortages under a resource constraint. We find the basic reproduction number corresponding to fuel shortages in Miami during Hurricane Irma to be 3.98. Using the control model we estimated the level of intervention needed to mitigate the fuel-shortage epidemic. For example, our results indicate that for Naples-Fort Myers affected by Hurricane Irma, a per capita refueling rate of 0.1 for 2.2 days would have reduced the peak fuel shortage from 55% to 48% and a refueling rate of 0.75 for half a day before landfall would have reduced to 37%.	[Islam, Sabique; Namilae, Sirish; Prazenica, Richard] Embry Riddle Aeronaut Univ, Aerosp Engn, Daytona Beach, FL 32114 USA; [Liu, Dahai] Embry Riddle Aeronaut Univ, Dept Grad Studies, Daytona Beach, FL USA	Embry-Riddle Aeronautical University; Embry-Riddle Aeronautical University	Namilae, S (corresponding author), Embry Riddle Aeronaut Univ, Aerosp Engn, Daytona Beach, FL 32114 USA.	namilaes@erau.edu	Namilae, Sirish/B-6925-2017	Namilae, Sirish/0000-0003-1487-9573	Department of Transportation at the North Carolina AT University; Center for Advanced Transportation Mobility (CATM) at the North Carolina AT University	Department of Transportation at the North Carolina AT University; Center for Advanced Transportation Mobility (CATM) at the North Carolina AT University	We gratefully acknowledge the support of the Department of Transportation and the Center for Advanced Transportation Mobility (CATM) at the North Carolina A&T University.	Baker E., 2010, STATEWIDE REGIONAL E, V2; Bearman PS, 2004, AM J PUBLIC HEALTH, V94, P89, DOI 10.2105/AJPH.94.1.89; Burn MJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12838; CHANG CB, 1977, IEEE T AUTOMAT CONTR, V22, P99, DOI 10.1109/TAC.1977.1101412; Costa PJ, 2005, PROCEEDINGS OF THE IEEE SOUTHEASTCON 2004, P174, DOI 10.1109/SECON.2005.1423240; Earn DJ, 2008, MATH EPIDEMIOLOGY; Evensen G., 2003, OCEAN DYNAM, V53, P343, DOI [DOI 10.1007/S10236-003-0036-9, 10.1007/s10236-003-0036-9]; FDOT, 2018, HURR IRM EFF FLOR FU; Ferrara E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142390; Fu F, 2017, SCI REP-UK, V7, DOI 10.1038/srep43634; Hansen E, 2011, J MATH BIOL, V62, P423, DOI 10.1007/s00285-010-0341-0; Holland G, 2014, CLIM DYNAM, V42, P617, DOI 10.1007/s00382-013-1713-0; Julier S, 2000, IEEE T AUTOMAT CONTR, V45, P477, DOI 10.1109/9.847726; Kalman R. E., 1961, T ASME D, V83, P95, DOI DOI 10.1115/1.3658902; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Khare A, 2019, OR SPECTRUM, P1; Langelaan JW, 2007, J GUID CONTROL DYNAM, V30, P1414, DOI 10.2514/1.27770; Lee S, 1997, J GUID CONTROL DYNAM, V20, P104, DOI 10.2514/2.4001; Levin N, 2017, APPL GEOGR, V79, P115, DOI 10.1016/j.apgeog.2016.12.009; Lewis F. L., 2012, OPTIMAL CONTROL; Liu HW, 2008, BIOSIG BRNO, P13; Liu JS, 1998, J AM STAT ASSOC, V93, P1032, DOI 10.2307/2669847; Liu WP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42308; Moral P. D., 1996, MARKOV P REL FIELDS, V2, P555; Musoff H, 2009, FUNDAMENTALS KALMAN; National Hurricane Center, 2017, IRM GRAPH ARCH 5 DAY; Pontryagin LS, 1962, MATH THEORY OPTIMAL; Sabet MT, 2014, OCEAN ENG, V91, P329, DOI 10.1016/j.oceaneng.2014.09.013; SINGH G, 1990, J GUID CONTROL DYNAM, V13, P376, DOI 10.2514/3.56512; Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179; Traag VA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153539; Tsvetkova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087275; Wan EA, 2000, IEEE 2000 ADAPTIVE SYSTEMS FOR SIGNAL PROCESSING, COMMUNICATIONS, AND CONTROL SYMPOSIUM - PROCEEDINGS, P153, DOI 10.1109/ASSPCC.2000.882463; Yang K, 2015, KYBERNETES, V44, P475, DOI 10.1108/K-05-2014-0103; Yang W, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003583	36	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0229957	10.1371/journal.pone.0229957	http://dx.doi.org/10.1371/journal.pone.0229957			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236120	Green Published, Green Submitted, gold			2022-12-26	WOS:000535938700013
J	Provenzano, M; Rivoli, L; Garofalo, C; Faga, T; Pelagi, E; Perticone, M; Serra, R; Michael, A; Comi, N; Andreucci, M				Provenzano, Michele; Rivoli, Laura; Garofalo, Carlo; Faga, Teresa; Pelagi, Elena; Perticone, Maria; Serra, Raffaele; Michael, Ashour; Comi, Nicolino; Andreucci, Michele			Renal resistive index in chronic kidney disease patients: Possible determinants and risk profile	PLOS ONE			English	Article							VASCULAR-RESISTANCE; DIABETES-MELLITUS; SERUM PHOSPHORUS; DOPPLER INDEXES; PROGRESSION; PHOSPHATE; HYPERTENSION; DYSFUNCTION; MORTALITY; SMOKING	Background High ultrasound renal resistive index (RI) predicts poor cardiorenal outcomes in chronic kidney disease (CKD) and has recently emerged as a marker of nephroprotective drugs response. Thus, having a risk profile of CKD patients with abnormal RI may be relevant for the clinicians. Methods Consecutive patients referred to our non-dialysis CKD clinic from 01/01/2016 to 01/12/2016, were evaluated by clinical and ultrasound analysis. Inclusion criteria were age >18 years and presence of CKD defined as estimated glomerular filtration rate (eGFR)<60 mL/min/1.73m(2) and/or proteinuria>0.150g/24h. Renal artery stenosis, solitary kidney, acute kidney injury were the main exclusion criteria. RI value was the mean of three measures in segmental arteries in each kidney. Univariate analysis was performed to evaluate associations between continuous RI and clinical variables. Multivariate linear regression analysis, based on stepwise method with an elimination criterion of p<0.10, was used to assess the independent correlates of RI as continuous variable. Results We studied 73 patients (69.9% men). Mean RI was 0.67 +/- 0.09. Frequencies of diabetes and cardiovascular disease (CVD) were 19.2% and 20.6% and median eGFR 54.1 [30.0-84.6] mL/min/1.73m(2). From low (<0.65) to intermediate (0.65-0.70) to high (>0.70) RI categories, eGFR and haemoglobin levels were decreased while diabetes, cardiovascular disease (CVD), phosphate and smokers were higher. At univariate analysis, RI was significantly associated with age, presence of diabetes, CVD, serum phosphorus, eGFR, Urea and haemoglobin. Multi-adjusted stepwise regression analysis showed that lower eGFR levels (p<0.001), diabetes (p = 0.042), CVD (p = 0.009), smoking habit (p = 0.021) and higher serum phosphorus levels (p = 0.001) were associated with higher continuous RI. Serum phosphorus showed Area Under the Curves (AUC) values of 0.714 and 0.664 for discriminating RI cut-offs of 0.70 and 0.65. Conclusions This analysis suggests that RI is higher in CKD patients with CVD, diabetes, smoking habit and higher serum phosphorus, regardless of eGFR. Further studies are needed to verify whether higher RI indicates more complex pathway of intrarenal damage, besides and beyond kidney function.	[Provenzano, Michele; Rivoli, Laura; Faga, Teresa; Pelagi, Elena; Michael, Ashour; Comi, Nicolino; Andreucci, Michele] Magna Graecia Univ Catanzaro, Nephrol Unit, Catanzaro, Italy; [Garofalo, Carlo] Univ Campania Luigi Vanvitelli, Dept Sci Med & Chirurg Avanzate, Div Nephrol, Naples, Italy; [Perticone, Maria] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Serra, Raffaele] Headquarters Magna Graecia Univ Catanzaro, Interuniv Ctr Phlebolymphol CIFL, Int Res & Educ Program Clin & Expt Biotechnol, Catanzaro, Italy	Magna Graecia University of Catanzaro; Universita della Campania Vanvitelli; Magna Graecia University of Catanzaro	Provenzano, M (corresponding author), Magna Graecia Univ Catanzaro, Nephrol Unit, Catanzaro, Italy.	michiprov@hotmail.it	Serra, Raffaele/AAA-6874-2022; Garofalo, Carlo/Y-2385-2019	Serra, Raffaele/0000-0003-4477-7412; Garofalo, Carlo/0000-0001-9362-0281; Provenzano, Michele/0000-0002-2168-702X				Araujo NC, 2016, TRANSPL P, V48, P1955, DOI 10.1016/j.transproceed.2016.04.007; Boddi M, 2006, AM J NEPHROL, V26, P16, DOI 10.1159/000090786; Boddi M, 1996, AM J HYPERTENS, V9, P461, DOI 10.1016/0895-7061(96)00027-1; Caimi G, 2014, CLIN HEMORHEOL MICRO, V56, P359, DOI 10.3233/CH-131758; Cauwenberghs N, 2015, PULSE, V3, P172, DOI 10.1159/000442445; Chen CY, 2013, COPD, V10, P216, DOI 10.3109/15412555.2012.719051; Conte G, 2014, G ITAL NEFROL, V31; De Nicola L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172241; De Nicola L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127071; De Nicola L, 2011, CLIN J AM SOC NEPHRO, V6, P2421, DOI 10.2215/CJN.01180211; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Feodoroff M, 2016, ACTA DIABETOL, V53, P525, DOI 10.1007/s00592-015-0822-0; Fuiano G, 2005, KIDNEY INT, V68, P2773, DOI 10.1111/j.1523-1755.2005.00748.x; Gorriz JL, 2015, CLIN J AM SOC NEPHRO, V10, P654, DOI 10.2215/CJN.07450714; Hamano K, 2008, DIABETES CARE, V31, P1853, DOI 10.2337/dc08-0168; Harrell FE, 2001, REGRESSION MODELING; Ikee R, 2005, AM J KIDNEY DIS, V46, P603, DOI 10.1053/j.ajkd.2005.06.006; Itkonen ST, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-94; Iwashima Y, 2013, HYPERTENSION, V61, pE23, DOI 10.1161/HYPERTENSIONAHA.111.00664; John R, 2004, AM J KIDNEY DIS, V43, P825, DOI 10.1053/j.ajkd.2003.12.046; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT S, P31; Kim JH, 2017, KIDNEY RES CLIN PRAC, V36, P58, DOI 10.23876/j.krcp.2017.36.1.58; Kleinbaum D.G., 1988, APPL REGRESSION ANAL, P209; Krumme B, 1997, J AM SOC NEPHROL, V8, P813; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Kuznetsova T, 2015, AM J HYPERTENS, V28, P535, DOI 10.1093/ajh/hpu185; Leoncini G, 2002, NEPHRON, V90, P169, DOI 10.1159/000049038; Matsumoto N, 2000, NEPHRON, V86, P44, DOI 10.1159/000045711; Mehrotra R, 2013, KIDNEY INT, V84, P989, DOI 10.1038/ki.2013.145; Minutolo R, 2005, AM J KIDNEY DIS, V46, P18, DOI 10.1053/j.ajkd.2005.03.019; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; O'Neill WC, 2015, HYPERTENSION, V66, pE9, DOI 10.1161/HYP.0000000000000032; O'Neill WC, 2014, HYPERTENSION, V64, P915, DOI 10.1161/HYPERTENSIONAHA.114.04183; O'Neill WC, 2000, AM J KIDNEY DIS, V35, P1021, DOI 10.1016/S0272-6386(00)70036-9; Owaki A, 2018, RENAL FAILURE, V40, P475, DOI 10.1080/0886022X.2018.1499530; Parolini C, 2009, RADIOLOGY, V252, P888, DOI 10.1148/radiol.2523080351; Peralta CA, 2006, J AM SOC NEPHROL, V17, P2892, DOI 10.1681/ASN.2005101122; Perticone M, 2016, NUTR METAB CARDIOVAS, V26, P683, DOI 10.1016/j.numecd.2016.02.003; Ponte B, 2014, HYPERTENSION, V63, P136, DOI 10.1161/HYPERTENSIONAHA.113.02321; Rozemeijer S, 2019, SHOCK, V52, P43, DOI 10.1097/SHK.0000000000001246; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Russo D, 2005, SEMIN NEPHROL, V25, P431, DOI 10.1016/j.semnephrol.2005.05.015; Russo D, 2011, KIDNEY INT, V80, P112, DOI 10.1038/ki.2011.69; Salvatore SP, 2015, AM J NEPHROL, V41, P66, DOI 10.1159/000371727; SAWICKI PT, 1994, DIABETES CARE, V17, P126, DOI 10.2337/diacare.17.2.126; Solini A, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0621-8; Sugiura T, 2004, CLIN NEPHROL, V61, P119; Sugiura T, 2009, NEPHROL DIAL TRANSPL, V24, P2780, DOI 10.1093/ndt/gfp121; Tripepi G, 2017, NEPHROL DIAL TRANSPL, V32, P19, DOI 10.1093/ndt/gfw439; Tsioufis C, 2014, CURR VASC PHARMACOL, V12, P537, DOI 10.2174/157016111203140518173700; Viazzi F, 2014, J HYPERTENS, V32, P149, DOI 10.1097/HJH.0b013e328365b29c; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; Yamamoto R, 2010, AM J KIDNEY DIS, V56, P313, DOI 10.1053/j.ajkd.2010.02.351; Yaprak M, 2017, INT UROL NEPHROL, V49, P123, DOI 10.1007/s11255-016-1443-4; Zhang WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14090	57	17	18	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230020	10.1371/journal.pone.0230020	http://dx.doi.org/10.1371/journal.pone.0230020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236125	Green Published, gold			2022-12-26	WOS:000535938700014
J	Mannhardt, C; Rausch, TK; Fortmann, MI; Swoboda, I; Humberg, A; Spiegler, J; Gopel, W				Mannhardt, Clara; Rausch, Tanja K.; Fortmann, Mats Ingmar; Swoboda, Isabelle; Humberg, Alexander; Spiegler, Juliane; Goepel, Wolfgang			Genetic predisposition for vitamin D deficiency is not associated with adverse outcome of very low birth weight infants: A cohort study from the German Neonatal Network	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; RISK; PRETERM; PREGNANCY; CHILDHOOD; SYSTEM; HEALTH	Objective Postnatal vitamin D supplementation is standard of care in neonates and preterm infants. Despite routine supplementation of vitamin D, a wide range of complications related to vitamin D deficiency has been described in the literature. Since standard vitamin D supplementation might be not sufficient in preterm infants with a genetic predisposition for vitamin D deficiency, we investigated the outcome of preterm infants with regard to their genetic estimated vitamin D levels. Methods Preterm infants with a birth weight below 1500 grams were included in the German Neonatal Network at the time of their birth and tested at the age of five. The vitamin D level was genetically calculated based on three single nucleotide polymorphisms (SNPs: rs12794714, rs7944926 and rs2282679) which alter vitamin D synthesis pathways. Specific alleles of these polymorphisms are validated markers for low plasma vitamin D levels. Outcome data were based on baseline data at the time of birth, typical complications of prematurity, body measurements at the age of five and occurrence of bone fractures. T-test and Fisher's exact test were used for statistical comparison. Results According to their genetic predisposition, 1,924 preterm infants were divided into groups of low (gsVitD < 20. Percentile), intermediate and high vitamin D level estimates. Low genetic vitamin D level estimates could not be shown to be associated with any adverse outcome measures examined. The analyses covered data on aforementioned determinants. Conclusion Low genetic vitamin D level estimates could not be shown to be associated with previously described adverse outcome in preterm infants.	[Mannhardt, Clara; Rausch, Tanja K.; Fortmann, Mats Ingmar; Swoboda, Isabelle; Humberg, Alexander; Spiegler, Juliane; Goepel, Wolfgang] Univ Lubeck, Dept Pediat, Lubeck, Germany; [Rausch, Tanja K.] Univ Lubeck, Inst Med Biometr & Stat, Lubeck, Germany	University of Lubeck; University of Lubeck	Gopel, W (corresponding author), Univ Lubeck, Dept Pediat, Lubeck, Germany.	wolfgang.goepel@uksh.de	Spiegler, Juliane/AAK-1740-2020	Spiegler, Juliane/0000-0002-1737-0628; , Clara/0000-0002-0007-6780	German Federal Ministry of Education and Research (GNN) [BMBF 01ER0805, BMBF 01ER1501]	German Federal Ministry of Education and Research (GNN)	This study was funded by the German Federal Ministry of Education and Research (GNN, BMBF 01ER0805 and BMBF 01ER1501). Head of the study: Prof. Dr. Wolfgang Gopel. www.bmbf.de The funders had a say in study design, data collection and analysis, decision to publish, or preparation of the manuscript in accordance with the guidelines of BMBF.	Afzal S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6330; Anderson LN, 2017, AM J EPIDEMIOL, V185, P1255, DOI 10.1093/aje/kww204; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bodnar LM, 2010, J NUTR, V140, P999, DOI 10.3945/jn.109.119636; Buhrer C, 2016, MONATSSCHR KINDERH, V164, P660, DOI 10.1007/s00112-016-0122-y; Candido FG, 2014, INT J MOL SCI, V15, P6569, DOI 10.3390/ijms15046569; Choi JY, 2016, J CHILD NEUROL, V31, P603, DOI 10.1177/0883073815604229; Chowdhury R, 2014, BMJ-BRIT MED J, V1, P348, DOI DOI 10.1136/BMJ.G1903; Chung PW, 2015, STROKE, V46, P248, DOI 10.1161/STROKEAHA.114.007706; Hogberg U, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208033; Holick MF, 2006, J CLIN INVEST, V116, P2062, DOI 10.1172/JCI29449; Holick MF, 2017, REV ENDOCR METAB DIS, V18, P153, DOI 10.1007/s11154-017-9424-1; Jiang X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02662-2; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Leffelaar ER, 2010, BRIT J NUTR, V104, P108, DOI 10.1017/S000711451000022X; Litonjua AA, 2009, CURR OPIN ALLERGY CL, V9, P202, DOI 10.1097/ACI.0b013e32832b36cd; Griz LHM, 2014, ARQ BRAS ENDOCRINOL, V58, P1, DOI 10.1590/0004-2730000002535; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; Mokry LE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001866; Ong JS, 2016, INT J EPIDEMIOL, V45, P1619, DOI 10.1093/ije/dyw207; Pekcevik Y, 2014, IRAN J PEDIATR, V24, P191; Raju TNK, 2017, ACTA PAEDIATR, V106, P1409, DOI 10.1111/apa.13880; Roth DE, 2018, NEW ENGL J MED, V379, P535, DOI 10.1056/NEJMoa1800927; Tomaschitz A, 2010, CLIN CHIM ACTA, V411, P1354, DOI 10.1016/j.cca.2010.05.037; Vimaleswaran KS, 2014, LANCET DIABETES ENDO, V2, P719, DOI 10.1016/S2213-8587(14)70113-5; Voigt M, 2012, Z GEBURTSH NEONATOL, V216, P212, DOI 10.1055/s-0032-1316324; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Zhang Z, 2013, J BONE MINER RES, V28, P1784, DOI 10.1002/jbmr.1926	28	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230426	10.1371/journal.pone.0230426	http://dx.doi.org/10.1371/journal.pone.0230426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HO	32231377	gold, Green Published			2022-12-26	WOS:000535937400007
J	Aurpibul, L; Namwongprom, S; Sudjaritruk, T; Ounjaijean, S				Aurpibul, Linda; Namwongprom, Sirianong; Sudjaritruk, Tavitiya; Ounjaijean, Sakaewan			Metabolic syndrome, biochemical markers, and body composition in youth living with perinatal HIV infection on antiretroviral treatment	PLOS ONE			English	Article							RISK-FACTORS; CARDIOVASCULAR-DISEASE; FAT DISTRIBUTION; MASS INDEX; CHILDREN; INFLAMMATION; THERAPY; ASSOCIATION	People living with HIV who are on antiretroviral treatment are at increased risk of developing premature cardiovascular disease. Children with perinatal HIV infection (PHIV) have survived through their adolescence and are entering adulthood. We determined the prevalence of metabolic syndrome, abnormal biochemical markers, and characterized body composition parameters in youth living with perinatal HIV infection. This cross-sectional study was conducted at the Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand from December 2017 to February 2018. PHIV-youths between 15 < 25 years of age who were receiving ART were enrolled. Data collection included ART-related history, blood pressure, and anthropometric measurements. Body composition including android, gynoid fat mass, and total body fat were measured by dual-energy X-ray absorptiometry. Fasting blood was drawn to test for lipid profile, glucose, and high sensitivity c-reactive protein (hsCRP). One hundred and twenty PHIV-youths (48% female) were enrolled. Their mean age and the median duration on ART were 20.3 (SD2.6) and 14.1 (IQR 10.4-14.9) years, respectively; 76 (63%) were on first-line non-nucleoside reverse transcriptase inhibitors-based regimens. Thirty-three (28%), 74 (62%), and 13 (11%) of PHIV-youths were underweight (BMI < 18.5 kg/m(2)), normal (BMI 18.5-24.9 kg/m(2)), and overweight (BMI >= 25.0 kg/m(2)), respectively. The prevalence of metabolic syndrome was 10.6% (95%CI 5.0-16.0). Seventy-six of 113 (67.3%) of PHIV-youths had lipid alteration; the most prevalent types being low HDL (46.9%) and increased triglycerides (27.4%). Overall 43 (35.9%) had increased hsCRP (16.7% with immediate and 19.2% with high risk for CVD). Females had significantly higher percentage of android and gynoid fat, but lower Android to gynoid ratio (AGR) compared to males. There were 77%, 31%, and 21% of PHIV-youths in the overweight, normal weight, and underweight group with AGR in tertile 3, respectively. In conclusion, we documented presence of metabolic syndrome in 10.6% of PHIV-youths on ART. Increase AGR representing abdominal obesity was detected even in youths with normal BMI or underweight.	[Aurpibul, Linda; Sudjaritruk, Tavitiya; Ounjaijean, Sakaewan] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand; [Namwongprom, Sirianong] Chiang Mai Univ, Fac Med, Dept Radiol, Chiang Mai, Thailand; [Sudjaritruk, Tavitiya] Chiang Mai Univ, Fac Med, Dept Pediat, Chiang Mai, Thailand; [Sudjaritruk, Tavitiya] Chiang Mai Univ, Fac Med, Clin & Mol Epidemiol Emerging & Reemerging Infect, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University	Aurpibul, L (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand.	lindaa@rihes.org	Ounjaijean, Sakaewan/GQB-2632-2022; Aurpibul, Linda/AAA-6916-2021	Namwongprom, Sirianong/0000-0003-1332-0903	Chiang Mai University	Chiang Mai University	study was funded by Chiang Mai University, without other source of support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrovandi GM, 2009, AIDS, V23, P661, DOI 10.1097/QAD.0b013e3283269dfb; Arrive E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206745; Augustemak de Lima Luiz Rodrigo, 2018, PLoS One, V13, pe0190785, DOI 10.1371/journal.pone.0190785; Aurpibul L, 2007, ANTIVIR THER, V12, P1247; Aurpibul L, 2009, AIDS PATIENT CARE ST, V23, P1067, DOI 10.1089/apc.2009.0093; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Borges AH, 2013, AIDS, V27, P1433, DOI 10.1097/QAD.0b013e32835f6b0c; Brown TT, 2010, DIABETES CARE, V33, P2244, DOI 10.2337/dc10-0633; Daniels SR, 1999, CIRCULATION, V99, P541, DOI 10.1161/01.CIR.99.4.541; Dirajlal-Fargo S, 2017, PEDIATR INFECT DIS J, V36, P761, DOI [10.1097/INF.0000000000001544, 10.1097/inf.0000000000001544]; Fabbiani M, 2013, HIV MED, V14, P136, DOI 10.1111/j.1468-1293.2012.01044.x; Fisher SD, 2006, ATHEROSCLEROSIS, V185, P1, DOI 10.1016/j.atherosclerosis.2005.09.025; Freitas P, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-180; Freitas P, 2012, J CLIN HYPERTENS, V14, P593, DOI 10.1111/j.1751-7176.2012.00671.x; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Jacobson DL, 2011, AM J CLIN NUTR, V94, P1485, DOI 10.3945/ajcn.111.020271; Jahagirdar R, 2012, PEDIATR OBES, V7, pE37, DOI 10.1111/j.2047-6310.2012.00056.x; Lee V, 2018, OBES SCI PRACT, V4, P437, DOI 10.1002/osp4.297; Lu HD, 2019, AM J EPIDEMIOL, V188, P1994, DOI 10.1093/aje/kwz190; Miller TL, 2008, J PEDIATR-US, V153, P491, DOI 10.1016/j.jpeds.2008.04.016; Namwongprom S, 2014, J CLIN RES PEDIATR E, V6, P227, DOI [10.4274/Jcrpe.1576, 10.4274/jcrpe.1576]; National Institutes of Health, 2002, DET EV TREATM HIGH B; Quinn TC, 2008, AIDS, V22, pS7, DOI 10.1097/01.aids.0000327510.68503.e8; Roberts WL, 2004, CIRCULATION, V110, pE572, DOI 10.1161/01.CIR.0000148986.52696.07; Rosenson RS, 2002, CURR OPIN CARDIOL, V17, P325, DOI 10.1097/00001573-200207000-00001; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Sacilotto LB, 2017, J NUTR METAB, V2017, DOI 10.1155/2017/8260867; Sainz T, 2014, ATHEROSCLEROSIS, V233, P410, DOI 10.1016/j.atherosclerosis.2014.01.025; Santiprabhob J, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7481597; Sharma TS, 2018, PEDIATR INFECT DIS J, V37, P1002, DOI [10.1097/INF.0000000000001963, 10.1097/inf.0000000000001963]; SWRCB, 2015, EAR REP YEAR 2014; World Health Organization, 2008, WAIST CIRCUMFERENCE	34	7	7	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230707	10.1371/journal.pone.0230707	http://dx.doi.org/10.1371/journal.pone.0230707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HE	32226033	Green Published, gold			2022-12-26	WOS:000535936400013
J	Mayengo, G; Piel, AK; Treydte, AC				Mayengo, Gabriel; Piel, Alex K.; Treydte, Anna C.			The importance of nutrient hotspots for grazing ungulates in a Miombo ecosystem, Tanzania	PLOS ONE			English	Article							TERMITE MACROTERMES-MICHAELSENI; MAMMALIAN HERBIVORES; BODY-SIZE; AFRICAN SAVANNA; LAWN FORMATION; GRASS HEIGHT; VEGETATION; MOUNDS; DYNAMICS; RAINFALL	While movement patterns of grazing ungulates are strongly dependent on forage quality their use of nutrient hotspots such as termite mounds or grazing lawns has rarely been quantified, especially in savanna ecosystems where soil-nutrient quality is low. Additionally, few experiments have been conducted to determine the role of termite mound- and grazing lawn-derived soils in improving forage quality in the field. We studied wild ungulate grazing activities around ten termite mounds, six grazing lawns and their respective control sites in a Miombo system of Issa Valley, western Tanzania, in the same system. We used indirect observations (i.e., dung, tracks) to identify seasonal and spatial variations in habitat use of various wild mammalian grazers. Grazer visitation rates were nine and three times higher on termite mounds and grazing lawns, respectively, compared to control sites. During the rainy season, termite mounds were more frequently used than grazing lawns while the latter were used more often during the dry season. In an additional pot experiment with soils derived from different areas, we found that Cynodon dactylon in termite mound-derived soils had twice as high Nitrogen and Phosphorous contents and biomass compared to grasses planted in grazing lawn soils and control site soils. We highlight that both termite mounds and grazing lawns play a significant role in influencing seasonal nutrient dynamics, forage nutrient quality, habitat selectivity, and, hence, grazing activities and movement patterns of wild ungulate grazers in savannas. We conclude that termite mounds and grazing lawns are important for habitat heterogeneity in otherwise nutrient-poor savanna systems.	[Mayengo, Gabriel; Treydte, Anna C.] Nelson Mandela African Inst Sci & Technol, Dept Sustainable Agr Biodivers Conservat & Ecosys, Arusha, Tanzania; [Mayengo, Gabriel] Coll African Wildlife Management, Dept Wildlife Management, Mweka, Moshi, Tanzania; [Piel, Alex K.] Liverpool John Moores Univ, Sch Biol & Environm Sci, Liverpool, Merseyside, England; [Treydte, Anna C.] Univ Hohenheim, Hans Ruthenberg Inst, Agroecol Trop & Subtrop, Stuttgart, Germany	Nelson Mandela African Institution of Science & Technology; Liverpool John Moores University; University Hohenheim	Mayengo, G (corresponding author), Nelson Mandela African Inst Sci & Technol, Dept Sustainable Agr Biodivers Conservat & Ecosys, Arusha, Tanzania.; Mayengo, G (corresponding author), Coll African Wildlife Management, Dept Wildlife Management, Mweka, Moshi, Tanzania.	mayengogabriel@gmail.com		Piel, Alexander/0000-0002-4674-537X; Treydte, Anna/0000-0003-0605-3069; Mayengo, Gabriel/0000-0003-3404-3677	German Academic Exchange Service (DAAD); African Centre for Research, Agricultural advancement, Teaching Excellence and Sustainability (CREATES); Greater Mahale Ecosystem Research and Conservation Project (GMERC); UCSD/Salk Center for Academic Research and Training in Anthropogeny (CARTA)	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); African Centre for Research, Agricultural advancement, Teaching Excellence and Sustainability (CREATES); Greater Mahale Ecosystem Research and Conservation Project (GMERC); UCSD/Salk Center for Academic Research and Training in Anthropogeny (CARTA)	This research was funded by The German Academic Exchange Service (DAAD), the African Centre for Research, Agricultural advancement, Teaching Excellence and Sustainability (CREATES), and the Greater Mahale Ecosystem Research and Conservation Project (GMERC).Support for GMERC comes from the UCSD/Salk Center for Academic Research and Training in Anthropogeny (CARTA).	Acanakwo EF, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2554; Ahmed JB, 2018, PERTANIKA J SCI TECH, V26, P479; Almeida-Warren K, 2017, AM J PHYS ANTHROPOL, P1; Archibald S, 2008, J WILDLIFE MANAGE, V72, P492, DOI 10.2193/2007-045; Arsenault R, 2008, OIKOS, V117, P1711, DOI 10.1111/j.1600-0706.2008.16575.x; ARSHAD MA, 1982, AGRO-ECOSYSTEMS, V8, P47, DOI 10.1016/0304-3746(82)90014-2; Augustine DJ, 2003, J APPL ECOL, V40, P137, DOI 10.1046/j.1365-2664.2003.00778.x; Austrheim G, 2014, ARCT ANTARCT ALP RES, V46, P535, DOI 10.1657/1938-4246-46.3.535; BENSHAHAR R, 1991, AFR J ECOL, V29, P302, DOI 10.1111/j.1365-2028.1991.tb00468.x; Bhola N, 2012, J ANIM ECOL, V81, P1268, DOI 10.1111/j.1365-2656.2012.02000.x; Bremm C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150167; Burkepile DE, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00078.1; Chejara VK, 2010, WEED RES, V50, P174, DOI 10.1111/j.1365-3180.2010.00765.x; Chejara VK, 2008, WEED SCI, V56, P543, DOI 10.1614/WS-07-163.1; Chen CF, 2019, AGR ECOSYST ENVIRON, V277, P25, DOI 10.1016/j.agee.2019.03.001; Chris Stuart, 2006, FIELD GUIDE LARGER M, V6; Coetsee C, 2011, AFR J ECOL, V49, P62, DOI 10.1111/j.1365-2028.2010.01236.x; Cromsigt JPGM, 2008, OIKOS, V117, P1444, DOI 10.1111/j.0030-1299.2008.16651.x; Cromsigt JPGM, 2011, PERSPECT PLANT ECOL, V13, P207, DOI 10.1016/j.ppees.2011.04.004; Curtis RO, 1995, USDA FOR SERV PNW RE, P1; Cyril Lebogang Taolo, 1995, FEEDING HABITS ROAN; Daly K, 2017, IRISH J AGR FOOD RES, V56, P1, DOI 10.1515/ijafr-2017-0001; Dangerfield JM, 1998, J TROP ECOL, V14, P507, DOI 10.1017/S0266467498000364; Davies AB, 2016, OIKOS, V125, P726, DOI 10.1111/oik.02742; Davies AB, 2014, J VEG SCI, V25, P1405, DOI 10.1111/jvs.12200; dos Santos EJ, 2012, BRAZ ARCH BIOL TECHN, V55, P457, DOI 10.1590/S1516-89132012000300017; Durant D, 2004, J AVIAN BIOL, V35, P144, DOI 10.1111/j.0908-8857.2004.03166.x; Eby SL, 2014, J ANIM ECOL, V83, P1196, DOI 10.1111/1365-2656.12221; Frits van Oudtshoorn, 2002, GUIDE GRASSES SO AFR, P1; Gosling CM, 2016, BIOTROPICA, V48, P656, DOI 10.1111/btp.12337; Grant CC, 2006, BIOL CONSERV, V130, P426, DOI 10.1016/j.biocon.2006.01.004; Grohmann C, 2010, INSECT SOC, V57, P477, DOI 10.1007/s00040-010-0107-0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hartley SE, 2005, J ECOL, V93, P990, DOI 10.1111/j.1365-2745.2005.01025.x; HAYHOE HN, 1974, CAN J PLANT SCI, V54, P479, DOI 10.4141/cjps74-081; Hempson GP, 2015, BIOL REV, V90, P979, DOI 10.1111/brv.12145; Holdo RM, 2013, OIKOS, V122, P441, DOI 10.1111/j.1600-0706.2012.20735.x; Howery LD, 2010, ARIZONA COOP EXT, P1; Iida Eriko G., 2012, African Study Monographs, V33, P253; Jamet D., 2016, HS; Lamprey H. F., 1963, East African Wildlife Journal, V1, P63; LEPAGE M, 1984, J ANIM ECOL, V53, P107, DOI 10.2307/4345; Levick SR, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1066; Li H., 2017, PLOS ONE; Liebenberg L., 1990, ART TRACKING ORIGIN, V45; Lopez-Hernandez D, 2001, SOIL BIOL BIOCHEM, V33, P747, DOI 10.1016/S0038-0717(00)00220-0; Makita C., 2014, STUDY ELEMENTAL ANAL; Mandal AK, 2017, PHARM INNOV J, V6, P83; Mandlate LC, 2019, AUSTRAL ECOL; MCNAUGHTON SJ, 1983, ECOL MONOGR, V53, P291, DOI 10.2307/1942533; MCNAUGHTON SJ, 1984, AM NAT, V124, P863, DOI 10.1086/284321; MCNAUGHTON SJ, 1984, ECOL MONOGR, V55, P259; Mobaek R, 2005, J ZOOL, V267, P97, DOI 10.1017/S0952836905007272; Moe SR, 2009, PLANT ECOL, V202, P31, DOI 10.1007/s11258-009-9575-6; Muvengwi J, 2017, J VEG SCI, V28, P1008, DOI 10.1111/jvs.12560; Ngondya I, 2019, MDPI, P1; Piel AK, 2015, GLOB ECOL CONSERV, V3, P188, DOI 10.1016/j.gecco.2014.11.014; Piel Alex K., 2018, AFR J ECOL, P1, DOI 10.1111/aje.12570; Pollinger A., 2014, INT C AGR ENG ZUR; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; Rita P, 2012, INT J RES AYURVEDA P, V3; Roberts C, 2009, MARSUPIAL GRAZING LA; Roosendaal B., 1973, ANIM NUTR CONSUTANTS, P1; Serrano A, 2011, ANAL BIOANAL CHEM, V401, P735, DOI 10.1007/s00216-011-5094-0; Shantz AA, 2015, ECOL APPL, V25, P2142, DOI 10.1890/14-2209.1.sm; STEINKE T D, 1989, Journal of the Grassland Society of Southern Africa, V6, P152; Stewart FA, 2014, PRIMATES, V55, P35, DOI 10.1007/s10329-013-0362-6; Treydte AC, 2007, PERSPECT PLANT ECOL, V8, P197, DOI 10.1016/j.ppees.2007.03.001; Treydte AC, 2006, J MAMMAL, V87, P889, DOI 10.1644/05-MAMM-A-336R2.1; Treydte AC, 2011, MAMM BIOL, V76, P345, DOI 10.1016/j.mambio.2010.09.003; Treydte AC, 2010, J ARID ENVIRON, V74, P1597, DOI 10.1016/j.jaridenv.2010.07.003; Treydte AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082831; Tyrrell P, 2017, GLOB ECOL CONSERV, V12, P59, DOI 10.1016/j.gecco.2017.08.006; Vaisanen A, 2008, INT J ENVIRON AN CH, V88, P1005, DOI 10.1080/03067310802308483; Veldhuis MP, 2014, J ECOL, V102, P1506, DOI 10.1111/1365-2745.12322	75	8	8	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230192	10.1371/journal.pone.0230192	http://dx.doi.org/10.1371/journal.pone.0230192			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HE	32226036	Green Accepted, Green Published, gold			2022-12-26	WOS:000535936400002
J	Sumbele, IUN; Nkain, AJ; Ning, TR; Anchang-Kimbi, JK; Kimbi, HK				Sumbele, Irene Ule Ngole; Nkain, Ayeah Joy; Ning, Teh Rene; Anchang-Kimbi, Judith Kuoh; Kimbi, Helen Kuokuo			Influence of malaria, soil-transmitted helminths and malnutrition on haemoglobin level among school-aged children in Muyuka, Southwest Cameroon: A cross-sectional study on outcomes	PLOS ONE			English	Article							NUTRITIONAL-STATUS; MOUNT CAMEROON; ANEMIA; INFECTION; SCHOOLCHILDREN; COINFECTION; AFRICA	Background The health of school-aged children (SAC) is often compromised by malaria parasitaemia (MP), soil-transmitted helminths (STH), and malnutrition in the tropics. The aim of this study was to determine the prevalence and influence of MP, STH and malnutrition on haemoglobin (Hb) levels as well as identify its predictors. Methods This cross-sectional study was carried out in SAC (4-14 years) in Owe, Mpundu and Meanja villages in Muyuka, Southwest Cameroon. Hb concentration was measured using a URIT12 Hb meter while MP and STH were determined by Giemsa staining of blood films and Kato-Katz technique respectively. Anthropometric measures (weight, height and mid upper arm circumference (MUAC)) of malnutrition (z-scores of <- 2 standard deviations below mean) were obtained by standard methods. Categorical and continuous variables were compared appropriately, and multiple linear regression model was used to determine predictors of Hb level. Results The prevalence of MP, STH, anaemia and malnutrition in the 401 SAC examined were 33.9%, 2.2%, 75.3% and 24.4% respectively. The prevalence of MP varied significantly with locality (P = 0.031). Stunting occurred commonly (23.7%) and was significantly higher in males (28.6%), children 11-14 years old (38.3%) and those of Meanja locality (47.4%) than their counterparts. Significantly higher prevalence of anaemia was observed in children of Meanja (89.5%) and those both MP positive and malnourished (86.2%). Moderate anaemia occurred commonly (60.6%) and children <= 6 years old had significantly (P = 0.034) higher prevalence (75.0%). Mean Hb level varied significantly (P = 0.004) with age and those <= 6 years old infected with MP had significantly (P = 0.022) lower values. Significant predictors of Hb levels were the MUAC (P <0.001) and the MP status (P = 0.035). Based on the Hb level (>11g/dL) and the absence of MP, STH and malnutrition, 13.7% of the SAC were considered as healthy. Conclusions The health of a majority of SAC is compromised by malaria, helminthiasis, malnutrition and other conditions not investigated. Anaemia is of major public health concern hence, intervention programmes that integrate malaria control with improvement of educational levels especially on proper nutrition and health care practices are desirable.	[Sumbele, Irene Ule Ngole; Nkain, Ayeah Joy; Ning, Teh Rene; Anchang-Kimbi, Judith Kuoh; Kimbi, Helen Kuokuo] Univ Buea, Dept Zool & Anim Physiol, Buea, Cameroon; [Sumbele, Irene Ule Ngole] Cornell Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Kimbi, Helen Kuokuo] Univ Bamenda, Dept Med Lab Sci, Bamenda, Cameroon; [Nkain, Ayeah Joy] Univ Ibadan, Dept Gynaecol & Obstet, Ibadan, Nigeria	Cornell University; University of Ibadan	Sumbele, IUN (corresponding author), Univ Buea, Dept Zool & Anim Physiol, Buea, Cameroon.; Sumbele, IUN (corresponding author), Cornell Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	sumbelei@yahoo.co.uk		sumbele, Irene/0000-0003-2607-8845	IIE-SRF (Institute of International Education-Scholar Rescue Fund); MPH programme, College of Veterinary Medicine, Cornell University, Ithaca, New York	IIE-SRF (Institute of International Education-Scholar Rescue Fund); MPH programme, College of Veterinary Medicine, Cornell University, Ithaca, New York	The authors are thankful to the village chiefs of Owe, Mpundu and Meanja, head teachers of the various primary schools, parents/guardians as well as the children who participated in the study. We acknowledge the support of IIE-SRF (Institute of International Education-Scholar Rescue Fund) and MPH programme, College of Veterinary Medicine, Cornell University, Ithaca, New York in providing the fellowship and right academic environment respectively for the drafting of this manuscript.	Akiyama T, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1548-3; Akseer N, 2017, ANN NY ACAD SCI, V1393, P3, DOI 10.1111/nyas.13336; [Anonymous], 2012, J BACTERIOL PARASITO; [Anonymous], 2008, WORLDWIDE PREVALENCE; Bates I, 2007, PLOS MED, V4, P1285, DOI 10.1371/journal.pmed.0040231; Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157; Best C, 2010, FOOD NUTR BULL, V31, P400, DOI 10.1177/156482651003100303; Bogale TY, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5561-z; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Bryan FJ., 1992, DESIGN ANAL RES STUD; Cheesbrough M., 2009, DISTRICT LAB PRACT 2; Cheesbrough M, 2009, DISTRICT LAB PRACT 1; Ebai CB., 2016, INT J TROP DIS HEAL, V16, P1, DOI [DOI 10.9734/IJTDH/2016/25890, 10.9734/IJTDH/2016/25890]; Fazili A, 2012, ONLINE J HLTH ALLIED, V11, P2; Ghosh K, 2007, PARASITOL RES, V101, P1463, DOI 10.1007/s00436-007-0742-1; Hurlimann E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003287; Kimbi HK, 2012, J BACTERIOL PAROSITO, V3, P134; Kimbi HK., 2013, J BACTERIOL PARASITO, V4, P4172; Makoge V.D., 2012, EUR J ZOOL RES, V1, P54; Mathanga DP, 2015, AM J TROP MED HYG, V93, P779, DOI 10.4269/ajtmh.14-0618; Mbuh JV, 2013, J HELMINTHOL, V87, P46, DOI 10.1017/S0022149X12000016; Menber Y, 2018, J CLIN CELL IMMUNOL, V9, P1; MINSANTE, 2010, MIDT HLTH EXP FRAM 2; Mwangome MK, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-92; Mwaniki EW, 2013, AFR HEALTH SCI, V13, P39, DOI 10.4314/ahs.v13i1.6; Nankabirwa J, 2014, TROP MED INT HEALTH, V19, P1294, DOI 10.1111/tmi.12374; Nankabirwa J, 2013, AM J TROP MED HYG, V88, P1102, DOI 10.4269/ajtmh.12-0633; Ndamukong-Nyanga JL, 2015, S W CAMEROON INT J T, V8, P150; Nkuo-Akenji T. K., 2008, African Journal of Food, Agriculture, Nutrition and Development, V8, P252; Nkuo-Akenji TK, 2006, J PARASITOL, V92, P1191, DOI 10.1645/GE-895R.1; Ntonifor H. N., 2015, International Journal of Current Microbiology and Applied Sciences, V4, P1056; Nzobo BJ, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1009-4; Pasricha SR, 2013, BLOOD, V121, P2607, DOI 10.1182/blood-2012-09-453522; Schelp FP, 1998, NUTRITION, V14, P217, DOI 10.1016/S0899-9007(97)00436-X; Siekmans K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090108; STINSON S, 1985, YEARB PHYS ANTHROPOL, V28, P123, DOI 10.1002/ajpa.1330280507; Sumbele IUN, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-334; Sumbele IUN, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0266-6; Sumbele IUN, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2462-2; Sumbele IUN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123549; Sumbele IUN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-123; Tabi ESB, 2018, PAN AFR MED J, V30, DOI 10.11604/pamj.2018.30.74.15676; Tariku EZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206659; Tchinda V. H. M., 2012, Journal of Public Health and Epidemiology, V4, P253; Tchuem-Tchuente LA, 2009, PARASITOLOGY, V136, P1; Walldorf JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134061; Wani SA, 2008, J PARASITOL, V94, P591, DOI 10.1645/GE-1400.1; WHO, 2018, WORLD MAL REP 2018; WHO, 2006, WHO CHILD GROWTH STA; WHO World Health Organization, 2006, CONST WHO BAS DOC S; World Health Organization, 2001, IR DEF AN ASS PREV C; 2012, WORLD MAL REP 2012, P1	52	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230882	10.1371/journal.pone.0230882	http://dx.doi.org/10.1371/journal.pone.0230882			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HE	32226023	Green Published, gold, Green Submitted			2022-12-26	WOS:000535936400023
J	Harris, L; Griem, J; Gummery, A; Marsh, L; Defres, S; Bhojak, M; Das, K; Easton, A; Solomon, T; Kopelman, M				Harris, Lara; Griem, Julia; Gummery, Alison; Marsh, Laura; Defres, Sylviane; Bhojak, Maneesh; Das, Kumar; Easton, Ava; Solomon, Tom; Kopelman, Michael		ENCEPH UK Study Grp	Neuropsychological and psychiatric outcomes in encephalitis: A multi-centre case-control study	PLOS ONE			English	Article							HERPES-SIMPLEX ENCEPHALITIS; NMDA-RECEPTOR ENCEPHALITIS; MRI VOLUMETRIC-ANALYSIS; LIMBIC ENCEPHALITIS; COGNITIVE DEFICITS; ORGANIC AMNESIA; LEUCINE-RICH; ANTIBODIES; INVENTORY; DIAGNOSIS	Objectives Our aim was to compare neuropsychological and psychiatric outcomes across three encephalitis aetiological groups: Herpes simplex virus (HSV), other infections or autoimmune causes (Other), and encephalitis of unknown cause (Unknown). Methods Patients recruited from NHS hospitals underwent neuropsychological and psychiatric assessment in the short-term (4 months post-discharge), medium-term (9-12 months after the first assessment), and long-term (>1-year). Healthy control subjects were recruited from the general population and completed the same assessments. Results Patients with HSV were most severely impaired on anterograde and retrograde memory tasks. In the short-term, they also showed executive, IQ, and naming deficits, which resolved in the long-term. Patients with Other or Unknown causes of encephalitis showed moderate memory impairments, but no significant impairment on executive tests. Memory impairment was associated with hippocampal/medial temporal damage on magnetic resonance imaging (MRI), and naming impairment with left temporal and left frontal abnormalities. Patients reported more subjective cognitive complaints than healthy controls, with tiredness a significant problem, and there were high rates of depression and anxiety in the HSV and the Other encephalitis groups. These subjective, self-reported complaints, depression, and anxiety persisted even after objectively measured neuropsychological performance had improved. Conclusions Neuropsychological and psychiatric outcomes after encephalitis vary according to aetiology. Memory and naming are severely affected in HSV, and less so in other forms. Neuropsychological functioning improves over time, particularly in those with more severe short-term impairments, but subjective cognitive complaints, depression, and anxiety persist, and should be addressed in rehabilitation programmes.	[Harris, Lara; Griem, Julia; Marsh, Laura; Kopelman, Michael] Kings Coll London KCL, Inst Psychiat Psychol & Neurosci, London, England; [Gummery, Alison; Defres, Sylviane; Solomon, Tom] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England; [Gummery, Alison; Defres, Sylviane; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Defres, Sylviane] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Trop & Infect Dis Unit, Liverpool, Merseyside, England; [Bhojak, Maneesh; Das, Kumar; Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England; [Easton, Ava] Encephalitis Soc, Melton, England; [Easton, Ava] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; Walton Centre; University of Liverpool	Griem, J (corresponding author), Kings Coll London KCL, Inst Psychiat Psychol & Neurosci, London, England.	julia.griem@kcl.ac.uk	Marsh, Laura Clare/AAU-1246-2020; Body, Richard/C-2736-2010	Marsh, Laura Clare/0000-0002-7208-6726; Emsley, Hedley/0000-0003-0129-4488; Foy, Robbie/0000-0003-0605-7713; Michael, Benedict/0000-0002-8693-8926; Goldenberg, Simon/0000-0003-0837-7382; Sadarangani, Manish/0000-0002-9985-6452; Reed, Matthew/0000-0003-1308-4824; Martin, Natalie/0000-0003-1150-4602; Carrol, Enitan/0000-0001-8357-7726; Griem, Julia/0000-0002-1779-5255; Body, Richard/0000-0001-9089-8130; Thwaites, Guy/0000-0002-2858-2087; Easton, Ava/0000-0002-1739-2915	National Institute for Health Research [RP-PG-0108-10,048]; National Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections, NIHR Global Health Research Group on Brain Infections [17/63/110]; European Union's Horizon 2020 research and innovation program ZikaPLAN (Preparedness Latin America Network) [734584]; Biomedical Research Centre (BRC) of the Institute of Psychiatry, Psychology and Neuroscience; South London and Maudsley NHS Foundation Trust; King's College London	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections, NIHR Global Health Research Group on Brain Infections; European Union's Horizon 2020 research and innovation program ZikaPLAN (Preparedness Latin America Network); Biomedical Research Centre (BRC) of the Institute of Psychiatry, Psychology and Neuroscience; South London and Maudsley NHS Foundation Trust; King's College London	This article is independent research funded by the National Institute for Health Research (www.nihr.ac.uk) under its Programme Grants for Applied Research Programme (grant reference number RP-PG-0108-10,048). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England. TS is supported by the National Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections, NIHR Global Health Research Group on Brain Infections (number 17/63/110), and the European Union's Horizon 2020 research and innovation program ZikaPLAN (Preparedness Latin America Network), grant agreement No. 734584. MDK was supported by the Biomedical Research Centre (BRC) of the Institute of Psychiatry, Psychology and Neuroscience and the South London and Maudsley NHS Foundation Trust, as well as King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, ASSESSMENT CLIN MANU; Backman R, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0224-2; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brooks J, 2001, EPILEPSY RES, V43, P227, DOI 10.1016/S0920-1211(00)00198-4; Burgess P.W., 1997, HAYLING BRIXTON TEST; Butler CR, 2014, J NEUROL NEUROSUR PS, V85, P387, DOI 10.1136/jnnp-2013-306724; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; Colchester A, 2001, J NEUROL NEUROSUR PS, V71, P13, DOI 10.1136/jnnp.71.1.13; Company, 1994, DOORS PEOPLE TEST VI; Cooper J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151145; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Defres S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170215; Dubey D, 2018, ANN NEUROL, V83, P166, DOI 10.1002/ana.25131; Easton A, 2016, LIFE ENCEPHALITIS; Finke C, 2017, JAMA NEUROL, V74, P50, DOI 10.1001/jamaneurol.2016.4226; Finke C, 2012, J NEUROL NEUROSUR PS, V83, P195, DOI 10.1136/jnnp-2011-300411; FREEMAN M R, 1992, Brain Injury, V6, P65, DOI 10.3109/02699059209008124; Gable MS, 2012, CLIN INFECT DIS, V54, P899, DOI 10.1093/cid/cir1038; George BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104169; Granerod J, 2017, J NEUROL, V264, P407, DOI 10.1007/s00415-016-8316-8; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9; Hebert J, 2018, CAN J NEUROL SCI, V45, P540, DOI 10.1017/cjn.2018.33; Hokkanen L, 1996, ARCH NEUROL-CHICAGO, V53, P972, DOI 10.1001/archneur.1996.00550100038013; Hokkanen L, 1996, J NEUROL NEUROSUR PS, V61, P478, DOI 10.1136/jnnp.61.5.478; Holdnack H. A., 2001, WECHSLER TEST ADULT; Howard D., 1992, PYRAMID PALM TREES T; Irani SR, 2010, BRAIN, V133, P2734, DOI 10.1093/brain/awq213; KAPUR N, 1994, J NEUROL NEUROSUR PS, V57, P1334, DOI 10.1136/jnnp.57.11.1334; KENNARD C, 1981, BRAIN, V104, P129, DOI 10.1093/brain/104.1.129; Kopelman MD, 2001, J NEUROL NEUROSUR PS, V71, P23, DOI 10.1136/jnnp.71.1.23; Kopelman MD, 1990, AUTOBIOGRAPHICAL MEM; Lamb F, 2013, ARCH PHYS MED REHAB, V94, P1747, DOI 10.1016/j.apmr.2013.02.026; MCKENNA KF, 1992, CAN J PSYCHIAT, V37, P271, DOI 10.1177/070674379203700412; Nasr JT, 2000, PEDIATR NEUROL, V22, P8, DOI 10.1016/S0887-8994(99)00116-2; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Parpia AS, 2016, EMERG INFECT DIS, V22, P426, DOI 10.3201/eid2203.151545; Pewter SM, 2007, NEUROPSYCHOL REHABIL, V17, P478, DOI 10.1080/09602010701202238; Ramanuj PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103496; Reed LJ, 2005, NEUROPSYCHOLOGY, V19, P555, DOI 10.1037/0894-4105.19.5.555; Reitan RM., 1979, TRAIL MAKING TEST MA; Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014; Spreen O, 1998, COMPENDIUM NEUROPSYC; Titulaer MJ, 2013, LANCET NEUROL, V12, P157, DOI 10.1016/S1474-4422(12)70310-1; Utley TFM, 1997, NEUROPSY NEUROPSY BE, V10, P180; Vincent A, 2004, BRAIN, V127, P701, DOI 10.1093/brain/awh077; Vora NM, 2014, NEUROLOGY, V82, P443, DOI 10.1212/WNL.0000000000000086; Warrington EK, 1997, NEUROPSYCHOL REHABIL, V7, P143, DOI 10.1080/713755528; Warrington EK., 1991, VISUAL OBJECT SPACE; Wechsler D., 2011, WASI 2 WECHSLER ABBR	51	11	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230436	10.1371/journal.pone.0230436	http://dx.doi.org/10.1371/journal.pone.0230436			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9HN	32210460	Green Published, gold			2022-12-26	WOS:000535307600026
J	Wang, GN; Wu, M; Durham, AC; Radaelli, E; Mason, NJ; Xu, XW; Roth, DB				Wang, Guannan; Wu, Ming; Durham, Amy C.; Radaelli, Enrico; Mason, Nicola J.; Xu, XiaoWei; Roth, David B.			Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma	PLOS ONE			English	Article							PLCG1 MUTATIONS; GENE; PATHWAY; CANCER; NRAS; LANDSCAPE; P53	Angiosarcoma (AS) is a rare neoplasm with limited treatment options and a poor survival rate. Development of effective therapies is hindered by the rarity of this disease. Dogs spontaneously develop hemangiosarcoma (HSA), a common, histologically similar neoplasm. Metastatic disease occurs rapidly and despite chemotherapy, most dogs die several months after diagnosis. These features suggest that HSA might provide a tractable model to test experimental therapies in clinical trials. We previously reported whole exome sequencing of 20 HSA cases. Here we report development of a NGS targeted resequencing panel to detect driver mutations in HSA and other canine tumors. We validated the panel by resequencing the original 20 cases and sequenced 30 additional cases. Overall, we identified potential driver mutations in over 90% of the cases, including well-documented (in human cancers) oncogenic mutations in PIK3CA (46%), PTEN (6%), PLCG1(4%), and TP53 (66%), as well as previously undetected recurrent activating mutations in NRAS (24%). The driver role of these mutations is further demonstrated by augmented downstream signaling crucial to tumor growth. The recurrent, mutually exclusive mutation patterns suggest distinct molecular subtypes of HSA. Driver mutations in some subtypes closely resemble those seen in some AS cases, including NRAS, PLCG1, PIK3CA and TP53. Furthermore, activation of the MAPK and PI3K pathways appear to be key oncogenic mechanisms in both species. Together, these observations suggest that dogs with spontaneous HSA could serve as a useful model for testing the efficacy of targeted therapies, some of which could potentially be of therapeutic value in AS.	[Wang, Guannan; Xu, XiaoWei; Roth, David B.] Univ Penn, Dept Pathol & Lab Med, Raymond & Ruth Perelman Sch Med, Philadelphia, PA 19104 USA; [Wu, Ming] Illumine, San Diego, CA USA; [Durham, Amy C.; Radaelli, Enrico; Mason, Nicola J.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Mason, Nicola J.] Univ Penn, Sch Vet Med, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Wang, GN; Roth, DB (corresponding author), Univ Penn, Dept Pathol & Lab Med, Raymond & Ruth Perelman Sch Med, Philadelphia, PA 19104 USA.	wguannan@pennmedicine.upenn.edu; david.roth2@pennmedicine.upenn.edu		Radaelli, Enrico/0000-0002-2885-0221; Wang, Guannan/0000-0003-0130-3241	Sarcoma Pilot Grant from Abramson Cancer Center's sarcoma program	Sarcoma Pilot Grant from Abramson Cancer Center's sarcoma program	This study is in part supported by the Sarcoma Pilot Grant from Abramson Cancer Center's sarcoma program, awarded to GW, DBR and NJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Illumina provided support in the form of salaries for MW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adachi M, 2016, J VET MED SCI, V78, P649, DOI 10.1292/jvms.15-0625; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Behjati S, 2014, NAT GENET, V46, P376, DOI 10.1038/ng.2921; Bunney TD, 2012, STRUCTURE, V20, P2062, DOI 10.1016/j.str.2012.09.005; Burd CE, 2014, CANCER DISCOV, V4, P1418, DOI 10.1158/2159-8290.CD-14-0729; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Eskandarpour M, 2009, INT J CANCER, V124, P16, DOI 10.1002/ijc.23876; Fu XL, 2017, ONCOTARGET, V8, P81709, DOI 10.18632/oncotarget.20700; Georgescu Maria-Magdalena, 2010, Genes Cancer, V1, P1170, DOI 10.1177/1947601911407325; Gkeka P, 2014, PLOS COMPUT BIOL, V10; Gorden BH, 2014, AM J PATHOL, V184, P985, DOI 10.1016/j.ajpath.2013.12.025; Gustafson DL, 2018, PHARM THERAPEUTICS; Hobbs GA, 2016, J CELL SCI, V129, P1287, DOI 10.1242/jcs.182873; Huang SC, 2016, AM J SURG PATHOL, V40, P645, DOI 10.1097/PAS.0000000000000582; Italiano A, 2012, CANCER-AM CANCER SOC, V118, P5878, DOI 10.1002/cncr.27614; Kong G, 2016, LEUKEMIA, V30, P1935, DOI 10.1038/leu.2016.89; Liu NS, 2013, MOL CANCER THER, V12, P2319, DOI 10.1158/1535-7163.MCT-12-0993-T; Manso R, 2015, HAEMATOLOGICA, V100, pE25, DOI 10.3324/haematol.2014.113696; Massacesi C, 2016, ONCOTARGETS THER, V9, P203, DOI 10.2147/OTT.S89967; Millis SZ, 2016, JAMA ONCOL, V2, P1565, DOI 10.1001/jamaoncol.2016.0891; Murai A, 2012, J COMP PATHOL, V147, P430, DOI 10.1016/j.jcpa.2012.05.002; Murai A, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-128; Murali R, 2015, ONCOTARGET, V6, P36041, DOI 10.18632/oncotarget.5936; Naka N, 1996, J SURG ONCOL, V61, P170, DOI 10.1002/(SICI)1096-9098(199603)61:3<170::AID-JSO2>3.0.CO;2-8; Naka N, 1997, INT J CANCER, V71, P952, DOI 10.1002/(SICI)1097-0215(19970611)71:6<952::AID-IJC7>3.3.CO;2-N; Painter C, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.1519; Peck RW, 2018, ANNU REV PHARMACOL, V58, P105, DOI 10.1146/annurev-pharmtox-010617-052446; Samuels Y, 2011, CURR TOP MICROBIOL, V347, P21, DOI 10.1007/82_2010_68; Tamburini BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005549; Vallois D, 2016, BLOOD, V128, P1490, DOI 10.1182/blood-2016-02-698977; Vaque JP, 2014, BLOOD, V123, P2034, DOI 10.1182/blood-2013-05-504308; Wang M, 2017, ONCOTARGET, V8, P17763, DOI 10.18632/oncotarget.14846; Young RJ, 2010, LANCET ONCOL, V11, P983, DOI 10.1016/S1470-2045(10)70023-1; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; ZHANG HF, 2017, PLOS ONE, V12	36	11	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0229728	10.1371/journal.pone.0229728	http://dx.doi.org/10.1371/journal.pone.0229728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210430	Green Published, gold			2022-12-26	WOS:000535307600011
J	Armstrong, RA; Davey, T; Allsopp, AJ; Lanham-New, SA; Oduoza, U; Cooper, JA; Montgomery, HE; Fallowfield, JL				Armstrong, Richard A.; Davey, Trish; Allsopp, Adrian J.; Lanham-New, Susan A.; Oduoza, Uche; Cooper, Jacqueline A.; Montgomery, Hugh E.; Fallowfield, Joanne L.			Low serum 25-hydroxyvitamin D status in the pathogenesis of stress fractures in military personnel: An evidenced link to support injury risk management	PLOS ONE			English	Article							D-RECEPTOR GENE; VITAMIN-D SUPPLEMENTATION; BONE-MINERAL DENSITY; TRANSLATION INITIATION SITE; POLYMORPHISM; STRENGTH; CALCIUM; OSTEOPOROSIS; ASSOCIATION; HORMONE	Stress fractures are common amongst healthy military recruits and athletes. Reduced vitamin D availability, measured by serum 25-hydroxyvitamin D (25OHD) status, has been associated with stress fracture risk during the 32-week Royal Marines (RM) training programme. A gene-environment interaction study was undertaken to explore this relationship to inform specific injury risk mitigation strategies. Fifty-one males who developed a stress fracture during RM training (n = 9 in weeks 1-15; n = 42 in weeks 16-32) and 141 uninjured controls were genotyped for the vitamin D receptor (VDR) FokI polymorphism. Serum 25OHD was measured at the start, middle and end (weeks 1, 15 and 32) of training. Serum 25OHD concentration increased in controls between weeks 1-15 (61.8 +/- 29.1 to 72.6 +/- 28.8 nmol/L, p = 0.01). Recruits who fractured did not show this rise and had lower week-15 25OHD concentration (p = 0.01). Higher week-15 25OHD concentration was associated with reduced stress fracture risk (adjusted OR 0.55[0.32-0.96] per 1SD increase, p = 0.04): the greater the increase in 25OHD, the greater the protective effect (p = 0.01). The f-allele was over-represented in fracture cases compared with controls (p<0.05). Baseline 25OHD status interacted with VDR genotype: a higher level was associated with reduced fracture risk in f-allele carriers (adjusted OR 0.39[0.17-0.91], p = 0.01). Improved 25OHD status between weeks 1-15 had a greater protective effect in FF genotype individuals (adjusted OR 0.31[0.12-0.81] vs. 1.78[0.90-3.49], p<0.01). Stress fracture risk in RM recruits is impacted by the interaction of VDR genotype with vitamin D status. This further supports the role of low serum vitamin D concentrations in causing stress fractures, and hence prophylactic vitamin D supplementation as an injury risk mitigation strategy.	[Armstrong, Richard A.; Oduoza, Uche; Cooper, Jacqueline A.; Montgomery, Hugh E.] UCL, Ctr Human Hlth & Performance, London, England; [Armstrong, Richard A.; Oduoza, Uche; Cooper, Jacqueline A.; Montgomery, Hugh E.] UCL, Inst Sport Exercise & Hlth, London, England; [Davey, Trish; Allsopp, Adrian J.; Fallowfield, Joanne L.] Inst Naval Med, Alverstoke, Hants, England; [Lanham-New, Susan A.] Univ Surrey, Fac Hlth & Med Sci, Nutr Sci Dept, Guildford, Surrey, England	University of London; University College London; University of London; University College London; University of Surrey	Armstrong, RA (corresponding author), UCL, Ctr Human Hlth & Performance, London, England.; Armstrong, RA (corresponding author), UCL, Inst Sport Exercise & Hlth, London, England.	rarmstrong1@nhs.net	Armstrong, Richard/AAT-3953-2020; Montgomery, Hugh/C-2592-2008	Armstrong, Richard/0000-0001-9479-0143; Lanham-New, Susan/0000-0003-3153-6345; Montgomery, Hugh/0000-0001-8797-5019	United Kingdom Ministry of Defence; University College London Centre for Human Health and Performance (CHHP); National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, London, UK	United Kingdom Ministry of Defence; University College London Centre for Human Health and Performance (CHHP); National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, London, UK	Core study funding came from the United Kingdom Ministry of Defence; funds from the University College London Centre for Human Health and Performance (CHHP) supported genetic analysis. HM and the Institute for Sport, Exercise and Health (where the CHHP is housed) received funding from the National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, London, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen NE, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-38; Anderson PH, 2013, J STEROID BIOCHEM, V136, P190, DOI 10.1016/j.jsbmb.2012.08.008; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Bikle DD, 2012, CURR OSTEOPOROS REP, V10, P151, DOI 10.1007/s11914-012-0098-z; Bruckner P, 1999, STRESS FRACTURES; Burgi AA, 2011, J BONE MINER RES, V26, P2371, DOI 10.1002/jbmr.451; Chatzipapas C, 2009, HORM METAB RES, V41, P635, DOI 10.1055/s-0029-1216375; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dao D, 2015, AM J SPORT MED, V43, P2064, DOI 10.1177/0363546514555971; Davey T, 2016, OSTEOPOROSIS INT, V27, P171, DOI 10.1007/s00198-015-3228-5; Davey T, 2015, BONE, V73, P120, DOI 10.1016/j.bone.2014.12.018; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Francis R, 2013, VITAMIN D BONE HLTH; Friedman E, 2000, GENETIC BASIS STRESS, P105; Friedman E, 2014, GENET RES, V96, DOI 10.1017/S001667231400007X; Gaffney-Stomberg E, 2017, J BONE MINER RES, V32, P498, DOI 10.1002/jbmr.3008; Gaffney-Stomberg E, 2014, BONE, V68, P46, DOI 10.1016/j.bone.2014.08.002; Gennari L, 1999, J BONE MINER RES, V14, P1379, DOI 10.1359/jbmr.1999.14.8.1379; Gennari L, 2002, J STEROID BIOCHEM, V81, P1, DOI 10.1016/S0960-0760(02)00043-2; Gross C, 1996, J BONE MINER RES, V11, P1850; Henningsen A, 2006, Z ORTHOP GRENZGEB, V144, P502, DOI 10.1055/s-2006-942262; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; JONES BH, 1993, AM J SPORT MED, V21, P705, DOI 10.1177/036354659302100512; Kim H, 2015, J CLIN ENDOCR METAB, V100, P3118, DOI 10.1210/jc.2014-4320; Korvala J, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-95; Lappe J, 2008, J BONE MINER RES, V23, P741, DOI 10.1359/jbmr.080102; Li H, 2007, SCIENCE, V4, pe103, DOI DOI 10.1371/J0URNAL.PMED.0040103; Liu YZ, 2003, J ENDOCRINOL, V177, P147, DOI 10.1677/joe.0.1770147; Martin EN, 2015, J BONE MINER RES, V30, P475, DOI 10.1002/jbmr.2360; Mikkola TM, 2008, J BONE MINER RES, V23, P492, DOI 10.1359/JBMR.071205; Mohammadi Z, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0098-x; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Randerson-Moor JA, 2009, EUR J CANCER, V45, P3271, DOI 10.1016/j.ejca.2009.06.011; Reis JP, 2007, MIL MED, V172, P936, DOI 10.7205/MILMED.172.9.936; Rubin DB., 2004, MULTIPLE IMPUTATION; Shuler FD, 2012, SPORTS HEALTH, V4, P496, DOI 10.1177/1941738112461621; SINGER A, 1990, J BONE JOINT SURG AM, V72A, P444, DOI 10.2106/00004623-199072030-00020; Smolders J, 2009, J NEUROIMMUNOL, V207, P117, DOI 10.1016/j.jneuroim.2008.12.011; Valimaki VV, 2004, J CLIN ENDOCR METAB, V89, P76, DOI 10.1210/jc.2003-030817; van Leeuwen JPTM, 2001, CRIT REV EUKAR GENE, V11, P199; Warden Stuart J, 2006, Curr Osteoporos Rep, V4, P103; Wentz L, 2011, MIL MED, V176, P420, DOI 10.7205/MILMED-D-10-00322	44	13	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0229638	10.1371/journal.pone.0229638	http://dx.doi.org/10.1371/journal.pone.0229638			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208427	Green Published, gold			2022-12-26	WOS:000535305100006
J	Buglo, E; Sarmiento, E; Martuscelli, NB; Sant, DW; Danzi, MC; Abrams, AJ; Dallman, JE; Zuchner, S				Buglo, Elena; Sarmiento, Evan; Martuscelli, Nicole Belliard; Sant, David W.; Danzi, Matt C.; Abrams, Alexander J.; Dallman, Julia E.; Zuchner, Stephan			Genetic compensation in a stable slc25a46 mutant zebrafish: A case for using F0 CRISPR mutagenesis to study phenotypes caused by inherited disease	PLOS ONE			English	Article							OPTIC ATROPHY; MUTATIONS; IDENTIFICATION; ROLES; MICE; MOTONEURONS; REDUNDANCY; KNOCKOUT; RECEPTOR; REVEALS	A phenomenon of genetic compensation is commonly observed when an organism with a disease-bearing mutation shows incomplete penetrance of the disease phenotype. Such incomplete phenotypic penetrance, or genetic compensation, is more commonly found in stable knockout models, rather than transient knockdown models. As such, these incidents present a challenge for the disease modeling field, although a deeper understanding of genetic compensation may also hold the key for novel therapeutic interventions. In our study we created a knockout model of slc25a46 gene, which is a recently discovered important player in mitochondrial dynamics, and deleterious mutations in which are known to cause peripheral neuropathy, optic atrophy and cerebellar ataxia. We report a case of genetic compensation in a stable slc25a46 homozygous zebrafish mutant (hereafter referred as "mutant"), in contrast to a penetrant disease phenotype in the first generation (F0) slc25a46 mosaic mutant (hereafter referred as "crispant"), generated with CRISPR/Cas-9 technology. We show that the crispant phenotype is specific and rescuable. By performing mRNA sequencing, we define significant changes in slc25a46 mutant's gene expression profile, which are largely absent in crispants. We find that among the most significantly altered mRNAs, anxa6 gene stands out as a functionally relevant player in mitochondrial dynamics. We also find that our genetic compensation case does not arise from mechanisms driven by mutant mRNA decay. Our study contributes to the growing evidence of the genetic compensation phenomenon and presents novel insights about Slc25a46 function. Furthermore, our study provides the evidence for the efficiency of F0 CRISPR screens for disease candidate genes, which may be used to advance the field of functional genetics.	[Buglo, Elena; Danzi, Matt C.; Zuchner, Stephan] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Sarmiento, Evan; Martuscelli, Nicole Belliard; Dallman, Julia E.] Univ Miami, Dept Biol Sci, Coral Gables, FL 33124 USA; [Sant, David W.] Univ Utah, Dept Biomed Informat, Salt Lake City, UT USA; [Abrams, Alexander J.] Yale Univ, Dept Genet, New Haven, CT USA	University of Miami; University of Miami; Utah System of Higher Education; University of Utah; Yale University	Buglo, E (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA.	exb216@miami.edu	Dallman, Julia/AGG-3507-2022	Dallman, Julia/0000-0002-5839-807X; Danzi, Matt/0000-0003-1568-5965; Sant, David/0000-0001-7372-9896	American Heart Association [18PRE33960397]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [1R01NS075764-01A1]; National Institutes of Health [R21HD093021]	American Heart Association(American Heart Association); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	EB 18PRE33960397 American Heart Association www.heart.org The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SZ 1R01NS072248-06A1 National Institutes of Health/National Institute of Neurological Disorders and Stroke https://www.ninds.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SZ 1R01NS075764-01A1 National Institutes of Health/National Institute of Neurological Disorders and Stroke https://www.ninds.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JED R21HD093021 National Institutes of Health https://www.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams AJ, 2018, HUM MUTAT, V39, P1995, DOI 10.1002/humu.23639; Abrams AJ, 2015, NAT GENET, V47, P926, DOI 10.1038/ng.3354; Anderson JL, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007105; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Bouche N, 2001, CURR OPIN PLANT BIOL, V4, P111, DOI 10.1016/S1369-5266(00)00145-X; CADIGAN KM, 1994, P NATL ACAD SCI USA, V91, P6324, DOI 10.1073/pnas.91.14.6324; Carrington B, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv802; Casey JP, 2012, MOL GENET METAB, V106, P351, DOI 10.1016/j.ymgme.2012.04.017; Charlesworth G, 2016, MOVEMENT DISORD, V31, P1249, DOI 10.1002/mds.26716; Chen PP, 2016, GENOME RES, V26, P1355, DOI 10.1101/gr.205955.116; Chlystun M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053774; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Deng SH, 2007, J NEUROSCI, V27, P6333, DOI 10.1523/JNEUROSCI.5381-06.2007; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duchesne A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006597; El-Brolosy MA, 2019, NATURE, V568, P193, DOI 10.1038/s41586-019-1064-z; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; Franke A, 1999, MOL CELL, V4, P117, DOI 10.1016/S1097-2765(00)80193-8; Gao YB, 2015, P NATL ACAD SCI USA, V112, P2275, DOI 10.1073/pnas.1500365112; GONZALEZGAITAN M, 1994, P NATL ACAD SCI USA, V91, P8567, DOI 10.1073/pnas.91.18.8567; Gutierrez-Aguilar M, 2013, BIOCHEM J, V454, P371, DOI 10.1042/BJ20121753; Hammer MB, 2017, NEURODEGENER DIS, V17, P208, DOI 10.1159/000464445; HOFFMANN FM, 1991, TRENDS GENET, V7, P351, DOI 10.1016/0168-9525(91)90254-F; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Janer A, 2016, EMBO MOL MED, V8, P1019, DOI 10.15252/emmm.201506159; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Karakas B, 2007, CANCER BIOL THER, V6, P1025, DOI 10.4161/cbt.6.7.4202; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kozol RA, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00055; Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021; Lam EWF, 2000, J BIOL CHEM, V275, P3479, DOI 10.1074/jbc.275.5.3479; Law SHW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100268; Li Z, 2017, HUM MOL GENET, V26, P3776, DOI 10.1093/hmg/ddx262; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Ma ZP, 2019, NATURE, V568, P259, DOI 10.1038/s41586-019-1057-y; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; MUKHERJEE AS, 1965, NATURE, V207, P785, DOI 10.1038/207785a0; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; Nguyen M, 2017, CLIN GENET, V91, P121, DOI 10.1111/cge.12774; Novodvorsky P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141611; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Robinson KJ, 2019, ZEBRAFISH, V16, P8, DOI 10.1089/zeb.2018.1588; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; San B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210217; Sato-Maeda M, 2008, DEVELOPMENT, V135, P323, DOI 10.1242/dev.007559; Schmeisser MJ, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-18; Shah AN, 2015, NAT METHODS, V12, P535, DOI 10.1038/nmeth.3360; Steffen J, 2017, MOL BIOL CELL, V28, P600, DOI 10.1091/mbc.E16-07-0545; Sulaiman RA, 2017, CLIN GENET, V92, P230, DOI 10.1111/cge.12963; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Sztal TE, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007212; Tanabe K, 2010, J NEUROSCI, V30, P16983, DOI 10.1523/JNEUROSCI.3352-10.2010; Terzenidou ME, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006656; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Varshney GK, 2016, NAT PROTOC, V11, P2357, DOI 10.1038/nprot.2016.141; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Wan JJ, 2016, BRAIN, V139, P2877, DOI 10.1093/brain/aww212; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Zimmer AM, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.175737	64	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230566	10.1371/journal.pone.0230566	http://dx.doi.org/10.1371/journal.pone.0230566			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208444	Green Published, gold, Green Submitted			2022-12-26	WOS:000535305100022
J	Ejomah, AJ; Uyi, OO; Ekaye, SO				Ejomah, Afure J.; Uyi, Osariyekemwen O.; Ekaye, Sese-Owei			Exposure of the African mound building termite, Macrotermes bellicosus workers to commercially formulated 2,4-D and atrazine caused high mortality and impaired locomotor response	PLOS ONE			English	Article							2,4-DICHLOROPHENOXYACETIC ACID 2,4-D; ENVIRONMENTAL IMPACTS; HERBICIDE; ISOPTERA; GLYPHOSATE; MODE; POPULATIONS; SELECTIVITY; PESTICIDES; COLEOPTERA	Recent empirical evidence suggests that herbicides have damaging effects on non-target organisms in both natural and semi-natural ecosystems. The African mound building termite, Macrotermes bellicosus, is an important beneficial insect that functions as an ecosystem engineer due to its role in the breakdown of dead and decaying materials. Here, we examined the effects of 2,4-D amine salt (2,4-D) and atrazine based herbicides viz. Vestamine (R) and Ultrazine (R) on the survival and locomotion response of M. bellicosus. Worker termites were treated with a range of concentrations of Vestamine (R) (the recommended concentration: 6.25 ml per 500 ml of water, 0.25- and 0.5-fold below the recommended concentration and distilled water as control) and Ultrazine (R) (the recommended concentration: 3.75 ml per 500 ml of water, 0.25-, 0.5-, 2.0- and 4-fold of the recommended concentration and distilled water as control) for 24 hours for the mortality test, and allowed to run for 15 seconds for the locomotion trial. All concentrations of both Vestamine (R) and Ultrazine (R) were highly toxic to worker termites and mortality increased as the concentration and time after treatment increased. For both herbicides, concentrations far less than the recommended rates caused 100% mortality. The speed of termites was significantly influenced by both Vestamine (R) and Ultrazine (R) as termites exposed to all tested concentrations of the herbicides exhibited reduced running speed than the control. These findings suggest that beneficial insects, especially M. bellicosus may experience high mortality (up to 100%) and reduced mobility if they are sprayed upon or come in contact with plant materials that have been freshly sprayed with (less or more than) the recommended concentrations of Vestamine (R) and Ultrazine (R). The findings of our study calls for the reassessment of the usage of 2,4-D and atrazine based herbicides in weed control in termite and other beneficial insect populated habitats.	[Ejomah, Afure J.; Uyi, Osariyekemwen O.; Ekaye, Sese-Owei] Univ Benin, Dept Anim & Environm Biol, Benin, Nigeria; [Uyi, Osariyekemwen O.] Univ Ft Hare, Dept Zool & Entomol, Alice, South Africa; [Uyi, Osariyekemwen O.] Penn State Univ, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA	University of Benin; University of Fort Hare; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Uyi, OO (corresponding author), Univ Benin, Dept Anim & Environm Biol, Benin, Nigeria.; Uyi, OO (corresponding author), Univ Ft Hare, Dept Zool & Entomol, Alice, South Africa.; Uyi, OO (corresponding author), Penn State Univ, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA.	osariyekemwen.uyi@uniben.edu	Ekaye, Sese-Owei/HIK-4833-2022; Uyi, Osariyekemwen/AAQ-5353-2020	Uyi, Osariyekemwen/0000-0001-5268-4676				ADAMS JEAN B., 1960, CANADIAN JOUR ZOOL, V38, P285, DOI 10.1139/z60-035; Ainsworth N, 2003, BIOCONTROL SCI TECHN, V13, P547, DOI 10.1080/0958315031000151819; Aronzon CM, 2011, ENVIRON TOXICOL, V26, P373, DOI 10.1002/tox.20564; Burns CJ, 2001, OCCUP ENVIRON MED, V58, P24, DOI 10.1136/oem.58.1.24; Campero M, 2007, ECOL APPL, V17, P2111, DOI 10.1890/07-0442.1; Carmo EL, 2010, BIOCONTROL, V55, P455, DOI 10.1007/s10526-010-9269-y; Chikoye David, 2006, Journal of Food Agriculture & Environment, V4, P114; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; COLLINS NM, 1981, J ANIM ECOL, V50, P293, DOI 10.2307/4046; Cooper RL, 2007, BIRTH DEFECTS RES B, V80, P98, DOI 10.1002/bdrb.20110; Correia FV, 2010, B ENVIRON CONTAM TOX, V85, P264, DOI 10.1007/s00128-010-0089-7; Cox C., 2001, Journal of Pesticide Reform, V21, P12; Dangerfield JM, 2000, J TROP ECOL, V16, P717, DOI 10.1017/S026646740000167X; Dangerfield JM, 1998, J TROP ECOL, V14, P507, DOI 10.1017/S0266467498000364; Marcato ACD, 2017, WATER AIR SOIL POLL, V228, DOI 10.1007/s11270-017-3301-0; De Fine Licht HH, 2004, MYCOLOGICAL RES, V109, P314; Demolin Leite Germano Leao, 2015, Florida Entomologist, V98, P899; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; DEWEY SL, 1986, ECOLOGY, V67, P148, DOI 10.2307/1938513; Egan JF, 2014, AGR ECOSYST ENVIRON, V185, P77, DOI 10.1016/j.agee.2013.12.017; Eisler R, 1989, ATRAZINE HAZARDS FIS; Ellenhorn MJ, 1997, ELLENHORNS MEDICAL T, V2nd; FREEMARK K, 1995, AGR ECOSYST ENVIRON, V52, P67, DOI 10.1016/0167-8809(94)00534-L; Freydier L, 2016, ECOTOXICOLOGY, V25, P1270, DOI 10.1007/s10646-016-1680-4; Freymann BP, 2008, EUR J ENTOMOL, V105, P165, DOI 10.14411/eje.2008.025; Gely-Pernot A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2095-y; Gianessi LP, 2013, PEST MANAG SCI, V69, P1099, DOI 10.1002/ps.3598; Gill H.K., 2014, PESTIC TOXIC ASPECTS, V8, DOI [DOI 10.5772/57399, 10.5772/57399]; Herbert LT, 2014, J EXP BIOL, V217, P3457, DOI 10.1242/jeb.109520; Hill MP, 2012, BIOCONTROL SCI TECHN, V22, P1321, DOI 10.1080/09583157.2012.725825; Ibrahim MA, 1999, ENVIRON HEALTH PERSP, V96, P213; Islam F, 2018, ENVIRON INT, V111, P332, DOI 10.1016/j.envint.2017.10.020; Johnson JA, 2019, AQUAT TOXICOL, V213, DOI 10.1016/j.aquatox.2019.06.001; Jouquet P, 2006, APPL SOIL ECOL, V32, P153, DOI 10.1016/j.apsoil.2005.07.004; Jouquet P, 2016, SOIL SCI, V181, P157, DOI 10.1097/SS.0000000000000119; Jouquet P, 2011, EUR J SOIL BIOL, V47, P215, DOI 10.1016/j.ejsobi.2011.05.005; Kao LM, 1995, PESTIC SCI, V45, P331, DOI 10.1002/ps.2780450407; Khan MA, 2018, SUST PLANT CROP PRO, P201, DOI 10.1007/978-3-319-72110-1_10; Korb J, 1998, INSECT SOC, V45, P51, DOI 10.1007/s000400050068; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Kunkel BA, 2001, J ECON ENTOMOL, V94, P60, DOI 10.1603/0022-0493-94.1.60; LeBaron HM, 2008, TRIAZINE HERBICIDES: 50 YEARS REVOLUTIONIZING AGRICULTURE, P119, DOI 10.1016/B978-044451167-6.50013-1; LEPAGE M, 1984, J ANIM ECOL, V53, P107, DOI 10.2307/4345; Londono DK, 2004, CHEMOSPHERE, V56, P701, DOI 10.1016/j.chemosphere.2003.12.001; Martinez IM, 2001, CR ACAD SCI III-VIE, V324, P989, DOI 10.1016/S0764-4469(01)01384-1; Meyer MT, 2009, HANDBOOK OF WATER PURITY AND QUALITY, P289, DOI 10.1016/B978-0-12-374192-9.00013-3; MORTON H L, 1972, Environmental Entomology, V1, P102, DOI 10.1093/ee/1.1.102; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Oluwole O, 2009, INT J AGR SUSTAIN, V7, P153, DOI 10.3763/ijas.2009.0431; Park K, 2010, COMP BIOCHEM PHYS C, V151, P439, DOI 10.1016/j.cbpc.2010.01.009; PIMENTEL D, 1995, J AGR ENVIRON ETHIC, V8, P17, DOI 10.1007/BF02286399; Reis TC, 2018, AN ACAD BRAS CIENC, V90, P3625, DOI 10.1590/0001-3765201820170748; Relyea RA, 2005, ECOL APPL, V15, P618, DOI 10.1890/03-5342; Rohr J.R., 2018, ENCYCL ANTHROPOCENE, V5, P141, DOI [10.1016/b978-0-12-809665-9.09885-2, DOI 10.1016/B978-0-12-809665-9.09885-2]; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; SHIMABUKURO RH, 1969, J AGR FOOD CHEM, V17, P199, DOI 10.1021/jf60162a044; Shuman-Goodier ME, 2016, SCI TOTAL ENVIRON, V565, P758, DOI 10.1016/j.scitotenv.2016.04.205; Balbuena MS, 2015, J EXP BIOL, V218, P2799, DOI 10.1242/jeb.117291; Solomon KR, 1996, ENVIRON TOXICOL CHEM, V15, P31, DOI [10.1002/etc.5620150105, 10.1897/1551-5028(1996)015&lt;0031:ERAOAI&gt;2.3.CO;2]; Song YL, 2014, J INTEGR PLANT BIOL, V56, P106, DOI 10.1111/jipb.12131; Turner JS, 2006, DRYLAND ECOHYDROLOGY, P303, DOI 10.1007/1-4020-4260-4_17; van Huis A, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0137-z; Vogel A, 2015, J INSECT PHYSIOL, V72, P14, DOI 10.1016/j.jinsphys.2014.11.002	64	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230664	10.1371/journal.pone.0230664	http://dx.doi.org/10.1371/journal.pone.0230664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208460	Green Published, gold			2022-12-26	WOS:000535305100034
J	Broch, OJ; Klebert, P; Michelsen, FA; Alver, MO				Broch, Ole Jacob; Klebert, Pascal; Michelsen, Finn Are; Alver, Morten Omholt			Multiscale modelling of cage effects on the transport of effluents from open aquaculture systems	PLOS ONE			English	Article							MARGINAL ICE-ZONE; NUMERICAL-MODEL; FARM	Most Atlantic salmon mariculture operations use open sea cages for the grow out phase. The ultimate fate and effects of the effluents and the possibilities of disease transfer between fish farms are major concerns for farmers, governance and the general public alike. Numerical model systems applied to studying and managing effluents and disease transfer in mariculture must realistically resolve the hydrodynamics in the vicinity of the fish farms. In the present study, the effects of the aquaculture structures on the current patterns were introduced in the ocean model system SINMOD. The drag parameters for the ocean model were determined by comparing the simulation results from the ANSYS Fluent (R) software suite and SINMOD in an idealized channel setting with uniform currents. The model was run for a number of realistic scenarios in high horizontal resolution (similar to 30 m) with sea cages influencing the flow field. Comparisons between extensive current measurements and the simulation results showed that the model system reproduced the current local current field well. By running simulation scenarios with and without the effects of the sea cages on the flow field, it was possible to assess the importance of such effects for numerical dispersal models and aquaculture environment interactions simulations and hence for assessment of environmental impacts.	[Broch, Ole Jacob; Klebert, Pascal; Michelsen, Finn Are] SINTEF Ocean, Trondheim, Norway; [Alver, Morten Omholt] Norwegian Univ Sci & Technol, Dept Engn Cybernet, Trondheim, Norway	SINTEF; Norwegian University of Science & Technology (NTNU)	Broch, OJ (corresponding author), SINTEF Ocean, Trondheim, Norway.	ole.jacob.broch@sintef.no	klebert, pascal/DSX-4164-2022	Broch, Ole Jacob/0000-0003-3052-836X	RACE research grant program - SINTEF Ocean through the research project "Water currents in fish farms at site scale"	RACE research grant program - SINTEF Ocean through the research project "Water currents in fish farms at site scale"	OJB, PK, FAM and MOA all received funding from the RACE research grant program funded by SINTEF Ocean through the research project "Water currents in fish farms at site scale".	Beldring S, 2003, HYDROL EARTH SYST SC, V7, P304, DOI 10.5194/hess-7-304-2003; Broch OJ, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00199; Cornejo P, 2014, AQUACULTURE, V430, P195, DOI 10.1016/j.aquaculture.2014.04.015; Cranford PJ, 2012, AQUACULT ENV INTERAC, V2, P193, DOI 10.3354/aei00040; Cromey CJ, 2002, AQUACULTURE, V214, P211, DOI 10.1016/S0044-8486(02)00368-X; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Grant J, 2001, CAN J FISH AQUAT SCI, V58, P1003, DOI 10.1139/cjfas-58-5-1003; Hansen K, 1989, 19189C20 ICES OAOER; James SC, 2019, ENVIRON FLUID MECH, V19, P989, DOI 10.1007/s10652-019-09697-7; Jansen HM, 2018, AQUACULT ENV INTERAC, V10, P385, DOI 10.3354/aei00276; Js S, 1963, MON WEATHER REV, V91, P99, DOI [10.1175/1520-0493(1963)0912.3.CO;2, DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2, 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2, DOI 10.1175/1520-0493(1963)0912.3.CO;2]; Klebert P, 2015, OCEAN ENG, V104, P511, DOI 10.1016/j.oceaneng.2015.04.045; Michelsen FA, 2019, J SEA RES, V154, DOI 10.1016/j.seares.2019.101806; Moe H, 2003, NORWEGIAN J GEOGRAPH; Myksvoll M. S., 2018, PLOS ONE, V13, P1, DOI DOI 10.1371/J0URNAL.P0NE.0201338); O'Donncha F, 2013, AQUACULT ENG, V52, P14, DOI 10.1016/j.aquaeng.2012.07.006; Plew DR, 2011, AQUACULT ENV INTERAC, V1, P201, DOI 10.3354/aei00020; Reid GK, 2019, REV AQUACULTURE; Sandvik AD, 2016, AQUACULT ENV INTERAC, V8, P527, DOI 10.3354/aei00193; Satre R., 2007, NORWEGIAN COASTAL CU; Slagstad D, 2005, J MARINE SYST, V58, P1, DOI 10.1016/j.jmarsys.2005.05.005; Stigebrandt A, 2004, AQUACULTURE, V234, P239, DOI 10.1016/j.aquaculture.2003.11.029; STOLEHANSEN K, 1991, POLAR RES, V10, P33, DOI 10.1111/j.1751-8369.1991.tb00632.x; Sundfjord A, 2008, DEEP-SEA RES PT II, V55, P2154, DOI 10.1016/j.dsr2.2008.05.027; Venayagamoorthy SK, 2011, ENVIRON FLUID MECH, V11, P329, DOI 10.1007/s10652-011-9209-0; Wilcox D.C., 1988, TURBULENCE MODELING, V2nd ed.; Woodcock SH, 2018, MAR ENVIRON RES, V137, P16, DOI 10.1016/j.marenvres.2018.02.017; Wu YS, 2014, AQUACULT ENV INTERAC, V5, P235, DOI 10.3354/aei00108; Zhang ZH, 2020, ESTUAR COAST SHELF S, V232, DOI 10.1016/j.ecss.2019.106492; Zhao YP, 2015, AQUACULT ENG, V67, P24, DOI 10.1016/j.aquaeng.2015.05.005	30	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0228502	10.1371/journal.pone.0228502	http://dx.doi.org/10.1371/journal.pone.0228502			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GC	32203559	gold, Green Published			2022-12-26	WOS:000535303900003
J	Kallarackal, J; Burger, F; Bianco, S; Romualdi, A; Schad, M				Kallarackal, Jim; Burger, Florian; Bianco, Stefano; Romualdi, Alessandro; Schad, Martina			A 3-gene biomarker signature to predict response to taxane-based neoadjuvant chemotherapy in breast cancer	PLOS ONE			English	Article							EXPRESSION; PROGNOSIS; SCUBE2; TRANSCRIPTION; PROTEINS; FAMILY; DOMAIN	Breast cancer is the most common cancer in women worldwide, affecting one in eight women in their lifetime. Taxane-based chemotherapy is routinely used in the treatment of breast cancer. The purpose of this study was to develop and validate a predictive biomarker to improve the benefit/risk ratio for that cytotoxic chemotherapy. We explicitly strived for a biomarker that enables secure translation into clinical practice. We used genome-wide gene expression data of the Hatzis et al. discovery cohort of 310 patients for biomarker development and three independent cohorts with a total of 567 breast cancer patients for validation. We were able to develop a biomarker signature that consists of just the three gene products ELF5, SCUBE2 and NFIB, measured on RNA level. Compared to Hatzis et al., we achieved a significant improvement in predicting responders and non-responders in the Hatzis et al. validation cohort with an area under the receiver operating characteristics curve of 0.73 [95% CI, 69%-77%]. Moreover, we could confirm the performance of our biomarker on two further independent validation cohorts. The overall performance on all three validation cohorts expressed as area under the receiver operating characteristics curve was 0.75 [95% CI, 70%-80%]. At the clinically relevant classifier's operation point to optimize the exclusion of non-responders, the biomarker correctly predicts three out of four patients not responding to neoadjuvant taxane-based chemotherapy, independent of the breast cancer subtype. At the same time, the response rate in the group of predicted responders increased to 42% compared to 23% response rate in all patients of the validation cohorts.	[Kallarackal, Jim; Burger, Florian; Bianco, Stefano; Romualdi, Alessandro; Schad, Martina] OakLabs GmbH, Hennigsdorf, Germany		Schad, M (corresponding author), OakLabs GmbH, Hennigsdorf, Germany.	mschad@oak-labs.com		Kallarackal, Jim/0000-0002-4949-0800				Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Cheng CJ, 2009, CANCER RES, V69, P3634, DOI 10.1158/0008-5472.CAN-08-3615; Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Han W, 2008, GENE CHROMOSOME CANC, V47, P490, DOI 10.1002/gcc.20550; Harris L, 2015, DEV DYNAM, V244, P227, DOI 10.1002/dvdy.24182; Harris LN, 2016, J CLIN ONCOL, V34, P1134, DOI 10.1200/JCO.2015.65.2289; Hatzis C, 2011, VALIDATION COHORT GE; Hatzis C, 2011, DISCOVERY COHORT GEN; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Horak CE, 2013, BIOMARKER ANAL NEOAD; Horak CE, 2013, CLIN CANCER RES, V19, P1587, DOI 10.1158/1078-0432.CCR-12-1359; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Iwamoto T, 2011, J NATL CANCER I, V103, P264, DOI 10.1093/jnci/djq524; Kaufman B, 2015, J CLIN ONCOL, V33, P244, DOI 10.1200/JCO.2014.56.2728; Learn PA, 2005, CANCER-AM CANCER SOC, V103, P2252, DOI 10.1002/cncr.21037; Lin YC, 2011, J BIOL CHEM, V286, P27039, DOI 10.1074/jbc.M111.244418; Luk IY, 2018, MOLECULES, V23, DOI 10.3390/molecules23092191; Omata F, 2018, BREAST CANCER-TOKYO, V25, P489, DOI 10.1007/s12282-018-0842-z; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shi L, 2010, TRANSCRIPTION PROFIL; Song Q, 2015, ONCOL REP, V33, P1956, DOI 10.3892/or.2015.3790; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Tsai MT, 2009, BIOCHEM J, V422, P119, DOI 10.1042/BJ20090341; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vogel C, 2001, EUR J CANCER, V37, pS25, DOI 10.1016/S0959-8049(00)00405-6; Wang X, 2018, INT J CLIN EXP PATHO, V11, P972; Yang B, 2018, GENE, V672, P143, DOI 10.1016/j.gene.2018.06.012; Yang RB, 2002, J BIOL CHEM, V277, P46364, DOI 10.1074/jbc.M207410200; Zhang Q, 2015, ONCOL REP, V33, P1335, DOI 10.3892/or.2015.3715	30	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0230313	10.1371/journal.pone.0230313	http://dx.doi.org/10.1371/journal.pone.0230313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196521	Green Published, Green Submitted, gold			2022-12-26	WOS:000535303100027
J	Becker, AK; Auditore, A; Pischetsrieder, M; Messlinger, K; Fleming, T; Reeh, PW; Sauer, SK				Becker, Anna K.; Auditore, Andrea; Pischetsrieder, Monika; Messlinger, Karl; Fleming, Thomas; Reeh, Peter W.; Sauer, Susanne K.			Reactive dicarbonyl compounds cause Calcitonin Gene-Related Peptide release and synergize with inflammatory conditions in mouse skin and peritoneum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; inflammation; neuropeptide; pain; transient receptor potential channels (TRP channels); 3; 4-dideoxyglucosone-3-ene; 3-deoxyglucosone; glyoxal; methylglyoxal; uremia	GLUCOSE DEGRADATION-PRODUCTS; HYPERGLYCEMIC HYPOXIA; DIABETIC-NEUROPATHY; CAPSAICIN RECEPTOR; PROSTAGLANDIN E-2; SENSORY NEURONS; DIALYSIS FLUIDS; END-PRODUCTS; METHYLGLYOXAL; TRPA1	The plasmas of diabetic or uremic patients and of those receiving peritoneal dialysis treatment have increased levels of the glucose-derived dicarbonyl metabolites like methylglyoxal (MGO), glyoxal (GO), and 3-deoxyglucosone (3-DG). The elevated dicarbonyl levels can contribute to the development of painful neuropathies. Here, we used stimulated immunoreactive Calcitonin Gene?Related Peptide (iCGRP) release as a measure of nociceptor activation, and we found that each dicarbonyl metabolite induces a concentration-, TRPA1-, and Ca2+-dependent iCGRP release. MGO, GO, and 3-DG were about equally potent in the millimolar range. We hypothesized that another dicarbonyl, 3,4-dideoxyglucosone-3-ene (3,4-DGE), which is present in peritoneal dialysis (PD) solutions after heat sterilization, activates nociceptors. We also showed that at body temperatures 3,4-DGE is formed from 3-DG and that concentrations of 3,4-DGE in the micromolar range effectively induced iCGRP release from isolated murine skin. In a novel preparation of the isolated parietal peritoneum PD fluid or 3,4-DGE alone, at concentrations found in PD solutions, stimulated iCGRP release. We also tested whether inflammatory tissue conditions synergize with dicarbonyls to induce iCGRP release from isolated skin. Application of MGO together with bradykinin or prostaglandin E-2 resulted in an overadditive effect on iCGRP release, whereas MGO applied at a pH of 5.2 resulted in reduced release, probably due to an MGO-mediated inhibition of transient receptor potential (TRP) V1 receptors. These results indicate that several reactive dicarbonyls activate nociceptors and potentiate inflammatory mediators. Our findings underline the roles of dicarbonyls and TRPA1 receptors in causing pain during diabetes or renal disease.	[Becker, Anna K.; Messlinger, Karl; Reeh, Peter W.; Sauer, Susanne K.] Friedrich Alexander Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, Univ Str 17, D-91054 Erlangen, Germany; [Auditore, Andrea; Pischetsrieder, Monika] Friedrich Alexander Univ Erlangen Nurnberg, Dept Chem & Pharm, Food Chem, Nikolaus Fiebiger Str 10, D-91058 Erlangen, Germany; [Fleming, Thomas] Heidelberg Univ, Dept Med & Clin Chem & Pharmacol 1, INF 410, D-69120 Heidelberg, Germany; [Fleming, Thomas] Eberhard Karls Univ Tuebingen, German Ctr Diabet Res DZD, Otfried Muller Str 10, D-72076 Tubingen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Sauer, SK (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, Univ Str 17, D-91054 Erlangen, Germany.	Susanne.sauer@fau.de	Reeh, Peter W./J-8981-2012	Reeh, Peter W./0000-0002-4367-094X; Sauer, Susanne Katharina/0000-0002-9734-885X	Deutsche Forschungsgemeinschaft [SA 2126/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grant SA 2126/2-1 (to S. K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Andersen ST, 2018, DIABETES CARE, V41, P1068, DOI 10.2337/dc17-2062; Andersson DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077986; Averbeck B, 2001, NEUROPHARMACOLOGY, V40, P416, DOI 10.1016/S0028-3908(00)00171-4; Babes A, 2010, METHODS MOL BIOL, V617, P237, DOI 10.1007/978-1-60327-323-7_19; BANGSBO J, 1993, J PHYSIOL-LONDON, V462, P115, DOI 10.1113/jphysiol.1993.sp019546; Barriere DA, 2012, PAIN, V153, P553, DOI 10.1016/j.pain.2011.11.019; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; BRETAG AH, 1969, LIFE SCI PT 1 PHYSI, V8, P319, DOI 10.1016/0024-3205(69)90283-5; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; Ciobanu AC, 2016, J NEUROSCI RES, V94, P282, DOI 10.1002/jnr.23700; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Davison SN, 2014, SEMIN DIALYSIS, V27, P188, DOI 10.1111/sdi.12196; de la Roche J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36740; Distler L, 2014, CHEM RES TOXICOL, V27, P1421, DOI 10.1021/tx500153n; Dull MM, 2019, PAIN, V160, P2497, DOI 10.1097/j.pain.0000000000001644; Eberhardt MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13054-3; Eberhardt MJ, 2012, J BIOL CHEM, V287, P28291, DOI 10.1074/jbc.M111.328674; Roa-Coria JE, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-018-0483-3; Erixon M, 2008, PERITON DIALYSIS INT, V28, P277; Fischer MJM, 2014, PFLUG ARCH EUR J PHY, V466, P2229, DOI 10.1007/s00424-014-1497-z; Flasar MH, 2006, PRIMARY CARE, V33, P659, DOI 10.1016/j.pop.2006.06.004; Freshwater JD, 2002, DIABETES, V51, P2249, DOI 10.2337/diabetes.51.7.2249; Fuchs D, 2010, PAIN, V151, P496, DOI 10.1016/j.pain.2010.08.010; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; Gensberger S, 2012, ANAL BIOANAL CHEM, V403, P2923, DOI 10.1007/s00216-012-5817-x; Gensberger-Reigl S, 2019, CHEM RES TOXICOL, V32, P304, DOI 10.1021/acs.chemrestox.8b00320; GRAFE P, 1994, J PHYSIOL-LONDON, V480, P297, DOI 10.1113/jphysiol.1994.sp020360; Grafe Peter, 1998, P621; Griggs RB, 2019, NEUROBIOL DIS, V127, P76, DOI 10.1016/j.nbd.2019.02.019; Griggs RB, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00679; Hansen CS, 2015, DIABETIC MED, V32, P778, DOI 10.1111/dme.12753; Hiyama H, 2018, MOL PAIN, V14, DOI 10.1177/1744806918789812; Holzer Peter, 2009, Handb Exp Pharmacol, P283, DOI 10.1007/978-3-540-79090-7_9; Hu R, 2016, CURR MED CHEM, V23, P763, DOI 10.2174/0929867323666160210125416; Kalapos MP, 2013, DIABETES RES CLIN PR, V99, P260, DOI 10.1016/j.diabres.2012.11.003; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; KATO F, 1994, J AGR FOOD CHEM, V42, P2068, DOI 10.1021/jf00045a044; Kellogg AP, 2007, DIABETES, V56, P2997, DOI 10.2337/db07-0740; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lapolla A, 2005, ANN NY ACAD SCI, V1043, P267, DOI 10.1196/annals.1333.032; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; LEVINE JD, 1993, J NEUROSCI, V13, P2273, DOI 10.1523/JNEUROSCI.13-06-02273.1993; Linden T, 2002, KIDNEY INT, V62, P697, DOI 10.1046/j.1523-1755.2002.00490.x; LUNDBERG JM, 1992, ANN NY ACAD SCI, V657, P187, DOI 10.1111/j.1749-6632.1992.tb22767.x; McCoy ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036355; MCLELLAN AC, 1992, ANAL CHIM ACTA, V263, P137, DOI 10.1016/0003-2670(92)85435-9; Meents JE, 2019, J NEUROPHYSIOL, V121, P427, DOI 10.1152/jn.00524.2018; Mittelmaier S, 2011, ANAL CHEM, V83, P9660, DOI 10.1021/ac2025706; Mittelmaier S, 2011, ANAL BIOANAL CHEM, V401, P1183, DOI 10.1007/s00216-011-5195-9; Mittelmaier S, 2011, ANAL BIOANAL CHEM, V399, P1689, DOI 10.1007/s00216-010-4456-3; Nagaraj RH, 1996, ARCH BIOCHEM BIOPHYS, V325, P152, DOI 10.1006/abbi.1996.0019; Nam JS, 2014, KOREAN J PAIN, V27, P326, DOI 10.3344/kjp.2014.27.4.326; Niwa T, 2001, KIDNEY INT, V59, pS37, DOI 10.1046/j.1523-1755.2001.59780037.x; Niwa T, 1999, J CHROMATOGR B, V731, P23, DOI 10.1016/S0378-4347(99)00113-9; Ohkawara S, 2012, J TOXICOL SCI, V37, P831, DOI 10.2131/jts.37.831; Ortiz A, 2006, CURR MED CHEM, V13, P2695, DOI 10.2174/092986706778201576; Petho G, 2012, PHYSIOL REV, V92, P1699, DOI 10.1152/physrev.00048.2010; Pischetsrieder M, 2016, DRUG DISCOV TODAY, V21, P1620, DOI 10.1016/j.drudis.2016.06.011; Rabbani N, 2018, KIDNEY INT, V93, P803, DOI 10.1016/j.kint.2017.11.034; Riboulet-Chavey A, 2006, DIABETES, V55, P1289, DOI 10.2337/db05-0857; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Santoro Domenico, 2013, Clin Nephrol, V79 Suppl 1, pS2; Sauer SK, 1998, LIFE SCI, V62, P2045, DOI 10.1016/S0024-3205(98)00176-3; Scheijen JLJM, 2014, CLIN CHEM LAB MED, V52, P85, DOI 10.1515/cclm-2012-0878; SCHNEIDER U, 1993, J PHYSIOL-LONDON, V465, P679, DOI 10.1113/jphysiol.1993.sp019700; STRUPP M, 1991, AM J PHYSIOL, V261, pE389, DOI 10.1152/ajpendo.1991.261.3.E389; Suzawa S, 2016, BRAIN RES BULL, V125, P181, DOI 10.1016/j.brainresbull.2016.07.005; Talbot S, 2012, EXP NEUROL, V234, P373, DOI 10.1016/j.expneurol.2011.11.032; Talbot S, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-11; Tanaka K, 2002, ANAT EMBRYOL, V205, P307, DOI 10.1007/s00429-002-0254-9; Thornalley PJ, 2009, SEMIN DIALYSIS, V22, P400, DOI 10.1111/j.1525-139X.2009.00589.x; THORNALLEY PJ, 1988, BIOCHEM J, V254, P751, DOI 10.1042/bj2540751; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Trevisan G, 2013, EUR J PHARMACOL, V714, P332, DOI 10.1016/j.ejphar.2013.07.029; Vander Jagt David L., 2008, Drug Metabolism and Drug Interactions, V23, P93; Vistoli G, 2013, FREE RADICAL RES, V47, P3, DOI 10.3109/10715762.2013.815348; Wei H, 2009, ANESTHESIOLOGY, V111, P147, DOI 10.1097/ALN.0b013e3181a1642b; Weller K, 2011, NEUROPEPTIDES, V45, P391, DOI 10.1016/j.npep.2011.07.011; Weng HJ, 2015, NEURON, V85, P833, DOI 10.1016/j.neuron.2014.12.065; Zeier M, 2003, KIDNEY INT, V63, P298, DOI 10.1046/j.1523-1755.2003.00705.x; Ziegler D, 2008, DIABETES-METAB RES, V24, pS52, DOI 10.1002/dmrr.817; Zochodne DW, 1999, J NEUROL SCI, V166, P40, DOI 10.1016/S0022-510X(99)00111-2; Zuvela J, 2018, NEPHROLOGY, V23, P718, DOI 10.1111/nep.13243	87	2	2	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6330	6343		10.1074/jbc.RA120.012890	http://dx.doi.org/10.1074/jbc.RA120.012890			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32198181	Green Published, hybrid			2022-12-26	WOS:000537685000008
J	Choi, S; Singh, I; Singh, AK; Khan, M; Won, J				Choi, Seungho; Singh, Inderjit; Singh, Avtar K.; Khan, Mushfiquddin; Won, Jeseong			Asymmetric dimethylarginine exacerbates cognitive dysfunction associated with cerebrovascular pathology	FASEB JOURNAL			English	Article						actin stress fiber; Alzheimer's disease; asymmetric dimethylarginine (ADMA); brain endothelial barrier; endothelial nitric oxide synthase (eNOS); nitric oxide; vascular cognitive impairment and dementia (VCID)	NITRIC-OXIDE SYNTHASE; CEREBRAL VASOSPASM; S-NITROSOGLUTATHIONE; ENDOTHELIAL DYSFUNCTION; ENDOGENOUS INHIBITOR; BEHAVIORAL DEFICITS; PLASMA-LEVELS; BLOOD-FLOW; RAT MODEL; ADMA	Asymmetric dimethylarginine (ADMA), an endogenous inhibitor and uncoupler of nitric oxide synthase, has gained attention as a risk factor for cardiac disease, metabolic syndrome, and cerebrovascular disease. In this study, we investigated the role of systemic ADMA overburden in cerebromicrovascular pathology associated with cognitive dysfunction using APPSwDI transgenic mice expressing human beta-amyloid precursor protein Swedish (Tg-SwDI), a model of cerebrovascular beta-amyloidosis. To induce systemic overburden of ADMA, Tg-SwDI mice were treated with a daily dose of exogenous ADMA. ADMA treatment resulted in elevated ADMA levels in the blood and brain of Tg-SwDI mice. ADMA treatment induced the brain nitrosative stress and inflammation as well as enhanced the brain A beta deposition and cognitive impairment in Tg-SwDI mice. However, ADMA treatment had no such effects on wild type mice. ADMA treatment also exacerbated brain microvascular pathology in Tg-SwDI mice as observed by increased blood-brain barrier dysfunction, loss of tight junction proteins, increased endothelial stress fibers, and decreased microvessel density in the brain. In addition, similar observations were made in cultured human brain microvessel endothelial cells, where ADMA in the presence of VEGF-induced endothelial cell signaling for F-actin stress fiber inducing endothelial barrier dysfunction. Overall, these data document the potential role of ADMA in the cognitive pathology under conditions of cerebrovascular beta-amyloidosis.	[Choi, Seungho; Singh, Inderjit; Khan, Mushfiquddin] Med Univ South Carolina, Dept Pediat, 173 Ashley Ave,DCRI Room 509, Charleston, SC 29425 USA; [Singh, Inderjit] Ralph H Johnson Vet Adm Med Ctr, Res Serv, Charleston, SC USA; [Singh, Avtar K.; Won, Jeseong] Med Univ South Carolina, Dept Pathol & Lab Med, 173 Ashley Ave,DCRI Room 510, Charleston, SC 29425 USA; [Singh, Avtar K.] Ralph H Johnson Vet Adm Med Ctr, Pathol & Lab Med Serv, Charleston, SC USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Singh, I (corresponding author), Med Univ South Carolina, Dept Pediat, 173 Ashley Ave,DCRI Room 509, Charleston, SC 29425 USA.; Won, J (corresponding author), Med Univ South Carolina, Dept Pathol & Lab Med, 173 Ashley Ave,DCRI Room 510, Charleston, SC 29425 USA.	singhi@musc.edu; wonj@musc.edu	Singh, Ashok/HGF-2506-2022; SINGH, ANIL KUMAR/M-4786-2017	SINGH, ANIL KUMAR/0000-0003-2933-4058	NIH HHS [NS037766] Funding Source: Medline; BLRD VA [I01 BX003401] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BLRD VA		Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alvarez XA, 2018, J ALZHEIMERS DIS, V63, P1003, DOI 10.3233/JAD-160477; Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Appel D, 2018, NEUROCRIT CARE, V29, P84, DOI 10.1007/s12028-018-0520-1; Atamer A, 2008, J INT MED RES, V36, P54, DOI 10.1177/147323000803600108; Bestermann WH, 2011, CARDIORENAL MED, V1, P211, DOI 10.1159/000332382; Borgeraas H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152029; Chen SF, 2012, INT J MOL SCI, V13, P15983, DOI 10.3390/ijms131215983; Choi S, 2019, NITRIC OXIDE-BIOL CH, V83, P51, DOI 10.1016/j.niox.2018.12.007; Fan R, 2007, J NEUROSCI, V27, P3057, DOI 10.1523/JNEUROSCI.4371-06.2007; Ganz T, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2836; Gaston Benjamin M, 2003, Mol Interv, V3, P253, DOI 10.1124/mi.3.5.253; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; He WL, 2016, REDOX BIOL, V9, P1, DOI 10.1016/j.redox.2016.05.002; Helman AM, 2016, BBA-MOL BASIS DIS, V1862, P975, DOI 10.1016/j.bbadis.2015.12.009; Jung CS, 2007, J NEUROSURG, V107, P945, DOI 10.3171/JNS-07/11/0945; Jung CS, 2012, NEUROSCI LETT, V524, P20, DOI 10.1016/j.neulet.2012.06.076; Jung CS, 2004, J NEUROSURG, V101, P836, DOI 10.3171/jns.2004.101.5.0836; Kajimoto H, 2012, KIDNEY INT, V81, P762, DOI 10.1038/ki.2011.476; Karbach S, 2014, CURR PHARM DESIGN, V20, P3579, DOI 10.2174/13816128113196660748; Khan M, 2006, NITRIC OXIDE-BIOL CH, V15, P114, DOI 10.1016/j.niox.2006.01.008; Khan M, 2016, BRAIN RES, V1630, P159, DOI 10.1016/j.brainres.2015.11.015; Khan M, 2012, J NEUROCHEM, V123, P86, DOI 10.1111/j.1471-4159.2012.07947.x; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kielstein JT, 2006, STROKE, V37, P2024, DOI 10.1161/01.STR.0000231640.32543.11; Kocak H, 2011, J CLIN LAB ANAL, V25, P174, DOI 10.1002/jcla.20452; Konya Hiroyuki, 2015, World J Exp Med, V5, P110, DOI 10.5493/wjem.v5.i2.110; Kurtoglu E, 2014, ANGIOLOGY, V65, P788, DOI 10.1177/0003319713507333; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Li N, 2011, NEUROL RES, V33, P541, DOI 10.1179/016164111X13007856084403; Lu TM, 2004, AM J CARDIOL, V94, P157, DOI 10.1016/j.amjcard.2004.03.052; MACALLISTER RJ, 1994, BRIT J PHARMACOL, V112, P43, DOI 10.1111/j.1476-5381.1994.tb13026.x; Mahoney ER, 2019, MOL PSYCHIATR, P1; Marten-Lobenhoffer J, 2007, J NEUROSCI METH, V164, P155, DOI 10.1016/j.jneumeth.2007.04.005; Nishiyama Y, 2010, J NEUROL SCI, V290, P12, DOI 10.1016/j.jns.2009.12.020; OGAWA T, 1989, J BIOL CHEM, V264, P10205; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; Prakash R, 2012, DIABETES, V61, P1533, DOI 10.2337/db11-1528; Ravi K, 2004, P NATL ACAD SCI USA, V101, P2619, DOI 10.1073/pnas.0300464101; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Seabra AB, 2007, BRIT J DERMATOL, V156, P814, DOI 10.1111/j.1365-2133.2006.07718.x; Snyder HM, 2015, ALZHEIMERS DEMENT, V11, P710, DOI 10.1016/j.jalz.2014.10.008; Suhardja A, 2004, NAT CLIN PRACT CARD, V1, P110, DOI 10.1038/ncpcardio0046; Takiuchi S, 2004, AM J HYPERTENS, V17, P802, DOI 10.1016/j.amjhyper.2004.05.005; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Tran CTL, 2000, GENOMICS, V68, P101, DOI 10.1006/geno.2000.6262; Visser M, 2010, EUR J HEART FAIL, V12, P1274, DOI 10.1093/eurjhf/hfq158; Wahlstrom MR, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-98; Won JS, 2013, J ALZHEIMERS DIS, V34, P621, DOI 10.3233/JAD-121786; Xu F, 2007, NEUROSCIENCE, V146, P98, DOI 10.1016/j.neuroscience.2007.01.043; Xu Q, 2017, FREE RADICAL BIO MED, V109, P84, DOI 10.1016/j.freeradbiomed.2017.03.004; Yao Y, 2011, J CELL SCI, V124, P1486, DOI 10.1242/jcs.082834; Zafar MI, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0363-0	55	8	8	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6808	6823		10.1096/fj.201901318R	http://dx.doi.org/10.1096/fj.201901318R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32239698				2022-12-26	WOS:000531325500056
J	Ninou, I; Sevastou, I; Magkrioti, C; Kaffe, E; Stamatakis, G; Thivaios, S; Panayotou, G; Aoki, J; Kollias, G; Aidinis, V				Ninou, Ioanna; Sevastou, Ioanna; Magkrioti, Christiana; Kaffe, Eleanna; Stamatakis, George; Thivaios, Spyros; Panayotou, George; Aoki, Junken; Kollias, George; Aidinis, Vassilis			Genetic deletion of Autotaxin from CD11b(+) cells decreases the severity of experimental autoimmune encephalomyelitis	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID PRODUCTION; EXPRESSION; CONTRIBUTES; PROMOTES; PATHOGENESIS; ACTIVATION; DISEASE; BINDING; TNF; ATX	Autotaxin (ATX) is a secreted lysophospholipase D catalyzing the extracellular production of lysophosphatidic acid (LPA), a growth factor-like signaling lysophospholipid. ATX and LPA signaling have been incriminated in the pathogenesis of different chronic inflammatory diseases and various types of cancer. In this report, deregulated ATX and LPA levels were detected in the spinal cord and plasma of mice during the development of experimental autoimmune encephalomyelitis (EAE). Among the different sources of ATX expression in the inflamed spinal cord, F4/80(+) CD11b(+) cells, mostly activated macrophages and microglia, were found to express ATX, further suggesting an autocrine role for ATX/LPA in their activation, an EAE hallmark. Accordingly, ATX genetic deletion from CD11b(+) cells attenuated the severity of EAE, thus proposing a pathogenic role for the ATX/LPA axis in neuroinflammatory disorders.	[Ninou, Ioanna; Sevastou, Ioanna; Magkrioti, Christiana; Kaffe, Eleanna; Stamatakis, George; Thivaios, Spyros; Panayotou, George; Kollias, George; Aidinis, Vassilis] Biomed Sci Res Ctr Alexander Fleming, Athens, Greece; [Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan	Alexander Fleming Biomedical Sciences Research Center; Tohoku University	Aidinis, V (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Athens, Greece.	V.Aidinis@Fleming.gr	Aidinis, Vassilis/AAF-5380-2021	Aidinis, Vassilis/0000-0001-9531-7729	European Union; Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call Research - Create - Innovate [T1EDK-0049]	European Union(European Commission); Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call Research - Create - Innovate	This work has been co-financed by the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call Research - Create - Innovate (project code: T1EDK-0049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa S, 2015, J BIOCHEM, V157, P81, DOI 10.1093/jb/mvu077; Balood M, 2014, HUM IMMUNOL, V75, P411, DOI 10.1016/j.humimm.2014.02.021; Barbayianni E, 2015, PROG LIPID RES, V58, P76, DOI 10.1016/j.plipres.2015.02.001; Benesch MGK, 2016, J BIOMED RES, V30, P272, DOI 10.7555/JBR.30.20150058; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Brandon JA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208099; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; D'Souza K, 2018, J LIPID RES, V59, P1805, DOI 10.1194/jlr.M082008; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Dennis J, 2005, J NEUROSCI RES, V82, P737, DOI 10.1002/jnr.20686; Dennis J, 2008, MOL CELL NEUROSCI, V37, P412, DOI 10.1016/j.mcn.2007.10.018; Dusaulcy R, 2011, J LIPID RES, V52, P1247, DOI 10.1194/jlr.M014985; Emo J, 2012, J IMMUNOL, V188, P3784, DOI 10.4049/jimmunol.1102956; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Giganti A, 2008, J BIOL CHEM, V283, P7776, DOI 10.1074/jbc.M708705200; Greenman R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00053; Hammack BN, 2004, MULT SCLER, V10, P245, DOI 10.1191/1352458504ms1023oa; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Jiang DX, 2018, NEUROL RES, V40, P335, DOI 10.1080/01616412.2018.1446256; Kaffe E, 2017, HEPATOLOGY, V65, P1369, DOI 10.1002/hep.28973; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Knowlden SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101655; Leblanc R, 2014, BLOOD, V124, P3141, DOI 10.1182/blood-2014-04-568683; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Ma L, 2010, J NEUROCHEM, V115, P643, DOI 10.1111/j.1471-4159.2010.06955.x; Magkrioti C, 2019, J AUTOIMMUN, V104, DOI 10.1016/j.jaut.2019.102327; MARGOLIS G, 1956, LAB INVEST, V5, P459; Matralis AN, 2019, MED RES REV, V39, P976, DOI 10.1002/med.21551; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Ninou I, 2018, AUTOTAXIN PATHOPHYSI; Nishimura S, 2014, DIABETES, V63, P4154, DOI 10.2337/db13-1694; Nogaroli L, 2009, NEUROCHEM RES, V34, P182, DOI 10.1007/s11064-008-9772-z; Oikonomou N, 2012, AM J RESP CELL MOL, V47, P566, DOI 10.1165/rcmb.2012-0004OC; Pamuklar Z, 2009, J BIOL CHEM, V284, P7385, DOI 10.1074/jbc.M807820200; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Ray R, 2017, BLOOD, DOI [10.1371/journal.pone.0136629, DOI 10.1371/JOURNAL.PONE.0136629]; Reich DS, 2018, NEW ENGL J MED, V378, P169, DOI 10.1056/NEJMra1401483; Santos-Nogueira E, 2015, J NEUROSCI, V35, P10224, DOI 10.1523/JNEUROSCI.4703-14.2015; Savaskan NE, 2007, CELL MOL LIFE SCI, V64, P230, DOI 10.1007/s00018-006-6412-0; Schmitz K, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0446-4; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Song JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136629; Thirunavukkarasu K, 2016, J PHARMACOL EXP THER, V359, P207, DOI 10.1124/jpet.116.234013; Tsakiri N, 2012, EUR J IMMUNOL, V42, P403, DOI 10.1002/eji.201141659; Wheeler NA, 2015, J NEUROSCI, V35, P11399, DOI 10.1523/JNEUROSCI.0345-15.2015; Yuelling LM, 2008, BBA-MOL CELL BIOL L, V1781, P525, DOI 10.1016/j.bbalip.2008.04.009; Yung YC, 2015, NEURON, V85, P669, DOI 10.1016/j.neuron.2015.01.009; Zahednasab H, 2014, J NEUROIMMUNOL, V273, P120, DOI 10.1016/j.jneuroim.2014.06.006; Zhao CQ, 2011, J LIPID RES, V52, P1307, DOI 10.1194/jlr.M008045	54	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0226050	10.1371/journal.pone.0226050	http://dx.doi.org/10.1371/journal.pone.0226050			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240164	Green Published, Green Submitted, gold			2022-12-26	WOS:000535945000006
J	Pearce, SC; Weber, GJ; van Sambeek, DM; Soares, JW; Racicot, K; Breault, DT				Pearce, Sarah C.; Weber, Gregory J.; van Sambeek, Dana M.; Soares, Jason W.; Racicot, Kenneth; Breault, David T.			Intestinal enteroids recapitulate the effects of short-chain fatty acids on the intestinal epithelium	PLOS ONE			English	Article							BARRIER FUNCTION; GENE-EXPRESSION; TUFT CELLS; MUCOSAL IMMUNITY; GUT MICROBIOTA; DIETARY FIBER; GOBLET CELLS; CACO-2 CELLS; BUTYRATE; HOST	Enteroids are cultured primary intestinal epithelial cells that recapitulate epithelial lineage development allowing for a more complex and physiologically relevant model for scientific study. The large presence of intestinal stem cells (ISC) in these enteroids allows for the study of metabolite effects on cellular processes and resulting progeny cells. Short-chain fatty acids (SCFA) such as butyrate (BUT) are bacterial metabolites produced in the gastrointestinal tract that are considered to be beneficial to host cells. Therefore, the objective was to study the effects of SCFAs on biomarkers of ISC activity, differentiation, barrier function and epithelial defense in the intestine using mouse and human enteroid models. Enteroids were treated with two concentrations of acetate (ACET), propionate (PROP), or BUT for 24 h. Enteroids treated with BUT or PROP showed a decrease in proliferation via EdU uptake relative to the controls in both mouse and human models. Gene expression of Lgr5 was shown to decrease with BUT and PROP treatments, but increased with ACET. As a result of BUT and PROP treatments, there was an increase in differentiation markers for enterocyte, Paneth, goblet, and enteroendocrine cells. Gene expression of antimicrobial proteins Reg3 beta, Reg3 gamma, and Defb1 were stimulated by BUT and PROP, but not by ACET which had a greater effect on expression of tight junction genes Cldn3 and Ocln in 3D enteroids. Similar results were obtained with human enteroids treated with 10 mM SCFAs and grown in either 3D or Transwwell (TM) model cultures, although tight junctions were influenced by BUT and PROP, but not ACET in monolayer format. Furthermore, BUT and PROP treatments increased transepithelial electrical resistance after 24 h compared to ACET or control. Overall, individual SCFAs are potent stimulators of cellular gene expression, however, PROP and especially BUT show great efficacy for driving cell differentiation and gene expression.	[Pearce, Sarah C.; Weber, Gregory J.; van Sambeek, Dana M.] Combat Capabil Dev Command Soldier Ctr, Combat Feeding Directorate, Performance Nutr Team, Natick, MA 01760 USA; [Soares, Jason W.; Racicot, Kenneth] Combat Capabil Dev Command Soldier Ctr, Soldier Performance Optimizat Directorate, Biol Sci & Technol Team, Natick, MA USA; [Breault, David T.] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Breault, David T.] Harvard Stem Cell Inst, Cambridge, MA USA; [Breault, David T.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School	Pearce, SC (corresponding author), Combat Capabil Dev Command Soldier Ctr, Combat Feeding Directorate, Performance Nutr Team, Natick, MA 01760 USA.	Sarah.c.pearce.civ@mail.mil	Breault, David/HDN-6048-2022	Pearce, Sarah/0000-0003-4822-6896	Department of Defense Combat Feeding Research and Engineering Program through project "Gut Microbiome and Performance Nutrition [TB 15-19]	Department of Defense Combat Feeding Research and Engineering Program through project "Gut Microbiome and Performance Nutrition	Funding was provided by the Department of Defense Combat Feeding Research and Engineering Program through project "Gut Microbiome and Performance Nutrition (TB 15-19).	Altay G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46497-x; Asarat M, 2015, IMMUNOL INVEST, V44, P678, DOI 10.3109/08820139.2015.1085389; Burger-van Paassen N, 2009, BIOCHEM J, V420, P211, DOI 10.1042/BJ20082222; Campbell Y, 2012, EUR J NUTR, V51, P899, DOI 10.1007/s00394-012-0415-4; Chairatana P, 2017, CRIT REV BIOCHEM MOL, V52, P45, DOI 10.1080/10409238.2016.1243654; Chang MC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124071; Chen TT, 2017, FOOD FUNCT, V8, P1166, DOI [10.1039/c6fo01532h, 10.1039/C6FO01532H]; Clarke G, 2014, MOL ENDOCRINOL, V28, P1221, DOI 10.1210/me.2014-1108; D'Souza WN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180190; Elphick DA, 2005, GUT, V54, P1802, DOI 10.1136/gut.2005.068601; Ferrer-Picon E, 2019, INFLAMM BOWEL DIS, DOI [10.1111/j.1365-2249.2004.02431.x, DOI 10.1111/J.1365-2249.2004.02431.X]; FINNIE IA, 1995, GUT, V36, P93, DOI 10.1136/gut.36.1.93; Foulke-Abel J, 2016, GASTROENTEROLOGY, V150, P638, DOI 10.1053/j.gastro.2015.11.047; Freire R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43426-w; Gassler Nikolaus, 2017, World J Gastrointest Pathophysiol, V8, P150, DOI 10.4291/wjgp.v8.i4.150; Gaudier E, 2004, AM J PHYSIOL-GASTR L, V287, pG1168, DOI 10.1152/ajpgi.00219.2004; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Hatayama H, 2007, BIOCHEM BIOPH RES CO, V356, P599, DOI 10.1016/j.bbrc.2007.03.025; Hidaka M, 2018, LIFE SCI, V197, P73, DOI 10.1016/j.lfs.2018.02.003; Kaiko GE, 2016, CELL, V167, P1137, DOI 10.1016/j.cell.2016.10.034; Karve SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178966; 김자원, 2015, [Journal of Internet Computing and Services, 인터넷정보학회논문지], V16, P71, DOI 10.7472/jksii.2015.16.3.71; Kishida K, 2017, AM J PHYSIOL-GASTR L, V312, pG592, DOI 10.1152/ajpgi.00416.2016; Knight PA, 2008, PARASITOLOGY, V135, P655, DOI 10.1017/S0031182008004319; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kozuka K, 2017, STEM CELL REP, V9, P1976, DOI 10.1016/j.stemcr.2017.10.013; Larraufie P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18259-0; Larraufie P, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12648; Lee HJ, 2009, BIOCHEM J, V420, P403, DOI 10.1042/BJ20081850; Lukovac S, 2014, MBIO, V5, DOI 10.1128/mBio.01438-14; Matsuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063053; May R, 2014, STEM CELLS, V32, P822, DOI 10.1002/stem.1566; Mirmonsef P, 2012, AM J REPROD IMMUNOL, V67, P391, DOI 10.1111/j.1600-0897.2011.01089.x; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; Okazawa A, 2004, CLIN EXP IMMUNOL, V136, P269, DOI 10.1111/j.1365-2249.2004.02431.x; Park J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156334; Pearce SC, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01584; Russell WR, 2013, CURR OPIN MICROBIOL, V16, P246, DOI 10.1016/j.mib.2013.07.002; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Schilderink R, 2016, AM J PHYSIOL-GASTR L, V310, pG1138, DOI 10.1152/ajpgi.00411.2015; Schwab M, 2008, IMMUNOLOGY, V125, P241, DOI 10.1111/j.1365-2567.2008.02834.x; Sinagoga KL, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.165795; Steele SP, 2016, TRENDS MOL MED, V22, P921, DOI 10.1016/j.molmed.2016.09.005; Sun J, 2005, FOOD CHEM TOXICOL, V43, P1773, DOI 10.1016/j.fct.2005.05.020; Tran CP, 1998, AM J PHYSIOL-GASTR L, V275, pG85, DOI 10.1152/ajpgi.1998.275.1.G85; Hung TV, 2018, J AGR FOOD CHEM, V66, P108, DOI 10.1021/acs.jafc.7b04233; Tsuruta T, 2016, BIOCHEM BIOPH RES CO, V474, P161, DOI 10.1016/j.bbrc.2016.03.165; Uchiyama K, 2016, SCI REP-UK, V6, DOI 10.1038/srep32094; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vemula PK, 2016, TRANSL CANCER RES, V5, pS536, DOI 10.21037/tcr.2016.08.24; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wang YL, 2017, CELL MOL GASTROENTER, V4, P165, DOI 10.1016/j.jcmgh.2017.02.011; Wolnerhanssen BK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08487-9; Yamane M, 2007, ARCH BIOCHEM BIOPHYS, V459, P159, DOI 10.1016/j.abb.2007.01.008; Yan H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179586; Yandrapu Harathi, 2015, Curr Gastroenterol Rep, V17, P24, DOI 10.1007/s11894-015-0452-2; Zheng L, 2017, J IMMUNOL, V199, P2976, DOI 10.4049/jimmunol.1700105; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	59	31	31	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230231	10.1371/journal.pone.0230231	http://dx.doi.org/10.1371/journal.pone.0230231			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240190	gold, Green Published			2022-12-26	WOS:000535945000020
J	Chandrashekar, DS; Chakravarthi, BVSK; Robinson, AD; Anderson, JC; Agarwal, S; Balasubramanya, SAH; Eich, ML; Bajpai, AK; Davuluri, S; Guru, MS; Guru, AS; Naik, G; Della Manna, DL; Acharya, KK; Carskadon, S; Manne, U; Crossman, DK; Ferguson, JE; Grizzle, WE; Palanisamy, N; Willey, CD; Crowley, MR; Netto, GJ; Yang, ES; Varambally, S; Sonpavde, G				Chandrashekar, Darshan S.; Chakravarthi, Balabhadrapatruni V. S. K.; Robinson, Alyncia D.; Anderson, Joshua C.; Agarwal, Sumit; Balasubramanya, Sai Akshaya Hodigere; Eich, Marie-Lisa; Bajpai, Akhilesh Kumar; Davuluri, Sravanthi; Guru, Maya S.; Guru, Arjun S.; Naik, Gurudatta; Della Manna, Deborah L.; Acharya, Kshitish K.; Carskadon, Shannon; Manne, Upender; Crossman, David K.; Ferguson, James E.; Grizzle, William E.; Palanisamy, Nallasivam; Willey, Christopher D.; Crowley, Michael R.; Netto, George J.; Yang, Eddy S.; Varambally, Sooryanarayana; Sonpavde, Guru			Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression	ONCOGENE			English	Article							METASTATIC UROTHELIAL CARCINOMA; CISPLATIN-INELIGIBLE PATIENTS; GENE-EXPRESSION; BREAST-CANCER; TUMOR-GROWTH; SINGLE-ARM; CELLS; SURVIVAL; PROLIFERATION; CHEMOTHERAPY	Muscle-invasive bladder carcinomas (MIBCs) are aggressive genitourinary malignancies. Metastatic urothelial carcinoma of the bladder is generally incurable by current chemotherapy and leads to early mortality. Recent studies have identified molecular subtypes of MIBCs with different sensitivities to frontline therapy, suggesting tumor heterogeneity. We have performed multi-omic profiling of the kinome in bladder cancer patients with the goal of identify therapeutic targets. Our analyses revealed amplification, overexpression, and elevated kinase activity of P21 (RAC1) activated kinase 4 (PAK4) in a subset of Bladder cancer (BLCA). Using bladder cancer cells, we confirmed the role of PAK4 in BLCA cell proliferation and invasion. Furthermore, we observed that a PAK4 inhibitor was effective in curtailing growth of BLCA cells. Transcriptomic analyses identified elevated expression of another kinase, protein tyrosine kinase 6 (PTK6), upon treatment with a PAK4 inhibitor and RNA interference of PAK4. Treatment with a combination of kinase inhibitors (vandetanib and dasatinib) showed enhanced sensitivity compared with either drug alone. Thus, PAK4 may be therapeutically actionable for a subset of MIBC patients with amplified and/or overexpressed PAK4 in their tumors. Our results also indicate that combined inhibition of PAK4 and PTK6 may overcome resistance to PAK4. These observations warrant clinical investigations with selected BLCA patients.	[Chandrashekar, Darshan S.; Chakravarthi, Balabhadrapatruni V. S. K.; Robinson, Alyncia D.; Agarwal, Sumit; Balasubramanya, Sai Akshaya Hodigere; Eich, Marie-Lisa; Manne, Upender; Grizzle, William E.; Netto, George J.; Varambally, Sooryanarayana] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Anderson, Joshua C.; Della Manna, Deborah L.; Willey, Christopher D.; Yang, Eddy S.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL USA; [Bajpai, Akhilesh Kumar; Davuluri, Sravanthi; Acharya, Kshitish K.] Shodhaka Life Sci Private Ltd, Bengaluru, India; [Guru, Maya S.; Guru, Arjun S.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Naik, Gurudatta] Univ Alabama Birmingham, Div Hematol & Oncol, Birmingham, AL USA; [Naik, Gurudatta; Manne, Upender; Netto, George J.; Yang, Eddy S.; Varambally, Sooryanarayana] Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Birmingham, AL 35294 USA; [Acharya, Kshitish K.] Inst Bioinformat & Appl Biotechnol, Biotech Pk, Bengaluru 560100, Karnataka, India; [Carskadon, Shannon; Palanisamy, Nallasivam] Henry Ford Hlth Syst, Dept Urol, Vattikuti Urol Inst, Detroit, MI 48202 USA; [Crossman, David K.; Crowley, Michael R.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Ferguson, James E.; Grizzle, William E.; Willey, Christopher D.] Univ Alabama Birmingham, Dept Urol, Birmingham, AL USA; [Varambally, Sooryanarayana] Univ Alabama Birmingham, Informat Inst, Birmingham, AL 35294 USA; [Sonpavde, Guru] Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Henry Ford Health System; Henry Ford Hospital; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Harvard University; Dana-Farber Cancer Institute	Varambally, S (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.; Varambally, S (corresponding author), Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Birmingham, AL 35294 USA.; Varambally, S (corresponding author), Univ Alabama Birmingham, Informat Inst, Birmingham, AL 35294 USA.; Sonpavde, G (corresponding author), Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA.	svarambally@uabmc.edu; GuruP_Sonpavde@DFCI.HARVARD.EDU	Palanisamy, Nallasivam/ABC-8844-2020; naik, Gurudatta/O-7284-2015	Palanisamy, Nallasivam/0000-0002-0633-9772; naik, Gurudatta/0000-0001-7265-6605; Anderson, Joshua/0000-0002-6977-9054; Netto, George/0000-0003-3915-9134	Department of Pathology of the University of Alabama at Birmingham; School of Medicine of the University of Alabama at Birmingham; Department of IT, BT and S&T, Government of Karnataka, India	Department of Pathology of the University of Alabama at Birmingham; School of Medicine of the University of Alabama at Birmingham; Department of IT, BT and S&T, Government of Karnataka, India	This study was supported in part by institutional funds (Department of Pathology and School of Medicine of the University of Alabama at Birmingham) awarded to SV. IBAB is supported by the Department of IT, BT and S&T, Government of Karnataka, India. The authors thank Dr Donald Hill for critical reading and editing of this manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139267; [Anonymous], 2018, Cancer Discov, V8, pOF6, DOI 10.1158/2159-8290.CD-NB2018-085; Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Balar AV, 2017, LANCET ONCOL, V18, P1483, DOI 10.1016/S1470-2045(17)30616-2; Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Bandiera S, 2015, J HEPATOL, V62, P448, DOI 10.1016/j.jhep.2014.10.004; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Bellmunt J, 2015, EUR UROL, V68, P547, DOI 10.1016/j.eururo.2015.04.025; Bennett RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062347; Brooks MD, 2013, INT J DENT, V2013, DOI 10.1155/2013/592843; Callegari E, 2018, MOL THER-NUCL ACIDS, V11, P485, DOI 10.1016/j.omtn.2018.04.002; Chakravarthi BVSK, 2018, NEOPLASIA, V20, P894, DOI 10.1016/j.neo.2018.07.006; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chen CJ, 2019, MOL MED REP, V19, P3477, DOI 10.3892/mmr.2019.10055; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Choudhury NJ, 2016, J CLIN ONCOL, V34, P2165, DOI 10.1200/JCO.2015.66.3047; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Conrad C, 2019, CLIN SCI, V133, P83, DOI 10.1042/CS20180906; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Griffiths G, 2011, J CLIN ONCOL, V29, P2171, DOI 10.1200/JCO.2010.32.3139; Grizzle W.E., 2005, MOL DIAGNOSTICS, V33, P421; Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; Han H, 2018, NUCLEIC ACIDS RES, V46, pD380, DOI 10.1093/nar/gkx1013; Hao JQ, 2008, CHINESE MED J-PEKING, V121, P602, DOI 10.1097/00029330-200804010-00006; He LF, 2017, ONCOTARGET, V8, P17573, DOI 10.18632/oncotarget.7466; Huang XH, 2011, J PATHOL, V225, P463, DOI 10.1002/path.2877; Iguchi Y, 2015, CELL STRUCT FUNCT, V40, P61, DOI 10.1247/csf.15001; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jacobs JJL, 1999, SEMIN CELL DEV BIOL, V10, P227, DOI 10.1006/scdb.1999.0304; Jian B, 2016, TUMOR BIOL, V37, P8941, DOI 10.1007/s13277-015-4727-x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimmelman AC, 2008, P NATL ACAD SCI USA, V105, P19372, DOI 10.1073/pnas.0809966105; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li N, 2019, CLIN CANCER RES, V25, P369, DOI 10.1158/1078-0432.CCR-18-1776; Li SQ, 2015, IUBMB LIFE, V67, P768, DOI 10.1002/iub.1433; Li YS, 2019, ONCOGENE, V38, P808, DOI 10.1038/s41388-018-0456-0; Loriot Y, 2019, NEW ENGL J MED, V381, P338, DOI 10.1056/NEJMoa1817323; Mahlamaki EH, 2004, NEOPLASIA, V6, P432, DOI 10.1593/neo.04130; Mao K, 2017, INT J ONCOL, V51, P1521, DOI 10.3892/ijo.2017.4122; McConkey DJ, 2015, HEMATOL ONCOL CLIN N, V29, P377, DOI 10.1016/j.hoc.2014.11.003; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Park JJ, 2018, ONCOGENE, V37, P5147, DOI 10.1038/s41388-018-0327-8; Petrylak DP, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.7_suppl.TPS497; Phatak Pornima, 2018, Oncotarget, V9, P28391, DOI 10.18632/oncotarget.25375; Puvirajesinghe TM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10318; Ravipaty Shobha, 2017, J Mol Biomark Diagn, V8, DOI 10.4172/2155-9929.1000323; Ricciardelli C, 2017, ONCOTARGET, V8, P17819, DOI 10.18632/oncotarget.14867; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Robertson AG, 2017, CELL, V171, P540, DOI 10.1016/j.cell.2017.09.007; Rogers Michael S., 1999, Neoplasia (New York), V1, P220, DOI 10.1038/sj.neo.7900029; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sonpavde G, 2017, NEW ENGL J MED, V376, P1073, DOI 10.1056/NEJMe1701182; Sonpavde G, 2015, HEMATOL ONCOL CLIN N, V29, P361, DOI 10.1016/j.hoc.2014.10.008; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Thillai K, 2018, FUTURE ONCOL, V14, P579, DOI 10.2217/fon-2017-0458; Tyagi N, 2014, ONCOTARGET, V5, P8778, DOI 10.18632/oncotarget.2398; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Wang HY, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.152559; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Y, 2016, AM J TRANSL RES, V8, P3056; Xiao J, 2017, ONCOTARGET, V8, P71759, DOI 10.18632/oncotarget.17606; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Xu HT, 2016, CANCER RES, V76, P5732, DOI 10.1158/0008-5472.CAN-15-3373; Xu XL, 2017, J CANCER, V8, P3464, DOI 10.7150/jca.21318; Ye LP, 2018, INT J CANCER, V143, P2602, DOI 10.1002/ijc.31766; Yu W, 2009, CANCER GENET CYTOGEN, V193, P29, DOI 10.1016/j.cancergencyto.2009.03.017; Zeng B, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3949-2; Zhang HS, 2016, ARCH BIOCHEM BIOPHYS, V598, P50, DOI 10.1016/j.abb.2016.03.031	79	12	13	2	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	20					4077	4091		10.1038/s41388-020-1275-7	http://dx.doi.org/10.1038/s41388-020-1275-7		MAR 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LN3GC	32231273	Green Submitted			2022-12-26	WOS:000522380700002
J	Dhital, S; Vyavahare, NR				Dhital, Saphala; Vyavahare, Naren R.			Nanoparticle-based targeted delivery of pentagalloyl glucose reverses elastase-induced abdominal aortic aneurysm and restores aorta to the healthy state in mice	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; LOADED ALBUMIN NANOPARTICLES; MOUSE MODEL; PROGRESSION; THERAPY; CALCIFICATION; MACROPHAGES; INHIBITION; POLYPHENOL; PREVENTION	Aim Abdominal aortic aneurysms (AAA) is a life-threatening weakening and expansion of the abdominal aorta due to inflammatory cell infiltration and gradual degeneration of extracellular matrix (ECM). There are no pharmacological therapies to treat AAA. We tested the hypothesis that nanoparticle (NP) therapy that targets degraded elastin and delivers anti-inflammatory, anti-oxidative, and ECM stabilizing agent, pentagalloyl glucose (PGG) will reverse advance stage aneurysm in an elastase-induced mouse model of AAA. Method and results Porcine pancreatic elastase (PPE) was applied periadventitially to the infrarenal aorta in mice and AAA was allowed to develop for 14 days. Nanoparticles loaded with PGG (EL-PGG-NPs) were then delivered via IV route at 14-day and 21-day (10 mg/kg of body weight). A control group of mice received no therapy. The targeting of NPs to the AAA site was confirmed with fluorescent dye marked NPs and gold NPs. Animals were sacrificed at 28-d. We found that targeted PGG therapy reversed the AAA by decreasing matrix metalloproteinases MMP-9 and MMP-2, and the infiltration of macrophages in the medial layer. The increase in diameter of the aorta was reversed to healthy controls. Moreover, PGG treatment restored degraded elastic lamina and increased the circumferential strain of aneurysmal aorta to the healthy levels. Conclusion Our results support that site-specific delivery of PGG with targeted nanoparticles can be used to treat already developed AAA. Such therapy can reverse inflammatory markers and restore arterial homeostasis.	[Dhital, Saphala; Vyavahare, Naren R.] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA	Clemson University	Vyavahare, NR (corresponding author), Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.	narenv@clemson.edu		Dhital, Saphala/0000-0001-5566-0733; Vyavahare, Naren/0000-0002-4889-6542	National Institutes of Health (NIH) [R01HL133662, R01HL145064, P20GM103444, P30GM131959]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study is supported by the grants from the National Institutes of Health (NIH) (R01HL133662, R01HL145064, P20GM103444, P30GM131959 to NRV).	Ailawadi G, 2009, J THORAC CARDIOV SUR, V138, P1392, DOI 10.1016/j.jtcvs.2009.07.075; An FF, 2017, THERANOSTICS, V7, P3667, DOI 10.7150/thno.19365; ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020; Benjamin Mina M, 2012, Exp Suppl, V103, P209, DOI 10.1007/978-3-0348-0364-9_7; Bhamidipati CM, 2012, SURGERY, V152, P238, DOI 10.1016/j.surg.2012.02.010; Bigatel DA, 1999, J VASC SURG, V29, P130, DOI 10.1016/S0741-5214(99)70354-X; Chen Jeff Z, 2019, Circ Rep, V1, P199, DOI 10.1253/circrep.CR-18-0012; Cocciolone AJ, 2018, AM J PHYSIOL-HEART C, V315, pH189, DOI 10.1152/ajpheart.00087.2018; Cook JR, 2015, ARTERIOSCL THROM VAS, V35, P911, DOI 10.1161/ATVBAHA.114.305150; Dale MA, 2016, J IMMUNOL, V196, P4536, DOI 10.4049/jimmunol.1502454; Dale MA, 2015, ATHEROSCLEROSIS, V243, P621, DOI 10.1016/j.atherosclerosis.2015.10.006; Dhital S, 2017, CELL IMMUNOL, V312, P25, DOI 10.1016/j.cellimm.2016.11.006; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Horiguchi M, 2012, J BIOCHEM, V152, P321, DOI 10.1093/jb/mvs089; Isenburg JC, 2007, CIRCULATION, V115, P1729, DOI 10.1161/CIRCULATIONAHA.106.672873; Karamched SR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39639-8; Kloesch B, 2013, INT IMMUNOPHARMACOL, V15, P400, DOI 10.1016/j.intimp.2013.01.003; Lareyre F, 2017, ARTERIOSCL THROM VAS, V37, P2171, DOI 10.1161/ATVBAHA.117.309999; Lei Y, 2014, J CONTROL RELEASE, V196, P79, DOI 10.1016/j.jconrel.2014.09.029; Liu ZZ, 2018, INT J MOL MED, V42, P3395, DOI 10.3892/ijmm.2018.3923; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Merodio M, 2001, EUR J PHARM SCI, V12, P251, DOI 10.1016/S0928-0987(00)00169-X; Minami K, 2018, EXP THER MED, V15, P4465, DOI 10.3892/etm.2018.5959; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Nosoudi N, 2016, J CARDIOVASC TRANSL, V9, P445, DOI 10.1007/s12265-016-9709-x; Nosoudi N, 2016, THERANOSTICS, V6, P1975, DOI 10.7150/thno.16547; Nosoudi N, 2015, CIRC RES, V117, pE80, DOI 10.1161/CIRCRESAHA.115.307207; Parasaram V, 2018, BIOCHEM BIOPH RES CO, V499, P24, DOI 10.1016/j.bbrc.2018.03.100; Patnaik SS, 2019, BIOENGINEERING-BASEL, V6, DOI 10.3390/bioengineering6030058; Patnaik SS, 2019, ANN BIOMED ENG, V47, P39, DOI 10.1007/s10439-018-02145-5; Philips N, 2010, J COSMET SCI, V61, P125; Raffort J, 2017, NAT REV CARDIOL, V14, P457, DOI 10.1038/nrcardio.2017.52; SAGE H, 1979, COMP BIOCHEM PHYS B, V64, P313, DOI 10.1016/0305-0491(79)90277-3; Setozaki S, 2017, J VASC SURG, V65, P1803, DOI 10.1016/j.jvs.2016.06.003; Sinha A, 2014, BIOCHEM BIOPH RES CO, V444, P205, DOI 10.1016/j.bbrc.2014.01.027; Sivaraman B, 2012, DRUG DELIV TRANSL RE, V2, P323, DOI 10.1007/s13346-012-0070-6; Uemura Y, 1997, BIOCHEM MOL BIOL INT, V41, P1085; Wang C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09674-4; Wang XY, 2019, THERANOSTICS, V9, P4156, DOI 10.7150/thno.34441; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354	40	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0227165	10.1371/journal.pone.0227165	http://dx.doi.org/10.1371/journal.pone.0227165			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218565	Green Published, Green Submitted, gold			2022-12-26	WOS:000535935400001
J	Negrini, F; O'Grady, K; Hyvonen, M; Folta, KM; Baraldi, E				Negrini, Francesca; O'Grady, Kevin; Hyvonen, Marko; Folta, Kevin M.; Baraldi, Elena			Genomic structure and transcript analysis of the Rapid Alkalinization Factor (RALF) gene family during host-pathogen crosstalk in Fragaria vesca and Fragaria x ananassa strawberry	PLOS ONE			English	Article							ATTACHMENT REGIONS; PEPTIDE-HORMONE; ARABIDOPSIS; MYB; IDENTIFICATION; INTEGRITY; INSIGHTS; REVEALS; TOMATO; GROWTH	Rapid Alkalinization Factors (RALFs) are cysteine-rich peptides ubiquitous within plant kingdom. They play multiple roles as hormonal signals in diverse processes, including root elongation, cell growth, pollen tube development, and fertilization. Their involvement in host-pathogen crosstalk as negative regulators of immunity in Arabidopsis has also been recognized. In addition, peptides homologous to RALF are secreted by different fungal pathogens as effectors during early stages of infection. Previous studies have identified nine RALF genes in the diploid strawberry (Fragaria vesca) genome. This work describes the genomic organization of the RALF gene families in commercial octoploid strawberry (Fragaria x ananassa) and the re-annotated genome of F. vesca, and then compares findings with orthologs in Arabidopsis thaliana. We reveal the presence of 15 RALF genes in F. vesca genotype Hawaii 4 and 50 in Fragaria x ananassa cv. Camarosa, showing a non-homogenous localization of genes among the different Fragaria x ananassa subgenomes. Expression analysis of Fragaria x ananassa RALF genes upon infection with Colletotrichum acutatum or Botrytis cinerea showed that FanRALF3-1 was the only fruit RALF gene upregulated after fungal infection. In silico analysis was used to identify distinct pathogen inducible elements upstream of the FanRALF3-1 gene. Agroinfiltration of strawberry fruit with deletion constructs of the FanRALF3-1 promoter identified a 5' region required for FanRALF3-1 expression in fruit, but failed to identify a region responsible for fungal induced expression.	[Negrini, Francesca; Baraldi, Elena] Univ Bologna, Lab Plant Pathol & Biotechnol, DISTAL, Bologna, Italy; [Negrini, Francesca; O'Grady, Kevin; Folta, Kevin M.] Univ Florida, Dept Hort Sci, Gainesville, FL USA; [Hyvonen, Marko] Univ Cambridge, Dept Biochem, Cambridge, England; [O'Grady, Kevin] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA	University of Bologna; State University System of Florida; University of Florida; University of Cambridge; State University System of Florida; University of Florida	Baraldi, E (corresponding author), Univ Bologna, Lab Plant Pathol & Biotechnol, DISTAL, Bologna, Italy.	elena.baraldi@unibo.it		Negrini, Francesca/0000-0003-1760-4778	EMBO short fellowship [7779]; MIUR (Ministry of Instruction, University and Research)	EMBO short fellowship; MIUR (Ministry of Instruction, University and Research)(Ministry of Education, Universities and Research (MIUR))	Protein studies were conducted at the University of Cambridge, UK, thanks to EMBO short fellowship number 7779. FN has been supported by PhD fellowship from MIUR (Ministry of Instruction, University and Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Moya-Leon MA, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00615; Alkan N, 2015, NEW PHYTOL, V205, P801, DOI 10.1111/nph.13087; Amil-Ruiz F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070603; Anand L., 2019, BIORXIV, DOI [10.1101/605600v1, DOI 10.1101/605600V1]; Atkinson NJ, 2013, PLANT PHYSIOL, V162, P2028, DOI 10.1104/pp.113.222372; Boa E., 2001, PLANT PATHOL, V50, P138; BREYNE P, 1994, TRANSGENIC RES, V3, P195, DOI 10.1007/BF01973987; Campbell L, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00037; Chen J, 2016, FERONIA INTERACTS AB, P5519; Covey PA, 2010, PLANT PHYSIOL, V153, P703, DOI 10.1104/pp.110.155457; Degenhardt J, 1996, PLANT CELL, DOI [10.2307/3870066, DOI 10.2307/3870066]; Dobon A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004800; Du CQ, 2016, P NATL ACAD SCI USA, V113, pE8326, DOI 10.1073/pnas.1609626113; Dunser K, 2019, EMBO J, V38, DOI 10.15252/embj.2018100353; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edger PP, 2019, NAT GENET, V51, P541, DOI 10.1038/s41588-019-0356-4; Edger PP, 2017, GIGASCIENCE, V7, DOI 10.1093/gigascience/gix124; Feliziani E, 2016, J BERRY RES, V6, P47, DOI 10.3233/JBR-150113; Feng W, 2018, CURR BIOL, V28, P666, DOI 10.1016/j.cub.2018.01.023; Fernandes TR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006621; Folta KM, 2019, HORTIC RES-ENGLAND, V6, DOI 10.1038/s41438-019-0181-z; Forlani S, 2019, J EXP BOT, V70, P2993, DOI 10.1093/jxb/erz112; Galindo-Trigo S, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2015.01260, 10.3389/fpls.2016.01269]; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Ge Z, 2017, SCIENCE, V80; Ge ZX, 2019, NEW PHYTOL, V222, P687, DOI 10.1111/nph.15645; Gonneau M, 2018, CURR BIOL, V28, P2452, DOI 10.1016/j.cub.2018.05.075; Grace ML, 2004, J BIOL CHEM; GROTEWOLD E, 1994, CELL, V76, P543, DOI 10.1016/0092-8674(94)90117-1; Guidarelli M, 2011, PLANT PATHOL, V60, P685, DOI 10.1111/j.1365-3059.2010.02423.x; Haruta M, 2014, SCIENCE, V343, P408, DOI 10.1126/science.1244454; Hawkins C, 2017, HORTIC RES-ENGLAND, V4, DOI 10.1038/hortres.2017.29; Hecker A, 2015, PLANT PHYSIOL, V168, P130, DOI 10.1104/pp.15.00409; Higo K, 1998, NUCLEIC ACIDS RES, V26, P358, DOI 10.1093/nar/26.1.358; Hollender CA, 2014, PLANT PHYSIOL, V165, P1062, DOI 10.1104/pp.114.237529; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Jia M., 2017, FRONT PLANT SCI, V8, P1; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jung S, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0931-5; Kang CY, 2013, PLANT CELL, V25, P1960, DOI 10.1105/tpc.113.111732; Klepper K, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-9; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Li C, 2015, ELIFE, V4, DOI [10.7554/eLife.06587, 10.1155/2015/757269]; Li YP, 2019, HORTIC RES-ENGLAND, V6, DOI 10.1038/s41438-019-0142-6; Liu JY, 2015, MOL PLANT, V8, P689, DOI 10.1016/j.molp.2015.03.012; Masachis S, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.43, 10.1038/nmicrobiol.2016.43]; Mecchia MA, 2017, SCIENCE, V358, P1600, DOI 10.1126/science.aao5467; Merida A, 2007, PLANT CELL, DOI [10.2307/3870694, DOI 10.2307/3870694]; Merino P, 2019, CHEMICAL BIOLOGY OF NEURODEGENERATION: A MOLECULAR APPROACH, P1, DOI 10.1002/9783527813421; Moussu S, 2019, BIORXIV, DOI [10.1101/695874, DOI 10.1101/695874]; Murphy E, 2012, PLANT CELL, V24, P3198, DOI 10.1105/tpc.112.099010; Nakamura M, 2002, PLANT J, V29, P1, DOI 10.1046/j.0960-7412.2001.01188.x; Olsson V, 2019, ANNU REV PLANT BIOL, V70, P153, DOI 10.1146/annurev-arplant-042817-040413; Pascuzzi PE, 2014, PLANT CELL, V26, P102, DOI 10.1105/tpc.113.121194; Pearce G, 2001, P NATL ACAD SCI USA, V98, P12843, DOI 10.1073/pnas.201416998; Pearce G, 2010, PEPTIDES, V31, P1973, DOI 10.1016/j.peptides.2010.08.012; Pireyre M, 2015, MOL PLANT, V8, P378, DOI 10.1016/j.molp.2014.11.022; Prusky D., 1996, ANN REV PHYTOPATHOL; Ramirez V, 2011, PLANT SIGNAL BEHAV, V6, P911, DOI 10.4161/psb.6.6.15354; Ramirez V, 2011, PLANT PHYSIOL, V155, P1920, DOI 10.1104/pp.110.171843; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seijo TE, 2008, PROC FL STATE HORTIC, V121, P246; Sharma A, 2016, PLANT PHYSIOL BIOCH, V106, P82, DOI 10.1016/j.plaphy.2016.03.037; Srivastava R, 2009, PLANT J, V59, P930, DOI 10.1111/j.1365-313X.2009.03926.x; Stegmann M, 2017, SCIENCE, V355, P287, DOI 10.1126/science.aal2541; Tavormina P, 2015, PLANT CELL, V27, P2095, DOI 10.1105/tpc.15.00440; Thynne E, 2017, MOL PLANT PATHOL, V18, P811, DOI 10.1111/mpp.12444; Toljamo A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161078; Wang PY, 2020, PLANT BIOTECHNOL J, V18, P415, DOI 10.1111/pbi.13208; Wu JS, 2007, PLANT J, V52, P877, DOI 10.1111/j.1365-313X.2007.03289.x; Xiao Y, 2019, NATURE, V572, P270, DOI 10.1038/s41586-019-1409-7; Xiong JS, 2018, PHYSIOL MOL PLANT P, V104, P77, DOI 10.1016/j.pmpp.2018.08.005; Yuan HZ, 2019, HORTIC RES-ENGLAND, V6, DOI 10.1038/s41438-019-0126-6; Zhao SL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S10-P16; Zhao YY, 2019, HORTIC RES-ENGLAND, V6, DOI 10.1038/s41438-019-0135-5	76	4	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0226448	10.1371/journal.pone.0226448	http://dx.doi.org/10.1371/journal.pone.0226448			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214345	Green Published, gold, Green Submitted			2022-12-26	WOS:000535934200003
J	Chia, SY; Macharia, J; Diiro, GM; Kassie, M; Ekesi, S; van Loon, JJA; Dicke, M; Tanga, CM				Chia, Shaphan Y.; Macharia, John; Diiro, Gracious M.; Kassie, Menale; Ekesi, Sunday; van Loon, Joop J. A.; Dicke, Marcel; Tanga, Chrysantus M.			Smallholder farmers' knowledge and willingness to pay for insect-based feeds in Kenya	PLOS ONE			English	Article							ADOPT INSECTS; FOOD; CONSUMERS; FISH; DETERMINANTS; PREFERENCES; ACCEPTANCE; FERTILIZER; WTP	Edible insects are increasingly being considered as sustainable alternatives to fish and soybean meals in animal feed because of their high nutritional quality and environmental benefits. However, successful introduction of a new product to the market depends on the target user's acceptance. Thus, evaluating the potential demand of insect-based feeds would provide relevant information for policy development. The present study assessed farmers' knowledge on edible insects as feed, their acceptance of integrating insect meals in animal feeds and willingness to pay (WTP) for insect-based feed (IBF) using a contingent valuation method. A household survey was conducted among 957 randomly selected farmers including: 409 poultry, 241 fish and 307 pig farmers in four counties in Kenya. Results of the study reveal that over 70 and 80% of poultry and fish farmers, respectively, are aware that insects can be used as a feed ingredient. In addition, over 60 and 75% of poultry and fish farmers, respectively, consider insects as a good component of feed. Poultry, pig and fish farmers interviewed accepted and showed willingness to pay for IBF. Regression analysis indicated that age, gender, education, marital status, distance to feed trader, awareness of insects as feed, attitude towards insects, acceptance of insect species, availability of agricultural inputs, use of commercial feeds, availability of training and market information had a significant influence on the WTP for IBF. Therefore, increased extension services to educate famers on the nutritional benefits of insect meals in animal feeds and existing market opportunities are expected to improve farmers' attitude towards utilization and consequently enhance WTP for IBF, which in return would significantly reduce the existing pressure on conventional fishmeal feed resources. Our findings provide the first insights into the market opportunities of including insect meals in the animal feed value chain in Kenya.	[Chia, Shaphan Y.; van Loon, Joop J. A.; Dicke, Marcel] Wageningen Univ & Res, Lab Entomol, Wageningen, Netherlands; [Chia, Shaphan Y.; Macharia, John; Diiro, Gracious M.; Kassie, Menale; Ekesi, Sunday; Tanga, Chrysantus M.] Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya	Wageningen University & Research; International Centre of Insect Physiology & Ecology (ICIPE)	Tanga, CM (corresponding author), Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya.	ctanga@icipe.org	Chia, Shaphan/ABG-7238-2020; Dicke, Marcel/B-2300-2010; Kassie, Menale/ADT-2906-2022; Macharia, John/AAY-1135-2020; Ekesi, Sunday/P-8944-2019; Chia, Shaphan/ABF-6414-2020; van Loon, Joop J.A./B-3744-2009	Chia, Shaphan/0000-0001-7489-3233; Dicke, Marcel/0000-0001-8565-8896; Macharia, John/0000-0003-0278-6994; , Menale Kassie/0000-0002-6754-2432; van Loon, Joop J.A./0000-0002-4260-0501	Netherlands Organization for Scientific Research, WOTRO Science for Global Development (NWO-WOTRO) [ILIPA-W 08.250.202]; Canadian International Development Research Centre (IDRC); Australian Centre for International Agricultural Research (ACIAR) [108866-001]; Rockefeller Foundation through the International Centre of Insect Physiology and Ecology (icipe) [SiPFeed-2018 FOD 009]; UK Aid from the Government of the United Kingdom; Department for International Development (DFID), UK; Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany; Federal Democratic Republic of Ethiopia; Kenyan Government	Netherlands Organization for Scientific Research, WOTRO Science for Global Development (NWO-WOTRO); Canadian International Development Research Centre (IDRC); Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res); Rockefeller Foundation through the International Centre of Insect Physiology and Ecology (icipe); UK Aid from the Government of the United Kingdom; Department for International Development (DFID), UK; Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany; Federal Democratic Republic of Ethiopia; Kenyan Government	This research was financially supported by the Netherlands Organization for Scientific Research, WOTRO Science for Global Development (NWO-WOTRO) (ILIPA-W 08.250.202), the Canadian International Development Research Centre (IDRC) and the Australian Centre for International Agricultural Research (ACIAR) (INSFEED-Phase 2: Cultivate Grant No: 108866-001) and The Rockefeller Foundation (SiPFeed-2018 FOD 009) through the International Centre of Insect Physiology and Ecology (icipe). We also gratefully acknowledge the icipe core funding provided by UK Aid from the Government of the United Kingdom; Department for International Development (DFID), UK, Swedish International Development Cooperation Agency (Sida); the Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany, Federal Democratic Republic of Ethiopia; and the Kenyan Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiodun E, 2019, CATFISH CATFISH FEED; Alemu MH, 2015, 201510 IFRO U COP; ANGELLA N, 2014, J DEV AGR EC, V6, P345, DOI DOI 10.5897/JDAE2014.0580; Ankamah-Yeboah I, 2018, BRIT FOOD J, V120, P2395, DOI 10.1108/BFJ-11-2017-0604; [Anonymous], 2014, CISC VIS NETW IND GL; Asaminew E., 2014, AFR J AGR EC RURAL D, V2, P155; Bazoche P., 2016, JOURNEES RECHERCHE S, P1; Chia SY, 2018, PEERJ, V6, DOI 10.7717/peerj.5885; Chirwa E. W., 2005, Development Southern Africa, V22, P1, DOI 10.1080/03768350500044065; Etim N. A., 2016, J AGR ECOLOGY RES IN, V6, P1; Falk A, 2018, SCIENCE, V362, DOI 10.1126/science.aas9899; Food and Agriculture Organization, 2009, STAT FOOD AGR LIV BA, DOI 10.1017/S2078633610001128; Githigia S.M., 2012, FAO ANIMAL PRODUCTIO; Gordon D.V., 2012, AQUACULT ECON MANAG, V19, P29; GREEN DAG, 1993, J AGR ECON, V44, P99, DOI 10.1111/j.1477-9552.1993.tb00253.x; HANEMANN M, 1991, AM J AGR ECON, V73, P1255, DOI 10.2307/1242453; Heinzen RR, 2008, INT J TECHNOL ASSESS, V24, P481, DOI 10.1017/S026646230808063X; Henry M, 2015, ANIM FEED SCI TECH, V203, P1, DOI 10.1016/j.anifeedsci.2015.03.001; Henson S, 1996, J AGR ECON, V47, P403, DOI 10.1111/j.1477-9552.1996.tb00701.x; Hernandez-Maskivker GM, 2019, TOURISM MANAGE, V71, P165, DOI 10.1016/j.tourman.2018.10.003; Herriges JA, 1999, AM J AGR ECON, V81, P231, DOI 10.2307/1244462; Huis A., 2013, EDIBLE INSECTS FUTUR; Kar Mun A.T., 2017, INT J FISH AQUAT STU, V5, P278, DOI [10.1016/j.adiac.2009.12.001, DOI 10.1016/J.ADIAC.2009.12.001]; Katende C, 2017, DAILY MONITOR; Kenyan National Bureau of standards (KNBS), 2017, REV 2017 GROSS DOM P; KMFRI, 2017, KEN AQ BRIEF 2017 ST; Kostecka J, 2017, J ECOL ENG, V18, P166, DOI 10.12911/22998993/68301; Kumar P, 2017, AGR REV, V38, P141; Laureati M, 2016, ITAL J FOOD SCI, V28, P652, DOI 10.14674/1120-1770%2Fijfs.v476; Lombardi A, 2019, FOOD QUAL PREFER, V72, P177, DOI 10.1016/j.foodqual.2018.10.001; Makkar HPS, 2018, ANIMAL, V12, P1744, DOI [10.1017/S175173111700324X, 10.1017/s175173111700324x]; Makkar HPS, 2016, ANIM PROD SCI, V56, P519, DOI 10.1071/AN15557; Makkar HPS, 2014, ANIM FEED SCI TECH, V198, P309, DOI 10.1016/j.anifeedsci.2014.09.018; Makkar HPS, 2014, ANIM FEED SCI TECH, V197, P1, DOI 10.1016/j.anifeedsci.2014.07.008; Mancuso T, 2016, AQUACULT INT, V24, P1489, DOI 10.1007/s10499-016-0007-z; Manja LP, 2015, IJ SSHS, V7, P16; Martinez-Carrasco L., 2015, Spanish Journal of Agricultural Research, V13, pe0109, DOI 10.5424/sjar/2015134-8233; Mengistu MG, 2016, RENEW ENERG, V93, P215, DOI 10.1016/j.renene.2016.02.066; Mosig J, 2018, IS COST FEED ONLY FA; Mulugeta M.S., 2009, RES PERSPECTIVES DEV, V6, P2009; Nakano R., 2016, DETERMINANTS WILLING; Njoko S, 2017, WATER SA, V43, P229, DOI 10.4314/wsa.v43i2.07; Nkonya E, 1997, J AGR ECON, V48, P1, DOI 10.1111/j.1477-9552.1997.tb01126.x; Norton EC, 2018, HEALTH SERV RES, V53, P859, DOI 10.1111/1475-6773.12712; Nwokocha J., 2013, INT J ACAD RES BUSIN, V3, P296; Nyandat B, 2013, AQUACULTURE NEEDS AS; Okpukpara B., 2016, JAPS J ANIMAL PLANT, V26; Oladele O. I., 2008, Agricultura Tropica et Subtropica, V41, P165; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445; Panzone L, 2016, J INT FOOD AGRIBUS M, V28, P286, DOI 10.1080/08974438.2016.1145611; Popoff M, 2017, J INSECTS FOOD FEED, V3, P131, DOI 10.3920/JIFF2016.0032; Republic of Kenya Ministry of Agriculture, 2019, DRAFT NAT LIV POL KE; Rumpold BA, 2013, MOL NUTR FOOD RES, V57, P802, DOI 10.1002/mnfr.201200735; Rumpold BA, 2013, INNOV FOOD SCI EMERG, V17, P1, DOI 10.1016/j.ifset.2012.11.005; Ryan AM, 2011, J ECON PSYCHOL, V32, P674, DOI 10.1016/j.joep.2011.07.004; Shava E, 2017, JAMBA-J DISASTER RIS, V9, DOI 10.4102/jamba.v9i1.491; Shibia M., 2017, 2017 SO AGR EC ASS S; Ssepuuya G, 2017, J INSECTS FOOD FEED, V3, P289, DOI [10.3920/jiff2017.0007, 10.3920/JIFF2017.0007]; Tan HSG, 2015, FOOD QUAL PREFER, V42, P78, DOI 10.1016/j.foodqual.2015.01.013; Thornton PK, 2010, PHILOS T R SOC B, V365, P2853, DOI 10.1098/rstb.2010.0134; van Huis A, 2015, J INSECTS FOOD FEED, V1, P3, DOI 10.3920/JIFF2015.x002; van Huis A, 2013, ANNU REV ENTOMOL, V58, P563, DOI 10.1146/annurev-ento-120811-153704; Verbeke W, 2015, ANIM FEED SCI TECH, V204, P72, DOI 10.1016/j.anifeedsci.2015.04.001; Verbeke W, 2015, FOOD QUAL PREFER, V39, P147, DOI 10.1016/j.foodqual.2014.07.008; Vernooij A, 2018, REGIONALIZATION POUL	65	21	21	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230552	10.1371/journal.pone.0230552	http://dx.doi.org/10.1371/journal.pone.0230552			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9HN	32210461	Green Published, gold			2022-12-26	WOS:000535307600031
J	Horita, T; Gaballah, MH; Fukuta, M; Kanno, S; Kato, H; Takamiya, M; Aoki, Y				Horita, Tetsuya; Gaballah, Mohammed Hassan; Fukuta, Mamiko; Kanno, Sanae; Kato, Hideaki; Takamiya, Masataka; Aoki, Yasuhiro			Time course analysis of large-scale gene expression in incised muscle using correspondence analysis	PLOS ONE			English	Article							LEUKOCYTE PROTEASE INHIBITOR; PROINFLAMMATORY CYTOKINES IL-1-BETA; SKELETAL-MUSCLE; DIFFERENTIAL EXPRESSION; INFLAMMATORY CYTOKINES; TNF-ALPHA; MICROARRAY; MACROPHAGES; IDENTIFICATION; INDUCTION	Studying the time course of gene expression in injured skeletal muscle would help to estimate the timing of injuries. In this study, we investigated large-scale gene expression in incision-injured mouse skeletal muscle by DNA microarray using correspondence analysis (CA). Biceps femoris muscle samples were collected 6, 12, and 24 hours after injury, and RNA was extracted and prepared for microarray analysis. On a 2-dimensional plot by CA, the genes (row score coordinate) located farther from each time series (column score coordinate) had more upregulation at particular times. Each gene was situated in 6 subdivided triangular areas according to the magnitude of the relationship of the fold change (FC) value at each time point compared to the control. In each area, genes for which the ratios of two particular FC values were close to 1 were distributed along the two border lines. There was a tendency for genes whose FC values were almost equal to be distributed near the intersection of these 6 areas. Therefore, the gene marker candidates for estimation of the timing of injuries were detectable according to the location on the CA plot. Moreover, gene sets created by a specific gene and its surrounding genes were composed of genes that showed similar or identical fluctuation patterns to the specific gene. In various analyses on these sets, significant gene ontology term and pathway activity may reflect changes in specific genes. In conclusion, analyses of gene sets based on CA plots is effective for investigation of the time-dependent fluctuation in gene expression after injury.	[Horita, Tetsuya; Fukuta, Mamiko; Kanno, Sanae; Kato, Hideaki; Aoki, Yasuhiro] Nagoya City Univ, Dept Forens Med, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Gaballah, Mohammed Hassan] Minist Justice, Egyptian Forens Med Author, Zainab, Cairo Governora, Egypt; [Takamiya, Masataka] Iwate Med Univ, Dept Forens Med, Morioka, Iwate, Japan	Nagoya City University; Ministry of Justice - Egypt; Iwate Medical University	Horita, T; Aoki, Y (corresponding author), Nagoya City Univ, Dept Forens Med, Grad Sch Med Sci, Nagoya, Aichi, Japan.	ttyh@med.nagoya-cu.ac.jp; aokiy@med.nagoya-cu.ac.jp	Gaballah, Mohammed/AAQ-5423-2021	Gaballah, Mohammed/0000-0002-1610-0175; Horita, Tetsuya/0000-0002-6728-5659				Agilent Technologies I, 2017, AG GEN US MAN; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; Authier FJ, 1999, CELL DEATH DIFFER, V6, P1012, DOI 10.1038/sj.cdd.4400576; Can I, 2008, J IMMUNOL, V180, P207, DOI 10.4049/jimmunol.180.1.207; Chen L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-471; Choi SC, 2011, J IMMUNOL, V187, P3483, DOI 10.4049/jimmunol.1101549; Clausen SE, 1988, QUANTITATIVE APPL SO, V121; Cooper L, 2005, GENOME BIOL, V6; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Feezor RJ, 2004, PHYSIOL GENOMICS, V16, P341, DOI 10.1152/physiolgenomics.00101.2003; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; Gaballah MH, 2018, TOHOKU J EXP MED, V245, P29, DOI 10.1620/tjem.245.29; Gaballah MH, 2016, FORENSIC SCI INT, V266, P357, DOI 10.1016/j.forsciint.2016.06.027; Gorska P, 2000, Med Sci Monit, V6, P171; Graham LM, 2012, J BIOL CHEM, V287, P25964, DOI 10.1074/jbc.M112.384164; Grellner W, 2002, FORENSIC SCI INT, V130, P90, DOI 10.1016/S0379-0738(02)00342-0; Grellner W, 2000, FORENSIC SCI INT, V113, P251, DOI 10.1016/S0379-0738(00)00218-8; Grellner W, 2007, FORENSIC SCI INT, V165, P150, DOI 10.1016/j.forsciint.2006.05.029; Hansen L, 2004, BIOCHEM BIOPH RES CO, V323, P685, DOI 10.1016/j.bbrc.2004.08.146; Hardman MJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r80; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kondo T, 1996, INT J LEGAL MED, V108, P231, DOI 10.1007/BF01369816; Long TT, 2019, MOL MED REP, V19, P2029, DOI 10.3892/mmr.2019.9878; MEEK RL, 1986, J EXP MED, V164, P2006, DOI 10.1084/jem.164.6.2006; Mortensen OH, 2008, J PHYSIOL-LONDON, V586, P3551, DOI 10.1113/jphysiol.2008.153551; National Research Council Committee for the Update of the Guide for the C. U. o. L., 2011, DRUG DISCOVERY EVALU; O'Grady NP, 1999, J INFECT DIS, V179, P136, DOI 10.1086/314559; Parnes JR, 2000, IMMUNOL REV, V176, P75; ROKITA H, 1987, J IMMUNOL, V139, P3849; Roy S, 2008, PHYSIOL GENOMICS, V34, P162, DOI 10.1152/physiolgenomics.00045.2008; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288; Shen L, 2016, ONCOL LETT, V11, P1382, DOI 10.3892/ol.2015.4051; Shen YT, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01298; Slonim DK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000543; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tan QH, 2004, J BIOMED INFORM, V37, P358, DOI 10.1016/j.jbi.2004.06.001; te Pas M. F. W., 2008, Advances in Bioinformatics, V2008, P719468, DOI 10.1155/2008/719468; THOMPSON RC, 1986, P NATL ACAD SCI USA, V83, P6692, DOI 10.1073/pnas.83.18.6692; Thorey IS, 2001, J BIOL CHEM, V276, P35818, DOI 10.1074/jbc.M104871200; WALZ A, 1991, J EXP MED, V174, P1355, DOI 10.1084/jem.174.6.1355; Yahiaoui L, 2008, J PHYSIOL-LONDON, V586, P3991, DOI 10.1113/jphysiol.2008.152090; Yang IV, 2002, GENOME BIOL, V3; Yano K, 2006, NUCLEIC ACIDS RES, V34, P1532, DOI 10.1093/nar/gkl058; ZWADLO G, 1988, CLIN EXP IMMUNOL, V72, P510	49	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230737	10.1371/journal.pone.0230737	http://dx.doi.org/10.1371/journal.pone.0230737			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210454	Green Published, gold			2022-12-26	WOS:000535307600044
J	Marsland, R; Cui, WP; Goldford, J; Mehta, P				Marsland, Robert; Cui, Wenping; Goldford, Joshua; Mehta, Pankaj			The Community Simulator: A Python package for microbial ecology	PLOS ONE			English	Article							NICHE	Natural microbial communities contain hundreds to thousands of interacting species. For this reason, computational simulations are playing an increasingly important role in microbial ecology. In this manuscript, we present a new open-source, freely available Python package called Community Simulator for simulating microbial population dynamics in a reproducible, transparent and scalable way. The Community Simulator includes five major elements: tools for preparing the initial states and environmental conditions for a set of samples, automatic generation of dynamical equations based on a dictionary of modeling assumptions, random parameter sampling with tunable levels of metabolic and taxonomic structure, parallel integration of the dynamical equations, and support for metacommunity dynamics with migration between samples. To significantly speed up simulations using Community Simulator, our Python package implements a new Expectation-Maximization (EM) algorithm for finding equilibrium states of community dynamics that exploits a recently discovered duality between ecological dynamics and convex optimization. We present data showing that this EM algorithm improves performance by between one and two orders compared to direct numerical integration of the corresponding ordinary differential equations. We conclude by listing several recent applications of the Community Simulator to problems in microbial ecology, and discussing possible extensions of the package for directly analyzing microbiome compositional data.	[Marsland, Robert; Cui, Wenping; Mehta, Pankaj] Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA; [Cui, Wenping] Boston Coll, Dept Phys, Chestnut Hill, MA 02167 USA; [Goldford, Joshua] Boston Univ, Bioinformat Program, Boston, MA 02215 USA	Boston University; Boston College; Boston University	Marsland, R (corresponding author), Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.	marsland@bu.edu		Marsland III, Robert/0000-0002-5007-6877; Cui, Wenping/0000-0002-9900-5092	NIH NIGMS grant [1R35GM119461]; Simons Investigator in the Mathematical Modeling of Living Systems (MMLS) award	NIH NIGMS grant; Simons Investigator in the Mathematical Modeling of Living Systems (MMLS) award	This work was supported by NIH NIGMS grant 1R35GM119461 and a Simons Investigator in the Mathematical Modeling of Living Systems (MMLS) award to PM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani M, 2018, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/aab04e; Agrawal A., 2018, J CONTROL DECIS, V5, P42, DOI [10.1080/23307706.2017.1397554, DOI 10.1080/23307706.2017.1397554]; Barbier M, 2018, P NATL ACAD SCI USA, V115, P2156, DOI 10.1073/pnas.1710352115; Bunin G, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.042414; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHESSON P, 1990, THEOR POPUL BIOL, V37, P26, DOI 10.1016/0040-5809(90)90025-Q; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Cui W, 2019, ARXIV19040261; Cui W, 2019, 191102595 ARXIV; Diamond S, 2016, J MACH LEARN RES, V17; Dickens B, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.022423; Embree M, 2015, P NATL ACAD SCI USA, V112, P15450, DOI 10.1073/pnas.1506034112; Fisher CK, 2014, P NATL ACAD SCI USA, V111, P13111, DOI 10.1073/pnas.1405637111; Gause GF, 1935, AM NAT, V69, P596, DOI 10.1086/280628; Goldford JE, 2018, SCIENCE, V361, P469, DOI 10.1126/science.aat1168; Hindmarsh AC, 1983, SCI COMPUT, V1, P55; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jeraldo P, 2012, P NATL ACAD SCI USA, V109, P9692, DOI 10.1073/pnas.1206721109; Jones E., 2001, SCIPY OPEN SOURCE SC; Kessler DA, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.042705; LEVIN SA, 1970, AM NAT, V104, P413, DOI 10.1086/282676; LOREAU M, 1995, AM NAT, V145, P22, DOI 10.1086/285726; MACARTHUR R, 1970, Theoretical Population Biology, V1, P1, DOI 10.1016/0040-5809(70)90039-0; Marsland IIIR, 2019, ARXIV190109673; Marsland R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006793; Marsland R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60130-2; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Mehta P, 2019, PHYS REV E, V99, DOI 10.1103/PhysRevE.99.052111; Mehta P, 2019, PHYS REP, V810, P1, DOI 10.1016/j.physrep.2019.03.001; Muscarella ME, 2019, SPECIES DYNAMICS INT, V518449; Pacheco AR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07946-9; Sen Datta M, 2013, P NATL ACAD SCI USA, V110, P7354, DOI 10.1073/pnas.1217517110; Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621; Tilman D., 1982, Monographs in Population Biology, pi; Vega NM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000633	37	11	11	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230430	10.1371/journal.pone.0230430	http://dx.doi.org/10.1371/journal.pone.0230430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LA1PZ	32208436	gold, Green Published, Green Submitted			2022-12-26	WOS:000523728200001
J	Marzban, EN; Eldeib, AM; Yassine, IA; Kadah, YM				Marzban, Eman N.; Eldeib, Ayman M.; Yassine, Inas A.; Kadah, Yasser M.		Alzheimers Dis Neurodegenerative I	Alzheimer's disease diagnosis from diffusion tensor images using convolutional neural networks	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; WHITE-MATTER CHANGES; ENTORHINAL CORTEX; LEWY BODIES; DEMENTIA; PROGRESSION; ATROPHY; PATTERNS; VOLUME; HYPOMETABOLISM	Machine learning algorithms are currently being implemented in an escalating manner to classify and/or predict the onset of some neurodegenerative diseases; including Alzheimer's Disease (AD); this could be attributed to the fact of the abundance of data and powerful computers. The objective of this work was to deliver a robust classification system for AD and Mild Cognitive Impairment (MCI) against healthy controls (HC) in a low-cost network in terms of shallow architecture and processing. In this study, the dataset included was downloaded from the Alzheimer's disease neuroimaging initiative (ADNI). The classification methodology implemented was the convolutional neural network (CNN), where the diffusion maps, and gray-matter (GM) volumes were the input images. The number of scans included was 185, 106, and 115 for HC, MCI and AD respectively. Ten-fold cross-validation scheme was adopted and the stacked mean diffusivity (MD) and GM volume produced an AUC of 0.94 and 0.84, an accuracy of 93.5% and 79.6%, a sensitivity of 92.5% and 62.7%, and a specificity of 93.9% and 89% for AD/HC and MCI/HC classification respectively. This work elucidates the impact of incorporating data from different imaging modalities; i.e. structural Magnetic Resonance Imaging (MRI) and Diffusion Tensor Imaging (DTI), where deep learning was employed for the aim of classification. To the best of our knowledge, this is the first study assessing the impact of having more than one scan per subject and propose the proper maneuver to confirm the robustness of the system. The results were competitive among the existing literature, which paves the way for improving medications that could slow down the progress of the AD or prevent it.	[Marzban, Eman N.; Eldeib, Ayman M.; Yassine, Inas A.; Kadah, Yasser M.] Cairo Univ, Fac Engn, Biomed Engn & Syst, Giza, Egypt; [Kadah, Yasser M.] King Abdulaziz Univ, Elect & Comp Engn Dept, Biomed Engn Program, Jeddah, Saudi Arabia	Egyptian Knowledge Bank (EKB); Cairo University; King Abdulaziz University	Marzban, EN (corresponding author), Cairo Univ, Fac Engn, Biomed Engn & Syst, Giza, Egypt.		Kadah, Yasser/B-2746-2011	Kadah, Yasser/0000-0002-2166-3191; Marzban, Eman/0000-0002-6021-8664				Acosta-Cabronero J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049072; Ahmed N, 2019, DIAGNOSTICS, V9; Alger JR, 2012, J NEUROSCI, V32, P7418, DOI 10.1523/JNEUROSCI.4687-11.2012; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; [Anonymous], 2019, SCIKIT LEARN DEV 3 1; [Anonymous], 2019, STANFORD CS CLASS CS; Arbabshirani MR, 2017, NEUROIMAGE, V145, P137, DOI 10.1016/j.neuroimage.2016.02.079; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Asl EH, 2018, FRONT BIOSCI-LANDMRK, V23, P584, DOI 10.2741/4606; Avetisian M., 2017, DATA ANAL MANAGEMENT, P5; Ben Ahmed O, 2017, NEUROCOMPUTING, V220, P98, DOI 10.1016/j.neucom.2016.08.041; Boston University School of Public Health, 2017, TESTS MATCH SAMPL; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bratic B, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-1071-x; Chan D, 2001, ANN NEUROL, V49, P433, DOI 10.1002/ana.92.abs; Christ PF, 2017, I S BIOMED IMAGING, P839, DOI 10.1109/ISBI.2017.7950648; Clerx L, 2012, J ALZHEIMERS DIS, V29, P405, DOI 10.3233/JAD-2011-110797; Demirhan A, 2015, I S BIOMED IMAGING, P126, DOI 10.1109/ISBI.2015.7163832; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2001, NEUROBIOL AGING, V22, P747, DOI 10.1016/S0197-4580(01)00271-8; Douaud G, 2013, J NEUROSCI, V33, P2147, DOI 10.1523/JNEUROSCI.4437-12.2013; Dyrba Martin, 2012, Multimodal Brain Image Analysis. Proceedings Second International Workshop, MBIA 2012. Held in Conjunction with MICCAI 2012, P18, DOI 10.1007/978-3-642-33530-3_2; Dyrba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064925; Elshahidi MH, 2017, NEUROPSYCH DIS TREAT, V13, P715, DOI 10.2147/NDT.S127605; Ewers M, 2011, PROG NEUROBIOL, V95, P535, DOI 10.1016/j.pneurobio.2011.06.004; Ewers M, 2011, TRENDS NEUROSCI, V34, P430, DOI 10.1016/j.tins.2011.05.005; Firbank MJ, 2007, PSYCHIAT RES-NEUROIM, V155, P135, DOI 10.1016/j.pscychresns.2007.01.001; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Functional Imaging Laboratory-Wellcome Trust Center for Neuroimaging, 2015, SPM12 MANUAL; Gaser C, 2019, MANUAL COMPUTATIONAL; Gaugler J, 2019, ALZHEIMERS DEMENT, V15, P321, DOI 10.1016/j.jalz.2019.01.010; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Gibbons JD, 2003, NONPARAMETRIC STAT I, P168; Goceri E., 2018, INT C MATH ICOMATH20; Goceri E, 2018, INT C ADV TECHN ANT; Goceri E., 2017, INT C COMP GRAPH VIS; Goceri E, 2019, IET IMAGE PROCESS; Goceri E, 2019, 2019 9 INT C IM PROC; Goceri E., 2019, INT J NUMER METH BIO, V35, P1; Goceri E., 2018, INT C APPL AN MATH M; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Grothe MJ, 2017, NEUROLOGY, V89, P2031, DOI 10.1212/WNL.0000000000004643; Grothe MJ, 2016, CEREB CORTEX, V26, P2411, DOI 10.1093/cercor/bhv062; Grothe MJ, 2016, HUM BRAIN MAPP, V37, P35, DOI 10.1002/hbm.23018; Henf J, 2018, NEUROIMAGE-CLIN, V17, P579, DOI 10.1016/j.nicl.2017.10.005; Hett K., 2019, SCI REP-UK, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Hinton G, 2014, LECT 6 OVERVIEW MINI; Islam Jyoti, 2018, Brain Inform, V5, P2, DOI 10.1186/s40708-018-0080-3; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jang H, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Kantarci K, 2010, NEUROLOGY, V74, P1814, DOI 10.1212/WNL.0b013e3181e0f7cf; Khvostikov A, 2018, 3D CNN BASED CLASSIF; Killiany RJ, 2002, NEUROLOGY, V58, P1188, DOI 10.1212/WNL.58.8.1188; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lee W, 2015, LECT NOTES COMPUT SC, V9226, P489; Lin MH, 2014, ASIA-PAC EDUC RES, V23, P577, DOI 10.1007/s40299-013-0131-8; Lin W., 2018, FRONTIERS NEUROSCI, V12, P1, DOI DOI 10.3389/FNINS.2018.00001; Liu MX, 2018, IEEE J BIOMED HEALTH, V22, P1476, DOI 10.1109/JBHI.2018.2791863; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Mielke MM, 2012, ALZHEIMERS DEMENT, V8, P105, DOI 10.1016/j.jalz.2011.05.2416; Mizurio B, 2007, 15TH IEEE INTERNATIONAL CONFERENCE ON ADVANCED THERMAL PROCESSING OF SEMICONDUCTORS - RTP 2007, P1; Nair V, 2010, P INT C MACH LEARN; Nasrabady SE, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0515-3; Nir TM, 2015, NEUROBIOL AGING, V36, pS132, DOI 10.1016/j.neurobiolaging.2014.05.037; Oishi K, 2011, J ALZHEIMERS DIS, V26, P287, DOI 10.3233/JAD-2011-0007; Parikh R, 2008, INDIAN J OPHTHALMOL, V56, P45, DOI 10.4103/0301-4738.37595; Pereira S, 2016, IEEE T MED IMAGING, V35, P1240, DOI 10.1109/TMI.2016.2538465; Petersen RC, 2008, CNS SPECTRUMS, V13, P45, DOI 10.1017/S1092852900016151; Petrella JR, 2003, RADIOLOGY, V226, P315, DOI 10.1148/radiol.2262011600; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Rose SE, 2008, J MAGN RESON IMAGING, V27, P20, DOI 10.1002/jmri.21231; SCHNEIDER J., 1997, CROSS VALIDATION; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Shorten C, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0197-0; Simonyan K., 2015, 3 INT C LEARN REPR I; Smith AD, 2002, P NATL ACAD SCI USA, V99, P4135, DOI 10.1073/pnas.082107399; Stawiaski J., 2017, ARXIV171002316; Trevethan R., 2017, FRONT PUBLIC HEALTH, V5, P1, DOI DOI 10.3389/; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Villemagne VL, 2011, J NUCL MED, V52, P1210, DOI 10.2967/jnumed.111.089730; Wen J, 2018, ORG HUM BRAIN MAPP A; 2009, DIFFUSION MRI, P1	85	23	27	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230409	10.1371/journal.pone.0230409	http://dx.doi.org/10.1371/journal.pone.0230409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208428	Green Published, gold, Green Submitted			2022-12-26	WOS:000535305100017
J	Andersen, GE; McGregor, HW; Johnson, CN; Jones, ME				Andersen, Georgina E.; McGregor, Hugh W.; Johnson, Christopher N.; Jones, Menna E.			Activity and social interactions in a wide-ranging specialist scavenger, the Tasmanian devil (Sarcophilus harrisii), revealed by animal-borne video collars	PLOS ONE			English	Article							DASYURID CARNIVORES; FEEDING ECOLOGY; TRANSMISSION; POPULATION; BEHAVIOR; DISEASE; PATTERNS; CONTACT; DIET	Observing animals directly in the field provides the most accurate understanding of animal behaviour and resource selection. However, making prolonged observation of undisturbed animals is difficult or impossible for many species. To overcome this problem for the Tasmanian devil (Sarcophilus harrisii), a cryptic and nocturnal carnivore, we developed animal-borne video collars to investigate activity patterns, foraging behaviour and social interactions. We collected 173 hours of footage from 13 individual devils between 2013 and 2017. Devils were active mostly at night, and resting was the most common behaviour in all diel periods. Devils spent more time scavenging than hunting and exhibited opportunistic and flexible foraging behaviours. Scavenging occurred mostly in natural vegetation but also in anthropogenic vegetation and linear features (roads and fence lines). Scavenging frequency was inversely incremental with size e.g. small carcasses were scavenged most frequently. Agonistic interactions with conspecifics occurred most often when devils were traveling but also occurred over carcasses or dens. Interactions generally involved vocalisations and brief chases without physical contact. Our results highlight the importance of devils as a scavenger in the Tasmanian ecosystem, not just of large carcasses for which devils are well known but in cleaning up small items of carrion in the bush. Our results also show the complex nature of intraspecific interactions, revealing greater detail on the context in which interactions occur. In addition, this study demonstrates the benefits of using animal-borne imaging in quantifying behaviour of elusive, nocturnal carnivores not previously seen using conventional field methods.	[Andersen, Georgina E.; McGregor, Hugh W.; Johnson, Christopher N.; Jones, Menna E.] Univ Tasmania, Sch Nat Sci, Hobart, Tas, Australia; [Johnson, Christopher N.] Univ Tasmania, Australian Res Council Ctr Excellence Australian, Hobart, Tas, Australia	University of Tasmania; University of Tasmania	Andersen, GE (corresponding author), Univ Tasmania, Sch Nat Sci, Hobart, Tas, Australia.	georgina.andersen@utas.edu.au	Johnson, Christopher/J-7894-2014; McGregor, Hugh/T-2283-2017	Johnson, Christopher/0000-0002-9719-3771; Andersen, Georgina/0000-0001-9425-8296; McGregor, Hugh/0000-0003-3255-9282; Jones, Menna/0000-0001-7558-9022	Australian Research Council Discovery Scheme grant [DP110103069]; Christopher Johnson Holsworth Wildlife Research Endowment	Australian Research Council Discovery Scheme grant(Australian Research Council); Christopher Johnson Holsworth Wildlife Research Endowment	Australian Research Council Discovery Scheme grant (DP110103069) to Menna Jones and Christopher Johnson Holsworth Wildlife Research Endowment (http://www.ecolsoc.org.au/endowments) to Georgina Andersen The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2015, J ARID LAND, V7, P860, DOI 10.1007/s40333-015-0007-2; Andersen GE, 2020, AUSTRAL ECOL, V45, P355, DOI 10.1111/aec.12865; Andersen GE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188529; Andersen GE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11454-z; Baynes B., 2007, SPATIAL BEHAV LANDSC; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; Cirovic D, 2016, BIOL CONSERV, V199, P51, DOI 10.1016/j.biocon.2016.04.027; Cunningham CX, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1582; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Hamede RK, 2008, AUSTRAL ECOL, V33, P614, DOI 10.1111/j.1442-9993.2007.01827.x; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hamilton DG, 2019, BEHAV ECOL, V30, P1087, DOI 10.1093/beheco/arz054; Hebblewhite M, 2005, ECOLOGY, V86, P2135, DOI 10.1890/04-1269; Hohenlohe PA, 2019, CONSERV GENET, V20, P81, DOI 10.1007/s10592-019-01157-5; Holekamp K.E., 2009, P234; Hollings T, 2016, ECOLOGY, V97, P394, DOI 10.1890/15-0204.1; Hollings T, 2014, CONSERV BIOL, V28, P63, DOI 10.1111/cobi.12152; Jones M, 1997, ECOLOGY, V78, P2569; Jones M.E., 2003, PREDATORS POUCHES BI, P281; Jones M.E., 1995, THESIS; Jones ME, 2000, WILDLIFE RES, V27, P289, DOI 10.1071/WR98069; Jones ME, 1998, J ZOOL, V246, P239, DOI 10.1111/j.1469-7998.1998.tb00152.x; Jones ME, 1998, J ANIM ECOL, V67, P410, DOI 10.1046/j.1365-2656.1998.00203.x; Jones ME, 1997, PHYSIOL ZOOL, V70, P53, DOI 10.1086/639541; Jones ME, 2000, J MAMMAL, V81, P434, DOI 10.1644/1545-1542(2000)081<0434:NDASAD>2.0.CO;2; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Kruuk H., 1972, THE SPOTTED HYENA; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; Lazenby BT, 2018, J APPL ECOL, V55, P1368, DOI 10.1111/1365-2664.13088; McCallum H, 2009, ECOLOGY, V90, P3379, DOI 10.1890/08-1763.1; Moleon M, 2014, BIOSCIENCE, V64, P394, DOI 10.1093/biosci/biu034; O'Bryan CJ, 2018, NAT ECOL EVOL, V2, P229, DOI 10.1038/s41559-017-0421-2; OWENS MJ, 1978, E AFR WILDL J, V16, P113; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; PEMBERTON D, 1993, AUST J ZOOL, V41, P507, DOI 10.1071/ZO9930507; Pemberton D., 1990, THESIS; Pemberton David, 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P13; Pereira LM, 2014, MAMMAL REV, V44, P44, DOI 10.1111/mam.12005; Pinheiro J., 2019, R PACKAGE VERSION, V3, P1; R Core Team, 2013, R LANG ENV STAT COMP; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Thalmann S, 2013, AUST MAMMAL, V35, P241, DOI 10.1071/AM12041; Thompson ID, 2012, WILDLIFE SOC B, V36, P365, DOI 10.1002/wsb.130; Van Valkenburgh B., 1989, CARNIVORE BEHAV ECOL, P410, DOI DOI 10.1007/978-1-4757-4716-4; Wall R, 2012, VET PARASITOL, V189, P44, DOI 10.1016/j.vetpar.2012.03.031; Wells K, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2613; Yirga G, 2015, WILDLIFE RES, V42, P563, DOI 10.1071/WR14228	48	7	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230216	10.1371/journal.pone.0230216	http://dx.doi.org/10.1371/journal.pone.0230216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KY9IV	32203534	gold, Green Published, Green Accepted			2022-12-26	WOS:000522889000001
J	Cunha, CF; Ferraz-Nogueira, R; Costa, VFA; Pimentel, MIF; Chometon, TQ; Lyra, MR; Schubach, AO; Da-Cruz, AM; Bertho, AL				Cunha, Clarissa F.; Ferraz-Nogueira, Raquel; Costa, Vanessa F. A.; Pimentel, Maria Ines F.; Chometon, Thaize Q.; Lyra, Marcelo R.; Schubach, Armando O.; Da-Cruz, Alda Maria; Bertho, Alvaro Luiz			Contribution of Leishmania braziliensis antigen-specific CD4(+) T, CD8(+) T, NK and CD3(+)CD56(+)NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DISEASE; IDENTIFICATION; PATHOGENESIS; SENESCENCE; APOPTOSIS; SCARS; CURE	The pathogenesis of cutaneous leishmaniasis (CL) caused by Leishmania (Viannia) braziliensis is dictated mainly by the immune-mediated-tissue inflammation developed. The understanding of the immunological mechanisms that generate tissue damage or resolution of lesions is the key to the development of effective vaccine protocols and proper therapeutic schemes. It is clear that the specific immune response mediated by T cells is responsible for the beneficial outcome of the disease, however, the roles of CD4(+) T, CD8(+) T, NK and NKT cell subpopulations in immunopathogenesis of CL need to be elucidated. Peripheral blood cells from patients before, during and after the antimonial therapy, as well as healthy individuals (HI) were cultured with (LbAgS) or without (NS) L. braziliensis antigens (LbAg). Afterwards, the frequencies of LbAg-specific-cytotoxic CD8(+) T, CD4(+) T, NK and CD3(+)CD56(+) NKT cells, as well as their activation and exhaustion profiles, were defined by flow cytometry. We observed higher frequencies of CD8(+) T, NK and CD3(+)CD56(+) NKT cells and lower frequencies of CD4(+) T lymphocytes in LbAgS cell cultures from patients before treatment. The specific response to LbAg resulted in an expansion of cytotoxic-activated CD4(+) T, CD8(+) T, and NK cells, before and during treatment, indicating specificity in the response by these cells against L. braziliensis. Furthermore, comparing the differences of frequencies of cytotoxic-activated CD4(+) T, CD8(+) T, and NK cells, among before and during treatment patients and HI groups, we conclude that these cell populations are in charge of immune response elicited by antimonial therapy. Interestingly, we also observed that NK cells were induced by LbAg to an exhaustion profile during all clinical stages of the disease. The increased antigen-specific activation and cytotoxic activity are in line with the strong inflammatory response described in this disease, a likely cause of tissue damage. These findings reinforce the involvement of these distinct cytotoxic-activated cell populations in the immunopathogenesis of CL, showing a character of specificity in this immune response.	[Cunha, Clarissa F.; Ferraz-Nogueira, Raquel; Costa, Vanessa F. A.; Bertho, Alvaro Luiz] Fiocruz MS, Lab Immunoparasitol, Oswaldo Cruz Inst, Rio De Janeiro, RJ, Brazil; [Ferraz-Nogueira, Raquel; Costa, Vanessa F. A.; Chometon, Thaize Q.; Bertho, Alvaro Luiz] Fiocruz MS, Flow Cytometry Core Facil, Oswaldo Cruz Inst, Rio De Janeiro, RJ, Brazil; [Pimentel, Maria Ines F.; Lyra, Marcelo R.; Schubach, Armando O.] Fiocruz MS, Lab Surveillance Leishmaniasis, Evandro Chagas Natl Inst Infectol, Rio De Janeiro, RJ, Brazil; [Da-Cruz, Alda Maria] Fiocruz MS, Lab Interdisciplinary Med Res, Oswaldo Cruz Inst, Rio De Janeiro, RJ, Brazil; [Cunha, Clarissa F.] Hosp Fed Univ Juiz de Fora, Hematol & Oncol Unit, Juiz De Fora, MG, Brazil; [Ferraz-Nogueira, Raquel] Beckman Coulter Life Sci, Sao Paulo, SP, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Beckman Coulter Inc.	Bertho, AL (corresponding author), Fiocruz MS, Lab Immunoparasitol, Oswaldo Cruz Inst, Rio De Janeiro, RJ, Brazil.; Bertho, AL (corresponding author), Fiocruz MS, Flow Cytometry Core Facil, Oswaldo Cruz Inst, Rio De Janeiro, RJ, Brazil.	alvaro.bertho@ioc.fiocruz.br		Quiroga Chometon Pedro, Thaize/0000-0002-7389-2324	Oswaldo Cruz Institute-FIOCRUZ [PROEP-CNPq-IOC (402557/2011-5), FIOTEC IOC008-FIO-15-47, PAEF II-IOC-023-18-2-47]; FAPERJ [APQ1 E 26/110332/2014]	Oswaldo Cruz Institute-FIOCRUZ; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This research was supported in part by Oswaldo Cruz Institute-FIOCRUZ internal funding (PROEP-CNPq-IOC (402557/2011-5); FIOTEC IOC008-FIO-15-47; and PAEF II-IOC-023-18-2-47); and FAPERJ APQ1 E 26/110332/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Ameen M, 2010, CLIN EXP DERMATOL, V35, P699, DOI 10.1111/j.1365-2230.2010.03851.x; Amprey JL, 2004, J EXP MED, V200, P895, DOI 10.1084/jem.20040704; Antonelli LRV, 2005, IMMUNOL LETT, V101, P226, DOI 10.1016/j.imlet.2005.06.004; Bertho AL, 2000, BRAZ J MED BIOL RES, V33, P317, DOI 10.1590/S0100-879X2000000300010; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bogdan C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00069; Campos-Martin Y, 2006, J IMMUNOL, V176, P6172, DOI 10.4049/jimmunol.176.10.6172; Cardoso TM, 2015, INFECT IMMUN, V83, P898, DOI 10.1128/IAI.02404-14; Casado JL, 2015, HIV MED, V16, P240, DOI 10.1111/hiv.12206; Cunha CF, 2016, PARASITE IMMUNOL, V38, P244, DOI 10.1111/pim.12312; Da-Cruz AM, 2005, BRIT J DERMATOL, V153, P537, DOI 10.1111/j.1365-2133.2005.06647.x; DACRUZ AM, 1994, INFECT IMMUN, V62, P2614, DOI 10.1128/IAI.62.6.2614-2618.1994; de Oliveira-Neto MP, 2000, INT J DERMATOL, V39, P506, DOI 10.1046/j.1365-4362.2000.00969.x; Ferraz R, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2152-2; Ferraz R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0799-x; Gillespie PM, 2016, VACCINE, V34, P2992, DOI 10.1016/j.vaccine.2015.12.071; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; Karmakar S, 2011, EUR J IMMUNOL, V41, P1376, DOI 10.1002/eji.201040981; Lieke T, 2011, PARASITOLOGY, V138, P1898, DOI 10.1017/S0031182011001363; Maasho K, 1998, INFECT IMMUN, V66, P2698, DOI 10.1128/IAI.66.6.2698-2704.1998; Mendonca MG, 2004, J INFECT DIS, V189, P1018, DOI 10.1086/382135; Naouar I, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/636039; Novais FO, 2018, J IMMUNOL, V200, P1737, DOI 10.4049/jimmunol.1701597; Oliveira WN, 2014, CYTOKINE, V66, P127, DOI 10.1016/j.cyto.2013.12.016; Pace D, 2014, J INFECTION, V69, pS10, DOI 10.1016/j.jinf.2014.07.016; Pereira LIA, 2009, AM J TROP MED HYG, V81, P378, DOI 10.4269/ajtmh.2009.81.378; Quarona V, 2013, CYTOM PART B-CLIN CY, V84B, P207, DOI 10.1002/cyto.b.21092; Ruiz JH, 2007, PARASITE IMMUNOL, V29, P671, DOI 10.1111/j.1365-3024.2007.00991.x; Saito H, 2019, ANTICANCER RES, V39, P443, DOI 10.21873/anticanres.13132; Santos CD, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00165; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Schubach A, 1998, J INFECT DIS, V178, P911, DOI 10.1086/515355; Scott P, 2016, NAT REV IMMUNOL, V16, P581, DOI 10.1038/nri.2016.72; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; World Health Organization (WHO), LEISHMANIASIS; Zamora-Chimal J, 2017, IMMUNOBIOLOGY, V222, P641, DOI 10.1016/j.imbio.2016.11.014	39	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0229400	10.1371/journal.pone.0229400	http://dx.doi.org/10.1371/journal.pone.0229400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GC	32203546	Green Published, gold			2022-12-26	WOS:000535303900006
J	Gompo, TR; Shah, BR; Karki, S; Koirala, P; Maharjan, M; Bhatt, DD				Gompo, Tulsi Ram; Shah, Bikas Raj; Karki, Surendra; Koirala, Pragya; Maharjan, Manju; Bhatt, Diker Dev			Risk factors associated with Avian Influenza subtype H9 outbreaks in poultry farms in Kathmandu valley, Nepal	PLOS ONE			English	Article							HUMAN INFECTION; VIRUS	The poultry sector contributes four percent to the national GDP of Nepal. However, this sector is under threat with periodic outbreaks of Avian Influenza (AI) subtypes H5 and H9 since 2009. This has been both a public health threat and an economic issue. Since the past few years, outbreaks of AI subtype H9 have caused huge economic losses in major poultry producing areas of Nepal. However, the risk factors associated with these outbreaks have not been assessed. A retrospective case-control study was conducted from April 2018 to May 2019 to understand the risk factors associated with AI subtype H9 outbreaks in Kathmandu valley. Out of 100 farms selected, 50 were "case" farms, confirmed positive to H9 at Central Veterinary Laboratory, Kathmandu, and another 50 farms were "control" farms, matched for farm size and locality within a radius of three km from the case farm. Each farm was visited to collect information using a semi-structured questionnaire. Twelve potential risk factors were included in the questionnaire under the broad categories: birds and farm characteristics, and management and biosecurity status of the farms. Univariable and multivariable logistic regression analysis was conducted and corresponding odds ratios were calculated. Risk factors, associated with AI subtype H9 outbreaks in Kathmandu valley, identified in the final multivariable model were: "farms that have flock size greater than median flock size of study farms (> 1500)" (OR = 4.41, 95% CI: 1.53-12.71, p = 0.006), "farms that did not apply rules to wear boots for visitors inside the farms" (OR = 4.32, 95% CI: 1.52-12.29, p = 0.006) and "other commercial farms located within one km periphery" (OR = 10, 95% CI: 1.8-50, p = 0.007). This study showed that outbreaks of AI subtype H9 in Kathmandu valley were associated with a higher population of birds in the farm, poor management practices, and weak biosecurity measures in poultry farms. We suggest improving management practices and increase biosecurity in the farms to reduce incidences of AI subtype H9 outbreaks in Kathmandu valley.	[Gompo, Tulsi Ram; Koirala, Pragya; Maharjan, Manju; Bhatt, Diker Dev] Cent Vet Lab, Dept Livestock Serv, Kathmandu, Nepal; [Shah, Bikas Raj] Tribhuvan Univ, Inst Agr & Anim Sci, Kathmandu, Nepal; [Karki, Surendra] Himalayan Coll Agr Sci & Technol, Kathmandu, Nepal	Tribhuvan University; Institute of Agriculture & Animal Science (IAAS) - Nepal	Gompo, TR (corresponding author), Cent Vet Lab, Dept Livestock Serv, Kathmandu, Nepal.	tulsigompo@gmail.com		Karki, Surendra/0000-0003-3329-2575; Shah, Bikas/0000-0001-7170-3887				Agriculture Information and Training Center, 2019, AGR DIAR 2019; Alexander DJ, 2009, REV SCI TECH OIE, V28, P19, DOI 10.20506/rst.28.1.1856; Biswas PK, 2009, EMERG INFECT DIS, V15, P1931, DOI 10.3201/eid1512.090643; Brugh M, 1987, P 2 INT S AV INFL US, P177; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Carnaccini S, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a038588; Central Bureau of Statistics (CBS), 2015, NEP COMM POULTR SURV; Central Veterinary Laboratory (CVL), 2018, ANN TECHN B; Chaudhry M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119019; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; Ducatez MF, 2008, VACCINE, V26, pD67, DOI 10.1016/j.vaccine.2008.07.064; Government of Nepal, 2003, NAT CONT PLAN PREV C; Government of Nepal, 2008, NAT SURV PLAN HIGHL; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Karki S, 2014, ZOONOSES PUBLIC HLTH, V61, P442, DOI 10.1111/zph.12097; Liu D, 2014, LANCET, V383, P869, DOI 10.1016/S0140-6736(14)60386-X; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; NEUPANE D, 2012, BMC INFECT DIS, V12, DOI DOI 10.1186/1471-2334-12-12; Nishiguchi A, 2007, ZOONOSES PUBLIC HLTH, V54, P337, DOI 10.1111/j.1863-2378.2007.01074.x; OIE, 2019, IMM NOT REP, P1; Pant GR, 2007, AVIAN DIS, V51, P352, DOI 10.1637/7649-051806R.1; Peacock TP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070620; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Permin A., 2002, NEED HOLISTIC VIEW D; Poudel S, 2012, P 1 INT C INF DIS NA; Satyal U, 2019, HIMALAYAN TIMES; Sergeant ESG, 2018, EPITOOLS EPIDEMIOLOG; Tombari W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053524; Turner Elizabeth L, 2010, Epidemiol Perspect Innov, V7, P9, DOI 10.1186/1742-5573-7-9; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; World Health Organization, 2019, INF AV INFL H5N1 ID; World Organization for Animal Health (OIE), 2009, AV INFL PORT	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0223550	10.1371/journal.pone.0223550	http://dx.doi.org/10.1371/journal.pone.0223550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240166	Green Published, Green Submitted, gold			2022-12-26	WOS:000535945000003
J	Steggerda, JA; Bloom, MB; Noureddin, M; Brennan, TV; Todo, T; Nissen, NN; Klein, AS; Kim, IK				Steggerda, Justin A.; Bloom, Matthew B.; Noureddin, Mazen; Brennan, Todd, V; Todo, Tsuyoshi; Nissen, Nicholas N.; Klein, Andrew S.; Kim, Irene K.			Higher thresholds for the utilization of steatotic allografts in liver transplantation: Analysis from a US national database	PLOS ONE			English	Article							HEPATIC STEATOSIS; GRAFT STEATOSIS; FATTY LIVER; DONOR; SURVIVAL; OUTCOMES; GRADE	Background Historically, liver allografts with >30% macrosteatosis (MaS) on donor biopsy have been associated with early allograft dysfunction and worse graft survival; however, successful outcomes have been reported in small cohorts. This study proposes an elevated MaS threshold for organ utilization without detriment to graft survival. Methods The UNOS Standard Transplant Analysis and Research database was evaluated for transplants between 2006-2015. Graft survival up to 1-year was evaluated by Kaplan-Meier (KM) survival analyses, and by univariate and multivariable logistic regression analyses, including donor and recipient characteristics. Odds ratios (OR) with 95% confidence intervals (CI) for risk of graft loss are reported. Results Thirty-day risk of graft loss was increased with MaS as low as 10-19% (OR [95% CI] 1.301 [1.055-1.605], p<0.0001) and peaked with MaS 50-59% (2.921 [1.672-5.103]). At 1-year, risk of graft loss remained elevated with MaS 40-49% (1.465 [1.002-2.142]) and MaS 50-59% (1.978 [1.281-3.056], p = 0.0224). Multivariable models were created for Lower and Higher MELD recipients and MaS cutoffs were established. In Lower MELD recipients, organs with >= 50% MaS had increased risk of graft loss at 30 days (2.451 [1.541-3.897], p = 0.0008) and 1-year post-transplant (1.720 [1.224-2.418], p = 0.0125). Higher MELD recipients had increased risk of graft loss at 30 days with allografts showing MaS >= 40% (4.204 [1.440-5.076], p = 0.0016). At 1-year the risk remained increased, but MaS was not significant predictor of graft loss.048 [1.131-3.710], p = 0.0616). In both MELD cohorts, organs with MaS levels below threshold had similar survival to those transplanted without a donor biopsy. Conclusions In conjunction with recipient selection, organs with MaS up to 50% may be safely used without detriment to outcomes.	[Steggerda, Justin A.; Bloom, Matthew B.; Brennan, Todd, V; Todo, Tsuyoshi; Nissen, Nicholas N.; Klein, Andrew S.; Kim, Irene K.] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Bloom, Matthew B.] Cedars Sinai Med Ctr, Div Trauma & Crit Care Surg, Los Angeles, CA 90048 USA; [Noureddin, Mazen] Cedars Sinai Med Ctr, Dept Hepatol, Los Angeles, CA 90048 USA; [Brennan, Todd, V; Todo, Tsuyoshi; Nissen, Nicholas N.; Klein, Andrew S.; Kim, Irene K.] Cedars Sinai Med Ctr, Div Transplant Surg, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Kim, IK (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA.; Kim, IK (corresponding author), Cedars Sinai Med Ctr, Div Transplant Surg, Los Angeles, CA 90048 USA.	irene.kim@cshs.org	Bloom, Matthew/E-5660-2013	Bloom, Matthew/0000-0001-8102-4394				ADAM R, 1991, TRANSPLANT P, V23, P1538; Andert A, 2017, HEPATOB PANCREAT DIS, V16, P617, DOI 10.1016/S1499-3872(17)60064-X; Angele MK, 2008, AM J SURG, V195, P214, DOI 10.1016/j.amjsurg.2007.02.023; Baccarani U, 2009, TRANSPL P, V41, P1313, DOI 10.1016/j.transproceed.2009.03.084; Chavin KD, 2013, CLIN TRANSPLANT, V27, P732, DOI 10.1111/ctr.12211; Collett D., 2015, MODELLING SURVIVAL D, DOI DOI 10.1201/B18041; Crowley H, 2000, HUM PATHOL, V31, P1209, DOI 10.1053/hupa.2000.18473; de Graaf EL, 2012, J GASTROEN HEPATOL, V27, P540, DOI 10.1111/j.1440-1746.2011.06844.x; Deroose JP, 2011, HPB, V13, P417, DOI 10.1111/j.1477-2574.2011.00310.x; Doyle MBM, 2010, ARCH SURG-CHICAGO, V145, P653, DOI 10.1001/archsurg.2010.119; El-Badry AM, 2009, ANN SURG, V250, P691, DOI 10.1097/SLA.0b013e3181bcd6dd; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; Gabriel M, 2012, ANN HEPATOL, V11, P891, DOI 10.1016/S1665-2681(19)31415-2; Halon A, 2006, TRANSPLANT P, V38, P193, DOI 10.1016/j.transproceed.2005.11.088; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kim W R, 2019, Am J Transplant, V19 Suppl 2, P184, DOI 10.1111/ajt.15276; Kwon CHD, 2006, TRANSPLANT P, V38, P2106, DOI 10.1016/j.transproceed.2006.07.018; Li J, 2009, TRANSPL P, V41, P3560, DOI 10.1016/j.transproceed.2009.06.222; McCormack L, 2007, ANN SURG, V246, P940, DOI 10.1097/SLA.0b013e31815c2a3f; Neuberger J, 2013, NAT REV GASTRO HEPAT, V10, P328, DOI 10.1038/nrgastro.2013.74; Noujaim HM, 2009, TRANSPLANTATION, V87, P919, DOI 10.1097/TP.0b013e31819b3f76; Pais R, 2016, J HEPATOL, V65, P1245, DOI 10.1016/j.jhep.2016.07.033; Petrowsky H, 2014, ANN SURG, V259, P1186, DOI 10.1097/SLA.0000000000000265; Pezzati D, 2015, WORLD J HEPATOL, V7, P2636, DOI 10.4254/wjh.v7.i26.2636; Rey JW, 2009, TRANSPL P, V41, P2557, DOI 10.1016/j.transproceed.2009.06.121; Spitzer AL, 2010, LIVER TRANSPLANT, V16, P874, DOI 10.1002/lt.22085; Steggerda JA, 2019, TRANSPLANTATION, V103, P122, DOI 10.1097/TP.0000000000002379; TODO S, 1989, TRANSPLANTATION, V47, P903, DOI 10.1097/00007890-198905000-00034; Trevisani F, 1996, J HEPATOL, V24, P114, DOI 10.1016/S0168-8278(96)80195-4; Verran D, 2003, LIVER TRANSPLANT, V9, P500, DOI 10.1053/jlts.2003.50099; Wiesner RH, 2001, LIVER TRANSPLANT, V7, P567, DOI 10.1053/jlts.2001.25879; Wong TCL, 2016, LIVER TRANSPLANT, V22, P226, DOI 10.1002/lt.24335; Wu CJ, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012026; Yersiz H, 2013, LIVER TRANSPLANT, V19, P437, DOI 10.1002/lt.23615	34	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230995	10.1371/journal.pone.0230995	http://dx.doi.org/10.1371/journal.pone.0230995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240235	Green Published, gold			2022-12-26	WOS:000535945000073
J	Xue, YF; Guo, CZ; Hu, F; Zhu, WY; Mao, SY				Xue, Yanfeng; Guo, Changzheng; Hu, Fan; Zhu, Weiyun; Mao, Shengyong			Undernutrition-induced lipid metabolism disorder triggers oxidative stress in maternal and fetal livers using a model of pregnant sheep	FASEB JOURNAL			English	Article						antioxidant capacity; BHBA; mother and fetus; NEFAs; PPARA; RXRA signaling	FATTY-ACIDS ACTIVATE; B SIGNALING PATHWAY; INSULIN-RESISTANCE; MALONALDEHYDE; PATHOGENESIS; DISEASE	This study aimed to evaluate the oxidative status and antioxidant capacity in maternal and fetal livers upon undernutrition as well as the connection between oxidative stress and lipid metabolism disorder. Ten ewes, who were pregnant for 115 days, were restricted to a 30% level of ad libitum feed intake to develop an undernourished model, while another 10 pregnant ewes were fed normally as controls. Undernutrition induced severe lipid metabolism disorder and oxidative stress in blood, maternal liver, and fetal liver. RNA-sequencing data displayed that antioxidant capacity was changed and antioxidant genes were downregulated in maternal and fetal livers of the undernourished model. Non-esterified fatty acids (NEFAs) and beta-hydroxybutyrate (BHBA) levels showed a positive correlation with oxidative indices and negative correlation with the expression of antioxidant genes both in maternal and fetal livers. Primary hepatocytes experiments confirmed that both high levels of NEFAs and BHBA could elicit oxidative stress and decrease antioxidant capacity, and the peroxisome proliferator-activated receptor alpha (PPARA)/retinoid X receptor alpha (RXRA) signaling pathway played a vital role in enhancing antioxidant capacity and relieving oxidative stress. In conclusion, maternal undernutrition induced lipid metabolism disorder, which downregulated antioxidant genes, decreased antioxidant activity, and further triggered oxidative stress both in maternal and fetal livers. Activation of PPARA/RXRA signaling could enhance antioxidant capacity and mitigate oxidative stress. Our findings contribute to protecting the pregnant mother and her fetus from oxidative stress.	[Xue, Yanfeng; Guo, Changzheng; Hu, Fan; Zhu, Weiyun; Mao, Shengyong] Nanjing Agr Univ, Coll Anim Sci & Technol, Jiangsu Key Lab Gastrointestinal Nutr & Anim Hlth, Lab Gastrointestinal Microbiol, Weigang 1, Nanjing 210095, Peoples R China; [Xue, Yanfeng; Guo, Changzheng; Hu, Fan; Zhu, Weiyun; Mao, Shengyong] Nanjing Agr Univ, Natl Expt Teaching Demonstrat Ctr Anim Sci, Natl Ctr Int Res Anim Gut Nutr, Nanjing, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Mao, SY (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Jiangsu Key Lab Gastrointestinal Nutr & Anim Hlth, Lab Gastrointestinal Microbiol, Weigang 1, Nanjing 210095, Peoples R China.	maoshengyong@njau.edu.cn			National Key Research and Development Program of China [2016YFD0501200]	National Key Research and Development Program of China	National Key Research and Development Program of China, Grant/Award Number: 2016YFD0501200	Allen Matthew, 1994, Clinical Materials, V16, P189; Barazzoni R, 2012, DIABETOLOGIA, V55, P773, DOI 10.1007/s00125-011-2396-x; BERTICS SJ, 1992, J DAIRY SCI, V75, P1914, DOI 10.3168/jds.S0022-0302(92)77951-X; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Davis JE, 2009, HORM METAB RES, V41, P523, DOI 10.1055/s-0029-1202852; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; EIFAR AH, 2010, J AM SCI, V6, P742; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; HARTMAN PE, 1983, ENVIRON MUTAGEN, V5, P603, DOI 10.1002/em.2860050409; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Iwersen M, 2013, J DAIRY SCI, V96, P7719, DOI 10.3168/jds.2013-7121; Li XW, 2013, CELL BIOCHEM BIOPHYS, V67, P1157, DOI 10.1007/s12013-013-9629-1; Li XW, 2012, MOL CELL BIOCHEM, V359, P385, DOI 10.1007/s11010-011-1032-x; LOFFLER G, 1988, PHYSL CHEM; MacNee W, 2001, EUR J PHARMACOL, V429, P195, DOI 10.1016/S0014-2999(01)01320-6; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X; Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821; Poulsen LL, 2012, SEMIN CELL DEV BIOL, V23, P631, DOI 10.1016/j.semcdb.2012.01.003; PRYOR WA, 1975, J ORG CHEM, V40, P3615, DOI 10.1021/jo00912a038; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Riserus U, 2008, DIABETES, V57, P332, DOI 10.2337/db07-1318; Roberts CK, 2006, METABOLISM, V55, P928, DOI 10.1016/j.metabol.2006.02.022; Robertson Graham, 2001, American Journal of Physiology, V281, pG1135; Shi XX, 2015, J STEROID BIOCHEM, V145, P103, DOI 10.1016/j.jsbmb.2014.10.014; Shi XX, 2014, CELL PHYSIOL BIOCHEM, V33, P920, DOI 10.1159/000358664; Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5; Song YX, 2014, APOPTOSIS, V19, P984, DOI 10.1007/s10495-014-0982-3; Xu TL, 2018, J AGR FOOD CHEM, V66, P6281, DOI 10.1021/acs.jafc.8b01439; Xue YF, 2019, ANIMAL, V13, P992, DOI 10.1017/S1751731118002136; Xue YF, 2019, FASEB J, V33, P9990, DOI 10.1096/fj.201900406R; Xue YF, 2018, METABOLITES, V8, DOI 10.3390/metabo8040085; Zhang ZG, 2012, VET J, V191, P323, DOI 10.1016/j.tvjl.2011.01.008	34	10	10	4	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6508	6520		10.1096/fj.201902537R	http://dx.doi.org/10.1096/fj.201902537R		MAR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32232897				2022-12-26	WOS:000522486900001
J	Le Du, F; Fujii, T; Kida, K; Davis, DW; Park, M; Liu, DD; Wu, WG; Chavez-MacGregor, M; Barcenas, CH; Valero, V; Tripathy, D; Reuben, JM; Ueno, NT				Le Du, Fanny; Fujii, Takeo; Kida, Kumiko; Davis, Darren W.; Park, Minjeong; Liu, Diane D.; Wu, Weiguo; Chavez-MacGregor, Mariana; Barcenas, Carlos H.; Valero, Vicente; Tripathy, Debu; Reuben, James M.; Ueno, Naoto T.			EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream (R) in patients with breast cancer treated with primary systemic therapy	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; SURVIVAL; PROGRESSION; METASTASIS	Background Tumor cells with a mesenchymal phenotype and/or cancer stem-like cells (CSCs) are known to contribute to metastasis and drug resistance. Circulating tumor cells (CTCs) undergoing epithelial-mesenchymal transition (EMT) and CTCs reflecting a dedifferentiated CSC phenotype may not be detected using only an anti-EpCAM antibody to capture them. We used an antibody-independent CTC enrichment platform, ApoStream (R), which does not rely on any antibody, including anti-EpCAM, to capture EMT- and CSC-CTCs in breast cancer patients who received neoadjuvant chemotherapy and correlated them to pathological complete response (pCR). Methods Blood samples from newly diagnosed breast cancer patients were prospectively collected before neoadjuvant chemotherapy (T-0), after chemotherapy but before surgery (T-1), and after surgery (T-2) and processed using ApoStream. CTCs detected were stained with additional markers to define 3 CTC subsets with the following phenotypes: epithelial CTCs (CK +, EpCAM+ or E-cadherin+), EMT-CTCs (beta- catenin+ or vimentin+), and CSC-CTCs (CD44 + and CD24(low)). Results We enrolled 55 patients, 47 of which had data for analysis. EMT-CTCs were detected in 57%, 62%, and 72% and CSC-CTCs in 9%, 22%, and 19% at the T-0, T-1, and T-2 time points, respectively. Counts of epithelial (P = 0.225) and EMT (P = 0.522) phenotypes of CTCs at T-0 did not significantly predict pCR. Moreover, no correlation between CTC count change and pCR was demonstrated. Conclusions ApoStream was successful in detecting EMT-CTCs among patients after neoadjuvant chemotherapy. However, EMT-/CSC-CTC counts did not correlate with pCR. Due to the small sample size and heterogeneity of this patient population, further study in a larger cohort of molecularly homogeneous patients is warranted.	[Le Du, Fanny; Fujii, Takeo; Kida, Kumiko; Chavez-MacGregor, Mariana; Barcenas, Carlos H.; Valero, Vicente; Tripathy, Debu; Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Sect Translat Breast Canc Res, Houston, TX 77030 USA; [Le Du, Fanny] Eugene Marquis Canc Ctr, Dept Med Oncol, Rennes, France; [Davis, Darren W.; Wu, Weiguo] ApoCell Inc, Houston, TX USA; [Park, Minjeong; Liu, Diane D.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; UNICANCER; Centre Eugene Marquis; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ueno, NT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Sect Translat Breast Canc Res, Houston, TX 77030 USA.	nueno@mdanderson.org	Fujii, Takeo/GYJ-8304-2022; Fujii, Takeo/AAX-4717-2021		Dr. Ueno's grant	Dr. Ueno's grant	Dr. Ueno's grant funded the study. ApoCell provided support in the form of salaries for authors (DWD, WW), but did not have any additional role in the study design, data collection, decision to publish. These authors read and approved the manuscript for submission.	Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Azim HA, 2013, BREAST, V22, P1060, DOI 10.1016/j.breast.2013.08.014; Babayan A, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0533-6; Balasubramanian P, 2015, MOL CANCER THER, V14, pC18, DOI [10.1158/1535-7163.TARG-15-C18, DOI 10.1158/1535-7163.TARG-15-C18]; Balasubramanian P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175414; Balasubramanian P, 2013, MOL CANCER THER, V12, DOI 10.1158/1535-7163.TARG-13-C197; Bidard FC, 2018, JNCI-J NATL CANCER I, V110, P560, DOI 10.1093/jnci/djy018; Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Fujii T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185231; Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907; Gupta V, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4731647; Helissey C, 2015, CANCER LETT, V360, P213, DOI 10.1016/j.canlet.2015.02.010; Kasimir-Bauer S, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0679-3; Kasimir-Bauer S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3099; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Mego M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-014-0507-6; Mego M, 2012, INT J CANCER, V130, P808, DOI 10.1002/ijc.26037; Monteiro J, 2010, EUR J CANCER, V46, P1198, DOI 10.1016/j.ejca.2010.02.030; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P190, DOI 10.1038/nrclinonc.2009.23; Pierga JY, 2017, ANN ONCOL, V28, P103, DOI 10.1093/annonc/mdw535; Riethdorf S, 2010, CLIN CANCER RES, V16, P2634, DOI 10.1158/1078-0432.CCR-09-2042; Rugo HS, 2018, CLIN CANCER RES, V24, P3348, DOI 10.1158/1078-0432.CCR-17-3059; Smerage JB, 2014, J CLIN ONCOL, V32, P3483, DOI 10.1200/JCO.2014.56.2561; Sparano JA, 2019, JNCI-J NATL CANCER I, V111, P339, DOI 10.1093/jnci/djy153; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Thery L, 2019, JNCI CANCER SPECT, V3, DOI 10.1093/jncics/pkz026; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822	34	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0229903	10.1371/journal.pone.0229903	http://dx.doi.org/10.1371/journal.pone.0229903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214335	Green Published, gold			2022-12-26	WOS:000535934200013
J	Edenborough, KM; Mu, A; Muhldorfer, K; Lechner, J; Lander, A; Bokelmann, M; Couacy-Hymann, E; Radonic, A; Kurth, A				Edenborough, Kathryn M.; Mu, Andre; Muehldorfer, Kristin; Lechner, Johanna; Lander, Angelika; Bokelmann, Marcel; Couacy-Hymann, Emmanuel; Radonic, Aleksandar; Kurth, Andreas			Microbiomes in the insectivorous bat species Mops condylurus rapidly converge in captivity	PLOS ONE			English	Article							INFECTION; VIRUS	Bats are well known reservoir hosts for RNA and DNA viruses. The use of captive bats in research has intensified over the past decade as researchers aim to examine the virus-reservoir host interface. In this study, we investigated the effects of captivity on the fecal bacterial microbiome of an insectivorous microbat, Mops condylurus, a species that roosts in close proximity to humans and has likely transmitted viral infections to humans. Using amplicon 16S rRNA gene sequencing, we characterized changes in fecal bacterial community composition for individual bats directly at the time of capture and again after six weeks in captivity. We found that microbial community richness by measure of the number of observed operational taxonomic units (OTUs) in bat feces increases in captivity. Importantly, we found the similarity of microbial community structures of fecal microbiomes between different bats to converge during captivity. We propose a six week-acclimatization period prior to carrying out infection studies or other research influenced by the microbiome composition, which may be advantageous to reduce variation in microbiome composition and minimize biological variation inherent to in vivo experimental studies.	[Edenborough, Kathryn M.; Lander, Angelika; Bokelmann, Marcel; Kurth, Andreas] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany; [Mu, Andre] Univ Melbourne, Peter Doherty Inst, Dept Microbiol & Immunol, Microbiol Diagnost Unit,Publ Hlth Lab, Melbourne, Vic, Australia; [Muehldorfer, Kristin] Leibniz Inst Zoo & Wildlife Res, Dept Wildlife Dis, Berlin, Germany; [Lechner, Johanna; Radonic, Aleksandar] Robert Koch Inst, Methodol & Res Infrastruct, Berlin, Germany; [Couacy-Hymann, Emmanuel] Lab Natl Appui Dev Agr, Bingerville, LANADA, Bingerville, Cote Ivoire; [Edenborough, Kathryn M.] Monash Univ, Inst Vector Borne Dis, Clayton, Vic, Australia	Robert Koch Institute; University of Melbourne; Leibniz Institut fur Zoo und Wildtierforschung; Robert Koch Institute; Monash University	Edenborough, KM (corresponding author), Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany.; Edenborough, KM (corresponding author), Monash Univ, Inst Vector Borne Dis, Clayton, Vic, Australia.	Kat.Edenborough@monash.edu	Edenborough, Kathryn/K-2626-2019	Edenborough, Kathryn/0000-0002-9598-5740; Mu, Andre/0000-0002-0853-9743	RKI	RKI	This publication was financially supported by the RKI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00191-16; Barnard SM, 2009, BATS CAPTIVITY; Carrillo-Araujo M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00447; Chen Y, 2015, BEHAVIOUR, V152, P1083, DOI 10.1163/1568539X-00003269; Clayton JB, 2016, P NATL ACAD SCI USA, V113, P10376, DOI 10.1073/pnas.1521835113; Esposti MD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176573; Dominguez-Diaz C, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00256; Freuling C, 2009, J GEN VIROL, V90, P2493, DOI 10.1099/vir.0.011510-0; Hughes GM, 2018, PEERJ, V6, DOI 10.7717/peerj.4174; Illumina, 2013, PREPARING 16S RIBOSO; Janssen S, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00021-18; Jones EM, 2015, VIRUSES, P7; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kasso M, 2013, ECOLOGICAL EC IMPORT, V2013, P1; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kohl KD, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou009; Kolodny O, 2019, NAT ECOL EVOL, V3, P116, DOI 10.1038/s41559-018-0731-z; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lemieux-Labonte V, 2016, PEERJ, V4, DOI 10.7717/peerj.2430; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McKenzie VJ, 2017, INTEGR COMP BIOL, V57, P690, DOI 10.1093/icb/icx090; Miyoshi J, 2018, PEERJ, V6, DOI 10.7717/peerj.5166; Morton JT, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00162-16; Nearing JT, 2018, PEERJ, V6, DOI 10.7717/peerj.5364; Paweska JT, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020029; Pfeiffer JK, 2016, SCIENCE, V351, DOI 10.1126/science.aad5872; Phillips CD, 2017, INTEGR COMP BIOL, V57, P743, DOI 10.1093/icb/icx011; Saez AM, 2015, EMBO MOL MED, V7, P17, DOI 10.15252/emmm.201404792; Schuh AJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14446; Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336; VENGUST M, 2018, PLOS ONE, V13, DOI DOI 10.1371/journal.pone.0196728; Wang L-F, 2015, BATS VIRUSES NEW FRO, DOI [10.1002/9781118818824, DOI 10.1002/9781118818824]; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Xiao YH, 2019, PEERJ, V7, DOI 10.7717/peerj.6844	34	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0223629	10.1371/journal.pone.0223629	http://dx.doi.org/10.1371/journal.pone.0223629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196505	Green Published, Green Submitted, gold			2022-12-26	WOS:000535303100002
J	Xu, L; Chen, X; Cui, M; Ren, CA; Yu, HY; Gao, W; Li, DG; Zhao, W				Xu, Ling; Chen, Xi; Cui, Ming; Ren, Chuan; Yu, Haiyi; Gao, Wei; Li, Dongguo; Zhao, Wei			The improvement of the shear stress and oscillatory shear index of coronary arteries during Enhanced External Counterpulsation in patients with coronary heart disease	PLOS ONE			English	Article							FRACTIONAL FLOW RESERVE; BLOOD-FLOW; PULSATILE FLOW; FOLLOW-UP; FLUID; BIFURCATION; PRESSURE; ATHEROSCLEROSIS; ANGIOGRAPHY; PATTERNS	Background Enhanced External Counterpulsation (EECP) can chronically relieve ischemic chest pain and improve the prognosis of coronary heart disease (CHD). Despite its role in mitigating heart complications, EECP and the mechanisms behind its therapeutic nature, such as its effects on blood flow hemodynamics, are still not fully understood. This study aims to elucidate the effect of EECP on significant hemodynamic parameters in the coronary arterial tree. Methods A finite volume method was used in conjunction with the inlet pressure wave (surrogated by the measured aortic pressure) before and during EECP and outlet flow resistance, assuming the blood as newtonian fluid. The time-average wall shear stress (TAWSS) and oscillatory shear index (OSI) were determined from the flow field. Results Regardless of the degree of vascular stenosis, hemodynamic conditions and flow patterns could be improved during EECP. In comparison with the original tree, the tree with a severe stenosis (75% area stenosis) demonstrated more significant improvement in hemodynamic conditions and flow patterns during EECP, with surface area ratio of TAWSS risk area (SAR-TAWSS) reduced from 12.3% to 6.7% (vs. SAR-TAWSS reduced from 7.2% to 5.6% in the original tree) and surface area ratio of OSI risk area (SAR-OSI) reduced from 6.8% to 2.5% (vs. SAR-OSI of both 0% before and during EECP in the original tree because of mild stenosis). Moreover, it was also shown that small ratio of diastolic pressure (D) and systolic pressure (S) (D/S) could only improve the hemodynamic condition mildly. The SAR-TAWSS reduction ratio significantly increased as D/S became larger. Conclusions A key finding of the study was that the improvement of hemodynamic conditions along the LMCA trees during EECP became more significant with the increase of D/S and the severity degree of stenoses at the bifurcation site. These findings have important implications on EECP as adjuvant therapy before or after percutaneous coronary intervention (PCI) in patients with diffuse atherosclerosis.	[Xu, Ling; Cui, Ming; Ren, Chuan; Yu, Haiyi; Gao, Wei; Zhao, Wei] Peking Univ, Dept Cardiol, NHC Key Lab Cardiovasc Mol Biol & Regulatory Pept, Hosp 3, Beijing, Peoples R China; [Chen, Xi; Li, Dongguo] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China	Peking University; Capital Medical University	Zhao, W (corresponding author), Peking Univ, Dept Cardiol, NHC Key Lab Cardiovasc Mol Biol & Regulatory Pept, Hosp 3, Beijing, Peoples R China.; Li, DG (corresponding author), Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China.	ldg213@ccmu.edu.cn; beate_vv@bjmu.edu.cn		Gao, Wei/0000-0003-3541-9568; Xu, Ling/0000-0001-8171-5670	National Natural Science Foundation of China [11802187]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This Paper has been partly funded by National Natural Science Foundation of China (Grant No. 81601968, Wei Zhao) and National Natural Science Foundation of China (Grant No. 11802187, Xi Chen).	Braith RW, 2012, EXERC SPORT SCI REV, V40, P145, DOI 10.1097/JES.0b013e318253de5e; CARO CG, 1971, CLIN SCI, V40, pP5; Chatzizisis YS, 2008, CIRCULATION, V117, P993, DOI 10.1161/CIRCULATIONAHA.107.695254; Chen SH, 2018, CMES-COMP MODEL ENG, V116, P149, DOI 10.31614/cmes.2018.04133; Chiastra C, 2017, J BIOMECH, V58, P79, DOI 10.1016/j.jbiomech.2017.04.016; Choy JS, 2008, J APPL PHYSIOL, V104, P1281, DOI 10.1152/japplphysiol.01261.2007; DOLE WP, 1984, CARDIOVASC RES, V18, P548, DOI 10.1093/cvr/18.9.548; Du JH, 2015, MOL CELL BIOMECH, V12, P249; Fan TT, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13487; Fung Y C, 1960, BLOOD FLOW ARTERIES; Gao H, 2009, BRIT J RADIOL, V82, pS46, DOI 10.1259/bjr/20307071; Gijsen F, 2013, J BIOMECH, V46, P240, DOI 10.1016/j.jbiomech.2012.11.006; Gurovich AN, 2013, HYPERTENS RES, V36, P297, DOI 10.1038/hr.2012.169; Huo Y, 2007, AM J PHYSIOL-HEART C, V293, pH2959, DOI 10.1152/ajpheart.00586.2007; Huo YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073769; Huo YL, 2012, J R SOC INTERFACE, V9, P190, DOI 10.1098/rsif.2011.0270; Huo YL, 2009, J APPL PHYSIOL, V107, P500, DOI 10.1152/japplphysiol.91013.2008; Kleinstreuer C, 2001, CRIT REV BIOMED ENG, V29, P1, DOI 10.1615/CritRevBiomedEng.v29.i1.10; KLOCKE FJ, 1981, J CLIN INVEST, V68, P970, DOI 10.1172/JCI110351; Koskinas KC, 2009, CURR OPIN CARDIOL, V24, P580, DOI 10.1097/HCO.0b013e328331630b; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Lefevre T, 2000, CATHETER CARDIO INTE, V49, P274, DOI 10.1002/(SICI)1522-726X(200003)49:3<274::AID-CCD11>3.0.CO;2-N; Li B, 2018, MED BIOL ENG COMPUT, V56, P1959, DOI 10.1007/s11517-018-1834-z; Loh PH, 2008, CLIN CARDIOL, V31, P159, DOI 10.1002/clc.20117; Michaels AD, 2002, CIRCULATION, V106, P1237, DOI 10.1161/01.CIR.0000028336.95629.B0; Nejad AA, 2018, COMPUT METH PROG BIO, V154, P109, DOI 10.1016/j.cmpb.2017.11.016; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012; Ramaswamy SD, 2004, ANN BIOMED ENG, V32, P1628, DOI 10.1007/s10439-004-7816-3; Sankaranarayanan M, 2006, AM J PHYSIOL-HEART C, V291, pH283, DOI 10.1152/ajpheart.01347.2005; Schrauwen JTC, 2016, J BIOMECH, V49, P2127, DOI 10.1016/j.jbiomech.2015.11.036; Spaan JAE, 2006, CIRCULATION, V113, P446, DOI 10.1161/CIRCULATIONAHA.105.587196; Su BY, 2014, COMPUT BIOL MED, V47, P130, DOI 10.1016/j.compbiomed.2014.01.001; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; van der Giessen AG, 2011, J BIOMECH, V44, P1089, DOI 10.1016/j.jbiomech.2011.01.036; Venturini G, 2019, AM J PHYSL CELL PHYS; Zhang B, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0425-9; Zhang JM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/514729; Zhang Y, 2007, CIRCULATION, V116, P526, DOI 10.1161/CIRCULATIONAHA.106.647248; Zhou YF, 1999, PHYS MED BIOL, V44, P2929, DOI 10.1088/0031-9155/44/12/306	41	12	12	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230144	10.1371/journal.pone.0230144	http://dx.doi.org/10.1371/journal.pone.0230144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191730	gold, Green Published			2022-12-26	WOS:000535302300026
J	Zhu, NN; Lu, MJ; Chen, YQ; Jin, XJ; Zhou, X; Wei, HW; Liu, XQ; Duan, LS; Yin, L; Guo, JR				Zhu, Na-Na; Lu, Ming-Jun; Chen, Yong-Quan; Jin, Xiao-Ju; Zhou, Xun; Wei, Han-Wei; Liu, Xiao-Qian; Duan, Li-Shuang; Yin, Lei; Guo, Jian-Rong			Autologous blood transfusion stimulates wound healing in diabetic mice through activation of the HIF-1 alpha pathway by improving the blood preservation solution	FASEB JOURNAL			English	Article						autologous blood transfusion; diabetes; HIF-1 alpha; improved blood preservation solution; wound healing	PROMOTES ANGIOGENESIS; IN-VIVO; EXPRESSION; HIF-1; SURGERY; CELLS	Transfusion of autologous blood is a timesaving, convenient, safe, and effective therapy from a clinical perspective, and often employed for the treatment of diabetic patients. Stabilization of HIF-1 alpha has been widely reported to be a critical factor in the improvement of wound healing in diabetes. Therefore, our study reveals the roles of improved autologous blood in wound healing in diabetes, through autologous blood transfusion in a mouse model. Initially, BALB/c mice were subjected to streptozotocin for diabetic mouse model establishment. Diabetic mice were transfused with improved or standard autologous blood in perfusion culture system. Roles of improved autologous blood in mediating HIF-1 alpha pathway were determined by measuring expression of VEGF, EGF, HIF-1 alpha, and HSP-90. In order to assess the detailed regulatory mechanism of improved autologous blood in perspective of wound healing, cell proliferation, migration and cell cycle, fibroblasts isolated from diabetic mice were transfected with HIF-1 alpha siRNA. Mice transfused with improved autologous blood exhibited increased levels of CD31 and alpha-SMA in skin tissues, and reduced TNF-alpha, IL-1 beta, and IL-6 levels, indicating that improved autologous blood promoted wound healing ability and reduced the release of inflammatory factors. Diabetic mice transfused with improved autologous blood presented activated HIF-1 alpha pathway. The survival rate, proliferation, and migration of fibroblasts were elevated via activation of the HIF-1 alpha pathway. Taken together, improved blood preservation solution could enhance the oxygen carrying capacity of red blood cells and wound healing in mice with diabetes, which is achieved through regulation of HIF-1 alpha pathway.	[Zhu, Na-Na; Lu, Ming-Jun; Zhou, Xun; Liu, Xiao-Qian; Duan, Li-Shuang; Yin, Lei; Guo, Jian-Rong] Second Mil Med Univ, Gongli Hosp, Dept Anesthesiol, 219 Miaopu Rd, Shanghai 200135, Peoples R China; [Chen, Yong-Quan; Jin, Xiao-Ju; Wei, Han-Wei] Wannan Med Coll, Yijishan Hosp, Dept Anesthesiol, Wuhu, Peoples R China; [Zhou, Xun; Guo, Jian-Rong] Ningxia Med Univ, Gongli Hosp, Shanghai Pudong New Area Training Base, Shanghai, Peoples R China	Naval Medical University; Wannan Medical College; Ningxia Medical University	Guo, JR (corresponding author), Second Mil Med Univ, Gongli Hosp, Dept Anesthesiol, 219 Miaopu Rd, Shanghai 200135, Peoples R China.	g_jianrong@yeah.net						Badr G, 2016, J CELL PHYSIOL, V231, P2159, DOI 10.1002/jcp.25328; Chen QY, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9726503; Deppe J, 2016, ARCH TOXICOL, V90, P1141, DOI 10.1007/s00204-015-1549-y; Dumont LJ, 2009, TRANSFUSION, V49, P458, DOI 10.1111/j.1537-2995.2008.02038.x; FONG YM, 1994, AM J SURG, V167, P256, DOI 10.1016/0002-9610(94)90087-6; Galeano M, 2004, DIABETES, V53, P2509, DOI 10.2337/diabetes.53.9.2509; Guo JR, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0290-6; Heun Y, 2017, MOL THER, V25, P1616, DOI 10.1016/j.ymthe.2017.04.007; Khamaisi M, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2929; Lacci Kathleen M., 2010, Yale Journal of Biology and Medicine, V83, P1; Li SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171081; Ma HS, 2016, CHIN J TRAUMATOL, V19, P371, DOI 10.1016/j.cjtee.2016.04.007; Mace KA, 2007, WOUND REPAIR REGEN, V15, P636, DOI 10.1111/j.1524-475X.2007.00278.x; Mao ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep20084; Marrotte EJ, 2010, J CLIN INVEST, V120, P4207, DOI 10.1172/JCI36858; Morgan TM, 2013, UROL ONCOL-SEMIN ORI, V31, P871, DOI 10.1016/j.urolonc.2011.07.012; Pawaskar A, 2017, KNEE SURG SPORT TR A, V25, P2957, DOI 10.1007/s00167-016-4116-z; Pesce M, 2013, EUR CYTOKINE NETW, V24, P1, DOI 10.1684/ecn.2013.0332; Piccin A, 2015, BLOOD TRANSFUS, V14, P1; Piccin A, 2017, BLOOD TRANSFUS, V15, P1, DOI DOI 10.2450/2016.0058-16; Piccin A, 2017, TRANSFUSION, V57, P2220, DOI 10.1111/trf.14205; Piccin A, 2016, REGEN MED, V11, P459, DOI 10.2217/rme-2016-0031; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shabbir A, 2015, STEM CELLS DEV, V24, P1635, DOI 10.1089/scd.2014.0316; Shen KK, 2012, BIOCHEM PHARMACOL, V84, P784, DOI 10.1016/j.bcp.2012.05.024; Sugimoto T, 2014, BLOOD TRANSFUS-ITALY, V12, pS209, DOI 10.2450/2013.0271-12; Sunkari VG, 2015, WOUND REPAIR REGEN, V23, P98, DOI 10.1111/wrr.12253; Suthar M, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0324-1; Vishwakarma S, 2017, INDIAN J HEMATOL BLO, V33, P293, DOI 10.1007/s12288-016-0715-6; Vogler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069128; Wang CG, 2018, ACTA PHARMACOL SIN, V39, P393, DOI 10.1038/aps.2017.161; Wang H, 2017, ONCOTARGET, V8; Wang HY, 2016, ONCOTARGET, V7, P20193, DOI 10.18632/oncotarget.7935; Zhang JJ, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0306-2; Zhou J, 2016, BRAZ J MED BIOL RES, V49, DOI [10.1590/1414-431X20165493, 10.1590/1414-431x20165493]	35	3	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6038	6054		10.1096/fj.201900324RRR	http://dx.doi.org/10.1096/fj.201900324RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32202355				2022-12-26	WOS:000531325500006
J	Burgess, TL; Amason, JD; Rubin, JS; Duveau, DY; Lamy, L; Roberts, DD; Farrell, CL; Inglese, J; Thomas, CJ; Miller, TW				Burgess, Teresa L.; Amason, Joshua D.; Rubin, Jeffrey S.; Duveau, Damien Y.; Lamy, Laurence; Roberts, David D.; Farrell, Catherine L.; Inglese, James; Thomas, Craig J.; Miller, Thomas W.			A homogeneous SIRP alpha-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncology	PLOS ONE			English	Article							SIGNAL-REGULATORY-PROTEIN; ALPHA SIRP-ALPHA; CD47 BLOCKADE; CANCER; IMMUNOSURVEILLANCE; NIVOLUMAB	CD47 is an immune checkpoint protein that downregulates both the innate and adaptive antitumor immune response via its counter receptor SIRP alpha. Biologics, including humanized CD47 monoclonal antibodies and decoy SIRP alpha receptors, that block the SIRP alpha-CD47 interaction, are currently being developed as cancer immunotherapy agents. However, adverse side effects and limited penetration of tumor tissue associated with their structure and large size may impede their clinical application. We recently developed a quantitative high throughput screening assay platform to identify small molecules that disrupt the binding of SIRP alpha and CD47 as an alternative approach to these protein-based therapeutics. Here, we report on the development and optimization of a cell-based binding assay to validate active small molecules from our biochemical screening effort. This assay has a low volume, high capacity homogenous format that relies on laser scanning cytometry (LSC) and associated techniques to enhance signal to noise measurement of cell surface binding. The LSC assay is specific, concentration dependent, and validated for the two major human SIRP alpha variants (V1 and V2), with results that parallel those of our biochemical data as well as published studies. We also utilized the LSC assay to confirm published studies showing that the inhibition of amino-terminal pyroglutamate formation on CD47 using the glutaminyl cyclase inhibitor SEN177 disrupts SIRP alpha binding. The SIRP alpha-CD47 interaction could be quantitatively measured in live and fixed tumor cells. Use of fixed cells reduces the burden of cell maintenance and provides stable cell standards to control for inter-and intra-assay variations. We also demonstrate the utility of the assay to characterize the activity of the first reported small molecule antagonists of the SIRP alpha-CD47 interaction. This assay will support the screening of thousands of compounds to identify or validate active small molecules as hits, develop structure activity relationships and assist in the optimization of hits to leads by a typical iterative medicinal chemistry campaign.	[Burgess, Teresa L.; Amason, Joshua D.; Rubin, Jeffrey S.; Farrell, Catherine L.; Miller, Thomas W.] Paradigm Shift Therapeut LLC, Rockville, MD 20850 USA; [Amason, Joshua D.; Roberts, David D.; Miller, Thomas W.] NCI, Lab Pathol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Duveau, Damien Y.; Lamy, Laurence; Inglese, James; Thomas, Craig J.] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Studies, Rockville, MD USA; [Amason, Joshua D.] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC USA; [Miller, Thomas W.] Inst Paoli Calmettes, Canc Res Ctr Marseille, Marseille, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; Duke University; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Miller, TW (corresponding author), Paradigm Shift Therapeut LLC, Rockville, MD 20850 USA.; Miller, TW (corresponding author), NCI, Lab Pathol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.; Miller, TW (corresponding author), Inst Paoli Calmettes, Canc Res Ctr Marseille, Marseille, France.	thomas.miller@pstherx.com	Miller, Thomas W/G-1215-2011; Roberts, David D./A-9699-2008	Miller, Thomas W/0000-0001-8645-2785; Roberts, David D./0000-0002-2481-2981; Thomas, Craig/0000-0001-9386-9001	Avon Foundation for Women [02-2015-045, 022014-051, 02-2015-095, 02-2017-034]; National Cancer Institute [1U01CA218259-01A1]; NCI [ZIASC009172]; NCATS [1ZIATR000053-03]	Avon Foundation for Women; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the Avon Foundation for Women (02-2015-045, 022014-051, 02-2015-095, 02-2017-034; TWM, TLB, CLF), the National Cancer Institute (1U01CA218259-01A1; TWM, TLB, CLF, JSR) the Intramural Research Programs of NCATS (Project 1ZIATR000053-03, JI) and NCI (Project ZIASC009172, DDR). The funder provided support in the form of salaries for authors [TWM, JDA, TLB, CLF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Advani R, 2018, NEW ENGL J MED, V379, P1711, DOI 10.1056/NEJMoa1807315; Ansell S, 2016, BLOOD, V128; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Eckelman B, 2017, Patent No. [US9663575B2, 9663575]; Edris B, 2012, P NATL ACAD SCI USA, V109, P6656, DOI 10.1073/pnas.1121629109; England E, 2015, J BIOMOL SCREEN, V20, P536, DOI 10.1177/1087057114557776; Farina MS, 2017, DRUGS, V77, P1077, DOI 10.1007/s40265-017-0748-7; Feliz-Mosquea YR, 2018, BREAST CANCER RES TR, V172, P69, DOI 10.1007/s10549-018-4884-x; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Garrido F, 1997, IMMUNOL TODAY, V18, P89, DOI 10.1016/S0167-5699(96)10075-X; Gedye CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105602; Gettinger S, 2016, J CLIN ONCOL, V34, P2980, DOI 10.1200/JCO.2016.66.9929; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Hatherley D, 2014, J BIOL CHEM, V289, P10024, DOI 10.1074/jbc.M114.550558; Hdeib Alia, 2015, CNS Oncol, V4, P63, DOI 10.2217/cns.14.54; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jimenez-Sanchez M, 2015, NAT CHEM BIOL, V11, P347, DOI [10.1038/nchembio.1790, 10.1038/NCHEMBIO.1790]; Lim WA, 2017, CELL, V168, P724, DOI 10.1016/j.cell.2017.01.016; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137345; Liu XJ, 2015, NAT MED, V21, P1209, DOI 10.1038/nm.3931; Logtenberg MEW, 2019, NAT MED, V25, P612, DOI 10.1038/s41591-019-0356-z; Maxhimer JB, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000139; Miller TW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218897; Miraglia S, 1999, J BIOMOL SCREEN, V4, P193, DOI 10.1177/108705719900400407; Murata Y, 2018, CANCER SCI, V109, P2349, DOI 10.1111/cas.13663; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Pietsch EC, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.7; Pozzi C, 2018, J BIOL INORG CHEM, V23, P1219, DOI 10.1007/s00775-018-1605-1; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Schwartz AL, 2019, CANCER IMMUNOL IMMUN, V68, P1805, DOI 10.1007/s00262-019-02397-7; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Sikic BI, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.3019; Smyth MJ, 2001, NAT IMMUNOL, V2, P293, DOI 10.1038/86297; Sockolosky JT, 2016, P NATL ACAD SCI USA, V113, pE2646, DOI 10.1073/pnas.1604268113; Soto-Pantoja DR, 2015, CRIT REV BIOCHEM MOL, V50, P212, DOI 10.3109/10409238.2015.1014024; Soto-Pantoja DR, 2014, CANCER RES, V74, P6771, DOI 10.1158/0008-5472.CAN-14-0037-T; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Van VQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041972; Zhang M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153550; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108; Zuck P, 1999, P NATL ACAD SCI USA, V96, P11122, DOI 10.1073/pnas.96.20.11122	46	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0226661	10.1371/journal.pone.0226661	http://dx.doi.org/10.1371/journal.pone.0226661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240171	Green Published, Green Submitted, gold			2022-12-26	WOS:000535945000008
J	Mcarley, TJ; Hickey, AJR; Herbert, NA				Mcarley, Tristan J.; Hickey, Anthony J. R.; Herbert, Neill A.			Acute high temperature exposure impairs hypoxia tolerance in an intertidal fish	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSES; WARM ACCLIMATION; STRESSORS; OXYGEN; ADAPTATION; GROWTH; SHIFTS	Acute heat shock has previously been shown to improve subsequent low O2 (hypoxia) tolerance in an intertidal fish species, a process known as cross-tolerance, but it is not known whether this is a widespread phenomenon. This study examined whether a rock pool specialist, the triplefin fish Bellapiscis medius, exhibits heat shock induced cross-tolerance to hypoxia, i.e., longer time to loss of equilibrium (LOE) and lower critical O-2 saturation (S-crit) after recovering from an acute heat challenge. Non-heat shock controls had a median time to loss of equilibrium (LOE50) of 54.4 min under severe hypoxia (7% of air saturation) and a S-crit of 15.8% air saturation. Contrary to expectations, however, treatments that received an 8 or 10 degrees C heat shock showed a significantly shorter LOE50 in hypoxia (+8 degrees C = 41.5 min; +10 degrees C = 28.7 min) and no significant change in S-crit (+8 degrees C = 17.0% air saturation; +10 degrees C = 18.3% of air saturation). Thus, there was no evidence of heat shock induced cross-tolerance to hypoxia in B. medius because exposure to acute heat shock impaired hypoxia tolerance.	[Mcarley, Tristan J.; Herbert, Neill A.] Univ Auckland, Inst Marine Sci, Leigh, New Zealand; [Hickey, Anthony J. R.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand	University of Auckland; University of Auckland	Mcarley, TJ (corresponding author), Univ Auckland, Inst Marine Sci, Leigh, New Zealand.	tmca008@aucklanduni.ac.nz		McArley, Tristan/0000-0002-5248-2828	University of Auckland Scholarship Office	University of Auckland Scholarship Office	T.J.M. would like to acknowledge support from the University of Auckland Scholarship Office for doctoral funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila K, 2015, J EXP BIOL, V218, P1471, DOI 10.1242/jeb.119115; Behrens JW, 2007, MAR BIOL, V150, P1365, DOI 10.1007/s00227-006-0456-4; Claireaux G, 2016, J FISH BIOL, V88, P232, DOI 10.1111/jfb.12833; Clark TD, 2008, AM J PHYSIOL-REG I, V295, pR1631, DOI 10.1152/ajpregu.90461.2008; Cook DG, 2013, J EXP BIOL, V216, P369, DOI 10.1242/jeb.073023; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Cumming H, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow033; Devor DP, 2016, PHYSIOL BIOCHEM ZOOL, V89, P1, DOI 10.1086/684812; Gunderson AR, 2016, ANNU REV MAR SCI, V8, P357, DOI 10.1146/annurev-marine-122414-033953; Hilton Z, 2008, FUNCT ECOL, V22, P1108, DOI 10.1111/j.1365-2435.2008.01465.x; Hilton Z, 2010, J COMP PHYSIOL B, V180, P979, DOI 10.1007/s00360-010-0477-7; HUGGETT J, 1986, MAR ECOL PROG SER, V29, P189, DOI 10.3354/meps029189; Khan JR, 2014, AQUACULTURE, V430, P107, DOI 10.1016/j.aquaculture.2014.03.046; Legrand E, 2018, REG STUD MAR SCI, V17, P1, DOI 10.1016/j.rsma.2017.11.003; Mandic M, 2013, PHYSIOL BIOCHEM ZOOL, V86, P92, DOI 10.1086/667938; Mandic M, 2009, P ROY SOC B-BIOL SCI, V276, P735, DOI 10.1098/rspb.2008.1235; McArley TJ, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.189993; McArley TJ, 2017, J EXP BIOL, V220, P3527, DOI 10.1242/jeb.162099; McBryan TL, 2013, INTEGR COMP BIOL, V53, P648, DOI 10.1093/icb/ict066; McBryan TL, 2016, J EXP BIOL, V219, P474, DOI 10.1242/jeb.133413; MORRIS S, 1983, ESTUAR COAST SHELF S, V17, P339, DOI 10.1016/0272-7714(83)90026-4; Norin T, 2014, J EXP BIOL, V217, P244, DOI 10.1242/jeb.089755; Perkins SE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053361; Richards JG, 2011, J EXP BIOL, V214, P191, DOI 10.1242/jeb.047951; Rogers NJ, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow012; Schurmann H, 1997, J FISH BIOL, V50, P1166, DOI 10.1006/jfbi.1997.0387; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Speers-Roesch B, 2013, J EXP MAR BIOL ECOL, V449, P239, DOI 10.1016/j.jembe.2013.10.006; Todgham AE, 2005, PHYSIOL BIOCHEM ZOOL, V78, P133, DOI 10.1086/425205; Todgham AE, 2013, INTEGR COMP BIOL, V53, P539, DOI 10.1093/icb/ict086; TRUCHOT JP, 1980, RESP PHYSIOL, V39, P241, DOI 10.1016/0034-5687(80)90056-0	31	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0231091	10.1371/journal.pone.0231091	http://dx.doi.org/10.1371/journal.pone.0231091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240240	gold, Green Published			2022-12-26	WOS:000535945000092
J	Shafie, AA; Supian, A; Hassali, MAA; Ngu, LH; Thong, MK; Ayob, H; Chaiyakunapruk, N				Shafie, Asrul Akmal; Supian, Azuwana; Hassali, Mohamed Azmi Ahmad; Ngu, Lock-Hock; Thong, Meow-Keong; Ayob, Hatijah; Chaiyakunapruk, Nathorn			Rare disease in Malaysia: Challenges and solutions	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; INBORN ERROR; ORPHAN DRUGS; PILOT	Objective Rare diseases are often underdiagnosed, and their management is frequently complicated by a lack of access to treatment and information about the diseases. To allow for better policy planning, we sought to examine the current status of managing rare diseases in Malaysia. Methods This study was conducted in two phases. In the first phase, we triangulated information from reviews of journal publications, documents from the Malaysian government and in-depth interviews among selected key healthcare stakeholders in Malaysia. The second phase was designed as a cross-sectional survey to estimate the number of cases and treatment coverage for rare diseases in Malaysia. Results Malaysia has no official definition of rare disease yet but currently in the process of reviewing them for Malaysia. There are 13 rare disease specialists and a dozen medical doctors in genetic clinics around Malaysia, mainly in public health facilities. From the survey, 1,249 patients were diagnosed with rare diseases in public hospitals. Only 60% received their medications or supplements, and the rest continued with symptomatic treatment. Conclusion Generally, Malaysia has made significant progress in the management of rare diseases, but there are still opportunities for development in critical areas. Ultimately, if all healthcare providers, government, society, and politicians work together to manage rare diseases, we will see an improvement in patient outcomes.	[Shafie, Asrul Akmal; Supian, Azuwana; Hassali, Mohamed Azmi Ahmad] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Social & Adm Pharm, Minden, Penang, Malaysia; [Supian, Azuwana] Minist Hlth Malaysia, Pharmaceut Serv Div, Petaling Jaya, Selangor, Malaysia; [Ngu, Lock-Hock] Hosp Kuala Lumpur, Genet Clin, Kuala Lumpur, Malaysia; [Thong, Meow-Keong] Univ Malaya, Fac Med, Dept Paediat, Genet & Metab Unit, Kuala Lumpur, Malaysia; [Ayob, Hatijah] Malaysian Rare Disorders Soc, Petaling Jaya, Selangor, Malaysia; [Chaiyakunapruk, Nathorn] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA	Universiti Sains Malaysia; Kementerian Kesihatan Malaysia; Universiti Malaya; Utah System of Higher Education; University of Utah	Shafie, AA (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Social & Adm Pharm, Minden, Penang, Malaysia.	aakmal@usm.my	Ngu, Lock-Hock/Y-6055-2019; Ngu, Lock Hock/R-4473-2019; Thong, Meow-Keong/B-9960-2010; Shafie, Asrul/F-7026-2010	Thong, Meow-Keong/0000-0002-7288-7910; Ngu, Lock Hock/0000-0002-2396-1686; Shafie, Asrul/0000-0002-5629-9270; Chaiyakunapruk, Nathorn/0000-0003-4572-8794				Almalki ZS, 2012, INTRACTABLE RARE DIS, V1, P139, DOI 10.5582/irdr.2012.v1.4.139; [Anonymous], 2018, LANCET CHILD ADOLESC, V2, P543, DOI 10.1016/S2352-4642(18)30211-6; Ayme S, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0251-8; Bearryman E., 2016, DOES YOUR RARE DIS H; Budych K, 2012, HEALTH POLICY, V105, P154, DOI 10.1016/j.healthpol.2012.02.018; Byrne P, 2012, ORPHANET J RARE D S2, DOI [10.1186/1750-1172-7-S2-A15, DOI 10.1186/1750-1172-7-S2-A15]; Cohen JS, 2010, AM J MED GENET A, V152A, P1136, DOI 10.1002/ajmg.a.33380; Denis A., 2009, POLICIES RARE DIS OR, P132; Department of Health UK, 2013, UK STRAT RAR DIS, P40; Esquivel-Sada D, 2018, J COMMUN GENET, V9, P37, DOI 10.1007/s12687-017-0320-x; Field M. J., 2010, ACC RES DEV RAR DIS; Gliklich RE, 2014, REGISTRIES EVALUATIN; Kaplan W., 2013, PRIORITY MED EUROPE; Lee JMH, 2013, J GENET COUNS, V22, P911, DOI 10.1007/s10897-013-9589-z; Leong YH, 2014, MALAYS J MED SCI, V21, P64; Lim JS, 2014, MOL GENET METAB, V113, P53, DOI 10.1016/j.ymgme.2014.07.018; Malaysia Lysosomal Diseases Association, 2016, RM 1 EV LIF COUNTS; Malaysian Rare Disorders Society, 2013, RAR DIS; Ministry of Health Malaysia, 2012, GUID TREATM LYS STOR; Ministry of Health Malaysia, 2012, MAL NAT MED POL 2012; National Pharmaceutical Regulatory Agency, 2016, DRUG REG GUID DOC DR; Orphanet, 1997, ONL DAT RAR DIS ORPH; Rath A, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2287-7; Song PP, 2012, INTRACTABLE RARE DIS, V1, P3, DOI 10.5582/irdr.2012.v1.1.3; Song PP, 2012, BIOSCI TRENDS, V6, P48, DOI 10.5582/bst.2012.v6.2.48; Teerawattananon Y, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i244; Teerawattananon Y, 2014, Z EVIDENZ FORTBILD Q, V108, P397, DOI 10.1016/j.zefq.2014.06.017; The European Parliament and of The Council of the European Union Regulation (EC) No 141/2000 of The European Parliament and of The Council of 16 December 1999 on orphan medicinal products, 2000, J EUROPEAN COMMUNITI, P1; Thong Meow Keong, 2008, Ann Acad Med Singap, V37, P66; United Nations Development Programme, 2016, H CLARK WRITT STAT 1; World Health Organisation, 2007, STRENGTH HLTH SYST I; Yoon HR, 2005, CLIN CHIM ACTA, V354, P167, DOI 10.1016/j.cccn.2004.11.032; Yunus ZM, 2016, J PEDIATR ENDOCR MET, V29, P1031, DOI 10.1515/jpem-2016-0028	33	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230850	10.1371/journal.pone.0230850	http://dx.doi.org/10.1371/journal.pone.0230850			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240232	gold, Green Published			2022-12-26	WOS:000535945000047
J	Goldfine, H				Goldfine, Howard			Life without air	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						lipid; acyl carrier protein (ACP); plasmalogen; anaerobiosis; Clostridium; cyclopropane fatty acids; lipidomes; Listeria	MEMBRANE-LIPID-COMPOSITION; CYCLOPROPANE FATTY-ACIDS; LISTERIA-MONOCYTOGENES; PHOSPHOLIPASE-C; CLOSTRIDIUM-BUTYRICUM; ESCHERICHIA-COLI; OUTER-MEMBRANE; CRYSTAL-STRUCTURE; PHASE-BEHAVIOR; BIOSYNTHESIS	An early exposure to lipid biochemistry in the laboratory of Konrad Bloch resulted in a fascination with the biosynthesis, structures, and functions of bacterial lipids. The discovery of plasmalogens (1-alk-1?-enyl, 2-acyl phospholipids) in anaerobic Gram-positive bacteria led to studies on the physical chemistry of these lipids and the cellular regulation of membrane lipid polymorphism in bacteria. Later studies in several laboratories showed that the formation of the alk-1-enyl ether bond involves an aerobic process in animal cells and thus is fundamentally different from that in anaerobic organisms. Our work provides evidence for an anaerobic process in which plasmalogens are formed from their corresponding diacyl lipids. Studies on the roles of phospholipases in Listeria monocytogenes revealed distinctions between its phospholipases and those previously discovered in other bacteria and showed how the Listeria enzymes are uniquely fitted to the intracellular lifestyle of this significant human pathogen.	[Goldfine, Howard] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Goldfine, H (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	goldfinh@pennmedicine.upenn.edu						AMES GF, 1974, J BACTERIOL, V117, P406, DOI 10.1128/JB.117.2.406-416.1974; Bannam T, 1999, INFECT IMMUN, V67, P182, DOI 10.1128/IAI.67.1.182-186.1999; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; BAUMANN NA, 1965, J BIOL CHEM, V240, P1559; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; BROQUIST HP, 1951, J BIOL CHEM, V188, P431; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Dowhan W, 2017, J BIOL CHEM, V292, P10755, DOI 10.1074/jbc.X117.794891; GANDHI AJ, 1993, J BACTERIOL, V175, P8014, DOI 10.1128/JB.175.24.8014-8017.1993; GEOFFROY C, 1991, INFECT IMMUN, V59, P2382, DOI 10.1128/IAI.59.7.2382-2388.1991; GOLDFINE H, 1971, J LIPID RES, V12, P214; GOLDFINE H, 1987, BIOCHEMISTRY-US, V26, P2814, DOI 10.1021/bi00384a024; GOLDFINE H, 1960, J BIOL CHEM, V235, P2238; GOLDFINE H, 1995, P NATL ACAD SCI USA, V92, P2979, DOI 10.1073/pnas.92.7.2979; GOLDFINE H, 1993, J BACTERIOL, V175, P4298, DOI 10.1128/JB.175.14.4298-4306.1993; GOLDFINE H, 1992, INFECT IMMUN, V60, P4059, DOI 10.1128/IAI.60.10.4059-4067.1992; GOLDFINE H, 1987, BIOCHIM BIOPHYS ACTA, V904, P283, DOI 10.1016/0005-2736(87)90377-4; GOLDFINE H, 1958, J BIOL CHEM, V232, P577; GOLDFINE H, 1961, J BIOL CHEM, V236, P2596; Goldfine H, 2017, FEBS LETT, V591, P2714, DOI 10.1002/1873-3468.12714; Guan ZQ, 2019, LIPIDS, V54, P423, DOI 10.1002/lipd.12181; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P186, DOI 10.1016/j.bbalip.2010.12.010; HAGEN PO, 1967, J BIOL CHEM, V242, P5700; HARLEY JB, 1978, J BACTERIOL, V134, P808, DOI 10.1128/JB.134.3.808-820.1978; HECHEMY K, 1971, BIOCHEM BIOPH RES CO, V42, P245, DOI 10.1016/0006-291X(71)90094-5; Heine A, 2014, PROTEINS, V82, P2041, DOI 10.1002/prot.24557; ISRAELACHVILI JN, 1980, Q REV BIOPHYS, V13, P121, DOI 10.1017/S0033583500001645; JOHNSTON NC, 1985, BIOCHIM BIOPHYS ACTA, V813, P10, DOI 10.1016/0005-2736(85)90339-6; Johnston NC, 2010, J LIPID RES, V51, P1953, DOI 10.1194/jlr.M004788; KAUFMAN AE, 1988, J BACTERIOL, V170, P2770, DOI 10.1128/jb.170.6.2770-2774.1988; KOGA Y, 1984, J BACTERIOL, V159, P597, DOI 10.1128/JB.159.2.597-604.1984; Konovalova A, 2017, ANNU REV MICROBIOL, V71, P539, DOI 10.1146/annurev-micro-090816-093754; KOPLOW J, 1974, J BACTERIOL, V117, P527, DOI 10.1128/JB.117.2.527-543.1974; LOHNER K, 1984, CHEM PHYS LIPIDS, V34, P163, DOI 10.1016/0009-3084(84)90041-0; LUEKING DR, 1975, J BIOL CHEM, V250, P8530; MALTHANER M, 1987, BIOCHEMISTRY-US, V26, P5826, DOI 10.1021/bi00392a037; MALTHANER M, 1987, BIOCHIM BIOPHYS ACTA, V900, P191, DOI 10.1016/0005-2736(87)90333-6; MARINARI LA, 1974, BIOCHEMISTRY-US, V13, P1978, DOI 10.1021/bi00706a030; McIntyre TM, 2008, N COMP BIOC, P245, DOI 10.1016/B978-044453219-0.50011-8; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Moser J, 1997, J MOL BIOL, V273, P269, DOI 10.1006/jmbi.1997.1290; Poussin MA, 2009, MICROB PATHOGENESIS, V46, P1, DOI 10.1016/j.micpath.2008.09.008; Rilfors L, 2002, COLLOID SURFACE B, V26, P112, DOI 10.1016/S0927-7765(01)00310-1; Rilfors L, 1993, Subcell Biochem, V20, P109; ROONEY SA, 1972, J BACTERIOL, V111, P531, DOI 10.1128/JB.111.2.531-541.1972; SCHEUERBRANDT G, 1961, J BIOL CHEM, V236, pPC70; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Spiering MJ, 2019, J BIOL CHEM, V294, P14876, DOI 10.1074/jbc.CL119.010972; Tian B, 2013, BBA-MOL CELL BIOL L, V1831, P1185, DOI 10.1016/j.bbalip.2013.03.005; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Wadsworth SJ, 1999, INFECT IMMUN, V67, P1770; Wadsworth SJ, 2002, INFECT IMMUN, V70, P4650, DOI 10.1128/IAI.70.8.4650-4660.2002; Wei ZY, 2005, INFECT IMMUN, V73, P6639, DOI 10.1128/IAI.73.10.6639-6646.2005; Wei ZY, 2005, P NATL ACAD SCI USA, V102, P12927, DOI 10.1073/pnas.0501725102; WIESLANDER A, 1986, BIOCHEMISTRY-US, V25, P7511, DOI 10.1021/bi00371a038; ZALKIN H, 1963, J BIOL CHEM, V238, P1242; Zhang YM, 2008, J LIPID RES, V49, P1867, DOI 10.1194/jlr.R800005-JLR200; Zuckert WR, 1998, INFECT IMMUN, V66, P4823	59	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2020	295	13					4124	4133		10.1074/jbc.X120.013022	http://dx.doi.org/10.1074/jbc.X120.013022			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KZ7MI	32221031	Green Published, hybrid			2022-12-26	WOS:000523442500006
J	Bwalya, P; Hang'ombe, BM; Gamil, AA; Munang'andu, HM; Evensen, O; Mutoloki, S				Bwalya, Patricia; Hang'ombe, Bernard M.; Gamil, Amr A.; Munang'andu, Hetron M.; Evensen, Oystein; Mutoloki, Stephen			A whole-cell Lactococcus garvieae autovaccine protects Nile tilapia against infection	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; SALMO-SALAR L.; RAINBOW-TROUT; INTRAPERITONEAL INJECTION; ENTEROCOCCUS-SERIOLICIDA; FISH; VACCINES; SYSTEMS	The autovaccine was produced in-house using a bacterial isolate from a diseased fish from the target farm. Three groups of 150 fish each were injected with either 1) an oil-adjuvanted, inactivated whole cell autovaccine, 2) adjuvant only or 3) PBS (negative control). Approximately 660 degree days post vaccination, the fish were challenged with 9x10(5) cfu bacteria/fish by intraperitoneal injection and monitored for a further 28 days. Protection against infections was measured by lack of/reduced bacterial loads both by bacterial re-isolation and immunohistochemistry as well as absence of clinical signs/pathology. Significantly less L. garvieae (p<0.03) was re-isolated from either the adjuvant only or control groups compared to the vaccinated group. Furthermore, a significantly high amount (p<0.001) of anti-L. garvieae specific antibodies were observed in the vaccinated group compared to the adjuvant only or control groups at time of challenge. This coincided with protection against infection measured by absence/reduced L. garvieae re-isolation from internal organs, reduced clinical signs and lack of pathology in this group. In the adjuvant only and control groups, bacteria were re-isolated from the kidney, liver, spleen, brain and eyes during the first 14 days. The findings suggest that oil-based vaccines can protect tilapia against L. garvieae infection through an antibody mediated response.	[Bwalya, Patricia; Gamil, Amr A.; Munang'andu, Hetron M.; Evensen, Oystein; Mutoloki, Stephen] Norwegian Univ Life Sci, Fac Vet Med, Oslo, Norway; [Bwalya, Patricia; Hang'ombe, Bernard M.] Univ Zambia, Samora Machel Sch Vet Med, Lusaka, Zambia; [Bwalya, Patricia] Minist Fisheries & Livestock, Dept Vet & Livestock Serv, Lusaka, Zambia	Norwegian University of Life Sciences; University of Zambia	Mutoloki, S (corresponding author), Norwegian Univ Life Sci, Fac Vet Med, Oslo, Norway.	stephen.mutoloki@nmbu.no	Munang'andu, Hetron Mweemba/C-5926-2014	Munang'andu, Hetron Mweemba/0000-0002-1021-6396; Gamil, Amr/0000-0001-9920-6487	Nowergian Agency for Development Cooperation (NORAD) under the NORHED program [TAN-13/0027]	Nowergian Agency for Development Cooperation (NORAD) under the NORHED program	This work was supported by the Nowergian Agency for Development Cooperation (NORAD) under the NORHED program (TAN-13/0027).	Avci H, 2014, J FISH DIS, V37, P481, DOI 10.1111/jfd.12132; Bastardo A, 2012, FISH SHELLFISH IMMUN, V32, P756, DOI 10.1016/j.fsi.2012.01.028; Bwalya P, 2017, CHALLENGE MODEL LACT; Bwalya P, 2020, AQUACULTURE, V523, DOI 10.1016/j.aquaculture.2020.735185; CARSON J, 1993, J FISH DIS, V16, P381, DOI 10.1111/j.1365-2761.1993.tb00871.x; Chang PH, 2002, B EUR ASSOC FISH PAT, V22, P319; Draayer HA, 2004, DEV BIOL BASEL, V117, P5; Eldar A, 1999, DIS AQUAT ORGAN, V36, P227, DOI 10.3354/dao036227; Eldar A, 1996, CURR MICROBIOL, V32, P85, DOI 10.1007/s002849900015; Evans JJ, 2009, EMERG INFECT DIS, V15, P774, DOI 10.3201/eid1505.080222; Genschick S., 2017, AQUACULTURE ZAMBIA O; Goulden EF, 2013, WOODHEAD PUBL FOOD S, P246, DOI 10.1533/9780857097460.1.246; Hastein T, 2005, DEV BIOLOGICALS, V121, P55; Hera AB J., 2004, DEV BIOL BASEL, V117, P7; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; KUSUDA R, 1991, INT J SYST BACTERIOL, V41, P406, DOI 10.1099/00207713-41-3-406; Martinson SA, 2008, J VET DIAGN INVEST, V20, P51, DOI 10.1177/104063870802000109; Midtlyng Paul J, 2011, Biologicals, V39, P117, DOI 10.1016/j.biologicals.2011.02.001; Munang'andu HM, 2012, VACCINE, V30, P4007, DOI 10.1016/j.vaccine.2012.04.039; Munang'andu HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148467; Munang'andu HM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-7; Mutoloki S, 2006, VACCINE, V24, P578, DOI 10.1016/j.vaccine.2005.08.070; Mutoloki S, 2004, FISH SHELLFISH IMMUN, V16, P633, DOI 10.1016/j.fsi.2003.10.002; Rattanachaikunsopon P, 2009, BIOSCI BIOTECH BIOCH, V73, P2085, DOI 10.1271/bbb.90294; Ravelo C, 2001, B EUR ASSOC FISH PAT, V21, P136; Saganuwan SA, 2011, AFR J PHARM PHARMACO, V5, P4; Schaeck M, 2013, ATLA-ALTERN LAB ANIM, V41, P219, DOI 10.1177/026119291304100305; Schijns VEJC, 2001, CRIT REV IMMUNOL, V21, P75; Tsai MA, 2013, J GEN APPL MICROBIOL, V59, P437, DOI 10.2323/jgam.59.437; Tsai MA, 2012, DIS AQUAT ORGAN, V102, P43, DOI 10.3354/dao02516; Vendrell D, 2006, COMP IMMUNOL MICROB, V29, P177, DOI 10.1016/j.cimid.2006.06.003; Zlotkin A, 1998, J CLIN MICROBIOL, V36, P983, DOI 10.1128/JCM.36.4.983-985.1998	32	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230739	10.1371/journal.pone.0230739	http://dx.doi.org/10.1371/journal.pone.0230739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214386	Green Published, gold			2022-12-26	WOS:000535934200050
J	Sumner-Kalkun, JC; Sjolund, MJ; Arnsdorf, YM; Carnegie, M; Highet, F; Ouvrard, D; Greenslade, AFC; Bell, JR; Sigvald, R; Kenyon, DM				Sumner-Kalkun, J. C.; Sjolund, M. J.; Arnsdorf, Y. M.; Carnegie, M.; Highet, F.; Ouvrard, D.; Greenslade, A. F. C.; Bell, J. R.; Sigvald, R.; Kenyon, D. M.			A diagnostic real-time PCR assay for the rapid identification of the tomato-potato psyllid, Bactericera cockerelli (Sulc, 1909) and development of a psyllid barcoding database	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER SOLANACEARUM; ZEBRA CHIP DISEASE; 1ST REPORT; HEMIPTERA TRIOZIDAE; EPIDEMIOLOGY; ASSOCIATION; ALIGNMENT; OREGON	The accurate and rapid identification of insect pests is an important step in the prevention and control of outbreaks in areas that are otherwise pest free. The potato-tomato psyllid Bactericera cockerelli (Sulc, 1909) is the main vector of 'Candidatus Liberibacter solanacearum' on potato and tomato crops in North America and New Zealand; and is considered a threat for introduction in Europe and other pest-free regions. This study describes the design and validation of the first species-specific TaqMan probe-based real-time PCR assay, targeting the ITS2 gene region of B. cockerelli. The assay detected B. cockerelli genomic DNA from adults, immatures, and eggs, with 100% accuracy. This assay also detected DNA from cloned plasmids containing the ITS2 region of B. cockerelli with 100% accuracy. The assay showed 0% false positives when tested on genomic and cloned DNA from 73 other psyllid species collected from across Europe, New Zealand, Mexico and the USA. This included 8 other species in the Bactericera genus and the main vectors of 'Candidatus Liberibacter solanacearum' worldwide. The limit of detection for this assay at optimum conditions was 0.000001ng DNA (similar to 200 copies) of ITS2 DNA which equates to around a 1:10000 dilution of DNA from one single adult specimen. This assay is the first real-time PCR based method for accurate, robust, sensitive and specific identification of B. cockerelli from all life stages. It can be used as a surveillance and monitoring tool to further study this important crop pest and to aid the prevention of outbreaks, or to prevent their spread after establishment in new areas.	[Sumner-Kalkun, J. C.; Sjolund, M. J.; Arnsdorf, Y. M.; Carnegie, M.; Highet, F.; Kenyon, D. M.] SASA, Edinburgh, Midlothian, Scotland; [Ouvrard, D.] Nat Hist Museum, Dept Life Sci, London, England; [Ouvrard, D.] ANSES, Entomol & Invas Plants Unit, Plant Hlth Lab, Montferrier Sur Lez, France; [Greenslade, A. F. C.; Bell, J. R.] Rothamsted Res, Rothamsted Insect Survey, Harpenden, Herts, England; [Sigvald, R.] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Natural History Museum London; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Swedish University of Agricultural Sciences	Sumner-Kalkun, JC (corresponding author), SASA, Edinburgh, Midlothian, Scotland.	jason.sumner-kalkun@sasa.gov.scot	; Sjolund, Jennifer/M-8626-2014	Ouvrard, David/0000-0003-2931-6116; Sjolund, Jennifer/0000-0001-9599-3516; Bell, James/0000-0003-1640-6120; Sumner-Kalkun, Jason/0000-0002-6485-1731	EU Horizon2020 Programme [635646]; Scottish Government [RRL/001/14]; Biotechnology and Biological Sciences Research Council [BBS/E/C/000J0200]; BBSRC [BBS/E/C/000J0200] Funding Source: UKRI	EU Horizon2020 Programme; Scottish Government; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	DK: This work was supported by the EU Horizon2020 Programme under grant agreement No. 635646, POnTE (Pest Organisms Threatening Europe) https://ec.europa.eu/programmes/horizon2020/en and the Scottish Government [RRL/001/14]. JB: The Rothamsted Insect Survey, a National Capability, is funded by the Biotechnology and Biological Sciences Research Council under the Core Capability Grant BBS/E/C/000J0200. https://bbsrc.ukri.org/funding/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar E, 2013, PLANT DIS, V97, P1376, DOI 10.1094/PDIS-04-13-0453-PDN; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anonymous, 2016, Bulletin OEPP, V46, P501, DOI 10.1111/epp.12344; Australian Government Department of Agriculture and Water Resources, 2017, DET BACT COCK TOM PO; Bell JR, 2015, J ANIM ECOL, V84, P21, DOI 10.1111/1365-2656.12282; Bextine B, 2013, PLANT DIS, V97, P1245, DOI 10.1094/PDIS-03-13-0248-PDN; Borges KM, 2017, ENVIRON ENTOMOL, V46, P210, DOI 10.1093/ee/nvw174; Burckhardt D, 2012, ZOOTAXA, P1; Butler Casey D., 2012, Terrestrial Arthropod Reviews, V5, P87, DOI 10.1163/187498312X634266; Carrillo CC, 2019, B INSECTOL, V72, P85; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; CNAS, 2006, EC IMP ZEBR CHIP TEX; Cooper WR, 2019, AM J POTATO RES, V96, P262, DOI 10.1007/s12230-019-09712-z; Crosslin JM, 2012, PLANT DIS, V96, P452, DOI 10.1094/PDIS-10-11-0894; DEFRA, 2017, PEST AL BACT COCK; DHAMI MK, 2016, FRONT MOL BIOSCI, V3, DOI DOI 10.3389/FMOLB.2016.00001; EPPO. PM 9/25 (1), 2017, B OEPP EPPO B, V47, P513, DOI [10.1111/epp.12442, DOI 10.1111/EPP.12442]; European Network of GMO Laboratories, 2015, DEF MIN PERF REQ AN, DOI [10.2788/65827, DOI 10.2788/65827]; Greenway GA, 2018, AM J POTATO RES, V95, P362, DOI 10.1007/s12230-018-9636-2; Grimm KDS, 2019, PLANT DIS, V103, P468, DOI [10.1094/PDIS-06-18-0937-RE, 10.1094/pdis-06-18-0937-re]; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Johnson D., 2017, NEWS LETT CAN POTATO, P1, DOI [10.15713/ins.mmj.3, DOI 10.15713/INS.MMJ.3]; Kaur N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201506; KNOWLTON GEORGE F., 1934, JOUR ECON ENT, V27, P547, DOI 10.1093/jee/27.2.547; Li DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131887; Liefting LW, 2008, PLANT DIS, V92, P1474, DOI 10.1094/PDIS-92-10-1474A; Liefting LW, 2009, INT J SYST EVOL MICR, V59, P2274, DOI 10.1099/ijs.0.007377-0; Liefting LW, 2009, PLANT DIS, V93, P208, DOI 10.1094/PDIS-93-3-0208; Liu D, 2006, ENTOMOL EXP APPL, V118, P177, DOI 10.1111/j.1570-7458.2006.00383.x; Martin Nicholas A., 2008, Weta, V35, P12; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Munyaneza JE, 2012, PLANT DIS, V96, P453, DOI 10.1094/PDIS-10-11-0871; Munyaneza JE, 2014, PLANT DIS, V98, P154, DOI 10.1094/PDIS-06-13-0598-PDN; Munyaneza JE, 2013, PLANT DIS, V97, P1654, DOI 10.1094/PDIS-06-13-0641-PDN; Munyaneza JE, 2013, PLANT DIS, V97, P1244, DOI 10.1094/PDIS-03-13-0247-PDN; Munyaneza JE, 2009, PLANT DIS, V93, P1076, DOI 10.1094/PDIS-93-10-1076A; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Munyaneza JE, 2010, J ECON ENTOMOL, V103, P1060, DOI 10.1603/EC10027; Nelson WR, 2011, EUR J PLANT PATHOL, V130, P5, DOI 10.1007/s10658-010-9737-3; Ouvrard D., 2018, 2018 PSYLLIST WORLD; Peccoud J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072454; Percy DM, 2003, EVOLUTION, V57, P2540, DOI 10.1111/j.0014-3820.2003.tb01498.x; PLETSCH D. J., 1947, Bull. Mont. agric. Exp. Stn., V446; Prager SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094047; Sjolund M. J., 2016, The Dundee Conference: Crop Protection in Northern Britain 2016, 23-24 February 2016, Dundee, UK, P279; Soliman T., 2012, EC IMPACT ASSESSMENT; Swisher KD, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu023; Swisher KD, 2013, AM J POTATO RES, V90, P570, DOI 10.1007/s12230-013-9330-3; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Teulon D. A. J., 2009, New Zealand Plant Protection, V62, P136; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Virgilio M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031581; WALLIS R. L., 1955, Technical Bulletin. United States Department of Agriculture; WALLIS RL, 1951, J ECON ENTOMOL, V44, P815, DOI 10.1093/jee/44.5.815; Wen A, 2009, PLANT DIS, V93, P1102, DOI 10.1094/PDIS-93-11-1102; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; 2013, EPPO B, V43, P202, DOI DOI 10.1111/EPP.12044	58	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230741	10.1371/journal.pone.0230741	http://dx.doi.org/10.1371/journal.pone.0230741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214353	Green Published, gold			2022-12-26	WOS:000535934200051
J	Ullah, K; Zhang, JQ				Ullah, Kashif; Zhang, Jiquan			GIS-based flood hazard mapping using relative frequency ratio method: A case study of Panjkora River Basin, eastern Hindu Kush, Pakistan	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK; FUZZY INFERENCE SYSTEM; RISK-ASSESSMENT; SPATIAL PREDICTION; SUSCEPTIBILITY ASSESSMENT; LOGISTIC-REGRESSION; VULNERABILITY ANALYSIS; ENSEMBLE BIVARIATE; STATISTICAL-MODELS; AREA	Flood is the most devastating and prevalent disaster among all-natural disasters. Every year, flood claims hundreds of human lives and causes damage to the worldwide economy and environment. Consequently, the identification of flood-vulnerable areas is important for comprehensive flood risk management. The main objective of this study is to delineate flood-prone areas in the Panjkora River Basin (PRB), eastern Hindu Kush, Pakistan. An initial extensive field survey and interpretation of Landsat-7 and Google Earth images identified 154 flood locations that were inundated in 2010 floods. Of the total, 70% of flood locations were randomly used for building a model and 30% were used for validation of the model. Eight flood parameters including slope, elevation, land use, Normalized Difference Vegetation Index (NDVI), topographic wetness index (TWI), drainage density, and rainfall were used to map the flood-prone areas in the study region. The relative frequency ratio was used to determine the correlation between each class of flood parameter and flood occurrences. All of the factors were resampled into a pixel size of 30x30 m and were reclassified through the natural break method. Finally, a final hazard map was prepared and reclassified into five classes, i.e., very low, low, moderate, high, very high susceptibility. The results of the model were found reliable with area under curve values for success and prediction rate of 82.04% and 84.74%, respectively. The findings of this study can play a key role in flood hazard management in the target region; they can be used by the local disaster management authority, researchers, planners, local government, and line agencies dealing with flood risk management.	[Ullah, Kashif; Zhang, Jiquan] Northeast Normal Univ, Sch Environm, Inst Nat Disaster Res, Changchun, Peoples R China; [Zhang, Jiquan] Northeast Normal Univ, State Environm Protect Key Lab Wetland Ecol & Veg, Changchun, Peoples R China; [Zhang, Jiquan] Minist Educ, Key Lab Vegetat Ecol, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China	Zhang, JQ (corresponding author), Northeast Normal Univ, Sch Environm, Inst Nat Disaster Res, Changchun, Peoples R China.; Zhang, JQ (corresponding author), Northeast Normal Univ, State Environm Protect Key Lab Wetland Ecol & Veg, Changchun, Peoples R China.; Zhang, JQ (corresponding author), Minist Educ, Key Lab Vegetat Ecol, Changchun, Peoples R China.	zhangjq022@nenu.edu.cn	ullah, kashif/AHI-8210-2022	ullah, kashif/0000-0003-2880-0977	national key research and development program of china [2018YFC1508804]; Key Scientific and Technology Research and Development Program of Jilin Province [20180201035SF]; Key Scientific and Technology Program of Jilin Province [20180201035SF, 20170204035SF]	national key research and development program of china; Key Scientific and Technology Research and Development Program of Jilin Province; Key Scientific and Technology Program of Jilin Province	This research is supported by the national key research and development program of china (2018YFC1508804); The Key Scientific and Technology Research and Development Program of Jilin Province (20180201033SF); The Key Scientific and Technology Research and Development Program of Jilin Province (20180201035SF); The Key Scientific and Technology Program of Jilin Province (20170204035SF). The funders provided support in the form of salaries for authors [Jiquan Zhang], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaszadeh P, 2016, WATER RESOUR MANAG, V30, P1701, DOI 10.1007/s11269-016-1246-5; Acharya TD, 2019, KSCE J CIV ENG, V23, P763, DOI 10.1007/s12205-018-0156-x; Aditian A, 2018, GEOMORPHOLOGY, V318, P101, DOI 10.1016/j.geomorph.2018.06.006; Aghdam IN, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-015-5233-6; Althuwaynee OF, 2014, CATENA, V114, P21, DOI 10.1016/j.catena.2013.10.011; Arabameri A, 2018, ENVIRON EARTH SCI, V77, DOI 10.1007/s12665-018-7808-5; Areu-Rangel OS, 2019, WATER-SUI, V11, DOI 10.3390/w11020304; Caliz J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125787; Cao C, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8090948; Charlton R, 2006, CLIMATIC CHANGE, V74, P475, DOI 10.1007/s10584-006-0472-x; Chen W, 2017, GEOMORPHOLOGY, V297, P69, DOI 10.1016/j.geomorph.2017.09.007; Chung CJF, 2003, NAT HAZARDS, V30, P451, DOI 10.1023/B:NHAZ.0000007172.62651.2b; Couasnon A, 2018, WATER-SUI, V10, DOI 10.3390/w10091190; Danandeh A, 2017, PARETO OPTIMAL MOVIN, DOI [10.1016/j.jhydrol.2017.04.045, DOI 10.1016/J.JHYDROL.2017.04.045]; Dandapat K, 2017, MODEL EARTH SYST ENV, V3, P1627, DOI 10.1007/s40808-017-0388-7; Dano UL, 2019, WATER-SUI, V11, DOI 10.3390/w11030615; Das S, 2019, REMOTE SENS APPL, V14, P60, DOI 10.1016/j.rsase.2019.02.006; Das S, 2018, ARAB J GEOSCI, V11, DOI 10.1007/s12517-018-3933-4; Dou J, 2020, LANDSLIDES, V17, P641, DOI 10.1007/s10346-019-01286-5; Dou XY, 2018, STOCH ENV RES RISK A, V32, P1131, DOI 10.1007/s00477-017-1429-5; Gain AK, 2015, NAT HAZARDS, V79, P1499, DOI 10.1007/s11069-015-1911-7; Guo EL, 2014, NAT HAZARDS, V74, P947, DOI 10.1007/s11069-014-1238-9; Haghizadeh A, 2017, J EARTH SYST SCI, V126, DOI 10.1007/s12040-017-0819-x; Hong HY, 2018, SCI TOTAL ENVIRON, V621, P1124, DOI 10.1016/j.scitotenv.2017.10.114; Jahangir MH, 2019, WEATHER CLIM EXTREME, V25, DOI 10.1016/j.wace.2019.100215; Janizadeh S, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11195426; Khosravi K, 2019, EXTREME HYDROLOGY CL, P419; Khosravi K, 2018, SCI TOTAL ENVIRON, V627, P744, DOI 10.1016/j.scitotenv.2018.01.266; Khosravi K, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5665-9; Khosravi K, 2016, NAT HAZARDS, V83, P947, DOI 10.1007/s11069-016-2357-2; Kia MB, 2012, ENVIRON EARTH SCI, V67, P251, DOI 10.1007/s12665-011-1504-z; Liuzzo L, 2019, WATER RESOUR MANAG, V33, P3155, DOI 10.1007/s11269-019-02293-w; Mahmood S, 2019, ENVIRON EARTH SCI, V78, DOI 10.1007/s12665-018-8041-y; Mahmood S, 2016, INT J DISAST RISK RE, V16, P215, DOI 10.1016/j.ijdrr.2016.02.009; Merz B, 2014, NAT HAZARD EARTH SYS, V14, P1921, DOI 10.5194/nhess-14-1921-2014; Mukerji A, 2009, J HYDROL ENG, V14, P647, DOI 10.1061/(ASCE)HE.1943-5584.0000040; Nandi A, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5323-0; Naulin JP, 2013, J HYDROL, V486, P88, DOI 10.1016/j.jhydrol.2013.01.044; Nicu IC, 2017, J CULT HERIT, V28, P172, DOI 10.1016/j.cuther.2017.06.002; Ozdemir A, 2013, J ASIAN EARTH SCI, V64, P180, DOI 10.1016/j.jseaes.2012.12.014; Paul G.C., 2019, REMOTE SENS EARTH SY, V2, P120, DOI [DOI 10.1007/S41976-019-00018-6, 10.1007/s41976-019-00018-6]; Pradhan B, 2010, COMPUT ENVIRON URBAN, V34, P216, DOI 10.1016/j.compenvurbsys.2009.12.004; Radmehr A, 2015, WATER RESOUR MANAG, V29, P4427, DOI 10.1007/s11269-015-1068-x; Rahman A.U., 2019, OXFORD 12 RES ENCY N, DOI [10.1093/acrefore/9780199389407.013.316, DOI 10.1093/ACREFORE/9780199389407.013.316]; Rahmati O, 2016, GEOCARTO INT, V31, P42, DOI 10.1080/10106049.2015.1041559; Rao GN, 2001, P INDIAN AS-EARTH, V110, P87, DOI 10.1007/BF02702232; Razandi Y, 2015, EARTH SCI INFORM, V8, P867, DOI 10.1007/s12145-015-0220-8; Regmi AD, 2014, J MT SCI-ENGL, V11, P1266, DOI 10.1007/s11629-013-2847-6; Sahana M, 2019, ENVIRON EARTH SCI, V78, DOI 10.1007/s12665-019-8285-1; Samanta RK, 2018, MODEL EARTH SYST ENV, V4, P395, DOI 10.1007/s40808-018-0427-z; Sangeeta, 2019, INDIAN GEOTECH J, V49, P108, DOI 10.1007/s40098-018-0334-2; Scheuer S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189451; Shafizadeh-Moghadam H, 2018, J ENVIRON MANAGE, V217, P1, DOI 10.1016/j.jenvman.2018.03.089; Shahabi H, 2013, ARAB J GEOSCI, V6, P3885, DOI 10.1007/s12517-012-0650-2; Siahkamari S, 2018, GEOCARTO INT, V33, P927, DOI 10.1080/10106049.2017.1316780; Tehrany MS, 2017, GEOMAT NAT HAZ RISK, V8, P1538, DOI 10.1080/19475705.2017.1362038; Tehrany MS, 2015, CATENA, V125, P91, DOI 10.1016/j.catena.2014.10.017; Tehrany MS, 2013, J HYDROL, V504, P69, DOI 10.1016/j.jhydrol.2013.09.034; Tiwari MK, 2010, J HYDROL, V382, P20, DOI 10.1016/j.jhydrol.2009.12.013; Ullah S, 2019, CLIM DYNAM, V53, P6329, DOI 10.1007/s00382-019-04934-7; Ullah S, 2019, INT J CLIMATOL, V39, P1457, DOI 10.1002/joc.5894; Ullah S, 2018, ATMOS RES, V210, P1, DOI 10.1016/j.atmosres.2018.04.007; Vojtek M, 2019, WATER-SUI, V11, DOI 10.3390/w11020364; Wang ZL, 2015, J HYDROL, V527, P1130, DOI 10.1016/j.jhydrol.2015.06.008; Youssef AM, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-015-4830-8; ZHANG JY, 2019, SUSTAINABILITY BASEL, V0011, DOI DOI 10.3390/SU11102738; Zou Q, 2013, STOCH ENV RES RISK A, V27, P525, DOI 10.1007/s00477-012-0598-5	67	45	45	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0229153	10.1371/journal.pone.0229153	http://dx.doi.org/10.1371/journal.pone.0229153			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210424	Green Published, gold			2022-12-26	WOS:000535307600006
J	Allen, MR; Wallace, J; McNerney, E; Nyman, J; Avin, K; Chen, N; Moe, S				Allen, Matthew R.; Wallace, Joseph; McNerney, Erin; Nyman, Jeffry; Avin, Keith; Chen, Neal; Moe, Sharon			N-acetylcysteine (NAC), an anti-oxidant, does not improve bone mechanical properties in a rat model of progressive chronic kidney disease-mineral bone disorder	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; ANIMAL-MODEL; NONENZYMATIC GLYCATION; SKELETAL PROPERTIES; OXIDATIVE STRESS; ZOLEDRONIC ACID; CORTICAL BONE; QUALITY	Individuals with chronic kidney disease have elevated levels of oxidative stress and are at a significantly higher risk of skeletal fracture. Advanced glycation end products (AGEs), which accumulate in bone and compromise mechanical properties, are known to be driven in part by oxidative stress. The goal of this study was to study effects of N-acetylcysteine (NAC) on reducing oxidative stress and improving various bone parameters, most specifically mechanical properties, in an animal model of progressive CKD. Male Cy/+ (CKD) rats and unaffected littermates were untreated (controls) or treated with NAC (80 mg/kg, IP) from 30 to 35 weeks of age. Endpoint measures included serum biochemistries, assessments of systemic oxidative stress, bone morphology, and mechanical properties, and AGE levels in the bone. CKD rats had the expected phenotype that included low kidney function, elevated parathyroid hormone, higher cortical porosity, and compromised mechanical properties. NAC treatment had mixed effects on oxidative stress markers, significantly reducing TBARS (a measure of lipid peroxidation) while not affecting 8-OHdG (a marker of DNA oxidation) levels. AGE levels in the bone were elevated in CKD animals and were reduced with NAC although this did not translate to a benefit in bone mechanical properties. In conclusion, NAC failed to significantly improve bone architecture/geometry/mechanical properties in our rat model of progressive CKD.	[Allen, Matthew R.; McNerney, Erin; Moe, Sharon] Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA; [Allen, Matthew R.; Wallace, Joseph] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Allen, Matthew R.; Avin, Keith; Chen, Neal; Moe, Sharon] Indiana Univ Sch Med, Dept Med, Div Nephrol, Indianapolis, IN 46202 USA; [Allen, Matthew R.; Moe, Sharon] Roudebush VA Med Ctr, Indianapolis, IN 46202 USA; [Nyman, Jeffry] Vanderbilt Univ, Med Ctr, Dept Orthopaed Surg, 221 Kirkland Hall, Nashville, TN 37235 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Vanderbilt University	Allen, MR (corresponding author), Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA.; Allen, MR (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.; Allen, MR (corresponding author), Indiana Univ Sch Med, Dept Med, Div Nephrol, Indianapolis, IN 46202 USA.; Allen, MR (corresponding author), Roudebush VA Med Ctr, Indianapolis, IN 46202 USA.	matallen@iu.edu	; Allen, Matthew/A-8799-2015	Nyman, Jeffry/0000-0001-7403-7605; Allen, Matthew/0000-0002-1174-9004	NIH [DK110871, DK110429]; VA [I01BX001471, I01BX003025]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA(US Department of Veterans Affairs)	SM/MA -DK110871, NIH, http://grantome.com/grant/NIH/R01-DK110871-04 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KA -DK110429 -NIH -http://grantome.com/grant/NIH/K08-DK110429-02.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SM -I01BX001471 -VA -https://www.research.va.gov/about/funded-proj-details.cfm?pid=545734.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MA I01BX003025 -VA -https://www.research.va.gov/about/funded-proj-details.cfm?pid=522036.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 2015, OSTEOPOROSIS INT, V26, P977, DOI 10.1007/s00198-014-2978-9; Allen MR, 2013, OSTEOPOROSIS INT, V24, P1471, DOI 10.1007/s00198-012-2103-x; Aoki C, 2013, LAB INVEST, V93, P1170, DOI 10.1038/labinvest.2013.105; Avin KG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159411; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brown JH, 2005, J AM SOC NEPHROL, V16, P3517, DOI 10.1681/ASN.2005060601; Burr DB, 2011, J MUSCULOSKEL NEURON, V11, P270; Daenen K, 2019, PEDIATR NEPHROL, V34, P975, DOI 10.1007/s00467-018-4005-4; McCarthy AD, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.1000276; Feng DM, 2015, MUTAT RES-GEN TOX EN, V792, P35, DOI 10.1016/j.mrgentox.2015.09.004; Finamor IA, 2014, NEUROCHEM RES, V39, P1681, DOI 10.1007/s11064-014-1360-9; Garnero P, 2015, CALCIFIED TISSUE INT, V97, P229, DOI 10.1007/s00223-015-9996-2; Gattone VH, 2004, ANAT REC PART A, V277A, P384, DOI 10.1002/ar.a.20022; Hunt HB, 2019, J BONE MINER RES, V34, P1191, DOI 10.1002/jbmr.3711; Lankin VZ, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1081, DOI 10.1134/S0006297907100069; Malluche HH, 2013, NAT REV NEPHROL, V9, P671, DOI 10.1038/nrneph.2013.198; Manali BP, 2011, RENAL FAILURE, V33, P341, DOI 10.3109/0886022X.2011.560987; McNerny EMB, 2019, BONE, V125, P16, DOI 10.1016/j.bone.2019.05.002; McNerny EMB, 2017, CURR OSTEOPOROS REP, V15, P207, DOI 10.1007/s11914-017-0366-z; Misselwitz J, 2002, PEDIATR NEPHROL, V17, P316, DOI 10.1007/s00467-001-0815-9; Moe SM, 2015, J BONE MINER RES, V30, P539, DOI 10.1002/jbmr.2372; Moe SM, 2014, J BONE MINER RES, V29, P902, DOI 10.1002/jbmr.2089; Moe SM, 2011, J BONE MINER RES, V26, P2672, DOI 10.1002/jbmr.485; Moe SM, 2009, KIDNEY INT, V75, P176, DOI 10.1038/ki.2008.456; Newman CL, 2016, AM J NEPHROL, V43, P20, DOI 10.1159/000444423; Newman CL, 2016, KIDNEY INT, V89, P95, DOI 10.1038/ki.2015.315; Newman CL, 2015, BONE, V77, P50, DOI 10.1016/j.bone.2015.04.021; Newman CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099262; Nickolas TL, 2013, J BONE MINER RES, V28, P1811, DOI 10.1002/jbmr.1916; Nickolas TL, 2011, J AM SOC NEPHROL, V22, P1560, DOI 10.1681/ASN.2010121275; Nickolas TL, 2010, J AM SOC NEPHROL, V21, P1371, DOI 10.1681/ASN.2009121208; Nickolas TL, 2010, KIDNEY INT, V77, P1046, DOI 10.1038/ki.2009.558; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Rodrigues SD, 2015, LIFE SCI, V121, P110, DOI 10.1016/j.lfs.2014.11.024; Saito M, 2015, CALCIFIED TISSUE INT, V97, P242, DOI 10.1007/s00223-015-9985-5; Seeman E, 2017, NEPHROLOGY, V22, P34, DOI 10.1111/nep.13024; Suliman ME, 2003, J AM SOC NEPHROL, V14, P1614, DOI 10.1097/01.ASN.0000067413.32377.CF; Tang SY, 2007, BONE, V40, P1144, DOI 10.1016/j.bone.2006.12.056; Tang SY, 2009, OSTEOPOROSIS INT, V20, P887, DOI 10.1007/s00198-008-0754-4; Thornalley PJ, 2009, SEMIN DIALYSIS, V22, P400, DOI 10.1111/j.1525-139X.2009.00589.x; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; US Department of Health and Prevention C for DC and PH. Centers for Disease Control and Prevention, 2017, NAT CHRON KIDN DIS F, V2017, P1; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Willett TL, 2013, BONE, V52, P611, DOI 10.1016/j.bone.2012.11.014	44	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230379	10.1371/journal.pone.0230379	http://dx.doi.org/10.1371/journal.pone.0230379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GC	32203558	Green Published, gold			2022-12-26	WOS:000535303900019
J	Li, JN; Alvero, AB; Nuti, S; Tedja, R; Roberts, CM; Pitruzzello, M; Li, YM; Xiao, Q; Zhang, S; Gan, YQ; Wu, XY; Mor, G; Yin, G				Li, Juanni; Alvero, Ayesha B.; Nuti, Sudhakar; Tedja, Roslyn; Roberts, Cai M.; Pitruzzello, Mary; Li, Yimin; Xiao, Qing; Zhang, Sai; Gan, Yaqi; Wu, Xiaoying; Mor, Gil; Yin, Gang			CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential	ONCOGENE			English	Article							CANCER STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; OVARIAN-CANCER; TUMOR-SUPPRESSOR; E-CADHERIN; POLYCOMB; CARCINOMA; GROWTH; CHEMORESISTANCE; EXPRESSION	Deaths from ovarian cancer usually occur when patients succumb to overwhelmingly numerous and widespread micrometastasis. Whereas epithelial-mesenchymal transition is required for epithelial ovarian cancer cells to acquire metastatic potential, the cellular phenotype at secondary sites and the mechanisms required for the establishment of metastatic tumors are not fully determined. Using in vitro and in vivo models we show that secondary epithelial ovarian cancer cells (sEOC) do not fully reacquire the molecular signature of the primary epithelial ovarian cancer cells from which they are derived. Despite displaying an epithelial morphology, sEOC maintains a high expression of the mesenchymal effector, TWIST-1. TWIST-1 is however transcriptionally nonfunctional in these cells as it is precluded from binding its E-box by the PcG protein, CBX7. Deletion of CBX7 in sEOC was sufficient to reactivate TWIST-1-induced transcription, prompt mesenchymal transformation, and enhanced tumorigenicity in vivo. This regulation allows secondary tumors to achieve an epithelial morphology while conferring the advantage of prompt reversal to a mesenchymal phenotype upon perturbation of CBX7. We also describe a subclassification of ovarian tumors based on CBX7 and TWIST-1 expression, which predicts clinical outcomes and patient prognosis.	[Li, Juanni; Li, Yimin; Xiao, Qing; Zhang, Sai; Gan, Yaqi; Wu, Xiaoying; Yin, Gang] Cent South Univ, Sch Basic Med Sci, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China; [Alvero, Ayesha B.; Nuti, Sudhakar; Tedja, Roslyn; Roberts, Cai M.; Pitruzzello, Mary; Mor, Gil] Yale Sch Med, Div Reprod Sci, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Mor, Gil] Wayne State Univ, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI USA	Central South University; Yale University; Wayne State University	Yin, G (corresponding author), Cent South Univ, Sch Basic Med Sci, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China.; Mor, G (corresponding author), Yale Sch Med, Div Reprod Sci, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA.	gmor@med.wayne.edu; gang.yin@csu.edu.cn		Alvero, Ayesha/0000-0002-6593-3595; Gan, Yaqi/0000-0001-8097-4603	NIH NCI [R01CA199004]; National Natural Science Foundation of China [81572900]; National Key R&D Program of China; Stem Cell and Translation Research [2016YFA0102000]; Hunan Provincial Natural Science Foundation of China [2018JJ3820]	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Stem Cell and Translation Research; Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	This study is supported in part by grants from NIH NCI R01CA199004 (GM), The National Natural Science Foundation of China No. 81572900 (GY), The National Key R&D Program of China, Stem Cell and Translation Research No. 2016YFA0102000 (GY), and Hunan Provincial Natural Science Foundation of China No. 2018JJ3820 (JL).	Alvero AB, 2006, CANCER-AM CANCER SOC, V106, P599, DOI 10.1002/cncr.21633; Alvero AB, 2017, SCI REP-UK, V7, DOI 10.1038/srep40989; Alvero AB, 2016, MOL CANCER THER, V15, P1279, DOI 10.1158/1535-7163.MCT-16-0005; Alvero AB, 2014, ONCOTARGET, V5, P8703, DOI 10.18632/oncotarget.2367; Alvero AB, 2009, CANCER-AM CANCER SOC, V115, P3204, DOI 10.1002/cncr.24397; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Armstrong DK, 2002, ONCOLOGIST, V7, P20, DOI 10.1634/theoncologist.7-suppl_5-20; Bao ZY, 2017, ONCOTARGET, V8, P39048, DOI 10.18632/oncotarget.16587; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Bernard D, 2005, ONCOGENE, V24, P5543, DOI 10.1038/sj.onc.1208735; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Cardenas C, 2017, APOPTOSIS, V22, P558, DOI 10.1007/s10495-016-1339-x; Carmona-Fontaine C, 2011, DEV CELL, V21, P1026, DOI 10.1016/j.devcel.2011.10.012; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Craveiro V, 2013, CANCER MED-US, V2, P751, DOI 10.1002/cam4.115; Duan RS, 2018, CELL DEATH DIFFER, V25, P1598, DOI 10.1038/s41418-018-0064-0; Fabregat I, 2016, J CLIN MED, V5, DOI 10.3390/jcm5030037; Federico A, 2019, BBA-GENE REGUL MECH, V1862, P509, DOI 10.1016/j.bbagrm.2019.02.006; Forzati F, 2014, BIOL OPEN, V3, P871, DOI 10.1242/bio.20147872; Forzati F, 2012, CELL CYCLE, V11, P1888, DOI 10.4161/cc.20022; Forzati F, 2012, J CLIN INVEST, V122, P612, DOI 10.1172/JCI58620; GLACKIN CA, 1992, BIOCHEM INT, V28, P67; Glackin CA, 2014, MATURITAS, V79, P48, DOI 10.1016/j.maturitas.2014.06.015; Glackin Carlotta A., 1994, Molecular and Cellular Differentiation, V2, P309; Goff Barbara A, 2013, Gynecol Oncol, V130, P9; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; HILDRETH NG, 1981, AM J EPIDEMIOL, V114, P398, DOI 10.1093/oxfordjournals.aje.a113207; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Jarboe EA, 2008, HISTOPATHOLOGY, V53, P127, DOI 10.1111/j.1365-2559.2007.02938.x; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Jolly MK, 2017, MOL ONCOL, V11, P755, DOI 10.1002/1878-0261.12083; Jordan NV, 2011, CELL CYCLE, V10, P2865, DOI 10.4161/cc.10.17.17188; Kamsteeg M, 2003, ONCOGENE, V22, P2611, DOI 10.1038/sj.onc.1206422; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kian W, 2018, TRANSL LUNG CANCER R, V7, pS334, DOI 10.21037/tlcr.2018.12.01; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Leeb M, 2010, CELL CYCLE, V9, P2692, DOI 10.4161/cc.9.14.12455; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mas G, 2016, CURR OPIN CELL BIOL, V43, P87, DOI 10.1016/j.ceb.2016.09.006; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Pallante P, 2015, AM J CANCER RES, V5, P1594; Pallante P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098295; Pizzonia J, 2012, AM J REPROD IMMUNOL, V67, P84, DOI 10.1111/j.1600-0897.2011.01070.x; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Scott CL, 2007, P NATL ACAD SCI USA, V104, P5389, DOI 10.1073/pnas.0608721104; Seto ML, 2001, AM J MED GENET, V104, P323, DOI 10.1002/ajmg.10065; Shen CH, 2011, J BUON, V16, P733; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Tedja R, 2019, J BIOL CHEM, V294, P5082, DOI 10.1074/jbc.RA118.005921; Thrall MM, 2011, GYNECOL ONCOL, V122, P100, DOI 10.1016/j.ygyno.2011.03.022; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Vergara D, 2010, CANCER LETT, V291, P59, DOI 10.1016/j.canlet.2009.09.017; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wu WN, 2017, AM J CANCER RES, V7, P64; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yang-Hartwich Y, 2015, ONCOGENE, V34, P3605, DOI 10.1038/onc.2014.296; Yang-Hartwich Y, 2019, MOL CANCER RES, V17, P153, DOI 10.1158/1541-7786.MCR-18-0238; Yao DB, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-432; Yao DB, 2011, MOL CANCER RES, V9, P1608, DOI 10.1158/1541-7786.MCR-10-0568; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Yin G, 2013, ONCOGENE, V32, P39, DOI 10.1038/onc.2012.33; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111; Yuen HF, 2007, J CLIN PATHOL, V60, P510, DOI 10.1136/jcp.2006.039099; Zanudo JGT, 2019, PHYS BIOL, V16, DOI 10.1088/1478-3975/aaffa1; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang YY, 2018, ONCOL RES, V26, P1327, DOI 10.3727/096504018X15165493852990; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	78	16	16	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	20					3965	3979		10.1038/s41388-020-1269-5	http://dx.doi.org/10.1038/s41388-020-1269-5		MAR 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LN3GC	32205869	Green Accepted			2022-12-26	WOS:000521527500001
J	Neiswanger, K; Mukhopadhyay, N; Rajagopalan, S; Leslie, EJ; Sanchez, CA; Hecht, JT; Orioli, IM; Poletta, FA; de Salamanca, JE; Weinberg, SM; Marazita, ML				Neiswanger, Katherine; Mukhopadhyay, Nandita; Rajagopalan, Shwetha; Leslie, Elizabeth J.; Sanchez, Carla A.; Hecht, Jacqueline T.; Orioli, Ieda M.; Poletta, Fernando A.; Enriquez de Salamanca, Javier; Weinberg, Seth M.; Marazita, Mary L.			Individuals with nonsyndromic orofacial clefts have increased asymmetry of fingerprint patterns	PLOS ONE			English	Article							FLUCTUATING DERMATOGLYPHIC ASYMMETRY; PALATE PATIENTS; ORAL CLEFTS; UNAFFECTED RELATIVES; LIP; PARENTS; RISK; CHILDREN; POPULATION; PHENOTYPE	Dermatoglyphic patterns on the fingers often differ in syndromes and other conditions with a developmental component, compared to the general population. Previous literature on the relationship between orofacial clefts-the most common craniofacial birth defect in humans-and dermatoglyphics is inconsistent, with some studies reporting altered pattern frequencies and/or increased asymmetry and others failing to find differences. To investigate dermatoglyphics in orofacial clefting, we obtained dermatoglyphic patterns in a large multiethnic cohort of orofacial cleft cases (N = 367), their unaffected family members (N = 836), and controls (N = 299). We categorized fingerprint pattern types from males and females who participated at five sites of the Pittsburgh Orofacial Cleft study (Hungary, United States of America (Pennsylvania, Texas), Spain, and Argentina). We also calculated a pattern dissimilarity score for each individual as a measure of left-right asymmetry. We tested for group differences in the number of arches, ulnar and radial loops, and whorls on each individual's hands, and in the pattern dissimilarity scores using ANOVA. After taking sex and site differences into account, we did not find any significant pattern count differences between cleft and non-cleft individuals. Notably, we did observe increased pattern dissimilarity in individuals with clefts, compared to both their unaffected relatives and controls. Increased dermatoglyphic pattern dissimilarity in individuals with nonsyndromic orofacial clefts may reflect a generalized developmental instability.	[Neiswanger, Katherine; Mukhopadhyay, Nandita; Rajagopalan, Shwetha; Leslie, Elizabeth J.; Sanchez, Carla A.; Weinberg, Seth M.; Marazita, Mary L.] Univ Pittsburgh, Ctr Craniofacial & Dent Genet, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA 15260 USA; [Hecht, Jacqueline T.] Univ Texas McGovern Med Ctr, Dept Pediat, Houston, TX USA; [Orioli, Ieda M.] Oswaldo Cruz Inst, Lab Congenital Malformat Epidemiol, Rio De Janeiro, Brazil; [Poletta, Fernando A.] Estudio Collaborat Latino Amer Malformac Congenit, Ctr Med Educ & Clin Res, Buenos Aires, DF, Argentina; [Enriquez de Salamanca, Javier] Hosp Infantil Univ Nino Jesus, Secc Cirugla Plast, Madrid, Spain; [Weinberg, Seth M.; Marazita, Mary L.] Univ Pittsburgh, Dept Human Genet, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Weinberg, Seth M.] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA; [Marazita, Mary L.] Univ Pittsburgh, Sch Med, Clin & Translat Sci, Pittsburgh, PA USA; [Leslie, Elizabeth J.] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fundacao Oswaldo Cruz; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University	Neiswanger, K (corresponding author), Univ Pittsburgh, Ctr Craniofacial & Dent Genet, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA 15260 USA.	knacct@pitt.edu	Sánchez, Carla/HDO-0444-2022; Leslie, Elizabeth/AAP-8941-2021	Leslie, Elizabeth/0000-0002-5735-1712; Weinberg, Seth/0000-0001-9467-4556; Poletta, Fernando/0000-0002-6102-8416; Neiswanger, Katherine/0000-0002-1250-6813	National Institute of Dental and Craniofacial Research [R01-DE016148, R21-DE016930, R01-DE011931]	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by the National Institute of Dental and Craniofacial Research, grant numbers R01-DE016148 (MLM, SMW), R21-DE016930 (MLM), and R01-DE011931 (JTH); (URL: https://www.nidcr.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, R LANG ENV STAT COMP; Arquimbau R, 1993, Anthropol Anz, V51, P267; Arrieta I, 2003, HUM BIOL, V75, P265, DOI 10.1353/hub.2003.0029; Azumi J, 1966, NIHONIJISHINPO, V2900, P43; Babler W J, 1991, Birth Defects Orig Artic Ser, V27, P95; Balgir R S, 1993, Indian Pediatr, V30, P341; BALGIR RS, 1984, ISRAEL J MED SCI, V20, P622; Martelli DRB, 2012, BRAZ J OTORHINOLAR, V78, P116, DOI 10.5935/1808-8694.20120018; Buchwald W, 2015, HOMO, V66, P60, DOI 10.1016/j.jchb.2014.07.001; Claes P, 2018, NAT GENET, V50, P414, DOI 10.1038/s41588-018-0057-4; CRAWFORD FC, 1987, J MED GENET, V24, P163, DOI 10.1136/jmg.24.3.163; CUMMINS H, 1943, FINGER PRINTS PALMS; DEBIE S, 1977, CLEFT PALATE J, V14, P222; Deroo LA, 2008, AM J EPIDEMIOL, V168, P638, DOI 10.1093/aje/kwn186; DESHMUKH RN, 1981, INDIAN J MED RES, V73, P584; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Eslami N, 2013, J CRANIOFAC SURG, V24, P769, DOI 10.1097/SCS.0b013e3182869870; Esteban E, 1993, Anthropol Anz, V51, P159; HOLT SB, 1968, GENETICS DERMAL RIDG; Honein MA, 2007, EPIDEMIOLOGY, V18, P226, DOI 10.1097/01.ede.0000254430.61294.c0; Jahanbin A, 2010, CLEFT PALATE-CRAN J, V47, P9, DOI 10.1597/08-045.1; JANTZ RL, 1987, ANNU REV ANTHROPOL, V16, P161; KANEMATSU N, 1986, J MAXILLOFAC SURG, V14, P74, DOI 10.1016/S0301-0503(86)80265-X; Kobyliansky E, 1999, COLLEGIUM ANTROPOL, V23, P1; Leite BDGL, 2015, J PLAST SURG HAND SU, V49, P289, DOI 10.3109/2000656X.2015.1042387; Leslie EJ, 2016, HUM MOL GENET, V25, P2862, DOI 10.1093/hmg/ddw104; Leslie EJ, 2013, AM J MED GENET C, V163, P246, DOI 10.1002/ajmg.c.31381; LIVSHITS G, 1991, HUM BIOL, V63, P441; Ma HF, 2014, CLEFT PALATE-CRAN J, V51, P76, DOI 10.1597/11-172; Maheshwari Neha, 2013, J Indian Soc Pedod Prev Dent, V31, P260, DOI 10.4103/0970-4388.121829; Marazita ML, 2007, ORTHOD CRANIOFAC RES, V10, P82, DOI 10.1111/j.1601-6343.2007.00386.x; Martin J, 1996, AM J HUM BIOL, V8, P305, DOI 10.1002/(SICI)1520-6300(1996)8:3<305::AID-AJHB1>3.0.CO;2-Z; Mathew L, 2005, J Indian Soc Pedod Prev Dent, V23, P179; Meier R J, 1991, Birth Defects Orig Artic Ser, V27, P253; MILLER JR, 1973, J INVEST DERMATOL, V60, P435, DOI 10.1111/1523-1747.ep12702906; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Munger RG, 2009, BIRTH DEFECTS RES A, V85, P151, DOI 10.1002/bdra.20516; Naugler CT, 1996, AM J MED GENET, V66, P11, DOI 10.1002/(SICI)1096-8628(19961202)66:1<11::AID-AJMG3>3.0.CO;2-Z; Neiswanger K, 2002, Orthod Craniofac Res, V5, P140, DOI 10.1034/j.1600-0544.2002.02196.x; Rosa A, 2001, J INTELL DISABIL RES, V45, P416, DOI 10.1046/j.1365-2788.2001.00351.x; S Mayall Sandeep, 2017, Int J Clin Pediatr Dent, V10, P245, DOI 10.5005/jp-journals-10005-1444; Saujanya K, 2016, J Indian Soc Pedod Prev Dent, V34, P48, DOI 10.4103/0970-4388.175512; Saxena RS, 2013, CLEFT PALATE-CRAN J, V50, pE105, DOI 10.1597/11-186; SCHAUMANN B, 1976, DERMATOGLYPHICS MED; Scott NM, 2005, HUM BIOL, V77, P257, DOI 10.1353/hub.2005.0042; Scott NM, 2005, CLEFT PALATE-CRAN J, V42, P362, DOI 10.1597/04-040.1; Seidenberg-Kajabova H, 2010, BIOMED PAP, V154, P211, DOI 10.5507/bp.2010.032; Silver W E, 1966, Cleft Palate J, V3, P368; Singh P, 2017, CLEFT PALATE-CRAN J, V54, P588, DOI 10.1597/15-168; Smarius Bram, 2017, World J Methodol, V7, P93, DOI 10.5662/wjm.v7.i3.93; Vormittag W, 1979, Birth Defects Orig Artic Ser, V15, P649; Weinberg SM, 2006, CLEFT PALATE-CRAN J, V43, P7, DOI 10.1597/04-122R1.1; WOOLF CM, 1976, AM J HUM GENET, V28, P400; WOOLF CM, 1977, AM J HUM GENET, V29, P503; Yamagata Y., 1973, SHIKOKU ACTA MEDICA, V29, P143	55	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0230534	10.1371/journal.pone.0230534	http://dx.doi.org/10.1371/journal.pone.0230534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196525	Green Published, gold			2022-12-26	WOS:000535303100036
J	Chirkova, T; Ha, B; Rimawi, BH; Oomens, AGP; Hartert, TV; Anderson, LJ				Chirkova, Tatiana; Ha, Binh; Rimawi, Bassam H.; Oomens, Antonius G. P.; Hartert, Tina, V; Anderson, Larry J.			In vitro model for the assessment of human immune responses to subunit RSV vaccines	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; REGULATORY T-CELLS; BLOOD MONONUCLEAR-CELLS; DENDRITIC CELL; COTTON RATS; MONOCLONAL-ANTIBODY; BALB/C MICE; OX40 LIGAND; PULMONARY EOSINOPHILIA; G-GLYCOPROTEIN	Respiratory syncytial virus (RSV) is the single most important cause of serious lower respiratory tract disease in infants and young children worldwide and a high priority for vaccine development. Despite over 50 years of research, however, no vaccine is yet available. One block to vaccine development is an incomplete understanding of the aberrant memory response to the formalin-inactivated RSV vaccine (FI-RSV) given to children in the 1960s. This vaccine caused enhanced respiratory disease (ERD) with later natural RSV infection. Concern that any non-live virus vaccine may also cause ERD has blocked development of subunit vaccines for young children. A number of animal FI-RSV studies suggest various immune mechanisms behind ERD. However, other than limited data from the original FI-RSV trial, there is no information on the human ERD-associated responses. An in vitro model with human blood specimens may shed light on the immune memory responses likely responsible for ERD. Memory T cell responses to an antigen are guided by the innate responses, particularly dendritic cells that present an antigen in conjunction with co-stimulatory molecules and cytokine signaling. Our in vitro model involves human monocyte derived dendritic cells (moDC) and allogenic T cell cultures to assess innate responses that direct T cell responses. Using this model, we evaluated human responses to live RSV, FI-RSV, and subunit RSV G vaccines (G-containing virus-like particles, G-VLP). Similar to findings in animal studies, FI-RSV induced prominent Th2/Th17-biased responses with deficient type-1 responses compared to live virus. Responses to G-VLPs were similar to live virus, i.e. biased towards a Th1 and not a Th2/Th17. Also mutating CX3C motif in G gave a more pronounced moDC responses associated with type-1 T cell responses. This in vitro model identifies human immune responses likely associated with ERD and provides another preclinical tool to assess the safety of RSV vaccines.	[Chirkova, Tatiana; Ha, Binh; Anderson, Larry J.] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA; [Rimawi, Bassam H.] WakeMed Hlth & Hosp, Maternal Fetal Med, Raleigh, NC USA; [Oomens, Antonius G. P.] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [Hartert, Tina, V] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN USA	Emory University; Oklahoma State University System; Oklahoma State University - Stillwater; Vanderbilt University	Anderson, LJ (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA.	larry.anderson@emory.edu		Rimawi, Bassam/0000-0002-8178-9212; Anderson, Larry/0000-0002-0652-6834; Hartert, Tina/0000-0001-7470-1166	NIH [2U19AI095227]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	TC, TVH, and LJA received funding through the NIH 2U19AI095227 (https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-16-065.html).The Emory Pediatric/Winship Flow Cytometry Core provided support for flow cytometry services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta PL, 2016, CLIN VACCINE IMMUNOL, V23, P189, DOI 10.1128/CVI.00609-15; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106; ANDERSON LJ, 1994, J INFECT DIS, V170, P1201, DOI 10.1093/infdis/170.5.1201; Antonis AFG, 2003, J VIROL, V77, P12067, DOI 10.1128/JVI.77.22.12067-12073.2003; Bont L, 2000, J INFECT DIS, V181, P1772, DOI 10.1086/315433; Bougarn Salim, 2019, F1000Res, V8, P284, DOI 10.12688/f1000research.18533.1; Boyoglu-Barnum S, 2017, J VIROL, V91, DOI 10.1128/JVI.02059-16; Boyoglu-Barnum S, 2015, VIROLOGY, V483, P117, DOI 10.1016/j.virol.2015.02.035; Boyoglu-Barnum S, 2014, J VIROL, V88, P10569, DOI 10.1128/JVI.01503-14; Boyoglu-Barnum S, 2013, J VIROL, V87, P10955, DOI 10.1128/JVI.01164-13; Cahill EF, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0021-5; Chen AI, 1999, IMMUNITY, V11, P689, DOI 10.1016/S1074-7613(00)80143-0; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Chirkova T, 2013, J VIROL, V87, P13466, DOI 10.1128/JVI.01741-13; CONNORS M, 1992, J VIROL, V66, P7444, DOI 10.1128/JVI.66.12.7444-7451.1992; CONNORS M, 1994, J VIROL, V68, P5321, DOI 10.1128/JVI.68.8.5321-5325.1994; Day SL, 2008, J IMMUNOL, V180, P7158, DOI 10.4049/jimmunol.180.11.7158; Derscheid RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081472; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Douville RN, 2006, J IMMUNOL, V176, P5848, DOI 10.4049/jimmunol.176.10.5848; Durant LR, 2013, J VIROL, V87, P10946, DOI 10.1128/JVI.01295-13; Ennaciri J, 2007, J LEUKOCYTE BIOL, V81, P625, DOI 10.1189/jlb.0806507; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Fleming EH, 2018, J MED VIROL, V90, P26, DOI 10.1002/jmv.24917; FULGINITI VA, 1969, AM J EPIDEMIOL, V89, P435, DOI 10.1093/oxfordjournals.aje.a120956; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Goritzka M, 2015, J EXP MED, V212, P699, DOI 10.1084/jem.20140825; Haynes LM, 2003, J VIROL, V77, P9831, DOI 10.1128/JVI.77.18.9831-9844.2003; Hicar MD, 2010, JAIDS-J ACQ IMM DEF, V54, P223, DOI 10.1097/QAI.0b013e3181dc98a3; Hwang HS, 2017, HUM VACC IMMUNOTHER, V13, P1031, DOI 10.1080/21645515.2016.1272743; Hwang HS, 2016, VIROLOGY, V494, P215, DOI 10.1016/j.virol.2016.04.014; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jackson M, 1996, J MED VIROL, V49, P161, DOI 10.1002/(SICI)1096-9071(199607)49:3<161::AID-JMV2>3.0.CO;2-2; Jenkins SJ, 2007, J IMMUNOL, V179, P3515, DOI 10.4049/jimmunol.179.6.3515; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Konig B, 1996, J LEUKOCYTE BIOL, V59, P403; Krause A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-375; KRILOV LR, 1989, J INFECT DIS, V160, P777, DOI 10.1093/infdis/160.5.777; Kumar P, 2017, SCI REP-UK, V7, DOI 10.1038/srep39751; Kurche JS, 2012, J IMMUNOL, V188, P585, DOI 10.4049/jimmunol.1102550; Lee DCP, 2010, J VIROL, V84, P8790, DOI 10.1128/JVI.00796-10; Lehmann S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132304; Loebbermann J, 2013, P NATL ACAD SCI USA, V110, P2987, DOI 10.1073/pnas.1217580110; Lyszkiewicz M, 2011, EUR J IMMUNOL, V41, P1256, DOI 10.1002/eji.201040977; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Majumder S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048727; Mangodt TC, 2015, PEDIATR RES, V78, P483, DOI 10.1038/pr.2015.143; Marinelarena A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33307-z; Mayer A, 2014, EUR J IMMUNOL, V44, P3252, DOI 10.1002/eji.201444646; Mazur NI, 2018, LANCET INFECT DIS, V18, pE295, DOI 10.1016/S1473-3099(18)30292-5; Mitra R, 2012, J VIROL, V86, P4432, DOI 10.1128/JVI.06744-11; Muralidharan A, 2017, EXPERT REV VACCINES, V16, P351, DOI 10.1080/14760584.2017.1260452; Murata K, 2000, J EXP MED, V191, P365, DOI 10.1084/jem.191.2.365; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Ohshima Y, 1997, J IMMUNOL, V158, P629; Ohshima Y, 1997, J IMMUNOL, V159, P3838; Okamoto M, 2009, J IMMUNOL, V183, P2995, DOI 10.4049/jimmunol.0900692; Ontiveros F, 2011, IMMUNOLOGY, V132, P549, DOI 10.1111/j.1365-2567.2010.03400.x; PIEDRA PA, 1989, VACCINE, V7, P34, DOI 10.1016/0264-410X(89)90008-X; Ponnuraj EM, 2003, J INFECT DIS, V187, P1257, DOI 10.1086/374604; Ponnuraj EM, 2001, J GEN VIROL, V82, P2663, DOI 10.1099/0022-1317-82-11-2663; PRESTON FM, 1995, J INFECT DIS, V172, P919, DOI 10.1093/infdis/172.4.919; PRINCE GA, 1986, J VIROL, V57, P721, DOI 10.1128/JVI.57.3.721-728.1986; Prince GA, 2001, J GEN VIROL, V82, P2881, DOI 10.1099/0022-1317-82-12-2881; Rey GU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083075; Ruckwardt TJ, 2009, J VIROL, V83, P3019, DOI 10.1128/JVI.00036-09; Russell MS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00597; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sawada A, 2016, MICROBIOL IMMUNOL, V60, P234, DOI 10.1111/1348-0421.12365; Scheltema NM, 2018, LANCET RESP MED, V6, P257, DOI 10.1016/S2213-2600(18)30055-9; Schijf MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081695; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Soukup JM, 2003, CLIN IMMUNOL, V107, P178, DOI 10.1016/S1521-6616(03)00038-X; Tarrant TK, 2012, ARTHRITIS RHEUM-US, V64, P1379, DOI 10.1002/art.34320; Tindemans I, 2017, J ALLERGY CLIN IMMUN, V140, P1079, DOI 10.1016/j.jaci.2016.11.046; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; Tripp RA, 2003, J VIROL, V77, P6580, DOI 10.1128/JVI.77.11.6580-6584.2003; Tripp RA, 2002, J INFECT DIS, V185, P1388, DOI 10.1086/340505; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; van Erp EA, 2017, J VIROL, V91, DOI 10.1128/JVI.00851-17; Vissers M, 2013, JOVE-J VIS EXP, DOI 10.3791/50766; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Waris ME, 1996, J VIROL, V70, P2852, DOI 10.1128/JVI.70.5.2852-2860.1996; Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273; Wu PS, 2011, EXPERT REV ANTI-INFE, V9, P731, DOI [10.1586/eri.11.92, 10.1586/ERI.11.92]; Yoneyama H, 2002, J EXP MED, V195, P1257, DOI 10.1084/jem.20011983; Yui I, 2003, J MED VIROL, V70, P481, DOI 10.1002/jmv.10421; Zeng RH, 2012, J VIROL, V86, P4505, DOI 10.1128/JVI.07091-11	93	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0229660	10.1371/journal.pone.0229660	http://dx.doi.org/10.1371/journal.pone.0229660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191728	Green Submitted, gold, Green Published			2022-12-26	WOS:000535302300013
J	Frola, CE; Zalazar, V; Cardozo, N; Vazquez, ML; Aristegui, I; Lucas, M; Gun, A; Cahn, P; Sued, O				Frola, Claudia E.; Zalazar, Virginia; Cardozo, Nadir; Vazquez, Maria L.; Aristegui, Ines; Lucas, Mar; Gun, Ana; Cahn, Pedro; Sued, Omar			Home-based HIV testing: Using different strategies among transgender women in Argentina	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; INFECTION; SEX; DIAGNOSIS; RESERVOIR; SYPHILIS; WORKERS; PEOPLE; GAY; MEN	Background In Argentina, HIV prevalence among transgender women (TGW) has been reported at 34%. The stigma is one of the most important factors limiting their access to healthcare services. The aims of this study were to compare different HIV testing methodologies, to determine the factors associated with HIV diagnosis and to determine the feasibility of a home-based HIV testing service for TGW. Methods A multidisciplinary team performed home-based HIV testing interventions in four cities of Argentina. Participants self-identified as TGW, older than 14 years and with a negative or unknown HIV status. Blood samples were screened by two rapid tests (RT), one based on antibodies (Determine (TM) HIV-1/2) and the other on antigen and antibodies (Determine (TM) HIV-1/2 Combo), and the subsequent blood processing via 4th generation ELISA (VIDAS HIV DUO). All reactive samples were confirmed with a viral load (VL). We compared the results of both RT with the ELISA. Samples were pooled in groups of 6 and a VL (Abbott Real Time) performed to identify acute HIV infections. Factors associated with HIV infection were evaluated with multivariate logistic regression analysis. Results A total of 260 TGW were tested, 51 tested positive (HIV prevalence 19.6%). There were no discordant results between both RTs nor between RTs and 4th generation ELISA, therefore the correlation was 100%. The VL identified 2 additional positive samples. The final analytic sample for positive cases consisted of 53 TGW. In the multivariate analysis, factors associated with a positive HIV result were history of other sexually transmitted infections (STIs) and not being previously tested for HIV. TGW tested for the first time were at 4 times greater risk of being HIV positive compared to those that were tested previously. Conclusions A multidisciplinary home-based HIV testing service among TGW is feasible and effective to detect cases of HIV infection. The testing algorithm should start with an RT followed by molecular diagnosis. The history of STIs and never having been tested for HIV were the factors associated with HIV-positive results and should determine efforts to reach this population. Home-based testing reaches individuals that were not tested before and who have more risk of acquiring HIV.	[Frola, Claudia E.] Juan A Fernandez Hosp, Div Infect Dis, Buenos Aires, DF, Argentina; [Frola, Claudia E.; Zalazar, Virginia; Cardozo, Nadir; Vazquez, Maria L.; Aristegui, Ines; Lucas, Mar; Gun, Ana; Cahn, Pedro; Sued, Omar] Fdn Huesped, Clin Res Dept, Buenos Aires, DF, Argentina; [Cardozo, Nadir] Assoc Transvestites Transsexuals & Transgenders A, Buenos Aires, DF, Argentina; [Aristegui, Ines] Univ Palermo, Buenos Aires, DF, Argentina	University of Buenos Aires	Frola, CE (corresponding author), Juan A Fernandez Hosp, Div Infect Dis, Buenos Aires, DF, Argentina.; Frola, CE (corresponding author), Fdn Huesped, Clin Res Dept, Buenos Aires, DF, Argentina.	claudia.frola@huesped.org.ar	Sued, Omar/GRJ-3964-2022	Aristegui, Ines/0000-0002-1196-5620	AlereT	AlereT	AlereT provided the 4th generation rapid test (Determine T HIV-1/2 Ag/Ab Combo) and contributed with funds for the study expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosioni J, 2014, EXPERT REV ANTI-INFE, V12, P793, DOI 10.1586/14787210.2014.913981; Ananworanich J, 2015, CURR OPIN HIV AIDS, V10, P18, DOI 10.1097/COH.0000000000000122; Aristegui I., 2014, LEY IDENTIDAD GENERO; Aristegui I, 2017, INT J TRANSGENDERISM, V18, P446, DOI 10.1080/15532739.2017.1314796; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Bauer GR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-292; Bowles KE, 2008, PUBLIC HEALTH REP, V123, P78, DOI 10.1177/00333549081230S310; Buzon MJ, 2014, J VIROL, V88, P10056, DOI 10.1128/JVI.01046-14; Cakeres CF, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000327436.36161.80; CDC, 2006, REVISED RECOMMENDATI, V55; Ribeiro LVD, 2015, SEX TRANSM INFECT, V91, P94, DOI 10.1136/sextrans-2014-051625; DiNenno EA, 2017, MMWR-MORBID MORTAL W, V66, P830, DOI 10.15585/mmwr.mm6631a3; Farias MSD, 2011, INT J INFECT DIS, V15, pE635, DOI 10.1016/j.ijid.2011.05.007; Socias ME, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0081-7; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Frola C., 2018, ACTUALIZACIONES SIDA, V26, P1; Ganguli Ishani, 2009, Curr HIV/AIDS Rep, V6, P217, DOI 10.1007/s11904-009-0029-5; Genberg BL, 2016, AIDS BEHAV, V20, P2452, DOI 10.1007/s10461-016-1307-z; Grant JM., 2011, INJUSTICE EVERY TURN; Horberg MA, 2012, JAIDS-J ACQ IMM DEF, V60, P183, DOI 10.1097/QAI.0b013e31824bd605; Jackson D, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18744; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Lahuerta M, 2011, SEX TRANSM INFECT, V87, P136, DOI 10.1136/sti.2010.043067; Lipsitz MC, 2014, INT J STD AIDS, V25, P325, DOI 10.1177/0956462413507443; Maughan-Brown B, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20658; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Ministerio de Salud y Desarrollo Social, 2018, B VIH SID ITS ARG N, V35; Ministerio de Salud y Desarrollo Social, 2018, AT INT SAL PERS TRAN; Miro JM, 2004, ENFERM INFEC MICR CL, V22, P643, DOI 10.1157/13069207; Parker MM, 2018, J CLIN VIROL, V104, P89, DOI 10.1016/j.jcv.2018.05.005; Pilcher CD, 2002, JAMA-J AM MED ASSOC, V288, P216, DOI 10.1001/jama.288.2.216; Poteat T, 2014, CURR OPIN HIV AIDS, V9, P168, DOI 10.1097/COH.0000000000000030; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Reisner SL, 2009, AIDS BEHAV, V13, P822, DOI 10.1007/s10461-008-9430-0; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Roland KB, 2017, HEALTH EQUITY, V1, P61, DOI 10.1089/heq.2017.0001; Rutstein SE, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21579; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; UNAIDS, 2014, UND FAST TRACK ACC A; WHO, 2015, CONSOLIDATED GUIDELI; WHO, 2016, SUPPL GUID HIV SELF; Wolff B, 2005, HEALTH POLICY PLANN, V20, P109, DOI 10.1093/heapol/czi013	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230429	10.1371/journal.pone.0230429	http://dx.doi.org/10.1371/journal.pone.0230429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191761	Green Published, gold, Green Submitted			2022-12-26	WOS:000535302300045
J	Pilquil, C; Alvandi, Z; Opas, M				Pilquil, Carlos; Alvandi, Zahra; Opas, Michal			Calreticulin regulates a switch between osteoblast and chondrocyte lineages derived from murine embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell (ESC); glycogen synthase kinase 3 (GSK-3); Wnt signaling; chondrogenesis; NFAT transcription factor; calreticulin; osteogenesis; nuclear factor of activated T cells 1 (NFATC1); gene regulation; cell fate decision; development	ENDOPLASMIC-RETICULUM; BONE-FORMATION; CALCINEURIN; CALCIUM; NFAT; DIFFERENTIATION; DICKKOPF-1; UPSTREAM; CA2+; DKK1	Calreticulin is a highly conserved, ubiquitous Ca2+-buffering protein in the endoplasmic reticulum that controls transcriptional activity of various developmental programs and also of embryonic stem cell (ESC) differentiation. Calreticulin activates calcineurin, which dephosphorylates and induces the nuclear import of the osteogenic transcription regulator nuclear factor of activated T cells 1 (NFATC1). We investigated whether calreticulin controls a switch between osteogenesis and chondrogenesis in mouse ESCs through NFATC1. We found that in the absence of calreticulin, intranuclear transport of NFATC1 is blocked and that differentiation switches from osteogenic to chondrogenic, a process that could be mimicked by chemical inhibition of NFAT translocation. Glycogen synthase kinase 3? (GSK3?) deactivation and nuclear localization of ?-catenin critical to osteogenesis were abrogated by calreticulin deficiency or NFAT blockade. Chemically induced GSK3? inhibition bypassed the calreticulin/calcineurin axis and increased osteoblast output from both control and calreticulin-deficient ESCs, while suppressing chondrogenesis. Calreticulin-deficient ESCs or cells treated with an NFAT blocker had enhanced expression of dickkopf WNT-signaling pathway inhibitor 1 (Dkk1), a canonical Wnt pathway antagonist that blocks GSK3? deactivation. The addition of recombinant mDKK1 switched osteogenic ESC differentiation toward chondrogenic differentiation. The results of our study indicate a role for endoplasmic reticulum calcium signaling via calreticulin in the differentiation of ESCs to closely associated osteoblast or chondrocyte lineages.	[Pilquil, Carlos; Alvandi, Zahra; Opas, Michal] Univ Toronto, Dept Lab Med & Pathobiol, 1 Kings Coll Circle,Med Sci Bldg,Rm 6326, Toronto, ON M5S 1A8, Canada	University of Toronto	Pilquil, C (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, 1 Kings Coll Circle,Med Sci Bldg,Rm 6326, Toronto, ON M5S 1A8, Canada.	cs2.pilquil@gmail.com		Pilquil, Carlos/0000-0002-4033-5054; Alvandi, Zahra/0000-0003-0097-4713	Canadian Institutes of Health Research (CIHR) [MOP-106461, MOP-130551]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grants MOP-106461 and MOP-130551 (to M. O.). The authors declare that they have no conflicts of interest with the contents of this article.	BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Craft AM, 2013, DEVELOPMENT, V140, P2597, DOI 10.1242/dev.087890; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Djuric SW, 2000, J MED CHEM, V43, P2975, DOI 10.1021/jm990615a; FRUMAN DA, 1992, EUR J IMMUNOL, V22, P2513, DOI 10.1002/eji.1830221008; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Groenendyk J, 2004, MOL CELLS, V17, P383; Guo L, 2002, J BIOL CHEM, V277, P50776, DOI 10.1074/jbc.M209900200; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Kumar D, 2014, CELL REP, V8, P1419, DOI 10.1016/j.celrep.2014.07.038; Lerner UH, 2015, J INTERN MED, V277, P630, DOI 10.1111/joim.12368; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Lynch J, 2005, J CELL BIOL, V170, P37, DOI 10.1083/jcb.200412156; Lynch J, 2003, BIOCHEM BIOPH RES CO, V311, P1173, DOI 10.1016/j.bbrc.2003.08.040; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; MICHAYLOVA V, 1971, ANAL CHIM ACTA, V53, P194, DOI 10.1016/S0003-2670(01)80088-X; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Papp S, 2003, J CELL BIOL, V160, P475, DOI 10.1083/jcb.200207136; Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169; Schwarz DS, 2016, CELL MOL LIFE SCI, V73, P79, DOI 10.1007/s00018-015-2052-6; Sitara D, 2010, IMMUNOL REV, V233, P286, DOI 10.1111/j.0105-2896.2009.00849.x; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Sun L, 2005, P NATL ACAD SCI USA, V102, P17130, DOI 10.1073/pnas.0508480102; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Tonelli FMP, 2012, ADV EXP MED BIOL, V740, P891, DOI 10.1007/978-94-007-2888-2_40; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Yu YH, 2016, METHODS MOL BIOL, V1341, P425, DOI 10.1007/7651_2014_126; Yu YH, 2015, DIFFERENTIATION, V89, P1, DOI 10.1016/j.diff.2014.12.003; Zhong L, 2016, STEM CELLS DEV, V25, P1808, DOI 10.1089/scd.2016.0222; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	41	6	6	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6861	6875		10.1074/jbc.RA119.011029	http://dx.doi.org/10.1074/jbc.RA119.011029			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32220932	Green Published, hybrid			2022-12-26	WOS:000536212600008
J	Lavenus, SB; Tudor, SM; Ullo, MF; Vosatka, KW; Logue, JS				Lavenus, Sandrine B.; Tudor, Sara M.; Ullo, Maria F.; Vosatka, Karl W.; Logue, Jeremy S.			A flexible network of vimentin intermediate filaments promotes migration of amoeboid cancer cells through confined environments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; metastasis; epithelial-to-mesenchymal transition (EMT); cell migration; cytoskeleton; vimentin; amoeboid; bleb; bundling; simvastatin	MOTILITY; CHOLESTEROL; PERSISTENCE; PROTEIN	Tumor cells can spread to distant sites through their ability to switch between mesenchymal and amoeboid (bleb-based) migration. Because of this difference, inhibitors of metastasis must account for each migration mode. However, the role of vimentin in amoeboid migration has not been determined. Because amoeboid leader bleb?based migration (LBBM) occurs in confined spaces and vimentin is known to strongly influence cell-mechanical properties, we hypothesized that a flexible vimentin network is required for fast amoeboid migration. To this end, here we determined the precise role of the vimentin intermediate filament system in regulating the migration of amoeboid human cancer cells. Vimentin is a classic marker of epithelial-to-mesenchymal transition and is therefore an ideal target for a metastasis inhibitor. Using a previously developed polydimethylsiloxane slab?based approach to confine cells, RNAi-based vimentin silencing, vimentin overexpression, pharmacological treatments, and measurements of cell stiffness, we found that RNAi-mediated depletion of vimentin increases LBBM by ?50% compared with control cells and that vimentin overexpression and simvastatin-induced vimentin bundling inhibit fast amoeboid migration and proliferation. Importantly, these effects were independent of changes in actomyosin contractility. Our results indicate that a flexible vimentin intermediate filament network promotes LBBM of amoeboid cancer cells in confined environments and that vimentin bundling perturbs cell-mechanical properties and inhibits the invasive properties of cancer cells.	[Lavenus, Sandrine B.; Tudor, Sara M.; Ullo, Maria F.; Vosatka, Karl W.; Logue, Jeremy S.] Albany Med Coll, Dept Regenerat & Canc Cell Biol, 47 New Scotland Ave,Bldg Med Sci MS,Rm MS420, Albany, NY 12208 USA	Albany Medical College	Logue, JS (corresponding author), Albany Med Coll, Dept Regenerat & Canc Cell Biol, 47 New Scotland Ave,Bldg Med Sci MS,Rm MS420, Albany, NY 12208 USA.	loguej@mail.amc.edu			Albany Medical College	Albany Medical College	This work was supported by start-up funds provided by Albany Medical College. The authors declare that they have no conflicts of interest with the contents of this article.	Benn M, 2011, JNCI-J NATL CANCER I, V103, P508, DOI 10.1093/jnci/djr008; Bergert M, 2015, NAT CELL BIOL, V17, P524, DOI 10.1038/ncb3134; CHOU YH, 1991, J BIOL CHEM, V266, P7325; Costigliola N, 2017, P NATL ACAD SCI USA, V114, P5195, DOI 10.1073/pnas.1614610114; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; DEGRELLA RF, 1982, J BIOL CHEM, V257, P4256; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Eckes B, 2000, J CELL SCI, V113, P2455; Elmen J, 2005, NUCLEIC ACIDS RES, V33, P439, DOI 10.1093/nar/gki193; Fiorenza AM, 2000, INT J CLIN LAB RES, V30, P141, DOI 10.1007/s005990070013; Galou M, 1996, J CELL BIOL, V133, P853, DOI 10.1083/jcb.133.4.853; Gan Z, 2016, CELL SYST, V3, P252, DOI 10.1016/j.cels.2016.08.007; GEORGATOS SD, 1987, J CELL BIOL, V105, P117, DOI 10.1083/jcb.105.1.117; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Henrion D, 1997, J CLIN INVEST, V100, P2909, DOI 10.1172/JCI119840; Jiu YM, 2015, CELL REP, V11, P1511, DOI 10.1016/j.celrep.2015.05.008; Leduc C, 2017, J CELL BIOL, V216, P1689, DOI 10.1083/jcb.201607045; Li M, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-109; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Logue J., 2018, PROTOC EXCH, DOI [10.1038/protex.2018.033, DOI 10.1038/PROTEX.2018.033]; Logue JS, 2018, ONCOGENE, V37, P2104, DOI 10.1038/s41388-017-0071-5; Logue JS, 2015, ELIFE, V4, DOI 10.7554/eLife.08314; Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145; Makise M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4454-y; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mendez MG, 2014, BIOPHYS J, V107, P314, DOI 10.1016/j.bpj.2014.04.050; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Mostajeran Z, 2019, VIMENTIN PROVIDES TH, DOI [10.1101/720946., DOI 10.1101/720946]; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Patteson A, VIMENTIN PROTECTS ST, DOI [10.1101/566174., DOI 10.1101/566174, 10.1101/566174]; Paul CD, 2017, NAT REV CANCER, V17, P131, DOI 10.1038/nrc.2016.123; Petrie RJ, 2014, SCIENCE, V345, P1062, DOI 10.1126/science.1256965; Phua DCY, 2009, MOL BIOL CELL, V20, P2841, DOI 10.1091/mbc.E08-02-0199; Raab M, 2016, SCIENCE, V352, P359, DOI 10.1126/science.aad7611; Ruprecht V, 2015, CELL, V160, P673, DOI 10.1016/j.cell.2015.01.008; Stroka KM, 2014, CELL, V157, P611, DOI 10.1016/j.cell.2014.02.052; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Trogden KP, 2018, FASEB J, V32, P2841, DOI 10.1096/fj.201700663R; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yamada KM, 2019, NAT REV MOL CELL BIO, V20, P738, DOI 10.1038/s41580-019-0172-9	45	18	18	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6700	6709		10.1074/jbc.RA119.011537	http://dx.doi.org/10.1074/jbc.RA119.011537			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32234762	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000537685000035
J	Lim, KS; Yong, ZWE; Wang, HJ; Tan, TZ; Huang, RYJ; Yamamoto, D; Inaki, N; Hazawa, M; Wong, RW; Oshima, H; Oshima, M; Ito, Y; Voon, DCC				Lim, Kee Siang; Yong, Zachary Wei Ern; Wang, Huajing; Tan, Tuan Zea; Huang, Ruby Yun-Ju; Yamamoto, Daisuke; Inaki, Noriyuki; Hazawa, Masaharu; Wong, Richard W.; Oshima, Hiroko; Oshima, Masanobu; Ito, Yoshiaki; Voon, Dominic Chih-Cheng			Inflammatory and mitogenic signals drive interleukin 23 subunit alpha (IL23A) secretion independent of IL12B in intestinal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine induction; inflammation; colorectal cancer; intestinal epithelium; mitogen-activated protein kinase (MAPK); IL23A; MAPK; NF-?B; RUNX; IL23A secretion; intestinal epithelial cells; mitogenic signal; carcinogenesis; non-canonical IL-23; innate immunity; cytokine signaling	NF-KAPPA-B; LYMPHOTOXIN-BETA; IL-23 P19; IN-VITRO; GENE-EXPRESSION; HUMAN COLON; C-REL; ACTIVATION; RUNX3; DABRAFENIB	The heterodimeric cytokine interleukin-23 (IL-23 or IL23A/IL12B) is produced by dendritic cells and macrophages and promotes the proinflammatory and regenerative activities of T helper 17 (Th17) and innate lymphoid cells. A recent study has reported that IL-23 is also secreted by lung adenoma cells and generates an inflammatory and immune-suppressed stroma. Here, we observed that proinflammatory tumor necrosis factor (TNF)/NF-?B and mitogen-activated protein kinase (MAPK) signaling strongly induce IL23A expression in intestinal epithelial cells. Moreover, we identified a strong crosstalk between the NF-?B and MAPK/ERK kinase (MEK) pathways, involving the formation of a transcriptional enhancer complex consisting of proto-oncogene c-Jun (c-Jun), RELA proto-oncogene NF-?B subunit (RelA), RUNX family transcription factor 1 (RUNX1), and RUNX3. Collectively, these proteins induced IL23A secretion, confirmed by immunoprecipitation of endogenous IL23A from activated human colorectal cancer (CRC) cell culture supernatants. Interestingly, IL23A was likely secreted in a noncanonical form, as it was not detected by an ELISA specific for heterodimeric IL-23 likely because IL12B expression is absent in CRC cells. Given recent evidence that IL23A promotes tumor formation, we evaluated the efficacy of MAPK/NF-?B inhibitors in attenuating IL23A expression and found that the MEK inhibitor trametinib and BAY 11?7082 (an IKK?/I?B inhibitor) effectively inhibited IL23A in a subset of human CRC lines with mutant KRAS or BRAFV600E mutations. Together, these results indicate that proinflammatory and mitogenic signals dynamically regulate IL23A in epithelial cells. They further reveal its secretion in a noncanonical form independent of IL12B and that small-molecule inhibitors can attenuate IL23A secretion.	[Lim, Kee Siang; Tan, Tuan Zea; Huang, Ruby Yun-Ju; Ito, Yoshiaki] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Lim, Kee Siang; Wong, Richard W.; Oshima, Hiroko; Oshima, Masanobu] Kanazawa Univ, WPI Nanolife Sci Inst NanoLSI, Kanazawa, Ishikawa 9201192, Japan; [Yong, Zachary Wei Ern; Yamamoto, Daisuke; Oshima, Hiroko; Oshima, Masanobu; Voon, Dominic Chih-Cheng] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 9201192, Japan; [Wang, Huajing] Agcy Sci Technol & Res, Inst Bioengn & Nanotechnol, Singapore 138669, Singapore; [Huang, Ruby Yun-Ju] Natl Univ Singapore Hosp, Dept Obstet & Gynaecol, Singapore 119228, Singapore; [Yamamoto, Daisuke] Ishikawa Prefectural Cent Hosp, Dept Gastroenterol Surg, Kanazawa, Ishikawa 9208530, Japan; [Inaki, Noriyuki] Juntendo Univ, Dept Digest & Gen Surg, Urayasu Hosp, Chiba 2790021, Japan; [Hazawa, Masaharu; Wong, Richard W.] Kanazawa Univ, Inst Nat Sci & Technol, Fac Nat Syst, Kanazawa, Ishikawa 9201192, Japan; [Hazawa, Masaharu; Wong, Richard W.; Voon, Dominic Chih-Cheng] Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa 9201192, Japan	National University of Singapore; Kanazawa University; Kanazawa University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); National University of Singapore; Ishikawa Prefectural Central Hospital; Juntendo University; Kanazawa University; Kanazawa University	Ito, Y (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore.; Voon, DCC (corresponding author), Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 9201192, Japan.; Voon, DCC (corresponding author), Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa 9201192, Japan.	yoshi_ito@nus.edu.sg; dvoon@staff.kanazawa-u.ac.jp	HAZAWA, Masaharu/A-6520-2016; Tan, Tuan Zea/I-9227-2019; Lim, Kee Siang/AAH-1407-2019; Wong, Richard W./E-9155-2011; Inaki, Noriyuki/B-4361-2018; Hazawa, M/AAA-2712-2021	Tan, Tuan Zea/0000-0001-6624-1593; Inaki, Noriyuki/0000-0002-4241-5015; Huang, Ruby Yun-Ju/0000-0001-6376-3185; Oshima, Hiroko/0000-0001-6855-4008; Voon, Dominic Chih-Cheng/0000-0002-2963-9305; Wong, Richard/0000-0002-2131-6595	Ministry of Education Academic Research Fund (AcRF) Tier 2 Grant [MOE2014-T2-2-143]; Ministry of Education, Culture, Sports, Science and Technology of Japan [JP18K07228]; Institute for Frontier Science Initiative, Kanazawa University, inter-disciplinary research grant	Ministry of Education Academic Research Fund (AcRF) Tier 2 Grant; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute for Frontier Science Initiative, Kanazawa University, inter-disciplinary research grant	This work was supported by Ministry of Education Academic Research Fund (AcRF) Tier 2 Grant MOE2014-T2-2-143 (to Y. I.); a Ministry of Education, Culture, Sports, Science and Technology of Japan Grant-in-Aid for Scientific Research JP18K07228 (to D. C.-C. V.); and an Institute for Frontier Science Initiative, Kanazawa University, inter-disciplinary research grant. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Salleeh F, 2008, J IMMUNOL, V181, P4523, DOI 10.4049/jimmunol.181.7.4523; Al-Sammak F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075192; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Broad Institute TCGA Genome Data Analysis Center, 2016, AN READ STAND TCGA D; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Ciccia F, 2009, ARTHRITIS RHEUM-US, V60, P955, DOI 10.1002/art.24389; Corcoran RB, 2018, CANCER DISCOV, V8, P428, DOI 10.1158/2159-8290.CD-17-1226; Corcoran RB, 2015, J CLIN ONCOL, V33, P4023, DOI 10.1200/JCO.2015.63.2471; Croxford AL, 2014, CYTOKINE GROWTH F R, V25, P415, DOI 10.1016/j.cytogfr.2014.07.017; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036739; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Floss DM, 2015, CYTOKINE GROWTH F R, V26, P569, DOI 10.1016/j.cytogfr.2015.07.005; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hamelin V, 2006, BLOOD, V107, P3106, DOI 10.1182/blood-2005-07-2953; Hasegawa H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00479; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hor YT, 2014, CELL REP, V8, P50, DOI 10.1016/j.celrep.2014.06.003; Imai Y, 2004, MOL CELL BIOL, V24, P1033, DOI 10.1128/MCB.24.3.1033-1043.2004; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kopp T, 2003, J IMMUNOL, V170, P5438, DOI 10.4049/jimmunol.170.11.5438; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; LI YC, 1991, MOL CELL BIOL, V11, P1883, DOI 10.1128/MCB.11.4.1883; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Liu L, 2015, CLIN CANCER RES, V21, P1639, DOI 10.1158/1078-0432.CCR-14-2339; Macho-Fernandez E, 2015, MUCOSAL IMMUNOL, V8, P403, DOI 10.1038/mi.2014.78; McGeachy MJ, 2007, SEMIN IMMUNOL, V19, P372, DOI 10.1016/j.smim.2007.10.012; Michaud J, 2002, BLOOD, V99, P1364, DOI 10.1182/blood.V99.4.1364; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Morrison PJ, 2011, IMMUNOLOGY, V133, P397, DOI 10.1111/j.1365-2567.2011.03454.x; Moscat J, 2003, EMBO REP, V4, P31, DOI 10.1038/sj.embor.embor704; Mouradov D, 2014, CANCER RES, V74, P3238, DOI 10.1158/0008-5472.CAN-14-0013; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oh YS, 2013, CELL, V152, P831, DOI 10.1016/j.cell.2013.01.014; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Ramnath D, 2015, IMMUNOL CELL BIOL, V93, P771, DOI 10.1038/icb.2015.77; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Subrata LS, 2012, CYTOKINE, V60, P498, DOI 10.1016/j.cyto.2012.05.029; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051; Utsugi M, 2006, J IMMUNOL, V177, P4550, DOI 10.4049/jimmunol.177.7.4550; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; Voon DC, 2004, J IMMUNOL, V172, P4332, DOI 10.4049/jimmunol.172.7.4332; Voon DC, 2001, J INTERF CYTOK RES, V21, P921, DOI 10.1089/107999001753289532; Voon DCC, 2012, STEM CELLS, V30, P2088, DOI 10.1002/stem.1183; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Yao WL, 2016, J BIOL CHEM, V291, P21694, DOI 10.1074/jbc.M116.738302	59	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6387	6400		10.1074/jbc.RA120.012943	http://dx.doi.org/10.1074/jbc.RA120.012943			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32209656	hybrid, Green Published			2022-12-26	WOS:000537685000012
J	Markovic, MA; Srikrishnaraj, A; Tsang, D; Brubaker, PL				Markovic, Melanie A.; Srikrishnaraj, Arjuna; Tsang, Derek; Brubaker, Patricia L.			Requirement for the intestinal epithelial insulin-like growth factor-1 receptor in the intestinal responses to glucagon-like peptide-2 and dietary fat	FASEB JOURNAL			English	Article						APOC3; CD36; enterocyte; FATP-4; GLP-2; MTP; Western diet	ACID TRANSPORT; CHYLOMICRON PRODUCTION; LIPID ABSORPTION; CD36; MICE; LOCALIZATION; DEFICIENCY; RESISTANCE; EXPRESSION; SECRETION	The intestinal hormone, glucagon-like peptide-2 (GLP-2), enhances the enterocyte chylomicron production. However, GLP-2 is known to require the intestinal-epithelial insulin-like growth factor-1 receptor (IE-IGF-1R) for its other actions to increase intestinal growth and barrier function. The role of the IE-IGF-1R in enterocyte lipid handling was thus tested in the GLP-2 signaling pathway, as well as in response to a Western diet (WD). IE-IGF-1R knockout (KO) and control mice were treated for 11 days with h(GLY(2))GLP-2 or fed a WD for 18 weeks followed by a duodenal fat tolerance test with C-14-labeled triolein. Human Caco-2BBE cells were treated with an IGF-1R antagonist or signaling inhibitors to determine triglyceride-associated protein expression. The IE-IGF-1R was required for GLP-2-induced increases in CD36 and FATP-4 in chow-fed mice, and for expression in vitro; FATP-4 also required PI3K/Akt. Although WD-fed IE-IGF-1R KO mice demonstrated normal CD36 expression, the protein was incorrectly localized 2h post-duodenal fat administration. IE-IGF-1R KO also prevented the WD-induced increase in MTP and decrease in APOC3, increased jejunal mucosal C-14-fat accumulation, and elevated plasma triglyceride and C-14-fat levels. Collectively, these studies elucidate new roles for the IE-IGF-1R in enterocyte lipid handling, under basal conditions and in response to GLP-2 and WD-feeding.	[Markovic, Melanie A.; Srikrishnaraj, Arjuna; Tsang, Derek; Brubaker, Patricia L.] Univ Toronto, Dept Physiol, Rm 3366 Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada; [Brubaker, Patricia L.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto	Brubaker, PL (corresponding author), Univ Toronto, Dept Physiol, Rm 3366 Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	p.brubaker@utoronto.ca		Srikrishnaraj, Arjuna/0000-0002-7828-2779				Alexander AN, 2001, AM J PHYSIOL-GASTR L, V280, pG222, DOI 10.1152/ajpgi.2001.280.2.G222; Bjerknes M, 2001, P NATL ACAD SCI USA, V98, P12497, DOI 10.1073/pnas.211278098; Brubaker PL, 2018, COMPR PHYSIOL, V8, P1185, DOI 10.1002/cphy.c170055; Brubaker PL, 1997, AM J PHYSIOL-ENDOC M, V272, pE1050, DOI 10.1152/ajpendo.1997.272.6.E1050; Buttet M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145626; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Crawley SW, 2014, CELL, V157, P433, DOI 10.1016/j.cell.2014.01.067; Dash S, 2014, GASTROENTEROLOGY, V147, P1275, DOI 10.1053/j.gastro.2014.08.037; Desmarchelier C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-84; Dong CX, 2014, ENDOCRINOLOGY, V155, P370, DOI 10.1210/en.2013-1871; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Dube PE, 2008, ENDOCRINOLOGY, V149, P291, DOI 10.1210/en.2007-0561; Dube PE, 2006, GASTROENTEROLOGY, V131, P589, DOI 10.1053/j.gastro.2006.05.055; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Feingold KR, 2000, EFFECT ENDOCRINE DIS; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Haidari M, 2002, J BIOL CHEM, V277, P31646, DOI 10.1074/jbc.M200544200; Hernandez V. S. J., 2009, AM J PHYSIOL-GASTR L, V296, P782; Hsieh J, 2015, ENDOCRINOLOGY, V156, P3538, DOI 10.1210/EN.2015-1110; Hsieh J, 2009, GASTROENTEROLOGY, V137, P997, DOI 10.1053/j.gastro.2009.05.051; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-14; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Jain SS, 2015, FEBS LETT, V589, P2769, DOI 10.1016/j.febslet.2015.08.010; Jeppesen PB, 2015, CURR OPIN ENDOCRINOL, V22, P14, DOI 10.1097/MED.0000000000000120; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Khalifeh-Soltani A, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87418; Kraus D., 2015, BIO PROTOC, V5, pe1375; Kumar NS, 1999, AM J PHYSIOL-GASTR L, V276, pG378, DOI 10.1152/ajpgi.1999.276.2.G378; Kuwasako T, 2003, DIABETES CARE, V26, P1647, DOI 10.2337/diacare.26.5.1647-a; Larsson M, 2013, J BIOL CHEM, V288, P33997, DOI 10.1074/jbc.M113.495366; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobo MVT, 2001, J HISTOCHEM CYTOCHEM, V49, P1253, DOI 10.1177/002215540104901007; Markovic MA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49510-5; Masuda D, 2009, J LIPID RES, V50, P999, DOI 10.1194/jlr.P700032-JLR200; Meier JJ, 2006, GASTROENTEROLOGY, V130, P44, DOI 10.1053/j.gastro.2005.10.004; MEYER JH, 1974, AM J PHYSIOL, V226, P1178; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Nelson DW, 2008, AM J PHYSIOL-REG I, V294, pR1175, DOI 10.1152/ajpregu.00238.2007; Nelson DW, 2014, J BIOL CHEM, V289, P17338, DOI 10.1074/jbc.M114.555961; Nelson DW, 2011, J LIPID RES, V52, P1723, DOI 10.1194/jlr.M016840; Orskov C, 2005, REGUL PEPTIDES, V124, P105, DOI 10.1016/j.regpep.2004.07.009; Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; Rowland KJ, 2011, GASTROENTEROLOGY, V141, P2166, DOI 10.1053/j.gastro.2011.09.014; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Thi TTT, 2011, J BIOL CHEM, V286, P25201, DOI 10.1074/jbc.M111.233551; Thorne RF, 2010, BBA-MOL CELL RES, V1803, P1298, DOI 10.1016/j.bbamcr.2010.07.002; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Wang F, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.247; WATANABE S, 1988, AM J PHYSIOL, V254, pG837, DOI 10.1152/ajpgi.1988.254.6.G837; Xiao CT, 2019, DIABETES OBES METAB, V21, P2535, DOI 10.1111/dom.13839; Xiao CT, 2018, TRENDS ENDOCRIN MET, V29, P151, DOI 10.1016/j.tem.2017.12.001; Yusta B, 2000, GASTROENTEROLOGY, V119, P744, DOI 10.1053/gast.2000.16489; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200	61	5	6	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6628	6640		10.1096/fj.202000169R	http://dx.doi.org/10.1096/fj.202000169R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32212202	Bronze			2022-12-26	WOS:000531325500044
J	Avancini, A; Skroce, K; Tregnago, D; Frada, P; Trestini, I; Cercato, MC; Bonaiuto, C; Tarperi, C; Schena, F; Milella, M; Pilotto, S; Lanza, M				Avancini, Alice; Skroce, Kristina; Tregnago, Daniela; Frada, Paolo; Trestini, Ilaria; Cercato, Maria Cecilia; Bonaiuto, Clelia; Tarperi, Cantor; Schena, Federico; Milella, Michele; Pilotto, Sara; Lanza, Massimo			"Running with cancer": A qualitative study to evaluate barriers and motivations in running for female oncological patients	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; EXERCISE PROGRAM; LIFE-STYLE; OF-LIFE; HEALTH; SURVIVORS	Nowadays, it is widely acknowledged that low physical activity levels are associated with an increase in terms of both disease recurrence and mortality in cancer survivors. In this light, deciphering those factors able to hamper or facilitate an active lifestyle is crucial in order to increase patients' adherence to physical activity. The purpose of this study was to explore barriers and motivations in a sample of female oncological patients, practising running using the ecological model and compare them with healthy controls. Focus group interviews were conducted at Verona University. Participants were 12 female cancer survivors and 7 matched healthy controls who had participated at "Run for Science" project. The interviews were transcribed verbatim and analyzed using content analysis. Transcripts were categorized according to the ecological model, identifying barriers and motivations as themes. About motivations, three sub-themes were included: personal, interpersonal and environmental/organizational factors. Regarding barriers, another sub-theme was recognized: community/policy factors. Compared to healthy controls, survivors expressed motivations and barriers specifically related to their oncological disease. Running was a challenge with their cancer and a hope to give to other patients. Main barriers were represented by treatment-related side effects, inexperienced trainers and external factors, e.g. delivery of incorrect information. Running programs dedicated to oncological patients should consider intrinsic obstacles, related to cancer and its treatment. The interventions should offer a personalized program performed by qualified trainers, together with a motivational approach able to improve participants' adherence to an active lifestyle.	[Avancini, Alice] Univ Verona Hosp Trust, Dept Med Biomed Clin & Expt Sci, Verona, Italy; [Skroce, Kristina; Frada, Paolo; Tarperi, Cantor; Schena, Federico; Lanza, Massimo] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Tregnago, Daniela; Trestini, Ilaria; Bonaiuto, Clelia; Milella, Michele; Pilotto, Sara] Univ Verona Hosp Trust, Dept Oncol, Verona, Italy; [Cercato, Maria Cecilia] IRCCS, Epidemiol & Canc Registry Unit, Regina Elena Natl Canc Inst, Rome, Italy; [Tarperi, Cantor] Univ Turin, Dept Clin & Biol Sci, Turin, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Turin	Avancini, A (corresponding author), Univ Verona Hosp Trust, Dept Med Biomed Clin & Expt Sci, Verona, Italy.	alice.avancini@univr.it	Milella, Michele/ABH-8606-2020; Skroce, Kristina/HDN-5407-2022; Avancini, Alice/ABE-2707-2020; Cercato, Maria Cecilia/K-2406-2018	Avancini, Alice/0000-0003-2439-4799; Cercato, Maria Cecilia/0000-0002-8346-6601; Schena, Federico/0000-0002-2052-5117				Aiom A., 2018, NUMERI NEL CANCRO IT; Blaney J, 2010, PHYS THER, V90, P1135, DOI 10.2522/ptj.20090278; Campbell KL, 2019, MED SCI SPORT EXER, V51, P2375, DOI 10.1249/MSS.0000000000002116; Casla S, 2015, BREAST CANCER RES TR, V153, P371, DOI 10.1007/s10549-015-3541-x; Chen HM, 2016, BRIT J CANCER, V115, P1304, DOI 10.1038/bjc.2016.356; Cormie P, 2017, EPIDEMIOL REV, V39, P71, DOI 10.1093/epirev/mxx007; Danese E, 2017, ONCOTARGET, V8, P52775, DOI 10.18632/oncotarget.17188; Erlingsson C, 2017, AFR J EMERG MED, V7, P93, DOI 10.1016/j.afjem.2017.08.001; Frensham LJ, 2018, INT J ENV RES PUBLIC, V15; Gavazzi C, 2018, NUTRITION, V55-56, P140, DOI 10.1016/j.nut.2018.04.002; Hardcastle SJ, 2018, SUPPORT CARE CANCER, V26, P1289, DOI 10.1007/s00520-017-3952-9; Hardcastle SJ, 2017, PSYCHO-ONCOLOGY, V26, P199, DOI 10.1002/pon.4111; Henriksson A, 2016, PATIENT EDUC COUNS, V99, P1220, DOI 10.1016/j.pec.2016.01.019; Husebo AML, 2015, J CLIN NURS, V24, P500, DOI 10.1111/jocn.12633; King KM, 2018, ACSMS HEALTH FIT J, V22, P29, DOI 10.1249/FIT.0000000000000397; Kostopoulou V, 2006, J MED ETHICS, V32, P693, DOI 10.1136/jme.2005.015487; Lee DC, 2017, PROG CARDIOVASC DIS, V60, P45, DOI 10.1016/j.pcad.2017.03.005; Lippi G, 2017, J LAB PRECISION MED, V2; McIntosh M, 2019, EUR J ONCOL NURS, V41, P135, DOI 10.1016/j.ejon.2019.06.006; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Rogers LQ, 2017, PSYCHO-ONCOLOGY, V26, P1901, DOI 10.1002/pon.4254; Rogers LQ, 2015, BREAST CANCER RES TR, V149, P109, DOI 10.1007/s10549-014-3216-z; Scott JM, 2018, J CLIN ONCOL, V36, P2297, DOI 10.1200/JCO.2017.77.5809; Singh B, 2018, ARCH PHYS MED REHAB, V99, P2621, DOI 10.1016/j.apmr.2018.03.026; Stene GB, 2013, CRIT REV ONCOL HEMAT, V88, P573, DOI 10.1016/j.critrevonc.2013.07.001; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van Dyck D, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111315; Zach S, 2017, J SPORT HEALTH SCI, V6, P302, DOI 10.1016/j.jshs.2015.10.003	29	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0227846	10.1371/journal.pone.0227846	http://dx.doi.org/10.1371/journal.pone.0227846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8KJ	32240181	gold, Green Published, Green Submitted			2022-12-26	WOS:000535945000013
J	Rhead, B; Sheo, XR; Quach, H; Ghai, P; Barcellos, LF; Bowcock, AM				Rhead, Brooke; Sheo, Xiaorong; Hong Quach; Ghai, Poonam; Barcellos, Lisa F.; Bowcock, Anne M.			Global expression and CpG methylation analysis of primary endothelial cells before and after TNFa stimulation reveals gene modules enriched in inflammatory and infectious diseases and associated DMRs	PLOS ONE			English	Article							DNA METHYLATION; PSORIASIS; DATABASE; OBESITY	Endothelial cells are a primary site of leukocyte recruitment during inflammation. An increase in tumor necrosis factor-alpha (TNFa) levels as a result of infection or some autoimmune diseases can trigger this process. Several autoimmune diseases are now treated with TNFa inhibitors. However, genomic alterations that occur as a result of TNF-mediated inflammation are not well understood. To investigate molecular targets and networks resulting from increased TNFa, we measured DNA methylation and gene expression in 40 human umbilical vein endothelial cell primary cell lines before and 24 hours after stimulation with TNFa via microarray. Weighted gene co-expression network analysis identified 15 gene groups (modules) with similar expression correlation patterns; four modules showed a strong association with TNFa treatment. Genes in the top TNFa-associated module were all up-regulated, had the highest proportion of hypomethylated regions, and were associated with 136 Disease Ontology terms, including autoimmune/inflammatory, infectious and cardiovascular diseases, and cancers. They included chemokines CXCL1, CXCL10 and CXCL8, and genes associated with autoimmune diseases including HLA-C, DDX58, IL4, NFKBIA and TNFAIP3. Cardiovascular and metabolic disease genes, including APOC1, ACLY, ELOVL6, FASN and SCD, were overrepresented in a module that was not associated with TNFa treatment. Of 223 hypomethylated regions identified, several were in promoters of autoimmune disease GWAS loci (ARID5B, CD69, HDAC9, IL7R, TNIP1 and TRAF1). Results reveal specific gene groups acting in concert in endothelial cells, delineate those driven by TNFa, and establish their relationship to DNA methylation changes, which has strong implications for understanding disease etiology and precision medicine approaches.	[Rhead, Brooke; Sheo, Xiaorong; Hong Quach; Barcellos, Lisa F.] Univ Calif Berkeley, Genet Epidemiol & Genom Lab, Berkeley, CA 94720 USA; [Rhead, Brooke; Barcellos, Lisa F.] Univ Calif Berkeley, Computat Biol Grad Grp, Berkeley, CA 94720 USA; [Ghai, Poonam; Bowcock, Anne M.] Natl Heart & Lung Inst, London, England; [Bowcock, Anne M.] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA; [Bowcock, Anne M.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Bowcock, Anne M.] Icahn Sch Med Mt Sinai, Dept Genet & Genome Sci, New York, NY 10029 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Imperial College London; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Bowcock, AM (corresponding author), Natl Heart & Lung Inst, London, England.; Bowcock, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA.; Bowcock, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.; Bowcock, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genome Sci, New York, NY 10029 USA.	anne.bowcock@mssm.edu		Rhead, Brooke/0000-0002-1839-4883	NIH [AR050266, R01ES017080, F31NS096885]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH (https://www.nih.gov) grants AR050266 to A.M.B, R01ES017080 to L.F.B., and F31NS096885 to B.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn J, 2015, CLIN IMMUNOL, V161, P59, DOI 10.1016/j.clim.2015.05.024; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Atehortua L, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9680729; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brown G, 2017, J AM ACAD DERMATOL, V76, P334, DOI 10.1016/j.jaad.2016.08.012; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; Durante Alessandro, 2015, J Clin Med Res, V7, P379, DOI 10.14740/jocmr2122w; Endo Y, 2017, CELL MOL LIFE SCI, V74, P1231, DOI 10.1007/s00018-016-2399-3; Fishilevich S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax028; Gheorghe M, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gky1210; Granata M, 2017, PATHOBIOLOGY, V84, P71, DOI 10.1159/000447777; Haeussler M, 2019, NUCLEIC ACIDS RES, V47, pD853, DOI 10.1093/nar/gky1095; Harden JL, 2015, J AUTOIMMUN, V64, P66, DOI 10.1016/j.jaut.2015.07.008; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Kemanetzoglou E, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0742-1; Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lindhaus C, 2017, J DTSCH DERMATOL GES, V15, P281, DOI 10.1111/ddg.13200; Luo CY, 2018, SCIENCE, V361, P1336, DOI 10.1126/science.aat6806; McCartney DL, 2016, GENOM DATA, V9, P22, DOI 10.1016/j.gdata.2016.05.012; Murdaca G, 2015, EXPERT OPIN DRUG SAF, V14, P571, DOI 10.1517/14740338.2015.1009036; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Peng K, 2013, NUCLEIC ACIDS RES, V41, pD553, DOI 10.1093/nar/gks1244; Perron P, 2016, PLOS ONE, V8, P1; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tirado-Magallanes R, 2017, ONCOTARGET, V8, P5629, DOI 10.18632/oncotarget.13562; Van Raemdonck K, 2018, AUTOIMMUN REV, V17, P821, DOI 10.1016/j.autrev.2018.02.007; Williams EL, 2009, RHEUMATOLOGY, V48, P716, DOI 10.1093/rheumatology/kep080; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012; Zhou FS, 2018, CELL IMMUNOL, V331, P16, DOI 10.1016/j.cellimm.2018.04.016	37	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230884	10.1371/journal.pone.0230884	http://dx.doi.org/10.1371/journal.pone.0230884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LC8NI	32231389	gold, Green Published			2022-12-26	WOS:000525589200001
J	Touloumi, G; Kalpourtzi, N; Papastamopoulos, V; Paparizos, V; Adamis, G; Antoniadou, A; Chini, M; Karakosta, A; Makrilakis, K; Gavana, M; Vantarakis, A; Psichogiou, M; Metallidis, S; Sipsas, NV; Sambatakou, H; Hadjichristodoulou, C; Voulgari, PV; Chrysos, G; Gogos, C; Chlouverakis, G; Tripsianis, G; Alamanos, Y; Stergiou, G				Touloumi, Giota; Kalpourtzi, Natasa; Papastamopoulos, Vasileios; Paparizos, Vasilios; Adamis, Georgios; Antoniadou, Anastasia; Chini, Maria; Karakosta, Argiro; Makrilakis, Konstantinos; Gavana, Magda; Vantarakis, Apostolos; Psichogiou, Mina; Metallidis, Simeon; Sipsas, Nikolaos, V; Sambatakou, Helen; Hadjichristodoulou, Christos; Voulgari, Paraskevi V.; Chrysos, George; Gogos, Charalambos; Chlouverakis, Grigoris; Tripsianis, Grigoris; Alamanos, Yannis; Stergiou, George		AMACS; EMENO	Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in Greece	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; BODY-MASS INDEX; HIV-1-INFECTED PATIENTS; UNINFECTED INDIVIDUALS; COLLABORATIVE ANALYSIS; DISEASE; HYPERTENSION; PREVALENCE; SCORE; AGE	Background Although combined antiretroviral therapy has substantially improved the prognosis of people living with HIV (PLHIV), mortality remains higher compared to the general population, mainly due to higher prevalence of non-HIV-related comorbidities, including cardiovascular diseases (CVD). We assessed the prevalence of CVD risk and its contributing factors in adult PLHIV versus general population controls in Greece. Settings Cross-sectional comparison of PLHIV (Athens-Multicenter-AIDS-Cohort-Study; AMACS) versus general population controls (National health examination survey; EMENO). Methods All HIV-infected adults with >= 1 measurement of interest (blood pressure, lipids, glucose, weight, height) between 2012-2014 and all EMENO participants (2014-2016) were included. Ten-year total CVD risk was estimated using the Framingham (FRS) or the Systematic Coronary Risk Evaluation (SCORE) equations. Results 5839 PLHIV (median age:41.6 years, 85.4% males) and 4820 controls (median age:48 years, 48.4% males) were included. Adjusting for age, sex and origin, PLHIV were more likely to be current smokers (adjusted OR:1.53 [95% CI:1.35-1.74]) and dyslipidemic (aOR:1.18; [1.04-1.34]), less likely to be obese (aOR:0.44 [0.38-0.52], with no differences in hypertension, diabetes or high (>= 20%) FRS but with greater odds of high (>= 5%) SCORE (aOR:1.55 [1.05-2.30]). Further adjustment for educational level, anti-HCV positivity and BMI showed higher prevalence of hypertension in PLHIV. Conclusions Despite the relative absence of obesity, PLHIV have higher prevalence of traditional CVD risk factors and higher risk of fatal CVD compared to general population. Regular screening and early management of CVD risk factors in PLHIV should be of high priority for CVD prevention.	[Touloumi, Giota; Kalpourtzi, Natasa; Karakosta, Argiro] Natl & Kapodistrian Univ Athens, Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Papastamopoulos, Vasileios] Evaggelismos Gen Hosp, Dept Internal Med 5, Athens, Greece; [Papastamopoulos, Vasileios] Evaggelismos Gen Hosp, Infect Dis Unit, Athens, Greece; [Paparizos, Vasilios] Syngros Hosp, AIDS Unit, Clin Venereol & Dermatol Dis, Athens, Greece; [Adamis, Georgios] Gennimatas Gen Hosp, Dept Internal Med & Infect Dis 1, Athens, Greece; [Antoniadou, Anastasia] Natl & Kapodistrian Univ Athens, Attikon Gen Hosp, Med Sch, Dept Internal Med 4, Athens, Greece; [Chini, Maria] Red Cross Gen Hosp, Dept Internal Med 3, Infect Dis Unit, Athens, Greece; [Makrilakis, Konstantinos] Natl & Kapodistrian Univ Athens, Med Sch, Hellen Diabet Assoc, Athens, Greece; [Gavana, Magda] Aristotle Univ Thessaloniki, Sch Hlth Sci, Med Dept, Lab Primary Hlth Care Gen Med & Hlth Serv Res, Thessaloniki, Greece; [Vantarakis, Apostolos] Univ Patras, Med Sch, Environm Hlth, Patras, Greece; [Psichogiou, Mina] Natl & Kapodistrian Univ Athens, Med Sch, Dept Internal Med 1, Athens, Greece; [Metallidis, Simeon] Aristotle Univ Thessaloniki, Ahepa Univ Hosp, Internal Med Dept 1, Infect Dis Unit, Thessaloniki, Greece; [Sipsas, Nikolaos, V] Natl & Kapodistrian Univ Athens, Dept Pathophysiol, Infect Dis Unit, Laikon Athens Gen Hosp, Athens, Greece; [Sipsas, Nikolaos, V] Natl & Kapodistrian Univ Athens, Med Sch, Athens, Greece; [Sambatakou, Helen] Natl & Kapodistrian Univ Athens, Hippokrat Gen Hosp, Med Sch, Dept Internal Med 2,HIV Unit, Athens, Greece; [Hadjichristodoulou, Christos] Univ Thessaly, Med Fac, Dept Hyg & Epidemiol, Larisa, Greece; [Voulgari, Paraskevi V.] Univ Ioannina, Dept Internal Med, Rheumatol Clin, Ioannina, Greece; [Chrysos, George] Tzane Gen Hosp Piraeus, Infect Dis Unit, Athens, Greece; [Gogos, Charalambos] Univ Patras, Dept Internal Med & Infect Dis, Gen Hosp, Patras, Greece; [Chlouverakis, Grigoris] Univ Crete, Sch Med, Div Biostat, Iraklion, Greece; [Tripsianis, Grigoris] Democritus Univ Thrace, Med Fac, Dept Med Stat, Alexandroupolis, Greece; [Alamanos, Yannis] Inst Epidemiol Prevent Med & Publ Hlth, Corfu, Greece; [Stergiou, George] Natl & Kapodistrian Univ Athens, Sotiria Hosp, Hypertens Ctr, Sch Med,STRIDE 7,Dept Med 3, Athens, Greece	National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; University Hospital Attikon; National & Kapodistrian University of Athens; Aristotle University of Thessaloniki; University of Patras; National & Kapodistrian University of Athens; Aristotle University of Thessaloniki; Ahepa University Hospital; Laiko General Hospital; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; University of Thessaly; University of Ioannina; University of Patras; University of Crete; Democritus University of Thrace; Athens Medical School; National & Kapodistrian University of Athens	Touloumi, G (corresponding author), Natl & Kapodistrian Univ Athens, Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece.	gtouloum@med.uoa.gr	Gavana, Magda/ABE-7184-2020	Hadjichristodoulou, Christos/0000-0002-4769-8376; Paraskevis, Dimitrios/0000-0001-6167-7152; Vantarakis, Apostolos/0000-0003-4411-3739	Gilead Sciences Europe; EU Social Fund and National resources; Hellenic Diabetes Association	Gilead Sciences Europe(Gilead Sciences); EU Social Fund and National resources; Hellenic Diabetes Association	This study was supported by Gilead Sciences Europe. EMENO study was co-funded by the EU Social Fund and National resources. Additional funding was obtained from the Hellenic Diabetes Association to measure glycated hemoglobin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Gilead Sciences Europe have supported the first author of this manuscript to participate and present some early results of this study in the 2017 IAS Conference. This does not alter our adherence to PLOS ONE policies on sharing data and materials	Antonello VS, 2015, J AM SOC HYPERTENS, V9, P403, DOI 10.1016/j.jash.2015.03.008; Baekken M, 2008, J HYPERTENS, V26, P2126, DOI 10.1097/HJH.0b013e32830ef5fb; Ballocca F, 2017, TRENDS CARDIOVAS MED, V27, P558, DOI 10.1016/j.tcm.2017.06.005; Ballocca F, 2016, PROG CARDIOVASC DIS, V58, P565, DOI 10.1016/j.pcad.2016.02.008; Benard A, 2007, AIDS PATIENT CARE ST, V21, P458, DOI 10.1089/apc.2006.0142; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; Carpenter J. R., 2013, MULTIPLE IMPUTATION; Centre for Multilevel Modelling, 2018, MLWIN 3 02; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; d'Arminio Monforte A, 2019, HIV MED, V20, P99, DOI 10.1111/hiv.12683; De Socio GVL, 2007, SCAND J INFECT DIS, V39, P805, DOI 10.1080/00365540701230884; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Dudina A, 2011, EUR J CARDIOV PREV R, V18, P731, DOI 10.1177/1741826711412039; Duncan AD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194199; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Gelpi M, 2018, CLIN INFECT DIS, V67, P579, DOI 10.1093/cid/ciy146; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Hernandez-Romieu AC, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2016-000304; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Holloway CJ, 2017, CURR OPIN HIV AIDS, V12, P509, DOI 10.1097/COH.0000000000000420; Jain A, 2018, CURR OPIN CARDIOL, V33, P429, DOI 10.1097/HCO.0000000000000520; Kakinami L, 2013, INT J CLIN PRACT, V67, P6, DOI 10.1111/j.1742-1241.2012.02953.x; Kendall CE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-161; Kwarisiima D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156309; Legarth RA, 2002, J ACQ IMMUN DEF SYND, V71, P213; Lu JP, 2017, LANCET, V390, P2549, DOI [10.1016/S0140-6736(17)32478-9, 10.1016/s0140-6736(17)32478-9]; Mdodo R, 2015, ANN INTERN MED, V162, P335, DOI 10.7326/M14-0954; Muiru AN, 2018, JAIDS-J ACQ IMM DEF, V78, P458, DOI [10.1097/QAI.0000000000001696, 10.1097/qai.0000000000001696]; Muller CJ, 2014, INT J EPIDEMIOL, V43, P962, DOI 10.1093/ije/dyu029; Onen NF, 2010, HIV CLIN TRIALS, V11, P100, DOI 10.1310/hct1102-100; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Papke LE, 2008, J ECONOMETRICS, V145, P121, DOI 10.1016/j.jeconom.2008.05.009; Petoumenos K, 2014, HIV MED, V15, P595, DOI 10.1111/hiv.12162; Pirs M, 2014, ACTA DERMATOVEN ALP, V23, P43, DOI 10.15570/actaapa.2014.11; Rasmussen LD, 2015, CLIN INFECT DIS, V60, P1415, DOI 10.1093/cid/civ013; Rasmussen LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044575; Roka R, 2015, HIGH BLOOD PRESS CAR, V22, P265, DOI 10.1007/s40292-015-0106-3; Schouten J, 2014, CLIN INFECT DIS, V59, P1787, DOI 10.1093/cid/ciu701; Srinivasa S, 2014, EUR J ENDOCRINOL, V170, pR185, DOI 10.1530/EJE-13-0967; Thompson-Paul AM, 2016, CLIN INFECT DIS, V63, P1508, DOI 10.1093/cid/ciw615; Touloumi G, 2019, JMIR RES PROTOC, V8, P42, DOI 10.2196/10997; Triant VA, 2018, CIRCULATION, V137, P2203, DOI [10.1161/CIRCULATIONAHA.117.028975, 10.1161/circulationaha.117.028975]; Trickey A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160460; van Zoest RA, 2016, CLIN INFECT DIS, V63, P205, DOI 10.1093/cid/ciw285; Vourli G, 2019, AIDS, V33, P133, DOI 10.1097/QAD.0000000000002034; Zhang NN, 2017, J INT MED RES, V45, P594, DOI 10.1177/0300060517693178	49	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230730	10.1371/journal.pone.0230730	http://dx.doi.org/10.1371/journal.pone.0230730			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HE	32226048	Green Published, gold			2022-12-26	WOS:000535936400016
J	Song, JH; Wang, CJ; Long, DL; Li, ZG; You, LS; Brand-Saberi, B; Wang, G; Yang, XS				Song, Jinhuan; Wang, Chaojie; Long, Denglu; Li, Ziguang; You, Lingsen; Brand-Saberi, Beate; Wang, Guang; Yang, Xuesong			Dysbacteriosis-induced LPS elevation disturbs the development of muscle progenitor cells by interfering with retinoic acid signaling	FASEB JOURNAL			English	Article						gut microbiota dysbiosis; LPS; myogenesis; retinoic acid signaling; somitogenesis	INTRAUTERINE FETAL-DEATH; REGULATORY FACTORS MYF5; SKELETAL-MUSCLE; GUT DYSBIOSIS; CHICK-EMBRYO; IN-VIVO; DIFFERENTIATION; SOMITOGENESIS; EXPRESSION; MYOGENESIS	Whether myogenesis is affected by the maternal gut dysbacteriosis still remains ambiguous. In this study, first we show the elevated level of lipopolysaccharides (LPS) in a gut microbiota dysbiosis mouse model. Second, we demonstrate that the diameter of muscle fibers, limb development, and somitogenesis were inhibited in both the gut microbiota dysbiosis and LPS exposed mice and chicken embryos. These might be due to LPS disturbed the cell survival and key genes which regulate the somitogenesis and myogenesis. RNA sequencing and subsequent validation experiments verified that retinoic acid (RA) signaling perturbation was mainly responsible for the aberrant somite formation and differentiation. Subsequently, we found that LPS-induced reactive oxygen species (ROS generation and antioxidant genes such as Nrf2, AKR1B10) contributed to the above -mentioned interference with RA signaling. These findings highlight that the gut microbiota homeostasis is also involved in regulating the development of muscle progenitor cells during pregnancy.	[Song, Jinhuan; Wang, Chaojie; Long, Denglu; Li, Ziguang; You, Lingsen; Wang, Guang; Yang, Xuesong] Jinan Univ, Int Joint Lab Embryon Dev & Prenatal Med, Div Histol & Embryol, Guangzhou 510632, Peoples R China; [Brand-Saberi, Beate] Ruhr Univ Bochum, Inst Anat, Dept Anat & Mol Embryol, Bochum, Germany; [Yang, Xuesong] Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Peoples R China	Jinan University; Ruhr University Bochum; Jinan University	Wang, G; Yang, XS (corresponding author), Jinan Univ, Int Joint Lab Embryon Dev & Prenatal Med, Div Histol & Embryol, Guangzhou 510632, Peoples R China.	wangguang7453@126.com; yang_xuesong@126.com	Brand-Saberi, Beate/GVT-9451-2022; Wang, Guang/AAC-4624-2019		National Natural Science Foundation of China (NSFC) [31771331, 31971108]; National College Students Innovation and Entrepreneurship Training Program [CX18044, CX2019098]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National College Students Innovation and Entrepreneurship Training Program	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31771331 and 31971108; National College Students Innovation and Entrepreneurship Training Program, Grant/Award Number: CX18044 and CX2019098	Aisemberg J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056161; Aleshukina A. V., 2012, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P74; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Awad N, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.030; Bayha E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005845; BUMCROT DA, 1995, CURR BIOL, V5, P612, DOI 10.1016/S0960-9822(95)00123-0; Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705; Chal J, 2017, DEVELOPMENT, V144, P2104, DOI 10.1242/dev.151035; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Cheng X, 2019, J CELL PHYSIOL, V234, P2593, DOI 10.1002/jcp.27025; Chkhaidze I G, 1998, Zh Mikrobiol Epidemiol Immunobiol, P12; Collins JJP, 2012, AM J PHYSIOL-LUNG C, V303, pL778, DOI 10.1152/ajplung.00280.2011; Duester Gregg, 2007, Birth Defects Research, V81, P84, DOI 10.1002/bdrc.20092; Emoto Y, 2005, DEV BIOL, V278, P415, DOI 10.1016/j.ydbio.2004.11.023; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; Galli LM, 2008, DEV DYNAM, V237, P1862, DOI 10.1002/dvdy.21585; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hay AJ, 2016, ADV APPL MICROBIOL, V96, P43, DOI 10.1016/bs.aambs.2016.07.019; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Huang RL, 2014, STEM CELLS DEV, V23, P277, DOI 10.1089/scd.2013.0345; Iimura T, 2009, CURR TOP DEV BIOL, V88, P201, DOI 10.1016/S0070-2153(09)88007-1; Jaiswal YK, 2009, FERTIL STERIL, V91, P2095, DOI 10.1016/j.fertnstert.2008.04.050; Joint FAO/WHO Expert Committee on Food Additives, 2009, TOX EV CERT VET DRUG; Kablar B, 2003, DEV BIOL, V258, P307, DOI 10.1016/S0012-1606(03)00139-8; Kam RKT, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-11; Kohmura Y, 2000, MICROBIOL IMMUNOL, V44, P897, DOI 10.1111/j.1348-0421.2000.tb02581.x; Kurita N, 2017, J NEUROL SCI, V381, P875, DOI 10.1016/j.jns.2017.08.2466; Lee ASJ, 2013, DEV DYNAM, V242, P1043, DOI 10.1002/dvdy.23998; Lin CY, 2006, DEV BIOL, V299, P594, DOI 10.1016/j.ydbio.2006.08.042; Long Y, 2018, CELL CYCLE, V17, P1757, DOI 10.1080/15384101.2018.1496743; Misske J, 2007, PEDIATR CARDIOL, V28, P263, DOI 10.1007/s00246-006-0109-x; Musumeci G, 2015, ACTA HISTOCHEM, V117, P313, DOI 10.1016/j.acthis.2015.02.011; Naiche LA, 2011, P NATL ACAD SCI USA, V108, P4018, DOI 10.1073/pnas.1007417108; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Nuriel-Ohayon M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01031; Olivera-Martinez I, 2000, DEVELOPMENT, V127, P4611; Penning TM, 2017, CHEM RES TOXICOL, V30, P162, DOI 10.1021/acs.chemrestox.6b00319; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Pitt JA, 1997, REPROD TOXICOL, V11, P771, DOI 10.1016/S0890-6238(97)00060-9; Porte S, 2013, CHEM-BIOL INTERACT, V202, P186, DOI 10.1016/j.cbi.2012.11.014; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rashidi H, 2009, BIOESSAYS, V31, P459, DOI 10.1002/bies.200800168; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Rogers GB, 2016, MOL PSYCHIATR, V21, P738, DOI 10.1038/mp.2016.50; Serino M, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0540-1; Smith CA, 1995, TERATOLOGY, V52, P333, DOI 10.1002/tera.1420520604; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Straley ME, 2014, PLACENTA, V35, P533, DOI 10.1016/j.placenta.2014.06.001; TAM PPL, 1981, J EMBRYOL EXP MORPH, V65, P103; Trajkovski M, 2016, NATURE, V534, P185, DOI 10.1038/534185a; Vadiveloo PK, 2001, BBA-MOL CELL RES, V1539, P140, DOI 10.1016/S0167-4889(01)00102-1; Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205; Vattemi G, 2005, NEUROPATH APPL NEURO, V31, P45, DOI 10.1111/j.1365-2990.2004.00602.x; Wang HJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085484, 10.1371/journal.pone.0097917]; Ward L, 2018, DEV BIOL, V439, P3, DOI 10.1016/j.ydbio.2018.04.005; Ruiz FX, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00058; Xu DX, 2007, TOXICOLOGY, V234, P167, DOI 10.1016/j.tox.2007.02.010; Yang Y, 2014, DIS MODEL MECH, V7, P1131, DOI 10.1242/dmm.016428; Yusuf F, 2006, DEV DYNAM, V235, P3007, DOI 10.1002/dvdy.20951; Zammit PS, 2017, SEMIN CELL DEV BIOL, V72, P19, DOI 10.1016/j.semcdb.2017.11.011; Zhang P, 2018, CELL PHYSIOL BIOCHEM, V49, P2483, DOI 10.1159/000493874; Zhang P, 2017, TOXICOL LETT, V281, P53, DOI 10.1016/j.toxlet.2017.09.010; Zhang YJ, 2015, INT J MOL SCI, V16, P7493, DOI 10.3390/ijms16047493; Zhao K, 2014, EUR J PHARMACOL, V737, P57, DOI 10.1016/j.ejphar.2014.05.011	64	7	7	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6837	6853		10.1096/fj.201902965R	http://dx.doi.org/10.1096/fj.201902965R		MAR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32223025				2022-12-26	WOS:000522485900001
J	Schulz-Mirbach, T; Ladich, F; Mittone, A; Olbinado, M; Bravin, A; Maiditsch, IP; Melzer, RR; Krysl, P; Hess, M				Schulz-Mirbach, Tanja; Ladich, Friedrich; Mittone, Alberto; Olbinado, Margie; Bravin, Alberto; Maiditsch, Isabelle P.; Melzer, Roland R.; Krysl, Petr; Hess, Martin			Auditory chain reaction: Effects of sound pressure and particle motion on auditory structures in fishes	PLOS ONE			English	Article							INNER-EAR; DIVERSITY; OTOLITHS; TELEOST; HEARING; SYSTEM	Despite the diversity in fish auditory structures, it remains elusive how otolith morphology and swim bladder-inner ear (= otophysic) connections affect otolith motion and inner ear stimulation. A recent study visualized sound-induced otolith motion; but tank acoustics revealed a complex mixture of sound pressure and particle motion. To separate sound pressure and sound-induced particle motion, we constructed a transparent standing wave tubelike tank equipped with an inertial shaker at each end while using X-ray phase contrast imaging. Driving the shakers in phase resulted in maximised sound pressure at the tank centre, whereas particle motion was maximised when shakers were driven out of phase (180 degrees). We studied the effects of two types of otophysic connections-i.e. the Weberian apparatus (Carassius auratus) and anterior swim bladder extensions contacting the inner ears (Etroplus canarensis)-on otolith motion when fish were subjected to a 200 Hz stimulus. Saccular otolith motion was more pronounced when the swim bladder walls oscillated under the maximised sound pressure condition. The otolith motion patterns mainly matched the orientation patterns of ciliary bundles on the sensory epithelia. Our setup enabled the characterization of the interplay between the auditory structures and provided first experimental evidence of how different types of otophysic connections affect otolith motion.	[Schulz-Mirbach, Tanja; Melzer, Roland R.; Hess, Martin] Ludwig Maximilians Univ Munchen, Dept Biol 2, Planegg Martinsried, Germany; [Ladich, Friedrich; Maiditsch, Isabelle P.] Univ Vienna, Dept Behav & Cognit Biol, Vienna, Austria; [Mittone, Alberto; Olbinado, Margie; Bravin, Alberto] European Synchrotron Radiat Facil, Grenoble, France; [Melzer, Roland R.] Bavarian State Collect Zool, Munich, Germany; [Krysl, Petr] Univ Calif San Diego, Dept Struct Engn, La Jolla, CA 92093 USA; [Mittone, Alberto] Cells ALBA Synchrotron Light Source, Barcelona, Spain; [Olbinado, Margie] Paul Scherrer Inst, Swiss Light Source, Villigen, Switzerland	University of Munich; University of Vienna; European Synchrotron Radiation Facility (ESRF); University of California System; University of California San Diego; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Schulz-Mirbach, T (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biol 2, Planegg Martinsried, Germany.	schulz-mirbach@biologie.uni-muenchen.de	Mittone, Alberto/C-8653-2018; Olbinado, Margie/ABF-6952-2021	Mittone, Alberto/0000-0002-2018-5714; Bravin, Alberto/0000-0001-6868-2755; Maiditsch, Isabelle/0000-0002-2351-7809	European Synchrotron Radiation Facility [LS-2752]; Bavaria California Technology Center (BaCaTeC) [[2017]-1]; Austrian Science Fund [P31045]; Munchener Universitatsgesellschaft (MUG) [31983]	European Synchrotron Radiation Facility; Bavaria California Technology Center (BaCaTeC); Austrian Science Fund(Austrian Science Fund (FWF)); Munchener Universitatsgesellschaft (MUG)	This study received funding from: European Synchrotron Radiation Facility (project no. LS-2752, TSM, MH, FL); https://www.esrf.eu/Bavaria California Technology Center (BaCaTeC, project no. [2017]-1, TSM, PK); http://www.bacatec.de/en/Austrian Science Fund (project no. P31045, FL), https://www.fwf.ac.at/en/Munchener Universitatsgesellschaft (MUG, project no. 31983, TSM, MH), https://www.unigesellschaft.de/foerderprojekte.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1959, J EXP BIOL, V36, P333; ALEXANDER RM, 1966, BIOL REV, V41, P141, DOI 10.1111/j.1469-185X.1966.tb01542.x; [Anonymous], 2016, FRONT ECOL EVOL, DOI DOI 10.3389/FEVO.2016.00028; Braun Christopher B., 2008, V32, P99; Bravin A, 2013, PHYS MED BIOL, V58, pR1, DOI 10.1088/0031-9155/58/1/R1; Burlet H. M.de, 1929, Zeitschrift fuer Anatomie Entw Mech, V89, P11, DOI 10.1007/BF02117946; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; Campbell J, 2019, BEHAV PROCESS, V164, P38, DOI 10.1016/j.beproc.2019.04.001; Chranilov N. S., 1929, Zoologische Jahrbuecher Jena Anatomie, V51, P323; Chranilov N. S., 1927, Zoologische Jahrbuecher Jena Abteilungen Anatomie, V49, P501; CLARKE NL, 1975, BIOPHYS J, V15, P307, DOI 10.1016/S0006-3495(75)85821-8; Codarin A, 2009, MAR POLLUT BULL, V58, P1880, DOI 10.1016/j.marpolbul.2009.07.011; Dehadrai P. V., 1959, Proceedings of the National Institute of Sciences of India, V25B, P254; DeVRIES H., 1950, ACTA OTO LARYNGOL, V38, P262, DOI 10.3109/00016485009118384; Fay R. R., 1988, HEARING VERTEBRATES; FAY RR, 1984, SCIENCE, V225, P951, DOI 10.1126/science.6474161; FAY RR, 1970, J COMP PHYSIOL PSYCH, V73, P175, DOI 10.1037/h0030245; FAY RR, 1974, J EXP BIOL, V61, P243; Finneran JJ, 2000, J ACOUST SOC AM, V108, P1308, DOI 10.1121/1.1286099; Grande Terry, 2004, P429; Hawkins A.D., 1976, Developments Aquacult Fish Sci, V5, P149; Hawkins A.D., 1993, Fish and Fisheries Series, V7, P129; HUDSPETH AJ, 1985, SCIENCE, V230, P745, DOI 10.1126/science.2414845; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; KLEEREKOPER H., 1959, CANADIAN JOUR ZOOL, V37, P1; Krysl P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042591; Ladich F, 2003, HEARING RES, V182, P119, DOI 10.1016/S0378-5955(03)00188-6; Ladich F, 2013, REV FISH BIOL FISHER, V23, P317, DOI 10.1007/s11160-012-9297-z; Lechner W, 2008, J EXP BIOL, V211, P1681, DOI 10.1242/jeb.016436; Lychakov DV, 2000, HEARING RES, V143, P83, DOI 10.1016/S0378-5955(00)00026-5; Mittone A, 2017, J SYNCHROTRON RADIAT, V24, P1226, DOI 10.1107/S160057751701222X; Mokso R, 2015, SCI REP-UK, V5, DOI 10.1038/srep08727; NELSON EDWARD M., 1955, FIELDIANA ZOOL, V37, P121; Nolf D., 1985, Handbook of Paleoichthyology, V10, P1; PLATT C, 1977, J COMP NEUROL, V172, P283, DOI 10.1002/cne.901720207; PLATT C, 1981, HEARING SOUND COMMUN, P3, DOI DOI 10.1007/978-1-4615-7186-5_; Popper AN, 2005, MAR FRESHWATER RES, V56, P497, DOI 10.1071/MF04267; POPPER AN, 1983, J MORPHOL, V176, P121, DOI 10.1002/jmor.1051760202; POPPER AN, 1974, J EXP BIOL, V60, P295; Rack A, 2010, J X-RAY SCI TECHNOL, V18, P429, DOI 10.3233/XST-2010-0273; Ramcharitar J, 2001, BRAIN BEHAV EVOLUT, V58, P152, DOI 10.1159/000047269; Ramcharitar JU, 2004, J COMP NEUROL, V475, P531, DOI 10.1002/cne.20192; Reichenbacher B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112459; ROGERS PH, 1988, J ACOUST SOC AM, V83, P338, DOI 10.1121/1.396444; SAND O, 1978, J COMP PHYSIOL, V123, P85, DOI 10.1007/BF00657346; Schulz-Mirbach T, 2019, BIOL REV, V94, P457, DOI 10.1111/brv.12463; Schulz-Mirbach T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21367-0; Schulz-Mirbach T, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-25; Schulz-Mirbach T, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-75; Schulz-Mirbach T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042292; Schwarzhans W, 2018, NEUES JAHRB GEOL P-A, V287, P75, DOI 10.1127/njgpa/2018/0707; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; Sparks JS, 2008, B AM MUS NAT HIST, P5; Stetter H., 1929, Z VERGL PHYSIOL, P339; Tomas J, 2003, J FISH BIOL, V63, P1383, DOI 10.1111/j.1095-8649.2003.00245.x; Tuset VM, 2008, SCI MAR, V72, P7, DOI 10.3989/scimar.2008.72s1199; Van Bergeijk W A, 1967, Contrib Sens Physiol, V2, P1; VANBERGEIJK WA, 1966, AM ZOOL, V6, P371; Vetter BJ, 2019, J COMP PHYSIOL A, V205, P163, DOI 10.1007/s00359-018-01314-0; von Frisch K., 1938, FISCHE Z VGL PHYSL, V25, P703; Weber E.H., 1820, AURE AUDITU HOMINI 1; Wohlfahrt T. A., 1932, Zeitschrift fuer Vergleichende Physiologie, V17, P659, DOI 10.1007/BF00339066; Wysocki LE, 2007, J ACOUST SOC AM, V121, P2559, DOI 10.1121/1.2713661	63	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0230578	10.1371/journal.pone.0230578	http://dx.doi.org/10.1371/journal.pone.0230578			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218605	Green Published, gold			2022-12-26	WOS:000535935400014
J	Cap, M; Cingolani, C; Lires, C; Mozgovoj, M; Soteras, T; Sucari, A; Gentiluomo, J; Descalzo, A; Grigioni, G; Signorini, M; Horak, C; Vaudagna, S; Leotta, G				Cap, Mariana; Cingolani, Celeste; Lires, Carla; Mozgovoj, Marina; Soteras, Trinidad; Sucari, Adriana; Gentiluomo, Jimena; Descalzo, Adriana; Grigioni, Gabriela; Signorini, Marcelo; Horak, Celina; Vaudagna, Sergio; Leotta, Gerardo			Combination of organic acids and low-dose gamma irradiation as antimicrobial treatment to inactivate Shiga toxin-producing Escherichia coli inoculated in beef trimmings: Lack of benefits in relation to single treatments	PLOS ONE			English	Article							LACTIC-ACID; GROUND-BEEF; ACETIC-ACID; MEAT; QUALITY; PORK; INTERVENTION; WATER	The aim of this study was to assess the efficacy of lactic acid (LA), caprylic acid (CA), high-(HDI) and low- (LDI) dose gamma irradiation and LDI combined with LA or CA on the inactivation of a pool of Shiga toxin-producing Escherichia coli (STEC) strains inoculated on beef trimmings. The three most efficacious treatments were selected to study their effect on meat quality parameters and sensory attributes. The inoculum included five native STEC serogroups (O26, O103, O111, O145 and O157). The treatments applied were 0.5% LA, 0.04% CA, 0.5 kGy LDI, 2 kGy HDI, LDI+LA and LDI+CA. Beef trimmings were divided into two groups; one was inoculated with high (7 log CFU/g) and the other with low (1 log CFU/g) level of inoculum. Efficacy was assessed by estimating log reduction and reduction of stx- and eae-positive samples after enrichment, respectively. Results showed that treatments with organic acids alone were not effective in reducing STEC populations. For high inoculum samples, the most effective treatment was HDI followed by LDI+LA and LDI alone or combined with CA. For low inoculum samples, the most effective treatment was HDI followed by LDI alone or combined with organic acids. Concerning meat quality parameters and sensory attributes, irradiation treatments (LDI and HDI) caused minimal changes, while LDI+LA modified them significantly compared with the control. Therefore, based on our results, no benefits were observed after combining organic acids with gamma irradiation.	[Cap, Mariana; Mozgovoj, Marina; Soteras, Trinidad; Descalzo, Adriana; Grigioni, Gabriela; Vaudagna, Sergio] INTA, Inst Tecnol Alimentos, Buenos Aires, DF, Argentina; [Cingolani, Celeste; Lires, Carla; Horak, Celina] CNEA, Ctr Atom Ezeiza, Buenos Aires, DF, Argentina; [Sucari, Adriana; Gentiluomo, Jimena] Lab Alimentos Stamboulian, Div Higiene & Seguridad Alimentaria & Ambiental, Buenos Aires, DF, Argentina; [Signorini, Marcelo] INTA, Estn Expt Agr Rafaela, Buenos Aires, DF, Argentina; [Leotta, Gerardo] UNLP, CONICET LA PLATA, IGEVET Inst Genet Vet Ing Fernando N Dulout, Fac Ciencias Vet, La Plata, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Comision Nacional de Energia Atomica (CNEA); Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Cap, M (corresponding author), INTA, Inst Tecnol Alimentos, Buenos Aires, DF, Argentina.	cap.mariana@inta.gob.ar	Mozgovoj, Marina/T-1204-2019; Signorini, Marcelo/B-7097-2009	Mozgovoj, Marina/0000-0002-9832-5932; Grigioni, Gabriela/0000-0002-9413-0599; Soteras, Trinidad/0000-0003-3812-6808; Descalzo, Adriana Maria/0000-0002-3261-5865; Signorini, Marcelo/0000-0001-6537-8782	R&D Program of the Institute for the Promotion of Argentine Beef (IPCVA) under the project "Characterization of risk and mitigation of impact of STEC in the beef chain"; National Institute of Agriculture Technology (INTA) [PNAIyAV 1130042]	R&D Program of the Institute for the Promotion of Argentine Beef (IPCVA) under the project "Characterization of risk and mitigation of impact of STEC in the beef chain"; National Institute of Agriculture Technology (INTA)	This study was funded by the R&D Program of the Institute for the Promotion of Argentine Beef (IPCVA) (http://www.ipcva.com.ar/) under the project "Characterization of risk and mitigation of impact of STEC in the beef chain", and by public funds from the research project PNAIyAV 1130042 of the National Institute of Agriculture Technology (INTA). Funders colaborated in the study design and decision to publish. The funders had no role in the data collection and analysis or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aaslyng MD, 2003, FOOD QUAL PREFER, V14, P277, DOI 10.1016/S0950-3293(02)00086-1; AMSA AMSA, 2012, MEAT COL MEAS GUID, DOI [10.1007/s11786-018-0341-9, DOI 10.1007/S11786-018-0341-9]; Andreoletti O, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3138; [Anonymous], FOOD SCI TECHNOLOGY; [Anonymous], 2015, RES GUID COOK SENS E; Bhide MR, 2001, MEAT SCI, V58, P253, DOI 10.1016/S0309-1740(00)00162-5; Brewer S, 2004, MEAT SCI, V68, P1, DOI 10.1016/j.meatsci.2004.02.007; Brusa V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183248; Xavier MD, 2014, MEAT SCI, V98, P383, DOI 10.1016/j.meatsci.2014.06.037; Descalzo AM, 2005, MEAT SCI, V70, P35, DOI 10.1016/j.meatsci.2004.11.018; Fernandez J, 1997, FOOD CHEM, V59, P345, DOI 10.1016/S0308-8146(96)00114-8; Friedrich L, 2008, MEAT SCI, V79, P332, DOI 10.1016/j.meatsci.2007.10.012; FSIS, 2012, SHIG TOX PROD ESCH C; Harris D, 2012, MEAT SCI, V90, P783, DOI 10.1016/j.meatsci.2011.11.014; Hulankova R, 2013, MEAT SCI, V95, P190, DOI 10.1016/j.meatsci.2013.05.003; International Organization for Standardization, 41202004 ISO; JECFA, 2005, EV CERT FOOD ADD CON, P1; Jensen RG, 2002, J DAIRY SCI, V85, P295, DOI 10.3168/jds.S0022-0302(02)74079-4; Kalchayanand N, 2012, J FOOD PROTECT, V75, P1207, DOI 10.4315/0362-028X.JFP-11-531; Kilcast D., 2010, SENSORY ANAL FOOD BE, DOI [10.1533/9781845699512, DOI 10.1533/9781845699512]; Kim BH, 2004, J FOOD PROTECT, V67, P168, DOI 10.4315/0362-028X-67.1.168; Koseki S, 2003, J FOOD PROTECT, V66, P2010, DOI 10.4315/0362-028X-66.11.2010; KWOH TL, 1971, J AM OIL CHEM SOC, V48, P550, DOI 10.1007/BF02544560; Mohan A, 2016, LWT-FOOD SCI TECHNOL, V65, P868, DOI 10.1016/j.lwt.2015.08.077; Munoz A.M., 1992, SENSORY EVALUATION Q; Nanke KE, 1999, J FOOD SCI, V64, P272, DOI 10.1111/j.1365-2621.1999.tb15881.x; Ransom J. R., 2003, Food Protection Trends, V23, P24; Rodriguez-Melcon C, 2017, MEAT SCI, V129, P169, DOI 10.1016/j.meatsci.2017.01.007; Rogers L., 2017, SENSORY PANEL MANAGE; Sohaib M, 2016, J FOOD SCI TECH MYS, V53, P19, DOI 10.1007/s13197-015-1985-y; Sommers C, 2015, FOOD MICROBIOL, V49, P231, DOI 10.1016/j.fm.2015.02.013; Sprong RC, 2001, ANTIMICROB AGENTS CH, V45, P1298, DOI 10.1128/AAC.45.4.1298-1301.2001; SURVE AN, 1991, MEAT SCI, V29, P309, DOI 10.1016/0309-1740(91)90010-N	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230812	10.1371/journal.pone.0230812	http://dx.doi.org/10.1371/journal.pone.0230812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214399	Green Published, gold			2022-12-26	WOS:000535934200066
J	Cash, MC; Cunnane, K; Fan, CY; Romero-Sandoval, EA				Cash, Mary Catherine; Cunnane, Katharine; Fan, Chuyin; Romero-Sandoval, E. Alfonso			Mapping cannabis potency in medical and recreational programs in the United States	PLOS ONE			English	Article							INHALED CANNABIS; MARIJUANA; PAIN; DISPENSARIES; SYMPTOMS; COLORADO; IMPACTS; PRICES; SAFETY; ONSET	Cannabis related online searches are associated with positive attitudes toward medical cannabis, particularly when information is obtained from dispensaries. Since pain is the main reason for medicinal cannabis use, information from dispensary websites has the potential to shape the attitude of pain patients towards cannabis. This is relevant because cannabis has demonstrated efficacy in neuropathic pain with low tetrahydrocannabinol (THC) concentrations (< 5-10%), in contrast to potent cannabis (> 15% THC), which is highly rewarded in the recreational realm. The role of CBD in pain is not clear, however it has gained popularity. Thus, we hypothesize that the potency of medical cannabis that is advertised online is similar to the cannabis advertised for recreational purposes, which would potentially create a misconception towards medical cannabis. The current lack of knowledge surrounding advertised potencies in the legal cannabis market limits the ability to generate clear policies regarding online advertising to protect patients that are willing to use cannabis for their condition. Thus, we evaluated the advertised THC and CBD content of cannabis products offered online in dispensaries in the United States to determine products' suitability to medicinal use and compare the strength of products offered in legal medical and recreational programs. We recorded THC and CBD concentrations for all herb cannabis products provided by dispensary websites and compared them between or within states. Four Western states (CA, CO, NM, WA) and five Northeastern states (ME, MA, NH, RI, VT) were included. A total of 8,505 cannabis products across 653 dispensaries were sampled. Despite the clear differences between medicinal and recreational uses of cannabis, the average THC concentration advertised online in medicinal programs was similar (19.2% +/- 6.2) to recreational programs (21.5% +/- 6.0) when compared between states with different programs, or between medicinal and recreational programs within the same states (CO or WA). Lower CBD concentrations accompanied higher THC products. The majority of products, regardless of medicinal or recreational programs, were advertised to have > 15% THC (70.3% - 91.4% of products). These stated concentrations seem unsuitable for medicinal purposes, particularly for patients with chronic neuropathic pain. Therefore, this information could induce the misconception that high potency cannabis is safe to treat pain. This data is consistent with reports in which THC and CBD in products from legal dispensaries or in nationwide products from the illegal market were actually measured, which indicates that patients consuming these products may be at risk of acute intoxication or long-term side effects. Our study offers grounds to develop policies that help prevent misconceptions toward cannabis and reduce risks in pain patients.	[Cash, Mary Catherine; Fan, Chuyin] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA; [Cunnane, Katharine; Romero-Sandoval, E. Alfonso] Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Winston Salem, NC 27109 USA	University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Wake Forest Baptist Medical Center	Romero-Sandoval, EA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Winston Salem, NC 27109 USA.	earomero.sandoval@gmail.com			Department of Anesthesiology at Wake Forest University School of Medicine	Department of Anesthesiology at Wake Forest University School of Medicine	Funding from Department of Anesthesiology at Wake Forest University School of Medicine (E.A.R.s.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the Department of Anesthesiology at Wake Forest University School of Medicine for funding.	Abrams DI, 2007, NEUROLOGY, V68, P515, DOI 10.1212/01.wnl.0000253187.66183.9c; Andreae MH, 2015, J PAIN, V16, P1221, DOI 10.1016/j.jpain.2015.07.009; [Anonymous], 2017, HLTH EFF CANN CANN C; Arterberry BJ, 2019, DRUG ALCOHOL DEPEN, V195, P186, DOI 10.1016/j.drugalcdep.2018.11.012; Bagot KS, 2015, SUBST ABUS, V36, P524, DOI 10.1080/08897077.2014.995332; Baron EP, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0862-2; Boehnke KF, 2019, J PAIN, V20, P830, DOI 10.1016/j.jpain.2019.01.010; Bonn-Miller MO, 2017, JAMA-J AM MED ASSOC, V318, P2142, DOI 10.1001/jama.2017.18218; Bradford AC, 2018, JAMA INTERN MED, V178, P667, DOI 10.1001/jamainternmed.2018.0266; Capler R, 2017, INT J DRUG POLICY, V47, P1, DOI 10.1016/j.drugpo.2017.05.046; CAPPELL H, 1973, PSYCHOPHARMACOLOGIA, V29, P177, DOI 10.1007/BF00414031; Caputi TL, 2018, AM J PREV MED, V54, P719, DOI 10.1016/j.amepre.2018.01.032; Cavazos-Rehg PA, 2019, PREV SCI, V20, P280, DOI 10.1007/s11121-018-0889-2; Chandra S, 2019, EUR ARCH PSY CLIN N, V269, P997, DOI 10.1007/s00406-019-01020-1; Chandra S, 2019, EUR ARCH PSY CLIN N, V269, P5, DOI 10.1007/s00406-019-00983-5; CLARK WC, 1981, J CLIN PHARMACOL, V21, pS299, DOI 10.1002/j.1552-4604.1981.tb02608.x; Corroon J, 2018, CANNABIS CANNABINOID, V3, P152, DOI 10.1089/can.2018.0006; Di Forti M, 2019, LANCET PSYCHIAT, V6, P427, DOI 10.1016/S2215-0366(19)30048-3; Donoghue K, 2014, PSYCHIAT RES, V215, P528, DOI 10.1016/j.psychres.2013.12.038; Ellis RJ, 2009, NEUROPSYCHOPHARMACOL, V34, P672, DOI 10.1038/npp.2008.120; ElSohly MA, 2000, J FORENSIC SCI, V45, P24; ElSohly MA, 2016, BIOL PSYCHIAT, V79, P613, DOI 10.1016/j.biopsych.2016.01.004; Englund A, 2013, J PSYCHOPHARMACOL, V27, P19, DOI 10.1177/0269881112460109; FDA AACatDSaRMAC, 2014, SUMM MIN JONT ARTH A; Freeman TP, 2015, PSYCHOL MED, V45, P3181, DOI 10.1017/S0033291715001178; Freeman TP, 2018, PSYCHOL MED, V48, P2346, DOI 10.1017/S0033291717003877; Hunt P, 2017, J PRIM PREV, V38, P221, DOI 10.1007/s10935-017-0471-x; Iffland K, 2017, CANNABIS CANNABINOID, V2, P139, DOI 10.1089/can.2016.0034; Jikomes N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22755-2; Klieger SB, 2017, ADDICTION, V112, P2206, DOI 10.1111/add.13910; Lewis N, 2019, INT J DRUG POLICY, V73, P219, DOI 10.1016/j.drugpo.2019.01.005; Li XX, 2019, COMPLEMENT THER MED, V46, P123, DOI 10.1016/j.ctim.2019.07.022; Liang D, 2018, ADDICTION, V113, P2060, DOI 10.1111/add.14382; Lin LA, 2016, ADDICT BEHAV, V61, P99, DOI 10.1016/j.addbeh.2016.05.015; Monte AA, 2019, ANN INTERN MED, V170, P531, DOI 10.7326/M18-2809; Morgan CJA, 2012, PSYCHOL MED, V42, P391, DOI 10.1017/S0033291711001322; Morgan CJA, 2010, BRIT J PSYCHIAT, V197, P285, DOI 10.1192/bjp.bp.110.077503; Obradovic I, 2021, INT J DRUG POLICY, V91, DOI 10.1016/j.drugpo.2019.11.002; Peiper NC, 2017, SUBST ABUS-RES TREAT, V11, DOI 10.1177/1178221817725515; Raji MA, 2019, PREV MED, V125, P62, DOI 10.1016/j.ypmed.2019.05.012; Romero-Sandoval EA, 2018, PHARMACOTHERAPY, V38, P651, DOI 10.1002/phar.2115; Schubart CD, 2011, SCHIZOPHR RES, V130, P216, DOI 10.1016/j.schres.2011.04.017; Shi YY, 2019, INT J DRUG POLICY, V74, P1, DOI 10.1016/j.drugpo.2019.07.037; Smart R, 2017, ADDICTION, V112, P2167, DOI 10.1111/add.13886; van der Pol P, 2014, ADDICTION, V109, P1101, DOI 10.1111/add.12508; Vergara D, 2017, SCI REP-UK, V7, DOI 10.1038/srep46528; Vigil JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187795; Vindenes V, 2013, FORENSIC SCI INT, V226, P197, DOI 10.1016/j.forsciint.2013.01.017; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Wallace M, 2007, ANESTHESIOLOGY, V107, P785, DOI 10.1097/01.anes.0000286986.92475.b7; Wallace MS, 2015, J PAIN, V16, P616, DOI 10.1016/j.jpain.2015.03.008; Walsh J., 2015, URUGUAYS DRUG POLICY; Ware MA, 2010, CAN MED ASSOC J, V182, pE694, DOI 10.1503/cmaj.091414; WHO, 2016, HLTH SOCIAL EFFECTS; Wilsey B, 2008, J PAIN, V9, P506, DOI 10.1016/j.jpain.2007.12.010; Wilsey B, 2013, J PAIN, V14, P136, DOI 10.1016/j.jpain.2012.10.009	56	39	39	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230167	10.1371/journal.pone.0230167	http://dx.doi.org/10.1371/journal.pone.0230167			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8GI	32214334	Green Published, gold			2022-12-26	WOS:000535934200020
J	Mikhail, AS; Mauda-Havakuk, M; Partanen, A; Karanian, JW; Pritchard, WF; Wood, BJ				Mikhail, Andrew S.; Mauda-Havakuk, Michal; Partanen, Ari; Karanian, John W.; Pritchard, William F.; Wood, Bradford J.			Liver-specific 3D sectioning molds for correlating in vivo CT and MRI with tumor histopathology in woodchucks (Marmota monax)	PLOS ONE			English	Article							PROSTATECTOMY SPECIMENS; TISSUE-SHRINKAGE; RESONANCE; RADIOMICS; VALIDATION; FIXATION	Purpose To evaluate the spatial registration and correlation of liver and tumor histopathology sections with corresponding in vivo CT and MRI using 3D, liver-specific cutting molds in a woodchuck (Marmota monax) hepatic tumor model. Methods Five woodchucks chronically infected with woodchuck hepatitis virus following inoculation at birth and with confirmed hepatic tumors were imaged by contrast enhanced CT or MRI. Virtual 3D liver or tumor models were generated by segmentation of in vivo CT or MR imaging. A specimen-specific cavity was created inside a block containing cutting slots aligned with an imaging plane using computer-aided design software, and the final cutting molds were fabricated using a 3D printer. Livers were resected two days after initial imaging, fixed with formalin or left unfixed, inserted into the 3D molds, and cut into parallel pieces by passing a sharp blade through the parallel slots in the mold. Histopathology sections were acquired and their spatial overlap with in vivo image slices was quantified using the Dice similarity coefficient (DSC). Results Imaging of the woodchucks revealed heterogeneous hepatic tumors of varying size, number, and location. Specimen-specific 3D molds provided accurate co-localization of histopathology of whole livers, liver lobes, and pedunculated tumors with in vivo CT and MR imaging, with or without tissue fixation. Visual inspection of histopathology sections and corresponding in vivo image slices revealed spatial registration of analogous pathologic features. The mean DSC for all specimens was 0.83+/-0.05. Conclusion Use of specimen-specific 3D molds for en bloc liver dissection provided strong spatial overlap and feature correspondence between in vivo image slices and histopathology sections.	[Mikhail, Andrew S.; Mauda-Havakuk, Michal; Partanen, Ari; Karanian, John W.; Pritchard, William F.; Wood, Bradford J.] NIH, Ctr Intervent Oncol Radiol & Imaging Sci, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Mikhail, AS (corresponding author), NIH, Ctr Intervent Oncol Radiol & Imaging Sci, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA.	andrew.mikhail@nih.gov	Mikhail, Andrew S./AAE-7439-2019; Wood, Bradford/M-7995-2017	Mikhail, Andrew S./0000-0001-9206-5765; Wood, Bradford/0000-0002-4297-0051	Center for Interventional Oncology in the Intramural Research Program of the National Institutes of Health (NIH) by intramural NIH Grants [NIH Z01 1ZID, BC011242, CL040015]; Intramural Program of the National Institute for Biomedical Imaging and Bioengineering	Center for Interventional Oncology in the Intramural Research Program of the National Institutes of Health (NIH) by intramural NIH Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Program of the National Institute for Biomedical Imaging and Bioengineering	This work was supported by the Center for Interventional Oncology in the Intramural Research Program of the National Institutes of Health (NIH) by intramural NIH Grants NIH Z01 1ZID, BC011242 and CL040015, as well as the Intramural Program of the National Institute for Biomedical Imaging and Bioengineering. NIH has a Materials Transfer Agreement with Northeastern Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absinta M, 2014, J NEUROPATH EXP NEUR, V73, P780, DOI 10.1097/NEN.0000000000000096; Chernyak V, 2018, RADIOLOGY, V289, P816, DOI 10.1148/radiol.2018181494; Costa DN, 2017, INVEST RADIOL, V52, P507, DOI 10.1097/RLI.0000000000000372; Drew B, 2010, J MAGN RESON IMAGING, V32, P992, DOI 10.1002/jmri.22303; Dwivedi DK, 2018, UROLOGY, V112, P209, DOI 10.1016/j.urology.2017.08.056; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Harmon SA, 2019, DIAGN INTERV RADIOL, V25, P183, DOI 10.5152/dir.2019.19125; Jackson ASN, 2009, BRIT J RADIOL, V82, P148, DOI 10.1259/bjr/89518905; Jhavar SG, 2005, J CLIN PATHOL, V58, P504, DOI 10.1136/jcp.2004.021808; Jonmarker S, 2006, VIRCHOWS ARCH, V449, P297, DOI 10.1007/s00428-006-0259-5; Kwak JT, 2016, INT J COMPUT ASS RAD, V11, P657, DOI 10.1007/s11548-015-1287-x; Lambin P, 2017, NAT REV CLIN ONCOL, V14, P749, DOI 10.1038/nrclinonc.2017.141; Liu ZY, 2019, THERANOSTICS, V9, P1303, DOI 10.7150/thno.30309; Mikhail AS, 2018, RADIOLOGY, V289, P396, DOI 10.1148/radiol.2018172571; Orczyk C, 2012, PROC SPIE, V8316, DOI 10.1117/12.911369; Partanen A, 2013, BJU INT, V112, P508, DOI 10.1111/bju.12126; Piert M, 2018, EJNMMI RES, V8, DOI 10.1186/s13550-018-0377-5; POPPER H, 1987, P NATL ACAD SCI USA, V84, P866, DOI 10.1073/pnas.84.3.866; Priester A, 2017, J UROLOGY, V197, P320, DOI 10.1016/j.juro.2016.07.084; Schned AR, 1996, AM J SURG PATHOL, V20, P1501, DOI 10.1097/00000478-199612000-00009; Shah V, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3242697; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tennant BC, 2004, GASTROENTEROLOGY, V127, pS283, DOI 10.1053/j.gastro.2004.09.043; Tran T, 2015, J CANCER, V6, P759, DOI 10.7150/jca.12094; Trivedi H, 2012, UROLOGY, V79, P233, DOI 10.1016/j.urology.2011.10.002; Trout AT, 2017, J CLIN PATHOL, V70, P984, DOI 10.1136/jclinpath-2016-204293; Turkbey B, 2011, J UROLOGY, V186, P1818, DOI 10.1016/j.juro.2011.07.013; Wu HH, 2019, J MAGN RESON IMAGING, V49, P270, DOI 10.1002/jmri.26189; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	29	4	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230794	10.1371/journal.pone.0230794	http://dx.doi.org/10.1371/journal.pone.0230794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214365	gold, Green Published, Green Submitted			2022-12-26	WOS:000535934200061
J	Mu, C; Xing, QL; Zhai, YK				Mu, Chun; Xing, Qiuling; Zhai, Yangkui			Psychometric properties of the Chinese version of the Hypoglycemia Fear SurveyII for patients with type 2 diabetes mellitus in a Chinese metropolis	PLOS ONE			English	Article							QUANTIFICATION	Purpose To evaluate the psychometric properties of the Chinese version of the Hypoglycemia Fear SurveyII (HFS-II) in patients with type 2 diabetes mellitus from Tianjin City. Methods The original HFS-II was translated and adapted to Chinese.350 inpatients from five hospitals of Tianjin completed the Chinese HFS-II. We examined the validity (content and construct validity) and reliability (internal consistency and test-retest reliability) of the scale. Content validity was evaluated by the content validity index (CVI) and the average agreement CVI(S-CVI/Ave). The construct validity was assessed by exploratory factor analysis. Reliability was measured by intraclass correlation coefficient (ICC) and Cronbach's alpha. Results The mean age of the 350 patients was 55.5 +/- 9.3years. The CVI was 0.71 similar to 1.0 and S-CVI/Ave was 0.92 respectively. By exploratory factor analysis, four factors were extracted which accounted for 52.15% of the total variance in the 23-item scale. The Chinese HFS-II displayed good internal consistency (Cronbach's alpha = 0.90) and test-retest reliability (ICC = 0.96). Conclusions The Chinese version of HFSII had excellent psychometric properties and it could provide a useful tool for clinicians and nursing staff to assess the fear of hypoglycemia.	[Mu, Chun; Xing, Qiuling; Zhai, Yangkui] Chu Hisen I Mem Hosp, Tianjin Key Lab Metab Dis, NHC Key Lab Hormones & Dev, Tianjin, Peoples R China; [Mu, Chun; Xing, Qiuling; Zhai, Yangkui] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, Peoples R China	Tianjin Medical University	Zhai, YK (corresponding author), Chu Hisen I Mem Hosp, Tianjin Key Lab Metab Dis, NHC Key Lab Hormones & Dev, Tianjin, Peoples R China.	kuikuihuahua@163.com		Xing, Qiuling/0000-0003-0137-0540	Tianjin Medical University Chu Hisen-I Memorial Hospital [2016DX06, 2019ZDKF09]	Tianjin Medical University Chu Hisen-I Memorial Hospital	Funding from scientific research funding of Tianjin Medical University Chu Hisen-I Memorial Hospital (2016DX06) to Dr Chun Mu and scientific research funding of Tianjin Medical University Chu Hisen-I Memorial Hospital (2019ZDKF09) to Dr Yangkui Zhai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderbro T, 2008, PATIENT EDUC COUNS, V73, P127, DOI 10.1016/j.pec.2008.03.022; [Anonymous], HDB PSYCHOL DIABETES; Chinese Medical Association Diabetes Branch, 2012, CHINA DIABETES J, V20, pS1; COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617; Gonder-Frederick LA, 2013, DIABETIC MED, V30, P603, DOI 10.1111/dme.12129; Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343; GONDERFREDERICK LA, 1989, HEALTH PSYCHOL, V8, P45, DOI 10.1037/0278-6133.8.1.45; LYNN MR, 1986, NURS RES, V35, P382; Marrett Elizabeth, 2011, BMC Res Notes, V4, P251, DOI 10.1186/1756-0500-4-251; Nunnally J.C., 1994, PSYCHOM THEORY; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Ostenson CG, 2014, DIABETIC MED, V31, P92, DOI 10.1111/dme.12261; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480; Shi Jingcheng, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P152, DOI 10.3969/j.issn.1672-7347.2012.02.007; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stargardt T, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-91; Streiner D. L., 2003, HLTH MEASUREMENT SCA; Williams SA, 2011, DIABETES RES CLIN PR, V91, P363, DOI 10.1016/j.diabres.2010.12.027; [余红梅 Yu Hongmei], 2011, [中国卫生统计, Chinese Journal of Health Statistics], V28, P497; 1994, J PEDIATR US, V125, P177	21	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0229562	10.1371/journal.pone.0229562	http://dx.doi.org/10.1371/journal.pone.0229562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9HN	32210481	Green Published, gold			2022-12-26	WOS:000535307600010
J	Guo, Y; Zhang, GZ; Guo, BJ; Qu, CY; Zhang, MX; Kong, FM; Zhao, Y; Li, SS				Guo, Ying; Zhang, Guizhi; Guo, Baojin; Qu, Chunyan; Zhang, Mingxia; Kong, Fanmei; Zhao, Yan; Li, Sishen			QTL mapping for quality traits using a high-density genetic map of wheat	PLOS ONE			English	Article							BAKING QUALITY; HEXAPLOID WHEAT; FALLING NUMBER; WINTER-WHEAT; SSR MARKERS; BREAD; SEQUENCE; HMW; NUCLEOTIDE; PROTEIN	Protein- and starch-related quality traits, which are quantitatively inherited and significantly influenced by the environment, are critical determinants of the end-use quality of wheat. We constructed a high-density genetic map containing 10,739 loci (5,399 unique loci) using a set of 184 recombinant inbred lines (RILs) derived from a cross of 'Tainong 18 x Linmai 6' (TL-RILs). In this study, a quantitative trait loci (QTLs) analysis was used to examine the genetic control of grain protein content, sedimentation value, farinograph parameters, falling number and the performance of the starch pasting properties using TL-RILs grown in a field for three years. A total of 106 QTLs for 13 quality traits were detected, distributed on the 21 chromosomes. Of these, 38 and 68 QTLs for protein- and starch-related traits, respectively, were detected in three environments and their average values (AV). Twenty-six relatively high-frequency QTLs (RHF-QTLs) that were detected in more than two environments. Twelve stable QTL clusters containing at least one RHF-QTL were detected and classified into three types: detected only for protein-related traits (type I), detected only for starch-related traits (type II), and detected for both protein- and starch-related traits (type III). A total of 339 markers flanked with 11 QTL clusters (all except C6), were found to be highly homologous with 282 high confidence (HC) and 57 low confidence (LC) candidate genes based on IWGSC RefSeq v 1.0. These stable QTLs and RHF-QTLs, especially those grouped into clusters, are credible and should be given priority for QTL fine-mapping and identification of candidate genes with which to explain the molecular mechanisms of quality development and inform marker-assisted breeding in the future.	[Guo, Ying; Zhang, Guizhi; Guo, Baojin; Qu, Chunyan; Zhang, Mingxia; Kong, Fanmei; Zhao, Yan; Li, Sishen] Shandong Agr Univ, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Guizhi] Shandong Acad Agr Sci, Cotton Res Ctr, Jinan, Shandong, Peoples R China; [Qu, Chunyan] Zaozhuang Univ, Zaozhuang, Shandong, Peoples R China	Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shandong Academy of Agricultural Sciences; Zaozhuang University	Li, SS (corresponding author), Shandong Agr Univ, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	ssli@sdau.edu.cn		Kong, Fanmei/0000-0003-1650-9146; Kong, Fanmei/0000-0001-5499-7588	National Key Research and Development Program of China [2017YFD0100600]	National Key Research and Development Program of China	The National Key Research and Development Program of China (2017YFD0100600) to YG.	Alamri M. S., 2009, PLANT SCI RES, V2, P23; Alamri M, 2009, CEREAL FOOD WORLD, V54, P124, DOI 10.1094/CFW-54-3-0124; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Boehm JD, 2017, J CEREAL SCI, V77, P73, DOI 10.1016/j.jcs.2017.07.007; Brevis JC, 2010, J CEREAL SCI, V51, P357, DOI 10.1016/j.jcs.2010.02.004; Carter AH, 2012, THEOR APPL GENET, V124, P1079, DOI 10.1007/s00122-011-1770-x; Chen HM, 2005, CHINESE SCI BULL, V50, P2328, DOI 10.1360/982005-379; CHURCHILL GA, 1994, GENETICS, V138, P963; Cui F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04028-6; Cui F, 2016, THEOR APPL GENET, V129, P469, DOI 10.1007/s00122-015-2641-7; De Bustos A, 2000, THEOR APPL GENET, V100, P1085, DOI 10.1007/s001220051390; Deng ZY, 2015, EUPHYTICA, V203, P221, DOI 10.1007/s10681-014-1318-7; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Echeverry-Solarte M, 2015, THEOR APPL GENET, V128, P893, DOI 10.1007/s00122-015-2478-0; Feng B, 2011, MOL BREEDING, V28, P163, DOI 10.1007/s11032-010-9470-9; Fofana B, 2009, EUPHYTICA, V165, P509, DOI 10.1007/s10681-008-9766-6; Gao FM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01099; Goel S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0200669; Gu YQ, 2006, GENETICS, V174, P1493, DOI 10.1534/genetics.106.060756; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Gwirtz J.A., 2006, FUTURE FLOUR, P17; HAGBERG S, 1960, CEREAL CHEM, V37, P218; HALFORD NG, 1987, THEOR APPL GENET, V75, P117, DOI 10.1007/BF00249151; He ZH, 2005, CEREAL CHEM, V82, P345, DOI 10.1094/CC-82-0345; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Jin H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01032; Kuchel H, 2006, THEOR APPL GENET, V112, P1487, DOI 10.1007/s00122-006-0252-z; Kulwal Pawan, 2005, Functional & Integrative Genomics, V5, P254, DOI 10.1007/s10142-005-0136-3; Kumar A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221826; Kunert A, 2007, THEOR APPL GENET, V115, P683, DOI 10.1007/s00122-007-0600-7; Li FJ, 2018, THEOR APPL GENET, V131, P1903, DOI 10.1007/s00122-018-3122-6; Li J, 2012, EUPHYTICA, V183, P207, DOI 10.1007/s10681-011-0448-4; Li SS, 2007, MOL BREEDING, V20, P167, DOI 10.1007/s11032-007-9080-3; Mann G, 2009, THEOR APPL GENET, V118, P1519, DOI 10.1007/s00122-009-1000-y; McCartney CA, 2006, PLANT BREEDING, V125, P565, DOI 10.1111/j.1439-0523.2006.01256.x; Mohler V, 2014, PLANT BREEDING, V133, P448, DOI 10.1111/pbr.12177; Nedelkou IP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179851; Nelson JC, 2006, EUPHYTICA, V149, P145, DOI 10.1007/s10681-005-9062-7; Pan HaiTao, 2010, Scientia Agricultura Sinica, V43, P452; PERTEN H, 1964, CEREAL CHEM, V41, P127; Prasad M, 2003, THEOR APPL GENET, V106, P659, DOI 10.1007/s00122-002-1114-y; Reif JC, 2011, THEOR APPL GENET, V122, P961, DOI 10.1007/s00122-010-1502-7; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Simons K, 2012, CROP SCI, V52, P2182, DOI 10.2135/cropsci2012.03.0175; Sun HY, 2008, PROG NAT SCI-MATER, V18, P825, DOI 10.1016/j.pnsc.2007.12.013; Tang H, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-2028-8; THOMPSON RD, 1985, NUCLEIC ACIDS RES, V13, P6833, DOI 10.1093/nar/13.19.6833; Tsilo TJ, 2011, GENOME, V54, P460, DOI [10.1139/G11-012, 10.1139/g11-012]; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; van Poecke RMP, 2013, PLANT BIOTECHNOL J, V11, P809, DOI 10.1111/pbi.12072; Wang FF, 2017, STARCH-STARKE, V69, DOI 10.1002/star.201600077; Wang S, 2007, WINDOWS QTL CARTOGRA, V2, P5; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wen WE, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01389; Zhai SN, 2016, THEOR APPL GENET, V129, P377, DOI 10.1007/s00122-015-2634-6; Zhang G.H., 2014, THESIS	56	17	17	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230601	10.1371/journal.pone.0230601	http://dx.doi.org/10.1371/journal.pone.0230601			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208463	gold, Green Published			2022-12-26	WOS:000535305100025
J	Ito, S; Hashimoto, Y; Majima, R; Nakao, E; Aoki, H; Nishihara, M; Ohno-Urabe, S; Furusho, A; Hirakata, S; Nishida, N; Hayashi, M; Kuwahara, K; Fukumoto, Y				Ito, Sohei; Hashimoto, Yohei; Majima, Ryohei; Nakao, Eichi; Aoki, Hiroki; Nishihara, Michihide; Ohno-Urabe, Satoko; Furusho, Aya; Hirakata, Saki; Nishida, Norifumi; Hayashi, Makiko; Kuwahara, Koichiro; Fukumoto, Yoshihiro			MRTF-A promotes angiotensin II-induced inflammatory response and aortic dissection in mice	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-A; GENE-TRANSCRIPTION; MECHANICAL-STRESS; ACTIN DYNAMICS; MURINE MODEL; MYOCARDIN; ACTIVATION; ANEURYSM; EXPRESSION; APOPTOSIS	Aortic dissection (AD) is a major cause of acute aortic syndrome with high mortality due to the destruction of aortic walls. Although recent studies indicate the critical role of inflammation in the disease mechanism of AD, it is unclear how inflammatory response is initiated. Here, we demonstrate that myocardin-related transcription factor A (MRTF-A), a signal transducer of humoral and mechanical stress, plays an important role in pathogenesis of AD in a mouse model. A mouse model of AD was created by continuous infusion of angiotensin II (AngII) that induced MRTF-A expression and caused AD in 4 days. Systemic deletion of Mrtfa gene resulted in a marked suppression of AD development. Transcriptome and gene annotation enrichment analyses revealed that AngII infusion for 1 day caused pro-inflammatory and pro-apoptotic responses before AD development, which were suppressed by Mrtfa deletion. AngII infusion for 1 day induced pro-inflammatory response, as demonstrated by expressions of Il6, Tnf, and Ccl2, and apoptosis of aortic wall cells, as detected by TUNEL staining, in an MRTF-A-dependent manner. Pharmacological inhibition of MRTF-A by CCG-203971 during AngII infusion partially suppressed AD phenotype, indicating that acute suppression of MRTF-A is effective in preventing the aortic wall destruction. These results indicate that MRTF-A transduces the stress of AngII challenge to the pro-inflammatory and proapoptotic responses, ultimately leading to AD development. Intervening this pathway may represent a potential therapeutic strategy.	[Ito, Sohei; Hashimoto, Yohei; Majima, Ryohei; Nakao, Eichi; Nishihara, Michihide; Ohno-Urabe, Satoko; Furusho, Aya; Hirakata, Saki; Nishida, Norifumi; Hayashi, Makiko; Fukumoto, Yoshihiro] Kurume Univ, Dept Internal Med, Div Cardiovasc Med, Sch Med, Kurume, Fukuoka, Japan; [Aoki, Hiroki] Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka, Japan; [Kuwahara, Koichiro] Shinshu Univ, Dept Cardiovasc Med, Sch Med, Matsumoto, Nagano, Japan	Kurume University; Kurume University; Shinshu University	Aoki, H (corresponding author), Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka, Japan.	haoki@med.kurume-u.ac.jp	Kuwahara, Koichiro/AFK-1723-2022	Kuwahara, Koichiro/0000-0003-2670-7170; Ito, Sohei/0000-0003-1374-2946	Japan Society for the Promotion of Science [21390367, 24390334, 24659640, 26670621, 16H05428]; Daiichi Sankyo Foundation of Life Science; Uehara Memorial Foundation; Vehicle Racing Commemorative Foundation; Bristol-Myers Squib; Daiichi Sankyo	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Daiichi Sankyo Foundation of Life Science; Uehara Memorial Foundation(Uehara Memorial Foundation); Vehicle Racing Commemorative Foundation; Bristol-Myers Squib; Daiichi Sankyo(Daiichi Sankyo Company Limited)	H.A. Japan Society for the Promotion of Science 21390367, 24390334, 24659640, 26670621, and 16H05428 https://www.jsps.go.jp/english/index.html Daiichi Sankyo Foundation of Life Science http://www.ds-fdn.or.jp Uehara Memorial Foundation https://www.ueharazaidan.or.jp The Vehicle Racing Commemorative Foundation https://www.vecof.or.jp Bristol-Myers Squib https://www.bms.com TaNeDS grants from Daiichi Sankyo https://www.daiichisankyo.co.jp/corporate/rd/taneds/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2019, J MOL CELL CARDIOL, V133, P26, DOI 10.1016/j.yjmcc.2019.05.015; Anzai A, 2015, CIRC RES, V116, P612, DOI 10.1161/CIRCRESAHA.116.304918; Bell JL, 2013, BIOORG MED CHEM LETT, V23, P3826, DOI 10.1016/j.bmcl.2013.04.080; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Cao XL, 2011, BRAIN RES, V1385, P263, DOI 10.1016/j.brainres.2011.02.016; Cenik BK, 2016, DEVELOPMENT, V143, P2853, DOI 10.1242/dev.135855; Chen BY, 2018, BIOCHEM BIOPH RES CO, V503, P1732, DOI 10.1016/j.bbrc.2018.07.106; Chen QH, 2018, MOL CELL ENDOCRINOL, V460, P123, DOI 10.1016/j.mce.2017.07.014; Cifani N, 2015, ANN MED, V47, P441, DOI 10.3109/07853890.2015.1073346; Emrich FC, 2015, ARTERIOSCL THROM VAS, V35, P146, DOI 10.1161/ATVBAHA.114.304364; Haak AJ, 2014, J PHARMACOL EXP THER, V349, P480, DOI 10.1124/jpet.114.213520; Hirakata S, 2019, JACC BASIC TRANSL SC, DOI [10.1038/s41598-017-12248-z, DOI 10.1038/S41598-017-12248-Z]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isselbacher EM, 2016, CIRCULATION, V133, P2516, DOI 10.1161/CIRCULATIONAHA.116.009762; Jain N, 2018, NAT MATER, V17, P1134, DOI 10.1038/s41563-018-0190-6; Jia LX, 2015, J PATHOL, V236, P373, DOI 10.1002/path.4534; Jiang WJ, 2016, AGING-US, V8, P1923, DOI 10.18632/aging.101033; Kimura T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04051; Kong M, 2018, BIOCHEM BIOPH RES CO, V503, P344, DOI 10.1016/j.bbrc.2018.06.027; Kurihara T, 2012, CIRCULATION, V126, P3070, DOI 10.1161/CIRCULATIONAHA.112.097097; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Kuwahara K, 2010, MOL CELL BIOL, V30, P4134, DOI 10.1128/MCB.00154-10; Landenhed M, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001513; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Liu WJ, 2016, CELL PHYSIOL BIOCHEM, V38, P1391, DOI 10.1159/000443082; Logghe G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20673-x; Martin-Alonso M, 2015, CIRC RES, V117, pE13, DOI 10.1161/CIRCRESAHA.117.305108; Minami T, 2012, EMBO J, V31, P4428, DOI 10.1038/emboj.2012.296; Mokalled MH, 2010, DEVELOPMENT, V137, P2365, DOI 10.1242/dev.047605; Nienaber CA, 2004, CIRCULATION, V109, P3014, DOI 10.1161/01.CIR.0000130644.78677.2C; Nienaber CA, 2015, LANCET, V385, P800, DOI 10.1016/S0140-6736(14)61005-9; Ohno-Urabe S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007389; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pinard A, 2019, CIRC RES, V124, P588, DOI 10.1161/CIRCRESAHA.118.312436; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; Rateri DL, 2014, AM J PATHOL, V184, P2586, DOI 10.1016/j.ajpath.2014.05.014; Ren PP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12248-z; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Son BK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7994; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Wang DH, 2012, J BIOL CHEM, V287, P28067, DOI 10.1074/jbc.M112.379487; Xu Y, 2016, ONCOTARGET, V7, P87390, DOI 10.18632/oncotarget.13626; Yang YY, 2014, NUCLEIC ACIDS RES, V42, P10460, DOI 10.1093/nar/gku776; Yoshida S, 2019, ANN VASC DIS, V12, P187, DOI 10.3400/avd.oa.19-00007; Yu LM, 2014, J CELL SCI, V127, P4645, DOI 10.1242/jcs.152314; Zhao X, 2014, J MOL CELL CARDIOL, V75, P152, DOI 10.1016/j.yjmcc.2014.07.017; Zheng WX, 2015, EUR J PHARMACOL, V767, P201, DOI 10.1016/j.ejphar.2015.10.027; Zhong Z, 2016, CAN J PHYSIOL PHARM, V94, P379, DOI 10.1139/cjpp-2014-0461; Zhong Z, 2015, INT J MOL MED, V36, P753, DOI 10.3892/ijmm.2015.2261	49	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0229888	10.1371/journal.pone.0229888	http://dx.doi.org/10.1371/journal.pone.0229888			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208430	Green Published, gold			2022-12-26	WOS:000535305100007
J	Ritter, SM; Gu, XJ; Crijns, M; Biekens, P				Ritter, Simone M.; Gu, Xiaojing; Crijns, Maurice; Biekens, Peter			Fostering students' creative thinking skills by means of a one-year creativity training program	PLOS ONE			English	Article							HIPPOCAMPAL REPLAY; INCUBATION; BRAIN; IDEAS	Creative thinking is among the most sought-after life and work skills in the 21st century. The demand for creativity, however, exceeds the degree to which it is available and developed. The current project aimed to test the effectiveness of a one-year creativity training program for higher education. The creativity of students following the training was measured before, halfway, and after the training. In addition to the within-subjects comparison across time, performance was compared to a matched control group. At each of the measurement points, different versions of seven well-validated creativity tasks (capturing divergent and convergent creative thinking skills) were employed. The creativity training increased students' ideation skills and, more importantly their cognitive flexibility. However, no difference in originality was observed. Finally, an increase in performance was observed for one of the convergent creativity tasks, the Remote Associate Test. Implications for educational settings and directions for future research are discussed.	[Ritter, Simone M.] Radboud Univ Nijmegen, Nijmegen Sch Management, Inst Management Res, Nijmegen, Netherlands; [Gu, Xiaojing] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands; [Crijns, Maurice] Brainnovat Fdn, Eindhoven, Netherlands; [Biekens, Peter] Fontys Univ Appl Sci, Venlo, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Gu, XJ (corresponding author), Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands.	x.gu@bsi.ru.nl	Gu, Xiaojing/AAP-6581-2021	Gu, Xiaojing/0000-0001-5842-3821				Amabile T. M., 1996, CREATIVITY CONTEXT; AMABILE TM, 1983, J PERS SOC PSYCHOL, V45, P357, DOI 10.1037/0022-3514.45.2.357; [Anonymous], 2012, STATE CREATE STUDY; Australian Curriculum Assessment and Reporting Authority (ACARA), 2012, GEN CAP; Bateman K., 2013, COMPUTERWEEKLY  0418; Beaty RE, 2018, P NATL ACAD SCI USA, V115, P1087, DOI 10.1073/pnas.1713532115; Beaty RE, 2014, NEUROPSYCHOLOGIA, V64, P92, DOI 10.1016/j.neuropsychologia.2014.09.019; Beghetto RA, 2005, DOES ASSESSMENT KILL, P46268; Beghetto RA, 2007, THINK SKILLS CREAT, V2, P1, DOI 10.1016/j.tsc.2006.09.002; Bendor D, 2012, NAT NEUROSCI, V15, P1439, DOI 10.1038/nn.3203; Blair CS, 2007, J CREATIVE BEHAV, V41, P197, DOI 10.1002/j.2162-6057.2007.tb01288.x; Cai DJ, 2009, P NATL ACAD SCI USA, V106, P10130, DOI 10.1073/pnas.0900271106; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colzato LS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00116; Cotter KN, 2016, PSYCHOL AESTHET CREA, V10, P2, DOI 10.1037/a0039831; Cropley A. J., 1990, CREATIVITY RES J, V13, P167, DOI DOI 10.1080/10400419009534351; Curriculum Development Council (CDC), 2000, LEARN LEARN WAY FORW; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Davies D, 2013, THINK SKILLS CREAT, V8, P80, DOI 10.1016/j.tsc.2012.07.004; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feist GJ, 1998, REV GEN PSYCHOL, V2, P3, DOI DOI 10.1037/1089-2680.2.1.3; Gabora L, 2010, CREATIVITY RES J, V22, P1, DOI 10.1080/10400410903579494; Gu XJ, 2019, THINK SKILLS CREAT, V32, P92, DOI 10.1016/j.tsc.2019.05.002; GUILFORD JP, 1967, J CREATIVE BEHAV, V1, P3, DOI 10.1002/j.2162-6057.1967.tb00002.x; Heinonen J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162234; Hirt ER, 2008, J PERS SOC PSYCHOL, V94, P214, DOI 10.1037/0022-3514.94.2.94.2.214; Kaufman JC, 2002, CREATIVITY RES J, V14, P27, DOI 10.1207/S15326934CRJ1401_3; Keynan JN, 2019, NAT HUM BEHAV, V3, P63, DOI 10.1038/s41562-018-0484-3; Kienitz E, 2014, THINK SKILLS CREAT, V13, P57, DOI 10.1016/j.tsc.2014.03.002; Kleibeuker SW, 2016, NEW DIR CHILD ADOLES, V151, P73, DOI 10.1002/cad.20148; Litchfield RC, 2013, IND MARKET MANAG, V42, P106, DOI 10.1016/j.indmarman.2012.11.010; MACKINNON DW, 1962, AM PSYCHOL, V17, P484, DOI 10.1037/h0046541; Mann S, 2014, CREATIVITY RES J, V26, P165, DOI 10.1080/10400419.2014.901073; MEDNICK SA, 1962, PSYCHOL REV, V69, P220, DOI 10.1037/h0048850; Mourgues C, 2014, OXFORD HDB HUMAN DEV, DOI [10.1093/oxfordhb/9780199948550.013.16, DOI 10.1093/OXFORDHB/9780199948550.013.16]; Mumford MD, 2003, CREATIVITY RES J, V15, P107, DOI 10.1207/S15326934CRJ152&3_01; National Advisory Committee on Creative and Cultural Education (NACCCE), 1999, ALL OUR FUT CREAT CU; Olafsdottir HF, 2015, ELIFE, V4, DOI 10.7554/eLife.06063; Oppezzo M, 2014, J EXP PSYCHOL LEARN, V40, P1142, DOI 10.1037/a0036577; Otani A., 2015, THESE ARE SKILLS YOU; Polman E, 2011, PERS SOC PSYCHOL B, V37, P492, DOI 10.1177/0146167211398362; Puccio GJ, 2017, J CREATIVE BEHAV, V51, P330, DOI 10.1002/jocb.203; Reiter-Palmon R, 1998, CREATIVITY RES J, V11, P187, DOI 10.1207/s15326934crj1103_1; Rietzschel EF, 2018, INDIVIDUAL CREATIVIT; Rietzschel EF, 2014, CREATIVITY RES J, V26, P185, DOI 10.1080/10400419.2014.901084; Rietzschel EF, 2010, BRIT J PSYCHOL, V101, P47, DOI 10.1348/000712609X414204; Ritter SM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00215; Ritter SM, 2012, J EXP SOC PSYCHOL, V48, P961, DOI 10.1016/j.jesp.2012.02.009; Ritter SM, 2016, J COGN ENHANC, V1, P1; Robinson J., 2014, EMERGING JOHANNESBUR, P275; Runco M. A., 2004, CREATIVITY POTENTIAL, P21, DOI [DOI 10.1037/10692-002, 10.1037/10692-002]; Scholte FA, 2008, SALUD PUBLICA MEXICO, V50, pS273, DOI 10.1590/S0036-36342008000800021; Scott G, 2004, CREATIVITY RES J, V16, P361, DOI 10.1207/s15326934crj1604_1; Simonton DK, 2000, DEV REV, V20, P283, DOI 10.1006/drev.1999.0504; Sio UN, 2009, PSYCHOL BULL, V135, P94, DOI 10.1037/a0014212; Sternberg R.J., 1999, HDB CREAT, V1, P3; Sternberg RJ, 2009, TEACHING FOR WISDOM: CROSS-CULTURAL PERSPECTIVES ON FOSTERING WISDOM, P37, DOI 10.1007/978-1-4020-6532-3_3; US. Bureau of Labor Statistics, 2017, NUMB JOBS LAB MARK E; Wallas G., 1926, ART THOUGHT; Ward TB, 2004, J BUS VENTURING, V19, P173, DOI 10.1016/S0883-9026(03)00005-3; Ward TB, 1997, CREATIVE THOUGHT INV, DOI [10.1002/cad.20148, DOI 10.1002/CAD.20148]; Ward TB, 1995, CREATIVITY MIND; Wieth MB, 2011, THINK REASONING, V17, P387, DOI 10.1080/13546783.2011.625663; Wyse D, 2015, BRIT EDUC RES J, V41, P30, DOI 10.1002/berj.3135	64	12	13	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0229773	10.1371/journal.pone.0229773	http://dx.doi.org/10.1371/journal.pone.0229773			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9FU	32196509	Green Published, gold			2022-12-26	WOS:000535303100013
J	Strobel, EJ; Lis, JT; Lucks, JB				Strobel, Eric J.; Lis, John T.; Lucks, Julius B.			Chemical roadblocking of DNA transcription for nascent RNA display	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription; RNA polymerase; RNA; RNA folding; biotin; desthiobiotin; etheno-dA; RNAP roadblocking; site-specific transcription arrest; translesion synthesis	QUANTITATIVE-ANALYSIS; PROTEIN INTERACTIONS; POLYMERASE BYPASS; STRAND BREAKS; ABASIC SITES; MUTAGENESIS; ELONGATION; RIBOSWITCH; MECHANISM	Site-specific arrest of RNA polymerases (RNAPs) is fundamental to several technologies that assess RNA structure and function. Current in vitro transcription ?roadblocking? approaches inhibit transcription elongation by blocking RNAP with a protein bound to the DNA template. One limitation of protein-mediated transcription roadblocking is that it requires inclusion of a protein factor extrinsic to the minimal in vitro transcription reaction. In this work, we developed a chemical approach for halting transcription by Escherichia coli RNAP. We first established a sequence-independent method for site-specific incorporation of chemical lesions into dsDNA templates by sequential PCR and translesion synthesis. We then show that interrupting the transcribed DNA strand with an internal desthiobiotin-triethylene glycol modification or 1,N-6-etheno-2?-deoxyadenosine base efficiently and stably halts Escherichia coli RNAP transcription. By encoding an intrinsic stall site within the template DNA, our chemical transcription roadblocking approach enables display of nascent RNA molecules from RNAP in a minimal in vitro transcription reaction.	[Strobel, Eric J.; Lucks, Julius B.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Lucks, Julius B.] Northwestern Univ, Ctr Synthet Biol, Evanston, IL 60208 USA; [Strobel, Eric J.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Northwestern University; Northwestern University; Cornell University	Strobel, EJ (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.; Strobel, EJ (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	eric.strobel@northwestern.edu	Lucks, Julius/L-2801-2016	Lis, John/0000-0003-1201-9406; Lucks, Julius/0000-0002-0619-6505; Strobel, Eric/0000-0002-7082-2881	Arnold O. Beckman postdoctoral fellowship; NIGMS, National Institutes of Health [GM025232]; Searle Funds at The Chicago Community Trust	Arnold O. Beckman postdoctoral fellowship; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Searle Funds at The Chicago Community Trust	This work was supported by an Arnold O. Beckman postdoctoral fellowship (to E. J. S.), NIGMS, National Institutes of Health Grant GM025232 (to J. T. L.)., and Searle Funds at The Chicago Community Trust (to J. B. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Buenrostro JD, 2014, NAT BIOTECHNOL, V32, P562, DOI 10.1038/nbt.2880; Chauvier A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13892; Clauson CL, 2010, P NATL ACAD SCI USA, V107, P3657, DOI 10.1073/pnas.0913191107; Fiala KA, 2007, J MOL BIOL, V365, P590, DOI 10.1016/j.jmb.2006.10.008; Frieda KL, 2012, SCIENCE, V338, P397, DOI 10.1126/science.1225722; Landick R, 1996, METHOD ENZYMOL, V274, P334; Luzzietti N, 2012, NAT PROTOC, V7, P643, DOI 10.1038/nprot.2012.008; Luzzietti N, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1004; McDonald JP, 2006, NUCLEIC ACIDS RES, V34, P1102, DOI 10.1093/nar/gkj512; METZGER W, 1989, EMBO J, V8, P2745, DOI 10.1002/j.1460-2075.1989.tb08416.x; PAVCO PA, 1990, J BIOL CHEM, V265, P9960; Pupov D, 2019, BIOCHEM BIOPH RES CO, V510, P122, DOI 10.1016/j.bbrc.2019.01.062; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; STRAUSS BS, 1991, BIOESSAYS, V13, P79, DOI 10.1002/bies.950130206; Strobel EJ, 2019, NAT CHEM BIOL, V15, P1067, DOI 10.1038/s41589-019-0382-7; Strobel EJ, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx233; Strobel EJ, 2015, P NATL ACAD SCI USA, V112, pE4374, DOI 10.1073/pnas.1512986112; Tome JM, 2014, NAT METHODS, V11, P683, DOI [10.1038/NMETH.2970, 10.1038/nmeth.2970]; VANHOUTEN B, 1987, J BIOL CHEM, V262, P13180; Viswanathan A, 1998, J BIOL CHEM, V273, P21276, DOI 10.1074/jbc.273.33.21276; Viswanathan A, 1999, ANN NY ACAD SCI, V870, P386, DOI 10.1111/j.1749-6632.1999.tb08909.x; Wang HX, 2001, MOL BIOTECHNOL, V19, P133, DOI 10.1385/MB:19:2:133; Watters KE, 2016, NAT STRUCT MOL BIOL, V23, P1124, DOI 10.1038/nsmb.3316; Widom JR, 2019, RNA, V25, P1457, DOI 10.1261/rna.071613.119; ZHOU W, 1993, P NATL ACAD SCI USA, V90, P6601, DOI 10.1073/pnas.90.14.6601	26	7	7	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6401	6412		10.1074/jbc.RA120.012641	http://dx.doi.org/10.1074/jbc.RA120.012641			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32209658	Green Published, hybrid			2022-12-26	WOS:000537685000013
J	Rainczuk, AK; Klatt, S; Yamaryo-Botte, Y; Brammananth, R; McConville, MJ; Coppel, RL; Crellin, PK				Rainczuk, Arek K.; Klatt, Stephan; Yamaryo-Botte, Yoshiki; Brammananth, Rajini; McConville, Malcolm J.; Coppel, Ross L.; Crellin, Paul K.			MtrP, a putative methyltransferase in Corynebacteria, is required for optimal membrane transport of trehalose mycolates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; cell wall; lipid bilayer; fatty acid; microbiology; Corynebacterium; glutamicum	MYCOLIC ACID BIOSYNTHESIS; MYCOBACTERIUM-TUBERCULOSIS; CLONING VECTORS; IDENTIFICATION; MMPL3; MONOMYCOLATE; METHYLATION; GLUTAMICUM; TARGETS; GENE	Pathogenic bacteria of the genera Mycobacterium and Corynebacterium cause severe human diseases such as tuberculosis (Mycobacterium tuberculosis) and diphtheria (Corynebacterium diphtheriae). The cells of these species are surrounded by protective cell walls rich in long-chain mycolic acids. These fatty acids are conjugated to the disaccharide trehalose on the cytoplasmic side of the bacterial cell membrane. They are then transported across the membrane to the periplasm where they act as donors for other reactions. We have previously shown that transient acetylation of the glycolipid trehalose monohydroxycorynomycolate (hTMCM) enables its efficient transport to the periplasm in Corynebacterium glutamicum and that acetylation is mediated by the membrane protein TmaT. Here, we show that a putative methyltransferase, encoded at the same genetic locus as TmaT, is also required for optimal hTMCM transport. Deletion of the C. glutamicum gene NCgl2764 (Rv0224c in M. tuberculosis) abolished acetyltrehalose monocorynomycolate (AcTMCM) synthesis, leading to accumulation of hTMCM in the inner membrane and delaying its conversion to trehalose dihydroxycorynomycolate (h2TDCM). Complementation with NCgl2764 normalized turnover of hTMCM to h2TDCM. In contrast, complementation with NCgl2764 derivatives mutated at residues essential for methyltransferase activity failed to rectify the defect, suggesting that NCgl2764/Rv0224c encodes a methyltransferase, designated here as MtrP. Comprehensive analyses of the individual mtrP and tmaT mutants and of a double mutant revealed strikingly similar changes across several lipid classes compared with WT bacteria. These findings indicate that both MtrP and TmaT have nonredundant roles in regulating AcTMCM synthesis, revealing additional complexity in the regulation of trehalose mycolate transport in the Corynebacterineae.	[Rainczuk, Arek K.; Brammananth, Rajini; Coppel, Ross L.; Crellin, Paul K.] Monash Univ, Infect & Immun Program, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Rainczuk, Arek K.; Brammananth, Rajini; Coppel, Ross L.; Crellin, Paul K.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Klatt, Stephan; Yamaryo-Botte, Yoshiki; McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Bio21 Inst Mol Sci & Biotechnol, Parkville, Vic 3010, Australia; [Klatt, Stephan] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne Dementia Res Ctr, 30 Royal Parade, Parkville, Vic 3052, Australia; [Yamaryo-Botte, Yoshiki] Univ Grenoble Alpes, ApicoLipid Team, Inst Adv Biosci, CNRS,UMR5309,INSERM,U1209, Grenoble, France	Monash University; Monash University; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Crellin, PK (corresponding author), Monash Univ, Infect & Immun Program, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia.; Crellin, PK (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.	paul.crellin@monash.edu		Crellin, Paul K/0000-0002-2017-4935; Klatt, Stephan/0000-0003-0064-3367; McConville, Malcolm/0000-0002-7107-7887	National Health and Medical Research Council of Australia [1064466]; Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics Grant [COE562063]; Australian Research Council [180102463]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics Grant(Australian Research Council); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council of Australia Project Grant 1064466 (to P. K. C., R. L. C., and M. J. M.), Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics Grant COE562063 (to R. L. C.), and Australian Research Council Discovery Grant 180102463 (to R. L. C. and M. J. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Alderwick LJ, 2006, J BIOL CHEM, V281, P15653, DOI 10.1074/jbc.M600045200; Alsayed SSR, 2019, CURR MOL PHARMACOL, V12, P27, DOI 10.2174/1874467211666181025141114; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Belardinelli JM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47159-8; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cashmore TJ, 2017, J BIOL CHEM, V292, P4976, DOI 10.1074/jbc.M116.772202; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16; Druszczynska M, 2017, CURR MED CHEM, V24, P4267, DOI 10.2174/0929867324666170823130445; Dupont C, 2019, J BIOL CHEM, V294, P17512, DOI 10.1074/jbc.RA119.010135; Fernandes ND, 1996, GENE, V170, P95, DOI 10.1016/0378-1119(95)00842-X; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Hattori Y, 2011, BIOCHEM BIOPH RES CO, V409, P304, DOI 10.1016/j.bbrc.2011.04.146; Jankute M, 2015, ANNU REV MICROBIOL, V69, P405, DOI 10.1146/annurev-micro-091014-104121; Keller JP, 2002, STRUCTURE, V10, P1475, DOI 10.1016/S0969-2126(02)00876-6; Klatt S, 2018, J LIPID RES, V59, P1190, DOI 10.1194/jlr.M082784; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Lea-Smith DJ, 2008, J BIOL CHEM, V283, P6773, DOI 10.1074/jbc.M707139200; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Li W, 2019, ACS INFECT DIS, V5, P1001, DOI 10.1021/acsinfecdis.9b00048; Li W, 2014, ANTIMICROB AGENTS CH, V58, P6413, DOI 10.1128/AAC.03229-14; Liao HW, 2015, J CLIN INVEST, V125, P4529, DOI 10.1172/JCI82826; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; McKean S, 2005, MICROBES INFECT, V7, P1352, DOI 10.1016/j.micinf.2005.05.002; Mishra AK, 2008, MOL MICROBIOL, V68, P1595, DOI 10.1111/j.1365-2958.2008.06265.x; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Rainczuk AK, 2012, J BIOL CHEM, V287, P42726, DOI 10.1074/jbc.M112.373415; Raman K, 2005, PLOS COMPUT BIOL, V1, P349, DOI 10.1371/journal.pcbi.0010046; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Su CC, 2019, P NATL ACAD SCI USA, V116, P11241, DOI 10.1073/pnas.1901346116; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Williams JT, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00547-19; Xu ZJ, 2017, P NATL ACAD SCI USA, V114, P7993, DOI 10.1073/pnas.1700062114; Yamaryo-Botte Y, 2015, ACS CHEM BIOL, V10, P734, DOI 10.1021/cb5007689; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6	50	8	8	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6108	6119		10.1074/jbc.RA119.011688	http://dx.doi.org/10.1074/jbc.RA119.011688			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32217691	Green Published, hybrid			2022-12-26	WOS:000531417300021
J	Al-Hashem, G; Rotimi, VO; Albert, MJ				Al-Hashem, Ghayda; Rotimi, Vincent O.; Albert, M. John			Genetic relatedness of serial rectal isolates of Acinetobacter baumannii in an adult intensive care unit of a tertiary hospital in Kuwait	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; SEQUENCE TYPING SCHEME; MOLECULAR EPIDEMIOLOGY; EVOLUTION; SPREAD	Acinetobacter baumannii is an opportunistic pathogen of intensive care unit (ICU) patients. A. baumannii colonizes many parts of the body including the gastrointestinal tract. Endemic and epidemic strains are polyclonal. There is no clarity on the origin of polyclonality of A. baumannii. The objective of the study was to define the genetic relatedness of serial isolates and the origin of polyclonality. Serial rectal isolates from ICU patients whose rectum was colonized on >= 5 sampling occasions were selected. From a total of 32 eligible colonized patients, isolates from a subgroup of 13 patients (a total of 108 isolates) showing different patterns of colonization as revealed by pulsed-field gel electrophoresis (PFGE) were studied. The isolates were analyzed by PFGE pulsotypes, sequence types (STs) by multi-locus sequence typing (MLST) and clonal complex (CC) by eBURST analysis. Serial isolates constituted a mixture of identical, related and unrelated pulsotypes. Analysis by STs and CCs were less discriminatory. The data suggest a combination of an initial colonizing isolate undergoing mutation as well as colonization by independent isolates. Further clarity on the origin of diversity should be better obtained by whole-genome sequencing.	[Al-Hashem, Ghayda; Rotimi, Vincent O.; Albert, M. John] Kuwait Univ, Fac Med, Dept Microbiol, Kuwait, Kuwait	Kuwait University	Albert, MJ (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Kuwait, Kuwait.	john@hsc.edu.kw			Kuwait University Research grant [YM03/15]	Kuwait University Research grant	The study was funded by a Kuwait University Research grant (YM03/15) to MJA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayats J, 1997, J HOSP INFECT, V37, P287, DOI 10.1016/S0195-6701(97)90145-6; Barbolla RE, 2008, AM J INFECT CONTROL, V36, P444, DOI 10.1016/j.ajic.2007.09.010; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Chan AP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0701-6; Chatterjee S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01126; CLSI, M100 CLSI, V29th; Deplano A, 2011, J CLIN MICROBIOL, V49, P3616, DOI 10.1128/JCM.00528-11; Di Venanzio G, 2019, P NATL ACAD SCI USA, V116, P1378, DOI 10.1073/pnas.1812557116; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; DIJKSHOORN L, 1987, EPIDEMIOL INFECT, V99, P659, DOI 10.1017/S0950268800066516; Djahmi N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/305784; Durmaz R, 2009, JPN J INFECT DIS, V47, P2452, DOI [10.1128/JCM.00476-09.6, DOI 10.1128/JCM.00476-09.6]; Ewers C, 2017, INT J ANTIMICROB AG, V49, P37, DOI 10.1016/j.ijantimicag.2016.09.033; Hamidian M, 2017, J CLIN MICROBIOL, V55, P2287, DOI 10.1128/JCM.00533-17; Hamouda A, 2010, J CLIN MICROBIOL, V48, P2476, DOI 10.1128/JCM.02431-09; Higgins PG, 2007, CLIN MICROBIOL INFEC, V13, P1199, DOI 10.1111/j.1469-0691.2007.01819.x; Imperi F, 2011, IUBMB LIFE, V63, P1068, DOI 10.1002/iub.531; Jamal W., 2017, OPEN FORUM INFECT DI, V4, pS174, DOI DOI 10.1093/OFID/OFX163.317; Johnson JK, 2016, DIAGN MICR INFEC DIS, V86, P345, DOI 10.1016/j.diagmicrobio.2016.08.024; Kenyon JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062160; Kian Baharak, 2018, Iran J Pathol, V13, P144; Li HN, 2015, ANTIMICROB AGENTS CH, V59, P1168, DOI 10.1128/AAC.04609-14; Li PY, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00997; Rafei R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115969; Rafei R, 2014, FUTURE MICROBIOL, V9, P1179, DOI [10.2217/fmb.14.63, 10.2217/FMB.14.63]; Runnegar N, 2010, J CLIN MICROBIOL, V48, P4051, DOI 10.1128/JCM.01208-10; Saffari F, 2017, J MED MICROBIOL, V66, P1656, DOI 10.1099/jmm.0.000619; Sarovich DS, 2013, J MED MICROBIOL, V62, P1295, DOI 10.1099/jmm.0.052381-0; Schwarze K, 2018, GENET MED, V20, P1122, DOI 10.1038/gim.2017.247; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; Sheng WH, 2010, INT J INFECT DIS, V14, pE764, DOI 10.1016/j.ijid.2010.02.2254; Talaga K, 2016, ANAESTH INTENSIVE TH, V48, P166, DOI 10.5603/AIT.a2016.0021; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Vanegas Múnera Johanna M., 2019, Infect., V23, P205, DOI 10.22354/in.v23i2.778; Villalon P, 2011, J CLIN MICROBIOL, V49, P875, DOI 10.1128/JCM.01026-10; Zarrilli R, 2013, INT J ANTIMICROB AG, V41, P11, DOI 10.1016/j.ijantimicag.2012.09.008; Zowawi HM, 2015, J CLIN MICROBIOL, V53, P896, DOI 10.1128/JCM.02784-14	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230976	10.1371/journal.pone.0230976	http://dx.doi.org/10.1371/journal.pone.0230976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240218	gold, Green Published			2022-12-26	WOS:000535945000068
J	Sanchez, MCA; Celeste, BJ; Lindoso, JAL; Fujimori, M; de Almeida, RP; Fortaleza, CMCB; Druzian, AF; Lemos, APF; de Melo, VCA; Paniago, AMM; Queiroz, IT; Goto, H				Arroyo Sanchez, Maria Carmen; Celeste, Beatriz Julieta; Lauletta Lindoso, Jose Angelo; Fujimori, Mahyumi; de Almeida, Roque Pacheco; Castelo Branco Fortaleza, Carlos Magno; Druzian, Angelita Fernandes; Freitas Lemos, Ana Priscila; Andrade de Melo, Vanessa Campos; Miranda Paniago, Anamaria Mello; Queiroz, Igor Thiago; Goto, Hiro			Performance of rK39-based immunochromatographic rapid diagnostic test for serodiagnosis of visceral leishmaniasis using whole blood, serum and oral fluid	PLOS ONE			English	Article							DIRECT AGGLUTINATION-TEST; RK39 ANTIGEN; FIELD; STATISTICS	Background The development of rK39-based immunochromatographic rapid diagnostic tests represents an important advance for serodiagnosis of visceral leishmaniasis, being cheap and easy to use at the point of care (POC). Although the use of rK39 have considerably improved the sensitivity and specificity of serological tests compared with total antigens, great variability in sensitivity and specificity was reported. This study aimed at the evaluation of "Kalazar Detect (TM) Rapid Test, Whole Blood" (Kalazar Detect RDT) for Visceral Leishmaniasis (VL) diagnosis using oral fluid, whole blood and serum specimens collected at different endemic areas of VL of Brazil. Methodology To evaluate Kalazar Detect RDT, oral fluid, whole blood and serum specimens from 128 VL patients, 85 healthy individuals, 22 patients with possible cross-reactivity diseases and 20 VL/aids coinfected patients were collected and assayed at the POC. Principal findings and conclusions The performance of Kalazar Detect RDT in whole blood and serum was similar; however, using oral fluid, the sensitivity was low. Particularly in samples from the city of Natal, Rio Grande do Norte state in Northeastern Brazil, we observed low sensitivity, 80.0% (95% CI: 62.7-90.5), using whole blood and serum, and poor sensitivity, 43.3% (95% CI: 27.4-60.8) with oral fluid. Those values were much lower than in the other regions, where sensitivity ranged from 92.7-96.3% in whole blood and serum, and 80.0-88.9% in oral fluid. Besides, in VL/aids coinfected patients, lower sensitivity was achieved compared with VL patients. In samples from Natal, the sensitivity was 0.0% (95% CI: 0.0-49.0) and 25.0% (95% CI: 4.6-69.9), using oral fluid and serum/whole blood, respectively; in samples from the other regions, the sensitivity ranged from 40.0-63.6% and 80.0-81.8%, respectively. As for specificity, high values were observed across the fluids, 100.0% (95% CI: 96.5-100.0) in whole blood, 96.3% (95% CI: 90.8-98.5) in serum, and 95.3% (95% CI: 89.5-98.0) in oral fluid; across localities, specificity ranged from 85.7-100.0%. Serum samples sent by the collaborating centers to Instituto de Medicina Tropical (n = 250) were tested by Kalazar Detect RDT, Direct Agglutination Test, Indirect immunofluorescence assay, Enzyme-linked immunosorbent assay, and IT-Leish (R) RDT. The regional difference in the performance of rK39-based RDT and lower sensitivity in Leishmania/HIV coinfected patients raise concern on the routine use of these products for the diagnosis of VL.	[Arroyo Sanchez, Maria Carmen; Celeste, Beatriz Julieta; Fujimori, Mahyumi; Goto, Hiro] Univ Sao Paulo, Inst Med Trop, Lab Soroepidemiol & Imunobiol, Fac Med, Sao Paulo, SP, Brazil; [Lauletta Lindoso, Jose Angelo] Univ Sao Paulo, Fac Med, Dept Doencas Infecciosas & Parasitarias, Sao Paulo, SP, Brazil; [Lauletta Lindoso, Jose Angelo] Inst Infectol Emilio Ribas, Secretaria Estado Saude, Sao Paulo, SP, Brazil; [de Almeida, Roque Pacheco] Univ Fed Sergipe, Hosp Univ EBSERH, Dept Med Interna & Patol, Aracaju, SE, Brazil; [Castelo Branco Fortaleza, Carlos Magno] Univ Estadual Paulista, Dept Doencas Trop & Diagnost Imagem, Botucatu, SP, Brazil; [Druzian, Angelita Fernandes] Univ Fed Mato Grosso, Hosp Univ Maria Aparecida Pedrossian, Campo Grande, MS, Brazil; [Freitas Lemos, Ana Priscila] Univ Fed Rio Grande do Norte, Hosp Univ Onofre Lopes, Natal, RN, Brazil; [Andrade de Melo, Vanessa Campos; Queiroz, Igor Thiago] Hosp Giselda Trigueiro, Secretaria Estadual Seguranca Publ, Natal, RN, Brazil; [Miranda Paniago, Anamaria Mello] Univ Fed Mato Grosso do Sul, Fac Med, Campo Grande, MS, Brazil; [Goto, Hiro] Univ Sao Paulo, Fac Med, Dept Med Prevent, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sergipe; Universidade Estadual Paulista; Universidade Federal de Mato Grosso; Universidade Federal do Rio Grande do Norte; Universidade Federal de Mato Grosso do Sul; Universidade de Sao Paulo	Sanchez, MCA (corresponding author), Univ Sao Paulo, Inst Med Trop, Lab Soroepidemiol & Imunobiol, Fac Med, Sao Paulo, SP, Brazil.	arroyo@usp.br	Paniago, Anamaria M M/B-7747-2012; Goto, Hiro/B-5745-2009; Paniago, Anamaria/AGS-6094-2022; Lindoso, José Angelo Lauletta/E-9339-2012; Fujimori, Mahyumi/AAH-4746-2020; Sanchez, Maria Carmen Arroyo/D-8886-2012; Fortaleza, Carlos Magno C. B./C-3807-2013	Paniago, Anamaria M M/0000-0002-8925-7712; Goto, Hiro/0000-0001-7048-562X; Paniago, Anamaria/0000-0002-8925-7712; Lindoso, José Angelo Lauletta/0000-0002-4405-4401; Fujimori, Mahyumi/0000-0001-7790-9827; Sanchez, Maria Carmen Arroyo/0000-0003-4055-5556; Fortaleza, Carlos Magno C. B./0000-0003-4120-1258; Celeste, Beatriz Julieta/0000-0003-0815-359X	Ministry of Health, Brazil [084727/2010]; Laboratorio de Investigacao Medica Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo [LIM-38]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Ministry of Health, Brazil; Laboratorio de Investigacao Medica Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Ministry of Health, Brazil (SICONV N omicron 084727/2010) and Laboratorio de Investigacao Medica (LIM-38) Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo. HG recieved research fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; [Anonymous], 2019, CASOS CONFIRMADOS LE; [Anonymous], 2000, LETALIDADE LEISHMANI; [Anonymous], 2019, LEISHMANIOSE VISCERA; Attia J, 2002, AUSTR PRESCRIBER, P26; Bangert M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006277; Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Bhattacharyya T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002057; da Silva MRB, 2018, PARASITOL RES, V117, P419, DOI 10.1007/s00436-017-5716-3; Boelaert M., 2007, Nature Reviews Microbiology, pS30, DOI 10.1038/nrmicro1766; BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775; Celeste Beatriz Julieta, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P287, DOI 10.1590/S0036-46651998000500004; Chappuis F, 2006, TROP MED INT HEALTH, V11, P31, DOI 10.1111/j.1365-3156.2005.01533.x; Chappuis F, 2005, J CLIN MICROBIOL, V43, P5973, DOI 10.1128/JCM.43.12.5973-5977.2005; Cota GF, 2013, AM J TROP MED HYG, V89, P570, DOI 10.4269/ajtmh.13-0239; Cunningham J, 2012, CLIN INFECT DIS, V55, P1312, DOI 10.1093/cid/cis716; da Silva MRB, 2015, TROP BIOMED, V32, P247; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; ELHARITH A, 1988, J CLIN MICROBIOL, V26, P1321, DOI 10.1128/JCM.26.7.1321-1325.1988; Fleiss JL., 2003, STAT METHODS RATES P; Freire ML, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007484; Furukawa TA, 2008, USERS GUIDES MED LIT, P195; Galai Y, 2011, J CLIN MICROBIOL, V49, P3150, DOI 10.1128/JCM.00267-11; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; GUIMARAES MCS, 1989, B WORLD HEALTH ORGAN, V67, P643; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lindoso JAL, 2012, RES REP TROP MED, V3, P69, DOI 10.2147/RRTM.S24764; Maia Z, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001484; Ferreira GEM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036242; Mikaeili Fattaneh, 2007, Iran J Immunol, V4, P116; Mohapatra S, 2016, J ARTHROPOD-BORNE DI, V10, P87; Motoie G, 2013, INFECT GENET EVOL, V18, P48, DOI 10.1016/j.meegid.2013.04.031; Pedras MJ, 2008, T ROY SOC TROP MED H, V102, P172, DOI 10.1016/j.trstmh.2007.11.004; Peruhype-Magalhaes V, 2012, MEM I OSWALDO CRUZ, V107, P951, DOI 10.1590/S0074-02762012000700019; Ritmeijer K, 2006, AM J TROP MED HYG, V74, P76, DOI 10.4269/ajtmh.2006.74.76; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Singh DP, 2010, J HEALTH POPUL NUTR, V28, P281; Srivastava P, 2011, T ROY SOC TROP MED H, V105, P1, DOI 10.1016/j.trstmh.2010.09.006; Srividya G, 2012, PARASITOL RES, V110, P1065, DOI 10.1007/s00436-011-2680-1; Sundar S, 1998, LANCET, V351, P563, DOI 10.1016/S0140-6736(97)04350-X; Vaish M, 2012, AM J TROP MED HYG, V86, P598, DOI 10.4269/ajtmh.2012.11-0127; van Griensven J, 2019, INFECT DIS CLIN N AM, V33, P79, DOI 10.1016/j.idc.2018.10.005; World Health Organization, 2019, LEISHMANIASIS	45	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230610	10.1371/journal.pone.0230610	http://dx.doi.org/10.1371/journal.pone.0230610			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240188	Green Published, gold			2022-12-26	WOS:000535945000032
J	He, L; Pan, XH; Yang, JZ; Ma, QQ; Jiang, J; Wang, W; Qiu, JQ; Zou, YZ; Wang, P; Zhao, DS; Wang, H; Jiang, TT				He, Lin; Pan, Xiaohong; Yang, Jiezhe; Ma, Qiaoqin; Jiang, Jun; Wang, Wei; Qiu, Jiaquan; Zou, Yazhou; Wang, Ping; Zhao, Dongshe; Wang, Hui; Jiang, Tingting			HIV risk behavior and HIV testing among rural and urban men who have sex with men in Zhejiang Province, China: A respondent-driven sampling study	PLOS ONE			English	Review							INTERNET; GAY; PREVALENCE; MSM; COMMUNITIES; RECRUIT; STIGMA; YUNNAN; WOMEN	Background Currently, human immunodeficiency virus (HIV) sentinel surveillance among men who have sex with men (MSM) in China conducted in large and medium-sized cities, and no HIV sentinel surveillance conducted in rural areas. HIV testing and intervention is predominantly conducted in urban areas, there have been a limited number of studies in rural areas MSM, it is necessary to conduct the investigation of HIV risk sexual behavior, HIV testing among rural and urban MSM. Method Between December 2013 and August 2015, a cross-sectional study was conducted in rural and urban areas in Zhejiang Province using respondent-driven sampling (RDS). Participants completed face-to-face interviewer-administered questionnaire surveys and were tested for HIV. Results A total of 710 MSM participants were recruited, of whom 36.1% were from rural areas. The overall HIV prevalence was 16.6%, and was considerably lower among MSM living in rural areas (3.9%) than those living in urban areas (24.2%). 61.1% participants had not condom use with male sexual behavior in the past 6 months (86.7% in rural areas and 46.7% in urban areas). The social demographic and behavioral characteristics had significance difference among rural and urban MSM. Multivariate logistic regression revealed that, compared to men living in urban areas, MSM living in rural areas MSM were more likely to use dating apps to find sexual partners, were more likely to engage in bisexual behavior, and had lower condom use. 43.0% participants had been tested for HIV in the past year (41.8% in rural areas and 43.6% in urban areas). Multivariate logistic regression also revealed that among participants living in rural areas, having rural health insurance and not accepting HIV intervention were associated with lower HIV testing rates, while a higher monthly income and through use of internet to find sexual partner were associated with higher rates of HIV testing. Conclusion High risk behavior was prevalent, and HIV testing rates were low among MSM living in rural areas compare to urban areas in Zhejiang Province, therefore, preventative intervention measures should be immediately among rural MSM urgently to reduce HIV transmission and to promote HIV testing.	[He, Lin; Pan, Xiaohong; Yang, Jiezhe; Ma, Qiaoqin; Jiang, Jun; Wang, Hui; Jiang, Tingting] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Wang, Wei; Zou, Yazhou] Quzhou Ctr Dis Control & Prevent, Quzhou, Zhejiang, Peoples R China; [Qiu, Jiaquan] Kaihua Cty Ctr Dis Control & Prevent, Quzhou, Zhejiang, Peoples R China; [Wang, Ping] Jiangshan Ctr Dis Control & Prevent, Quzhou, Zhejiang, Peoples R China; [Zhao, Dongshe] Lucheng Dist Ctr Dis Control & Prevent, Quzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Pan, XH; Ma, QQ (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	xhpan@cdc.zj.cn; qqma@cdc.zj.cn			National S & T Major Project Foundation of China [2012ZX10001-001, 2017ZX10201101002]; Zhejiang Provincial Medicine Science and Technology Plan [2015PYA004]; Social Development Project of Public Welfare Technology Research in Zhejiang Province [LGF18H260006]	National S & T Major Project Foundation of China; Zhejiang Provincial Medicine Science and Technology Plan; Social Development Project of Public Welfare Technology Research in Zhejiang Province	The study was funded by a grant from `National S & T Major Project Foundation of China' (2012ZX10001-001) to XP and (2017ZX10201101002) to XP, Zhejiang Provincial Medicine Science and Technology Plan (2015PYA004) to XP and Social Development Project of Public Welfare Technology Research in Zhejiang Province (LGF18H260006) to LH. The funding body had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	[Anonymous], 2019, ANN REPORT HIV STI H; Baral S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-766; Bowen A, 2005, J SEX RES, V42, P317, DOI 10.1080/00224490509552287; Bowen A, 2004, AIDS BEHAV, V8, P311, DOI 10.1023/B:AIBE.0000044078.43476.1f; Bowen AM, 2008, J BEHAV MED, V31, P463, DOI 10.1007/s10865-008-9171-6; Bowen AM, 2007, HEALTH EDUC RES, V22, P120, DOI 10.1093/her/cyl057; Cai R, 2014, AIDS BEHAV, V18, P1560, DOI 10.1007/s10461-014-0735-x; Cao BL, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7251; Carrel M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088512; Chen X, 2015, PLOS ONE, V10; Chow EPF, 2012, HIV MED, V13, P255, DOI 10.1111/j.1468-1293.2011.00974.x; Chow EPF, 2013, SEX HEALTH, V10, P533, DOI 10.1071/SH13097; Chow EPF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-242; Colby D, 2008, SEX TRANSM INFECT, V84, P439, DOI 10.1136/sti.2008.031294; Davis A, 2016, INT J STD AIDS, V27, P840, DOI 10.1177/0956462415596302; Horvath KJ, 2006, HEALTH PSYCHOL, V25, P237, DOI 10.1037/0278-6133.25.2.237; Imrie J, 2013, AIDS BEHAV, V17, pS70, DOI 10.1007/s10461-012-0356-1; Kakietek J, 2011, AIDS EDUC PREV, V23, P118, DOI 10.1521/aeap.2011.23.2.118; Koo FK, 2014, CULT HEALTH SEX, DOI [10.1136/sti.2005.016790, DOI 10.1136/STI.2005.016790]; Lea T, 2013, DRUG ALCOHOL REV, V32, P39, DOI 10.1111/j.1465-3362.2012.00494.x; Li R, 2017, PLOS ONE, V12; Li RH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3806-2; Neilands TB, 2008, ARCH SEX BEHAV, V37, P838, DOI 10.1007/s10508-007-9305-x; Pan XH, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008466; Paz-Bailey G, 2013, MMWR-MORBID MORTAL W, V62, P958; Preston DB, 2004, AIDS EDUC PREV, V16, P291, DOI 10.1521/aeap.16.4.291.40401; Rosenberger JG, 2014, J HOMOSEXUAL, V61, P1192, DOI 10.1080/00918369.2014.872525; Steward WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071778; Wang B, 2013, AIDS CARE, V25, P249, DOI 10.1080/09540121.2012.701714; Wang LM, 2019, MMWR-MORBID MORTAL W, V68, P478, DOI 10.15585/mmwr.mm6821a3; Wei L, 2019, BMJ OPEN, V9; Williams M, 2010, HEALTH PROMOT PRACT, V11, P474, DOI 10.1177/1524839908324783; Williams ML, 2005, J RURAL HEALTH, V21, P48, DOI 10.1111/j.1748-0361.2005.tb00061.x; Williams PB, 2010, J NATL MED ASSOC, V102, P1139; Wong WCW, 2006, SEX TRANSM INFECT, V82, P127, DOI 10.1136/sti.2005.016790; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Xu ZX, 2012, HIV HCV SYPHILIS INF, P6484; Yang JZ, 2014, ANAL HIV SENTINEL SU, P922, DOI [10.1093/cid/cit210, DOI 10.1093/CID/CIT210]; Zhao YJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000534	39	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0231026	10.1371/journal.pone.0231026	http://dx.doi.org/10.1371/journal.pone.0231026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8KJ	32240244	Green Published, gold			2022-12-26	WOS:000535945000081
J	Kondrak, M; Kopp, A; Uri, C; Sos-Hegedus, A; Csakvari, E; Schiller, M; Barta, E; Cernak, I; Polgar, Z; Taller, J; Banfalvi, Z				Kondrak, Mihaly; Kopp, Andrea; Uri, Csilla; Sos-Hegedus, Anita; Csakvari, Edina; Schiller, Matyas; Barta, Endre; Cernak, Istvan; Polgar, Zsolt; Taller, Janos; Banfalvi, Zsofia			Mapping and DNA sequence characterisation of the Ry(sto) locus conferring extreme virus resistance to potato cultivar 'White Lady'	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; CHROMOSOME-XII; SOLANUM-STOLONIFERUM; MOLECULAR MARKERS; GENOME SEQUENCE; CELL-DEATH; GENE; PVY; IDENTIFICATION; EXPRESSION	Virus resistance genes carried by wild plant species are valuable resources for plant breeding. The Ry(sto) gene, conferring a broad spectrum of durable resistance, originated from Solanum stoloniferum and was introgressed into several commercial potato cultivars, including 'White Lady', by classical breeding. Ry(sto) was mapped to chromosome XII in potato, and markers used for marker-assisted selection in breeding programmes were identified. Nevertheless, there was no information on the identity of the Ry(sto) gene. To begin to reveal the identification of Ry(sto), fine-scale genetic mapping was performed which, in combination with chromosome walking, narrowed down the locus of the gene to approximately 1 Mb. DNA sequence analysis of the locus identified six full-length NBS-LRR-type (short NLR-type) putative resistance genes. Two of them, designated TMV2 and TMV3, were similar to a TMV resistance gene isolated from tobacco and to Y-1, which co-segregates with Ry(adg), the extreme virus resistance gene originated from Solanum andigena and localised to chromosome XI. Furthermore, TMV2 of 'White Lady' was found to be 95% identical at the genomic sequence level with the recently isolated Ry(sto) gene of the potato cultivar 'Alicja'. In addition to the markers identified earlier, this work generated five tightly linked new markers which can serve potato breeding efforts for extreme virus resistance.	[Kondrak, Mihaly; Kopp, Andrea; Uri, Csilla; Sos-Hegedus, Anita; Csakvari, Edina; Schiller, Matyas; Barta, Endre; Banfalvi, Zsofia] NARIC Agr Biotechnol Inst, Godollo, Hungary; [Cernak, Istvan; Polgar, Zsolt] Univ Pannonia, Potato Res Ctr, Keszthely, Hungary; [Taller, Janos] Univ Pannonia, Georgikon Fac, Dept Plant Sci & Biotechnol, Keszthely, Hungary	University of Pannonia; University of Pannonia	Banfalvi, Z (corresponding author), NARIC Agr Biotechnol Inst, Godollo, Hungary.	banfalvi.zsofia@abc.naik.hu	Barta, Endre/B-1166-2008; Csákvári, Edina/AAK-2872-2021; Taller, Janos/ABB-9586-2021	Barta, Endre/0000-0002-6753-0714; Csákvári, Edina/0000-0002-1089-7603; 	Hungarian Ministry of Agriculture [71214]; National Research, Development and Innovation Office [K120641, NN124441]	Hungarian Ministry of Agriculture; National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	The work was conducted within the framework of programme no. 71214 of the Hungarian Ministry of Agriculture. Publication was supported by the National Research, Development and Innovation Office grants K120641 and NN124441. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Bakker E, 2011, THEOR APPL GENET, V123, P493, DOI 10.1007/s00122-011-1602-z; Bendahmane A, 2000, PLANT J, V21, P73, DOI 10.1046/j.1365-313x.2000.00654.x; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; Boualem A, 2016, CURR OPIN VIROL, V17, P32, DOI 10.1016/j.coviro.2015.12.001; Cernak I, 2008, ACTA BIOL HUNG, V59, P195, DOI 10.1556/ABiol.59.2008.2.6; Cernak I, 2008, BREEDING SCI, V58, P309, DOI 10.1270/jsbbs.58.309; COCKERHAM G, 1970, HEREDITY, V25, P309, DOI 10.1038/hdy.1970.35; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Davie K, 2017, VIRUS RES, V241, P95, DOI 10.1016/j.virusres.2017.06.012; DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777; Decsi K, 2012, SCIENCEMED, V3, P215; Dietze J., 1995, P24; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; Faize M, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-53; Flis B, 2005, MOL BREEDING, V15, P95, DOI 10.1007/s11032-004-2736-3; Fraile A, 2016, CURR OPIN VIROL, V17, P50, DOI 10.1016/j.coviro.2016.01.008; Fulladolsa AC, 2015, AM J POTATO RES, V92, P444, DOI 10.1007/s12230-015-9431-2; Grech-Baran M, 2020, PLANT BIOTECHNOL J, V18, P655, DOI 10.1111/pbi.13230; Hamalainen JH, 1997, THEOR APPL GENET, V94, P192, DOI 10.1007/s001220050399; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Horvath S, 1998, BEITRAGE ZUR ZUCHTUNGSFORSCHUNG, VOL 4 NO 2, 1998, P75; Hosaka K, 2001, AM J POTATO RES, V78, P191, DOI 10.1007/BF02883544; Jones JDG, 2014, PHILOS T R SOC B, V369, DOI [10.1098/rstb.2013.0087, 10.1098/rstb.2013.008]; Jupe F, 2013, PLANT J, V76, P530, DOI 10.1111/tpj.12307; Kehr J, 2006, J EXP BOT, V57, P767, DOI 10.1093/jxb/erj087; Kopp A., 2015, Acta Phytopathologica et Entomologica Hungarica, V50, P151, DOI 10.1556/038.50.2015.2.1; Lee C, 2010, J AGR FOOD CHEM, V58, P7245, DOI 10.1021/jf101037k; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; Milbourne D, 1998, MOL GEN GENET, V259, P233, DOI 10.1007/s004380050809; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Muthamilarasan M, 2013, J BIOSCIENCES, V38, P433, DOI 10.1007/s12038-013-9302-2; Nie XZ, 2016, CAN J PLANT SCI, V96, P737, DOI 10.1139/cjps-2015-0335; Ortega F, 2012, POTATO RES, V55, P1, DOI 10.1007/s11540-011-9202-5; Palukaitis P, 2012, PLANT PATHOLOGY J, V28, P248, DOI 10.5423/PPJ.RW.06.2012.0075; Poczai P, 2010, AM J BOT, V97, pE142, DOI 10.3732/ajb.1000360; RITTER E, 1991, MOL GEN GENET, V227, P81, DOI 10.1007/BF00260710; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; SHURE M, 1983, CELL, V35, P225, DOI 10.1016/0092-8674(83)90225-8; Solomon-Blackburn RM, 2001, HEREDITY, V86, P8, DOI 10.1046/j.1365-2540.2001.00798.x; Song YS, 2008, AM J POTATO RES, V85, P159, DOI 10.1007/s12230-008-9012-8; Song YS, 2005, THEOR APPL GENET, V111, P879, DOI 10.1007/s00122-005-0010-7; STIEKEMA WJ, 1988, PLANT MOL BIOL, V11, P255, DOI 10.1007/BF00027383; Stiller I, 2007, J BIOTECHNOL, V128, P335, DOI 10.1016/j.jbiotec.2006.10.015; Sukarta OCA, 2016, SEMIN CELL DEV BIOL, V56, P134, DOI 10.1016/j.semcdb.2016.05.012; Valkonen JPT, 2008, ANN APPL BIOL, V152, P121, DOI 10.1111/j.1744-7348.2007.00194.x; van der Vossen EAG, 2000, PLANT J, V23, P567, DOI 10.1046/j.1365-313x.2000.00814.x; van Eck HJ, 2017, THEOR APPL GENET, V130, P515, DOI 10.1007/s00122-016-2831-y; Vidal S, 2002, MOL PLANT MICROBE IN, V15, P717, DOI 10.1094/MPMI.2002.15.7.717; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158	53	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0224534	10.1371/journal.pone.0224534	http://dx.doi.org/10.1371/journal.pone.0224534			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HO	32231371	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000535937400002
J	Tan, L; Hu, Y; Li, YL; Yang, LC; Cai, X; Liu, W; He, JY; Wu, YX; Liu, TB; Wang, ND; Yang, Y; Adelstein, RS; Wang, AB				Tan, Lei; Hu, Yi; Li, Yalan; Yang, Lingchen; Cai, Xiong; Liu, Wei; He, Jiayi; Wu, Yingxin; Liu, Tanbin; Wang, Naidong; Yang, Yi; Adelstein, Robert S.; Wang, Aibing			Investigation of the molecular biology underlying the pronounced high gene targeting frequency at the Myh9 gene locus in mouse embryonic stem cells	PLOS ONE			English	Article							COPY TRANSGENIC MICE; HOMOLOGOUS RECOMBINATION; MAMMALIAN GENOME; ES CELLS; KNOCK-IN; EXPRESSION; INTEGRATION; GENERATION; MODELS; EFFICIENCY	The generation of genetically modified mouse models derived from gene targeting (GT) in mouse embryonic stem (ES) cells (mESCs) has greatly advanced both basic and clinical research. Our previous finding that gene targeting at the Myh9 exon2 site in mESCs has a pronounced high homologous recombination (HR) efficiency (> 90%) has facilitated the generation of a series of nonmuscle myosin II (NM II) related mouse models. Furthermore, the Myh9 gene locus has been well demonstrated to be a new safe harbor for site-specific insertion of other exogenous genes. In the current study, we intend to investigate the molecular biology underlying for this high HR efficiency from other aspects. Our results confirmed some previously characterized properties and revealed some unreported observations: 1) The comparison and analysis of the targeting events occurring at the Myh9 and several widely used loci for targeting transgenesis, including ColA1, HPRT, ROSA26, and the sequences utilized for generating these targeting constructs, indicated that a total length about 6 kb with approximate 50% GC-content of the 5' and 3' homologous arms, may facilitate a better performance in terms of GT efficiency. 2) Despite increasing the length of the homologous arms, shifting the targeting site from the Myh9 exon2, to intron2, or exon3 led to a gradually reduced GT frequency (91.7, 71.8 and 50.0%, respectively). This finding provides the first evidence that the HR frequency may also be associated with the targeting site even in the same locus. Meanwhile, the decreased trend of the GT efficiency at these targeting sites was consistent with the reduced percentage of simple sequence repeat (SSR) and short interspersed nuclear elements (SINEs) in the sequences for generating the targeting constructs, suggesting the potential effects of these DNA elements on GT efficiency; 3) Our series of targeting experiments and analyses with truncated 5' and 3' arms at the Myh9 exon2 site demonstrated that GT efficiency positively correlates with the total length of the homologous arms (R = 0.7256, p< 0.01), confirmed that a 2:1 ratio of the length, a 50% GCcontent and the higher amount of SINEs for the 5' and 3' arms may benefit for appreciable GT frequency. Though more investigations are required, the Myh9 gene locus appears to be an ideal location for identifying HR-related cis and trans factors, which in turn provide mechanistic insights and also facilitate the practical application of gene editing.	[Tan, Lei; Hu, Yi; Li, Yalan; Yang, Lingchen; Liu, Wei; He, Jiayi; Wu, Yingxin; Liu, Tanbin; Wang, Aibing] Hunan Agr Univ HUNAU, Coll Vet Med, Lab Anim Dis Prevent & Control & Anim Model, Key Lab Anim Vaccine & Prot Engn, Changsha, Hunan, Peoples R China; [Cai, Xiong] Hunan Univ Chinese Med, Inst Innovat & Appl Res Chinese Med, Changsha, Hunan, Peoples R China; [Wang, Naidong; Yang, Yi] HUNAU, Lab Funct Prote LFP, Key Lab Anim Vaccine & Prot Engn, Coll Vet Med, Changsha, Hunan, Peoples R China; [Adelstein, Robert S.; Wang, Aibing] NHLBI, Lab Mol Cardiol LMC, NIH, Bldg 10, Bethesda, MD 20892 USA	Hunan University of Chinese Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Wang, AB (corresponding author), Hunan Agr Univ HUNAU, Coll Vet Med, Lab Anim Dis Prevent & Control & Anim Model, Key Lab Anim Vaccine & Prot Engn, Changsha, Hunan, Peoples R China.; Wang, AB (corresponding author), NHLBI, Lab Mol Cardiol LMC, NIH, Bldg 10, Bethesda, MD 20892 USA.	bingaiwang@hunau.edu.cn		WANG, AIBING/0000-0002-0470-8220; Tan, Lei/0000-0002-9358-4898	General Program of National Natural Science Foundation of China [31571432, 31802252]; Hunan Provincial Natural Science Foundation of China [2015JC3097]	General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	This work was supported by General Program of National Natural Science Foundation of China (Grants Nos. 31571432 and 31802252) and Hunan Provincial Natural Science Foundation of China (Grant No. 2015JC3097). Support was also provided by "Shennong" Scholar funding to AW.	Aida T, 2014, DEV GROWTH DIFFER, V56, P34, DOI 10.1111/dgd.12101; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Belizario JE, 2012, J APPL GENET, V53, P295, DOI 10.1007/s13353-012-0096-y; Bouabe H, 2013, METHODS MOL BIOL, V1064, P315, DOI 10.1007/978-1-62703-601-6_23; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Burland T G, 2000, Methods Mol Biol, V132, P71; Buzina A, 1996, NUCLEIC ACIDS RES, V24, P1525, DOI 10.1093/nar/24.8.1525; Cai HW, 2005, THEOR APPL GENET, V112, P158, DOI 10.1007/s00122-005-0118-9; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Clauss S, 2019, NAT REV CARDIOL, V16, P457, DOI 10.1038/s41569-019-0179-0; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Cornea AM, 2010, NUCLEIC ACIDS RES, V38, P3582, DOI 10.1093/nar/gkq095; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365; Deyle DR, 2014, NAT STRUCT MOL BIOL, V21, P969, DOI 10.1038/nsmb.2895; Dickel DE, 2014, NAT METHODS, V11, P566, DOI [10.1038/NMETH.2886, 10.1038/nmeth.2886]; Du TT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09074-4; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Flemr M, 2015, CELL REP, V12, P709, DOI 10.1016/j.celrep.2015.06.051; Ge XL, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.100; Goyal A, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw883; Gurumurthy CB, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.029462; HABER J E, 1992, Current Opinion in Cell Biology, V4, P401, DOI 10.1016/0955-0674(92)90005-W; Ishii A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108236; Kumagai K, 2017, EXP ANIM TOKYO, V66, P125, DOI 10.1538/expanim.16-0075; Lee H, 2014, BIOMOL THER, V22, P267, DOI 10.4062/biomolther.2014.074; Li HB, 2019, PROTEIN CELL, V10, P20, DOI 10.1007/s13238-018-0556-1; Liu PH, 2019, METHODS MOL BIOL, V1874, P115, DOI 10.1007/978-1-4939-8831-0_7; Liu TB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192641; Lu ZH, 2003, BLOOD, V102, P1531, DOI 10.1182/blood-2003-03-0708; Mak TW, 2007, CELL, V131, P1027, DOI 10.1016/j.cell.2007.11.033; Menke DB, 2013, GENESIS, V51, P605, DOI 10.1002/dvg.22422; Muller U, 1999, MECH DEVELOP, V82, P3, DOI 10.1016/S0925-4773(99)00021-0; Oji A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31666; Osiak A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028911; Palais G, 2009, PHYSIOL GENOMICS, V37, P140, DOI 10.1152/physiolgenomics.90328.2008; Porteus Matthew, 2007, Biotechnol Genet Eng Rev, V24, P195; Raynard SJ, 2002, J IMMUNOL, V168, P2332, DOI 10.4049/jimmunol.168.5.2332; REID LH, 1991, MOL CELL BIOL, V11, P2769, DOI 10.1128/MCB.11.5.2769; Rezza A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40181-w; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; Saito S, 2016, BIOL PHARM BULL, V39, P25, DOI 10.1248/bpb.b15-00701; Samuel MS, 2009, GENESIS, V47, P440, DOI 10.1002/dvg.20519; Seibt KM, 2016, PLANT J, V86, P268, DOI 10.1111/tpj.13170; Singh M, 2012, CANCER RES, V72, P2695, DOI 10.1158/0008-5472.CAN-11-2786; Smith K, 2001, REPROD NUTR DEV, V41, P465, DOI 10.1051/rnd:2001102; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sosa MAG, 2010, BRAIN STRUCT FUNCT, V214, P91, DOI 10.1007/s00429-009-0230-8; Strathdee D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000004; Templeton NS, 1997, GENE THER, V4, P700, DOI 10.1038/sj.gt.3300457; Tikhonov AP, 2001, CHROMOSOME RES, V9, P325, DOI 10.1023/A:1016650830798; Ukai H, 2017, NAT PROTOC, V12, P2513, DOI 10.1038/nprot.2017.110; VALANCIUS V, 1991, MOL CELL BIOL, V11, P4389, DOI 10.1128/MCB.11.9.4389; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Wang AB, 2011, BIOCHEM SOC T, V39, P1131, DOI 10.1042/BST0391131; Wang AB, 2010, P NATL ACAD SCI USA, V107, P14645, DOI 10.1073/pnas.1004023107; Wang BM, 2015, BIOTECHNIQUES, V59, P201, DOI 10.2144/000114339; Yanez RJ, 2002, NUCLEIC ACIDS RES, V30, P4892, DOI 10.1093/nar/gkf614; Zhang YF, 2018, MOL BIOL CELL, V29, P2326, DOI 10.1091/mbc.E17-12-0713; Zhang YF, 2012, BLOOD, V119, P238, DOI 10.1182/blood-2011-06-358853	60	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230126	10.1371/journal.pone.0230126	http://dx.doi.org/10.1371/journal.pone.0230126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HE	32226034	gold, Green Published			2022-12-26	WOS:000535936400001
J	Balsam, JS; Stevenson, PA				Balsam, Julia S.; Stevenson, Paul A.			Pre-adult aggression and its long-term behavioural consequences in crickets	PLOS ONE			English	Article							FIELD CRICKET; GRYLLUS-BIMACULATUS; AGONISTIC BEHAVIOR; LOCUSTA-MIGRATORIA; OCTOPAMINE; INTEGER; SYSTEM; COMPETITION; ORTHOPTERA; EXPOSURE	Social experience, particularly aggression, is considered a major determinant of consistent inter-individual behavioural differences between animals of the same species and sex. We investigated the influence of pre-adult aggressive experience on future behaviour in male, last instar nymphs of the cricket Gryllus bimaculatus. We found that aggressive interactions between male nymphs are far less fierce than for adults in terms of duration and escalation. This appears to reflect immaturity of the sensory apparatus for releasing aggression, rather than the motor system controlling it. First, a comparison of the behavioural responses of nymphs and adults to mechanical antennal stimulation using freshly excised, untreated and hexane-washed antennae taken from nymphs and adults, indicate that nymphs neither respond to nor produce sex-specific cuticular semiochemicals important for releasing aggressive behaviour in adults. Second, treatment with the octopamine agonist chlordime-form could at least partially compensate for this deficit. In further contrast to adults, which become hyper-aggressive after victory, but submissive after defeat, such winner and loser effects are not apparent in nymphs. Aggressive competition between nymphs thus appears to have no consequence for future behaviour in crickets. Male nymphs are often attacked by adult males, but not by adult females. Furthermore, observations of nymphs raised in the presence, or absence of adult males, revealed that social subjugation by adult males leads to reduced aggressiveness and depressed exploratory behaviour when the nymphs become adult. We conclude that social subjugation by adults during pre-adult development of nymphs is a major determinant of consistent inter-individual behavioural differences in adult crickets.	[Balsam, Julia S.; Stevenson, Paul A.] Univ Leipzig, Inst Biol, Fac Life Sci, Leipzig, Germany	Leipzig University	Stevenson, PA (corresponding author), Univ Leipzig, Inst Biol, Fac Life Sci, Leipzig, Germany.	stevenson@rz.uni-leipzig.de		Stevenson, Paul Anthony/0000-0002-3232-5155	Deutsche Forschungsgemeinschaft [STE 714/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was financed by a grant of the Deutsche Forschungsgemeinschaft (https://www.dfg.de/en/) to PAS, Grant Nr. STE 714/5-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2018, ANIM BEHAV, V141, P1, DOI 10.1016/j.anbehav.2018.05.003; ADAMO SA, 1995, ANIM BEHAV, V49, P1491, DOI 10.1016/0003-3472(95)90070-5; Andrews JC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004356; Anton S, 2002, MICROSC RES TECHNIQ, V56, P281, DOI 10.1002/jemt.10032; Arseneault L, 2017, WORLD PSYCHIATRY, V16, P27, DOI 10.1002/wps.20399; Boivin G, 2000, ECOL LETT, V3, P469, DOI 10.1046/j.1461-0248.2000.00174.x; Briffa M, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.1007; Caldeira V, 2012, J FAM VIOLENCE, V27, P687, DOI 10.1007/s10896-012-9453-1; De Boer S.F., 2016, STRESS CONCEPTS COGN, DOI [10.1016/B978-0-12-800951-2.00036-4., DOI 10.1016/B978-0-12-800951-2.00036-4]; DIXON KA, 1986, ANIM BEHAV, V34, P340, DOI 10.1016/S0003-3472(86)80102-6; Han CS, 2018, EVOLUTION, V72, P2435, DOI 10.1111/evo.13600; HIRIPI L, 1984, CELL MOL NEUROBIOL, V4, P199, DOI 10.1007/BF00733585; Hofmann HA, 2001, ANIM BEHAV, V62, P337, DOI 10.1006/anbe.2001.1746; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; HUBER R, 1995, BRAIN BEHAV EVOLUT, V46, P72, DOI 10.1159/000113260; Iwasaki M, 2008, COMP BIOCHEM PHYS A, V149, P306, DOI 10.1016/j.cbpa.2008.01.008; Jager HY, 2019, BEHAV ECOL, V30, P1012, DOI 10.1093/beheco/arz042; Judge KA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003980; Kortet R, 2007, BIOL J LINN SOC, V91, P475, DOI 10.1111/j.1095-8312.2007.00812.x; Kutsch W, 1997, PHYSIOL ENTOMOL, V22, P47, DOI 10.1111/j.1365-3032.1997.tb01139.x; Nagamoto J, 2005, ZOOL SCI, V22, P1079, DOI 10.2108/zsj.22.1079; Niemela PT, 2012, FUNCT ECOL, V26, P450, DOI 10.1111/j.1365-2435.2011.01939.x; Nosil P, 2002, CAN J ZOOL, V80, P409, DOI 10.1139/Z02-018; Patoka J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41333-8; PFLUGER HJ, 1994, J NEUROSCI, V14, P6946; RAPER JA, 1983, J NEUROSCI, V3, P20; Rillich J., 2019, NEUROFORUM, V25, P3, DOI [10.1515/nf-2017-0040, DOI 10.1515/NF-2017-0040]; Rillich J, 2007, ANIM BEHAV, V74, P823, DOI 10.1016/j.anbehav.2006.11.022; Rillich J, 2019, HORM BEHAV, V114, DOI 10.1016/j.yhbeh.2019.06.006; Rillich J, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00233; Rillich J, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00095; Rillich J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028891; Rillich J, 2011, P ROY SOC B-BIOL SCI, V278, P1873, DOI 10.1098/rspb.2010.2099; Rose J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184121; Rose J, 2017, ANIM BEHAV, V123, P441, DOI 10.1016/j.anbehav.2016.11.021; SAKAI M, 1990, J COMP PHYSIOL A, V166, P775, DOI 10.1007/BF00187322; Sakura M, 2013, J EXP BIOL, V216, P2221, DOI 10.1242/jeb.079400; SIMMONS LW, 1986, ANIM BEHAV, V34, P567, DOI 10.1016/S0003-3472(86)80126-9; SIMMONS LW, 1987, J ANIM ECOL, V56, P1015, DOI 10.2307/4963; Staudacher EM, 2009, PHYSIOL ENTOMOL, V34, P18, DOI 10.1111/j.1365-3032.2008.00647.x; Stevenson PA, 2000, J NEUROBIOL, V43, P107; STEVENSON PA, 1988, J COMP PHYSIOL A, V162, P247, DOI 10.1007/BF00606089; Stevenson PA, 2016, CURR ZOOL, V62, P265, DOI 10.1093/cz/zow028; Stevenson PA, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500060; Stevenson PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074965; Thibert J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151451; Thomas ML, 2008, J INSECT PHYSIOL, V54, P1081, DOI 10.1016/j.jinsphys.2008.04.012; Wommack JC, 2003, HORM BEHAV, V43, P229, DOI 10.1016/S0018-506X(02)00029-6; WOODRING JP, 1988, J INSECT PHYSIOL, V34, P759, DOI 10.1016/0022-1910(88)90149-7	49	5	5	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230743	10.1371/journal.pone.0230743	http://dx.doi.org/10.1371/journal.pone.0230743			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214350	gold, Green Published			2022-12-26	WOS:000535934200053
J	Blakely, T; Nghiem, N; Genc, M; Mizdrak, A; Cobiac, L; Mhurchu, CN; Swinburn, B; Scarborough, P; Cleghorn, C				Blakely, Tony; Nghiem, Nhung; Genc, Murat; Mizdrak, Anja; Cobiac, Linda; Mhurchu, Cliona Ni; Swinburn, Boyd; Scarborough, Peter; Cleghorn, Christine			Modelling the health impact of food taxes and subsidies with price elasticities: The case for additional scaling of food consumption using the total food expenditure elasticity	PLOS ONE			English	Article							NUTRITION EDUCATION; PURCHASES; DISCOUNTS; DEMAND; BEVERAGES; OUTCOMES	Background Food taxes and subsidies are one intervention to address poor diets. Price elasticity (PE) matrices are commonly used to model the change in food purchasing. Usually a PE matrix is generated in one setting then applied to another setting with differing starting consumptions and prices of foods. This violates econometric assumptions resulting in likely mis-estimation of total food consumption. In this paper we demonstrate this problem, canvass possible options for rescaling all consumption after applying a PE matrix, and illustrate the use of a total food expenditure elasticity (TFEe; the expenditure elasticity for all food combined given the policy-induced change in the total price of food). We use case studies of: NZ$2 per 100g saturated fat (SAFA) tax, NZ$0.4 per 100g sugar tax, and a 20% fruit and vegetable (F&V) subsidy. Methods We estimated changes in food purchasing using a NZ PE matrix applied conventionally, and then with TFEe adjustment. Impacts were quantified for pre- to post-policy changes in total food expenditure and health adjusted life years (HALYs) for the total NZ population alive in 2011 over the rest of their lifetime using a multistate lifetable model. Results Two NZ studies gave TFEe's of 0.68 and 0.83, with international estimates ranging from 0.46 to 0.90 (except a UK outlier of 0.04). Without TFEe adjustment, total food expenditure decreased with the tax policies and increased with the F&V subsidy-implausible directions of shift given economic theory and the external TFEe estimates. After TFEe adjustment, HALY gains reduced by a third to a half for the two taxes and reversed from an apparent health loss to a health gain for the F&V subsidy. With TFEe adjustment, HALY gains (in 1000's) were: 1,805 (95% uncertainty interval 1,337 to 2,340) for the SAFA tax; 1,671 (1,220 to 2,269) for the sugar tax; and 953 (453 to 1,308) for the F&V subsidy. Conclusions If PE matrices are applied in settings beyond where they were derived, additional scaling is likely required. We suggest that the TFEe is a useful scalar, but we also encourage other researchers to examine this issue and propose alternative options.	[Blakely, Tony] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Populat Intervent Unit, Melbourne, Vic, Australia; [Blakely, Tony; Nghiem, Nhung; Mizdrak, Anja; Cleghorn, Christine] Univ Otago, Dept Publ Hlth, Burden Dis Epidemiol, Equ & Cost Effectiveness Programme, Wellington, New Zealand; [Genc, Murat] Univ Otago, Dept Econ, Dunedin, New Zealand; [Cobiac, Linda; Scarborough, Peter] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Mhurchu, Cliona Ni] Univ Auckland, Natl Inst Hlth Innovat, Auckland, New Zealand; [Swinburn, Boyd] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand	University of Melbourne; University of Otago; University of Otago; University of Oxford; University of Auckland; University of Auckland	Blakely, T (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Populat Intervent Unit, Melbourne, Vic, Australia.; Blakely, T (corresponding author), Univ Otago, Dept Publ Hlth, Burden Dis Epidemiol, Equ & Cost Effectiveness Programme, Wellington, New Zealand.	ablakely@unimelb.edu.au	Scarborough, Peter/ABD-6111-2021	Scarborough, Peter/0000-0002-2378-2944; Mizdrak, Anja/0000-0002-2897-3002; Genc, Murat/0000-0002-5443-2146	Health Research Council of New Zealand [10/248, 13/724]	Health Research Council of New Zealand(Health Research Council of New Zealand)	Health Research Council of New Zealand Programme Grants: Burden of Disease Epidemiology, Equity and Cost Effectiveness Programme (10/248); Effective interventions and policies to improve population nutrition and health (13/724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; Ball K, 2015, AM J CLIN NUTR, V101, P1055, DOI 10.3945/ajcn.114.096735; Basu S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001582; Brannlund R, 2007, ENERG ECON, V29, P1, DOI 10.1016/j.eneco.2005.09.003; Briggs ADM, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0085-1; BRIGGS ADM, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F6189; Brimblecombe J, 2017, LANCET PUBLIC HEALTH, V2, pE82, DOI 10.1016/S2468-2667(16)30043-3; Cleghorn CL, 2018, TECHNICAL REPORT BOD; Cobiac LJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002232; Dey MM, 2011, MAR RESOUR ECON, V26, P35, DOI 10.5950/0738-1360-26.1.35; Dharmasena S, 2012, HEALTH ECON, V21, P669, DOI 10.1002/hec.1738; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1; Klonaris S, 2003, APPL ECON, V35, P503, DOI 10.1080/00036840210148058; Mexican National Institute of Public Health and the Carolina Population Center at the University of North Carolina, 2015, MEX NAT I PUBL HLTH; Mhurchu CN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128477; Mhurchu CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075934; Michelini C., 1997, NEW ZEAL ECON PAP, V31, P153, DOI [10.1080/00779959709544272, DOI 10.1080/00779959709544272]; Michelini C., 1999, NZ EC PAPERS, V33, P15, DOI DOI 10.1080/; Nghiem N, T BAYES GOES VIRTUAL; Nghiem N, 2013, AM J PUBLIC HEALTH, V103, P1954, DOI 10.2105/AJPH.2013.301337; Ni Mhurchu C, 2010, AM J CLIN NUTR, V91, P736, DOI 10.3945/ajcn.2009.28742; Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214; Raunikar R, 1987, FOOD DEMAND ANAL; Roberto CA, 2015, LANCET, V385, P2400, DOI 10.1016/S0140-6736(14)61744-X; Rolls BJ, 2009, PHYSIOL BEHAV, V97, P609, DOI 10.1016/j.physbeh.2009.03.011; SHEMILT I, 2015, BMC PUBLIC HEALTH, V15, DOI DOI 10.1186/S12889-015-2459-X; Silver LD, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002283; Smed S, 2016, EUR J CLIN NUTR, V70, P681, DOI 10.1038/ejcn.2016.6; University of Otago and Ministry of Health, 2011, FOC NUTR KEY FIND 20; Waterlander W, EFFECT RANDOMIZED CH; Waterlander WE, 2019, LANCET PUBLIC HEALTH, V4, pE394, DOI 10.1016/S2468-2667(19)30105-7; Waterlander WE, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3277-5; Waterlander WE, 2013, AM J CLIN NUTR, V97, P886, DOI 10.3945/ajcn.112.041632; Williams RA, 2013, APPETITE, V66, P75, DOI 10.1016/j.appet.2013.03.004; World Cancer Research Fund International, 2015, NURISHING FRAMEWORK	40	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230506	10.1371/journal.pone.0230506	http://dx.doi.org/10.1371/journal.pone.0230506			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8GI	32214329	Green Published, Green Submitted, gold			2022-12-26	WOS:000535934200028
J	Gil-Calvo, M; Jimenez-Perez, I; Priego-Quesada, JI; Lucas-Cuevas, AG; Perez-Soriano, P				Gil-Calvo, Marina; Jimenez-Perez, Irene; Ignacio Priego-Quesada, Jose; Lucas-Cuevas, Angel G.; Perez-Soriano, Pedro			Effect of custom-made and prefabricated foot orthoses on kinematic parameters during an intense prolonged run	PLOS ONE			English	Article							LOWER-EXTREMITY MECHANICS; ORTHOTIC SHOE INSERTS; LOWER-LIMB KINEMATICS; CONCURRENT VALIDITY; RUNNING INJURIES; IMPACT FORCES; INSOLES; INTERVENTION; RUNNERS; RELIABILITY	Foot orthoses are one of the most used strategies by healthy runners in injury prevention and performance improvement. However, their effect on running kinematics throughout an intense prolonged run in this population is unknown. Moreover, there is some controversy regarding the use of custom-made versus prefabricated foot orthoses. This study analysed the effect of different foot orthoses (custom-made, prefabricated and a control condition) on spatio-temporal and angular (knee flexion and foot eversion) kinematic parameters and their behaviour during an intense prolonged run. Twenty-four recreational runners performed three similar tests that consisted of running 20 min on a treadmill at 80% of their maximal aerobic speed, each one with a different foot orthosis condition. Contact and flight time, and stride length and stride rate were measured every 5 min by an optical measurement photoelectric cell system. Knee flexion and foot eversion kinematic parameters were measured by two high-speed cameras. No significant differences were found between the different foot orthoses in any of the time points studied and between the interaction of foot orthosis and behaviour over time, in any of the variables studied (P > 0.05). The use of custom-made and prefabricated foot orthoses during an intense prolonged run does not produce changes in spatio-temporal and kinematic parameters in healthy runners. These results suggest that a healthy runner maintains its ideal movement pattern throughout a 20 minute prolonged run, regardless the type of foot orthosis used.	[Gil-Calvo, Marina; Jimenez-Perez, Irene; Ignacio Priego-Quesada, Jose; Lucas-Cuevas, Angel G.; Perez-Soriano, Pedro] Univ Valencia, Res Grp Sport Biomech GIBD, Dept Phys Educ & Sports, Valencia, Spain; [Jimenez-Perez, Irene; Ignacio Priego-Quesada, Jose] Univ Valencia, Dept Physiol, Res Grp Med Phys GIFIME, Valencia, Spain	University of Valencia; University of Valencia	Jimenez-Perez, I (corresponding author), Univ Valencia, Res Grp Sport Biomech GIBD, Dept Phys Educ & Sports, Valencia, Spain.; Jimenez-Perez, I (corresponding author), Univ Valencia, Dept Physiol, Res Grp Med Phys GIFIME, Valencia, Spain.	i.jimenez.gibd@gmail.com	Gil-Calvo, Marina/AAB-4266-2019; Jimenez-Perez, Irene/AAW-7931-2020	Gil-Calvo, Marina/0000-0003-4792-1782; Jimenez-Perez, Irene/0000-0001-7886-2602	Spanish Government (Ministerio de Ciencia, Innovacion y Universidades) [FPU14//05626]; Spanish Government (Ministerio de Economia y Competitividad, Subdireccion General de Proyectos de Investigacion. Convocatoria Proyectos I+D "Excelencia", Subprograma de Generacion de Conocimiento, 2013) [DEP2013-48420-P]	Spanish Government (Ministerio de Ciencia, Innovacion y Universidades)(Spanish Government); Spanish Government (Ministerio de Economia y Competitividad, Subdireccion General de Proyectos de Investigacion. Convocatoria Proyectos I+D "Excelencia", Subprograma de Generacion de Conocimiento, 2013)	The work of IJP was supported by the Spanish Government (Ministerio de Ciencia, Innovacion y Universidades, Grant FPU14//05626). In addition, the research project was supported by the Spanish Government (Ministerio de Economia y Competitividad, Subdireccion General de Proyectos de Investigacion. Convocatoria Proyectos I+D "Excelencia", Subprograma de Generacion de Conocimiento, 2013 (project DEP2013-48420-P)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonroeder TG, 2016, J ORTHOP SPORT PHYS, V46, P749, DOI 10.2519/jospt.2016.6253; Bazuelo-Ruiz B, 2018, PEERJ, V6, DOI 10.7717/peerj.4489; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Chan-Roper M, 2012, J SPORT SCI MED, V11, P77; Chevalier TL, 2011, J AM PODIAT MED ASSN, V101, P341, DOI 10.7547/1010341; CLARKE TE, 1983, MED SCI SPORT EXER, V15, P376; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Lucca Leonardo, 2012, Rev. bras. cineantropom. desempenho hum., V14, P428, DOI 10.5007/1980-0037.2012v14n4p428; Derrick TR, 2004, MED SCI SPORT EXER, V36, P832, DOI 10.1249/01.MSS.0000126779.65353.CB; Derrick TR, 2002, MED SCI SPORT EXER, V34, P998, DOI 10.1097/00005768-200206000-00015; Dixon SJ, 2007, MIL MED, V172, P446, DOI 10.7205/MILMED.172.4.446; Donoghue OA, 2008, SPORT BIOMECH, V7, P194, DOI 10.1080/14763140701841407; ENG JJ, 1994, PHYS THER, V74, P836, DOI 10.1093/ptj/74.9.836; Ferber R, 2003, CLIN BIOMECH, V18, P350, DOI 10.1016/S0268-0033(03)00025-1; Lucas-Cuevas AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173179; Garcia-Perez JA, 2013, GAIT POSTURE, V38, P929, DOI 10.1016/j.gaitpost.2013.04.026; Gil-Calvo M, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab1c8c; GROSS ML, 1991, AM J SPORT MED, V19, P409, DOI 10.1177/036354659101900416; Hespanhol LC, 2015, SPORTS MED, V45, P1455, DOI 10.1007/s40279-015-0359-y; House CM, 2002, GAIT POSTURE, V16, P297, DOI 10.1016/S0966-6362(02)00021-8; Jimenez-Perez I, 2019, MAT SPORTS EQUIPMENT, P451, DOI DOI 10.1016/B978-0-08-102582-6.00016-2; Jones AM, 1996, J SPORT SCI, V14, P321, DOI 10.1080/02640419608727717; Kellis E, 2009, J ORTHOP SPORT PHYS, V39, P210, DOI 10.2519/jospt.2009.2859; Kirby KA, 2010, ATHLETIC FOOTWEAR AND ORTHOSES IN SPORTS MEDICINE, P19, DOI 10.1007/978-0-387-76416-0_2; Koblbauer IF, 2014, J SCI MED SPORT, V17, P419, DOI 10.1016/j.jsams.2013.05.013; Landorf KB, 2000, J AM PODIAT MED ASSN, V90, P149, DOI 10.7547/87507315-90-3-149; Lee MM, 2014, J PHYS THER SCI, V26, P81, DOI 10.1589/jpts.26.81; Lewinson RT, 2016, GAIT POSTURE, V48, P99, DOI 10.1016/j.gaitpost.2016.04.012; Lucas-Cuevas AG, 2014, J MARKETING MANAGEME, P1; Lucas-Cuevas AG, 2016, THESIS; MacLean CL, 2008, CLIN J SPORT MED, V18, P338, DOI 10.1097/MJT.0b013e31815fa75a; MacLean CL, 2010, J APPL BIOMECH, V26, P390, DOI 10.1123/jab.26.4.390; Majumdar R, 2013, J REHABIL RES DEV, V50, P1331, DOI 10.1682/JRRD.2013.02.0038; Maykut JN, 2015, INT J SPORTS PHYS TH, V10, P136; Mills K, 2011, MED SCI SPORT EXER, V43, P1507, DOI 10.1249/MSS.0b013e31820e783f; Mundermann A, 2004, J APPL BIOMECH, V20, P71, DOI 10.1123/jab.20.1.71; Nigg BM, 2017, MED SCI SPORT EXER, V49, P1641, DOI 10.1249/MSS.0000000000001260; Nigg BM, 2003, MED SCI SPORT EXER, V35, P314, DOI 10.1249/01.MSS.0000048828.02268.79; Nigg BM, 2015, BRIT J SPORT MED; O'Leary K, 2008, J AM PODIAT MED ASSN, V98, P36, DOI 10.7547/0980036; Quesada JIP, 2017, APPL OPTICS, V56, P5559, DOI 10.1364/AO.56.005559; Razeghi M, 2000, SPORTS MED, V29, P425, DOI 10.2165/00007256-200029060-00005; Rodrigues P, 2013, GAIT POSTURE, V37, P526, DOI 10.1016/j.gaitpost.2012.09.027; Salles AS, 2013, J SPORT SCI, V31, P442, DOI 10.1080/02640414.2012.736629; Saragiotto BT, 2014, J ORTHOP SPORT PHYS, V44, P733, DOI 10.2519/jospt.2014.5710; Saxena A, 2003, J AM PODIAT MED ASSN, V93, P264, DOI 10.7547/87507315-93-4-264; Scherr J, 2013, EUR J APPL PHYSIOL, V113, P147, DOI 10.1007/s00421-012-2421-x; Sinclair J, 2015, J APPL BIOMECH, V31, P28, DOI [10.1123/jab.2014-0086, 10.1123/JAB.2014-0086]; Stackhouse CL, 2004, CLIN BIOMECH, V19, P64, DOI 10.1016/j.clinbiomech.2003.09.002; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; Vernillo G, 2015, J SPORTS SCI, P1; Werd MB, 2017, ATHLETIC FOOTWEAR OR, P165; Wilkinson M, 2018, EUR J SPORT SCI, V18, P497, DOI 10.1080/17461391.2018.1444094; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7	54	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230877	10.1371/journal.pone.0230877	http://dx.doi.org/10.1371/journal.pone.0230877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214390	gold, Green Published			2022-12-26	WOS:000535934200070
J	Gmeiner, A; Gaglia, A; Habicher, S; Rumpold, T; Sussenbacher, S; Schrank, B; Amering, M				Gmeiner, A.; Gaglia, A.; Habicher, S.; Rumpold, T.; Suessenbacher, S.; Schrank, B.; Amering, M.			Power to the voice hearer-The German version of the voice power differential scale	PLOS ONE			English	Article							AUDITORY VERBAL HALLUCINATIONS; SYMPTOM RATING-SCALES; COMMAND HALLUCINATIONS; SCHIZOPHRENIA; BEHAVIOR; BELIEFS; THERAPY; QUESTIONNAIRE; OMNIPOTENCE; DIMENSIONS	Voice power is an important concept in daily life of voice hearers and in the support and therapy for voice hearers who seek help. Therefore, the ability to examine voice power differentials between a voice and a voice hearer is essential. The present study aimed to collect data on voice power differentials and to further validate the Voice Power Differential Scale (VPD). 105 participants aged >= 18 with an ICD10 F2-diagnosis that included hearing voices were included in this study. Internal consistency was good (alpha = 0.792), as well as test-retest-reliability (r = 0.855) and correlations with other constructs were generally as expected. The VPD questionnaire results correlated negatively with the Beliefs About Voices Questionnaire-Revised's (BAVQ-R) items of Benevolence and Engagement-emotion. It correlated positively with Omnipotence and Resistance-emotion, as well as with Negative Content on the Psychotic Symptoms Rating-Scale (PSYRATS). Unexpectedly, no correlations were found with overall severity and command hallucinations. The Voice Power Differential Scale is an important tool for assessing and formulating a voice hearer's experience when they seek treatment or support for their verbal auditory hallucinations. The results of this study enrich the on-going discussion about the importance of voice power for voice hearers.	[Gmeiner, A.; Gaglia, A.; Habicher, S.; Rumpold, T.; Suessenbacher, S.; Amering, M.] Med Univ Vienna, Div Social Psychiat, Dept Psychiat & Psychotherapy, Vienna, Austria; [Gaglia, A.] Bangor Univ Wales, Div Psychol, Bangor, Gwynedd, Wales; [Schrank, B.] Karl Landsteiner Univ Hlth Sci, Univ Clin Tulln, Dept Adult Psychiat, Vienna, Austria	Medical University of Vienna; Bangor University	Gmeiner, A (corresponding author), Med Univ Vienna, Div Social Psychiat, Dept Psychiat & Psychotherapy, Vienna, Austria.	andrea.gmeiner@meduniwien.ac.at		Gmeiner, Andrea/0000-0003-0265-3083; Schrank, Beate/0000-0002-9397-3076	Anniversary Fund of the Oesterreichische Nationalbank (OeNB) [16390]	Anniversary Fund of the Oesterreichische Nationalbank (OeNB)	MA, Anniversary Fund of the Oesterreichische Nationalbank (OeNB -project number 16390). https://www.oenb.at/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister D, 2017, CLIN PSYCHOL REV, V51, P125, DOI 10.1016/j.cpr.2016.10.010; Berman BA, 2010, J CLIN PSYCHIAT, V71, P497, DOI 10.4088/JCP.08m04753yel; Birchwood M, 2000, PSYCHOL MED, V30, P337, DOI 10.1017/S0033291799001828; Birchwood M, 2004, PSYCHOL MED, V34, P1571, DOI 10.1017/S0033291704002636; Birchwood M, 2018, PSYCHOL MED, V48, P1966, DOI 10.1017/S0033291717003488; Birchwood M, 2014, LANCET PSYCHIAT, V1, P23, DOI 10.1016/S2215-0366(14)70247-0; Boateng GO, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00149; Busner Joan, 2007, Psychiatry (Edgmont), V4, P28; Chadwick P, 2000, BRIT J PSYCHIAT, V177, P229, DOI 10.1192/bjp.177.3.229; CHADWICK P, 1994, BRIT J PSYCHIAT, V164, P190, DOI 10.1192/bjp.164.2.190; Connor C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00213; Corstens D, 2014, SCHIZOPHRENIA BULL, V40, pS285, DOI 10.1093/schbul/sbu007; Craig TKJ, 2018, LANCET PSYCHIAT, V5, P31, DOI 10.1016/S2215-0366(17)30427-3; Dold M, 2014, EVID-BASED MENT HEAL, V17, P33, DOI 10.1136/eb-2014-101813; Garrison JR, 2019, SCHIZOPHRENIA BULL, V45, P733, DOI 10.1093/schbul/sby157; Gilbert P, 2001, PSYCHOL MED, V31, P1117, DOI 10.1017/S0033291701004093; Gmeiner A, 2018, NEUROPSYCHIATRIE, V32, P214, DOI 10.1007/s40211-018-0291-0; Haddock G, 1999, PSYCHOL MED, V29, P879, DOI 10.1017/S0033291799008661; Haro JM, 2003, ACTA PSYCHIAT SCAND, V107, P16, DOI 10.1034/j.1600-0447.107.s416.5.x; Hazell CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178715; Kennedy L, 2017, COMMUNITY MENT HLT J, V53, P127, DOI 10.1007/s10597-016-0030-6; Kronmuller KT, 2011, COMPR PSYCHIAT, V52, P102, DOI 10.1016/j.comppsych.2010.04.014; LANDMARK J, 1990, BRIT J PSYCHIAT, V156, P388, DOI 10.1192/bjp.156.3.388; Laroi F, 2019, CLIN PSYCHOL REV, V67, P1, DOI 10.1016/j.cpr.2018.11.001; Lincoln TM, 2019, SCHIZOPHR RES, V203, P66, DOI 10.1016/j.schres.2017.12.014; Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626; Mawson A, 2010, CLIN PSYCHOL REV, V30, P248, DOI 10.1016/j.cpr.2009.11.006; Murray RM, 2016, BRIT J PSYCHIAT, V209, P363, DOI 10.1192/bjp.bp.116.182683; Paulik G, 2019, CLIN PSYCHOL PSYCHOT; Peters ER, 2012, PSYCHOL MED, V42, P1507, DOI 10.1017/S0033291711002650; Reynolds N, 2010, J FORENSIC PSYCHI PS, V21, P121, DOI 10.1080/14789940903194111; ROMME MAJ, 1989, SCHIZOPHRENIA BULL, V15, P209, DOI 10.1093/schbul/15.2.209; Sartorius N, 1996, SOC PSYCH PSYCH EPID, V31, P55, DOI 10.1007/BF00801901; Schneider SD, 2011, PSYCHIAT RES, V188, P13, DOI 10.1016/j.psychres.2010.12.013; Sibitz I, 2013, PSYCHIAT PRAX, V40, P83, DOI 10.1055/s-0032-1332878; Simms G., 1992, ICD 10 CLASS MENT BE; Simms J, 2007, PSYCHOL PSYCHOTHER-T, V80, P39, DOI 10.1348/147608306X99386; Slotema CW, 2017, PSYCHOPATHOLOGY, V50, P255, DOI 10.1159/000477669; Sommer IEC, 2012, SCHIZOPHRENIA BULL, V38, P704, DOI 10.1093/schbul/sbs034; Strauss C, 2018, PSYCHIAT RES, V259, P95, DOI 10.1016/j.psychres.2017.09.089; Thomas N, 2014, SCHIZOPHRENIA BULL, V40, pS202, DOI 10.1093/schbul/sbu037; Trower P, 2004, BRIT J PSYCHIAT, V184, P312, DOI 10.1192/bjp.184.4.312; Varese F, 2017, PSYCHOL PSYCHOTHER-T, V90, P720, DOI 10.1111/papt.12135; Woodward TS, 2014, SCHIZOPHRENIA BULL, V40, pS265, DOI 10.1093/schbul/sbu014	44	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230778	10.1371/journal.pone.0230778	http://dx.doi.org/10.1371/journal.pone.0230778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8GI	32214352	Green Published, gold			2022-12-26	WOS:000535934200056
J	Hong, JW; Noh, JH; Kim, DJ				Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun			The prevalence of and demographic factors associated with radiographic knee osteoarthritis in Korean adults aged >= 50 years: The 2010-2013 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							PAIN; HIP; EPIDEMIOLOGY; ARTHRITIS; COHORT; RISK; OCCUPATION; LIFE	Background To reduce the social burden of knee osteoarthritis (OA) by addressing it in the early stages in the population at greatest risk, the epidemiology of knee OA needs to be understood and associated demographic factors need to be identified. Objectives We evaluated the weighted prevalence of and demographic factors associated with radiographic knee OA in Korean adults. Methods We analyzed data from 12,287 individuals aged. 50 years who had radiographs of the knee taken in the 2010-2013 Korea National Health and Nutrition Examination Survey (KNHANES). Radiographic knee OA was defined based on the Kellgren-Lawrence grade, as follows: 0: No abnormal finding 1: Mild degenerative changes, minute osteophytes 2: Mild knee OA, definite osteophytes 3: Moderate knee OA, moderate joint-space narrowing and definite osteophytes 4: Severe knee OA, severe joint-space narrowing with subchondral sclerosis. Results We found that the prevalence of radiographic knee OA in the Korean adult population was 35.1%. Logistic regression analyses were performed to identify factors associated independently with radiographic knee OA, with age, sex, area of residence, education level, household income, and obesity serving as covariates. Women were at greater risk than men of having knee OA (OR 2.12, 95% CI 1.90-2.37, p < 0.001). Compared with subjects aged 50-59 years, adults aged. 80 years were at 8.87-fold (95% CI 7.12-11.06, p < 0.001) greater risk of having knee OA. Residence in a rural area was associated with a greater risk of having radiographic knee OA than was residence in an urban area (OR 1.26, 95% CI 1.0-81.48, p = 0.004), regardless of knee OA severity (Kellgren-Lawrence grades >= 2, >= 3, and 4). Elementary school graduates had 1.71-fold (p < 0.001) greater risks of having knee OA than did college graduates. Household incomes <= 24th percentile were associated with a greater risk of having knee OA compared with those >= 75th percentile (OR 1.28, 95% CI 1.08-1.52, p = 0.004). Obesity was associated with an approximately two-fold greater risk of knee OA, regardless of knee OA severity (Kellgren-Lawrence grades >= 2, >= 3, and 4). Conclusions Using data from the 2010-2013 KNHANES and defining knee OA as Kellgren-Lawrence grade >= 2, we found that the prevalence of radiographic knee OA was 35.1% (24.4% in men, 44.3% in women) in a representative sample of Korean adults aged >= 50 years, with the highest prevalence (78.7%) observed in women aged >= 80 years. Low socioeconomic status and traditional factors, including age, female sex, and obesity, were associated with the risk of knee OA.	[Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Internal Med, Koyang, Gyeonggi Do, South Korea	Inje University	Kim, DJ (corresponding author), Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Internal Med, Koyang, Gyeonggi Do, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/AAU-8113-2020					Callahan LF, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3492; FELSON DT, 1988, EPIDEMIOL REV, V10, P1; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Fransen M, 2011, INT J RHEUM DIS, V14, P113, DOI 10.1111/j.1756-185X.2011.01608.x; HANNAN MT, 1992, J CLIN EPIDEMIOL, V45, P139, DOI 10.1016/0895-4356(92)90006-9; Hannan MT, 2000, J RHEUMATOL, V27, P1513; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000611; Hong JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167210; Jorgensen KT, 2011, OSTEOARTHR CARTILAGE, V19, P1176, DOI 10.1016/j.joca.2011.07.009; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kiadaliri AA, 2017, SCAND J RHEUMATOL, V46, P143, DOI 10.1080/03009742.2016.1181203; Kulkarni K, 2016, MATURITAS, V89, P22, DOI 10.1016/j.maturitas.2016.04.006; Kwon S, 2019, J OCCUP HEALTH, V61, P54, DOI 10.1002/1348-9585.12022; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nguyen USDT, 2011, ANN INTERN MED, V155, P725, DOI 10.7326/0003-4819-155-11-201112060-00004; Reyes C, 2015, OSTEOARTHR CARTILAGE, V23, P1323, DOI 10.1016/j.joca.2015.03.020; Silverwood V, 2015, OSTEOARTHR CARTILAGE, V23, P507, DOI 10.1016/j.joca.2014.11.019; SPECTOR TD, 1993, ANN RHEUM DIS, V52, P790, DOI 10.1136/ard.52.11.790; SUMMERS MN, 1988, ARTHRITIS RHEUM, V31, P204, DOI 10.1002/art.1780310208; Tang X, 2016, ARTHRITIS RHEUMATOL, V68, P648, DOI 10.1002/art.39465; Verbeek J, 2017, SAF HEALTH WORK-KR, V8, P130, DOI 10.1016/j.shaw.2017.02.001; VINGARD E, 1991, INT J EPIDEMIOL, V20, P1025, DOI 10.1093/ije/20.4.1025; Wallace IJ, 2017, P NATL ACAD SCI USA, V114, P9332, DOI 10.1073/pnas.1703856114; Zhang W, 2010, ANN RHEUM DIS, V69, P483, DOI 10.1136/ard.2009.113100	27	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0230613	10.1371/journal.pone.0230613	http://dx.doi.org/10.1371/journal.pone.0230613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196540	Green Published, gold			2022-12-26	WOS:000535303100040
J	Mohan, MK; Abraham, N; Rajesh, RP; Jayaseelan, BF; Ragnarsson, L; Lewis, RJ; Sarma, SP				Mohan, Madhan Kumar; Abraham, Nikita; Rajesh, R. P.; Jayaseelan, Benjamin Franklin; Ragnarsson, Lotten; Lewis, Richard J.; Sarma, Siddhartha P.			Structure and allosteric activity of a single-disulfide conopeptide from Conus zonatus at human?3?4 and?7 nicotinic acetylcholine receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nicotinic acetylcholine receptors (nAChR); allosteric regulation; nuclear magnetic resonance (NMR); disulfide; neuropeptide; peptide conformation; molecular pharmacology; allosteric modulation; conformational exchange; nAChR receptor antagonists; proline cis; trans isomerism; single-disulfide conopeptides	ALPHA-CONOTOXIN; PROTEIN STRUCTURES; MASS-SPECTROMETRY; MARINE SNAIL; XPLOR-NIH; NMR; VENOM; PEPTIDES; IDENTIFICATION; SPECTROSCOPY	Conopeptides are neurotoxic peptides in the venom of marine cone snails and have broad therapeutic potential for managing pain and other conditions. Here, we identified the single-disulfide peptides Czon1107 and Cca1669 from the venoms of Conus zonatus and Conus caracteristicus, respectively. We observed that Czon1107 strongly inhibits the human ?3?4 (IC50 15.7 ? 3.0 ?m) and ?7 (IC50 77.1 ? 0.05 ?m) nicotinic acetylcholine receptor (nAChR) subtypes, but the activity of Cca1669 remains to be identified. Czon1107 acted at a site distinct from the orthosteric receptor site. Solution NMR experiments revealed that Czon1107 exists in equilibrium between conformational states that are the result of a key Ser(4)?Pro(5) cis-trans isomerization. Moreover, we found that the X-Pro amide bonds in the inter-cysteine loop are rigidly constrained to cis conformations. Structure-activity experiments of Czon1107 and its variants at positions P5 and P7 revealed that the conformation around the X-Pro bonds (cis-trans) plays an important role in receptor subtype selectivity. The cis conformation at the Cys(6)?Pro(7) peptide bond was essential for ?3?4 nAChR subtype allosteric selectivity. In summary, we have identified a unique single-disulfide conopeptide with a noncompetitive, potentially allosteric inhibitory mechanism at the nAChRs. The small size and rigidity of the Czon1107 peptide could provide a scaffold for rational drug design strategies for allosteric nAChR modulation. This new paradigm in the ?conotoxinomic? structure-function space provides an impetus to screen venom from other Conus species for similar, short bioactive peptides that allosterically modulate ligand-gated receptor function.	[Mohan, Madhan Kumar; Sarma, Siddhartha P.] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Abraham, Nikita; Ragnarsson, Lotten; Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, Queensland Biosci Precinct, 306 Carmody Rd, St Lucia, Qld 4072, Australia; [Rajesh, R. P.] Sathyabama Inst Sci & Technol, Chennai 600119, Tamil Nadu, India; [Jayaseelan, Benjamin Franklin] Bombay Nat Hist Soc, Hornbill House, Mumbai 400001, Maharashtra, India	Indian Institute of Science (IISC) - Bangalore; University of Queensland; Sathyabama Institute of Science & Technology	Sarma, SP (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.; Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, Queensland Biosci Precinct, 306 Carmody Rd, St Lucia, Qld 4072, Australia.	r.lewis@uq.edu.au; sidd@iisc.ac.in	R P, Rajesh/AAA-3266-2022; Ragnarsson, Lotten/A-8632-2012; Lewis, Richard J./E-8674-2013	Sarma, Siddhartha/0000-0001-7619-8904; Ragnarsson, Lotten/0000-0002-7137-1656; Mohan, Madhan Kumar/0000-0002-5498-7280; R P, Rajesh/0000-0003-0058-247X; Lewis, Richard J./0000-0003-3470-923X	DBT-IISc Partnership Program; NHMRC [APP1072113]; ARC [DP170104792]	DBT-IISc Partnership Program; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council)	We (M. M. K., R. R. P., B. F. J. and S. P. S.) thank the Department of Science and Technology and the Department of Biotechnology, Government of India for the NMR and Mass spectrometric Facilities at the Indian Institute of Science. S. P. S. thanks the DBT-IISc Partnership Program for funds to defray costs of the project. R. J. L. acknowledges support from the NHMRC Program Grant APP1072113 and ARC Dicovery Grant DP170104792.	Abraham N, 2018, MAR DRUGS, V16, DOI 10.3390/md16060208; Aguilar MB, 2006, PEPTIDES, V27, P500, DOI 10.1016/j.peptides.2005.07.020; Akondi KB, 2014, CHEM REV, V114, P5815, DOI 10.1021/cr400401e; [Anonymous], 1995, MANUAL LIVING CONIDA; Balaji RA, 2000, J BIOL CHEM, V275, P39516, DOI 10.1074/jbc.M006354200; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; BIEMANN K, 1990, METHOD ENZYMOL, V193, P455, DOI 10.1016/0076-6879(90)93433-L; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BOTHNERBY AA, 1984, J AM CHEM SOC, V106, P811, DOI 10.1021/ja00315a069; CAVANAGH J, 1992, J MAGN RESON, V96, P670, DOI 10.1016/0022-2364(92)90357-D; Chhabra S, 2014, J MED CHEM, V57, P9933, DOI 10.1021/jm501126u; Craig AG, 1999, J BIOL CHEM, V274, P13752, DOI 10.1074/jbc.274.20.13752; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; DORMAN DE, 1973, J ORG CHEM, V38, P2379, DOI 10.1021/jo00953a021; Dutertre S, 2008, J BIOL CHEM, V283, P7100, DOI 10.1074/jbc.M706477200; Dutertre S, 2014, TOXICON, V91, P135, DOI 10.1016/j.toxicon.2014.09.011; Franklin JB, 2009, ZOOTAXA, P1; Franklin JB, 2017, TOXICON, V132, P50, DOI [10.1016/j.toxicon.2017.04.003, 10.1016/j.toxicon.2017.04]; Gehrmann J, 1998, J MOL BIOL, V278, P401, DOI 10.1006/jmbi.1998.1701; GRAY WR, 1983, J BIOL CHEM, V258, P2247; GRAY WR, 1981, J BIOL CHEM, V256, P4734; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; Haber-Pohlmeier S, 2007, BIOPHYS J, V92, P3207, DOI 10.1529/biophysj.106.094847; HILLYARD DR, 1992, NEURON, V9, P69, DOI 10.1016/0896-6273(92)90221-X; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jacobsen R, 1998, J PEPT RES, V51, P173; JOHNSON CE, 1958, J CHEM PHYS, V29, P1012, DOI 10.1063/1.1744645; Kaas Q, 2012, NUCLEIC ACIDS RES, V40, pD325, DOI 10.1093/nar/gkr886; Kaas Q, 2010, TOXICON, V55, P1491, DOI 10.1016/j.toxicon.2010.03.002; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kumar GS, 2005, BIOCHEM BIOPH RES CO, V335, P965, DOI 10.1016/j.bbrc.2005.08.002; Lamthanh H, 1999, FEBS LETT, V454, P293, DOI 10.1016/S0014-5793(99)00831-5; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lebbe EKM, 2016, J VENOM ANIM TOXINS, V22, DOI 10.1186/s40409-016-0083-6; Mandal AK, 2007, J AM SOC MASS SPECTR, V18, P1396, DOI 10.1016/j.jasms.2007.04.009; MCINTOSH JM, 1994, J BIOL CHEM, V269, P16733; MCINTOSH JM, 1984, J BIOL CHEM, V259, P4343; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; NIELSEN DB, 1994, TOXICON, V32, P845, DOI 10.1016/0041-0101(94)90009-4; Olivera BM, 2008, CHANNELS, V2, P143, DOI 10.4161/chan.2.2.6276; Olivera BM, 2007, MOL INTERV, V7, P251, DOI 10.1124/mi.7.5.7; Olivera BM, 2014, ANNU REV ANIM BIOSCI, V2, P487, DOI 10.1146/annurev-animal-022513-114124; Olivera Baldomero M., 2000, P74, DOI 10.1159/000062483; Pennington MW, 2018, BIOORGAN MED CHEM, V26, P2738, DOI 10.1016/j.bmc.2017.09.029; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; RAMILO CA, 1992, BIOCHEMISTRY-US, V31, P9919, DOI 10.1021/bi00156a009; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Sabareesh V, 2006, PEPTIDES, V27, P2647, DOI 10.1016/j.peptides.2006.07.009; Schrodinger LLC, 2015, JYMOL MOL GRAPH DEV; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; SHON KJ, 1995, BIOCHEMISTRY-US, V34, P4913, DOI 10.1021/bi00015a002; Skinner SP, 2016, J BIOMOL NMR, V66, P111, DOI 10.1007/s10858-016-0060-y; Steiner AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078456; Sudarslal S, 2004, BIOCHEM BIOPH RES CO, V317, P682, DOI 10.1016/j.bbrc.2004.03.100; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Terrat Y, 2012, TOXICON, V59, P34, DOI 10.1016/j.toxicon.2011.10.001; Thakur SS, 2007, RAPID COMMUN MASS SP, V21, P3420, DOI 10.1002/rcm.3225; Vijayasarathy M, 2017, J PROTEOME RES, V16, P763, DOI 10.1021/acs.jproteome.6b00776; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WAGNER G, 1987, J MOL BIOL, V196, P611, DOI 10.1016/0022-2836(87)90037-4; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P1; ZAFARALLA GC, 1988, BIOCHEMISTRY-US, V27, P7102, DOI 10.1021/bi00418a065	68	5	7	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					7096	7112		10.1074/jbc.RA119.012098	http://dx.doi.org/10.1074/jbc.RA119.012098			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32234761	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000536212600025
J	Sreelatha, A; Nolan, C; Park, BC; Pawlowski, K; Tomchick, DR; Tagliabracci, VS				Sreelatha, Anju; Nolan, Christine; Park, Brenden C.; Pawlowski, Krzysztof; Tomchick, Diana R.; Tagliabracci, Vincent S.			A Legionella effector kinase is activated by host inositol hexakisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial protein kinase; bacterial pathogenesis; inositol phosphate; enzyme structure; allosteric regulation; effector; inositol hexikisphosphate; Legionella	PROTEIN DRRA; X-RAY; FEATURES; PATHWAY; FAMILY; DOMAIN; SERVER; MODEL; IP6; CK2	The transfer of a phosphate from ATP to a protein substrate, a modification known as protein phosphorylation, is catalyzed by protein kinases. Protein kinases play a crucial role in virtually every cellular activity. Recent studies of atypical protein kinases have highlighted the structural similarity of the kinase superfamily despite notable differences in primary amino acid sequence. Here, using a bioinformatics screen, we searched for putative protein kinases in the intracellular bacterial pathogen Legionella pneumophila and identified the type 4 secretion system effector Lpg2603 as a remote member of the protein kinase superfamily. Employing an array of biochemical and structural biology approaches, including in vitro kinase assays and isothermal titration calorimetry, we show that Lpg2603 is an active protein kinase with several atypical structural features. Importantly, we found that the eukaryote-specific host signaling molecule inositol hexakisphosphate (IP6) is required for Lpg2603 kinase activity. Crystal structures of Lpg2603 in the apo-form and when bound to IP6 revealed an active-site rearrangement that allows for ATP binding and catalysis. Our results on the structure and activity of Lpg2603 reveal a unique mode of regulation of a protein kinase, provide the first example of a bacterial kinase that requires IP6 for its activation, and may aid future work on the function of this effector during Legionella pathogenesis.	[Sreelatha, Anju] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Nolan, Christine; Park, Brenden C.; Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Tomchick, Diana R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Tomchick, Diana R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Pawlowski, Krzysztof] Warsaw Univ Life Sci, Inst Biol, PL-02787 Warsaw, Poland	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Warsaw University of Life Sciences	Sreelatha, A (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Tagliabracci, VS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	anju.sreelatha@utsouthwestern.edu; vincent.tagliabracci@utsouthwestern.edu	Tomchick, Diana/HGV-2018-2022; Pawlowski, Krzysztof/C-2949-2013	Tomchick, Diana/0000-0002-7529-4643; Pawlowski, Krzysztof/0000-0002-5367-0935; Sreelatha, Anju/0000-0001-9485-0214; Tagliabracci, Vincent/0000-0002-9735-4678	National Institutes of Health [R00DK099254, DP2GM137419, T32DK007257-37]; Welch Foundation [I-1911]; Polish National Agency for Scientific Exchange Scholarship [PPN/BEK/2018/1/00431]; Office of the Director, National Institutes of Health [S10OD025018]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Polish National Agency for Scientific Exchange Scholarship; Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R00DK099254 and DP2GM137419 (to V. S. T.) and T32DK007257-37 (to A. S.), Welch Foundation Grants I-1911 (to V. S. T.), Polish National Agency for Scientific Exchange Scholarship PPN/BEK/2018/1/00431 (to K. P.), and Award S10OD025018 (D. R. T.) from the Office of the Director, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Anderson DM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004944; Beyrakhova K, 2018, J BIOL CHEM, V293, P13044, DOI 10.1074/jbc.RA118.003845; Bhogaraju S, 2019, NATURE, V572, P382, DOI 10.1038/s41586-019-1440-8; Black MH, 2019, SCIENCE, V364, P787, DOI 10.1126/science.aaw7446; Burstein D, 2016, NAT GENET, V48, P167, DOI 10.1038/ng.3481; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doolittle LK, 2013, METHODS MOL BIOL, V1046, P273, DOI 10.1007/978-1-62703-538-5_16; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Fischer EH, 2013, BIOCHEM BIOPH RES CO, V430, P865, DOI 10.1016/j.bbrc.2012.10.024; Gan NH, 2019, NATURE, V572, P387, DOI 10.1038/s41586-019-1439-1; Ge JN, 2009, P NATL ACAD SCI USA, V106, P13725, DOI 10.1073/pnas.0907200106; Haenssler E, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00064; Hervet E, 2011, INFECT IMMUN, V79, P1936, DOI 10.1128/IAI.00805-10; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hubber A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004222; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Kanev GK, 2019, TRENDS PHARMACOL SCI, V40, P818, DOI 10.1016/j.tips.2019.09.002; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee PC, 2018, CELL HOST MICROBE, V24, P429, DOI 10.1016/j.chom.2018.08.004; Lee WK, 2013, P NATL ACAD SCI USA, V110, P19360, DOI 10.1073/pnas.1304670110; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu YC, 2007, INFECT IMMUN, V75, P592, DOI 10.1128/IAI.01278-06; Lopez VA, 2019, CELL, V179, P205, DOI 10.1016/j.cell.2019.08.020; Losick VP, 2010, CELL MICROBIOL, V12, P1083, DOI 10.1111/j.1462-5822.2010.01452.x; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michard C, 2015, MBIO, V6, DOI 10.1128/mBio.00354-15; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moss SM, 2019, CELL HOST MICROBE, V25, P454, DOI 10.1016/j.chom.2019.01.006; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nguyen KB, 2016, P NATL ACAD SCI USA, V113, pE3482, DOI 10.1073/pnas.1605917113; Park BC, 2019, IUBMB LIFE, V71, P749, DOI 10.1002/iub.2040; Salomon D, 2013, CELL HOST MICROBE, V14, P269, DOI 10.1016/j.chom.2013.07.008; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shamsuddin AK, 2012, CURR SIGNAL TRANSD T, V7, P289; Shamsuddin AM, 1999, ANTICANCER RES, V19, P3733; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Sreelatha A, 2018, CELL, V175, P809, DOI 10.1016/j.cell.2018.08.046; Sulpizio A, 2019, ELIFE, V8, DOI 10.7554/eLife.51162; Tagliabracci VS, 2015, CELL, V161, P1619, DOI 10.1016/j.cell.2015.05.028; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Wang Q, 2015, ELIFE, V4, DOI 10.7554/eLife.06074; Weber ANR, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01454; Xu D, 2015, BIOINFORMATICS, V31, P2098, DOI 10.1093/bioinformatics/btv092; Xu D, 2014, BIOINFORMATICS, V30, P660, DOI 10.1093/bioinformatics/btt578; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430	54	10	10	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6214	6224		10.1074/jbc.RA120.013067	http://dx.doi.org/10.1074/jbc.RA120.013067			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32229585	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000531417300029
J	Chacon, AI; Baer, A; Wheeler, JK; Pittermann, J				Chacon, Alexander, I; Baer, Alexander; Wheeler, James K.; Pittermann, Jarmila			Two coastal Pacific evergreens, Arbutus menziesii, Pursh. and Quercus agrifolia, Nee show little water stress during California's exceptional drought	PLOS ONE			English	Article							VULNERABILITY CURVES; CAVITATION RESISTANCE; FOREST STRUCTURE; XYLEM; EFFICIENCY; MECHANISMS; TEMPERATE; VESSELS; ROOTS; TREES	California's coastal climate is characterized by rainy winters followed by a dry summer season that is supplemented by frequent fog. While rising temperatures and drought caused massive tree mortality in central California during the 2011-2015 extreme drought, dying trees were less common in the central coast region. We hypothesized that cooler, maritime-ameliorated temperatures reduced the effects of drought stress on coastal vegetation. To test this, weekly measurements of water potential and stomatal conductance were made on two coast evergreen tree species, Arbutus menziesii and Quercus agrifolia, throughout the summer 2014 dry season. Water potential remained generally constant during this period but stomatal conductance declined in both species as the dry season progressed. Species' resistance to embolism was determined using the centrifuge method, and showed Q. agrifolia to be more vulnerable to embolism than A. menziesii. The stem vulnerability curves were consistent with species' seasonal water relations as well as their anatomy; the ring-porous Q. agrifolia had substantially larger conduits than the diffuse-porous A. menziesii. Leaf turgor loss points differed significantly as did other pressure-volume parameters but these data were consistent with the trees' seasonal water relations. Overall, the two species appear to employ differing water use strategies; A. menziesii is more profligate in its water use, while Q. agrifolia is more conservative, with a narrower safety margin against drought-induced loss of xylem transport capacity. Despite the extended drought, these species exhibited neither branch die-back nor any obvious symptoms of pronounced water-stress during the study period, implying that the maritime climate of California's central coast may buffer the local vegetation against the severe effects of prolonged drought.	[Chacon, Alexander, I; Baer, Alexander; Wheeler, James K.; Pittermann, Jarmila] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Pittermann, J (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	jpitterm@ucsc.edu			National Science Foundation (NSF) [IOS-1656876, IOS-1258186]; NSF REU grant [1157090]	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF REU grant(National Science Foundation (NSF)NSF - Office of the Director (OD))	National Science Foundation (NSF) grants IOS-1656876 and IOS-1258186 to JP NSF REU grant 1157090 to Drs. Laurel Fox and Barry Sinervo at UC Santa Cruz, funds for this grant were used to support then undergraduate student Alexander Chacon www.nsf.gov NSF played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HD, 2017, NAT ECOL EVOL, V1, P1285, DOI 10.1038/s41559-017-0248-x; Alder NN, 1997, J EXP BOT, V48, P665, DOI 10.1093/jxb/48.3.665; [Anonymous], 2019, R LANG ENV STAT COMP; Brodribb TJ, 2016, NEW PHYTOL, V209, P1403, DOI 10.1111/nph.13846; CALLAWAY RM, 1990, AM J BOT, V77, P1469, DOI 10.2307/2444757; Cannon WA., 1914, PLANT WORLD, V17, P223; Carlquist S., REV VASICENTRIC TRAC, V33; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Christman MA, 2012, NEW PHYTOL, V193, P713, DOI 10.1111/j.1469-8137.2011.03984.x; Cochard H, 2013, J EXP BOT, V64, P4779, DOI 10.1093/jxb/ert193; Cochard H, 2010, PLANT CELL ENVIRON, V33, P1543, DOI 10.1111/j.1365-3040.2010.02163.x; Corbin JD, 2005, OECOLOGIA, V145, P511, DOI 10.1007/s00442-005-0152-y; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Fischer DT, 2009, J BIOGEOGR, V36, P783, DOI 10.1111/j.1365-2699.2008.02025.x; Gilbert GS, 2010, J VEG SCI, V21, P388, DOI 10.1111/j.1654-1103.2009.01151.x; Goulden ML, 1996, TREE PHYSIOL, V16, P417; GREENIDGE KNH, 1952, AM J BOT, V39, P570, DOI 10.2307/2438704; Griffin D, 2014, GEOPHYS RES LETT, V41, P9017, DOI 10.1002/2014GL062433; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; Hacke UG, 2006, TREE PHYSIOL, V26, P689, DOI 10.1093/treephys/26.6.689; Hacke UG, 2000, BASIC APPL ECOL, V1, P31, DOI 10.1078/1439-1791-00006; Hacke UG, 2015, NEW PHYTOL, V205, P116, DOI 10.1111/nph.13017; Haff TM, 2008, NATURAL HIST UC SANT; Hochberg U, 2018, TRENDS PLANT SCI, V23, P112, DOI 10.1016/j.tplants.2017.11.002; Jacobsen AL, 2007, ECOL MONOGR, V77, P99, DOI 10.1890/05-1879; Jacobsen AL, 2019, IAWA J, V40, P4, DOI 10.1163/22941932-40190233; Jacobsen AL, 2018, NEW PHYTOL, V219, P498, DOI 10.1111/nph.15186; Jacobsen AL, 2012, NEW PHYTOL, V194, P982, DOI 10.1111/j.1469-8137.2012.04118.x; Barotto AJ, 2016, TREE PHYSIOL, V36, P1485, DOI 10.1093/treephys/tpw072; Kolb KJ, 1999, ECOLOGY, V80, P2373, DOI 10.1890/0012-9658(1999)080[2373:DIDABS]2.0.CO;2; Kueppers LM, 2005, P NATL ACAD SCI USA, V102, P16281, DOI 10.1073/pnas.0501427102; Martin-StPaul NK, 2014, TREE PHYSIOL, V34, P894, DOI 10.1093/treephys/tpu059; Martinez-Vilalta J, 2002, OECOLOGIA, V133, P19, DOI 10.1007/s00442-002-1009-2; McCulloh K, 2010, NEW PHYTOL, V186, P439, DOI 10.1111/j.1469-8137.2010.03181.x; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McIntyre PJ, 2015, P NATL ACAD SCI USA, V112, P1458, DOI 10.1073/pnas.1410186112; Meinzer FC, 2014, PLANT CELL ENVIRON, V37, P2577, DOI 10.1111/pce.12327; Pereira L, 2020, PLANT CELL ENVIRON, V43, P131, DOI 10.1111/pce.13647; Pratt RB, 2020, TREE PHYSIOL, V40, P5, DOI 10.1093/treephys/tpz092; Rockwell FE, 2014, PLANT PHYSIOL, V164, P1649, DOI 10.1104/pp.113.233817; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skelton RP, 2019, NEW PHYTOL, V223, P1296, DOI 10.1111/nph.15886; Skelton RP, 2018, PLANT PHYSIOL, V177, P1066, DOI 10.1104/pp.18.00103; Taneda H, 2008, TREE PHYSIOL, V28, P1641, DOI 10.1093/treephys/28.11.1641; Torres-Ruiz JM, 2014, PHYSIOL PLANTARUM, V152, P465, DOI 10.1111/ppl.12185; Venturas MD, 2019, PLANT CELL ENVIRON, V42, P2422, DOI 10.1111/pce.13565; Venturas MD, 2017, J INTEGR PLANT BIOL, V59, P356, DOI 10.1111/jipb.12534; Wheeler JK, 2013, PLANT CELL ENVIRON, V36, P1938, DOI 10.1111/pce.12139; ZWIENIECKI MA, 1995, PLANT SOIL, V172, P181, DOI 10.1007/BF00011320	50	3	3	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230868	10.1371/journal.pone.0230868	http://dx.doi.org/10.1371/journal.pone.0230868			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240222	Green Published, gold			2022-12-26	WOS:000535945000052
J	Lucardi, RD; Cunard, CE; Hughes, SC; Burgeset, KS; Reed, JN; Whitehurst, LE; Worthy, SJ; Marsico, TD				Lucardi, Rima D.; Cunard, Chelsea E.; Hughes, Steven C.; Burgeset, Kevin S.; Reed, Jennifer N.; Whitehurst, Lauren E.; Worthy, Samantha J.; Marsico, Travis D.			An initial industrial flora: A framework for botanical research in cooperation with industry for biodiversity conservation	PLOS ONE			English	Article							EMERALD ASH BORER; PROPAGULE PRESSURE; INVASION ECOLOGY; GLOBAL CONSEQUENCES; DISTURBANCE; ESTABLISHMENT; DIVERSITY; HISTORY; FOREST	Humans have created an accelerating, increasingly connected, globalized economy, resulting in a more globalized, shared flora. The prevention of new, establishing species is less costly, both economically and ecologically, and is more manageable than eradicating nonnative invasive species once they are widespread and negatively impactful. We ask if international trade hubs and points-of-entry with high-volume trade, constant disturbance, and propagule rain have a higher number of nonnative species compared to surrounding areas and if they may serve as initial establishment sites and refugia of nonnative, invasive populations. Therefore, we partnered with various federal, state, and private interests to evaluate the floristic composition at the Garden City Terminal of the Port of Savannah, Georgia, USA. We conducted the following study to demonstrate the collaborative relationship-building between researchers and industry and to develop a framework for biodiversity conservation. In our study, we collected all reproductive vascular plants in the secured areas of the Garden City Terminal during four major seasonal time points over two years. The percent of nonnative species and number of nonnative plant species per hectare at this industrial location exceeded all other comparison floras. The mean coefficient of conservatism was lowest among the comparison floras, indicating a highly disturbed habitat with nonnative, weedy native, and other native species tolerant of disturbance. Our study represents one of the first inventories of an Industrialized Flora and indicates that such areas are hot-spots of nonnative plant diversity and possible sources of emergent plant invasions. We posit that industrial sites and international points-of-entry should be considered laboratories for research on species transport and introduction, adaptability, and taxonomic delineation to better understand the mechanisms and consequences of biotic homogenization due to the volume and frequency of anthropogenic activities.	[Lucardi, Rima D.; Cunard, Chelsea E.] US Dept Agr USDA, Forest Serv, Athens, GA 30605 USA; [Cunard, Chelsea E.; Reed, Jennifer N.; Marsico, Travis D.] Arkansas State Univ, Dept Biol Sci, Jonesboro, AR 72401 USA; [Hughes, Steven C.] Univ Georgia, Herbarium, Dept Plant Biol, Athens, GA 30602 USA; [Burgeset, Kevin S.; Whitehurst, Lauren E.; Worthy, Samantha J.] Columbus State Univ, Dept Biol, Columbus, GA USA; [Whitehurst, Lauren E.] Univ Florida, Dept Biol, Gainesville, FL USA; [Worthy, Samantha J.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Arkansas State University; University System of Georgia; University of Georgia; University System of Georgia; Columbus State University; State University System of Florida; University of Florida; University System of Maryland; University of Maryland College Park	Lucardi, RD (corresponding author), US Dept Agr USDA, Forest Serv, Athens, GA 30605 USA.; Marsico, TD (corresponding author), Arkansas State Univ, Dept Biol Sci, Jonesboro, AR 72401 USA.	Rima.Lucardi@USDA.gov; TMarsico@astate.edu		Worthy, Samantha/0000-0003-0414-2607	USDA Forest Service, Southern Research Station [15JV11330129032]; Columbus State University [15JV11330129031]	USDA Forest Service, Southern Research Station(United States Department of Agriculture (USDA)United States Forest Service); Columbus State University	This research was supported by the USDA Forest Service, Southern Research Station to Arkansas State University (15JV11330129032 to TDM) and Columbus State University (15JV11330129031 to KSB). RDL conceived the research idea, contributed to study design, and was involved in every aspect of this research as primary author and as program manager of the above agreements for financial support.	[Anonymous], 2019, GAPORTS; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Briski E, 2012, BIOL INVASIONS, V14, P1843, DOI 10.1007/s10530-012-0194-0; Brockerhoff EG, 2014, ECOLOGY, V95, P594, DOI 10.1890/13-0465.1; Brockerhoff EG, 2006, CAN J FOREST RES, V36, P289, DOI [10.1139/x05-250, 10.1139/X05-250]; Calinger KM, 2013, ECOL LETT, V16, P1037, DOI 10.1111/ele.12135; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Crawford PHC, 2009, J BIOGEOGR, V36, P651, DOI 10.1111/j.1365-2699.2008.02043.x; Dolan RW, 2017, AM J BOT, V104, P1179, DOI 10.3732/ajb.1700136; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ellis EC, 2015, ECOL MONOGR, V85, P287, DOI 10.1890/14-2274.1; Elton, 1958, METHUEN; Eschtruth AK, 2009, ECOL MONOGR, V79, P265, DOI 10.1890/08-0221.1; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Feeley KJ, 2011, DIVERS DISTRIB, V17, P1132, DOI 10.1111/j.1472-4642.2011.00813.x; Fofonoff P.W., 2018, NATL EXOTIC MARINE E; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; Harris S, 2018, DEV INVASIVE SPECIES; Herms DA, 2014, ANNU REV ENTOMOL, V59, P13, DOI 10.1146/annurev-ento-011613-162051; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Jehlik J., 2008, BIODIVERSITY RES CON, V11-12, P27; JEHLIK V, 1974, Folia Geobotanica and Phytotaxonomica, V9, P241; Kowarik I, 2012, DIVERS DISTRIB, V18, P1243, DOI 10.1111/ddi.12009; Leung B, 2014, FRONT ECOL ENVIRON, V12, P273, DOI 10.1890/130311; Liebhold AM, 2017, J APPL ECOL, V54, P1968, DOI 10.1111/1365-2664.12895; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; LUDYANSKIY ML, 1993, BIOSCIENCE, V43, P533, DOI 10.2307/1311948; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McGeoch MA, 2016, BIOL INVASIONS, V18, P299, DOI 10.1007/s10530-015-1013-1; MINCHIN PR, 1987, VEGETATIO, V69, P89, DOI 10.1007/BF00038690; Minchinton TE, 2002, J EXP MAR BIOL ECOL, V281, P89, DOI 10.1016/S0022-0981(02)00438-0; MUHLENBACH V, 1979, ANN MO BOT GARD, V66, P1, DOI 10.2307/2398794; Palmer M., 2013, FLORAS N AM PROJECT; Palmer MW, 2012, CASTANEA, V77, P46, DOI 10.2179/11-035; Palmer MW, 2002, ENVIRONMETRICS, V13, P121, DOI 10.1002/env.516; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Poland TM, 2006, J FOREST, V104, P118; Richardson DM, 2008, DIVERS DISTRIB, V14, P161, DOI 10.1111/j.1472-4642.2007.00464.x; Soltis PS, 2017, AM J BOT, V104, P1281, DOI 10.3732/ajb.1700281; Starfinger Uwe, 2003, Biological Invasions, V5, P323, DOI 10.1023/B:BINV.0000005573.14800.07; Kartesz JT, 2015, BIOTA N AM PROGRAM B; Thellung A., 1915, PFLANZENWANDERUNGEN; United States of America Department of Agriculture Animal and Plant Health Inspection Services, 2010, FED NOX WEED LIST; Willis CG, 2017, TRENDS ECOL EVOL, V32, P531, DOI 10.1016/j.tree.2017.03.015; Zomlefer WB, 2013, SOUTHEAST NAT, V12, P790, DOI 10.1656/058.012.0426	47	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230729	10.1371/journal.pone.0230729	http://dx.doi.org/10.1371/journal.pone.0230729			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236107	gold, Green Published			2022-12-26	WOS:000535938700025
J	Miyao, N; Hata, Y; Izumi, H; Nagaoka, R; Oku, Y; Takasaki, I; Ishikawa, T; Takarada, S; Okabe, M; Nakaoka, H; Ibuki, K; Ozawa, S; Yoshida, T; Hasegawa, H; Makita, N; Nishida, N; Mori, H; Ichida, F; Hirono, K				Miyao, Nariaki; Hata, Yukiko; Izumi, Hironori; Nagaoka, Ryo; Oku, Yuko; Takasaki, Ichiro; Ishikawa, Taisuke; Takarada, Shinya; Okabe, Mako; Nakaoka, Hideyuki; Ibuki, Keijiro; Ozawa, Sayaka; Yoshida, Tomoyuki; Hasegawa, Hideyuki; Makita, Naomasa; Nishida, Naoki; Mori, Hisashi; Ichida, Fukiko; Hirono, Keiichi			TBX5 R264K acts as a modifier to develop dilated cardiomyopathy in mice independently of T-box pathway	PLOS ONE			English	Article							HOLT-ORAM-SYNDROME; DIASTOLIC DYSFUNCTION; TRANSCRIPTION FACTOR; MOLECULAR-BASIS; MUTATION; MODEL; EXPRESSION; FEATURES; GENE	Background TBX5 is a transcription factor that has an important role in development of heart. TBX5 variants in the region encoding the T-box domain have been shown to cause cardiac defects, such as atrial septal defect or ventricular septal defect, while TBX5 variants have also been identified in a few cardiomyopathy patients and considered causative. We identified a TBX5 variant (c.791G> A, p.Arg264Lys), that is over-represented in cardiomyopathy patients. This variant is located outside of the T-box domain, and its pathogenicity has not been confirmed by functional analyses. Objective To investigate whether the TBX5 R264K is deleterious and could contribute to the pathogenesis of cardiomyopathy. Methods and results We developed mice expressing Tbx5 R264K. Mice homozygous for this variant displayed compensated dilated cardiomyopathy; mild decreased fractional shortening, dilatation of the left ventricle, left ventricular wall thinning and increased heart weight without major heart structural disorders. There was no difference in activation of the ANF promotor, a transcriptional target of Tbx5, compared to wild-type. However, analysis of RNA isolated from left ventricular samples showed significant increases in the expression of Acta1 in left ventricle with concomitant increases in the protein level of ACTA1. Conclusions Mice homozygous for Tbx5 R264K showed compensated dilated cardiomyopathy. Thus, TBX5 R264K may have a significant pathogenic role in some cardiomyopathy patients independently of T-box domain pathway.	[Miyao, Nariaki; Takarada, Shinya; Okabe, Mako; Nakaoka, Hideyuki; Ibuki, Keijiro; Ozawa, Sayaka; Ichida, Fukiko; Hirono, Keiichi] Univ Toyama, Dept Pediat, Toyama, Japan; [Hata, Yukiko; Oku, Yuko; Nishida, Naoki] Univ Toyama, Dept Legal Med, Toyama, Japan; [Izumi, Hironori; Yoshida, Tomoyuki; Mori, Hisashi] Univ Toyama, Dept Mol Neurosci, Toyama, Japan; [Nagaoka, Ryo; Hasegawa, Hideyuki] Univ Toyama, Lab Med Informat Sensing, Toyama, Japan; [Takasaki, Ichiro] Univ Toyama, Grad Sch Sci & Engn, Dept Pharmacol, Toyama, Japan; [Ishikawa, Taisuke; Makita, Naomasa] Natl Cerebral & Cardiovasc Ctr, Omics Res Ctr, Osaka, Japan	University of Toyama; University of Toyama; University of Toyama; University of Toyama; University of Toyama; National Cerebral & Cardiovascular Center - Japan	Hirono, K (corresponding author), Univ Toyama, Dept Pediat, Toyama, Japan.	khirono1973@gmail.com		Yoshida, Tomoyuki/0000-0002-8476-3798				Al-Qattan MM, 2015, GENE, V560, P129, DOI 10.1016/j.gene.2015.02.017; Arimura T, 2010, J AM COLL CARDIOL, V55, P1503, DOI 10.1016/j.jacc.2009.10.065; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Brassington AME, 2003, AM J HUM GENET, V73, P74, DOI 10.1086/376436; Brooks WW, 2009, COMPARATIVE MED, V59, P339; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Copeland O, 2010, J MUSCLE RES CELL M, V31, P207, DOI 10.1007/s10974-010-9224-7; Dressen M, 2016, MOL GENET GENOM MED, V4, P557, DOI 10.1002/mgg3.234; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Garst AD, 2009, BBA-GENE REGUL MECH, V1789, P584, DOI 10.1016/j.bbagrm.2009.06.004; Grune J, 2018, HYPERTENSION, V71, P599, DOI 10.1161/HYPERTENSIONAHA.117.10360; Guo DF, 2016, MOL MED REP, V13, P4349, DOI 10.3892/mmr.2016.5043; Hatcher CJ, 2000, DEV DYNAM, V219, P90, DOI 10.1002/1097-0177(200009)219:1<90::AID-DVDY1033>3.0.CO;2-L; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Lin F, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01116; Lindsey ML, 2018, AM J PHYSIOL-HEART C, V314, pH733, DOI 10.1152/ajpheart.00339.2017; Ma XW, 2011, SCI CHINA LIFE SCI, V54, P493, DOI 10.1007/s11427-011-4183-9; Matsuoka R, 2006, P 2 IREIIMS OP S TOK, V43, P151; McDermott DA, 2005, PEDIATR RES, V58, P981, DOI 10.1203/01.PDR.0000182593.95441.64; Mikhailov AT, 2016, HEART FAIL REV, V21, P783, DOI 10.1007/s10741-016-9569-0; Nadadur RD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4891; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Plageman TF, 2006, DEV DYNAM, V235, P2868, DOI 10.1002/dvdy.20923; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Ravenscroft G, 2013, HUM MOL GENET, V22, P3987, DOI 10.1093/hmg/ddt252; Reza N, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002243; Ross Samantha Barratt, 2018, HeartRhythm Case Rep, V4, P146, DOI 10.1016/j.hrcr.2017.12.002; Segura A, 2014, HEART FAIL REV, V19, P173, DOI 10.1007/s10741-012-9365-4; Segura AM, 2011, CARDIOVASC PATHOL, V20, P139, DOI [10.1016/j.carpath.2010.01.011, 10.1016/j.carpath.2010.08.003]; Smemo S, 2012, HUM MOL GENET, V21, P3255, DOI 10.1093/hmg/dds165; Steimle JD, 2017, CURR TOP DEV BIOL, V122, P195, DOI 10.1016/bs.ctdb.2016.08.008; Su W, 2017, CLIN GENET, V91, P349, DOI 10.1111/cge.12835; Waldron L, 2016, DEV CELL, V36, P262, DOI 10.1016/j.devcel.2016.01.009; Wang J, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00100; Wang L., 2017, ENTROPY, V19, P1, DOI DOI 10.1080/10286020.2016.1241771; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Yoshida A, 2016, J HUM GENET, V61, P157, DOI 10.1038/jhg.2015.126; Zhang RF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160467; Zhang XL, 2015, BIOCHEM BIOPH RES CO, V459, P166, DOI 10.1016/j.bbrc.2015.02.094; Zhou YQ, 2005, AM J PHYSIOL-HEART C, V289, pH992, DOI 10.1152/ajpheart.00027.2005; Zhu T, 2017, AM J TRANSL RES, V9, P442; Zhu Y, 2008, P NATL ACAD SCI USA, V105, P5519, DOI 10.1073/pnas.0801779105	43	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0227393	10.1371/journal.pone.0227393	http://dx.doi.org/10.1371/journal.pone.0227393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236096	Green Published, gold			2022-12-26	WOS:000535938700002
J	Poh, AH; Adikan, FRM; Moghavvemi, M; Omar, SFS; Poh, K; Mahyuddin, MBH; Yan, G; Ariffin, MAA; Harun, SW				Poh, Abdul Halim; Adikan, Faisal Rafiq Mahamd; Moghavvemi, Mahmoud; Omar, Sharifah Faridah Syed; Poh, Khadijah; Mahyuddin, Mohamad Badrol Hisyam; Yan, Grace; Ariffin, Mohammad Aizuddin Azizah; Harun, Sulaiman Wadi			Precursors to non-invasive clinical dengue screening: Multivariate signature analysis of in-vivo diffuse skin reflectance spectroscopy on febrile patients in Malaysia	PLOS ONE			English	Article							RAMAN-SPECTROSCOPY; VIRUS; FEVER; RASH; DIAGNOSIS; MELANIN; TISSUE	Dengue diagnostics have come a long way. Attempts at breaking away from lab-oriented dengue detection, such as NS1 antigen, IgM or IgG antibodies detection have extensively received numerous coverage. As a result, rapid detection tests (RDTs) have started to gain inroads in medical practice. Rapid detection tests notwithstanding, analysis of blood serum is still a relatively complicated task. This includes the necessity of phlebotomy, centrifugation for blood serum, and other reagent-based tests. Therefore, a non-invasive method of dengue detection was considered. In this study, we present the utility of diffuse reflectance skin spectroscopy (bandwidth of 200-2500nm) on the forearm during the triaging period for dengue screening potential. This is performed with multivariate analysis of 240 triaged febrile/suspected dengue patients. The data is then scrutinized for its clinical validity to be included as either confirmed or probable dengue, or a control group. Based on discriminant analysis of several data normalization models, we can predict the patients' clinical dengue-positivity at ranges of accuracy between similar to 93-98% depending on mode of the data, with a probably optimal sensitivity and specificity to the clinical diagnosis of similar to 89% and similar to 100% respectively. From the outcomes of this study, we recommend further trials with cautious optimism. With these findings, it is hoped that the elusive non-invasive detection of tropical diseases may gain platform in the near future.	[Poh, Abdul Halim; Adikan, Faisal Rafiq Mahamd; Moghavvemi, Mahmoud; Mahyuddin, Mohamad Badrol Hisyam; Harun, Sulaiman Wadi] Univ Malaya, Fac Engn, Dept Elect Engn, Kuala Lumpur, Malaysia; [Poh, Abdul Halim; Adikan, Faisal Rafiq Mahamd; Yan, Grace] Univ Malaya, Fac Engn, Integrated Lightwave Res Grp, Kuala Lumpur, Malaysia; [Poh, Abdul Halim; Moghavvemi, Mahmoud] Univ Malaya, Fac Engn, Ctr Res Appl Elect CRAE, Kuala Lumpur, Malaysia; [Moghavvemi, Mahmoud; Ariffin, Mohammad Aizuddin Azizah] Univ Sci & Culture, Tehran, Iran; [Omar, Sharifah Faridah Syed; Poh, Khadijah] Univ Malaya, Fac Med, Kuala Lumpur, Malaysia; [Omar, Sharifah Faridah Syed] Univ Malaya, Infect Dis & Med, Kuala Lumpur, Malaysia; [Mahyuddin, Mohamad Badrol Hisyam; Harun, Sulaiman Wadi] Univ Malaya, Fac Engn, Photon Engn, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Adikan, FRM (corresponding author), Univ Malaya, Fac Engn, Dept Elect Engn, Kuala Lumpur, Malaysia.; Adikan, FRM (corresponding author), Univ Malaya, Fac Engn, Integrated Lightwave Res Grp, Kuala Lumpur, Malaysia.	rafiq@um.edu.my	Poh, Khadijah/ABF-1642-2020; OMAR, SHARIFAH FARIDAH SFSO SYED/B-9752-2010; Poh, Khadijah/S-7049-2018; Moghavvemi, Mahmoud/B-8912-2010; Poh, Khadijah/AAW-6781-2021; Azizah Ariffin, Mohammad Aizuddin/AAA-1838-2022	Poh, Khadijah/0000-0003-1374-5012; Moghavvemi, Mahmoud/0000-0001-6447-4203; Poh, Khadijah/0000-0003-1374-5012; Azizah Ariffin, Mohammad Aizuddin/0000-0002-6093-6842	Ministry of Higher Education Malaysia [PR001-2019B, PRGS/2/2019/SKK02/UM/01/1]; University of Malaya's Postgraduate Grant (PPP) [PG0962016A]; Ministry of Higher Education's Fundamental Research Grant Scheme (FRGS Grant) [FP003-2014B]; FRMA Malaysia's High Impact Research Grant (HIR Grant) [HIR UM.00000005/HIR.C1]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); University of Malaya's Postgraduate Grant (PPP); Ministry of Higher Education's Fundamental Research Grant Scheme (FRGS Grant); FRMA Malaysia's High Impact Research Grant (HIR Grant)	This study was supported by Prototype Research Grant Scheme (PR001-2019B, PRGS/2/2019/SKK02/UM/01/1) by Ministry of Higher Education Malaysia. Rceived by: AHP University of Malaya's Postgraduate Grant (PPP, PG0962016A), https://umresearch.um.edu.my/funding-opportunities-information Role: Data collection Rceived by:MM Ministry of Higher Education's Fundamental Research Grant Scheme (FRGS Grant, FP003-2014B), https://mastic.mestecc.gov.my/sti-incentive/fundamental-research-grantscheme-frgs Role: Setup procurement Rceived by: FRMA Malaysia's High Impact Research Grant (HIR Grant, HIR UM.00000005/HIR.C1) https://www.um.edu.my/faq-research-high-impactresearch-grant Role: Setup materials	ANDERSON RR, 1981, J INVEST DERMATOL, V77, P13, DOI 10.1111/1523-1747.ep12479191; Atkins CG, 2017, APPL SPECTROSC, V71, P767, DOI 10.1177/0003702816686593; Azfar NA, 2012, J PAK ASS DERMATOL, V22, P320; Bilal M, 2017, LASER PHYS, V27, P1, DOI 10.1088/1555-6611/aa5a94; Boden I, 2013, SKIN RES TECHNOL, V19, pE473, DOI 10.1111/j.1600-0846.2012.00668.x; Borisova E, 2018, BIOPHOTONICS PHOTONI; Cooksey CC, 2015, PROC SPIE, V9461, DOI 10.1117/12.2184485; Dahlstrand U, 2018, SKIN RES TECHNOLOGY; Firdous S, 2012, LASER PHYS LETT, V9, P317, DOI 10.1002/lapl.201110126; Ganguli A, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0209-9; Hafirassou ML, 2017, CELL REP, V21, P3900, DOI 10.1016/j.celrep.2017.11.094; Hani A, 2011, 5 KUAL LUMP INT C BI; Hunsperger EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005719; Ivory MO, 2015, J INVEST DERMATOL, V135, P1711, DOI 10.1038/jid.2014.544; Jaenisch T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1440-3; Jahanshahi P, 2017, BIOENGINEERED, V8, P239, DOI 10.1080/21655979.2016.1223413; Janus S, 2018, SPECTROCHIM ACTA A, V188, P37; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Kalia S, 2018, PIGM CELL MELANOMA R, V31, P31, DOI 10.1111/pcmr.12624; Khan S, 2017, APPL SPECTROSC, V71, P2111, DOI 10.1177/0003702817695571; Kocsis L, 2006, PHYS MED BIOL, V51, pN91, DOI 10.1088/0031-9155/51/5/N02; Kos S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174966; Lee K, 2018, J MICROBIOLOGY IMMUN; Li C, 2018, IEEE J SELECTED TOPI; Lim JK, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2789-8; Lim LA, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3525288; Lum LCS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003836; Manoharan KS, 2017, PAEDIAT CHILD HLTH, V27, P196; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; Matas A, 2002, VIB SPECTROSC, V28, P45, DOI 10.1016/S0924-2031(01)00144-8; Mayer JK, 2017, PATHOLOGY, V49, P329, DOI 10.1016/j.pathol.2016.11.013; Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649; Mustapa M, 2018, IEEE SENSORS J; Nath A, 2004, J BIOMED OPT, V9, P523, DOI 10.1117/1.1695562; Nijssen A, 2002, J INVEST DERMATOL, V119, P64, DOI 10.1046/j.1523-1747.2002.01807.x; Nogueira MS, 2018, BIOPHOTONICS PHOTONI; Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459; Pingen M, 2017, TRENDS PARASITOL, V33, P645, DOI 10.1016/j.pt.2017.04.003; Sanchez-Purra M, 2017, ACS INFECT DIS, V3, P767, DOI 10.1021/acsinfecdis.7b00110; Schaafsma W., 1982, HDB STAT, V2, P857; See JA, 2018, J DERMATOL, V45, P522, DOI 10.1111/1346-8138.14314; Sharma V, 2018, CLIN EXPT DERMATOLOG; Silpa-Archa N, 2017, J AM ACAD DERMATOL, V77, P591, DOI 10.1016/j.jaad.2017.01.035; Soller B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-396; Sprigle S, 2002, MED ENG PHYS, V24, P651, DOI 10.1016/S1350-4533(02)00149-2; Srikiatkhachorn A, 2007, PEDIATR INFECT DIS J, V26, P283, DOI 10.1097/01.inf.0000258612.26743.10; Srivastava A, 2017, INT J DERMATOL, V56, P873, DOI 10.1111/ijd.13627; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tan T., 2018, KNOWLEDGE BASED SYST; Tjandra ET, 2017, J DTSCH DERMATOL GES, V15, P82, DOI 10.1111/ddg.12941; Vargis E, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3646210; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553; Yeo ASL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092240	54	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0228923	10.1371/journal.pone.0228923	http://dx.doi.org/10.1371/journal.pone.0228923			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236132	Green Published, gold			2022-12-26	WOS:000535938700008
J	Figueiredo, AM; Valente, AM; Barros, T; Carvalho, J; Silva, DAM; Fonseca, C; de Carvalho, LM; Torres, RT				Figueiredo, Ana M.; Valente, Ana M.; Barros, Tania; Carvalho, Joao; Silva, Davide A. M.; Fonseca, Carlos; de Carvalho, Luis Madeira; Torres, Rita Tinoco			What does the wolf eat? Assessing the diet of the endangered Iberian wolf (Canis lupus signatus) in northeast Portugal	PLOS ONE			English	Article							FOOD-HABITS; LIVESTOCK DEPREDATION; UNGULATE COMMUNITIES; LARGE CARNIVORES; TROPHIC ECOLOGY; FEEDING ECOLOGY; WOLVES; PREY; PREDATION; WILD	The Iberian wolf (Canis lupus signatus) is a top predator that inhabits the Iberian Peninsula. In Portugal, its numbers and distribution declined throughout the 20th century, due to human persecution, habitat degradation and prey decline, which have led to higher predation rates of livestock in the remaining packs. In Montesinho Natural Park (northeast Portugal), wild ungulate populations have been increasing in the last years, which may have led wolf to predate upon them. In order to assess Iberian wolf diet in this area, 85 wolf scats were collected from transects distributed throughout the study area in two periods between November 2017 and August 2019. Scat analysis indicated a high predation on wild ungulates, where the frequency of occurrence showed that roe deer was the most consumed prey (44%), followed by red deer (26%) and wild boar (24%). Domestic/wild cat (6%), domestic goat and stone marten (5%) were consumed in lower quantities. It was found a higher selection towards roe deer (D = 0.71) and this was the only prey item which was significantly dependent of the season of the year (chi(2) = 16.95, df = 3, p < 0.001). This is the first study in Portugal where was recorded that wolves feed mainly on wild ungulates. We conclude that lower livestock predation may be correlated with higher wild ungulates densities in our study area, as well as suitable husbandry practices, leading to a shift on Iberian wolf diet from mainly live-stock on previous studies to wild ungulates.	[Figueiredo, Ana M.; Valente, Ana M.; Barros, Tania; Carvalho, Joao; Silva, Davide A. M.; Fonseca, Carlos; Torres, Rita Tinoco] Univ Aveiro, Dept Biol, Aveiro, Portugal; [Figueiredo, Ana M.; Valente, Ana M.; Barros, Tania; Carvalho, Joao; Silva, Davide A. M.; Fonseca, Carlos; Torres, Rita Tinoco] Univ Aveiro, CESAM, Aveiro, Portugal; [Valente, Ana M.] Inst Invest Recursos Cineget UCLM CSIC JCCM, Ciudad Real, Spain; [de Carvalho, Luis Madeira] Univ Lisbon, Fac Vet Med, CIISA Ctr Interdisciplinary Res Anim Hlth, Lisbon, Portugal	Universidade de Aveiro; Universidade de Aveiro; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Universidade de Lisboa	Torres, RT (corresponding author), Univ Aveiro, Dept Biol, Aveiro, Portugal.; Torres, RT (corresponding author), Univ Aveiro, CESAM, Aveiro, Portugal.	rita.torres@ua.pt	Fonseca, Carlos MMS/D-9744-2011; Silva, Davide/AAG-4854-2021; Figueiredo, Ana/O-5559-2019; de Carvalho, Madeira/G-9316-2016; Torres, Rita Tinoco/G-1638-2011; Valente, Ana/U-8941-2018	Fonseca, Carlos MMS/0000-0001-6559-7133; Silva, Davide/0000-0003-2892-8292; Figueiredo, Ana/0000-0002-2623-6340; de Carvalho, Madeira/0000-0002-7548-667X; Torres, Rita Tinoco/0000-0003-4570-459X; Valente, Ana/0000-0002-2985-7687; Carvalho, Joao/0000-0002-9792-9259	FCT [SFRH/BPD/112482/2015, SFRH/BD/127817/2016]; European Social Fund POPH-QREN program; CIISAFMV-ULisboa [UID/CVT/00276/2013]; University of Aveiro (Department of Biology); FCT/MEC [UID/AMB/50017]; FEDER, within the PT2020 Partnership Agreement	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Social Fund POPH-QREN program; CIISAFMV-ULisboa; University of Aveiro (Department of Biology); FCT/MEC(Portuguese Foundation for Science and Technology); FEDER, within the PT2020 Partnership Agreement	R.T. Torres and Ana M. Valente were supported by a post-doctoral and PhD grant from FCT, respectively (SFRH/BPD/112482/2015, SFRH/BD/127817/2016), co-financed by the European Social Fund POPH-QREN program. CIISAFMV-ULisboa, under project UID/CVT/00276/2013 (FCT), provided additional funding. We would like to thank University of Aveiro (Department of Biology) and FCT/MEC for the financial support to CESAM RU (UID/AMB/50017) through national funds and, where applicable, co-financed by the FEDER, within the PT2020 Partnership Agreement. CIISAFMV-ULisboa, under project UID/CVT/00276/2013 (FCT), provided additional funding.	alvares F., 2011, THESIS; Andersone A, 2004, ACTA THERIOL, V49, P357, DOI 10.1007/BF03192534; Ansorge H, 2006, ACTA THERIOL, V51, P99, DOI 10.1007/BF03192661; Ballard Warren B., 2003, P259; Barja I, 2009, WILDLIFE BIOL, V15, P147, DOI 10.2981/07-096; Barros T, 2016, MAMM BIOL, V81, P176, DOI 10.1016/j.mambio.2015.09.003; Boitani L., 2000, ACTION PLAN CONSERVA; Boyce MS, 2018, J MAMMAL, V99, P1021, DOI 10.1093/jmammal/gyy115; Brunner T, 2014, PROC SPIE, V9052, DOI 10.1117/12.2045715; Cabral M.J.C., 2005, LIVRO VERMELHO VERTE, V1st ed., P660; Carvalho J, 2018, DIVERS DISTRIB, V24, P551, DOI 10.1111/ddi.12703; Castro J, 2010, NATURAL HERITAGE FROM EAST TO WEST: CASE STUDIES FROM 6 EU COUNTRIES, P119, DOI 10.1007/978-3-642-01577-9_15; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Ciucci P, 1996, WILDLIFE BIOL, V2, P37, DOI 10.2981/wlb.1996.006; CUESTA L, 1991, MAMMALIA, V55, P239, DOI 10.1515/mamm.1991.55.2.239; De Marinis AM, 2006, WILDLIFE BIOL, V12, P305, DOI 10.2981/0909-6396(2006)12[305:HIKOWA]2.0.CO;2; DRAEDM, 1993, GUIA ID RAC CAPR OV, V20, P54; Eggermann J, 2011, MAMM BIOL, V76, P217, DOI 10.1016/j.mambio.2010.10.010; Ferretti F, 2019, MAMM BIOL, V99, P119, DOI 10.1016/j.mambio.2019.10.008; FLOYD TJ, 1978, J WILDLIFE MANAGE, V42, P528, DOI 10.2307/3800814; Gazzola A, 2005, J ZOOL, V266, P205, DOI 10.1017/S0952836905006801; Guindani M, 2006, BAYESIAN INFERENCE FOR GENE EXPRESSION AND PROTEOMICS, P238; HUGGARD DJ, 1993, CAN J ZOOL, V71, P130, DOI 10.1139/z93-019; HURLBERT SH, 1978, ECOLOGY, V59, P67, DOI 10.2307/1936632; Iliopoulos Y, 2009, ACTA THERIOL, V54, P11, DOI 10.1007/BF03193133; INE, 2011, REC AGR 2009 AN PRIN; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Jedrzejewski W, 2012, J MAMMAL, V93, P1480, DOI 10.1644/10-MAMM-A-132.1; Lagos L, 2018, MAMMAL RES, V63, P125, DOI 10.1007/s13364-018-0352-6; Lanszki J, 2012, ACTA THERIOL, V57, P189, DOI 10.1007/s13364-011-0063-8; Leonard JA, 2014, EVOL ECOL RES, V16, P461; Levins R., 1968, EVOLUTION CHANGING E; Llaneza L, 1996, ACTA VERTEBRATA, V23, P201; MacDonald D., 1993, COLLINS FIELD GUIDE; Marucco F, 2010, J APPL ECOL, V47, P789, DOI 10.1111/j.1365-2664.2010.01831.x; Mateos-Quesada Patricio, 2000, Etologia, V8, P17; Meriggi A, 1996, J APPL ECOL, V33, P1561, DOI 10.2307/2404794; Milanesi P, 2012, ETHOL ECOL EVOL, V24, P81, DOI 10.1080/03949370.2011.592220; Nores C, 2008, WILDLIFE BIOL, V14, P44, DOI 10.2981/0909-6396(2008)14[44:WBSSMB]2.0.CO;2; Nowak S, 2005, ACTA THERIOL, V50, P263, DOI 10.1007/BF03194489; Okarma H, 1995, ACTA THERIOL, V40, P335, DOI 10.4098/AT.arch.95-35; Paixao de Magalhaes C, 1982, T INT C GAME BIOL, V14, P281; Palumbo D., 2003, BOLOGNIA RICCRCHE MO, P52; PAPAGEORGIOU N, 1994, ACTA THERIOL, V39, P411, DOI 10.4098/AT.arch.94-48; Pimenta V, 2018, BIOL CONSERV, V228, P331, DOI 10.1016/j.biocon.2018.11.008; Pimenta V, 2017, BIOL CONSERV, V207, P17, DOI 10.1016/j.biocon.2017.01.008; R Core Team, 2021, R LANGUAGE ENV STAT; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roque S., 2001, Galemys, V13, P179; Roskaft E, 2007, WILDLIFE BIOL, V13, P172, DOI 10.2981/0909-6396(2007)13[172:HATLCI]2.0.CO;2; Roy S, 2019, MAMM BIOL, V96, P110, DOI 10.1016/j.mambio.2018.09.013; RUPRECHT A L, 1979, Acta Ornithologica (Warsaw), V16, P493; SACCONE C, 1987, J MOL EVOL, V26, P205, DOI 10.1007/BF02099853; SALAZAR D.R, 2009, THESIS; SALVADOR A, 1987, MAMMALIA, V51, P45, DOI 10.1515/mamm.1987.51.1.45; Sarmento P, 1996, ACTA THERIOL, V41, P409, DOI 10.4098/AT.arch.96-39; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teenrik B. J., 1991, HAIR W EUROPEAN MAMM, P223; Torres R. T., 2015, Journal of Forest Science (Prague), V61, P422, DOI 10.17221/52/2015-JFS; Torres R. T., 2018, CASE STUDIES GLOBE, V139; Torres RT, 2016, BIODIVERS CONSERV, V25, P411, DOI 10.1007/s10531-016-1061-6; Torres RT, 2015, ANN ZOOL FENN, V52, P339, DOI 10.5735/086.052.0508; Torres RT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129379; Valente A. M., 2015, ATLAS PELOS MAMIFERO; Valente AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088459; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Vingada Jose, 2010, P392; Vogel JT, 2018, WILDLIFE BIOL, DOI 10.2981/wlb.00424; Vos J, 2000, J ZOOL, V251, P457, DOI 10.1111/j.1469-7998.2000.tb00801.x; Wagner C, 2012, MAMM BIOL, V77, P196, DOI 10.1016/j.mambio.2011.12.004; WEAVER JL, 1993, J WILDLIFE MANAGE, V57, P534, DOI 10.2307/3809278; WEAVER W, 1949, MATH THEORY COMMUNIC; Zlatanova D, 2014, ACTA ZOOL BULGAR, V66, P439	74	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230433	10.1371/journal.pone.0230433	http://dx.doi.org/10.1371/journal.pone.0230433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HO	32231379	Green Published, gold			2022-12-26	WOS:000535937400008
J	Zhang, Y; Pavlov, A; Malik, S; Chen, H; Kim, N; Li, ZQ; Zhang, XH; DePamphilis, ML; Roeder, RG; Ge, H				Zhang, Yan; Pavlov, Andrei; Malik, Sohail; Chen, Hong; Kim, Nancy; Li, Ziqing; Zhang, Xiaohong; DePamphilis, Melvin L.; Roeder, Robert G.; Ge, Hui			Efficacy of a small molecule inhibitor of the transcriptional cofactor PC4 in prevention and treatment of non-small cell lung cancer	PLOS ONE			English	Article							POSITIVE COACTIVATOR 4; ACTIVATION; GENE; DNA; HOMOLOGY; TARGET	The human positive coactivator 4 (PC4) was originally identified as a multi-functional cofactor capable of mediating transcription activation by diverse gene- and tissue-specific activators. Recent studies suggest that PC4 might also function as a novel cancer biomarker and therapeutic target for different types of cancers. siRNA knockdown studies indicated that down-regulation of PC4 expression could inhibit tumorigeneicity of A549 non-small cell lung cancer tumor model in nude mice. Here we show that AG-1031, a small molecule identified by high throughput screening, can inhibit the double-stranded DNA binding activity of PC4, more effectively than its single-stranded DNA binding activity. AG-1031 also specifically inhibited PC4-dependent transcriptional activation in vitro using purified transcription factors. AG-1031 inhibited proliferation of several cultured cell lines derived from non-small cell lung cancers (NSCLC) and growth of tumors that formed from A549 cell xenografts in immuno-compromised mice. Moreover, pre-injection of AG-1031 in these mice not only reduced tumor size, but also prevented tumor formation in 20% of the animals. AG-1031 treated A549 cells and tumors from AG-1031 treated animals showed a significant decrease in the levels of both PC4 and VEGFC, a key mediator of angiogenesis in cancer. On the other hand, all tested mice remained constant weight during animal trials. These results demonstrated that AG-1031 could be a potential therapy for PC4-positive NSCLC.	[Zhang, Yan; Pavlov, Andrei; Chen, Hong; Kim, Nancy; Li, Ziqing; Ge, Hui] AscentGene Inc, Gaithersburg, MD 20878 USA; [Malik, Sohail; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, 1230 York Ave, New York, NY 10021 USA; [Zhang, Xiaohong; DePamphilis, Melvin L.] NICHHD, NIH, Bethesda, MD 20892 USA	Rockefeller University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ge, H (corresponding author), AscentGene Inc, Gaithersburg, MD 20878 USA.	hge@ascentgene.com			AscentGene, Inc.; NIH [DK071900, CA129325]; Intramural Research Program of NICHD, NIH	AscentGene, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of NICHD, NIH	This work was supported by AscentGene, Inc. (YZ, AP, HC, NK, ZL and HG), NIH grants DK071900 and CA129325 to RGR (and SM) and by the Intramural Research Program of NICHD, NIH to MLD (and XZ).	Ansari J, 2016, TRANSL LUNG CANCER R, V5, P155, DOI 10.21037/tlcr.2016.02.02; Bahce I, 2017, LUNG CANCER, V107, P1, DOI 10.1016/j.lungcan.2016.05.025; Bansal P, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00112; Batta K, 2007, MOL CELL BIOL, V27, P7603, DOI 10.1128/MCB.01064-07; Bhardwaj B, 2016, ANN TRANSL MED, V4, DOI 10.3978/j.issn.2305-5839.2015.10.35; Chen L, 2014, J NEUROL SCI, V346, P293, DOI 10.1016/j.jns.2014.09.014; Das C, 2010, J MOL BIOL, V397, P1, DOI 10.1016/j.jmb.2009.12.058; Forde PM, 2013, ONCOLOGIST, V18, P1203, DOI 10.1634/theoncologist.2013-0171; GE H, 1994, P NATL ACAD SCI USA, V91, P12691, DOI 10.1073/pnas.91.26.12691; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Hao S, 2018, BRAIN RES, V1699, P1, DOI 10.1016/j.brainres.2018.06.026; Henry NL, 1996, J BIOL CHEM, V271, P21842, DOI 10.1074/jbc.271.36.21842; Jonker HRA, 2006, FEBS J, V273, P1430, DOI 10.1111/j.1742-4658.2006.05165.x; Knaus R, 1996, EMBO J, V15, P1933, DOI 10.1002/j.1460-2075.1996.tb00544.x; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; Kumar BRP, 2001, J BIOL CHEM, V276, P16804, DOI 10.1074/jbc.M100934200; Malik S, 2003, METHOD ENZYMOL, V364, P257; Pan ZQ, 1996, J BIOL CHEM, V271, P22111, DOI 10.1074/jbc.271.36.22111; Peng Y, 2012, CANCER GENE THER, V19, P690, DOI 10.1038/cgt.2012.52; Qian D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.416; Tao SL, 2015, AM J CANCER RES, V5, P1878; Wang JY, 2004, MOL CELL BIOL, V24, P6084, DOI 10.1128/MCB.24.13.6084-6093.2004; Wang Y, 2018, J CELL BIOCHEM, V119, P5893, DOI 10.1002/jcb.26781; Xu L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-275; Yokoi S, 2002, AM J PATHOL, V161, P207, DOI 10.1016/S0002-9440(10)64172-7; Zhu X., 2014, AUSTIN J CLIN MED, V1, P1016	26	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230670	10.1371/journal.pone.0230670	http://dx.doi.org/10.1371/journal.pone.0230670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HO	32231397	Green Published, gold			2022-12-26	WOS:000535937400016
J	Chen, L; Fang, K; Dong, XF; Yang, AL; Li, YX; Zhang, HB				Chen, Lin; Fang, Kai; Dong, Xing-Fan; Yang, Ai-Ling; Li, Yu-Xuan; Zhang, Han-Bo			Characterization of the fungal community in the canopy air of the invasive plant Ageratina adenophora and its potential to cause plant diseases	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; LEAF-SPOT; ENHANCED SPECIFICITY; SOIL BIOTA; PATHOGEN; ALTERNARIA; RELEASE; SPORES; DIVERSITY; DYNAMICS	Airborne fungi and their ecological functions have been largely ignored in plant invasions. In this study, high-throughput sequencing technology was used to characterize the airborne fungi in the canopy air of the invasive weed Ageratina adenophora. Then, representative phytopathogenic strains were isolated from A. adenophora leaf spots and their virulence to A.adenophora as well as common native plants in the invaded range was tested. The fungal alpha diversities were not different between the sampling sites or between the high/low part of the canopy air, but fungal co-occurrences were less common in the high than in the low part of the canopy air. Interestingly, we found that the phytopathogenic Didymellaceae fungi co-occurred more frequently with themselves than with other fungi. Disease experiments indicated that all 5 Didymellaceae strains could infect A. adenophora as well as the 16 tested native plants and that there was large variation in the virulence and host range. Our data suggested that the diverse pathogens in the canopy air might be a disease infection source that weakens the competition of invasive weeds, a novel phenomenon that remains to be explored in other invasive plants.	[Chen, Lin; Fang, Kai; Zhang, Han-Bo] Yunnan Univ, Sch Ecol & Environm Sci, Kunming, Yunnan, Peoples R China; [Chen, Lin; Fang, Kai; Dong, Xing-Fan; Yang, Ai-Ling; Li, Yu-Xuan; Zhang, Han-Bo] Yunnan Univ, State Key Lab Conservat & Utilizat Bioresources Y, Kunming, Yunnan, Peoples R China; [Chen, Lin; Fang, Kai; Dong, Xing-Fan; Yang, Ai-Ling; Li, Yu-Xuan; Zhang, Han-Bo] Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China	Yunnan University; Yunnan University; Yunnan University	Zhang, HB (corresponding author), Yunnan Univ, Sch Ecol & Environm Sci, Kunming, Yunnan, Peoples R China.; Zhang, HB (corresponding author), Yunnan Univ, State Key Lab Conservat & Utilizat Bioresources Y, Kunming, Yunnan, Peoples R China.; Zhang, HB (corresponding author), Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China.	zhhb@ynu.edu.cn	Li, Yuxuan/GWC-8159-2022	Fang, Kai/0000-0001-5030-6081; Chen, Lin/0000-0002-6352-4704	National Natural Science Foundation of China [31770585, 31360153]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (grant Nos. 31770585, 31360153). H-BZ received the awards.	Aira MJ, 2013, INT J BIOMETEOROL, V57, P265, DOI 10.1007/s00484-012-0550-x; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Aveskamp MM, 2008, FUNGAL DIVERS, V31, P1; Aveskamp MM, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.65.01; Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; BECK JJ, 1995, PHYTOPATHOLOGY, V85, P319, DOI 10.1094/Phyto-85-319; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borer ET, 2007, P NATL ACAD SCI USA, V104, P5473, DOI 10.1073/pnas.0608573104; Buccellato L, 2012, BIOL CONTROL, V61, P222, DOI 10.1016/j.biocontrol.2012.02.004; Burge HA, 2002, J ALLERGY CLIN IMMUN, V110, P544, DOI 10.1067/mai.2002.128674; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen Q, 2017, STUD MYCOL, P105, DOI 10.1016/j.simyco.2017.06.002; Chen S, 2005, PLANT PATHOL, V54, P671, DOI 10.1111/j.1365-3059.2005.01249.x; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Connell J.H., 1971, ROLE NATURAL ENEMIES; Crandall SG, 2017, ATMOS ENVIRON, V162, P87, DOI 10.1016/j.atmosenv.2017.05.018; Crous PW, 2004, STUD MYCOL, P19; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fang K, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02919; Fang K, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1520; Flory SL, 2013, J ECOL, V101, P607, DOI 10.1111/1365-2745.12078; Flory SL, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00191.1; Fujinawa MF, 2016, PLANT DIS, V100, P655, DOI 10.1094/PDIS-09-15-1097-PDN; Garcia-Guzman G, 2014, NEW PHYTOL, V201, P1106, DOI 10.1111/nph.12562; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Grinn-Gofron A, 2013, INT J BIOMETEOROL, V57, P759, DOI 10.1007/s00484-012-0604-0; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Aira MJ, 2012, GRANA, V51, P293, DOI 10.1080/00173134.2012.717636; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; Khan MAW, 2019, FEMS MICROBIOL ECOL, V95, DOI 10.1093/femsec/fiy230; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; LANGENBERG WJ, 1977, PHYTOPATHOLOGY, V67, P879, DOI 10.1094/Phyto-67-879; Larena I, 1999, J BIOTECHNOL, V75, P187, DOI 10.1016/S0168-1656(99)00154-6; Le HT, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy155; Levetin E, 2006, AEROBIOLOGIA, V22, P3, DOI 10.1007/s10453-005-9012-9; Luo Y, 2007, EUR J PLANT PATHOL, V118, P145, DOI 10.1007/s10658-007-9124-x; MALLAIAH KV, 1982, T BRIT MYCOL SOC, V78, P21, DOI 10.1016/S0007-1536(82)80072-7; Malmstrom CM, 2005, OECOLOGIA, V145, P153, DOI 10.1007/s00442-005-0099-z; Manstretta V, 2015, EUR J PLANT PATHOL, V143, P873, DOI 10.1007/s10658-015-0722-8; MARTIN RA, 1984, CAN J PLANT PATHOL, V6, P105, DOI 10.1080/07060668409501569; Mei L, 2014, MICROB ECOL, V67, P402, DOI 10.1007/s00248-013-0319-8; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Moradi M. G., 2010, International Journal of Nuts and Related Sciences (IJNRS), V1, P54; Pangga IB, 2011, PLANT PATHOL, V60, P70, DOI 10.1111/j.1365-3059.2010.02408.x; Purse BV, 2013, BIOL INVASIONS, V15, P529, DOI 10.1007/s10530-012-0305-y; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rottstock T, 2014, ECOLOGY, V95, P1907, DOI 10.1890/13-2317.1; Sadys M, 2017, AEROBIOLOGIA, V33, P445, DOI 10.1007/s10453-017-9482-6; SCHERM H, 1995, PHYTOPATHOLOGY, V85, P552, DOI 10.1094/Phyto-85-552; Shen CC, 2019, FEMS MICROBIOL ECOL, V95, DOI 10.1093/femsec/fiz003; Strauss A, 2012, FUNCT ECOL, V26, P1249, DOI 10.1111/1365-2435.12011; Stricker KB, 2016, ECOL LETT, V19, P469, DOI 10.1111/ele.12583; Tao YH, 2007, CHINESE J BIOL CONTR, V23, P37, DOI [10.1002/ccd.25492, DOI 10.1002/CCD.25492]; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Torchin ME, 2004, FRONT ECOL ENVIRON, V2, P183, DOI 10.1890/1540-9295(2004)002[0183:PPAIBP]2.0.CO;2; Troutt C, 2001, INT J BIOMETEOROL, V45, P64, DOI 10.1007/s004840100087; Tu Ran, 2009, Journal of Yunnan University - Natural Sciences Edition, V31, P521; Turnbull LA, 2010, OIKOS, V119, P1040, DOI 10.1111/j.1600-0706.2009.17914.x; UNITE Community U, 2017, FULL MOTH UNITE INSD, DOI [10.15156/910/587479, DOI 10.15156/910/587479]; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; VLOUTOGLOU I, 1995, EUR J PLANT PATHOL, V101, P639, DOI 10.1007/BF01874868; Wahl P. G. von, 1991, Aerobiologia, V7, P111, DOI 10.1007/BF02270679; Wang F, 1997, AUSTRALAS PLANT PATH, V26, P165, DOI 10.1071/AP97027; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang R, 2006, DIVERS DISTRIB, V12, P397, DOI 10.1111/j.1366-9516.2006.00250.x; WEBSTER J, 1989, MYCOL RES, V93, P297, DOI 10.1016/S0953-7562(89)80156-X; Widder S, 2014, P NATL ACAD SCI USA, V111, P12799, DOI 10.1073/pnas.1411723111; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	72	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230822	10.1371/journal.pone.0230822	http://dx.doi.org/10.1371/journal.pone.0230822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214396	gold, Green Published			2022-12-26	WOS:000535934200068
J	Nayakwadi, S; Ramu, R; Sharma, AK; Gupta, VK; Rajukumar, K; Kumar, V; Shirahatti, PS; Rashmi, L; Basalingappa, KM				Nayakwadi, Shivasharanappa; Ramu, Ramith; Sharma, Anil Kumar; Gupta, Vivek Kumar; Rajukumar, K.; Kumar, Vijay; Shirahatti, Prithvi S.; Rashmi, L.; Basalingappa, Kanthesh M.			Toxicopathological studies on the effects of T-2 mycotoxin and their interaction in juvenile goats	PLOS ONE			English	Article							TOXIN-INDUCED APOPTOSIS; TRICHOTHECENE MYCOTOXINS; BIOGENIC MONOAMINES; ANTIOXIDANT ENZYMES; MICROARRAY ANALYSIS; GENE-EXPRESSION; INDUCTION; CELLS; DEOXYNIVALENOL; CYTOTOXICITY	Food and feeds contaminated with mycotoxins have been a threat to the rearing industry by causing some of the most fatal toxic reactions not only in the farm animals but also in humans who consume them. Toxicity to juvenile goats was induced by feed contamination with T-2 toxin (at 10 and 20 ppm dosage; group I and II, respectively). The toxicity impact was assessed on days 15 and 30 post treatment with respect to growth performance, oxidative stress, apoptotic studies and detailed pathomorphology. The study revealed that apart from the obvious clinical toxicosis (weakness, lethargy, and retardation in growth), the toxin fed groups also exhibited significant haematological (reduced hemoglobin, total leukocyte and thrombocyte counts) and biochemical changes (increased levels of oxidative stress markers with concomitant decrease in levels of serum and tissue catalase and superoxide dismutase). The pathomorphological and histological alterations suggested that the liver and intestine were the most affected organs. Ultra-structurally, varying degrees of degeneration, cytoplasmic vacuolations and pleomorphic mitochondria were observed in the hepatocytes and the enterocytes of the intestine. Kidney also revealed extensive degeneration of the cytoplasmic organelles with similar condensation of the heterochromatin whereas the neuronal degeneration was characterized by circular, whirling structures. In addition, the central vein and portal triad of the hepatocytes, cryptic epithelial cells of the intestine, MLNs in the lymphoid follicles, PCT and DCT of the nephronal tissues and the white pulp of the spleen exhibited extensive apoptosis. In this study, it was also observed that the expression of HSPs, pro-apoptotic proteins and pro-inflammatory cytokines were significantly upregulated in response to the toxin treatment. These results suggest that the pathogenesis of T-2 toxicosis in goats employs oxidative, apoptotic and inflammatory mechanisms.	[Nayakwadi, Shivasharanappa; Sharma, Anil Kumar; Kumar, Vijay] Cent Inst Res Goats CIRG, Makhdoom, Mathura, India; [Nayakwadi, Shivasharanappa] ICAR Cent Coastal Agr Res Inst, Anim Sci Sect, Ela, Goa, India; [Ramu, Ramith] JSS Acad Higher Educ & Res Deemed Univ, Div Biotechnol & Bioinformat, Dept Water & Hlth Sci, Fac Life Sci, Mysuru, India; [Sharma, Anil Kumar] Indian Vet Res Inst, Div Pathol, Mycot & Mycotox Dis Lab, Izatnagar, Uttar Pradesh, India; [Gupta, Vivek Kumar] ICAR Indian Vet Res Inst, CADRAD, Izatnagar, Uttar Pradesh, India; [Rajukumar, K.] ICAR Natl Inst High Secur Anim Dis, Bhopal, India; [Shirahatti, Prithvi S.] Teresian Coll, Dept Biotechnol, Mysuru, India; [Rashmi, L.] Karnataka Vet Anim Fisheries Univ, Bidar, Karnataka, India; [Basalingappa, Kanthesh M.] JSS Acad Higher Educ & Res Deemed Univ, Div Mol Biol, Dept Water & Hlth Sci, Fac Life Sci, Mysuru, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Institute for Research on Goats; Indian Council of Agricultural Research (ICAR); ICAR - Central Coastal Agricultural Research Institute; JSS Academy of Higher Education & Research; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of High Security Animal Diseases; JSS Academy of Higher Education & Research	Nayakwadi, S (corresponding author), Cent Inst Res Goats CIRG, Makhdoom, Mathura, India.; Nayakwadi, S (corresponding author), ICAR Cent Coastal Agr Res Inst, Anim Sci Sect, Ela, Goa, India.	drshivasharan@gmail.com	RAMU, RAMITH/AAY-3039-2020; BM, Kanthesh/AAX-8650-2020	BM, Kanthesh/0000-0002-6970-4546; RAMU, Dr. RAMITH/0000-0003-2776-5815; Sharma, Anil/0000-0002-9768-1644				Ahmadi K, 2008, J IMMUNOL, V5, P177; Albarenque SM, 1999, HISTOL HISTOPATHOL, V14, P337, DOI 10.14670/HH-14.337; [Anonymous], 1995, OFFICIAL METHODS ANA; Atroshi F, 1997, MOL ASPECTS MED, V18, pS255; Boonchuvit B, 1975, POULTRY SCI, P541; Bouaziz C, 2006, TOXICON, V48, P343, DOI 10.1016/j.toxicon.2006.06.004; BOYD KE, 1988, CAN J VET RES, V52, P181; Chaudhari M, 2009, J BIOCHEM MOL TOXIC, V23, P212, DOI 10.1002/jbt.20282; Chaudhari M, 2009, TOXICOLOGY, V262, P153, DOI 10.1016/j.tox.2009.06.002; Cheeke PR, 1998, MYCOTOXINS CEREAL GR, P87; Doi K., 2006, J TOXICOL PATHOL, V19, P15; DWIVEDI P, 1984, RES VET SCI, V36, P104, DOI 10.1016/S0034-5288(18)32010-1; EC (European commission), 2001, OP SCI COMM FOOD FUS; Faifer GC, 1991, TOXICOLOGY, V5, P169; FAO/WHO Expert Committee on Food Additives Evaluation of certain mycotoxins in food, 2002, WHO TECH REP SER, V906, P1; Ferreras MC, 2013, J COMP PATHOL, V148, P236, DOI 10.1016/j.jcpa.2012.05.016; Fink GJ, 2007, ANIM FEED SCI TECHNO; FRIEND SCE, 1983, CAN J COMP MED, V47, P291; Frisvad JC, 2006, ADV EXP MED BIOL, V571, P3, DOI 10.1007/0-387-28391-9_1; GENTRY PA, 1981, CAN J COMP MED, V45, P400; GENTRY PA, 1984, VET HUM TOXICOL, V26, P24; GLAVITS R, 1989, ACTA VET HUNG, V37, P75; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hassen W, 2005, TOXICOLOGY, V207, P293, DOI 10.1016/j.tox.2004.10.001; HELFERICH WG, 1986, J ANIM SCI, V62, P691, DOI 10.2527/jas1986.623691x; HSU IC, 1972, APPL MICROBIOL, V24, P684, DOI 10.1128/AEM.24.5.684-690.1972; Jaradat ZW, 2005, R FOOD NUTRIT TOX, V4, P173; Josephs RD, 2004, TOXICOL LETT, V153, P123, DOI 10.1016/j.toxlet.2004.04.028; KEGL T, 1991, MAGY ALLATORVOSOK, V46, P467; Konigs M, 2009, TOXICOLOGY, V258, P106, DOI 10.1016/j.tox.2009.01.012; Li G., 1997, J TOXICOL PATHOL, V10, P59; Li GM, 1997, EXP TOXICOL PATHOL, V49, P447, DOI 10.1016/S0940-2993(97)80132-7; Luna LG, 1972, MANUAL HISTOLOGICAL; MANN DD, 1983, AM J VET RES, V44, P1757; Manojkumar, 2007, THESIS; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; Meissonnier GM, 2008, TOXICOLOGY, V247, P46, DOI 10.1016/j.tox.2008.02.003; Mirocha CJ, 1976, MYCOTOXINS PHYTOTOXI, P409; MORGAVI D, 2007, ANIM FEED SCI TECHNO; Nagase M, 2002, IMMUNOL LETT, V84, P23, DOI 10.1016/S0165-2478(02)00127-X; Nagase M, 2001, BIOSCI BIOTECH BIOCH, V65, P1741, DOI 10.1271/bbb.65.1741; Nagata T, 2001, EXP TOXICOL PATHOL, V53, P309, DOI 10.1078/0940-2993-00196; Nayakwadi Shivasharanappa, 2013, THESIS; Obremski K, 2008, POL J VET SCI, V11, P339; Pestka JJ, 2008, FOOD ADDIT CONTAM A, V25, P1128, DOI 10.1080/02652030802056626; Pestka J, 2006, TOXICOL SCI, V92, P445, DOI 10.1093/toxsci/kfl012; Pestka JJ, 2004, TOXICOL LETT, V153, P61, DOI 10.1016/j.toxlet.2004.04.023; PESTKA JJ, 2007, ANIM FEED SCI TECHNO; PETRIE L, 1977, VET REC, V101, P326, DOI 10.1136/vr.101.16.326; PIER AC, 1980, J AM VET MED ASSOC, V176, P719; Polla BS, 1996, P NATL ACAD SCI USA, V93, P6458, DOI 10.1073/pnas.93.13.6458; Prabu PC, 2013, EXP TOXICOL PATHOL, V65, P277, DOI 10.1016/j.etp.2011.09.003; Prasanna K., 2003, THESIS; Quiroga M. A., 2009, Brazilian Journal of Veterinary Pathology, V2, P16; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rocha O, 2005, FOOD ADDIT CONTAM A, V22, P369, DOI 10.1080/02652030500058403; Sachin RS, 2012, THESIS; SCF (Scientific Committee on Food), 2001, OP SCI PAN FOOD FU 5; Schoental R, 1979, BIOCHEM SOC T, V7, P127, DOI 10.1042/bst0070127; SCHUSTER A, 1987, TOXICON, V25, P1321, DOI 10.1016/0041-0101(87)90010-9; SEGAL R, 1983, TOXICOL APPL PHARM, V70, P343, DOI 10.1016/0041-008X(83)90152-7; Sehata S, 2005, EXP TOXICOL PATHOL, V57, P15, DOI 10.1016/j.etp.2005.02.005; Sehata S, 2004, FOOD CHEM TOXICOL, V42, P1727, DOI 10.1016/j.fct.2004.06.006; Shifrin VI, 1999, J BIOL CHEM, V274, P13985, DOI 10.1074/jbc.274.20.13985; Shinozuka J, 1997, EXP TOXICOL PATHOL, V49, P387, DOI 10.1016/S0940-2993(97)80124-8; Shokri F, 2000, TOXICOLOGY, V146, P171, DOI 10.1016/S0300-483X(00)00172-4; Vandenbroucke V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023871; VOSS KA, 2007, ANIM FEED SCI TECHNO; Wang Guan-yu, 2007, Journal of Zhejiang University-Science B, V8, P248, DOI 10.1631/jzus.2007.B0248; WANG J, 1993, FOOD CHEM TOXICOL, V31, P191, DOI 10.1016/0278-6915(93)90093-E; Wang J, 1998, FOOD CHEM TOXICOL, V36, P955, DOI 10.1016/S0278-6915(98)00079-9; Wannemacher R. W. Jr., 1991, Mycotoxins and animal foods., P499; WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P475, DOI 10.1083/jcb.4.4.475; WEAVER GA, 1980, CAN VET J, V21, P210; WHO, 1990, WHO ENV HLTH CRIT; Wong SS, 1998, FOOD CHEM TOXICOL, V36, P409, DOI 10.1016/S0278-6915(97)00167-1; Wu J, 2011, TOXICOL LETT, V202, P168, DOI 10.1016/j.toxlet.2011.01.029; Wu QH, 2010, DRUG METAB REV, V42, P250, DOI [10.3109/03602530903125807, 10.1080/03602530903125807]; Yang GH, 2000, TOXICOL APPL PHARM, V164, P149, DOI 10.1006/taap.1999.8888; Yiannikouris A, 2002, ANIM RES, V51, P81, DOI 10.1051/animres:2002012	80	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0229463	10.1371/journal.pone.0229463	http://dx.doi.org/10.1371/journal.pone.0229463			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214355	gold, Green Published			2022-12-26	WOS:000535934200009
J	Islam, MK; Haque, MR; Hema, PS				Islam, Md. Kamrul; Haque, Md. Rabiul; Hema, Prianka Sultana			Regional variations of contraceptive use in Bangladesh: A disaggregate analysis by place of residence	PLOS ONE			English	Article							WOMENS EMPOWERMENT; RURAL BANGLADESH; CHILD MARRIAGE; PATTERNS; DETERMINANTS; ADOLESCENTS; BEHAVIOR; TRENDS	This study advances current knowledge on contraceptive use in Bangladesh by providing new insights into the extent of regional variations in contraceptive use across rural and urban areas of Bangladesh. We examined the regional variations in contraceptive use among 15,699 currently married women ages 15-49 years using data from the 2014 Bangladesh Demographic and Health Survey (BDHS). Multivariate logistic regression models of contraceptive use were calibrated with sociodemographic attributes and cultural factors. Based on the aggregate sample (i.e., rural and urban combined), we found significant regional variations in contraceptive use across the administrative divisions in Bangladesh. Based on a disaggregate sample (i.e., rural and urban separately), we found that there were significant differences in divisional variations in contraceptive use in rural areas. In contrast, no significant variation in contraceptive use across divisions in urban areas of Bangladesh was found. More specifically, among women living in rural areas, the Rajshahi and Rangpur divisions had higher odds of contraceptive use than the Barisal division, whereas the Chittagong and Sylhet divisions had much lower odds of contraceptive use even after adjusting for selected sociodemographic attributes and cultural factors. A separate analysis of the divisional variations in usage of modern methods of contraception also revealed similar findings with only one exception. Findings of this study provide an evidence-based direction for adapting a pragmatic approach to reducing the divisional disparity of contraceptive use in rural areas of Bangladesh.	[Islam, Md. Kamrul] Univ Lethbridge, Prentice Inst Global Populat & Econ, Lethbridge, AB, Canada; [Haque, Md. Rabiul; Hema, Prianka Sultana] Univ Dhaka, Dept Populat Sci, Dhaka, Bangladesh	University of Lethbridge; University of Dhaka	Haque, MR (corresponding author), Univ Dhaka, Dept Populat Sci, Dhaka, Bangladesh.	rabiuldps@du.ac.bd		HAQUE, MD RABIUL/0000-0001-7015-8493				Adebowale SA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-40; AHMED B, 1987, DEMOGRAPHY, V24, P361, DOI 10.2307/2061303; Ajong AB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202967; Anderson S, 2009, J DEV ECON, V90, P179, DOI 10.1016/j.jdeveco.2008.10.004; [Anonymous], 2017, PREL REP HOUS INC EX; Bamiwuye S. O., 2013, African Population Studies, V27, P164, DOI 10.11564/27-2-438; Bangladesh Planning Commission, 2015, MO PLANN; Bertrand J., 1994, HDB INDICATORS FAMIL; Blanc AK, 1998, STUD FAMILY PLANN, V29, P106, DOI 10.2307/172153; Blanc AK, 2009, INT PERSPECT SEX R H, V35, P63, DOI 10.1363/ipsrh.35.063.09; Caldwell JC, 1999, POPUL DEV REV, V25, P67, DOI 10.1111/j.1728-4457.1999.00067.x; Cleland J, 2006, REPROD HEALTH MATTER, V14, P17, DOI 10.1016/S0968-8080(06)28250-8; Dias JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121758; Directorate General of Family Planning, 2017, 4 HLTH POP NUTR SECT; Elfstrom KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040670; Farre L, 2012, ROLE MEN GENDER EQUA; Glei DA, 1999, FAM PLANN PERSPECT, V31, P73, DOI 10.2307/2991642; Godfrey EM, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-5; GOLDSCHEIDER C, 1988, STUD FAMILY PLANN, V19, P48, DOI 10.2307/1966739; Greenspan A, 1992, Asia Pac Pop Policy, P1; Hameed W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104633; Haq Iqramul, 2017, Med Sci (Basel), V5, DOI 10.3390/medsci5040031; Haque M., 2011, BANGLADESH E J SOCIO, V8, P17; Hasan MS, 2014, J POPULATION DEV, V1, P53; Hirsch JS, 2008, STUD FAMILY PLANN, V39, P93, DOI 10.1111/j.1728-4465.2008.00156.x; Hossain MB, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5098-1; Hossain MB, 2005, J BIOSOC SCI, V37, P529, DOI 10.1017/S0021932004007096; Huda FA, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0333-2; HUMAYUN A, 2017, MED SCI, V4, DOI DOI 10.1017/GMH.2017.1; Islam MM., 2003, GENUS, V59, P103; Islam MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188294; Khan HTA, 1997, CONTRACEPTION, V55, P91, DOI 10.1016/S0010-7824(96)00278-8; Khuda B., 1996, HLTH TRANSITION RE S, V6, P155; Kibria GMA., 2016, J MOL STUD MED RES, V2, P70, DOI [10.18801/jmsmr.020116.09, DOI 10.18801/JMSMR.020116.09]; Kibria Gulam Muhammed Al, 2017, Matern Health Neonatol Perinatol, V3, P10, DOI 10.1186/s40748-017-0049-x; Machiyama K, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0514-7; Molla M. A. M., 2019, DAILY STAR; Nagai M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218187; National Research Council, 1995, RES ALL FAM PLANN DE; New JR, 2017, LANCET GLOBAL HLTH, V5; Newman L, 2001, INT ENCY SOCIAL BEHA, P697; NIPORT Mitra and Associates ICF International, 2016, BANGL DEM HLTH SURV; Nour NM, 2006, EMERG INFECT DIS, V12, P1644, DOI 10.3201/eid1211.060510; Orso CE, 2016, J DEV STUD, V52, P895, DOI 10.1080/00220388.2015.1107046; Parsons J, 2015, REV FAITH INT AFF, V13, P12, DOI 10.1080/15570274.2015.1075757; Poudel S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202107; Rahman M. M., 2010, Journal of Population and Social Studies, V18, P87; Saleem Shabana, 2005, Reprod Health, V2, P8, DOI 10.1186/1742-4755-2-8; Samari G, 2018, CULT HEALTH SEX, V20, P458, DOI 10.1080/13691058.2017.1356938; SCHULER SR, 1994, STUD FAMILY PLANN, V25, P65, DOI 10.2307/2138085; Shah R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197243; SHAPIRO D, 1994, STUD FAMILY PLANN, V25, P96, DOI 10.2307/2138087; Srikanthan A, 2008, J OBSTET GYNAECOL CA, V30, P129, DOI 10.1016/S1701-2163(16)32736-0; Streatfield PK, 2013, J PAK MED ASSOC, V63, P73; Uddin M M, 1985, Rural Demogr, V12, P1; Wall-Wieler E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211284; Wodon Q, 2017, EC IMPACTS CHILD MAR; World Bank, 2019, DAT CAT DAT CAT; Yaya S, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0658-5; Zimmerman LA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218157	60	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230143	10.1371/journal.pone.0230143	http://dx.doi.org/10.1371/journal.pone.0230143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9HN	32210443	gold, Green Published			2022-12-26	WOS:000535307600018
J	Grassi, ES; Pantazopoulou, V; Pietras, A				Grassi, Elisa Stellaria; Pantazopoulou, Vasiliki; Pietras, Alexander			Hypoxia-induced release, nuclear translocation, and signaling activity of a DLK1 intracellular fragment in glioma	ONCOGENE			English	Article							STEM-CELLS; TUMOR; INTERACTS; PREF-1; AKT; HIF-2-ALPHA; INHIBITION; ACTIVATION; EXPRESSION; PHENOTYPE	Glioblastoma multiforme is characterized in part by severe hypoxia associated with tumor necrosis. The cellular response to hypoxia can influence several properties of tumor cells associated with aggressive tumor growth, including metabolic adaptations and tumor cell migration and invasion. Here, we found that Delta Like Non-Canonical Notch Ligand 1 (DLK1) expression was elevated as compared with normal brain in a genetically engineered mouse model of glioma, and that DLK1 expression increased with tumor grade in human glioma samples. DLK1 expression was highest in hypoxic and perivascular tumor areas, and we found that hypoxia induced the release and nuclear translocation of an intracellular fragment of DLK1 in murine glioma as well as in human glioma cultures. Release of the intracellular fragment was dependent on ADAM17 and Hypoxia-inducible Factor 1alpha and 2alpha (HIF-1alpha/HIF-2alpha), as ADAM17 inhibitors and HIF1A/HIF2A siRNA blocked DLK1 cleavage. Expression of a cleavable form of DLK1 amplified several hypoxia-induced traits of glioma cells such as colony formation, stem cell marker gene expression, a PI3K-pathway-mediated metabolic shift, and enhanced invasiveness. Effects of DLK1 were dependent on DLK1-cleavage by ADAM17, as expression of non-cleavable DLK1 could not replicate the DLK1-induced hypoxic phenotype. Finally, forced expression of DLK1 resulted in more invasive tumor growth in a PDGFB-induced glioma mouse model without affecting overall survival. Together, our findings suggest a previously undescribed role for DLK1 as an intracellular signaling molecule.	[Grassi, Elisa Stellaria; Pantazopoulou, Vasiliki; Pietras, Alexander] Lund Univ, Div Translat Canc Res, Dept Lab Med, Lund, Sweden; [Grassi, Elisa Stellaria] Univ Milan, Dept Clin Sci & Community Hlth DISCCO, Milan, Italy	Lund University; University of Milan	Pietras, A (corresponding author), Lund Univ, Div Translat Canc Res, Dept Lab Med, Lund, Sweden.	Alexander.Pietras@med.lu.se	Grassi, Elisa Stellaria/K-4402-2016	Grassi, Elisa Stellaria/0000-0002-0410-1277; Pietras, Alexander/0000-0002-5783-9347; Pantazopoulou, Vasiliki/0000-0002-5965-5795	Ragnar Soderberg Foundation; Swedish Cancer Society; Swedish Research Council; Swedish Childhood Cancer Fund; Ollie & Elof Ericssons foundation; Jeanssons stiftelser; Crafoord foundation; Gosta Miltons donationsfond; Stiftelsen Cancera	Ragnar Soderberg Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Fund; Ollie & Elof Ericssons foundation; Jeanssons stiftelser; Crafoord foundation; Gosta Miltons donationsfond; Stiftelsen Cancera	The authors thank Christina Moller for skillful technical assistance and A HGCC (www.hgcc.se) (Lene Uhrbom, Bengt Westermark, Karin Forsberg Nilsson and Sven Nelander, Uppsala University, Sweden) for human GBM cultures. This work was supported by grants from the Ragnar Soderberg Foundation, the Swedish Cancer Society, the Swedish Research Council, the Swedish Childhood Cancer Fund, Ollie & Elof Ericssons foundation, Jeanssons stiftelser, the Crafoord foundation, Gosta Miltons donationsfond, and Stiftelsen Cancera.	Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Bernstock JD, 2020, J NEUROSURG, V133, P655, DOI 10.3171/2019.5.JNS19364; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Bowman RL, 2017, NEURO-ONCOLOGY, V19, P139, DOI 10.1093/neuonc/now247; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Ceder JA, 2008, EUR UROL, V54, P1344, DOI 10.1016/j.eururo.2008.03.006; Cho SJ, 2008, MOL MED REP, V1, P83; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Falix FA, 2012, BBA-MOL BASIS DIS, V1822, P988, DOI 10.1016/j.bbadis.2012.02.003; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; Gulyaeva O, 2018, CELL REP, V25, P1002, DOI 10.1016/j.celrep.2018.09.086; Hambardzumyan D, 2015, TRENDS CANCER, V1, P252, DOI 10.1016/j.trecan.2015.10.009; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Huang CC, 2019, ONCOGENE, V38, P3201, DOI 10.1038/s41388-018-0658-5; Hudak Carolyn S, 2013, Front Endocrinol (Lausanne), V4, P79, DOI 10.3389/fendo.2013.00079; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Jawhari S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.318; Johansson E, 2017, CELL REP, V20, P1641, DOI 10.1016/j.celrep.2017.07.049; Kim Y, 2009, CANCER RES, V69, P9271, DOI 10.1158/0008-5472.CAN-09-1605; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099222; Ma JC, 2009, MOL CELL BIOCHEM, V331, P161, DOI 10.1007/s11010-009-0154-x; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Masui K, 2015, BRAIN PATHOL, V25, P755, DOI 10.1111/bpa.12307; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Pelullo M, 2019, CANCER RES, V79, P5575, DOI 10.1158/0008-5472.CAN-19-0145; Pietras A, 2008, J PATHOL, V214, P482, DOI 10.1002/path.2304; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Puchalski RB, 2018, SCIENCE, V360, P660, DOI 10.1126/science.aaf2666; Strickland M, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00043; Tong B, 2018, EXP CELL RES, V371, P122, DOI 10.1016/j.yexcr.2018.08.002; Traustadottir GA, 2019, CYTOKINE GROWTH F R, V46, P17, DOI 10.1016/j.cytogfr.2019.03.006; Traustadottir GA, 2017, INT J BIOL MACROMOL, V97, P460, DOI 10.1016/j.ijbiomac.2017.01.067; Villanueva C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036134; Wang YH, 2006, MOL CELL BIOL, V26, P5421, DOI 10.1128/MCB.02437-05; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Xie Y, 2015, EBIOMEDICINE, V2, P1351, DOI 10.1016/j.ebiom.2015.08.026; Yin D, 2006, ONCOGENE, V25, P1852, DOI 10.1038/sj.onc.1209219; Yun Z, 2015, J CLIN INVEST, V125, P2264, DOI 10.1172/JCI82058; Zhang Z, 2018, MOL MED REP, V18, P3547, DOI 10.3892/mmr.2018.9375; Zhao Z, 2020, BIORXIV, DOI [10.1101/2020.01.20.911982, DOI 10.1101/2020.01.20.911982]; Zheng XG, 2007, CANCER SCI, V98, P674, DOI 10.1111/j.1349-7006.2007.00440.x	47	15	15	3	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	20					4028	4044		10.1038/s41388-020-1273-9	http://dx.doi.org/10.1038/s41388-020-1273-9		MAR 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LN3GC	32205867	hybrid, Green Published			2022-12-26	WOS:000521527400001
J	Chavula, K; Guenther, T; Valsangkar, B; Lwesha, V; Banda, G; Wensaas, MB; Luhanga, R; Chimtembo, L; Kinney, MV; Dube, Q				Chavula, Kondwani; Guenther, Tanya; Valsangkar, Bina; Lwesha, Victoria; Banda, Gedesi; Wensaas, Marte Boe; Luhanga, Richard; Chimtembo, Lydia; Kinney, Mary, V; Dube, Queen			Improving Skin-to-Skin Practice for babies in Kangaroo Mother Care in Malawi through the use of a customized baby wrap: A randomized control trial	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; BARRIERS	Background Complications of prematurity are a leading cause of newborn death in Malawi. Despite early adoption of Kangaroo mother care (KMC), coverage remains low and women have expressed challenges in using the traditional wrapper-chitenje. In 2016, a study was conducted to evaluate the acceptability and effectiveness of a customized KMC wrap in improving adherence to KMC practices among mothers. Methods Mother-baby dyads (301) were randomized to receive either a customized CarePlus Wrap developed by Laerdal Global Health or a traditional chitenje. Enrolled mother-baby dyads were assessed in the KMC ward at 2-3 days after of admission, and then again at 7-15 days post-discharge. Topics covered included skin-to-skin practices, breastfeeding, perceptions of the wrap, and family/community support. Chi square tests were used to assess associations between wrap type and KMC practices. The study received ethics approval. Results This study found that a customized KMC wrap is highly acceptable to women and improved skin-to-skin practices in facility-based KMC: 44% of mothers using a customized wrap reported 20 or more hours per day, compared to 33% of mothers using the traditional chitenje. Women using the customized wrap reported being comfortable in keeping the baby in skin-to-skin position more often than women using the chitenje (96% vs. 71%), and they were able to tie on the wrap themselves (86% vs. 10%). At the time of discharge from KMC, more women who used the customized wrap were satisfied with the wrap than those who used the traditional chitenje (94% vs. 56%). The customized wrap did not appear to impact other newborn practices, such as breastfeeding. Conclusions This study provides evidence that a customized KMC wrap is highly acceptable to mothers, and it can contribute to better skin-to-skin practices. Use of a customized wrap may be one mechanism to support mothers in practicing KMC and skin-to-skin contact in addition to other interventions.	[Chavula, Kondwani; Lwesha, Victoria; Banda, Gedesi; Luhanga, Richard; Chimtembo, Lydia] Save Children, Lilongwe, Malawi; [Guenther, Tanya; Valsangkar, Bina; Kinney, Mary, V] Save Children US, Dept Global Hlth, Washington, DC USA; [Wensaas, Marte Boe] Save Children, Oslo, Norway; [Dube, Queen] Univ Malawi, Coll Med, Blantyre, Malawi	Save the Children; Save the Children; Save the Children; University of Malawi	Chavula, K (corresponding author), Save Children, Lilongwe, Malawi.	Kondwani.Chavula@savethechildren.org	Valsangkar, Bina/CAF-1920-2022; Kinney, Mary/M-6952-2013	Kinney, Mary/0000-0002-2903-0161	Laerdal Global Health; Save the Children -Saving Newborn Lives	Laerdal Global Health; Save the Children -Saving Newborn Lives	Research was funded by Laerdal Global Health and implemented by Save the Children Norway, Malawi and US. The research, including the analysis and writing of the results, was also funded by Save the Children -Saving Newborn Lives. Any opinion, finding and conclusion, or recommendation expressed in this material is that of the authors. The funders did not influence the interpretation of the results.	Amaliya S, 2017, COMPR CHILD ADOLES N, V40, P52, DOI 10.1080/24694193.2017.1386971; Banda G, 2018, J DEV COMMUNICATION, V29; Blencowe H, 2009, J TROP PEDIATRICS, V55, P244, DOI 10.1093/tropej/fmn116; Chan G, 2017, HEALTH POLICY PLANN, V32, P1466, DOI 10.1093/heapol/czx098; Chavula K, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020802; Chisenga JZ, 2015, MIDWIFERY, V31, P305, DOI 10.1016/j.midw.2014.04.008; Conde-Agudelo A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002771.pub4; Dube Q, 2014, KMC ANAL MALAWI FIND; Dumbaugh M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-269; Hasan R, 2017, FACILITY READINESS I; Joshi S, 2014, 10 INT C KANG MOTH C; Lawn JE, 2010, INT J EPIDEMIOL, pi1; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Lydon M, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.010703; Malawi Ministry of Health, 2015, MAL EV NEWB ACT PLAN; Malawi Ministry of Health, 2019, MAL NAT GUID KANG MO; Manjanja V, 2014, 10 INT C KANG MOTH C; Mazumder S, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5197-z; Nguah SB, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-99; Pratiwi IGAPE, 2009, PAEDIATR INDONES, V49, P253, DOI 10.14238/pi49.5.2009.253-8; Raajashri R, 2018, J MATERN-FETAL NEO M, V31, P666, DOI 10.1080/14767058.2017.1293035; Rai C., 2016, PROMOTING KANGAROO M; Save the Children, 2018, BRIEF EARL OUTC NEWB; Save the Children Malawi, 2018, BRIEF IMPR AV QUAL R; Seidman G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125643; Smith ER, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-016-0769-5; Suman RPN, 2008, INDIAN PEDIATR, V45, P17; Thapa K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207206; Van Rooyen E., 2007, GUIDELINES MOTHERS K; Watkins HC, 2018, ACTA PAEDIATR, V107, P1541, DOI 10.1111/apa.14344; World Health Organization, 2015, WHO RECOMMENDATIONS	31	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0229720	10.1371/journal.pone.0229720	http://dx.doi.org/10.1371/journal.pone.0229720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191729	Green Published, gold			2022-12-26	WOS:000535302300015
J	Nteziyaremye, J; Iramiot, SJ; Nekaka, R; Musaba, MW; Wandabwa, J; Kisegerwa, E; Kiondo, P				Nteziyaremye, Julius; Iramiot, Stanley Jacob; Nekaka, Rebecca; Musaba, Milton W.; Wandabwa, Julius; Kisegerwa, Enoch; Kiondo, Paul			Asymptomatic bacteriuria among pregnant women attending antenatal care at Mbale Hospital, Eastern Uganda	PLOS ONE			English	Article							SUSCEPTIBILITY PATTERN; ESCHERICHIA-COLI; ENTEROBACTERIACEAE; PREVALENCE	Background Asymptomatic bacteriuria in pregnancy (ASBP) is associated with adverse pregnancy outcomes such as pyelonephritis, preterm or low birth weight delivery if untreated. The aim of this study was to determine the prevalence of asymptomatic bacteriuria, the isolated bacterial agents, and their antibiotic sensitivity patterns in pregnant women attending antenatal care at Mbale Hospital. Methods This was a cross sectional study in which 587 pregnant women with no symptoms and signs of urinary tract infection were recruited from January to March 2019. Mid-stream clean catch urine samples were collected from the women using sterile containers. The urine samples were cultured using standard laboratory methods. The bacterial colonies were identified and antibiotic sensitivity was done using disc diffusion method. Chi squared tests and logistic regression were done to identify factors associated with asymptomatic bacteriuria. A p value < 0.05 was considered statistically significant. Results Out of the 587 pregnant women, 22 (3.75%) tested positive for asymptomatic bacteriuria. Women aged 20-24 years were less likely to have ASBP when compared to women aged less than 20 years (AOR = 0.14, 95%CI 0.02-0.95, P = 0.004). The most common isolates in descending order were E. coli (n = 13, 46.4%) and S.aureus (n = 9, 32.1%). Among the gram negative isolates, the highest sensitivity was to gentamycin (82.4%) and imipenem (82.4%). The gram positive isolates were sensitive to gentamycin (90.9%) followed by imipenem (81.8%). All the isolates were resistant to sulphamethoxazole with trimethoprim (100%). Multidrug resistance was 82.4% among gram negative isolates and 72.4% among the gram positive isolates. Conclusion There was high resistance to the most commonly used antibiotics. There is need to do urine culture and sensitivity from women with ASBP so as to reduce the associated complications.	[Nteziyaremye, Julius; Kiondo, Paul] Makerere Univ, Coll Hlth Sci, Dept Obstet & Gynecol, Kampala, Uganda; [Nteziyaremye, Julius; Musaba, Milton W.; Wandabwa, Julius] Busitema Univ, Fac Hlth Sci, Dept Obstet & Gynecol, Mbale, Uganda; [Iramiot, Stanley Jacob] Busitema Univ, Fac Hlth Sci, Dept Microbiol & Immunol, Mbale, Uganda; [Nekaka, Rebecca] Busitema Univ, Fac Hlth Sci, Dept Community & Publ Hlth, Mbale, Uganda; [Kisegerwa, Enoch] Mulago Hosp, Dept Obstet & Gynecol, Kampala, Uganda	Makerere University; Mulago National Referral Hospital	Kiondo, P (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Obstet & Gynecol, Kampala, Uganda.	kiondop@yahoo.com	Nteziyaremye, Julius/ABC-1324-2020; JacobStanley, Iramiot/AAN-4257-2020; Nekaka, Rebecca/GYQ-7546-2022	JacobStanley, Iramiot/0000-0002-9239-6641; Nekaka, Rebecca/0000-0002-9199-7197; Musaba, Milton/0000-0003-4145-4044				Adler A, 2016, INFECT DIS CLIN N AM, V30, P347, DOI 10.1016/j.idc.2016.02.003; Ali IE, 2018, TURK J UROL, V44, P251, DOI 10.5152/tud.2018.07741; Andabati G, 2010, AFR HEALTH SCI, V10, P349; Angelescu K, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1128-0; Ayoyi AO, 2017, PAN AFR MED J, V26, DOI 10.11604/pamj.2017.26.41.10975; (CLSI) CaLSI, 2015, M100S25 CLSI; Demilie T, 2012, ETHIOP J HEALTH SCI, V22, P121; Eksi F, 2011, J MICROBIOL IMMUNOL, V44, P57, DOI 10.1016/j.jmii.2011.01.011; Ekwealor Perpetua A, 2016, Int J Microbiol, V2016, P9740273, DOI 10.1155/2016/9740273; Emiru Tazebew, 2013, BMC Res Notes, V6, P292, DOI 10.1186/1756-0500-6-292; Farkash E, 2012, EUR J OBSTET GYN R B, V162, P24, DOI 10.1016/j.ejogrb.2012.01.024; Fredrick B., 2019, J ADV MED MED RES, V29, P1; Glaser AP, 2015, UROL CLIN N AM, V42, P547, DOI 10.1016/j.ucl.2015.05.004; Imade PE, 2010, N AM J MED SCI, V2, P263, DOI 10.4297/najms.2010.2263; Izuchukwu KE, 2017, PAN AFR MED J, V27, DOI 10.11604/pamj.2017.27.69.10492; Kazemier BM, 2015, LANCET INFECT DIS, V15, P1324, DOI 10.1016/S1473-3099(15)00070-5; Kibret M, 2011, AFR HEALTH SCI, V11, pS40; Masinde A, 2009, Tanzan J Health Res, V11, P154; Mohammed Ahmed, 2016, Afr Health Sci, V16, P69, DOI 10.4314/ahs.v16i1.9; Najjuka Christine F, 2016, BMC Res Notes, V9, P235, DOI 10.1186/s13104-016-2049-8; Oli AN, 2010, NIGER J CLIN PRACT, V13, P409; Owens DK, 2019, JAMA-J AM MED ASSOC, V322, P1188, DOI 10.1001/jama.2019.13069; Petersen I, 2010, J ANTIMICROB CHEMOTH, V65, P2238, DOI 10.1093/jac/dkq307; Prabhu Kavitha, 2011, J Lab Physicians, V3, P25, DOI 10.4103/0974-2727.78558; Renko M, 2011, DIABETES CARE, V34, P230, DOI 10.2337/dc10-0421; Ronald Mayanja PK, 2016, AM SCI RES J ENG TEC, V25, P131; SCHLESSELMAN JJ, 1974, AM J EPIDEMIOL, V99, P381, DOI 10.1093/oxfordjournals.aje.a121625; Smaill FM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000490.pub3; Stanley IJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200093; SUCAK A, 2011, ISRN OBSTET GYNECOLO, V2011, DOI DOI 10.5402/2011/721872; Sujatha R, 2014, J CLIN DIAGN RES, V8, pDC1, DOI 10.7860/JCDR/2014/6599.4205; Sultan A, 2015, UROL ANNALS, V7, P26, DOI 10.4103/0974-7796.148585; Tadesse Endale, 2014, BMC Res Notes, V7, P155, DOI 10.1186/1756-0500-7-155; Teklu DS, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0488-4; Wingert A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2017-021347; Yadav KK, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0085-0	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230523	10.1371/journal.pone.0230523	http://dx.doi.org/10.1371/journal.pone.0230523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191758	Green Published, gold			2022-12-26	WOS:000535302300055
J	Chen, Y; Cai, GH; Xia, B; Wang, X; Zhang, CC; Xie, BC; Shi, XC; Liu, H; Lu, JF; Zhang, RX; Zhu, MQ; Liu, M; Yang, SZ; Yang, ZD; Chu, XY; Khan, R; Wang, YL; Wu, JW				Chen Yan; Cai Guo He; Xia Bo; Wang Xin; Zhang Cong Cong; Xie Bao Cai; Shi Xiao Chen; Liu Huan; Lu Jun Feng; Zhang Rui Xin; Zhu Meng Qing; Liu Min; Yang Shi Zhen; Yang Zhang Dan; Chu Xin Yi; Khan, Rajwali; Wang Yong Liang; Wu Jiang Wei			Mitochondrial aconitase controls adipogenesis through mediation of cellular ATP production	FASEB JOURNAL			English	Article						cell differentiation; mitochondrial metabolism; TCA cycle	TRICARBOXYLIC-ACID CYCLE; WHITE ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; DYSFUNCTION; BIOGENESIS; OBESITY; MICE; LIPOGENESIS; DEFICIENCY; METABOLISM	Mitochondrial aconitase (Aco2) catalyzes the conversion of citrate to isocitrate in the TCA cycle, which produces NADH and FADH2, driving synthesis of ATP through OXPHOS. In this study, to explore the relationship between adipogenesis and mitochondrial energy metabolism, we hypothesize that Aco2 may play a key role in the lipid synthesis. Here, we show that overexpression of Aco2 in 3T3-L1 cells significantly increased lipogenesis and adipogenesis, accompanied by elevated mitochondrial biogenesis and ATP production. However, when ATP is depleted by rotenone, an inhibitor of the respiratory chain, the promotive role of Aco2 in adipogenesis is abolished. In contrast to Aco2 overexpression, deficiency of Aco2 markedly reduced lipogenesis and adipogenesis, along with the decreased mitochondrial biogenesis and ATP production. Supplementation of isocitrate efficiently rescued the inhibitory effect of Aco2 deficiency. Similarly, the restorative effect of isocitrate was abolished in the presence of rotenone. Together, these results show that Aco2 sustains normal adipogenesis through mediating ATP production, revealing a potential mechanistic link between TCA cycle enzyme and lipid synthesis. Our work suggest that regulation of adipose tissue mitochondria function may be a potential way for combating abnormal adipogenesis related diseases such as obesity and lipodystrophy.	[Chen Yan; Cai Guo He; Xia Bo; Wang Xin; Zhang Cong Cong; Xie Bao Cai; Shi Xiao Chen; Liu Huan; Lu Jun Feng; Zhang Rui Xin; Zhu Meng Qing; Liu Min; Yang Shi Zhen; Yang Zhang Dan; Chu Xin Yi; Khan, Rajwali; Wang Yong Liang; Wu Jiang Wei] Northwest A&F Univ, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Wu, JW (corresponding author), Northwest A&F Univ, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.	wujiangwei@nwafu.edu.cn	Liu, Huan/HIK-2282-2022; Zhu, Mengqing/GLT-5795-2022; Lu, Junfeng/AFN-9843-2022; Khan, Rajwali/N-2609-2019	Zhu, Mengqing/0000-0001-9422-6550; Lu, Junfeng/0000-0002-2640-8595; Khan, Rajwali/0000-0001-5191-3457; xie, baocai/0000-0003-0611-0131				Aljohani A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52339-7; Bardella C, 2012, MOL CELL BIOL, V32, P3081, DOI 10.1128/MCB.06160-11; Bissonnette S, 2018, AM J CLIN NUTR, V108, P62, DOI 10.1093/ajcn/nqy070; Bouwkamp CG, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000223; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Chen CM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112480; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Chow HM, 2019, J CELL BIOL, V218, P909, DOI 10.1083/jcb.201806197; Cummins TD, 2014, AM J PHYSIOL-ENDOC M, V307, pE262, DOI 10.1152/ajpendo.00271.2013; Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421; Danson MJ, 2001, METHOD ENZYMOL, V331, P3; DeVisser A, 2011, NEUROBIOL DIS, V44, P161, DOI 10.1016/j.nbd.2011.06.005; Du D, 2018, J PROTEOME RES, V17, P2092, DOI 10.1021/acs.jproteome.8b00028; Fernandes J, 2015, BIOCHEMISTRY-US, V54, P4008, DOI 10.1021/acs.biochem.5b00375; Figarola JL, 2013, INT J MOL MED, V31, P1166, DOI 10.3892/ijmm.2013.1313; Fortier M, 2005, J LIPID RES, V46, P1860, DOI 10.1194/jlr.M500081-JLR200; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Gesta S, 2011, P NATL ACAD SCI USA, V108, P2771, DOI 10.1073/pnas.1019704108; Hada K, 2019, J BIOL CHEM, V294, P3091, DOI 10.1074/jbc.RA118.004726; Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Heinonen S, 2015, DIABETES, V64, P3135, DOI 10.2337/db14-1937; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Hresko RC, 1998, J BIOL CHEM, V273, P20658, DOI 10.1074/jbc.273.32.20658; Jiang HC, 2017, CELL METAB, V26, P686, DOI 10.1016/j.cmet.2017.08.016; Jung SJ, 2015, FEBS LETT, V589, P822, DOI 10.1016/j.febslet.2015.02.015; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Kusminski CM, 2012, TRENDS ENDOCRIN MET, V23, P435, DOI 10.1016/j.tem.2012.06.004; Levin K, 2001, DIABETOLOGIA, V44, P824; Li S, 2016, BBA-BIOENERGETICS, V1857, P643, DOI 10.1016/j.bbabio.2016.03.009; Liu QF, 2019, FEBS LETT, V593, P2118, DOI 10.1002/1873-3468.13509; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Metodiev MD, 2014, J MED GENET, V51, P834, DOI 10.1136/jmedgenet-2014-102532; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Moreno M, 2015, FASEB J, V29, P1529, DOI 10.1096/fj.14-258996; Munnich A, 2008, NAT GENET, V40, P1148, DOI 10.1038/ng1008-1148; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003; Przybyla-Zawislak B, 1999, GENETICS, V152, P153; Putti R, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00109; Rogge MM, 2009, BIOL RES NURS, V10, P356, DOI 10.1177/1099800408329408; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Shi XR, 2008, J BIOL CHEM, V283, P30658, DOI 10.1074/jbc.M800510200; SLAUGHTER CA, 1977, ANN HUM GENET, V40, P385; Spiegel K, 2012, AM J HUM GENET, V90, P518, DOI 10.1016/j.ajhg.2012.01.009; Tejerina S, 2009, J CELL SCI, V122, P145, DOI 10.1242/jcs.027508; Ugrankar R, 2019, DEV CELL, V50, P557, DOI 10.1016/j.devcel.2019.07.021; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Wiles MV, 2015, MAMM GENOME, V26, P501, DOI 10.1007/s00335-015-9565-z; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Wu JW, 2012, ENDOCRINOLOGY, V153, P2198, DOI 10.1210/en.2011-1518; Yang H, 2016, DIABETES, V65, P3396, DOI 10.2337/db16-0136; Yin X, 2014, J CLIN ENDOCR METAB, V99, pE209, DOI 10.1210/jc.2013-3042; Zhu CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047584; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004	56	5	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6688	6702		10.1096/fj.201903224RR	http://dx.doi.org/10.1096/fj.201903224RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32212192				2022-12-26	WOS:000531325500048
J	Arai, K; Murata, D; Takao, S; Verissiomo, AR; Nakayama, K				Arai, Kenichi; Murata, Daiki; Takao, Shoko; Verissiomo, Ana Raquel; Nakayama, Koichi			Cryopreservation method for spheroids and fabrication of scaffold-free tubular constructs	PLOS ONE			English	Article							TESTICULAR TISSUE; VITRIFICATION	Cryopreservation is a method used for preserving living cells by cooling them to very low temperatures. Although cryopreservation methods for oocytes and embryos have been developed for use in reproductive medicine, there are no established methods yet for preserving cell aggregates (spheroids) in regenerative medicine. We have developed a bio-three-dimensional (3D) printer that can fabricate scaffold-free 3D constructs by loading spheroids onto a needle array. We fabricated several constructs such as blood vessels, liver, diaphragm, and a conduit for nerves by using this method. These constructs have the potential to be applied in patients. However, the process of fabricating tissue constructs (harvesting cells, expanding cells, making spheroids using cultured cells, printing constructs, and maturing constructs) is time-consuming. Therefore, cryopreservation methods for spheroids or constructs should be developed to increase the efficiency of this method for clinical use. Here, we developed a method for cryopreserving spheroids, which were then used to fabricate constructs. Fibroblast cell-based spheroids were cryopreserved in phosphate-buffered saline or cryopreservation solution at - 80 degrees C for 1 week. After thawing, spheroids in cryopreservation solution began to fuse on day 1. Cryopreserved spheroids were printed onto a needle array to fabricate a scaffold-free tubular construct using a bio-3D printer. After 7 days, the printed spheroids fused and formed scaffold-free constructs. We confirmed the viability of cells in the cryopreserved spheroids and fabricated tubular constructs. Our results indicate that spheroids can be cryopreserved and used to prepare scaffold-free constructs for clinical use.	[Arai, Kenichi; Murata, Daiki; Takao, Shoko; Verissiomo, Ana Raquel; Nakayama, Koichi] Saga Univ, Fac Med, Dept Regenerat Med & Biomed Engn, Saga, Japan	Saga University	Nakayama, K (corresponding author), Saga Univ, Fac Med, Dept Regenerat Med & Biomed Engn, Saga, Japan.	nakayama@me.sagu-u.ac.jp		Nakayama, Koichi/0000-0002-7324-8862; Arai, Kenichi/0000-0002-2556-4473	Science and Technology Promotion Division from Okinawa Prefecture Government	Science and Technology Promotion Division from Okinawa Prefecture Government	This work was supported by Science and Technology Promotion Division from Okinawa Prefecture Government.	Arai K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209162; Best BP, 2015, REJUV RES, V18, P422, DOI 10.1089/rej.2014.1656; Demeestere I, 2015, HUM REPROD, V30, P2107, DOI 10.1093/humrep/dev128; Gao D, 2000, ILAR J, V41, P187; Gao HH, 2016, EUR J OBSTET GYN R B, V204, P104, DOI 10.1016/j.ejogrb.2016.06.016; Gook DA, 2011, REPROD BIOMED ONLINE, V23, P281, DOI 10.1016/j.rbmo.2010.10.018; Itoh M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136681; Jang TH, 2017, INTEGR MED RES, V6, P12, DOI 10.1016/j.imr.2016.12.001; Konig G, 2009, BIOMATERIALS, V30, P1542, DOI 10.1016/j.biomaterials.2008.11.011; Lee JH, 2012, TRANSPL P, V44, P1015, DOI 10.1016/j.transproceed.2012.03.009; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Maehara M, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-58; Marquez-Curtis LA, 2015, CRYOBIOLOGY, V71, P181, DOI 10.1016/j.cryobiol.2015.07.003; Matsumura K, 2011, CRYOBIOLOGY, V63, P76, DOI 10.1016/j.cryobiol.2011.05.003; Matsumura K, 2009, BIOMATERIALS, V30, P4842, DOI 10.1016/j.biomaterials.2009.05.025; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; Miyagi-Shiohira C, 2015, CELL MED, V8, P3, DOI 10.3727/215517915X689100; Onofre J, 2016, HUM REPROD UPDATE, V22, P744, DOI 10.1093/humupd/dmw029; Sambu S, 2015, PEERJ, V3, DOI 10.7717/peerj.1039; Strobel HA, 2018, TISSUE ENG PT A, V24, P1492, DOI [10.1089/ten.tea.2017.0492, 10.1089/ten.TEA.2017.0492]; Ting DSW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08276-4; Unni S, 2012, FERTIL STERIL, V97, P200, DOI 10.1016/j.fertnstert.2011.10.018; Yavin S, 2007, THERIOGENOLOGY, V67, P81, DOI 10.1016/j.theriogenology.2006.09.029; Yurie H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171448; Zhang XY, 2018, BIOMATERIALS, V167, P1, DOI 10.1016/j.biomaterials.2018.03.012	25	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230428	10.1371/journal.pone.0230428	http://dx.doi.org/10.1371/journal.pone.0230428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240195	gold, Green Published, Green Submitted			2022-12-26	WOS:000535945000026
J	Barrero, F; Mallada-Frechin, J; Martinez-Gines, ML; Marzo, ME; Meca-Lallana, V; Izquierdo, G; Ara, JR; Oreja-Guevare, C; Meca-Lallana, J; Forero, L; Sanchez-Veram, I; Moreno, MJ				Barrero, Francisco; Mallada-Frechin, Javier; Luisa Martinez-Gines, Maria; Eugenia Marzo, Maria; Meca-Lallana, Virginia; Izquierdo, Guillermo; Ramon Ara, Jose; Oreja-Guevare, Celia; Meca-Lallana, Jose; Forero, Lucia; Sanchez-Veram, Irene; Jose Moreno, Maria		MS NEXT Study Investigators	Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study	PLOS ONE			English	Article							CLINICAL-PRACTICE; ORAL FINGOLIMOD; NATALIZUMAB; PERSISTENCE; DISABILITY; EFFICACY; SAFETY; RISK	Purpose The objective of this study was to characterize the demographic and clinical profile of RRMS patients receiving fingolimod in Spain, and to evaluate drug effectiveness and safety in clinical practice. Methods This observational, retrospective, multicentre, nationwide study was performed at 56 Spanish hospitals and involved 804 RRMS patients who received oral fingolimod (0.5 mg) since November 2011, with a minimum follow-up of 12 months. Results The mean annualized relapse rate (ARR) in the year before fingolimod was 1.08 and the median EDSS was 3; patients were exposed to fingolimod for 2.2 years as average; regarding magnetic resonance imaging (MRI) activity, more than half of the patients had > 20 lesions at baseline. Patients were previously treated with first-line injectable DMTs (60.3%), or natalizumab (31.3%), and 8.3% were naive patients. Overall, the ARR significantly decreased to 0.28, 0.22 and 0.17 (74.1%, 79.7% and 83.5% of relative reduction, respectively) after 12, 24 and 36 months of treatment, P<0.001. The ARR of patients who switched from natalizumab to fingolimod was stable over the study. Most of the patients (88.7%) were free from confirmed disability and MRI activity (67.3%) after 24 months. The persistence after 12 months on fingolimod was 93.9%. Conclusions The subgroups of patients analysed showed differential baseline demographic and clinical characteristics. The analysis of patients who received fingolimod in routine clinical practice confirmed adequate efficacy and safety, even for long-term treatment. The present data also confirmed the positive benefit/risk balance with fingolimod in real-world clinical practice setting.	[Barrero, Francisco] Hosp Uniersitario San Cecilio Granada, Neurol Dept, Granada, Spain; [Mallada-Frechin, Javier] Hosp Gen Univ Elda, Neurol Dept, Alicante, Spain; [Luisa Martinez-Gines, Maria] Hosp Gen Univ Gregorio Maranon, Neurol Dept, Madrid, Spain; [Eugenia Marzo, Maria] Hosp San Pedro, Neurol Dept, Logrono, Spain; [Meca-Lallana, Virginia] Hosp Univ La Princesa, Demyelinating Disorders Unit, Madrid, Spain; [Izquierdo, Guillermo] Hosp Univ Virgen Macarena, Neurol Dept, Seville, Spain; [Ramon Ara, Jose] Hosp Univ Miguel Servet, Neurol Dept, Zaragoza, Spain; [Oreja-Guevare, Celia] Hosp Univ Clin San Carlos, Neurol Dept, Madrid, Spain; [Meca-Lallana, Jose] Hosp Virgen Arrixaca IMIB Arrixaca, Murcia, Spain; [Forero, Lucia] Hosp Univ Puerta Mar, Neurol Dept, Cadiz, Spain; [Sanchez-Veram, Irene; Jose Moreno, Maria] Novartis Farmaceut SA, Barcelona, Spain	General University Gregorio Maranon Hospital; Hospital de La Princesa; Hospital Universitario Virgen Macarena; Miguel Servet University Hospital; Hospital Clinico Universitario Virgen de la Arrixaca; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Novartis	Moreno, MJ (corresponding author), Novartis Farmaceut SA, Barcelona, Spain.	mariajose.moreno@novartis.com		Forero, Lucia/0000-0003-0256-6748; Ara Callizo, Jose Ramon/0000-0002-9788-2083; Meca-Lallana, Virginia/0000-0001-9418-4127; Barrero Hernandez, Francisco Javier/0000-0001-8490-2789	Novartis Farmaceutica S.A.; Good Clinical Practices and ICH standards	Novartis Farmaceutica S.A.; Good Clinical Practices and ICH standards	The study was funded by Novartis Farmaceutica S.A. (www.Novartis.es).The funder of the study contributed to the study design, data analysis and preparation of the manuscript. The funder of the study had no role in data collection or the decision to publish. The specific roles of all authors are articulated in the `author contributions' section.; The authors thank Maria Yuste (Dynamic Science S.L) for medical writing assistance which was funded by Novartis Farmace ' utica SA, in accordance with guidelines of Good Clinical Practices and ICH standards.	Agashivala N, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-138; Alcala-Vicente C, 2017, REV NEUROLOGIA, V64, P445, DOI 10.33588/rn.6410.2016359; Bergvall Niklas, 2014, J Med Econ, V17, P696, DOI 10.3111/13696998.2014.940422; Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3; Chaudhuri A, 2013, J NEURAL TRANSM, V120, P1463, DOI 10.1007/s00702-013-1080-3; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Confavreux C, 2006, CLIN NEUROL NEUROSUR, V108, P327, DOI 10.1016/j.clineuro.2005.11.018; Esposito F, 2018, J NEUROL, V265, P896, DOI 10.1007/s00415-018-8791-1; Fernandez O, 2012, J NEUROL, V259, P1814, DOI 10.1007/s00415-012-6414-9; Frisell T, 2016, MULT SCLER J, V22, P85, DOI 10.1177/1352458515579216; Sanchez-Seco VG, 2017, CLIN NEUROPHARMACOL, V40, P29, DOI 10.1097/WNF.0000000000000196; Giovannoni G, 2016, MULT SCLER RELAT DIS, V9, pS5, DOI 10.1016/j.msard.2016.07.003; Hersh CM, 2015, INT J NEUROSCI, V125, P678, DOI 10.3109/00207454.2014.969839; Hunter SF, 2016, CNS DRUGS, V30, P135, DOI 10.1007/s40263-015-0297-0; Izquierdo G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176174; Jokubaitis VG, 2014, NEUROLOGY, V82, P1204, DOI 10.1212/WNL.0000000000000283; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Mazibrada Gordon, 2018, Mult Scler J Exp Transl Clin, V4, p2055217318801638, DOI 10.1177/2055217318801638; Pato-Pato A, 2016, REV NEUROLOGIA, V63, pS13; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Roux T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00183; Sanford M, 2014, DRUGS, V74, P1411, DOI 10.1007/s40265-014-0264-y; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Warrender-Sparkes M, 2016, MULT SCLER J, V22, P520, DOI 10.1177/1352458515594041; Ziemssen T, 2018, NEUROTHERAPEUTICS, V15, P190, DOI 10.1007/s13311-017-0595-y; Ziemssen T, 2017, AUTOIMMUN REV, V16, P355, DOI 10.1016/j.autrev.2017.02.007	28	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230846	10.1371/journal.pone.0230846	http://dx.doi.org/10.1371/journal.pone.0230846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240213	Green Published, gold			2022-12-26	WOS:000535945000045
J	Maekawa, T; Uchida, T; Nakata-Horiuchi, Y; Kobayashi, H; Kawauchi, S; Kinoshita, M; Saitoh, D; Sato, S				Maekawa, Takaaki; Uchida, Takahiro; Nakata-Horiuchi, Yuka; Kobayashi, Hiroaki; Kawauchi, Satoko; Kinoshita, Manabu; Saitoh, Daizoh; Sato, Shunichi			Oral ascorbic acid 2-glucoside prevents coordination disorder induced via laser-induced shock waves in rat brain	PLOS ONE			English	Article							OXIDATIVE STRESS; HYDROGEN-PEROXIDE; GENE-TRANSFER; INJURY; EXPOSURE; INFLAMMATION; APOPTOSIS; SYSTEM; CELLS; MICE	Oxidative stress is considered to be involved in the pathogenesis of primary blast-related traumatic brain injury (bTBI). We evaluated the effects of ascorbic acid 2-glucoside (AA2G), a well-known antioxidant, to control oxidative stress in rat brain exposed to laser-induced shock waves (LISWs). The design consisted of a controlled animal study using male 10-week-old Sprague-Dawley rats. The study was conducted at the University research laboratory. Low-impulse (54 Pa.s) LISWs were transcranially applied to rat brain. Rats were randomized to control group (anesthesia and head shaving, n = 10), LISW group (anesthesia, head shaving and LISW application, n = 10) or LISW + post AA2G group (AA2G administration after LISW application, n = 10) in the first study. In another study, rats were randomized to control group (n = 10), LISW group (n = 10) or LISW + pre and post AA2G group (AA2G administration before and after LISW application, n = 10). The measured outcomes were as follows: (i) motor function assessed by accelerating rotarod test; (ii) levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), an oxidative stress marker; (iii) ascorbic acid in each group of rats. Ascorbic acid levels were significantly decreased and 8-OHdG levels were significantly increased in the cerebellum of the LISW group. Motor coordination disorder was also observed in the group. Prophylactic AA2G administration significantly increased the ascorbic acid levels, reduced oxidative stress and mitigated the motor dysfunction. In contrast, the effects of therapeutic AA2G administration alone were limited. The results suggest that the prophylactic administration of ascorbic acid can reduce shock wave-related oxidative stress and prevented motor dysfunction in rats.	[Maekawa, Takaaki; Uchida, Takahiro; Nakata-Horiuchi, Yuka; Kobayashi, Hiroaki] Japan Ground Self Def Force, Test & Evaluat Command, Mil Med Res Unit, Setagaya Ku, Tokyo, Japan; [Maekawa, Takaaki] Natl Def Med Coll, Dept Internal Med, Div Hematol, Tokorozawa, Saitama, Japan; [Uchida, Takahiro] Tokyo Med Univ, Dept Nephrol, Hachi Med Ctr, Hachioji, Tokyo, Japan; [Kawauchi, Satoko; Sato, Shunichi] Natl Def Med Coll, Div Bioinformat & Therapeut Syst, Res Inst, Tokorozawa, Saitama, Japan; [Kinoshita, Manabu] Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama, Japan; [Saitoh, Daizoh] Natl Def Med Coll, Div Traumatol, Res Inst, Tokorozawa, Saitama, Japan	National Defense Medical College - Japan; Tokyo Medical University; National Defense Medical College - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan	Maekawa, T (corresponding author), Japan Ground Self Def Force, Test & Evaluat Command, Mil Med Res Unit, Setagaya Ku, Tokyo, Japan.; Maekawa, T (corresponding author), Natl Def Med Coll, Dept Internal Med, Div Hematol, Tokorozawa, Saitama, Japan.	tmaekawa-ndmc@umin.ac.jp		Maekawa, Takaaki/0000-0002-8611-0862				Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Aizawa K, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253325; Alley M., 2009, THESIS, DOI [10.1089/neu.1994.11.187, DOI 10.1089/NEU.1994.11.187]; Ando T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051744; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Brown SL, 2010, RADIAT RES, V173, P462, DOI 10.1667/RR1716.1; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; Chen X, 2018, BIOMED PHARMACOTHER, V97, P75, DOI 10.1016/j.biopha.2017.10.030; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; de Lanerolle NC, 2015, SEMIN NEUROL, V35, P12, DOI 10.1055/s-0035-1544240; Elsayed NM, 1997, TOXICOLOGY, V121, P81, DOI 10.1016/S0300-483X(97)03657-3; Gu M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2075463; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ito Y, 2013, INT J MOL SCI, V14, P19618, DOI 10.3390/ijms141019618; Jenkins TG, 2011, FERTIL STERIL, V95, P2001, DOI 10.1016/j.fertnstert.2011.02.023; Jiang XF, 2013, J SURG RES, V184, pE27, DOI 10.1016/j.jss.2013.03.067; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kaur C, 1996, ARCH HISTOL CYTOL, V59, P239, DOI 10.1679/aohc.59.239; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Koppula S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/823902; Koyama S, 1998, MUTAT RES-FUND MOL M, V421, P45, DOI 10.1016/S0027-5107(98)00153-5; Kuriakose M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44147-w; Kurita A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3628313; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lee S, 2020, ANTIOXID REDOX SIGN, V32, P35, DOI 10.1089/ars.2019.7743; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lindley TE, 2009, AM J PHYSIOL-REG I, V296, pR1, DOI 10.1152/ajpregu.00078.2008; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mathew D, 2007, J RADIAT RES, V48, P369, DOI 10.1269/jrr.07007; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Moretti M, 2017, CNS NEUROSCI THER, V23, P921, DOI 10.1111/cns.12767; Ogura M, 2004, LASER SURG MED, V34, P242, DOI 10.1002/lsm.20024; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Sato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082891; Sato S, 2011, OPT LETT, V36, P4545, DOI 10.1364/OL.36.004545; Sato T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117020; Satoh Y, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2128432; Satoh Y, 2018, J NEUROPATH EXP NEUR, V77, P827, DOI 10.1093/jnen/nly060; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Sorice A, 2014, MINI-REV MED CHEM, V14, P444, DOI 10.2174/1389557514666140428112602; Studlack PE, 2018, BRAIN INJURY, V32, P1866, DOI 10.1080/02699052.2018.1536282; Toyokuni S, 1997, LAB INVEST, V76, P365; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Yamamoto T, 2010, J RADIAT RES, V51, P145, DOI 10.1269/jrr.09078; Zhang JY, 2017, MED GAS RES, V7, P113, DOI 10.4103/2045-9912.208517	59	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230774	10.1371/journal.pone.0230774	http://dx.doi.org/10.1371/journal.pone.0230774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240226	Green Published, gold			2022-12-26	WOS:000535945000042
J	Stevens, BS; Luukkonen, DR; Stewart, CA; Porter, WF; Bence, JR; Jones, ML				Stevens, Bryan S.; Luukkonen, David R.; Stewart, C. Alan; Porter, William F.; Bence, James R.; Jones, Michael L.			Spatial-temporal dynamics of hunter effort for wild turkeys in Michigan	PLOS ONE			English	Article							RECRUITMENT; DECLINE; DEER	Wild turkeys (Meleagris gallopavo; hereafter turkeys) are an important game animal whose popularity among hunters has increased in recent decades. Yet, the number of hunters pursuing turkeys appears to be in flux, patterns of hunter abundance have primarily been described at broad spatial scales, and the ability of management to impact hunter numbers in the post-restoration era of management through opportunity for quality hunting is unclear. We used county-scale estimates of turkey hunter numbers collected over a 14-year period (2001-2014) and time-series analyses to evaluate the spatial scales at which spring and fall turkey hunter populations fluctuate, and also used generalized linear mixed models to evaluate whether attributes related to quality turkey hunting explain recent patterns in hunter abundance. We found heterogeneity in turkey hunter population growth at finer spatial scales than has been previously described (i.e., counties and management units), and provide evidence for spatial structuring of hunter population dynamics among counties that did not always correspond with existing management units. Specifically, the directionality of hunter population change displays spatial structure along an east-west gradient in southern Michigan. We also found little evidence that factors providing opportunity for quality turkey hunting had meaningful impacts on recent spatial-temporal patterns of hunter numbers. Our results imply that providing quality turkey hunting opportunities alone may be insufficient for sustaining populations of turkey hunters in the future, and that modern determinants of hunter participation extend beyond the availability of abundant turkey populations. Moreover, our results demonstrate that interpretation of harvest data as indices of abundance for turkey populations is difficult in the absence of hunter effort data, as changes to turkey harvest are a function of potentially fine-scaled changes in populations of hunters, not simply changes to turkey populations.	[Stevens, Bryan S.; Luukkonen, David R.; Porter, William F.; Bence, James R.; Jones, Michael L.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Luukkonen, David R.; Stewart, C. Alan] Michigan Dept Nat Resources, Lansing, MI USA; [Stevens, Bryan S.] Univ Idaho, Idaho Cooperat Fish & Wildlife Res Unit, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA	Michigan State University; Idaho; University of Idaho	Stevens, BS (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.; Stevens, BS (corresponding author), Univ Idaho, Idaho Cooperat Fish & Wildlife Res Unit, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA.	bstevens@uidaho.edu			Federal Aid in Wildlife Restoration Act [W-155-R]; U.S. Fish and Wildlife Service, Wildlife and Sport Fish Restoration Program; Michigan Department of Natural Resources; Crockett Quantitative Wildlife Center at Michigan State University; Quantitative Fisheries Center at Michigan State University	Federal Aid in Wildlife Restoration Act; U.S. Fish and Wildlife Service, Wildlife and Sport Fish Restoration Program; Michigan Department of Natural Resources; Crockett Quantitative Wildlife Center at Michigan State University; Quantitative Fisheries Center at Michigan State University	Funding for this project was provided by: the Federal Aid in Wildlife Restoration Act grant number W-155-R in cooperation with the U.S. Fish and Wildlife Service, Wildlife and Sport Fish Restoration Program (BSS); Michigan Department of Natural Resources (DRL,CAS); Boone and Crockett Quantitative Wildlife Center at Michigan State University (WFP); and the Quantitative Fisheries Center at Michigan State University (JRB, MLJ).	[Anonymous], TURKEY HUNTING 2006; [Anonymous], 2016, P NATL WILD TURKEY S; Bailey R.W., 1980, Proceedings of the National Wild Turkey Symposium, P1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CARTWRIGHT ME, 1990, P NATL WILD TURKEY S, V6, P177; Clawson MV, 2015, WILDLIFE SOC B, V39, P116, DOI 10.1002/wsb.503; Enck JW, 2000, WILDLIFE SOC B, V28, P817; ENCK JW, 1993, WILDLIFE SOC B, V21, P10; ERICKSEN RE, 2016, P NATL WILD TURKEY S, V11, P7; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Frawley BJ, 2014, 3392 MICH DEP NAT RE; Frawley BJ, 2014, 3579 MICH DEP NAT RE; Frawley BJ, 2015, 3607 MICH DEP NAT RE; HAWN LJ, 1987, WILDLIFE SOC B, V15, P233; Hilbe J., 2011, NEGATIVE BINOMIAL RE; HILBORN R, 1992; Holmes EE, 2014, ANAL MULTIVARIATE TI; Holmes EE, 2012, DERIVATION ALGORITHM; Irwin BJ, 2013, T AM FISH SOC, V142, P171, DOI 10.1080/00028487.2012.728163; Isabelle JL, 2016, P NATL WILD TURKEY S, V11, P249; Larson L. R., 2014, Human Dimensions of Wildlife, V19, P105, DOI 10.1080/10871209.2014.850126; Lewis J. B, 2001, P 8 NAT WILD TURK S, V8, P7; Little D.A., 2000, P NATL WILD TURKEY S, V8, P223; Manfredo Michael J., 2003, Human Dimensions of Wildlife, V8, P287, DOI 10.1080/716100425; Manfredo Michael J., 1995, P17; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icesjms.2006.05.008; Miller C.A., 2003, HUM DIMENS WILDL, V8, P263, DOI DOI 10.1080/716100421; MILLER JR, 1982, ANN REGIONAL SCI, V16, P79, DOI 10.1007/BF01293289; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Porter W.F., 2011, NATL WILD TURKEY S, V10, P1; Riley SJ, 2003, ECOSCIENCE, V10, P455, DOI 10.1080/11956860.2003.11682793; RYAN EL, 2011, HUM DIMENS WILDL, V16, P311, DOI DOI 10.1080/10871209.2011.559530; Schorr RA, 2014, J WILDLIFE MANAGE, V78, P944, DOI 10.1002/jwmg.732; Skaug HD, 2011, R PACKAGE VERSION 0; Swanson D. A., 2007, P NATL WILD TURKEY S, V9, P325; Tapley J. I., 2007, P NATL WILD TURKEY S, V9, P21; TAPLEY JL, 2001, P NAT WILD TURK S, V8, P15; Vrtiska MP, 2013, WILDLIFE SOC B, V37, P380, DOI 10.1002/wsb.245; Winkler R, 2013, POPUL ENVIRON, V34, P460, DOI 10.1007/s11111-012-0172-6	39	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230747	10.1371/journal.pone.0230747	http://dx.doi.org/10.1371/journal.pone.0230747			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236108	Green Published, Green Submitted, gold			2022-12-26	WOS:000535938700027
J	Karletsos, D; Greenbaum, CR; Kobayashi, E; McConnell, M				Karletsos, Dimitris; Greenbaum, Charlotte R.; Kobayashi, Emily; McConnell, Margaret			Willingness to use PrEP among female university students in Lesotho	PLOS ONE			English	Article							CONCURRENT SEXUAL PARTNERSHIPS; PREEXPOSURE PROPHYLAXIS; HIV; PREVALENCE; VIOLENCE; MEN	Oral pre-exposure prophylaxis (PrEP) for HIV-negative individuals at high risk was introduced in Lesotho in April 2016. To assess the feasibility and acceptability of PrEP in Lesotho and to study the attitudes and beliefs around HIV risk and prevention measures among young women, between September and December 2016 we asked 302 female university students at fourteen higher education institutions in Lesotho about their sexual behavior, experiences of sexual coercion and abuse, HIV risk perception, willingness to use PrEP, as well as their attitudes toward condom use and self-administration of daily medications. Overall, 57.3% of the sample reported perceiving themselves at risk of acquiring HIV and 32.1% reported being strongly willing to use PrEP if it were available in their community. In a multivariate mediation analysis, perceived HIV risk was associated with 11.5 percentage points increase in likelihood of using PrEP (p = 0.041). Multiple concurrent sexual partnership was associated with 16.1 percentage points increase in likelihood of self-perceived HIV risk (p = 0.007), while having sexual partners in polygamous relationships was associated with 17.8 percentage points increase in likelihood of self-perceived HIV risk (p = 0.002) and the mediated indirect effect accounted for 18.2% of its total effect. Those who reported strong adherence to antibiotics were 23.1 percentage points more likely to express willingness to use PrEP than those who did not (p = 0.004), and those who reported to dislike condoms were 19.1 percentage points more likely to be willing to use PrEP than those who did not report aversion to condom use: these effect were direct and not mediated by HIV risk perception. Intimate partner violence (IPV) in the network of peers was also directly associated with willingness to use PrEP and its effect was not significantly mediated by HIV risk perception: those who had friends who experienced intimate partner violence were 14.9 percentage points more likely to be willing to use PrEP than those who did not report IPV in their network of peers (p = 0.009). These findings support the inclusion of individuals with multiple concurrent sexual partners among the key populations for PrEP provision and confirm that willingness to use PrEP is not solely driven by HIV risk perception. They also indicate that the presence of IPV in peer networks is related to one's willingness to use PrEP. PrEP service provision may generate synergies with IPV prevention programs when offered within this framework.	[Karletsos, Dimitris] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA; [Greenbaum, Charlotte R.; McConnell, Margaret] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Kobayashi, Emily] Clinton Hlth Access Initiat, Boston, MA USA	Tulane University; Harvard University; Harvard T.H. Chan School of Public Health	Karletsos, D (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA.	dkarletsos@tulane.edu			Magic Pebble Foundation; Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) [T76MC00001]	Magic Pebble Foundation; Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS)	This study was funded by the Magic Pebble Foundation. This project was also partially supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant T76MC00001 and entitled Training Grant in Maternal and Child Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2014, JAIDS-J ACQ IMM DEF, V65, P99, DOI 10.1097/QAI.0b013e3182a9c22a; Aguero JM, 2017, IDB WORKING PAPER SE; [Anonymous], 2016, NAT GUID US ANT THER; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Division of HIV/AIDS Prevention and Centers for Disease Control and Prevention and National Center for HIV/AIDS, 2018, VIR HEP SEX TRANSM D; Dunkle KL, 2007, SOC SCI MED, V65, P1235, DOI 10.1016/j.socscimed.2007.04.029; Eaton JW, 2011, AIDS BEHAV, V15, P687, DOI 10.1007/s10461-010-9787-8; Epstein H, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-13; Fulfer JL, 2007, J INTERPERS VIOLENCE, V22, P238, DOI 10.1177/0886260506295814; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Khawcharoenporn T, 2015, INT J STD AIDS, V26, P1007, DOI 10.1177/0956462414564607; Kilburn K, 2018, AIDS, V32, P1669, DOI 10.1097/QAD.0000000000001866; Langen Tabitha T, 2005, Afr Health Sci, V5, P188; Lesotho Ministry of Health, 2016, 2014 LES DEM HLTH SU; Marrazzo JM, 2013, 20 C RETR OPP INF CR; Mittal M, 2013, WOMEN HLTH, V53, P10; Mulawa M. I., 2017, CULTURE HLTH SEXUALI, V20, P474; Rigby SW, 2017, INFECT DIS MODELLING; Sawers L, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-34; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; Wamoyi J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20992; Wirtz AL, 2015, JAIDS-J ACQ IMM DEF, V68, pS171, DOI 10.1097/QAI.0000000000000451; Wood K, 2001, CHANGING MEN S AFRIC	27	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230565	10.1371/journal.pone.0230565	http://dx.doi.org/10.1371/journal.pone.0230565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8HO	32231394	gold, Green Published			2022-12-26	WOS:000535937400012
J	Li, JW; Jian, SY; Lane, CS; Lu, YH; He, XR; Wang, GS; Mayes, MA; Dzantor, KE; Hui, DF				Li, Jianwei; Jian, Siyang; Lane, Chad S.; Lu, YueHan; He, Xiaorui; Wang, Gangsheng; Mayes, Melanie A.; Dzantor, Kudjo E.; Hui, Dafeng			Effects of nitrogen fertilization and bioenergy crop type on topsoil organic carbon and total Nitrogen contents in middle Tennessee USA	PLOS ONE			English	Article							PARALLEL FACTOR-ANALYSIS; SOIL CARBON; BIOMASS YIELD; FLUORESCENCE SPECTROSCOPY; SWITCHGRASS CULTIVARS; EASTERN GAMAGRASS; SPATIAL VARIATION; COVER CROP; LAND-USE; MATTER	Nitrogen (N) fertilization affects bioenergy crop growth and productivity and consequently carbon (C) and N contents in soil, it however remains unclear whether N fertilization and crop type individually or interactively influence soil organic carbon (SOC) and total N (TN). In a three-year long fertilization experiment in switchgrass (SG: Panicum virgatum L.) and gamagrass (GG: Tripsacum dactyloides L.) croplands in Middle Tennessee USA, soil samples (0-15cm) were collected in plots with no N input (NN), low N input (LN: 84 kg N ha(-1) yr(-1) in urea) and high N input (HN: 168 kg N ha(-1) yr(-1) in urea). Besides SOC and TN, the aboveground plant biomass was also quantified. In addition to a summary of published root morphology data based on a separated mesocosm experiment, the root leachable dissolved organic matter (DOM) of both crops was also measured using archived samples. Results showed no significant interaction of N fertilization and crop type on SOC, TN or plant aboveground biomass (ABG). Relative to NN, HN (not LN) significantly increased SOC and TN in both crops. Though SG showed a 15-68% significantly higher ABG than GG, GG showed a 9.3-12% significantly higher SOC and TN than SG. The positive linear relationships of SOC or TN with ABG were identified for SG. However, GG showed structurally more complex and less readily decomposed root DOM, a larger root volume, total root length and surface area than SG. Collectively, these suggested that intensive N fertilization could increase C and N stocks in bioenergy cropland soils but these effects may be more likely mediated by the aboveground biomass in SG and root chemistry and morphology in GG. Future studies are expected to examine the root characteristics in different bioenergy croplands under the field fertilization experiment.	[Li, Jianwei; Jian, Siyang; Dzantor, Kudjo E.] Tennessee State Univ, Dept Agr & Environm Sci, Nashville, TN 37203 USA; [Lane, Chad S.] Univ North Carolina Wilmington, Dept Earth & Ocean Sci, Wilmington, NC USA; [Lu, YueHan; He, Xiaorui] Univ Alabama, Dept Geol Sci, Tuscaloosa, AL USA; [Wang, Gangsheng] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [Wang, Gangsheng] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Mayes, Melanie A.] Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN USA; [Mayes, Melanie A.] Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA; [Hui, Dafeng] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA	Tennessee State University; University of North Carolina; University of North Carolina Wilmington; University of Alabama System; University of Alabama Tuscaloosa; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Tennessee State University	Li, JW (corresponding author), Tennessee State Univ, Dept Agr & Environm Sci, Nashville, TN 37203 USA.	jli2@tnstate.edu	He, Xiaorui/O-8711-2018; JIAN, SIYANG/HGB-4845-2022; Li, Jianwei/G-5299-2012	He, Xiaorui/0000-0002-8757-4933; JIAN, SIYANG/0000-0001-5286-1679; Lu, Yuehan/0000-0002-0536-532X; Li, Jianwei/0000-0002-0429-3627	US National Science Foundation (NSF) HBCU-EiR [1900885]; US Department of Agriculture (USDA) Agricultural Research Service (ARS) 1890s Faculty Research Sabbatical Program [58-3098-9-005]; USDA Evans-Allen Grant [1017802]	US National Science Foundation (NSF) HBCU-EiR(National Science Foundation (NSF)); US Department of Agriculture (USDA) Agricultural Research Service (ARS) 1890s Faculty Research Sabbatical Program; USDA Evans-Allen Grant	This study was supported by funding awarded to JL from a US National Science Foundation (NSF) HBCU-EiR (No. 1900885), US Department of Agriculture (USDA) Agricultural Research Service (ARS) 1890s Faculty Research Sabbatical Program (No. 58-3098-9-005), and USDA Evans-Allen Grant (No. 1017802). The URL of NSF is https://www.nsf.gov/and the URL of USDA is https://www.ars.usda.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins J, 2016, GEODERMA, V262, P147, DOI 10.1016/j.geoderma.2015.08.019; An Y, 2013, ACTA AGR SCAND B-S P, V63, P497, DOI 10.1080/09064710.2013.810770; Anderson EK, 2016, GCB BIOENERGY, V8, P1178, DOI 10.1111/gcbb.12328; Austin EE, 2017, GCB BIOENERGY, V9, P1252, DOI 10.1111/gcbb.12428; Bennett E., 2011, GLOBAL FERTILIZER MA; Bransby DI, 1998, BIOMASS BIOENERG, V14, P379, DOI 10.1016/S0961-9534(97)10074-5; Clark RB, 1998, PLANT SOIL, V200, P33, DOI 10.1023/A:1004256100631; Cory RM, 2005, ENVIRON SCI TECHNOL, V39, P8142, DOI 10.1021/es0506962; Cui ZL, 2018, NATURE, V555, P363, DOI 10.1038/nature25785; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; de Graaff MA, 2013, SOIL BIOL BIOCHEM, V58, P198, DOI 10.1016/j.soilbio.2012.11.015; DEHAAN H, 1987, WATER RES, V21, P731, DOI 10.1016/0043-1354(87)90086-8; Deng Q, 2017, AGR ECOSYST ENVIRON, V248, P29, DOI 10.1016/j.agee.2017.07.023; Dietzel R, 2017, SOIL-GERMANY, V3, P139, DOI 10.5194/soil-3-139-2017; Dzantor K., 2015, COAL COMBUSTION GASI, V7, P33, DOI DOI 10.4177/CCGP-D-15-00002.1; Garten CT, 2010, AGR ECOSYST ENVIRON, V136, P177, DOI 10.1016/j.agee.2009.12.019; Garten CT, 2011, AGR ECOSYST ENVIRON, V140, P289, DOI 10.1016/j.agee.2010.12.016; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Gil JL, 2001, AGRON J, V93, P902, DOI 10.2134/agronj2001.934902x; Gregory AS, 2018, BIOENERG RES, V11, P382, DOI 10.1007/s12155-018-9903-6; Groffman PM, 2009, ECOSYSTEMS, V12, P927, DOI 10.1007/s10021-009-9268-y; GROSS KL, 1995, J ECOL, V83, P357, DOI 10.2307/2261590; Heggenstaller AH, 2009, AGRON J, V101, P1363, DOI 10.2134/agronj2008.0225x; Helms JR, 2008, LIMNOL OCEANOGR, V53, P955, DOI 10.4319/lo.2008.53.3.0955; Helms JR, 2013, MAR CHEM, V155, P81, DOI 10.1016/j.marchem.2013.05.015; Hu Y, 2016, J GEOPHYS RES-BIOGEO, V121, P466, DOI 10.1002/2015JG003082; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jaron A, 2014, SWITCHGRASS ROOT DEC, P37; Jian SY, 2016, SOIL BIOL BIOCHEM, V101, P32, DOI 10.1016/j.soilbio.2016.07.003; Jung JY, 2011, GEODERMA, V166, P145, DOI 10.1016/j.geoderma.2011.07.023; Jungers JM, 2015, BIOENERG RES, V8, P279, DOI 10.1007/s12155-014-9525-6; Kering MK, 2013, BIOENERG RES, V6, P329, DOI 10.1007/s12155-012-9261-8; Kibet LC, 2016, ENERGY SUSTAIN SOC, V6, DOI 10.1186/s13705-015-0065-5; Lai LM, 2018, CATENA, V163, P288, DOI 10.1016/j.catena.2017.12.030; Le X., 2011, Journal of Environmental Protection, V2, P940, DOI 10.4236/jep.2011.27107; Lee DK, 2007, AGRON J, V99, P462, DOI 10.2134/agronj2006.0152; Lemus R, 2005, CRIT REV PLANT SCI, V24, P1, DOI 10.1080/07352680590910393; Li J., 2018, JOVE-J VIS EXP; Li J, 2019, SCI REPORTS; Li JW, 2018, GCB BIOENERGY, V10, P565, DOI 10.1111/gcbb.12515; Li JW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18486-5; Li JW, 2010, GEODERMA, V156, P60, DOI 10.1016/j.geoderma.2010.01.008; Lu CQ, 2017, EARTH SYST SCI DATA, V9, P181, DOI 10.5194/essd-9-181-2017; Lu YH, 2014, BIOGEOCHEMISTRY, V119, P275, DOI 10.1007/s10533-014-9965-2; Lu YH, 2015, OCEAN DYNAM, V65, P17, DOI 10.1007/s10236-014-0793-7; Lu YH, 2013, J GEOPHYS RES-BIOGEO, V118, P566, DOI 10.1002/jgrg.20048; Ma Z, 2000, BIOMASS BIOENERG, V18, P469, DOI 10.1016/S0961-9534(00)00013-1; Ma Z, 2000, BIOMASS BIOENERG, V18, P105, DOI 10.1016/S0961-9534(99)00076-8; Matamala R, 2003, SCIENCE, V302, P1385, DOI 10.1126/science.1089543; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; Monti A, 2012, GCB BIOENERGY, V4, P420, DOI 10.1111/j.1757-1707.2011.01142.x; Murphy KR, 2013, ANAL METHODS-UK, V5, P6557, DOI 10.1039/c3ay41160e; Ohno T, 2002, ENVIRON SCI TECHNOL, V36, P4196, DOI 10.1021/es020113d; Pedroso GM, 2014, FIELD CROP RES, V161, P149, DOI 10.1016/j.fcr.2014.02.003; R Core Team, 2013, R LANG ENV STAT COMP; Rangel-Castro JI, 2005, ENVIRON MICROBIOL, V7, P828, DOI 10.1111/j.1462-2920.2005.00756.x; RASMUSSEN PE, 1980, SOIL SCI SOC AM J, V44, P596, DOI 10.2136/sssaj1980.03615995004400030033x; Robles-Aguilar AA, 2019, PLANT SOIL, V434, P65, DOI 10.1007/s11104-018-3787-2; Sainju UM, 2017, PEDOSPHERE, V27, P223, DOI 10.1016/S1002-0160(17)60312-6; Shang P, 2018, SCI TOTAL ENVIRON, V612, P1442, DOI 10.1016/j.scitotenv.2017.08.322; Springer TL, 2017, BIOENERG RES, V10, P648, DOI 10.1007/s12155-017-9827-6; Stedmon CA, 2008, LIMNOL OCEANOGR-METH, V6, P572, DOI 10.4319/lom.2008.6.572; Stewart CE, 2016, GCB BIOENERGY, V8, P1201, DOI 10.1111/gcbb.12326; Stewart CE, 2015, GCB BIOENERGY, V7, P288, DOI 10.1111/gcbb.12142; Tiemann LK, 2015, GCB BIOENERGY, V7, P161, DOI 10.1111/gcbb.12126; Trumbore S, 2000, ECOL APPL, V10, P399, DOI 10.1890/1051-0761(2000)010[0399:AOSOMA]2.0.CO;2; Tulbure MG, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045903; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; Valdez ZP, 2017, BIOENERG RES, V10, P456, DOI 10.1007/s12155-016-9810-7; Wang LX, 2009, GEODERMA, V149, P402, DOI 10.1016/j.geoderma.2008.12.014; Ward D, 2017, SOIL BIOL BIOCHEM, V115, P415, DOI 10.1016/j.soilbio.2017.08.035; Wheeler KI, 2017, J GEOPHYS RES-BIOGEO, V122, P2233, DOI 10.1002/2016JG003677; Woo DK, 2014, ENVIRON SCI TECHNOL, V48, P12090, DOI 10.1021/es5023762; Wright L, 2010, BIOMASS BIOENERG, V34, P851, DOI 10.1016/j.biombioe.2010.01.030; Yu CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep30149; Zhu SS, 2016, APPL SOIL ECOL, V107, P324, DOI 10.1016/j.apsoil.2016.07.009	76	4	4	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230688	10.1371/journal.pone.0230688	http://dx.doi.org/10.1371/journal.pone.0230688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HE	32226037	Green Published, Green Submitted, gold			2022-12-26	WOS:000535936400012
J	Stefani, A; Aramini, B; Baraldi, C; Pellesi, L; Della Casa, G; Morandil, U; Guerzoni, S				Stefani, Alessandro; Aramini, Beatrice; Baraldi, Carlo; Pellesi, Lanfranco; Della Casa, Giovanni; Morandil, Uliano; Guerzoni, Simona			Secondary spontaneous pneumothorax and bullous lung disease in cannabis and tobacco smokers: A case-control study	PLOS ONE			English	Article							SMOKING; RISK; MARIJUANA; BULLAE; BLEBS	Background The notion that smoking cannabis may damage the respiratory tract has been introduced in recent years but there is still a paucity of studies on this subject. The aim of this study was to investigate the relationship between cannabis smoking, pneumothorax and bullous lung disease in a population of operated patients. Methods and findings We performed a retrospective study on patients operated on for spontaneous pneumothorax. Patients were divided into three groups according to their smoking habit: cannabis smokers, only-tobacco smokers and nonsmokers. Cannabis lifetime exposure was expressed in dose-years (1d/y = 1 gram of cannabis/week for one year). Clinical, radiological and perioperative variables were collected. The variables were analyzed to find associations with smoking habit. The impact of the amount of cannabis consumption was also investigated by ROC curves analysis. Of 112 patients, 39 smoked cannabis, 23 smoked only tobacco and 50 were nonsmokers. Median cannabis consumption was 28 dose/years, median tobacco consumption was 6 pack/years. Cannabis smokers presented with more severe chronic respiratory symptoms and bullous lung disease and with a higher incidence of tension pneumothorax than both tobacco smokers and nonsmokers. Cannabis smokers also developed a larger pneumothorax, experienced prolonged postoperative stay and demonstrated a higher incidence of pneumothorax recurrence after the operation than nonsmokers did. The risk of occurrence of chronic respiratory symptoms and bullous lung disease in cannabis smokers was dose-related. Conclusions Cannabis smoking seems to increase the risk of suffering from respiratory complaints and can have detrimental effects on lung parenchyma, in a dose-dependent manner. Cannabis smoking also negatively affected the outcome of patients operated for spontaneous pneumothorax. A history of cannabis abuse should always be taken in patients with pneumothorax. There may be need for a specific treatment for pneumothorax in cannabis smokers.	[Stefani, Alessandro; Aramini, Beatrice; Morandil, Uliano] Univ Modena & Reggio Emilia, Thorac Surg Unit, Reggio Emilia, Italy; [Baraldi, Carlo; Pellesi, Lanfranco; Guerzoni, Simona] Univ Modena & Reggio Emilia, Toxicol Unit, Reggio Emilia, Italy; [Baraldi, Carlo; Pellesi, Lanfranco; Guerzoni, Simona] Univ Modena & Reggio Emilia, Drug Abuse Ctr, Reggio Emilia, Italy; [Della Casa, Giovanni] Univ Modena & Reggio Emilia, Dept Radiol, Reggio Emilia, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Stefani, A (corresponding author), Univ Modena & Reggio Emilia, Thorac Surg Unit, Reggio Emilia, Italy.	alessandro.stefani@unimore.it		Baraldi, Carlo/0000-0001-8432-1888				Aldington S, 2007, THORAX, V62, P1058, DOI 10.1136/thx.2006.077081; Asano H, 2019, J THORAC DIS, V11, P1940, DOI 10.21037/jtd.2019.04.105; BENSE L, 1987, CHEST, V92, P1009, DOI 10.1378/chest.92.6.1009; Beshay M, 2007, EUR J CARDIO-THORAC, V32, P834, DOI 10.1016/j.ejcts.2007.07.039; Kogel CC, 2017, DRUG ALCOHOL DEPEN, V176, P109, DOI 10.1016/j.drugalcdep.2017.03.010; Casali C, 2013, ANN THORAC SURG, V95, P249, DOI 10.1016/j.athoracsur.2012.05.073; European Monitoring Centre for Drugs and Drug Addiction, EUR DRUG REP 2019 TR; Fiorelli A, 2013, ASIAN CARDIOVASC THO, V22, P65, DOI [10.1177/, DOI 10.1177/]; Gill A, 2005, AM J SURG PATHOL, V29, P980, DOI 10.1097/01.pas.0000157998.68800.cb; Hancox RJ, 2010, EUR RESPIR J, V35, P42, DOI 10.1183/09031936.00065009; Kawaguchi T, 2013, RESPIR INVESTIG, V51, P224, DOI 10.1016/j.resinv.2013.04.004; Macleod J, 2015, BRIT J GEN PRACT, V65, pE89, DOI 10.3399/bjgp15X683521; Martinasek MP, 2016, RESP CARE, V61, P1543, DOI 10.4187/respcare.04846; Miech R, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0982; Moore BA, 2005, J GEN INTERN MED, V20, P33, DOI 10.1111/j.1525-1497.2004.40081.x; Olesen WH, 2017, EUR J CARDIO-THORAC, V52, P679, DOI 10.1093/ejcts/ezx160; Ouanes-Besbes L, 2007, RESP MED, V101, P230, DOI 10.1016/j.rmed.2006.05.016; Ruppert AM, 2018, DIAGN INTERV IMAG, V99, P465, DOI 10.1016/j.diii.2018.01.017; Tan C, 2006, J ROY SOC MED, V99, P77, DOI 10.1258/jrsm.99.2.77; TASHKIN DP, 1987, AM REV RESPIR DIS, V135, P209; Underner M, 2018, REV PNEUMOL CLIN, V74, P400, DOI 10.1016/j.pneumo.2018.06.003; WU TC, 1988, NEW ENGL J MED, V318, P347, DOI 10.1056/NEJM198802113180603	22	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230419	10.1371/journal.pone.0230419	http://dx.doi.org/10.1371/journal.pone.0230419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HE	32226050	Green Published, gold			2022-12-26	WOS:000535936400006
J	Wang, Y; Ma, RN; Liu, B; Kong, JY; Lin, HY; Yu, X; Wang, RY; Li, L; Gao, M; Zhou, BS; Mohan, M; Yu, H; Hou, ZY; Shen, HB; Qian, BY				Wang, Yu; Ma, Rongna; Liu, Ben; Kong, Jinyu; Lin, Hongyan; Yu, Xiao; Wang, Ruoyang; Li, Lei; Gao, Ming; Zhou, Baosen; Mohan, Man; Yu, Herbert; Hou, Zhaoyuan; Shen, Hongbin; Qian, Biyun			SNP rs17079281 decreases lung cancer risk through creating an YY1-binding site to suppress DCBLD1 expression	ONCOGENE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENETIC SUSCEPTIBILITY; IDENTIFICATION; TUMORS	Genome-wide association studies (GWAS) have identified numerous genetic variants that are associated with lung cancer risk, but the biological mechanisms underlying these associations remain largely unknown. Here we investigated the functional relevance of a genetic region in 6q22.2 which was identified to be associated with lung cancer risk in our previous GWAS. We performed linkage disequilibrium (LD) analysis and bioinformatic prediction to screen functional SNPs linked to a tagSNP in 6q22.2 loci, followed by two case-control studies and a meta-analysis with 4403 cases and 5336 controls to identify if these functional SNPs were associated with lung cancer risk. A novel SNP rs17079281 in the DCBLD1 promoter was identified to be associated with lung cancer risk in Chinese populations. Compared with those with C allele, patients with T allele had lower risk of adenocarcinoma (adjusted OR = 0.86; 95% CI: 0.80-0.92), but not squamous cell carcinoma (adjusted OR = 0.99; 95% CI: 0.91-1.10), and patients with the C/T or T/T genotype had lower levels of DCBLD1 expression than those with C/C genotype in lung adenocarcinoma tissues. We performed functional assays to characterize its biological relevance. The results showed that the T allele of rs17079281 had higher binding affinity to transcription factor YY1 than the C allele, which suppressed DCBLD1 expression. DCBLD1 behaved like an oncogene, promoting tumor growth by influencing cell cycle progression. These findings suggest that the functional variant rs17079281C>T decreased lung adenocarcinoma risk by creating an YY1-binding site to suppress DCBLD1 expression, which may serve as a biomarker for assessing lung cancer susceptibility.	[Wang, Yu; Ma, Rongna; Lin, Hongyan; Yu, Xiao; Wang, Ruoyang; Li, Lei; Qian, Biyun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Tongren Hosp, Hongqiao Int Inst Med, Shanghai 200025, Peoples R China; [Wang, Yu; Ma, Rongna; Lin, Hongyan; Yu, Xiao; Wang, Ruoyang; Li, Lei; Qian, Biyun] Shanghai Jiao Tong Univ, Sch Med, Fac Publ Hlth, Shanghai 200025, Peoples R China; [Liu, Ben; Kong, Jinyu; Gao, Ming] Tianjin Med Univ, Dept Canc Epidemiol & Biostat, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin 300060, Peoples R China; [Zhou, Baosen] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110001, Liaoning, Peoples R China; [Mohan, Man] Shanghai Jiao Tong Univ, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai 200025, Peoples R China; [Yu, Herbert] Univ Hawaii, Canc Epidemiol Program, Canc Ctr, Honolulu, HI 96813 USA; [Hou, Zhaoyuan] Shanghai Jiao Tong Univ, Fac Basic Med, Sch Med, Hongqiao Inst Med,Shanghai Tongren Hosp, Shanghai 200025, Peoples R China; [Shen, Hongbin] Nanjing Med Univ, Canc Ctr, Sect Clin Epidemiol, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing 211166, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tianjin Medical University; China Medical University; Shanghai Jiao Tong University; Cancer Research Center of Hawaii; University of Hawaii System; Shanghai Jiao Tong University; Nanjing Medical University	Qian, BY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Tongren Hosp, Hongqiao Int Inst Med, Shanghai 200025, Peoples R China.; Qian, BY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Fac Publ Hlth, Shanghai 200025, Peoples R China.	qianbiyun@sjtu.edu.cn	Liu, Ben/AAZ-4649-2021	Liu, Ben/0000-0001-8452-5397; Mohan, Man/0000-0002-8811-8542	National Natural Science Foundation of China [81573231]; Natural Science Foundation of Shanghai [15ZR1424400]; National Human Genetic Resources Sharing Service Platform [2005DKA21300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); National Human Genetic Resources Sharing Service Platform	This work was supported by the National Natural Science Foundation of China (Grant no. 81573231), Natural Science Foundation of Shanghai (Grant no.15ZR1424400), National Human Genetic Resources Sharing Service Platform(2005DKA21300). We thank Cancer Biobank of Tianjin Medical University Cancer Institute and Hospital for providing the biological samples. We thank Cancer Biobank of Tianjin Medical University Cancer Institute and Hospital for providing the biological samples.	Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; Han JY, 2014, PHARMACOGENOMICS J, V14, P20, DOI 10.1038/tpj.2013.7; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hong QY, 2015, CANCER-AM CANCER SOC, V121, P3080, DOI 10.1002/cncr.29584; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Koshikawa K, 2002, ONCOGENE, V21, P2822, DOI 10.1038/sj.onc.1205405; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Liu B, 2015, ONCOTARGET, V6, P9445, DOI 10.18632/oncotarget.3255; Liu SG, 2015, GENET MOL RES, V14, P4469, DOI 10.4238/2015.May.4.4; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McKay JD, 2017, NAT GENET, V49, P1126, DOI 10.1038/ng.3892; Pashos EE, 2017, CELL STEM CELL, V20, P558, DOI 10.1016/j.stem.2017.03.017; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rimkunas VM, 2012, CLIN CANCER RES, V18, P4449, DOI 10.1158/1078-0432.CCR-11-3351; Ryan BM, 2015, CANCER RES, V75, P566, DOI 10.1158/0008-5472.CAN-14-2101; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Xie D, 2013, CELL, V155, P713, DOI 10.1016/j.cell.2013.09.043; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Zhang XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041930	25	17	18	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	20					4092	4102		10.1038/s41388-020-1278-4	http://dx.doi.org/10.1038/s41388-020-1278-4		MAR 2020	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LN3GC	32231272	Green Published, hybrid			2022-12-26	WOS:000522380700001
J	Johnsen, SAL; Bollmann, J				Johnsen, Simen Alexander Linge; Bollmann, Jorg			Coccolith mass and morphology of different Emiliania huxleyi morphotypes: A critical examination using Canary Islands material	PLOS ONE			English	Article							CARBONATE CHEMISTRY; OCEAN ACIDIFICATION; CALCITE PRODUCTION; CO2 CONCENTRATION; STANDING STOCKS; SOUTHERN-OCEAN; CALCIFICATION; SYSTEM; VOLUME; BLOOM	Different morphotypes of the abundant marine calcifying algal species Emiliania huxleyi are commonly linked to various degrees of E. huxleyi calcification, but few studies have been done to validate this assumption. This study investigated therefore whether E. huxleyi morphotypes can be related to coccolithophore calcification and coccolith mass. Samples from January (high productivity) and September (low productivity) 1997 at an open ocean and a coastal site near the Canary Islands were analysed using a combination of thickness measurements (Circular Polarizer Retardation estimates (CPR) method), Scanning Electron Microscope imaging, and Markov Chain Monte Carlo (MCMC) models. Mean E. huxleyi coccolith mass varied from a maximum of 2.9pg at the open ocean station in January to a minimum of 1.7pg in September at both stations. In contrast, overall calcite produced by E. huxleyi (assuming 23 coccoliths/cell) varied from a maximum of 2.6 mu gL(-1) at the coastal station in January to a minimum of 0.5 mu gL(-1) in September at the open ocean site. The relative abundance of "Overcalcified" Type A, Type A, Group B and malformed coccoliths was determined from SEM images. The mean coccolith mass of "Overcalcified" Type A was 2.0pg using the CPR-method, while mean mass of Type A and Group B coccoliths was determined using coccolith length measurements from SEM images and MCMC models relating thickness measurements to morphotype relative abundance. Type A cocccolith mass varied from a 1.6pg to 2.6pg and Group B coccolith mass varied from 1.5pg to 2.0pg. These results demonstrate that the coccolith mass of Type A, "Overcalcified" Type A, and Group B do not differ systematically and there is no systematic relationship between relative abundance of a morphotype and the overall calcite production of E. huxleyi. Therefore, morphotype appearance and relative abundance can not be uniformly used as reliable indicators of E. huxleyi calcification or calcite production.	[Johnsen, Simen Alexander Linge; Bollmann, Jorg] Univ Toronto, Dept Earth Sci, Toronto, ON, Canada	University of Toronto	Johnsen, SAL (corresponding author), Univ Toronto, Dept Earth Sci, Toronto, ON, Canada.	simen.johnsen@mail.utoronto.ca			NSERC through J. B.'s NSERC Discovery Grant; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada; E.U. project CANIGO [598]	NSERC through J. B.'s NSERC Discovery Grant; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada; E.U. project CANIGO	This work was funded by NSERC through J. B.'s NSERC Discovery Grant [https://www.nserccrsng.gc.ca/] and by the Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada. Sampling was funded by the E.U. 598 project CANIGO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes F, 2002, DEEP-SEA RES PT II, V49, P3599, DOI 10.1016/S0967-0645(02)00100-5; Agnini C, 2017, LETHAIA, V50, P58, DOI 10.1111/let.12176; Anabalon V, 2014, PROG OCEANOGR, V120, P320, DOI 10.1016/j.pocean.2013.10.015; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bach LT, 2015, BIOGEOSCIENCES, V12, P4939, DOI 10.5194/bg-12-4939-2015; Bach LT, 2012, BIOGEOSCIENCES, V9, P3449, DOI 10.5194/bg-9-3449-2012; BALCH WM, 1992, CONT SHELF RES, V12, P1353, DOI 10.1016/0278-4343(92)90059-S; Balch WM, 2000, DEEP-SEA RES PT II, V47, P1301, DOI 10.1016/S0967-0645(99)00145-9; Beaufort L, 2008, BIOGEOSCIENCES, V5, P1101, DOI 10.5194/bg-5-1101-2008; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Beaufort L, 2001, MAR MICROPALEONTOL, V43, P27, DOI 10.1016/S0377-8398(01)00020-2; Bollmann J, 2014, BIOGEOSCIENCES, V11, P1899, DOI 10.5194/bg-11-1899-2014; Bollmann J, 2002, MAR MICROPALEONTOL, V44, P163, DOI 10.1016/S0377-8398(01)00040-8; Bollmann J., 2013, BIOGEOSCIENCES DISCU, V10, P11155, DOI [DOI 10.5194/BGD-10-11155-2013, 10.5194/bgd-10-11155-2013]; Bollmann J, 2007, AM GEOPH UN FALL M 2; Bollmann J., 2013, BIOGEOSCIENCES DISCU, V10, pC6961; Cachao Mario, 2000, Journal of Nannoplankton Research, V22, P29; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Charalampopoulou A, 2016, BIOGEOSCIENCES, V13, P5917, DOI 10.5194/bg-13-5917-2016; Cook DI, 2003, PROCEEDINGS OF THE 3RD FEDERATION OF EUROPEAN PHYSIOLOGICAL SOCIETIES (FEPS), P1; CRAIG DB, 1961, AM MINERAL, V46, P757; Cubillos JC, 2007, MAR ECOL PROG SER, V348, P47, DOI 10.3354/meps07058; D'Amario B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201161; Davenport R, 2002, DEEP-SEA RES PT II, V49, P3481, DOI 10.1016/S0967-0645(02)00095-4; De Bodt C, 2010, BIOGEOSCIENCES, V7, P1401, DOI 10.5194/bg-7-1401-2010; DERICHE R, 1987, INT J COMPUT VISION, V1, P167, DOI 10.1007/BF00123164; Engel A, 2005, LIMNOL OCEANOGR, V50, P493, DOI 10.4319/lo.2005.50.2.0493; Fabry V. L., 2010, GUIDE BEST PRACTICES, P201, DOI DOI 10.2777/66906; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feng Y. B., 2014, THESIS; Feng YY, 2017, LIMNOL OCEANOGR, V62, P519, DOI 10.1002/lno.10442; Fiorini S, 2011, J PHYCOL, V47, P1281, DOI 10.1111/j.1529-8817.2011.01080.x; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Gomez-Gesteira M, 2008, ANN NY ACAD SCI, V1146, P320, DOI 10.1196/annals.1446.004; Gonzalez-Davila M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001993; Gonzalez-Lemos S, 2018, BIOGEOSCIENCES, V15, P1079, DOI 10.5194/bg-15-1079-2018; Hagino K, 2005, MAR MICROPALEONTOL, V55, P19, DOI 10.1016/j.marmicro.2005.02.002; Hagino K, 2011, J PHYCOL, V47, P1164, DOI 10.1111/j.1529-8817.2011.01053.x; Haidar AT, 2000, DEEP-SEA RES PT II, V47, P1907, DOI 10.1016/S0967-0645(00)00011-4; Hansen E. W., 1988, Proceedings of the SPIE - The International Society for Optical Engineering, V891, P190, DOI 10.1117/12.944306; Hogg DW, 2018, ASTROPHYS J SUPPL S, V236, DOI 10.3847/1538-4365/aab76e; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Iglesias-Rodriguez MD, 2008, SCIENCE, V322, DOI 10.1126/science.1161501; Irish Marine Data Centre, 2000, CANIGO PROJ DAT; Johnsen SAL, 2018, J MICROSC-OXFORD, V269, P321, DOI 10.1111/jmi.12641; Johnsen SAL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220725; Jones BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061868; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; KNAPPERTSBUSCH M, 1993, MAR MICROPALEONTOL, V21, P219, DOI 10.1016/0377-8398(93)90016-Q; Knoll M, 1998, ESTOC CANIGO CRUISES; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Langer Gerald, 2011, Journal of Nannoplankton Research, V32, P29; Leon P, 2018, ESTUAR COAST SHELF S, V202, P302, DOI 10.1016/j.ecss.2018.01.011; Lochte AA, 2014, SINGLE COCCOLITH WEI; Matson PG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162313; McClelland HLO, 2016, SCI REP-UK, V6, DOI 10.1038/srep34263; MCINTYRE A, 1967, DEEP-SEA RES, V14, P561, DOI 10.1016/0011-7471(67)90065-4; Medlin LK, 1996, J MARINE SYST, V9, P13, DOI 10.1016/0924-7963(96)00013-9; Meier KJS, 2014, BIOGEOSCIENCES, V11, P2857, DOI 10.5194/bg-11-2857-2014; Muller MN, 2015, MAR ECOL PROG SER, V531, P81, DOI 10.3354/meps11309; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Paasche E, 1996, PHYCOLOGIA, V35, P394, DOI 10.2216/i0031-8884-35-5-394.1; PAASCHE E, 1994, PHYCOLOGIA, V33, P324, DOI 10.2216/i0031-8884-33-5-324.1; PAASCHE E, 1963, PHYSIOL PLANTARUM, V16, P186, DOI 10.1111/j.1399-3054.1963.tb08302.x; Parnell A., 2017, LARGE SET JAGS EXAMP; Parrilla G, 2002, DEEP-SEA RES PT II, V49, P3409, DOI 10.1016/S0967-0645(02)00104-2; Pelegri JL, 2005, J MARINE SYSTEMS, V54; Poulton AJ, 2013, GLOBAL BIOGEOCHEM CY, V27, P1023, DOI 10.1002/2013GB004641; Poulton AJ, 2011, MAR ECOL PROG SER, V443, P1, DOI 10.3354/meps09445; Richier S, 2011, MAR BIOL, V158, P551, DOI 10.1007/s00227-010-1580-8; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U, 2008, SCIENCE, V322, DOI 10.1126/science.1161096; Smith HEK, 2012, P NATL ACAD SCI USA, V109, P8845, DOI 10.1073/pnas.1117508109; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Stephens M, 2000, J ROY STAT SOC B, V62, P795, DOI 10.1111/1467-9868.00265; SWANN MM, 1950, J EXP BIOL, V27, P226; Triantaphyllou M, 2010, GEOBIOS-LYON, V43, P99, DOI 10.1016/j.geobios.2009.09.002; VANBLEIJSWIJK JDL, 1994, SARSIA, V79, P307, DOI 10.1080/00364827.1994.10413563; von Dassow P, 2018, BIOGEOSCIENCES, V15, P1515, DOI 10.5194/bg-15-1515-2018; WESTBROEK P, 1993, GLOBAL PLANET CHANGE, V8, P27, DOI 10.1016/0921-8181(93)90061-R; Young JR, 2014, BIOGEOSCIENCES, V11, P4771, DOI 10.5194/bg-11-4771-2014; YOUNG JR, 1991, MAR MICROPALEONTOL, V18, P5, DOI 10.1016/0377-8398(91)90004-P; Young JR, 2000, DEEP-SEA RES PT II, V47, P1679, DOI 10.1016/S0967-0645(00)00003-5; Young JR, CENOZOIC MODERN COCC; Zondervan I, 2002, J EXP MAR BIOL ECOL, V272, P55, DOI 10.1016/S0022-0981(02)00037-0	86	8	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0230569	10.1371/journal.pone.0230569	http://dx.doi.org/10.1371/journal.pone.0230569			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218602	Green Published, gold			2022-12-26	WOS:000535935400013
J	van Woerden, I; Brewis, A; Hruschka, D; Dunton, G; Adams, MA; Bruening, M				van Woerden, Irene; Brewis, Alexandra; Hruschka, Daniel; Dunton, Genevieve; Adams, Marc A.; Bruening, Meg			Young adults' BMI and changes in romantic relationship status during the first semester of college	PLOS ONE			English	Article							BODY-MASS INDEX; WEIGHT; OBESITY; DISCRIMINATION; STIGMA; SELECTION; MARRIAGE; FAT; SEX	Purpose Identify how higher Body Mass Index (BMI) and weight discrimination are associated with romantic relationship formation and termination in young adults, and if the association was consistent for males and females. Methods First-year students (N = 1096) at entry to university (Time 1) provided BMI and self-reports of weight discrimination and romantic relationship status (in a relationship vs single); 550 were successfully resampled four months later (Time 2). Logistic generalized estimating equations (GEEs) examined if Time 1 relationship status was predicted by BMI and weight discrimination. Logistic GEEs were used to determine if Time 1 BMI and weight discrimination predicted Time 2 relationship status for the strata of students in, and out, of a relationship at Time 1. Results At baseline, students were less likely to be in a relationship if they had a higher BMI (OR = 0.94, 95% CI = 0.92, 0.96) or reported weight discrimination (OR = 0.69, 95% CI = 0.53, 0.90). When stratified by gender, the association between higher BMI and weight discrimination with relationship status was only observed for females. Longitudinally, a BMI-based selection effect was observed for romantic relationship formation, but not termination. Of the students who were single at Time 1, each one unit higher baseline BMI decreased the odds of the student transitioning to a relationship by 9% at Time 2 (OR = 0.91, 95% CI = 0.85, 0.96). When stratified by gender the association of higher BMI decreased odds of relationship formation was only significant for females. No weight discrimination differences for selection in or out of a romantic relationship were observed. Conclusions These findings suggest a weight-related selection effect for romantic relationship initiation, but not termination, in young female adults with lower BMIs. Weight discrimination was not associated with romantic relationship initiation or termination in this sample.	[van Woerden, Irene] Idaho State Univ, Coll Nursing, Pocatello, ID 83209 USA; [Brewis, Alexandra; Hruschka, Daniel] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA; [Dunton, Genevieve] Univ Southern Calif, Inst Hlth Promot & Dis Prevent, Los Angeles, CA 90007 USA; [Adams, Marc A.; Bruening, Meg] Arizona State Univ, Coll Hlth Solut, Phoenix, AZ 85004 USA	Idaho; Idaho State University; Arizona State University; Arizona State University-Tempe; University of Southern California; Arizona State University; Arizona State University-Downtown Phoenix	Bruening, M (corresponding author), Arizona State Univ, Coll Hlth Solut, Phoenix, AZ 85004 USA.	meg.bruening@asu.edu		van Woerden, Irene/0000-0001-6339-5335	National Institutes of Health Common Fund from the Office of the Director; Office of Behavioral and Social Sciences Research [1DP5OD017910]	National Institutes of Health Common Fund from the Office of the Director; Office of Behavioral and Social Sciences Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health Common Fund from the Office of the Director and the Office of Behavioral and Social Sciences Research (https://commonfund.nih.gov/earlyindependence), grant number 1DP5OD017910 (Principal Investigator: MB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health. The sponsors/funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogardus ES, 1933, SOCIOLOGY SOCIAL RES; Boyes AD, 2009, J SEX MARITAL THER, V35, P282, DOI 10.1080/00926230902851280; Bruening M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3536-5; Carr D, 2005, J HEALTH SOC BEHAV, V46, P244, DOI 10.1177/002214650504600303; Chen EY, 2005, OBES RES, V13, P1393, DOI 10.1038/oby.2005.168; Fielder RL, 2013, J ADOLESCENT HEALTH, V52, P657, DOI 10.1016/j.jadohealth.2012.09.001; Fikkan JL, 2012, SEX ROLES, V66, P575, DOI 10.1007/s11199-011-0022-5; Garcia JR., 2008, J SOC EVOL CULT PSYC, V2, DOI [10.1037/h0099345, DOI 10.1037/H0099345]; Garcia JR, 2012, REV GEN PSYCHOL, V16, P161, DOI 10.1037/a0027911; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Grello CM, 2006, J SEX RES, V43, P255, DOI 10.1080/00224490609552324; Halpern CT, 2005, J RES ADOLESCENCE, V15, P535, DOI 10.1111/j.1532-7795.2005.00110.x; Hanson KL, 2014, MARRIAGE FAM REV, V50, P373, DOI 10.1080/01494929.2013.879555; Heatherton TF., 1993, PSYCHOL ADDICT BEHAV, V7, P225, DOI DOI 10.1037/0893-164X.7.4.225; Himmelstein MS, 2018, OBESITY; Jeffery RW, 2002, OBES RES, V10, P809, DOI 10.1038/oby.2002.109; Kaufman P., 2014, NEW DIR HIGHER EDUC, V2014, P35, DOI [10.1002/he.20093, DOI 10.1002/HE.20093]; Oreffice S, 2010, ECON HUM BIOL, V8, P373, DOI 10.1016/j.ehb.2010.05.001; Owen JJ, 2010, ARCH SEX BEHAV, V39, P653, DOI 10.1007/s10508-008-9414-1; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Roehling MV, 2007, J VOCAT BEHAV, V71, P300, DOI 10.1016/j.jvb.2007.04.008; Sheets Virgil, 2005, Eat Behav, V6, P1, DOI 10.1016/j.eatbeh.2004.08.008; Simpkins SD, 2013, J RES ADOLESCENCE, V23, P537, DOI 10.1111/j.1532-7795.2012.00836.x; Tang-Peronard JL, 2008, OBES REV, V9, P522, DOI 10.1111/j.1467-789X.2008.00509.x; The NS, 2009, OBESITY, V17, P1441, DOI 10.1038/oby.2009.97; Tomiyama AJ, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1116-5; Trainer S, 2015, HUM ORGAN, V74, P266, DOI 10.17730/0018-7259-74.3.266; Williams AL, 2013, FAM CONSUM SCI RES J, V41, P284, DOI 10.1111/fcsr.12020	29	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230806	10.1371/journal.pone.0230806	http://dx.doi.org/10.1371/journal.pone.0230806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8GI	32214397	Green Published, gold			2022-12-26	WOS:000535934200065
J	Habeck, C; Gazes, Y; Razlighi, Q; Stern, Y				Habeck, Christian; Gazes, Yunglin; Razlighi, Qolamreza; Stern, Yaakov			Cortical thickness and its associations with age, total cognition and education across the adult lifespan	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BRAIN STRUCTURE; INTELLIGENCE; RESERVE; SEGMENTATION; CORTEX; MODEL	Early-life education (years of schooling) has been investigated in regards to cognition, health outcomes and mortality. It has been shown to confer cognitive reserve that might lessen the impact of brain pathology and its impact on cognitive and motor functioning in a variety of neurodegenerative diseases and, for instance, to influence electrical activity [Begum, T., Reza, F., Ahmed, I., & Abdullah, J. M. (2014). Influence of education level on design-induced N170 and P300 components of event related potentials in the human brain. J Integr Neurosci, 13(1), 71-88. doi:10.1142/S0219635214500058]. On the other hand, demonstrations of a direct association between education and brain-structural measures have been more equivocal and scant. The current study sought to identify univariate cortical-thickness patterns underlying education and general intelligence after adjusting for age, gender and possible in-scanner movement in 353 individuals aged 40 to 80. We followed up this idea with multivariate analyses as well. For univariate analyses, our analyses yielded no robust associations between education and general intelligence beyond confounding effects of gender, age and extraneous in-scanner movement. A subsequent multivariate analyses showed a relationship between education and regional cortical thickness with a robust pattern of negative as well as positive loadings in several right-sided brain areas, speaking to a subtle but robust distributed effect of education on cortical thickness. Cortical thickness variance that is the residual of this education-related pattern was shown to be positively associated with age and extraneous in-scanner movement. Our study thus presents a complex picture of the association of education with regional cortical thickness: education was associated with a distributed brain-wide pattern of positive as well as negative loadings with unaccounted residuals being larger for older participants. Focal regional associations beyond demographic and age covariates were not identified.	[Habeck, Christian; Gazes, Yunglin; Razlighi, Qolamreza; Stern, Yaakov] Columbia Univ, Dept Neurol, Med Ctr, Cognit Neurosci Div, New York, NY 10027 USA	Columbia University	Habeck, C (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, Cognit Neurosci Div, New York, NY 10027 USA.	ch629@columbia.edu		Habeck, Christian/0000-0001-9961-7446	NIH/NIA [R01AG038465, R01AG026458]	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support from NIH/NIA grants R01AG038465 and R01AG026458 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Cho H, 2015, INT PSYCHOGERIATR, V27, P111, DOI 10.1017/S1041610214001483; Choi YY, 2008, J NEUROSCI, V28, P10323, DOI 10.1523/JNEUROSCI.3259-08.2008; Cox SR, 2016, NEUROLOGY, V87, P1820, DOI 10.1212/WNL.0000000000003247; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Ecker C, 2009, NEUROREPORT, V20, P1155, DOI 10.1097/WNR.0b013e32832ec181; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gazzina S, 2019, J NEUROL NEUROSUR PS, V90, P1124, DOI 10.1136/jnnp-2019-320439; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; Habeck C, 2017, CEREB CORTEX, V27, P3962, DOI 10.1093/cercor/bhw208; Habeck C, 2010, CELL BIOCHEM BIOPHYS, V58, P53, DOI 10.1007/s12013-010-9093-0; Habeck Christian Georg, 2010, J Vis Exp, DOI 10.3791/1988; Hayes A. F., 2013, INTRO MEDIATION HAYE; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hurtz S, 2014, DEMENT GER COGN D EX, V4, P221, DOI 10.1159/000362872; Kim JP, 2015, NEUROLOGY, V85, P806, DOI 10.1212/WNL.0000000000001884; Lee JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24284; Liu YW, 2012, NEURORADIOLOGY, V54, P929, DOI 10.1007/s00234-012-1005-0; Mattis S., 2002, DEMENTIA RATING SCAL; McGinnis SM, 2011, BRAIN TOPOGR, V24, P279, DOI 10.1007/s10548-011-0198-6; MOELLER JR, 1987, J CEREBR BLOOD F MET, V7, P649, DOI 10.1038/jcbfm.1987.118; Mungas D, 2018, NEUROBIOL AGING, V68, P142, DOI 10.1016/j.neurobiolaging.2018.04.002; Park H, 2014, COMPUT BIOL MED, V47, P139, DOI 10.1016/j.compbiomed.2014.02.003; Park S, 2015, J CHILD NEUROL, V30, P1757, DOI 10.1177/0883073815579710; Perneczky R, 2009, J ALZHEIMERS DIS, V17, P855, DOI 10.3233/JAD-2009-1117; Pillai JA, 2012, J CLIN EXP NEUROPSYC, V34, P925, DOI 10.1080/13803395.2012.702733; Raven J., 1962, ADV PROGR MATRICES S; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ritchie SJ, 2015, INTELLIGENCE, V51, P47, DOI 10.1016/j.intell.2015.05.001; Savalia NK, 2017, HUM BRAIN MAPP, V38, P472, DOI 10.1002/hbm.23397; Schnack HG, 2015, CEREB CORTEX, V25, P1608, DOI 10.1093/cercor/bht357; Shaw ME, 2016, NEUROBIOL AGING, V39, P202, DOI 10.1016/j.neurobiolaging.2015.12.009; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; Stern Y, 2013, FOLIA PHONIATR LOGO, V65, P49, DOI 10.1159/000353443; Uttl B, 2002, J CLIN EXP NEUROPSYC, V24, P1123, DOI 10.1076/jcen.24.8.1123.8375; Valizadeh SA, 2017, HUM BRAIN MAPP, V38, P997, DOI 10.1002/hbm.23434; Wechsler D., 1997, WECHSLER ADULT INTEL	39	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230298	10.1371/journal.pone.0230298	http://dx.doi.org/10.1371/journal.pone.0230298			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210453	gold, Green Published			2022-12-26	WOS:000535307600019
J	Kozlova, V; Ledererova, A; Ladungova, A; Peschelova, H; Janovska, P; Slusarczyk, A; Domagala, J; Kopcil, P; Vakulova, V; Oppelt, J; Bryja, V; Doubek, M; Mayer, J; Pospisilova, S; Smida, M				Kozlova, Veronika; Ledererova, Aneta; Ladungova, Adriana; Peschelova, Helena; Janovska, Pavlina; Slusarczyk, Aleksander; Domagala, Joanna; Kopcil, Pavel; Vakulova, Viera; Oppelt, Jan; Bryja, Vitezslav; Doubek, Michael; Mayer, Jiri; Pospisilova, Sarka; Smida, Michal			CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; ACTIVATION; EXPRESSION; PYK2; LYMPHOMA; MOLECULE; CHANNEL; ANTIGEN	Surface protein CD20 serves as the critical target of immunotherapy in various B-cell malignancies for decades, however its biological function and regulation remain largely elusive. Better understanding of CD20 function may help to design improved rational therapies to prevent development of resistance. Using CRISPR/Cas9 technique, we have abrogated CD20 expression in five different malignant B-cell lines. We show that CD20 deletion has no effect upon B-cell receptor signaling or calcium flux. Also B-cell survival and proliferation is unaffected in the absence of CD20. On the contrary, we found a strong defect in actin cytoskeleton polymerization and, consequently, defective cell adhesion and migration in response to homeostatic chemokines SDF1 alpha, CCL19 and CCL21. Mechanistically, we could identify a reduction in chemokine-triggered PYK2 activation, a calcium-activated signaling protein involved in activation of MAP kinases and cytoskeleton regulation. These cellular defects in consequence result in a severely disturbed homing of B cells in vivo.	[Kozlova, Veronika; Ledererova, Aneta; Ladungova, Adriana; Peschelova, Helena; Kopcil, Pavel; Vakulova, Viera; Oppelt, Jan; Doubek, Michael; Mayer, Jiri; Pospisilova, Sarka; Smida, Michal] Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic; [Kozlova, Veronika; Ledererova, Aneta; Doubek, Michael; Mayer, Jiri; Pospisilova, Sarka; Smida, Michal] Masaryk Univ, Med Fac, Dept Internal Med Hematol & Oncol, Brno, Czech Republic; [Kozlova, Veronika; Ledererova, Aneta; Doubek, Michael; Mayer, Jiri; Pospisilova, Sarka; Smida, Michal] Univ Hosp Brno, Brno, Czech Republic; [Janovska, Pavlina; Bryja, Vitezslav] Masaryk Univ, Fac Sci, Dept Expt Biol, Brno, Czech Republic; [Slusarczyk, Aleksander; Domagala, Joanna] Med Univ Warsaw, Dept Immunol, Warsaw, Poland	Masaryk University Brno; Masaryk University Brno; University Hospital Brno; Masaryk University Brno; Medical University of Warsaw	Smida, M (corresponding author), Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic.; Smida, M (corresponding author), Masaryk Univ, Med Fac, Dept Internal Med Hematol & Oncol, Brno, Czech Republic.; Smida, M (corresponding author), Univ Hosp Brno, Brno, Czech Republic.	michal.smida@ceitec.muni.cz	Pospisilova, Sarka/D-7200-2012; Ślusarczyk, Aleksander/GQI-2548-2022; Janovska, Pavlina/AAM-2683-2020; Oppelt, Jan/H-7388-2017; Smida, Michal/J-5046-2014	Pospisilova, Sarka/0000-0001-7136-2680; Oppelt, Jan/0000-0002-3076-4840; Smida, Michal/0000-0002-7335-3435	Ministry of Health of the Czech Republic [15-33561A]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This research was supported by the Ministry of Health of the Czech Republic, grant nr. 15-33561A. All rights reserved. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMASRI NM, 1992, AM J HEMATOL, V40, P259, DOI 10.1002/ajh.2830400404; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews S., 2010, FASTQC QUALITY CONTR; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Bobrowicz M, 2017, BLOOD, V130, P1628, DOI [10.1182/blood-2016-08-736066, 10.1182/blood-2016-08736066]; BUBIEN JK, 1993, J CELL BIOL, V121, P1121, DOI 10.1083/jcb.121.5.1121; CAO L, 1995, IMMUNOBIOLOGY, V193, P1; de Jong MRW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193098; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Gismondi A, 2003, J IMMUNOL, V170, P3065, DOI 10.4049/jimmunol.170.6.3065; Hiraga J, 2009, BLOOD, V113, P4885, DOI 10.1182/blood-2008-08-175208; Ivanov A, 2009, J CLIN INVEST, V119, P2143, DOI 10.1172/JCI37884; Kanzaki M, 1997, J BIOL CHEM, V272, P14733, DOI 10.1074/jbc.272.23.14733; Kim CH, 1999, J LEUKOCYTE BIOL, V65, P6, DOI 10.1002/jlb.65.1.6; Kuijpers TW, 2010, J CLIN INVEST, V120, P214, DOI 10.1172/JCI40231; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li HD, 2003, J BIOL CHEM, V278, P42427, DOI 10.1074/jbc.M308802200; Lim SH, 2010, HAEMATOL-HEMATOL J, V95, P135, DOI 10.3324/haematol.2008.001628; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; O'Keefe TL, 1998, IMMUNOGENETICS, V48, P125, DOI 10.1007/s002510050412; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Pavlasova G, 2018, LEUKEMIA, V32, P2028, DOI 10.1038/s41375-018-0211-0; Pavlasova G, 2016, BLOOD, V128, P1609, DOI 10.1182/blood-2016-04-709519; Polyak MJ, 2008, J BIOL CHEM, V283, P18545, DOI 10.1074/jbc.M800784200; REFF ME, 1994, BLOOD, V83, P435; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; TEDDER TE, 1994, IMMUNOL TODAY, V15, P450, DOI 10.1016/0167-5699(94)90276-3; TEDDER TF, 1985, J IMMUNOL, V135, P973; Uchida J, 2004, INT IMMUNOL, V16, P119, DOI 10.1093/intimm/dxh009; Winiarska M, 2012, J BIOL CHEM, V287, P31983, DOI 10.1074/jbc.M112.374751; Young RM, 2013, NAT REV DRUG DISCOV, V12, P229, DOI 10.1038/nrd3937	34	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0229170	10.1371/journal.pone.0229170	http://dx.doi.org/10.1371/journal.pone.0229170			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210425	gold, Green Published			2022-12-26	WOS:000535307600007
J	Zarraga-Granados, G; Mucino-Hernandez, G; Sanchez-Carbente, MR; Villamizar-Galvez, W; Penas-Rincon, A; Arredondo, C; Andres, ME; Wood, C; Covarrubias, L; Castro-Obregon, S				Zarraga-Granados, Gabriela; Mucino-Hernandez, Gabriel; Sanchez-Carbente, Maria R.; Villamizar-Galvez, Wendy; Penas-Rincon, Ana; Arredondo, Cristian; Andres, Maria E.; Wood, Christopher; Covarrubias, Luis; Castro-Obregon, Susana			The nuclear receptor NR4A1 is regulated by SUMO modification to induce autophagic cell death	PLOS ONE			English	Article							NEURONAL DEATH; SUBSTANCE-P; PATHWAY; NUR77; UBIQUITINATION; TRANSCRIPTION; INFLAMMATION; FORM	NR4A is a nuclear receptor protein family whose members act as sensors of cellular environment and regulate multiple processes such as metabolism, proliferation, migration, apoptosis, and autophagy. Since the ligand binding domains of these receptors have no cavity for ligand interaction, their function is most likely regulated by protein abundance and post-translational modifications. In particular, NR4A1 is regulated by protein abundance, phosphorylation, and subcellular distribution (nuclear-cytoplasmic translocation), and acts both as a transcription factor and as a regulator of other interacting proteins. SUMOylation is a post-translational modification that can affect protein stability, transcriptional activity, alter protein-protein interactions and modify intracellular localization of target proteins. In the present study we evaluated the role of SUMOylation as a posttranslational modification that can regulate the activity of NR4A1 to induce autophagy-dependent cell death. We focused on a model potentially relevant for neuronal cell death and demonstrated that NR4A1 needs to be SUMOylated to induce autophagic cell death. We observed that a triple mutant in SUMOylation sites has reduced SUMOylation, increased transcriptional activity, altered intracellular distribution, and more importantly, its ability to induce autophagic cell death is impaired.	[Zarraga-Granados, Gabriela; Mucino-Hernandez, Gabriel; Villamizar-Galvez, Wendy; Penas-Rincon, Ana; Castro-Obregon, Susana] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neurodesarrollo & Fisiol, Div Neurociencias, Mexico City, DF, Mexico; [Sanchez-Carbente, Maria R.] Univ Autonoma Estado Morelos, Biotechnol Res Ctr, Cuernavaca, Morelos, Mexico; [Arredondo, Cristian; Andres, Maria E.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Santiago, Chile; [Wood, Christopher] UNAM, Inst Biotecnol, Lab Nacl Microscopia Avanzada, Cuernavaca, Morelos, Mexico; [Covarrubias, Luis] UNAM, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos; Pontificia Universidad Catolica de Chile; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Castro-Obregon, S (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neurodesarrollo & Fisiol, Div Neurociencias, Mexico City, DF, Mexico.	scastro@ifc.unam.mx	Wood, Christopher D/H-5606-2012; Castro-Obregon, Susana/AAE-5105-2020	Wood, Christopher D/0000-0001-7175-7121; 	CONACyT [CB2013-220515, FC-921, 255401, 588372]; PAPIIT/UNAM [IN206015, IN206518]; ICGEB [MEX03/06]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT/UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); ICGEB	CONACyT CB2013-220515 and FC-921; PAPIIT/UNAM IN206015 and IN206518 to SCO. Collaboration between UNAM and Pontificia Universidad Catolica de Chile was fostered by ICGEB MEX03/06 grant to SCO. CONACyT fellowship was awarded to GZG (255401) and GMH (588372).	Arredondo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055035; Beard JA, 2015, CELL SIGNAL, V27, P257, DOI 10.1016/j.cellsig.2014.11.009; Bouzas-Rodriguez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046422; Bridi MS, 2013, NEUROBIOL LEARN MEM, V105, P151, DOI 10.1016/j.nlm.2013.06.020; Castro-Obregon S, 2002, CELL DEATH DIFFER, V9, P807, DOI 10.1038/sj.cdd.4401035; Chiocca S, 2007, BIOCHEM SOC T, V35, P1419, DOI 10.1042/BST0351419; Droescher M, 2013, NEUROMOL MED, V15, P639, DOI 10.1007/s12017-013-8258-6; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Godoi PHC, 2016, J BIOL CHEM, V291, P14072, DOI 10.1074/jbc.M116.715235; Hannoun Z, 2010, TOXICOLOGY, V278, P288, DOI 10.1016/j.tox.2010.07.013; Hawk JD, 2012, J CLIN INVEST, V122, P3593, DOI 10.1172/JCI64145; Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Honkaniemi J, 1999, EUR J NEUROSCI, V11, P10, DOI 10.1046/j.1460-9568.1999.00401.x; Hu MJ, 2017, MOL CELL, V66, P141, DOI 10.1016/j.molcel.2017.03.008; Kanzleiter T, 2009, BBA-MOL BASIS DIS, V1792, P777, DOI 10.1016/j.bbadis.2009.05.002; Katagiri Y, 2000, NAT CELL BIOL, V2, P435, DOI 10.1038/35017072; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kurakula K, 2014, BBA-MOL CELL RES, V1843, P2543, DOI 10.1016/j.bbamcr.2014.06.010; Liu HT, 1999, P NATL ACAD SCI USA, V96, P12096, DOI 10.1073/pnas.96.21.12096; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Malewicz M, 2011, GENE DEV, V25, P2031, DOI 10.1101/gad.16872411; Mohan HM, 2012, CLIN CANCER RES, V18, P3223, DOI 10.1158/1078-0432.CCR-11-2953; Munoz M, 2014, AMINO ACIDS, V46, P1727, DOI 10.1007/s00726-014-1736-9; Oita RC, 2009, MECH AGEING DEV, V130, P240, DOI 10.1016/j.mad.2008.12.004; Paillasse MR, 2015, MED HYPOTHESES, V84, P135, DOI 10.1016/j.mehy.2014.12.003; Pawlak A, 2015, STEROIDS, V95, P1, DOI 10.1016/j.steroids.2014.12.020; Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016; Qin HP, 2019, INT J MOL MED, V44, P25, DOI 10.3892/ijmm.2019.4184; Raman N, 2013, CHROMOSOMA, V122, P475, DOI 10.1007/s00412-013-0429-6; Rao RV, 2004, J BIOL CHEM, V279, P177, DOI 10.1074/jbc.M304490200; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Segala G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01948-9; Silvente-Poirot S, 2018, AUTOPHAGY, V14, P555, DOI 10.1080/15548627.2018.1425059; Slagsvold HH, 2002, BIOCHEM BIOPH RES CO, V291, P1146, DOI 10.1006/bbrc.2002.6579; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Turner RJ, 2013, BRAIN SCI, V3, P123, DOI 10.3390/brainsci3010123; Walton M, 1999, BRAIN RES REV, V29, P137, DOI 10.1016/S0165-0173(98)00053-8; Wang WJ, 2014, NAT CHEM BIOL, V10, P133, DOI [10.1038/nchembio.1406, 10.1038/NCHEMBIO.1406]; Wasik U, 2014, BIOCH BIOPHYS ACTA; Wingate AD, 2006, BIOCHEM SOC T, V34, P1107, DOI 10.1042/BST0341107; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Wu WS, 2002, ONCOGENE, V21, P3925, DOI 10.1038/sj.onc.1205491; Zhang H, 2015, TRENDS CELL BIOL, V25, P376, DOI 10.1016/j.tcb.2015.03.001; Zhang L, 2017, CELL DEATH DIFFER, V24, P1530, DOI 10.1038/cdd.2017.29	46	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0222072	10.1371/journal.pone.0222072	http://dx.doi.org/10.1371/journal.pone.0222072			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210435	Green Published, gold, Green Submitted			2022-12-26	WOS:000535307600002
J	Zheng, MB; Campbell, KJ; Scanlan, E; McNaughton, SA				Zheng, Miaobing; Campbell, Karen J.; Scanlan, Emily; McNaughton, Sarah A.			Development and evaluation of a food frequency questionnaire for use among young children	PLOS ONE			English	Article							DIETARY ASSESSMENT METHODS; MULTIPLE-PASS METHOD; RELATIVE VALIDITY; SEMIQUANTITATIVE FFQ; TOTAL-ENERGY; SELF-REPORT; OBESITY; CHILDHOOD; REPRODUCIBILITY; VALIDATION	Background/Objectives This study described the development of a parent food frequency questionnaire (FFQ) for measuring diets of young children over the past month and the validation of this FFQ against three non-consecutive 24 hour recalls. Subjects/Methods Food and nutrient intakes from a 68-item FFQ were compared with three non-consecutive 24 hour recalls in a follow-up cohort of children aged 1.5, 3.5 and 5.0 years old. Data from both methods were available for 231, 172 and 187 participants at ages 1.5, 3.5 and 5.0 years, respectively. Results Out of 11 nutrients, four (protein, fat, fibre, iron), two (Vitamin C, folate) and three (protein, vitamin C and folate) nutrients showed good-acceptable outcome for 2 out of 3 group-level validation tests at ages 1.5, 3.5 and 5.0 years, respectively. Of 26 food groups, good-acceptable outcome for 2 out of 3 group-level validation tests was revealed for two, four and six food groups at ages 1.5, 3.5 and 5.0 years, respectively. For individual-level validation tests, all nutrients showed good-acceptable outcome for 2 out of 3 individual level tests across three time points, except for folate at age 1.5 years and energy intake at age 3.5 years. Most food groups (22 out of 26) at age 1.5 years and all food groups at both ages 3.5 and 5.0 years showed good-acceptable outcome for 2 out of 3 individual-level validation tests. Conclusions At all three time points, the FFQ demonstrated good-acceptable validity for some nutrients and food groups at group-level, and good-acceptable validity for most nutrients and food groups at individual-level. This quantitative FFQ is a valid and robust tool for assessing total diet of young children and ranking individuals according to nutrient and food intakes.	[Zheng, Miaobing; Campbell, Karen J.; Scanlan, Emily; McNaughton, Sarah A.] Deakin Univ, Inst Phys Act & Nutr IPAN, Sch Exercise & Nutr Sci, Burwood, Vic, Australia	Deakin University	Zheng, MB (corresponding author), Deakin Univ, Inst Phys Act & Nutr IPAN, Sch Exercise & Nutr Sci, Burwood, Vic, Australia.	j.zheng@deakin.edu.au	McNaughton, Sarah A/B-2075-2012	McNaughton, Sarah A/0000-0001-5936-9820	Australian National Health Research Medical Council Early Career Fellowship [GNT1124283]	Australian National Health Research Medical Council Early Career Fellowship	MZ is supported by an Australian National Health Research Medical Council Early Career Fellowship (GNT1124283).	Ambrosini GL, 2014, OBESITY, V22, P458, DOI 10.1002/oby.20542; Andersen LF, 2004, PUBLIC HEALTH NUTR, V7, P757, DOI 10.1079/PHN2004613; Andersen LF, 2003, EUR J CLIN NUTR, V57, P881, DOI 10.1038/sj.ejcn.1601621; [Anonymous], 2007, AUSTR FOOD SUPPLEMEN; Bell LK, 2014, BRIT J NUTR, V112, P627, DOI 10.1017/S0007114514001184; Bell LK, 2013, J OBES, V2013, DOI 10.1155/2013/709626; Bennett CA, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-71; Blanton CA, 2006, J NUTR, V136, P2594, DOI 10.1093/jn/136.10.2594; Brisbois TD, 2012, OBES REV, V13, P347, DOI 10.1111/j.1467-789X.2011.00965.x; Buch-Andersen T, 2016, PUBLIC HEALTH NUTR, V19, P1184, DOI 10.1017/S136898001500275X; Burrows TL, 2010, J AM DIET ASSOC, V110, P1501, DOI 10.1016/j.jada.2010.07.008; Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318; Campbell K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-103; Campbell KJ, 2013, PEDIATRICS, V131, P652, DOI 10.1542/peds.2012-2576; Carter RC, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0411-5; Collins CE, 2006, ARCH PEDIAT ADOL MED, V160, P906, DOI 10.1001/archpedi.160.9.906; Collins CE, 2013, J ACAD NUTR DIET, V113, P459, DOI 10.1016/j.jand.2012.09.021; Conway JM, 2003, AM J CLIN NUTR, V77, P1171, DOI 10.1093/ajcn/77.5.1171; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Devenish G, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111361; Flood VM, 2014, PUBLIC HEALTH NUTR, V17, P498, DOI 10.1017/S1368980013000414; Giles GG, 1996, DIETARY QUESTIONNAIR; Golley RK, 2017, J HUM NUTR DIET, V30, P36, DOI 10.1111/jhn.12399; Hebert JR, 2001, ANN EPIDEMIOL, V11, P417, DOI 10.1016/S1047-2797(01)00212-5; HEBERT JR, 1995, INT J EPIDEMIOL, V24, P389, DOI 10.1093/ije/24.2.389; Hesketh KD, 2013, CONTEMP CLIN TRIALS, V34, P145, DOI 10.1016/j.cct.2012.10.008; Huybrechts I, 2009, INT J ENV RES PUB HE, V6, P382, DOI 10.3390/ijerph6010382; Koleilat M, 2016, J ACAD NUTR DIET, V116, P931, DOI 10.1016/j.jand.2016.02.014; Lioret S, 2013, EUR J CLIN NUTR, V67, P275, DOI 10.1038/ejcn.2012.218; Lombard MJ, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0027-y; Lovell A, 2017, J NUTR SCI, V6, DOI 10.1017/jns.2017.12; Madruga SW, 2012, REV SAUDE PUBL, V46, P376, DOI 10.1590/S0034-89102012005000016; Magarey A, 2011, INT J PEDIATR OBES, V6, P2, DOI 10.3109/17477161003728469; Mameli C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090838; Marriott LD, 2009, PUBLIC HEALTH NUTR, V12, P967, DOI 10.1017/S1368980008003388; Mikkila V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418; Nelson M., 1997, DESIGN CONCEPTS NUTR, P123; Shim JS, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014009; Siega-Riz AM, 2010, J AM DIET ASSOC, V110, pS38, DOI 10.1016/j.jada.2010.09.001; Sochacka-Tatara E, 2014, PUBLIC HEALTH NUTR, V17, P1738, DOI 10.1017/S1368980013002292; STRYKER WS, 1991, J AM DIET ASSOC, V91, P172; Subar AF, 2015, J NUTR, V145, P2639, DOI 10.3945/jn.115.219634; Tabacchi G, 2016, PUBLIC HEALTH NUTR, V19, P1168, DOI 10.1017/S1368980015002505; Tabacchi G, 2014, PUBLIC HEALTH NUTR, V17, P2700, DOI 10.1017/S1368980013003157; Vioque J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167338; WHO, 2006, WHO CHILD GROWTH STA; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd, DOI DOI 10.1093/ACPROF:OSO/9780199754038.001.0001; Willett W., 2012, NUTR EPIDEMIOLOGY, DOI [10.1097/EDE.0b013e31825afb0b, DOI 10.1097/EDE.0B013E31825AFB0B]; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	50	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230669	10.1371/journal.pone.0230669	http://dx.doi.org/10.1371/journal.pone.0230669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210467	Green Published, gold			2022-12-26	WOS:000535307600041
J	Binder, JL; Chander, P; Deretic, V; Weick, JP; Bhaskar, K				Binder, Jessica L.; Chander, Praveen; Deretic, Vojo; Weick, Jason P.; Bhaskar, Kiran			Optical induction of autophagy via Transcription factor EB (TFEB) reduces pathological tau in neurons	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PHOSPHORYLATED TAU; GENE-EXPRESSION; PROTEIN-TAU; ACTIVATION; BRAIN; LIGHT; DEMENTIA; BINDING; TARGET	Pathological accumulation of microtubule associated protein tau in neurons is a major neuropathological hallmark of Alzheimer's disease (AD) and related tauopathies. Several attempts have been made to promote clearance of pathological tau (p-Tau) from neurons. Transcription factor EB (TFEB) has shown to clear p-Tau from neurons via autophagy. However, sustained TFEB activation and autophagy can create burden on cellular bioenergetics and can be deleterious. Here, we modified previously described two-plasmid systems of Light Activated Protein (LAP) from bacterial transcription factor-EL222 and Light Responsive Element (LRE) to encode TFEB. Upon blue-light (465 nm) illumination, the conformation changes in LAP induced LRE-driven expression of TFEB, its nuclear entry, TFEB-mediated expression of autophagy-lysosomal genes and clearance of p-Tau from neuronal cells and AD patient-derived human iPSC-neurons. Turning the blue-light off reversed the expression of TFEB-target genes and attenuated p-Tau clearance. Together, these results suggest that optically regulated TFEB expression unlocks the potential of opto-therapeutics to treat AD and other dementias.	[Binder, Jessica L.; Deretic, Vojo; Bhaskar, Kiran] Univ New Mexico, Dept Mol Genet & Microbiol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Chander, Praveen; Weick, Jason P.] Univ New Mexico, Dept Neurosci, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Deretic, Vojo] Univ New Mexico, Hlth Sci Ctr, Autophagy Inflammat & Metab Ctr Biomed Res Excell, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Bhaskar, K (corresponding author), Univ New Mexico, Dept Mol Genet & Microbiol, Hlth Sci Ctr, Albuquerque, NM 87131 USA.; Weick, JP (corresponding author), Univ New Mexico, Dept Neurosci, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	JPWeick@salud.unm.edu; KBhaskar@salud.unm.edu		Deretic, Vojo/0000-0002-3624-5208; Chander, Praveen/0000-0002-7682-3404	National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) [R21NS093442, R01NS083704, R21NS077089]; University of New Mexico (UNM) Health Sciences Center Bridge Funding; UNM Department of Molecular Genetics and Microbiology; Autophagy Inflammation and Metabolism (AIM) Center for Biomedical Research Excellence (CoBRE) Center from NIH [P20GM121176]	National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of New Mexico (UNM) Health Sciences Center Bridge Funding; UNM Department of Molecular Genetics and Microbiology; Autophagy Inflammation and Metabolism (AIM) Center for Biomedical Research Excellence (CoBRE) Center from NIH	This work was primarily funded by National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) R21NS093442. Additional support was from R01NS083704 and R21NS077089 from NIH/NINDS. Other funding support was also from University of New Mexico (UNM) Health Sciences Center Bridge Funding, UNM Department of Molecular Genetics and Microbiology intradepartmental grant funding, Dr. Stephanie Ruby travel award (to J.B.). This study was also supported in part by Autophagy Inflammation and Metabolism (AIM) Center for Biomedical Research Excellence (CoBRE) Center from NIH grant P20GM121176 (to V.D.).	Agholme L, 2012, J ALZHEIMERS DIS, V31, P343, DOI 10.3233/JAD-2012-120001; Barnett A, 2011, J ALZHEIMERS DIS, V25, P385, DOI 10.3233/JAD-2011-101989; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bielefeld Pascal, 2017, Neurogenesis (Austin), V4, pe1262934, DOI 10.1080/23262133.2016.1262934; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buee L, 1997, ANN NY ACAD SCI, V826, P7, DOI 10.1111/j.1749-6632.1997.tb48457.x; Chauhan S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9620; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Citron Bruce A, 2015, Am J Neurodegener Dis, V4, P40; Cortes CJ, 2014, NAT NEUROSCI, V17, P1180, DOI 10.1038/nn.3787; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; Deretic V, 2012, TRENDS CELL BIOL, V22, P397, DOI 10.1016/j.tcb.2012.04.008; Dumanchin C, 1998, HUM MOL GENET, V7, P1825, DOI 10.1093/hmg/7.11.1825; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Gaugler J, 2019, ALZHEIMERS DEMENT, V15, P321, DOI 10.1016/j.jalz.2019.01.010; Gong CX, 2008, CURR MED CHEM, V15, P2321, DOI 10.2174/092986708785909111; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hernandez F, 2013, J ALZHEIMERS DIS, V37, P507, DOI 10.3233/JAD-130545; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iqbal K, 2008, J ALZHEIMERS DIS, V14, P365; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Ittner A, 2018, NEURON, V99, P13, DOI 10.1016/j.neuron.2018.06.003; Jeong E, 2018, ELIFE, V7, DOI 10.7554/eLife.40856; Kadavath H, 2015, P NATL ACAD SCI USA, V112, P7501, DOI 10.1073/pnas.1504081112; Khayati K, 2017, FASEB J, V31, P598, DOI 10.1096/fj.201600915R; Kim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24933; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liu B, 2014, NEURAL REGEN RES, V9, P1288, DOI 10.4103/1673-5374.137576; Lu KP, 2016, JAMA NEUROL, V73, P1356, DOI 10.1001/jamaneurol.2016.2027; Lu PJ, 1999, NATURE, V399, P784; Majumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025416; Martin L, 2011, NEUROCHEM INT, V58, P458, DOI 10.1016/j.neuint.2010.12.023; Martina JA, 2018, J BIOL CHEM, V293, P12525, DOI 10.1074/jbc.RA118.003471; Martini-Stoica H, 2018, J EXP MED, V215, P2355, DOI 10.1084/jem.20172158; Mertens J, 2015, CELL STEM CELL, V17, P705, DOI 10.1016/j.stem.2015.09.001; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Motta-Mena LB, 2014, NAT CHEM BIOL, V10, P196, DOI [10.1038/NCHEMBIO.1430, 10.1038/nchembio.1430]; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Nash AI, 2011, P NATL ACAD SCI USA, V108, P9449, DOI 10.1073/pnas.1100262108; Polesskaya O, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0411-6; Polito VA, 2014, EMBO MOL MED, V6, P1142, DOI 10.15252/emmm.201303671; Puyal J, 2009, ANN NEUROL, V66, P378, DOI 10.1002/ana.21714; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Randall AD, 2016, J PHYSIOL-LONDON, V594, P6569, DOI 10.1113/JP273348; Reddy K, 2016, CELL REP, V14, P2166, DOI 10.1016/j.celrep.2016.02.006; Rivera-Cancel G, 2012, BIOCHEMISTRY-US, V51, P10024, DOI 10.1021/bi301306t; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Saijo E, 2017, ACTA NEUROPATHOL, V133, P751, DOI 10.1007/s00401-017-1692-z; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sarkis C, 2000, P NATL ACAD SCI USA, V97, P14638, DOI 10.1073/pnas.260472897; Schwalbe M, 2015, STRUCTURE, V23, P1448, DOI 10.1016/j.str.2015.06.002; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2011, AUTOPHAGY, V7, P1379, DOI 10.4161/auto.7.11.17166; Shahani N, 2006, J NEUROSCI, V26, P6103, DOI 10.1523/JNEUROSCI.4245-05.2006; Shi RY, 2012, CNS NEUROSCI THER, V18, P250, DOI 10.1111/j.1755-5949.2012.00295.x; Tung YT, 2012, J BIOSCIENCES, V37, P157, DOI 10.1007/s12038-011-9176-0; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Weick JP, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4190438; WENGER RH, 1994, ANAL BIOCHEM, V221, P416, DOI 10.1006/abio.1994.1436; Williams DR, 2005, BRAIN, V128, P1247, DOI 10.1093/brain/awh488; Yang DS, 2008, AM J PATHOL, V173, P665, DOI 10.2353/ajpath.2008.071176; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yonekawa T, 2013, ESSAYS BIOCHEM, V55, P105, DOI [10.1042/BSE0550105, 10.1042/bse0550105]; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9; Zhao Enpeng, 2012, Hepatology, V55, P1632, DOI 10.1002/hep.25619; Zoltowski BD, 2013, BIOCHEMISTRY-US, V52, P6653, DOI 10.1021/bi401040m; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P8771, DOI 10.1021/bi200976a	74	12	13	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230026	10.1371/journal.pone.0230026	http://dx.doi.org/10.1371/journal.pone.0230026			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208437	Green Submitted, Green Published, gold			2022-12-26	WOS:000535305100009
J	Scheunert, A; Dorfner, M; Lingl, T; Oberprieler, C				Scheunert, Agnes; Dorfner, Marco; Lingl, Thomas; Oberprieler, Christoph			Can we use it? On the utility of de novo and reference-based assembly of Nanopore data for plant plastome sequencing	PLOS ONE			English	Article							CHLOROPLAST DNA; READ ALIGNMENT; GENOME; MITOCHONDRIAL; EVOLUTIONARY; ANGIOSPERMS; POPULATION; REPEAT; REGION; RATES	The chloroplast genome harbors plenty of valuable information for phylogenetic research. Illumina short-read data is generally used for de novo assembly of whole plastomes. PacBio or Oxford Nanopore long reads are additionally employed in hybrid approaches to enable assembly across the highly similar inverted repeats of a chloroplast genome. Unlike for PacBio, plastome assemblies based solely on Nanopore reads are rarely found, due to their high error rate and non-random error profile. However, the actual quality decline connected to their use has rarely been quantified. Furthermore, no study has employed reference-based assembly using Nanopore reads, which is common with Illumina data. Using Leucanthemum Mill. as an example, we compared the sequence quality of seven chloroplast genome assemblies of the same species, using combinations of two sequencing platforms and three analysis pipelines. In addition, we assessed the factors which might influence Nanopore assembly quality during sequence generation and bioinformatic processing. The consensus sequence derived from de novo assembly of Nanopore data had a sequence identity of 99.59% compared to Illumina short-read de novo assembly. Most of the errors detected were indels (81.5%), and a large majority of them is part of homopolymer regions. The quality of reference-based assembly is heavily dependent upon the choice of a close-enough reference. When using a reference with 0.83% sequence divergence from the studied species, mapping of Nanopore reads results in a consensus comparable to that from Nanopore de novo assembly, and of only slightly inferior quality compared to a reference-based assembly with Illumina data. For optimal de novo assembly of Nanopore data, appropriate filtering of contaminants and chimeric sequences, as well as employing moderate read coverage, is essential. Based on these results, we conclude that Nanopore long reads are a suitable alternative to Illumina short reads in plastome phylogenomics. Few errors remain in the finalized assembly, which can be easily masked in phylogenetic analyses without loss in analytical accuracy. The easily applicable and cost-effective technology might warrant more attention by researchers dealing with plant chloroplast genomes.	[Scheunert, Agnes; Dorfner, Marco; Lingl, Thomas; Oberprieler, Christoph] Univ Regensburg, Inst Plant Sci, Evolutionary & Systemat Bot Grp, Regensburg, Germany	University of Regensburg	Scheunert, A (corresponding author), Univ Regensburg, Inst Plant Sci, Evolutionary & Systemat Bot Grp, Regensburg, Germany.	agnes.scheunert@gmx.net			Deutsche Forschungsgemeinschaft via the DFG priority program [SPP 1991, OB 155/13-1]	Deutsche Forschungsgemeinschaft via the DFG priority program(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft via the DFG priority program SPP 1991 "Taxon-omics -New Approaches for Discovering and Naming Biodiversity", specific grant number OB 155/13-1, awarded to CO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Bakker Freek T., 2017, Webbia, V72, P35, DOI 10.1080/00837792.2017.1313383; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Belser C, 2018, NAT PLANTS, V4, P879, DOI 10.1038/s41477-018-0289-4; Bendich AJ, 2004, PLANT CELL, V16, P1661, DOI 10.1105/tpc.160771; Bethune K, 2019, APPL PLANT SCI, V7, DOI 10.1002/aps3.1243; BIRKY CW, 1992, GENETICS, V130, P677; Bleidorn C, 2016, SYST BIODIVERS, V14, P1, DOI 10.1080/14772000.2015.1099575; Bushnell B., 2014, BBTOOLS SOFTWARE PAC; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chaney L, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1600063; Chen HM, 2020, MITOCHONDRIAL DNA B, V5, P19, DOI 10.1080/23802359.2019.1693922; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Civan P, 2014, GENOME BIOL EVOL, V6, P897, DOI 10.1093/gbe/evu061; Cronn R, 2012, AM J BOT, V99, P291, DOI 10.3732/ajb.1100356; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Curci PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120589; De Coster W, 2018, BIOINFORMATICS, V34, P2666, DOI 10.1093/bioinformatics/bty149; Dong WP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08348; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; Doyle J. J., 1987, PHYTOCHEM B, P11; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; Ferrarini M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-670; Gao K, 2019, TREE GENET GENOMES, V15, DOI 10.1007/s11295-019-1342-9; Goodwin S, 2015, GENOME RES, V25, P1750, DOI 10.1101/gr.191395.115; Greiner S, 2019, NUCLEIC ACIDS RES, V47, pW59, DOI 10.1093/nar/gkz238; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Huang H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-151; Izan S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01271; Jain M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1103-0; Jansen HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07650-6; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kang HI, 2019, FORESTS, V10, DOI 10.3390/f10070600; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; Kolmogorov M, 2019, NAT BIOTECHNOL, V37, P540, DOI 10.1038/s41587-019-0072-8; KOLODNER R, 1979, P NATL ACAD SCI USA, V76, P41, DOI 10.1073/pnas.76.1.41; Konowalik K, 2015, MOL PHYLOGENET EVOL, V92, P308, DOI 10.1016/j.ympev.2015.06.003; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kuck U, 2005, PRAKTIKUM MOLEKULARG, P376; Laehnemann D, 2016, BRIEF BIOINFORM, V17, P154, DOI 10.1093/bib/bbv029; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Leggett RM, 2017, J EXP BOT, V68, P5419, DOI 10.1093/jxb/erx289; Lehwark P, 2019, GENOMICS, V111, P759, DOI 10.1016/j.ygeno.2018.05.003; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057533; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]; Mariac C, 2014, MOL ECOL RESOUR, V14, P1103, DOI 10.1111/1755-0998.12258; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Oberprieler Christoph, 2007, Willdenowia, V37, P89, DOI 10.3372/wi.37.37104; Okonechnikov K, 2016, BIOINFORMATICS, V32, P292, DOI 10.1093/bioinformatics/btv566; PALMER JD, 1983, NATURE, V301, P92, DOI 10.1038/301092a0; Payne A, 2019, BIOINFORMATICS, V35, P2193, DOI 10.1093/bioinformatics/bty841; Perry AS, 2002, J MOL EVOL, V55, P501, DOI 10.1007/s00239-002-2333-y; Rabah SO, 2019, J SYST EVOL, V57, P1, DOI 10.1111/jse.12425; Rang FJ, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1462-9; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sancho R, 2018, NEW PHYTOL, V218, P1631, DOI 10.1111/nph.14926; Schmidt MHW, 2017, PLANT CELL, V29, P2336, DOI 10.1105/tpc.17.00521; Shaw J, 2014, AM J BOT, V101, P1987, DOI 10.3732/ajb.1400398; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Takamatsu T, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00266; Tillich M, 2017, NUCLEIC ACIDS RES, V45, pW6, DOI 10.1093/nar/gkx391; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Twyford AD, 2017, MOL ECOL RESOUR, V17, P858, DOI 10.1111/1755-0998.12626; Uribe-Convers S, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1300063; Wagner F, 2019, NEW PHYTOL, V223, P2039, DOI 10.1111/nph.15784; Wala J, 2016, BIOINFORMATICS, V32, P2029, DOI 10.1093/bioinformatics/btw111; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Walker JF, 2015, AM J BOT, V102, P1751, DOI 10.3732/ajb.1500299; Wang SB, 2018, GENES-BASEL, V9, DOI 10.3390/genes9110547; Wang WW, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5348-8; Warris S, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5164-1; White Ruby, 2017, F1000Res, V6, P631, DOI 10.12688/f1000research.11547.1; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595; Wick Ryan R, 2015, Bioinformatics, V31, P3350, DOI 10.1093/bioinformatics/btv383; Wicke S, 2015, REGNUM VEG, V158, P9; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Xiang BB, 2016, MOLECULES, V21, DOI 10.3390/molecules21081029; Yang JB, 2014, MOL ECOL RESOUR, V14, P1024, DOI 10.1111/1755-0998.12251; Zhu AD, 2016, NEW PHYTOL, V209, P1747, DOI 10.1111/nph.13743	91	14	15	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0226234	10.1371/journal.pone.0226234	http://dx.doi.org/10.1371/journal.pone.0226234			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208422	Green Published, Green Submitted, gold			2022-12-26	WOS:000535305100005
J	Klein, PW; Geiger, T; Chavis, NS; Cohen, SM; Ofori, AB; Umali, KT; Hauck, H				Klein, Pamela W.; Geiger, Tanya; Chavis, Nicole S.; Cohen, Stacy M.; Ofori, Alexa B.; Umali, Kathryn T.; Hauck, Heather			The Health Resources and Services Administration's Ryan White HIV/AIDS Program in rural areas of the United States: Geographic distribution, provider characteristics, and clinical outcomes	PLOS ONE			English	Article							HIV CARE; BARRIERS; URBAN; CONTINUUM; COMMUNITIES; TELEHEALTH; ENGAGEMENT; RESIDENTS; VETERANS; CAROLINA	Background People living with HIV (PLWH) residing in rural areas experience substantial barriers to HIV care, which may contribute to poor HIV health outcomes, including retention in HIV care and viral suppression. The Health Resources and Services Administration's Ryan White HIV/AIDS Program (HRSA RWHAP) is an important source of HIV medical care and support services in rural areas. The purpose of this analysis was to (1) assess the reach of the RWHAP in rural areas of the United States, (2) compare the characteristics and funded services of RWHAP provider organizations in rural and non-rural areas, and (3) compare the characteristics and clinical outcomes of RWHAP clients accessing medical care and support services in rural and non-rural areas. Methods and findings Data for this analysis were abstracted from the 2017 RWHAP Services Report (RSR), the primary source of annual, client-level RWHAP data. Organizations funded to deliver RWHAP any service ("RWHAP providers") were categorized as rural or non-rural according to the HRSA FORHP's definition of modified Rural-Urban Commuting Area (RUCA) codes. RWHAP clients were categorized based on their patterns of RWHAP service use as "visited only rural providers," "visited only non-rural providers," or "visited rural and non-rural providers." In 2017, among the 2,113 providers funded by the RWHAP, 6.2% (n = 132) were located in HRSA-designated rural areas. Rural providers were funded to deliver a greater number of service categories per site than non-rural providers (44.7% funded for >= 5 services vs. 34.1% funded for >= 5 services, respectively). Providers in rural areas served fewer clients than providers in non-rural areas; 47.3% of RWHAP providers in rural areas served 1-99 clients, while 29.6% of non-rural providers served 1-99 clients. Retention in care and viral suppression outcomes did not differ on the basis of whether a client accessed services from rural or non-rural providers. Conclusions RWHAP providers are a crucial component of HIV care delivery in the rural United States despite evidence of significant barriers to engagement in care for rural PLWH, RWHAP clients who visited rural providers were just as likely to be retained in care and reach viral suppression as their counterparts who visited non-rural providers. The RWHAP, especially in partnership with Rural Health Clinics and federally funded Health Centers, has the infrastructure and expertise necessary to address the HIV epidemic in rural America.	[Klein, Pamela W.; Geiger, Tanya; Chavis, Nicole S.; Cohen, Stacy M.; Hauck, Heather] Hlth Resources & Serv Adm, HIV AIDS Bur, Rockville, MD 20852 USA; [Ofori, Alexa B.; Umali, Kathryn T.] Hlth Resources & Serv Adm, Fed Off Rural Hlth Policy, Rockville, MD USA; [Geiger, Tanya] Subst Abuse & Mental Hlth Serv Adm, Natl Mental Hlth & Subst Use Policy Lab, Rockville, MD USA	United States Health Resources & Service Administration (HRSA); United States Health Resources & Service Administration (HRSA)	Klein, PW (corresponding author), Hlth Resources & Serv Adm, HIV AIDS Bur, Rockville, MD 20852 USA.	pklein@hrsa.gov		Chavis, Nicole/0000-0001-8311-5804; Klein, Pamela/0000-0003-4613-3725; Cohen, Stacy/0000-0002-0475-1122				AIDS Education & Training Center Program National Coordinating Resource Center, RUR HLTH COMM 2014; Bradley H, 2019, ANN EPIDEMIOLOGY; Centers for Disease Control and Prevention, 2016, MON SEL NAT HIV PREV; Centers for Disease Control and Prevention, 2018, HIV SURV REP 2017; Centers for Disease Control and Prevention, 2018, HIV SURV URB NON AR; Clawar M, 2018, ACCESS CARE POPULAIT; Cohn SE, 2001, J ACQ IMMUN DEF SYND, V28, P385, DOI 10.1097/00126334-200112010-00013; Conrad C, 2015, MMWR-MORBID MORTAL W, V64, P443; Cosby AG, 2019, AM J PUBLIC HEALTH, V109, P155, DOI [10.2105/ajph.2018.304787, 10.2105/AJPH.2018.304787]; Douthit N, 2015, PUBLIC HEALTH, V129, P611, DOI 10.1016/j.puhe.2015.04.001; Evans ME, 2018, MMWR-MORBID MORTAL W, V67, P257, DOI 10.15585/mmwr.mm6708a6; Federal Office of Rural Health Policy, 2018, DEF RUR POP; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Health Resources and Services Administration Ryan White HIV/AIDS Program, 2018, RYAN WHIT HIV AIDS P; Kalichman S, 2017, PREV SCI, V18, P517, DOI 10.1007/s11121-017-0761-9; Li ZH, 2019, MMWR-MORBID MORTAL W, V68, P267; Lopes BLW, 2017, JAIDS-J ACQ IMM DEF, V76, P171, DOI 10.1097/QAI.0000000000001483; Meit M, 2014, 2014 UPDATE RURAL UR; Montalvo S, 2015, OPEN FORUM INFECT S1, V2, P1024; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Nelson JA, 2018, J RURAL HEALTH, V34, P63, DOI 10.1111/jrh.12208; Ness TE, 2017, AIDS EDUC PREV, V29, P516, DOI 10.1521/aeap.2017.29.6.516; Ohl M, 2010, MED CARE, V48, P1064, DOI 10.1097/MLR.0b013e3181ef60c2; Ohl ME, 2014, J RURAL HEALTH, V30, P412, DOI 10.1111/jrh.12070; Pellowski JA, 2013, J ASSOC NURSE AIDS C, V24, P422, DOI 10.1016/j.jana.2012.08.007; Ratcliffe M., 2016, DEFINING RURAL US CE; Reif S, 2005, AIDS CARE, V17, P558, DOI 10.1080/09540120412331319750; Schafer KR, 2017, JAIDS-J ACQ IMM DEF, V75, P35, DOI 10.1097/qai.0000000000001329; Schranz AJ, 2018, CURR HIV-AIDS REP, V15, P245, DOI 10.1007/s11904-018-0393-0; Schur CL, 2002, J RURAL HEALTH, V18, P337, DOI 10.1111/j.1748-0361.2002.tb00895.x; Singh GK, 2014, AM J PREV MED, V46, pE19, DOI 10.1016/j.amepre.2013.10.017; Syed ST, 2013, J COMMUN HEALTH, V38, P976, DOI 10.1007/s10900-013-9681-1; United States Department of Agriculture, FRONTIER REMOTE AREA; US Department of Health and Human Services, REG OFF; Van Handel MM, 2016, JAIDS-J ACQ IMM DEF, V73, P323, DOI 10.1097/QAI.0000000000001098; Wao H., 2016, Journal of the International Society for Telemedicine and eHealth, V4, pe14; Weis KE, 2010, J RURAL HEALTH, V26, P105, DOI 10.1111/j.1748-0361.2010.00271.x; Weissman S, 2015, SOUTH MED J, V108, P180, DOI 10.14423/SMJ.0000000000000255; Wilson LE, 2011, AIDS CARE, V23, P971, DOI 10.1080/09540121.2010.543878; Wood BR, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw123; Yehia BR, 2014, JAIDS-J ACQ IMM DEF, V65, P333, DOI 10.1097/QAI.0000000000000023; Zibbell JE, 2015, MMWR MORBIDITY MORTA, V64	42	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230121	10.1371/journal.pone.0230121	http://dx.doi.org/10.1371/journal.pone.0230121			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9GC	32203556	Green Published, gold			2022-12-26	WOS:000535303900010
J	Leermakers, PA; Remels, AHV; Zonneveld, MI; Rouschop, KMA; Schols, AMWJ; Gosker, HR				Leermakers, Pieter A.; Remels, Alexander H. V.; Zonneveld, Marijke I.; Rouschop, Kasper M. A.; Schols, Annemie M. W. J.; Gosker, Harry R.			Iron deficiency-induced loss of skeletal muscle mitochondrial proteins and respiratory capacity; the role of mitophagy and secretion of mitochondria-containing vesicles	FASEB JOURNAL			English	Article						extracellular vesicles; mitochondrial clearance; myotubes; iron depletion	QUALITY-CONTROL; INDUCTION; AUTOPHAGY; ANEMIA; ENZYMES	Iron homeostasis is essential for mitochondrial function, and iron deficiency has been associated with skeletal muscle weakness and decreased exercise capacity in patients with different chronic disorders. We hypothesized that iron deficiency-induced loss of skeletal muscle mitochondria is caused by increased mitochondrial clearance. To study this, C2C12 myotubes were subjected to the iron chelator deferiprone. Mitochondrial parameters and key constituents of mitophagy pathways were studied in presence or absence of pharmacological autophagy inhibition or knockdown of mitophagy-related proteins. Furthermore, it was explored if mitochondria were present in extracellular vesicles (EV). Iron chelation resulted in an increase in BCL2/Adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3) and BNIP3-like gene and protein levels, and the appearance of mitochondria encapsulated by lysosome-like vesicular structures in myotubes. Moreover, mitochondria were secreted via EV. These changes were associated with cellular mitochondrial impairments. These impairments were unaltered by autophagy inhibition, knockdown of mitophagy-related proteins BNIP3 and BNIP3L, or knockdown of their upstream regulator hypoxia-inducible factor 1 alpha. In conclusion, mitophagy is not essential for development of iron deficiency-induced reductions in mitochondrial proteins or respiratory capacity. The secretion of mitochondria-containing EV could present an additional pathway via which mitochondria can be cleared from iron chelation-exposed myotubes.	[Leermakers, Pieter A.; Schols, Annemie M. W. J.; Gosker, Harry R.] Maastricht Univ, Med Ctr, Dept Resp Med, NUTRIM Sch Nutr & Translat Res Metab, POB 5800, Maastricht 6202 AZ, Netherlands; [Remels, Alexander H. V.] Maastricht Univ, Med Ctr, Dept Pharmacol & Toxicol, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [Zonneveld, Marijke I.; Rouschop, Kasper M. A.] Maastricht Univ, Med Ctr, Dept Radiotherapy, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University	Gosker, HR (corresponding author), Maastricht Univ, Med Ctr, Dept Resp Med, NUTRIM Sch Nutr & Translat Res Metab, POB 5800, Maastricht 6202 AZ, Netherlands.	h.gosker@maastrichtuniversity.nl	Leermakers, Pieter/AAY-1341-2021	Leermakers, Pieter/0000-0002-0145-742X; Rouschop, Kasper/0000-0002-4208-5415; Zonneveld, Marijke/0000-0002-7200-5199; Gosker, Harry/0000-0002-7659-0225				ACKRELL BAC, 1984, J BIOL CHEM, V259, P53; Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Barberan-Garcia A, 2015, RESPIROLOGY, V20, P1089, DOI 10.1111/resp.12591; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Boyer-Guittaut M, 2014, AUTOPHAGY, V10, P986, DOI 10.4161/auto.28390; CARTIER LJ, 1986, J BIOL CHEM, V261, P3827; DAVIES KJA, 1984, AM J PHYSIOL, V246, pE535, DOI 10.1152/ajpendo.1984.246.6.E535; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066; Eiyama A, 2015, CURR OPIN CELL BIOL, V33, P95, DOI 10.1016/j.ceb.2015.01.002; Esteva S, 2008, J ANAT, V212, P836, DOI 10.1111/j.1469-7580.2008.00908.x; EVANS TC, 1985, BIOCHEM MED METAB B, V34, P93, DOI 10.1016/0006-2944(85)90065-1; Falchi AM, 2013, HISTOCHEM CELL BIOL, V139, P221, DOI 10.1007/s00418-012-1045-x; Forterre A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084153; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; HAGLER L, 1981, AM J CLIN NUTR, V34, P2169, DOI 10.1093/ajcn/34.10.2169; Keulers TG, 2015, RADIOTHER ONCOL, V116, P417, DOI 10.1016/j.radonc.2015.06.023; Kim S, 2018, CELL PHYSIOL BIOCHEM, V48, P1829, DOI 10.1159/000492505; Kurz T, 2011, INT J BIOCHEM CELL B, V43, P1686, DOI 10.1016/j.biocel.2011.08.016; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; MACDONALD VW, 1985, J LAB CLIN MED, V105, P11; Matsuda N, 2016, J BIOCHEM, V159, P379, DOI 10.1093/jb/mvv125; Nagi M, 2016, AUTOPHAGY, V12, P1259, DOI 10.1080/15548627.2016.1183080; OHIRA Y, 1987, AM J PHYSIOL, V253, pC639, DOI 10.1152/ajpcell.1987.253.5.C639; Okuyama S, 2016, ASIA-PAC INT SYM ELE, P50, DOI 10.1109/APEMC.2016.7522776; Palikaras K, 2014, EXP GERONTOL, V56, P182, DOI 10.1016/j.exger.2014.01.021; Phinney DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9472; Romanello V, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00422; Schiavi A, 2015, CURR BIOL, V25, P1810, DOI 10.1016/j.cub.2015.05.059; Slot IGM, 2016, J CELL PHYSIOL, V231, P377, DOI 10.1002/jcp.25083; Stotland A, 2015, BBA-MOL CELL RES, V1853, P2802, DOI 10.1016/j.bbamcr.2014.12.041; Stugiewicz M, 2016, EUR J HEART FAIL, V18, P762, DOI 10.1002/ejhf.467; Tkaczyszyn M, 2018, J CACHEXIA SARCOPENI, V9, P547, DOI 10.1002/jcsm.12282; Van Deun J, 2017, NAT METHODS, V14, P228, DOI 10.1038/nmeth.4185; Van Deun J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24858; Wang XY, 2016, NEUROBIOL AGING, V47, P168, DOI 10.1016/j.neurobiolaging.2016.07.025; Watson A, 2016, CELL SIGNAL, V28, P412, DOI 10.1016/j.cellsig.2016.01.014; Wei HF, 2015, BBA-MOL CELL RES, V1853, P2784, DOI 10.1016/j.bbamcr.2015.03.013; WILLIS WT, 1987, J APPL PHYSIOL, V62, P2442, DOI 10.1152/jappl.1987.62.6.2442; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	41	20	20	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6703	6717		10.1096/fj.201901815R	http://dx.doi.org/10.1096/fj.201901815R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32202346	Green Published, hybrid			2022-12-26	WOS:000531325500049
J	O'Connell, CM; Jasperse, B; Hagen, CJ; Titong, A; Verardi, PH				O'Connell, Caitlin M.; Jasperse, Brittany; Hagen, Caitlin J.; Titong, Allison; Verardi, Paulo H.			Replication-inducible vaccinia virus vectors with enhanced safety in vivo	PLOS ONE			English	Article							VIRION MEMBRANE BIOGENESIS; E8R GENE-PRODUCT; SMALLPOX VACCINATION; IMMUNODEFICIENT MICE; DOMINANT SELECTION; ESCHERICHIA-COLI; IMMUNE-RESPONSES; GAMMA-INTERFERON; ADVERSE EVENTS; TET-REPRESSOR	Vaccinia virus (VACV) has been used extensively as the vaccine against smallpox and as a viral vector for the development of recombinant vaccines and cancer therapies. Replication-competent, non-attenuated VACVs induce strong, long-lived humoral and cell-mediated immune responses and can be effective oncolytic vectors. However, complications from uncontrolled VACV replication in vaccinees and their close contacts can be severe, particularly in individuals with predisposing conditions. In an effort to develop replication-competent VACV vectors with improved safety, we placed VACV late genes encoding core or virion morphogenesis proteins under the control of tet operon elements to regulate their expression with tetracycline antibiotics. These replication-inducible VACVs would only express the selected genes in the presence of tetracyclines. VACVs inducibly expressing the A3L or A6L genes replicated indistinguishably from wild-type VACV in the presence of tetracyclines, whereas there was no evidence of replication in the absence of antibiotics. These outcomes were reflected in mice, where the VACV inducibly expressing the A6L gene caused weight loss and mortality equivalent to wild-type VACV in the presence of tetracyclines. In the absence of tetracyclines, mice were protected from weight loss and mortality, and viral replication was not detected. These findings indicate that replication-inducible VACVs based on the conditional expression of the A3L or A6L genes can be used for the development of safer, next-generation live VACV vectors and vaccines. The design allows for administration of replication-inducible VACV in the absence of tetracyclines (as a replication-defective vector) or in the presence of tetracyclines (as a replication-competent vector) with enhanced safety.	[O'Connell, Caitlin M.; Verardi, Paulo H.] Univ Connecticut, Dept Pathobiol & Vet Sci, Coll Agr Hlth & Nat Resources, Storrs, CT 06269 USA; Univ Connecticut, Ctr Excellence Vaccine Res, Coll Agr Hlth & Nat Resources, Storrs, CT USA; [Jasperse, Brittany] Univ North Carolina Chapel Hill, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Hagen, Caitlin J.] Novartis Inst Biomed Res, Cambridge, MA USA; [Titong, Allison] AbStudio Inc, Hayward, CA USA	University of Connecticut; University of Connecticut; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Novartis	Verardi, PH (corresponding author), Univ Connecticut, Dept Pathobiol & Vet Sci, Coll Agr Hlth & Nat Resources, Storrs, CT 06269 USA.	paulo.verardi@uconn.edu		Jasperse, Brittany/0000-0001-9141-3246	National Institutes of Health [AI128737]; University of Connecticut Research Foundation (UCRF)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Connecticut Research Foundation (UCRF)	This work was supported by a National Institutes of Health grant AI128737 (https://www.nih.gov) and a University of Connecticut Research Foundation (UCRF) grant awarded to PHV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P478; Bakacs T, 2012, IMMUNOBIOLOGY, V217, P583, DOI 10.1016/j.imbio.2011.07.005; Bertram R, 2008, MICROB BIOTECHNOL, V1, P2, DOI 10.1111/j.1751-7915.2007.00001.x; Buller R, 1992, SAFETY ATTENUATION V, P235; BULLER RML, 1985, NATURE, V317, P813, DOI 10.1038/317813a0; Cao JX, 1997, BIOTECHNIQUES, V22, P276, DOI 10.2144/97222bm17; Carlin EP, 2017, PUBLIC HEALTH NURS, V34, P200, DOI 10.1111/phn.12291; Casey CG, 2005, JAMA-J AM MED ASSOC, V294, P2734, DOI 10.1001/jama.294.21.2734; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P561; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Chung CS, 2006, J VIROL, V80, P2127, DOI 10.1128/JVI.80.5.2127-2140.2006; DAVISON AJ, 1989, J MOL BIOL, V210, P771, DOI 10.1016/0022-2836(89)90108-3; Doglio L, 2002, J VIROL, V76, P9773, DOI 10.1128/JVI.76.19.9773-9786.2002; Drexler I, 1998, J GEN VIROL, V79, P347, DOI 10.1099/0022-1317-79-2-347; Durski KN, 2018, MMWR-MORBID MORTAL W, V67, P306, DOI 10.15585/mmwr.mm6710a5; Earl P L, 2001, Curr Protoc Mol Biol, VChapter 16, DOI 10.1002/0471142727.mb1617s43; FALKNER FG, 1988, J VIROL, V62, P1849, DOI 10.1128/JVI.62.6.1849-1854.1988; FALKNER FG, 1990, J VIROL, V64, P3108, DOI 10.1128/JVI.64.6.3108-3111.1990; FARYAR K, 1992, CURR GENET, V21, P345, DOI 10.1007/BF00351693; FLEXNER C, 1987, NATURE, V330, P259, DOI 10.1038/330259a0; FUERST TR, 1989, P NATL ACAD SCI USA, V86, P2549, DOI 10.1073/pnas.86.8.2549; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P251, DOI 10.1086/375825; GATZ C, 1988, P NATL ACAD SCI USA, V85, P1394, DOI 10.1073/pnas.85.5.1394; GIAVEDONI LD, 1992, P NATL ACAD SCI USA, V89, P3409, DOI 10.1073/pnas.89.8.3409; Grigg P, 2013, P NATL ACAD SCI USA, V110, P15407, DOI 10.1073/pnas.1314483110; Haddad D, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00096; Hagen CJ, 2014, VIRUS RES, V181, P43, DOI 10.1016/j.virusres.2013.12.033; Hatch GJ, 2013, J VIROL, V87, P7805, DOI 10.1128/JVI.03481-12; Hayasaka D, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-22; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Hughes CM, 2011, EMERG INFECT DIS, V17, P730, DOI 10.3201/eid1704.101010; Jasperse B, 2020, MOL THER-METH CLIN D, V17, P731, DOI 10.1016/j.omtm.2020.03.026; Jesus DM, 2015, VIROLOGY, V481, P1, DOI 10.1016/j.virol.2015.02.020; Jezek Z, 1988, HUMAN MONKEYPOX; Kato SEM, 2007, VIROLOGY, V367, P398, DOI 10.1016/j.virol.2007.05.002; Kato SEM, 2004, VIROLOGY, V330, P127, DOI 10.1016/j.virol.2004.08.038; Kemper Alex R, 2002, Eff Clin Pract, V5, P84; LAI ACK, 1991, BIOTECHNIQUES, V10, P564; Lane JM, 2003, ANN INTERN MED, V138, P488, DOI 10.7326/0003-4819-138-6-200303180-00014; Lederman ER, 2012, J INFECT DIS, V206, P1372, DOI 10.1093/infdis/jis510; Legrand FA, 2005, P NATL ACAD SCI USA, V102, P2940, DOI 10.1073/pnas.0409846102; Legrand FA, 2004, J VIROL, V78, P2770, DOI 10.1128/JVI.78.6.2770-2779.2004; Lindholm DA, 2019, CLIN INFECT DIS; Maki J, 2017, VET RES, V48, DOI 10.1186/s13567-017-0459-9; Meng XZ, 2017, J VIROL, V91, DOI 10.1128/JVI.02405-16; Meng XZ, 2012, J VIROL, V86, P5603, DOI 10.1128/JVI.00330-12; Meng XL, 2014, 2014 INTERNATIONAL CONFERENCE ON POWER SYSTEM TECHNOLOGY (POWERCON), P1433, DOI 10.1109/POWERCON.2014.6993730; Moss B, 1996, P NATL ACAD SCI USA, V93, P11341, DOI 10.1073/pnas.93.21.11341; MOSS B, 1973, J MOL BIOL, V81, P267, DOI 10.1016/0022-2836(73)90195-2; Moss B, 2015, VIROLOGY, V479, P619, DOI 10.1016/j.virol.2015.02.003; Moussatche N, 2015, VIROLOGY, V475, P204, DOI 10.1016/j.virol.2014.11.020; Pathak PK, 2018, P NATL ACAD SCI USA, V115, P7028, DOI 10.1073/pnas.1805855115; RAMSHAW IA, 1987, NATURE, V329, P545, DOI 10.1038/329545a0; Reynolds MG, 2012, TRENDS MICROBIOL, V20, P80, DOI 10.1016/j.tim.2011.12.001; SAROV I, 1972, VIROLOGY, V50, P579, DOI 10.1016/0042-6822(72)90409-6; Shao H, 2013, MMWR-MORBID MORTAL W, V62, P145; Stebbins MJ, 2001, P NATL ACAD SCI USA, V98, P10775, DOI 10.1073/pnas.121186498; Stieger K, 2009, ADV DRUG DELIVER REV, V61, P527, DOI 10.1016/j.addr.2008.12.016; TARTAGLIA J, 1992, VIROLOGY, V188, P217, DOI 10.1016/0042-6822(92)90752-B; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Tolonen N, 2001, MOL BIOL CELL, V12, P2031, DOI 10.1091/mbc.12.7.2031; Traktman P, 2000, J VIROL, V74, P3682, DOI 10.1128/JVI.74.8.3682-3695.2000; Unger B, 2004, J VIROL, V78, P8885, DOI 10.1128/JVI.78.16.8885-8901.2004; Upton C, 2003, J VIROL, V77, P7590, DOI 10.1128/JVI.77.13.7590-7600.2003; Van Dam CN, 2009, CLIN INFECT DIS, V48, pE47, DOI 10.1086/596553; Verardi PH, 2012, HUM VACC IMMUNOTHER, V8, P961, DOI 10.4161/hv.21080; Verardi PH, 2002, J VIROL, V76, P484, DOI 10.1128/JVI.76.2.484-491.2002; Verardi PH, 2001, J VIROL, V75, P11, DOI 10.1128/JVI.75.1.11-18.2001; Webber Bryant J, 2014, MSMR, V21, P2; WEHRLE PF, 1980, J INFECT DIS, V142, P636, DOI 10.1093/infdis/142.4.636; Wilton S, 1995, VIROLOGY, V214, P503, DOI 10.1006/viro.1995.0061; Wu X, 2012, J VIROL, V86, P11276, DOI 10.1128/JVI.01502-12; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939; YILMA T, 1994, DEV BIOL STAND, V82, P201; Zachertowska A, 2006, J VIROL METHODS, V132, P1, DOI 10.1016/j.jviromet.2005.08.015; Zhu Z, 2002, SEMIN CELL DEV BIOL, V13, P121, DOI 10.1016/S1084-9521(02)00018-6	78	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230711	10.1371/journal.pone.0230711	http://dx.doi.org/10.1371/journal.pone.0230711			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240193	Green Published, gold			2022-12-26	WOS:000535945000037
J	Hepping, AM; Barvelink, B; Ploegmakers, JJW; van der Palen, J; Geertzen, JHB; Bulstra, SK; Harbers, JS; Stevens, M				Hepping, Ann M.; Barvelink, Britt; Ploegmakers, Joris J. W.; van der Palen, Job; Geertzen, Jan H. B.; Bulstra, Sjoerd K.; Harbers, Jorrit S.; Stevens, Martin			Recovery of strength after reduced pediatric fractures of the forearm, wrist or hand; A prospective study	PLOS ONE			English	Article							COMPLICATIONS; CHILDREN; SPLINT	Introduction The way strength recovers after reduction of pediatric fractures of the upper extremity has not previously been the specific scope of research. This is remarkable, since strength measurements are often used as an outcome measure in studies on trauma of the upper extremity. The aim of this study was to evaluate how strength recovers after sustainment of fractures of the forearm, wrist or hand treated by closed or open reduction in children and adolescents in the first 6 months after trauma. How much strength is lost at 6 weeks, 3 months and 6 months after trauma, and is this loss significant? Are there differences in the pattern of recovery between children who underwent a different treatment? And finally, which of the following factors are associated with an increase in the ratio between affected grip strength and expected strength: type of fracture, cast immobilization, occurrence of complications, and degree of pain? Design Prospective observational study. Participants Children and adolescents aged 4-18 years with a reduced fracture of the forearm, wrist or hand. Methods Grip strength, key grip and three-jaw chuck grip were measured twice in each hand 6 weeks, 3 months and 6 months after trauma. Details on fracture type and location, treatment received, cast immobilization and complications were obtained. Hand-dominance and pain were verbally confirmed. Results Loss of strength was more prominent and prolonged the more invasive the treatment, hence most extensive in the group receiving open reduction with internal fixation (ORIF), intermediate in the group receiving closed reduction with percutaneous pinning (CRIF), and least extensive in the group undergoing closed reduction without internal fixation (CR). Besides time passed, gender and age were of significant influence on strength, although there was no difference in pattern of recovery over time between children who received a different treatment. In the period of 6 weeks to 3 months after trauma, female gender, type of fracture sustained and occurrence of an unwanted event were associated with an increased ratio between affected and expected grip strength. For the later phase of recovery, between 3 and 6 months, this was only true for the occurrence of an unwanted event.	[Hepping, Ann M.; Geertzen, Jan H. B.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [Hepping, Ann M.] Roessingh Ctr Rehabil, Enschede, Netherlands; [Barvelink, Britt; Ploegmakers, Joris J. W.; Bulstra, Sjoerd K.; Stevens, Martin] Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands; [van der Palen, Job] Univ Twente, Dept Res Methodol Measurement & Data Anal, Enschede, Netherlands; [van der Palen, Job] Med Sch Twente, Med Spectrum Twente, Enschede, Netherlands; [Harbers, Jorrit S.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands	University of Groningen; University of Groningen; University of Twente; Medical Spectrum Twente; University of Groningen	Hepping, AM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands.; Hepping, AM (corresponding author), Roessingh Ctr Rehabil, Enschede, Netherlands.	a.m.hepping@umcg.nl	Stevens, Martin/A-5196-2013	Stevens, Martin/0000-0001-8183-6894; van der Palen, Job/0000-0003-1071-6769				Abraham A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007907.pub2; BALOGUN JA, 1991, ARCH PHYS MED REHAB, V72, P280; Boutis K, 2010, CAN MED ASSOC J, V182, P1507, DOI 10.1503/cmaj.100119; Cramer K E, 1992, J Orthop Trauma, V6, P407, DOI 10.1097/00005131-199212000-00002; Davison PG, 2016, PLAST RECONSTR SURG, V137, P908, DOI 10.1097/01.prs.0000479974.45051.78; Eismann EA, 2013, J BONE JOINT SURG AM, V95A, P1345, DOI 10.2106/JBJS.L.00764; Hepping AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143476; Innes E, 1999, AUST OCCUP THER J, V46, P120, DOI DOI 10.1046/J.1440-1630.1999.00182.X; Jauregui JJ, 2019, J PEDIATR ORTHOPED, V39, pE130, DOI 10.1097/BPO.0000000000000916; Lindstrom-Hazel D, 2009, AM J OCCUP THER, V63, P193, DOI 10.5014/ajot.63.2.193; Pershad J, 2000, ACAD EMERG MED, V7, P1152, DOI 10.1111/j.1553-2712.2000.tb01267.x; Roth KC, 2014, ARCH ORTHOP TRAUM SU, V134, P1699, DOI 10.1007/s00402-014-2091-8; Sinikumpu JJ, 2013, INJURY, V44, P431, DOI 10.1016/j.injury.2012.08.032; Teoh KH, 2009, J CHILD ORTHOP, V3, P367, DOI 10.1007/s11832-009-0197-2; Tomlinson D, 2010, PEDIATRICS, V126, pE1168, DOI 10.1542/peds.2010-1609; Valencia M, 2015, J PEDIATR ORTHOPED, V35, P606, DOI 10.1097/BPO.0000000000000337; van den Beld WA, 2006, DISABIL REHABIL, V28, P1303, DOI 10.1080/09638280600631047; von Baeyer Carl L, 2006, Pain Res Manag, V11, P157; Vopat ML, 2014, ORTHOP REV, V6, P94, DOI 10.4081/or.2014.5325; Yung SH, 1998, J BONE JOINT SURG BR, V80B, P91, DOI 10.1302/0301-620X.80B1.8110	20	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230862	10.1371/journal.pone.0230862	http://dx.doi.org/10.1371/journal.pone.0230862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236117	Green Published, Green Submitted, gold			2022-12-26	WOS:000535938700034
J	Scimone, MT; Cramer, HC; Hopkins, P; Estrada, JB; Franck, C				Scimone, Mark T.; Cramer, Harry C. I. I. I. I. I. I.; Hopkins, Paul; Estrada, Jonathan B.; Franck, Christian			Application of mild hypothermia successfully mitigates neural injury in a 3D in-vitro model of traumatic brain injury	PLOS ONE			English	Article							PHARMACOLOGICALLY INDUCED HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; PROFESSIONAL FOOTBALL; MODERATE HYPOTHERMIA; GAME IMPACTS; II-SPECTRIN; CASPASE-3; CALPAIN; ACCUMULATION; PROTEOLYSIS	Therapeutic hypothermia (TH) is an attractive target for mild traumatic brain injury (mTBI) treatment, yet significant gaps in our mechanistic understanding of TH, especially at the cellular level, remain and need to be addressed for significant forward progress to be made. Using a recently-established 3D in-vitro neural hydrogel model for mTBI we investigated the efficacy of TH after compressive impact injury and established critical treatment parameters including target cooling temperature, and time windows for application and maintenance of TH. Across four temperatures evaluated (31.5, 33, 35, and 37 degrees C), 33 degrees C was found to be most neuroprotective after 24 and 48 hours post-injury. Assessment of TH administration onset time and duration showed that TH should be administered within 4 hours post-injury and be maintained for at least 6 hours for achieving maximum viability. Cellular imaging showed TH reduced the percentage of cells positive for caspases 3/7 and increased the expression of calpastatin, an endogenous neuroprotectant. These findings provide significant new insight into the biological parameter space that renders TH effective in mitigating the deleterious effects of cellular mTBI and provides a quantitative foundation for the future development of animal and preclinical treatment protocols.	[Scimone, Mark T.; Cramer, Harry C. I. I. I. I. I. I.; Hopkins, Paul] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Scimone, Mark T.; Cramer, Harry C. I. I. I. I. I. I.; Hopkins, Paul] Brown Univ, Ctr Biomed Engn, Providence, RI 02912 USA; [Estrada, Jonathan B.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Franck, Christian] Univ Wisconsin, Mech Engn, Madison, WI 53706 USA	Brown University; Brown University; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison	Franck, C (corresponding author), Univ Wisconsin, Mech Engn, Madison, WI 53706 USA.	cfranck@wisc.edu	Estrada, Jon B/ABC-3088-2020; Franck, Christian/C-6077-2012	Estrada, Jon B/0000-0003-1083-4597; Scimone, Mark/0000-0003-0123-3765; Cramer, Harry/0000-0002-3353-7723; Franck, Christian/0000-0002-2347-620X	United States Office of Naval Research (ONR) [N00014-13-1-0708, N00014-16-1-2869, N00014-17-1-2644]; Brown University	United States Office of Naval Research (ONR)(Office of Naval Research); Brown University	This research was supported by grants from the United States Office of Naval Research (ONR) - https://www.onr.navy.mil; grant numbers: N00014-13-1-0708, N00014-16-1-2869, and N00014-17-1-2644. Jonathan Estrada received a GAANN Fellowship from Brown University. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2002, J EXP BIOL, V205, P1831; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Carslaw H.S., 1986, CONDUCTION HEAT SOLI; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; CLIFTON GL, 1992, J NEUROTRAUM, V9, pS487; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Darwazeh R, 2013, NEURAL REGEN RES, V8, P2677, DOI 10.3969/j.issn.1673-5374.2013.28.010; Davoli MA, 2002, NEUROSCIENCE, V115, P125, DOI 10.1016/S0306-4522(02)00376-7; Dingle YTL, 2015, TISSUE ENG PART C-ME, V21, P1274, DOI [10.1089/ten.tec.2015.0135, 10.1089/ten.TEC.2015.0135]; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Hopkins AM, 2015, PROG NEUROBIOL, V125, P1, DOI 10.1016/j.pneurobio.2014.11.003; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kobeissy FH, 2015, MOL NEUROBIOL, V52, P696, DOI 10.1007/s12035-014-8898-z; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P21, DOI 10.1016/j.biocel.2009.09.013; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Lu J, 2014, WORLD J EMERG MED, V5, P298, DOI 10.5847/wjem.j.issn.1920-8642.2014.04.010; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Ming X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084557; Mrozek S, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/989487; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Saad Hesham, 2013, Glob Cardiol Sci Pract, V2013, P44, DOI 10.5339/gcsp.2013.7; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Sadick JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep33999; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Samanci MY, 2019, WORLD NEUROSURG, V121, pE481, DOI 10.1016/j.wneu.2018.09.142; Scimone MT, 2018, NAT PROTOC, V13, P3042, DOI 10.1038/s41596-018-0077-7; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; van der Poel C, 2008, CLIN EXP PHARMACOL P, V35, P1482, DOI 10.1111/j.1440-1681.2008.05050.x; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Yildiz-Unal A, 2015, NEUROPSYCH DIS TREAT, V11, P297, DOI 10.2147/NDT.S78226; Yokobori S, 2013, J NEUROSURG, V118, P370, DOI 10.3171/2012.10.JNS12725	51	1	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0229520	10.1371/journal.pone.0229520	http://dx.doi.org/10.1371/journal.pone.0229520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236105	Green Published, gold			2022-12-26	WOS:000535938700010
J	Thuring, J; Kuhl, CK; Barabasch, A; Hitpass, L; Bode, M; Bunting, N; Bruners, P; Kramer, NA				Thuering, Johannes; Kuhl, Christiane Katharina; Barabasch, Alexandra; Hitpass, Lea; Bode, Maike; Bunting, Nina; Bruners, Philipp; Kraemer, Nils Andreas			Signal changes in T2-weighted MRI of liver metastases under bevacizumab-A practical imaging biomarker?	PLOS ONE			English	Article							TUMOR RESPONSE; PREOPERATIVE CHEMOTHERAPY; PATHOLOGICAL RESPONSE; SURVIVAL; HETEROGENEITY; IRINOTECAN; THERAPY; RECIST; TRIAL; SIZE	Objective The purpose of this study was to investigate signal changes in T2-weighted magnetic resonance imaging of liver metastases under treatment with and without bevacizumab-containing chemotherapy and to compare these signal changes to tumor contrast enhancement. Materials and methods Retrospective analysis of 44 patients, aged 36-84 years, who underwent liver magnetic resonance imaging including T2-weighted and dynamic contrast enhancement sequences. Patients received bevacizumab-containing (n = 22) or conventional cytotoxic chemotherapy (n = 22). Magnetic resonance imaging was obtained at baseline and at three follow-ups (on average 3, 6 and 9 months after initial treatment). Three independent readers rated the T2 signal intensity and the relative contrast enhancement of the metastases on a 5-point scale. Results T2 signal intensity of metastases treated with bevacizumab showed a significant (p< 0.001) decrease in T2 signal intensity after initial treatment and exhibit compared to conventionally treated metastases significantly (p< 0.001 for each follow-up) hypointense (bevacizumab: 0.70 +/- 0.83 before vs. -1.55 +/- 0.61, -1.91 +/- 0.62, and -1.97 +/- 0.52; cytotoxic: 0.73 +/- 0.79 before vs. -0.69 +/- 0.81, -0.71 +/- 0.68, and -0.75 +/- 0.65 after 3, 6, and 9 months, respectively). T2 signal intensity was strongly correlated with tumor contrast enhancement (r = 0.71; p< 0.001). Intra-observer agreement for T2-signal intensity was substantial (kappa = 0.75). The agreement for tumoral contrast enhancement between the readers was considerably lower (kappa = 0.39). Conclusion Liver metastases exhibit considerably hypointense in T2-weighted imaging after treatment with bevacizumab, in contrast to conventionally treated liver metastases. Therefore, T2-weighted imaging seems to reflect the effect of bevacizumab.	[Thuering, Johannes; Kuhl, Christiane Katharina; Barabasch, Alexandra; Hitpass, Lea; Bode, Maike; Bunting, Nina; Bruners, Philipp; Kraemer, Nils Andreas] RWTH Aachen Univ Hosp, Dept Diagnost & Intervent Radiol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Thuring, J (corresponding author), RWTH Aachen Univ Hosp, Dept Diagnost & Intervent Radiol, Aachen, Germany.	jthuering@ukaachen.de	Kuhl, Christiane K/H-3301-2013; Bruners, Philipp/AAK-9165-2021; Kraemer, Nils/ABD-9509-2020	Kuhl, Christiane K/0000-0001-8696-2363; Bruners, Philipp/0000-0002-5790-3687; Kraemer, Nils/0000-0001-5406-6396; Hitpass, Lea/0000-0003-0548-1854	Faculty of Medicine of the RWTH Aachen University	Faculty of Medicine of the RWTH Aachen University	The project was supported by the,START-Program"of the Faculty of Medicine of the RWTH Aachen University. The authors gratefully thank Daniel Truhn and Alexander Ciritsis for careful assistance during this investigation.	Altman D.G., 1990, PRACTICAL STAT MED R, DOI DOI 10.1201/9780429258589; Bell R, 2017, ANN ONCOL, V28, P754, DOI 10.1093/annonc/mdw665; Bennett IE, 2017, J NEURO-ONCOL, V131, P321, DOI 10.1007/s11060-016-2300-0; Birlik B, 2015, MAGN RESON IMAGING, V33, P201, DOI 10.1016/j.mri.2014.08.041; Boonsirikamchai P, 2011, AM J ROENTGENOL, V197, pW1060, DOI 10.2214/AJR.11.6459; Brendle C, 2016, EUR J NUCL MED MOL I, V43, P123, DOI 10.1007/s00259-015-3137-z; Chapiro J, 2015, EUR RADIOL, V25, P1993, DOI 10.1007/s00330-015-3595-5; Chun YS, 2009, JAMA-J AM MED ASSOC, V302, P2338, DOI 10.1001/jama.2009.1755; Consolino L, 2017, GASTRIC CANCER, V20, P629, DOI 10.1007/s10120-016-0672-7; Detsky JS, 2018, PHYS IMAG RADIAT ONC, V5, P9, DOI 10.1016/j.phro.2018.01.001; Ellingson BM, 2015, INT J ONCOL, V46, P1883, DOI 10.3892/ijo.2015.2891; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Perez-Larraya JG, 2012, NEURO-ONCOLOGY, V14, P667, DOI 10.1093/neuonc/nos070; Hotker AM, 2016, AM J ROENTGENOL, V206, P756, DOI 10.2214/AJR.15.14912; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jalali S, 2014, NEURO-ONCOLOGY, V16, P868, DOI 10.1093/neuonc/nou040; Krajewski KM, 2014, CANCER-AM CANCER SOC, V120, P711, DOI 10.1002/cncr.28493; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lastoria S, 2013, J NUCL MED, V54, P2062, DOI 10.2967/jnumed.113.119909; Longo DL, 2015, MAGN RESON IMAGING, V33, P725, DOI 10.1016/j.mri.2015.03.005; Matsushima S, 2017, CLIN IMAG, V41, P1, DOI 10.1016/j.clinimag.2016.08.013; MURAMATSU Y, 1986, RADIOLOGY, V160, P49, DOI 10.1148/radiology.160.1.3012632; O'Connor JPB, 2011, BRIT J CANCER, V105, P139, DOI 10.1038/bjc.2011.191; OUTWATER E, 1991, RADIOLOGY, V180, P327, DOI 10.1148/radiology.180.2.2068294; Pahwa S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20726-1; Brufau BP, 2013, RADIOGRAPHICS, V33, P1691, DOI 10.1148/rg.336125110; Ribero D, 2007, CANCER-AM CANCER SOC, V110, P2761, DOI 10.1002/cncr.23099; Rivera F, 2015, 1 LINE TREATMENT MOD; Shenoy-Bhangle A, 2017, WORLD J HEPATOL, V9, P1081, DOI 10.4254/wjh.v9.i26.1081; Shindoh J, 2012, J CLIN ONCOL, V30, P4566, DOI 10.1200/JCO.2012.45.2854; Smith AD, 2016, RADIOLOGY, V281, P484, DOI 10.1148/radiol.2016160143; Stella GM, 2017, EBIOMEDICINE, V24, P34, DOI 10.1016/j.ebiom.2017.09.025	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230553	10.1371/journal.pone.0230553	http://dx.doi.org/10.1371/journal.pone.0230553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HO	32231380	gold, Green Published			2022-12-26	WOS:000535937400009
J	Alashkar, F; Rottinghaus, S; Vance, C; Herich-Terhurne, D; Duhrsen, U; Assert, R; Roth, A				Alashkar, Ferras; Rottinghaus, Scott; Vance, Colin; Herich-Terhuerne, Doerte; Duehrsen, Ulrich; Assert, Roland; Roeth, Alexander			No evidence for hypogammaglobulinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with ravulizumab	PLOS ONE			English	Article							COMPLEMENT INHIBITOR ECULIZUMAB; HEMOLYSIS; EFFICACY; RECEPTOR; SAFETY; IGG	Introduction Ravulizumab (ALXN1210) is a long-lasting recycling IgG monoclonal antibody with an increased affinity for the neonatal Fc receptor (FcRn). The FcRn is essential for regulating IgG homeostasis. Saturation of the FcRn pathway is seen under high IgG doses as they compete with endogenous IgG to bind the FcRn by their Fc regions, resulting in enhanced IgG clearance. Patients/Methods Between Jan 2016 and Jun 2019 (median observation time 21.6 months (6-37.7 months)) serum IgG concentrations and IgG1-4 subclasses were evaluated over a longitudinal course (post-hoc analysis) in 12 ravulizumab-treated adult patients with paroxysmal nocturnal hemoglobinuria (PNH) (58% (7/12) males, median age 50 years (yrs) (18-70 yrs)). All patients were enrolled in one of the three ravulizumab-PNH-related trials (201-, 301-, or 302-study) at the University Hospital Essen. Results Baseline IgG concentrations were documented in 11 out of the 12 patients prior to ravulizumab treatment (median IgG 9.9 g/L (5-13.5 g/L)). In two female patients a clinically not relevant hypogammaglobulinemia with an associated IgG1 or a combined IgG1/IgG2 deficiency prior to treatment was documented. The data were further stratified with regard to various treatment intervals as multiple analyses were obtained. Throughout observation time IgG concentrations remained within physiologic ranges with no evidence of a treatment-related IgG depletion (median IgG at study endpoint 10.1 g/L (6-13.4 g/L)). Conclusion In ravulizumab-treated PNH patients, IgG and IgG subclass levels which are regulated by the FcRn remained unaffected. Therefore, no treatment associated hypogammaglobulinemia is to be feared under chronic ravulizumab therapy.	[Alashkar, Ferras; Herich-Terhuerne, Doerte; Duehrsen, Ulrich; Roeth, Alexander] Univ Hosp Essen, West German Canc Ctr, Dept Hematol, Essen, Germany; [Rottinghaus, Scott] Alexion Pharmaceut Inc, Boston, MA USA; [Vance, Colin] Rhein Westfalisches Inst Wirtschaftsforsch, Essen, Germany; [Assert, Roland] Univ Hosp Essen, Dept Clin Chem, Essen, Germany	University of Duisburg Essen; RWI - Leibniz Institut fur Wirtschaftsforschung; University of Duisburg Essen	Roth, A (corresponding author), Univ Hosp Essen, West German Canc Ctr, Dept Hematol, Essen, Germany.	alexander.roeth@uk-essen.de		Alashkar, Ferras/0000-0001-7530-8892	Alexion Pharmaceuticals, Inc.; University Medicine Essen Academy (UMEA) program - German Research Foundation (DFG) [FU356/12-1]; Faculty of Medicine, University of Duisburg-Essen; Alexion Pharmaceuticals, Inc., Boston, MA, USA [ALXN1210-PNH-201, ALXN1210-PNH-301, ALXN1210-PNH-302]	Alexion Pharmaceuticals, Inc.; University Medicine Essen Academy (UMEA) program - German Research Foundation (DFG); Faculty of Medicine, University of Duisburg-Essen; Alexion Pharmaceuticals, Inc., Boston, MA, USA	A.R. and U.D. received honoraria, consulting fees, and research support from Alexion Pharmaceuticals, Inc. S.R. is an employee and stockholder of Alexion Pharmaceuticals, Inc. F.A. was supported as a Clinician Scientist within the University Medicine Essen Academy (UMEA) program, funded by the German Research Foundation (DFG; grant FU356/12-1) and the Faculty of Medicine, University of Duisburg-Essen. The 3 clinical studies (ALXN1210-PNH-201, ALXN1210-PNH-301, and ALXN1210-PNH-302) were sponsored by Alexion Pharmaceuticals, Inc., Boston, MA, USA. Alexion Pharmaceuticals, Inc., the marketing-authorization holder of ravulizumab, was offered an opportunity to provide a scientific accuracy review. Changes resulting from comments received were made by the authors on the basis of scientific and editorial merit. Alexion Pharmaceuticals, Inc. did not play any role in the study design, data collection, or decision to publish the manuscript.	AMADOR E, 1963, CLIN CHEM, V9, P391; Baldwin WM, 2019, AM J TRANSPLANT, V19, P1881, DOI 10.1111/ajt.15366; BRAMBELL FW, 1966, LANCET, V2, P1087, DOI 10.1016/S0140-6736(66)92190-8; Brodsky RA, 2008, BLOOD, V111, P1840, DOI 10.1182/blood-2007-06-094136; Brodsky RA, 2014, BLOOD, V124, P2804, DOI 10.1182/blood-2014-02-522128; de Latour RP, 2015, BLOOD, V125, P775, DOI 10.1182/blood-2014-03-560540; Doumas B.T., 1972, STAND METHODS CLIN C, V7, P175; FAHEY JL, 1963, J EXP MED, V118, P845, DOI 10.1084/jem.118.5.845; Faqi A. S., COMPREHENSIVE GUIDE; Guancial E. A., 2010, BLOOD, V116; Hill A, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.28; Hill A, 2010, HAEMATOL-HEMATOL J, V95, P567, DOI 10.3324/haematol.2009.007229; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; Hillmen P, 2007, BLOOD, V110, P4123, DOI 10.1182/blood-2007-06-095646; Hillmen Peter, 2008, Hematology Am Soc Hematol Educ Program, P116, DOI 10.1182/asheducation-2008.1.116; Hillmen P, 2013, BRIT J HAEMATOL, V162, P62, DOI 10.1111/bjh.12347; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Kontermann R., THERAPEUTIC PROTEINS; Kulasekararaj AG, 2019, BLOOD, V133, P540, DOI 10.1182/blood-2018-09-876805; Lee JW, 2019, BLOOD, V133, P530, DOI 10.1182/blood-2018-09-876136; Lee SCW, 2014, J CLIN INVEST, V124, P4227, DOI 10.1172/JCI77984; Loschi M, 2016, AM J HEMATOL, V91, P366, DOI 10.1002/ajh.24278; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; Nakayama H, 2016, BIOL PHARM BULL, V39, P285, DOI 10.1248/bpb.b15-00703; Pyzik M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01540; Pyzik M, 2015, J IMMUNOL, V194, P4595, DOI 10.4049/jimmunol.1403014; Risitano Antonio M, 2008, Biologics, V2, P205; Roth A, 2018, BLOOD ADV, V2, P2176, DOI 10.1182/bloodadvances.2018020644; Roth A, 2011, INT J HEMATOL, V93, P704, DOI 10.1007/s12185-011-0867-y; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Sheridan D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195909; SIMISTER NE, 1985, EUR J IMMUNOL, V15, P733, DOI 10.1002/eji.1830150718; WEICHSELBAUM T E, 1946, Am J Clin Pathol, V10, P40	33	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0230869	10.1371/journal.pone.0230869	http://dx.doi.org/10.1371/journal.pone.0230869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218584	Green Published, gold			2022-12-26	WOS:000535935400027
J	Schrijvers-Gonlag, M; Skarpe, C; Andreassen, HP				Schrijvers-Gonlag, Marcel; Skarpe, Christina; Andreassen, Harry Peter			Influence of light availability and soil productivity on insect herbivory on bilberry (Vaccinium myrtillus L.) leaves following mammalian herbivory	PLOS ONE			English	Article							ASPEN POPULUS-TREMULA; GREY-SIDED VOLES; WOODY-PLANTS; HABITAT PRODUCTIVITY; PHENOLIC-COMPOUNDS; BETA REGRESSION; CLIMATE-CHANGE; NITROGEN; RESPONSES; GROWTH	Vegetative parts of bilberry (Vaccinium myrtillus) are important forage for many boreal forest mammal, bird and insect species. Plant palatability to insects is affected by concentration of nutrients and defense compounds in plants. We expected that palatability of bilberry leaves to insect herbivores is influenced by light availability and soil productivity (both affecting nitrogen concentration and constitutive carbon-based defense compound concentration) and herbivory by mammals (affecting nitrogen concentration and induced carbon-based defense compound concentration). We studied bilberry leaf herbivory under different light availability, soil productivity and mammalian herbivory pressure in small sampling units (1m x 1m) in boreal forest in Norway. We used generalized linear mixed models and generalized additive mixed models to model insect herbivory on bilberry leaves as a function of shade, soil productivity and mammalian herbivory. Observed insect herbivory on bilberry leaves increased with increasing shade levels. Predicted insect herbivory increased with increasing previous mammalian herbivory at high shade levels and this response was magnified at higher soil productivity levels. At low to intermediate shade levels, this response was only present under high soil productivity levels. Our results indicate that light availability is more important for variation in bilberry leaf palatability than soil nutrient conditions.	[Schrijvers-Gonlag, Marcel; Skarpe, Christina; Andreassen, Harry Peter] Inland Norway Univ Appl Sci, Fac Appl Ecol Agr Sci & Biotechnol, Campus Evenstad, Koppang, Norway	Inland Norway University of Applied Sciences	Schrijvers-Gonlag, M (corresponding author), Inland Norway Univ Appl Sci, Fac Appl Ecol Agr Sci & Biotechnol, Campus Evenstad, Koppang, Norway.	marcel.schrijversgonlag@inn.no		Schrijvers-Gonlag, Marcel/0000-0002-3922-6897	Inland Norway University of Applied Sciences; Research Council of Norway (NFR project) [221056]	Inland Norway University of Applied Sciences; Research Council of Norway (NFR project)	This study is a part of the BEcoDyn project supported by Inland Norway University of Applied Sciences and a grant from The Research Council of Norway (NFR project 221056; https://prosjektbanken.forskningsradet.no/#/project/NFR/221056/Sprak=en) to HPA. Work done by MSG was only partly funded. The Research Council of Norway (https://www.forskningsradet.no/en/) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, 2 INT S INF THEOR 19; [Anonymous], 1999, NATL ATLAS NORWAY VE; ATLEGRIM O, 1989, OECOLOGIA, V79, P136, DOI 10.1007/BF00378251; BAJWA R, 1985, NEW PHYTOL, V101, P459, DOI 10.1111/j.1469-8137.1985.tb02852.x; Ballare CL, 2014, ANNU REV PLANT BIOL, V65, P335, DOI 10.1146/annurev-arplant-050213-040145; Baque M, 2013, INT J LEGAL MED, V127, P213, DOI 10.1007/s00414-012-0675-9; Barrett MA, 2007, ECOL RES, V22, P268, DOI 10.1007/s11284-006-0021-0; Baruch Z, 2000, INT J PLANT SCI, V161, P107, DOI 10.1086/314233; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boonstra R, 2016, BIOSCIENCE, V66, P722, DOI 10.1093/biosci/biw080; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Bryant J. P., 1991, Phytochemical induction by herbivores., P135; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; CALDWELL MM, 1983, PHYSIOL PLANTARUM, V58, P445, DOI 10.1111/j.1399-3054.1983.tb04206.x; Cederlung G., 1980, Viltrevy (Stockholm), V11, P169; Chen YH, 2013, ECOGRAPHY, V36, P178, DOI 10.1111/j.1600-0587.2011.06833.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Danell K, 1997, ECOSCIENCE, V4, P296, DOI 10.1080/11956860.1997.11682408; DANELL K, 1985, OIKOS, V44, P75, DOI 10.2307/3544046; DUTOIT JT, 1990, ECOLOGY, V71, P149; Evans DM, 2006, J APPL ECOL, V43, P499, DOI 10.1111/j.1365-2664.2006.01158.x; Fagerstrom T, 1987, FUNCT ECOL, V1, P73, DOI 10.2307/2389708; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Field C., 1986, EC PLANT FORM FUNCTI, P22; Flower-Ellis J., 1971, THESIS; Fremstad E., 1997, VEGETASJONSTYPER NOR, DOI [10.1177/002221949703000602, DOI 10.1177/002221949703000602]; Haukioja E, 1998, CHEMOECOLOGY, V8, P133, DOI 10.1007/s000490050018; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hjalten J, 2004, ACTA THERIOL, V49, P53, DOI 10.1007/BF03192508; Holopainen JK, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01445; Jaakola L, 2010, PLANT CELL ENVIRON, V33, P1239, DOI 10.1111/j.1365-3040.2010.02154.x; Jones CG, 1999, OIKOS, V86, P27, DOI 10.2307/3546567; Julkunen-Tiitto R, 2015, CABI CLIM CHANGE SER, V7, P54, DOI 10.1079/9781780643786.0054; Karban R, 1999, TRENDS ECOL EVOL, V14, P443, DOI 10.1016/S0169-5347(99)01678-X; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kent M., 2012, A PRACTICAL APPROACH; Keski-Saari S, 2005, GLOBAL CHANGE BIOL, V11, P1180, DOI 10.1111/j.1365-2486.2005.00964.x; Kessler A, 2015, CURR OPIN INSECT SCI, V8, P47, DOI 10.1016/j.cois.2015.02.002; Koricheva J, 1998, ANNU REV ENTOMOL, V43, P195, DOI 10.1146/annurev.ento.43.1.195; Koricheva J, 2012, ECOL REV, P34; KREBS CJ, 1986, WILDLIFE SOC B, V14, P286; Lavola A, 1998, BIOCHEM SYST ECOL, V26, P1, DOI 10.1016/S0305-1978(97)00104-X; Lenart EA, 2002, CAN J ZOOL, V80, P664, DOI 10.1139/Z02-034; Loomis WE., 1932, P AM SOC HORTIC SCI, V29, P240; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Martinsen GD, 1998, ECOLOGY, V79, P192, DOI 10.1890/0012-9658(1998)079[0192:IIMBCP]2.0.CO;2; Martz F, 2010, J CHEM ECOL, V36, P1017, DOI 10.1007/s10886-010-9836-9; Mathisen KM, 2010, J VEG SCI, V21, P705, DOI 10.1111/j.1654-1103.2010.01180.x; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; Menge DNL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042045; Moe SR, 2018, BASIC APPL ECOL, V31, P44, DOI 10.1016/j.baae.2018.05.015; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; MOORBY J, 1963, ANN BOT-LONDON, V27, P291, DOI 10.1093/oxfordjournals.aob.a083846; Nestby R., 2011, EUR J PLANT SCI BIOT, V5, P5; Nissinen K, 2017, CAN J FOREST RES, V47, P1350, DOI 10.1139/cjfr-2017-0188; Nordin A, 2006, ENVIRON POLLUT, V141, P167, DOI 10.1016/j.envpol.2005.08.017; Nordin A, 1998, FUNCT ECOL, V12, P691, DOI 10.1046/j.1365-2435.1998.00240.x; Norwegian Meteorological Institute, 2019, WEATH CLIM DAT NORW; Nybakken L, 2013, SCAND J FOREST RES, V28, P319, DOI 10.1080/02827581.2012.749941; OHLSON M, 1995, FUNCT ECOL, V9, P596, DOI 10.2307/2390150; OKSANEN L, 1987, OIKOS, V50, P371, DOI 10.2307/3565498; Olofsson J, 2007, ECOSCIENCE, V14, P48, DOI 10.2980/1195-6860(2007)14[48:GVITSO]2.0.CO;2; Palmroth S, 2014, OECOLOGIA, V175, P457, DOI 10.1007/s00442-014-2923-9; Peinetti HR, 2001, OECOLOGIA, V127, P334, DOI 10.1007/s004420000593; Persson IL, 2012, J CHEM ECOL, V38, P1225, DOI 10.1007/s10886-012-0209-4; Pinheiro J, R PACKAGE VERSION; R Core Team, 2021, R LANGUAGE ENV STAT; Rhoades D. F., 1979, HERBIVORES THEIR INT, P3; Richardson SJ, 2002, J ECOL, V90, P544, DOI 10.1046/j.1365-2745.2002.00681.x; RITCHIE JC, 1956, J ECOL, V44, P291, DOI 10.2307/2257181; Sack L, 2002, OECOLOGIA, V131, P175, DOI 10.1007/s00442-002-0873-0; Schowalter TD, 2011, INSECT ECOLOGY: AN ECOSYSTEM APPROACH, 3RD EDITION, P1; Scogings P, 2005, PLANT ECOL, V179, P193, DOI 10.1007/s11258-004-7809-1; Scogings PF, 2014, PLANT ECOL, V215, P73, DOI 10.1007/s11258-013-0279-6; Selas V, 2011, BASIC APPL ECOL, V12, P227, DOI 10.1016/j.baae.2011.01.004; Sivadasan U, 2018, CAN J FOREST RES, V48, P629, DOI 10.1139/cjfr-2017-0380; Skarpe C, 2002, ARCT ANTARCT ALP RES, V34, P282, DOI 10.2307/1552485; Skarpe Christina, 2008, V195, P217, DOI 10.1007/978-3-540-72422-3_9; Smithson M, 2006, PSYCHOL METHODS, V11, P54, DOI 10.1037/1082-989X.11.1.54; Soininen EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068128; SPIDSO TK, 1980, ORNIS SCAND, V11, P99, DOI 10.2307/3675914; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Strengbom J, 2003, OIKOS, V103, P133, DOI 10.1034/j.1600-0706.2003.12680.x; Strengbom J, 2002, J ECOL, V90, P61, DOI 10.1046/j.0022-0477.2001.00629.x; TUOMI J, 1988, P57; Tuomi J, 1991, PHYTOCHEMICAL INDUCT, P85; Virjamo V, 2014, GLOBAL CHANGE BIOL, V20, P2252, DOI 10.1111/gcb.12464; VIRO P, 1985, ACTA THERIOL, V30, P259, DOI 10.4098/AT.arch.85-17; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Waterman P.G., 1989, P107; Wegge P, 2008, J ORNITHOL, V149, P237, DOI 10.1007/s10336-007-0265-7; Witzell J, 2004, J CHEM ECOL, V30, P1937, DOI 10.1023/B:JOEC.0000045587.75128.a4; Wood SN, 2016, J AM STAT ASSOC, V111, P1548, DOI 10.1080/01621459.2016.1180986; Zuur AF, 2016, METHODS ECOL EVOL, V7, P636, DOI 10.1111/2041-210X.12577; Zuur Alain F., 2009, P1; Zvereva EL, 2006, GLOBAL CHANGE BIOL, V12, P27, DOI 10.1111/j.1365-2486.2005.01086.x	97	0	0	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0230509	10.1371/journal.pone.0230509	http://dx.doi.org/10.1371/journal.pone.0230509			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218604	Green Published, gold, Green Submitted			2022-12-26	WOS:000535935400012
J	Simlat, M; Szewczyk, A; Ptak, A				Simlat, Magdalena; Szewczyk, Agnieszka; Ptak, Agata			Melatonin promotes seed germination under salinity and enhances the biosynthesis of steviol glycosides in Stevia rebaudiana Bertoni leaves	PLOS ONE			English	Article							GENE-EXPRESSION; EXOGENOUS APPLICATION; STRESS TOLERANCE; LEAF SENESCENCE; ABIOTIC STRESS; PLANT-GROWTH; PATHWAY	Melatonin (MEL) can act as a plant growth regulator and biostimulator in stressful situations. Using MEL in seed pretreatment also affects the future growth of plants. Therefore, this research investigated the effects of MEL on seed germination and seedling growth under NaCl in in vitro conditions. The additional effects of MEL on the accumulation of steviol glycosides (SGs) and on the expression of appropriate genes were also studied. Five mu M of MEL was the best concentration for seed germination, while 20 mu M exerted a positive impact on the biomass of stevia plantlets. NaCl significantly decreased seed germination, but MEL alleviated this effect when seeds were germinated in 50 mM of NaCl. Under salinity, the values of almost all morphological traits decreased as MEL concentration increased. The highest amounts of stevioside and rebaudioside A (Reb A) were observed as a result of treating seeds with 5 and 20 mu M of MEL, respectively. When adding NaCl, positive impacts of MEL on the accumulation of both SGs were also observed. Expression analyses of the genes involved in SGs biosynthesis was explored in seeds and leaves, and the transcripts of key enzymes occurred in both the tissues. However, quantitative polymerase chain reaction (qPCR) analysis showed that all tested genes were upregulated in younger leaves, contrary to older ones. Also in younger, rather than older, leaves SG gene expression varied according to MEL concentration. This study, therefore, presents the promising potential of MEL for improving stevia seed germination under salinity conditions and for enhancing the production of SGs in stevia plants.	[Simlat, Magdalena; Ptak, Agata] Agr Univ Krakow, Dept Plant Breeding Physiol & Seed Sci, Krakow, Poland; [Szewczyk, Agnieszka] Jagiellonian Univ, Fac Pharm, Dept Pharmaceut Bot, Med Coll, Krakow, Poland	Agricultural University Krakow; Jagiellonian University; Collegium Medicum Jagiellonian University	Simlat, M (corresponding author), Agr Univ Krakow, Dept Plant Breeding Physiol & Seed Sci, Krakow, Poland.	m.simlat@ur.krakow.pl	Simlat, Magdalena/AAC-5838-2021; Ptak, Agata/AAC-1530-2021	Simlat, Magdalena/0000-0001-9296-3303; Ptak, Agata/0000-0001-6614-0258; Szewczyk, Agnieszka/0000-0003-3010-679X	Ministry of Science and Higher Education of the Republic of Poland	Ministry of Science and Higher Education of the Republic of Poland(Ministry of Science and Higher Education, Poland)	The research was financed by the Ministry of Science and Higher Education of the Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnao MB, 2018, ANN BOT-LONDON, V121, P195, DOI 10.1093/aob/mcx114; Arnao M.B., 2014, ADV BOT, V2014, P1, DOI [DOI 10.1155/2014/815769, 10.1155/2014/815769]; Arnao MB, 2007, J PINEAL RES, V42, P147, DOI 10.1111/j.1600-079X.2006.00396.x; Arnao MB, 2014, TRENDS PLANT SCI, V19, P789, DOI 10.1016/j.tplants.2014.07.006; Bayraktar M, 2016, PLANT CELL TISS ORG, V127, P289, DOI 10.1007/s11240-016-1049-7; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Brandle JE, 2007, PHYTOCHEMISTRY, V68, P1855, DOI 10.1016/j.phytochem.2007.02.010; Chen GF, 2003, LIFE SCI, V73, P19, DOI 10.1016/S0024-3205(03)00252-2; Chen YE, 2018, PHYSIOL PLANTARUM, V164, P349, DOI 10.1111/ppl.12737; Coskun Y, 2019, PLANT CELL TISS ORG, V138, P89, DOI 10.1007/s11240-019-01605-7; Fallah F, 2017, CELL MOL BIOL, V63, P102, DOI 10.14715/cmb/2017.63.7.17; Geuns JMC, 2000, RRD PHYTOCHEM, P75; Ghaheri M, 2019, MOL BIOL REP, V46, P7, DOI 10.1007/s11033-018-4250-4; Ghaheri M, 2018, CELL MOL BIOL, V64, P17, DOI 10.14715/cmb/2018.64.2.4; Gupta B, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/701596; Gupta P, 2016, J APPL RES MED AROMA, V3, P160, DOI 10.1016/j.jarmap.2016.03.004; Hashempoor S, 2018, CELL MOL BIOL, V64, P28, DOI 10.14715/cmb/2018.64.2.6; Hernandez-Ruiz J, 2005, J PINEAL RES, V39, P137, DOI 10.1111/j.1600-079X.2005.00226.x; Hernandez-Ruiz J, 2008, PLANT GROWTH REGUL, V55, P29, DOI 10.1007/s10725-008-9254-y; Jiang XW, 2016, PAK J BOT, V48, P1345; Kumar H, 2012, GENE, V492, P276, DOI 10.1016/j.gene.2011.10.015; Li JP, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071735; Liang CZ, 2015, J PINEAL RES, V59, P91, DOI 10.1111/jpi.12243; Liopa-Tsakalidi A, 2012, RES J MED PLANTS, V6, P416, DOI [10.3923/rjmp.2012.416.424, DOI 10.3923/RJMP.2012.416.424]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manchester LC, 2000, LIFE SCI, V67, P3023, DOI 10.1016/S0024-3205(00)00896-1; Mohamed AAA, 2011, J PLANT PHYSIOL, V168, P1136, DOI 10.1016/j.jplph.2011.01.030; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nasrullah N, 2018, PHARMACOGN MAG, V14, pS327, DOI 10.4103/pm.pm_554_17; Nawaz MA, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01230; Park S, 2013, J PINEAL RES, V53, P385; Posmyk MM, 2008, J PINEAL RES, V45, P24, DOI 10.1111/j.1600-079X.2007.00552.x; Ptak A, 2019, IND CROP PROD, V138, DOI 10.1016/j.indcrop.2019.06.021; Raji Akintunde Abdullateef, 2011, International Journal of Biology, V3, P83; Rakesh Kumar, 2012, International Journal of Medicinal and Aromatic Plants, V2, P468; Reiter RJ, 2015, MOLECULES, V20, P7396, DOI 10.3390/molecules20047396; Santo A, 2017, PLANT BIOLOGY, V19, P368, DOI 10.1111/plb.12539; Simlat M, 2018, PEERJ, V6, DOI 10.7717/peerj.5009; Simlat M, 2016, SCI HORTIC-AMSTERDAM, V211, P295, DOI 10.1016/j.scienta.2016.09.009; Wang P, 2013, J PINEAL RES, V54, P292, DOI [10.1111/j.1600-079X.2012.00999.x, 10.1111/jpi.12017]; Weeda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093462; Wei W, 2015, J EXP BOT, V66, P695, DOI 10.1093/jxb/eru392; Wen D, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00718; Xiao S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216575; Yadav AK, 2011, CAN J PLANT SCI, V91, P1, DOI 10.4141/CJPS10086; Zeng L, 2018, J INTEGR AGR, V17, P328, DOI [10.1016/S2095-3119(17)61757-X, 10.1016/s2095-3119(17)61757-x]; Zhang HJ, 2014, J PINEAL RES, V57, P269, DOI 10.1111/jpi.12167; Zhang HX, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12551; Zhao Y, 2013, J PINEAL RES, V55, P79, DOI 10.1111/jpi.12044	49	9	9	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0230755	10.1371/journal.pone.0230755	http://dx.doi.org/10.1371/journal.pone.0230755			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218594	Green Published, gold			2022-12-26	WOS:000535935400023
J	Beral, A; Rincent, R; Le Gouis, J; Girousse, C; Allard, V				Beral, Aurore; Rincent, Renaud; Le Gouis, Jacques; Girousse, Christine; Allard, Vincent			Wheat individual grain-size variance originates from crop development and from specific genetic determinism	PLOS ONE			English	Article							SEED WEIGHT; PHENOTYPIC PLASTICITY; FRUITING EFFICIENCY; YIELD COMPONENTS; HIGH-TEMPERATURE; HEAT-STRESS; KERNEL SIZE; NUMBER; GENOTYPE; PHYSIOLOGISTS	Wheat grain yield is usually decomposed in the yield components: number of spikes / m(2), number of grains / spike, number of grains / m(2) and thousand kernel weight (TKW). These are correlated one with another due to yield component compensation. Under optimal conditions, the number of grains per m(2) has been identified as the main determinant of yield. However, with increasing occurrences of post-flowering abiotic stress associated with climate change, TKW may become severely limiting and hence a target for breeding. TKW is usually studied at the plot scale as it represents the average mass of a grain. However, this view disregards the large intra-genotypic variance of individual grain mass and its effect on TKW. The aim of this study is to investigate the determinism of the variance of individual grain size. We measured yield components and individual grain size variances of two large genetic wheat panels grown in two environments. We also carried out a genome-wide association study using a dense SNPs array. We show that the variance of individual grain size partly originates from the pre-flowering components of grain yield; in particular it is driven by canopy structure via its negative correlation with the number of spikes per m(2). But the variance of final grain size also has a specific genetic basis. The genome-wide analysis revealed the existence of QTL with strong effects on the variance of individual grain size, independently from the other yield components. Finally, our results reveal some interesting drivers for manipulating individual grain size variance either through canopy structure or through specific chromosomal regions.	[Beral, Aurore; Rincent, Renaud; Le Gouis, Jacques; Girousse, Christine; Allard, Vincent] Univ Clermont Auvergne, UMR 1095 GDEC, INRAE, Clermont Ferrand, France	INRAE; Universite Clermont Auvergne (UCA)	Beral, A (corresponding author), Univ Clermont Auvergne, UMR 1095 GDEC, INRAE, Clermont Ferrand, France.	aurore.beral@inrae.fr	Allard, Vincent/B-8806-2009	Allard, Vincent/0000-0003-1949-9158; Beral, Aurore/0000-0002-8273-5400; Rincent, Renaud/0000-0003-0885-0969	Agence Nationale de la Recherche of the French government through the programmme "Investissements d'Avenir'' [16-IDEX-0001 CAP 20-25]; CAP 20-25; INRA AgroEnv division; BreedWheat [ANR-10-BTBR-03]; PHENOME [ANR-11-INBS-0012]	Agence Nationale de la Recherche of the French government through the programmme "Investissements d'Avenir''(French National Research Agency (ANR)); CAP 20-25; INRA AgroEnv division; BreedWheat; PHENOME	This study was supported by the Agence Nationale de la Recherche of the French government through the programmme "Investissements d'Avenir'' (16-IDEX-0001 CAP 20-25). A. Beral PhD Scholarship was funded by CAP 20-25 and INRA AgroEnv division.; The authors also acknowledge the projects BreedWheat (ANR-10-BTBR-03) and PHENOME (ANR-11-INBS-0012) for providing raw data. The authors want to thank, D. Cormier and B. Adam for managing the Pheno3C phenotyping platform, W. Ngo, L. Bonjean and members of UE PHACC for their technical assistance. The authors want also to thank R. Rincent and A. Mini for providing script and useful help regarding to adjusted means calculation and GWAS analysis. The authors thank Dr. Sandy Land (www.rescript.co.nz) for language editing and proofreading of the manuscript.	Abley K, 2016, ANN BOT-LONDON, V117, P733, DOI 10.1093/aob/mcw016; Acreche MM, 2006, FIELD CROP RES, V98, P52, DOI 10.1016/j.fcr.2005.12.005; Aparicio N, 2002, J AGR SCI-CAMBRIDGE, V139, P143, DOI 10.1017/S0021859602002411; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Araus JL, 2008, CRIT REV PLANT SCI, V27, P377, DOI 10.1080/07352680802467736; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Baillot N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209597; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Boz H, DIFFERENCES SOME PHY, V8; Bradshaw AD, 2006, NEW PHYTOL, V170, P644, DOI 10.1111/j.1469-8137.2006.01761.x; BREMNER PM, 1978, AUST J PLANT PHYSIOL, V5, P61, DOI 10.1071/PP9780061; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Breseghello F, 2007, FIELD CROP RES, V101, P172, DOI 10.1016/j.fcr.2006.11.008; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Calderini DF, 2003, CROP SCI, V43, P141, DOI 10.2135/cropsci2003.0141; Charmet G, 2005, THEOR APPL GENET, V111, P540, DOI 10.1007/s00122-005-2045-1; CLARKE JM, 1979, CAN J PLANT SCI, V59, P959, DOI 10.4141/cjps79-152; Clarke MP, 2004, J SCI FOOD AGR, V84, P227, DOI 10.1002/jsfa.1657; Cormier F, 2014, THEOR APPL GENET, V127, P2679, DOI 10.1007/s00122-014-2407-7; Cristina D, GENETIC CONTROL GRAI, V8; DORNBOS DL, 1991, CAN J PLANT SCI, V71, P373, DOI 10.4141/cjps91-052; DUMOULIN V, 1994, CROP SCI, V34, P992, DOI 10.2135/cropsci1994.0011183X003400040030x; Fabre D, 2005, FIELD CROP RES, V92, P11, DOI 10.1016/j.fcr.2004.07.024; Farooq M, 2014, CRIT REV PLANT SCI, V33, P331, DOI 10.1080/07352689.2014.875291; Farooq M, 2011, CRIT REV PLANT SCI, V30, P491, DOI 10.1080/07352689.2011.615687; Feng F, 2018, FRONT PLANT SCI, V9, DOI [10.3389/fpls.2018.00009, DOI 10.3389/FPLS.2018.00009]; Ferrante A, 2017, FIELD CROP RES, V203, P114, DOI 10.1016/j.fcr.2016.12.028; Finch-Savage WE, 2016, J EXP BOT, V67, P567, DOI 10.1093/jxb/erv490; Fischer RA, 2008, FIELD CROP RES, V105, P15, DOI 10.1016/j.fcr.2007.04.002; Gambin BL, 2010, ANN APPL BIOL, V156, P91, DOI 10.1111/j.1744-7348.2009.00367.x; Gambin BL, 2005, CROP SCI, V45, P553, DOI 10.2135/cropsci2005.0553; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Hasan MM, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0366-8; Imbert E, 2002, PERSPECT PLANT ECOL, V5, P13, DOI 10.1078/1433-8319-00021; Jimenez-Gomez JM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002295; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Kusmec A, 2017, NAT PLANTS, V3, P715, DOI 10.1038/s41477-017-0007-7; LAFOND GP, 1986, CROP SCI, V26, P341, DOI 10.2135/cropsci1986.0011183X002600020027x; Li CH, 2019, THEOR APPL GENET, V132, P3309, DOI 10.1007/s00122-019-03426-w; Li Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155351; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Matilla A, 2005, SEED SCI RES, V15, P63, DOI 10.1079/SSR2005203; MIRALLES DJ, 1995, FIELD CROP RES, V43, P55, DOI 10.1016/0378-4290(95)00041-N; Mitchell JH, 2012, CROP PASTURE SCI, V63, P128, DOI 10.1071/CP11260; Mitchell J, 2017, J EXP BOT, V68, P809, DOI 10.1093/jxb/erw397; Mulder HA, 2013, J DAIRY SCI, V96, P7306, DOI 10.3168/jds.2013-6818; Nuttall JG, 2017, FIELD CROP RES, V202, P136, DOI 10.1016/j.fcr.2015.12.011; Pradhan GP, 2012, FUNCT PLANT BIOL, V39, P190, DOI 10.1071/FP11245; Ramya P, 2010, J APPL GENET, V51, P421, DOI 10.1007/BF03208872; Reynolds M, 2012, PLANT CELL ENVIRON, V35, P1799, DOI 10.1111/j.1365-3040.2012.02588.x; Rimbert H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0186329; Rincent R, 2019, THEOR APPL GENET, V132, P3399, DOI 10.1007/s00122-019-03432-y; Rincent R, 2018, G3-GENES GENOM GENET, V8, P3961, DOI 10.1534/g3.118.200760; Rincent R, 2014, GENETICS, V197, P375, DOI 10.1534/genetics.113.159731; Sadras VO, 2012, FIELD CROP RES, V127, P215, DOI 10.1016/j.fcr.2011.11.014; Sadras VO, 2009, NEW PHYTOL, V183, P565, DOI 10.1111/j.1469-8137.2009.02848.x; Semenov MA, 2009, J EXP BOT, V60, P2791, DOI 10.1093/jxb/erp164; Sharma DL, 2004, AUST J AGR RES, V55, P797, DOI 10.1071/AR03265; Shen X, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002839; SLAFER GA, 1993, FIELD CROP RES, V31, P351, DOI 10.1016/0378-4290(93)90073-V; SLAFER GA, 1994, AUST J PLANT PHYSIOL, V21, P393, DOI 10.1071/PP9940393; Slafer GA, 2003, ANN APPL BIOL, V142, P117, DOI 10.1111/j.1744-7348.2003.tb00237.x; Slafer GA, 2015, FOOD ENERGY SECUR, V4, P92, DOI 10.1002/fes3.59; Slafer GA, 2014, FIELD CROP RES, V157, P71, DOI 10.1016/j.fcr.2013.12.004; SOFIELD I, 1977, AUST J PLANT PHYSIOL, V4, P785, DOI 10.1071/PP9770785; STANTON ML, 1984, AM J BOT, V71, P1090, DOI 10.2307/2443384; Stone PJ, 1995, AUST J PLANT PHYSIOL, V22, P927, DOI 10.1071/PP9950927; TASHIRO T, 1990, ANN BOT-LONDON, V65, P51, DOI 10.1093/oxfordjournals.aob.a087908; Terrile II, 2017, FIELD CROP RES, V201, P86, DOI 10.1016/j.fcr.2016.09.026; Touzy G, 2019, THEOR APPL GENET, V132, P2859, DOI 10.1007/s00122-019-03393-2; Wang SS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01166; Wolc A, 2012, ANIM GENET, V43, P87, DOI 10.1111/j.1365-2052.2012.02381.x; Xie Q, 2015, J EXP BOT, V66, P6715, DOI 10.1093/jxb/erv378; Xu HC, 2015, J INTEGR AGR, V14, P1958, DOI 10.1016/S2095-3119(15)61094-2; Yabe S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207627; Yan X, 2019, SCI REPORTS, V9, DOI [10.1038/s41598-018-36956-2, DOI 10.1038/S41598-018-36956-2]; Zhai P., 2019, CLIMATE CHANGE LAND; ZHANG JH, 1995, OECOLOGIA, V102, P353, DOI 10.1007/BF00329802	78	11	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230689	10.1371/journal.pone.0230689	http://dx.doi.org/10.1371/journal.pone.0230689			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214360	Green Published, gold, Green Submitted			2022-12-26	WOS:000535934200040
J	Gongora-Rivera, F; Grijalva, I; Infante-Valenzuela, A; Camara-Lemarroy, C; Garza-Gonzalez, E; Paredes-Cruz, M; Grajales-Muniz, C; Guerrero-Cantera, J; Vargas-Ramos, I; Soares, J; Abrams, JY; Styczynski, AR; Camacho-Ortiz, A; Villarino, ME; Belay, ED; Schonberger, LB; Sejvar, JJ				Gongora-Rivera, Fernando; Grijalva, Israel; Infante-Valenzuela, Adrian; Camara-Lemarroy, Carlos; Garza-Gonzalez, Elvira; Paredes-Cruz, Martin; Grajales-Muniz, Concepcion; Guerrero-Cantera, Jose; Vargas-Ramos, Ignacio; Soares, Jesus; Abrams, Joseph Y.; Styczynski, Ashley R.; Camacho-Ortiz, Adrian; Villarino, Margarita E.; Belay, Ermias D.; Schonberger, Lawrence B.; Sejvar, James J.		GBS HU-IMSS Working Grp	Zika Virus infection and Guillain-Barre' syndrome in Northeastern Mexico: A case-control study	PLOS ONE			English	Article							OUTBREAK; COLOMBIA; HISTORY; STATES; CUCUTA	Background Beginning August 2017, we conducted a prospective case-control investigation in Monterrey, Mexico to assess the association between Zika virus (ZIKV) and Guillain-Barre' syndrome (GBS). Methods For each of 50 GBS case-patients, we enrolled 2-3 afebrile controls (141 controls in total) matched by sex, age group, and presentation to same hospital within 7 days. Results PCR results for ZIKV in blood and/or urine were available on all subjects; serum ZIKV IgM antibody for 52% of case-patients and 80% of controls. Subjects were asked about antecedent illness in the two months prior to neurological onset (for case-patients) or interview (for controls). Laboratory evidence of ZIKV infection alone (PCR+ or IgM+) was not significantly different between case-patients and controls (OR: 1.26, 95% CI: 0.45-3.54) but antecedent symptomatic ZIKV infection [a typical ZIKV symptom (rash, joint pain, or conjunctivitis) plus laboratory evidence of ZIKV infection] was higher among case-patients (OR: 12.45, 95% CI: 1.45-106.64). GBS case-patients with laboratory evidence of ZIKV infection were significantly more likely to have had typical ZIKV symptoms than controls with laboratory evidence of ZIKV infection (OR: 17.5, 95% CI: 3.2-96.6). This association remained significant even when only GBS case-patients who were afebrile for 5 days before onset were included in the analysis, (OR 9.57 (95% CI: 1.07 to 85.35). Conclusions During ZIKV epidemics, this study indicates that increases in GBS will occur primarily among those with antecedent symptomatic ZIKV.	[Gongora-Rivera, Fernando; Infante-Valenzuela, Adrian; Camara-Lemarroy, Carlos] Univ Autonoma Nuevo Leon, Dept Neurol, Univ Hosp Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico; [Grijalva, Israel; Paredes-Cruz, Martin; Guerrero-Cantera, Jose] UMAE Hosp Especialidades, Med Res Unit Neurol Dis, Ctr Med Nacl Siglo XXI, Inst Mexicano Seguro Social, Mexico City, DF, Mexico; [Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Dept Gastroenterol, Univ Hosp Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico; [Grajales-Muniz, Concepcion] Inst Mexicano Seguro Social, Epidemiol Surveillance Div Transmissible Dis, Epidemiol Surveillance Coordinat, Mexico City, DF, Mexico; [Vargas-Ramos, Ignacio] UMAE Hosp Especialidades 25, Dept Neurol, Inst Mexicano Seguro Social, Monterrey, Nuevo Leon, Mexico; [Soares, Jesus; Abrams, Joseph Y.; Belay, Ermias D.; Schonberger, Lawrence B.; Sejvar, James J.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Prion & Publ Hlth Off, Atlanta, GA 30333 USA; [Styczynski, Ashley R.] Stanford Univ, Dept Infect Dis, Palo Alto, CA 94304 USA; [Camacho-Ortiz, Adrian] Univ Autonoma Nuevo Leon, Dept Infect Dis, Univ Hosp Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico; [Villarino, Margarita E.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, CDC Mexico Country Off, Atlanta, GA USA	Universidad Autonoma de Nuevo Leon; Instituto Mexicano del Seguro Social; Universidad Autonoma de Nuevo Leon; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Centers for Disease Control & Prevention - USA; Stanford University; Universidad Autonoma de Nuevo Leon; Centers for Disease Control & Prevention - USA	Sejvar, JJ (corresponding author), Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Prion & Publ Hlth Off, Atlanta, GA 30333 USA.	zea3@cdc.gov	; Soares, Jesus/D-2992-2016	Abrams, Joseph/0000-0002-2278-2467; Belay, Ermias/0000-0002-9837-0960; PAREDES CRUZ, MARTIN/0000-0002-7029-1865; GONGORA-RIVERA, FERNANDO/0000-0003-1224-3942; Soares, Jesus/0000-0002-8640-8618; MARFIL, ALEJANDRO/0000-0002-8578-0338; Styczynski, Ashley/0000-0002-4682-8087	United States Centers for Disease Control and Prevention	United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by the United States Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0; Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007; Arcila-Londono X, 2012, SEMIN NEUROL, V32, P179, DOI 10.1055/s-0032-1329196; Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016; Barbi L, 2018, BRAZ J INFECT DIS, V22, P137, DOI 10.1016/j.bjid.2018.02.005; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; del Carpio-Orantes L, 2020, NEUROLOGIA, V35, P429, DOI 10.1016/j.nrl.2018.05.002; Dirlikov E, 2017, JAMA-J AM MED ASSOC, V318, P1498, DOI 10.1001/jama.2017.11483; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Duijster JW, 2016, INFECTION, V44, P797, DOI 10.1007/s15010-016-0906-y; Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006533; Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329; Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381; GeurtsvanKessel CH, 2018, ANN CLIN TRANSL NEUR, V5, P606, DOI 10.1002/acn3.556; Joob B, 2018, ARQ NEURO-PSIQUIAT, V76, P63, DOI 10.1590/0004-282X20170173; Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]; Moreira J, 2018, CLIN MICROBIOL INFEC, V24, P827, DOI 10.1016/j.cmi.2018.05.001; Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564; Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002; Reveiz L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180220; Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Simon O, 2018, J NEUROVIROL, V24, P362, DOI 10.1007/s13365-018-0621-9; Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869; Wijdicks EFM, 2017, MAYO CLIN PROC, V92, P467, DOI 10.1016/j.mayocp.2016.12.002; Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X; Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230132	10.1371/journal.pone.0230132	http://dx.doi.org/10.1371/journal.pone.0230132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214354	Green Published, gold			2022-12-26	WOS:000535934200018
J	Berger, H; Melamed, N; Davis, BM; Hasan, H; Mawjee, K; Barrett, J; McDonald, SD; Geary, M; Ray, JG				Berger, Howard; Melamed, Nir; Davis, Beth Murray; Hasan, Haroon; Mawjee, Karizma; Barrett, Jon; McDonald, Sarah D.; Geary, Michael; Ray, Joel G.			Impact of diabetes, obesity and hypertension on preterm birth: Population-based study	PLOS ONE			English	Article							BODY-MASS INDEX; RISK; ASPIRIN; WEIGHT	Objective To determine the impact of pre-pregnancy diabetes mellitus (D), obesity (O) and chronic hypertension (H) on preterm birth (PTB). Methods Retrospective population-based cohort study in Ontario, Canada between 2012-2016. Women who had a singleton livebirth or stillbirth at > 20 weeks gestation were included in the cohort. Exposures of interest were D, O and H, individually, and in various combinations. The primary outcome was PTB at 241/7 to 366/7 weeks. PTB was further analyzed by spontaneous or provider-initiated, early (< 34 weeks) or late (34-37 weeks), and the co-presence of preeclampsia, large for gestational age (LGA), and small for gestational age (SGA). Multivariable Poisson regression models with robust error variance were used to generate relative risks (RR), further adjusted for maternal age and parity (aRR). Population attributable fractions (PAF) were calculated for each of the outcomes by exposure state. Results 506,483 women were eligible for analysis. 30,139 pregnancies (6.0%) were complicated by PTB < 37 weeks, of which 7375 (24.5%) had D or O or H. Relative to women without D or O or H, the aRR for PTB < 37 weeks was higher for D (3.51; 95% CI 3.26-3.78) and H (3.81; 95% CI 3.55-4.10) than O (1.14; 95% CI 1.10-1.17). The combined state of DH was associated with a significantly higher aRR of PTB < 37 weeks (6.34; 95% CI 5.14-7.80) and < 34 weeks (aRR 10.33, 95% CI 6.96-15.33) than D alone. The risk of provider initiated PTB was generally higher than that for spontaneous PTB. Pre-pregnancy hypertension was associated with the highest risk for PTB with preeclampsia (aRR 45.42, 95% CI 39.69-51.99) and PTB with SGA (aRR 9.78, 95% CI 7.81-12.26) while pre-pregnancy diabetes was associated with increased risk for PTB with LGA (aRR 28.85, 95% CI 24.65-33.76). C Conclusion Combinations of DOH significantly magnify the risk of PTB, especially provider initiated PTB, and PTB with altered fetal growth or preeclampsia.	[Berger, Howard; Mawjee, Karizma] Univ Toronto, St Michaels Hosp, Dept Obstet & Gynecol, Div Maternal Fetal Med, Toronto, ON, Canada; [Melamed, Nir] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, Toronto, ON, Canada; [Davis, Beth Murray; Barrett, Jon] McMaster Univ, Midwifery Educ Program, Dept Obstet & Gynecol, Hamilton, ON, Canada; [Hasan, Haroon] Childrens Hosp Eastern Ontario CHEO, Better Outcomes Registry & Network BORN Ontario, Ottawa, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Div Maternal Fetal Med, Dept Obstet & Gynecol, Hamilton, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Div Maternal Fetal Med, Dept Radiol & Hlth Res Methods, Hamilton, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Div Maternal Fetal Med, Dept Evidence & Impact, Hamilton, ON, Canada; [Geary, Michael] Rotunda Hosp, Dept Obstet & Gynaecol, Dublin 1, Ireland; [Ray, Joel G.] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON, Canada; [Ray, Joel G.] Univ Toronto, St Michaels Hosp, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; University of Ottawa; Children's Hospital of Eastern Ontario; McMaster University; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Berger, H (corresponding author), Univ Toronto, St Michaels Hosp, Dept Obstet & Gynecol, Div Maternal Fetal Med, Toronto, ON, Canada.	Howard.Berger@unityhealth.to	Berger, Howard/N-6424-2019	Berger, Howard/0000-0003-3842-213X	Canadian Institute of Health Research (CIHR) [146442]; Department of Obstetrics and Gynaecology at the University of Toronto; McMaster University; Sunnybrook Research Institute; Unity Health Toronto; Tier II Canada Research Chair; Hamilton Health Sciences Early Career Award	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Department of Obstetrics and Gynaecology at the University of Toronto; McMaster University; Sunnybrook Research Institute(University of Toronto); Unity Health Toronto; Tier II Canada Research Chair; Hamilton Health Sciences Early Career Award	This study was funded by the Canadian Institute of Health Research (CIHR) (Grant#146442; Non-communicable Diseases in Obstetrics: Improving Quality of Care and Maternal-infant Outcomes Through an Obstetrical Research Network). Matched funding was provided by the Department of Obstetrics and Gynaecology at the University of Toronto, McMaster University, Sunnybrook Research Institute, and Unity Health Toronto. Dr. Sarah D. McDonald is supported by a Tier II Canada Research Chair. Dr. Beth MurrayDavis is supported by a Hamilton Health Sciences Early Career Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman BT, 2012, AM J OBSTET GYNECOL, V206, DOI [10.1016/j.ajog.2012.02.039, 10.1016/j.ajog.2011.07.030, 10.1016/j.ajog.2011.10.878]; Bennett JE, 2018, LANCET, V392, P1072, DOI 10.1016/S0140-6736(18)31992-5; Berger H, 2019, J OBSTET GYNAECOL CA, V41, P1579, DOI 10.1016/j.jogc.2019.01.020; Bodnar LM, 2007, EPIDEMIOLOGY, V18, P234, DOI 10.1097/01.ede.0000254119.99660.e7; Bramham K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2301; Branum Amy M, 2016, Natl Vital Stat Rep, V65, P1; Canadian Institute for Health Information, 2009, TOO EARL TOO SMALL P; Chatzi L, 2009, AM J EPIDEMIOL, V170, P829, DOI 10.1093/aje/kwp211; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Cheung BMY, 2012, CURR ATHEROSCLER REP, V14, P160, DOI 10.1007/s11883-012-0227-2; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Daly LE, 1998, AM J EPIDEMIOL, V147, P783; Dodd JM, 2019, LANCET DIABETES ENDO, V7, P15, DOI [10.1016/s2213-8587(18)30310-3, 10.1016/S2213-8587(18)30310-3]; Dodd JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1285; Fell Deshayne B, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2011.300606; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Fuchs F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11432-5; Kock K, 2010, J MATERN-FETAL NEO M, V23, P1004, DOI 10.3109/14767050903551392; Kong LH, 2019, JAMA PEDIATR, V173, P371, DOI 10.1001/jamapediatrics.2018.5541; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Lisonkova S, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-39; McDonald SD, 2018, CAN J PUBLIC HEALTH, V109, P527, DOI 10.17269/s41997-018-0086-x; McDonald Sarah D, 2010, BMJ, V341, pc3428, DOI 10.1136/bmj.c3428; Miao Q, 2019, ARCH GYNECOL OBSTET, V300, P135, DOI 10.1007/s00404-019-05177-x; National Research Council, 2010, WEIGHT GAIN PREGNANC; Panaitescu AM, 2017, ULTRASOUND OBST GYN, V50, P228, DOI 10.1002/uog.17493; Pearson-Stuttard J, 2018, LANCET DIABETES ENDO, V6, pE6, DOI [10.1016/S2213-8587(18)30150-5, 10.1016/S2213-8587(17)30366-2, 10.1016/52213-8587(17)30366-2, 10.1016/s2213-8587(17)30366-2]; Poston L, 2015, LANCET DIABETES ENDO, V3, P767, DOI 10.1016/S2213-8587(15)00227-2; Rolnik DL, 2017, NEW ENGL J MED, V377, P613, DOI 10.1056/NEJMoa1704559; Santos S, 2019, BJOG-INT J OBSTET GY, V126, P984, DOI 10.1111/1471-0528.15661; Statistics Canada, TABL 051 0001 EST PO; Stout MJ, 2017, PAEDIATR PERINAT EP, V31, P245, DOI 10.1111/ppe.12352; Viguiliouk E, 2017, J OBSTET GYNAECOL CA, V39, P722, DOI 10.1016/j.jogc.2017.04.040; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; World Health Organization,, 1998, WHO TECHN REP SER; Yanit KE, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.066; You JJ, 2010, CAN MED ASSOC J, V182, P143, DOI 10.1503/cmaj.090979	37	18	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0228743	10.1371/journal.pone.0228743	http://dx.doi.org/10.1371/journal.pone.0228743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210434	Green Published, gold			2022-12-26	WOS:000535307600005
J	Flores, YN; Toth, S; Crespi, CM; Ramirez-Palacios, P; McCarthy, WJ; Briseno-Perez, A; Granados-Garcia, V; Salmeron, J				Flores, Yvonne N.; Toth, Samantha; Crespi, Catherine M.; Ramirez-Palacios, Paula; McCarthy, William J.; Briseno-Perez, Arely; Granados-Garcia, Victor; Salmeron, Jorge			Risk of developing pre-diabetes or diabetes over time in a cohort of Mexican health workers	PLOS ONE			English	Article							NORMAL GLUCOSE REGULATION; FREE LIFE EXPECTANCY; URIC-ACID LEVELS; UNITED-STATES; SOCIOECONOMIC-STATUS; GENERAL-POPULATION; LATIN-AMERICA; METABOLIC SYNDROME; HDL CHOLESTEROL; FAMILY-HISTORY	Aim To determine the association between known risk factors (e.g., obesity, metabolic syndrome and its components) and the development of pre-diabetes or diabetes over time in a cohort of Mexican health workers. Methods Participants in the Mexican Health Worker Cohort Study with complete information at two waves of data collection, 2004-2006 (W1) and 2011-2013 (W2), were included in the analysis (n = 1,174). Multivariable binary and multinomial logistic regression were used to examine the cross-sectional associations between specific risk factors and diabetes status (diabetes, pre-diabetes, or neither) at W1 and the longitudinal associations between changes in risk factors and progression of diabetes status from W1 to W2, respectively. Results Mean time between waves was 7.0 years (SD 1.1). Prevalence of pre-diabetes and diabetes was 16% and 10% at W1 and increased to 30% and 16% at W2, respectively. The cross-sectional prevalence of pre-diabetes and diabetes was significantly higher among men, participants over the age of 45 years, and individuals who were overweight or obese or had metabolic syndrome (MS), three or more components of the MS, elevated alanine amino-transferase (ALT) levels, or elevated uric acid. In longitudinal analyses, remaining obese or gaining weight between waves was associated with an increased risk of developing pre-diabetes. A greater risk of developing pre-diabetes or diabetes was also observed among individuals who either maintained or acquired MS, elevated ALT, or elevated uric acid (only for diabetes) from W1 to W2. Conclusions Weight gain and acquiring or maintaining MS, elevated ALT levels, or elevated uric acid were associated with a significant risk of developing pre-diabetes or diabetes. Our findings, especially in the context of the obesity epidemic in Mexico, point towards an urgent need for initiatives to help reduce excess weight in order to avert future cases of pre-diabetes and diabetes.	[Flores, Yvonne N.; Ramirez-Palacios, Paula; Briseno-Perez, Arely] Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud, Delegac Morelos, Cuernavaca, Morelos, Mexico; [Flores, Yvonne N.; McCarthy, William J.] Univ Calif Los Angeles, Dept Hlth Policy & Management, Los Angeles, CA 90025 USA; [Flores, Yvonne N.; McCarthy, William J.] Kaiser Permanente, Ctr Hlth Equ, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Flores, Yvonne N.; Crespi, Catherine M.; McCarthy, William J.] Univ Calif Los Angeles, Canc Prevent & Control Res Ctr, Fielding Sch Publ Hlth, Los Angeles, CA 90025 USA; [Flores, Yvonne N.; Crespi, Catherine M.; McCarthy, William J.] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA; [Toth, Samantha; Crespi, Catherine M.] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Granados-Garcia, Victor] Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud Area Envejec, Mexico City, DF, Mexico; [Salmeron, Jorge] Univ Nacl Autonoma Mexico, Ctr Invest Polit Poblac & Salud, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social; University of California System; University of California Los Angeles; Kaiser Permanente; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Instituto Mexicano del Seguro Social; Universidad Nacional Autonoma de Mexico	Flores, YN (corresponding author), Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud, Delegac Morelos, Cuernavaca, Morelos, Mexico.; Flores, YN (corresponding author), Univ Calif Los Angeles, Dept Hlth Policy & Management, Los Angeles, CA 90025 USA.; Flores, YN (corresponding author), Kaiser Permanente, Ctr Hlth Equ, Fielding Sch Publ Hlth, Los Angeles, CA USA.; Flores, YN (corresponding author), Univ Calif Los Angeles, Canc Prevent & Control Res Ctr, Fielding Sch Publ Hlth, Los Angeles, CA 90025 USA.; Flores, YN (corresponding author), Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA.	ynflores@ucla.edu	Granados-García, Víctor/AAR-5788-2020	Granados-García, Víctor/0000-0002-9075-576X; Ramirez-Palacios, Paula/0000-0002-2586-4396; Salmeron, Jorge/0000-0002-5113-299X	Instituto Mexicano del Seguro Social (IMSS); Consejo Nacional de Ciencia y Tecnologia (CONACYT) [26267M, SALUD-2011-01-161930]; NIH [UL1TR000124]; NIH/NCI [K07CA197179]	Instituto Mexicano del Seguro Social (IMSS); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the Instituto Mexicano del Seguro Social (IMSS), and the Consejo Nacional de Ciencia y Tecnologia (CONACYT) grants #26267M and SALUD-2011-01-161930. https://www.conacyt.gob.mx/CMC was supported by NIH UL1TR000124 and YNF was supported by NIH/NCI K07CA197179. The funding agency did not play any role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Abbasi A, 2013, J CLIN ENDOCR METAB, V98, pE1352, DOI 10.1210/jc.2013-1680; Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Marron-Ponce JA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010045; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; American Diabetes Association (ADA), 2018, DIAGN DIAB LEARN PRE; Andrade F, 2009, REV PANAM SALUD PUBL, V26, P9, DOI 10.1590/S1020-49892009000700002; Andrade FCD, 2010, J GERONTOL B-PSYCHOL, V65, P381, DOI 10.1093/geronb/gbp119; Angotti T, 2013, LAT AM PERSPECT, V40, P5, DOI 10.1177/0094582X12466832; Aschner P, 2002, DIABETES-METAB RES, V18, pS27, DOI 10.1002/dmrr.280; Astudillo O, 2014, LANCET DIABETES ENDO, V2, P15, DOI 10.1016/S2213-8587(13)70160-8; Aviles-Santa ML, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00298; Bansal N, 2015, WORLD J DIABETES, V6, P296, DOI 10.4239/wjd.v6.i2.296; Barquera S, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-3; Beavers KM, 2015, OBES RES CLIN PRACT, V9, P266, DOI 10.1016/j.orcp.2014.09.003; Bhole V, 2010, AM J MED, V123, P957, DOI 10.1016/j.amjmed.2010.03.027; Canella DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092752; CDC, 2017, PRED; Centers for Disease Control and Prevention (CDC), 2017, NAT DIAB STAT REP 20; Robles-Ordaz MD, 2018, PUBLIC HEALTH NUTR, V21, P333, DOI 10.1017/S1368980017002658; Denova-Gutierrez E, 2016, SALUD PUBLICA MEXICO, V58, P708, DOI 10.21149/spm.v58i6.8299; DiBonaventura MD, 2018, DIABETES METAB SYNDR, V11, P1, DOI 10.2147/DMSO.S129247; Do OH, 2016, DIABETOLOGIA, V59, P1222, DOI 10.1007/s00125-016-3942-3; Dufour DL, 2004, AM J HUM BIOL, V16, P395, DOI 10.1002/ajhb.20043; Edelstein SL, 2005, DIABETES CARE, V28, P138, DOI 10.2337/diacare.28.1.138; Edwards CM, 2016, ENDOCRIN METAB CLIN, V45, P751, DOI 10.1016/j.ecl.2016.06.007; Encuesta Nacional de Salud y Nutricion de Medio Camino, 2016, INF FIN RES; Esparza-Romero J, 2015, DIABETES CARE, V38, P2075, DOI 10.2337/dc15-0089; Fernald LCH, 2007, SOC SCI MED, V64, P2030, DOI 10.1016/j.socscimed.2007.02.002; Flores YN, 2008, AM J GASTROENTEROL, V103, P2231, DOI 10.1111/j.1572-0241.2008.02022.x; Flores YN, 2016, J DIGEST DIS, V17, P304, DOI 10.1111/1751-2980.12341; Florez JC, 2009, DIABETOLOGIA, V52, P1528, DOI 10.1007/s00125-009-1412-x; Gallegos-Carrillo K, 2013, HEALTH PSYCHOL, V32, P609, DOI 10.1037/a0029276; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Grontved A, 2012, ARCH INTERN MED, V172, P1306, DOI 10.1001/archinternmed.2012.3138; Villanueva-Sosa LG, 2015, METAB SYNDR RELAT D, V13, P352, DOI 10.1089/met.2015.0040; Guthrie A, 2017, B WORLD HEALTH ORGAN, V95, P393, DOI 10.2471/BLT.17.020617; Haase CL, 2015, DIABETES, V64, P3328, DOI 10.2337/db14-1603; Hernandez-Avila M, 2003, SISTEMA EVALUACION H; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Huang D, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7839101; Huang YL, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5953; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Instituto Nacional de Estadistica y Geografia (INEGI), 2018, CAR DEF REG MEX DUR; International Diabetes Federation, 2018, IDF DIABETES ATLAS; Ioannou GN, 2006, AM J GASTROENTEROL, V101, P76, DOI 10.1111/j.1572-0241.2005.00341.x; Jiles Ruth, 2005, Morbidity and Mortality Weekly Report, V54, P1; Juraschek SP, 2014, AM J EPIDEMIOL, V179, P684, DOI 10.1093/aje/kwt320; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ko SH, 2015, WORLD J GASTROENTERO, V21, P7478, DOI 10.3748/wjg.v21.i24.7478; Kramer CK, 2010, J HUM HYPERTENS, V24, P519, DOI 10.1038/jhh.2009.103; Kumar A, 2016, ANN EPIDEMIOL, V26, P163, DOI 10.1016/j.annepidem.2015.12.006; Langenberg C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001647; Levasseur P, 2015, SOC SCI MED, V136, P165, DOI 10.1016/j.socscimed.2015.05.018; Lopez-Olmedo N, 2018, J NUTR, V148, P109, DOI 10.1093/jn/nxx007; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Lv Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056864; Markus MRP, 2018, NUTR METAB CARDIOVAS, V28, P234, DOI 10.1016/j.numecd.2017.12.005; Medina Catalina, 2017, PLoS One, V12, pe0188518, DOI 10.1371/journal.pone.0188518; Meneses-Leon J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-446; Meza R, 2015, PREV MED, V81, P445, DOI 10.1016/j.ypmed.2015.10.015; Mondragon HEV, 2010, DIABETES CARE, V33, P2260, DOI 10.2337/dc10-0992; Monteiro CA, 2018, PUBLIC HEALTH NUTR, V21, P18, DOI 10.1017/S1368980017001379; Monteiro CA, 2018, PUBLIC HEALTH NUTR, V21, P5, DOI 10.1017/S1368980017000234; Morales LS, 2014, SALUD PUBLICA MEXICO, V56, P197; Mortada I, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0770-x; Mortby ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073697; NHLBI, 2010, CLIN GUID ID EV TREA; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Perreault L, 2014, DIABETES CARE, V37, P2622, DOI 10.2337/dc14-0656; Perreault L, 2012, LANCET, V379, P2243, DOI 10.1016/S0140-6736(12)60525-X; Pinto G, 2015, SALUD PUBLICA MEXICO, V57, pS15; Rivera-Paredez B, 2018, BRIT J NUTR, V120, P210, DOI 10.1017/S0007114518001411; Scott RA, 2013, DIABETOLOGIA, V56, P60, DOI 10.1007/s00125-012-2715-x; Soto-Estrada G, 2018, GAC SANIT, V32, P283, DOI 10.1016/j.gaceta.2017.08.001; Speakman JR, 2018, INT J OBESITY, V42, P1524, DOI 10.1038/s41366-018-0147-5; Stahl CH, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-89; Sullivan PW, 2005, DIABETES CARE, V28, P1599, DOI 10.2337/diacare.28.7.1599; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tate JR, 1999, CLIN CHEM LAB MED, V37, P949, DOI 10.1515/CCLM.1999.140; Tietz N W., 1994, TXB CLIN CHEM, V2nd; Urena-Bogarin EL, 2015, FAM PRACT, V32, P159, DOI 10.1093/fampra/cmu047; van't Riet E, 2010, DIABETES CARE, V33, P763, DOI 10.2337/dc09-1586; Viazzi F, 2011, DIABETES CARE, V34, P126, DOI 10.2337/dc10-0918; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Xu Yi-Li, 2016, Chronic Dis Transl Med, V2, P81, DOI 10.1016/j.cdtm.2016.09.003; Yazgan S, 2017, CURR EYE RES, V42, P1039, DOI 10.1080/02713683.2016.1264606; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	88	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0229403	10.1371/journal.pone.0229403	http://dx.doi.org/10.1371/journal.pone.0229403			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9HN	32210432	Green Published, Green Submitted, gold			2022-12-26	WOS:000535307600009
J	Yang, G; Zhang, M; Zhao, YW; Pan, Y; Kan, MJ; Li, J; He, K; Zhang, XW				Yang, Guang; Zhang, Min; Zhao, Yawei; Pan, Yue; Kan, Mujie; Li, Jing; He, Kan; Zhang, Xuewen			HNF-4 alpha inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway	PLOS ONE			English	Article							EXPRESSION; MICRORNA-122	Hepatocellular carcinoma (HCC) is one of the most common human cancers, its prevalence and severity need us to discover novel early diagnostic biomarkers and new therapeutic strategies. MicroRNA-122 is the most abundant microRNA in the liver, and acts as a tumor suppressor and represses HCC development. In our study we showed that HNF-4 alpha and MiR-122 were down-regulated significantly in hepatocellular carcinoma. Over-expression of HNF-4 alpha inhibit hepatocellular carcinoma cells proliferation. And miR-122 is one of the down-stream effector of HNF-4 alpha. Up-regulated miR-122 inhibited hepatocellular carcinoma cells proliferation through regulating ADAM17. Collectively, our results suggested that HNF-4 alpha could inhibit hepatocellular carcinoma proliferation with miR-122 being a downstream target of it. And miR-122 would inhibit hepatocellular carcinoma proliferation by regulating ADAM17 signal pathway.	[Yang, Guang; Zhang, Xuewen] Jilin Univ, Affiliated Hosp 2, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China; [Zhang, Min; Zhao, Yawei; Pan, Yue; Li, Jing; He, Kan] Jilin Univ, Coll Basic Med Sci, Dept Pharmacol, Changchun, Peoples R China; [Kan, Mujie] Jilin Univ, Dept Biochem, Coll Basic Med Sci, Changchun, Peoples R China	Jilin University; Jilin University; Jilin University	Zhang, XW (corresponding author), Jilin Univ, Affiliated Hosp 2, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China.; He, K (corresponding author), Jilin Univ, Coll Basic Med Sci, Dept Pharmacol, Changchun, Peoples R China.	hek@jlu.edu.cn; zxw515@sohu.com						Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Borel F, 2012, J HEPATOL, V56, P1371, DOI 10.1016/j.jhep.2011.11.026; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li ZY, 2011, J HEPATOL, V55, P602, DOI 10.1016/j.jhep.2010.12.023; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Miyaaki H, 2014, LIVER INT, V34, pE302, DOI 10.1111/liv.12429; Nakao K, 2014, J GASTROENTEROL; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Shen J, 2015, GASTROENTEROLOGY RES; Shen J, 2016, CANC RES, V76; Shen J, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0105-1; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song, 2013, BIOSCI TRENDS; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Wang H, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0680-1; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875	22	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230450	10.1371/journal.pone.0230450	http://dx.doi.org/10.1371/journal.pone.0230450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210451	Green Published, Green Submitted, gold			2022-12-26	WOS:000535307600027
J	Alam, J; Lee, A; Lee, J; Il Kwon, D; Park, HK; Park, JH; Jeon, S; Baek, K; Lee, J; Park, SH; Choi, Y				Alam, Jehan; Lee, Ahreum; Lee, Junho; Il Kwon, Dong; Park, Hee Kyung; Park, Jung-Hyun; Jeon, Sumin; Baek, Keumjin; Lee, Jennifer; Park, Sung-Hwan; Choi, Youngnim			Dysbiotic oral microbiota and infected salivary glands in Sjogren's syndrome	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CLASSIFICATION CRITERIA; EPITHELIAL-CELLS; ASSOCIATION; EXPRESSION	Key events in the pathogenesis of Sjogren syndrome (SS) include the change of salivary gland epithelial cells into antigen-presenting cell-like phenotypes and focal lymphocytic sialadenitis (FLS). However, what triggers these features in SS is unknown. Dysbiosis of the gut and oral microbiomes is a potential environmental factor in SS, but its connection to the etiopathogenesis of SS remains unclear. This study aimed to characterize the oral microbiota in SS and to investigate its potential role in the pathogenesis of SS. Oral bacterial communities were collected by whole mouthwash from control subjects (14 without oral dryness and 11 with dryness) and primary SS patients (8 without oral dryness and 17 with dryness) and were analyzed by pyrosequencing. The SS oral microbiota was characterized by an increased bacterial load and Shannon diversity. Through comparisons of control and SS in combined samples and then separately in non-dry and dry conditions, SS-associated taxa independent of dryness were identified. Three SS-associated species and 2 control species were selected and used to challenge human submandibular gland tumor (HSG) cells. Among the selected SS-associated bacterial species, Prevotella melaninogenica uniquely upregulated the expression of MHC molecules, CD80, and IFN lambda in HSG cells. Concomitantly, P. melaninogenica efficiently invaded HSG cells. Sections of labial salivary gland (LSG) biopsies from 8 non-SS subjects and 15 SS patients were subjected to in situ hybridization using universal and P. melaninogenica-specific probes. Ductal cells and the areas of infiltration were heavily infected with bacteria in the LSGs with FLS. Collectively, dysbiotic oral microbiota may initiate the deregulation of SGECs and the IFN signature through bacterial invasion into ductal cells. These findings may provide new insights into the etiopathogenesis of SS.	[Alam, Jehan; Lee, Ahreum; Lee, Junho; Il Kwon, Dong; Jeon, Sumin; Baek, Keumjin; Choi, Youngnim] Seoul Natl Univ, Sch Dent, Dept Immunol, Seoul, South Korea; [Alam, Jehan; Lee, Ahreum; Lee, Junho; Il Kwon, Dong; Jeon, Sumin; Baek, Keumjin; Choi, Youngnim] Seoul Natl Univ, Sch Dent, Dept Mol Microbiol, Seoul, South Korea; [Park, Hee Kyung] Seoul Natl Univ, Sch Dent & Dent Res Inst, Dept Oral Med, Seoul, South Korea; [Park, Hee Kyung] Seoul Natl Univ, Sch Dent & Dent Res Inst, Dept Oral Diag, Seoul, South Korea; [Park, Jung-Hyun] NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Lee, Jennifer; Park, Sung-Hwan] Catholic Univ Korea, Seoul St Marys Hosp, Div Rheumatol, Internal Med, Seoul, South Korea; [Alam, Jehan] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Il Kwon, Dong] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Catholic University of Korea; Seoul St. Mary's Hospital; Baylor College of Medicine; Pohang University of Science & Technology (POSTECH)	Choi, Y (corresponding author), Seoul Natl Univ, Sch Dent, Dept Immunol, Seoul, South Korea.; Choi, Y (corresponding author), Seoul Natl Univ, Sch Dent, Dept Mol Microbiol, Seoul, South Korea.	youngnim@snu.ac.kr	Alam, Jehan/B-4893-2013; Choi, Youngnim/AAL-8140-2020	Alam, Jehan/0000-0001-5658-4736; Choi, Youngnim/0000-0002-6496-5560	Korea Health Industry Development Institute [HI13C0016]; National Research Foundation of Korea [2016R1E1A1A01942402]; Sjogren's International Collaborative Clinical Alliance [SICCA] under National Institute of Dental and Craniofacial Research [N01 DE32636]; National Eye Institute; Office for Research in Women's Health	Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); National Research Foundation of Korea(National Research Foundation of Korea); Sjogren's International Collaborative Clinical Alliance [SICCA] under National Institute of Dental and Craniofacial Research; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Office for Research in Women's Health	This study was supported by a grant [HI13C0016] awarded to Youngnim Choi from the Korea Health Industry Development Institute and a grant [2016R1E1A1A01942402] awarded to Youngnim Choi from the National Research Foundation of Korea. Labial salivary gland biopsy specimens used in this manuscript are from the Sjogren's International Collaborative Clinical Alliance [SICCA], funded under contract N01 DE32636 by the National Institute of Dental and Craniofacial Research, with funding support from the National Eye Institute and the Office for Research in Women's Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON TC, 1983, J IMMUNOL, V130, P203; Alam J, 2016, IMMUNOL RES, V64, P848, DOI 10.1007/s12026-016-8786-x; Baek K, 2018, J DENT RES, V97, P192, DOI 10.1177/0022034517732754; Barone F, 2008, J IMMUNOL, V180, P5130, DOI 10.4049/jimmunol.180.7.5130; Belstrom D, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0031-4; Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080; CEDERLUND H, 1993, J ANTIMICROB CHEMOTH, V32, P355, DOI 10.1093/jac/32.3.355; Choi YS, 2015, JOVE-J VIS EXP, DOI 10.3791/52836; Christodoulou MI, 2010, J AUTOIMMUN, V34, P400, DOI 10.1016/j.jaut.2009.10.004; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; Daniels TE, 2011, ARTHRITIS RHEUM-US, V63, P2021, DOI 10.1002/art.30381; de Paiva CS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23561; Jonsson MV, 2007, J RHEUMATOL, V34, P2044; Jonsson MV, 2006, ARTHRITIS RHEUM, V54, P2300, DOI 10.1002/art.21945; Kaneda Y, 2009, EUR J ORAL SCI, V117, P506, DOI 10.1111/j.1600-0722.2009.00667.x; Kelly BJ, 2015, BIOINFORMATICS, V31, P2461, DOI 10.1093/bioinformatics/btv183; Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001; Li MR, 2016, ARCH ORAL BIOL, V70, P143, DOI 10.1016/j.archoralbio.2016.06.016; Lugonja B, 2016, J CLIN PERIODONTOL, V43, P26, DOI 10.1111/jcpe.12485; Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782; Manganelli P, 1997, J RHEUMATOL, V24, P1552; Munoz-Bellido JL, 2000, INT J ANTIMICROB AG, V14, P177, DOI 10.1016/S0924-8579(99)00154-5; Nikitakis NG, 2017, ORAL DIS, V23, P828, DOI 10.1111/odi.12589; Ogawa N, 2002, ARTHRITIS RHEUM-US, V46, P2730, DOI 10.1002/art.10577; Rusthen S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218319; Salomonsson S, 2003, ARTHRITIS RHEUM-US, V48, P3187, DOI 10.1002/art.11311; Schiodt M, 2001, ORAL DIS, V7, P106, DOI 10.1034/j.1601-0825.2001.70207.x; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sembler-Moller ML, 2019, J ORAL MICROBIOL, V11, DOI 10.1080/20002297.2019.1660566; Sharma D, 2020, ORAL DIS, V26, P295, DOI 10.1111/odi.13191; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; Siddiqui H, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.31119; Spachidou MP, 2007, CLIN EXP IMMUNOL, V147, P497, DOI 10.1111/j.1365-2249.2006.03311.x; Tsunawaki S, 2002, J RHEUMATOL, V29, P1884; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Van der Meulen TA, 2018, RHEUMATOLOGY, V57, P2225, DOI 10.1093/rheumatology/key215; van der Meulen TA, 2018, ANN RHEUM DIS, V77, P1542, DOI 10.1136/annrheumdis-2018-213026; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Xu X, 2015, ENVIRON MICROBIOL, V17, P699, DOI 10.1111/1462-2920.12502; Zheng LY, 2010, ORAL SURG ORAL MED O, V109, P844, DOI 10.1016/j.tripleo.2010.01.006	41	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230667	10.1371/journal.pone.0230667	http://dx.doi.org/10.1371/journal.pone.0230667			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208441	Green Published, gold			2022-12-26	WOS:000535305100035
J	Fadhil, RS; Wei, MQ; Nikolarakos, D; Good, D; Nair, RG				Fadhil, Rushdi S.; Wei, Ming Q.; Nikolarakos, Dimitrios; Good, David; Nair, Raj G.			Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR; CANCER; PROLIFERATION; SUPPRESSOR; EXPRESSION; SIGNATURES; PROFILE	Backgrounds MicroRNAs (miRNA) are a class of non-protein-coding RNAs that have significant biological and pathological functions. The importance of miRNAs as potential cancer diagnostic biomarkers is gaining attention due to their influence in the regulation of cellular processes such as cell differentiation, proliferation and apoptosis. The aim of this study was to identify significant miRNAs from saliva as potential diagnostic biomarkers in the early diagnosis and prognosis of head and neck squamous cell carcinoma (HNSCC). Materials and methods Five differentially expressed miRNAs (miR-7703, miR-let-7a-5p, miR-345-5p, miR-3928 and miR-1470) were selected from Next Generation Sequencing (NGS) miRNA data generated from our previous study using saliva of 12 HNSCC patients and 12 healthy controls. Their differential expressed miRNAs were subsequently validated by RT-qPCR using saliva samples from healthy controls (n = 80) and HNSCC patients (n = 150). Total RNA was isolated from 150 saliva samples of HNSCC patients and was transcripted into cDNA by Taq-Man MicroRNA Reverse Transcription Kit. Using quantitative RT-PCR analysis, salivary miRNAs were identified in HNSCC patients (n = 150) and healthy controlled cases (n = 80). T-tests were used to compare the differences among the various clinical variants. Results On average 160 ng/mu l was isolated from 500 mu l of saliva. Overall, a good correlation observed between the HNSCC and some of miRNAs expression levels. Salivary miR-let7a-5p (P<0.0001) and miR-3928 (P< 0.01) were significantly down regulated in saliva of HNSCC patients relative to age and sex-matched healthy controls. A number of salivary miRNAs (miR-let-7a-5p and miR-3928) were correlated with lymph node metastasis (p = 0.003, p = 0.049) and tumour size (p = 0.01, p = 0.02), respectively. However, our preliminary analysis showed no significant differences in salivary miR-1470, miR-345-5p or miR-7703 expression between patients and healthy controls. Most notably, our analysis showed that salivary miR-let-7a-5p and miR-3928 expression levels have significant sensitivity and specificity to distinguish between patients with HNSCC and healthy controls. Conclusion This study concluded that salivary miR-let-7a-5p and miR-3928 has the potential to be novel non-invasive biomarkers for early detection and prognosis of HNSCC.	[Fadhil, Rushdi S.; Wei, Ming Q.] Griffith Uni, Sch Med Sci, Gold Coast, Qld, Australia; [Fadhil, Rushdi S.; Wei, Ming Q.] Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Fadhil, Rushdi S.; Nair, Raj G.] Griffith Univ Gold Coast, Sch Dent & Oral Hlth, Gold Coast, Qld, Australia; [Nikolarakos, Dimitrios] Gold Coast Univ Hosp, Oral & Maxillofacial Surg, Queensland Hlth, Gold Coast, Qld, Australia; [Good, David] Australian Catholic Univ, Sch Allied Hlth, Discipline Physiotherapy, Banyo, Qld, Australia; [Nair, Raj G.] Gold Coast Univ Hosp, Oral Oncol Haematol & Oncol, Gold Coast, Qld, Australia	Menzies Health Institute Queensland; Griffith University; Gold Coast University Hospital; Queensland Health; Australian Catholic University; Gold Coast University Hospital	Wei, MQ (corresponding author), Griffith Uni, Sch Med Sci, Gold Coast, Qld, Australia.; Wei, MQ (corresponding author), Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia.; Nair, RG (corresponding author), Griffith Univ Gold Coast, Sch Dent & Oral Hlth, Gold Coast, Qld, Australia.; Nair, RG (corresponding author), Gold Coast Univ Hosp, Oral Oncol Haematol & Oncol, Gold Coast, Qld, Australia.	m.wei@griffith.edu.au; r.nair@griffith.edu.au		Nair, Raj/0000-0002-9881-8585	Australian Government; Griffith University; Iraqi Government, Iraqi Center for Cancer and Medical Genetic Research; Al-Mustansiryah University	Australian Government(Australian GovernmentCGIAR); Griffith University(Griffith University); Iraqi Government, Iraqi Center for Cancer and Medical Genetic Research; Al-Mustansiryah University	RSF is a recipient of PhD scholarship from Australian Government and Griffith University. RSF wish to express his gratitude towards the Iraqi Government, Iraqi Center for Cancer and Medical Genetic Research and Al-Mustansiryah University for research scholarship.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Bailey UM, 2012, J CHROMATOGR B, V911, P21, DOI 10.1016/j.jchromb.2012.10.023; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang KW, 2008, J DENT RES, V87, P1063, DOI 10.1177/154405910808701116; Chang L, 2012, RNA BIOL, V9, P1247, DOI 10.4161/rna.21821; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen X, 2011, J INT MED RES, V39, P2110, DOI 10.1177/147323001103900607; Cheng YSL, 2011, ORAL ONCOL, V47, P1122, DOI 10.1016/j.oraloncology.2011.07.032; Dalmay T, 2008, J INTERN MED, V263, P366, DOI 10.1111/j.1365-2796.2008.01926.x; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Fabryova H, 2014, ORAL DIS, V20, P146, DOI 10.1111/odi.12098; Ferlay J., 2004, GLOBOCAN2002; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Genco Robert J, 2012, J Am Dent Assoc, V143, p3S; Ghanbari R., 2015, BIOMARKERS CANC, V7; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Gorugantula LM, 2012, OR SURG OR MED OR PA, V114, P215, DOI 10.1016/j.oooo.2012.03.013; He XY, 2009, FEBS LETT, V583, P3501, DOI 10.1016/j.febslet.2009.10.007; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li Y, 2004, J DENT RES, V83, P199, DOI 10.1177/154405910408300303; Mansoori Behzad, 2016, Asian Pac J Cancer Prev, V17, P1887; Nagadia R, 2013, CELL ONCOL, V36, P1, DOI 10.1007/s13402-012-0122-4; Niu J., 2012, J BIOL CHEM; Park N.J., 2009, CLIN CANCER RES, P1078; Patel RS, 2011, ARCH ORAL BIOL, V56, P1506, DOI 10.1016/j.archoralbio.2011.05.015; Pfaffe T., 2011, CLIN CHEM; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Salazar C, 2014, CELL ONCOL, V37, P331, DOI 10.1007/s13402-014-0188-2; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Schulz BL, 2013, CRIT REV BIOTECHNOL, V33, P246, DOI 10.3109/07388551.2012.687361; Shishodia G, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0385-2; Song H, 2015, ONCOL REP, V33, P997, DOI 10.3892/or.2014.3674; Szabo Z., 2016, UROL ONCOL; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; Wang QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044398; WINGO PA, 1995, CA-CANCER J CLIN, V45, P8, DOI 10.3322/canjclin.45.1.8; Wong David T W, 2012, J Am Dent Assoc, V143, p19S; Xu HD, 2014, CELL PHYSIOL BIOCHEM, V33, P1547, DOI 10.1159/000358718; Ye F.-G., 2015, CANC RES; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Yu YJ, 2012, CARCINOGENESIS, V33, P68, DOI 10.1093/carcin/bgr246; Zhang DG, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-115; Zhang QG, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0681-y	48	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0221779	10.1371/journal.pone.0221779	http://dx.doi.org/10.1371/journal.pone.0221779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208417	gold, Green Published			2022-12-26	WOS:000535305100002
J	Jangid, A; Fukuda, S; Seki, M; Horiuchi, T; Suzuki, Y; Taylor, TD; Ohno, H; Prakash, T				Jangid, Aditi; Fukuda, Shinji; Seki, Masahide; Horiuchi, Terumi; Suzuki, Yutaka; Taylor, Todd D.; Ohno, Hiroshi; Prakash, Tulika			Association of colitis with gut-microbiota dysbiosis in clathrin adapter AP-1B knockout mice	PLOS ONE			English	Article							ULCERATIVE-COLITIS; HYDROGEN-SULFIDE; QUALITY-CONTROL; INFLAMMATION; BARRIER; HOST; ENTEROBACTERIACEAE; SPECTRUM; DISEASE	Inflammatory bowel disease results from alterations in the immune system and intestinal microbiota. The role of intestinal epithelial cells (IECs) in maintaining gut homeostasis is well known and its perturbation often causes gastrointestinal disorders including IBD. The epithelial specific adaptor protein (AP)-1B is involved in the establishment of the polarity of IECs. Deficiency of the AP-1B mu subunit (Ap1m2-/-) leads to the development of chronic colitis in mice. However, how this deficiency affects the gut microbes and its potential functions remains elusive. To gain insights into the gut microbiome of Ap1m2-/- mice having the colitis phenotype, we undertook shotgun metagenomic sequencing analysis of knockout mice. We found important links to the microbial features involved in altering various physiological pathways, including carbohydrate metabolism, nutrient transportation, oxidative stress, and bacterial pathogenesis (cell motility). In addition, an increased abundance of sulfur-reducing and lactate-producing bacteria has been observed which may aggravate the colitis condition.	[Jangid, Aditi; Taylor, Todd D.; Prakash, Tulika] Indian Inst Technol Mandi, BioX Ctr, Mandi, Himachal Prades, India; [Jangid, Aditi; Taylor, Todd D.; Prakash, Tulika] Indian Inst Technol Mandi, Sch Basic Sci, Mandi, Himachal Prades, India; [Fukuda, Shinji; Ohno, Hiroshi] RIKEN Ctr Integrat Med Sci, Lab Intestinal Ecosyst, Yokohama, Kanagawa, Japan; [Fukuda, Shinji; Ohno, Hiroshi] Kanagawa Inst Ind Sci & Technol, Intestinal Microbiota Project, Kawasaki, Kanagawa, Japan; [Fukuda, Shinji] Univ Tsukuba, Transborder Med Res Ctr, Tsukuba, Ibaraki, Japan; [Seki, Masahide; Horiuchi, Terumi; Suzuki, Yutaka] Univ Tokyo, Dept Computat Biol & Med Sci, Kashiwa, Chiba, Japan; [Taylor, Todd D.; Prakash, Tulika] RIKEN Ctr Integrat Med Sci, Lab Microbiome Sci, Yokohama, Kanagawa, Japan; [Fukuda, Shinji] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Mandi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Mandi; RIKEN; Kanagawa Academy Science & Technology; University of Tsukuba; University of Tokyo; RIKEN; Keio University	Prakash, T (corresponding author), Indian Inst Technol Mandi, BioX Ctr, Mandi, Himachal Prades, India.; Prakash, T (corresponding author), Indian Inst Technol Mandi, Sch Basic Sci, Mandi, Himachal Prades, India.; Prakash, T (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Microbiome Sci, Yokohama, Kanagawa, Japan.	tulika@iitmandi.ac.in	Taylor, Todd/A-7121-2009	Taylor, Todd/0000-0003-4247-6253	Japan Society For The Promotion of Science (JSPS) KAKENHI [18H04805]; Japan Science and Technology Agency (JST) PRESTO [JPMJPR1537]; JST ERATO [JPMJER1902]; Advanced Research & Development Programs for Medical Innovation (AMED-CREST) [JP19gm1010009]; Takeda Science Foundation; Food Science Institute Foundation; Program for the Advancement of Research in Core Projects under Keio University's Longevity Initiative; JSPS KAKENHI [16H06279]; Council of Scientific and Industrial Research, India	Japan Society For The Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency (JST) PRESTO(Japan Science & Technology Agency (JST)); JST ERATO(Japan Science & Technology Agency (JST)); Advanced Research & Development Programs for Medical Innovation (AMED-CREST); Takeda Science Foundation(Takeda Science Foundation (TSF)); Food Science Institute Foundation; Program for the Advancement of Research in Core Projects under Keio University's Longevity Initiative; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported in part by Japan Society For The Promotion of Science (JSPS) KAKENHI (grant no. 18H04805 to S.F.), Japan Science and Technology Agency (JST) PRESTO (grant no. JPMJPR1537 to S.F.), JST ERATO (grant no. JPMJER1902 to S.F.), Advanced Research & Development Programs for Medical Innovation (AMED-CREST; grant no. JP19gm1010009 to S.F.), the Takeda Science Foundation (to S.F.), the Food Science Institute Foundation (to S.F.), the Program for the Advancement of Research in Core Projects under Keio University's Longevity Initiative (to S.F.). This study was also supported in part by JSPS KAKENHI (grant no. 16H06279 to Y.S.). The Council of Scientific and Industrial Research, India provided support in the form of a fellowship to AJ. TP received support in the form of salary from IIT Mandi. In addition, the HPC facility at IIT Mandi has been used for bioinformatics analysis. RIKEN provided material support and support in the form of salaries for TT and HO. The specific roles of these authors are articulated in the `author contributions' section.	Andrews S., 2010, FASTQC QUALITY CONTR; Berry D, 2012, ISME J, V6, P2091, DOI 10.1038/ismej.2012.39; Bhatia M, 2015, HANDB EXP PHARMACOL, V230, P165, DOI 10.1007/978-3-319-18144-8_8; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gkouskou KK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00028; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Jones MB, 2015, P NATL ACAD SCI USA, V112, P14024, DOI 10.1073/pnas.1519288112; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Kaitha Sindhu, 2015, World J Gastrointest Pathophysiol, V6, P62, DOI 10.4291/wjgp.v6.i3.62; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lavelle A, 2015, GUT, V64, P1553, DOI 10.1136/gutjnl-2014-307873; Levine J, 1998, AM J GASTROENTEROL, V93, P83, DOI 10.1111/j.1572-0241.1998.083_c.x; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Liu YL, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090920; Lo CC, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0366-2; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Marquet P, 2009, FEMS MICROBIOL LETT, V299, P128, DOI 10.1111/j.1574-6968.2009.01750.x; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Murakami S, 2015, BASED COMPLEMENT ALT, V2015, P824395, DOI [10.1155/2015/824395, DOI 10.1155/2015/82439526798400]; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Nagao-Kitamoto H, 2017, IMMUNE NETW, V17, P1, DOI 10.4110/in.2017.17.1.1; Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Pitcher MCL, 2000, GUT, V46, P64, DOI 10.1136/gut.46.1.64; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rooks MG, 2014, ISME J, V8, P1403, DOI 10.1038/ismej.2014.3; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schwab C, 2014, ISME J, V8, P1101, DOI 10.1038/ismej.2013.223; Sharpton T, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00036-17; Shen Z, 2016, INFECT IMMUN, V84, P2307, DOI 10.1128/IAI.00235-16; Sherrill C, 1998, J BACTERIOL, V180, P1454, DOI 10.1128/JB.180.6.1454-1459.1998; Skuja V, 2018, EUR J GASTROEN HEPAT, V30, P92, DOI 10.1097/MEG.0000000000000989; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Takahashi D, 2011, GASTROENTEROLOGY, V141, P621, DOI 10.1053/j.gastro.2011.04.056; Wang HB, 2012, DIGEST DIS SCI, V57, P3126, DOI 10.1007/s10620-012-2259-4; Ye Z, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0520-6; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zheng HH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01703	51	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0228358	10.1371/journal.pone.0228358	http://dx.doi.org/10.1371/journal.pone.0228358			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LA1RH	32208434	Green Submitted, gold, Green Published			2022-12-26	WOS:000523731600001
J	Mastracci, TL; Colvin, SC; Padgett, LR; Mirmira, RG				Mastracci, Teresa L.; Colvin, Stephanie C.; Padgett, Leah R.; Mirmira, Raghavendra G.			Hypusinated eIF5A is expressed in the pancreas and spleen of individuals with type 1 and type 2 diabetes	PLOS ONE			English	Article							DEOXYHYPUSINE SYNTHASE; POSTTRANSLATIONAL SYNTHESIS; PROMOTES TRANSLATION; AMINO-ACID; CELLS; INHIBITION; IDENTIFICATION; LYMPHOCYTES; SPERMIDINE; INITIATION	The gene encoding eukaryotic initiation factor 5A (EIF5A) is found in diabetes-susceptibility loci in mouse and human. eIF5A is the only protein known to contain hypusine (hydroxyputrescine lysine), a polyamine-derived amino acid formed post-translationally in a reaction catalyzed by deoxyhypusine synthase (DHPS). Previous studies showed pharmacologic blockade of DHPS in type 1 diabetic NOD mice and type 2 diabetic db/db mice improved glucose tolerance and preserved beta cell mass, which suggests that hypusinated eIF5A (eIF5A(Hyp)) may play a role in diabetes pathogenesis by direct action on the beta cells and/or altering the adaptive or innate immune responses. To translate these findings to human, we examined tissue from individuals with and without type 1 and type 2 diabetes to determine the expression of eIF5A(Hyp). We detected eIF5A(Hyp) in beta cells, exocrine cells and immune cells; however, there was also unexpected enrichment of eIF5A(Hyp) in pancreatic polypeptide-expressing PP cells. Interestingly, the presence of eIF5A(Hyp) co-expressing PP cells was not enhanced with disease. These data identify new aspects of eIF5A biology and highlight the need to examine human tissue to understand disease.	[Mastracci, Teresa L.; Padgett, Leah R.] Indiana Biosci Res Inst, Indianapolis, IN 46202 USA; [Mastracci, Teresa L.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Colvin, Stephanie C.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Physiol, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Mastracci, TL (corresponding author), Indiana Biosci Res Inst, Indianapolis, IN 46202 USA.; Mastracci, TL (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	tmastrac@iu.edu		Mastracci, Teresa L./0000-0003-1956-1951; Mirmira, Raghavendra/0000-0002-5013-6075	Juvenile Diabetes Research Foundation [5-CDA-2016-194-A-N]; National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK60581]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	TLM 5-CDA-2016-194-A-N Juvenile Diabetes Research Foundation https://www.jdrf.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RGM R01 DK60581 National Institute of Diabetes and Digestive and Kidney Diseases https://www.niddk.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052026; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; Brereton MF, 2015, J HISTOCHEM CYTOCHEM, V63, P575, DOI 10.1369/0022155415583535; Campbell-Thompson M, 2012, DIABETES-METAB RES, V28, P608, DOI 10.1002/dmrr.2316; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Colvin SC, 2013, J BIOL CHEM, V288, P36226, DOI 10.1074/jbc.M113.473942; Grzesik WJ, 2015, J CLIN ENDOCR METAB, V100, pE387, DOI 10.1210/jc.2014-3630; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hatanaka M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03869-5; Holzer P, 2012, NEUROPEPTIDES, V46, P261, DOI 10.1016/j.npep.2012.08.005; JAKUS J, 1993, J BIOL CHEM, V268, P13151; Levasseur EM, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aax0715; LIU XW, 2013, NEUROLOGY S, V80; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maier B, 2010, DISCOV MED, V10, P18; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Mastracci TL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003278; McDuffie M, 2008, DIABETES, V57, P199, DOI 10.2337/db07-0830; Nishiki Y, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-421; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; PARK MH, 1994, J BIOL CHEM, V269, P27827; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Robbins RD, 2010, J BIOL CHEM, V285, P39943, DOI 10.1074/jbc.M110.170142; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Schlee M, 2004, J VIROL, V78, P3941, DOI 10.1128/JVI.78.8.3941-3952.2004; Schuller AP, 2017, MOL CELL, V66, P194, DOI 10.1016/j.molcel.2017.03.003; Serreze DV, 1997, J IMMUNOL, V158, P3978; Stull ND, 2012, JOVE-J VIS EXP, DOI 10.3791/4137; Tersey SA, 2014, AMINO ACIDS, V46, P633, DOI 10.1007/s00726-013-1560-7; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0	32	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230627	10.1371/journal.pone.0230627	http://dx.doi.org/10.1371/journal.pone.0230627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208453	Green Published, Green Submitted, gold			2022-12-26	WOS:000535305100027
J	Urashima, K; Ichinose, K; Kondo, H; Maeda, T; Kawakami, A; Ozawa, H				Urashima, Kayoko; Ichinose, Kunihiro; Kondo, Hideaki; Maeda, Takahiro; Kawakami, Atsushi; Ozawa, Hiroki			The prevalence of insomnia and restless legs syndrome among Japanese outpatients with rheumatic disease: A cross-sectional study	PLOS ONE			English	Article							SLEEP QUALITY; DIAGNOSTIC-CRITERIA; ARTHRITIS; ASSOCIATION; VALIDATION; SEVERITY; INDEX; FATIGUE; RISK; PAIN	The prevalence of symptomatic insomnia and the prevalence of restless legs syndrome (RLS) are known to be higher among patients with rheumatic diseases compared to the general population. The prevalences of insomnia and RLS reported in a questionnaire by Japanese patients with rheumatic diseases at an outpatient clinic were analyzed herein. The association between the patients' disease activity and their sleep quality was analyzed. Of 121 rheumatic disease patients, 70 were enrolled. The median (interquartile range) age at enrollment was 62.0 (47.8-68.0) years. There were 58 women (82.9%) and 12 men (17.1%), and 43 patients (61.4%) with rheumatoid arthritis (RA), nine (12.9%) with systemic lupus erythematosus (SLE), and 18 (25.7%) with other rheumatic diseases. Twenty patients (28.6%) had one or more moderate-to-severe insomnia symptoms, and 10 (14.3%) were diagnosed with RLS. Among the patients with RA, the swollen joint count based on a 28-joint assessment (SJC28) was significantly higher in the insomnia group (n = 13) compared to the non-insomnia group (n = 30) (p = 0.006). A classification and regression tree (CART) analysis showed that the cut-off points of >= 3 mg/day prednisolone (PSL) treatment and < 16.54% as the transferrin saturation (TSAT) value would best predict RLS in rheumatic disease. Patients with rheumatic disease had a high prevalence of symptomatic insomnia and RLS. A higher dose of PSL and lower TSAT were associated with the occurrence of RLS.	[Urashima, Kayoko; Ozawa, Hiroki] Nagasaki Univ, Dept Neuropsychiat Med & Dent Sci, Grad Sch Biomed Sci, Nagasaki, Japan; [Ichinose, Kunihiro; Kawakami, Atsushi] Nagasaki Univ, Div Adv Prevent Med Sci, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Nagasaki, Japan; [Kondo, Hideaki; Maeda, Takahiro] Nagasaki Univ, Dept Gen Med, Grad Sch Biomed Sci, Nagasaki, Japan; [Kondo, Hideaki] Univ Tsukuba, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan	Nagasaki University; Nagasaki University; Nagasaki University; University of Tsukuba	Ichinose, K (corresponding author), Nagasaki Univ, Div Adv Prevent Med Sci, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Nagasaki, Japan.	kichinos@nagasaki-u.ac.jp	Ichinose, Kunihiro/I-2126-2019	Ichinose, Kunihiro/0000-0001-8794-7106; Kondo, Hideaki/0000-0003-0856-6650	Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering	Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering	This work was supported by a grant from the Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering (to K.I.).	Abbasi M, 2013, Niger J Med, V22, P181; Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Allen RP, 2002, SLEEP MED, V3, pS3, DOI 10.1016/S1389-9457(02)00140-5; Allen RP, 2014, SLEEP MED, V15, P860, DOI 10.1016/j.sleep.2014.03.025; Allen RP, 2009, SLEEP MED, V10, P1097, DOI 10.1016/j.sleep.2008.10.007; Aviel YB, 2011, RHEUMATOLOGY, V50, P2051, DOI 10.1093/rheumatology/ker256; Balaban H, 2012, SLEEP MED, V13, P953, DOI 10.1016/j.sleep.2012.04.009; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Breiman L, 1984, WADS WORTH BROOKS CO; Buysse D J, 1989, Psychiatry Res, V28, P193; Chandrasekhara PKS, 2009, MOD RHEUMATOL, V19, P407, DOI 10.1007/s10165-009-0185-x; Hassan N, 2011, J RHEUMATOL, V38, P874, DOI 10.3899/jrheum.101039; Hsiao YH, 2015, SLEEP, V38, P581, DOI 10.5665/sleep.4574; Irwin MR, 2012, SLEEP, V35, P537, DOI 10.5665/sleep.1742; Ishaq M, 2013, MOD RHEUMATOL, V23, P705, DOI 10.1007/s10165-012-0714-x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Katz DA, 1998, ARCH INTERN MED, V158, P1099, DOI 10.1001/archinte.158.10.1099; Kondo H, 2016, J SLEEP MED, V10, P577; Kucuk A, 2017, INT J RHEUM DIS, V20, P469, DOI 10.1111/1756-185X.12793; Kushida CA, 2007, AM J MED, V120, pS4, DOI 10.1016/j.amjmed.2006.11.002; Lopez A, 2016, LANCET, V387, P907, DOI 10.1016/S0140-6736(15)60865-0; Luyster FS, 2011, J CLIN SLEEP MED, V7, P49; Munezawa T., 2009, JPN J PSYCHIAT TREAT, V24, P219; Nomura T, 2008, MOVEMENT DISORD, V23, P2363, DOI 10.1002/mds.22274; Ohayon MM, 2012, SLEEP MED REV, V16, P283, DOI 10.1016/j.smrv.2011.05.002; Oran M, 2014, NEUROPSYCH DIS TREAT, V10, P953, DOI 10.2147/NDT.S63599; Oscroft NS, 2010, SLEEP MED, V11, P596, DOI 10.1016/j.sleep.2009.11.010; Palagini L, 2014, LUPUS, V23, P1350, DOI 10.1177/0961203314540762; Palma BD, 2006, AM J PHYSIOL-REG I, V291, pR1527, DOI 10.1152/ajpregu.00186.2006; Sangle SR, 2015, CURR OPIN PULM MED, V21, P553, DOI 10.1097/MCP.0000000000000215; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Son CN, 2015, KOREAN J INTERN MED, V30, P384, DOI 10.3904/kjim.2015.30.3.384; Stipelman BA, 2013, J BEHAV MED, V36, P539, DOI 10.1007/s10865-012-9447-8; Takegami M, 2009, SLEEP MED, V10, P556, DOI 10.1016/j.sleep.2008.04.015; Taylor-Gjevre RM, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-378; Theander L, 2010, RHEUMATOLOGY, V49, P1177, DOI 10.1093/rheumatology/keq023; Trenkwalder C, 2018, LANCET NEUROL, V17, P994, DOI 10.1016/S1474-4422(18)30311-9; Ueda N, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091173; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B; Vina ER, 2013, JCR-J CLIN RHEUMATOL, V19, P7, DOI 10.1097/RHU.0b013e31827cd20d; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wali S, 2018, J CLIN SLEEP MED, V14, P557, DOI 10.5664/jcsm.7044; Wali S, 2015, SLEEP BREATH, V19, P579, DOI 10.1007/s11325-014-1049-y; Weinstock LB, 2012, SLEEP MED REV, V16, P341, DOI 10.1016/j.smrv.2011.09.003; Wolfe F, 2006, J RHEUMATOL, V33, P1942	45	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0230273	10.1371/journal.pone.0230273	http://dx.doi.org/10.1371/journal.pone.0230273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32197267	Green Published, gold			2022-12-26	WOS:000535303100025
J	Yuan, ML; Yin, W; Tao, ZW; Tan, WJ; Hu, Y				Yuan, Mingli; Yin, Wen; Tao, Zhaowu; Tan, Weijun; Hu, Yi			Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; INFLUENZA-A; PNEUMONIA; CT; MERS	Radiologic characteristics of 2019 novel coronavirus (2019-nCoV) infected pneumonia (NCIP) which had not been fully understood are especially important for diagnosing and predicting prognosis. We retrospective studied 27 consecutive patients who were confirmed NCIP, the clinical characteristics and CT image findings were collected, and the association of radiologic findings with mortality of patients was evaluated. 27 patients included 12 men and 15 women, with median age of 60 years (IQR 47-69). 17 patients discharged in recovered condition and 10 patients died in hospital. The median age of mortality group was higher compared to survival group (68 (IQR 63-73) vs 55 (IQR 35-60), P = 0.003). The comorbidity rate in mortality group was significantly higher than in survival group (80% vs 29%, P = 0.018). The predominant CT characteristics consisted of ground glass opacity (67%), bilateral sides involved (86%), both peripheral and central distribution (74%), and lower zone involvement (96%). The median CT score of mortality group was higher compared to survival group (30 (IQR 7-13) vs 12 (IQR 11-43), P = 0.021), with more frequency of consolidation (40% vs 6%, P = 0.047) and air bronchogram (60% vs 12%, P = 0.025). An optimal cutoff value of a CT score of 24.5 had a sensitivity of 85.6% and a specificity of 84.5% for the prediction of mortality. 2019-nCoV was more likely to infect elderly people with chronic comorbidities. CT findings of NCIP were featured by predominant ground glass opacities mixed with consolidations, mainly peripheral or combined peripheral and central distributions, bilateral and lower lung zones being mostly involved. A simple CT scoring method was capable to predict mortality.	[Yuan, Mingli; Yin, Wen; Tao, Zhaowu; Tan, Weijun; Hu, Yi] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pulm & Crit Care Med, Cent Hosp Wuhan, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Hu, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pulm & Crit Care Med, Cent Hosp Wuhan, Wuhan, Hubei, Peoples R China.	Huyi_pub@163.com						Ajlan AM, 2014, AM J ROENTGENOL, V203, P782, DOI 10.2214/AJR.14.13021; Al-Tawfiq JA, 2014, CURR OPIN INFECT DIS, V27, P411, DOI 10.1097/QCO.0000000000000089; [Anonymous], 2020, GLOBAL SURVEILLANCE, V1, P31; [Anonymous], 2019, WUHAN MUNICIPAL HLTH, V12, P31; [Anonymous], 2020, NATL HLTH COMMISSION, V2, P4; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Fang YC, 2020, RADIOLOGY, V295, P208, DOI [10.1148/radiol.2020200280, 10.1148/2020200280]; Feng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093885; Grinblat L, 2003, RADIOLOGY, V228, P802, DOI 10.1148/radiol.2283030671; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Li Q., 2020, NEW ENGL J MED, V382, P1199; Marchiori E, 2011, EUR J RADIOL, V80, pE500, DOI 10.1016/j.ejrad.2010.10.003; Ooi GC, 2004, RADIOLOGY, V230, P836, DOI 10.1148/radiol.2303030853; Shi H.S., 2020, RADIOLOGY, V295, P20, DOI [10.1148/radiol.2020200269, DOI 10.1148/RADIOL.2020200269]; Song FX, 2020, RADIOLOGY, V295, P210, DOI [10.1148/radiol.2020200274, 10.1148/radiol.2020209021]; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang QL, 2013, RADIOLOGY, V268, P882, DOI 10.1148/radiol.13130988; Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689; Who, 2020, COR, V2, P5; Wong KT, 2003, RADIOLOGY, V228, P401, DOI 10.1148/radiol.2282030593; Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196	21	233	248	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230548	10.1371/journal.pone.0230548	http://dx.doi.org/10.1371/journal.pone.0230548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191764	Green Published, Green Submitted, gold			2022-12-26	WOS:000535302300059
J	Back, CR; Higman, VA; Le Vay, K; Patel, VV; Parnell, AE; Frankel, D; Jenkinson, HF; Burston, SG; Crump, MP; Nobbs, AH; Race, PR				Back, Catherine R.; Higman, Victoria A.; Le Vay, Kristian; Patel, Viren V.; Parnell, Alice E.; Frankel, Daniel; Jenkinson, Howard F.; Burston, Steven G.; Crump, Matthew P.; Nobbs, Angela H.; Race, Paul R.			The streptococcal multidomain fibrillar adhesin CshA has an elongated polymeric architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); small-angle X-ray scattering (SAXS); adhesin; protein folding; fibril; microbiology; virulence factor; biofilm; bacterial pathogenicity; CshA	FIMBRIAE-ASSOCIATED ADHESIN; MUTANS ANTIGEN-I/II; CRYSTAL-STRUCTURE; CELL-SURFACE; MICROBIAL BIOGEOGRAPHY; STRUCTURE VALIDATION; ISOPEPTIDE BONDS; GORDONII; PROTEIN; BINDING	The cell surfaces of many bacteria carry filamentous polypeptides termed adhesins that enable binding to both biotic and abiotic surfaces. Surface adherence is facilitated by the exquisite selectivity of the adhesins for their cognate ligands or receptors and is a key step in niche or host colonization and pathogenicity. Streptococcus gordonii is a primary colonizer of the human oral cavity and an opportunistic pathogen, as well as a leading cause of infective endocarditis in humans. The fibrillar adhesin CshA is an important determinant of S. gordonii adherence, forming peritrichous fibrils on its surface that bind host cells and other microorganisms. CshA possesses a distinctive multidomain architecture comprising an N-terminal target-binding region fused to 17 repeat domains (RDs) that are each ?100 amino acids long. Here, using structural and biophysical methods, we demonstrate that the intact CshA repeat region (CshA_RD1?17, domains 1?17) forms an extended polymeric monomer in solution. We recombinantly produced a subset of CshA RDs and found that they differ in stability and unfolding behavior. The NMR structure of CshA_RD13 revealed a hitherto unreported all ?-fold, flanked by disordered interdomain linkers. These findings, in tandem with complementary hydrodynamic studies of CshA_RD1?17, indicate that this polypeptide possesses a highly unusual dynamic transitory structure characterized by alternating regions of order and disorder. This architecture provides flexibility for the adhesive tip of the CshA fibril to maintain bacterial attachment that withstands shear forces within the human host. It may also help mitigate deleterious folding events between neighboring RDs that share significant structural identity without compromising mechanical stability.	[Back, Catherine R.; Jenkinson, Howard F.; Nobbs, Angela H.] Univ Bristol, Bristol Dent Sch, Lower Maudlin St, Bristol BS1 2LY, Avon, England; [Back, Catherine R.; Le Vay, Kristian; Patel, Viren V.; Parnell, Alice E.; Burston, Steven G.; Race, Paul R.] Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Back, Catherine R.; Parnell, Alice E.; Burston, Steven G.; Crump, Matthew P.; Race, Paul R.] Univ Bristol, BrisSynBio Synthet Biol Res Ctr, Bristol BS8 1TQ, Avon, England; [Higman, Victoria A.; Crump, Matthew P.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Le Vay, Kristian] Univ Bristol, Bristol Ctr Funct Nanomat, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England; [Frankel, Daniel] Newcastle Univ, Sch Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of Bristol; Newcastle University - UK	Nobbs, AH (corresponding author), Univ Bristol, Bristol Dent Sch, Lower Maudlin St, Bristol BS1 2LY, Avon, England.; Race, PR (corresponding author), Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.	Angela.Nobbs@bristol.ac.uk; Paul.Race@bristol.ac.uk	Nobbs, Angela/AAS-3926-2020; Jenkinson, Howard/AAD-9282-2022; Jenkinson, Howard/ABI-1842-2020; Le Vay, Kristian/AAN-1269-2020	Le Vay, Kristian/0000-0003-2455-8706; Crump, Matthew/0000-0002-7868-5818; Frankel, Daniel/0000-0002-9891-2942; Jenkinson, Howard/0000-0002-9195-7945; Burston, Steven/0000-0003-1848-1853; Nobbs, Angela/0000-0003-3813-4410	National Institutes of Health [DE016690]; Biotechnology and Biological Sciences Research Council [BB/L01386X/1, BB/M025624/1]; Royal Society University Research Fellowship [UF080534]; Engineering and Physical Sciences Research Council Bristol Centre for Functional Nanomaterials Ph.D. studentship [EP/G036780/1]; BBSRC [BB/L01386X/1, BB/M025624/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society University Research Fellowship(Royal Society of London); Engineering and Physical Sciences Research Council Bristol Centre for Functional Nanomaterials Ph.D. studentship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by National Institutes of Health Grant DE016690 (to H. F. J.), by Biotechnology and Biological Sciences Research Council Grants BB/L01386X/1 and BB/M025624/1, and through the award of Royal Society University Research Fellowship UF080534 (to P. R. R.) and Engineering and Physical Sciences Research Council Bristol Centre for Functional Nanomaterials Ph.D. studentship EP/G036780/1 (to K. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen WJ, 2012, CURR OPIN STRUC BIOL, V22, P500, DOI 10.1016/j.sbi.2012.02.001; Back CR, 2017, J BIOL CHEM, V292, P1538, DOI 10.1074/jbc.M116.760975; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doreleijers JF, 2012, J BIOMOL NMR, V54, P267, DOI 10.1007/s10858-012-9669-7; Forster S, 2010, J APPL CRYSTALLOGR, V43, P639, DOI 10.1107/S0021889810008289; Formosa-Dague C, 2016, P NATL ACAD SCI USA, V113, P410, DOI 10.1073/pnas.1519265113; Forsgren N, 2010, J MOL BIOL, V397, P740, DOI 10.1016/j.jmb.2010.01.065; Forsgren N, 2009, PROTEIN SCI, V18, P1896, DOI 10.1002/pro.200; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Gruszka DT, 2016, P NATL ACAD SCI USA, V113, P11841, DOI 10.1073/pnas.1608762113; Gruszka DT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8271; Gruszka DT, 2012, P NATL ACAD SCI USA, V109, pE1011, DOI 10.1073/pnas.1119456109; Holmes AR, 1996, INFECT IMMUN, V64, P4680, DOI 10.1128/IAI.64.11.4680-4685.1996; Jakubovics NS, 2009, MICROBIOL-SGM, V155, P3572, DOI 10.1099/mic.0.032078-0; JAMESON MW, 1995, MICROBIOL-UK, V141, P2729, DOI 10.1099/13500872-141-10-2729; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Klemm P, 2010, APPL MICROBIOL BIOT, V88, P451, DOI 10.1007/s00253-010-2805-y; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Larson MR, 2011, J BIOL CHEM, V286, P21657, DOI 10.1074/jbc.M111.231100; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linge JP, 2004, J MAGN RESON, V167, P334, DOI 10.1016/j.jmr.2004.01.010; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Macintosh RL, 2009, J BACTERIOL, V191, P7007, DOI 10.1128/JB.00764-09; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McNab R, 1996, INFECT IMMUN, V64, P4204, DOI 10.1128/IAI.64.10.4204-4210.1996; McNab R, 1999, J BACTERIOL, V181, P3087, DOI 10.1128/JB.181.10.3087-3095.1999; PAKULA R, 1963, J GEN MICROBIOL, V31, P125, DOI 10.1099/00221287-31-1-125; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Rego S, 2016, J BIOL CHEM, V291, P15985, DOI 10.1074/jbc.M116.726562; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smith BO, 2006, J BIOL CHEM, V281, P5821, DOI 10.1074/jbc.M510868200; Troffer-Charlier N, 2002, J MOL BIOL, V318, P179, DOI 10.1016/S0022-2836(02)00025-6; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wizemann TM, 1999, EMERG INFECT DIS, V5, P395, DOI 10.3201/eid0503.990310; Wu H, 1999, MOL MICROBIOL, V34, P1070, DOI 10.1046/j.1365-2958.1999.01670.x; Wu H, 1998, MOL MICROBIOL, V28, P487, DOI 10.1046/j.1365-2958.1998.00805.x	45	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6689	6699		10.1074/jbc.RA119.011719	http://dx.doi.org/10.1074/jbc.RA119.011719			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32229583	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000537685000034
J	Ward, R; Kaylor, JJ; Cobice, DF; Pepe, DA; McGarrigle, EM; Brockerhoff, SE; Hurley, JB; Travis, GH; Kennedy, BN				Ward, Rebecca; Kaylor, Joanna J.; Cobice, Diego F.; Pepe, Dionissia A.; McGarrigle, Eoghan M.; Brockerhoff, Susan E.; Hurley, James B.; Travis, Gabriel H.; Kennedy, Breandan N.			Non-photopic and photopic visual cycles differentially regulate immediate, early, and late phases of cone photoreceptor-mediated vision	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vitamin A; vision; zebrafish; retina; pharmacology; chemical biology; cone-based visual behavior; Rpe65; visual cycle; zebrafish	RETINAL-PIGMENT EPITHELIUM; BINDING-PROTEIN; DIHYDROCERAMIDE DESATURASE; MOUSE MODEL; VITAMIN-A; RPE65; ISOMEROHYDROLASE; IDENTIFICATION; ISOMERASE; CRALBP	Cone photoreceptors in the retina enable vision over a wide range of light intensities. However, the processes enabling cone vision in bright light (i.e. photopic vision) are not adequately understood. Chromophore regeneration of cone photopigments may require the retinal pigment epithelium (RPE) and/or retinal M?ller glia. In the RPE, isomerization of all-trans-retinyl esters to 11-cis-retinol is mediated by the retinoid isomerohydrolase Rpe65. A putative alternative retinoid isomerase, dihydroceramide desaturase-1 (DES1), is expressed in RPE and M?ller cells. The retinol-isomerase activities of Rpe65 and Des1 are inhibited by emixustat and fenretinide, respectively. Here, we tested the effects of these visual cycle inhibitors on immediate, early, and late phases of cone photopic vision. In zebrafish larvae raised under cyclic light conditions, fenretinide impaired late cone photopic vision, while the emixustat-treated zebrafish unexpectedly had normal vision. In contrast, emixustat-treated larvae raised under extensive dark-adaptation displayed significantly attenuated immediate photopic vision concomitant with significantly reduced 11-cis-retinaldehyde (11cRAL). Following 30 min of light, early photopic vision was recovered, despite 11cRAL levels remaining significantly reduced. Defects in immediate cone photopic vision were rescued in emixustat- or fenretinide-treated larvae following exogenous 9-cis-retinaldehyde supplementation. Genetic knockout of Des1 (degs1) or retinaldehyde-binding protein 1b (rlbp1b) did not eliminate photopic vision in zebrafish. Our findings define molecular and temporal requirements of the nonphotopic or photopic visual cycles for mediating vision in bright light.	[Ward, Rebecca; Kennedy, Breandan N.] Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, UCD Conway Inst, Dublin D04 V1W8, Ireland; [Kaylor, Joanna J.; Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Cobice, Diego F.] Ulster Univ, Biomed Sci Res Inst, Sch Biomed Sci, Mass Spectrometry Ctr, Coleraine BT52 1SA, Londonderry, North Ireland; [Pepe, Dionissia A.; McGarrigle, Eoghan M.] Univ Coll Dublin, UCD Sch Chem, Ctr Synth & Chem Biol, Dublin D04 V1W8, Ireland; [Brockerhoff, Susan E.; Hurley, James B.] Univ Washington, Dept Biochem, Seattle, WA 98109 USA; [Brockerhoff, Susan E.; Hurley, James B.] Univ Washington, Dept Ophthalmol, Seattle, WA 98109 USA; [Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Travis, Gabriel H.] Univ Calif Los Angeles, Ophthalmol, Los Angeles, CA 90024 USA	University College Dublin; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ulster University; University College Dublin; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Kennedy, BN (corresponding author), Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, UCD Conway Inst, Dublin D04 V1W8, Ireland.	brendan.kennedy@ucd.ie	kennedy, Breandan/H-5643-2019; Travis, Gabriel Harvey/AIF-1062-2022	kennedy, Breandan/0000-0001-7991-4689; Travis, Gabriel Harvey/0000-0003-4020-9493; Pepe, Dionissia Barbara/0000-0001-5401-8407; Ward, Rebecca/0000-0003-2957-8642; Cobice, Diego/0000-0001-5283-2931; McGarrigle, Eoghan/0000-0001-8160-6431; Kaylor, Joanna/0000-0002-4535-2574	Research to Prevent Blindness	Research to Prevent Blindness(Research to Prevent Blindness (RPB))	We thank the UCD Biomedical Facility technicians for zebrafish maintenance and the UCD Conway Institute Imaging Core, with particular thanks to Dr. Dimitri Scholz and Dr. Niamh Stephens. We wish to acknowledge our Public and Patient Involvement panel and Fighting Blindness for providing meaningful insights into this project and Research to Prevent Blindness unrestricted grant (to the Jules Stein Eye Institute). We thank Prof. Jack Saari for helpful discussions surrounding this project and Dr. Ross Collery for proof-reading the manuscript.	Babino D, 2015, FASEB J, V29, P216, DOI 10.1096/fj.14-261693; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bilotta J, 2001, DEV DYNAM, V222, P564, DOI 10.1002/dvdy.1188; Boyer NP, 2012, J BIOL CHEM, V287, P22276, DOI 10.1074/jbc.M111.329235; Brockerhoff SE, 1998, VISION RES, V38, P1335, DOI 10.1016/S0042-6989(97)00227-7; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Collery R, 2008, INVEST OPHTH VIS SCI, V49, P3812, DOI 10.1167/iovs.08-1957; CORNWALL MC, 1994, J PHYSIOL-LONDON, V480, P261, DOI 10.1113/jphysiol.1994.sp020358; Crowley R., 2019, PROTOCOLSIO, DOI [10.17504/protocols.io.3jggkjw, DOI 10.17504/PROTOCOLS.IO.3JGGKJW]; Daly C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11513-5; Dobri N, 2013, INVEST OPHTH VIS SCI, V54, P85, DOI 10.1167/iovs.12-10050; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; Fan J, 2008, INVEST OPHTH VIS SCI, V49, P2384, DOI 10.1167/iovs.08-1727; Fleisch VC, 2008, J NEUROSCI, V28, P8208, DOI 10.1523/JNEUROSCI.2367-08.2008; Gearhart PM, 2010, ARCH OPHTHALMOL-CHIC, V128, P1442, DOI 10.1001/archophthalmol.2010.210; Gloriani AH, 2019, CURR BIOL, V29, P1206, DOI 10.1016/j.cub.2019.02.023; GOLDSTEI.EB, 1970, VISION RES, V10, P1065, DOI 10.1016/0042-6989(70)90082-9; HOOD DC, 1973, VISION RES, V13, P1943, DOI 10.1016/0042-6989(73)90065-5; Hussain RM, 2018, EXPERT OPIN BIOL TH, V18, P1049, DOI 10.1080/14712598.2018.1513486; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Kiser PD, 2019, FASEB J, V33, P5782, DOI 10.1096/fj.201802493R; Kiser PD, 2018, J GEN PHYSIOL, V150, P571, DOI 10.1085/jgp.201711815; Kolesnikov A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32667-w; Mata NL, 2013, RETINA-J RET VIT DIS, V33, P498, DOI 10.1097/IAE.0b013e318265801d; Mata NL, 2005, BIOCHEMISTRY-US, V44, P11715, DOI 10.1021/bi050942m; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Morshedian A, 2019, NEURON, V102, P1172, DOI 10.1016/j.neuron.2019.04.004; Motani A, 2009, J BIOL CHEM, V284, P7673, DOI 10.1074/jbc.M809654200; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; Rahmaniyan M, 2011, J BIOL CHEM, V286, P24754, DOI 10.1074/jbc.M111.250779; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; RODRIGUEZ KA, 1989, AM J PHYSIOL, V256, pR255, DOI 10.1152/ajpregu.1989.256.1.R255; Rosenfeld PJ, 2018, OPHTHALMOLOGY, V125, P1556, DOI 10.1016/j.ophtha.2018.03.059; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Saari JC, 2002, INVEST OPHTH VIS SCI, V43, P1730; Saari John C, 2016, Subcell Biochem, V81, P231; Saszik S, 1999, VISUAL NEUROSCI, V16, P881, DOI 10.1017/S0952523899165076; Schonthaler HB, 2007, EUR J NEUROSCI, V26, P1940, DOI 10.1111/j.1460-9568.2007.05801.x; Siddique MM, 2013, MOL CELL BIOL, V33, P2353, DOI 10.1128/MCB.00226-13; Takahashi Y, 2011, FEBS J, V278, P2913, DOI 10.1111/j.1742-4658.2011.08216.x; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wang JS, 2009, CURR BIOL, V19, P1665, DOI 10.1016/j.cub.2009.07.054; Ward R, 2020, DEV BIOL, V457, P226, DOI 10.1016/j.ydbio.2019.02.008; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Xue YL, 2015, J CLIN INVEST, V125, P727, DOI 10.1172/JCI79651; Zhang JY, 2015, J CLIN INVEST, V125, P2781, DOI 10.1172/JCI80950	54	10	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6482	6497		10.1074/jbc.RA119.011374	http://dx.doi.org/10.1074/jbc.RA119.011374			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32238432	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000537685000019
J	Cairns, L; Patterson, A; Weingartner, KA; Koehler, TJ; DeAngelis, DR; Tripp, KW; Bothner, B; Kavran, JM				Cairns, Leah; Patterson, Angela; Weingartner, Kyler A.; Koehler, T. J.; DeAngelis, Daniel R.; Tripp, Katherine W.; Bothner, Brian; Kavran, Jennifer M.			Biophysical characterization of SARAH domain?mediated multimerization of Hippo pathway complexes in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; Hippo pathway; Salvador (sav); structure-function; MST2 (mammalian sterile 20-like kinase 2); SARAH domain; Sav; RassF; Hpo domain; protein-protein interaction; cell proliferation	PROTEIN-PROTEIN INTERACTIONS; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; MST1 KINASE; ORGAN SIZE; STRUCTURAL BASIS; APOPTOSIS; GROWTH; SALVADOR; PHOSPHORYLATION	Hippo pathway signaling limits cell growth and proliferation and maintains the stem-cell niche. These cellular events result from the coordinated activity of a core kinase cassette that is regulated, in part, by interactions involving Hippo, Salvador, and dRassF. These interactions are mediated by a conserved coiled-coil domain, termed SARAH, in each of these proteins. SARAH domain?mediated homodimerization of Hippo kinase leads to autophosphorylation and activation. Paradoxically, SARAH domain?mediated heterodimerization between Hippo and Salvador enhances Hippo kinase activity in cells, whereas complex formation with dRassF inhibits it. To better understand the mechanism by which each complex distinctly modulates Hippo kinase and pathway activity, here we biophysically characterized the entire suite of SARAH domain?mediated complexes. We purified the three SARAH domains from Drosophila melanogaster and performed an unbiased pulldown assay to identify all possible interactions, revealing that isolated SARAH domains are sufficient to recapitulate the cellular assemblies and that Hippo is a universal binding partner. Additionally, we found that the Salvador SARAH domain homodimerizes and demonstrate that this interaction is conserved in Salvador's mammalian homolog. Using native MS, we show that each of these complexes is dimeric in solution. We also measured the stability of each SARAH domain complex, finding that despite similarities at both the sequence and structural levels, SARAH domain complexes differ in stability. The identity, stoichiometry, and stability of these interactions characterized here comprehensively reveal the nature of SARAH domain?mediated complex formation and provide mechanistic insights into how SARAH domain?mediated interactions influence Hippo pathway activity.	[Cairns, Leah; Weingartner, Kyler A.; Koehler, T. J.; DeAngelis, Daniel R.; Kavran, Jennifer M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 20215 USA; [Patterson, Angela; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Tripp, Katherine W.] Johns Hopkins Univ, Krieger Sch Arts & Sci, TC Jenkins Dept Biophys, Baltimore, MD 20121 USA; [Kavran, Jennifer M.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 20215 USA; [Kavran, Jennifer M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 20215 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Montana State University System; Montana State University Bozeman; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kavran, JM (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	jkavran@jhu.edu		Cairns, Leah/0000-0002-3907-001X	National Institutes of Health [R01GM134000, T32 GM007445, T32 GM080189, T32CA009110]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by National Institutes of Health Grants R01GM134000 (to J. M. K.), T32 GM007445 (to L. C.), T32 GM080189 (to T. J. K.), and T32CA009110 (to K. W. and D. D. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aruxandei DC, 2011, BIOCHEMISTRY-US, V50, P10990, DOI [10.1021/bi20111oh, 10.1021/bi201110h]; Bae SJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30278.001, 10.7554/eLife.30278]; Bitra A, 2017, SCI REP-UK, V7, DOI 10.1038/srep45020; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Cairns L, 2018, J BIOL CHEM, V293, P5532, DOI 10.1074/jbc.RA117.000923; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chaikuad A., 2014, CRYSTAL STRUCTURE ST; Chaikuad A., 2013, CRYSTAL STRUCTURE ST; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Colombani J, 2006, CURR BIOL, V16, P1453, DOI 10.1016/j.cub.2006.05.059; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Deng Y, 2003, J BIOL CHEM, V278, P11760, DOI 10.1074/jbc.M211085200; Deng YT, 2013, DEV BIOL, V375, P152, DOI 10.1016/j.ydbio.2012.12.017; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Gloss LM, 1997, BIOCHEMISTRY-US, V36, P5612, DOI 10.1021/bi970056e; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hauri S, 2013, MOL SYST BIOL, V9, DOI 10.1002/msb.201304750; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Hwang E, 2014, ACTA CRYSTALLOGR D, V70, P1944, DOI 10.1107/S139900471400947X; Jain A, 2014, P NATL ACAD SCI USA, V111, P17833, DOI 10.1073/pnas.1419425111; Jin YY, 2012, J BIOL CHEM, V287, P5784, DOI 10.1074/jbc.M111.310334; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Liu G. G., 2013, CRYSTAL STRUCTURE HU; Luo ML, 2016, NUCLEIC ACIDS RES, V44, P7385, DOI 10.1093/nar/gkw421; Makbul C, 2013, BIOCHEMISTRY-US, V52, P1045, DOI 10.1021/bi3014642; Margineanu A, 2016, SCI REP-UK, V6, DOI 10.1038/srep28186; Millward TA, 1999, J BIOL CHEM, V274, P33847, DOI 10.1074/jbc.274.48.33847; Mok YK, 1996, PROTEIN SCI, V5, P310; Ni LS, 2013, STRUCTURE, V21, P1757, DOI 10.1016/j.str.2013.07.008; Ohnishi S, 2007, FEBS LETT, V581, P462, DOI 10.1016/j.febslet.2007.01.008; Pace C N, 1986, Methods Enzymol, V131, P266; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Sanchez-Sanz G, 2016, BRIEF BIOINFORM, V17, P593, DOI 10.1093/bib/bbv070; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Street TO, 2008, METHOD CELL BIOL, V84, P295, DOI 10.1016/S0091-679X(07)84011-8; Szimler T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41972-x; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Wingfield P T, 2001, Curr Protoc Protein Sci, VAppendix 3, p3A, DOI 10.1002/0471140864.psa03as00; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053	56	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6202	6213		10.1074/jbc.RA120.012679	http://dx.doi.org/10.1074/jbc.RA120.012679			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32213597	Green Published, hybrid			2022-12-26	WOS:000531417300028
J	Iljas, JD; Homer, HA				Iljas, Juvita D.; Homer, Hayden A.			Sirt3 is dispensable for oocyte quality and female fertility in lean and obese mice	FASEB JOURNAL			English	Article						mitochondria; obesity; oocytes; oxidative stress; sirtuins	OXIDATIVE STRESS; SIRT3-DEPENDENT DEACETYLATION; CALORIE RESTRICTION; MATERNAL OBESITY; PROTEIN; MITOCHONDRIA; PROMETAPHASE; METABOLISM; MECHANISMS	Mammalian oocytes rely heavily on mitochondrial oxidative phosphorylation (OXPHOS) for generating ATP. However, mitochondria are also the primary source of damaging reactive oxygen species (ROS). Mitochondrial de-regulation, therefore, underpins poor oocyte quality associated with conditions such as obesity and aging. The mitochondrial sirtuin, Sirt3, is critical for mitochondrial respiration and redox regulation. Interestingly, however, Sirt3 knockout (Sirt3(-/-)) mice do not exhibit systemic compromise under basal conditions, only doing so under stressed conditions such as high-fat diet (HFD)-induced obesity. Mouse oocytes depleted of Sirt3 exhibit increased ROS in vitro, but it is unknown whether Sirt3 is necessary for female fertility in vivo. Here, we test this for the first time by investigating ovarian follicular reserve, oocyte maturation (including detailed spindle assembly and chromosome segregation), and female fertility in Sirt3(-/-) females. We find that under basal conditions, young Sirt3(-/-) females exhibit no defects in any parameters. Surprisingly, all parameters also remain intact following HFD-induced obesity. Despite markedly increased ROS levels in HFD Sirt3(-/-) oocytes, ATP levels nevertheless remain normal. Our data support that ATP is sustained in vivo through increased mitochondrial mass possibly secondary to compensatory upregulation of another sirtuin, Sirt1, which has overlapping functions with Sirt3.	[Iljas, Juvita D.; Homer, Hayden A.] Univ Queensland, Christopher Chen Oocyte Biol Res Lab, Clin Res Ctr, Brisbane, Qld 4029, Australia	University of Queensland	Homer, HA (corresponding author), Univ Queensland, Christopher Chen Oocyte Biol Res Lab, Clin Res Ctr, Brisbane, Qld 4029, Australia.	h.homer@uq.edu.au						Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Babayev E, 2015, CURR OPIN OBSTET GYN, V27, P175, DOI 10.1097/GCO.0000000000000164; Brenmoehl J, 2013, MITOCHONDRION, V13, P755, DOI 10.1016/j.mito.2013.04.002; Buso A, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00474; Busse E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52921-z; Chowdhury MKH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40159; Ciarlo E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04263-x; Dalton CM, 2013, J CELL SCI, V126, P2955, DOI 10.1242/jcs.128744; de Paula WBM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0263; EPPIG JJ, 1976, J EXP ZOOL, V198, P375, DOI 10.1002/jez.1401980311; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; Grindler NM, 2013, MOL HUM REPROD, V19, P486, DOI 10.1093/molehr/gat026; Gui LM, 2013, DEV CELL, V25, P43, DOI 10.1016/j.devcel.2013.02.008; Gui LM, 2012, DEVELOPMENT, V139, P1941, DOI 10.1242/dev.078352; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Han LS, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12431; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hill CM, 2016, AGING CELL, V15, P509, DOI 10.1111/acel.12467; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Homer H, 2009, SCIENCE, V326, P991, DOI 10.1126/science.1175326; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Johnson MT, 2007, BIOL REPROD, V77, P2, DOI 10.1095/biolreprod.106.059899; Kawamura Y, 2010, J CLIN INVEST, V120, P2817, DOI 10.1172/JCI42020; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Liu XH, 2017, CELL CYCLE, V16, P1302, DOI 10.1080/15384101.2017.1320004; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lombard DB, 2014, GERONTOLOGY, V60, P56, DOI 10.1159/000354382; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/NMETH.2972, 10.1038/nmeth.2972]; Luzzo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049217; May-Panloup P, 2016, HUM REPROD UPDATE, V22, P725, DOI 10.1093/humupd/dmw028; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Pillai VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7656; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tilly Jonathan L, 2003, Reprod Biol Endocrinol, V1, P11, DOI 10.1186/1477-7827-1-11; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887; Wei Z, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06510-9; Winnik S, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0399-0; Yang W, 2016, CELL, V167, P985, DOI 10.1016/j.cell.2016.10.016; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhang L, 2015, CELL CYCLE, V14, P2959, DOI 10.1080/15384101.2015.1026517; Zhou CX, 2019, J CELL SCI, V132, DOI 10.1242/jcs.233379	47	14	14	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6641	6653		10.1096/fj.202000153R	http://dx.doi.org/10.1096/fj.202000153R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32212196				2022-12-26	WOS:000531325500045
J	Hopwood, CJ; Bleidorn, W; Schwaba, T; Chen, S				Hopwood, Christopher J.; Bleidorn, Wiebke; Schwaba, Ted; Chen, Sophia			Health, environmental, and animal rights motives for vegetarian eating	PLOS ONE			English	Article							LIFE-STYLE; MEAT CONSUMPTION; FOOD; ATTITUDES; PERSONALITY; IDENTITY; STUDENTS; VEGAN; YOUNG; PERCEPTIONS	Health, the environment, and animal rights represent the three main reasons people cite for vegetarian diet in Western societies. However, it has not been shown that these motives can be distinguished empirically, and little is known about what kind of people are likely to be compelled by these different motives. This study had three goals. First, we aimed to use construct validation to test whether develop health, environmental, and animal rights motives for a vegetarian diet could be distinguished. Second, we evaluated whether these motivations were associated with different demographic, behavioral, and personality profiles in three diverse samples. Third, we examined whether peoples' motivations were related to responses to vegetarian advocacy materials. We created the Vegetarian Eating Motives Inventory, a 15-item measure whose structure was invariant across three samples (N = 1006, 1004, 5478) and two languages (English and Dutch). Using this measure, we found that health was the most common motive for non-vegetarians to consider vegetarian diets and it had the broadest array of correlates, which primarily involved communal and agentic values. Correlates of environmental and animal rights motives were limited, but these motives were strong and specific predictors of advocacy materials in a fourth sample (N = 739). These results provide researchers with a useful tool for identifying vegetarian motives among both vegetarian and non-vegetarian respondents, offer useful insights into the nomological net of vegetarian motivations, and provide advocates with guidance about how to best target campaigns promoting a vegetarian diet.	[Hopwood, Christopher J.; Bleidorn, Wiebke; Schwaba, Ted; Chen, Sophia] Univ Calif Davis, Davis, CA 95616 USA	University of California System; University of California Davis	Hopwood, CJ (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	chopwoodmsu@gmail.com		Hopwood, Christopher/0000-0001-6645-8645	Animal Charity Evaluators	Animal Charity Evaluators	Funding was provided to Christopher J. Hopwood and Wiebke Bleidorn by Animal Charity Evaluators (https://animalcharityevaluators.org).The funding agency advised on study design issues prior to data collection; all decisions about study design were determined by the authors.	Allen MW, 2000, J SOC PSYCHOL, V140, P405, DOI 10.1080/00224540009600481; Arbit N, 2017, FOOD QUAL PREFER, V59, P35, DOI 10.1016/j.foodqual.2017.02.002; Aston LM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001072; Baines S, 2007, PUBLIC HEALTH NUTR, V10, P436, DOI 10.1017/S1368980007217938; Ball M., 2009, ANIMAL ACTIVISTS HDB; Barr SI, 2002, J AM DIET ASSOC, V102, P354, DOI 10.1016/S0002-8223(02)90083-0; Bastian B, 2012, PERS SOC PSYCHOL B, V38, P247, DOI 10.1177/0146167211424291; Beardsworth A., 1999, British Food Journal, V101, P289, DOI 10.1108/00070709910272169; Bilewicz M, 2011, EUR J SOC PSYCHOL, V41, P201, DOI 10.1002/ejsp.766; Bleidorn W, 2019, PERS SOC PSYCHOL REV, V23, P190, DOI 10.1177/1088868318772990; Bobic J, 2012, COLLEGIUM ANTROPOL, V36, P795; Byrd-Bredbenner C, 2010, NUTR DIET, V67, P143, DOI 10.1111/j.1747-0080.2010.01446.x; Caviola L, 2019, LIKING DEVALUING ANI, DOI 10.31234/osf.io/sx5uw; Caviola L, 2019, J PERS SOC PSYCHOL, V116, P1011, DOI 10.1037/pspp0000182; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Chin MG, 2002, ANTHROZOOS, V15, P332, DOI 10.2752/089279302786992441; Cooney N, 2014, VEGANOMICS SURPRISIN, P194; de Boer J, 2011, ECOL ECON, V70, P1259, DOI 10.1016/j.ecolecon.2011.03.001; DIETZ T, 1995, RURAL SOCIOL, V60, P533, DOI 10.1111/j.1549-0831.1995.tb00589.x; Dyett PA, 2013, APPETITE, V67, P119, DOI 10.1016/j.appet.2013.03.015; Fox N, 2008, APPETITE, V50, P422, DOI 10.1016/j.appet.2007.09.007; Francione G.L., 2015, EAT YOU CARE EXAMINA; Furnham A, 2003, ANTHROZOOS, V16, P135, DOI 10.2752/089279303786992260; Gale CR, 2007, BMJ-BRIT MED J, V334, P245, DOI 10.1136/bmj.39030.675069.55; Godfray HCJ, 2018, SCIENCE, V361, DOI 10.1126/science.aam5324; Green R, 2015, CLIMATIC CHANGE, V129, P253, DOI 10.1007/s10584-015-1329-y; Haddad EH, 2003, AM J CLIN NUTR, V78, p626S, DOI 10.1093/ajcn/78.3.626S; Haverstock K, 2012, APPETITE, V58, P1030, DOI 10.1016/j.appet.2012.02.048; Hirschler CA, 2011, SOC ANIM, V19, P156, DOI 10.1163/156853011X562999; Hoek AC, 2004, APPETITE, V42, P265, DOI 10.1016/j.appet.2003.12.003; Hoffman SR, 2013, APPETITE, V65, P139, DOI 10.1016/j.appet.2013.02.009; Hopwood CJ, 2019, FOOD QUAL PREFER, V75, P10, DOI 10.1016/j.foodqual.2019.02.004; Izmirli S, 2011, BRIT FOOD J, V113, P436, DOI 10.1108/00070701111116482; Jabs J, 1998, J NUTR EDUC, V30, P196, DOI 10.1016/S0022-3182(98)70319-X; Jackson B, 2003, J RES PERS, V37, P297, DOI 10.1016/S0092-6566(02)00574-3; Joy M., 2008, STRATEGIC ACTION ANI; JOYCE A, 2014, ENERGY EMISS CONTROL, V2, P33, DOI DOI 10.2147/EECT.S58518; Kalof L, 1999, RURAL SOCIOL, V64, P500, DOI 10.1111/j.1549-0831.1999.tb00364.x; Kaluza J, 2012, STROKE, V43, P2556, DOI 10.1161/STROKEAHA.112.663286; Kerschke-Risch P., 2015, Ernahrungs Umschau, V62, P98; Lea E, 2001, APPETITE, V36, P127, DOI 10.1006/appe.2000.0386; Leenaert T., 2017, CREATE VEGAN WORLD P; Lindeman M, 2000, APPETITE, V34, P55, DOI 10.1006/appe.1999.0293; Lindeman M, 1999, APPETITE, V33, P141, DOI 10.1006/appe.1999.0241; Loughnan S, 2010, APPETITE, V55, P156, DOI 10.1016/j.appet.2010.05.043; Lund TB, 2016, ANTHROZOOS, V29, P89, DOI 10.1080/08927936.2015.1083192; Macdiarmid JI, 2016, APPETITE, V96, P487, DOI 10.1016/j.appet.2015.10.011; MacNair R. M., 1998, Vegetarian Nutrition, V2, P96; Mathews S, 1997, SOC ANIM, V5, P169, DOI 10.1163/156853097X00060; Mertens E, 2017, PUBLIC HEALTH NUTR, V20, P739, DOI 10.1017/S1368980016002664; Oppenlander R. A., 2013, FOOD CHOICE SUSTAINA; Phillips CJC, 2012, ANIM WELFARE, V21, P87, DOI 10.7120/096272812799129466; Piazza J, 2015, APPETITE, V91, P114, DOI 10.1016/j.appet.2015.04.011; Poore J, 2018, SCIENCE, V360, P987, DOI 10.1126/science.aaq0216; Preylo BD, 2008, ANTHROZOOS, V21, P387, DOI 10.2752/175303708X371654; Radnitz C, 2015, APPETITE, V90, P31, DOI 10.1016/j.appet.2015.02.026; Renner B, 2012, APPETITE, V59, P117, DOI 10.1016/j.appet.2012.04.004; Rimal A. P, 2002, FAMILY EC NUTR REV, V14, P36; Rimer BK, 2006, J COMMUN, V56, pS184, DOI 10.1111/j.1460-2466.2006.00289.x; Robinson-O'brien R, 2009, J AM DIET ASSOC, V109, P648, DOI 10.1016/j.jada.2008.12.014; Rosenfeld DL, 2019, MOTIV EMOTION, V43, P400, DOI 10.1007/s11031-018-9747-6; Rosenfeld DL, 2018, APPETITE, V127, P182, DOI 10.1016/j.appet.2018.05.003; Rosenfeld DL, 2017, APPETITE, V116, P456, DOI 10.1016/j.appet.2017.05.039; Rosenfeld DL, 2017, APPETITE, V112, P78, DOI 10.1016/j.appet.2017.01.017; Rothgerber H, 2014, APPETITE, V72, P98, DOI 10.1016/j.appet.2013.10.002; Rozin P, 1997, PSYCHOL SCI, V8, P67, DOI 10.1111/j.1467-9280.1997.tb00685.x; Ruby MB, 2012, APPETITE, V58, P141, DOI 10.1016/j.appet.2011.09.019; Ruby MB, 2011, APPETITE, V56, P447, DOI 10.1016/j.appet.2011.01.018; Sedova I, 2016, APPETITE, V107, P415, DOI 10.1016/j.appet.2016.08.102; Simikas S, 2018, IS PERCENTAGE VEGETA; Spencer EH, 2007, J AM DIET ASSOC, V107, P72, DOI 10.1016/j.jada.2006.10.034; STEPTOE A, 1995, APPETITE, V25, P267, DOI 10.1006/appe.1995.0061; Tiplady C. M., 2015, ANIMAL STUDIES J, V4, P116; Vainio A, 2016, APPETITE, V106, P92, DOI 10.1016/j.appet.2016.03.002; Vinnari M, 2010, BRIT FOOD J, V112, P836, DOI 10.1108/00070701011067451; White RF, 1999, J AM DIET ASSOC, V99, P595, DOI 10.1016/S0002-8223(99)00146-7; Worsley A, 1998, APPETITE, V30, P151, DOI 10.1006/appe.1997.0118	77	39	39	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230609	10.1371/journal.pone.0230609	http://dx.doi.org/10.1371/journal.pone.0230609			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LI0PP	32240198	Green Published, gold, Green Accepted			2022-12-26	WOS:000529188400001
J	Jani, J; Lusk, MG; Yang, YY; Toor, GS				Jani, Jariani; Lusk, Mary G.; Yang, Yun-Ya; Toor, Gurpal S.			Wet season nitrogen export from a residential stormwater pond	PLOS ONE			English	Article							ORGANIC NITROGEN; WATER-QUALITY; MANAGEMENT; RETENTION; BIOAVAILABILITY; URBANIZATION; RUNOFF; DON	Stormwater runoff is recognized as a cause of water quality degradation because it may carry nitrogen (N) and other pollutants to aquatic ecosystems. Stormwater ponds are a stormwater control measure often used to manage stormwater runoff by holding a permanent pool of water, which reduces the peak flow, magnitude of runoff volume, and concentrations of nutrients and pollutants. We instrumented the outlet of a stormwater pond in an urban residential neighbourhood in Florida, United States to (1) investigate the concentration and composition of N forms during the summer rainy season (May to September 2016), and (2) determine the bioavailability of organic N in the stormwater pond with a bioassay experiment. A total of 144 outflow water samples over 13 storm events were collected at the outlet of the stormwater pond that collects runoff from the residential catchment. Samples were analysed for various inorganic N [ammonium (NH4-N), nitrate (NO3-N)], and organic N forms [dissolved organic nitrogen (DON), and particulate organic nitrogen (PON)]. Flow-weighted mean concentration of total N (TN) in pond outflow for all collected storm events was 1.3 +/- 1.42 mg L-1, with DON as the dominant form (78%), followed by PON and NO3-N (each at 8%), and NH4-N (6%). In the bioassay experiment, organic N (DON+PON) was significantly decreased by 25-28% after 5 days of incubation, suggesting that a portion of the DON carried from the pond outflow to receiving water bodies may be bioavailable. These results suggest that efforts to mitigate stormwater N outflows from urban ponds should incorporate both inorganic and organic N in management plans.	[Jani, Jariani] Univ Malaya, Chem Dept, Kuala Lumpur, Malaysia; [Lusk, Mary G.] Univ Florida, Gulf Coast Res & Educ Ctr, Soil & Water Sci Dept, Wimauma, FL 33598 USA; [Yang, Yun-Ya; Toor, Gurpal S.] Univ Maryland, Dept Environm Sci & Technol, College Pk, MD 20742 USA	Universiti Malaya; State University System of Florida; University of Florida; University System of Maryland; University of Maryland College Park	Lusk, MG (corresponding author), Univ Florida, Gulf Coast Res & Educ Ctr, Soil & Water Sci Dept, Wimauma, FL 33598 USA.	mary.lusk@ufl.edu	Yang, Yun-Ya/I-6722-2019; MOHD JANI, SITI JARIANI/ABH-2751-2021	Yang, Yun-Ya/0000-0002-9919-2457; MOHD JANI, SITI JARIANI/0000-0002-4783-1640	Florida Department of Environmental Protection and Center for Landscape Conservation and Ecology of the University of Florida; Ministry of Higher Education, Malaysia	Florida Department of Environmental Protection and Center for Landscape Conservation and Ecology of the University of Florida; Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	This project was funded by grants from Florida Department of Environmental Protection and Center for Landscape Conservation and Ecology of the University of Florida and by a PhD Fellowship to Jariani Jani from the Ministry of Higher Education, Malaysia."The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Beckingham B, 2019, FRONT ENV SCI-SWITZ, V7, DOI 10.3389/fenvs.2019.00117; Betts AT, 2014, URBAN WATER J, V11, P11, DOI 10.1080/1573062X.2012.750370; Bijoor NS, 2008, GLOBAL CHANGE BIOL, V14, P2119, DOI 10.1111/j.1365-2486.2008.01617.x; Bronk DA, 2007, BIOGEOSCIENCES, V4, P283, DOI 10.5194/bg-4-283-2007; Butler SM, 2012, OECOLOGIA, V168, P819, DOI 10.1007/s00442-011-2133-7; Causse J, 2015, CRIT REV ENV SCI TEC, V45, P2245, DOI 10.1080/10643389.2015.1010432; Charbeneau RJ, 1998, WATER ENVIRON RES, V70, P1295, DOI 10.2175/106143098X123679; Collins KA, 2010, ECOL ENG, V36, P1507, DOI 10.1016/j.ecoleng.2010.03.015; Cornell S, 2011, PROCEDIA ENVIRON SCI, V6, P96, DOI 10.1016/j.proenv.2011.05.010; DeLorenzo ME, 2012, ENVIRON MONIT ASSESS, V184, P343, DOI 10.1007/s10661-011-1972-3; Fasching C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04981; Gold AC, 2017, ECOL ENG, V105, P240, DOI 10.1016/j.ecoleng.2017.05.003; Gold A.C., 2018, WATER RES; Gold AC, 2019, WATER RESOUR RES, V55, P7027, DOI 10.1029/2019WR024769; Guillemette F, 2012, ENVIRON MICROBIOL, V14, P1432, DOI 10.1111/j.1462-2920.2012.02728.x; Hancock GS, 2010, J AM WATER RESOUR AS, V46, P1145, DOI 10.1111/j.1752-1688.2010.00481.x; Harper H.H., 2007, EVALUATION CURRENT S; Jani J, 2018, WATER RES, V137, P344, DOI 10.1016/j.watres.2018.02.042; Koch BJ, 2014, J AM WATER RESOUR AS, V50, P1594, DOI 10.1111/jawr.12223; Lewitus AJ, 2008, HARMFUL ALGAE, V8, P60, DOI 10.1016/j.hal.2008.08.012; Li L, 2014, ENV SCI TECHNOLOGY; Lusk MG, 2020, SCI TOTAL ENVIRON, V707, DOI 10.1016/j.scitotenv.2019.135962; Lusk MG, 2016, WATER RES, V96, P225, DOI 10.1016/j.watres.2016.03.060; Lusk MG, 2016, ENVIRON SCI TECHNOL, V50, P3391, DOI 10.1021/acs.est.5b05714; Nagy RC, 2012, HYDROL PROCESS, V26, P2019, DOI 10.1002/hyp.8336; Osborne DM, 2013, RAPID COMMUN MASS SP, V27, P851, DOI 10.1002/rcm.6521; Petrone KC, 2009, BIOGEOCHEMISTRY, V92, P27, DOI 10.1007/s10533-008-9238-z; Rosenzweig BR, 2011, J ENVIRON QUAL, V40, P598, DOI 10.2134/jeq2010.0300; Sansalone JJ, 1997, J ENVIRON ENG-ASCE, V123, P134, DOI 10.1061/(ASCE)0733-9372(1997)123:2(134); Seitzinger SP, 2002, LIMNOL OCEANOGR, V47, P353, DOI 10.4319/lo.2002.47.2.0353; Sinclair JS, 2020, SCI TOTAL ENVIRON, V711, DOI 10.1016/j.scitotenv.2019.135133; Song K, 2013, J ENVIRON MANAGE, V127, P317, DOI 10.1016/j.jenvman.2013.05.052; Taylor GD, 2005, WATER RES, V39, P1982, DOI 10.1016/j.watres.2005.03.022; Toor G.S., 2021, UFIFAS SERIES DEPART; Williams CJ, 2013, ECOL APPL, V23, P1384, DOI 10.1890/12-0825.1; Yang YY, 2018, CURR POLLUT REP, V4, P112, DOI 10.1007/s40726-018-0087-7	36	6	6	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230908	10.1371/journal.pone.0230908	http://dx.doi.org/10.1371/journal.pone.0230908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236119	Green Published, gold			2022-12-26	WOS:000535938700038
J	Gorin, G; Wang, MY; Golding, I; Xu, H				Gorin, Gennady; Wang, Mengyu; Golding, Ido; Xu, Heng			Stochastic simulation and statistical inference platform for visualization and estimation of transcriptional kinetics	PLOS ONE			English	Article							RNA DEGRADATION; GENE-EXPRESSION; DYNAMICS; DISTRIBUTIONS; PROTEIN; MODELS; NOISE	Recent advances in single-molecule fluorescent imaging have enabled quantitative measurements of transcription at a single gene copy, yet an accurate understanding of transcriptional kinetics is still lacking due to the difficulty of solving detailed biophysical models. Here we introduce a stochastic simulation and statistical inference platform for modeling detailed transcriptional kinetics in prokaryotic systems, which has not been solved analytically. The model includes stochastic two-state gene activation, mRNA synthesis initiation and stepwise elongation, release to the cytoplasm, and stepwise co-transcriptional degradation. Using the Gillespie algorithm, the platform simulates nascent and mature mRNA kinetics of a single gene copy and predicts fluorescent signals measurable by time-lapse single-cell mRNA imaging, for different experimental conditions. To approach the inverse problem of estimating the kinetic parameters of the model from experimental data, we develop a heuristic optimization method based on the genetic algorithm and the empirical distribution of mRNA generated by simulation. As a demonstration, we show that the optimization algorithm can successfully recover the transcriptional kinetics of simulated and experimental gene expression data. The platform is available as a MATLAB software package at https:// data.caltech.edu/records/1287.	[Gorin, Gennady] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Wang, Mengyu; Golding, Ido] Univ Illinois, Dept Phys, Grainger Coll Engn, Urbana, IL USA; [Wang, Mengyu; Golding, Ido] Univ Illinois, Ctr Phys Living Cells, Urbana, IL USA; [Xu, Heng] Shanghai Jiao Tong Univ, Sch Phys & Astron, Shanghai, Peoples R China; [Xu, Heng] Shanghai Jiao Tong Univ, Inst Nat Sci, Shanghai, Peoples R China	California Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, H (corresponding author), Shanghai Jiao Tong Univ, Sch Phys & Astron, Shanghai, Peoples R China.; Xu, H (corresponding author), Shanghai Jiao Tong Univ, Inst Nat Sci, Shanghai, Peoples R China.	heng_xu@sjtu.edu.cn		Gorin, Gennady/0000-0001-6097-2029; WANG, MENGYU/0000-0002-5457-2456	National Institutes of Health [NIH U19MH114830, R01 GM082837]; Undergraduate Asian Studies Internship Award (U-ASIA) 2017. Rice University Chao Center for Asian Studies; National Science Foundation [PHY 1430124]; National Key R&D Program of China [2018YFC0310803]; National Natural Science Foundation of China [11774225]; Thousand Talents Plan of China, Program for Young Professionals. 1000plan; National Science Foundation of Shanghai [18ZR1419800]; Burroughs Wellcome Fund Career Award at the Scientific Interface [1013907]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Undergraduate Asian Studies Internship Award (U-ASIA) 2017. Rice University Chao Center for Asian Studies; National Science Foundation(National Science Foundation (NSF)); National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thousand Talents Plan of China, Program for Young Professionals. 1000plan; National Science Foundation of Shanghai; Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund)	The authors were funded by the following sources during the completion of this research: GG: NIH U19MH114830. National Institutes of Health. nih.gov. GG: Undergraduate Asian Studies Internship Award (U-ASIA) 2017. Rice University Chao Center for Asian Studies. chaocenter.rice.edu. MW, IG: R01 GM082837. National Institutes of Health. nih.gov. MW, IG: PHY 1430124. National Science Foundation. nsf.gov. HX: 2018YFC0310803. National Key R&D Program of China. http://most.gov.cn/HX: 11774225. National Natural Science Foundation of China. nsfc.gov.cn. HX: Thousand Talents Plan of China, Program for Young Professionals. 1000plan.org.cn. HX: 18ZR1419800. National Science Foundation of Shanghai. stcsm.sh.gov.cn. HX: 1013907. Burroughs Wellcome Fund Career Award at the Scientific Interface. bwfund.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aijo T, 2016, HUM HERED, V81, P62, DOI 10.1159/000446614; [Anonymous], 2018, MATLAB R2018A GLOB O; Baudrimont A, 2019, CELL REP, V26, P3752, DOI 10.1016/j.celrep.2019.03.001; Bokes P, 2012, J MATH BIOL, V64, P829, DOI 10.1007/s00285-011-0433-5; Catala M, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0441-3; Chen HY, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145794; Choubey S, 2018, PHYS REV E, V97, DOI 10.1103/PhysRevE.97.022402; Coenen-Stass AML, 2019, RNA BIOL, V16, P696, DOI 10.1080/15476286.2019.1582956; Corrigan AM, 2016, ELIFE, V5, DOI 10.7554/eLife.13051; Daigle BJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-68; Dar RD, 2012, P NATL ACAD SCI USA, V109, P17454, DOI 10.1073/pnas.1213530109; Deza M. M., 2009, ENCY DISTANCES; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Eng CHL, 2019, NATURE, V568, P235, DOI 10.1038/s41586-019-1049-y; Eron L, 1971, P NAT ACAD SCI US, V5; George L, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180104; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Golightly A, 2011, INTERFACE FOCUS, V1, P807, DOI 10.1098/rsfs.2011.0047; Hansen MMK, 2018, CELL SYST, V7, P384, DOI 10.1016/j.cels.2018.08.002; Honkela A, 2015, P NATL ACAD SCI USA, V112, P13115, DOI 10.1073/pnas.1420404112; Iyer S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw596; Jahnke T, 2007, J MATH BIOL, V54, P1, DOI 10.1007/s00285-006-0034-x; Johansson M, 2014, CELL REP, V7, P1534, DOI 10.1016/j.celrep.2014.04.034; Kim S, 2019, CELL, V179, P106, DOI 10.1016/j.cell.2019.08.033; Kim S, 2018, BIOPHYS J, V114, P1718, DOI 10.1016/j.bpj.2018.02.010; Lammers NC, 2020, P NATL ACAD SCI USA, V117, P836, DOI 10.1073/pnas.1912500117; Lee JH, 2017, WIRES SYST BIOL MED, V9, DOI 10.1002/wsbm.1369; Munsky B, 2018, P NATL ACAD SCI USA, V115, P7533, DOI 10.1073/pnas.1804060115; Munsky B, 2015, METHODS, V85, P12, DOI 10.1016/j.ymeth.2015.06.009; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Narsky I., 2013, STAT ANAL TECHNIQUES, DOI [10.1002/9783527677320, DOI 10.1002/9783527677320]; Neuert G, 2013, SCIENCE, V339, P584, DOI 10.1126/science.1231456; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Poovathingal SK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-414; Sanchez A, 2013, SCIENCE, V342, P1188, DOI 10.1126/science.1242975; Schnoerr D, 2017, J PHYS A-MATH THEOR, V50, P1, DOI 10.1088/1751-8121/aa54d9; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Skinner SO, 2016, ELIFE, V5, DOI 10.7554/eLife.12175; Tian TH, 2007, BIOINFORMATICS, V23, P84, DOI 10.1093/bioinformatics/btl552; Tripathi T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011921; Wang MY, 2019, NAT MICROBIOL, V4, P2118, DOI 10.1038/s41564-019-0553-z; Xu H, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.128101; Yamada T, 2018, GENE EXPRESSION REGU; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhou TS, 2012, SIAM J APPL MATH, V72, P789, DOI 10.1137/110852887	48	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230736	10.1371/journal.pone.0230736	http://dx.doi.org/10.1371/journal.pone.0230736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214380	Green Published, Green Accepted, gold			2022-12-26	WOS:000535934200049
J	Federico, MB; Siri, SO; Calzetta, NL; Paviolo, NS; de la Vega, MB; Martino, J; Campana, MC; Wiesmuller, L; Gottifredi, V				Federico, Maria Belen; Siri, Sebastian Omar; Calzetta, Nicolas Luis; Paviolo, Natalia Soledad; de la Vega, Maria Belen; Martino, Julieta; Campana, Maria Carolina; Wiesmueller, Lisa; Gottifredi, Vanesa			Unscheduled MRE11 activity triggers cell death but not chromosome instability in polymerase eta-depleted cells subjected to UV irradiation	ONCOGENE			English	Article							XERODERMA-PIGMENTOSUM VARIANT; STALLED REPLICATION FORKS; TRANSLESION DNA-SYNTHESIS; DAMAGE TOLERANCE; STRUCTURAL BASIS; REPAIR; CISPLATIN; BREAK; SURVIVAL; PATHWAY	The elimination of DNA polymerase eta (pol eta) causes discontinuous DNA elongation and fork stalling in UV-irradiated cells. Such alterations in DNA replication are followed by S-phase arrest, DNA double-strand break (DSB) accumulation, and cell death. However, their molecular triggers and the relative timing of these events have not been fully elucidated. Here, we report that DSBs accumulate relatively early after UV irradiation in pol eta-depleted cells. Despite the availability of repair pathways, DSBs persist and chromosome instability (CIN) is not detectable. Later on cells with pan-nuclear gamma H2AX and massive exposure of template single-stranded DNA (ssDNA), which indicate severe replication stress, accumulate and such events are followed by cell death. Reinforcing the causal link between the accumulation of pan-nuclear ssDNA/gamma H2AX signals and cell death, downregulation of RPA increased both replication stress and the cell death of pol eta-deficient cells. Remarkably, DSBs, pan-nuclear ssDNA/gamma H2AX, S-phase arrest, and cell death are all attenuated by MRE11 nuclease knockdown. Such results suggest that unscheduled MRE11-dependent activities at replicating DNA selectively trigger cell death, but not CIN. Together these results show that pol eta-depletion promotes a type of cell death that may be attractive as a therapeutic tool because of the lack of CIN.	[Federico, Maria Belen; Siri, Sebastian Omar; Calzetta, Nicolas Luis; Paviolo, Natalia Soledad; de la Vega, Maria Belen; Martino, Julieta; Campana, Maria Carolina; Gottifredi, Vanesa] Consejo Nacl Invest Cient & Tecn, Cell Cycle & Genom Stabil Lab, Fdn Inst Leloir, Ave Patricias Argentinas 435, Buenos Aires, DF, Argentina; [Wiesmueller, Lisa] Ulm Univ, Dept Obstet & Gynecol, D-89075 Ulm, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Ulm University	Gottifredi, V (corresponding author), Consejo Nacl Invest Cient & Tecn, Cell Cycle & Genom Stabil Lab, Fdn Inst Leloir, Ave Patricias Argentinas 435, Buenos Aires, DF, Argentina.	vgottifredi@leloir.org.ar		Gottifredi, Vanesa/0000-0001-9656-5951; Calzetta, Nicolas Luis/0000-0002-5790-0515; Martino, Julieta/0000-0001-9880-2682	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 2015-1217]; Instituto Nacional del Cancer (INC)-"Asistencia Financiera a proyectos de investigacion de cancer de origen nacional III; German Cancer Aid, Priority Program "Translational Oncology" [70112504]; Deutsche Forschungsgemeinschaft (DFG); CONICET; ANPCyT; Alexander von Humboldt Foundation	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Instituto Nacional del Cancer (INC)-"Asistencia Financiera a proyectos de investigacion de cancer de origen nacional III; German Cancer Aid, Priority Program "Translational Oncology"; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We would like to thank Professors AR Lehmann (University of Sussex), for the gift of XPV cells. We also thank Carlos Menck at the University of Sao Paolo and all the members of the Gottifredi laboratory for fruitful discussions. The excellent support of Andres H. Rossi and Anabel Alvarez Julia in the microscopy and tissue cultures facilities is acknowledged. This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) grant number PICT 2015-1217, Instituto Nacional del Cancer (INC)-"Asistencia Financiera a proyectos de investigacion de cancer de origen nacional III to VG and the German Cancer Aid, Priority Program "Translational Oncology" 70112504 and by the Deutsche Forschungsgemeinschaft (DFG, Research Training Group 2544) to LW. MBF, SOS, NLC, NSP, JM, and MBdlV were supported by fellowships from CONICET and ANPCyT. VG is a researcher from CONICET and was supported by the Friedrich Wilhelm Bessel from Alexander von Humboldt Foundation.	Albertella MR, 2005, CANCER RES, V65, P9799, DOI 10.1158/0008-5472.CAN-05-1095; Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; Ashworth A, 2018, NAT REV CLIN ONCOL, V15, P564, DOI 10.1038/s41571-018-0055-6; Barnes RP, 2018, CANCER RES, V78, P6549, DOI 10.1158/0008-5472.CAN-17-3931; Federico MB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005792; Vallerga MB, 2015, P NATL ACAD SCI USA, V112, pE6624, DOI 10.1073/pnas.1508543112; Bertolin AP, 2015, DNA REPAIR, V32, P158, DOI 10.1016/j.dnarep.2015.04.027; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bryant PE, 2004, RADIOTHER ONCOL, V72, P251, DOI 10.1016/j.radonc.2004.07.005; Buisson R, 2015, MOL CELL, V59, P1011, DOI 10.1016/j.molcel.2015.07.029; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Ceppi P, 2009, CLIN CANCER RES, V15, P1039, DOI 10.1158/1078-0432.CCR-08-1227; Chen YW, 2006, MOL CANCER RES, V4, P257, DOI 10.1158/1541-7786.MCR-05-0118; Cleaver JE, 1999, CANCER RES, V59, P1102; Cruet-Hennequart S, 2006, DNA REPAIR, V5, P491, DOI 10.1016/j.dnarep.2006.01.008; Cruet-Hennequart S, 2010, SUBCELL BIOCHEM, V50, P189, DOI 10.1007/978-90-481-3471-7_10; Deniz M, 2013, MUTAT RES-FUND MOL M, V743, P132, DOI 10.1016/j.mrfmmm.2013.03.009; Despras E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13326; Despras E, 2010, HUM MOL GENET, V19, P1690, DOI 10.1093/hmg/ddq046; Eckert Kristin A, 2019, Oncotarget, V10, P620, DOI 10.18632/oncotarget.26572; Elvers I, 2011, NUCLEIC ACIDS RES, V39, P7049, DOI 10.1093/nar/gkr420; EVENO E, 1995, CANCER RES, V55, P4325; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gonzalez Besteiro MA, 2019, EMBO J, V38, DOI 10.15252/embj.2018101284; Gueranger Q, 2008, DNA REPAIR, V7, P1551, DOI 10.1016/j.dnarep.2008.05.012; Gursoy-Yuzugullu O, 2016, J MOL BIOL, V428, P1846, DOI 10.1016/j.jmb.2015.11.021; Hamppa S, 2016, P NATL ACAD SCI USA, V113, pE4311, DOI 10.1073/pnas.1605828113; Hashimoto Y, 2012, NAT STRUCT MOL BIOL, V19, P17, DOI 10.1038/nsmb.2177; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; Hendel A, 2008, DNA REPAIR, V7, P1636, DOI 10.1016/j.dnarep.2008.06.008; Ireno IC, 2014, CARCINOGENESIS, V35, P2273, DOI 10.1093/carcin/bgu160; Jansen JG, 2014, NUCLEIC ACIDS RES, V42, P11071, DOI 10.1093/nar/gku779; Jeggo PA, 2014, EXP CELL RES, V329, P69, DOI 10.1016/j.yexcr.2014.09.023; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Kannouche P, 2003, BIOCHIMIE, V85, P1123, DOI 10.1016/j.biochi.2003.10.009; Lemacon D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01180-5; Lerner LK, 2017, NUCLEIC ACIDS RES, V45, P1270, DOI 10.1093/nar/gkw1196; Limoli CL, 2002, P NATL ACAD SCI USA, V99, P233, DOI 10.1073/pnas.231611798; Limoli CL, 2000, P NATL ACAD SCI USA, V97, P7939, DOI 10.1073/pnas.130182897; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Masutani C, 1999, EMBO J, V18, P3491, DOI 10.1093/emboj/18.12.3491; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Mouron S, 2013, NAT STRUCT MOL BIOL, V20, P1383, DOI 10.1038/nsmb.2719; Murfuni I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003910; Ochs F, 2016, NAT STRUCT MOL BIOL, V23, P714, DOI 10.1038/nsmb.3251; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Paull TT, 2018, MOL CELL, V71, P419, DOI 10.1016/j.molcel.2018.06.033; Pellegrino S, 2017, CELL REP, V19, P1819, DOI 10.1016/j.celrep.2017.05.016; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Quinet A, 2016, NUCLEIC ACIDS RES, V44, P5717, DOI 10.1093/nar/gkw280; Quinet A, 2014, DNA REPAIR, V14, P27, DOI 10.1016/j.dnarep.2013.12.005; Roerink SF, 2014, GENOME RES, V24, P954, DOI 10.1101/gr.170431.113; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Paviolo NS, 2020, GENET MOL BIOL, V43, DOI [10.1590/1678-4685-GMB-2019-0070, 10.1590/1678-4685-gmb-2019-0070]; Spivak G, 2015, DNA REPAIR, V36, P13, DOI 10.1016/j.dnarep.2015.09.003; Stary A, 2003, J BIOL CHEM, V278, P18767, DOI 10.1074/jbc.M211838200; Syed A, 2018, ANNU REV BIOCHEM, V87, P263, DOI 10.1146/annurev-biochem-062917-012415; Teng KY, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-126; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Ummat A, 2012, NAT STRUCT MOL BIOL, V19, P628, DOI 10.1038/nsmb.2295; Villafanez F, 2019, ONCOGENE, V38, P4310, DOI 10.1038/s41388-019-0724-7; Xu XY, 2013, P NATL ACAD SCI USA, V110, P18638, DOI 10.1073/pnas.1303958110; Yang Y, 2018, CELL CYCLE, V17, P833, DOI 10.1080/15384101.2018.1456296; Yoon JH, 2019, CELL, V176, P1295, DOI 10.1016/j.cell.2019.01.023; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109; Ziv O, 2009, P NATL ACAD SCI USA, V106, P11552, DOI 10.1073/pnas.0812548106	70	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	19					3952	3964		10.1038/s41388-020-1265-9	http://dx.doi.org/10.1038/s41388-020-1265-9		MAR 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LK4OF	32203168				2022-12-26	WOS:000521527500003
J	Oleszkiewicz, A; Kupczyk, T				Oleszkiewicz, Anna; Kupczyk, Teresa			Sensory impairment reduces money sharing in the Dictator Game regardless of the recipient's sensory status	PLOS ONE			English	Article							VISION IMPAIRMENT; FAIRNESS; ALTRUISM; DISTANCE; RECIPROCITY; BLINDNESS; TRUST; SEX	Altruism varies as a function of minimal social cues. Sensory impaired individuals elicit more altruistic behaviors, at the same time being more prone to be exploited. We tested whether information about recipient's sensory impairment (blindness or deafness or no impairment) would increase of the amount of money given to the anonymous partner in the Dictator Game (DG). We manipulated information about sensory status of a fictional recipient by indicating their sensory impairment (the same as the participant) or not. Sample of DG players included blind (n = 99) and deaf (n = 74) individuals and their fully functional counterparts (n = 197). Age, socioeconomic status (SES), and education were controlled. We observed higher offers in the sighted and hearing subjects as compared to sensory impaired subjects, regardless of information about the recipient's sensory status.	[Oleszkiewicz, Anna] Univ Wroclaw, Inst Psychol, Wroclaw, Poland; [Oleszkiewicz, Anna] Tech Univ Dresden, Dept Otorhinolaryngol Smell & Taste Clin, Dresden, Germany; [Kupczyk, Teresa] Gen Tadeusz Kosciuszko Mil Univ Land Forces Wrocl, Wroclaw, Poland	University of Wroclaw; Technische Universitat Dresden; General Tadeusz Kosciuszko Military University of Land Forces	Oleszkiewicz, A (corresponding author), Univ Wroclaw, Inst Psychol, Wroclaw, Poland.; Oleszkiewicz, A (corresponding author), Tech Univ Dresden, Dept Otorhinolaryngol Smell & Taste Clin, Dresden, Germany.	ania.oleszkiewicz@gmail.com	Kupczyk, Teresa/HDO-0975-2022	Kupczyk, Teresa/0000-0003-0361-2128; Oleszkiewicz, Anna/0000-0003-2217-1858	Polish Ministry of Science and Higher Education [626/STYP/12/2017]; Polish National Science Centre OPUS Grant [2017/25/B/HS6/00561]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish National Science Centre OPUS Grant	This work was supported by the Polish Ministry of Science and Higher Education scholarship for years 2018-2021 (#626/STYP/12/2017) and the Polish National Science Centre OPUS Grant (#2017/25/B/HS6/00561) both awarded to AO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoni J, 2002, ECONOMETRICA, V70, P737, DOI 10.1111/1468-0262.00302; Andreoni J, 2001, Q J ECON, V116, P293, DOI 10.1162/003355301556419; Andreoni James., 2010, BEHAVIOURAL EXPT EC, P6, DOI [10.1057/9780230280786_2, DOI 10.1057/9780230280786_2]; BAKER LD, 1978, J SOC PSYCHOL, V104, P19, DOI 10.1080/00224545.1978.9924034; Baldassarri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058750; Bourne RRA, 2017, LANCET GLOB HEALTH, V5, pE888, DOI 10.1016/S2214-109X(17)30293-0; Bourquin E, 2008, J VISUAL IMPAIR BLIN, V102, P352, DOI 10.1177/0145482X0810200604; Branas-Garza P, 2018, MPRA PAP; Branas-Garza P, 2016, PHYSIOL BEHAV, V156, P79, DOI 10.1016/j.physbeh.2016.01.008; Callan MJ, 2017, SOC PSYCHOL PERS SCI, V8, P660, DOI 10.1177/1948550616673877; Charness G, 2008, J ECON BEHAV ORGAN, V68, P29, DOI 10.1016/j.jebo.2008.03.001; Chen Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078254, 10.1371/journal.pone.0080879, 10.1371/journal.pone.0080419]; Cooper SB, 2013, AM ANN DEAF, V157, P413, DOI 10.1353/aad.2013.0003; DeGusta D, 2002, J ARCHAEOL SCI, V29, P1435, DOI 10.1006/jasc.2001.0808; Eckel CC, 1996, GAME ECON BEHAV, V16, P181, DOI 10.1006/game.1996.0081; Eckel CC, 1998, ECON J, V108, P726, DOI 10.1111/1468-0297.00311; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; Espin AM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00728; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Fong CM, 2007, ECON J, V117, P1008, DOI 10.1111/j.1468-0297.2007.02076.x; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Franco-Watkins AM, 2013, J BEHAV DECIS MAKING, V26, P79, DOI 10.1002/bdm.762; Goodall J., 1990, WINDOW MY 30 YEARS C, DOI [10.1086/418396, DOI 10.1086/418396]; Gracia A, 2009, P NATL ACAD SCI USA, V106, P6573, DOI 10.1073/pnas.0900965106; Hogan S, 2010, AER J RES PRACT VIS, V3; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P6429, DOI 10.1073/pnas.0902614106; KAHNEMAN D, 1986, J BUS, V59, pS285, DOI 10.1086/296367; Lebel S, 2001, P NATL ACAD SCI USA, V98, P11097, DOI 10.1073/pnas.181353998; LONNQVIST JE, 2019, FRONT PSYCHOL, V10, DOI DOI 10.3389/FPSYG.2019; Lordkipanidze D, 2005, NATURE, V434, P717, DOI 10.1038/434717b; Masalski M, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2798; Masalski M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2222; Muehlbacher S., 2009, J NEUROSCIENCE PSYCH, V2, P59, DOI DOI 10.1037/A0015458; Oxoby RJ, 2008, J ECON BEHAV ORGAN, V65, P703, DOI 10.1016/j.jebo.2005.12.006; Povinelli DJ., 2001, ETHOLOGY, V107, P463, DOI [10.1046/j.1439-0310.2001.00683.x, DOI 10.1046/J.1439-0310.2001.00683.X]; Rigdon M, 2009, J ECON PSYCHOL, V30, P358, DOI 10.1016/j.joep.2009.02.002; swidzinski M., 2014, SITUATION DEAF PEOPL; Trinkaus E., 1983, J HUM EVOL, V16, P429; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Wei ZY, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00952; Wilson RK, 2006, POLIT RES QUART, V59, P189, DOI 10.1177/106591290605900202; Zizzo DJ, 2010, EXP ECON, V13, P75, DOI 10.1007/s10683-009-9230-z	44	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230637	10.1371/journal.pone.0230637	http://dx.doi.org/10.1371/journal.pone.0230637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9GC	32203566	gold, Green Published			2022-12-26	WOS:000535303900032
J	Williams, M; Liu, XH; Zhang, YQ; Reske, J; Bahal, D; Gohl, TG; Hollern, D; Ensink, E; Kiupel, M; Luo, RC; Das, R; Xiao, H				Williams, Mark; Liu, Xinhui; Zhang, Yueqi; Reske, Jake; Bahal, Devika; Gohl, Trevor G.; Hollern, Daniel; Ensink, Elliot; Kiupel, Matti; Luo, Rongcheng; Das, Rupali; Xiao, Hua			NCOA5 deficiency promotes a unique liver protumorigenic microenvironment through p21(WAF1/CIP1) overexpression, which is reversed by metformin	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; NONALCOHOLIC STEATOHEPATITIS; DIABETIC-PATIENTS; GENE-EXPRESSION; T-CELLS; CANCER; TUMORIGENESIS; IL-6; P21; INFLAMMATION	Prevention and treatment options for hepatocellular carcinoma (HCC) are presently limited, underscoring the necessity for further elucidating molecular mechanisms underlying HCC development and identifying new prevention and therapeutic targets. Here, we demonstrate a unique protumorigenic niche in the livers of Ncoa5(+/)(-) mouse model of HCC, which is characterized by altered expression of a subset of genes including p21(WAF1/CIP1) and proinflammatory cytokine genes, increased putative hepatic progenitors, and expansions of activated and tissue-resident memory (TRM) CD8+ T lymphocytes, myeloid-derived suppressor cells (MDSCs), and alternatively activated M2 macrophages. Importantly, prophylactic metformin treatment reversed these characteristics including aberrant p21(WAF1/CIP1) expression and subsequently reduced HCC incidence in Ncoa5(+/-) male mice. Heterozygous deletion of the p21(WAF1/CIP1) gene alleviated the key features associated with the protumorigenic niche in the livers of Ncoa5(+/-) male mice. Moreover, transcriptomic analysis reveals that preneoplastic livers of Ncoa5(+/-) mice are similar to the livers of nonalcoholic steatohepatitis patients as well as the adjacent noncancerous liver tissues of a subset of HCC patients with a relatively poor prognosis. Together, our results suggest that p21(WAF1/CIP1) overexpression is essential in the development of protumorigenic microenvironment induced by NCOA5 deficiency and metformin prevents HCC development via alleviating p21(WAF1/CIP1) overexpression and protumorigenic microenvironment.	[Williams, Mark; Liu, Xinhui; Zhang, Yueqi; Reske, Jake; Gohl, Trevor G.; Ensink, Elliot; Das, Rupali; Xiao, Hua] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Williams, Mark; Zhang, Yueqi] Michigan State Univ, Cellular & Mol Biol Program, E Lansing, MI 48824 USA; [Liu, Xinhui; Luo, Rongcheng] Southern Med Univ, Canc Ctr, Guangzhou 510315, Guangdong, Peoples R China; [Liu, Xinhui] Southern Med Univ, Integrated Hosp Tradit Chinese Med, Guangzhou 510315, Guangdong, Peoples R China; [Bahal, Devika] Michigan State Univ, Comparat Med & Integrat Biol Program, E Lansing, MI 48824 USA; [Hollern, Daniel] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Kiupel, Matti] Michigan State Univ, Dept Pathobiol & Diagnost Invest, Lansing, MI 48910 USA; [Gohl, Trevor G.] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Southern Medical University - China; Southern Medical University - China; Michigan State University; University of North Carolina; University of North Carolina Chapel Hill; Michigan State University; Michigan State University; Michigan State University College of Osteopathic Medicine	Xiao, H (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	xiaoh@msu.edu		Bahal, Devika/0000-0002-4423-6387	National Cancer Institute [R01 CA188305, R21 CA185021]; NIH-NCI K22 award [5K22CA18814802]; NIH F32 student training fellowship [5 T32 GM 92715-3]; Integrated Hospital of Traditional Chinese Medicine, Southern Medical University	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-NCI K22 award; NIH F32 student training fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrated Hospital of Traditional Chinese Medicine, Southern Medical University	This work was supported by the grants (R01 CA188305 and R21 CA185021) of National Cancer Institute to HX and a NIH-NCI K22 award (5K22CA18814802) to RD. MW was supported by a NIH F32 student training fellowship (5 T32 GM 92715-3). XL was partially supported by a fellowship from Integrated Hospital of Traditional Chinese Medicine, Southern Medical University. The authors thank J. Rennhack and E. Andrechek for sharing expertise in RNA-seq data analysis; E. Andrechek for manuscript comments; and members of the HX lab for helpful discussions. The results reported here are partially based on data generated by the TCGA Research Network: http://cancergenome.nih.gov, which we also gratefully acknowledge.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Algire C, 2012, CANCER PREV RES, V5, P536, DOI 10.1158/1940-6207.CAPR-11-0536; Arendt BM, 2015, HEPATOLOGY, V61, P1565, DOI 10.1002/hep.27695; Bhalla K, 2012, CANCER PREV RES, V5, P544, DOI 10.1158/1940-6207.CAPR-11-0228; Cmielova J, 2011, J CELL BIOCHEM, V112, P3502, DOI 10.1002/jcb.23296; DePeralta DK, 2016, CANCER-AM CANCER SOC, V122, P1216, DOI 10.1002/cncr.29912; Dhar D, 2014, CELL METAB, V19, P6, DOI 10.1016/j.cmet.2013.12.010; Donadon V, 2010, LIVER INT, V30, P750, DOI 10.1111/j.1478-3231.2010.02223.x; Ehedego H, 2015, CANCER RES, V75, P1144, DOI 10.1158/0008-5472.CAN-14-1356; Eikawa S, 2015, P NATL ACAD SCI USA, V112, P1809, DOI 10.1073/pnas.1417636112; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Finkin S, 2015, NAT IMMUNOL, V16, P1235, DOI 10.1038/ni.3290; Fujita K, 2016, WORLD J GASTROENTERO, V22, P6100, DOI 10.3748/wjg.v22.i27.6100; Gao SL, 2013, CANCER CELL, V24, P725, DOI 10.1016/j.ccr.2013.11.005; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Gerbes A, 2018, GUT, V67, P594, DOI 10.1136/gutjnl-2017-315068corr1; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Lee S, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0128448, 10.1371/journal.pone.0136385]; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu XH, 2017, CANCER LETT, V391, P152, DOI 10.1016/j.canlet.2017.01.028; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Luo XL, 2016, CELL REP, V17, P2979, DOI 10.1016/j.celrep.2016.11.048; Marhenke S, 2014, GUT, V63, P1501, DOI 10.1136/gutjnl-2013-304829; Molnar Z, 2014, INT J CHRONIC DIS, V2014, P327640; Nakagawa H, 2012, WORLD J GASTROENTERO, V18, P4071, DOI 10.3748/wjg.v18.i31.4071; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nicolae CM, 2018, ONCOGENE, V37, P3647, DOI 10.1038/s41388-018-0219-y; Noren Hooten N, 2016, AGING CELL, V15, P572, DOI 10.1111/acel.12469; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Nguyen P, 2018, CELL REP, V24, P1597, DOI 10.1016/j.celrep.2018.07.014; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Rohr-Udilova N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24437-5; Schulte L, 2019, LIVER INT, V39, P714, DOI 10.1111/liv.14048; Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302; Sia D, 2017, GASTROENTEROLOGY, V153, P812, DOI 10.1053/j.gastro.2017.06.007; Tajima K, 2013, AM J PHYSIOL-ENDOC M, V305, pE987, DOI 10.1152/ajpendo.00133.2013; Tan XL, 2015, PANCREAS, V44, P636, DOI 10.1097/MPA.0000000000000308; Tomita K, 2012, J HEPATOL, V57, P837, DOI 10.1016/j.jhep.2012.05.013; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Verdura S, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1633235; Villanueva A, 2015, HEPATOLOGY, V61, P1945, DOI 10.1002/hep.27732; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; Yano M, 2013, LIVER INT, V33, P1218, DOI 10.1111/liv.12176; Yu LX, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0048-z; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035	52	7	7	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	19					3821	3836		10.1038/s41388-020-1256-x	http://dx.doi.org/10.1038/s41388-020-1256-x		MAR 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LK4OF	32203160	Green Accepted			2022-12-26	WOS:000520614000002
J	Joszai, J; Thamm, K; Karbanova, J; Janich, P; Fargeas, CA; Huttner, WB; Corbeil, D				Joszai, Jazsef; Thamm, Kristina; Karbanova, Jana; Janich, Peggy; Fargeas, Christine A.; Huttner, Wieland B.; Corbeil, Denis			Prominins control ciliary length throughout the animal kingdom: New lessons from human prominin-1 and zebrafish prominin-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prominin-1 (PROM1); cilia; zebrafish; membrane protein; ADP-ribosylation factor (ARF); development; CD133; left-right asymmetry; MDCK; membrane polarity; ADP-ribosylation factor-like protein 13B (Arl13b); cilium; Kupffer's vesicle; ciliopathy; development	CELL MARKER CD133; POLYTOPIC MEMBRANE-PROTEIN; EPITHELIAL-CELLS; PLASMA-MEMBRANE; INTRAFLAGELLAR TRANSPORT; NEURAL PROGENITORS; PRIMARY CILIUM; STEM-CELLS; ARL13B; CHOLESTEROL	Prominins (proms) are transmembrane glycoproteins conserved throughout the animal kingdom. They are associated with plasma membrane protrusions, such as primary cilia, as well as extracellular vesicles derived thereof. Primary cilia host numerous signaling pathways affected in diseases known as ciliopathies. Human PROM1 (CD133) is detected in both somatic and cancer stem cells and is also expressed in terminally differentiated epithelial and photoreceptor cells. Genetic mutations in the PROM1 gene result in retinal degeneration by impairing the proper formation of the outer segment of photoreceptors, a modified cilium. Here, we investigated the impact of proms on two distinct examples of ciliogenesis. First, we demonstrate that the overexpression of a dominant-negative mutant variant of human PROM1 (i.e. mutation Y819F/Y828F) significantly decreases ciliary length in Madin?Darby canine kidney cells. These results contrast strongly to the previously observed enhancing effect of WT PROM1 on ciliary length. Mechanistically, the mutation impeded the interaction of PROM1 with ADP-ribosylation factor?like protein 13B, a key regulator of ciliary length. Second, we observed that in vivo knockdown of prom3 in zebrafish alters the number and length of monocilia in the Kupffer's vesicle, resulting in molecular and anatomical defects in the left-right asymmetry. These distinct loss-of-function approaches in two biological systems reveal that prom proteins are critical for the integrity and function of cilia. Our data provide new insights into ciliogenesis and might be of particular interest for investigations of the etiologies of ciliopathies.	[Joszai, Jazsef; Thamm, Kristina; Karbanova, Jana; Janich, Peggy; Fargeas, Christine A.; Corbeil, Denis] Tech Univ Dresden, Tissue Engn Labs, Biotechnol Ctr BIOTEC, Tatzberg 47-49, D-01307 Dresden, Germany; [Joszai, Jazsef; Thamm, Kristina; Karbanova, Jana; Janich, Peggy; Fargeas, Christine A.; Corbeil, Denis] Tech Univ Dresden, Ctr Mol & Cellular Bioengn, Tatzberg 47-49, D-01307 Dresden, Germany; [Joszai, Jazsef] Techn Univ Dresden, Fak Med, Inst Anat, Fiedlerstr 42, D-01307 Dresden, Germany; [Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany; [Thamm, Kristina] DenovoMATRIX GmbH, Tatzberg 47, D-01307 Dresden, Germany; [Janich, Peggy] Swiss Canc League, Effingerstr 40, CH-3001 Bern, Switzerland	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Max Planck Society	Joszai, J; Corbeil, D (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Tatzberg 47-49, D-01307 Dresden, Germany.	jozsef.jaszai@tu-dresden.de; denis.corbeil@tu-dresden.de	Corbeil, Denis/L-2340-2019; Corbeil, Denis/AFL-1008-2022	Corbeil, Denis/0000-0003-1181-3659; Karbanova, Jana/0000-0001-7687-0983	Intramural Funds of the Medical Faculty of TU Dresden (MeDDrive grant); Deutsche Forschungsgemeinschaft (DFG) [CO298/5-1]; DFG [CO298/5-1, SFB655]	Intramural Funds of the Medical Faculty of TU Dresden (MeDDrive grant); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by Intramural Funds of the Medical Faculty of TU Dresden (MeDDrive grant) and Deutsche Forschungsgemeinschaft (DFG) Grant CO298/5-1 (to J. J.), DFG Grant SFB655 A2 (to W. B. H.), and DFG Grants SFB655 B3 and CO298/5-1 (to D. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Amack Jeffrey D, 2014, Bioarchitecture, V4, P6, DOI 10.4161/bioa.28014; Bachor TP, 2017, NEUROBIOL DIS, V108, P13, DOI 10.1016/j.nbd.2017.07.010; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bae YK, 2009, CURR BIOL, V19, P1599, DOI 10.1016/j.cub.2009.08.045; Bauer N, 2011, EMBO MOL MED, V3, P398, DOI 10.1002/emmm.201100147; Bhattacharya S, 2017, INVEST OPHTH VIS SCI, V58, P2366, DOI 10.1167/iovs.16-21162; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Boivin D, 2009, BIOCHEMISTRY-US, V48, P3998, DOI 10.1021/bi900159d; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Copeland J, 2020, SEMIN CELL DEV BIOL, V102, P132, DOI 10.1016/j.semcdb.2019.12.005; Copeland SJ, 2018, MOL BIOL CELL, V29, P1611, DOI 10.1091/mbc.E18-02-0088; Corbeil D, 1999, J CELL SCI, V112, P1023; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; Corbeil D, 2019, J BIOL CHEM, V294, P17166, DOI 10.1074/jbc.L119.011198; Corbeil D, 2013, ADV EXP MED BIOL, V777, P3, DOI 10.1007/978-1-4614-5894-4_1; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Dilan TL, 2019, J NEUROSCI, V39, P1347, DOI 10.1523/JNEUROSCI.1761-18.2018; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Drummond ML, 2018, J CELL BIOL, V217, P3255, DOI 10.1083/jcb.201703196; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Duldulao NA, 2009, DEVELOPMENT, V136, P4033, DOI 10.1242/dev.036350; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Fargeas CA, 2007, TISSUE ANTIGENS, V69, P602, DOI 10.1111/j.1399-0039.2007.00825.x; Fargeas CA, 2003, J BIOL CHEM, V278, P8586, DOI 10.1074/jbc.M210640200; Fargeas CA, 2006, FUTURE LIPIDOL, V1, P213, DOI 10.2217/17460875.1.2.213; Fargeas CA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00091; Fargeas CA, 2013, ADV EXP MED BIOL, V777, P25, DOI 10.1007/978-1-4614-5894-4_2; Florek M, 2007, CELL TISSUE RES, V328, P31, DOI 10.1007/s00441-006-0324-z; Freund D, 2006, STEM CELLS DEV, V15, P815, DOI 10.1089/scd.2006.15.815; Garcia-Gonzalo FR, 2015, DEV CELL, V34, P400, DOI 10.1016/j.devcel.2015.08.001; Goldberg AFX, 2016, PROG RETIN EYE RES, V55, P52, DOI 10.1016/j.preteyeres.2016.05.003; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Gurudev N, 2013, ADV EXP MED BIOL, V777, P55, DOI 10.1007/978-1-4614-5894-4_4; Han Z, 2012, INVEST OPHTH VIS SCI, V53, P361, DOI 10.1167/iovs.11-8635; Hanke-Gogokhia C, 2017, J BIOL CHEM, V292, P21442, DOI 10.1074/jbc.RA117.000141; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hsiao Yi-Chun, 2012, Cilia, V1, P4, DOI 10.1186/2046-2530-1-4; Ivanova AA, 2017, J BIOL CHEM, V292, P11091, DOI 10.1074/jbc.M117.784025; Izumi H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39229-8; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Jaszai J, 2003, DEVELOPMENT, V130, P6611, DOI 10.1242/dev.00899; Jaszai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063457; Jaszai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017590; Jaszai J, 2010, HISTOCHEM CELL BIOL, V133, P527, DOI 10.1007/s00418-010-0690-1; Jensen V, 2015, EMBO J, V34, P2537, DOI 10.15252/embj.201488044; Jones AT, 1998, J BIOL CHEM, V273, P25301, DOI 10.1074/jbc.273.39.25301; Kania G, 2005, STEM CELLS, V23, P791, DOI 10.1634/stemcells.2004-0232; Karbanova J, 2008, J HISTOCHEM CYTOCHEM, V56, P977, DOI 10.1369/jhc.2008.951897; Karbanova J, 2018, STEM CELL TRANSL MED, V7, P155, DOI 10.1002/sctm.17-0223; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Lee S, 2018, J CELL BIOL, V217, P2831, DOI 10.1083/jcb.201711104; Li YJ, 2010, J CELL BIOL, V189, P1039, DOI 10.1083/jcb.200912001; Liu CJ, 2016, J BIOL CHEM, V291, P15540, DOI 10.1074/jbc.M115.712976; Lu H, 2015, DEV BIOL, V397, P225, DOI 10.1016/j.ydbio.2014.11.009; Lu ZJ, 2019, J BIOL CHEM, V294, P17167, DOI 10.1074/jbc.RL119.011224; Lu ZJ, 2019, J BIOL CHEM, V294, P13953, DOI 10.1074/jbc.RA119.008618; Mak AB, 2012, CELL REP, V2, P951, DOI 10.1016/j.celrep.2012.09.016; Malicki J, 2014, ORGANOGENESIS, V10, P138, DOI 10.4161/org.29055; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Marzesco AM, 2013, ADV EXP MED BIOL, V777, P41, DOI 10.1007/978-1-4614-5894-4_3; Marzesco AM, 2009, FEBS LETT, V583, P897, DOI 10.1016/j.febslet.2009.01.048; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; May-Simera Helen L, 2012, Cilia, V1, P7, DOI 10.1186/2046-2530-1-7; McGrail M, 2010, DEV DYNAM, V239, P1849, DOI 10.1002/dvdy.22307; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Morleo M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080905; Nager AR, 2017, CELL, V168, P252, DOI 10.1016/j.cell.2016.11.036; Nozaki S, 2017, J CELL SCI, V130, P563, DOI 10.1242/jcs.197004; Orhon I, 2016, AUTOPHAGY, V12, P2258, DOI 10.1080/15548627.2016.1212790; Pintado P, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.161102; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Roy K, 2017, J BIOL CHEM, V292, P17703, DOI 10.1074/jbc.M117.792937; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Singer D, 2019, EMBO J, V38, DOI 10.15252/embj.201899845; Spencer WJ, 2019, P NATL ACAD SCI USA, V116, P27043, DOI 10.1073/pnas.1913518117; Steiner AB, 2014, P NATL ACAD SCI USA, V111, pE1393, DOI 10.1073/pnas.1318692111; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Taieb N, 2009, CANCER LETT, V278, P164, DOI 10.1016/j.canlet.2009.01.013; Thamm K, 2019, TRAFFIC, V20, P39, DOI 10.1111/tra.12618; Thamm K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164079; Tuscher O, 1997, FEBS LETT, V419, P271, DOI 10.1016/S0014-5793(97)01471-3; Walker TL, 2013, J NEUROSCI, V33, P3010, DOI 10.1523/JNEUROSCI.3363-12.2013; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wotton KR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-171; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Yeyati PL, 2017, J CELL BIOL, V216, P999, DOI 10.1083/jcb.201607032; Yu Y, 2002, J BIOL CHEM, V277, P20711, DOI 10.1074/jbc.M202349200; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128	96	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6007	6022		10.1074/jbc.RA119.011253	http://dx.doi.org/10.1074/jbc.RA119.011253			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32201384	Green Published, hybrid			2022-12-26	WOS:000531417300014
J	Shikha, S; Schneider, A				Shikha, Shikha; Schneider, Andre			The single CCA-adding enzyme of T. brucei has distinct functions in the cytosol and in mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Trypanosoma brucei; transfer RNA (tRNA); mitochondria; RNA processing; RNA interference (RNAi); mitochondrial tRNA import	TRANSFER-RNA NUCLEOTIDYLTRANSFERASE; TRYPANOSOMA-BRUCEI; IMPORT; GENE; IDENTIFICATION; CONSEQUENCES; TRANSLATION; TRANSLOCASE; MECHANISMS; EXPRESSION	tRNAs universally carry a CCA nucleotide triplet at their 3?-ends. In eukaryotes, the CCA is added post-transcriptionally by the CCA-adding enzyme (CAE). The mitochondrion of the parasitic protozoan Trypanosoma brucei lacks tRNA genes and therefore imports all of its tRNAs from the cytosol. This has generated interest in the tRNA modifications and their distribution in this organism, including how CCA is added to tRNAs. Here, using a BLAST search for genes encoding putative CAE proteins in T. brucei, we identified a single ORF, Tb927.9.8780, as a potential candidate. Knockdown of this putative protein, termed TbCAE, resulted in the accumulation of truncated tRNAs, abolished translation, and inhibited both total and mitochondrial CCA-adding activities, indicating that TbCAE is located both in the cytosol and mitochondrion. However, mitochondrially localized tRNAs were much less affected by the TbCAE ablation than the other tRNAs. Complementation assays revealed that the N-terminal 10 amino acids of TbCAE are dispensable for its activity and mitochondrial localization and that deletion of 10 further amino acids abolishes both. A growth arrest caused by the TbCAE knockdown was rescued by the expression of the cytosolic isoform of yeast CAE, even though it was not imported into mitochondria. This finding indicated that the yeast enzyme complements the essential function of TbCAE by adding CCA to the primary tRNA transcripts. Of note, ablation of the mitochondrial TbCAE activity, which likely has a repair function, only marginally affected growth.	[Shikha, Shikha; Schneider, Andre] Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland	University of Bern	Schneider, A (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.	andre.schneider@dcb.unibe.ch		Schneider, Andre/0000-0001-5421-0909; , Shikha/0000-0002-7878-1463	NCCR "RNA Disease" [175563]; Swiss National Science Foundation	NCCR "RNA Disease"; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by NCCR "RNA & Disease" and Grant 175563 from the Swiss National Science Foundation.	Aeby E, 2010, NUCLEIC ACIDS RES, V38, P5833, DOI 10.1093/nar/gkq345; Aeby E, 2009, MOL BIOCHEM PARASIT, V168, P191, DOI 10.1016/j.molbiopara.2009.08.007; Aeby E, 2009, P NATL ACAD SCI USA, V106, P5088, DOI 10.1073/pnas.0901575106; Alfonzo JD, 1999, EMBO J, V18, P7056, DOI 10.1093/emboj/18.24.7056; Alfonzo JD, 2009, BIOL CHEM, V390, P717, DOI 10.1515/BC.2009.101; BEJA O, 1993, MOL BIOCHEM PARASIT, V57, P223, DOI 10.1016/0166-6851(93)90198-7; Betat H, 2015, BIOESSAYS, V37, P975, DOI 10.1002/bies.201500043; Bouzaidi-Tiali N, 2007, EMBO J, V26, P4302, DOI 10.1038/sj.emboj.7601857; Charriere F, 2006, P NATL ACAD SCI USA, V103, P6847, DOI 10.1073/pnas.0602362103; Charriere F, 2009, J BIOL CHEM, V284, P16210, DOI 10.1074/jbc.M109.005348; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Crain PF, 2002, RNA, V8, P752, DOI 10.1017/S1355838202022045; Cristodero M, 2010, MOL MICROBIOL, V78, P757, DOI 10.1111/j.1365-2958.2010.07368.x; HANCOCK K, 1992, J BIOL CHEM, V267, P23963; Harsman A, 2012, J BIOL CHEM, V287, P31437, DOI 10.1074/jbc.M112.392118; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Huot JL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47268-4; HURT EC, 1987, NATURE, V325, P499, DOI 10.1038/325499a0; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Leibovitch M, 2013, BIOCHEM J, V453, P401, DOI 10.1042/BJ20121577; Mani J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7646; Maraia RJ, 2011, WIRES RNA, V2, P362, DOI 10.1002/wrna.64; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Morl M, 2001, EMBO REP, V2, P17, DOI 10.1093/embo-reports/kve006; Niemann M, 2017, P NATL ACAD SCI USA, V114, pE7679, DOI 10.1073/pnas.1711430114; Niemann M, 2013, MOL CELL PROTEOMICS, V12, P515, DOI 10.1074/mcp.M112.023093; Niemann M, 2011, TRENDS PARASITOL, V27, P429, DOI 10.1016/j.pt.2011.03.011; Paris Z, 2018, IUBMB LIFE, V70, P1207, DOI 10.1002/iub.1957; Peikert CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15272; Pusnik M, 2011, CURR BIOL, V21, P1738, DOI 10.1016/j.cub.2011.08.060; Regev-Rudzki N, 2008, J CELL SCI, V121, P2423, DOI 10.1242/jcs.029207; Rettig J, 2012, NUCLEIC ACIDS RES, V40, P1299, DOI 10.1093/nar/gkr794; Reuven NB, 1997, J BIOL CHEM, V272, P33255, DOI 10.1074/jbc.272.52.33255; RIBEIRO S, 1995, ANAL BIOCHEM, V228, P330, DOI 10.1006/abio.1995.1359; Roggy JL, 1999, MOL BIOCHEM PARASIT, V98, P1, DOI 10.1016/S0166-6851(98)00114-5; Rossmanith W, 2012, BBA-GENE REGUL MECH, V1819, P1017, DOI 10.1016/j.bbagrm.2011.11.003; Salavati R, 2001, MOL BIOCHEM PARASIT, V115, P109, DOI 10.1016/S0166-6851(01)00273-0; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010; Schneider Andre, 2007, Methods Mol Biol, V372, P67, DOI 10.1007/978-1-59745-365-3_5; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Seidman D, 2012, J BIOL CHEM, V287, P8892, DOI 10.1074/jbc.M111.300186; Shikha S, 2019, CHIMIA, V73, P395, DOI 10.2533/chimia.2019.395; Sieber F, 2011, INT REV CEL MOL BIO, V287, P145, DOI 10.1016/B978-0-12-386043-9.00004-9; Tan THP, 2002, MOL CELL BIOL, V22, P3707, DOI 10.1128/MCB.22.11.3707-3716.2002; TARASSOV I, 1995, EMBO J, V14, P3461, DOI 10.1002/j.1460-2075.1995.tb07352.x; Taschner A, 2012, CELL REP, V2, P19, DOI 10.1016/j.celrep.2012.05.021; Tschopp F, 2011, EMBO REP, V12, P825, DOI 10.1038/embor.2011.111; von Braun SS, 2007, J EXP BOT, V58, P4083, DOI 10.1093/jxb/erm267; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wohlgamuth-Benedum JM, 2009, J BIOL CHEM, V284, P23947, DOI 10.1074/jbc.M109.029421; Wolfe CL, 1996, J BIOL CHEM, V271, P4679; WOLFE CL, 1994, J BIOL CHEM, V269, P13361; ZHU LQ, 1987, EMBO J, V6, P2473, DOI 10.1002/j.1460-2075.1987.tb02528.x	54	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6138	6150		10.1074/jbc.RA119.011877	http://dx.doi.org/10.1074/jbc.RA119.011877			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32234763	hybrid, Green Published			2022-12-26	WOS:000531417300023
J	Freeman, AR; Ophir, AG; Sheehan, MJ				Freeman, Angela R.; Ophir, Alexander G.; Sheehan, Michael J.			The giant pouched rat (Cricetomys ansorgei) olfactory receptor repertoire	PLOS ONE			English	Article							EVOLUTIONARY DYNAMICS; GENE REPERTOIRE; ODORANT; BULB; SUPERFAMILY; VOMERONASAL; EXPANSION; GAMBIANUS; FAMILIES; PRIMATES	For rodents, olfaction is essential for locating food, recognizing mates and competitors, avoiding predators, and navigating their environment. It is thought that rodents may have expanded olfactory receptor repertoires in order to specialize in olfactory behavior. Despite being the largest clade of mammals and depending on olfaction relatively little work has documented olfactory repertoires outside of conventional laboratory species. Here we report the olfactory receptor repertoire of the African giant pouched rat (Cricetomys ansorgei), a Muroid rodent distantly related to mice and rats. The African giant pouched rat is notable for its large cortex and olfactory bulbs relative to its body size compared to other sympatric rodents, which suggests anatomical elaboration of olfactory capabilities. We hypothesized that in addition to anatomical elaboration for olfaction, these pouched rats might also have an expanded olfactory receptor repertoire to enable their olfactory behavior. We examined the composition of the olfactory receptor repertoire to better understand how their sensory capabilities have evolved. We identified 1145 intact olfactory genes, and 260 additional pseudogenes within 301 subfamilies from the African giant pouched rat genome. This repertoire is similar to mice and rats in terms of size, pseudogene percentage and number of subfamilies. Analyses of olfactory receptor gene trees revealed that the pouched rat has 6 expansions in different subfamilies compared to mice, rats and squirrels. We identified 81 orthologous genes conserved among 4 rodent species and an additional 147 conserved genes within the Muroid rodents. The orthologous genes shared within Muroidea suggests that there may be a conserved Muroid-specific olfactory receptor repertoire. We also note that the description of this repertoire can serve as a complement to other studies of rodent olfaction, as the pouched rat is an outgroup within Muroidea. Thus, our data suggest that African giant pouched rats are capable of both natural and trained olfactory behaviors with a typical Muriod olfactory receptor repertoire.	[Freeman, Angela R.; Ophir, Alexander G.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; [Sheehan, Michael J.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University; Cornell University	Freeman, AR (corresponding author), Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA.	arf86@cornell.edu		Freeman, Angela/0000-0001-5103-5674	Army Research Office; DARPA [65344-LS]; Cornell University College of Arts and Sciences	Army Research Office; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Cornell University College of Arts and Sciences	This work was supported by funding from the Army Research Office and DARPA to A.G. O. (65344-LS), and from the Cornell University College of Arts and Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaffy T, 2006, J NEUROCHEM, V97, P1506, DOI 10.1111/j.1471-4159.2006.03859.x; Adipietro KA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002821; Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Alioto TS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-173; Altenhoff AM, 2019, METHODS MOL BIOL, V1910, P149, DOI 10.1007/978-1-4939-9074-0_5; Ballesteros JA, 2016, MOL BIOL EVOL, V33, P2117, DOI 10.1093/molbev/msw069; BARON G, 1983, J HIRNFORSCH, V24, P551; Baud O, 2015, SCI REP-UK, V5, DOI 10.1038/srep14948; BHATNAGAR KP, 1974, J MORPHOL, V142, P71, DOI 10.1002/jmor.1051420104; Bird DJ, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0100; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Nguyen DT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-584; Dugas JC, 2001, GENOMICS, V71, P53, DOI 10.1006/geno.2000.6415; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI [10.1186/1471-2148-12-12, DOI 10.1186/1471-2148-12-12]; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Freeman AR, 2019, ANIM BEHAV, V148, P123, DOI 10.1016/j.anbehav.2018.12.010; Freeman AR, 2018, J MAMMAL, V99, P1430, DOI 10.1093/jmammal/gyy137; Garrett EC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2828; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Hashiguchi Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004083; Hayden S, 2010, GENOME RES, V20, P1, DOI 10.1101/gr.099416.109; HEALY S, 1990, EVOLUTION, V44, P339, DOI 10.1111/j.1558-5646.1990.tb05203.x; Huchon D, 2007, P NATL ACAD SCI USA, V104, P7495, DOI 10.1073/pnas.0701289104; Hughes GM, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0909; Hughes GM, 2018, MOL BIOL EVOL, V35, P1390, DOI 10.1093/molbev/msy028; Hughes GM, 2013, MOL ECOL RESOUR, V13, P510, DOI 10.1111/1755-0998.12087; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Ibe CS, 2014, ONDERSTEPOORT J VET, V81, DOI [10.4102/ojvr.v8111.644, 10.4102/ojvr.v81i1.644]; Jansa SA, 2004, MOL PHYLOGENET EVOL, V31, P256, DOI 10.1016/j.ympev.2003.07.002; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Keverne EB, 2004, PHYSIOL BEHAV, V83, P177, DOI 10.1016/j.physbeh.2004.08.013; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; LEE K, 2013, BMC GENOMICS, V14, DOI DOI 10.1186/1471-2164-14-14; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; Liu A, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6290-0; Liu K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027731; Mainland JD, 2014, NAT NEUROSCI, V17, P114, DOI 10.1038/nn.3598; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nielsen BL, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00226; Niimura Y, 2005, GENE, V346, P13, DOI 10.1016/j.gene.2004.09.025; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Niimura Y, 2018, MOL BIOL EVOL, V35, P1437, DOI 10.1093/molbev/msy042; Niimura Y, 2014, GENOME RES, V24, P1485, DOI 10.1101/gr.169532.113; Niimura Yoshihito, 2013, Methods Mol Biol, V1003, P39, DOI 10.1007/978-1-62703-377-0_3; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Nzalak JO, 2008, J ANIM VET ADV, V7, P1090; Nzalak JO, 2005, TROP VET, V23, P87; Olayemi A, 2012, ZOOL J LINN SOC-LOND, V165, P700, DOI 10.1111/j.1096-3642.2012.00823.x; Onyono PN, 2017, TISSUE CELL, V49, P612, DOI 10.1016/j.tice.2017.07.005; Peterlin Z, 2014, J GEN PHYSIOL, V143, P527, DOI 10.1085/jgp.201311151; Poling A, 2010, PSYCHOL REC, V60, P715, DOI 10.1007/BF03395741; Prieto-Godino LL, 2016, NATURE, V539, P93, DOI 10.1038/nature19824; Quignon P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r83; Quignon P, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r80; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Snitz K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003184; Steppan SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183070; Tange O., 2018, GNU PARALLEL 2018, DOI [10.5281/zenodo 1146014, 10.5281/zenodo.1146014]; Weetjens BJ, 2009, INT J TUBERC LUNG D, V13, P737; Yohe LR, 2020, MOL ECOL RESOUR, V20, P140, DOI 10.1111/1755-0998.13093; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	71	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0221981	10.1371/journal.pone.0221981	http://dx.doi.org/10.1371/journal.pone.0221981			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240170	Green Submitted, gold, Green Published			2022-12-26	WOS:000535945000001
J	Ahmed, KY; Page, A; Arora, A; Ogbo, FA				Ahmed, Kedir Y.; Page, Andrew; Arora, Amit; Ogbo, Felix Akpojene		Global Maternal Child Hlth Res Col	Associations between infant and young child feeding practices and acute respiratory infection and diarrhoea in Ethiopia: A propensity score matching approach	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; UNDER-5 MORTALITY; NIGERIA EVIDENCE; AIR-POLLUTION; BREAST; IMPACT; COUNTRIES; DISEASES; OUTCOMES; WATER	Background Acute respiratory infection (ARI) and diarrhoea are the leading causes of childhood morbidity and mortality in Ethiopia. Understanding the associations between infant and young child feeding (IYCF) and ARI and diarrhoea can inform IYCF policy interventions and advocacy in Ethiopia. This study aimed to investigate the relationship between IYCF practices and ARI and diarrhoea in Ethiopian children. Methods This study used the Ethiopia Demographic and Health Survey (EDHS) data for the years 2000 (n = 3680), 2005 (n = 3528), 2011 (n = 4037), and 2016 (n = 3861). The association between IYCF practices and (i) ARI and (ii) diarrhoea were investigated using propensity score matching and multivariable logistic regression models. The IYCF practices include early initiation of breastfeeding, exclusive breastfeeding (EBF), predominant breastfeeding, introduction of complementary foods, continued breastfeeding at two years and bottle feeding. Results Infants and young children who were breastfed within 1-hour of birth and those who were exclusively breastfed had a lower prevalence of ARI. Infants who were exclusively and predominantly breastfed had a lower prevalence of diarrhoea. Early initiation of breastfeeding (Odds ratio [OR]: 0.81; 95% confidence interval [CI]: 0.72, 0.92) and EBF (OR: 0.65; 95% CI: 0.51, 0.83) were associated with lower risk of ARI. Bottle-fed children had higher odds of ARI (OR: 1.36; 95% CI: 1.10, 1.68). Early initiation of breastfeeding and EBF were associated with lower odds of diarrhoea (OR: 0.88; 95% CI: 0.79, 0.94 for Early initiation of breastfeeding and OR: 0.51; 95% CI: 0.39, 0.65 for EBF). Infants who were predominantly breastfed were less likely to experience diarrhoea (OR: 0.69; 95% CI: 0.53, 0.89). Conclusion The recommended best practices for preventing ARI and diarrhoeal diseases in infants and young children namely: the early initiation of breastfeeding, EBF and avoidance of bottle feeding should be institutionalized and scale-up in Ethiopia as part of implementation science approach to cover the know-do-gaps.	[Ahmed, Kedir Y.] Samara Univ, Coll Med & Hlth Sci, Samara, Ethiopia; [Ahmed, Kedir Y.; Page, Andrew; Arora, Amit; Ogbo, Felix Akpojene] Western Sydney Univ, Translat Hlth Res Inst, Campbelltown, NSW, Australia; [Arora, Amit] Western Sydney Univ, Sch Sci & Hlth, Campbelltown, NSW, Australia; [Arora, Amit] NSW Hlth, Oral Hlth Serv, Sydney Local Hlth Dist & Sydney Dent Hosp, Sydney, NSW, Australia; [Arora, Amit] Univ Sydney, Fac Med & Hlth, Sydney Med Sch, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia; [Ogbo, Felix Akpojene] Prescot Specialist Med Ctr Makurdi, Gen Practice Unit, Makurdi, Benue State, Nigeria	Samara University; University of Sydney; Western Sydney University; University of Sydney; Western Sydney University; University of Sydney	Ahmed, KY (corresponding author), Samara Univ, Coll Med & Hlth Sci, Samara, Ethiopia.; Ahmed, KY (corresponding author), Western Sydney Univ, Translat Hlth Res Inst, Campbelltown, NSW, Australia.	kedirymam331@gmail.com	Akombi-Inyang, Blessing/AAT-6507-2020; Ahmed, Kedir Y./AAC-5114-2019; Agho, Kingsley/AAW-5622-2021	Akombi-Inyang, Blessing/0000-0002-6410-4154; Ahmed, Kedir Y./0000-0003-3797-5234; Agho, Kingsley/0000-0003-4111-3207				Acharya D, 2018, J INFECT PUBLIC HEAL, V11, P69, DOI 10.1016/j.jiph.2017.04.007; Admasie A, 2018, J ENVIRON PUBLIC HEA, V2018, DOI 10.1155/2018/9320603; Agunbiade OM, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-5; Ahmed KY, 2020, MATERN CHILD NUTR, V16, DOI 10.1111/mcn.12926; Ahmed KY, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-019-0234-9; Amsalu ET, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215572; [Anonymous], 2015, HLTH SECT TRANSF PLA; [Anonymous], 2019, TOTAL POPULATION COU; Assefa T, 2013, ASSESSMENT STATUS IN; Austin PC, 2018, STAT METHODS MED RES, V27, P1240, DOI 10.1177/0962280216658920; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bbaale E, 2011, AUSTRALAS MED J, V4, P400, DOI 10.4066/AMJ.2011.723; Blewett HJH, 2008, ADV FOOD NUTR RES, V54, P45, DOI 10.1016/S1043-4526(07)00002-2; Boone KM, 2016, J PEDIATR-US, V174, P118, DOI 10.1016/j.jpeds.2016.04.006; Central Statistics Agency (CSA) [Ethiopia] and ORC Macro, 2006, ETH DEM HLTH SURV 20; Central Statistics Agency (CSA) [Ethiopia] and ORC Macro, 2001, ETH DEM HLTH SURV 20; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; Chen QX, 2016, STAT MED, V35, P4546, DOI 10.1002/sim.7021; Croft TN, 2018, GUIDE DHS STAT; CSA IJAA, 2012, ETH DEM HLTH SURV 20, P430; DaviesAdetugbo AA, 1997, SOC SCI MED, V45, P113, DOI 10.1016/S0277-9536(96)00320-6; DuGoff EH, 2014, HEALTH SERV RES, V49, P284, DOI 10.1111/1475-6773.12090; Edmond K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031239; Ethiopian Public Health Institute (EPHI) [Ethiopia] and ICF, 2019, ETH MIN DEM HLTH SUR; Ezeh OK, 2014, INT J ENV RES PUB HE, V11, P9256, DOI 10.3390/ijerph110909256; Ezeh OK, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-113; Garrido MM, 2014, HEALTH SERV RES, V49, P1701, DOI 10.1111/1475-6773.12182; Gautam Om Prasad, 2015, COMPLEMENTARY FOOD H; Goldfield EC, 2006, PEDIATR RES, V60, P450, DOI 10.1203/01.pdr.0000238378.24238.9d; Grube MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122534; Gupta GR, 2012, LANCET, V379, P2123, DOI 10.1016/S0140-6736(12)60907-6; Hajeebhoy N, 2014, INT BREASTFEED J, V9, DOI 10.1186/1746-4358-9-12; Hajeebhoy N, 2013, FOOD NUTR BULL, V34, pS181, DOI 10.1177/15648265130343S205; Horta BL., 2013, SHORT TERM EFFECTS B, V49; Howe-Heyman A, 2016, J MIDWIFERY WOM HEAL, V61, P77, DOI 10.1111/jmwh.12376; Jiang M, 2013, HEALTH SERV RES, V48, P628, DOI 10.1111/j.1475-6773.2012.01456.x; Kaferstein FK, 2003, B WORLD HEALTH ORGAN, V81, P842; Kerr RB, 2008, SOC SCI MED, V66, P1095, DOI 10.1016/j.socscimed.2007.11.019; Khan MSB, 2018, ENVIRON SCI POLLUT R, V25, P24778, DOI 10.1007/s11356-018-2513-1; Kim HY, 2011, ASIA PAC ALLERGY, V1, P30, DOI 10.5415/apallergy.2011.1.1.30; Labiner-Wolfe J, 2008, PEDIATRICS, V122, pS85, DOI 10.1542/peds.2008-1315k; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Mannion CA, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-4; Minas AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164128; Morgan CJ, 2018, J NUCL CARDIOL, V25, P404, DOI 10.1007/s12350-017-1012-y; Naz S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173256; Naz S, 2015, INT J ENV RES PUB HE, V12, P12847, DOI 10.3390/ijerph121012847; Negin J, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0880-5; Ogbo FA, 2017, PUBLIC HEALTH NUTR, V20, P3109, DOI 10.1017/S1368980017002567; Ogbo FA, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0110-4; Ogbo FA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171792; Ogbo FA, 2016, PAEDIATR PERINAT EP, V30, P346, DOI 10.1111/ppe.12293; Ogbo FA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020413; Ogbo FA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071611; Ogbo FA, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-019-0198-9; Ogbo FA, 2018, TROP MED HEALTH, V46, DOI 10.1186/s41182-018-0084-y; Palmeira P, 2016, REV ASSOC MED BRAS, V62, P584, DOI 10.1590/1806-9282.62.06.584; Perez-Escamilla R, 2016, MATERN CHILD NUTR, V12, P402, DOI 10.1111/mcn.12294; Nguyen P, 2020, ARCH DIS CHILD, V105, P122, DOI 10.1136/archdischild-2019-316937; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P5736, DOI 10.1021/es300022c; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 2000, J AM STAT ASSOC, V95, P573, DOI 10.2307/2669400; Santos FS, 2016, J TEXTO CONTEXTO ENF, V25, DOI [10.1016/j.optom.2018.03.002, DOI 10.1016/J.OPTOM.2018.03.002]; Sinha B, 2015, ACTA PAEDIATR, V104, P114, DOI 10.1111/apa.13127; Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518; Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6; StataCorp, 2017, STAT SURV DAT REF MA; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Stuebe Alison, 2009, Rev Obstet Gynecol, V2, P222; The Federal Democratic Republic of Ethiopia, 2008, NAT NUTR STRAT; Troeger CE, LANCET INFECT DIS; Troeger C, 2018, LANCET INFECT DIS, V18, P1191, DOI 10.1016/S1473-3099(18)30310-4; Tsegaye M, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-019-0200-6; UNICEF, 2015, PROGR SAN DRINK WAT; UNICEF-Ethiopia, 2018, WAT SAN HYG WASH ADD; United Nations (UN), 2015, TRANSF OUR WORLD 203; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Walker CW, 2013, DEV AQUAC FISH SCI, V38, P25, DOI 10.1016/B978-0-12-396491-5.00003-4; Wazny K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001446; WHO, 2003, COMMUNITY BASED STRA; WHO, 2019, DIARRH DIS 2017; WHO, 2018, CAPT MOM EARL IN BRE; World Health Organization, 2010, Indicators for assessing infant and young child feeding practices, part 2: measurement; World Health Organization, 2018, PROT PROM SUPP BREAS; World Health Organization UNICEF, 2013, END PREV CHILD DEATH	87	6	6	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230978	10.1371/journal.pone.0230978	http://dx.doi.org/10.1371/journal.pone.0230978			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8IA	32236145	Green Published, gold			2022-12-26	WOS:000535938700043
J	Zeng, N; Okumura, T; Alauddin, M; Khozooei, S; Rajaxavier, J; Zhang, SQ; Singh, Y; Shi, B; Brucker, SY; Wallwiener, D; Takeda, S; Lang, F; Salker, MS				Zeng, Ni; Okumura, Toshiyuki; Alauddin, Md; Khozooei, Shayan; Rajaxavier, Janet; Zhang, Shaqiu; Singh, Yogesh; Shi, Bing; Brucker, Sara Y.; Wallwiener, Diethelm; Takeda, Satoru; Lang, Florian; Salker, Madhuri S.			LEFTY2/endometrial bleeding-associated factor up-regulates Na+ Coupled Glucose Transporter SGLT1 expression and Glycogen Accumulation in Endometrial Cancer Cells	PLOS ONE			English	Article							CYTOSOLIC PH REGULATION; LEFT-RIGHT ASYMMETRY; AEROBIC GLYCOLYSIS; METABOLISM; HALLMARKS; FAMILY; TARGET; GROWTH; ACID; EGFR	LEFTY2 (endometrial bleeding associated factor; EBAF or LEFTYA), a cytokine released shortly before menstrual bleeding, is a negative regulator of cell proliferation and tumour growth. LEFTY2 down-regulates Na+/H+ exchanger activity with subsequent inhibition of glycolytic flux and lactate production in endometrial cancer cells. Glucose can be utilized not only for glycolysis but also for glycogen formation. Both glycolysis and glycogen formation require cellular glucose uptake which could be accomplished by the Na+ coupled glucose transporter-1 (SGLT1; SLC5A1). The present study therefore explored whether LEFTY2 modifies endometrial SGLT1 expression and activity as well as glycogen formation. Ishikawa and HEC1a cells were exposed to LEFTY2, SGLT1 and glycogen synthase (GYS1) transcript levels determined by qRT-PCR. SGLT1, GYS1 and phospho-GYS1 protein abundance was quantified by western blotting, cellular glucose uptake from 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose (2-NBDG) uptake, and cellular glycogen content utilizing an enzymatic assay and subsequent colorimetry. As a result, a 48-hour treatment with LEFTY2 significantly increased SGLT1 and GYS1 transcript levels as well as SGLT1 and GYS1 protein abundance in both Ishikawa and HEC1a cells. 2-NBDG uptake and cellular glycogen content were upregulated significantly in Ishikawa (type 1) but not in type 2 endometrial HEC1a cells, although there was a tendency of increased 2-NBDG uptake. Further, none of the effects were seen in human benign endometrial cells (HESCs). Interestingly, in both Ishikawa and HEC1a cells, a co-treatment with TGF-beta reduced SGLT1, GYS and phospho-GYS protein levels, and thus reduced glycogen levels and again HEC1a cells had no significant change. In conclusion, LEFTY2 up-regulates expression and activity of the Na+ coupled glucose transporter SGLT1 and glycogen synthase GYS1 in a cell line specific manner. We further show the treatment with LEFTY2 fosters cellular glucose uptake and glycogen formation and TGF-beta can negate this effect in endometrial cancer cells.	[Zeng, Ni; Shi, Bing] Sichuan Univ, State Key Lab Oral Dis, Chengdu, Peoples R China; [Zeng, Ni; Shi, Bing] Sichuan Univ, Natl Clin Res Ctr Oral Dis, Chengdu, Peoples R China; [Zeng, Ni; Shi, Bing] Sichuan Univ, West China Hosp Stomatol, Chengdu, Peoples R China; [Zeng, Ni; Shi, Bing] Sichuan Univ, West China Hosp Stomatol, Dept Cleft Lip & Palate Surg, Chengdu, Peoples R China; [Zeng, Ni; Okumura, Toshiyuki; Alauddin, Md; Khozooei, Shayan; Rajaxavier, Janet; Zhang, Shaqiu; Brucker, Sara Y.; Wallwiener, Diethelm; Salker, Madhuri S.] Univ Tubingen, Womens Hlth Res Inst, Dept Obstet & Gynecol, Tubingen, Germany; [Okumura, Toshiyuki; Takeda, Satoru] Juntendo Univ, Dept Obstet & Gynecol, Sch Med, Tokyo, Japan; [Zhang, Shaqiu] Sichuan Agr Univ, Inst Prevent Vet Med, Chengdu, Peoples R China; [Singh, Yogesh] Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany; [Lang, Florian] Univ Tubingen, Dept Internal Med 3, Tubingen, Germany	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Juntendo University; Sichuan Agricultural University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Salker, MS (corresponding author), Univ Tubingen, Womens Hlth Res Inst, Dept Obstet & Gynecol, Tubingen, Germany.	madhuri.salker@med.uni-tuebingen.de	Singh, Yogesh/T-8230-2017	Singh, Yogesh/0000-0001-6919-6273; Salker, Madhuri Sonal/0000-0002-7939-289X	Zukunftskonzept award (Deutsche Forschungsgemeinschaft) [ZUK63]; Margarete von Wrangell Habilitationsprogramm fur Frauen (Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg) [31-7635.41/118/3]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of the University of Tubingen; IZKF [25100-0]	Zukunftskonzept award (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Margarete von Wrangell Habilitationsprogramm fur Frauen (Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of the University of Tubingen; IZKF	This work was supported by funding to M.S.S the Zukunftskonzept award (Deutsche Forschungsgemeinschaft; ZUK63), the IZKF (25100-0) and the Margarete von Wrangell Habilitationsprogramm fur Frauen (31-7635.41/118/3; Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg). We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of the University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelazeem KNM, 2017, CELL PHYSIOL BIOCHEM, V41, P2374, DOI 10.1159/000475655; Adijanto J, 2012, CURR TOP MEMBR, V70, P275, DOI 10.1016/B978-0-12-394316-3.00009-0; Barron CC, 2016, METABOLISM, V65, P124, DOI 10.1016/j.metabol.2015.10.007; Bauer DE, 2004, FASEB J, V18, P1303, DOI 10.1096/fj.03-1001fje; Blum M, 2014, DEV BIOL, V393, P109, DOI 10.1016/j.ydbio.2014.06.014; BOITEUX A, 1981, PHILOS T ROY SOC B, V293, P5, DOI 10.1098/rstb.1981.0056; Brosens JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03894; Casneuf VF, 2008, CANCER INVEST, V26, P852, DOI 10.1080/07357900801956363; Cavallari C, 2013, ONCOGENE, V32, P819, DOI 10.1038/onc.2012.114; Charni S, 2010, J IMMUNOL, V185, P3498, DOI 10.4049/jimmunol.1001250; Dean M, 2014, J REPROD DEVELOP, V60, P438, DOI 10.1262/jrd.2014-013; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Guo GF, 2011, MED ONCOL, V28, pS197, DOI 10.1007/s12032-010-9696-8; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kalyan A, 2017, MOL CANCER THER, V16, P787, DOI 10.1158/1535-7163.MCT-16-0215; Klil-Drori AJ, 2017, NAT REV CLIN ONCOL, V14, P85, DOI 10.1038/nrclinonc.2016.120; Koepsell H, 2017, PHARMACOL THERAPEUT, V170, P148, DOI 10.1016/j.pharmthera.2016.10.017; Kong SC, 2014, BIOCHEM CELL BIOL, V92, P449, DOI 10.1139/bcb-2014-0078; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Malchenko S, 2010, J CELL PHYSIOL, V225, P390, DOI 10.1002/jcp.22280; Mayor S, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3832; Miyata N, 2012, PANCREAS, V41, P745, DOI 10.1097/MPA.0b013e31823b66d3; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Nagaraj NS, 2010, EXPERT OPIN INV DRUG, V19, P77, DOI 10.1517/13543780903382609; Naidu DG, 2008, FRONT BIOSCI-LANDMRK, V13, P7193, DOI 10.2741/3221; Neugebauer JM, 2014, DEV BIOL, V386, P123, DOI 10.1016/j.ydbio.2013.11.020; Ong SG, 2012, PHARMACOL THERAPEUT, V136, P69, DOI 10.1016/j.pharmthera.2012.07.005; Papageorgiou I, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-122; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Ren JG, 2013, PROSTATE, V73, P1453, DOI 10.1002/pros.22692; Reshkin SJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0100; Rosa A, 2014, DEV BIOL, V391, P81, DOI 10.1016/j.ydbio.2014.03.020; Rose T, 2010, J BIOL CHEM, V285, P14898, DOI 10.1074/jbc.M110.104232; Saito A, 2013, FASEB J, V27, P2165, DOI 10.1096/fj.12-221432; Salker MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11674-3; Salker MS, 2015, BIOCHEM BIOPH RES CO, V460, P845, DOI 10.1016/j.bbrc.2015.03.120; Scafoglio C, 2015, P NATL ACAD SCI USA, V112, pE4111, DOI 10.1073/pnas.1511698112; Singh Y, 2016, J BIOL CHEM, V291, P23662, DOI 10.1074/jbc.M116.730259; Sun G, 2014, J NEUROL SCI, V347, P137, DOI 10.1016/j.jns.2014.09.034; Tabibzadeh S, 2011, ANN NY ACAD SCI, V1221, P98, DOI 10.1111/j.1749-6632.2010.05944.x; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Wilting J, 2011, CURR MED CHEM, V18, P5519, DOI 10.2174/092986711798347252; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Wright EM, 2017, PHYSIOLOGY, V32, P435, DOI 10.1152/physiol.00021.2017	51	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230044	10.1371/journal.pone.0230044	http://dx.doi.org/10.1371/journal.pone.0230044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236143	Green Published, gold			2022-12-26	WOS:000535938700016
J	Anastassopoulou, C; Russo, L; Tsakris, A; Siettos, C				Anastassopoulou, Cleo; Russo, Lucia; Tsakris, Athanasios; Siettos, Constantinos			Data-based analysis, modelling and forecasting of the COVID-19 outbreak	PLOS ONE			English	Article							CORONAVIRUS; PNEUMONIA	Since the first suspected case of coronavirus disease-2019 (COVID-19) on December 1st, 2019, in Wuhan, Hubei Province, China, a total of 40,235 confirmed cases and 909 deaths have been reported in China up to February 10, 2020, evoking fear locally and internationally. Here, based on the publicly available epidemiological data for Hubei, China from January 11 to February 10, 2020, we provide estimates of the main epidemiological parameters. In particular, we provide an estimation of the case fatality and case recovery ratios, along with their 90% confidence intervals as the outbreak evolves. On the basis of a SusceptibleInfectious-Recovered-Dead (SIDR) model, we provide estimations of the basic reproduction number (Ro), and the per day infection mortality and recovery rates. By calibrating the parameters of the SIRD model to the reported data, we also attempt to forecast the evolution of the outbreak at the epicenter three weeks ahead, i.e. until February 29. As the number of infected individuals, especially of those with asymptomatic or mild courses, is suspected to be much higher than the official numbers, which can be considered only as a subset of the actual numbers of infected and recovered cases in the total population, we have repeated the calculations under a second scenario that considers twenty times the number of confirmed infected cases and forty times the number of recovered, leaving the number of deaths unchanged. Based on the reported data, the expected value of Ro as computed considering the period from the 11th of January until the 18th of January, using the official counts of confirmed cases was found to be similar to 4.6, while the one computed under the second scenario was found to be similar to 3.2. Thus, based on the SIRD simulations, the estimated average value of Ro was found to be similar to 2.6 based on confirmed cases and similar to 2 based on the second scenario. Our forecasting flashes a note of caution for the presently unfolding outbreak in China. Based on the official counts for confirmed cases, the simulations suggest that the cumulative number of infected could reach 180,000 (with a lower bound of 45,000) by February 29. Regarding the number of deaths, simulations forecast that on the basis of the up to the 10th of February reported data, the death toll might exceed 2,700 (as a lower bound) by February 29. Our analysis further reveals a significant decline of the case fatality ratio from January 26 to which various factors may have contributed, such as the severe control measures taken in Hubei, China (e.g. quarantine and hospitalization of infected individuals), but mainly because of the fact that the actual cumulative numbers of infected and recovered cases in the population most likely are much higher than the reported ones. Thus, in a scenario where we have taken twenty times the confirmed number of infected and forty times the confirmed number of recovered cases, the case fatality ratio is around similar to 0.15% in the total population. Importantly, based on this scenario, simulations suggest a slow down of the outbreak in Hubei at the end of February.	[Anastassopoulou, Cleo; Tsakris, Athanasios] Univ Athens, Med Sch, Dept Microbiol, Athens, Greece; [Russo, Lucia] CNR, Sci & Technol Energy & Sustainable Mobil, Naples, Italy; [Siettos, Constantinos] Univ Napoli Federico II, Dipartimento Matemat & Applicaz Renato Caccioppol, Naples, Italy	National & Kapodistrian University of Athens; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II	Anastassopoulou, C (corresponding author), Univ Athens, Med Sch, Dept Microbiol, Athens, Greece.; Siettos, C (corresponding author), Univ Napoli Federico II, Dipartimento Matemat & Applicaz Renato Caccioppol, Naples, Italy.	cleoa@med.uoa.gr; constantinos.siettos@unina.it	Anastassopoulou, Cleo/AAO-8539-2020	Anastassopoulou, Cleo/0000-0001-7666-9198; Siettos, Constantinos/0000-0002-9568-3355				[Anonymous], 2018, MATLAB R2018B; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Gale J., 2020, XINHUA REPORTS; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Imai N, 2019, INT J INFECT DIS; Li Q., 2020, NANO RES, DOI DOI 10.1007/S12274-022-4292-8; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Patel A, 2020, MMWR-MORBID MORTAL W, V69, P140, DOI 10.15585/mmwr.mm6905e1; Siettos CI, 2013, VIRULENCE, V4, P295, DOI 10.4161/viru.24041; The Johns Hopkins Center for Health Security, 2020, COR COVID 19 GLOB CA; The Johns Hopkins Center for Health Security, 2020, DAIL UPD EM NOV COR; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; WHO, 2020, WHO STAT REG CLUST P; World Health Organization, 2021, NOV COR 2019 NCOV SI; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Wu P, 2020, EUROSURVEILLANCE, V25, P4, DOI 10.2807/1560-7917.ES.2020.25.3.2000044; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]	21	375	388	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230405	10.1371/journal.pone.0230405	http://dx.doi.org/10.1371/journal.pone.0230405			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HO	32231374	gold, Green Published, Green Submitted			2022-12-26	WOS:000535937400006
J	Petropoulos, F; Makridakis, S				Petropoulos, Fotios; Makridakis, Spyros			Forecasting the novel coronavirus COVID-19	PLOS ONE			English	Article								What will be the global impact of the novel coronavirus (COVID-19)? Answering this question requires accurate forecasting the spread of confirmed cases as well as analysis of the number of deaths and recoveries. Forecasting, however, requires ample historical data. At the same time, no prediction is certain as the future rarely repeats itself in the same way as the past. Moreover, forecasts are influenced by the reliability of the data, vested interests, and what variables are being predicted. Also, psychological factors play a significant role in how people perceive and react to the danger from the disease and the fear that it may affect them personally. This paper introduces an objective approach to predicting the continuation of the COVID-19 using a simple, but powerful method to do so. Assuming that the data used is reliable and that the future will continue to follow the past pattern of the disease, our forecasts suggest a continuing increase in the confirmed COVID-19 cases with sizable associated uncertainty. The risks are far from symmetric as underestimating its spread like a pandemic and not doing enough to contain it is much more severe than overspending and being over careful when it will not be needed. This paper describes the timeline of a live fore-casting exercise with massive potential implications for planning and decision making and provides objective forecasts for the confirmed cases of COVID-19.	[Petropoulos, Fotios] Univ Bath, Sch Management, Bath, Avon, England; [Makridakis, Spyros] Univ Nicosia, Inst Future IFF, Nicosia, Cyprus	University of Bath; University of Nicosia	Petropoulos, F (corresponding author), Univ Bath, Sch Management, Bath, Avon, England.	t.petropoulos@bath.ac.uk	Petropoulos, Fotios/AAB-2399-2021; Lin, Chen/AFV-2163-2022	Petropoulos, Fotios/0000-0003-3039-4955				[Anonymous], BBC NEWS; [Anonymous], BBC; [Anonymous], NY TIMES; Bariso J., B GATES E MUSK JUST; della Cava M., US TODAY; Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762; Hao K., MIT TECHNOLOGY REV; Haren P, HARVARD BUSINESS REV; Hyndman RJ, 2002, INT J FORECASTING, V18, P439, DOI 10.1016/S0169-2070(01)00110-8; Makridakis S, 2000, INT J FORECASTING, V16, P451, DOI 10.1016/S0169-2070(00)00057-1; MAKRIDAKIS S, 1982, J FORECASTING, V1, P111, DOI 10.1002/for.3980010202; Makridakis S., 2019, FORESIGHT INT J APPL, P28; Makridakis S, 2020, INT J FORECASTING, V36, P54, DOI 10.1016/j.ijforecast.2019.04.014; Medicine Net, FLU KILLS 646000 PEO; Nash C., HARVARD PROFESSOR SO; Norman J., 2020, SYSTEMIC RISK PANDEM; Petropoulos F, 2018, J OPER MANAG, V60, P34, DOI 10.1016/j.jom.2018.05.005; Salzberg Steven, 2020, FORBES; Sunstein CR, BLOOMBERG; Taylor JW, 2003, INT J FORECASTING, V19, P715, DOI 10.1016/S0169-2070(03)00003-7; Winck B, MARKETS INSIDER; Wu Z, 2020, J AM MED ASS; Yahoo Finance, BLACK SWAN AUTHOR E	23	251	255	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0231236	10.1371/journal.pone.0231236	http://dx.doi.org/10.1371/journal.pone.0231236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8HO	32231392	Green Published, gold			2022-12-26	WOS:000535937400024
J	Nunez, CR; Ortega, AF; Waisburd, GS; Cordero, AM; Jaramillo, EY; Cardenas, RH; Gomez, LGB				Nunez, Camilo Romero; Ortega, Ariadna Flores; Waisburd, Galia Sheinberg; Cordero, Alberto Martin; Jaramillo, Enrique Yarto; Cardenas, Rafael Heredia; Gomez, Linda G. Bautista			Evaluation of the effect of afoxalaner with milbemycin 1 oxime in the treatment of rabbits naturally infected with Psoroptes cuniculi	PLOS ONE			English	Article								Rabbits (Oryctolagus cuniculi) are very popular as pets. However, problems of otitits caused by Psoroptes cuniculi are one of the main reasons to visit the veterinarian. Isoxazolines are an alternative treatment to treat this mite, and therefore, an evaluation of the effectiveness of oral afoxalaner with milbemycin oxime in rabbits infected with P. cuniculi was carried out. Nineteen rabbits, of New Zealand breed, with otitis due to an infection with P. cuniculi, were treated, whereas six rabbits were left untreated and formed the control group. The ear canals of each individual were examined, through the collection of otic exudate samples with cotton swabs. These were visualized under the microscope to identify the ectoparasite. Each animal was treated with a single oral dose of 2.50 mg / kg of afoxolaner, and 0.50 mg / kg of milbemycin oxime. Clinical signs and lesions associated with the infection, such as the presence of detritus, cerumen and / or scabs, and erythema, were evaluated. After receiving the treatment, all the lesions were classified as: mild, moderate and intense, with a visual analog scale. A week after providing medication, there was a decrease in the lesions of the group treated with Nexgard Spectra (R), without further topical or systemic treatment. The decrease was gradual in the treated group and no recurrence was detected of P. cuniculi infection in both ears. Thus, the administration of a single oral dose of afoxolaner with milbemycin oxime was effective for the treatment of P. cuniculi infection in rabbits.	[Nunez, Camilo Romero; Ortega, Ariadna Flores; Cardenas, Rafael Heredia; Gomez, Linda G. Bautista] Univ Autonoma Estado Mexico, Ctr Univ UAEM Amecameca, Amecameca De Juarez, Estado De Mexic, Mexico; [Waisburd, Galia Sheinberg; Jaramillo, Enrique Yarto] Ctr Vet Mexico, Ciudad De Mexico, Mexico; [Cordero, Alberto Martin] Vet Dermatol Vet Especializada, Guadalajara, Jalisco, Mexico		Ortega, AF (corresponding author), Univ Autonoma Estado Mexico, Ctr Univ UAEM Amecameca, Amecameca De Juarez, Estado De Mexic, Mexico.	ariadnafloresortega@gmail.com		Bautista, Linda/0000-0002-3990-5937; Flores Ortega, Ariadna/0000-0002-1064-8906				Acar A, 2007, TURK J VET ANIM SCI, V31, P423; Bulliot C, 2013, J EXOT PET MED, V22, P400, DOI 10.1053/j.jepm.2013.10.003; Drag M, 2017, J VET PHARMACOL THER, V40, P447, DOI 10.1111/jvp.12375; Elhawary NM, 2017, POL J VET SCI, V20, P521, DOI 10.1515/pjvs-2017-0063; Errouissi F, 2010, MED VET ENTOMOL, V24, P433, DOI 10.1111/j.1365-2915.2010.00891.x; Fehr Michael, 2013, Veterinary Clinics of North America Exotic Animal Practice, V16, P611, DOI 10.1016/j.cvex.2013.05.011; Ferrand N, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P207, DOI 10.1007/1-4020-4904-8_7; Letendre L, 2017, J VET PHARMACOL THER, V40, P35, DOI 10.1111/jvp.12332; Mellgren M, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-1; Rogel-Gaillard Claire, 2009, V3, P165, DOI 10.1007/978-3-540-73835-0_7; Shapiro S., 1965, BIOMETRIKA, V52, P291; Sheinberg G, 2017, VET DERMATOL, V28, P393, DOI 10.1111/vde.12429; Shepherd AJ, 2008, JAVMA-J AM VET MED A, V232, P695, DOI 10.2460/javma.232.5.695; Sojka PA, 2018, J EXOT PET MED, V27, P118, DOI 10.1053/j.jepm.2018.02.038; Wen HQ, 2010, PARASITOL RES, V106, P607, DOI 10.1007/s00436-009-1704-6	15	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0230753	10.1371/journal.pone.0230753	http://dx.doi.org/10.1371/journal.pone.0230753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218595	gold, Green Published			2022-12-26	WOS:000535935400022
J	Delihas, N				Delihas, Nicholas			Formation of human long intergenic non-coding RNA genes, pseudogenes, and protein genes: Ancestral sequences are key players	PLOS ONE			English	Article							TRANSFERASE GENE; EXPRESSION; EVOLUTION; DATABASE; REPEATS; REFSEQ	Pathways leading to formation of non-coding RNA and protein genes are varied and complex. We report finding a conserved repeat sequence present in human and chimpanzee genomes that appears to have originated from a common primate ancestor. This sequence is repeatedly copied in human chromosome 22 (chr22) low copy repeats (LCR22) or segmental duplications and forms twenty-one different genes, which include the human long intergenic non-coding RNA (lincRNA) family FAM230, a newly discovered lincRNA gene family termed conserved long intergenic non-coding RNAs (clincRNA), pseudogene families, as well as the gamma-glutamyltransferase (GGT) protein gene family and the RNA pseudogenes that originate from GGT sequences. Of particular interest are the GGT5 and USP18 protein genes that appear to have formed from an homologous repeat sequence that also forms the clincRNA gene family. The data point to ancestral DNA sequences, conserved through evolution and duplicated in humans by chromosomal repeat sequences that may serve as functional genomic elements in the development of diverse genes.	[Delihas, Nicholas] SUNY Stony Brook, Dept Mol Genet & Microbiol, Renaissance Sch Med, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Delihas, N (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Renaissance Sch Med, Stony Brook, NY 11794 USA.	Nicholas.Delihas@stonybrook.edu		Delihas, Nicholas/0000-0002-1704-2587				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Babcock M, 2003, GENOME RES, V13, P2519, DOI 10.1101/gr.1549503; Babcock M, 2007, GENOME RES, V17, P451, DOI 10.1101/gr.5651507; Basters A, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180250; Braschi B, 2019, NUCLEIC ACIDS RES, V47, pD786, DOI 10.1093/nar/gky930; BULLE F, 1987, HUM GENET, V76, P283; Delihas Nicholas, 2018, Non-Coding RNA, V4, P16, DOI 10.3390/ncrna4030016; Delihas N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195702; Demaerel W., 2018, 22Q11 LOW COPY REPEA, DOI [10.1101/403873, DOI 10.1101/403873]; Dennis MY, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0069; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Emera D, 2016, P NATL ACAD SCI USA, V113, pE2617, DOI 10.1073/pnas.1603718113; Espinosa JM, 2017, TRENDS GENET, V33, P660, DOI 10.1016/j.tig.2017.07.005; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Farrell CM, 2014, NUCLEIC ACIDS RES, V42, pD865, DOI 10.1093/nar/gkt1059; Guo XY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-71; Heisterkamp N, 2008, HUM GENET, V123, P321, DOI 10.1007/s00439-008-0487-7; Hezroni H, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1293-0; Liu WH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4156-x; Liu ZL, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1701-8; Long MY, 2013, ANNU REV GENET, V47, P307, DOI 10.1146/annurev-genet-111212-133301; Marnetto D, 2018, AM J HUM GENET, V102, P207, DOI 10.1016/j.ajhg.2017.12.014; McDonald-McGinn DM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.71; Niazi F, 2012, RNA, V18, P825, DOI 10.1261/rna.029520.111; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Radwan Safaa, 2007, Pak J Biol Sci, V10, P294, DOI 10.3923/pjbs.2007.294.301; Redaelli S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051095; Ruffier M, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax020; Stelzer G., 2016, CURRENT PROTOCOLS BI, V54; Sweeney BA, 2019, NUCLEIC ACIDS RES, V47, pD221, DOI [10.1093/nar/gky1034, 10.1093/nar/gky1206]; Szabo L, 2015, GENOME BIOL, V16, DOI [10.1186/s13059-015-0690-5, 10.1186/s13059-016-1123-9]; Talyan S, 2018, NUCLEIC ACIDS RES, V46, P8720, DOI 10.1093/nar/gky608; Ulitsky I, 2016, NAT REV GENET, V17, P601, DOI 10.1038/nrg.2016.85; VISVIKIS A, 1991, P NATL ACAD SCI USA, V88, P7361, DOI 10.1073/pnas.88.16.7361; Xie C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002942; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230236	10.1371/journal.pone.0230236	http://dx.doi.org/10.1371/journal.pone.0230236			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214344	Green Published, Green Submitted, gold			2022-12-26	WOS:000535934200023
J	Hu, ZP; Yu, PF; Du, GY; Wang, WY; Zhu, HB; Li, N; Zhao, HJ; Dong, ZJ; Ye, L; Tian, JW				Hu, Zhengping; Yu, Pengfei; Du, Guangying; Wang, Wenyan; Zhu, Haibo; Li, Ning; Zhao, Huijuan; Dong, Zhaoju; Ye, Liang; Tian, Jingwei			PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, produces an antitumor effect in B16-F10 melanoma-bearing mice	PLOS ONE			English	Article							IN-VITRO; INDOLEAMINE 2,3-DIOXYGENASE; IMMUNOTHERAPY; BLOCKADE; REVERSES; CELLS	The increased PD-L1 expression induces poorer prognosis in melanoma. The small molecule inhibitors of PD-1/PD-L1 pathways have been an encouraging drug development strategy because of good affinity and oral bioavailability without immunogenicity and immunotoxicities of PD-1/PD-L1 antibodies. In this study, we studied the effects of PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, on PD-1/PD-L1 binding and the cytokines secretion in human CD3(+) cells in vitro. We also investigated the antitumor and immunomodulatory activity of PCC0208025 and the pharmacokinetics properties in B16-F10 melanoma-bearing mice. The results showed that PCC0208025 inhibited the PD-1/PD-L1 proteins binding, and rescued PD-L1-mediated inhibition of IFN-. production in human CD3(+) T cells in vitro. Furthermore, in B16-F10 melanoma-bearing mice, PCC0208025 presented the antitumor effects, enhanced IFN-gamma levels in plasma, increased the frequency of CD3(+)CD8(+) T and CD8(+)IFN-gamma(+) T and the ratios of CD8(+)/Treg, and deceased the CD4(+)CD25(+)CD127(low/-) (Treg) number in tumor. Pharmacokinetics study found that PCC0208025 was absorbed and distributed into the tumors with much higher concentrations than those of the blockade against PD-1/PD-L1 binding. Our work suggests that PCC0208025 exhibited anti-tumor effects through inhibiting Treg expansion and increasing cytotoxic activity of tumor-infiltrating CD8(+) T cells by the blockade of PD-/PD-L1 binding, which may provide the pharmacological basis to develop small molecule inhibitors of PD-1/PD-L1 binding for PCC0208025 as a lead compound.	[Hu, Zhengping] Binzhou Med Univ, Med & Pharm Res Ctr, Yantai, Shandong, Peoples R China; [Yu, Pengfei; Zhu, Haibo; Li, Ning; Zhao, Huijuan; Dong, Zhaoju; Ye, Liang] Binzhou Med Univ, Sch Publ Hlth & Management, Yantai, Shandong, Peoples R China; [Yu, Pengfei; Zhu, Haibo; Li, Ning; Zhao, Huijuan; Dong, Zhaoju; Ye, Liang] Binzhou Med Univ, Inst Toxicol, Yantai, Shandong, Peoples R China; [Du, Guangying; Wang, Wenyan; Tian, Jingwei] Yantai Univ, Sch Pharm, Key Lab Mol Pharmacol & Drug Evaluat, Minist Educ,Collaborat Innovat Ctr Adv Drug Deliv, Yantai, Peoples R China	Binzhou Medical University; Binzhou Medical University; Binzhou Medical University; Yantai University	Ye, L (corresponding author), Binzhou Med Univ, Sch Publ Hlth & Management, Yantai, Shandong, Peoples R China.; Ye, L (corresponding author), Binzhou Med Univ, Inst Toxicol, Yantai, Shandong, Peoples R China.; Tian, JW (corresponding author), Yantai Univ, Sch Pharm, Key Lab Mol Pharmacol & Drug Evaluat, Minist Educ,Collaborat Innovat Ctr Adv Drug Deliv, Yantai, Peoples R China.	project0088@hotmail.com; tianjeanswest@gmail.com	Tian, Jingwei/GPJ-9819-2022		National Natural Science Foundation of China [81473188]; Natural Science Foundation of Shandong Province, China [ZR2014HM091]; Natural Science Foundation of Shandong Province [ZR2016HP15]; Scientific Research Foundation of Binzhou Medical College, Shandong Province, China [BY2013KYQD21]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Scientific Research Foundation of Binzhou Medical College, Shandong Province, China	This work was supported by the National Natural Science Foundation of China (grant no. 81473188), the Natural Science Foundation of Shandong Province, China (No. ZR2014HM091), Natural Science Foundation of Shandong Province (No. ZR2016HP15), and the Scientific Research Foundation of Binzhou Medical College, Shandong Province, China (No. BY2013KYQD21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chupak LS, 2015, Patent No. [WO2015034820 A1, 2015034820, WO2015034820]; Crunkhorn S, 2017, NAT REV DRUG DISCOV, V16, P16, DOI [10.1038/nrd.2016.273, 10.1038/nrd.2017.258]; Hu ZP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18641-y; Islas-Vazquez L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/430943; Kim HM, 2007, INT IMMUNOPHARMACOL, V7, P1793, DOI 10.1016/j.intimp.2007.08.007; Lee L, 2016, J CLIN PHARMACOL, V56, DOI 10.1002/jcph.591; Li K, 2019, J DRUG TARGET, V27, P244, DOI 10.1080/1061186X.2018.1440400; Lv GY, 2017, ACTA PHARM SIN B, V7, P52, DOI 10.1016/j.apsb.2016.06.005; Ma YT, 2018, J NAT PROD, V81, P524, DOI 10.1021/acs.jnatprod.7b00857; Magiera-Mularz K, 2017, ANGEW CHEM INT EDIT, V56, P13732, DOI 10.1002/anie.201707707; Mahoney KM, 2015, CLIN THER, V37, P764, DOI 10.1016/j.clinthera.2015.02.018; Meng XJ, 2017, INT J IMMUNOPATH PH, V30, P215, DOI 10.1177/0394632017714696; Sasikumar PG, 2018, BIODRUGS, V32, P481, DOI 10.1007/s40259-018-0303-4; Scott LJ, 2015, DRUGS, V75, P1413, DOI 10.1007/s40265-015-0442-6; Skalniak L, 2017, ONCOTARGET, V8, P72167, DOI 10.18632/oncotarget.20050; Sun SY, 2018, INT J IMMUNOPATH PH, V32, DOI 10.1177/2058738418787991; Toor SM, 2018, CLIN EXP IMMUNOL, V191, P189, DOI 10.1111/cei.13060; Udhwani T, 2019, BIOINFORMATION, V15, P139, DOI 10.6026/97320630015139; Wang WS, 2009, INT IMMUNOL, V21, P1065, DOI 10.1093/intimm/dxp072; Weinmann H, 2016, CHEMMEDCHEM, V11, P450, DOI 10.1002/cmdc.201500566; Whiteside TL, 2018, EXPERT OPIN THER TAR, V22, P353, DOI 10.1080/14728222.2018.1451514; Yamada H, 2019, ANTI-CANCER DRUG, V30, P105, DOI 10.1097/CAD.0000000000000677; Yang YT, 2018, TOXICOL APPL PHARM, V341, P98, DOI 10.1016/j.taap.2018.01.015; Zak KM, 2016, ONCOTARGET, V7, P30323, DOI 10.18632/oncotarget.8730; Zarganes-Tzitzikas T, 2016, EXPERT OPIN THER PAT, V26, P973, DOI 10.1080/13543776.2016.1206527; Zhang D, 2018, INT J NANOMED, V13, P4549, DOI 10.2147/IJN.S170067; Zhu ZQ, 2016, CRIT REV ONCOL HEMAT, V99, P91, DOI 10.1016/j.critrevonc.2015.12.002	27	18	18	6	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0228339	10.1371/journal.pone.0228339	http://dx.doi.org/10.1371/journal.pone.0228339			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214351	Green Published, gold			2022-12-26	WOS:000535934200005
J	Scoville, EA; Tindle, HA; Wells, QS; Peyton, SC; Gurwara, S; Pointer, SO; Horst, SN; Schwartz, DA; Adams, DW; Freiberg, MS; Gatskie, V; King, S; Abney, LR; Beaulieu, DB				Scoville, Elizabeth A.; Tindle, Hilary A.; Wells, Quinn S.; Peyton, Shannon C.; Gurwara, Shelly; Pointer, Stephanie O.; Horst, Sara N.; Schwartz, David A.; Adams, Dawn W.; Freiberg, Matthew S.; Gatskie, Vanessa; King, Stephen; Abney, Lesa R.; Beaulieu, Dawn B.			Precision nicotine metabolism-informed care for smoking cessation in Crohn's disease: A pilot study	PLOS ONE			English	Article							QUALITY-OF-LIFE; SUSTAINED-RELEASE BUPROPION; RECEPTOR PARTIAL AGONIST; CIGARETTE-SMOKING; TRANSDERMAL NICOTINE; CLINICAL-COURSE; PLACEBO; RATIO; VARENICLINE; ASSOCIATION	Introduction Smoking is a strong risk factor for disease severity in Crohn's disease (CD) and cessation improves outcomes. The nicotine metabolite ratio (NMR) predicts cessation success with pharmacotherapy: varenicline doubles cessation over nicotine replacement therapy (NRT) for "normal", but not "slow" metabolizers. Varenicline side effects are heightened in slow metabolizers. Methods using NMR to optimize cessation pharmacotherapy have not been evaluated in CD. Aims We aim to determine the prevalence of smoking in a CD population and then assess these smokers' attitudes toward a personalized metabolism-informed care (MIC) approach to cessation. Methods In this observational study, we surveyed 1098 patients visiting an inflammatory bowel disease center about their smoking history. We then evaluated a subgroup of individuals with CD (n = 32) who participated in a randomized controlled trial of smoking cessation using MIC versus usual care. For MIC, medication selection was informed by the NMR (normal >= 0.31 vs. slow <0.31). The primary outcomes were intervention satisfaction and match rates between NMR and medication choice. Results The baseline prevalence of smoking in our CD population was 13%. Intervention participants reported high rates of satisfaction (85%) and chose a medication that matched their NMR result more often in the MIC group (100% vs. 64%, p = 0.01). Six of 16 (37.5%) patients prescribed varenicline discontinued due to side effects. Conclusion MIC produced high rates of satisfaction and matching between NMR and medication in CD patients, supporting patient acceptance and feasibility of precision smoking cessation in this population. To reduce smoking in CD, therapies such as MIC are needed to maximize efficacy and minimize side effects.	[Scoville, Elizabeth A.; Peyton, Shannon C.; Horst, Sara N.; Schwartz, David A.; Adams, Dawn W.; Beaulieu, Dawn B.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol, Nashville, TN 37235 USA; [Tindle, Hilary A.; King, Stephen; Abney, Lesa R.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Tindle, Hilary A.; Freiberg, Matthew S.] Vet Affairs Tennessee Valley Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Nashville, TN USA; [Wells, Quinn S.; Freiberg, Matthew S.] Vanderbilt Univ, Div Cardiol, Dept Med, Med Ctr, Nashville, TN 37232 USA; [Gurwara, Shelly] Wake Forest Sch Med, Div Gastroenterol, Winston Salem, NC 27101 USA; [Pointer, Stephanie O.] Ohio State Univ, Div Gastroenterol, Wexner Med Ctr, Columbus, OH 43210 USA; [Gatskie, Vanessa] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Wake Forest University; University System of Ohio; Ohio State University; Vanderbilt University	Scoville, EA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol, Nashville, TN 37235 USA.	elizabeth.a.scoville@vumc.org		Scoville, Elizabeth/0000-0001-5326-2221	Vanderbilt Center for Tobacco, Addiction, and Lifestyle (ViTAL), V3CREATE, The Vanderbilt Center for Clinical Cardiovascular Outcomes Research and Trial Evaluation; Vanderbilt Clinical and Translational Science Award (VICTR) grant [UL1TR000445]; National Institutes of Health training grant [2T32HD060554-06A1]; National Institutes of Health KL2 [5KL2TR002245]	Vanderbilt Center for Tobacco, Addiction, and Lifestyle (ViTAL), V3CREATE, The Vanderbilt Center for Clinical Cardiovascular Outcomes Research and Trial Evaluation; Vanderbilt Clinical and Translational Science Award (VICTR) grant; National Institutes of Health training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health KL2(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Vanderbilt Center for Tobacco, Addiction, and Lifestyle (ViTAL), V3CREATE, The Vanderbilt Center for Clinical Cardiovascular Outcomes Research and Trial Evaluation. Additional support was provided by a Vanderbilt Clinical and Translational Science Award (VICTR) grant to EAS (National Institutes of Health (NIH) grant number UL1TR000445). EAS was supported by National Institutes of Health training grant (grant number 2T32HD060554-06A1) and KL2 (grant number 5KL2TR002245). These funding sources had no role in the study design, collection, analysis or interpretation of data, writing the manuscript, or the decision to submit the paper for publication.	Anthenelli RM, 2016, LANCET, V387, P2507, DOI 10.1016/S0140-6736(16)30272-0; Breuer-Katschinski BD, 1996, EUR J GASTROEN HEPAT, V8, P1075, DOI [10.1097/00042737-199611000-00009, DOI 10.1097/00042737-199611000-00009]; Cosnes J, 1999, ALIMENT PHARM THERAP, V13, P1403; Cosnes J, 2001, GASTROENTEROLOGY, V120, P1093, DOI 10.1053/gast.2001.23231; COTTONE M, 1994, GASTROENTEROLOGY, V106, P643, DOI 10.1016/0016-5085(94)90697-1; Dempsey D, 2004, CLIN PHARMACOL THER, V76, P64, DOI 10.1016/j.clpt.2004.02.011; DUFFY LC, 1990, AM J PREV MED, V6, P161, DOI 10.1016/S0749-3797(18)31021-3; Fiore MC, 2008, RESP CARE, V53, P1217; Gambier N, 2005, PHARMACOGENOMICS J, V5, P271, DOI 10.1038/sj.tpj.6500314; Gionchetti P, 2017, J CROHNS COLITIS, V11, P135, DOI 10.1093/ecco-jcc/jjw169; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; HARVEY RF, 1980, LANCET, V1, P514; Ho MK, 2009, CLIN PHARMACOL THER, V85, P635, DOI 10.1038/clpt.2009.19; Hughes MA, 2014, MATER RES EXPRESS, V1, DOI 10.1088/2053-1591/1/2/026304; Irvine EJ, 1996, AM J GASTROENTEROL, V91, P1571; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Kennelly RP, 2013, J CROHNS COLITIS, V7, P631, DOI 10.1016/j.crohns.2012.08.019; Lerman C, 2015, LANCET RESP MED, V3, P131, DOI 10.1016/S2213-2600(14)70294-2; Leung Y, 2012, DIGEST DIS SCI, V57, P1026, DOI 10.1007/s10620-012-2038-2; Lichtenstein E, 2010, AM PSYCHOL, V65, P252, DOI 10.1037/a0018598; Lichtenstein GR, 2018, AM J GASTROENTEROL, V113, P481, DOI 10.1038/ajg.2018.27; LINDBERG E, 1992, GUT, V33, P779, DOI 10.1136/gut.33.6.779; Lunney PC, 2015, ALIMENT PHARM THER, V42, P61, DOI 10.1111/apt.13239; Mahid SS, 2006, MAYO CLIN P, V82, P890; McAfee TA, 2007, AM J PREV MED, V33, pS357, DOI 10.1016/j.amepre.2007.09.011; Nunes T, 2016, AM J GASTROENTEROL, V111, P411, DOI 10.1038/ajg.2015.401; Nunes T, 2013, J CROHNS COLITIS, V7, P202, DOI 10.1016/j.crohns.2012.04.011; Patterson F, 2008, CLIN PHARMACOL THER, V84, P320, DOI 10.1038/clpt.2008.57; Russel MG, 1996, EUR J GASTROEN HEPAT, V8, P1075, DOI 10.1097/00042737-199611000-00009; Schnoll RA, 2015, JAMA INTERN MED, V175, P504, DOI 10.1001/jamainternmed.2014.8313; Schnoll RA, 2013, NICOTINE TOB RES, V15, P348, DOI 10.1093/ntr/nts129; Schnoll RA, 2009, PHARMACOL BIOCHEM BE, V92, P6, DOI 10.1016/j.pbb.2008.10.016; Severs M, 2017, J CROHNS COLITIS, V11, P342, DOI 10.1093/ecco-jcc/jjw160; Shivashankar R, 2017, CLIN GASTROENTEROL H, V15, P857, DOI 10.1016/j.cgh.2016.10.039; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Strasser AA, 2011, CANCER EPIDEM BIOMAR, V20, P234, DOI 10.1158/1055-9965.EPI-10-0674; SUTHERLAND LR, 1990, GASTROENTEROLOGY, V98, P1123, DOI 10.1016/0016-5085(90)90324-T; To N, 2016, ALIMENT PHARM THER, V43, P549, DOI 10.1111/apt.13511; Ungar B, 2016, CLIN GASTROENTEROL H, V14, P550, DOI 10.1016/j.cgh.2015.10.025; Wells QS, 2018, NICOTINE TOB RES, V20, P1489, DOI 10.1093/ntr/ntx235; West O, 2011, PSYCHOPHARMACOLOGY, V218, P313, DOI 10.1007/s00213-011-2341-1	42	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230656	10.1371/journal.pone.0230656	http://dx.doi.org/10.1371/journal.pone.0230656			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214373	gold, Green Published			2022-12-26	WOS:000535934200036
J	Menec, VH; Newall, NE; Mackenzie, CS; Shooshtari, S; Nowicki, S				Menec, Verena H.; Newall, Nancy E.; Mackenzie, Corey S.; Shooshtari, Shahin; Nowicki, Scott			Examining social isolation and loneliness in combination in relation to social support and psychological distress using Canadian Longitudinal Study of Aging (CLSA) data	PLOS ONE			English	Article							OLDER-ADULTS; RISK-FACTORS; SCALE K10; HEALTH; MORTALITY; DEPRESSION; INTERVENTIONS; CONSEQUENCES; ASSOCIATION; METAANALYSIS	Background Although a large body of research has focused on social isolation and loneliness, few studies have examined social isolation and loneliness together. The objectives of this study were to examine: 1) the relationship between four groups derived from combining social isolation and loneliness (socially isolated and lonely; only socially isolated; only lonely; neither socially isolated nor lonely) and the desire for more social participation, and social support; and 2) the relationship between the four groups and psychological distress. Methods The study was based on the Comprehensive Cohort of the Canadian Longitudinal Study on Aging. Using CLSA baseline data (unweighted N = 30,079), ordinary and logistic regression analysis was used to examine the cross-sectional relationship between the four social isolation/loneliness groups and desire for more social participation and four types of social support (tangible, positive interaction, affection, and emotional support). Prospective logistic regression analysis was possible for psychological distress, which was derived from the Maintaining Contact Questionnaire administered about 18 months after the baseline questionnaire (unweighted N = 28,789). Results Findings indicate that being socially isolated and lonely was associated with the most social support gaps; this group also had an increased likelihood of psychological distress, relative to those who were neither socially isolated nor lonely. Participants who were only socially isolated, and those only lonely also perceived some social support gaps. In addition, the only lonely group was more likely to be psychologically distressed than the only socially isolated group and the neither isolated nor lonely group. Conclusion Examining the four social isolation/loneliness was useful, as it provided more nuanced risk profiles than would have been possible had we examined social isolation and loneliness separately. Findings may suggest avenues for interventions tailored to the unique needs of at-risk individuals.	[Menec, Verena H.; Shooshtari, Shahin; Nowicki, Scott] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Newall, Nancy E.] Brandon Univ, Dept Psychol, Brandon, MB, Canada; [Mackenzie, Corey S.] Univ Manitoba, Dept Psychol, Winnipeg, MB, Canada	University of Manitoba; Brandon University; University of Manitoba	Menec, VH (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada.	verena.menec@umanitoba.ca			Government of Canada through the Canadian Institutes of Health Research (CIHR) [LSA 9447]; Canada Foundation for Innovation; CIHR grant [373098]	Government of Canada through the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); CIHR grant(Canadian Institutes of Health Research (CIHR))	This research was made possible using the data/biospecimens collected by the Canadian Longitudinal Study on Aging (CLSA). Funding for the Canadian Longitudinal Study on Aging (CLSA) is provided by the Government of Canada through the Canadian Institutes of Health Research (CIHR) under grant reference: LSA 9447 and the Canada Foundation for Innovation. This research has been conducted using the CLSA Baseline Tracking Dataset 3.2, Baseline Comprehensive Dataset 3.1, under Application Number 170303. The CLSA is led by Drs. Parminder Raina, Christina Wolfson and Susan Kirkland. The analyses presented in this paper were funded by a CIHR grant (#373098) for V. Menec.	Anderson TM, 2013, AM J GERIAT PSYCHIAT, V21, P596, DOI 10.1016/j.jagp.2013.01.009; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; Antonucci TC, 2014, GERONTOLOGIST, V54, P82, DOI 10.1093/geront/gnt118; Barlow MA, 2015, HEALTH PSYCHOL, V34, P870, DOI 10.1037/hea0000182; Beller J, 2018, HEALTH PSYCHOL, V37, P808, DOI 10.1037/hea0000605; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI DOI 10.4135/9781412952576.N192]; Boss L, 2015, INT PSYCHOGERIATR, V27, P541, DOI 10.1017/S1041610214002749; Brown EG, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13031; Cacioppo JT, 2015, PERSPECT PSYCHOL SCI, V10, P202, DOI 10.1177/1745691614564876; Cacioppo JT, 2011, ANN NY ACAD SCI, V1231, P17, DOI 10.1111/j.1749-6632.2011.06028.x; Canadian Longitudinal Study on Aging, 2017, SAMPLING COMPUTATION; Cohen-Mansfield J, 2016, INT PSYCHOGERIATR, V28, P557, DOI 10.1017/S1041610215001532; Cohen-Mansfield J, 2015, AM J HEALTH PROMOT, V29, pE109, DOI 10.4278/ajhp.130418-LIT-182; Cornwell EY, 2009, J HEALTH SOC BEHAV, V50, P31, DOI 10.1177/002214650905000103; Courtin E, 2017, HEALTH SOC CARE COMM, V25, P799, DOI 10.1111/hsc.12311; Coyle CE, 2012, J AGING HEALTH, V24, P1346, DOI 10.1177/0898264312460275; de Jong Gierveld J., 1998, REV CLIN GERONTOLOGY, V8, P73, DOI DOI 10.1017/S0959259898008090; Drapeau A., 2014, BMC PSYCHOL, V2, P1, DOI [10.1186/s40359-014-0025-4, DOI 10.1186/S40359-014-0025-4]; Dykstra PA, 2009, EUR J AGEING, V6, P91, DOI 10.1007/s10433-009-0110-3; Eagle DE, 2019, J SOC PERS RELAT, V36, P2055, DOI 10.1177/0265407518776134; Enticott JC, 2018, AUST NZ J PSYCHIAT, V52, P227, DOI 10.1177/0004867417708612; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Gierveld JD, 2006, CAMBRIDGE HANDBOOK OF PERSONAL RELATIONSHIPS, P485, DOI 10.1017/CBO9780511606632.027; Harasemiw O, 2019, AGING MENT HEALTH, V23, P1413, DOI 10.1080/13607863.2018.1495176; Harasemiw O, 2018, RES AGING, V40, P715, DOI 10.1177/0164027517734587; Hawkley LC, 2003, BRAIN BEHAV IMMUN, V17, pS98; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Holwerda TJ, 2012, PSYCHOL MED, V42, P843, DOI 10.1017/S0033291711001772; Holwerda TJ, 2014, J NEUROL NEUROSUR PS, V85, P135, DOI 10.1136/jnnp-2012-302755; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Ibrahim R, 2013, PSYCHOGERIATRICS, V13, P71, DOI 10.1111/psyg.12000; IISD, 2018, SEYCH LAUNCH 1 BLUE; Santini ZI, 2015, J AFFECT DISORDERS, V175, P53, DOI 10.1016/j.jad.2014.12.049; Jang YR, 2016, J AGING HEALTH, V28, P3, DOI 10.1177/0898264315584578; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kiecolt-Glaser JK, 2017, ANNU REV CLIN PSYCHO, V13, P421, DOI 10.1146/annurev-clinpsy-032816-045111; Kirkland SA, 2015, CAN J AGING, V34, P366, DOI 10.1017/S071498081500029X; Kobayashi KM, 2009, J AGING HEALTH, V21, P374, DOI 10.1177/0898264308329022; Kobayashi LC, 2018, ANN BEHAV MED, V52, P582, DOI 10.1093/abm/kax033; Lee Y, 2018, J SOC PERS RELAT, V35, P1340, DOI 10.1177/0265407517712902; Leigh-Hunt N, 2017, PUBLIC HEALTH, V152, P157, DOI 10.1016/j.puhe.2017.07.035; Liu LJ, 2016, J HEALTH PSYCHOL, V21, P750, DOI 10.1177/1359105314536941; Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503; Luo Y, 2012, SOC SCI MED, V74, P907, DOI 10.1016/j.socscimed.2011.11.028; Masi CM, 2011, PERS SOC PSYCHOL REV, V15, P219, DOI 10.1177/1088868310377394; Menec VH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211143; Newall NEG, 2020, AGEING SOC, V40, P2671, DOI 10.1017/S0144686X19000801; Newall NEG, 2019, J SOC PERS RELAT, V36, P925, DOI 10.1177/0265407517749045; Newall NEG, 2015, J APPL GERONTOL, V34, P958, DOI 10.1177/0733464813510063; Newall NEG, 2013, HEALTH PSYCHOL, V32, P921, DOI 10.1037/a0029413; Peerenboom L, 2015, J AFFECT DISORDERS, V182, P26, DOI 10.1016/j.jad.2015.04.033; Peplau L.A., 1982, LONELINESS SOURCEBOO, DOI DOI 10.2307/2068915; Pinquart M, 2001, BASIC APPL SOC PSYCH, V23, P245, DOI 10.1207/S15324834BASP2304_2; Poscia A, 2018, EXP GERONTOL, V102, P133, DOI 10.1016/j.exger.2017.11.017; Power JEM, 2019, PSYCHOL AGING, V34, P152, DOI 10.1037/pag0000287; Rafnsson SB, 2020, J GERONTOL B-PSYCHOL, V75, P114, DOI 10.1093/geronb/gbx087; Raina P, 2019, INT J EPIDEMIOL, P1, DOI [10.1093/ije/dyy184, DOI 10.1093/IJE/DYY184]; Raina PS, 2009, CAN J AGING, V28, P221, DOI 10.1017/S0714980809990055; Shankar A, 2011, HEALTH PSYCHOL, V30, P377, DOI 10.1037/a0022826; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Smith KJ, 2019, AGEING SOC, V39, P1709, DOI 10.1017/S0144686X18000132; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Tanskanen J, 2016, AM J PUBLIC HEALTH, V106, P2042, DOI 10.2105/AJPH.2016.303431; Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592; Turon H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210111; Uchino BN, 2009, PERSPECT PSYCHOL SCI, V4, P236, DOI 10.1111/j.1745-6924.2009.01122.x; Valtorta NK, 2016, HEART, V102, P1009, DOI 10.1136/heartjnl-2015-308790; Valtorta NK, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010799; Vasiliadis HM, 2015, PSYCHIAT RES, V228, P89, DOI 10.1016/j.psychres.2015.04.019; Victor, 2009, SOCIAL WORLD OLDER P; Wenger GC, 2004, CAN J AGING, V23, P115, DOI 10.1353/cja.2004.0028	76	50	50	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230673	10.1371/journal.pone.0230673	http://dx.doi.org/10.1371/journal.pone.0230673			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9GC	32203553	Green Published, gold			2022-12-26	WOS:000535303900034
J	Hailu, HE; Mondul, AM; Rozek, LS; Geleta, T				Hailu, Haimanot E.; Mondul, Alison M.; Rozek, Laura S.; Geleta, Temesgen			Descriptive Epidemiology of breast and gynecological cancers among patients attending Saint Paul's Hospital Millennium Medical College, Ethiopia	PLOS ONE			English	Article							CERVICAL-CANCER; BURDEN	Introduction Cancer is a leading cause of death in both more and less economically developed countries; the burden is expected to grow in less developed countries, such as Ethiopia. Lack of adequate information is one of the major problems preventing the design of cancer control strategies in Ethiopia. Objective To characterize gynecological and breast cancers among clients attending Gynecologic clinic of Saint Paul Hospital Millennium Medical college over 5 year period. Methods We retrospectively reviewed characteristics of 2,002 female cancer patients who visited the Oncology unit of Saint Paul's Hospital Millennium Medical College from 2014-2018. We estimated the proportion, pattern and trend of common types of gynecologic cancers as well as breast cancer. The ten years incidence projection was also computed. Result From the 2,002 malignancies, cervical (46.7%) was the most frequent cancer followed by breast (29.3%) and ovarian cancers (13%). The majority of breast cancers were observed among younger patients whereas cervical cancer was predominantly observed among older women. An overall increment in number of breast and gynecologic cancer was observed over the five years period. Conclusion In this descriptive study, we found that breast and gynecologic cancers are important public health problems among women in Addis Ababa, and that the number of patients seeking care for these cancers is increasing. Additional studies are needed to identify risk factors for these cancers, particularly among younger women, to characterize the trends over time and to project the scope of the cancer problem expected in the future to inform cancer control programs. Increasing public awareness on the possible risk factors and screening is mandatory in addition to resource allocation for further studies and targeted intervention.	[Hailu, Haimanot E.; Geleta, Temesgen] St Pauls Hosp Millennium Med Coll, Dept Publ Hlth, Aa, Ethiopia; [Mondul, Alison M.; Rozek, Laura S.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hailu, HE (corresponding author), St Pauls Hosp Millennium Med Coll, Dept Publ Hlth, Aa, Ethiopia.	metiewnetu@gmail.com		Hailu, Haimanot/0000-0001-9608-0364	Saint Paul's Hospital Millennium Medical College	Saint Paul's Hospital Millennium Medical College	This study is funded by Saint Paul's Hospital Millennium Medical College.	Abate S.M., 2016, CERV CANC, V1; American Cancer Society, 2011, CANC AFR; AMIR H, 1994, E AFR MED J, V71, P215; Australian Institute of Health and Welfare Australasian Association of Cancer Registries, 2012, CANC SER, V2012; Baquet CR, 2008, J NATL MED ASSOC, V100, P480, DOI 10.1016/S0027-9684(15)31294-3; Brinton LA, 2014, BREAST CANCER RES TR, V144, P467, DOI 10.1007/s10549-014-2868-z; Cancer research UK, 2011, OV CANC STAT; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Earl H., 1995, MED INT, V32; Fatiregun OA, 2015, J DENT MED SCI, V14; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Gaudette L, 1996, HLTH REP, V8; Hadgu E, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0531-2; HASSAN I, 1995, E AFR MED J, V72, P280; Howlader N, 2013, SEER CANC STAT REV 1; International Agency for Research on Cancer, 2003, CHIN CIT BLU BOOK, P153; Joseph A, 2015, J BASIC CLIN REPROD, V4; Kurman RJ, 2016, AM J PATHOL, V186, P733, DOI 10.1016/j.ajpath.2015.11.011; Ly M, 2011, B CANCER, V98, P797, DOI 10.1684/bdc.2011.1392; Memirie ST, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00175; Mohyuddin S, 2012, PJMHS, V6; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Parkin DM, 1997, IARC SCI PUBL, VVII, P143; Rahman M, 2014, MED TODAY, V26, P78; Robbins HA, 2015, J NATL CANC I, V107; Sankaranarayanan R, 2006, BEST PRACT RES CL OB, V20, P207, DOI 10.1016/j.bpobgyn.2005.10.007; Tigeneh W, 2015, INT J CANC RES MOL M, V1; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vizcaino AP, 1998, INT J CANCER, V75, P536, DOI 10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U; WHO, 2010, HUM PAP REL CANC ETH; World Health Organization, 2008, WORLD CANC REPORT 20	32	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0230625	10.1371/journal.pone.0230625	http://dx.doi.org/10.1371/journal.pone.0230625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196536	Green Published, gold			2022-12-26	WOS:000535303100042
J	Abbasi, S; Safaie, N; Sadeghi, A; Shamsbakhsh, M				Abbasi, Sakineh; Safaie, Naser; Sadeghi, Akram; Shamsbakhsh, Masoud			Tissue-specific synergistic bio-priming of pepper by two Streptomyces species against Phytophthora capsici	PLOS ONE			English	Article							DEFENSE-RELATED GENES; TRICHODERMA-HARZIANUM; SYSTEMIC RESISTANCE; GROWTH PROMOTION; PLANT-GROWTH; DAMPING-OFF; ROOT-ROT; SUPPRESSION; BIOCONTROL; INDUCTION	Among several studied strains, Streptomyces rochei IT20 and S. vinaceusdrappus SS14 showed a high level of inhibitory effect against Phytophthora capsici, the causal agent of pepper blight. The effect of two mentioned superior antagonists, as single or combination treatments, on suppression of stem and fruit blight diseases and reproductive growth promotion was investigated in pepper. To explore the induced plant defense reactions, ROS generation and transcriptional changes of selected genes in leaf and fruit tissues of the plant were evaluated. The plants exposed to the combination of two species responded differently in terms of H2O2 accumulation and expression ratio of GST gene compared to single treatments upon pathogen inoculation. Besides, the increment of shoot length, flowering, and fruit weight were observed in healthy plants compared to control. Likely, these changes depended on the coordinated relationships between PR1, ACCO genes and transcription factors WRKY40 enhanced after pathogen challenge. Our findings indicate that appropriate tissue of the host plant is required for inducing Streptomyces-based priming and relied on the up-regulation of SUS and differential regulation of ethylene-dependent genes.	[Abbasi, Sakineh; Safaie, Naser; Shamsbakhsh, Masoud] Tarbiat Modares Univ, Fac Agr, Dept Plant Pathol, Tehran, Iran; [Sadeghi, Akram] Agr Res Educ & Extens Org AREEO, Agr Biotechnol Res Inst Iran ABRII, Dept Microbial Biotechnol, Karaj, Iran	Tarbiat Modares University	Safaie, N (corresponding author), Tarbiat Modares Univ, Fac Agr, Dept Plant Pathol, Tehran, Iran.; Sadeghi, A (corresponding author), Agr Res Educ & Extens Org AREEO, Agr Biotechnol Res Inst Iran ABRII, Dept Microbial Biotechnol, Karaj, Iran.	nsafaie@modares.ac.ir; aksadeghi@abrii.ac.ir	Safaie, Naser/E-1269-2018	Safaie, Naser/0000-0001-6065-7010; sadeghi, akram/0000-0001-9181-4787; Abbasi, Sakineh/0000-0003-0331-0058; Shams-bakhsh, Masoud/0000-0002-4336-7705	Agricultural Biotechnology Research Institute of Iran (ABRII) [12-05-05-034-09454-950941]	Agricultural Biotechnology Research Institute of Iran (ABRII)	AS received fund. The grant numbers: 12-05-05-034-09454-950941 Agricultural Biotechnology Research Institute of Iran (ABRII) http://www.abrii.ac.ir/en/The funder played NO role in study design, data collection and analysis decision to publish or preparation of the manuscript.	Abbasi S, 2016, IRAN J BIOTECHNOL, V14, P260, DOI 10.15171/ijb.1224; Abbasi S, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01505; Bending GD, 2007, NEW PHYTOL, V174, P707, DOI 10.1111/j.1469-8137.2007.02076.x; Bolouri Moghaddam MR, 2012, J EXP BOT, V63, P3989, DOI 10.1093/jxb/ers129; Cai HY, 2015, J EXP BOT, V66, P3163, DOI 10.1093/jxb/erv125; Chen X, 2019, GENES-BASEL, V10, DOI 10.3390/genes10050360; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Das K, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00053; De Vrieze M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02573; Dilley DR, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt031; Esmaeel Q, 2019, WORLD J MICROB BIOT, V35, DOI 10.1007/s11274-019-2613-1; Ezziyyani M, 2007, J PHYTOPATHOL, V155, P342, DOI 10.1111/j.1439-0434.2007.01237.x; Foster JM, 2010, PLANT DIS, V94, P24, DOI 10.1094/PDIS-94-1-0024; Glosier BR, 2008, EUPHYTICA, V162, P23, DOI 10.1007/s10681-007-9532-1; Gomez-Ariza J, 2007, MOL PLANT MICROBE IN, V20, P832, DOI 10.1094/MPMI-20-7-0832; Goudjal Y, 2014, MICROBIOL RES, V169, P59, DOI 10.1016/j.micres.2013.06.014; Gregor AK, 2003, CAN J MICROBIOL, V49, P483, DOI 10.1139/W03-061; Grosch R, 2012, PLANT SOIL, V361, P343, DOI 10.1007/s11104-012-1239-y; Guan R, 2015, PLANT PHYSIOL, V169, P299, DOI 10.1104/pp.15.00659; Gullner G, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01836; Hausbeck MK, 2004, PLANT DIS, V88, P1292, DOI 10.1094/PDIS.2004.88.12.1292; Hussain A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051426; Jakab G, 2001, EUR J PLANT PATHOL, V107, P29, DOI 10.1023/A:1008730721037; Jambhulkar PP, 2018, EUR J PLANT PATHOL, V152, P747, DOI 10.1007/s10658-018-1519-3; Jin JH, 2016, FRONT PLANT SCI, V6, DOI [10.3389/fpls.2015.01217, 10.3382/fpis.2015.01217]; Kim KD, 1997, APPL SOIL ECOL, V5, P169, DOI 10.1016/S0929-1393(96)00138-2; Koramutla MK, 2019, GENE, V707, P126, DOI 10.1016/j.gene.2019.04.059; Korir H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00141; Kunova A, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0886-1; Lee SC, 2005, PLANTA, V221, P790, DOI 10.1007/s00425-005-1488-6; Lehr NA, 2007, NEW PHYTOL, V174, P892, DOI 10.1111/j.1469-8137.2007.02021.x; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.010497; Lyons R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127699; Malinovsky FG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00178; Mohsin Tariq, 2012, African Journal of Biotechnology, V11, P15012; Nguyen XH, 2015, J BASIC MICROB, V55, P45, DOI 10.1002/jobm.201300820; Ngwene B, 2016, PLANT SOIL, V405, P231, DOI 10.1007/s11104-015-2779-8; Oelke LM, 2003, J AM SOC HORTIC SCI, V128, P213, DOI 10.21273/JASHS.128.2.0213; Ogawara T, 2003, J PLANT PHYSIOL, V160, P1335, DOI 10.1078/0176-1617-01129; Palaniyandi SA, 2013, APPL MICROBIOL BIOT, V97, P9621, DOI 10.1007/s00253-013-5206-1; Parada-Rojas CH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23438-8; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pieterse CMJ, 2014, ANNU REV PHYTOPATHOL, V52, P347, DOI 10.1146/annurev-phyto-082712-102340; REIFSCHNEIDER FJB, 1992, EUPHYTICA, V62, P45, DOI 10.1007/BF00036086; Roylawar P, 2015, PHYSIOL MOL PLANT P, V91, P88, DOI 10.1016/j.pmpp.2015.06.004; Sadeghi A, 2017, BIOCONTROL, V62, P805, DOI 10.1007/s10526-017-9838-4; Salehi M, 2019, PLANT CELL TISS ORG, V137, P587, DOI 10.1007/s11240-019-01593-8; Salehi M, 2019, PLANT CELL TISS ORG, V136, P161, DOI 10.1007/s11240-018-1503-9; Salehi M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29762-3; Sang MK, 2018, ANN APPL BIOL, V172, P208, DOI 10.1111/aab.12413; Sang MK, 2010, PHYTOPATHOLOGY, V100, P774, DOI 10.1094/PHYTO-100-8-0774; Santiago CD, 2017, MICROBES ENVIRON, V32, P14, DOI [10.1264/jsme2.ME16127, 10.1264/jsme2.me16127]; Soe KM, 2013, SOIL SCI PLANT NUTR, V59, P361, DOI 10.1080/00380768.2013.794437; Thampi A, 2017, BIOL CONTROL, V109, P1, DOI 10.1016/j.biocontrol.2017.03.006; Velivelli SLS, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.4161/15592324.2014.988076; Walters DR, 2007, ANN APPL BIOL, V151, P307, DOI 10.1111/j.1744-7348.2007.00176.x; Walters DR, 2013, J EXP BOT, V64, P1263, DOI 10.1093/jxb/ert026; Wilson DC, 2013, PLANT MOL BIOL, V83, P235, DOI 10.1007/s11103-013-0083-7; Wingler A, 2018, PLANT PHYSIOL, V176, P1075, DOI 10.1104/pp.17.01229	59	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230531	10.1371/journal.pone.0230531	http://dx.doi.org/10.1371/journal.pone.0230531			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191748	Green Published, gold			2022-12-26	WOS:000535302300056
J	Tulsawani, R; Sharma, P; Sethy, NK; Kumari, P; Ganju, L; Prakash, S; Chouhan, S				Tulsawani, Rajkumar; Sharma, Purva; Sethy, Niroj Kumar; Kumari, Pooja; Ganju, Lilly; Prakash, Satya; Chouhan, Satish			Acute exposure of 532 nm laser differentially regulates skin tissue transcription factors	PLOS ONE			English	Article							CELL-DEATH; SIGNALING PATHWAY; TGF-BETA; WNT; EXPRESSION; P53; THRESHOLDS; ACTIVATION; RADIATION; DAMAGE	High energy laser, particularly 532 nm, is widely used in defense and medical applications and there is need to address its occupational safety. Thermal and non-thermal effects of 532 nm high energy laser on skin are cause of concern. This study indicates impact of 532 nm laser on rat skin and first of its kind of attempt to understand transcriptional activation of genes as an early response following laser exposure. Skin of experimental rats were exposed to 532 nm radiance at 0.1, 0.25 and 0.50 W/cm(2) for 10 sec. Thermographic changes of skin exposed to 532 nm laser exhibited increased Tmax temperature in radiance dependent manner. After thermal imaging, skin of experimental rats was collected 1 h post laser exposure for studying differential gene expression. The skin exposed to lower power density (0.1 W/cm(2)) did not show significant changes in expression of gene pathways studied. At moderate radiance (0.25 W/cm(2)), predominantly canonical wnt/B-catenin pathway genes notch1, axin2, ccdn1, wnt5a and redox homeostasis genes; txn1, nqo1 and txnrd1 were expressed. At higher radiance (0.5 W/cm(2)), significant repression of genes related to wound healing process particularly notch/wnt pathway viz. hes5, wnt1, wn3b with higher expression of dab2 was recorded. The data obtained from these studies would help in drawing safety limits for skin exposure to 532 nm laser. Further, genes expressed at moderate and high level of radiance exposure to skin were distinct and differential and provide new avenue to configure pathway to counteract laser induced delay in tissue injury and hair follicular damage.	[Tulsawani, Rajkumar; Sharma, Purva; Sethy, Niroj Kumar; Kumari, Pooja; Ganju, Lilly; Chouhan, Satish] Def Inst Physiol & Allied Sci, Delhi, India; [Prakash, Satya] Laser Sci & Technol Ctr, Metcalfe House, Delhi, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS); Defence Research & Development Organisation (DRDO); Laser Science & Technology Centre (LASTEC)	Tulsawani, R (corresponding author), Def Inst Physiol & Allied Sci, Delhi, India.	rktulsawani@yahoo.com	Tulsawani, Rajkumar/AAF-2017-2019	Sethy, Niroj/0000-0003-0675-1481	Defence Research and Development Organisation, MiInistry of Defence, India	Defence Research and Development Organisation, MiInistry of Defence, India	The study was funded by Defence Research and Development Organisation, MiInistry of Defence, India	Abe Y, 2017, J DEV BIOL, V5, DOI 10.3390/jdb5040012; Adamic Metka, 2007, J Cosmet Laser Ther, V9, P113, DOI 10.1080/14764170701280693; Ambler CA, 2007, DEV DYNAM, V236, P1595, DOI 10.1002/dvdy.21151; Arany PR, 2016, J DENT RES, V95, P977, DOI 10.1177/0022034516648939; Arany PR, 2007, WOUND REPAIR REGEN, V15, P866, DOI 10.1111/j.1524-475X.2007.00306.x; Arany PR, 2009, PROC SPIE, V7165, DOI 10.1117/12.809839; Archbold HC, 2012, ACTA PHYSIOL, V204, P74, DOI 10.1111/j.1748-1716.2011.02293.x; Baek S, 2017, LASER MED SCI, V32, P2121, DOI 10.1007/s10103-017-2338-z; Beljan JR, 1986, LASER SURG MED, V256, P900, DOI [10.1001/jama.256.7.900, DOI 10.1001/JAMA.256.7.900]; Bellavia G, 2014, J DERMATOL SCI, V73, P3, DOI 10.1016/j.jdermsci.2013.08.007; Bielefeld KA, 2013, CELL MOL LIFE SCI, V70, P2059, DOI 10.1007/s00018-012-1152-9; Bin Cho S, 2010, J COSMET LASER THER, V12, P77, DOI 10.3109/14764171003706174; Bukowska J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071956; Cain CP, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2338815; Cain CP, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2187987; CHAN MC, 1987, INT J CLIN PHARM TH, V25, P527; Chen B, 2005, LASER SURG MED, V37, P373, DOI 10.1002/lsm.20243; Chen B, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2402114; Chen B, 2007, HEALTH PHYS, V93, P273, DOI 10.1097/01.HP.0000264936.67385.04; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DeLisi MP, 2018, PROC SPIE, V10492, DOI 10.1117/12.2290093; Donati G, 2014, P NATL ACAD SCI USA, V111, pE1501, DOI 10.1073/pnas.1312880111; Eggleston TA, 2000, COMPARATIVE MED, V50, P391; Elsaie Mohamed Lotfy, 2008, Indian J Dermatol, V53, P49, DOI 10.4103/0019-5154.41643; ENOCH T, 1995, TRENDS BIOCHEM SCI, V20, P426, DOI 10.1016/S0968-0004(00)89093-3; Fang L, 2017, ONCOTARGET, V8, P30092, DOI 10.18632/oncotarget.15617; Fu BS, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4698167; Gold MH, 2019, J COSMET LASER THER, V21, P147, DOI 10.1080/14764172.2018.1481514; Gu Qingyang, 1999, Journal of Environmental Pathology Toxicology and Oncology, V18, P319; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Houschyar KS, 2015, ORGANOGENESIS, V11, P95, DOI 10.1080/15476278.2015.1086052; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang Y, 2008, ONCOGENE, V27, P1865, DOI 10.1038/sj.onc.1210829; Juzych MS, 2004, OPHTHALMOLOGY, V111, P1853, DOI 10.1016/j.ophtha.2004.04.030; Karagiannis DA, 2009, CLIN INTERV AGING, V4, P315; KASTAN MB, 1991, CANCER RES, V51, P6304; Knappe V, 2004, PHOTOMED LASER SURG, V22, P411, DOI 10.1089/pho.2004.22.411; Komiya Yuko, 2008, Organogenesis, V4, P68; Lee B, 2014, DEV CELL, V29, P47, DOI 10.1016/j.devcel.2014.03.005; Lee HC, 2000, J BIOMED SCI, V7, P2, DOI 10.1007/BF02255913; Li SD, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-20; Lichtenberger BM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10537; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maini AK, 2003, IETE TECH REV, V20, P175, DOI 10.1080/02564602.2003.11417082; Moali C, 2009, EUR J DERMATOL, V19, P552, DOI 10.1684/ejd.2009.0770; Morgan SE, 1997, ADV CANCER RES, V71, P1, DOI 10.1016/S0065-230X(08)60095-0; Mori R, 2014, AM J PATHOL, V184, P2465, DOI 10.1016/j.ajpath.2014.05.012; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Oliver JW, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.125002; Oliver JW, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3523622; Osterberg EC, 2013, UROLOGY, V82, P680, DOI 10.1016/j.urology.2013.04.071; Perper M, 2017, GIORN ITAL DERMAT V, V152, P360, DOI 10.23736/S0392-0488.17.05641-3; Purschke M, 2010, J INVEST DERMATOL, V130, P86, DOI 10.1038/jid.2009.205; Rico PJ, 2000, COMPARATIVE MED, V50, P633; Schacht SAL, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.12.121614; Schafer M, 2007, ANNU REV CELL DEV BI, V23, P69, DOI 10.1146/annurev.cellbio.23.090506.123609; Schambony A, 2004, DIFFERENTIATION, V72, P307, DOI 10.1111/j.1432-0436.2004.07207002.x; Shakir EA, 2018, LASER MED SCI, V33, P1717, DOI 10.1007/s10103-018-2527-4; Shi Y, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0103-4; Siebert N, 2011, LAB INVEST, V91, P1753, DOI 10.1038/labinvest.2011.125; Sliney DH, 1993, MED LASERS THEIR SAF, P72, DOI [10.1007/978-1-4613-9252-1_5, DOI 10.1007/978-1-4613-9252-1_5]; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2015, STEROIDS, V103, P72, DOI 10.1016/j.steroids.2015.04.006; Tang E, 2017, J PERIODONTAL RES, V52, P360, DOI 10.1111/jre.12399; Teng A, 2007, BBA-MOL BASIS DIS, V1772, P89, DOI 10.1016/j.bbadis.2006.08.012; THOMSEN S, 1991, PHOTOCHEM PHOTOBIOL, V53, P825, DOI 10.1111/j.1751-1097.1991.tb09897.x; Thomsen S, 2011, OPTICAL THERMAL RESPONSE OF LASER-IRRADIATED TISSUE, SECOND EDITION, P487, DOI 10.1007/978-90-481-8831-4_13; Ting PT, 2011, CURR PROBL DERMATOL, V42, P67, DOI 10.1159/000328264; Torbeck R, 2016, MED DEVICES-EVID RES, V9, P63, DOI 10.2147/MDER.S77993; Vincelette R, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.3.035007; Widelitz Randall B, 2008, Organogenesis, V4, P123; Xie XQ, 2013, J VOICE, V27, P245, DOI 10.1016/j.jvoice.2012.11.006; Yan S, 2014, CHIN J INJ REPAIR WO, V2, P151, DOI [10.1186/s13287-015-0103-4, DOI 10.1186/S13287-015-0103-4]; Yazdi Alireza, 2017, J Med Case Rep, V11, P316, DOI 10.1186/s13256-017-1469-y	77	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230175	10.1371/journal.pone.0230175	http://dx.doi.org/10.1371/journal.pone.0230175			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191734	gold, Green Published			2022-12-26	WOS:000535302300028
J	Miranda, CJ; Fernandez, N; Kamel, N; Turner, D; Benzenhafer, D; Bolch, SN; Andring, JT; McKenna, R; Smith, WC				Miranda, Connie Jaqueline; Fernandez, Nicole; Kamel, Nader; Turner, Daniel; Benzenhafer, Del; Bolch, Susan N.; Andring, Jacob T.; McKenna, Robert; Smith, W. Clay			An arrestin-1 surface opposite of its interface with photoactivated rhodopsin engages with enolase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arrestin; glycolysis; photoreceptor; phototransduction; protein complex; G protein-coupled receptor (GPCR); protein conformation; enolase; fluorescence quench protection; light sensing	VISUAL ARRESTIN; CRYSTAL-STRUCTURE; S-ANTIGEN; BINDING; PROTEIN; ROD; MECHANISM; MOVEMENT; PHOSPHORYLATION; TRANSLOCATION	Arrestin-1 is the arrestin family member responsible for inactivation of the G protein?coupled receptor rhodopsin in photoreceptors. Arrestin-1 is also well-known to interact with additional protein partners and to affect other signaling cascades beyond phototransduction. In this study, we investigated one of these alternative arrestin-1 binding partners, the glycolysis enzyme enolase-1, to map the molecular contact sites between these two proteins and investigate how the binding of arrestin-1 affects the catalytic activity of enolase-1. Using fluorescence quench protection of strategically placed fluorophores on the arrestin-1 surface, we observed that arrestin-1 primarily engages enolase-1 along a surface that is opposite of the side of arrestin-1 that binds photoactivated rhodopsin. Using this information, we developed a molecular model of the arrestin-1?enolase-1 complex, which was validated by targeted substitutions of charge-pair interactions. Finally, we identified the likely source of arrestin's modulation of enolase-1 catalysis, showing that selective substitution of two amino acids in arrestin-1 can completely remove its effect on enolase-1 activity while still remaining bound to enolase-1. These findings open up opportunities for examining the functional effects of arrestin-1 on enolase-1 activity in photoreceptors and their surrounding cells.	[Miranda, Connie Jaqueline; Fernandez, Nicole; Kamel, Nader; Turner, Daniel; Benzenhafer, Del; Bolch, Susan N.; Smith, W. Clay] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Andring, Jacob T.; McKenna, Robert] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Turner, Daniel] Duke Univ, Dept Med, Durham, NC 27710 USA; [Benzenhafer, Del] Univ Colorado, Dept Radiol, Denver, CO 80204 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Duke University; University of Colorado System; University of Colorado Denver	Smith, WC (corresponding author), Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA.	wcsmith@ufl.edu	Smith, W. Clay/AAQ-1589-2021	Andring, Jacob/0000-0002-6632-6391	Research to Prevent Blindness; Oxnard Foundation; Foundation Fighting Blindness Grant [TA-NMT-0619-0770-UFL]	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Oxnard Foundation; Foundation Fighting Blindness Grant	This research was supported by Research to Prevent Blindness, the Oxnard Foundation, and Foundation Fighting Blindness Grant TA-NMT-0619-0770-UFL. The authors declare that they have no conflicts of interest with the contents of this article.	BROEKHUYSE RM, 1985, CURR EYE RES, V4, P613, DOI 10.3109/02713688508999993; DONOSO LA, 1990, CURR EYE RES, V9, P343, DOI 10.3109/02713689008999622; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Gurevich VV, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00125; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; Haire SE, 2006, INVEST OPHTH VIS SCI, V47, P3745, DOI 10.1167/iovs.06-0086; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Haque A, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8020033; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; HSU SC, 1991, J BIOL CHEM, V266, P21745; Huang SP, 2010, J NEUROSCI, V30, P9381, DOI 10.1523/JNEUROSCI.1207-10.2010; Hurley JB, 2015, J NEUROSCI RES, V93, P1079, DOI 10.1002/jnr.23583; Kang HJ, 2008, ACTA CRYSTALLOGR D, V64, P651, DOI 10.1107/S0907444908008561; Kang YY, 2016, FEBS J, V283, P816, DOI 10.1111/febs.13561; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; McDowell J. H., 1993, PHOTORECEPTOR CELLS, V15, P123; McDowell JH, 1999, BIOCHEMISTRY-US, V38, P6119, DOI 10.1021/bi990175p; Mookerjee SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152016; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Ostermaier MK, 2014, P NATL ACAD SCI USA, V111, P1825, DOI 10.1073/pnas.1319402111; Peterson YK, 2017, PHARMACOL REV, V69, P256, DOI 10.1124/pr.116.013367; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; Schreier B, 2010, BIOCHEMISTRY-US, V49, P7582, DOI 10.1021/bi100954f; Sente A, 2018, NAT STRUCT MOL BIOL, V25, P541, DOI 10.1038/s41594-018-0071-3; Smith WC, 2011, INVEST OPHTH VIS SCI, V52, P1832, DOI 10.1167/iovs.10-5724; Sommer ME, 2007, J BIOL CHEM, V282, P25560, DOI 10.1074/jbc.M702155200; Vajda S, 2017, PROTEINS, V85, P435, DOI 10.1002/prot.25219; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2013, J BIOL CHEM, V288, P3394, DOI 10.1074/jbc.M112.445437; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; WILDEN U, 1995, BIOCHEMISTRY-US, V34, P1446, DOI 10.1021/bi00004a040; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Wold F., 1971, ENZYMES, P499; Wu N, 2006, J MOL BIOL, V364, P955, DOI 10.1016/j.jmb.2006.09.075; Zhou XE, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.21; Zhu XM, 2002, MOL VIS, V8, P462	44	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6498	6508		10.1074/jbc.RA120.013043	http://dx.doi.org/10.1074/jbc.RA120.013043			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32238431	Green Published, hybrid			2022-12-26	WOS:000537685000020
J	Rios, N; Radi, R; Kalyanaraman, B; Zielonka, J				Rios, Natalia; Radi, Rafael; Kalyanaraman, Balaraman; Zielonka, Jacek			Tracking isotopically labeled oxidants using boronate-based redox probes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrogen peroxide; superoxide ion; reactive oxygen species (ROS); reactive nitrogen species (RNS); oxygen radicals; isotopic tracer; mass spectrometry (MS); oxygen-18; peroxymonocarbonate; peroxynitrite; reaction mechanism; redox probes; hypochlorous acid; superoxide radical anion; isotope tracing	IMAGING HYDROGEN-PEROXIDE; REACTIVE OXYGEN; NITRIC-OXIDE; IN-VIVO; FLUORESCENT-PROBES; INTRACELLULAR SUPEROXIDE; MYELOPEROXIDASE ACTIVITY; PEROXYNITRITE FORMATION; BIOLOGICAL-SYSTEMS; FLUOROGENIC PROBES	Reactive oxygen and nitrogen species have been implicated in many biological processes and diseases, including immune responses, cardiovascular dysfunction, neurodegeneration, and cancer. These chemical species are short-lived in biological settings, and detecting them in these conditions and diseases requires the use of molecular probes that form stable, easily detectable, products. The chemical mechanisms and limitations of many of the currently used probes are not well-understood, hampering their effective applications. Boronates have emerged as a class of probes for the detection of nucleophilic two-electron oxidants. Here, we report the results of an oxygen-18?labeling MS study to identify the origin of oxygen atoms in the oxidation products of phenylboronate targeted to mitochondria. We demonstrate that boronate oxidation by hydrogen peroxide, peroxymonocarbonate, hypochlorite, or peroxynitrite involves the incorporation of oxygen atoms from these oxidants. We therefore conclude that boronates can be used as probes to track isotopically labeled oxidants. This suggests that the detection of specific products formed from these redox probes could enable precise identification of oxidants formed in biological systems. We discuss the implications of these results for understanding the mechanism of conversion of the boronate-based redox probes to oxidant-specific products.	[Rios, Natalia; Radi, Rafael] Univ Republica, Fac Med, Dept Bioquim, Montevideo 11800, Uruguay; [Rios, Natalia; Radi, Rafael] Univ Republica, Fac Med, Ctr Invest Biomed CEINBIO, Montevideo 11800, Uruguay; [Kalyanaraman, Balaraman; Zielonka, Jacek] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Medical College of Wisconsin	Zielonka, J (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jzielonk@mcw.edu	Zielonka, Jacek/N-9546-2014	Zielonka, Jacek/0000-0002-2524-0145; Rios, Natalia/0000-0001-5114-3130	NCI, National Institutes of Health [U01CA178960, R01CA208648]; Espacio Interdisciplinario 2015, Universidad de la Republica, Uruguay; CSIC Grupos 2018, Universidad de la Republica, Uruguay; American Cancer Society [IRG 16-183-31]; MCW Cancer Center; Agencia Nacional de Investigacion e Innovacion (ANII); Universidad de la Republica; Programa de Desarrollo de Ciencias Basicas (PEDECIBA, Uruguay)	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Espacio Interdisciplinario 2015, Universidad de la Republica, Uruguay; CSIC Grupos 2018, Universidad de la Republica, Uruguay; American Cancer Society(American Cancer Society); MCW Cancer Center; Agencia Nacional de Investigacion e Innovacion (ANII); Universidad de la Republica; Programa de Desarrollo de Ciencias Basicas (PEDECIBA, Uruguay)	This work was supported by NCI, National Institutes of Health Grants U01CA178960 and R01CA208648 (to B. K.) and by Espacio Interdisciplinario 2015 and CSIC Grupos 2018, Universidad de la Republica, Uruguay (to R. R.). This work was also supported by American Cancer Society Institutional Research Grant IRG 16-183-31 and the MCW Cancer Center (to J. Z.); by Agencia Nacional de Investigacion e Innovacion (ANII) and Universidad de la Republica fellowships (to N. R.); and by Programa de Desarrollo de Ciencias Basicas (PEDECIBA, Uruguay) (to R. R. and N. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains Fig. S1.	Alvarez MN, 2002, METHOD ENZYMOL, V359, P353; Bakhmutova-Albert EV, 2010, INORG CHEM, V49, P11287, DOI 10.1021/ic1007389; Bennett DA, 2001, INORG CHEM, V40, P2996, DOI 10.1021/ic000910h; Cairns Andrew G, 2015, Methods Mol Biol, V1265, P25, DOI 10.1007/978-1-4939-2288-8_3; Carroll V, 2014, J AM CHEM SOC, V136, P14742, DOI 10.1021/ja509198w; Cheng G, 2018, J BIOL CHEM, V293, P10363, DOI 10.1074/jbc.RA118.003044; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Cocheme HM, 2012, NAT PROTOC, V7, P946, DOI 10.1038/nprot.2012.035; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; Dagnell M, 2019, J BIOL CHEM, V294, P12330, DOI 10.1074/jbc.RA119.009001; Debowska K, 2015, PHARMACOL REP, V67, P756, DOI 10.1016/j.pharep.2015.03.016; Dickinson BC, 2013, NAT PROTOC, V8, P1249, DOI 10.1038/nprot.2013.064; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Ferrer-Sueta G, 2018, CHEM REV, V118, P462, DOI 10.1021/acs.chemrev.7b00568; Forman HJ, 2014, J MOL CELL CARDIOL, V73, P2, DOI 10.1016/j.yjmcc.2014.01.018; Hardy M, 2018, ANTIOXID REDOX SIGN, V28, P1416, DOI 10.1089/ars.2017.7398; Hawkins CL, 2019, J BIOL CHEM, V294, P19683, DOI 10.1074/jbc.REV119.006217; Jang C, 2018, CELL, V173, P822, DOI 10.1016/j.cell.2018.03.055; Kabeya LM, 2013, ANAL BIOCHEM, V437, P130, DOI 10.1016/j.ab.2013.02.020; Kalyanaraman B, 2017, ARCH BIOCHEM BIOPHYS, V617, P38, DOI 10.1016/j.abb.2016.08.021; Kalyanaraman B, 2014, BBA-GEN SUBJECTS, V1840, P739, DOI 10.1016/j.bbagen.2013.05.008; Koto T, 2014, FREE RADICAL RES, V48, P478, DOI 10.3109/10715762.2014.886774; Lehmann WD, 2017, MASS SPECTROM REV, V36, P58, DOI 10.1002/mas.21497; Lin VS, 2013, METHOD ENZYMOL, V526, P19, DOI 10.1016/B978-0-12-405883-5.00002-8; Lippert AR, 2011, ACCOUNTS CHEM RES, V44, P793, DOI 10.1021/ar200126t; Lippert AR, 2010, CHEM COMMUN, V46, P7510, DOI 10.1039/c0cc01560a; Maghzal GJ, 2014, J BIOL CHEM, V289, P5580, DOI 10.1074/jbc.M113.539486; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; Michalski R, 2014, J BIOL CHEM, V289, P22536, DOI 10.1074/jbc.M114.553727; Michalski R, 2014, FREE RADICAL BIO MED, V67, P278, DOI 10.1016/j.freeradbiomed.2013.10.816; Michalski R, 2013, FREE RADICAL BIO MED, V54, P135, DOI 10.1016/j.freeradbiomed.2012.09.018; MOTTLEY C, 1986, BIOCHEM BIOPH RES CO, V141, P622, DOI 10.1016/S0006-291X(86)80218-2; Pattison DI, 2012, FREE RADICAL RES, V46, P975, DOI 10.3109/10715762.2012.667566; Peskin AV, 2019, FREE RADICAL BIO MED, V145, P1, DOI 10.1016/j.freeradbiomed.2019.09.010; Prolo C, 2018, FREE RADICAL BIO MED, V128, P59, DOI 10.1016/j.freeradbiomed.2018.02.017; Prolo C, 2015, FREE RADICAL BIO MED, V87, P346, DOI 10.1016/j.freeradbiomed.2015.06.027; Proniewski B, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7838406; Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010; Richardson DE, 2000, J AM CHEM SOC, V122, P1729, DOI 10.1021/ja9927467; Rinkel J, 2015, BEILSTEIN J ORG CHEM, V11, P2493, DOI 10.3762/bjoc.11.271; Rios N, 2016, FREE RADICAL BIO MED, V101, P284, DOI 10.1016/j.freeradbiomed.2016.08.033; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Sedgwick AC, 2018, J AM CHEM SOC, V140, P14267, DOI 10.1021/jacs.8b08457; Seredenina T, 2016, FREE RADICAL BIO MED, V97, P95, DOI 10.1016/j.freeradbiomed.2016.05.016; Seven O, 2017, SENSOR ACTUAT B-CHEM, V239, P1318, DOI 10.1016/j.snb.2016.09.120; Shan XP, 2006, J INORG BIOCHEM, V100, P421, DOI 10.1016/j.jinorgbio.2006.01.014; Shchepinova MM, 2017, CELL CHEM BIOL, V24, P1285, DOI 10.1016/j.chembiol.2017.08.003; Sikora A, 2011, CHEM RES TOXICOL, V24, P687, DOI 10.1021/tx100439a; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Smulik R, 2014, J BIOL CHEM, V289, P35570, DOI 10.1074/jbc.M114.597740; Srikun D, 2010, J AM CHEM SOC, V132, P4455, DOI 10.1021/ja100117u; Talib J, 2016, FREE RADICAL BIO MED, V97, P124, DOI 10.1016/j.freeradbiomed.2016.05.004; Thomas DD, 2002, METHOD ENZYMOL, V359, P84; Truzzi DR, 2019, J BIOL CHEM, V294, P14055, DOI 10.1074/jbc.RA119.008825; Truzzi DR, 2017, HYDROGEN PEROXIDE ME, P81, DOI [10.1201/9781315154831-4, DOI 10.1201/9781315154831-4]; Van de Bittner GC, 2010, P NATL ACAD SCI USA, V107, P21316, DOI 10.1073/pnas.1012864107; VISSERS MC, 2017, HYDROGEN PEROXIDE ME; Wardman P, 2008, METHOD ENZYMOL, V441, P261, DOI 10.1016/S0076-6879(08)01214-7; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Winterbourn CC, 2020, CHEMTEXTS, V6, DOI 10.1007/s40828-019-0101-8; Winterbourn CC, 2018, ANTIOXID REDOX SIGN, V29, P541, DOI 10.1089/ars.2017.7425; Xiao HB, 2016, CHEM SCI, V7, P6153, DOI 10.1039/c6sc01793b; Xiao Y, 2019, ANTIOXID REDOX SIGN, V31, P359, DOI 10.1089/ars.2018.7535; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zhou HY, 2011, J AM CHEM SOC, V133, P15803, DOI 10.1021/ja2077137; Zielonka J, 2005, FREE RADICAL BIO MED, V39, P853, DOI 10.1016/j.freeradbiomed.2005.05.001; Zielonka J, 2008, FREE RADICAL BIO MED, V44, P835, DOI 10.1016/j.freeradbiomed.2007.11.013; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zielonka J, 2006, ARCH BIOCHEM BIOPHYS, V456, P39, DOI 10.1016/j.abb.2006.09.031; Zielonka J, 2018, FREE RADICAL BIO MED, V128, P3, DOI 10.1016/j.freeradbiomed.2018.03.032; Zielonka J, 2017, CELL BIOCHEM BIOPHYS, V75, P335, DOI 10.1007/s12013-017-0813-6; Zielonka J, 2016, FREE RADICAL BIO MED, V99, P32, DOI 10.1016/j.freeradbiomed.2016.07.023; Zielonka J, 2016, J BIOL CHEM, V291, P7029, DOI 10.1074/jbc.M115.702787; Zielonka Jacek, 2015, Methods Mol Biol, V1264, P171, DOI 10.1007/978-1-4939-2257-4_16; Zielonka J, 2014, J BIOL CHEM, V289, P16176, DOI 10.1074/jbc.M114.548693; Zielonka J, 2013, METHOD ENZYMOL, V526, P145, DOI 10.1016/B978-0-12-405883-5.00009-0; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031	86	9	9	5	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6665	6676		10.1074/jbc.RA120.013402	http://dx.doi.org/10.1074/jbc.RA120.013402			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32217693	Green Published, hybrid			2022-12-26	WOS:000537685000032
J	Salustiano, EJ; da Costa, KM; Freire-de-Lima, L; Mendonca-Previato, L; Previato, JO				Salustiano, Eduardo J.; da Costa, Kelli M.; Freire-de-Lima, Leonardo; Mendonca-Previato, Lucia; Previato, Jose O.			Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ceramide; glycosyltransferase; ganglioside; multidrug transporter; chronic myelogenous leukemia; lipid metabolism; cancer; active transport; multifactorial drug resistance; neoplasia	P-GLYCOPROTEIN; GLUCOSYLCERAMIDE SYNTHASE; INDUCED APOPTOSIS; DRUG-RESISTANCE; COLLATERAL SENSITIVITY; PERIPHERAL-BLOOD; PROTEIN-1 MRP1; CELL-LINES; CERAMIDE; EXPRESSION	Multidrug resistance (MDR) in cancer arises from cross-resistance to structurally- and functionally-divergent chemotherapeutic drugs. In particular, MDR is characterized by increased expression and activity of ATP-binding cassette (ABC) superfamily transporters. Sphingolipids are substrates of ABC proteins in cell signaling, membrane biosynthesis, and inflammation, for example, and their products can favor cancer progression. Glucosylceramide (GlcCer) is a ubiquitous glycosphingolipid (GSL) generated by glucosylceramide synthase, a key regulatory enzyme encoded by the UDP-glucose ceramide glucosyltransferase (UGCG) gene. Stressed cells increase de novo biosynthesis of ceramides, which return to sub-toxic levels after UGCG mediates incorporation into GlcCer. Given that cancer cells seem to mobilize UGCG and have increased GSL content for ceramide clearance, which ultimately contributes to chemotherapy failure, here we investigated how inhibition of GSL biosynthesis affects the MDR phenotype of chronic myeloid leukemias. We found that MDR is associated with higher UGCG expression and with a complex GSL profile. UGCG inhibition with the ceramide analog d-threo-1-(3,4,-ethylenedioxy)phenyl-2-palmitoylamino-3-pyrrolidino-1-propanol (EtDO-P4) greatly reduced GSL and monosialotetrahexosylganglioside levels, and co-treatment with standard chemotherapeutics sensitized cells to mitochondrial membrane potential loss and apoptosis. ABC subfamily B member 1 (ABCB1) expression was reduced, and ABCC-mediated efflux activity was modulated by competition with nonglycosylated ceramides. Consistently, inhibition of ABCC-mediated transport reduced the efflux of exogenous C-6-ceramide. Overall, UGCG inhibition impaired the malignant glycophenotype of MDR leukemias, which typically overcomes drug resistance through distinct mechanisms. This work sheds light on the involvement of GSL in chemotherapy failure, and its findings suggest that targeted GSL modulation could help manage MDR leukemias.	[Salustiano, Eduardo J.; da Costa, Kelli M.; Freire-de-Lima, Leonardo; Mendonca-Previato, Lucia; Previato, Jose O.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude C1 042, Inst Biofis Carlos Chagas Filho, Lab Glicobiol, Ave Carlos Chagas Filho 373,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Salustiano, EJ; Mendonca-Previato, L (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude C1 042, Inst Biofis Carlos Chagas Filho, Lab Glicobiol, Ave Carlos Chagas Filho 373,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.	salustiano@bioqmed.ufrj.br; luciamp@biof.ufrj.br	dos Santos, Eduardo Salustiano Jesus/G-6666-2012	dos Santos, Eduardo Salustiano Jesus/0000-0001-5572-6130; da Costa, Kelli/0000-0001-6178-0942; Mendonca Previato, Lucia/0000-0003-3927-3244; Freire-de-Lima, Leonardo/0000-0003-3013-3173	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq; Financiadora de Estudos e Projetos, FINEP; Fundacao do Cancer; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos, FINEP(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao do Cancer; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq; Financiadora de Estudos e Projetos, FINEP; Fundacao do Cancer; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES. The authors declare that they have no conflicts of interest with the contents of this article.	ABBASZADEGAN MR, 1994, CANCER RES, V54, P4676; Baran Y, 2007, J BIOL CHEM, V282, P10922, DOI 10.1074/jbc.M610157200; Bixby D, 2011, LEUKEMIA, V25, P7, DOI 10.1038/leu.2010.238; Carrett-Dias M, 2016, LEUKEMIA RES, V42, P13, DOI 10.1016/j.leukres.2016.01.008; Cebo C, 2006, J IMMUNOL, V176, P864, DOI 10.4049/jimmunol.176.2.864; Chang KT, 2015, BBA-BIOMEMBRANES, V1848, P2374, DOI 10.1016/j.bbamem.2015.07.013; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cole SPC, 2014, J BIOL CHEM, V289, P30880, DOI 10.1074/jbc.R114.609248; Da Costa KM, 2018, AN ACAD BRAS CIENC, V90, P3081, DOI 10.1590/0001-3765201820180364; Daflon-Yunes N, 2013, MOL CELL BIOCHEM, V383, P123, DOI 10.1007/s11010-013-1761-0; Davis MA, 2000, TOXICOL SCI, V53, P48, DOI 10.1093/toxsci/53.1.48; Dijkhuis AJ, 2006, J LIPID RES, V47, P1187, DOI 10.1194/jlr.M500518-JLR200; Dogan AL, 2004, LEUKEMIA RES, V28, P619, DOI 10.1016/j.leukres.2003.10.015; DRACH D, 1992, BLOOD, V80, P2729; Dyatlovitskaya EV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P10, DOI 10.1134/S0006297906010020; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Evseenko DA, 2007, DRUG METAB DISPOS, V35, P595, DOI 10.1124/dmd.106.011478; Freire-De-Lima L, 2011, P NATL ACAD SCI USA, V108, P17690, DOI 10.1073/pnas.1115191108; Gazzin S, 2008, J COMP NEUROL, V510, P497, DOI 10.1002/cne.21808; Gencer EB, 2011, ANN HEMATOL, V90, P1265, DOI 10.1007/s00277-011-1212-5; Grazide S, 2004, J BIOL CHEM, V279, P18256, DOI 10.1074/jbc.M314105200; Guan F, 2010, FASEB J, V24, P4889, DOI 10.1096/fj.10-162107; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Huang M, 2007, ANN BIOMED ENG, V35, P1276, DOI 10.1007/s10439-007-9265-2; Hummel I, 2011, MOL PHARMACOL, V79, P229, DOI 10.1124/mol.110.069013; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-71; Jiang YX, 2013, BIOMOLECULES, V3, P435, DOI 10.3390/biom3030435; Klappe K, 2004, INT J CANCER, V110, P511, DOI 10.1002/ijc.20140; Knapp P, 2017, GYNECOL ONCOL, V147, P139, DOI 10.1016/j.ygyno.2017.07.143; Kok JW, 1998, J CELL BIOL, V142, P25, DOI 10.1083/jcb.142.1.25; Krusch M, 2011, CURR MED CHEM, V18, P5174, DOI 10.2174/092986711798184271; Kyle-Cezar F, 2007, IMMUNOLOGY, V121, P122, DOI 10.1111/j.1365-2567.2007.02547.x; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Legrand O, 1999, ADV EXP MED BIOL, V457, P161; Leslie EM, 2001, TOXICOLOGY, V167, P3, DOI 10.1016/S0300-483X(01)00454-1; Liu Y, 2010, CANCER CHEMOTH PHARM, V66, P433, DOI 10.1007/s00280-009-1177-4; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Liu YY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-145; Lorendeau D, 2017, CURR MED CHEM, V24, P1186, DOI 10.2174/0929867324666161118130238; Daniotti JL, 2016, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00300; Madigan JP, 2020, EXP CELL RES, V388, DOI 10.1016/j.yexcr.2020.111860; Maia RC, 2018, MOLECULES, V23, DOI 10.3390/molecules23010119; Maia RC, 2011, INVEST NEW DRUG, V29, P1143, DOI 10.1007/s10637-010-9453-z; MARKS DC, 1993, BRIT J HAEMATOL, V84, P83, DOI 10.1111/j.1365-2141.1993.tb03028.x; Marques-Santos LF, 2003, BIOSCIENCE REP, V23, P199, DOI 10.1023/B:BIRE.0000007693.33521.18; Moreira MAM, 2014, LEUKEMIA RES, V38, P983, DOI 10.1016/j.leukres.2014.06.001; Meszaros P, 2013, BBA-BIOMEMBRANES, V1828, P340, DOI 10.1016/j.bbamem.2012.10.007; Moro Kazuki, 2018, Oncotarget, V9, P19874, DOI 10.18632/oncotarget.24903; NAKAMURA M, 1991, CANCER RES, V51, P1940; Pallis M, 2000, BLOOD, V95, P2897, DOI 10.1182/blood.V95.9.2897.009k14_2897_2904; Park JW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228848; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pluchino KM, 2012, DRUG RESIST UPDATE, V15, P98, DOI 10.1016/j.drup.2012.03.002; Raggers RJ, 1999, J CELL SCI, V112, P415; RAMU A, 1984, CANCER TREAT REP, V68, P637; Rumjanek VM, 2001, AN ACAD BRAS CIENC, V73, P57, DOI 10.1590/S0001-37652001000100007; Saddoughi SA, 2013, ADV CANCER RES, V117, P37, DOI 10.1016/B978-0-12-394274-6.00002-9; Salas A, 2011, BLOOD, V117, P5941, DOI 10.1182/blood-2010-08-300772; Salustiano EJS, 2010, INVEST NEW DRUG, V28, P139, DOI 10.1007/s10637-009-9231-y; Sanchenkov A, 2001, JNCI-J NATL CANCER I, V93, P347, DOI 10.1093/jnci/93.5.347; Sharom FJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00041; Stefanovic M, 2016, ONCOTARGET, V7, P8253, DOI 10.18632/oncotarget.6982; Strouse JJ, 2013, ANAL BIOCHEM, V437, P77, DOI 10.1016/j.ab.2013.02.018; Sun YL, 2006, NEOPLASMA, V53, P1; van der Kolk DM, 1998, CLIN CANCER RES, V4, P1727; Vasconcelos FC, 2007, LEUKEMIA RES, V31, P445, DOI 10.1016/j.leukres.2006.07.016; von Haefen C, 2002, ONCOGENE, V21, P4009, DOI 10.1038/sj.onc.1205497; Ween MP, 2015, CRIT REV ONCOL HEMAT, V96, P220, DOI 10.1016/j.critrevonc.2015.05.012; Wegner MS, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4084-4; Wu CP, 2011, MOL PHARMACEUT, V8, P1996, DOI 10.1021/mp200261n; Yamada A, 2018, MOL CANCER RES, V16, P1059, DOI 10.1158/1541-7786.MCR-17-0353; Yandim MK, 2013, CANCER CHEMOTH PHARM, V71, P13, DOI 10.1007/s00280-012-1984-x; YUSA K, 1989, CANCER RES, V49, P5002; Zhao S, 2004, J CELL PHYSIOL, V199, P47, DOI 10.1002/jcp.10453	75	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6457	6471		10.1074/jbc.RA120.013090	http://dx.doi.org/10.1074/jbc.RA120.013090			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32229586	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000537685000017
J	Cassina, L; Chiaravalli, M; Boletta, A				Cassina, Laura; Chiaravalli, Marco; Boletta, Alessandra			Increased mitochondrial fragmentation in polycystic kidney disease acts as a modifier of disease progression	FASEB JOURNAL			English	Article						cellular respiration; Mdivi-1; mitochondrial fragmentation; polycystic kidney disease	METABOLISM; ACTIVATION; OXIDATION; DYNAMICS; FISSION	Autosomal dominant polycystic kidney disease (ADPKD) is a common monogenic disorder, characterized by bilateral renal cyst formation. Multiple pathways are de-regulated in cystic epithelia offering good opportunities for therapy. Others and we have previously reported that metabolic reprogramming, including alterations of the TCA cycle, are prominent features of ADPKD. Several lines of evidence suggest that mitochondrial impairment might be responsible for the metabolic alterations. Here, we performed morphologic and morphometric evaluation of mitochondria by TEM in an orthologous mouse model of PKD caused by mutations in the Pkd1 gene (Ksp-Cre;Pkd1(flox/-)). Furthermore, we measured mitochondrial respiration by COX and SDH enzymatic activity in situ. We found several alterations including reduced mitochondrial mass, altered structure and fragmentation of the mitochondrial network in cystic epithelia of Ksp-Cre;Pkd1(flox/-) mice. At the molecular level, we found reduced expression of the pro-fusion proteins OPA1 and MFN1 and up-regulation of the pro-fission protein DRP1. Importantly, administration of Mdivi-1, which interferes with DRP1 rescuing mitochondrial fragmentation, significantly reduced kidney/body weight, cyst formation, and improved renal function in Ksp-Cre;Pkd1(flox/-) mice. Our data indicate that impaired mitochondrial structure and function play a role in disease progression, and that their improvement can significantly modify the course of the disease.	[Cassina, Laura; Chiaravalli, Marco; Boletta, Alessandra] IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Mol Basis Cyst Kidney Disorders Unit, Via Olgettina 58, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Boletta, A (corresponding author), IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Mol Basis Cyst Kidney Disorders Unit, Via Olgettina 58, I-20132 Milan, Italy.	boletta.alessandra@hsr.it	Cassina, Laura/AAN-3804-2020	Cassina, Laura/0000-0002-7350-3069	PKD Foundation (PKDF) [PKD-218G18A]; Associazione Italiana Rene Policistico (AIRP)	PKD Foundation (PKDF); Associazione Italiana Rene Policistico (AIRP)	PKD Foundation (PKDF), Grant/Award Number: PKD-218G18A; Associazione Italiana Rene Policistico (AIRP)	Bhargava P, 2017, NAT REV NEPHROL, V13, P629, DOI 10.1038/nrneph.2017.107; Bordt EA, 2017, DEV CELL, V40, P583, DOI 10.1016/j.devcel.2017.02.020; Brand CS, 2018, CELL SIGNAL, V50, P48, DOI 10.1016/j.cellsig.2018.06.012; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Cai J, 2018, GENE DEV, V32, P781, DOI 10.1101/gad.315127.118; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Hajarnis S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14395; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Ishimoto Y, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00337-17; Iuso A, 2017, METHODS MOL BIOL, V1567, P217, DOI 10.1007/978-1-4939-6824-4_13; Kuo IY, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aat7397; Lakhia R, 2018, AM J PHYSIOL-RENAL, V314, pF122, DOI 10.1152/ajprenal.00352.2017; Lin CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20856-6; Manczak M, 2019, HUM MOL GENET, V28, P177, DOI 10.1093/hmg/ddy335; Menezes LF, 2016, EBIOMEDICINE, V5, P183, DOI 10.1016/j.ebiom.2016.01.027; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Nigro EA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53061-0; Padovano V, 2018, NAT REV NEPHROL, V14, P678, DOI 10.1038/s41581-018-0051-1; Padovano V, 2017, MOL BIOL CELL, V28, P261, DOI 10.1091/mbc.E16-08-0597; Podrini C, 2020, CELL SIGNAL, V68, DOI 10.1016/j.cellsig.2019.109495; Podrini C, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0200-x; Rappold PM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6244; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Rossi A, 2019, BBA-MOL CELL RES, V1866, P1068, DOI 10.1016/j.bbamcr.2018.10.016; Rowe I, 2014, NEPHROL DIAL TRANSPL, V29, P1480, DOI 10.1093/ndt/gft521; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Sumida M, 2015, J AM SOC NEPHROL, V26, P2378, DOI 10.1681/ASN.2014080750; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Wodarczyk C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007137	34	14	15	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6493	6507		10.1096/fj.201901739RR	http://dx.doi.org/10.1096/fj.201901739RR		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32239723	hybrid			2022-12-26	WOS:000523590100001
J	Rudeck, J; Vogl, S; Banneke, S; Schonfelder, G; Lewejohann, L				Rudeck, Juliane; Vogl, Silvia; Banneke, Stefanie; Schoenfelder, Gilbert; Lewejohann, Lars			Repeatability analysis improves the reliability of behavioral data	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; PERSONALITY-TRAITS; MICE; PREFERENCE; STRAIN	Reliability of data has become a major concern in the course of the reproducibility crisis. Especially when studying animal behavior, confounding factors such as novelty of the test apparatus can lead to a wide variability of data which may mask treatment effects and consequently lead to misinterpretation. Habituation to the test situation is a common practice to circumvent novelty induced increases in variance and to improve the reliability of the respective measurements. However, there is a lack of published empirical knowledge regarding reasonable habituation procedures and a method validation seems to be overdue. This study aimed at setting up a simple strategy to increase reliability of behavioral data measured in a familiar test apparatus. Therefore, exemplary data from mice tested in an Open Field (OF) arena were used to elucidate the potential of habituation and how reliability of measures can be confirmed by means of a repeatability analysis using the software R. On seven consecutive days, male C57BL/6J, BALB/cJ and 129S1/SvImJ mice were tested in an OF arena once daily and individual mouse behavior was recorded. A repeatability analysis was conducted with regard to repeated trials of habituation. Our data analysis revealed that monitoring animal behavior during habituation is important to determine when individual differences of the measurements are stable. Repeatability values from distance travelled and average activity increased over the habituation period, revealing that around 60% of the variance of the data can be explained by individual differences between mice. The first day of habituation was significantly different from the following 6 days. A three-day habituation period appeared to be sufficient in this study. Overall, these results emphasize the importance of habituation and in depth analysis of habituation data to define the correct starting point of the experiment for improving the reliability and reproducibility of experimental data.	[Rudeck, Juliane; Vogl, Silvia; Banneke, Stefanie; Schoenfelder, Gilbert; Lewejohann, Lars] German Fed Inst Risk Assessment BfR, German Ctr Protect Lab Anim Bf3R, Berlin, Germany; [Schoenfelder, Gilbert] Charite Univ Med Berlin, Dept Toxicol, Inst Clin Pharmacol & Toxicol, Berlin, Germany; [Schoenfelder, Gilbert] Free Univ Berlin, Berlin, Germany; [Schoenfelder, Gilbert] Humboldt Univ, Berlin, Germany; [Schoenfelder, Gilbert] Berlin Inst Hlth, Berlin, Germany; [Lewejohann, Lars] Free Univ Berlin, Dept Vet Med, Inst Anim Welf Anim Behav & Lab Anim Sci, Berlin, Germany	Federal Institute for Risk Assessment; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin	Lewejohann, L (corresponding author), German Fed Inst Risk Assessment BfR, German Ctr Protect Lab Anim Bf3R, Berlin, Germany.; Lewejohann, L (corresponding author), Free Univ Berlin, Dept Vet Med, Inst Anim Welf Anim Behav & Lab Anim Sci, Berlin, Germany.	Lars.Lewejohann@bfr.bund.de	Rudeck, Juliane/AAJ-6501-2020; Rudeck, Juliane/AAG-4822-2021; Lewejohann, Lars/H-3717-2013	Rudeck, Juliane/0000-0001-9903-1779; Lewejohann, Lars/0000-0002-0202-4351; Schonfelder, Gilbert/0000-0001-6134-1990	Federal Ministry of Education and Research (BMBF) ' [031A262D]; Deutsche Forschungsgemeinschaft (DFG) [FOR 2591, LE 2356/5-1]; BMBF; DFG	Federal Ministry of Education and Research (BMBF) '(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	This work was supported by the Federal Ministry of Education and Research (BMBF) '[grant number 031A262D]' and by the Deutsche Forschungsgemeinschaft (DFG) [FOR 2591; LE 2356/5-1]. Prof. Schoenfelder wrote the BMBF proposal and raised the BMBF funding. Prof. Lewejohann wrote the DFG proposal and raised the DFG funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XL, 2011, EXP ANIM TOKYO, V60, P111, DOI 10.1538/expanim.60.111; Araya-Ajoy YG, 2015, METHODS ECOL EVOL, V6, P1462, DOI 10.1111/2041-210X.12430; Aso-Someya N, 2018, J PHYSIOL SCI, V68, P799, DOI 10.1007/s12576-018-0596-6; Augustsson H, 2004, PHYSIOL BEHAV, V81, P685, DOI 10.1016/j.physbeh.2004.03.014; Avgustinovich DF, 2000, BEHAV GENET, V30, P101, DOI 10.1023/A:1001999020138; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Bodden C, 2018, BEHAV BRAIN RES, V336, P261, DOI 10.1016/j.bbr.2017.08.029; Bohlen M, 2014, BEHAV BRAIN RES, V272, P46, DOI 10.1016/j.bbr.2014.06.017; Bowen RS, 2016, PHYSIOL BEHAV, V155, P149, DOI 10.1016/j.physbeh.2015.12.006; Brent LJN, 2014, INT J PRIMATOL, V35, P188, DOI 10.1007/s10764-013-9724-6; Breu M, 2016, DEV NEUROSCI-BASEL, V38, P83, DOI 10.1159/000442943; Brown SM, 2011, ANESTHESIOLOGY, V115, P1251, DOI 10.1097/ALN.0b013e318238fea0; Brust V, 2015, FRONT ZOOL, V12, DOI 10.1186/1742-9994-12-S1-S17; Burley NT, 2018, ECOL EVOL, V8, P2380, DOI 10.1002/ece3.3831; Chappell MA, 2004, J EXP BIOL, V207, P3839, DOI 10.1242/jeb.01213; Chellammal HSJ, 2019, BIOMED PHARMACOTHER, V109, P1454, DOI 10.1016/j.biopha.2018.10.189; de Sousa LP, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2778-8; Evans DA, 2019, TRENDS COGN SCI, V23, P334, DOI 10.1016/j.tics.2019.01.012; de Melo MFFT, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00009; Gouveia K, 2017, SCI REP-UK, V7, DOI 10.1038/srep44999; Haneke-Reinders M, 2017, ECOL EVOL, V7, P3414, DOI 10.1002/ece3.2937; Houle D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-25; Jirkof P, 2015, LAB ANIM-UK, V49, P177, DOI 10.1177/0023677214562849; Koski SE, 2011, BEHAV ECOL SOCIOBIOL, V65, P2161, DOI 10.1007/s00265-011-1224-0; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Leussis MP, 2006, NEUROSCI BIOBEHAV R, V30, P1045, DOI 10.1016/j.neubiorev.2006.03.006; Lewejohann L, 2011, DEV PSYCHOBIOL, V53, P624, DOI 10.1002/dev.20553; Mazzamuto MV, 2019, ETHOL ECOL EVOL, V31, P38, DOI 10.1080/03949370.2018.1488768; Milanovic D, 2016, NEUROTOX RES, V30, P434, DOI 10.1007/s12640-016-9629-1; Moreton E, 2019, BEHAV BRAIN RES, V363, P191, DOI 10.1016/j.bbr.2019.02.003; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nasehi M, 2017, PSYCHOPHARMACOLOGY, V234, P3117, DOI 10.1007/s00213-017-4688-4; Nikolaus S, 2016, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00352; Pagani JH, 2015, GENES BRAIN BEHAV, V14, P167, DOI 10.1111/gbb.12202; Pavkovic Z, 2018, PEDIATR ANESTH, V28, P537, DOI 10.1111/pan.13396; Podhorna J, 2002, GENES BRAIN BEHAV, V1, P96, DOI 10.1034/j.1601-183X.2002.10205.x; Pogany A, 2014, BEHAVIOUR, V151, P1885, DOI 10.1163/1568539X-00003221; Redfern WS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181068; Richter SH, 2019, APPL ANIM BEHAV SCI, V212, P1, DOI 10.1016/j.applanim.2018.12.012; Roche DG, 2016, J EXP BIOL, V219, P3832, DOI 10.1242/jeb.146712; Rudeck J, 2020, PHARMACOL BIOCHEM BE, V191, DOI 10.1016/j.pbb.2020.172877; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Simoes LR, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/6490652; Singh JCH, 2015, PHARM BIOL, V53, P630, DOI 10.3109/13880209.2014.935866; Stoeffel MA, 2018, INTRO REPEATABILITY; Taylor TB, 2013, EVOL APPL, V6, P535, DOI 10.1111/eva.12041; Teixeira LV, 2018, NEUROCHEM RES, V43, P1476, DOI 10.1007/s11064-018-2562-3; Toval A, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00042; Wirz A, 2015, EXP ANIM TOKYO, V64, P281, DOI 10.1538/expanim.14-0104; XUE M, 2018, PLOS ONE, V13, DOI DOI 10.1371/JOURNAL.PONE.0197197; Yamamoto Shinya, EXP ANIM TOKYO, V63, P107, DOI [10.1538/expanim.60.481, DOI 10.1538/EXPANIM.14-0104, 10.1538/expanim.63.107, DOI 10.1538/EXPANIM.60.481]	53	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230900	10.1371/journal.pone.0230900	http://dx.doi.org/10.1371/journal.pone.0230900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LE4LX	32240211	Green Submitted, Green Published, gold			2022-12-26	WOS:000526691900001
J	Chen, SY; Liu, MH; Liang, BW; Ge, SH; Peng, J; Huang, HY; Xu, YM; Tang, XL; Deng, LB				Chen, Siyang; Liu, Menghan; Liang, Bowen; Ge, Shanghua; Peng, Jie; Huang, Haiyue; Xu, Yanmei; Tang, Xiaoli; Deng, Libin			Identification of human peripheral blood monocyte gene markers for early screening of solid tumors	PLOS ONE			English	Article							MONONUCLEAR-CELLS; EXPRESSION; PROFILES	As cancer mortality is high in most regions of the world, early screening of cancer has become increasingly important. Minimally invasive screening programs that use peripheral blood mononuclear cells (PBMCs) are a new and reliable strategy that can achieve early detection of tumors by identifying marker genes. From 797 datasets, four (GSE12771, GSE24536, GSE27562, and GSE42834) including 428 samples, 236 solid tumor cases, and 192 healthy controls were chosen according to the inclusion criteria. A total of 285 genes from among 440 reported genes were selected by meta-analysis. Among them, 4 of the top significantly differentially expressed genes (ANXA1, IFI44, IFI44L, and OAS1) were identified as marker genes of PBMCs. Pathway enrichment analysis identified, two significant pathways, the 'primary immunodeficiency' pathway and the 'cytokine-cytokine receptor interaction' pathway. Protein- protein interaction (PPI) network analysis revealed the top 27 hubs with a degree centrality greater than 23 to be hub genes. We also identified 3 modules in Molecular Complex Detection (MCODE) analysis: Cluster 1 (related to ANXA1), Cluster 2 (related to IFI44 and IFI44L) and Cluster 3 (related to OAS1). Among the 4 marker genes, IFI44, IFI44L, and OAS1 are potential diagnostic biomarkers, even though their results were not as remarkable as those for ANXA1 in our study. ANXA1 is involved in the immunosuppressive mechanism in tumor-bearing hosts and may be used in a new strategy involving the use of the host's own immunity to achieve tumor suppression.	[Chen, Siyang; Ge, Shanghua; Peng, Jie; Deng, Libin] Nanchang Univ, Sch Publ Hlth, Jiangxi Prov Key Lab Prevent Med, Nanchang, Jiangxi, Peoples R China; [Liu, Menghan] Nanchang Univ, Clin Med Coll 2, Nanchang, Jiangxi, Peoples R China; [Liang, Bowen] Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Shenzhen, Guangdong, Peoples R China; [Huang, Haiyue; Tang, Xiaoli; Deng, Libin] Nanchang Univ, Sch Basic Med Sci, Nanchang, Jiangxi, Peoples R China; [Xu, Yanmei] Nanchang Univ, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China; [Deng, Libin] Nanchang Univ, Inst Translat Med, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Sun Yat Sen University; Nanchang University; Nanchang University; Nanchang University	Deng, LB (corresponding author), Nanchang Univ, Sch Publ Hlth, Jiangxi Prov Key Lab Prevent Med, Nanchang, Jiangxi, Peoples R China.; Deng, LB (corresponding author), Nanchang Univ, Sch Basic Med Sci, Nanchang, Jiangxi, Peoples R China.; Deng, LB (corresponding author), Nanchang Univ, Inst Translat Med, Nanchang, Jiangxi, Peoples R China.	denglb1937@163.com		Liang, Bowen/0000-0001-6259-7373; Peng, Jie/0000-0002-5278-3989; Deng, Libin/0000-0001-5863-3829	National Natural Science Foundation of China [81660041]; Natural Science Foundation of Jiangxi Province [20171BAB205109, 20181BAB205008]; Youth Science Foundation of Jiangxi Province [20161BAB215248]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); Youth Science Foundation of Jiangxi Province	This work was supported by National Natural Science Foundation of China [grant number 81660041 to L.D.]; Natural Science Foundation of Jiangxi Province [grant numbers 20171BAB205109 to X.T., 20181BAB205008 to L. D.]; Youth Science Foundation of Jiangxi Province [grant number 20161BAB215248 to Y.X.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaroe J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2472; Belvedere R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071967; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; Gao YS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-520; Han M, 2008, CLIN CANCER RES, V14, P455, DOI 10.1158/1078-0432.CCR-07-1801; Kamal AM, 2001, CLIN EXP ALLERGY, V31, P1116, DOI 10.1046/j.1365-2222.2001.01137.x; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Koseki H, 1997, SURG TODAY, V27, P30, DOI 10.1007/BF01366936; Marckmann G, 2014, BUNDESGESUNDHEITSBLA, V57, P327, DOI 10.1007/s00103-013-1913-0; Osman I, 2006, CLIN CANCER RES, V12, P3374, DOI 10.1158/1078-0432.CCR-05-2081; Parmeshwar R., 2018, SURGERY, V36, P139, DOI [10.1016/j.mpsur.2017.12.008, DOI 10.1016/J.MPSUR.2017.12.008]; Sakai Y, 2008, CANCER RES, V68, P10267, DOI 10.1158/0008-5472.CAN-08-0911; Schiffman Joshua D, 2015, Am Soc Clin Oncol Educ Book, P57, DOI 10.14694/EdBook_AM.2015.35.57; Sharma P, 2005, BREAST CANCER RES, V7, pR634, DOI 10.1186/bcr1203; Showe MK, 2009, CANCER RES, V69, P9202, DOI 10.1158/0008-5472.CAN-09-1378; Tainsky MA, 2009, BBA-REV CANCER, V1796, P176, DOI 10.1016/j.bbcan.2009.04.004; Torres LS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165833; Twine NC, 2003, CANCER RES, V63, P6069; Vecchi L, 2018, BBA-MOL CELL RES, V1865, P1368, DOI 10.1016/j.bbamcr.2018.06.010; Vinay DS, 2015, SEMIN CANCER BIOL, V35, pS185, DOI 10.1016/j.semcancer.2015.03.004; Weedon-Fekjaer H, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2092; Williams MA, 1999, LEUKEMIA LYMPHOMA, V34, P1	22	10	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230905	10.1371/journal.pone.0230905	http://dx.doi.org/10.1371/journal.pone.0230905			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HE	32226026	Green Published, gold			2022-12-26	WOS:000535936400026
J	Hopkinson, BM; King, AC; Owen, DP; Johnson-Roberson, M; Long, MH; Bhandarkar, SM				Hopkinson, Brian M.; King, Andrew C.; Owen, Daniel P.; Johnson-Roberson, Matthew; Long, Matthew H.; Bhandarkar, Suchendra M.			Automated classification of three-dimensional reconstructions of coral reefs using convolutional neural networks	PLOS ONE			English	Article							IMAGE; PATTERNS	Coral reefs are biologically diverse and structurally complex ecosystems, which have been severally affected by human actions. Consequently, there is a need for rapid ecological assessment of coral reefs, but current approaches require time consuming manual analysis, either during a dive survey or on images collected during a survey. Reef structural complexity is essential for ecological function but is challenging to measure and often relegated to simple metrics such as rugosity. Recent advances in computer vision and machine learning offer the potential to alleviate some of these limitations. We developed an approach to automatically classify 3D reconstructions of reef sections and assessed the accuracy of this approach. 3D reconstructions of reef sections were generated using commercial Structure-from-Motion software with images extracted from video surveys. To generate a 3D classified map, locations on the 3D reconstruction were mapped back into the original images to extract multiple views of the location. Several approaches were tested to merge information from multiple views of a point into a single classification, all of which used convolutional neural networks to classify or extract features from the images, but differ in the strategy employed for merging information. Approaches to merging information entailed voting, probability averaging, and a learned neural-network layer. All approaches performed similarly achieving overall classification accuracies of similar to 96% and > 90% accuracy on most classes. With this high classification accuracy, these approaches are suitable for many ecological applications.	[Hopkinson, Brian M.; Owen, Daniel P.] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [King, Andrew C.; Bhandarkar, Suchendra M.] Univ Georgia, Inst Artificial Intelligence, Athens, GA 30602 USA; [Johnson-Roberson, Matthew] Univ Michigan, Dept Naval Architecture & Marine Engn, Ann Arbor, MI 48109 USA; [Long, Matthew H.] Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA; [Bhandarkar, Suchendra M.] Univ Georgia, Dept Comp Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Michigan System; University of Michigan; Woods Hole Oceanographic Institution; University System of Georgia; University of Georgia	Hopkinson, BM (corresponding author), Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA.	bmhopkin@uga.edu		Hopkinson, Brian/0000-0002-0844-0794; Long, Matthew/0000-0003-1359-0233	Alfred P. Sloan Foundation [BR2014-049]; National Science Foundation [OCE-1657727]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF))	This study was funded by grants from the Alfred P. Sloan Foundation (BMH, BR2014-049; https://sloan.org), and the National Science Foundation (MHL, OCE-1657727; https://www.nsf.gov).The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso I, 2017, IEEE INT CONF COMP V, P2874, DOI 10.1109/ICCVW.2017.339; Apthorpe NJ, 2016, ADV NEURAL INFORM PR; Beijbom O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130312; Beijbom O, 2012, PROC CVPR IEEE, P1170, DOI 10.1109/CVPR.2012.6247798; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Burns JHR, 2015, PEERJ, V3, DOI 10.7717/peerj.1077; Burns JHR, 2016, METHODS OCEANOGR, V15, P49, DOI DOI 10.1016/J.MIO.2016.04.001; Burns JHR, 2016, J INVERTEBR PATHOL, V140, P51, DOI 10.1016/j.jip.2016.08.007; Edwards CB, 2017, CORAL REEFS, V36, P1291, DOI 10.1007/s00338-017-1624-3; Ferrari R, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020113; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Friedman A., 2013, AUTOMATED INTERPRETA; Friedman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050440; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Hartley R, 2003, MULTIPLE VIEW GEOMET, DOI 10.1016/S0143-8166(01)00145-2; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Henderson J, 2013, INT J NAUT ARCHAEOL, V42, P243, DOI 10.1111/1095-9270.12016; Hirschmuller H, 2005, PROC CVPR IEEE, P807, DOI 10.1109/cvpr.2005.56; Holbrook SJ, 2002, MAR FRESHWATER RES, V53, P1045, DOI 10.1071/MF02063; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; James MR, 2014, EARTH SURF PROC LAND, V39, P1413, DOI 10.1002/esp.3609; Johnson-Roberson M, 2017, J FIELD ROBOT, V34, P625, DOI 10.1002/rob.21658; Johnson-Roberson M, 2010, J FIELD ROBOT, V27, P21, DOI 10.1002/rob.20324; King A, 2019, IEEE COMP VIS PATT R, V2019, P1; King A, 2018, IEEE COMP VIS PATT R; Kingma DP., 2014, ADAM METHOD STOCHAST; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Krizhevsky A, 2012, P ADV NEURAL INFORM, V27, P3581; Kumar S, 2016, INT CONF 3D VISION, P148, DOI 10.1109/3DV.2016.23; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Leon JX, 2015, GEOMORPHOLOGY, V242, P21, DOI 10.1016/j.geomorph.2015.01.030; Li W, 2018, INT J REMOTE SENS, V39, P9269, DOI 10.1080/01431161.2018.1530809; Li X, 2013, PROC CVPR IEEE, P859, DOI 10.1109/CVPR.2013.116; Long MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058581; Lotte RG, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10091435; Maas HG, 2015, SENSORS-BASEL, V15, P18140, DOI 10.3390/s150818140; Mahmood A., 2016, AUTOMATIC ANNOTATION; Mahmood A, 2019, IEEE J OCEANIC ENG, V44, P121, DOI 10.1109/JOE.2017.2786878; Manderson T, 2017, J FIELD ROBOT, V34, P170, DOI 10.1002/rob.21698; Marques ACR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192011; Modasshir M, 2018, OCEANS 2018 MTS/IEEE CHARLESTON; Mur-Artal Raul, 2017, IEEE T ROBOTICS, V1, DOI DOI 10.1109/TR0.2017.2705103; Nguyen H, 2017, INT C DAT SCI ADV AN; Paszke A., 2017, AUTOMATIC DIFFERENTI, DOI DOI 10.1016/J.COMPAG.2018.04.002; Pavoni G, 2019, INT ARCH PHOTOGRAMME; Pizarro O, 2017, ECOL EVOL, V7, P1770, DOI 10.1002/ece3.2701; Rasmussen C, 2017, IEEE C COMP VIS WORK; Ruzicka RR, 2013, MAR ECOL PROG SER, V489, P125, DOI 10.3354/meps10427; Schmidt T, 2015, AUTON ROBOT, V39, P239, DOI 10.1007/s10514-015-9462-z; Shihavuddin ASM, 2013, REMOTE SENS-BASEL, V5, P1809, DOI 10.3390/rs5041809; Smith JE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.1985; Stokes MD, 2009, LIMNOL OCEANOGR-METH, V7, P157, DOI 10.4319/lom.2009.7.157; Storlazzi CD, 2016, CORAL REEFS, V35, P889, DOI 10.1007/s00338-016-1462-8; Taigman Y, 2014, PROC CVPR IEEE, P1701, DOI 10.1109/CVPR.2014.220; Thornton B, 2016, DEEP-SEA RES PT I, V116, P200, DOI 10.1016/j.dsr.2016.08.009; Williams ID, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00222; Xie SN, 2017, PROC CVPR IEEE, P5987, DOI 10.1109/CVPR.2017.634; Young GC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175341	58	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230671	10.1371/journal.pone.0230671	http://dx.doi.org/10.1371/journal.pone.0230671			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208447	Green Published, gold			2022-12-26	WOS:000535305100037
J	Lee, WY; Yang, DJ; Oh, JH				Lee, Wongyu; Yang, Dongjun; Oh, Je Hyeok			Differences in the performance of resuscitation according to the resuscitation guideline terminology during infant cardiopulmonary resuscitation: "Approximately 4 cm" versus "at least one-third the anterior-posterior diameter of the chest"	PLOS ONE			English	Article							BASIC LIFE-SUPPORT; HEART-ASSOCIATION GUIDELINES; 2010 INTERNATIONAL CONSENSUS; CARDIOVASCULAR CARE SCIENCE; COUNCIL GUIDELINES; KOREAN GUIDELINES; COMPRESSION DEPTH; QUALITY; 2-THUMB; FITNESS	Aim This study was conducted to investigate the effect of resuscitation guideline terminology on the performance of infant cardiopulmonary resuscitation (CPR). Methods A total of 40 intern or resident physicians conducted 2-min CPR with the two-finger technique (TFT) and two-thumb technique (TT) on a simulated infant cardiac arrest model with a 1-day interval. They were randomly assigned to Group A or B. The participants of Group A conducted CPR with the chest compression depth (CCD) target of "approximately 4 cm" and those of Group B conducted CPR with the CCD target of "at least one-third the anterior-posterior diameter of the chest". Single rescuer CPR was performed with a 15:2 compression to ventilation ratio on the floor. Results In both chest compression techniques, the average CCD of Group B was significantly deeper than that of Group A (TFT: 41.0 [range, 39.3-42.0] mm vs. 36.5 [34.0-37.9] mm, P = 0.002; TT: 42.0 [42.0-43.0] mm vs. 37.0 [35.3-38.0] mm, P < 0.001). Adequacy of CCD also showed similar results (Group B vs. A; TFT: 99% [82-100%] vs. 29% [12-58%], P = 0.001; TT: 100% [100-100%] vs. 28% [8-53%], P < 0.001). Conclusions Using the CCD target of "at least one-third the anterior-posterior diameter of the chest" resulted in deep and adequate chest compressions during simulated infant CPR in contrast to the CCD target of "approximately 4 cm". Therefore, changes in the terminology used in the guidelines should be considered to improve the quality of CPR.	[Lee, Wongyu; Yang, Dongjun; Oh, Je Hyeok] Chung Ang Univ, Dept Emergency Med, Coll Med, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital	Oh, JH (corresponding author), Chung Ang Univ, Dept Emergency Med, Coll Med, Seoul, South Korea.	jehyeokoh@cau.ac.kr	Oh, Je Hyeok/D-4755-2015	Oh, Je Hyeok/0000-0002-5211-3838				Atkins DL, 2015, CIRCULATION, V132, pS519, DOI 10.1161/CIR.0000000000000265; Berg RA, 2010, CIRCULATION, V122, pS685, DOI 10.1161/CIRCULATIONAHA.110.970939; Biarent D, 2005, RESUSCITATION, V67, pS97, DOI 10.1016/j.resuscitation.2005.10.010; Biarent D, 2010, RESUSCITATION, V81, P1364, DOI 10.1016/j.resuscitation.2010.08.012; Christman C, 2011, ARCH DIS CHILD-FETAL, V96, pF99, DOI 10.1136/adc.2009.180406; Chung SP, 2016, RESUSCITATION, V105, P145, DOI 10.1016/j.resuscitation.2016.05.025; de Caen AR, 2010, RESUSCITATION, V81, pE213, DOI 10.1016/j.resuscitation.2010.08.028; Deakin CD, 2018, RESUSCITATION, V124, P58, DOI 10.1016/j.resuscitation.2018.01.010; Dorfsman ML, 2000, ACAD EMERG MED, V7, P1077, DOI 10.1111/j.1553-2712.2000.tb01255.x; ECC Committee S and A, 2005, CIRC S24, V112, pIV1; Handley AJ, 2005, RESUSCITATION, V67, pS7, DOI 10.1016/j.resuscitation.2005.10.007; Hansen D, 2012, EUR J EMERG MED, V19, P28, DOI 10.1097/MEJ.0b013e328347a2aa; Huynh TK, 2012, J PEDIATR-US, V161, P658, DOI 10.1016/j.jpeds.2012.03.019; Int Liaison Comm Resuscitation, 2005, RESUSCITATION, V67, P181, DOI 10.1016/j.resuscitation.2005.09.010; International Liaison Committee on Resuscitation, 2005, Resuscitation, V67, P271; Kim CW, 2019, EUR J PEDIATR, V178, P795, DOI 10.1007/s00431-019-03357-0; Kim YS, 2016, J KOREAN MED SCI, V31, P997, DOI 10.3346/jkms.2016.31.6.997; Kleinman ME, 2015, CIRCULATION, V132, pS414, DOI 10.1161/CIR.0000000000000259; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Kleinman ME, 2010, CIRCULATION, V122, P8466, DOI [10.1161/CIRCULATIONAHA.110.971093, 10.1542/peds.2010-2972A]; Koster RW, 2010, RESUSCITATION, V81, pE48, DOI 10.1016/j.resuscitation.2010.08.005; Koster RW, 2010, RESUSCITATION, V81, P1277, DOI 10.1016/j.resuscitation.2010.08.009; Krikscionaitiene A, 2013, EMERG MED J, V30, P159, DOI 10.1136/emermed-2011-200634; Lee JS, 2016, CLIN EXP EMERG MED, V3, pS39, DOI 10.15441/ceem.16.131; Lee SY, 2018, EUR J EMERG MED, V25, P372, DOI 10.1097/MEJ.0000000000000461; Lopez-Gonzalez A, 2016, AM J EMERG MED, V34, P1845, DOI 10.1016/j.ajem.2016.06.058; Maconochie IK, 2015, RESUSCITATION, V95, pE147, DOI 10.1016/j.resuscitation.2015.07.044; Maconochie IK, 2015, RESUSCITATION, V95, P223, DOI 10.1016/j.resuscitation.2015.07.028; Oh JH, 2016, AM J EMERG MED, V34, P2411, DOI 10.1016/j.ajem.2016.09.006; Perkins GD, 2015, RESUSCITATION, V95, pE43, DOI 10.1016/j.resuscitation.2015.07.041; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Song KJ, 2016, CLIN EXP EMERG MED, V3, pS10, DOI 10.15441/ceem.16.129; Stiell IG, 2014, CIRCULATION, V130, P1962, DOI 10.1161/CIRCULATIONAHA.114.008671; Sutton RM, 2014, RESUSCITATION, V85, P1179, DOI 10.1016/j.resuscitation.2014.05.007; Trethewey SP, 2019, RESUSCITATION, V142, P91, DOI 10.1016/j.resuscitation.2019.07.016; Udassi S, 2010, RESUSCITATION, V81, P712, DOI 10.1016/j.resuscitation.2009.12.029	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230687	10.1371/journal.pone.0230687	http://dx.doi.org/10.1371/journal.pone.0230687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208443	gold, Green Published			2022-12-26	WOS:000535305100039
J	Wang, X; Hui, BS; Chen, SY				Wang, Xin; Hui, Bronson; Chen, Siyu			Language selective or non-selective in bilingual lexical access? It depends on lexical tones!	PLOS ONE			English	Article							SPOKEN WORD RECOGNITION; SENTENCE CONTEXT; SPEECH; SEGMENTATION; COMPETITION; PERCEPTION; ACTIVATION; REPRESENTATION; CONSTRAINTS; INFORMATION	Much of the literature surrounding bilingual spoken word recognition is based on bilinguals of non-tonal languages. In the Mandarin spoken word recognition literature, lexical tones are often considered as equally important as segments in lexical processing. It is unclear whether and how lexical tones contribute to bilingual language processing. One recent study demonstrates that tonal bilinguals require the availability of both tonal and segmental information to induce cross-language lexical competition during bilingual lexical access, even without phonological overlap between the target and non-target language. The current study investigates whether overt phonological overlap between the target and non-target language would equally require both tonal and segmental information available to induce cross-language lexical competition. We employed two auditory lexical decision experiments with both Mandarin-English bilinguals and English monolinguals to test whether inter-lingual homophones (IH) would induce lexical competition from the non-target language, L1 Mandarin. Our results show that cross-language lexical competition was only observed with the presence of lexical tones, in addition to segmental overlap.	[Wang, Xin] Macquarie Univ, Fac Human Sci, Dept Linguist, Sydney, NSW, Australia; [Wang, Xin] Univ Oxford, Dept Educ, Oxford, England; [Hui, Bronson] Michigan State Univ, Language Studies Program 2, E Lansing, MI 48824 USA; [Chen, Siyu] Univ Greenwich, Dept Languages & Linguist, London, England	Macquarie University; University of Oxford; Michigan State University; University of Greenwich	Wang, X (corresponding author), Macquarie Univ, Fac Human Sci, Dept Linguist, Sydney, NSW, Australia.; Wang, X (corresponding author), Univ Oxford, Dept Educ, Oxford, England.	x.wang1@mq.edu.au	CHEN, SI/GZL-4800-2022; Hui, Bronson/ABH-1681-2020	Hui, Bronson/0000-0003-1822-3109; Wang, Xin/0000-0003-0217-7347; CHEN, Siyu/0000-0002-7156-436X	John Fell OUP from University of Oxford [EPD06550]; Hong Kong Mobility Scholarship Fund from Macquarie University [99483509]	John Fell OUP from University of Oxford; Hong Kong Mobility Scholarship Fund from Macquarie University	This project was funded by John Fell OUP (EPD06550) from University of Oxford and Hong Kong Mobility Scholarship Fund (99483509) from Macquarie University to Dr Xin Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audacity Development Team, 2013, AUD VERS 2 0 3 COMP; Axmear E, 2005, LANG SPEECH HEAR SER, V36, P244, DOI 10.1044/0161-1461(2005/024); Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baayen R. H., 2008, ANAL LINGUISTICS DAT; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Basnight-Brown DM, 2007, MEM COGNITION, V35, P953, DOI 10.3758/BF03193468; Bialystok E., 1999, BILING-LANG COGN, V2, P127, DOI DOI 10.1017/S1366728999000231; Birdsong D, 2001, J MEM LANG, V44, P235, DOI 10.1006/jmla.2000.2750; Boersma P., 2013, PRAAT DOING PHONETIC; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; Caramazza A, 2001, J EXP PSYCHOL LEARN, V27, P1430, DOI 10.1037//0278-7393.27.6.1430; Chambers CG, 2009, J EXP PSYCHOL LEARN, V35, P1029, DOI 10.1037/a0015901; Costa A, 1999, J MEM LANG, V41, P365, DOI 10.1006/jmla.1999.2651; CUTLER A, 1988, J EXP PSYCHOL HUMAN, V14, P113, DOI 10.1037/0096-1523.14.1.113; CUTLER A, 1992, COGNITIVE PSYCHOL, V24, P381, DOI 10.1016/0010-0285(92)90012-Q; Dahan D., 2006, HDB PSYCHOLINGUISTIC, P249; Defence Language Institute, 1974, CONTR STUD ENGL MAND; DeFrancis John., 1986, CHINESE LANGUAGE FAC; DEGROOT AMB, 1991, J MEM LANG, V30, P90, DOI 10.1016/0749-596X(91)90012-9; Dijkstra T, 2000, J MEM LANG, V42, P445, DOI 10.1006/jmla.1999.2697; Dijkstra T, 1999, J MEM LANG, V41, P496, DOI 10.1006/jmla.1999.2654; Dijkstra T, 2002, BILING-LANG COGN, V5, P175, DOI 10.1017/S1366728902003012; Finkbeiner M, 2004, J MEM LANG, V51, P1, DOI 10.1016/j.jml.2004.01.004; Flege JE, 1997, J PHONETICS, V25, P437, DOI 10.1006/jpho.1997.0052; Goldinger SD, 1996, LANG COGNITIVE PROC, V11, P559, DOI 10.1080/016909696386944; Grainger J, 1998, LANG COGNITIVE PROC, V13, P601, DOI 10.1080/016909698386393; Grosjean F., 1988, LANG COGNITIVE PROC, V3, P233, DOI [10.1080/01690968808402089, DOI 10.1080/01690968808402089]; Hernandez A, 2005, TRENDS COGN SCI, V9, P220, DOI 10.1016/j.tics.2005.03.003; Hernandez AE, 2007, PSYCHOL BULL, V133, P638, DOI 10.1037/0033-2909.133.4.638; Ju M, 2004, PSYCHOL SCI, V15, P314, DOI 10.1111/j.0956-7976.2004.00675.x; Kessler B, 1997, J MEM LANG, V37, P295, DOI 10.1006/jmla.1997.2522; Lagrou E, 2013, BILING-LANG COGN, V16, P508, DOI 10.1017/S1366728912000508; Lagrou E, 2011, J EXP PSYCHOL LEARN, V37, P952, DOI 10.1037/a0023217; Lee CY, 2007, LANG SPEECH, V50, P101, DOI 10.1177/00238309070500010501; Lin Y.-H., 2007, SOUNDS CHINESE; Liu C, 2012, J ACOUST SOC AM, V131, pEL427, DOI 10.1121/1.4710836; Luce P. A., 1986, THESIS, DOI [10.1111/j.1467-9280.2009.02389.x, DOI 10.1111/J.1467-9280.2009.02389.X]; Luce PA, 1998, EAR HEARING, V19, P1, DOI 10.1097/00003446-199802000-00001; Malins JG, 2012, NEUROPSYCHOLOGIA, V50, P2032, DOI 10.1016/j.neuropsychologia.2012.05.002; Malins JG, 2010, J MEM LANG, V62, P407, DOI 10.1016/j.jml.2010.02.004; Marslen-Wilson W., 1989, LEXICAL REPRESENTATI, P3; MARSLENWILSON WD, 1987, COGNITION, V25, P71, DOI 10.1016/0010-0277(87)90005-9; MARSLENWILSON WD, 1978, COGNITIVE PSYCHOL, V10, P29, DOI 10.1016/0010-0285(78)90018-X; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; Nguyen-Hoan M, 2010, BILING-LANG COGN, V13, P217, DOI 10.1017/S1366728909990551; NORRIS D, 1995, J EXP PSYCHOL LEARN, V21, P1209, DOI 10.1037/0278-7393.21.5.1209; Ortega-Llebaria M, 2017, BILING-LANG COGN, V20, P367, DOI 10.1017/S1366728915000723; Pallier C, 2001, PSYCHOL SCI, V12, P445, DOI 10.1111/1467-9280.00383; Perea M, 2008, LANG COGNITIVE PROC, V23, P69, DOI 10.1080/01690960701578146; Quam C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169001; Schirmer A, 2005, J COGNITIVE NEUROSCI, V17, P1, DOI 10.1162/0898929052880057; Schneider W., 2002, E PRIME USERS GUIDE; Schulpen B, 2003, J EXP PSYCHOL HUMAN, V29, P1155, DOI 10.1037/0096-1523.29.6.1155; Shook A, 2016, J ACOUST SOC AM, V139, P3102, DOI 10.1121/1.4953692; Shuai L, 2016, BEHAV RES METHODS, P1, DOI DOI 10.3758/S13428-015-0567-2; Singh L, 2016, J EXP CHILD PSYCHOL, V147, P111, DOI 10.1016/j.jecp.2016.03.006; Spivey MJ, 1999, PSYCHOL SCI, V10, P281, DOI 10.1111/1467-9280.00151; Taft M., 1992, LANGUAGE PROCESSING, P151, DOI DOI 10.1016/S0166-4115(08)61891-9; Tan LH, 1997, J MEM LANG, V37, P41, DOI 10.1006/jmla.1997.2508; Vaden K. I., 2009, IRVINE PHONOTACTIC O; Van Assche E, 2009, PSYCHOL SCI, V20, P923, DOI 10.1111/j.1467-9280.2009.02389.x; van Hell JG, 2002, PSYCHON B REV, V9, P780, DOI 10.3758/BF03196335; van Heuven WJB, 1998, J MEM LANG, V39, P458, DOI 10.1006/jmla.1998.2584; Wang X, 2017, COGNITION, V169, P15, DOI 10.1016/j.cognition.2017.07.013; Wang X, 2015, BILING-LANG COGN, V18, P657, DOI 10.1017/S1366728914000650; Wang X, 2013, Q J EXP PSYCHOL, V66, P727, DOI 10.1080/17470218.2012.716072; Wang X, 2010, BILING-LANG COGN, V13, P327, DOI 10.1017/S1366728909990502; Weber A, 2004, J MEM LANG, V50, P1, DOI 10.1016/S0749-596X(03)00105-0; Zhou HX, 2010, Q J EXP PSYCHOL, V63, P2051, DOI 10.1080/17470211003718705	69	7	9	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230412	10.1371/journal.pone.0230412	http://dx.doi.org/10.1371/journal.pone.0230412			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9GC	32203524	Green Published, gold			2022-12-26	WOS:000535303900020
J	Ferioli, D; Bosio, A; Zois, J; La Torre, A; Rampinini, E				Ferioli, Davide; Bosio, Andrea; Zois, James; La Torre, Antonio; Rampinini, Ermanno			Seasonal changes in physical capacities of basketball players according to competitive levels and individual responses	PLOS ONE			English	Article							INTERMITTENT RECOVERY TEST; PHYSIOLOGICAL-RESPONSES; PREPARATION PERIOD; TRAINING LOADS; PERFORMANCE; FITNESS; STARTERS; JUMP	Purpose The aim of this study was to quantify changes in physical capacities of thirty-eight basketball players selected from different teams, as well as from varying competitive levels (i.e. Division I, Division II and Division III) during the preparation and in-season periods. Methods Pre (T1) and post (T2) preparation period and during regular season (T3), the players completed a Yo-Yo Intermittent Recovery test-level 1. Following a 3 to 8 days-break, players performed a 6-min continuous running test (Mognoni's test), a counter-movement jump test and a 5-min high-intensity intermittent running test. Results Blood lactate concentration measured after the Mognoni's test was significantly reduced from T1 to T2, and from T2 to T3 (P<0.001, ?(2) = 0.424). The distance covered during the Yo-Yo Intermittent Recovery test was significantly increased only from T1 to T2 in Division II and III (P<0.001, ?(2) = 0.789). Similarly, the physiological responses to high-intensity intermittent running test were improved only from T1 to T2 (all P<0.001, ?(2) = 0.495 to 0.652). Despite significant changes observed in running tests from T1 to T2, at individual level 35-55% of players did not show a very likely improvement. Relative peak power produced during vertical jumps at T3 by Division I players was increased compared to T1 (ANOVA interaction, P = 0.037, ?(2) = 0.134). Conclusions The main improvements in physical capacities occurred during the preparation period, when the aerobic fitness and the ability to sustain high-intensity intermittent efforts were moderately-to-largely improved. However, it appears that the preparation period does not consistently impact on vertical jump variables. Aerobic fitness and force/power production during vertical jumps appear to improve across the competitive season (slightly-to-moderately). Physical tests should be used to identify weaknesses in physical performance of players and to monitor their fatigue status, with the aim to develop individualized training programs.	[Ferioli, Davide; La Torre, Antonio] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Ferioli, Davide; Bosio, Andrea; Rampinini, Ermanno] MAPEI Sport Res Ctr, Human Performance Lab, Olgiate Olona, Varese, Italy; [Zois, James] Victoria Univ, Coll Sport & Exercise Sci, Inst Hlth & Sport, Melbourne, Vic, Australia; [La Torre, Antonio] IRCSS, Ist Ortoped Galeazzi, Milan, Italy	University of Milan; Victoria University; IRCCS Istituto Ortopedico Galeazzi	Ferioli, D (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.; Ferioli, D (corresponding author), MAPEI Sport Res Ctr, Human Performance Lab, Olgiate Olona, Varese, Italy.	ferio89@hotmail.it	Ferioli, Davide/K-7095-2015	Ferioli, Davide/0000-0002-2994-4158; Rampinini, Ermanno/0000-0002-9729-0862; Zois, James/0000-0001-5025-3119				Alis R, 2015, CLIN CHEM LAB MED, V53, pE249, DOI 10.1515/cclm-2014-1275; [Anonymous], 2001, STAATSBLAD KONINKRIJ, V31, P1; Aoki MS, 2017, J STRENGTH COND RES, V31, P348, DOI 10.1519/JSC.0000000000001507; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Ben Abdelkrim N, 2010, J STRENGTH COND RES, V24, P1346, DOI 10.1519/JSC.0b013e3181cf7510; Berkelmans DM, 2018, J STRENGTH COND RES, V32, P2383, DOI 10.1519/JSC.0000000000002194; BOLONCHUK WW, 1991, J SPORT MED PHYS FIT, V31, P165; Brunelli DT, 2012, OPEN ACCESS J SPORTS, V3, P43, DOI 10.2147/OAJSM.S30962; Buchheit M, 2012, EUR J APPL PHYSIOL, V112, P711, DOI 10.1007/s00421-011-2014-0; Castagna C, 2008, J SCI MED SPORT, V11, P202, DOI 10.1016/j.jsams.2007.02.013; Castagna C, 2008, J STRENGTH COND RES, V22, P923, DOI 10.1519/JSC.0b013e31816a4281; Caterisano A, 1997, J STRENGTH COND RES, V11, P21; Claudino JG, 2017, J SCI MED SPORT, V20, P397, DOI 10.1016/j.jsams.2016.08.011; Cohen J.E., 1988, STAT POWER ANAL BEHA; Drinkwater E., 2005, INT J PERF ANAL SPOR, V5, P107, DOI DOI 10.1080/24748668.2005.11868342; Drinkwater EJ, 2008, SPORTS MED, V38, P565, DOI 10.2165/00007256-200838070-00004; Drinkwater EJ, 2007, J SPORT SCI, V25, P869, DOI 10.1080/02640410600907870; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Ferioli D, 2020, INT J SPORT PHYSIOL, V15, P825, DOI 10.1123/ijspp.2019-0645; Ferioli D, 2019, INT J SPORT PHYSIOL, V14, P739, DOI 10.1123/ijspp.2018-0366; Ferioli D, 2018, INT J SPORT PHYSIOL, V13, P991, DOI 10.1123/ijspp.2017-0434; Ferioli D, 2020, J STRENGTH COND RES, V34, P172, DOI 10.1519/JSC.0000000000003039; Ferioli D, 2018, J SPORT SCI, V36, P2567, DOI 10.1080/02640414.2018.1469241; Ferioli D, 2018, J STRENGTH COND RES, V32, P790, DOI 10.1519/JSC.0000000000001823; FOX SM, 1971, ANN CLIN RES, V3, P404, DOI 10.1016/0091-7435(72)90079-5; Gonzalez AM, 2013, J STRENGTH COND RES, V27, P611, DOI 10.1519/JSC.0b013e31825dd2d9; Groves B, 1993, J STRENGTH COND RES, V7, P30; Hoffman J.R., 1991, J APPL SPORT SCI RES, V5, P144, DOI [10.1519/00124278-199108000-00006, DOI 10.1519/00124278-199108000-00006]; Hopkins W, 2017, SPORTSCIENCE, V21, P5; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hunter G.R., 1993, J STRENGTH COND RES, V7, P26, DOI DOI 10.1519/1533-4287(1993)0072.3.CO;2; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Krustrup P, 2003, MED SCI SPORT EXER, V35, P697, DOI 10.1249/01.MSS.0000058441.94520.32; Lorenzo J, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00421; Mancha-Triguero D, 2019, J SPORT MED PHYS FIT, V59, P1513, DOI 10.23736/S0022-4707.19.09180-1; Pliauga V, 2018, BIOL SPORT, V35, P373, DOI 10.5114/biolsport.2018.78058; Rampinini E, 2010, EUR J APPL PHYSIOL, V108, P401, DOI 10.1007/s00421-009-1221-4; Siri W., 1961, TECHNIQUES MEASURING, P223; Sirtori MD, 1993, MED DELLO SPORT, V43, P281; Sparks LM, 2017, DIABETOLOGIA, V60, P2329, DOI 10.1007/s00125-017-4461-6; Stojanovic E, 2018, SPORTS MED, V48, P111, DOI 10.1007/s40279-017-0794-z; TAVINO LP, 1995, J STRENGTH COND RES, V9, P75, DOI DOI 10.1519/00124278-199505000-00003; Wen N, 2018, J STRENGTH COND RES, V32, P2677, DOI 10.1519/JSC.0000000000002459; Ziv G, 2009, SPORTS MED, V39, P547, DOI 10.2165/00007256-200939070-00003	44	9	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230558	10.1371/journal.pone.0230558	http://dx.doi.org/10.1371/journal.pone.0230558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LC8OB	32191740	Green Published, Green Accepted, gold			2022-12-26	WOS:000525591100001
J	Gondhowiardjo, SA; Handoko; Adham, M; Rachmadi, L; Kodrat, H; Tobing, DL; Haryoga, IM; Dwiyono, AG; Kristian, YA; Permata, TBM				Gondhowiardjo, Soehartati A.; Handoko; Adham, Marlinda; Rachmadi, Lisnawati; Kodrat, Henry; Tobing, Demak Lumban; Haryoga, I. Made; Dwiyono, Agustinus Gatot; Kristian, Yoseph Adi; Permata, Tiara Bunga Mayang			Tumor microenvironment predicts local tumor extensiveness in PD-L1 positive nasopharyngeal cancer	PLOS ONE			English	Article							INFILTRATING LYMPHOCYTES; CELL INFILTRATION; T-CELLS; EXPRESSION; SURVIVAL	Tumor microenvironment have been implicated in many kind of cancers to hold an important role in determining treatment success especially with immunotherapy. In nasopharyngeal cancer, the prognostic role of this immune cells within tumor microenvironment is still doubtful. We conducted a study that included 25 nasopharyngeal cancer biopsy specimens to seek a more direct relationship between tumor infiltrating immune cells and tumor progression. Apart from that, we also checked the PD-L1 protein through immunohistochemistry. The PD-L1 was positively expressed in all our 25 samples with nasopharyngeal cancer WHO type 3 histology. Majority samples have > 50% PD-L1 expression in tumor cells. We also found that denser local tumor infiltrating immune cells population have relatively much smaller local tumor volume. The inverse applied, with the mean local tumor volumes were 181.92 cm(3) +/- 81.45 cm(3), 117.13 cm(3) +/- 88.72 cm(3), and 55.13 cm(3) +/- 25.06 cm(3) for mild, moderate, and heavy immune cells infiltration respectively (p = 0.013). Therefore, we concluded that tumor infiltrating immune cells play an important role in tumor progression, hence evaluating this simple and predictive factor may provide us with some valuable prognostic information.	[Gondhowiardjo, Soehartati A.; Handoko; Kodrat, Henry; Haryoga, I. Made; Dwiyono, Agustinus Gatot; Kristian, Yoseph Adi; Permata, Tiara Bunga Mayang] Univ Indonesia, Fac Med, Dept Radiotherapy, Cipto Mangunkusumo Natl Gen Hosp, Jakarta, Indonesia; [Adham, Marlinda] Univ Indonesia, Fac Med, Dept Ear Nose & Throat Head & Neck Surg, Cipto Mangunkusumo Natl Gen Hosp, Jakarta, Indonesia; [Rachmadi, Lisnawati] Univ Indonesia, Fac Med, Dept Anat Pathol, Cipto Mangunkusumo Natl Gen Hosp, Jakarta, Indonesia; [Tobing, Demak Lumban] Dharmais Natl Canc Hosp, Dept Clin Pathol, Jakarta, Indonesia	University of Indonesia; University of Indonesia; University of Indonesia; Dharmais Hospital	Handoko (corresponding author), Univ Indonesia, Fac Med, Dept Radiotherapy, Cipto Mangunkusumo Natl Gen Hosp, Jakarta, Indonesia.	handoko45@yahoo.com		Kodrat, Henry/0000-0003-3782-7901; Gondhowiardjo, Soehartati/0000-0002-9446-4361; Adham, Marlinda/0000-0003-2461-9628	SAG from Directorate of Research and Community Engagement, Universitas Indonesia	SAG from Directorate of Research and Community Engagement, Universitas Indonesia	The grant for this study was received by SAG from Directorate of Research and Community Engagement, Universitas Indonesia. The funder played no role in study design, data collection, analysis, decision to publish or preparation of the manuscript. URL of funder: https://research.ui.ac.id/research/en/home-en/	Cai TT, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006503; Chan OSH, 2017, ORAL ONCOL, V67, P52, DOI 10.1016/j.oraloncology.2017.02.002; Fang F, 2017, SEMIN IMMUNOL, V31, P37, DOI 10.1016/j.smim.2017.07.009; Fang WF, 2014, ONCOTARGET, V5, P12189, DOI 10.18632/oncotarget.2608; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Galdiero MR, 2016, INT J CANCER, V139, P446, DOI 10.1002/ijc.30076; Gardner A, 2016, TRENDS IMMUNOL, V37, P855, DOI 10.1016/j.it.2016.09.006; Gondhowiardjo SA, 2019, WORLD J ONCOL, V10; Hsu MC, 2010, MODERN PATHOL, V23, P1393, DOI 10.1038/modpathol.2010.130; Huang ZL, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0863-5; Jiang F, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5689-y; Karantanos T, 2019, CLIN TRANSL ONCOL, V21, P206, DOI 10.1007/s12094-018-1908-2; Lanitis E, 2017, ANN ONCOL, V28, P18, DOI 10.1093/annonc/mdx238; Larbcharoensub N, 2018, AM J CLIN ONCOL-CANC, V41, P1204, DOI 10.1097/COC.0000000000000449; Lee VHF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157969; Li J, 2012, J BIOL CHEM, V287, P35484, DOI 10.1074/jbc.M112.367532; Liu L, 2016, CANCER IMMUNOL IMMUN, V65, P73, DOI 10.1007/s00262-015-1775-4; Mantovani A, 2019, J INTERN MED, V285, P524, DOI 10.1111/joim.12886; Melero I, 2014, CANCER DISCOV, V4, P522, DOI 10.1158/2159-8290.CD-13-0985; Munz C, 2008, SEMIN CANCER BIOL, V18, P381, DOI 10.1016/j.semcancer.2008.10.002; Park CK, 2017, ONCOTARGET, V8, P14759, DOI 10.18632/oncotarget.14736; Ponzetta A, 2019, CELL, V178, P346, DOI 10.1016/j.cell.2019.05.047; Sackstein R, 2017, LAB INVEST, V97, P669, DOI 10.1038/labinvest.2017.25; Soyano AE, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0447-2; Szekely B, 2018, ANN ONCOL, V29, P2232, DOI 10.1093/annonc/mdy399; Thunnissen E, 2017, LUNG CANCER, V113, P102, DOI 10.1016/j.lungcan.2017.09.010; Wang K, 2017, HUM PATHOL, V69, P110, DOI 10.1016/j.humpath.2017.09.012; Wang M, 2018, INT J BIOL SCI, V14, P565, DOI 10.7150/ijbs.24562; Wilson JB, 2018, CANCERS, V10, DOI 10.3390/cancers10040109; Zhang JW, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0501-6; Zheng LF, 2017, ONCOTARGETS THER, V10, P5483, DOI 10.2147/OTT.S152007; Zhou YJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43627; Zhu Q, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1312240	33	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230449	10.1371/journal.pone.0230449	http://dx.doi.org/10.1371/journal.pone.0230449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191754	Green Published, gold			2022-12-26	WOS:000535302300051
J	Jika, AKN; Le Ru, B; Capdevielle-Dulac, C; Chardonnet, F; Silvain, JF; Kaiser, L; Dupas, S				Jika, Abdel Kader Naino; Le Ru, B.; Capdevielle-Dulac, C.; Chardonnet, F.; Silvain, J. F.; Kaiser, L.; Dupas, S.			Population genetics of the Mediterranean corn borer (Sesamia nonagrioides) differs between wild and cultivated plants	PLOS ONE			English	Article							MICROSATELLITE NULL ALLELES; LEPIDOPTERA-NOCTUIDAE; STEM BORER; LEFEBVRE LEPIDOPTERA; PHYTOPHAGOUS INSECTS; OSTRINIA-NUBILALIS; HOST; DISPERSAL; PROGRAM; DIFFERENTIATION	The population genetic structure of crop pest populations gives information about their spatial ecology, which helps in designing management strategies. In this paper, we investigated the genetic structure of the Mediterranean Corn Borer (MCB), Sesamia nonagrioides Lefebvre (Lepidoptera: Noctuidae), one of the most important maize pests in the Mediterranean countries, using microsatellite markers for the first time in this species. Insects were collected in twenty-five locations in southwest and southeast France from cultivated and wild host plants (Zea mays, Sorghum halepense and Typha domingensis). Contrary to what has been reported so far in France, we found that MCB populations could be locally abundant on wild poales plants. Analysis was carried out at 11 polymorphic microsatellite markers. Molecular variance was significantly determined by geography, then by host plant, with 17% and 4%, respectively, when considered as a major effect, and with 14% and 1%, respectively, when considered as a marginal effect in permutational analysis. Multidimensional scaling (MDS) and GENELAND Bayesian clustering suggested that populations infecting wild plants (T. domingensis and S. halepense) were more structured locally than those affecting cultivated maize. In S. halepense, significant Isolation By Distance (IBD) indicated that this factor could explain genetic differentiation of the moth populations. In T. domingensis, local population differentiation was strong but did not depend on distance. The implication of this absence of population structure in maize and the heterogeneity of population genetics patterns in wild plants are discussed in the context of the population dynamics hypothesis and population management strategies.	[Jika, Abdel Kader Naino; Le Ru, B.; Capdevielle-Dulac, C.; Chardonnet, F.; Silvain, J. F.; Kaiser, L.; Dupas, S.] IRD, UMR CNRS, Lab Evolut Genomes Comportement & Ecol, Gif Sur Yvette, France; [Jika, Abdel Kader Naino; Le Ru, B.; Capdevielle-Dulac, C.; Chardonnet, F.; Silvain, J. F.; Kaiser, L.; Dupas, S.] Univ Paris Sud Orsay, Gif Sur Yvette, France; [Le Ru, B.] ICIPE African Insect Sci Food & Hlth, Nairobi, Kenya; [Jika, Abdel Kader Naino] Alliance Biovers Int, Rome, Italy; [Jika, Abdel Kader Naino] Int Ctr Trop Agr CIAT, Rome, Italy; [Chardonnet, F.] USDA ARS EBCL, St Gely Du Fesc, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; International Centre of Insect Physiology & Ecology (ICIPE); Alliance; International Center for Tropical Agriculture - CIAT	Jika, AKN (corresponding author), IRD, UMR CNRS, Lab Evolut Genomes Comportement & Ecol, Gif Sur Yvette, France.; Jika, AKN (corresponding author), Univ Paris Sud Orsay, Gif Sur Yvette, France.; Jika, AKN (corresponding author), Alliance Biovers Int, Rome, Italy.; Jika, AKN (corresponding author), Int Ctr Trop Agr CIAT, Rome, Italy.	kaderjika@gmail.com	Le Ru, bruno/K-3480-2016	Le Ru, bruno/0000-0002-4208-3727; NAINO JIKA, Abdel Kader/0000-0003-4579-9330	Agence Nationale de la Recherche [ANR-09-PEXT-009]; INRA; CNRS; ICIPE; IRD	Agence Nationale de la Recherche(French National Research Agency (ANR)); INRA; CNRS(Centre National de la Recherche Scientifique (CNRS)); ICIPE; IRD	This work was funded by the Agence Nationale de la Recherche (6th Extinction call, Adaptanthrop project ANR-09-PEXT-009) and by the authors' operating grants from IRD, INRA, CNRS, and ICIPE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2013, ANIM BEHAV, V85, P1169, DOI 10.1016/j.anbehav.2013.03.002; Belkhir K, 2004, GENETIX 4 05 WINDOWS, P5000; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Bourguet D, 2000, P ROY SOC B-BIOL SCI, V267, P1177, DOI 10.1098/rspb.2000.1126; Bues R, 1996, CAN ENTOMOL, V128, P849, DOI 10.4039/Ent128849-5; Calatayud PA, 2008, ENTOMOL EXP APPL, V129, P348, DOI 10.1111/j.1570-7458.2008.00787.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Cheraghali Z, 2015, NORTH-WEST J ZOOL, V11, P70; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Cruz D, 2016, B INSECTOL, V69, P181; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; De La Poza M, 2008, ENVIRON ENTOMOL, V37, P1354, DOI 10.1603/0046-225X(2008)37[1354:GSOSNL]2.0.CO;2; Dumas P, 2015, GENETICA, V143, P305, DOI 10.1007/s10709-015-9829-2; Eizaguirre M, 2004, ENTOMOL EXP APPL, V113, P25, DOI 10.1111/j.0013-8703.2004.00201.x; Eizaguirre Matilde, 2012, Psyche (Cambridge), V2012, p7pp, DOI 10.1155/2012/854045; Esfandiari M, 2015, ACTA ZOOL ACAD SCI H, V61, P341, DOI 10.17109/AZH.61.4.341.2015; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; GALICHET PF, 1982, AGRONOMIE, V2, P561, DOI 10.1051/agro:19820609; Gemsi G. R., 1992, Applied Entomology and Phytopathology, V59, P31; Giacometti Rosa, 1995, Redia, V78, P19; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jones HBC, 2016, ECOL EVOL, V6, P181, DOI 10.1002/ece3.1861; Joyce AL, 2016, ECOL EVOL, V6, P8632, DOI 10.1002/ece3.2541; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kergoat GJ, 2015, ZOOL J LINN SOC-LOND, V175, P244, DOI 10.1111/zoj.12275; Langella O., 1999, POPULATIONS; Le Ru BP, 2006, ANN SOC ENTOMOL FR, V42, P353, DOI 10.1080/00379271.2006.10697467; Leniaud L, 2006, ENTOMOL EXP APPL, V120, P51, DOI 10.1111/j.1570-7458.2006.00427.x; Margaritopoulos JT, 2007, B ENTOMOL RES, V97, P299, DOI 10.1017/S000748530700507X; Martel C, 2003, HEREDITY, V90, P141, DOI 10.1038/sj.hdy.6800186; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Meglecz E, 2004, MOL ECOL, V13, P1693, DOI 10.1111/j.1365-294X.2004.02163.x; Midamegbe A, 2011, MOL ECOL, V20, P1414, DOI 10.1111/j.1365-294X.2011.05035.x; Moyal P, 2011, BIOL J LINN SOC, V103, P904, DOI 10.1111/j.1095-8312.2011.01666.x; Murphy SM, 2007, ECOL ENTOMOL, V32, P143, DOI 10.1111/j.1365-2311.2006.00824.x; Ong'amo GO, 2008, ENTOMOL EXP APPL, V128, P154, DOI 10.1111/j.1570-7458.2008.00735.x; Orsucci M, 2016, J EVOLUTION BIOL, V29, P114, DOI 10.1111/jeb.12766; Petit C, 2017, J PEST SCI, V90, P797, DOI 10.1007/s10340-017-0833-4; Petit C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136169; Pritchard JK, 2000, GENETICS, V155, P945; Prowell DP, 2004, ANN ENTOMOL SOC AM, V97, P1034, DOI 10.1603/0013-8746(2004)097[1034:MGAOHU]2.0.CO;2; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousseau D., 2009, PHYTOMA DEFENSE VEGE, V622-623, P38; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Safner T, 2011, INT J MOL SCI, V12, P865, DOI 10.3390/ijms12020865; Santiago R, 2013, J ECON ENTOMOL, V106, P2241, DOI 10.1603/EC13084; Sinama M, 2011, EUR J ENTOMOL, V108, P261, DOI 10.14411/eje.2011.035; Team R, 2010, COR LANG ENV STAT CO; Thomas Y, 2003, EVOLUTION, V57, P261; Ugelvig LV, 2012, MOL ECOL, V21, P3224, DOI 10.1111/j.1365-294X.2012.05592.x; Via Caillaud, 2017, AM NAT, V156, P606, DOI [10.2307/3079066, DOI 10.2307/3079066]; Zanakis GN, 2009, P 13 PANH ENT C COP, P302	58	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230434	10.1371/journal.pone.0230434	http://dx.doi.org/10.1371/journal.pone.0230434			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191750	Green Published, gold			2022-12-26	WOS:000535302300047
J	Kwiecien, JM; Dabrowski, W; Dabrowska-Bouta, B; Sulkowski, G; Oakden, W; Kwiecien-Delaney, CJ; Yaron, JR; Zhang, LQ; Schutz, L; Marzec-Kotarska, B; Stanisz, GJ; Karis, JP; Struzynska, L; Lucas, AR				Kwiecien, Jacek M.; Dabrowski, Wojciech; Dabrowska-Bouta, Beata; Sulkowski, Grzegorz; Oakden, Wendy; Kwiecien-Delaney, Christian J.; Yaron, Jordan R.; Zhang, Liqiang; Schutz, Lauren; Marzec-Kotarska, Barbara; Stanisz, Greg J.; Karis, John P.; Struzynska, Lidia; Lucas, Alexandra R.			Prolonged inflammation leads to ongoing damage after spinal cord injury	PLOS ONE			English	Article							CAVITY FORMATION; MESSENGER-RNA; ASTROCYTES; REGENERATION; CELLS; SCAR; METHYLPREDNISOLONE; EXPRESSION; IDENTIFICATION; MECHANISMS	The pathogenesis of spinal cord injury (SCI) remains poorly understood and treatment remains limited. Emerging evidence indicates that post-SCI inflammation is severe but the role of reactive astrogliosis not well understood given its implication in ongoing inflammation as damaging or neuroprotective. We have completed an extensive systematic study with MRI, histopathology, proteomics and ELISA analyses designed to further define the severe protracted and damaging inflammation after SCI in a rat model. We have identified 3 distinct phases of SCI: acute (first 2 days), inflammatory (starting day 3) and resolution (>3 months) in 16 weeks follow up. Actively phagocytizing, CD68(+)/CD163(-) macrophages infiltrate myelin-rich necrotic areas converting them into cavities of injury (COI) when deep in the spinal cord. Alternatively, superficial SCI areas are infiltrated by granulomatous tissue, or arachnoiditis where glial cells are obliterated. In the COI, CD68(+)/CD163(-) macrophage numbers reach a maximum in the first 4 weeks and then decline. Myelin phagocytosis is present at 16 weeks indicating ongoing inflammatory damage. The COI and arachnoiditis are defined by a wall of progressively hypertrophied astrocytes. MR imaging indicates persistent spinal cord edema that is linked to the severity of inflammation. Microhemorrhages in the spinal cord around the lesion are eliminated, presumably by reactive astrocytes within the first week post-injury. Acutely increased levels of TNF-alpha, IL-1beta, IFN-gamma and other proinflammatory cytokines, chemokines and proteases decrease and anti-inflammatory cytokines increase in later phases. In this study we elucidated a number of fundamental mechanisms in pathogenesis of SCI and have demonstrated a close association between progressive astrogliosis and reduction in the severity of inflammation.	[Kwiecien, Jacek M.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Dabrowski, Wojciech] Med Univ Lublin, Dept Anaesthesiol & Intens Therapy, Lublin, Poland; [Dabrowska-Bouta, Beata; Sulkowski, Grzegorz; Struzynska, Lidia] Polish Acad Sci, Mossakowski Med Res Ctr, Lab Pathoneurochem, Warsaw, Poland; [Oakden, Wendy; Stanisz, Greg J.] Sunnybrook Res Inst, Phys Sci, Toronto, ON, Canada; [Kwiecien-Delaney, Christian J.] McMaster Univ, Fac Sci, Hamilton, ON, Canada; [Yaron, Jordan R.; Zhang, Liqiang; Schutz, Lauren; Lucas, Alexandra R.] Arizona State Univ, Biodesign Inst, Ctr Personalized Diagnost, Tempe, AZ USA; [Yaron, Jordan R.; Zhang, Liqiang; Schutz, Lauren; Lucas, Alexandra R.] Arizona State Univ, Biodesign Inst, Ctr Immunotherapy Vaccines & Virotherapy, Tempe, AZ USA; [Marzec-Kotarska, Barbara] Med Univ Lublin, Dept Clin Pathomorphol, Lublin, Poland; [Stanisz, Greg J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Karis, John P.] Dign Hlth St Josephs Hosp & Med Ctr, Barrow Neurol Inst, Dept Neuroradiol, Phoenix, AZ USA	McMaster University; Medical University of Lublin; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Medical University of Lublin; University of Toronto; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Kwiecien, JM (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	kwiecien@mcmaster.ca	Yaron, Jordan R/S-1136-2019; Dabrowska-Bouta, Beata/X-8384-2018; Sulkowski, Grzegorz/X-8927-2018; Stanisz, Greg/A-4943-2013	Yaron, Jordan R/0000-0002-4133-474X; Dabrowska-Bouta, Beata/0000-0002-8625-4559; Sulkowski, Grzegorz/0000-0002-4812-2205; Stanisz, Greg/0000-0002-9488-7612; Dabrowski, Wojciech/0000-0003-0449-2375	Medical University of Lublin, Poland	Medical University of Lublin, Poland	Funding provided by the Medical University of Lublin, Poland.	Albrecht PJ, 2002, EXP NEUROL, V173, P46, DOI 10.1006/exnr.2001.7834; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Attar A, 2005, SURG NEUROL, V64, P28, DOI 10.1016/j.surneu.2005.07.057; Austin JW, 2012, J NEUROTRAUM, V29, P1838, DOI 10.1089/neu.2012.2354; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Barros MHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080908; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Blomster LV, 2013, EXP NEUROL, V247, P226, DOI 10.1016/j.expneurol.2013.05.002; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Escartin C, 2008, MOL NEUROBIOL, V38, P231, DOI 10.1007/s12035-008-8043-y; Evaniew N, 2015, J NEUROTRAUM, V32, P1674, DOI 10.1089/neu.2015.3963; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Hong J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082167; Horky LL, 2006, J COMP NEUROL, V498, P525, DOI 10.1002/cne.21065; Hu R, 2010, J NEUROSURG-SPINE, V13, P169, DOI 10.3171/2010.3.SPINE09190; Iannotti C, 2006, J NEUROTRAUM, V23, P853, DOI 10.1089/neu.2006.23.853; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Kumar H, 2018, MOL NEUROBIOL, V55, P2577, DOI 10.1007/s12035-017-0509-3; Kwiecien JM, 2008, J NEUROTRAUM, V25, P196, DOI 10.1089/neu.2007.0454; Kwiecien JM, 2019, FOLIA NEUROPATHOL, V57, P41, DOI 10.5114/fn.2019.83830; Kwiecien JM, 2016, NEUROL NEUROCHIR POL, V50, P7, DOI 10.1016/j.pjnns.2015.10.006; Kwiecien JM, 2015, FOLIA NEUROPATHOL, V53, P41, DOI 10.5114/fn.2015.49973; Kwiecien JM, 2013, FOLIA NEUROPATHOL, V51, P189, DOI 10.5114/fn.2013.37703; Kwiecien JM, 2010, COMPARATIVE MED, V60, P205; Kwiecien JM, 1998, J NEUROCYTOL, V27, P581, DOI 10.1023/A:1006922227791; Kwiecien JM, 2018, METHODS MOL BIOL METHODS MOL BIOL, V1826; Kwiecien JM, 2006, ADV MED BIOL, V94, P149; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Lee DH, 2014, J NEUROIMMUNOL, V274, P96, DOI 10.1016/j.jneuroim.2014.06.025; Levine DN, 2004, J NEUROL SCI, V220, P3, DOI 10.1016/j.jns.2004.01.014; Morizawa YM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00037-1; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; Najafi E, 2016, J NEUROSURG-SPINE, V24, P941, DOI 10.3171/2015.10.SPINE15538; Nesic O, 2008, J NEUROCHEM, V105, P628, DOI 10.1111/j.1471-4159.2007.05177.x; Norden DM, 2014, GLIA, V62, P881, DOI 10.1002/glia.22647; O'Connor LT, 1999, J NEUROSCI, V19, P3404; Oakden W, 2014, J NEUROSCI METH, V235, P92, DOI 10.1016/j.jneumeth.2014.06.018; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Ramer LM, 2004, J COMP NEUROL, V473, P1, DOI 10.1002/cne.20049; REDDY KKV, 1989, J NEUROSURG, V71, P239, DOI 10.3171/jns.1989.71.2.0239; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Guerrero AR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-40; Seki T, 2008, J NEUROSURG-SPINE, V8, P365, DOI 10.3171/SPI/2008/8/4/365; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stammers AT, 2012, J NEUROSCI RES, V90, P782, DOI 10.1002/jnr.22820; Tsai MC, 2008, SURG NEUROL, V70, P19, DOI 10.1016/j.surneu.2007.09.033; Tsiperson V, 2013, J IMMUNOL, V190, P1528, DOI 10.4049/jimmunol.1201387; Wang XJ, 2005, ACTA PHARMACOL SIN, V26, P934, DOI 10.1111/j.1745-7254.2005.00152.x; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; ZHU P, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/701970	57	40	42	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0226584	10.1371/journal.pone.0226584	http://dx.doi.org/10.1371/journal.pone.0226584			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191733	Green Published, gold, Green Submitted			2022-12-26	WOS:000535302300005
J	Guo, L; Zhu, ZM; Wang, GY; Cui, S; Shen, M; Song, ZH; Wang, JH				Guo, Li; Zhu, Zhaoming; Wang, Guangyan; Cui, Shan; Shen, Meng; Song, Zhenhua; Wang, Jin-Hui			microRNA-15b contributes to depression-like behavior in mice by affecting synaptic protein levels and function in the nucleus accumbens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neuroscience; microRNA (miRNA); stress; synapse; fusion protein	MEDIAL PREFRONTAL CORTEX; GAMMA-AMINOBUTYRIC-ACID; VENTRAL TEGMENTAL AREA; CHRONIC MILD STRESS; MESSENGER-RNA; GABAERGIC NEURONS; SIGNALING PATHWAY; MAJOR DEPRESSION; INHIBITORY DEFICITS; GENE-EXPRESSION	Major depression is a prevalent affective disorder characterized by recurrent low mood. It presumably results from stress-induced deteriorations of molecular networks and synaptic functions in brain reward circuits of genetically-susceptible individuals through epigenetic processes. Epigenetic regulator microRNA-15b inhibits neuronal progenitor proliferation and is up-regulated in the medial prefrontal cortex of mice that demonstrate depression-like behavior, indicating the contribution of microRNA-15 to major depression. Using a mouse model of major depression induced by chronic unpredictable mild stress (CUMS), here we examined the effects of microRNA-15b on synapses and synaptic proteins in the nucleus accumbens of these mice. The application of a microRNA-15b antagomir into the nucleus accumbens significantly reduced the incidence of CUMS-induced depression and reversed the attenuations of excitatory synapse and syntaxin-binding protein 3 (STXBP3A)/vesicle-associated protein 1 (VAMP1) expression. In contrast, the injection of a microRNA-15b analog into the nucleus accumbens induced depression-like behavior as well as attenuated excitatory synapses and STXBP3A/VAMP1 expression similar to the down-regulation of these processes induced by the CUMS. We conclude that microRNA-15b-5p may play a critical role in chronic stress-induced depression by decreasing synaptic proteins, innervations, and activities in the nucleus accumbens. We propose that the treatment of anti-microRNA-15b-5p may convert stress-induced depression into resilience.	[Guo, Li; Cui, Shan; Wang, Jin-Hui] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Guo, Li; Wang, Jin-Hui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhu, Zhaoming; Wang, Guangyan; Shen, Meng; Song, Zhenhua] Qingdao Univ, Sch Pharm, Qingdao 266021, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Qingdao University	Wang, JH (corresponding author), Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China.; Wang, JH (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	wangjinhui@ucas.ac.cn			National Key R&D Program of China [2016YFC1307101]; Natural Science Foundation of China [81971027, 81930033, 81671071]	National Key R&D Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key R&D Program of China Grant 2016YFC1307101 and Natural Science Foundation of China Grants 81971027, 81930033, and 81671071 (to J.-H. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonso-Grunz F, 2015, CELL MOL LIFE SCI, V72, P3127, DOI 10.1007/s00018-015-1922-2; [Anonymous], [No title captured]; Bai M, 2014, PHYSIOL BEHAV, V129, P135, DOI 10.1016/j.physbeh.2014.02.035; Bajbouj M, 2006, BIOL PSYCHIAT, V59, P395, DOI 10.1016/j.biopsych.2005.07.036; Banasr M, 2011, CURR OPIN CELL BIOL, V23, P730, DOI 10.1016/j.ceb.2011.09.002; Basar K, 2010, PROG NEUROBIOL, V92, P533, DOI 10.1016/j.pneurobio.2010.08.007; Beilharz TH, 2010, PROG MOL SUBCELL BIO, V50, P99, DOI 10.1007/978-3-642-03103-8_7; Bennett Paul, 2008, J Genet Couns, V17, P234, DOI 10.1007/s10897-007-9136-x; Bergstrom A, 2007, J MOL NEUROSCI, V33, P201, DOI 10.1007/s12031-007-0065-9; Bosch-Bouju M, 2016, CELL REP, V16, P1237, DOI 10.1016/j.celrep.2016.06.082; Camp NJ, 2005, TRENDS MOL MED, V11, P138, DOI 10.1016/j.molmed.2005.01.002; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Chen N, 2008, J CELL SCI, V121, P2961, DOI 10.1242/jcs.022368; Croarkin PE, 2011, NEUROSCI BIOBEHAV R, V35, P818, DOI 10.1016/j.neubiorev.2010.10.002; Dalmay T, 2013, ESSAYS BIOCHEM, V54, P29, DOI [10.1042/BSE0540029, 10.1042/bse0540029]; Day JJ, 2007, NEUROSCIENTIST, V13, P148, DOI 10.1177/1073858406295854; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dias C, 2014, NATURE, V516, P51, DOI 10.1038/nature13976; Duman CH, 2010, VITAM HORM, V82, P1, DOI 10.1016/S0083-6729(10)82001-1; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; Elizalde N, 2008, PSYCHOPHARMACOLOGY, V199, P1, DOI 10.1007/s00213-007-1035-1; Fadok JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012751; Feng J, 2017, NEUROPSYCHOPHARMACOL, V42, P1657, DOI 10.1038/npp.2017.6; Feng J, 2017, CEREB CORTEX, V27, P5858, DOI 10.1093/cercor/bhx292; Floresco SB, 2015, ANNU REV PSYCHOL, V66, P25, DOI 10.1146/annurev-psych-010213-115159; Francis TC, 2017, BIOL PSYCHIAT, V81, P645, DOI 10.1016/j.biopsych.2016.09.007; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gao ZL, 2019, BRAIN RES, V1721, DOI 10.1016/j.brainres.2019.146333; Gao ZL, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00285; Ge RJ, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-26; Ge RJ, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-19; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hamilton JP, 2013, NEUROBIOL DIS, V52, P4, DOI 10.1016/j.nbd.2012.01.015; Hammels C, 2015, NEUROSCI BIOBEHAV R, V59, P111, DOI 10.1016/j.neubiorev.2015.10.006; Haruno M, 2014, J COGNITIVE NEUROSCI, V26, P1861, DOI 10.1162/jocn_a_00589; Hettema JM, 2006, MOL PSYCHIATR, V11, P752, DOI 10.1038/sj.mp.4001845; Higuchi F, 2016, J NEUROSCI, V36, P7253, DOI 10.1523/JNEUROSCI.0319-16.2016; Hikida T, 2016, NEUROSCI RES, V108, P1, DOI 10.1016/j.neures.2016.01.004; Huang YH, 2011, BEHAV BRAIN RES, V216, P9, DOI 10.1016/j.bbr.2010.07.039; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jabbi M, 2008, ANN NY ACAD SCI, V1148, P42, DOI 10.1196/annals.1410.018; Karolewicz B, 2010, INT J NEUROPSYCHOPH, V13, P411, DOI 10.1017/S1461145709990587; Keers R, 2012, CURR PSYCHIAT REP, V14, P129, DOI 10.1007/s11920-011-0251-x; Khundakar A, 2011, INT PSYCHOGERIATR, V23, P644, DOI 10.1017/S1041610210001444; Kim KS, 2008, J NEUROCHEM, V107, P105, DOI 10.1111/j.1471-4159.2008.05592.x; Klengel T, 2013, CAN J PSYCHIAT, V58, P76, DOI 10.1177/070674371305800203; Kochenborger L, 2012, NEUROPHARMACOLOGY, V62, P427, DOI 10.1016/j.neuropharm.2011.08.019; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lei ZF, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00316; Levinson AJ, 2010, BIOL PSYCHIAT, V67, P458, DOI 10.1016/j.biopsych.2009.09.025; Li JZ, 2013, P NATL ACAD SCI USA, V110, P9950, DOI 10.1073/pnas.1305814110; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Lin LC, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00110; Liu BB, 2015, PSYCHOPHARMACOLOGY, V232, P541, DOI 10.1007/s00213-014-3690-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Lu W, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-38; Lv XH, 2014, EMBO REP, V15, P1305, DOI 10.15252/embr.201438923; Ma K, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.181; Ma K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159093; Maciag D, 2010, BIOL PSYCHIAT, V67, P465, DOI 10.1016/j.biopsych.2009.10.027; Manji HK, 2003, BIOL PSYCHIAT, V53, P707, DOI 10.1016/S0006-3223(03)00117-3; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; Monk CS, 2008, AM J PSYCHIAT, V165, P90, DOI 10.1176/appi.ajp.2007.06111917; Moreau MP, 2011, BIOL PSYCHIAT, V69, P188, DOI 10.1016/j.biopsych.2010.09.039; Moylan S, 2013, MOL PSYCHIATR, V18, P595, DOI 10.1038/mp.2012.33; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Orang AV, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/970607; Oruc L, 1997, NEUROPSYCHOBIOLOGY, V36, P62; Overstreet DH, 2012, METHODS MOL BIOL, V829, P125, DOI 10.1007/978-1-61779-458-2_7; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Plante DT, 2012, NEUROPSYCHOPHARMACOL, V37, P1548, DOI 10.1038/npp.2012.4; Price RB, 2009, BIOL PSYCHIAT, V65, P792, DOI 10.1016/j.biopsych.2008.10.025; Pujara M, 2014, NEUROSCIENTIST, V20, P82, DOI 10.1177/1073858413499407; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; Rajkowska G, 2015, J PSYCHIATR RES, V65, P53, DOI 10.1016/j.jpsychires.2015.04.010; Ravichandran V, 1997, J MOL NEUROSCI, V8, P159, DOI 10.1007/BF02736780; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Sanacora G, 2004, ARCH GEN PSYCHIAT, V61, P705, DOI 10.1001/archpsyc.61.7.705; Sandi C, 2015, NAT REV NEUROSCI, V16, P290, DOI 10.1038/nrn3918; Shen MM, 2019, PSYCHOPHARMACOLOGY, V236, P2119, DOI 10.1007/s00213-019-05209-z; Si YW, 2018, AM J MED GENET B, V177, P563, DOI 10.1002/ajmg.b.32651; Smalheiser NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033201; Smalheiser NR, 2011, INT J NEUROPSYCHOPH, V14, P1315, DOI 10.1017/S1461145710001628; Southwick SM, 2012, SCIENCE, V338, P79, DOI 10.1126/science.1222942; Sun XY, 2018, PROG NEURO-PSYCHOPH, V86, P150, DOI 10.1016/j.pnpbp.2018.05.023; Sun Y, 2019, J NEUROPHYSIOL, V122, P1002, DOI 10.1152/jn.00215.2019; Thomas KL, 2002, EUR J NEUROSCI, V16, P1789, DOI 10.1046/j.1460-9568.2002.02247.x; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Tzschentke TM, 2000, CRIT REV NEUROBIOL, V14, P131; Veeraiah P, 2014, BIOL PSYCHIAT, V76, P231, DOI 10.1016/j.biopsych.2013.09.024; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Volk N, 2016, CELL REP, V17, P1882, DOI 10.1016/j.celrep.2016.10.038; Volk N, 2014, J NEUROSCI, V34, P15070, DOI 10.1523/JNEUROSCI.0855-14.2014; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; Wang JH, 2001, J PHYSIOL-LONDON, V533, P407, DOI 10.1111/j.1469-7793.2001.0407a.x; Wang JL, 2018, INT SYM COMPUT INTEL, P7, DOI 10.1109/ISCID.2018.00008; Wang JH, 2008, J CELL SCI, V121, P2951, DOI 10.1242/jcs.025684; Wang Jin-Hui, 2019, F1000Res, V8, P457, DOI 10.12688/f1000research.18771.1; Wang Jin-Hui, 2017, F1000Res, V6, P283, DOI 10.12688/f1000research.11096.2; Wang JX, 2019, ANTIOXID REDOX SIGN, V31, P369, DOI 10.1089/ars.2018.7688; Wang W, 2010, NEUROPSYCHOPHARMACOL, V35, P2249, DOI 10.1038/npp.2010.99; Wang X, 2010, J NEUROSCI, V30, P12632, DOI 10.1523/JNEUROSCI.1264-10.2010; Waraczynski MA, 2006, NEUROSCI BIOBEHAV R, V30, P472, DOI 10.1016/j.neubiorev.2005.09.001; Wei J, 2004, NEUROSCIENCE, V127, P637, DOI 10.1016/j.neuroscience.2004.05.056; Wilde A, 2013, DEPRESS ANXIETY, V30, P267, DOI 10.1002/da.22000; Xu AP, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv122; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Yan FX, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5648390; Yang FC, 2014, NEUROBIOL LEARN MEM, V112, P186, DOI 10.1016/j.nlm.2013.07.017; Yang ZL, 2017, ONCOTARGET, V8, P72424, DOI 10.18632/oncotarget.19770; Yang ZL, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-1; Yu JD, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-26; Zhang FY, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-20; Zhang GJ, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-2; Zhu ZM, 2017, ONCOTARGET, V8, P35933, DOI 10.18632/oncotarget.16411	120	10	10	2	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6831	6848		10.1074/jbc.RA119.012047	http://dx.doi.org/10.1074/jbc.RA119.012047			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32209659	hybrid, Green Published			2022-12-26	WOS:000536212600006
J	Jarva, MA; Dramicanin, M; Lingford, JP; Mao, RY; John, A; Jarman, KE; Grinter, R; Goddard-Borger, ED				Jarva, Michael A.; Dramicanin, Marija; Lingford, James P.; Mao, Runyu; John, Alan; Jarman, Kate E.; Grinter, Rhys; Goddard-Borger, Ethan D.			Structural basis of substrate recognition and catalysis by fucosyltransferase 8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; fucosyltransferase; glycosyltransferase; substrate specificity; glycosylation; N-linked glycosylation; structural biology; enzyme mechanism; core fucose; enzyme evolution; fucosyltransferase 8 (FUT8); protein maturation	CORE FUCOSYLATION; MAMMALIAN ALPHA-1,6-FUCOSYL-TRANSFERASE; CELL-RECEPTOR; BINDING; FUT8; SPECIFICITY; MECHANISM; ACTIVATION; EXPRESSION; PHENOTYPE	Fucosylation of the innermost GlcNAc of N-glycans by fucosyltransferase 8 (FUT8) is an important step in the maturation of complex and hybrid N-glycans. This simple modification can dramatically affect the activities and half-lives of glycoproteins, effects that are relevant to understanding the invasiveness of some cancers, development of mAb therapeutics, and the etiology of a congenital glycosylation disorder. The acceptor substrate preferences of FUT8 are well-characterized and provide a framework for understanding N-glycan maturation in the Golgi; however, the structural basis of these substrate preferences and the mechanism through which catalysis is achieved remain unknown. Here we describe several structures of mouse and human FUT8 in the apo state and in complex with GDP, a mimic of the donor substrate, and with a glycopeptide acceptor substrate at 1.80?2.50 ? resolution. These structures provide insights into a unique conformational change associated with donor substrate binding, common strategies employed by fucosyltransferases to coordinate GDP, features that define acceptor substrate preferences, and a likely mechanism for enzyme catalysis. Together with molecular dynamics simulations, the structures also revealed how FUT8 dimerization plays an important role in defining the acceptor substrate-binding site. Collectively, this information significantly builds on our understanding of the core fucosylation process.	[Jarva, Michael A.; Dramicanin, Marija; Lingford, James P.; Mao, Runyu; John, Alan; Jarman, Kate E.; Goddard-Borger, Ethan D.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Jarva, Michael A.; Dramicanin, Marija; Lingford, James P.; Mao, Runyu; John, Alan; Jarman, Kate E.; Goddard-Borger, Ethan D.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Grinter, Rhys] Monash Univ, Monash Biomed Discovery Inst, Dept Microbiol, Clayton, Vic 3800, Australia	Walter & Eliza Hall Institute; University of Melbourne; Monash University	Goddard-Borger, ED (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.; Goddard-Borger, ED (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia.	goddard-borger.e@wehi.edu.au	John, Alan/AAX-1829-2020	John, Alan/0000-0002-6855-5470; Lingford, James/0000-0003-1980-3949; Dramicanin, Marija/0000-0003-3677-4019; Grinter, Rhys/0000-0002-8195-5348; Goddard-Borger, Ethan/0000-0002-8181-9733; Mao, Runyu/0000-0001-5267-3328; Jarva, Michael Antonio/0000-0002-8519-5622	Walter and Eliza Hall Institute of Medical Research; National Health and Medical Research Council of Australia [GNT1139549]; Australian Cancer Research Fund; Victorian State Government Operational Infrastructure support grant	Walter and Eliza Hall Institute of Medical Research; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Fund; Victorian State Government Operational Infrastructure support grant	This work was supported by The Walter and Eliza Hall Institute of Medical Research, National Health and Medical Research Council of Australia Project Grant GNT1139549, the Australian Cancer Research Fund, and a Victorian State Government Operational Infrastructure support grant. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agrawal P, 2017, CANCER CELL, V31, P804, DOI 10.1016/j.ccell.2017.05.007; AOYAGI Y, 1985, LANCET, V2, P1353; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Brzezinski K, 2012, ACTA CRYSTALLOGR D, V68, P160, DOI 10.1107/S0907444911053157; Calderon AD, 2016, ORG BIOMOL CHEM, V14, P4027, DOI 10.1039/c6ob00586a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii H, 2016, GASTROENTEROLOGY, V150, P1620, DOI 10.1053/j.gastro.2016.03.002; Fukuda T, 2011, J BIOL CHEM, V286, P18434, DOI 10.1074/jbc.M110.172536; Garcia-Garcia A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14794-z; Herrera H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102528; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ihara H, 2006, GLYCOBIOLOGY, V16, P333, DOI 10.1093/glycob/cwj068; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Iijima J, 2017, GLYCOBIOLOGY, V27, P1006, DOI 10.1093/glycob/cwx075; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaminska J, 1998, GLYCOCONJUGATE J, V15, P783, DOI 10.1023/A:1006959915435; Kirby N, 2016, ACTA CRYSTALLOGR D, V72, P1254, DOI 10.1107/S2059798316017174; Kirby NM, 2013, J APPL CRYSTALLOGR, V46, P1670, DOI 10.1107/S002188981302774X; Kotzler MP, 2013, ACS CHEM BIOL, V8, P1830, DOI 10.1021/cb400140u; Kotzler MP, 2012, BBA-GEN SUBJECTS, V1820, P1915, DOI 10.1016/j.bbagen.2012.08.018; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Li WZ, 2015, J IMMUNOL, V194, P2596, DOI 10.4049/jimmunol.1402678; Li ZJ, 2017, NAT CHEM BIOL, V13, P757, DOI 10.1038/nchembio.2381; Liang W, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00078; Lin HL, 2011, AM J PHYSIOL-RENAL, V300, pF1017, DOI 10.1152/ajprenal.00426.2010; Lira-Navarrete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025365; Manabe Y, 2019, ANGEW CHEM INT EDIT, V58, P18697, DOI 10.1002/anie.201911875; Matsumoto K, 2008, CANCER SCI, V99, P1611, DOI 10.1111/j.1349-7006.2008.00847.x; Nakayama K, 2019, J BIOCHEM, V165, P227, DOI 10.1093/jb/mvy098; Ng BG, 2018, AM J HUM GENET, V102, P188, DOI 10.1016/j.ajhg.2017.12.009; Niwa R, 2005, J IMMUNOL METHODS, V306, P151, DOI 10.1016/j.jim.2005.08.009; Okada M, 2017, CELL REP, V20, P1017, DOI 10.1016/j.celrep.2017.07.027; Okazaki A, 2004, J MOL BIOL, V336, P1239, DOI 10.1016/j.jmb.2004.01.007; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Takahashi T, 2000, GLYCOBIOLOGY, V10, P503, DOI 10.1093/glycob/10.5.503; Thaysen-Andersen M, 2012, GLYCOBIOLOGY, V22, P1440, DOI 10.1093/glycob/cws110; Tseng TH, 2017, J AM CHEM SOC, V139, P9431, DOI 10.1021/jacs.7b03729; Tu CF, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0904-8; Urbanowicz BR, 2017, PLANT J, V91, P931, DOI 10.1111/tpj.13628; Valero-Gonzalez J, 2016, NAT CHEM BIOL, V12, P240, DOI [10.1038/NCHEMBIO.2019, 10.1038/nchembio.2019]; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2009, J BIOCHEM, V145, P643, DOI 10.1093/jb/mvp022; Yang Q, 2017, J BIOL CHEM, V292, P14796, DOI 10.1074/jbc.M117.804070	48	11	11	5	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6677	6688		10.1074/jbc.RA120.013291	http://dx.doi.org/10.1074/jbc.RA120.013291			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32220931	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000537685000033
J	Morgan, SA; Lavenir, I; Fan, J; Masuda-Suzukake, M; Passarella, D; DeTure, MA; Dickson, DW; Ghetti, B; Goedert, M				Morgan, Sophie A.; Lavenir, Isabelle; Fan, Juan; Masuda-Suzukake, Masami; Passarella, Daniela; DeTure, Michael A.; Dickson, Dennis W.; Ghetti, Bernardino; Goedert, Michel			?-Synuclein filaments from transgenic mouse and human synucleinopathy-containing brains are major seed-competent species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein (?-synuclein); oligomer; neurodegeneration; Parkinson disease; fibril; brain disease; Lewy body; multiple system atrophy; seeded aggregation; synucleinopathy	MULTIPLE SYSTEM ATROPHY; PATHOLOGICAL ALPHA-SYNUCLEIN; GLIAL CYTOPLASMIC INCLUSIONS; PARKINSONS-DISEASE; LEWY BODIES; OLIVOPONTOCEREBELLAR ATROPHY; MUTATION; TRANSMISSION; NEURONS; PRIONS	Assembled ?-synuclein in nerve cells and glial cells is the defining pathological feature of neurodegenerative diseases called synucleinopathies. Seeds of ?-synuclein can induce the assembly of monomeric protein. Here, we used sucrose gradient centrifugation and transiently transfected HEK 293T cells to identify the species of ?-synuclein from the brains of homozygous, symptomatic mice transgenic for human mutant A53T ?-synuclein (line M83) that seed aggregation. The most potent fractions contained Sarkosyl-insoluble assemblies enriched in filaments. We also analyzed six cases of idiopathic Parkinson's disease (PD), one case of familial PD, and six cases of multiple system atrophy (MSA) for their ability to induce ?-synuclein aggregation. The MSA samples were more potent than those of idiopathic PD in seeding aggregation. We found that following sucrose gradient centrifugation, the most seed-competent fractions from PD and MSA brains are those that contain Sarkosyl-insoluble ?-synuclein. The fractions differed between PD and MSA, consistent with the presence of distinct conformers of assembled ?-synuclein in these different samples. We conclude that ?-synuclein filaments are the main driving force for amplification and propagation of pathology in synucleinopathies.	[Morgan, Sophie A.; Lavenir, Isabelle; Fan, Juan; Masuda-Suzukake, Masami; Passarella, Daniela; Goedert, Michel] MRC, Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [DeTure, Michael A.; Dickson, Dennis W.] Mayo Clin, Jacksonville, FL 32224 USA; [Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Goedert, Michel] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	MRC Laboratory Molecular Biology; Mayo Clinic; Indiana University System; Indiana University Bloomington; University of Cambridge	Goedert, M (corresponding author), MRC, Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	mg@mrc-lmb.cam.ac.uk		Passarella, Daniela/0000-0002-6145-2874; Masuda-Suzukake, Masami/0000-0001-6760-1669; Morgan, Sophie/0000-0002-5542-4324	United Kingdom Medical Research Council [MC_U105184291]; National Institutes of Health NIA [PHS P30 AG01033]; MRC [MC_U105184291] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the United Kingdom Medical Research Council Grant MC_U105184291 (to M. G.) and National Institutes of Health NIA Grant PHS P30 AG01033 (to B. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Aulic S, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-69; Ayers JI, 2017, J VIROL, V91, DOI 10.1128/JVI.02095-16; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2017, J PARKINSON DIS, V7, pS73, DOI 10.3233/JPD-179001; Breid S, 2016, J VIROL, V90, P9182, DOI 10.1128/JVI.01399-16; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Corriveau RA, 2017, NEUROLOGY, V89, P2381, DOI 10.1212/WNL.0000000000004717; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Crowther RA, 2000, NEUROSCI LETT, V292, P128, DOI 10.1016/S0304-3940(00)01440-3; Cykowski MD, 2015, BRAIN, V138, P2293, DOI 10.1093/brain/awv114; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Fanciulli A, 2015, NEW ENGL J MED, V372, P249, DOI 10.1056/NEJMra1311488; Froula JM, 2019, J BIOL CHEM, V294, P10392, DOI 10.1074/jbc.RA119.007743; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goedert M, 2017, J PARKINSON DIS, V7, pS53, DOI 10.3233/JPD-179005; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Jackson SJ, 2016, J NEUROSCI, V36, P762, DOI 10.1523/JNEUROSCI.3542-15.2016; Jellinger KA, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1016-8; Karpowicz RJ, 2019, LAB INVEST, V99, P971, DOI 10.1038/s41374-019-0195-z; KATO S, 1990, ACTA NEUROPATHOL, V79, P584, DOI 10.1007/BF00294235; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Kim S, 2019, NEURON, V103, P627, DOI 10.1016/j.neuron.2019.05.035; Klingstedt T, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0840-1; Konno T, 2016, PARKINSONISM RELAT D, V22, pS1, DOI 10.1016/j.parkreldis.2015.09.007; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; KOSAKA K, 1978, ACTA NEUROPATHOL, V42, P127, DOI 10.1007/BF00690978; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lavenir I, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0804-5; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Logan T, 2017, NAT NEUROSCI, V20, P681, DOI 10.1038/nn.4529; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Mirbaha H, 2018, ELIFE, V7, DOI 10.7554/eLife.36584; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Osterberg VR, 2015, CELL REP, V10, P1252, DOI 10.1016/j.celrep.2015.01.060; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Peelaerts W, 2018, CELL TISSUE RES, V373, P195, DOI 10.1007/s00441-018-2839-5; Peng C, 2018, NATURE, V557, P558, DOI 10.1038/s41586-018-0104-4; Perrin RJ, 2003, NEUROSCI LETT, V349, P133, DOI 10.1016/S0304-3940(03)00781-X; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Sacino AN, 2014, P NATL ACAD SCI USA, V111, P10732, DOI 10.1073/pnas.1321785111; Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Tarutani A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0532-2; Tarutani A, 2016, J BIOL CHEM, V291, P18675, DOI 10.1074/jbc.M116.734707; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Woerman AL, 2018, ACTA NEUROPATHOL, V135, P49, DOI 10.1007/s00401-017-1762-2; Woerman AL, 2015, P NATL ACAD SCI USA, V112, pE4949, DOI 10.1073/pnas.1513426112; Yamasaki TR, 2019, J BIOL CHEM, V294, P1045, DOI 10.1074/jbc.RA118.004471; Yoshino H, 2017, NEUROBIOL AGING, V57, DOI 10.1016/j.neurobiolaging.2017.05.022; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	74	13	13	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6652	6664		10.1074/jbc.RA119.012179	http://dx.doi.org/10.1074/jbc.RA119.012179			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32209651	Green Published, hybrid			2022-12-26	WOS:000537685000031
J	Poston, RG; Murphy, L; Rejepova, A; Ghaninejad-Esfahani, M; Segales, J; Mulligan, K; Saha, RN				Poston, Robert G.; Murphy, Lillian; Rejepova, Ayna; Ghaninejad-Esfahani, Mina; Segales, Joshua; Mulligan, Kimberly; Saha, Ramendra N.			Certain ortho-hydroxylated brominated ethers are promiscuous kinase inhibitors that impair neuronal signaling and neurodevelopmental processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						toxin; toxicology; axon; Drosophila; signal transduction; 6-OH?BDE-47; environmental toxins; MEK?ERK; neurodevelopmental toxicity; PBDE	POLYBROMINATED DIPHENYL ETHERS; ENDOCRINE-DISRUPTING CHEMICALS; ACTIVATED PROTEIN-KINASE; MAP KINASE; ANTIMICROBIAL SUBSTANCES; PRESYNAPTIC PLASTICITY; CALCIUM HOMEOSTASIS; CRYSTAL-STRUCTURES; FLAME RETARDANTS; HUMAN EXPOSURE	The developing nervous system is remarkably sensitive to environmental signals, including disruptive toxins, such as polybrominated diphenyl ethers (PBDEs). PBDEs are an environmentally pervasive class of brominated flame retardants whose neurodevelopmental toxicity mechanisms remain largely unclear. Using dissociated cortical neurons from embryonic Rattus norvegicus, we found here that chronic exposure to 6-OH?BDE-47, one of the most prevalent hydroxylated PBDE metabolites, suppresses both spontaneous and evoked neuronal electrical activity. On the basis of our previous work on mitogen-activated protein kinase (MAPK)/extracellular signal-related kinase (ERK) (MEK) biology and our observation that 6-OH?BDE-47 is structurally similar to kinase inhibitors, we hypothesized that certain hydroxylated PBDEs mediate neurotoxicity, at least in part, by impairing the MEK?ERK axis of MAPK signal transduction. We tested this hypothesis on three experimental platforms: 1) in silico, where modeling ligand?protein docking suggested that 6-OH?BDE-47 is a promiscuous ATP-competitive kinase inhibitor; 2) in vitro in dissociated neurons, where 6-OH?BDE-47 and another specific hydroxylated BDE metabolite similarly impaired phosphorylation of MEK/ERK1/2 and activity-induced transcription of a neuronal immediate early gene; and 3) in vivo in Drosophila melanogaster, where developmental exposures to 6-OH?BDE-47 and a MAPK inhibitor resulted in offspring displaying similarly increased frequency of mushroom-body ??lobe midline crossing, a metric of axonal guidance. Taken together, our results support that certain ortho-hydroxylated PBDE metabolites are promiscuous kinase inhibitors and can cause disruptions of critical neurodevelopmental processes, including neuronal electrical activity, pre-synaptic functions, MEK?ERK signaling, and axonal guidance.	[Poston, Robert G.; Rejepova, Ayna; Ghaninejad-Esfahani, Mina; Segales, Joshua; Saha, Ramendra N.] Univ Calif Merced, Sch Nat Sci, Mol & Cell Biol Dept, Merced, CA 95343 USA; [Murphy, Lillian; Mulligan, Kimberly] Calif State Univ Sacramento, Dept Biol Sci, Ctr Interdisciplinary Mol Biol Educ Res & Adv CIM, Sacramento, CA 95819 USA	University of California System; University of California Merced; California State University System; California State University Sacramento	Saha, RN (corresponding author), Univ Calif Merced, Rm 346,S&E Bldg 1,5200 North Lake Rd, Merced, CA 95343 USA.	rsaha3@ucmerced.edu	Saha, Ramendra/C-7000-2014	Saha, Ramendra/0000-0002-5494-2584; Murphy, Lillian/0000-0003-3015-808X	National Institutes of Health NIGMS-RISE Grant [R25GM122667]; NIEHS [R01ES028738]	National Institutes of Health NIGMS-RISE Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health NIGMS-RISE Grant R25GM122667 for the Drosophila portion of the study and by NIEHS Grant R01ES028738 (to R. N. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2017, NAT CHEM BIOL, V13, P537, DOI [10.1038/NCHEMBIO.2330, 10.1038/nchembio.2330]; Agarwal V, 2014, NAT CHEM BIOL, V10, P640, DOI 10.1038/nchembio.1564; Ageta-Ishihara N, 2009, J NEUROSCI, V29, P13720, DOI 10.1523/JNEUROSCI.3018-09.2009; Agnew C, 2019, J BIOL CHEM, V294, P13545, DOI 10.1074/jbc.RA119.009725; [Anonymous], ERK1 2 SIGNALLING DY; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112; Barf T, 2011, BIOORG MED CHEM LETT, V21, P3818, DOI 10.1016/j.bmcl.2011.04.018; Bramwell L, 2016, ENVIRON INT, V92-93, P680, DOI 10.1016/j.envint.2016.02.017; Braun JM, 2014, ENVIRON HEALTH PERSP, V122, P513, DOI 10.1289/ehp.1307261; Brown JP, 2016, TOXICOL SCI, V154, P126, DOI 10.1093/toxsci/kfw147; Bulow HE, 2004, NEURON, V42, P367, DOI 10.1016/S0896-6273(04)00246-6; Burkholder P. R, 1969, Lloydia, V32, P466; BUSSAU LJ, 1993, CLIN EXP PHARMACOL P, V20, P697, DOI 10.1111/j.1440-1681.1993.tb01654.x; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Charlesworth P, 2015, NEURAL DEV, V10, DOI 10.1186/s13064-014-0028-0; Chen HX, 2015, P NATL ACAD SCI USA, V112, pE5936, DOI 10.1073/pnas.1516319112; Chen H, 2017, TOXICOL SCI, V156, P375, DOI 10.1093/toxsci/kfw259; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Costa LG, 2014, TOXICOL LETT, V230, P282, DOI 10.1016/j.toxlet.2013.11.011; Dingemans MML, 2008, ENVIRON HEALTH PERSP, V116, P637, DOI 10.1289/ehp.11059; Dingemans MML, 2011, ENVIRON HEALTH PERSP, V119, P900, DOI 10.1289/ehp.1003035; Dorman DC, 2018, J TOXICOL ENV HEAL B, V21, P269, DOI 10.1080/10937404.2018.1514829; Erratico CA, 2013, CHEM RES TOXICOL, V26, P721, DOI 10.1021/tx300522u; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; Forli S, 2016, NAT PROTOC, V11, P905, DOI 10.1038/nprot.2016.051; Frank CL, 2017, TOXICOL SCI, V160, P121, DOI 10.1093/toxsci/kfx169; Frederiksen M, 2009, INT J HYG ENVIR HEAL, V212, P109, DOI 10.1016/j.ijheh.2008.04.005; Fu ZQ, 2016, ENVIRON SCI TECHNOL, V50, P8155, DOI 10.1021/acs.est.6b00524; Gassmann K, 2014, ARCH TOXICOL, V88, P1537, DOI 10.1007/s00204-014-1217-7; Giachello CNG, 2010, J CELL SCI, V123, P881, DOI 10.1242/jcs.056846; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Heald RA, 2012, J MED CHEM, V55, P4594, DOI 10.1021/jm2017094; Hertz-Picciotto I, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-1; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang SPC, 2010, TOXICOL SCI, V114, P124, DOI 10.1093/toxsci/kfp296; Igarashi M, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0476-x; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Kim K, 2018, J MOL BIOL, V430, P1521, DOI 10.1016/j.jmb.2018.04.001; Kumar A, 2005, J MOL BIOL, V348, P183, DOI 10.1016/j.jmb.2005.02.039; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; Lake D, 2016, CELL MOL LIFE SCI, V73, P4397, DOI 10.1007/s00018-016-2297-8; Lam J, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1632; Li T, 2013, TOXICOL SCI, V134, P111, DOI 10.1093/toxsci/kft083; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Li ZG, 2006, DEV GROWTH DIFFER, V48, P513, DOI 10.1111/j.1440-169x.2006.00889.x; Linares V, 2015, ARCH TOXICOL, V89, P335, DOI 10.1007/s00204-015-1457-1; Feo ML, 2013, ENVIRON HEALTH PERSP, V121, P440, DOI 10.1289/ehp.1205446; Lupton SJ, 2009, CHEM RES TOXICOL, V22, P1802, DOI 10.1021/tx900215u; Lyall K, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/ehp1079; Lyons MR, 2011, PROG NEUROBIOL, V94, P259, DOI 10.1016/j.pneurobio.2011.05.003; Malmberg T, 2005, ENVIRON SCI TECHNOL, V39, P5342, DOI 10.1021/es050574+; Malmvarn A, 2005, ENVIRON SCI TECHNOL, V39, P2990, DOI 10.1021/es0482886; Malmvarn A, 2008, CHEMOSPHERE, V72, P910, DOI 10.1016/j.chemosphere.2008.03.036; Mao LM, 2016, MOL NEUROBIOL, V53, P6309, DOI 10.1007/s12035-015-9535-1; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Messer A, 2010, PHYSIOL BEHAV, V100, P245, DOI 10.1016/j.physbeh.2010.01.011; Michel CI, 2004, J NEUROSCI, V24, P5798, DOI 10.1523/JNEUROSCI.1102-04.2004; Miksys S, 2004, DRUG METAB REV, V36, P313, DOI 10.1081/DMR-120034149; Millan MJ, 2013, NEUROPHARMACOLOGY, V68, P2, DOI 10.1016/j.neuropharm.2012.11.015; Mitchell MM, 2012, ENVIRON MOL MUTAGEN, V53, P589, DOI 10.1002/em.21722; Napoli E, 2013, TOXICOL SCI, V132, P196, DOI 10.1093/toxsci/kfs339; National Academies of Sciences Engineering and Medicine, 2017, APPL SYST REV METH O; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Pacyniak EK, 2007, TOXICOL SCI, V97, P94, DOI 10.1093/toxsci/kfm025; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Poston RG, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16152703; Poston RG, 2018, ENVIRON EPIGENETICS, V4, DOI 10.1093/eep/dvx020; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Rhim JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26547; Samuels IS, 2009, NEURON, V61, P160, DOI 10.1016/j.neuron.2009.01.001; Schenk U, 2005, J NEUROSCI, V25, P1654, DOI 10.1523/JNEUROSCI.3074-04.2005; Schmitt JM, 2005, J NEUROSCI, V25, P1281, DOI 10.1523/JNEUROSCI.4086-04.2005; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; Shafer TJ, 2019, TOXICOL SCI, V169, P436, DOI 10.1093/toxsci/kfz052; SHARMA GM, 1967, TETRAHEDRON LETT, P4147; SHARMA GM, 1970, J ORG CHEM, V35, P2823, DOI 10.1021/jo00833a084; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Sueyoshi T, 2014, TOXICOL SCI, V137, P292, DOI 10.1093/toxsci/kft243; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Tang FJ, 2005, J NEUROSCI, V25, P6702, DOI 10.1523/JNEUROSCI.0871-05.2005; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Traglia M, 2017, G3-GENES GENOM GENET, V7, P1287, DOI 10.1534/g3.117.039784; Trasande L, 2015, J CLIN ENDOCR METAB, V100, P1245, DOI 10.1210/jc.2014-4324; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tyssowski KM, 2018, NEURON, V98, P530, DOI 10.1016/j.neuron.2018.04.001; U. S. Environmental Protection Agency Office of Research and Development National Center for Environmental Assessment, 2010, EPA600R08086F; UNSON MD, 1994, MAR BIOL, V119, P1, DOI 10.1007/BF00350100; Van Boxtel AL, 2008, ENVIRON SCI TECHNOL, V42, P1773, DOI 10.1021/es0720863; Vara H, 2009, P NATL ACAD SCI USA, V106, P9872, DOI 10.1073/pnas.0900077106; Vuong AM, 2018, HORM BEHAV, V101, P94, DOI 10.1016/j.yhbeh.2017.11.008; Wahl M, 2010, TOXICOL LETT, V198, P119, DOI 10.1016/j.toxlet.2010.06.001; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wong S, 2016, CNS NEUROL DISORD-DR, V15, P614, DOI 10.2174/1871527315666160413122624; Woods R, 2012, HUM MOL GENET, V21, P2399, DOI 10.1093/hmg/dds046; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Xing L, 2016, ELIFE, V5, DOI 10.7554/elite.11123; Yang JH, 2017, MOL NEUROBIOL, V54, P7156, DOI 10.1007/s12035-016-0225-4; Ye BS, 2017, ENVIRON POLLUT, V227, P234, DOI 10.1016/j.envpol.2017.04.039; Zha MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044828; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhao Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179936; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882	111	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6120	6137		10.1074/jbc.RA119.011138	http://dx.doi.org/10.1074/jbc.RA119.011138			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32229587	Green Published, hybrid			2022-12-26	WOS:000531417300022
J	Agena, AG; Modiba, LM				Agena, Alemayehu Gebremariam; Modiba, Lebitsi M.			Labour admission assessment results of index pregnancy as predictors of intrapartum stillbirth in public health facilities of Addis Ababa: A case-control study	PLOS ONE			English	Article							NULLIPAROUS WOMEN; LOW-RISK	Background Approximately one-third of the global stillbirth burden occurs during intrapartum period. The ability to assess obstetric parameters including effacement, dilatation, uterine contraction, decent, rupture of the uterus, and moulding of the foetal head are among the essential competencies required by obstetric service providers admitting women for labour in health facilities. Misdiagnosis of these conditions could result in unnecessary obstetric interventions and unfavourable obstetric outcomes including intrapartum stillbirth. This study aimed to assess associations between missed diagnosis plus complication of labour on admission and intrapartum stillbirth. Methods A case-control study using primary data from chart review of medical records of women who experienced intrapartum stillbirth in 20 public health centres and three public hospitals of Addis Ababa between 01 July 2010 and 30 June 2015 was conducted. Data were collected from charts of all cases meeting the inclusion criteria. Medical records of women with livebirths were randomly selected and reviewed from each public health facilities in two to one (2:1) control to case ratio. Accordingly, 728 cases of stillbirth out of 1,056 charts met the inclusion criteria whereas 1,551 controls out of 1,705 were also considered in the study. Results Proportionally, more women in the stillbirth group (39.4%) than in the livebirth group (30.2%) experienced ruptured membrane on admission, with the difference being statistically significant (OR 1.7, 95% CI 1.37-2.03). Significantly higher proportion of women in the intrapartum stillbirth group experienced FRH lower than 110/min, a result suggestive of foetal distress on admission. Proportionally, more women in the intrapartum stillbirth group (14.5%) than in the livebirth group (4.5%) had breech foetal presentation on admission for labour, the difference being statistically significant (aOR 3.26 95% CI 1.93-5.50). Intrapartum stillbirth was slightly higher among women with cervical dilatation 4cm or more on admission (OR 1.2, 95% CI 1.00-1.45). This could be owing to delay in seeking obstetric care or misdiagnosis of the condition, a situation that seeks more rigorous study to determine the underlying causal links. Diagnosis of foetal member was missed among more cases than controls where the difference was statistically significant (aOR 1.51, CI 1.03-2.19). Conclusion Low FHR, non-vertex foetal presentations and ruptured cervical membrane were predictors of intrapartum stillbirth. Health facilities could avert unnecessary foetal loss by undertaking timely actions to manage obstetric emergencies on admission to labour.	[Modiba, Lebitsi M.] Univ South Africa, Coll Human Sci, Dept Hlth Studies, Pretoria, South Africa	University of South Africa		alemayehug2000@gmail.com	Gebremariam Agena, Alemayehu/GOP-0604-2022	Gebremariam Agena, Alemayehu/0000-0002-0638-3490	University of South Africa	University of South Africa	The University of South Africa provided partial funding whereas the remaining expenses were covered by the corresponding author.	Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Clotrida C, 2014, BMC PREGNANCY CHILDB, V14, P1; Ferreira JCP, 2015, ACTA OBSTET GYN SCAN, V94, P660, DOI 10.1111/aogs.12626; FMOH, 2010, HLTH HLTH REL IND; Hanley GE, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0857-4; Joy EL, 2010, BMC PREGNANCY CHI S1, V10, P1471; Kennedy B, 2017, INTRAPARTUM MANAGEME; Kjaergaard H, 2008, BMC PREGNANCY CHILDB, V8, P1; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Maaloe N, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1142-2; Marshall J.E., 2014, MYLES TXB MIDWIVES, V16th; Mikolajczyk RT, 2016, FRONT MED, V3, P1; Nassar N, 2006, BMJ-BRIT MED J, V333, P578, DOI 10.1136/bmj.38919.681563.4F; Neal JL, 2012, MED HYPOTHESES, V78, P319, DOI 10.1016/j.mehy.2011.11.012; Neal JL, 2010, J MIDWIFERY WOM HEAL, V55, P308, DOI 10.1016/j.jmwh.2009.08.004; Njemba MJ, 2018, J MATERN-FETAL NEO M, V32, P1; Rahman H, 2012, AUSTRALAS MED J, V5, P522, DOI 10.4066/AMJ.2012.1267; Sandhu G S, 2008, Med J Armed Forces India, V64, P43, DOI 10.1016/S0377-1237(08)80145-1; Sharma G, 2017, B WORLD HEALTH ORGAN, V95, P419, DOI [10.2471/BLT.16.179291, 10.2471/blt.16.179291]; Wayu A, 2014, BMC PREGNANCY CHILDB, V14, P1; World Health Organization, 1994, PART APPL WHO PART M; Zhang HL, 2015, EXP THER MED, V10, P561, DOI 10.3892/etm.2015.2559	22	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230478	10.1371/journal.pone.0230478	http://dx.doi.org/10.1371/journal.pone.0230478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240197	gold, Green Published			2022-12-26	WOS:000535945000027
J	Habimana, R; Okeno, TO; Ngeno, K; Mboumba, S; Assami, P; Gbotto, AA; Keambou, CT; Nishimwel, K; Mahorol, J; Yao, N				Habimana, Richard; Okeno, Tobias Otieno; Ngeno, Kiplangat; Mboumba, Sylvere; Assami, Pauline; Gbotto, Anique Ahou; Keambou, Christian Tiambo; Nishimwel, Kizito; Mahorol, Janvier; Yao, Nasser			Genetic diversity and population structure of indigenous chicken in Rwanda using microsatellite markers	PLOS ONE			English	Article							NATIVE CHICKENS; BREEDS; VARIABILITY; OBJECTIVES; DISTANCES; SOFTWARE	Rwanda has about 4.5 million of indigenous chicken (IC) that are very low in productivity. To initiate any genetic improvement programme, IC needs to be accurately characterized. The key purpose of this study was to ascertain the genetic diversity of IC in Rwanda using micro-satellite markers. Blood samples of IC sampled from 5 agro-ecological zones were collected from which DNA was extracted, amplified by PCR and genotyped using 28 microsatellite markers. A total of 325 (313 indigenous and 12 exotic) chickens were genotyped and revealed a total number of 305 alleles varying between 2 and 22 with a mean of 10.89 per locus. One hundred eighty-six (186) distinct alleles and 60 private alleles were also observed. The frequency of private alleles was highest in samples from the Eastern region, whereas those from the North West had the lowest. The influx of genes was lower in the Eastern agro-ecological zone than the North West. The mean observed heterozygosity was 0.6155, whereas the average expected heterozygosity was 0.688. The overall inbreeding coefficient among the population was 0.040. Divergence from the Hardy-Weinberg equilibrium was significant (p<0.05) in 90% of loci in all the populations. The analysis of molecular variance revealed that about 92% of the total variation originated from variation within populations. Additionally, the study demonstrated that IC in Rwanda could be clustered into four gene groups. In conclusion, there was considerable genetic diversity in IC in Rwanda, which represents a crucial genetic resource that can be conserved or optimized through genetic improvement.	[Habimana, Richard; Nishimwel, Kizito; Mahorol, Janvier] Univ Rwanda, Coll Agr, Anim Sci & Vet Med, Nyagatare, Rwanda; [Habimana, Richard; Okeno, Tobias Otieno; Ngeno, Kiplangat] Egerton Univ, Dept Anim Sci, Anim Breeding & Genom Grp, Nakuru, Kenya; [Mboumba, Sylvere] Masuku Univ Sci & Tech, Fac Agron & Biotechnol, Franceville, Gabon; [Assami, Pauline; Keambou, Christian Tiambo; Yao, Nasser] Int Livestock Res Inst Hub, Biosci Eastern & Cent Africa, Nairobi, Kenya; [Gbotto, Anique Ahou] Univ Nangui Abrogoua, Lab Genom Fonct & Ameliorat Genet, Abidjan, Cote Ivoire; [Keambou, Christian Tiambo] Univ Buea, Fac Agr & Vet Med, Buea, Cameroon	University of Rwanda; Egerton University	Habimana, R (corresponding author), Univ Rwanda, Coll Agr, Anim Sci & Vet Med, Nyagatare, Rwanda.; Habimana, R (corresponding author), Egerton Univ, Dept Anim Sci, Anim Breeding & Genom Grp, Nakuru, Kenya.	hrichard86@yahoo.com	HABIMANA, Richard/GRF-4197-2022	HABIMANA, Richard/0000-0002-5166-630X	BecA-ILRI Hub through Africa Biosciences Challenge Fund (ABCF) programmes; Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership; Syngenta Foundation for Sustainable Agriculture (SFSA); Bill & Melinda Gates Foundation (BMGF); UK Department for International Development (DFID); Swedish International Development Cooperation Agency (SIDA); United States Agency for International Development, as part of the Feed the Future initiative, under the CGIAR Fund [BFS-G-11-00002]; predecessor fund the Food Security and Crisis Mitigation II grant [EEM-G-00-04-00013]	BecA-ILRI Hub through Africa Biosciences Challenge Fund (ABCF) programmes; Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership(Australian Government); Syngenta Foundation for Sustainable Agriculture (SFSA)(Syngenta); Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); UK Department for International Development (DFID); Swedish International Development Cooperation Agency (SIDA); United States Agency for International Development, as part of the Feed the Future initiative, under the CGIAR Fund(United States Agency for International Development (USAID)); predecessor fund the Food Security and Crisis Mitigation II grant	This study was part of PhD research of the first author and he is thankful to the financial and technical support from BecA-ILRI Hub through Africa Biosciences Challenge Fund (ABCF) programmes. The ABCF Programmes is funded by the Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership; the Syngenta Foundation for Sustainable Agriculture (SFSA); the Bill & Melinda Gates Foundation (BMGF); the UK Department for International Development (DFID) and the Swedish International Development Cooperation Agency (SIDA). This material is also based upon work supported by the United States Agency for International Development, as part of the Feed the Future initiative, under the CGIAR Fund, award number BFS-G-11-00002, and the predecessor fund the Food Security and Crisis Mitigation II grant, award number EEM-G-00-04-00013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, 5000 CNRS UMR; AshleyM V, 1994, USE MICROSATELLITE A, P185, DOI [10.1007/978-3-0348-7527-1_10, DOI 10.1007/978-3-0348-7527-1_10]; Berthouly C, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-1; Boettcher PJ, 2010, ANIM GENET, V41, P64, DOI 10.1111/j.1365-2052.2010.02050.x; BRUFORD MW, 1993, CURR OPIN GENET DEV, V3, P939, DOI 10.1016/0959-437X(93)90017-J; Chen GH, 2008, ASIAN AUSTRAL J ANIM, V21, P331, DOI 10.5713/ajas.2008.70125; Cheng HW, 2010, POULTRY SCI, V89, P805, DOI 10.3382/ps.2009-00361; Clay DC, 1987, TROPICULTURA, P153; Clementino C. S., 2010, International Journal of Poultry Science, V9, P1100; Cuc NTK, 2006, INT J POULTRY SCI, V5, P905, DOI 10.3923/ijps.2006.905.911; Dana N., 2011, BREEDING PROGRAMS IN; Dana N, 2010, TROP ANIM HEALTH PRO, V42, P1519, DOI 10.1007/s11250-010-9602-6; Dawson DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-176; Ding FX, 2010, ASIAN AUSTRAL J ANIM, V23, P154; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eltanany M, 2011, ANIM GENET, V42, P666, DOI 10.1111/j.1365-2052.2011.02185.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FAO, 2011, AN PROD HLTH GUID, V9; Francis M., 2016, International Journal of Livestock Production, V7, P76; Garke C, 2012, ANIM GENET, V43, P419, DOI 10.1111/j.1365-2052.2011.02284.x; Getu A, 2014, INT J GENET, V2014, P4, DOI [10.5829/idosi.ijg.2014.4.1.8523, DOI 10.5829/IDOSI.IJG.2014.4.1.8523]; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hassen H, 2009, AFR J BIOTECHNOL, V8, P1347; Hirwa C. D., 2019, International Journal of Livestock Production, V10, P213; Huo JL, 2014, GENET MOL RES, V13, P3371, DOI 10.4238/2014.April.29.16; ISAG/FAO Standing Committee, 2004, 2 GUID DEV NAT FARM; Kaya M, 2008, BIOCHEM GENET, V46, P480, DOI 10.1007/s10528-008-9164-8; Keambou T. C., 2014, International Journal of Poultry Science, V13, P279; Laval G, 2002, GENET SEL EVOL, V34, P481, DOI [10.1051/gse:2002019, 10.1186/1297-9686-34-4-481]; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lyimo C.M, 2013, TROPENTAG 2013, P1; Mahoro J, 2018, TROP ANIM HEALTH PRO, V50, P121, DOI 10.1007/s11250-017-1411-8; Mahoro J, 2017, POULTRY SCI, V96, P4245, DOI 10.3382/ps/pex240; MINAGRI, 2011, RWAND MIN AGR AN RES; Ministry of Agriculture and Animal Resources (MINAGRI), 2012, STRAT INV PLAN STREN; Mohammadabadi MR, 2010, RUSS J GENET+, V46, P505, DOI 10.1134/S1022795410040198; Mwacharo JM, 2007, ANIM GENET, V38, P485, DOI 10.1111/j.1365-2052.2007.01641.x; Mwambene PL, 2019, POULTRY SCI, V98, P2734, DOI 10.3382/ps/pez076; Nadeem A, 2011, PAK VET J, P2074; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Ngeno K., 2015, Animal Genetic Resources, V56, P1, DOI 10.1017/S2078633614000484; Nigussie H, 2015, J BIOL, V5, P132; NISR, 2014, STAT YB 2014, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Pandey AK, 2002, ASIAN AUSTRAL J ANIM, V15, P1536, DOI 10.5713/ajas.2002.1536; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peripolli E, 2017, ANIM GENET, V48, P255, DOI 10.1111/age.12526; Perrier X., 2006, DARWIN SOFTWARE CIRA; Putman AI, 2014, ECOL EVOL, V4, P4399, DOI 10.1002/ece3.1305; Smith L. M., 2004, BMC Ecology, V4, P4, DOI 10.1186/1472-6785-4-4; Vanhala T, 1998, POULTRY SCI, V77, P783, DOI 10.1093/ps/77.6.783; Wilkinson S, 2012, ANIM GENET, V43, P552, DOI 10.1111/j.1365-2052.2011.02296.x; Wright, 1978, EVOLUTION GENETICS P, V4, P157; Yu YaBo, 2006, International Journal of Poultry Science, V5, P550; Zhu WQ, 2014, GENET MOL RES, V13, P3275, DOI 10.4238/2014.April.29.5	56	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0225084	10.1371/journal.pone.0225084	http://dx.doi.org/10.1371/journal.pone.0225084			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240167	Green Submitted, Green Published, gold			2022-12-26	WOS:000535945000004
J	Song, D; Qi, FF; Liu, SS; Tang, ZS; Duan, JH; Yao, ZB				Song, Dan; Qi, Fangfang; Liu, ShuaiShuai; Tang, Zhongsheng; Duan, Jinhai; Yao, Zhibin			The adoptive transfer of BCG-induced T lymphocytes contributes to hippocampal cell proliferation and tempers anxiety-like behavior in immune deficient mice	PLOS ONE			English	Article							NEUROGENESIS; INFLAMMATION; VACCINATION; SYSTEM	We previously have reported that neonatal Bacillus Calmette-Guerin (BCG) vaccination improves neurogenesis and behavior in early life through affecting the neuroimmune milieu in the brain, but it is uncertain whether activation phenotypes and functional changes in T lymphocytes shape brain development. Here, we studied the effects of BCG vaccination via the adoptive transfer of T lymphocytes from the BALB/c wild-type mice into naive mice. Our results show that mice adoptive BCG-induced lymphocytes (BCG-> naive mice) showed anxiolytic and antidepressant-like performance when completing an elevated plus maze (EPM) test. Meanwhile, BCG->naive mice possess more cell proliferation and newborn neurons than PBS->naive and nude mice in the hippocampus. IFN-gamma and IL-4 levels in the serum of BCG-> naive mice also increased, while TNF-alpha and IL-1 beta levels were reduced relative to those of PBS->naive and nude mice. We further found that BCG-> naive mice showed different repartition of CD4(+) and CD8(+) T cell to naive (CD62L(+)CD44(low)), effector memory (CD62L(-)CD44(hi)), central memory (CD62L(+)CD44(hi)) and acute/activated effector (CD62L(-)CD44(low)) cells in the spleen. Importantly, the adoptive transfer of BCG-induced T lymphocytes infiltrated into the dura mater and brain parenchyma of the nude mice. Activation phenotypes and functional changes in T lymphocytes are very likely to affect the neuroimmune milieu in the brain, and alterations in ratios of splenic CD4(+) and CD8(+) memory T cells may affect the expression of correlative cytokines in the serum, accounting for our behavioral results. We conclude thus that the adoptive transfer of BCG-induced T lymphocytes contributes to hippocampal cell proliferation and tempers anxiety-like behavior in immune deficient mice. Our work shows that BCG vaccination improves hippocampal cell proliferation outcomes and behaviors, likely as a result of splenic effector/memory T lymphocytes regulating the neuroimmune niche in the brain.	[Song, Dan; Qi, Fangfang; Yao, Zhibin] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Anat & Neurobiol, Guangzhou, Peoples R China; [Song, Dan; Qi, Fangfang; Yao, Zhibin] Sun Yat Sen Univ, Zhongshan Sch Med, Guangdong Prov Key Lab Brain Funct & Dis, Guangzhou, Peoples R China; [Liu, ShuaiShuai] Guangzhou Univ Chinese Med, Sch Basic Med Sci, Guangzhou, Peoples R China; [Tang, Zhongsheng] Guiyang Coll Tradit Chinese Med, Dept Anat, Guiyang, Peoples R China; [Duan, Jinhai] Guangdong Gen Hosp, Dept Neurol, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou University of Chinese Medicine; Guizhou University of Traditional Chinese Medicine; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Yao, ZB (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Anat & Neurobiol, Guangzhou, Peoples R China.; Yao, ZB (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Guangdong Prov Key Lab Brain Funct & Dis, Guangzhou, Peoples R China.	yao.zb@163.com			National Natural Science Foundation of China [31700914, 31600836]; Medical science and technology research fund of Guangdong province [A2017170]; Science and Technology Planning Project of GuangDong [2017ZC0278]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical science and technology research fund of Guangdong province; Science and Technology Planning Project of GuangDong	This study was funded by a grant from the National Natural Science Foundation of China (No. 31700914, recipient, Zhibin Yao; and No.31600836, recipient, Fangfang Qi), Medical science and technology research fund of Guangdong province (A2017170, Recipient, Fangfang Qi) and Science and Technology Planning Project of GuangDong (2017ZC0278, Recipient, Jinhai Duan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brachman RA, 2015, J NEUROSCI, V35, P1530, DOI 10.1523/JNEUROSCI.2278-14.2015; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; FIDEL PL, 1994, AM J OBSTET GYNECOL, V170, P1467, DOI 10.1016/S0002-9378(94)70180-6; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042054; Lewitus GM, 2009, MOL PSYCHIATR, V14, P532, DOI 10.1038/mp.2008.103; Li QQ, 2015, HUM VACCINES, V12, P140; Maier SF, 1998, PSYCHOL REV, V105, P83, DOI 10.1037/0033-295X.105.1.83; Qi FF, 2018, BRAIN BEHAV IMMUN, V71, P116, DOI 10.1016/j.bbi.2018.04.003; Qi FF, 2016, BRAIN BEHAV IMMUN, V53, P72, DOI 10.1016/j.bbi.2015.11.006; Radjavi A, 2014, BRAIN BEHAV IMMUN, V35, P58, DOI 10.1016/j.bbi.2013.08.013; Ritzel RM, 2016, J IMMUNOL, V196, P3318, DOI 10.4049/jimmunol.1502021; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Soares AP, 2013, J INFECT DIS, V207, P1084, DOI 10.1093/infdis/jis941; Song C, 2016, BRAIN BEHAV IMMUN, V57, P161, DOI 10.1016/j.bbi.2016.03.017; Sramek JJ, 2016, DIALOGUES CLIN NEURO, V18, P447; Urakubo A, 2001, SCHIZOPHR RES, V47, P27, DOI 10.1016/S0920-9964(00)00032-3; Wolf SA, 2009, J IMMUNOL, V182, P3979, DOI 10.4049/jimmunol.0801218; Yang JH, 2016, BRAIN RES BULL, V120, P25, DOI 10.1016/j.brainresbull.2015.10.012; Zarif H, 2018, BRAIN BEHAV IMMUN, V69, P235, DOI 10.1016/j.bbi.2017.11.016; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	21	2	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0225874	10.1371/journal.pone.0225874	http://dx.doi.org/10.1371/journal.pone.0225874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240169	gold, Green Published, Green Submitted			2022-12-26	WOS:000535945000005
J	Berner, DK; Wessolowski, L; Armbrust, F; Schneppenheim, J; Schlepckow, K; Koudelka, T; Scharfenberg, F; Lucius, R; Tholey, A; Kleinberger, G; Haass, C; Arnold, P; Becker-Pauly, C				Berner, Dennis Kristopher; Wessolowski, Luisa; Armbrust, Fred; Schneppenheim, Janna; Schlepckow, Kai; Koudelka, Tomas; Scharfenberg, Franka; Lucius, Ralph; Tholey, Andreas; Kleinberger, Gernot; Haass, Christian; Arnold, Philipp; Becker-Pauly, Christoph			Meprin beta cleaves TREM2 and controls its phagocytic activity on macrophages	FASEB JOURNAL			English	Article						ADAM10; Alzheimer's disease; cell surface protein; meprin beta; metalloprotease; phagocytosis; protein-protein interaction; TREM2	MYELOID CELLS-2 TREM2; METALLOPROTEASE MEPRIN; ALZHEIMERS-DISEASE; INFLAMMATORY RESPONSES; ALPHA-SUBUNIT; AMYLOID-BETA; ECTODOMAIN; MICROGLIA; RECEPTOR; VARIANTS	The triggering receptor expressed on myeloid cells 2 (TREM2) is a multifunctional surface protein that affects survival, migration, and phagocytic capacity of myeloid cells. Soluble TREM2 levels were found to be increased in early stages of sporadic and familial Alzheimer's disease (AD) probably reflecting a defensive microglial response to some initial brain damage. The disintegrin and metalloproteases (ADAM) 10 and 17 were identified as TREM2 sheddases. We demonstrate that meprin beta is a direct TREM2 cleaving enzyme using ADAM10/17 deficient HEK293 cells. LC-MS/MS analysis of recombinant TREM2 incubated with meprin beta revealed predominant cleavage between Arg136 and Asp137, distant to the site identified for ADAM10/17. We further demonstrate that the metalloprotease meprin beta cleaves TREM2 on macrophages concomitant with decreased levels of soluble TREM2 in the serum of Mep1b(-/-) mice compared to WT controls. Isolated BMDMs from Mep1b(-/-) mice showed significantly increased full-length TREM2 levels and enhanced phagocytosis efficiency compared to WT cells. The diminished constitutive shedding of TREM2 on meprin beta deficient macrophages could be rescued by ADAM stimulation through LPS treatment. Our data provide evidence that meprin beta is a TREM2 sheddase on macrophages and suggest that multiple proteases may be involved in the generation of soluble TREM2.	[Berner, Dennis Kristopher; Wessolowski, Luisa; Armbrust, Fred; Scharfenberg, Franka; Becker-Pauly, Christoph] Univ Kiel, Biochem Inst, Unit Degrad Protease Web, Kiel, Germany; [Schneppenheim, Janna; Lucius, Ralph; Arnold, Philipp] Univ Kiel, Anat Inst, Kiel, Germany; [Schlepckow, Kai; Haass, Christian] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Koudelka, Tomas; Tholey, Andreas] Univ Kiel, Inst Expt Med, Systemat Prote & Bioanalyt, Kiel, Germany; [Kleinberger, Gernot; Haass, Christian] Ludwig Maximilians Univ Munchen, Biomed Ctr, Biochem, Munich, Germany; [Kleinberger, Gernot; Haass, Christian] Munich Cluster Syst Neurol, Munich, Germany	University of Kiel; University of Kiel; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Kiel; University of Munich	Becker-Pauly, C (corresponding author), Christian Albrechts Univ Kiel, Unit Degrad Protease Web, Biochem Inst, Otto Hahn Pl 9, D-24118 Kiel, Germany.	cbeckerpauly@biochem.uni-kiel.de	Becker-Pauly, Christoph/B-7569-2011; Scharfenberg, Franka/AAS-9798-2021		Deutsche Forschungsgemeinschaft (DFG) [125440785 SFB877 A9/A15, 125440785 SFB877 Z2, 125440785 SFB877 A13, BE 4086/2-2, EXC 1010 SyNergy, HA1737/16-1, FOR2290]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: 125440785 SFB877 A9/A15, 125440785 SFB877 Z2, 125440785 SFB877 A13, BE 4086/2-2, EXC 1010 SyNergy, HA1737/16-1 and FOR2290	Arnold P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44053; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Bedau T, 2017, ONCOTARGET, V8, P54873, DOI 10.18632/oncotarget.18966; Bedau T, 2017, FASEB J, V31, P1226, DOI 10.1096/fj.201601113R; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Broder C, 2013, BIOCHEM J, V450, P253, DOI 10.1042/BJ20121751; Charles JF, 2008, INFECT IMMUN, V76, P2439, DOI 10.1128/IAI.00115-08; Colonna M, 2016, NAT REV NEUROSCI, V17, P201, DOI 10.1038/nrn.2016.7; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; Feuerbach D, 2017, NEUROSCI LETT, V660, P109, DOI 10.1016/j.neulet.2017.09.034; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hahn D, 2003, J BIOL CHEM, V278, P42829, DOI 10.1074/jbc.M211169200; Herzog Christian, 2016, Biochem Biophys Rep, V8, P146, DOI 10.1016/j.bbrep.2016.08.019; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Jiang T, 2016, NEUROBIOL AGING, V42, DOI 10.1016/j.neurobiolaging.2016.02.023; Jin SC, 2014, HUM MOL GENET, V23, P5838, DOI 10.1093/hmg/ddu277; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Keiffer TR, 2014, J BIOL CHEM, V289, P7580, DOI 10.1074/jbc.M113.546309; Kleinberger G, 2017, EMBO J, V36, P1837, DOI 10.15252/embj.201796516; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Li YJ, 2014, INT IMMUNOPHARMACOL, V18, P77, DOI 10.1016/j.intimp.2013.11.004; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Norman LP, 2003, MOL CELL BIOL, V23, P1221, DOI 10.1128/MCB.23.4.1221-1230.2003; Parhizkar S, 2019, NAT NEUROSCI, V22, P191, DOI 10.1038/s41593-018-0296-9; Riethmueller S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25550; Schlepckow K, 2017, EMBO MOL MED, V9, P1356, DOI 10.15252/emmm.201707672; Schonherr C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0084-5; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Sirkis DW, 2017, MOL BIOL CELL, V28, P2723, DOI 10.1091/mbc.E17-06-0423; Suarez-Calvet M, 2016, EMBO MOL MED, V8, P466, DOI 10.15252/emmm.201506123; Thornton P, 2017, EMBO MOL MED, V9, P1366, DOI 10.15252/emmm.201707673; Ulland TK, 2018, NAT REV NEUROL, V14, P667, DOI 10.1038/s41582-018-0072-1; Vazeille E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021199; Wichert R, 2017, CELL REP, V21, P2090, DOI 10.1016/j.celrep.2017.10.087; Wu K, 2015, J EXP MED, V212, P681, DOI 10.1084/jem.20141732; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Xiang XY, 2016, EMBO MOL MED, V8, P992, DOI 10.15252/emmm.201606370; Yeh FL, 2017, TRENDS MOL MED, V23, P512, DOI 10.1016/j.molmed.2017.03.008; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031; Zhao YH, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00140; Zhong L, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00204; Zhong L, 2017, J EXP MED, V214, P597, DOI 10.1084/jem.20160844; Zhong L, 2015, J BIOL CHEM, V290, P15866, DOI 10.1074/jbc.M115.645986	49	13	13	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6675	6687		10.1096/fj.201902183R	http://dx.doi.org/10.1096/fj.201902183R		APR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32237095	hybrid			2022-12-26	WOS:000522967100001
J	Parri, E; Kuusanmaki, H; van Adrichem, AJ; Kaustio, M; Wennerberg, K				Parri, Elina; Kuusanmaki, Heikki; van Adrichem, Arjan J.; Kaustio, Meri; Wennerberg, Krister			Identification of novel regulators of STAT3 activity	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; LYMPHOPROLIFERATIVE DISORDERS; MYCOPLASMA-FERMENTANS; ACTIVATION; KINASE; CANCER; INHIBITION; TRANSCRIPTION; MUTATIONS; SRC	STAT3 mediates signalling downstream of cytokine and growth factor receptors where it acts as a transcription factor for its target genes, including oncogenes and cell survival regulating genes. STAT3 has been found to be persistently activated in many types of cancers, primarily through its tyrosine phosphorylation (Y705). Here, we show that constitutive STAT3 activation protects cells from cytotoxic drug responses of several drug classes. To find novel and potentially targetable STAT3 regulators we performed a kinase and phosphatase siRNA screen with cells expressing either a hyperactive STAT3 mutant or IL6-induced wild type STAT3. The screen identified cell division cycle 7-related protein kinase (CDC7), casein kinase 2, alpha 1 (CSNK2), discoidin domain-containing receptor 2 (DDR2), cyclin-dependent kinase 8 (CDK8), phosphatidylinositol 4-kinase 2-alpha (PI4KII), C-terminal Src kinase (CSK) and receptor-type tyrosine-protein phosphatase H (PTPRH) as potential STAT3 regulators. Using small molecule inhibitors targeting these proteins, we confirmed dose and time dependent inhibition of STAT3-mediated transcription, suggesting that inhibition of these kinases may provide strategies for dampening STAT3 activity in cancers.	[Parri, Elina; Kuusanmaki, Heikki; van Adrichem, Arjan J.; Kaustio, Meri; Wennerberg, Krister] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Kuusanmaki, Heikki; Wennerberg, Krister] Univ Copenhagen, Biotech Res & Innovat Ctr BRIC, Copenhagen, Denmark; [Kuusanmaki, Heikki; Wennerberg, Krister] Univ Copenhagen, Novo Nordisk Fdn, Ctr Stem Cell Biol DanStem, Copenhagen, Denmark	University of Helsinki; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Wennerberg, K (corresponding author), Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland.; Wennerberg, K (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr BRIC, Copenhagen, Denmark.; Wennerberg, K (corresponding author), Univ Copenhagen, Novo Nordisk Fdn, Ctr Stem Cell Biol DanStem, Copenhagen, Denmark.	krister.wennerberg@bric.ku.dk	Wennerberg, Krister/AFM-0539-2022; Wennerberg, Krister/AAH-2919-2022	Wennerberg, Krister/0000-0002-1352-4220; Wennerberg, Krister/0000-0002-1352-4220; Kuusanmaki, Heikki/0000-0002-1903-0408; Parri, Elina/0000-0002-9144-5421	Academy of Finland [277293]; Sigrid Juselius Foundation; Cancer Society of Finland; University of Helsinki/Biocenter Finland	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; University of Helsinki/Biocenter Finland	This project was supported by grants from: Academy of Finland (277293) (KW) https://www.aka.fi/en Sigrid Juselius Foundation (KW) https://sigridjuselius.fi/en/Cancer Society of Finland (KW) https://www.cancersociety.fi/ In addition, this project was supported by University of Helsinki/Biocenter Finland Research infrastructure funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki D, 2005, GENES CELLS, V10, P357, DOI 10.1111/j.1365-2443.2005.00839.x; Ali AM, 2016, CHEMMEDCHEM, V11, P850, DOI 10.1002/cmdc.201600021; Aparicio-Siegmund S, 2014, ONCOTARGET, V5, P2131, DOI 10.18632/oncotarget.1852; Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; Bandyopadhyay S, 2014, DISCRETE AND CONTINUOUS SIMULATION: THEORY AND PRACTICE, P335; Beebe JD, 2018, PHARMACOL THERAPEUT, V191, P74, DOI 10.1016/j.pharmthera.2018.06.006; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cheng Y, 2014, MOL CANCER THER, V13, P675, DOI 10.1158/1535-7163.MCT-13-0416; Chong YP, 2006, J BIOL CHEM, V281, P32988, DOI 10.1074/jbc.M602951200; Choppa PC, 1998, MOL CELL PROBE, V12, P301, DOI 10.1006/mcpr.1998.0186; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; de Araujo ED, 2019, CANCERS, V11, DOI 10.3390/cancers11111757; Duan ZF, 2006, CLIN CANCER RES, V12, P5055, DOI 10.1158/1078-0432.CCR-06-0861; Dufva O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03987-2; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Fan LC, 2014, ONCOTARGET, V5, P6243, DOI 10.18632/oncotarget.2191; Faraci-Orf E, 2006, J CELL BIOCHEM, V97, P109, DOI 10.1002/jcb.20618; Gautam P, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0517-3; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Jerez A, 2012, BLOOD, V120, P3048, DOI 10.1182/blood-2012-06-435297; Johnson DE, 2018, NAT REV CLIN ONCOL, V15, P234, DOI 10.1038/nrclinonc.2018.8; Kanna R, 2018, LEUKEMIA LYMPHOMA, V59, P2068, DOI 10.1080/10428194.2017.1397668; Knuesel MT, 2009, MOL CELL BIOL, V29, P650, DOI 10.1128/MCB.00993-08; Kolosenko I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178844; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kuusanmaki H, 2017, ONCOTARGET, V8, P97516, DOI 10.18632/oncotarget.22178; Laudisi F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061787; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Lodige I, 2005, J BIOL CHEM, V280, P43087, DOI 10.1074/jbc.M509180200; MATOZAKI T, 1994, J BIOL CHEM, V269, P2075; McMurray JS, 2006, CHEM BIOL, V13, P1123, DOI 10.1016/j.chembiol.2006.11.001; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Ohgami RS, 2013, LEUKEMIA, V27, P2244, DOI 10.1038/leu.2013.104; Pemovska T, 2013, CANCER DISCOV, V3, P1416, DOI 10.1158/2159-8290.CD-13-0350; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Potdar S, 2020, BIOINFORMATICS, V36, P3602, DOI 10.1093/bioinformatics/btaa138; Read RD, 2004, MOL CELL BIOL, V24, P6676, DOI 10.1128/mcb.24.15.6676-6689.2004; Rozovski U, 2017, MOL CANCER RES, V15, P610, DOI 10.1158/1541-7786.MCR-16-0291; Sato T, 2015, ONCOL REP, V34, P1137, DOI 10.3892/or.2015.4082; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; Seo Y, 1997, BIOCHEM BIOPH RES CO, V231, P705, DOI 10.1006/bbrc.1997.6139; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; STAAB A, 2013, JAK STAT, V2, DOI DOI 10.4161/JKST.24275; Vojdani A, 1998, FEMS IMMUNOL MED MIC, V22, P355; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Wu ML, 2019, CANCER MANAG RES, V11, P4957, DOI 10.2147/CMAR.S206175; Yadav B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05193; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yuan J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17663; Zhang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020965; Zhang Y, 2012, GASTROENTEROLOGY, V142, P521, DOI 10.1053/j.gastro.2011.11.023; Zhang ZD, 2016, GENE, V584, P75, DOI 10.1016/j.gene.2016.03.012	58	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230819	10.1371/journal.pone.0230819	http://dx.doi.org/10.1371/journal.pone.0230819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HO	32231398	Green Published, gold			2022-12-26	WOS:000535937400019
J	Hedges, DW; Erickson, LD; Gale, SD; Anderson, JE; Brown, BL				Hedges, Dawson W.; Erickson, Lance D.; Gale, Shawn D.; Anderson, Jacqueline E.; Brown, Bruce L.			Association between exposure to air pollution and thalamus volume in adults: A cross-sectional study	PLOS ONE			English	Article							USE REGRESSION-MODELS; COGNITIVE DECLINE; PARTICULATE MATTER; LIFE-COURSE; BRAIN; DEMENTIA; POLLUTANTS; EDUCATION; RESERVE; NEUROTOXICITY	Background Air pollution has been associated with cognitive function and brain volume. While most previous research has examined the association between air pollution and brain volume in cortical structures or total brain volume, less research has investigated associations between exposure to air pollution and subcortical structures, including the thalamus. Further, the few available previous studies investigating associations between air pollution and thalamic volume have shown mixed results. Methods In this study, we evaluated the association between PM2.5, PM2.5-10, PM10, nitrogen dioxide, and nitrogen oxides and volume of the thalamus in adults using the UK Biobank resource, a large community-based sample, while adjusting for multiple covariates that could confound an association between air pollution and thalamic volume. Results In adjusted models, the left but not right thalamus volume was significantly inversely associated with PM2.5-10, although there were no significant associations between PM2.5, PM10, nitrogen dioxide, and nitrogen oxides with either left or right thalamic volumes. In addition, interactions between age and PM2.5-10 and PM10 were inversely associated with thalamic volume, such that thalamic volume in older people appeared more vulnerable to the adverse effects of PM2.5-10 and PM10, and interactions between educational attainment and PM2.5, nitrogen dioxide, and nitrogen oxides and between self-rated health and PM2.5-10 were positively associated with thalamic volume, such that higher educational attainment and better self-rated health appeared protective against the adverse effects of air pollution on the thalamus. Conclusion These findings suggest a possible association between thalamic volume and air pollution particularly in older people and in people with comparatively low educational attainment at levels of air pollution found in the United Kingdom.	[Hedges, Dawson W.; Gale, Shawn D.; Brown, Bruce L.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Hedges, Dawson W.; Gale, Shawn D.; Anderson, Jacqueline E.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Erickson, Lance D.] Brigham Young Univ, Dept Sociol, Provo, UT 84602 USA	Brigham Young University; Brigham Young University; Brigham Young University	Hedges, DW (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.; Hedges, DW (corresponding author), Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA.	dawson.hedges@byu.edu	Anderson, Jacqueline/GZG-9108-2022; Gale, Shawn/M-3144-2013	Anderson, Jacqueline/0000-0002-2588-6122; Gale, Shawn/0000-0002-8989-0964; Brown, Bruce L./0000-0002-5952-6475	 [41535]		This research has been conducted using the UK Biobank Resource under Application Number 41535.	Alfaro-Almagro F, 2018, NEUROIMAGE, V166, P400, DOI 10.1016/j.neuroimage.2017.10.034; Babadjouni RM, 2017, J CLIN NEUROSCI, V43, P16, DOI 10.1016/j.jocn.2017.04.028; Baumgart Matthew, 2015, Alzheimers Dement, V11, P718, DOI 10.1016/j.jalz.2015.05.016; Beelen R, 2013, ATMOS ENVIRON, V72, P10, DOI 10.1016/j.atmosenv.2013.02.037; Calderon-Garciduenas L, 2016, ENVIRON RES, V146, P404, DOI 10.1016/j.envres.2015.12.031; Casanova R, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00495; Cerza F, 2019, ENVIRON HEALTH-GLOB, V18, DOI 10.1186/s12940-019-0511-5; Chau CMY, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00051; Chen JC, 2015, ANN NEUROL, V78, P466, DOI 10.1002/ana.24460; Clifford A, 2016, ENVIRON RES, V147, P383, DOI 10.1016/j.envres.2016.01.018; Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P167, DOI 10.1289/ehp.0900994; Coffey CE, 1999, NEUROLOGY, V53, P189, DOI 10.1212/WNL.53.1.189; Costa LG, 2017, NEUROTOXICOLOGY, V59, P133, DOI 10.1016/j.neuro.2015.11.008; Cullen B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30568-6; Bert PD, 2018, CURR ENV HLTH REP, V5, P351, DOI 10.1007/s40572-018-0209-9; Eeftens M, 2012, ENVIRON SCI TECHNOL, V46, P11195, DOI 10.1021/es301948k; Ejaz S, 2014, ENVIRON SCI POLLUT R, V21, P3351, DOI 10.1007/s11356-013-2294-5; Gatto NM, 2014, NEUROTOXICOLOGY, V40, P1, DOI 10.1016/j.neuro.2013.09.004; Gregory AC, 2008, SCI TOTAL ENVIRON, V396, P42, DOI 10.1016/j.scitotenv.2008.01.065; Hedges DW, 2019, NEUROTOXICOLOGY, V74, P108, DOI 10.1016/j.neuro.2019.06.005; Hegde AN, 2011, RADIOGRAPHICS, V31, P5, DOI 10.1148/rg.311105041; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Karussis D, 2000, J NEUROL SCI, V172, P25, DOI 10.1016/S0022-510X(99)00267-1; Khan J, 2018, SCI TOTAL ENVIRON, V634, P661, DOI 10.1016/j.scitotenv.2018.03.374; Ku TT, 2016, CHEMOSPHERE, V163, P27, DOI 10.1016/j.chemosphere.2016.08.009; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Lucchini RG, 2012, NEUROTOXICOLOGY, V33, P838, DOI 10.1016/j.neuro.2011.12.001; Marden JR, 2017, AM J EPIDEMIOL, V186, P805, DOI 10.1093/aje/kwx155; Miller KL, 2016, NAT NEUROSCI, V19, P1523, DOI 10.1038/nn.4393; Newbury JB, 2019, JAMA PSYCHIAT, V76, P614, DOI 10.1001/jamapsychiatry.2019.0056; Oikonen M, 2003, NEUROEPIDEMIOLOGY, V22, P95, DOI 10.1159/000067108; Oudin A, 2016, ENVIRON HEALTH PERSP, V124, P306, DOI 10.1289/ehp.1408322; Parnaudeau S, 2018, BIOL PSYCHIAT, V83, P648, DOI 10.1016/j.biopsych.2017.11.008; Power MC, 2018, ENVIRON HEALTH PERSP, V126, DOI [10.1289/EHP2152, 10.1289/ehp2152]; Power MC, 2016, NEUROTOXICOLOGY, V56, P235, DOI 10.1016/j.neuro.2016.06.004; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004; Sharp ES, 2011, ALZ DIS ASSOC DIS, V25, P289, DOI 10.1097/WAD.0b013e318211c83c; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Suwa T, 2002, J AM COLL CARDIOL, V39, P935, DOI 10.1016/S0735-1097(02)01715-1; Szczepanski SM, 2014, NEURON, V83, P1002, DOI 10.1016/j.neuron.2014.08.011; Tamagawa E, 2008, AM J PHYSIOL-LUNG C, V295, pL79, DOI 10.1152/ajplung.00048.2007; Tatel DF, 2016, J NEUROL, V263, P2065, DOI 10.1007/s00415-016-8236-7; Tucker AM, 2011, CURR ALZHEIMER RES, V8, P354; Weuve J, 2012, ARCH INTERN MED, V172, P219, DOI 10.1001/archinternmed.2011.683; Wilker EH, 2016, J ALZHEIMERS DIS, V53, P1315, DOI 10.3233/JAD-151143; World Health Organization, 2018, AMB OUTD AIR POLL; Zhang RH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00827; Zhang X, 2018, P NATL ACAD SCI USA, V115, P9193, DOI 10.1073/pnas.1809474115; Zhao L, 2019, CEREB CORTEX, V29, P4169, DOI 10.1093/cercor/bhy300	51	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230829	10.1371/journal.pone.0230829	http://dx.doi.org/10.1371/journal.pone.0230829			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HE	32226035	gold, Green Published			2022-12-26	WOS:000535936400019
J	Acosta-Iborra, B; Tiana, M; Maeso-Alonso, L; Hernandez-Sierra, R; Herranz, G; Santamaria, A; Rey, C; Luna, R; Puente-Santamaria, L; Marques, MM; Marin, MC; del Peso, L; Jimenez, B				Acosta-Iborra, Barbara; Tiana, Maria; Maeso-Alonso, Laura; Hernandez-Sierra, Rosana; Herranz, Gonzalo; Santamaria, Andrea; Rey, Carlos; Luna, Raquel; Puente-Santamaria, Laura; Marques, Margarita M.; Marin, Maria C.; del Peso, Luis; Jimenez, Benilde			Hypoxia compensates cell cycle arrest with progenitor differentiation during angiogenesis	FASEB JOURNAL			English	Article						angiogenesis; embryoid bodies; endothelial proliferation; hypoxia; stem cells	PAS DOMAIN PROTEIN-1; INDUCIBLE FACTORS; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; GENE-EXPRESSION; PROLIFERATION; HIF-2-ALPHA; HIF-1-ALPHA; HIF; GROWTH	Angiogenesis, the main mechanism that allows vascular expansion for tissue regeneration or disease progression, is often triggered by an imbalance between oxygen consumption and demand. Here, by analyzing changes in the transcriptomic profile of endothelial cells (ECs) under hypoxia we uncovered that the repression of cell cycle entry and DNA replication stand as central responses in the early adaptation of ECs to low oxygen tension. Accordingly, hypoxia imposed a restriction in S-phase in ECs that is mediated by Hypoxia-Inducible Factors. Our results indicate that the induction of angiogenesis by hypoxia in Embryoid Bodies generated from murine Stem Cells is accomplished by the compensation of decreased S-phase entry in mature ECs and differentiation of progenitor cells. This conditioning most likely allows an optimum remodeling of the vascular network. Identification of the molecular underpinnings of cell cycle arrest by hypoxia would be relevant for the design of improved strategies aimed to suppress angiogenesis in pathological contexts where hypoxia is a driver of neovascularization.	[Acosta-Iborra, Barbara; Tiana, Maria; Hernandez-Sierra, Rosana; Herranz, Gonzalo; Santamaria, Andrea; Rey, Carlos; Luna, Raquel; Puente-Santamaria, Laura; del Peso, Luis; Jimenez, Benilde] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols CSIC UAM, Dept Bioquim, C Arturo Duperier 4, Madrid 28029, Spain; [Tiana, Maria; del Peso, Luis; Jimenez, Benilde] Hosp Univ La Paz, IdiPaz, Inst Invest Sanitaria, Madrid, Spain; [Tiana, Maria; del Peso, Luis; Jimenez, Benilde] Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Maeso-Alonso, Laura; Marin, Maria C.] Univ Leon, Inst Biomed, Dept Biol Mol, Lab Diferenciac Celular & Diseno Modelos Celulare, Leon, Spain; [Marques, Margarita M.] Univ Leon, Inst Desarrollo Ganadero & Sanidad Anim, Dept Prod Anim, Lab Diferenciac Celular & Diseno Modelos Celulare, Leon, Spain; [Tiana, Maria] CNIC, Madrid, Spain; [Herranz, Gonzalo; Rey, Carlos] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Luna, Raquel] Evotec France SAS, Toulouse, France	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de Leon; Universidad de Leon; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Evotec	Jimenez, B (corresponding author), Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols CSIC UAM, Dept Bioquim, C Arturo Duperier 4, Madrid 28029, Spain.	bjimenez@iib.uam.es	rey, carlos/Y-9185-2019; tiana, maria/G-4240-2016; Puente-Santamaria, Laura/GWM-4342-2022; Puente-Santamaria, Laura/AFV-5649-2022; del Peso, Luis/K-9391-2014; Maeso-Alonso, Laura/AAH-2571-2021; Cuenca, Benilde Jimenez/K-9959-2014; Tiana, María/AAA-1868-2020; Acosta-Iborra, Barbara/L-5570-2013	tiana, maria/0000-0003-0678-1154; Puente-Santamaria, Laura/0000-0001-9034-4576; Puente-Santamaria, Laura/0000-0001-9034-4576; del Peso, Luis/0000-0003-4014-5688; Tiana, María/0000-0003-0678-1154; Acosta-Iborra, Barbara/0000-0002-1517-114X; Rey Serra, Carlos/0000-0001-7635-0056; Jimenez Cuenca, Benilde/0000-0002-1806-6636; Maeso Alonso, Laura/0000-0001-7805-3792	Ministerio de Ciencia e Innovacion (MICINN) [SAF2014-53819-R, SAF2017-88771R, SAF2015-71381-R]; Consejeria de Educacion, Junta de Castilla y Leon (Ministry of Education, Government of Castile-Leon) [LE021P17]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Educacion, Junta de Castilla y Leon (Ministry of Education, Government of Castile-Leon)	Ministerio de Ciencia e Innovacion (MICINN), Grant/Award Number: SAF2014-53819-R, SAF2017-88771R and SAF2015-71381-R; Consejeria de Educacion, Junta de Castilla y Leon (Ministry of Education, Government of Castile-Leon), Grant/Award Number: LE021P17	Batie M, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6020047; Betsholtz C, 2016, NATURE, V529, P160, DOI 10.1038/nature16866; Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; Bunce C, 2016, CURR TOP DEV BIOL, V116, P153, DOI 10.1016/bs.ctdb.2015.10.001; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Casazza A, 2014, ONCOGENE, V33, P1743, DOI 10.1038/onc.2013.121; Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020; Choudhry H, 2018, CELL METAB, V27, P281, DOI 10.1016/j.cmet.2017.10.005; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Draoui N, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170219; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Fernandez-Alonso R, 2015, CELL DEATH DIFFER, V22, P1287, DOI 10.1038/cdd.2014.214; Fernandez-Barral A, 2014, NEOPLASIA, V16, P529, DOI 10.1016/j.neo.2014.06.001; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Germain S, 2010, CURR OPIN HEMATOL, V17, P245, DOI 10.1097/MOH.0b013e32833865b9; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang H, 2017, EMBO J, V36, P2334, DOI 10.15252/embj.201695518; Hubbi ME, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003417; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Jakobsson L, 2007, J CELL BIOL, V177, P751, DOI 10.1083/jcb.200701146; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kearney JB, 2002, BLOOD, V99, P2397, DOI 10.1182/blood.V99.7.2397; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lee SW, 2012, EMBO MOL MED, V4, P924, DOI 10.1002/emmm.201101107; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Martin-Lopez M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.432; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Ning W, 2004, PHYSIOL GENOMICS, V18, P70, DOI 10.1152/physiolgenomics.00221.2003; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Oladipupo SS, 2011, BLOOD, V117, P4142, DOI 10.1182/blood-2010-09-307538; Peters DG, 2006, PHYSIOL GENOMICS, V26, P99, DOI 10.1152/physiolgenomics.00152.2005; Pontes-Quero S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09875-7; Potente M, 2017, ANNU REV PHYSIOL, V79, P43, DOI 10.1146/annurev-physiol-021115-105134; Rey S, 2017, TRENDS CANCER, V3, P529, DOI 10.1016/j.trecan.2017.05.002; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salama R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134645; Scheurer SB, 2004, PROTEOMICS, V4, P1737, DOI 10.1002/pmic.200300689; Schito L, 2016, TRENDS CANCER, V2, P758, DOI 10.1016/j.trecan.2016.10.016; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Serra H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8935; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Skuli N, 2012, J CLIN INVEST, V122, P1427, DOI 10.1172/JCI57322; Skuli N, 2009, BLOOD, V114, P469, DOI 10.1182/blood-2008-12-193581; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tiana M, 2018, NUCLEIC ACIDS RES, V46, P120, DOI 10.1093/nar/gkx951; Torres-Capelli M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25357; Tsang KM, 2017, STEM CELL REP, V9, P796, DOI 10.1016/j.stemcr.2017.07.001; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Wong BW, 2017, EMBO J, V36, P2187, DOI 10.15252/embj.201696150; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	64	3	3	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6654	6674		10.1096/fj.201903082R	http://dx.doi.org/10.1096/fj.201903082R		MAR 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32223018	Green Submitted, Bronze			2022-12-26	WOS:000522485300001
J	Huang, JK; Samassekou, K; Alhmadi, HB; VanDerway, DR; Diaz, JD; Seiver, JA; McClenahan, SW; Holt, SM; Wen, L				Huang, Jenq-Kuen; Samassekou, Kadidia; Alhmadi, Hekmat B.; VanDerway, David R.; Diaz, Joshua D.; Seiver, Jacob A.; McClenahan, Shawn W.; Holt, Scott M.; Wen, Lisa			Knockout of secondary alcohol dehydrogenase in Nocardia cholesterolicum NRRL 5767 by CRISPR/Cas9 genome editing technology	PLOS ONE			English	Article							DOUBLE-BOND HYDRATASE; FATTY-ACID; OLEATE HYDRATASE; OLEIC-ACID; CLOSTRIDIUM-BEIJERINCKII; LACTOBACILLUS-PLANTARUM; MICROBIAL CONVERSION; RICINOLEIC ACID; SAFFLOWER OIL; LINOLEIC-ACID	Nocardia cholesterolicum NRRL 5767 is well-known for its ability to convert oleic acid to 10-hydroxystearic acid (similar to 88%, w/w) and 10-ketostearic acid (similar to 11%, w/w). Conversion of oleic acid to 10-hydroxystearic acid and then to 10-ketostearic acid has been proposed to be catalyzed by oleate hydratase and secondary alcohol dehydrogenase, respectively. Hydroxy fatty acids are value-added with many industrial applications. The objective of this study was to improve the Nocardia cholesterolicum NRRL5767 strain by CRISPR/Cas9 genome editing technology to knockout the secondary alcohol dehydrogenase gene, thus blocking the conversion of 10-hydroxystearic acid to 10-ketostearic acid. The improved strain would produce 10-hydroxystearic acid solely from oleic acid. Such improvement would enhance the production of 10-hydroxystearic acid by eliminating downstream separation of 10-hydroxystearic acid from 10-ketostearic acid. Here, we report: (1) Molecular cloning and characterization of two functional recombinant oleate hydratase isozymes and a functional recombinant secondary alcohol dehydrogenase from Nocardia cholesterolicum NRRL5767. Existence of two oleate hydratase isozymes may explain the high conversion yield of 10-hydroxystearic acid from oleic acid. (2) Construction of a CRISPR/Cas9/sgRNA chimeric plasmid that specifically targeted the secondary alcohol dehydrogenase gene by Golden Gate Assembly. (3) Transformation of the chimeric plasmid into Nocardia cholesterolicum NRRL 5767 by electroporation and screening of secondary alcohol dehydrogenase knockout mutants. Two mutants were validated by their lack of secondary alcohol dehydrogenase activity at the protein level and mutation at the targeted 5' coding region and the 5' upstream at the DNA level. The knockout mutants offer improvements by converting added oleic acid to solely 10-hydroxystearic acid, thus eliminating downstream separation of 10-hydroxystearic acid from 10-ketostearic acid. To the best of our knowledge, we report the first successful knockout of a target gene in the Nocardia species using CRISPR/Cas9/sgRNAmediated genome editing technology.	[Huang, Jenq-Kuen; Samassekou, Kadidia; Alhmadi, Hekmat B.; VanDerway, David R.; Diaz, Joshua D.; Seiver, Jacob A.; McClenahan, Shawn W.; Wen, Lisa] Western Illinois Univ, Dept Chem, Macomb, IL 61455 USA; [Holt, Scott M.] Western Illinois Univ, Dept Biol Sci, Macomb, IL 61455 USA; [Alhmadi, Hekmat B.] AL Muthanna Univ, Coll Med, Dept Chem, Samawah, Iraq	Western Illinois University; Western Illinois University; Al-Muthanna University	Huang, JK (corresponding author), Western Illinois Univ, Dept Chem, Macomb, IL 61455 USA.	J-Huang3@wiu.edu	HEKMAT B ALHMADI Department of chemistry, College of Medicine/V-5002-2019	HEKMAT B ALHMADI Department of chemistry, College of Medicine/0000-0001-6368-7231; Samassekou, Kadidia/0000-0002-3449-2037	University Research Council at Western Illinois University; Illinois Soybean Association	University Research Council at Western Illinois University; Illinois Soybean Association	This research was supported in part by grants from University Research Council at Western Illinois University (http://www.wiu.edu/sponsored_projects/urc/) and Illinois Soybean Association (https://www.ilsoy.org/) to JKH and SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhmadi H., 2017, THESIS; Bae JH, 2010, BIOTECHNOL BIOPROC E, V15, P953, DOI 10.1007/s12257-010-0057-4; Bagby M, 1989, FATS FUTURE, P301; Barrangou R, 2015, CURR OPIN IMMUNOL, V32, P36, DOI 10.1016/j.coi.2014.12.008; Bevers LE, 2009, J BACTERIOL, V191, P5010, DOI 10.1128/JB.00306-09; Biermann U, 2011, ANGEW CHEM INT EDIT, V50, P3854, DOI 10.1002/anie.201002767; Brissett NC, 2009, BIOCHEM SOC T, V37, P539, DOI 10.1042/BST0370539; Cao YJ, 2013, APPL MICROBIOL BIOT, V97, P3323, DOI 10.1007/s00253-013-4815-z; Chen YY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01561; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Dhakal D, 2016, GENETIC MANIPULATION, P40; ELSHARKAWY SH, 1992, APPL ENVIRON MICROB, V58, P2116, DOI 10.1128/AEM.58.7.2116-2122.1992; Engleder M, 2018, APPL MICROBIOL BIOT, V102, P5841, DOI 10.1007/s00253-018-9065-7; Engleder M, 2015, CHEMBIOCHEM, V16, P1730, DOI 10.1002/cbic.201500269; Erickson R. D, 1980, HDB SOY OIL PROCESSI; FLAMM RK, 1984, INFECT IMMUN, V44, P157, DOI 10.1128/IAI.44.1.157-161.1984; Goodhue CT, 1979, US, Patent No. 3884764A; Goodhue CT, 1975, US, Patent No. 3909359A; Green MR, 2012, MOL CLONING LAB MANU, V1; Groger H, 2014, ANGEW CHEM INT EDIT, V53, P3067, DOI 10.1002/anie.201308556; Hanukoglu I, 2015, BIOCHEM MOL BIOL EDU, V43, P206, DOI 10.1002/bmb.20849; Hirata A, 2015, J LIPID RES, V56, P1340, DOI 10.1194/jlr.M059444; Hou CT, 2009, NEW BIOTECHNOL, V26, P2, DOI 10.1016/j.nbt.2009.05.001; Huang H, 2015, ACTA BIOCH BIOPH SIN, V47, DOI 10.1093/abbs/gmv007; Huang JK, 2004, DNA SEQUENCE, V15, P26, DOI 10.1080/10425170310001652174; Huang JK, 2010, ASBMB ANN M AN CA, DOI [10.1096/fasebj.24.1_supplement.835.5, DOI 10.1096/FASEBJ.24.1_SUPPLEMENT.835.5]; Jang HY, 2016, GREEN CHEM, V18, P1089, DOI 10.1039/c5gc01017a; Jeon EY, 2015, APPL MICROBIOL BIOT, V99, P6267, DOI 10.1007/s00253-015-6392-9; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; Jin JF, 2011, CHEM COMMUN, V47, P2502, DOI 10.1039/c0cc04153j; Jo YS, 2014, J AGR FOOD CHEM, V62, P6736, DOI 10.1021/jf501081z; Joo YC, 2012, BIOCHIMIE, V94, P907, DOI 10.1016/j.biochi.2011.12.011; KANESHIRO T, 1995, CURR MICROBIOL, V31, P62, DOI 10.1007/BF00294636; Kang WR, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03351-16; Kim BN, 2012, APPL MICROBIOL BIOT, V95, P929, DOI 10.1007/s00253-011-3805-2; Kim BN, 2011, BIOTECHNOL LETT, V33, P993, DOI 10.1007/s10529-010-0516-1; Kim KR, 2015, BIOTECHNOL BIOENG, V112, P2206, DOI 10.1002/bit.25643; Kim KR, 2013, BIOTECHNOL ADV, V31, P1473, DOI 10.1016/j.biotechadv.2013.07.004; Kishimoto N, 2003, LIPIDS, V38, P1269, DOI 10.1007/s11745-003-1188-4; KISIC A, 1971, LIPIDS, V6, P541, DOI 10.1007/BF02531133; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; KORITALA S, 1992, J AM OIL CHEM SOC, V69, P575, DOI 10.1007/BF02636111; KORITALA S, 1989, APPL MICROBIOL BIOT, V32, P299; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Kuo TM, 2001, CURR MICROBIOL, V43, P198, DOI 10.1007/s002840010287; Lee B, 2015, J MICROBIOL BIOTECHN, V25, P452, DOI 10.4014/jmb.1501.01001; Lee B, 2015, BIOTECHNOL LETT, V37, P1101, DOI 10.1007/s10529-015-1775-7; Levin I, 2004, PROTEIN SCI, V13, P1547, DOI 10.1110/ps.03531404; Lorenzen J, 2018, CHEMCATCHEM, V10, P407, DOI 10.1002/cctc.201701350; LUDWIG B, 1995, APPL ENVIRON MICROB, V61, P3729, DOI 10.1128/AEM.61.10.3729-3733.1995; Masurekar PS, 1977, US, Patent No. 4052263A; MUTH G, 1989, MOL GEN GENET, V219, P341, DOI 10.1007/BF00259605; NIEHAUS WG, 1978, J BACTERIOL, V134, P177, DOI 10.1128/JB.134.1.177-183.1978; NIEHAUS WG, 1970, J BIOL CHEM, V245, P3790; Nordling E, 2002, EUR J BIOCHEM, V269, P4267, DOI 10.1046/j.1432-1033.2002.03114.x; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Ortega-Anaya J, 2015, BBA-BIOMEMBRANES, V1848, P3166, DOI 10.1016/j.bbamem.2015.09.014; Park AK, 2018, BIOCHEM BIOPH RES CO, V499, P772, DOI 10.1016/j.bbrc.2018.03.220; Rosberg-Cody E, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-9; Schmid J., 2017, J MOL CATAL B, V133, pS243, DOI [10.1016/j.molcatb.2017.01.010, DOI 10.1016/J.MOLCATB.2017.01.010]; Shin HY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15464; Shoger NJ, 2011, THESIS; Song JW, 2013, ANGEW CHEM INT EDIT, V52, P2534, DOI 10.1002/anie.201209187; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Sutak R, 2012, FEBS J, V279, P2768, DOI 10.1111/j.1742-4658.2012.08661.x; Takeuchi M, 2015, J BIOSCI BIOENG, V119, P636, DOI 10.1016/j.jbiosc.2014.10.022; Thomas M, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007994; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; VanDerway DR, 2016, THESIS; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Volkov A, 2013, ACTA CRYSTALLOGR D, V69, P648, DOI 10.1107/S0907444913000991; Volkov A, 2010, J BIOL CHEM, V285, P10353, DOI 10.1074/jbc.M109.081851; WALLEN LL, 1962, ARCH BIOCHEM BIOPHYS, V99, P249, DOI 10.1016/0003-9861(62)90006-1; Wang Y, 2016, ACS SYNTH BIOL, V5, P721, DOI 10.1021/acssynbio.6b00060; Wang Y, 2015, J BIOTECHNOL, V200, P1, DOI 10.1016/j.jbiotec.2015.02.005; Wen L, 2011, MOL CLONING SELECTED; Yang B, 2013, BIOTECHNOL LETT, V35, P75, DOI 10.1007/s10529-012-1044-y	78	4	4	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0230915	10.1371/journal.pone.0230915	http://dx.doi.org/10.1371/journal.pone.0230915			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218601	Green Published, gold			2022-12-26	WOS:000535935400031
J	Leal, E; Arrais, CR; Barreiros, M; Rodrigues, JKF; Sousa, NPS; Costa, DD; Santos, FDRP; Silva, AD; Viana, AIES; Barros, AK; Lima, K				Leal, Elcio; Arrais, Claudia Regina; Barreiros, Marta; Farias Rodrigues, Jessyca Kalynne; Silva Sousa, Nilviane Pires; Costa, Daniel Duarte; Rodrigo Pereira Santos, Francisco Dimitre; Silva, Antonio Dantas; Viana, Antonia Iracilda e Silva; Barros, Allan Kardec; Lima, Kledoaldo			Characterization of HIV-1 genetic diversity and antiretroviral resistance in the state of Maranhao, Northeast Brazil	PLOS ONE			English	Article							TRANSMITTED DRUG-RESISTANCE; SUBTYPE C; TRANSMISSION; PREVALENCE; ALIGNMENT	The HIV-1 epidemic in Brazil has been growing in northeast and north regions, particularly an increase in AIDS cases among the younger male population has been observed. This study aims to characterize the HIV-1 genetic diversity and to evaluate its antiretroviral resistance profile among individuals presenting virological failure in the state of Maranhao-Brazil. HIV-1 pol gene sequences from 633 patients on antiretroviral therapy were obtained from the Department of Surveillance, Prevention and Control of Sexually Transmitted Infections, HIV/AIDS and Viral Hepatitis of the Brazilian Ministry of Health. Phylogenetic and recombination analyses were performed to characterize viral genetic diversity. The presence of antiretroviral resistance mutations was assessed using the HIV Drug Resistance Database online platform of Stanford University. A predominance of subtype B (84.5%) was observed, followed by recombinant BF (9.5%), where more than half of the sequences were dispersed in 3 clusters. Antiretroviral resistance was detected in 74.1% of the sequences, and it was significantly higher for nucleoside analogue reverse-transcriptase inhibitors (NRTIs) than for non-nucleoside analogue reverse-transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs). Inference of putative transmissions clusters identified 11 clusters with 22 query sequences (22/633, 3.5%). Thus, we conclude that continuous monitoring of the molecular epidemiology of HIV-1 is essential for prevention strategies, epidemic control, and treatment adequacy.	[Leal, Elcio] Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil; [Arrais, Claudia Regina; Silva Sousa, Nilviane Pires; Barros, Allan Kardec] Univ Fed Maranhao, Grad Program Northeast Biotechnol Network, Sao Luis, Maranhao, Brazil; [Arrais, Claudia Regina; Viana, Antonia Iracilda e Silva] Univ Fed Maranhao, Med Course, Coordinat, Imperatriz, MA, Brazil; [Barreiros, Marta; Silva Sousa, Nilviane Pires; Barros, Allan Kardec] Univ Fed Maranhao, Dept Elect Engn, Sao Luis, Maranhao, Brazil; [Farias Rodrigues, Jessyca Kalynne] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil; [Costa, Daniel Duarte] Univ Fed Maranhao, Food Engn Coordinat, Imperatriz, MA, Brazil; [Rodrigo Pereira Santos, Francisco Dimitre] Higher Educ Unit Southern Maranhao, Imperatriz, MA, Brazil; [Silva, Antonio Dantas] Unimed Empress, Imperatriz, MA, Brazil; [Lima, Kledoaldo] Univ Fed Pernambuco, Clin Hosp, Recife, PE, Brazil; [Lima, Kledoaldo] European Virus Bioinformat Ctr, Jena, Germany	Universidade Federal do Para; Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Federal de Pernambuco; Universidade Federal do Maranhao; Universidade Federal de Pernambuco	Leal, E (corresponding author), Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil.	elcioleal@gmail.com	Santos, Francisco Dimitre Rodrigo Pereira/P-3225-2019; Barros, Allan Kardec/ABD-5032-2021; Leal, Elcio/J-6236-2016; Leal, Elcio/M-5275-2019	Santos, Francisco Dimitre Rodrigo Pereira/0000-0003-3036-7631; Barros, Allan Kardec/0000-0002-1654-0955; Leal, Elcio/0000-0003-3463-0492; Leal, Elcio/0000-0003-3463-0492; Farias Rodrigues, Jessyca Kalynne/0000-0001-6982-9886	Department of Surveillance, Prevention and Control of Sexually Transmitted Infections, HIV/AIDS and Viral Hepatitis of the Brazilian Ministry of Health; Federal University of Para	Department of Surveillance, Prevention and Control of Sexually Transmitted Infections, HIV/AIDS and Viral Hepatitis of the Brazilian Ministry of Health; Federal University of Para	We thank the Department of Surveillance, Prevention and Control of Sexually Transmitted Infections, HIV/AIDS and Viral Hepatitis of the Brazilian Ministry of Health for supporting this research. We also thank the Federal University of Para for funding the open access charge.	Machado LFA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2392-y; Almeida SEM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-306; Amaral AG, 2017, MEM I OSWALDO CRUZ, V112, P411, DOI 10.1590/0074-02760160458; Brites C, 2016, BRAZ J INFECT DIS, V20, P323, DOI 10.1016/j.bjid.2016.03.010; Carvalho BC, 2011, AIDS RES HUM RETROV, V27, P1081, DOI [10.1089/aid.2010.0334, 10.1089/AID.2010.0334]; Chaillon A, 2017, INFECT GENET EVOL, V54, P98, DOI 10.1016/j.meegid.2017.06.021; Reis MND, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178578; Soares CMPD, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19042; Dias CF, 2009, REV INST MED TROP SP, V51, P191, DOI 10.1590/S0036-46652009000400003; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Graf T, 2013, VIROLOGY, V435, P170, DOI 10.1016/j.virol.2012.08.048; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Junqueira D.M., 2016, PLOS ONE, V11; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Lima K., 2017, PLOS ONE, V11, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Lima K, 2017, J MED MICROBIOL, V66, P526, DOI 10.1099/jmm.0.000447; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Ministerio da Saude, 2018, MIN SAUD B EP HIV AI; Ministerio da Saude. Secretaria de Vigilancia em Saude, 2017, PREV CONTR INF SEX T; Leite TCNF, 2017, AIDS RES HUM RETROV, V33, P41, DOI [10.1089/aid.2016.0126, 10.1089/AID.2016.0126]; Pessoa R., 2014, PLOS ONE, V911, DOI [10.1371/journa.pone.0112674, DOI 10.1371/JOURNA.PONE.0112674]; Pessoa R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152499; Pond SLK, 2018, MOL BIOL EVOL, V35, P1812, DOI 10.1093/molbev/msy016; Reis MNG, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00097; Silva LD, 2016, AIDS RES HUM RETROV, V32, P373, DOI [10.1089/aid.2015.0280, 10.1089/AID.2015.0280]; Moura MES, 2015, J MED VIROL, V87, P798, DOI 10.1002/jmv.24087; Moura MES, 2015, AIDS RES HUM RETROV, V31, P250, DOI 10.1089/aid.2014.0261; Tarosso LF, 2014, AIDS RES HUM RETROV, V30, P190, DOI [10.1089/aid.2012.0243, 10.1089/AID.2012.0243]; Thomson MM, 2002, J GEN VIROL, V83, P107, DOI 10.1099/0022-1317-83-1-107; Wertheim JO, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006000	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0230878	10.1371/journal.pone.0230878	http://dx.doi.org/10.1371/journal.pone.0230878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218587	Green Submitted, gold, Green Published			2022-12-26	WOS:000535935400028
J	Hill, N; Michell, DL; Ramirez-Solano, M; Sheng, Q; Pusey, C; Vickers, KC; Woollard, KJ				Hill, N.; Michell, D. L.; Ramirez-Solano, M.; Sheng, Q.; Pusey, C.; Vickers, K. C.; Woollard, K. J.			Glomerular endothelial derived vesicles mediate podocyte dysfunction: A potential role for miRNA	PLOS ONE			English	Article							GROWTH-FACTOR; HIGH GLUCOSE; EXTRACELLULAR VESICLES; CELLS; MICRORNAS; SECRETION; MECHANISM; EXOSOMES; INJURY	MicroRNAs (miRNA) are shown to be involved in the progression of several types of kidney diseases. Podocytes maintain the integrity of the glomerular basement membrane. Extracellular vesicles (EV) are important in cell-to-cell communication as they can transfer cellular content between cells, including miRNA. However, little is known about how extracellular signals from the glomerular microenvironment regulate podocyte activity. Using a non-contact transwell system, communication between glomerular endothelial cells (GEnC) and podocytes was characterised in-vitro. Identification of transferred EV-miRNAs from GEnC to podocytes was performed using fluorescence cell tracking and miRNA mimetics. To represent kidney disease, podocyte molecular profiling and functions were analysed after EV treatments derived from steady state or activated GEnC. Our data shows activation of GEnC alters EV-miRNA loading, but activation was not found to alter EV secretion. EV delivery of miRNA to recipient podocytes altered cellular miRNA abundance and effector functions in podocytes, including decreased secretion of VEGF and increased mitochondrial stress which lead to altered cellular metabolism and cytoskeletal rearrangement. Finally, results support our hypothesis that miRNA-200c-3p is transfered by EVs from GEnC to podocytes in response to activation, ultimately leading to podocyte dysfunction.	[Hill, N.; Pusey, C.; Woollard, K. J.] Imperial Coll London, Dept Med, Ctr Inflammatory Dis, London, England; [Michell, D. L.; Vickers, K. C.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Ramirez-Solano, M.; Sheng, Q.] Vanderbilt Univ, Med Ctr, Ctr Quantitat Sci, Nashville, TN USA	Imperial College London; Vanderbilt University; Vanderbilt University	Woollard, KJ (corresponding author), Imperial Coll London, Dept Med, Ctr Inflammatory Dis, London, England.	k.woollard@imperial.ac.uk		Woollard, Kevin/0000-0002-9839-5463	Nadhmi Auchi Foundation; Imperial College London; Kidney Research UK [RP_019_20160303, RP_002_20170914]; Foundation for the National Institutes of Health [HL128996, HL127173, HL116263]; Institute for Health Research Biomedical Research Centre (Imperial College Healthcare NHS Trust); Institute for Health Research Biomedical Research Centre (Imperial College London)	Nadhmi Auchi Foundation; Imperial College London(General Electric); Kidney Research UK(Kidney Research UK (KRUK)); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Health Research Biomedical Research Centre (Imperial College Healthcare NHS Trust); Institute for Health Research Biomedical Research Centre (Imperial College London)	This study was funded by the Nadhmi Auchi Foundation, Imperial College London, Kidney Research UK (RP_019_20160303 and RP_002_20170914), the Foundation for the National Institutes of Health (HL128996, HL127173, and HL116263), and the Institute for Health Research Biomedical Research Centre (Imperial College Healthcare NHS Trust and Imperial College London). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2013, AM J PHYSIOL-RENAL, V305, pF1477, DOI 10.1152/ajprenal.00182.2013; Abe Y, 2010, AM J PHYSIOL-CELL PH, V299, pC464, DOI 10.1152/ajpcell.00563.2009; Allen RM, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1506198; Ballermann BJ, 2005, KIDNEY INT, V67, P1668, DOI 10.1111/j.1523-1755.2005.00260.x; Bjornson A, 2005, AM J PHYSIOL-RENAL, V288, pF748, DOI 10.1152/ajprenal.00202.2004; CAGLIERO E, 1995, LAB INVEST, V73, P667; Chandrasekaran K, 2012, KIDNEY INT, V81, P617, DOI 10.1038/ki.2011.448; Chen S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/839761; Cheng HF, 2010, INT J BIOCHEM CELL B, V42, P1380, DOI 10.1016/j.biocel.2010.05.014; Chevillet JR, 2014, P NATL ACAD SCI USA, V111, P14888, DOI 10.1073/pnas.1408301111; Choi YC, 2011, MOL CELLS, V32, P77, DOI 10.1007/s10059-011-1042-2; Foster RR, 2003, AM J PHYSIOL-RENAL, V284, pF1263, DOI 10.1152/ajprenal.00276.2002; Hakroush S, 2009, AM J PATHOL, V175, P1883, DOI 10.2353/ajpath.2009.080792; Konoshenko MY, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8545347; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Njock MS, 2015, BLOOD, V125, P3202, DOI 10.1182/blood-2014-11-611046; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Okoye IS, 2014, IMMUNITY, V41, P89, DOI [10.1016/j.immuni.2014.05.019, 10.1016/j.immuni.2014.08.008]; Oosthuyzen W, 2016, J AM SOC NEPHROL, V27, P3345, DOI 10.1681/ASN.2015050568; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; PASCUAL M, 1994, J EXP MED, V179, P889, DOI 10.1084/jem.179.3.889; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pitt JM, 2016, J CLIN INVEST, V126, P1139, DOI 10.1172/JCI87316; Ramirez MI, 2018, NANOSCALE, V10, P881, DOI 10.1039/c7nr08360b; Salmon AHJ, 2012, J PATHOL, V226, P562, DOI 10.1002/path.3964; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; Schell C, 2017, J AM SOC NEPHROL, V28, P3166, DOI 10.1681/ASN.2017020143; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Stieger N, 2012, METABOLISM, V61, P1073, DOI 10.1016/j.metabol.2011.12.003; Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Verstreken Patrik, 2008, V440, P349, DOI 10.1007/978-1-59745-178-9_26; Wu XM, 2016, BIOL OPEN, V5, P484, DOI 10.1242/bio.015990; Xu C, 2014, KIDNEY INT, V85, P72, DOI 10.1038/ki.2013.286; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001; Zomer A, 2015, CELL, V161, P1046, DOI 10.1016/j.cell.2015.04.042	41	11	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0224852	10.1371/journal.pone.0224852	http://dx.doi.org/10.1371/journal.pone.0224852			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214346	gold, Green Submitted, Green Published			2022-12-26	WOS:000535934200001
J	Todorov, H; Searle-White, E; Gerber, S				Todorov, Hristo; Searle-White, Emily; Gerber, Susanne			Applying univariate vs. multivariate statistics to investigate therapeutic efficacy in (pre)clinical trials: A Monte Carlo simulation study on the example of a controlled preclinical neurotrauma trial	PLOS ONE			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; ANIMAL-MODELS; EXPERIMENTAL STROKE; ISCHEMIC-STROKE; PLASTICITY; PATHOPHYSIOLOGY; INFLAMMATION; METAANALYSIS; DISCOVERY	Background Small sample sizes combined with multiple correlated endpoints pose a major challenge in the statistical analysis of preclinical neurotrauma studies. The standard approach of applying univariate tests on individual response variables has the advantage of simplicity of interpretation, but it fails to account for the covariance/correlation in the data. In contrast, multivariate statistical techniques might more adequately capture the multi-dimensional pathophysiological pattern of neurotrauma and therefore provide increased sensitivity to detect treatment effects. Results We systematically evaluated the performance of univariate ANOVA, Welch's ANOVA and linear mixed effects models versus the multivariate techniques, ANOVA on principal component scores and MANOVA tests by manipulating factors such as sample and effect size, normality and homogeneity of variance in computer simulations. Linear mixed effects models demonstrated the highest power when variance between groups was equal or variance ratio was 1:2. In contrast, Welch's ANOVA outperformed the remaining methods with extreme variance heterogeneity. However, power only reached acceptable levels of 80% in the case of large simulated effect sizes and at least 20 measurements per group or moderate effects with at least 40 replicates per group. In addition, we evaluated the capacity of the ordination techniques, principal component analysis (PCA), redundancy analysis (RDA), linear discriminant analysis (LDA), and partial least squares discriminant analysis (PLS-DA) to capture patterns of treatment effects without formal hypothesis testing. While LDA suffered from a high false positive rate due to multicollinearity, PCA, RDA, and PLS-DA were robust and PLS-DA outperformed PCA and RDA in capturing a true treatment effect pattern. Conclusions Multivariate tests do not provide an appreciable increase in power compared to univariate techniques to detect group differences in preclinical studies. However, PLS-DA seems to be a useful ordination technique to explore treatment effect patterns without formal hypothesis testing.	[Todorov, Hristo; Gerber, Susanne] Johannes Gutenberg Univ Mainz, Inst Dev Biol & Neurobiol, Fac Biol, Mainz, Germany; [Todorov, Hristo] Fresenius Kabi Deutschland GmbH, Oberursel, Germany; [Searle-White, Emily] Johannes Gutenberg Univ Mainz, Inst Math, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Gerber, S (corresponding author), Johannes Gutenberg Univ Mainz, Inst Dev Biol & Neurobiol, Fac Biol, Mainz, Germany.	sugerber@uni-mainz.de	Gerber, Susanne/I-6352-2018	Gerber, Susanne/0000-0001-9513-0729	Fresenius Kabi Deutschland GmbH [CRC 1193]; Center for Computational Sciences in Mainz (CSM)	Fresenius Kabi Deutschland GmbH; Center for Computational Sciences in Mainz (CSM)	The work of HT was funded by Fresenius Kabi Deutschland GmbH. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The work of SG was partly supported by the CRC 1193. ESW was supported by Center for Computational Sciences in Mainz (CSM). The funder provided support in the form of salaries for author HT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The specific roles of all authors are articulated in the `author contributions' section.	Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Batchelor PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072659; Bath PMW, 2009, BRIT J PHARMACOL, V157, P1157, DOI 10.1111/j.1476-5381.2009.00196.x; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Blanca MJ, 2018, BEHAV RES METHODS, V50, P937, DOI 10.3758/s13428-017-0918-2; Burton A, 2006, STAT MED, V25, P4279, DOI 10.1002/sim.2673; Cohen J.E., 1988, STAT POWER ANAL BEHA; Couillard-Despres S, 2017, NEUROLOGICAL ASPECTS; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Everitt JI, 2015, TOXICOL PATHOL, V43, P70, DOI 10.1177/0192623314555162; Ferguson AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059712; Ferguson AR, 2011, TRANSL STROKE RES, V2, P438, DOI 10.1007/s12975-011-0121-1; Finch W.H., 2007, MULTIPLE LINEAR REGR, V33, P12; Fitts DA, 2011, J AM ASSOC LAB ANIM, V50, P445; Frizzell JP, 2005, AACN ADV CRIT CARE, V16, P421, DOI 10.1097/00044067-200510000-00002; Hall JCE, 2012, J NEUROCHEM, V121, P738, DOI 10.1111/j.1471-4159.2012.07726.x; Hotelling H., 1951, P 2 BERKELEY S MATH, P23; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kigerl KA, 2006, J COMP NEUROL, V494, P578, DOI 10.1002/cne.20827; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim YH, 2017, CLIN ORTHOP SURG, V9, P1, DOI 10.4055/cios.2017.9.1.1; Kropf S., 1997, DRUG INF J, V31, P433; Laajala TD, 2016, SCI REP-UK, V6, DOI 10.1038/srep30723; Laban KG, 2015, J CEREBR BLOOD F MET, V35, P1085, DOI 10.1038/jcbfm.2015.89; Lee J., 2015, SURG OXFORD, V33, P238, DOI DOI 10.1016/J.MPSUR.2015.04.003; Liu XZ, 1997, J NEUROSCI, V17, P5395; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Maysami S, 2016, J CEREBR BLOOD F MET, V36, P596, DOI 10.1177/0271678X15606714; McCann SK, 2016, TRANSL STROKE RES, V7, P395, DOI 10.1007/s12975-016-0489-z; McCann SK, 2014, STROKE, V45, P3055, DOI 10.1161/STROKEAHA.114.006304; Milidonis X, 2015, STROKE, V46, P843, DOI 10.1161/STROKEAHA.114.007560; Muhlhausler BS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001481; Naes T, 2001, J CHEMOMETR, V15, P413, DOI 10.1002/cem.676; Nielson JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9581; Nielson JL, 2015, BRAIN RES, V1619, P124, DOI 10.1016/j.brainres.2014.10.048; Nielson JL, 2014, J NEUROTRAUM, V31, P1789, DOI 10.1089/neu.2014.3399; OLSON CL, 1976, PSYCHOL BULL, V83, P579, DOI 10.1037/0033-2909.83.4.579; OLSON CL, 1979, PSYCHOL BULL, V86, P1350, DOI 10.1037/0033-2909.86.6.1350; Pedder H, 2014, STROKE, V45, P563, DOI 10.1161/STROKEAHA.113.003128; PILLAI KCS, 1955, ANN MATH STAT, V26, P117, DOI 10.1214/aoms/1177728599; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; R Core Team, 2021, R LANGUAGE ENV STAT; Resnick DK, 2004, NEUROREPORT, V15, P837, DOI 10.1097/00001756-200404090-00020; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; ROY SN, 1953, ANN MATH STAT, V24, P220, DOI 10.1214/aoms/1177729029; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sutherland BA, 2012, INT J STROKE, V7, P407, DOI 10.1111/j.1747-4949.2012.00770.x; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Todorov H., 2018, GENOM COMPUT BIOL, V4, DOI [10.18547/gcb.2018.vol4.iss2.e100041, DOI 10.18547/GCB.2018.VOL4.ISS2.E100041]; van Luijk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089981; Warne R. T., 2014, PRACTICAL ASSESSMENT, V19, P1, DOI DOI 10.7275/SM63-7H70; Watzlawick R, 2014, JAMA NEUROL, V71, P91, DOI 10.1001/jamaneurol.2013.4684; WELCH BL, 1951, BIOMETRIKA, V38, P330, DOI 10.2307/2332579; Wilks SS, 1932, BIOMETRIKA, V24, P471	59	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230798	10.1371/journal.pone.0230798	http://dx.doi.org/10.1371/journal.pone.0230798			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8GI	32214370	Green Published, Green Submitted, gold			2022-12-26	WOS:000535934200062
J	Chen, K; Phan, T; Lin, A; Sardo, L; Mele, AR; Nonnemacher, MR; Klase, Z				Chen, Kenneth; Phan, Thienlong; Lin, Angel; Sardo, Luca; Mele, Anthony R.; Nonnemacher, Michael R.; Klase, Zachary			Morphine exposure exacerbates HIV-1 Tat driven changes to neuroinflammatory factors in cultured astrocytes	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-1 TAT; LONG TERMINAL REPEAT; BETA-CATENIN; NEUROTROPHIC FACTOR; TRANSCRIPTIONAL ACTIVITY; INFLAMMASOME ACTIVATION; RECEPTOR EXPRESSION; IFN-GAMMA; PROTEIN; REPLICATION	Despite antiretroviral therapy human immunodeficiency virus type-1 (HIV-1) infection results in neuroinflammation of the central nervous system that can cause HIV-associated neurocognitive disorders (HAND). The molecular mechanisms involved in the development of HAND are unclear, however, they are likely due to both direct and indirect consequences of HIV-1 infection and inflammation of the central nervous system. Additionally, opioid abuse in infected individuals has the potential to exacerbate HIV-comorbidities, such as HAND. Although restricted for productive HIV replication, astrocytes (comprising 40-70% of all brain cells) likely play a significant role in neuropathogenesis in infected individuals due to the production and response of viral proteins. The HIV-1 protein Tat is critical for viral transcription, causes neuroinflammation, and can be secreted from infected cells to affect uninfected bystander cells. The Wnt/beta-catenin signaling cascade plays an integral role in restricting HIV-1 infection in part by negatively regulating HIV-1 Tat function. Conversely, Tat can overcome this negative regulation and inhibit beta-catenin signaling by sequestering the critical transcription factor TCF-4 from binding to beta-catenin. Here, we aimed to explore how opiate exposure affects Tat-mediated suppression of beta-catenin in astrocytes and the downstream modulation of neuroinflammatory genes. We observed that morphine can potentiate Tat suppression of beta-catenin activity in human astrocytes. In contrast, Tat mutants deficient in secretion, and lacking neurotoxic effects, do not affect beta-catenin activity in the presence or absence of morphine. Finally, morphine treatment of astrocytes was sufficient to reduce the expression of genes involved in neuroinflammation. Examining the molecular mechanisms of how HIV-1 infection and opiate exposure exacerbate neuroinflammation may help us inform or predict disease progression prior to HAND development.	[Chen, Kenneth; Phan, Thienlong; Lin, Angel; Sardo, Luca; Klase, Zachary] Univ Sci, Dept Biol Sci, Philadelphia, PA 19104 USA; [Sardo, Luca] Merck & Co Inc, Dept Infect Dis & Vaccines, Current Inst, West Point, PA USA; [Mele, Anthony R.; Nonnemacher, Michael R.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Mele, Anthony R.; Nonnemacher, Michael R.] Drexel Univ, Coll Med, Ctr Mol Virol & Translat Neurosci, Inst Mol Med & Infect Dis, Philadelphia, PA 19104 USA	Merck & Company; Drexel University; Drexel University	Klase, Z (corresponding author), Univ Sci, Dept Biol Sci, Philadelphia, PA 19104 USA.	z.klase@usciences.edu	Lin, Angel/D-7238-2017	Lin, Angel/0000-0003-2676-8387; Chen, Kenneth/0000-0001-7391-977X	Public Health Service, National Institutes of Health through National Institute of Drug Abuse (NIDA) [DP2 DA044550, R03 DA039733]; Public Health Service, National Institutes of Health through National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS089435]; Public Health Service, National Institutes of Health through Ruth L. Kirschstein National Research Service Award [T32 MH079785]	Public Health Service, National Institutes of Health through National Institute of Drug Abuse (NIDA); Public Health Service, National Institutes of Health through National Institute of Neurological Disorders and Stroke (NINDS); Public Health Service, National Institutes of Health through Ruth L. Kirschstein National Research Service Award	This work was funded by the Public Health Service, National Institutes of Health, through grants from the (1) National Institute of Drug Abuse (NIDA) DP2 DA044550 (PI, Zachary A. Klase) and R03 DA039733 (PI, Zachary A. Klase); (2) the National Institute of Neurological Disorders and Stroke (NINDS) R01 NS089435 (PI, Michael R. Nonnemacher); and (3) the Ruth L. Kirschstein National Research Service Award T32 MH079785 (Dr. Brian Wigdahl, Principal Investigator of the Drexel University College of Medicine component and Dr. Olimpia Meucci as Co-Director). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0; Aksenov MY, 2010, NEUROSCI LETT, V475, P174, DOI 10.1016/j.neulet.2010.03.073; Al-Harthi L, 2012, J NEUROIMMUNE PHARM, V7, P731, DOI 10.1007/s11481-012-9411-y; Almad A, 2018, NAT REV NEUROL, V14, P351, DOI 10.1038/s41582-018-0010-2; Angelucci F, 2007, J PSYCHOPHARMACOL, V21, P820, DOI 10.1177/0269881107078491; Angelucci F, 2007, EUR NEUROPSYCHOPHARM, V17, P756, DOI 10.1016/j.euroneuro.2007.03.002; Anthony IC, 2008, FRONT BIOSCI-LANDMRK, V13, P1294, DOI 10.2741/2762; Aprea S, 2006, J NEUROSCI, V26, P4054, DOI 10.1523/JNEUROSCI.0603-06.2006; Bachis A, 2012, J NEUROSCI, V32, P9477, DOI 10.1523/JNEUROSCI.0865-12.2012; Balcom EF, 2019, CURR OPIN VIROL, V38, P54, DOI 10.1016/j.coviro.2019.06.004; Bednar MM, 2015, CURR HIV-AIDS REP, V12, P262, DOI 10.1007/s11904-015-0265-9; Bertrand SJ, 2013, EXP NEUROL, V248, P228, DOI 10.1016/j.expneurol.2013.06.020; Bozzelli PL, 2019, GLIA, V67, P1719, DOI 10.1002/glia.23642; Brailoiu E, 2006, J NEUROVIROL, V12, P17, DOI 10.1080/13550280500516427; Caporello E, 2006, J NEUROCHEM, V98, P146, DOI 10.1111/j.1471-4159.2006.03863.x; Carroll-Anzinger D, 2007, J VIROL, V81, P5864, DOI 10.1128/JVI.02234-06; Cass WA, 2003, BRAIN RES, V984, P133, DOI 10.1016/S0006-8993(03)03122-6; Chilunda V, 2019, BRAIN RES, V1724, DOI 10.1016/j.brainres.2019.146426; Churchill MJ, 2016, NAT REV MICROBIOL, V14, P55, DOI 10.1038/nrmicro.2015.5; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; Delannoy A, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030269; Diogenes MJ, 2004, J NEUROSCI, V24, P2905, DOI 10.1523/JNEUROSCI.4454-03.2004; Dossi E, 2018, BRAIN RES BULL, V136, P139, DOI 10.1016/j.brainresbull.2017.02.001; Dowling P, 1999, NEUROLOGY, V53, P1676, DOI 10.1212/WNL.53.8.1676; El-Hage N, 2005, GLIA, V50, P91, DOI 10.1002/glia.20148; El-Hage N, 2011, J VIROL, V85, P11601, DOI 10.1128/JVI.05239-11; Fan Y, 2011, J NEUROIMMUNE PHARM, V6, P121, DOI 10.1007/s11481-010-9217-8; Fann DYW, 2018, MOL NEUROBIOL, V55, P1082, DOI 10.1007/s12035-017-0394-9; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fitting S, 2013, BIOL PSYCHIAT, V73, P443, DOI 10.1016/j.biopsych.2012.09.026; Fitting S, 2012, EUR J PHARMACOL, V689, P96, DOI 10.1016/j.ejphar.2012.05.029; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Gatignol A, 2000, Adv Pharmacol, V48, P209; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Goutan E, 1998, MOL BRAIN RES, V59, P154, DOI 10.1016/S0169-328X(98)00156-9; Gray LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090620; Gupta VK, 2013, INT J MOL SCI, V14, P10122, DOI 10.3390/ijms140510122; Gurwell JA, 2001, NEUROSCIENCE, V102, P555, DOI 10.1016/S0306-4522(00)00461-9; Hahn YK, 2012, GLIA, V60, P1871, DOI 10.1002/glia.22403; Hauser KF, 2007, J NEUROCHEM, V100, P567, DOI 10.1111/j.1471-4159.2006.04227.x; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Henderson LJ, 2012, J NEUROSCI, V32, P16306, DOI 10.1523/JNEUROSCI.3145-12.2012; Henderson LJ, 2012, J VIROL, V86, P9495, DOI 10.1128/JVI.00486-12; HO DD, 1985, ANN INTERN MED, V103, P880, DOI 10.7326/0003-4819-103-6-880; Jacobs JL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02383; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kawazoe M, 2018, CLIN RHEUMATOL, V37, P2169, DOI 10.1007/s10067-017-3689-3; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Kukkonen S, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-30; Lamers SL, 2016, J VIROL, V90, P8968, DOI 10.1128/JVI.00674-16; Lee HC, 2019, J VIROL, V93, DOI 10.1128/JVI.01291-18; Li JL, 2002, J VIROL, V76, P4526, DOI 10.1128/JVI.76.9.4526-4535.2002; Li L, 2012, ADV VIROL, V2012, DOI 10.1155/2012/123605; Li W, 2011, J IMMUNOL, V186, P6771, DOI 10.4049/jimmunol.1100099; Li WX, 2008, J NEUROSCI, V28, P12190, DOI 10.1523/JNEUROSCI.3019-08.2008; Link RW, 2019, VIRUS RES, V272, DOI 10.1016/j.virusres.2019.197727; Luo XY, 2015, J NEUROVIROL, V21, P66, DOI 10.1007/s13365-014-0304-0; Mahajan SD, 2008, J CLIN IMMUNOL, V28, P528, DOI 10.1007/s10875-008-9208-1; Makhathini KB, 2018, METAB BRAIN DIS, V33, P1743, DOI 10.1007/s11011-018-0283-6; Marina N, 2018, GLIA, V66, P1185, DOI 10.1002/glia.23283; Masvekar RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100196; Maubert ME, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01512; Mele AR, 2018, TRAFFIC; Miguez-Burbano Maria Jose, 2014, J Int Assoc Provid AIDS Care, V13, P454, DOI 10.1177/2325957414535253; Murphy A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02445; Narasipura SD, 2012, J VIROL, V86, P1911, DOI 10.1128/JVI.06266-11; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; Norman JP, 2007, J IMMUNOL, V178, P869, DOI 10.4049/jimmunol.178.2.869; Ong CL, 2005, J VIROL, V79, P12763, DOI 10.1128/JVI.79.20.12763-12772.2005; Orsini MJ, 1996, J NEUROSCI, V16, P2546; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Polychronopoulos P, 2004, J MED CHEM, V47, P935, DOI 10.1021/jm031016d; Rana TM, 1999, ARCH BIOCHEM BIOPHYS, V365, P175, DOI 10.1006/abbi.1999.1206; Rayne F, 2010, CELL BIOL INT, V34, P409, DOI 10.1042/CBI20090376; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Sardo L, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0256-y; SCARPINI E, 1991, J NEUROL, V238, P356, DOI 10.1007/BF00315340; Sharma A, 2011, J NEUROIMMUNE PHARM, V6, P597, DOI 10.1007/s11481-011-9295-2; Spector C, 2019, MED MICROBIOL IMMUN, V208, P131, DOI 10.1007/s00430-019-00583-z; Thangaraj A, 2018, AUTOPHAGY, V14, P1596, DOI 10.1080/15548627.2018.1476810; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Turchan-Cholewo J, 2008, J NEUROSCI RES, V86, P2100, DOI 10.1002/jnr.21653; Tyagi M, 2016, CURR HIV RES, V14, P442, DOI 10.2174/1570162X14666160324124736; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Valvatne H, 1996, AIDS RES HUM RETROV, V12, P611, DOI 10.1089/aid.1996.12.611; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Verhoef K, 1998, AIDS RES HUM RETROV, V14, P1553, DOI 10.1089/aid.1998.14.1553; Wallet C, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00362; Williams R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005709; Wortman B, 2002, J VIROL, V76, P11159, DOI 10.1128/JVI.76.21.11159-11165.2002; Yezid H, 2009, J BIOL CHEM, V284, P22736, DOI 10.1074/jbc.M109.023705; Yi H, 2012, NEUROREPORT, V23, P189, DOI 10.1097/WNR.0b013e32834fab06; Yue S, 2016, HEPATOLOGY, V64, P1683, DOI 10.1002/hep.28739; Zayyad Z, 2015, CURR HIV-AIDS REP, V12, P16, DOI 10.1007/s11904-014-0255-3; Zhang JZ, 2005, GENE, V363, P67, DOI 10.1016/j.gene.2005.06.043; Zhang WP, 2018, J BIOL CHEM, V293, P15641, DOI 10.1074/jbc.RA118.002840; Zhou BY, 2004, MOL CELL NEUROSCI, V27, P296, DOI 10.1016/j.mcn.2004.07.003	104	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230563	10.1371/journal.pone.0230563	http://dx.doi.org/10.1371/journal.pone.0230563			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210470	Green Published, gold			2022-12-26	WOS:000535307600032
J	Choi, PW; So, WW; Yang, JZ; Liu, SB; Tong, KK; Kwan, KM; Kwok, JSL; Tsui, SKW; Ng, SK; Hales, KH; Hales, DB; Welch, WR; Crum, CP; Fong, WP; Berkowitz, RS; Ng, SW				Choi, Pui-Wah; So, Wai Wing; Yang, Junzheng; Liu, Shubai; Tong, Ka Kui; Kwan, Kin Ming; Kwok, Jamie S. -L.; Tsui, Stephen K. W.; Ng, Shu-Kay; Hales, Karen H.; Hales, Dale B.; Welch, William R.; Crum, Christopher P.; Fong, Wing-Ping; Berkowitz, Ross S.; Ng, Shu-Wing			MicroRNA-200 family governs ovarian inclusion cyst formation and mode of ovarian cancer spread	ONCOGENE			English	Article							E-CADHERIN; SEROUS CARCINOMAS; MIR-200 FAMILY; FALLOPIAN-TUBE; CELL; RISK; SRC; PHENOTYPE; INVASION; INTEGRIN	Epidemiologic and histopathologic findings and the laying hen model support the long-standing incessant ovulation hypothesis and cortical inclusion cyst involvement in sporadic ovarian cancer development. MicroRNA-200 (miR-200) family is highly expressed in ovarian cancer. Herewith, we show that ovarian surface epithelial (OSE) cells with ectopic miR-200 expression formed stabilized cysts in three-dimensional (3D) organotypic culture with E-cadherin fragment expression and steroid hormone pathway activation, whereas ovarian cancer 3D cultures with miR-200 knockdown showed elevated TGF-beta expression, mitotic spindle disorientation, increased lumenization, disruption of ROCK-mediated myosin II phosphorylation, and SRC signaling, which led to histotype-dependent loss of collective movement in tumor spread. Gene expression profiling revealed that epithelial-mesenchymal transition and hypoxia were the top enriched gene sets regulated by miR-200 in both OSE and ovarian cancer cells. The molecular changes uncovered by the in vitro studies were verified in both human and laying hen ovarian cysts and tumor specimens. As miR-200 is also essential for ovulation, our results of estrogen pathway activation in miR-200-expressing OSE cells add another intriguing link between incessant ovulation and ovarian carcinogenesis.	[Choi, Pui-Wah; Yang, Junzheng; Liu, Shubai; Berkowitz, Ross S.; Ng, Shu-Wing] Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Choi, Pui-Wah; So, Wai Wing; Tong, Ka Kui; Kwan, Kin Ming; Fong, Wing-Ping] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Peoples R China; [Kwan, Kin Ming] Chinese Univ Hong Kong, Ctr Cell & Dev Biol, Hong Kong, Peoples R China; [Kwan, Kin Ming] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Hong Kong, Peoples R China; [Kwok, Jamie S. -L.; Tsui, Stephen K. W.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Ng, Shu-Kay] Griffith Univ, Sch Med, Nathan, Qld 4111, Australia; [Ng, Shu-Kay] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld 4111, Australia; [Hales, Karen H.; Hales, Dale B.] Southern Illinois Sch Med, Dept Obstet Gynecol, Carbondale, IL 62901 USA; [Hales, Dale B.] Southern Illinois Sch Med, Dept Physiol Biochem & Mol Biol, Carbondale, IL 62901 USA; [Welch, William R.; Crum, Christopher P.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ng, Shu-Wing] Tufts Med Ctr, Mother Infant Res Inst, Dept Obstet & Gynecol, 800 Washington St, Boston, MA 02111 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Griffith University; Griffith University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Tufts Medical Center	Fong, WP (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Peoples R China.	wpfong@cuhk.edu.hk; sng1@tuftsmedicalcenter.org	; Tsui, Stephen Kwok-Wing/E-4385-2015	liu, shubai/0000-0001-8929-4209; Ng, Shu Kay/0000-0002-6865-9384; Tsui, Stephen Kwok-Wing/0000-0003-0686-4259	Robert and Deborah First Fund; Sperling Family Fund Foundation; Ruth N. White Gynecologic Oncology Research Fund; Women's Cancer Program; Gillette Center for Women's Cancer from Dana-Farber Cancer Institute; Ovarian Cancer Research Foundation; Adler Foundation, Inc.; Friends of Dana-Farber Cancer Institute; CNOOC	Robert and Deborah First Fund; Sperling Family Fund Foundation; Ruth N. White Gynecologic Oncology Research Fund; Women's Cancer Program; Gillette Center for Women's Cancer from Dana-Farber Cancer Institute; Ovarian Cancer Research Foundation; Adler Foundation, Inc.; Friends of Dana-Farber Cancer Institute; CNOOC	We acknowledge Dr. Gregory Goodall for the provision of lentiviral miR-200 expression constructs and control, Mr. Shi-Kin Ma for the help of constructing the polar graphs, the support of the CNOOC Grants to the first author, and the Robert and Deborah First Fund, the Sperling Family Fund Foundation, Ruth N. White Gynecologic Oncology Research Fund, Women's Cancer Program and Gillette Center for Women's Cancer from Dana-Farber Cancer Institute, Ovarian Cancer Research Foundation, Adler Foundation, Inc., and Friends of Dana-Farber Cancer Institute to The Laboratory of Gynecologic Oncology at Brigham and Women's Hospital.	Aguilar-Rojas A, 2016, INT J ONCOL, V48, P861, DOI 10.3892/ijo.2016.3346; Ansenberger K, 2009, GYNECOL ONCOL, V113, P362, DOI 10.1016/j.ygyno.2009.02.011; ATFI A, 1994, J BIOL CHEM, V269, P30688; Avizienyte E, 2004, MOL BIOL CELL, V15, P2794, DOI 10.1091/mbc.E03-12-0879; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Barnes MN, 2002, GYNECOL ONCOL, V87, P57, DOI 10.1006/gyno.2002.6806; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Canel M, 2013, J CELL SCI, V126, P393, DOI 10.1242/jcs.100115; Choi PW, 2016, ONCOTARGET, V7, P4110, DOI 10.18632/oncotarget.6588; Cochrane DR, 2017, J PATHOL, V243, P26, DOI 10.1002/path.4934; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P711; David JM, 2012, CANCER RES, V72, P2917, DOI 10.1158/0008-5472.CAN-11-3498; Drapkin R, 2004, HUM PATHOL, V35, P1014, DOI 10.1016/j.humpath.2004.04.014; Esselen KM, 2014, GYNECOL ONCOL, V132, P316, DOI 10.1016/j.ygyno.2013.12.007; FATHALLA MF, 1971, LANCET, V2, P163; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Giles JR, 2010, INT J GYNECOL CANCER, V20, P738, DOI 10.1111/IGC.0b013e3181da2c49; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gruessner C, 2014, AM J CANCER RES, V4, P61; HANKINSON SE, 1993, JAMA-J AM MED ASSOC, V270, P2813, DOI 10.1001/jama.270.23.2813; Hasuwa H, 2013, SCIENCE, V341, P71, DOI 10.1126/science.1237999; Ho Shuk-Mei, 2003, Reprod Biol Endocrinol, V1, P73, DOI 10.1186/1477-7827-1-73; Howitt BE, 2015, AM J SURG PATHOL, V39, P287, DOI 10.1097/PAS.0000000000000369; Hua YY, 2016, ONCOTARGET, V7, P66077, DOI 10.18632/oncotarget.11808; Johnson PA, 2013, NAT REV CANCER, V13, P432, DOI 10.1038/nrc3535; Kim J, 2015, ENDOCRINOLOGY, V156, P1975, DOI 10.1210/en.2014-1977; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kolin DL, 2018, J PATHOL, V244, P131, DOI 10.1002/path.5009; Kommoss F, 2017, AM J SURG PATHOL, V41, P161, DOI 10.1097/PAS.0000000000000757; Konecny GE, 2009, BRIT J CANCER, V101, P1699, DOI 10.1038/sj.bjc.6605381; Konze SA, 2014, MOL CELL PROTEOMICS, V13, P990, DOI 10.1074/mcp.M113.033423; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Matsumura N, 2011, GENOME RES, V21, P74, DOI 10.1101/gr.108803.110; McDaniel AS, 2015, JAMA ONCOL, V1, P1128, DOI 10.1001/jamaoncol.2015.1618; Mertens-Walker I, 2012, CANCER LETT, V324, P152, DOI 10.1016/j.canlet.2012.05.017; Messina A, 2016, NAT NEUROSCI, V19, P835, DOI 10.1038/nn.4298; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Przybycin CG, 2010, AM J SURG PATHOL, V34, P1407, DOI 10.1097/PAS.0b013e3181ef7b16; Rauh-Hain Jose A, 2011, Rev Obstet Gynecol, V4, P15; Rodriguez-Fraticelli AE, 2011, CURR OPIN CELL BIOL, V23, P638, DOI 10.1016/j.ceb.2011.07.002; Ryniers F, 2002, BIOL CHEM, V383, P159, DOI 10.1515/BC.2002.016; Sampson JA, 1927, AM J PATHOL, V3, P93; Scully RE, 1995, J CELL BIOCHEM, P208; Seidman JD, 2003, AM J SURG PATHOL, V27, P985, DOI 10.1097/00000478-200307000-00014; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Whiteman DC, 2000, JNCI-J NATL CANCER I, V92, P1172, DOI 10.1093/jnci/92.14.1172; Worley MJ, 2013, INT J MOL SCI, V14, P5367, DOI 10.3390/ijms14035367; Wu R, 2013, AM J PATHOL, V182, P1391, DOI 10.1016/j.ajpath.2012.12.031; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yang JZ, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3417-z; Zhao S, 2015, INT J CLIN EXP PATHO, V8, P10412	56	9	9	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	20					4045	4060		10.1038/s41388-020-1264-x	http://dx.doi.org/10.1038/s41388-020-1264-x		MAR 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LN3GC	32214198				2022-12-26	WOS:000521526300003
J	Takeuchi, E; Yamada, D; Suzuki, S; Saitoh, A; Itoh, M; Hayashi, T; Yamada, M; Wada, K; Sekiguchi, M				Takeuchi, Eri; Yamada, Daisuke; Suzuki, Satoshi; Saitoh, Akiyoshi; Itoh, Masayuki; Hayashi, Takashi; Yamada, Mitsuhiko; Wada, Keiji; Sekiguchi, Masayuki			Participation of the nucleus accumbens dopaminergic system in the antidepressant-like actions of a diet rich in omega-3 polyunsaturated fatty acids	PLOS ONE			English	Article							DEFICIENCY; DEPRESSION; BRAIN; NEUROTRANSMISSION; SUPPLEMENTATION; EXPRESSION; EFFICACY; MEMORY; RATS	The beneficial effects of omega (omega)-3 polyunsaturated fatty acid (PUFA) supplementation on major depressive disorder have been actively studied, but the underlying mechanism remains unknown. The present study examined the involvement of the nucleus accumbens (NAc) dopaminergic systems in behavioral changes in mice fed a diet high in omega-3 PUFAs. Mice fed a diet containing about double the amount of omega-3 PUFAs (krill oil (KO) diet) exerted shorter immobility times in the forced swim test (FST) than mice fed a control diet, containing only alpha-linolenic acid (ALA) as omega-3 PUFAs. The shorter immobility times were observed in both male and female mice. A dopamine metabolite, 3,4-dihydroxyphenylacetic acid, increased in the NAc in male mice fed the KO diet when compared with those fed the control diet. In addition, dopamine, 3-methoxytyramine, and homovanillic acid increased in the NAc in female mice fed the KO diet. Notably, the effects of the KO diet on the immobility time in the FST were abolished by microinjection of sulpiride, an antagonist of D-2-like receptors, into the NAc. A similar microinjection of an antagonist selective for D-1-like receptors, SKF83566, also abolished the reduction in immobility in the FST. Moreover, we found that tyrosine hydroxylase-positive cells increased in the ventral tegmental area (VTA) in mice fed the KO diet. These results suggest that modulation of the VTA-NAc dopaminergic pathway is one of the mechanisms by which a KO diet rich in omega-3 PUFAs reduces the immobility behavior in the mouse FST.	[Takeuchi, Eri; Yamada, Daisuke; Wada, Keiji; Sekiguchi, Masayuki] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Tokyo, Japan; [Suzuki, Satoshi; Saitoh, Akiyoshi; Yamada, Mitsuhiko] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Neuropsychopharmacol, Tokyo, Japan; [Itoh, Masayuki; Hayashi, Takashi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Biochem & Cellular Biol, Tokyo, Japan; [Wada, Keiji] Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Sekiguchi, M (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Tokyo, Japan.	sekiguch@ncnp.go.jp	Yamada, Mitsuhiko/AAO-1107-2020	Yamada, Mitsuhiko/0000-0002-5649-2310; Yamada, Daisuke/0000-0002-6989-6736; Hayashi, Takashi/0000-0003-3591-2109	JSPS KAKENHI [15K06730, 19K08086]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JSPS KAKENHI (15K06730 to MS, 19K08086 to ET).	Andraka JM, 2020, NEUROSCI RES, V157, P1, DOI 10.1016/j.neures.2019.08.001; Appleton KM, 2010, AM J CLIN NUTR, V91, P757, DOI 10.3945/ajcn.2009.28313; Burri L, 2015, NUTRIENTS, V7, P3300, DOI 10.3390/nu7053300; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Choi JY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122554; Delion S, 1996, J NEUROCHEM, V66, P1582; Frances H, 1996, LIFE SCI, V58, P1805, DOI 10.1016/0024-3205(96)00164-6; Green P, 2001, BBA-MOL CELL BIOL L, V1532, P203, DOI 10.1016/S1388-1981(01)00132-9; HIBBELN JR, 1995, AM J CLIN NUTR, V62, P1; Huang SY, 2008, J PSYCHIATR RES, V42, P58, DOI 10.1016/j.jpsychires.2006.09.004; Ikemoto S, 2015, BEHAV BRAIN RES, V290, P17, DOI 10.1016/j.bbr.2015.04.018; Jacka FN, 2013, BRIT J NUTR, V109, P2059, DOI 10.1017/S0007114512004102; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jump DB, 2018, PHARMACOL THERAPEUT, V181, P108, DOI 10.1016/j.pharmthera.2017.07.007; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; Kuperstein F, 2008, J NEUROCHEM, V106, P662, DOI 10.1111/j.1471-4159.2008.05418.x; Lee B, 2010, PROG NEURO-PSYCHOPH, V34, P1085, DOI 10.1016/j.pnpbp.2010.05.031; Lesperance F, 2011, J CLIN PSYCHIAT, V72, P1054, DOI 10.4088/JCP.10m05966blu; Miccadei S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00486; Mocking RJT, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.29; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nishi D, 2016, PSYCHIAT CLIN NEUROS, V70, P253, DOI 10.1111/pcn.12388; O'Connell TD, 2017, J MOL CELL CARDIOL, V103, P74, DOI 10.1016/j.yjmcc.2016.12.003; Ober MD, 1998, PROSTAG LEUKOTR ESS, V59, P127, DOI 10.1016/S0952-3278(98)90091-6; Park Y, 2012, J NUTR BIOCHEM, V23, P924, DOI 10.1016/j.jnutbio.2011.04.018; Paxinos G, 2012, PAXINOS FRANKLINS MO; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Richard JM, 2011, J NEUROSCI, V31, P12866, DOI 10.1523/JNEUROSCI.1339-11.2011; Saitoh A, 2008, BRAIN RES, V1208, P160, DOI 10.1016/j.brainres.2007.07.095; SALEM N, 1995, MOL MEMBR BIOL, V12, P131, DOI 10.3109/09687689509038508; Sublette ME, 2014, INT J NEUROPSYCHOPH, V17, P383, DOI 10.1017/S1461145713001399; Takao K, 2013, NEUROPSYCHOPHARMACOL, V38, P1409, DOI 10.1038/npp.2013.38; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; Venna VR, 2009, PSYCHONEUROENDOCRINO, V34, P199, DOI 10.1016/j.psyneuen.2008.08.025; Vines A, 2012, NEUROPHARMACOLOGY, V62, P184, DOI 10.1016/j.neuropharm.2011.06.017; Wibrand K, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-6; Wietrzych-Schindler M, 2011, BIOL PSYCHIAT, V69, P788, DOI 10.1016/j.biopsych.2010.12.017; Yamada D, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00164; Yamada D, 2014, NEUROPSYCHOPHARMACOL, V39, P1852, DOI 10.1038/npp.2014.32; Yang XG, 2011, NEUROCHEM INT, V58, P321, DOI 10.1016/j.neuint.2010.12.004; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7; Zimmer L, 2000, J LIPID RES, V41, P32; Zimmer L, 2002, AM J CLIN NUTR, V75, P662, DOI 10.1093/ajcn/75.4.662	43	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230647	10.1371/journal.pone.0230647	http://dx.doi.org/10.1371/journal.pone.0230647			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210469	Green Published, gold			2022-12-26	WOS:000535307600039
J	Bang, HJ; Kim, K; Shim, H; Kim, S; Jung, PY; Choi, YU; Bae, KS; Kim, IY; Jang, JY				Bang, Hui-Jae; Kim, Kwangmin; Shim, Hongjin; Kim, Seongyup; Jung, Pil Young; Choi, Young Un; Bae, Keum Seok; Kim, Ik Yong; Jang, Ji Young			Delta neutrophil index for predicting mortality in trauma patients who underwent emergent abdominal surgery: A case controlled study	PLOS ONE			English	Article							LACTATE CLEARANCE; COUNTS	Background Delta neutrophil index (DNI) can be used as a biomarker for infection to predict patient outcomes. We aimed to investigate the relationship between DNI and clinical outcomes in trauma patients who underwent abdominal surgery. Materials and methods We retrospectively analyzed injured patients who underwent emergent abdominal surgery in the regional trauma center of Wonju Severance Christian Hospital between March 2016 and May 2018. Patient characteristics, operation type, preoperative and postoperative laboratory findings, and clinical outcomes were evaluated. Logistic regression analysis was performed for risk factors associated with mortality. Results Overall, 169 patients (mean age, 53.8 years; 66.3% male) were enrolled in this study, of which 19 (11.2%) died. The median injury severity score (ISS) was 12. The non-survivors had a significantly higher ISS [25(9-50) vs. 10(1-50), p<0.001] and serum lactate level (9.00 +/- 4.10 vs. 3.04 +/- 2.23, p<0.001) and more frequent shock (63.2% vs 23.3%, p<0.001) and solid organ injury (52.6% vs. 25.3%, p = 0.013) than the survivors. There were significant differences in postoperative DNI between the two groups (p<0.009 immediate postoperation, p = 0.001 on postoperative day 1 [POD1], and p = 0.013 on POD2). Logistic regression analysis showed that the independent factors associated with mortality were postoperative lactate level (odds ratio [OR] 1.926, 95% confidence interval [CI] 1.101-3.089, p = 0.007), postoperative sequential organ failure assessment score (OR 1.593, 95% CI 1.160-2.187, p = 0.004), and DNI on POD1 (OR 1.118, 95% CI 1.028-1.215, p = 0.009). The receiver operating characteristics curve demonstrated that the area under the curve of DNI on POD1 was 0.887 (cut-off level: 7.1%, sensitivity 85.7%, and specificity 84.4%). Conclusions Postoperative DNI may be a useful biomarker to predict mortality in trauma patients who underwent emergent abdominal surgery.	[Bang, Hui-Jae; Shim, Hongjin; Kim, Seongyup; Jung, Pil Young; Choi, Young Un; Bae, Keum Seok; Kim, Ik Yong] Yonsei Univ, Dept Surg, Wonju Coll Med, Wonju, South Korea; [Kim, Kwangmin] Saidabad Clin, Dept Surg, Dhaka, Bangladesh; [Shim, Hongjin; Kim, Seongyup; Jung, Pil Young; Choi, Young Un; Bae, Keum Seok] Wonju Severance Christian Hosp, Reg Trauma Ctr, Wonju, South Korea; [Jang, Ji Young] Natl Hlth Insurance Serv Ilsan Hosp, Trauma Ctr, Dept Surg, Goyang Si, South Korea	Yonsei University; National Health Insurance Service	Jang, JY (corresponding author), Natl Hlth Insurance Serv Ilsan Hosp, Trauma Ctr, Dept Surg, Goyang Si, South Korea.	drjangjiyoung@gmail.com		Jang, Ji Young/0000-0001-6372-4194; JUNG, PIL YOUNG/0000-0001-6460-8072; Choi, Young Un/0000-0003-2410-7788; Kim, Kwangmin/0000-0003-0496-1303				ARDRON MJ, 1994, AM J CLIN PATHOL, V102, P646, DOI 10.1093/ajcp/102.5.646; Baxter J, 2016, J TRAUMA ACUTE CARE, V81, P555, DOI 10.1097/TA.0000000000001156; Chang David C, 2003, Curr Surg, V60, P632, DOI 10.1016/j.cursur.2003.07.011; Dekker SE, 2017, EUR J TRAUMA EMERG S, V43, P841, DOI 10.1007/s00068-016-0733-y; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; HyunNahm C, 2008, ANN CLIN LAB SCI, V38, P241; Kang HS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187629; Kim HW, 2012, SCAND J INFECT DIS, V44, P475, DOI 10.3109/00365548.2012.657232; Kim JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182325; Kofoed K, 2007, CRIT CARE, V11, DOI 10.1186/cc5723; Kong T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35796-4; Kong T, 2018, SHOCK, V49, P649, DOI 10.1097/SHK.0000000000001027; Kong T, 2018, SHOCK, V49, P317, DOI 10.1097/SHK.0000000000000957; Kong T, 2017, SHOCK, V48, P427, DOI 10.1097/SHK.0000000000000878; Lim TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086884; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Malone DL, 2001, J TRAUMA, V51, P458, DOI 10.1097/00005373-200109000-00006; Meisner M, 2006, CRIT CARE, V10, DOI 10.1186/cc3910; Odom SR, 2013, J TRAUMA ACUTE CARE, V74, P999, DOI 10.1097/TA.0b013e3182858a3e; Park BH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-299; Schnuriger B, 2010, J TRAUMA, V69, P302, DOI 10.1097/TA.0b013e3181bdcfaf; Seebach JD, 1997, AM J CLIN PATHOL, V107, P582; Seok Y, 2012, SHOCK, V37, P242, DOI 10.1097/SHK.0b013e3182454acf; Shapiro NI, 2009, CRIT CARE MED, V37, P96, DOI 10.1097/CCM.0b013e318192fd9d; Shin In Sik, 2017, Journal of Acute Care Surgery, V7, P61; Suarez-de-la-Rica A, 2015, SURG INFECT, V16, P346, DOI 10.1089/sur.2014.178; Yune HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120677	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230149	10.1371/journal.pone.0230149	http://dx.doi.org/10.1371/journal.pone.0230149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GC	32203541	gold, Green Published			2022-12-26	WOS:000535303900011
J	D'Amour, S; Harris, LR				D'Amour, Sarah; Harris, Laurence R.			The perceived size of the implicit representation of the dorsum and palm of the hand	PLOS ONE			English	Article							BODY MODEL; DISTORTIONS; PERCEPTION; PLASTICITY; ACCURACY; CORTEX	The perception of the body and its parts has traditionally been studied using the conscious body image. Here, we determine the implicit representation of the hand. Participants were sequentially shown two life-size images of either the dorsal or palmar surface of their hand. In one interval either the horizontal or vertical dimension of the image was varied using an adaptive staircase, while the other interval contained the full-size, undistorted image. Participants reported which image most closely matched their hand. The staircase honed in on the distorted image that was equally likely to be judged as matching their own hand as the accurate image. The implicit representation was taken as midway between these two images. The experiment was repeated with different hand orientations. Perceived width depended on the orientation, with differences found between the upright and right orientations. Interestingly, the perceived length of the dorsum and palm were different from each other-length of the dorsum was overestimated whereas palm length was perceived accurately. This study reveals distortions of the implicit representation of the hands in healthy individuals.	[D'Amour, Sarah; Harris, Laurence R.] York Univ, Ctr Vis Res, Toronto, ON, Canada	York University - Canada	D'Amour, S (corresponding author), York Univ, Ctr Vis Res, Toronto, ON, Canada.	saod16@yorku.ca	Harris, Laurence/AAT-9549-2021	Harris, Laurence/0000-0002-7154-8757	Natural Sciences and Engineering Council of Canada (NSERC) [46271-2015]; PGS-D3 NSERC; NSERC CREATE grant	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); PGS-D3 NSERC; NSERC CREATE grant	This work was supported by the Natural Sciences and Engineering Council of Canada (NSERC) grant #46271-2015 to LRH. SD was supported by a PGS-D3 NSERC graduate scholarship and an NSERC CREATE grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroziak KB, 2018, CONSCIOUS COGN, V61, P107, DOI 10.1016/j.concog.2018.01.002; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cardinali L, 2009, CURR BIOL, V19, pR478, DOI 10.1016/j.cub.2009.05.009; Cocchini G, 2018, Q J EXP PSYCHOL, V71, P2314, DOI 10.1177/1747021817741606; Coelho LA., 2018, PSYCHOL RES-PSYCH FO, V83, P1, DOI DOI 10.1007/S00426-018-1003-X; Coelho LA, 2019, EXP BRAIN RES, V237, P137, DOI 10.1007/s00221-018-5408-y; Coelho LA, 2018, PSYCHOL RES-PSYCH FO, V82, P866, DOI 10.1007/s00426-017-0870-x; Coelho LA, 2017, PSYCHOL RES-PSYCH FO, V81, P1224, DOI 10.1007/s00426-016-0815-9; COOPER PJ, 1987, INT J EAT DISORDER, V6, P485, DOI 10.1002/1098-108X(198707)6:4<485::AID-EAT2260060405>3.0.CO;2-O; D'Amour S, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02805; D'Amour S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177349; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; Gardner RM, 1996, J CLIN PSYCHOL, V52, P3, DOI 10.1002/(SICI)1097-4679(199601)52:1<3::AID-JCLP1>3.0.CO;2-X; GLEGHORN AA, 1987, J PSYCHOPATHOL BEHAV, V9, P203, DOI 10.1007/BF00960575; Hoover AEN, 2016, EXP BRAIN RES, V234, P3633, DOI 10.1007/s00221-016-4760-z; Hoover AEN, 2015, EXP BRAIN RES, V233, P1053, DOI 10.1007/s00221-014-4181-9; Ionta S, 2013, COGN AFFECT BEHAV NE, V13, P197, DOI 10.3758/s13415-012-0120-z; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; Knight FL, 2014, COGNITION, V131, P254, DOI 10.1016/j.cognition.2014.01.005; Longo MR, 2019, ACTA PSYCHOL, V196, P1, DOI 10.1016/j.actpsy.2019.03.002; Longo MR, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00656; Longo MR, 2015, PERCEPTION, V44, P1251, DOI 10.1177/0301006615594949; Longo MR, 2015, CONSCIOUS COGN, V36, P96, DOI 10.1016/j.concog.2015.06.009; Longo MR, 2015, ACTA PSYCHOL, V160, P77, DOI 10.1016/j.actpsy.2015.07.002; Longo MR, 2015, COGNITION, V142, P230, DOI 10.1016/j.cognition.2015.05.024; Longo MR, 2015, Q J EXP PSYCHOL, V68, P1116, DOI 10.1080/17470218.2014.975731; Longo MR, 2014, EXP BRAIN RES, V232, P1241, DOI 10.1007/s00221-014-3840-1; Longo MR, 2012, ACTA PSYCHOL, V141, P164, DOI 10.1016/j.actpsy.2012.07.015; Longo MR, 2012, PSYCHOL SCI, V23, P740, DOI 10.1177/0956797612441219; Longo MR, 2012, J EXP PSYCHOL HUMAN, V38, P9, DOI 10.1037/a0025428; Longo MR, 2011, J EXP PSYCHOL HUMAN, V37, P720, DOI 10.1037/a0021921; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Mancini F, 2011, NEUROPSYCHOLOGIA, V49, P1194, DOI 10.1016/j.neuropsychologia.2010.12.040; Marr D., 1982, VISION COMPUTATIONAL; McCabe Marita P, 2006, Body Image, V3, P163, DOI 10.1016/j.bodyim.2006.01.004; MOLINARI E, 1995, PERCEPT MOTOR SKILL, V81, P23, DOI 10.2466/pms.1995.81.1.23; Mussap AJ, 2008, BODY IMAGE, V5, P80, DOI 10.1016/j.bodyim.2007.07.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Peviani V, 2018, J COGN PSYCHOL, V30, P880, DOI 10.1080/20445911.2018.1538154; POWELL TPS, 1959, B JOHNS HOPKINS HOSP, V105, P133; Saulton A, 2016, ACTA PSYCHOL, V164, P103, DOI 10.1016/j.actpsy.2015.12.013; Saulton A, 2015, EXP BRAIN RES, V233, P1471, DOI 10.1007/s00221-015-4221-0; SLADE PD, 1973, PSYCHOL MED, V3, P188, DOI 10.1017/S0033291700048510; THOMPSON JK, 1988, INT J EAT DISORDER, V7, P521, DOI 10.1002/1098-108X(198807)7:4<521::AID-EAT2260070410>3.0.CO;2-H; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Weber E. H., 1996, EH WEBER TACTILE SEN, P21, DOI DOI 10.1002/1098-108X(198807)7:3.0.CO;2-H(199601)52:3::AID-3.0.CO;2-X	47	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230624	10.1371/journal.pone.0230624	http://dx.doi.org/10.1371/journal.pone.0230624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9GC	32203552	Green Published, gold			2022-12-26	WOS:000535303900029
J	Zhou, MS; Xu, R; Kaelber, DC; Gurney, ME				Zhou, Mengshi; Xu, Rong; Kaelber, David C.; Gurney, Mark E.			Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; DOUBLE-BLIND; MICROGLIA; TREM2; NEUROINFLAMMATION; ETANERCEPT; ALCOHOL; TRIALS; MODEL; NAMES	This large, retrospective case-control study of electronic health records from 56 million unique adult patients examined whether or not treatment with a Tumor Necrosis Factor (TNF) blocking agent is associated with lower risk for Alzheimer's disease (AD) in patients with rheumatoid arthritis (RA), psoriasis, and other inflammatory diseases which are mediated in part by TNF and for which a TNF blocker is an approved treatment. The analysis compared the diagnosis of AD as an outcome measure in patients receiving at least one prescription for a TNF blocking agent (etanercept, adalimumab, and infliximab) or for methotrexate. Adjusted odds ratios (AORs) were estimated using the Cochran-Mantel-Haenszel (CMH) method and presented with 95% confidence intervals (CIs) and p-values. RA was associated with a higher risk for AD (Adjusted Odds Ratio (AOR) = 2.06, 95% Confidence Interval: (2.02-2.10), P-value < 0.0001) as did psoriasis (AOR = 1.37 (1.31-1.42), P < 0.0001), ankylosing spondylitis (AOR = 1.57 (1.39-1.77), P < 0.0001), inflammatory bowel disease (AOR = 2.46 (2.33-2.59), P < 0.0001), ulcerative colitis (AOR = 1.82 (1.74-1.91), P < 0.0001), and Crohn's disease (AOR = 2.33 (2.22-2.43), P < 0.0001). The risk for AD in patients with RA was lower among patients treated with etanercept (AOR = 0.34 (0.25-0.47), P < 0.0001), adalimumab (AOR = 0.28 (0.19-0.39), P < 0.0001), or infliximab (AOR = 0.52 (0.39-0.69), P < 0.0001). Methotrexate was also associated with a lower risk for AD (AOR = 0.64 (0.61-0.68), P < 0.0001), while lower risk was found in patients with a prescription history for both a TNF blocker and methotrexate. Etanercept and adalimumab also were associated with lower risk for AD in patients with psoriasis: AOR = 0.47 (0.30-0.73 and 0.41 (0.20-0.76), respectively. There was no effect of gender or race, while younger patients showed greater benefit from a TNF blocker than did older patients. This study identifies a subset of patients in whom systemic inflammation contributes to risk for AD through a pathological mechanism involving TNF and who therefore may benefit from treatment with a TNF blocking agent.	[Zhou, Mengshi; Kaelber, David C.] Case Western Reserve Univ, Sch Med, Dept Populat & Quantitat Hlth Sci, Cleveland, OH USA; [Xu, Rong] Case Western Reserve Univ, Sch Med, Ctr Artificial Intelligence Drug Discovery, Cleveland, OH 44106 USA; [Kaelber, David C.] MetroHlth Syst, Dept Internal Med, Cleveland, OH USA; [Kaelber, David C.] MetroHlth Syst, Dept Pediat, Cleveland, OH USA; [Kaelber, David C.] MetroHlth Syst, Ctr Clin Informat Res & Educ, Cleveland, OH USA; [Gurney, Mark E.] Tetra Therapeut, Grand Rapids, MI 49506 USA	Case Western Reserve University; Case Western Reserve University; MetroHealth System; MetroHealth System; MetroHealth System	Xu, R (corresponding author), Case Western Reserve Univ, Sch Med, Ctr Artificial Intelligence Drug Discovery, Cleveland, OH 44106 USA.; Gurney, ME (corresponding author), Tetra Therapeut, Grand Rapids, MI 49506 USA.	rxx@case.edu; mark@tetratherapeutics.com		Kaelber, David/0000-0001-7855-9515	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under the NIH Director's New Innovator Award [DP2HD084068]; NIH National Institute of Aging [R01 AG057557, R01 AG061388, R56 AG062272]; National Institute of Mental Health [MH091791, MH107077]; American Cancer Society Research Scholar Grant [RSG-16-049-01 -MPC]	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under the NIH Director's New Innovator Award; NIH National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); American Cancer Society Research Scholar Grant(American Cancer Society)	R.X. acknowledges support from Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under the NIH Director's New Innovator Award number DP2HD084068, NIH National Institute of Aging R01 AG057557, R01 AG061388, R56 AG062272 and American Cancer Society Research Scholar Grant RSG-16-049-01 -MPC; Tetra Therapeutics provided support for the study in the form of salary for M.E.G. The specific roles of this author are articulated in the 'author contributions' section. M.E.G. acknowledges support from the National Institute of Mental Health awards MH091791 and MH107077. The funding sources had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Aisen PS, 2000, NEUROLOGY, V54, P588, DOI 10.1212/WNL.54.3.588; Aletaha D, 2018, JAMA-J AM MED ASSOC, V320, P1360, DOI 10.1001/jama.2018.13103; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Baumgart Matthew, 2015, Alzheimers Dement, V11, P718, DOI 10.1016/j.jalz.2015.05.016; Bemiller SM, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0216-6; Butchart J, 2015, NEUROLOGY, V84, P2161, DOI 10.1212/WNL.0000000000001617; Chakrabarty P, 2018, J EXP MED, V215, P2247, DOI 10.1084/jem.20180484; CHANG T, 2019, NEUROCHEM RES, P44, DOI DOI 10.1145/3332169.3333575; Cheng X, 2014, DRUG DISCOV TODAY, V19, P1822, DOI 10.1016/j.drudis.2014.06.029; Chou RC, 2016, CNS DRUGS, V30, P1111, DOI 10.1007/s40263-016-0374-z; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; Di Giuseppe D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4230; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Favalli EG, 2016, ARTHRIT CARE RES, V68, P432, DOI 10.1002/acr.22788; Ghosh M, 2012, GLIA, V60, P1839, DOI 10.1002/glia.22401; Gilsanz P, 2017, NEUROLOGY, V89, P1886, DOI [10.1212/WNL.0000000000004602, 10.1212/wnl.0000000000004602]; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gorenjak V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25553-y; Gurney ME, 2015, NEUROTHERAPEUTICS, V12, P49, DOI 10.1007/s13311-014-0309-7; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Huff SM, 1998, J AM MED INFORM ASSN, V5, P276, DOI 10.1136/jamia.1998.0050276; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; JESPERS LS, 1994, BIO-TECHNOL, V12, P899, DOI 10.1038/nbt0994-899; Jiang T, 2016, NEUROPHARMACOLOGY, V105, P196, DOI 10.1016/j.neuropharm.2016.01.028; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Kaelber DC, 2012, J AM MED INFORM ASSN, V19, P965, DOI 10.1136/amiajnl-2011-000782; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; KNIGHT DM, 1993, MOL IMMUNOL, V30, P1443, DOI 10.1016/0161-5890(93)90106-L; KURITZ SJ, 1988, ANNU REV PUBL HEALTH, V9, P123, DOI 10.1146/annurev.pu.09.050188.001011; Leoutsakos JMS, 2012, INT J GERIATR PSYCH, V27, P364, DOI 10.1002/gps.2723; Li P, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00460; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lindberg C, 1990, J Am Med Rec Assoc, V61, P40; Lu B, 2014, ARTHRITIS RHEUMATOL, V66, P1998, DOI 10.1002/art.38634; McAlpine FE, 2008, J INFLAMM RES, V1, P29; Meyer PF, 2019, NEUROLOGY, V92, pE2070, DOI 10.1212/WNL.0000000000007232; Millar J, 2016, STUD HEALTH TECHNOL, V225, P683, DOI 10.3233/978-1-61499-658-3-683; Nelson SJ, 2011, J AM MED INFORM ASSN, V18, P441, DOI 10.1136/amiajnl-2011-000116; Page TH, 2010, J IMMUNOL, V185, P3694, DOI 10.4049/jimmunol.1000906; Pan W, 2002, EXP NEUROL, V174, P193, DOI 10.1006/exnr.2002.7871; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Patel VN, 2014, J BIOMED INFORM, V52, P36, DOI 10.1016/j.jbi.2013.10.009; PEPPEL K, 1991, J EXP MED, V174, P1483, DOI 10.1084/jem.174.6.1483; Peter I, 2018, JAMA NEUROL, V75, P939, DOI 10.1001/jamaneurol.2018.0605; Piazza-Gardner AK, 2013, AGING MENT HEALTH, V17, P133, DOI 10.1080/13607863.2012.742488; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Qin BD, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0601-x; Reines SA, 2004, NEUROLOGY, V62, P66, DOI 10.1212/WNL.62.1.66; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Sugiyama D, 2010, ANN RHEUM DIS, V69, P70, DOI 10.1136/ard.2008.096487; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Tyring S, 2006, LANCET, V367, P29, DOI 10.1016/S0140-6736(05)67763-X; VENKATARAMAN A, 2019, RHEUMATOL ADV PRACT, V9, DOI DOI 10.1093/RAP/RKZ007; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; Willrich MAV, 2015, TRANSL RES, V165, P270, DOI 10.1016/j.trsl.2014.09.006; Wilson P, 2017, IMPLEMENT SCI, V12; Winhusen T, 2019, ADDICTION, V114, P1462, DOI 10.1111/add.14607; Yeh FL, 2017, TRENDS MOL MED, V23, P512, DOI 10.1016/j.molmed.2017.03.008	64	59	59	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0229819	10.1371/journal.pone.0229819	http://dx.doi.org/10.1371/journal.pone.0229819			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9GC	32203525	gold, Green Published, Green Submitted			2022-12-26	WOS:000535303900009
J	Deloche, F				Deloche, Francois			Fine-grained statistical structure of speech	PLOS ONE			English	Article							AUDITORY-NERVE FIBERS; VOCAL-TRACT; FREQUENCIES; BANDWIDTHS; RESONANCES; RESPONSES; CODE	In spite of its acoustic diversity, the speech signal presents statistical regularities that can be exploited by biological or artificial systems for efficient coding. Independent Component Analysis (ICA) revealed that on small time scales (similar to 10 ms), the overall structure of speech is well captured by a time-frequency representation whose frequency selectivity follows the same power law in the high frequency range 1-8 kHz as cochlear frequency selectivity in mammals. Variations in the power-law exponent, i.e. different time-frequency trade-offs, have been shown to provide additional adaptation to phonetic categories. Here, we adopt a parametric approach to investigate the variations of the exponent at a finer level of speech. The estimation procedure is based on a measure that reflects the sparsity of decompositions in a set of Gabor dictionaries whose atoms are Gaussian-modulated sinusoids. We examine the variations of the exponent associated with the best decomposition, first at the level of phonemes, then at an intra-phonemic level. We show that this analysis offers a rich interpretation of the fine-grained statistical structure of speech, and that the exponent values can be related to key acoustic properties. Two main results are: i) for plosives, the exponent is lowered by the release bursts, concealing higher values during the opening phases; ii) for vowels, the exponent is bound to formant bandwidths and decreases with the degree of acoustic radiation at the lips. This work further suggests that an efficient coding strategy is to reduce frequency selectivity with sound intensity level, congruent with the nonlinear behavior of cochlear filtering.	[Deloche, Francois] CNRS, EHESS, Ctr Anal & Math Sociales, Paris, France	Centre National de la Recherche Scientifique (CNRS)	Deloche, F (corresponding author), CNRS, EHESS, Ctr Anal & Math Sociales, Paris, France.	francois.deloche@ehess.fr		Deloche, Francois/0000-0002-6045-8166	PSL Maths Program; French National Research Agency, the ANR [ANR-15-CE37-0009-03]	PSL Maths Program; French National Research Agency, the ANR(French National Research Agency (ANR))	The author received a doctoral scholarship from the PSL Maths Program for this study (https://www.psl.eu/psl-maths).This work was partly funded by the project "SpeechCode" of the French National Research Agency, the ANR, contract ANR-15-CE37-0009-03 (http://www.agence-nationale-recherche.fr).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnela M, 2013, J ACOUST SOC AM, V133, P4197, DOI 10.1121/1.4803889; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Carlson NL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002594; CARNEY LH, 1988, J NEUROPHYSIOL, V60, P1653, DOI 10.1152/jn.1988.60.5.1653; Erra RG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148861; Fant G., 1972, SPEECH TRANSM LAB Q, V13, P28; Feichtinger HG, 2006, ANN MAT PUR APPL, V185, P105, DOI 10.1007/s10231-004-0130-8; Fleischer M, 2015, BIOMECH MODEL MECHAN, V14, P719, DOI 10.1007/s10237-014-0632-2; Garofolo JS, 1986, DARPA TIMIT ACOUSTIC, P1; Gazor S, 2003, IEEE SIGNAL PROC LET, V10, P204, DOI 10.1109/LSP.2003.813679; Grochenig K., 2014, APPL NUMERICAL HARMO; Hanna N, 2016, J ACOUST SOC AM, V139, P2924, DOI 10.1121/1.4948754; Hanson HM, 1999, J ACOUST SOC AM, V106, P1064, DOI 10.1121/1.427116; Hyvarinen A., 1999, Neural Computing Surveys, V2; Hyvarinen A, 2002, J MATH IMAGING VIS, V17, P139, DOI 10.1023/A:1020633503820; Johnson Keith, 2011, ACOUSTIC AUDITORY PH; Lee JH, 2002, NEURAL PROCESS LETT, V15, P235, DOI 10.1023/A:1015777200976; Lee JH, 2000, INT CONF ACOUST SPEE, P1631, DOI 10.1109/ICASSP.2000.862023; Lesica NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001655; Lewicki MS, 1999, J OPT SOC AM A, V16, P1587, DOI 10.1364/JOSAA.16.001587; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Lieb EH, 1990, J MATH PHYS, P625, DOI DOI 10.1063/1.528894; Miller RL, 1997, J ACOUST SOC AM, V101, P3602, DOI 10.1121/1.418321; Mlynarski W, 2018, NEURAL COMPUT, V30, P631, DOI 10.1162/neco_a_01048; MOLLER AR, 1977, J ACOUST SOC AM, V62, P135, DOI 10.1121/1.381495; NADAL JP, 1994, NETWORK-COMP NEURAL, V5, P565, DOI 10.1088/0954-898X/5/4/008; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Oxenham AJ, 2003, JARO-J ASSOC RES OTO, V4, P541, DOI 10.1007/s10162-002-3058-y; Rodriguez FA, 2010, J NEUROSCI, V30, P15969, DOI 10.1523/JNEUROSCI.0966-10.2010; Ruggero MA, 2005, P NATL ACAD SCI USA, V102, P18614, DOI 10.1073/pnas.0509323102; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Stevens Kenneth N., 1998, ACOUSTIC PHONETICS; Stilp C. E., 2013, P M ACOUSTICS 166ASA, V20; Story BH, 1996, J ACOUST SOC AM, V100, P537, DOI 10.1121/1.415960; Sumner CJ, 2018, P NATL ACAD SCI USA, V115, P11322, DOI 10.1073/pnas.1810766115; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; Verschooten E, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005164; Verschooten E, 2012, JARO-J ASSOC RES OTO, V13, P799, DOI 10.1007/s10162-012-0346-z; Zhang XD, 2001, J ACOUST SOC AM, V109, P648, DOI 10.1121/1.1336503	44	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0230233	10.1371/journal.pone.0230233	http://dx.doi.org/10.1371/journal.pone.0230233			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196513	gold, Green Published, Green Submitted			2022-12-26	WOS:000535303100022
J	Floren, M; Cruz, SR; Termini, CM; Marjon, KD; Lidke, KA; Gillette, JM				Floren, Muskan; Cruz, Sebastian; Termini, Christina M.; Marjon, Kristopher D.; Lidke, Keith A.; Gillette, Jennifer M.			Tetraspanin CD82 drives acute myeloid leukemia chemoresistance by modulating protein kinase C alpha and beta 1 integrin activation	ONCOGENE			English	Article							INTEGRIN PROMOTES CHEMORESISTANCE; P38 MAPK; PROGENITOR CELLS; DUAL INHIBITOR; PHASE-II; SURVIVAL; STEM; CLASSIFICATION; RESISTANCE; PKC	A principal challenge in treating acute myeloid leukemia (AML) is chemotherapy refractory disease. As such, there remains a critical need to identify key regulators of chemotherapy resistance in AML. In this study, we demonstrate that the membrane scaffold, CD82, contributes to the chemoresistant phenotype of AML. Using an RNA-seq approach, we identified the increased expression of the tetraspanin family member, CD82, in response to the chemotherapeutic, daunorubicin. Analysis of the TARGET and BEAT AML databases identifies a correlation between CD82 expression and overall survival of AML patients. Moreover, using a combination of cell lines and patient samples, we find that CD82 overexpression results in significantly reduced cell death in response to chemotherapy. Investigation of the mechanism by which CD82 promotes AML survival in response to chemotherapy identified a crucial role for enhanced protein kinase c alpha (PKC alpha) signaling and downstream activation of the beta 1 integrin. In addition, analysis of beta 1 integrin clustering by super-resolution imaging demonstrates that CD82 expression promotes the formation of dense beta 1 integrin membrane clusters. Lastly, evaluation of survival signaling following daunorubicin treatment identified robust activation of p38 mitogen-activated protein kinase (MAPK) downstream of PKC alpha and beta 1 integrin signaling when CD82 is overexpressed. Together, these data propose a mechanism where CD82 promotes chemoresistance by increasing PKC alpha activation and downstream activation/clustering of beta 1 integrin, leading to AML cell survival via activation of p38 MAPK. These observations suggest that the CD82-PKC alpha signaling axis may be a potential therapeutic target for attenuating chemoresistance signaling in AML.	[Floren, Muskan; Cruz, Sebastian; Termini, Christina M.; Marjon, Kristopher D.; Gillette, Jennifer M.] Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; [Lidke, Keith A.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; [Lidke, Keith A.; Gillette, Jennifer M.] Univ New Mexico, Ctr Comprehens Canc, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico	Gillette, JM (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA.; Gillette, JM (corresponding author), Univ New Mexico, Ctr Comprehens Canc, Albuquerque, NM 87131 USA.	jgillette@salud.unm.edu		Termini, Christina/0000-0002-1831-1347	NHLBI investigator grant [F31CA232480, F31HL124977, T32HL007736, RO1HL122483]; American Cancer Society Research Scholar Grant [130675]; UNM Spatiotemporal Modeling Center [P50GM085273]; UNM Comprehensive Cancer Center Support Grant [P30CA118100]	NHLBI investigator grant; American Cancer Society Research Scholar Grant(American Cancer Society); UNM Spatiotemporal Modeling Center; UNM Comprehensive Cancer Center Support Grant	This work was supported by fellowships: F31CA232480 to MF, F31HL124977 to CMT, and T32HL007736 to KDM, and an NHLBI investigator grant (RO1HL122483 to JMG), and an American Cancer Society Research Scholar Grant (130675 to JMG). This work was partially supported by the UNM Spatiotemporal Modeling Center (P50GM085273) and the UNM Comprehensive Cancer Center Support Grant (P30CA118100) through the following shared resources: Analytical and Translational Genomics, Human Tissue Repository, Fluorescence Microscopy, Flow Cytometry and Biostatistics. We also acknowledge Victoria Balise for critical manuscript review and the experimental assistance of Christian Doyle.	American Cancer Society, CANC FACTS FIG 2015, P2105; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aoudjit Fawzi, 2012, Chemother Res Pract, V2012, P283181, DOI 10.1155/2012/283181; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Bachegowda L, 2016, CANCER RES, V76, P4841, DOI 10.1158/0008-5472.CAN-15-3062; Beckwith KA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00091; Berrazouane S, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1593-2; Bonardi F, 2013, MOL CELL PROTEOMICS, V12, P626, DOI 10.1074/mcp.M112.021931; Bosman MCJ, 2016, CRIT REV ONCOL HEMAT, V98, P35, DOI 10.1016/j.critrevonc.2015.10.001; Boyer T, 2016, ONCOTARGET, V7, P62377, DOI 10.18632/oncotarget.11481; Brayer KJ, 2016, CANCER DISCOV, V6, P176, DOI 10.1158/2159-8290.CD-15-0859; Brockstein B, 2001, INVEST NEW DRUG, V19, P249, DOI 10.1023/A:1010628903248; Brown RB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176675; Burchert A, 1999, BRIT J HAEMATOL, V107, P494, DOI 10.1046/j.1365-2141.1999.01741.x; Byun JM, 2016, ANN HEMATOL, V95, P1223, DOI 10.1007/s00277-016-2691-1; Cloos J, 2006, LEUKEMIA, V20, P1217, DOI 10.1038/sj.leu.2404246; Cook AM, 2014, BLOOD, V123, P2826, DOI 10.1182/blood-2013-05-505735; Crump M, 2016, J CLIN ONCOL, V34, P2484, DOI 10.1200/JCO.2015.65.7171; Davoudi Z, 2014, ASIAN PAC J CANCER P, V15, P4353, DOI 10.7314/APJCP.2014.15.10.4353; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; El Fakih R, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7010004; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Frerich Candace A, 2018, Oncotarget, V9, P7341, DOI 10.18632/oncotarget.23641; Garcia-Manero G, 2015, CLIN CANCER RES, V21, P985, DOI 10.1158/1078-0432.CCR-14-1765; Gupta J, 2015, ONCOTARGET, V6, P8539, DOI 10.18632/oncotarget.3816; Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; HOCEVAR BA, 1992, J CELL SCI, V101, P671; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; Hwang S, 2019, CELL MOL LIFE SCI, V76, P1595, DOI 10.1007/s00018-019-03014-7; Ji HY, 2019, PEDIATR RES, V85, P1024, DOI 10.1038/s41390-019-0370-3; Jin JK, 2015, ONCOGENE, V34, P1811, DOI 10.1038/onc.2014.116; Kohmo S, 2010, CANCER RES, V70, P8025, DOI 10.1158/0008-5472.CAN-10-0996; Kolanus W, 1997, CURR OPIN CELL BIOL, V9, P725, DOI 10.1016/S0955-0674(97)80127-5; Kurinna S, 2006, LEUKEMIA, V20, P1316, DOI 10.1038/sj.leu.2404248; Kwon HY, 2015, CELL STEM CELL, V17, P152, DOI 10.1016/j.stem.2015.06.006; Marjon KD, 2016, ONCOGENE, V35, P4132, DOI 10.1038/onc.2015.449; McCubrey JA, 2008, LEUKEMIA, V22, P708, DOI 10.1038/leu.2008.27; Miranti CK, 2009, CELL SIGNAL, V21, P196, DOI 10.1016/j.cellsig.2008.08.023; Myklebust JH, 2000, BLOOD, V95, P510, DOI 10.1182/blood.V95.2.510; Naci D, 2014, CELL SIGNAL, V26, P2008, DOI 10.1016/j.cellsig.2014.05.016; Naci D, 2012, J BIOL CHEM, V287, P17065, DOI 10.1074/jbc.M112.349365; Nair MG, 2016, EXP CELL RES, V346, P137, DOI 10.1016/j.yexcr.2016.05.015; Nasir SS, 2017, CL LYMPH MYELOM LEUK, V17, P126, DOI 10.1016/j.clml.2016.09.011; Nishioka C, 2015, LEUKEMIA, V29, P2296, DOI 10.1038/leu.2015.219; Nishioka C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125017; Nishioka C, 2014, INT J CANCER, V134, P55, DOI 10.1002/ijc.28348; Nishioka C, 2013, INT J CANCER, V132, P2006, DOI 10.1002/ijc.27904; Okamoto Y, 2019, BONE MARROW TRANSPL, V54, P1489, DOI 10.1038/s41409-019-0461-0; Ramirez P, 2009, BLOOD, V114, P1340, DOI 10.1182/blood-2008-10-184721; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruvolo PP, 2011, J CELL BIOCHEM, V112, P1696, DOI 10.1002/jcb.23090; Saito-Reis CA, 2018, MOL BIOL CELL, V29, P2946, DOI 10.1091/mbc.E18-05-0305; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sansing HA, 2011, BIOCHEM BIOPH RES CO, V406, P171, DOI 10.1016/j.bbrc.2011.01.109; Scott MJ, 2008, J BIOL CHEM, V283, P29433, DOI 10.1074/jbc.M803905200; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Takami M, 2018, BIOCHEM BIOPH RES CO, V503, P1364, DOI 10.1016/j.bbrc.2018.07.049; Termini CM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29859; TERMINI CM, 2012, MOL BIOL CELL, V23, P1545; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Tonoli H, 2005, TRENDS MOL MED, V11, P563, DOI 10.1016/j.molmed.2005.10.002; Tsai YC, 2011, FEBS LETT, V585, P3166, DOI 10.1016/j.febslet.2011.08.031; Tyner JW, 2018, NATURE, V562, P526, DOI 10.1038/s41586-018-0623-z; Ullah Mujib, 2019, Oncotarget, V10, P3435, DOI 10.18632/oncotarget.26952; Valley CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123941; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Varet H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157022; Varterasian ML, 2000, CLIN CANCER RES, V6, P825; Veuger M, 2001, LEUKEMIA, V15, P503; Wakui M, 2008, INT J HEMATOL, V87, P144, DOI 10.1007/s12185-008-0025-3; Walter RB, 2013, BLOOD, V121, P2424, DOI 10.1182/blood-2012-10-462440; Wood CD, 2009, INT J BIOL SCI, V5, P428; Ye MT, 2017, BIOCHEM BIOPH RES CO, V486, P349, DOI 10.1016/j.bbrc.2017.03.044; Zhang J, 2019, ONCOTARGETS THER, V12, P1937, DOI 10.2147/OTT.S191621; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	77	6	7	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	19					3910	3925		10.1038/s41388-020-1261-0	http://dx.doi.org/10.1038/s41388-020-1261-0		MAR 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LK4OF	32203165	Green Accepted			2022-12-26	WOS:000520614100001
J	Penkhrue, W; Jendrossek, D; Khanongnuch, C; Pathom-aree, W; Aizawa, T; Behrens, RL; Lumyong, S				Penkhrue, Watsana; Jendrossek, Dieter; Khanongnuch, Chartchai; Pathom-aree, Wasu; Aizawa, Tomoyasu; Behrens, Rachel L.; Lumyong, S.			Response surface method for polyhydroxybutyrate (PHB) bioplastic accumulation in Bacillus drentensis BP17 using pineapple peel	PLOS ONE			English	Article							CITRIC-ACID PRODUCTION; POLYHYDROXYALKANOATES PHAS; RALSTONIA-EUTROPHA; WASTE; OPTIMIZATION; BACTERIA; BIOSYNTHESIS; MEGATERIUM; CEREUS; MOLASSES	Polyhydroxybutyrate (PHB) is a biodegradable biopolymer which is useful for various applications including packing, medical and coating materials. An endospore-forming bacterium (strain BP17) was isolated from composted soil and evaluated for PHB production. Strain BP17, taxonomically identified as Bacillus drentensis, showed enhanced PHB accumulation and was selected for further studies. To achieve maximum PHB production, the culture conditions for B. drentensis BP17 were optimized through response surface methodology (RSM) employing central composite rotatable design (CCRD). The final optimum fermentation conditions included: pineapple peel solution, 11.5% (v/v); tryptic soy broth (TSB), 60 g/L; pH, 6.0; inoculum size, 10% (v/v) and temperature, 28 degrees C for 36 h. This optimization yielded 5.55 g/L of PHB compared to the non-optimized condition (0.17 g/L). PHB accumulated by B. drentensis BP17 had a polydispersity value of 1.59 and an average molecular weight of 1.15x105 Da. Thermal analyses revealed that PHB existed as a thermally stable semi-crystalline polymer, exhibiting a thermal degradation temperature of 228 degrees C, a melting temperature of 172 degrees C and an apparent melting enthalpy of fusion of 83.69 J/g. It is evident that B. drentensis strain BP17 is a promising bacterium candidate for PHB production using agricultural waste, such as pineapple peel as a low-cost alternative carbon source for PHB production.	[Penkhrue, Watsana; Pathom-aree, Wasu; Lumyong, S.] Chiang Mai Univ, Fac Sci, Res Ctr Excellence Microbial Divers & Sustainable, Dept Biol, Chiang Mai, Thailand; [Penkhrue, Watsana] Suranaree Univ Technol, Sch Preclin, Inst Sci, Nakhon Ratchasima, Thailand; [Jendrossek, Dieter] Univ Stuttgart, Inst Microbiol, Stuttgart, Germany; [Khanongnuch, Chartchai] Chiang Mai Univ, Fac Agroind, Div Biotechnol, Chiang Mai, Thailand; [Aizawa, Tomoyasu] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan; [Aizawa, Tomoyasu] Hokkaido Univ, Global Inst Collaborat Res & Educ, Sapporo, Hokkaido, Japan; [Behrens, Rachel L.] UCSB, MRL, Santa Barbara, CA USA; [Lumyong, S.] Royal Soc Thailand, Acad Sci, Bangkok, Thailand	Chiang Mai University; Suranaree University of Technology; University of Stuttgart; Chiang Mai University; Hokkaido University; Hokkaido University; University of California System; University of California Santa Barbara	Lumyong, S (corresponding author), Chiang Mai Univ, Fac Sci, Res Ctr Excellence Microbial Divers & Sustainable, Dept Biol, Chiang Mai, Thailand.; Lumyong, S (corresponding author), Royal Soc Thailand, Acad Sci, Bangkok, Thailand.	scboi009@gmail.com		Pathom-aree, Wasu/0000-0003-0299-3731	Royal Golden Jubilee Ph.D. Program [PHD/0142/2553]; Center of Excellence in Material Science and Technology, Chiang Mai University; Research Center of Excellence on Biodiversity under Thailand's Office of the Higher Education Commission [BDC-PG2-159012]; MRSEC Program of the NSF [DMR 1720256]; NSF	Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Center of Excellence in Material Science and Technology, Chiang Mai University; Research Center of Excellence on Biodiversity under Thailand's Office of the Higher Education Commission; MRSEC Program of the NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This work was supported by the Royal Golden Jubilee Ph.D. Program (PHD/0142/2553), the Center of Excellence in Material Science and Technology, Chiang Mai University and the Research Center of Excellence on Biodiversity (BDC-PG2-159012) under Thailand's Office of the Higher Education Commission are thankfully acknowledged. The MRL Shared Experimental Facilities at UCSB are supported by the MRSEC Program of the NSF under Award No. DMR 1720256; a member of the NSF-funded Materials Research Facilities Network (www.mrfn.org).There is no conflict of interest.	ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Ashby RD, 2011, J AM OIL CHEM SOC, V88, P949, DOI 10.1007/s11746-011-1755-6; Baikar V, 2017, APPL BIOCHEM BIOTECH, V183, P241, DOI 10.1007/s12010-017-2441-4; Bomrungnok W, 2020, ENVIRON TECHNOL, V41, P3318, DOI 10.1080/09593330.2019.1608314; Bora L, 2013, J POLYM ENVIRON, V21, P415, DOI 10.1007/s10924-012-0529-z; Chanprateep S, 2010, J BIOSCI BIOENG, V110, P621, DOI 10.1016/j.jbiosc.2010.07.014; CHEN GQ, 1991, FEMS MICROBIOL LETT, V84, P173; Choonut A, 2014, ENRGY PROCED, V52, P242, DOI 10.1016/j.egypro.2014.07.075; Dai Y, 2008, J BIOTECHNOL, V134, P137, DOI 10.1016/j.jbiotec.2008.01.013; Dalsasso RR, 2019, PROCESS BIOCHEM, V85, P12, DOI 10.1016/j.procbio.2019.07.007; Dave Heena, 1996, Indian Journal of Experimental Biology, V34, P216; DEKONING GJM, 1992, POLYMER, V33, P3295, DOI 10.1016/0032-3861(92)90250-Z; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Getachew Anteneh, 2016, BMC Res Notes, V9, P509; Gouda MK, 2001, MICROBIOL RES, V156, P201, DOI 10.1078/0944-5013-00104; Gumel AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045214; Gungormedi G, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40530; Gunst RE, 1996, TECHNOMETRICS, V38, P284, DOI DOI 10.1080/00401706.1996.10484509; Gurieff N, 2007, BIORESOURCE TECHNOL, V98, P3393, DOI 10.1016/j.biortech.2006.10.046; Halami PM, 2008, WORLD J MICROB BIOT, V24, P805, DOI 10.1007/s11274-007-9543-z; Hassan MA, 2019, INT J ENVIRON SCI TE, V16, P3497, DOI 10.1007/s13762-018-1900-y; Heyrman J, 2004, INT J SYST EVOL MICR, V54, P47, DOI 10.1099/ijs.0.02723-0; Jan S, 1996, ENZYME MICROB TECH, V18, P195, DOI 10.1016/0141-0229(95)00096-8; Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838; Jendrossek D, 2007, APPL ENVIRON MICROB, V73, P586, DOI 10.1128/AEM.01839-06; Jendrossek D, 2014, ENVIRON MICROBIOL, V16, P2357, DOI 10.1111/1462-2920.12356; Khanna S, 2005, BIOTECHNOL PROGR, V21, P830, DOI 10.1021/bp0495769; Kim MY, 2017, J MICROBIOL BIOTECHN, V27, P342, DOI 10.4014/jmb.1610.10015; Kumar D, 2003, PROCESS BIOCHEM, V38, P1725, DOI 10.1016/S0032-9592(02)00253-4; Kumar T, 2009, J APPL MICROBIOL, V106, P2017, DOI 10.1111/j.1365-2672.2009.04160.x; LAGEVEEN RG, 1988, APPL ENVIRON MICROB, V54, P2924, DOI 10.1128/AEM.54.12.2924-2932.1988; Lagunes FG, 2016, BIORESOURCE TECHNOL, V221, P336, DOI 10.1016/j.biortech.2016.09.045; Lemoigne M., 1925, ANN I PASTEUR PARIS, V39, p144?173; Li MX, 2020, BIORESOURCE TECHNOL, V299, DOI 10.1016/j.biortech.2019.122676; Lopez-Cuellar MR, 2011, INT J BIOL MACROMOL, V48, P74, DOI 10.1016/j.ijbiomac.2010.09.016; Lu JN, 2009, POLYM REV, V49, P226, DOI 10.1080/15583720903048243; MACRAE RM, 1958, J GEN MICROBIOL, V19, P210, DOI 10.1099/00221287-19-1-210; Madhumathi R, 2016, CLEAN-SOIL AIR WATER, V44, P1066, DOI 10.1002/clen.201500163; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Meng DC, 2018, ADV BIOCHEM ENG BIOT, V162, P147, DOI 10.1007/10_2017_3; Mizuno K, 2010, POLYM DEGRAD STABIL, V95, P1335, DOI 10.1016/j.polymdegradstab.2010.01.033; NAKATA HM, 1963, J BACTERIOL, V86, P577, DOI 10.1128/JB.86.3.577-581.1963; Narayanan A, 2012, 3 BIOTECH, V2, P287, DOI 10.1007/s13205-012-0054-8; Nath A, 2008, BIORESOURCE TECHNOL, V99, P5749, DOI 10.1016/j.biortech.2007.10.017; Nigam JN, 1999, J BIOTECHNOL, V72, P197, DOI 10.1016/S0168-1656(99)00106-6; Pandian SR, 2010, BIORESOURCE TECHNOL, V101, P705, DOI 10.1016/j.biortech.2009.08.040; Parlane NA, 2017, ACS BIOMATER SCI ENG, V3, P3043, DOI 10.1021/acsbiomaterials.6b00355; Patel M, 2009, APPL MICROBIOL BIOT, V82, P545, DOI 10.1007/s00253-008-1836-0; Penkhrue W, 2015, WORLD J MICROB BIOT, V31, P1431, DOI 10.1007/s11274-015-1895-1; Poli A, 2011, ARCHAEA, V2011, DOI 10.1155/2011/693253; Prabisha TP, 2015, BIOCHEM ENG J, V101, P150, DOI 10.1016/j.bej.2015.05.012; Rai R, 2011, MAT SCI ENG R, V72, P29, DOI 10.1016/j.mser.2010.11.002; RAMSAY BA, 1989, APPL ENVIRON MICROB, V55, P584, DOI 10.1128/AEM.55.3.584-589.1989; Ray D, 2017, WOODH PUB S COMPOS S, P1; Rodriguez-Contreras A, 2013, FOOD TECHNOL BIOTECH, V51, P123; Salgaonkar BB, 2019, J POLYM ENVIRON, V27, P299, DOI 10.1007/s10924-018-1346-9; Saratale RG, 2019, BIORESOURCE TECHNOL, V282, P75, DOI 10.1016/j.biortech.2019.02.083; Sathiyanarayanan G, 2013, INT J BIOL MACROMOL, V59, P170, DOI 10.1016/j.ijbiomac.2013.04.040; Scherlach K, 2009, ORG BIOMOL CHEM, V7, P1753, DOI 10.1039/b821578b; Sharma V, 2017, BIOCATAL AGRIC BIOTE, V10, P122, DOI 10.1016/j.bcab.2017.02.014; Spiekermann P, 1999, ARCH MICROBIOL, V171, P73, DOI 10.1007/s002030050681; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Suriyamongkol P, 2007, BIOTECHNOL ADV, V25, P148, DOI 10.1016/j.biotechadv.2006.11.007; Tan GYA, 2014, POLYMERS-BASEL, V6, P706, DOI 10.3390/polym6030706; Tanaka K, 1999, J BIOSCI BIOENG, V87, P642, DOI 10.1016/S1389-1723(99)80128-5; Teeka J, 2012, J IND MICROBIOL BIOT, V39, P749, DOI 10.1007/s10295-012-1084-2; Thirumala M, 2010, J IND MICROBIOL BIOT, V37, P271, DOI 10.1007/s10295-009-0670-4; Tian PY, 2009, AFR J BIOTECHNOL, V8, P709; TRAN CT, 1995, BIOTECHNOL LETT, V17, P1107, DOI 10.1007/BF00143111; Tsuge T, 2002, J BIOSCI BIOENG, V94, P579, DOI 10.1016/S1389-1723(02)80198-0; Valappil SP, 2007, J BIOTECHNOL, V132, P251, DOI 10.1016/j.jbiotec.2007.03.013; Valappil SP, 2007, ANTON LEEUW INT J G, V91, P1, DOI 10.1007/s10482-006-9095-5; Vega-Castro O, 2016, J BIOTECHNOL, V231, P232, DOI 10.1016/j.jbiotec.2016.06.018; Vos P., 2011, BERGEYS MANUAL SYSTE, V3; Wang J, 2020, J APPL MICROBIOL, V128, P171, DOI 10.1111/jam.14463; Wang J, 2007, APPL MICROBIOL BIOT, V75, P871, DOI 10.1007/s00253-007-0870-7; Wu Q, 2001, ANTON LEEUW INT J G, V80, P111, DOI 10.1023/A:1012222625201; Yu ST, 2005, PROCESS BIOCHEM, V40, P2729, DOI 10.1016/j.procbio.2004.12.023; Zafar M, 2012, BIOCATAL AGRIC BIOTE, V1, P70, DOI 10.1016/j.bcab.2011.08.012; Zheng BX, 2015, APPL BIOCHEM BIOTECH, V175, P421, DOI 10.1007/s12010-014-1271-x; 2010, CANCER ETIOL DIAGN T, P1	81	38	39	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230443	10.1371/journal.pone.0230443	http://dx.doi.org/10.1371/journal.pone.0230443			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191752	Green Published, gold			2022-12-26	WOS:000535302300050
J	Yin, HS; Li, WN; Chatterjee, S; Xiong, XK; Saha, P; Yechoor, V; Ma, K				Yin Hongshan; Li Weini; Chatterjee, Somik; Xiong Xuekai; Saha, Pradip; Yechoor, Vijay; Ma Ke			Metabolic-sensing of the skeletal muscle clock coordinates fuel oxidation	FASEB JOURNAL			English	Article						circadian clock; skeletal muscle; glucose metabolism; fatty acid metabolism; hepatic steatosis	PERIPHERAL CIRCADIAN CLOCKS; FATTY-ACID OXIDATION; ARNT-LIKE 1; INSULIN SENSITIVITY; GLUCOSE-INTOLERANCE; MECHANISMS; PATHWAYS; RECEPTOR; BMAL1; BRAIN	Circadian clock confers temporal control in metabolism, with its disruption leading to the development of insulin resistance. Metabolic substrate utilization in skeletal muscle is coordinated with diurnal nutrient cycles. However, whether the molecular clock is involved in this coordination is largely unknown. Using a myocyte-selective genetic ablation mouse model of the essential clock activator Bmal1, here we identify muscle-intrinsic clock as a sensor of feeding cues to orchestrate skeletal muscle oxidation required for global nutrient flux. Bmal1 in skeletal muscle responds robustly to feeding in vivo and insulin induces its expression. Muscle Bmal1 deficiency impaired the transcriptional control of glucose metabolic pathway, resulting in markedly attenuated glucose utilization and fasting hyperglycemia. Notably, the loss of Bmal1 response to feeding abolished fasting-to-feeding metabolic fuel switch from fatty acids to glucose in skeletal muscle, leading to the activation of energy-sensing pathways for fatty acid oxidation. These altered metabolic substrate oxidations in Bmal1-deficient muscle ultimately depleted circulating lipid levels that prevented hepatic steatosis. Collectively, our findings highlight the key role of the metabolic-sensing function of skeletal muscle clock in partitioning nutrient flux between muscle and liver to maintain whole-body lipid and glucose homeostasis.	[Yin Hongshan] Hebei Med Univ, Dept Cardiol, Affiliated Hosp 3, Shijiazhuang, Hebei, Peoples R China; [Li Weini; Xiong Xuekai; Ma Ke] Beckman Res Inst City Hope, Dept Diabet Complicat & Metab, Duarte, CA 91010 USA; [Chatterjee, Somik; Saha, Pradip] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Yechoor, Vijay] Univ Pittsburgh, Dept Med, Diabet & Beta Cell Biol Ctr, Div Endocrinol Diabet & Metab, Pittsburgh, PA USA	Hebei Medical University; City of Hope; Beckman Research Institute of City of Hope; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ma, K (corresponding author), Beckman Res Inst City Hope, Dept Diabet Complicat & Metab, Duarte, CA 91010 USA.	kema@coh.org	Yechoor, Vijay/AAX-3244-2021; Chatterjee, Somik/P-1581-2016	Chatterjee, Somik/0000-0001-6869-4019	NIDDK NIH HHS [R01 DK097160, R01 DK112794] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Caruso M, 1997, J BIOL CHEM, V272, P7290, DOI 10.1074/jbc.272.11.7290; Chatterjee S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41059-7; Chatterjee S, 2013, J CELL SCI, V126, P2213, DOI 10.1242/jcs.120519; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Dyar KA, 2018, CELL, V174, P1571, DOI 10.1016/j.cell.2018.08.042; Dyar KA, 2014, MOL METAB, V3, P29, DOI 10.1016/j.molmet.2013.10.005; Dyar KA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005886; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fujita Y, 1998, DIABETOLOGIA, V41, P1459, DOI 10.1007/s001250051092; Glund S, 2012, DIABETOLOGIA, V55, P2044, DOI 10.1007/s00125-012-2554-9; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guo BY, 2012, FASEB J, V26, P3453, DOI 10.1096/fj.12-205781; Harfmann BD, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0082-x; Hodge BA, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0039-5; Karatsoreos IN, 2011, P NATL ACAD SCI USA, V108, P1657, DOI 10.1073/pnas.1018375108; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kinouchi K, 2018, CELL REP, V25, P3299, DOI 10.1016/j.celrep.2018.11.077; KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee J, 2013, MOL CELL BIOL, V33, P2327, DOI 10.1128/MCB.01421-12; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Meng ZX, 2017, MOL CELL, V66, P332, DOI 10.1016/j.molcel.2017.04.007; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Nam D., 2014, EXP CELL RES; Nam D, 2015, J CELL SCI, V128, P1835, DOI 10.1242/jcs.167643; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Stenvers DJ, 2019, NAT REV ENDOCRINOL, V15, P75, DOI 10.1038/s41574-018-0122-1; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Sugden MC, 2001, BIOCHEM SOC T, V29, P272, DOI 10.1042/0300-5127:0290272; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Xu WQ, 2019, MOL CELL ENDOCRINOL, V482, P1, DOI 10.1016/j.mce.2018.12.001; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	51	8	11	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6613	6627		10.1096/fj.201903226RR	http://dx.doi.org/10.1096/fj.201903226RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32212194	Green Accepted			2022-12-26	WOS:000531325500043
J	Bernabo, P; Viero, G; Lencioni, V				Bernabo, Paola; Viero, Gabriella; Lencioni, Valeria			A long noncoding RNA acts as a post-transcriptional regulator of heat shock protein (HSP70) synthesis in the cold hardy Diamesa tonsa under heat shock	PLOS ONE			English	Article							CLIMATE-CHANGE; GENE FAMILY; TRANSLATIONAL CONTROL; PHYLOGENETIC ANALYSIS; MOLECULAR CHAPERONES; SEQUENCE-ANALYSIS; MESSENGER-RNA; EXPRESSION; LARVAE; STRESS	Cold stenothermal insects living in glacier-fed streams are stressed by temperature variations resulting from glacial retreat during global warming. The molecular aspects of insect response to environmental stresses remain largely unexplored. The aim of this study was to expand our knowledge of how a cold stenothermal organism controls gene expression at the transcriptional, translational, and protein level under warming conditions. Using the chironomid Diamesa tonsa as target species and a combination of RACE, qPCR, polysomal profiling, western blotting, and bioinformatics techniques, we discovered a new molecular pathway leading to previously overlooked adaptive strategies to stress. We obtained and characterized the complete cDNA sequences of three heat shock inducible 70 (hsp70) and two members of heat-shock cognate 70 (hsc70). Strikingly, we showed that a novel pseudo-hsp70 gene encoding a putative long noncoding RNA (lncRNA) which is transcribed during thermal stress, acting as a ribosome sponge to provide post-transcriptional control of HSP70 protein levels. The expression of the pseudo-hsp70 gene and its function suggest the existence of a new and unexpected mechanism to cope with thermal stress: lowering the pace of protein production to save energy and optimize resources for recovery.	[Bernabo, Paola; Lencioni, Valeria] MUSE Museo Sci, Dept Invertebrate Zool & Hydrobiol, Trento, Italy; [Bernabo, Paola; Viero, Gabriella] CNR, Trento Unit, Inst Biophys, Trento, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Lencioni, V (corresponding author), MUSE Museo Sci, Dept Invertebrate Zool & Hydrobiol, Trento, Italy.	valeria.lencioni@muse.it	Lencioni, Valeria/O-4738-2019; Viero, Gabriella/G-2096-2012	Lencioni, Valeria/0000-0002-4341-9923; Viero, Gabriella/0000-0002-6755-285X	Cassa di Risparmio di Trento e Rovereto Foundation within the RACE-TN Project [2015.0199]	Cassa di Risparmio di Trento e Rovereto Foundation within the RACE-TN Project	This work was partially supported by the Cassa di Risparmio di Trento e Rovereto Foundation within the RACE-TN Project ("Valutazione del rischio ambientale dei contaminanti emergenti nei fiumi trentini: effetti sulla vita selvatica e sull'uomo"/"Environmental Risk assessment of emerging contaminants in Trentino rivers: effects on wildlife and human health", Grant CARITRO n. 2015.0199; October 2015-January 2018) coordinated by Valeria Lencioni. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder supported 1 m/m of the contract of the first author (Paola Bernabo) and the purchase of some consumables. There was no additional external funding received for this study.	Bernabo P, 2009, COMP BIOCHEM PHYS A, V154, pS4, DOI 10.1016/j.cbpa.2009.05.023; Bernabo P, 2015, J INSECT PHYSIOL, V76, P30, DOI 10.1016/j.jinsphys.2015.03.011; Bernabo P, 2011, CELL STRESS CHAPERON, V16, P403, DOI 10.1007/s12192-010-0251-5; Bond U, 2000, INT J BIOCHEM CELL B, V32, P643, DOI 10.1016/S1357-2725(00)00008-X; BOSCH TCG, 1988, P NATL ACAD SCI USA, V85, P7927, DOI 10.1073/pnas.85.21.7927; Brown LE, 2018, NAT ECOL EVOL, V2, P325, DOI 10.1038/s41559-017-0426-x; Cheetham SW, 2020, NAT REV GENET, V21, P191, DOI 10.1038/s41576-019-0196-1; Chen B, 2018, MOL ECOL, V27, P3040, DOI 10.1111/mec.14769; Clark MS, 2008, POLAR BIOL, V31, P1059, DOI 10.1007/s00300-008-0447-7; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Evgenev MB, 2014, HEAT SHOCK PROTEINS, DOI [10.14712/23361964.2015.79, DOI 10.14712/23361964.2015.79]; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Friedrich M, 1997, SYST BIOL, V46, P674, DOI 10.2307/2413500; Georg RC, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-231; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GUPTA RS, 1993, J MOL EVOL, V37, P573; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hofmann GE, 2005, J EXP MAR BIOL ECOL, V316, P79, DOI 10.1016/j.jembe.2004.10.007; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hotaling S, 2017, BIOL REV, V92, P2024, DOI 10.1111/brv.12319; HUANG J, 1991, MOL CELL BIOL, V11, P3180, DOI 10.1128/MCB.11.6.3180; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jeremias G, 2018, MOL ECOL, V27, P2790, DOI 10.1111/mec.14727; Kang YJ, 2017, NUCLEIC ACIDS RES, V45, pW12, DOI 10.1093/nar/gkx428; KAPOOR M, 1995, J BACTERIOL, V177, P212, DOI 10.1128/jb.177.1.212-221.1995; Knigge T, 2014, CELL STRESS CHAPERON, V19, P741, DOI 10.1007/s12192-014-0494-7; Kummasook A, 2007, DNA SEQUENCE, V18, P385, DOI 10.1080/10425170701309012; Lencioni V, 2018, SCI TOTAL ENVIRON, V622, P563, DOI 10.1016/j.scitotenv.2017.11.266; Lencioni V, 2017, INSECT SCI, V24, P314, DOI 10.1111/1744-7917.12278; Lencioni V, 2015, HYDROBIOLOGIA, V751, P73, DOI 10.1007/s10750-014-2172-2; Lencioni V, 2015, PHYSIOL ENTOMOL, V40, P43, DOI 10.1111/phen.12084; Lencioni V, 2013, ARCH INSECT BIOCHEM, V83, P1, DOI 10.1002/arch.21088; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Milner AM, 2017, P NATL ACAD SCI USA, V114, P9770, DOI 10.1073/pnas.1619807114; Montagna M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159124; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; Nguyen AD, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-015-0573-0; OOSTERBROEK P, 1995, ZOOL J LINN SOC-LOND, V115, P267, DOI 10.1111/j.1096-3642.1995.tb02462.x; Pallares S, 2020, INSECT CONSERV DIVER, V13, P271, DOI 10.1111/icad.12394; PERKINS LA, 1990, MOL CELL BIOL, V10, P3232, DOI 10.1128/MCB.10.6.3232; Place RF, 2014, CELL STRESS CHAPERON, V19, P159, DOI 10.1007/s12192-013-0456-5; Qin WS, 2003, CELL STRESS CHAPERON, V8, P144, DOI 10.1379/1466-1268(2003)008<0144:CACOAM>2.0.CO;2; Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6; Rinehart JP, 2006, P NATL ACAD SCI USA, V103, P14223, DOI 10.1073/pnas.0606840103; ROCHESTER DE, 1986, EMBO J, V5, P451, DOI 10.1002/j.1460-2075.1986.tb04233.x; Rossaro Bruno, 2015, European Journal of Environmental Sciences, V5, P62; RUBIN DM, 1993, GENE, V128, P155, DOI 10.1016/0378-1119(93)90558-K; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SNUTCH TP, 1988, GENE, V64, P241, DOI 10.1016/0378-1119(88)90339-3; STEFANI RMP, 1995, GENE, V152, P19, DOI 10.1016/0378-1119(95)00645-M; Tebaldi T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-220; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Wang QX, 2014, CLIM DYNAM, V43, P87, DOI 10.1007/s00382-013-1889-3; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WINTER J, 1988, MOL GEN GENET, V211, P315, DOI 10.1007/BF00330609; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055; YOST HJ, 1991, MOL CELL BIOL, V11, P1062, DOI 10.1128/MCB.11.2.1062; YOST HJ, 1988, SCIENCE, V242, P1544, DOI 10.1126/science.3201243	63	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0227172	10.1371/journal.pone.0227172	http://dx.doi.org/10.1371/journal.pone.0227172			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240200	Green Published, Green Submitted, gold			2022-12-26	WOS:000535945000011
J	Fogarty, FA; Cayan, DR; DeHaan, LL; Fleishman, E				Fogarty, Frank A.; Cayan, Daniel R.; DeHaan, Laurel L.; Fleishman, Erica			Associations of breeding-bird abundance with climate vary among species and trait-based groups in southern California	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; POPULATION-DYNAMICS; SONORAN DESERT; ARRIVAL DATE; PRECIPITATION; SURVIVAL; IMPACT; NORTH; MICROCLIMATE; TEMPERATURE	The responses of individuals and populations to climate change vary as functions of physiology, ecology, and plasticity. We investigated whether annual variation in seasonal temperature and precipitation was associated with relative abundances of breeding bird species at local and regional levels in southern California, USA, from 1968-2013. We tested our hypotheses that abundances were correlated positively with precipitation and negatively with temperature in this semiarid to arid region. We also examined whether responses to climate varied among groups of species with similar land-cover associations, nesting locations, and migratory patterns. We investigated relations between seasonal climate variables and the relative abundances of 41 species as estimated by the North American Breeding Bird Survey. Associations with climate variables varied among species. Results of models of species associated with arid scrublands or that nest on the ground strongly supported our hypotheses, whereas those of species associated with coniferous forests or that nest in cavities did not. Associations between climate variables and the abundances of other trait-based groups were diverse. Our results suggest that species in arid areas may be negatively affected by increased temperature and aridity, but species in nearby areas that are cooler and less arid may respond positively to those fluctuations in climate. Relations with climate variables can differ among similar species, and such knowledge may inform projections of future abundance trajectories and geographic ranges.	[Fogarty, Frank A.; Fleishman, Erica] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Cayan, Daniel R.; DeHaan, Laurel L.] Univ Calif San Diego, Scripps Inst Oceanog, Climate Atmospher Sci & Phys Oceanog Div, La Jolla, CA 92093 USA; [Fogarty, Frank A.] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA; [Fleishman, Erica] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA	University of California System; University of California Davis; University of California System; University of California San Diego; Scripps Institution of Oceanography; California State University System; California State Polytechnic University, Humboldt; Colorado State University	Fogarty, FA (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA.; Fogarty, FA (corresponding author), Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA.	frank.fogartyIII@humboldt.edu			US Geological Survey's Southwest Climate Science Center [G14AP00076]	US Geological Survey's Southwest Climate Science Center	This work was supported by the US Geological Survey's Southwest Climate Science Center (G14AP00076) award to EF and DRC. Funder website: https://www.swcasc.arizona.edu/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola MP, 2007, J ANIM ECOL, V76, P1045, DOI 10.1111/j.1365-2656.2007.01294.x; [Anonymous], 2018, CALIFORNIA ENERGY CO; Bart J, 1995, AUK, V112, P758; Berg N, 2015, J CLIMATE, V28, P6324, DOI 10.1175/JCLI-D-14-00624.1; Borgman CC, 2016, OECOLOGIA, V180, P279, DOI 10.1007/s00442-015-3456-6; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; BOTSFORD LW, 1988, J WILDLIFE MANAGE, V52, P469, DOI 10.2307/3801593; Bradshaw CJA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0744; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Brown DR, 2006, OECOLOGIA, V149, P22, DOI 10.1007/s00442-006-0418-z; Burger C, 2012, J ANIM ECOL, V81, P926, DOI 10.1111/j.1365-2656.2012.01968.x; Bystrak D., 1981, Studies in Avian Biology, P34; California Department of Fish and Wildlife (CDFW), 2015, CAL STAT WILDL ACT P; Cao MK, 2004, ECOSYSTEMS, V7, P233, DOI 10.1007/s10021-003-0189-x; Carroll JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143676; Chambers LE, 2005, EMU, V105, P1, DOI 10.1071/MU04033; Commission for Environmental Cooperation (CEC), 1997, EC N AM COMM PERSP; Cooper CE, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01405; Cooper SJ, 2004, CONDOR, V106, P852, DOI 10.1650/7588; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Dawson RD, 2005, OECOLOGIA, V144, P499, DOI 10.1007/s00442-005-0075-7; Dobrowski SZ, 2011, ECOL MONOGR, V81, P241, DOI 10.1890/10-1325.1; Duursma DE, 2018, DIVERS DISTRIB, V24, P1061, DOI 10.1111/ddi.12750; Ehrlich P., 1988, BIRDERS HDB; Goodman RE, 2012, GLOBAL CHANGE BIOL, V18, P63, DOI 10.1111/j.1365-2486.2011.02538.x; Gullett P, 2014, OIKOS, V123, P389, DOI 10.1111/j.1600-0706.2013.00620.x; Heffelfinger JR, 1999, J WILDLIFE MANAGE, V63, P154, DOI 10.2307/3802496; Heisler-White JL, 2008, OECOLOGIA, V158, P129, DOI 10.1007/s00442-008-1116-9; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Hudson MAR, 2017, CONDOR, V119, P526, DOI 10.1650/CONDOR-17-62.1; Iknayan KJ, 2018, P NATL ACAD SCI USA, V115, P8597, DOI 10.1073/pnas.1805123115; Jongsomjit D, 2013, LANDSCAPE ECOL, V28, P187, DOI 10.1007/s10980-012-9825-1; Lindstrom A, 2013, ECOGRAPHY, V36, P313, DOI 10.1111/j.1600-0587.2012.07799.x; Livneh B, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.42; Maclean IMD, 2008, GLOBAL CHANGE BIOL, V14, P2489, DOI 10.1111/j.1365-2486.2008.01666.x; Matthews SN, 2011, ECOGRAPHY, V34, P933, DOI 10.1111/j.1600-0587.2011.06803.x; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Miller-Rushing AJ, 2008, GLOBAL CHANGE BIOL, V14, P1959, DOI 10.1111/j.1365-2486.2008.01619.x; Morrison SA, 2002, OECOLOGIA, V133, P315, DOI 10.1007/s00442-002-1040-3; Mougeot F, 2014, J ARID ENVIRON, V102, P89, DOI 10.1016/j.jaridenv.2013.11.010; Mowll W, 2015, OECOLOGIA, V177, P959, DOI 10.1007/s00442-015-3232-7; Nevoux M, 2008, J ANIM ECOL, V77, P1143, DOI 10.1111/j.1365-2656.2008.01435.x; Okin GS, 2018, J GEOPHYS RES-BIOGEO, V123, P1927, DOI 10.1029/2018JG004485; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Peterjohn Bruce G., 1995, P3; Pillar AG, 2015, POPUL ECOL, V57, P163, DOI 10.1007/s10144-014-0467-9; Polade SD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11285-y; Redlisiak M, 2018, INT J BIOMETEOROL, V62, P1595, DOI 10.1007/s00484-018-1559-6; Rich JL, 2018, GLOBAL ECOL BIOGEOGR, V27, P461, DOI 10.1111/geb.12708; Robinson RA, 2007, IBIS, V149, P357, DOI 10.1111/j.1474-919X.2006.00648.x; Rodewald PG, 2015, BIRDS N AM; Rodriguez-Moreno VM, 2014, INT J CLIMATOL, V34, P3967, DOI 10.1002/joc.3955; Roder J, 2017, BIOTROPICA, V49, P217, DOI 10.1111/btp.12403; Rushing CS, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2846; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Samplonius JM, 2018, GLOBAL CHANGE BIOL, V24, P3780, DOI [10.1111/gcb.14160, 10.1111/gcb.141]; Saracco JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148570; Sauer John R., 2013, North American Fauna, V79, P2, DOI 10.3996/nafa.79.0001; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Smith EK, 2015, J EXP BIOL, V218, P3636, DOI 10.1242/jeb.128645; Strode PK, 2003, GLOBAL CHANGE BIOL, V9, P1137, DOI 10.1046/j.1365-2486.2003.00664.x; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Veloz S, 2015, CONSERV BIOL, V29, P1217, DOI 10.1111/cobi.12499; Visser ME, 2009, GLOBAL CHANGE BIOL, V15, P1859, DOI 10.1111/j.1365-2486.2009.01865.x; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Wachob DG, 1996, J FIELD ORNITHOL, V67, P525; Wang L, 2012, HYDROL EARTH SYST SC, V16, P2585, DOI 10.5194/hess-16-2585-2012; Wiebe KL, 2013, ECOSCIENCE, V20, P122, DOI 10.2980/20-2-3584; Wildlife Action Plan Team, 2012, NEV WILDL ACT PLAN; WITH KA, 1993, CONDOR, V95, P401, DOI 10.2307/1369363; WOLDA H, 1988, ANNU REV ECOL SYST, V19, P1, DOI 10.1146/annurev.es.19.110188.000245; Woodworth BK, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0176; Woodworth BK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14812; Yamashita T, 2007, COMMUN STAT-THEOR M, V36, P2395, DOI 10.1080/03610920701215639; Zuckerberg B, 2018, CONSERV BIOL, V32, P872, DOI 10.1111/cobi.13089; Zuckerberg B, 2009, GLOBAL CHANGE BIOL, V15, P1866, DOI 10.1111/j.1365-2486.2009.01878.x	77	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230614	10.1371/journal.pone.0230614	http://dx.doi.org/10.1371/journal.pone.0230614			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HO	32231388	gold, Green Published			2022-12-26	WOS:000535937400013
J	Souza, AIS; Saraiva, MMS; Casas, MRT; Oliveira, GM; Cardozo, MV; Benevides, VP; Barbosa, FO; Freitas, OC; Almeida, AM; Berchieri, A				Souza, Andrei I. S.; Saraiva, Mauro M. S.; Casas, Monique R. T.; Oliveira, Gustavo M.; Cardozo, Marita, V; Benevides, Valdinete P.; Barbosa, Fernanda O.; Freitas Neto, Oliveiro C.; Almeida, Adriana M.; Berchieri Junior, Angelo			High occurrence of beta-lactamase-producing Salmonella Heidelberg from poultry origin	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; CEPHALOSPORINS; RETAIL; PREVALENCE; MULTIPLEX; HUMANS	Salmonella Heidelberg is commonly reported in foodborne outbreaks around the world, and chickens and poultry products are known as important source of these pathogen. Multidrug-resistant S. Heidelberg strains are disseminated into poultry production chair, which can lead to severe clinical infections in humans and of difficult to treat. This study aimed at evaluating the beta-lactam susceptibility and genotypic relatedness of Salmonella Heidelberg at Brazilian poultry production chain. Sixty-two S. Heidelberg strains from poultry production chain (poultry, poultry meat and poultry farm) were used. All strains were evaluated to antimicrobial susceptibility by diffusion disk test, as well as beta-lactam resistance genes. Genotypic relatedness was assessed by Pulsed-Field Gel Eletrophoresis, using Xba1 restriction enzyme. Forty-one strains were characterized as multidrug-resistant according to phenotype characterization. The resistance susceptibility revealed 31 distinct profiles, with higher prevalence of streptomycin (61/62), nalidixic acid (50/62), tetracycline (43/62) and beta-lactam drugs (37/62). bla(CMY-2) was the more frequent beta-lactamase gene found (38/62); other resistance genes found were bla(CTX-M) (2/62), bla(SHV) (3/62) and bla(TEM-1) (38/62). No carbapenemase genes was found. The Pulsed-Field Gel Electrophoresis showed 58 different profiles. Strains with a larger number of antimicrobial resistance were grouped into ten major clusters apart from others. The spread of resistance by ampC continues to rise, thereby turning concern to public health, since the beta-lactam antimicrobials are used as a therapeutic treatment in humans.	[Souza, Andrei I. S.; Saraiva, Mauro M. S.; Oliveira, Gustavo M.; Benevides, Valdinete P.; Barbosa, Fernanda O.; Almeida, Adriana M.; Berchieri Junior, Angelo] Sao Paulo State Univ Unesp, Sch Agr & Veterinarian Sci, Dept Vet Pathol, Lab Avian Pathol, Jaboticabal, SP, Brazil; [Souza, Andrei I. S.; Benevides, Valdinete P.] Sao Paulo State Univ Unesp, Sch Agr & Veterinarian Sci, Agr & Livestock Microbiol Postgrad Program, Jaboticabal, SP, Brazil; [Casas, Monique R. T.] Adolfo Lutz Inst, Nucleus Enter Dis & Infect Special Pathogens Ctr, Sao Paulo, SP, Brazil; [Cardozo, Marita, V] Sao Paulo State Univ Unesp, Sch Agr & Veterinarian Sci, Dept Vet Pathol, Lab Microbiol, Jaboticabal, SP, Brazil; [Barbosa, Fernanda O.] Sao Paulo State Univ Unesp, Sch Agr Ad Veterinarian Sci, Vet Med Postgrad Program, Jaboticabal, SP, Brazil; [Freitas Neto, Oliveiro C.] Fed Univ Minas Gerais UFMG, Belo Horizonte, MG, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Instituto Adolfo Lutz; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal de Minas Gerais	Saraiva, MMS (corresponding author), Sao Paulo State Univ Unesp, Sch Agr & Veterinarian Sci, Dept Vet Pathol, Lab Avian Pathol, Jaboticabal, SP, Brazil.	saraiva_ufba@hotmail.com	Saraiva, Mauro/AAR-3642-2020; Berchieri Junior, Angelo/ABA-2618-2021; Tiba-Casas, Monique Ribeiro/AAT-1154-2021; Saraiva, Mauro M S/T-1745-2018	Saraiva, Mauro/0000-0003-1875-4495; Berchieri Junior, Angelo/0000-0003-2522-6500; Saraiva, Mauro M S/0000-0003-1875-4495; Itajahy Secundo de Souza, Andrei/0000-0001-5330-5148; Pereira Benevides, Valdinete/0000-0002-7552-1607	Sao Paulo Research Foundation (FAPESP) [2017/25200-3]; National Council of Technological and Scientific Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Sao Paulo Research Foundation (FAPESP, process no 2017/25200-3) - AISS National Council of Technological and Scientific Development (CNPq) - AISS, ABJ Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil - AISS Include this sentence at the end of your statement: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2004, ANTIMICROB AGENTS CH, V48, P1916, DOI 10.1128/AAC.48.5.1916-1917.2004; Abou-Shaaban M, 2016, INT J CLIN PHARM-NET, V38, P1367, DOI 10.1007/s11096-016-0392-4; [Anonymous], 2018, SURV ANT RES EUR ANN; Antunes P, 2016, CLIN MICROBIOL INFEC, V22, P110, DOI 10.1016/j.cmi.2015.12.004; Arlet G, 2006, MICROBES INFECT, V8, P1945, DOI 10.1016/j.micinf.2005.12.029; Baron S, 2014, ANTIMICROB AGENTS CH, V58, P5428, DOI 10.1128/AAC.03106-14; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; (Brazil) Ministerio da Agricultura Pecuaria e Abastecimento, 2003, INSTR NORM 09; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Bush K, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025247; Butaye P, 2006, MICROBES INFECT, V8, P1891, DOI 10.1016/j.micinf.2005.12.020; Campos J, 2018, INT J ANTIMICROB AG, V51, P151, DOI 10.1016/j.ijantimicag.2017.09.006; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Carlson SA, 1999, MOL CELL PROBE, V13, P213, DOI 10.1006/mcpr.1999.0240; (CDC) Centers for Disease Control and Prevention, 2013, MULT OUTBR MULT RES; (CDC) Centers for Disease Control and Prevention, 2013, MULT OUTBR SAM HEID; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Clothier Kristin A, 2016, J Vet Med, V2016, P6380890, DOI 10.1155/2016/6380890; CLSI, 2017, PERFORMANCE STANDARD; Codjoe Francis S, 2017, Med Sci (Basel), V6, DOI 10.3390/medsci6010001; Daehre K, 2018, MICROB DRUG RESIST, V24, P511, DOI 10.1089/mdr.2017.0150; Day MR, 2015, J ANTIMICROB CHEMOTH, V70, P2165, DOI 10.1093/jac/dkv075; Djeffal S, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1050-3; Dutil L, 2010, EMERG INFECT DIS, V16, P48, DOI 10.3201/eid1601.090729; European Food Safety Authority, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5077; Fischer J, 2013, J ANTIMICROB CHEMOTH, V68, P2954, DOI 10.1093/jac/dkt260; Fitch FM, 2016, MICROB DRUG RESIST, V22, P164, DOI 10.1089/mdr.2015.0143; Folster JP, 2012, FOODBORNE PATHOG DIS, V9, P638, DOI 10.1089/fpd.2012.1130; Gibbons JF, 2016, ZOONOSES PUBLIC HLTH, V63, P241, DOI 10.1111/zph.12225; Giuriatti J, 2017, MICROB PATHOGENESIS, V109, P195, DOI 10.1016/j.micpath.2017.05.040; Glen LM, 2013, MICROB DRUG RESIST; Heider LC, 2009, FOODBORNE PATHOG DIS; Hiki M, 2017, J VET DIAGN INVEST, V29, P716, DOI 10.1177/1040638717713794; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jeon HY, 2019, POULTRY SCI, V98, P1766, DOI 10.3382/ps/pey514; Kaldhone P, 2008, APPL ENVIRON MICROB, V74, P5038, DOI 10.1128/AEM.00409-08; Ktari S, 2015, J ANTIMICROB CHEMOTH, V70, P3405, DOI 10.1093/jac/dkv276; Landoni MF, 2015, VET J, V205, P21, DOI 10.1016/j.tvjl.2015.04.016; LENIN J, 2009, MAR TURT NEWSL   OCT, P2; Liakopoulos A, 2016, EMERG INFECT DIS, V22, P1257, DOI 10.3201/eid2207.151377; Lynne AM, 2009, FOODBORNE PATHOG DIS; Mairi A, 2018, EUR J CLIN MICROBIOL, V37, P587, DOI 10.1007/s10096-017-3112-7; Martin LC, 2012, APPL ENVIRON MICROB, V78, P1285, DOI 10.1128/AEM.06498-11; Miriagou V, 2004, INT J ANTIMICROB AG, V23, P547, DOI 10.1016/j.ijantimicag.2004.03.006; Medeiros MAN, 2011, REV PANAM SALUD PUBL, V30, P555, DOI 10.1590/S1020-49892011001200010; Park SH, 2015, J APPL MICROBIOL, V118, P152, DOI 10.1111/jam.12678; Patchanee P, 2008, FOODBORNE PATHOG DIS, V5, P839, DOI 10.1089/fpd.2008.0149; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Saraiva MMS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203158; Tiba-Casas MR, 2019, MICROB DRUG RESIST, V25, P271, DOI 10.1089/mdr.2018.0044; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; van Hoek AHAM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00203; Wright GD, 2016, TRENDS MICROBIOL, V24, P928, DOI 10.1016/j.tim.2016.07.008; Zhao S, 2008, APPL ENVIRON MICROB, V74, P6656, DOI 10.1128/AEM.01249-08	54	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230676	10.1371/journal.pone.0230676	http://dx.doi.org/10.1371/journal.pone.0230676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HO	32231395	gold, Green Published			2022-12-26	WOS:000535937400017
J	Martino, G; Catalano, A; Agostino, RM; Bellone, F; Morabito, N; Lasco, CG; Vicario, CM; Schwarz, P; Feldt-Rasmussen, U				Martino, Gabriella; Catalano, Antonino; Agostino, Rita Maria; Bellone, Federica; Morabito, Nunziata; Lasco, Carmen Giulia; Vicario, Carmelo Mario; Schwarz, Peter; Feldt-Rasmussen, Ulla			Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer	PLOS ONE			English	Article							ADJUVANT ENDOCRINE THERAPY; COGNITIVE FUNCTION; DISTRESS TRAJECTORIES; HOSPITAL ANXIETY; HEALTH SURVEY; DEPRESSION; ESTROGEN; TAMOXIFEN; ANASTROZOLE; SYMPTOMS	Introduction Aromatase inhibitors (AIs) dramatically increased breast cancer (BC) survival, leading to enhanced attention to their long-term consequences on psychological functioning. Conflicting data has been examined regarding the association between AIs administration and the clinical psychological features in BC survivors (BCSs). Purpose As psychological symptoms often occur in such chronic diseases, our study aimed at exploring anxious and depressive symptoms and the perceived quality of life (QoL) in BCSs assessed for osteoporosis. Methods The total sample consisted of a clinical sample of 51 outpatient postmenopausal women, diagnosed with BC, and a control group composed of 51 healthy postmenopausal women. All recruited participants were evaluated through the clinical gold standard interview and completed the following self-rating scales: the Hamilton Anxiety Rating Scale, Beck Depression Inventory II edition, and 36-Item Short Form Health Survey, which were administered at baseline and after 6 months in BCSs in AIs treatment, compared with controls. Moreover, all participants were assessed for vitamin D status, bone mineral density (BMD) and subclinical vertebral fractures. Data regarding age, age at menopause, body mass index (BMI), smoking habits and alcohol consumption was collected. Results BCSs (n = 51) showed higher anxious and depressive symptoms, and lower perceived QoL vs. controls (n = 51) (p<0.05 for all). After 6 months of treatment with AIs, BCSs showed significant reduction of anxious and depressive symptoms and a significantly higher perceived QoL for both physical and mental components, vs. controls. Conclusions The improvement of clinical psychological features and perceived QoL was associated with AIs treatment in women being treated with, for early breast cancer. Further studies are needed to obtain a deeper comprehension of the correlation between clinical psychological and physical features in BCSs.	[Martino, Gabriella; Catalano, Antonino; Bellone, Federica; Morabito, Nunziata; Lasco, Carmen Giulia] Univ Hosp Messina, Dept Clin & Expt Med, Messina, Italy; [Agostino, Rita Maria] Grand Metropolitan Hosp Bianchi Melacrino Morelli, Med Oncol Unit, Reggio Di Calabria, Italy; [Vicario, Carmelo Mario] Univ Messina, Dept Cognit Sci Psychol Educ & Cultural Studies, Messina, Italy; [Schwarz, Peter; Feldt-Rasmussen, Ulla] Rigshosp, Dept Med Endocrinol, Copenhagen Univ Hosp, Copenhagen, Denmark	AOU Policlinico Gaetano Martino; University of Messina; Rigshospitalet; University of Copenhagen	Martino, G (corresponding author), Univ Hosp Messina, Dept Clin & Expt Med, Messina, Italy.	martinog@unime.it	Feldt-Rasmussen, Ulla/AAB-9218-2021; VICARIO, CARMELO/AAR-2521-2021	Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Bellone, Federica/0000-0002-0467-4921; Schwarz, Peter/0000-0002-0483-8594				Ahles TA, 2012, J CLIN ONCOL, V30, P3675, DOI 10.1200/JCO.2012.43.0116; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Apolone G, 1998, J CLIN EPIDEMIOL, V51, P1025, DOI 10.1016/S0895-4356(98)00094-8; Barberis N, 2019, J PSYCHOSOM RES, V124, DOI 10.1016/j.jpsychores.2019.109787; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; Bender CM, 2007, MENOPAUSE, V14, P995, DOI 10.1097/gme.0b013e318148b28b; Bender CM, 2018, ONCOL NURS FORUM, V45, P308, DOI 10.1188/18.ONF.308-326; Bender CM, 2015, CANCER-AM CANCER SOC, V121, P2627, DOI 10.1002/cncr.29393; Bender CM, 2014, ONCOLOGY-NY, V28, P806; Bender CM, 2013, MENOPAUSE, V20, P922, DOI [10.1097/gme.0b013e3182843eff, 10.1097/GME.0b013e3182843eff]; Bidstrup PE, 2015, ACTA ONCOL, V54, P789, DOI 10.3109/0284186X.2014.1002571; Bove KB, 2014, EUR THYROID J, V3, P173, DOI 10.1159/000365211; Carmassi C, 2014, COMPR PSYCHIAT, V55, P1322, DOI 10.1016/j.comppsych.2014.03.001; Castelnuovo G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01557; Catalano A, 2017, J ENDOCRINOL INVEST, V40, P851, DOI 10.1007/s40618-016-0606-6; Catalano A, 2019, AGING CLIN EXP RES, V26, P1; Catalano A, 2019, CLIN DRUG INVEST, V39, P97, DOI 10.1007/s40261-018-0720-7; Catalano A, 2018, MENOPAUSE, V25, P1110, DOI [10.1097/GME.0000000000001123, 10.1097/gme.0000000000001123]; Catalano A, 2017, DRUG AGING, V34, P755, DOI 10.1007/s40266-017-0492-4; Cheng CM, 2001, FASEB J, V15, P907, DOI 10.1096/fj.00-0398com; Cholerton B, 2002, DRUG AGING, V19, P405, DOI 10.2165/00002512-200219060-00002; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Conti C, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00113; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Deleskog L, 2016, OSTEOPOROSIS INT, V27, P2317, DOI 10.1007/s00198-016-3532-8; Dell'Osso L, 2014, COMPR PSYCHIAT, V55, P357, DOI 10.1016/j.comppsych.2013.08.017; Dell'Osso L, 2011, CNS SPECTRUMS, V16, P1, DOI 10.1017/S1092852912000090; Di Giuseppe M, 2019, EUR J ONCOL NURS, V40, P104, DOI 10.1016/j.ejon.2019.04.003; Di Giuseppe M, 2018, J PSYCHOSOM RES, V115, P76, DOI 10.1016/j.jpsychores.2018.10.016; Donovan KA, 2014, ANN BEHAV MED, V47, P292, DOI 10.1007/s12160-013-9550-2; Fava GA, 2012, INT J CLIN PRACT, V66, P11, DOI 10.1111/j.1742-1241.2011.02825.x; Fiegl S, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01862; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Frank JS, 2014, J NEUROSCI NURS, V46, P274, DOI 10.1097/JNN.0000000000000078; Ganz PA, 2014, J CLIN ONCOL, V32, P3559, DOI 10.1200/JCO.2014.56.1662; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hara Y, 2015, PHYSIOL REV, V95, P785, DOI 10.1152/physrev.00036.2014; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Henselmans I, 2010, HEALTH PSYCHOL, V29, P160, DOI 10.1037/a0017806; Hermelink K, 2008, CANCER-AM CANCER SOC, V113, P2431, DOI 10.1002/cncr.23853; Ho SSM, 2013, EUR J ONCOL NURS, V17, P877, DOI 10.1016/j.ejon.2013.04.005; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Hurria A, 2014, CLIN BREAST CANCER, V14, P132, DOI 10.1016/j.clbc.2013.10.010; Husemoen LLN, 2016, EUR J CLIN NUTR, V70, P78, DOI 10.1038/ejcn.2015.129; Junghaenel DU, 2015, SUPPORT CARE CANCER, V23, P2579, DOI 10.1007/s00520-015-2616-x; Kant J, 2018, J PSYCHOSOM RES, V115, P6, DOI 10.1016/j.jpsychores.2018.09.012; Lam WWT, 2013, PSYCHO-ONCOLOGY, V22, P2831, DOI 10.1002/pon.3361; Langher V, 2017, MEDITERR J CLIN PSYC, V5, DOI 10.6092/2282-1619/2017.5.1670; Lauriola M, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01112; Lenzo V, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02875; Maass SWMC, 2015, MATURITAS, V82, P100, DOI 10.1016/j.maturitas.2015.04.010; Marchi L, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01735; Marchini F, 2018, MEDITERR J CLIN PSYC, V6, DOI 10.6092/2282-1619/2018.6.1981; Martino G, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00267; Martino G, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02502; Martino G, 2019, MEDITERR J CLIN PSYC, V7, DOI 10.6092/2282-1619/2019.7.2167; Martino G, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01779; Martino G, 2018, MEDITERR J CLIN PSYC, V6, DOI 10.6092/2282-1619/2018.6.1740; Matthews K, 1999, J AM GERIATR SOC, V47, P518, DOI 10.1111/j.1532-5415.1999.tb02563.x; Merriman JD, 2017, PSYCHO-ONCOLOGY, V26, P44, DOI 10.1002/pon.4009; Nabholtz JM, 2000, J CLIN ONCOL, V18, P3758, DOI 10.1200/JCO.2000.18.22.3758; Norbury R, 2003, EXP GERONTOL, V38, P109, DOI 10.1016/S0531-5565(02)00166-3; Norton S, 2013, J PSYCHOSOM RES, V74, P74, DOI 10.1016/j.jpsychores.2012.10.010; Piccinni A, 2012, J AFFECT DISORDERS, V138, P160, DOI 10.1016/j.jad.2011.12.042; Rahnea Nita RA., 2016, ARCH BALKAN MED UNIO, V51, P25; Rahnea-Nita RA, 2019, MEDITERR J CLIN PSYC, V7, DOI 10.6092/2282-1619/2019.7.2214; Ribi K, 2012, BRIT J CANCER, V106, P1618, DOI 10.1038/bjc.2012.156; RICKHAM PP, 1964, BRIT MED J, V2, P173; Roberts K, 2017, CRIT REV ONCOL HEMAT, V111, P66, DOI 10.1016/j.critrevonc.2017.01.010; Rocha-Cadman X, 2012, PALLIAT SUPPORT CARE, V10, P225, DOI 10.1017/S1478951512000636; Rosenberg SM, 2015, ONCOLOGIST, V20, P598, DOI 10.1634/theoncologist.2015-0007; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schagen SB, 2007, LANCET ONCOL, V8, P852, DOI 10.1016/S1470-2045(07)70287-5; Schilder CM, 2009, ACTA ONCOL, V48, P76, DOI 10.1080/02841860802314738; Settineri S, 2019, J MULTIDISCIP HEALTH, V12, P299, DOI 10.2147/JMDH.S193752; Sheikh SS, 2019, MEDITERR J CLIN PSYC, V7, DOI 10.6092/2282-1619/2019.7.2164; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Stanton AL, 2012, J CLIN ONCOL, V30, P1215, DOI 10.1200/JCO.2011.39.7406; Suppli NP, 2014, J CLIN ONCOL, V32, P3831, DOI 10.1200/JCO.2013.54.0419; Taira N, 2014, BREAST CANCER RES TR, V145, P155, DOI 10.1007/s10549-014-2935-5; Takei H, 2012, BREAST CANCER RES TR, V133, P227, DOI 10.1007/s10549-011-1943-y; Vance V, 2019, CANCER NURS, V42, pE43, DOI 10.1097/NCC.0000000000000612; Vicario CM, 2019, NEUROSCI BIOBEHAV R, V96, P219, DOI 10.1016/j.neubiorev.2018.12.012; Vodermaier A, 2011, SUPPORT CARE CANCER, V19, P1899, DOI 10.1007/s00520-011-1251-4; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watt T, 2012, EUR THYROID J, V1, P186, DOI 10.1159/000342623; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	88	36	37	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230681	10.1371/journal.pone.0230681	http://dx.doi.org/10.1371/journal.pone.0230681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8GI	32214378	gold, Green Published			2022-12-26	WOS:000535934200037
J	Ramesh, J; Parthasarathy, LK; Janckila, AJ; Begum, F; Murugan, R; Murthy, BPSS; El-Mallakh, RS; Parthasarathy, RN; Venugopal, B				Ramesh, Janani; Parthasarathy, Latha K.; Janckila, Anthony J.; Begum, Farhana; Murugan, Ramya; Murthy, Balakumar P. S. S.; El-Mallakh, Rif S.; Parthasarathy, Ranga N.; Venugopal, Bhuvarahamurthy			Characterisation of ACP5 missense mutations encoding tartrate-resistant acid phosphatase associated with spondyloenchondrodysplasia	PLOS ONE			English	Article							CEREBRAL CALCIFICATIONS; ALKALINE-PHOSPHATASE; IMMUNE DYSREGULATION; TETRAZOLIUM METHOD; EXPRESSION; METASTASIS; DEFICIENCY; DYSPLASIA; MARKER; CANCER	Biallelic mutations in ACP5, encoding tartrate-resistant acid phosphatase (TRACP), have recently been identified to cause the inherited immuno-osseous disorder, spondyloenchondrodysplasia (SPENCD). This study was undertaken to characterize the eight reported missense mutations in ACP5 associated with SPENCD on TRACP expression. ACP5 mutant genes were synthesized, transfected into human embryonic kidney (HEK-293) cells and stably expressing cell lines were established. TRACP expression was assessed by cytochemical and immuno-cytochemical staining with a panel of monoclonal antibodies. Analysis of wild (WT) type and eight mutant stable cell lines indicated that all mutants lacked stainable enzyme activity. All ACP5 mutant constructs were translated into intact proteins by HEK293 cells. The mutant TRACP proteins displayed variable immune reactivity patterns, and all drastically reduced enzymatic activity, revealing that there is no gross inhibition of TRACP biosynthesis by the mutations. But they likely interfere with folding thereby impairing enzyme function. TRACP exists as two isoforms. TRACP 5a is a less active monomeric enzyme (35kD), with the intact loop peptide and TRACP 5b is proteolytically cleaved highly active enzyme encompassing two subunits (23 kD and 16 kD) held together by disulfide bonds. None of the mutant proteins were proteolytically processed into isoform 5b intracellularly, and only three mutants were secreted in significant amounts into the culture medium as intact isoform 5a-like proteins. Analysis of antibody reactivity patterns revealed that T89I and M264K mutant proteins retained some native conformation, whereas all others were in "denatured" or "unfolded" forms. Western blot analysis with intracellular and secreted TRACP proteins also revealed similar observations indicating that mutant T89I is amply secreted as inactive protein. All mutant proteins were attacked by Endo-H sensitive glycans and none could be activated by proteolytic cleavage in vitro. In conclusion, determining the structure-function relationship of the SPENCD mutations in TRACP will expand our understanding of basic mechanisms underlying immune responsiveness and its involvement in dysregulated bone metabolism.	[Ramesh, Janani; Begum, Farhana; Murugan, Ramya; Parthasarathy, Ranga N.; Venugopal, Bhuvarahamurthy] Univ Madras, Dept Med Biochem, Dr ALM PGIBMS, Madras, Tamil Nadu, India; [Parthasarathy, Latha K.; El-Mallakh, Rif S.; Parthasarathy, Ranga N.] Univ Louisville, Sch Med, Dept Psychiat, Louisville, KY 40292 USA; [Janckila, Anthony J.] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Murthy, Balakumar P. S. S.] Tamilnadu Govt Multi Super Special Hosp, Dept Vasc & Endovasc Sci, Chennai, Tamil Nadu, India; [Parthasarathy, Ranga N.] Univ Louisville, Sch Med, Dept Psychiat Mol Biol & Biochem, Louisville, KY 40292 USA	University of Madras; University of Louisville; University of Louisville; University of Louisville	Venugopal, B (corresponding author), Univ Madras, Dept Med Biochem, Dr ALM PGIBMS, Madras, Tamil Nadu, India.	murthyboston@gmail.com	Ramesh, Janani/AAH-2138-2021	Ramesh, Janani/0000-0002-2137-500X; venugopal, bhuvarahamurthy/0000-0002-5073-4091	University Grants Commission - Special Assistance Programme (UGC - SAP); Department of Science and Technology - Promotion of University Research and Scientific Excellence (DST-PURSE)	University Grants Commission - Special Assistance Programme (UGC - SAP); Department of Science and Technology - Promotion of University Research and Scientific Excellence (DST-PURSE)	This work received partial support from the following sources: University Grants Commission - Special Assistance Programme (UGC - SAP) and Department of Science and Technology - Promotion of University Research and Scientific Excellence (DST-PURSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BAUMBACH GA, 1991, MOL CELL BIOCHEM, V105, P107; Behrens TW, 2011, NAT GENET, V43, P90, DOI 10.1038/ng0211-90; Bian ZQ, 2019, AM J CANCER RES, V9, P22; Bilginer Y, 2016, LUPUS, V25, P760, DOI 10.1177/0961203316629000; BRENAN M, 1989, J HISTOCHEM CYTOCHEM, V37, P1299, DOI 10.1177/37.8.2474024; Briggs TA, 2016, J CLIN IMMUNOL, V36, P220, DOI 10.1007/s10875-016-0252-y; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Chao TY, 2004, J BIOMED SCI, V11, P511, DOI 10.1159/000077901; Cho E, 2019, MOLECULES, V24, DOI 10.3390/molecules24183346; de Bruin C, 2016, HORM RES PAEDIAT, V85, P358, DOI 10.1159/000443684; Esfandiari E, 2006, J BONE MINER RES, V21, P1367, DOI 10.1359/JBMR.060611; Girschick H, 2015, PEDIATR RHEUMATOL, V13, DOI 10.1186/s12969-015-0035-7; Halleen JM, 1998, J BONE MINER RES, V13, P683, DOI 10.1359/jbmr.1998.13.4.683; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Hayman AR, 1996, DEVELOPMENT, V122, P3151; Hong SW, MEDICINE, V97, P13644, DOI [10.1097/MD, DOI 10.1097/MD]; Janckila AJ, 2005, J LEUKOCYTE BIOL, V77, P209, DOI 10.1189/jlb.0504287; JANCKILA AJ, 1978, AM J CLIN PATHOL, V70, P45; Janckila AJ, 2002, CLIN CHIM ACTA, V326, P113, DOI 10.1016/S0009-8981(02)00280-2; Janckila AJ, 2007, AM J CLIN PATHOL, V127, P556, DOI 10.1309/DGEA9BE2VE5VCFYH; Janckila AJ, 2009, CALCIFIED TISSUE INT, V85, P465, DOI 10.1007/s00223-009-9309-8; Kawaguchi T, 2008, CLIN BIOCHEM, V41, P1245, DOI 10.1016/j.clinbiochem.2008.07.010; Lausch E, 2011, NAT GENET, V43, P132, DOI 10.1038/ng.749; Li K, 2019, J CELL PHYSIOL, V234, P16263, DOI 10.1002/jcp.28289; Ljusberg J, 2005, J BIOL CHEM, V280, P28370, DOI 10.1074/jbc.M502469200; MCGADEY J, 1970, HISTOCHEMISTRY, V23, P180, DOI 10.1007/BF00305851; Navarro V, 2008, AM J MED GENET A, V146A, P2810, DOI 10.1002/ajmg.a.32518; Radzun H J, 1983, Hematol Oncol, V1, P321; REDDY SV, 1995, BONE, V16, P587, DOI 10.1016/8756-3282(95)00086-S; Ren X, 2018, ANTI-CANCER AGENT ME, V18, P1082, DOI 10.2174/1871520618666180411123447; Renella R, 2006, AM J MED GENET A, V140A, P541, DOI 10.1002/ajmg.a.31081; Sacri AS, 2017, PEDIATR BLOOD CANCER, V64, P306, DOI 10.1002/pbc.26195; Scott KL, 2011, CANCER CELL, V20, P92, DOI 10.1016/j.ccr.2011.05.025; Strater N, 2005, J MOL BIOL, V351, P233, DOI 10.1016/j.jmb.2005.04.014; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Utsumi T, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00157; Vaaraniemi J, 2004, J BONE MINER RES, V19, P1432, DOI 10.1359/JBMR.040603; VANNOORDEN CJF, 1987, HISTOCHEM J, V19, P94, DOI 10.1007/BF01682753; Walsh NC, 2003, GENE, V307, P111, DOI 10.1016/S0378-1119(03)00449-9; Wang YL, 2005, ARCH BIOCHEM BIOPHYS, V435, P147, DOI 10.1016/j.abb.2004.11.029; Zhang Q, 2019, J BIOL REG HOMEOS AG, V33, P557	42	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230052	10.1371/journal.pone.0230052	http://dx.doi.org/10.1371/journal.pone.0230052			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214327	gold, Green Published, Green Submitted			2022-12-26	WOS:000535934200016
J	Volozonoka, L; Rots, D; Kempa, I; Kornete, A; Rezeberga, D; Gailite, L; Miskova, A				Volozonoka, Ludmila; Rots, Dmitrijs; Kempa, Inga; Kornete, Anna; Rezeberga, Dace; Gailite, Linda; Miskova, Anna			Genetic landscape of preterm birth due to cervical insufficiency: Comprehensive gene analysis and patient next-generation sequencing data interpretation	PLOS ONE			English	Article								Preterm delivery is both a traumatizing experience for the patient and a burden on the healthcare system. A condition distinguishable by its phenotype in prematurity is cervical insufficiency, where certain cases exhibit a strong genetic component. Despite genomic advancements, little is known about the genetics of human cervix remodeling during pregnancy. Using selected gene approaches, a few studies have demonstrated an association of common gene variants with cervical insufficiency. However, until now, no study has employed comprehensive methods to investigate this important subject matter. In this study, we asked: i) are there genes reliably linked to cervical insufficiency and, if so, what are their roles? and ii) what is the proportion of cases of non-syndromic cervical insufficiency attributable to these genetic variations? We performed next-generation sequencing on 21 patients with a clinical presentation of cervical insufficiency. To assist the sequencing data interpretation, we retrieved all known genes implicated in cervical functioning through a systematic literature analysis and additional gene searches. These genes were then classified according to their relation to the questions being posed by the study. Patients' sequence variants were filtered for pathogenicity and assigned a likelihood of being contributive to phenotype development. Gene extraction and analysis revealed 12 genes primarily linked to cervical insufficiency, the majority of which are known to cause collagenopathies. Ten patients carried disruptive variants potentially contributive to the development of non-syndromic cervical insufficiency. Pathway enrichment analysis of variant genes from our cohort revealed an increased variation burden in genes playing roles in tissue mechanical and biomechanical properties, i.e. collagen biosynthesis and cell-extracellular matrix communications. Consequently, the proposed idea of cervical insufficiency being a subtle form of collagenopathy, now strengthened by our genetic findings, might open up new opportunities for improved patient evaluation and management.	[Volozonoka, Ludmila; Rots, Dmitrijs; Kempa, Inga; Gailite, Linda] Riga Stradins Univ, Sci Lab Mol Genet, Riga, Latvia; [Kornete, Anna; Rezeberga, Dace; Miskova, Anna] Riga Stradins Univ, Dept Obstet & Gynecol, Riga, Latvia	Riga Stradins University; Riga Stradins University	Volozonoka, L (corresponding author), Riga Stradins Univ, Sci Lab Mol Genet, Riga, Latvia.	ludmilavolozonoka@gmail.com	Miskova, Anna/ABD-6047-2021; Rots, Dmitrijs/X-7569-2018	Miskova, Anna/0000-0002-1592-1852; Volozonoka, Ludmila/0000-0003-0413-1481; Rots, Dmitrijs/0000-0002-4890-9147	Riga Stradins University Internal Study Grant	Riga Stradins University Internal Study Grant	The study was supported by a Riga Stradins University Internal Study Grant (to LV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, BJOG INT J OBSTET GY; [Anonymous], 2012, AM J OBSTET GYNECOL; [Anonymous], 2014, FIG WORK GROUP BEST; Anum EA, 2009, PLACENTA; Asimit J, 2010, ANN REV GENET; Banos N, 2015, FETAL DIAGNOSIS THER; Beighton P, 1969, J BONE JT SURG SER; Bezold KY, 2013, GENOME MED, V5, DOI 10.1186/gm438; Bomba L, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1212-4; Boyd HA, 2009, AM J EPIDEMIOL; Bukowski R, 2006, PLOS MED; Caritis SN, 2012, LANCET; Chawanpaiboon S, 2019, LANCET GLOB HLTH; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cremers FPM, 2019, GENET MED; Danforth DN, 1983, CLIN OBSTET GYNECOL; De Paepe A, 1989, EUR J OBSTET GYNECOL; De Vos M, 1999, FETAL DIAGN THER; Desvignes JP, 2018, NUCL ACIDS RES; Dunlop AL, 2015, ADV NEONATAL CARE; Eidem HR, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0099-8; Endres LK, 2003, AM J PERINATOL; Freed  D, 2017, SENTIEON GENOMICS TO; Frey HA, 2016, SEMINARS FETAL NEONA; Hassan SS, 2010, AM J OBSTET GYNECOL; Hassan SS, 2009, J MATERN NEONATAL ME; Huusko JM, 2018, PLOS GENET; Jameel ASMM, 2016, 2016 INTERNATIONAL CONFERENCE ON MEDICAL ENGINEERING, HEALTH INFORMATICS AND TECHNOLOGY (MEDITEC); Jordan J., 2009, CERVIX; Kamburov A, 2013, NUCLEIC ACIDS RES; Keelan JA, 2003, PLACENTA; Kendig KI, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00736; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kopanos C, 2019, BIOINFORMATICS; Kyrgiou M, 2017, COCHRANE DATABASE SY; Leduc L, 1992, AM J PERINATOL; Li H., 2013, ALIGNING SEQUENCE RE; Li J, 2017, PLOS GENET; Litjens SHM, 2006, TRENDS CELL BIOL; Makieva S, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.02.009; Malak TM, 1994, BJOG INT J OBSTET GY; Manuck TA, 2016, SEMINARS FETAL NEONA; McElroy JJ, 2013, HUM GENET; Minamoto T, 1987, AM J OBSTET GYNECOL; Mingione MJ, 2003, HUM REPROD; Moher D., 2009, BMJ, V339, P332; Myking S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-174; Odibo A., 2014, OBSTET GYNECOL; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Papiernik E, 1986, OBSTET GYNECOL; Pertea M., 2001, NUCL ACIDS RES; Petersen LK, 1996, EUR J OBSTET GYNECOL; Pezaro S, 2018, BR J MIDWIFERY; Plunkett J, 2008, ANN MED; Porter TF, 1997, OBSTET GYNECOL; Quang D, 2015, BIOINFORMATICS; Raffi F, 2007, J OBSTET GYNAECOL LA; Rechberger T, 1988, OBSTET GYNECOL; Reese MG, 1997, J COMPUTATIONAL BIOL; Ribeiro de Andrade Ramos B, 2018, REPROD SCI; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; ROMERO R, 2014, SCIENCE; Rudd NL, 1983, LANCET; Sakamoto Y, 2004, CLIN EXP IMMUNOL; Shapiro MB, 1987, NUCL ACIDS RES; Song JE, 2019, J MATERN NEONATAL ME; Strauss JF, 2018, AM J OBSTET GYNECOL; Strauss JF, 2013, REPROD SCI; Sundtoft I, 2016, GYNECOL OBSTET INVES; Timmons BC, 2007, REPROD SCI; Tzialidou I, 2007, Z GEBURTSHILFE NEONA; Uldbjerg N, 1983, Clin Obstet Gynecol, V26, P14, DOI 10.1097/00003081-198303000-00006; Varner MW, 2005, BJOG INT J OBSTET GY; Vink J, 2016, SEMINARS FETAL NEONA; Vink J, 2018, BEST PRACTICE RES CL; Warren JE, 2009, AM J OBSTET GYNECOL; Warren JE, 2007, OBSTET GYNECOL; Wiel L, 2019, HUM MUTAT; Winkvist A, 1998, INT J EPIDEMIOL; Word RA, 2007, SEMINARS REPROD MED; Xu H, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.029; Yeo G, 2004, J COMPUTATIONAL BIOL; Young NK, 2007, PRENAT DIAGN; Zhang H, 2015, GENET EPIDEMIOL	84	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230771	10.1371/journal.pone.0230771	http://dx.doi.org/10.1371/journal.pone.0230771			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214361	Green Published, gold			2022-12-26	WOS:000535934200054
J	Mebius, MJ; Bilardo, CM; Kneyber, MCJ; Modestini, M; Ebels, T; Berger, RMF; Bos, AF; Kooi, EMW				Mebius, Mirthe J.; Bilardo, Catherina M.; Kneyber, Martin C. J.; Modestini, Marco; Ebels, Tjark; Berger, Rolf M. F.; Bos, Arend F.; Kooi, Elisabeth M. W.			Onset of brain injury in infants with prenatally diagnosed congenital heart disease	PLOS ONE			English	Article							CEREBRAL OXYGEN-SATURATION; NEAR-INFRARED SPECTROSCOPY; FETAL CEREBROVASCULAR RESISTANCE; GENERAL MOVEMENTS; NEURODEVELOPMENTAL OUTCOMES; PREDICTIVE-VALUE; BLOOD-FLOW; PRETERM INFANTS; FETUSES; NEWBORNS	Background The exact onset of brain injury in infants with congenital heart disease (CHD) is unknown. Our aim was, therefore, to assess the association between prenatal Doppler flow patterns, postnatal cerebral oxygenation and short-term neurological outcome. Methods Prenatally, we measured pulsatility indices of the middle cerebral (MCA-PI) and umbilical artery (UA-PI) and calculated cerebroplacental ratio (CPR). After birth, cerebral oxygen saturation (r(c)SO(2)) and fractional tissue oxygen extraction (FTOE) were assessed during the first 3 days after birth, and during and for 24 hours after every surgical procedure within the first 3 months after birth. Neurological outcome was determined preoperatively and at 3 months of age by assessing general movements and calculating the Motor Optimality Score (MOS). Results Thirty-six infants were included. MOS at 3 months was associated with MCA-PI (rho 0.41, P = 0.04), UA-PI (rho -0.39, P = 0.047, and CPR (rho 0.50, P = 0.01). Infants with abnormal MOS had lower MCA-PI (P = 0.02) and CPR (P = 0.01) and higher UA-PI at the last measurement (P = 0.03) before birth. In infants with abnormal MOS, r(c)SO(2) tended to be lower during the first 3 days after birth, and FTOE was significantly higher on the second day after birth (P = 0.04). Intraoperative and postoperative r(c)SO(2) and FTOE were not associated with short-term neurological outcome. Conclusion In infants with prenatally diagnosed CHD, the prenatal period may play an important role in developmental outcome. Additional research is needed to clarify the relationship between preoperative, intra-operative and postoperative cerebral oxygenation and developmental outcome in infants with prenatally diagnosed CHD.	[Mebius, Mirthe J.; Bos, Arend F.; Kooi, Elisabeth M. W.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Neonatol, Groningen, Netherlands; [Bilardo, Catherina M.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [Kneyber, Martin C. J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Pediat Crit Care Med, Groningen, Netherlands; [Kneyber, Martin C. J.] Univ Groningen, Crit Care Anesthesiol Perioperat Emergency Med CA, Groningen, Netherlands; [Modestini, Marco] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, Groningen, Netherlands; [Ebels, Tjark] Univ Groningen, Univ Med Ctr, Dept Cardiothorac Surg, Ctr Congenital Heart Dis, Groningen, Netherlands; [Berger, Rolf M. F.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Ctr Congenital Heart Dis, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Mebius, MJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Neonatol, Groningen, Netherlands.	m.j.mebius01@umcg.nl	Kooi, Elisabeth/AAD-3926-2022; Kneyber, Martin/AAV-8437-2020	Kooi, Elisabeth/0000-0001-9195-4018; Kneyber, Martin/0000-0002-6008-3376; Modestini, Marco/0000-0001-8630-992X; Ebels, Tjark/0000-0002-7124-0058	University of Groningen Junior Scientific Masterclass grant	University of Groningen Junior Scientific Masterclass grant	M.J. Mebius was financially supported by a University of Groningen Junior Scientific Masterclass grant.	Al Nafisi B, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-65; Algra SO, 2014, J PEDIATR-US, V165, P1116, DOI 10.1016/j.jpeds.2014.08.066; Apers S, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0407-x; Arduini M, 2011, J MATERN-FETAL NEO M, V24, P1208, DOI 10.3109/14767058.2010.547961; Beca J, 2013, CIRCULATION, V127, P971, DOI 10.1161/CIRCULATIONAHA.112.001089; Bos AF, 1998, ACTA PAEDIATR, V87, P328, DOI 10.1080/08035259850157417; Brossard-Racine M, 2016, AM J NEURORADIOL, V37, P1338, DOI 10.3174/ajnr.A4716; Brossard-Racine M, 2014, AM J NEURORADIOL, V35, P1593, DOI 10.3174/ajnr.A3903; Bruggink JLM, 2009, EARLY HUM DEV, V85, P461, DOI 10.1016/j.earlhumdev.2009.04.002; Bruggink JLM, 2008, J PEDIATR-US, V153, P32, DOI 10.1016/j.jpeds.2007.12.047; Bruggink JLM, 2009, EARLY HUM DEV, V85, P25, DOI 10.1016/j.earlhumdev.2008.05.010; Burkhardt BEU, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009515.pub2; Clouchoux C, 2013, CEREB CORTEX, V23, P2932, DOI 10.1093/cercor/bhs281; Einspieler C, 1997, EARLY HUM DEV, V50, P47, DOI 10.1016/S0378-3782(97)00092-3; Einspieler C, 2005, MENT RETARD DEV D R, V11, P61, DOI 10.1002/mrdd.20051; Hadders-Algra M, 2004, CLIN REHABIL, V18, P287, DOI 10.1191/0269215504cr730oa; Hahn E, 2016, ULTRASOUND OBST GYN, V47, P460, DOI 10.1002/uog.14881; Hitzert MM, 2014, DEV MED CHILD NEUROL, V56, P869, DOI 10.1111/dmcn.12468; Kurth CD, 2002, J CEREBR BLOOD F MET, V22, P335, DOI 10.1097/00004647-200203000-00011; Kurth CD, 2001, ANN THORAC SURG, V72, P187, DOI 10.1016/S0003-4975(01)02632-7; Kussman BD, 2010, CIRCULATION, V122, P245, DOI 10.1161/CIRCULATIONAHA.109.902338; Leviton A, 2013, PEDIATR RES, V73, P362, DOI 10.1038/pr.2012.188; Licht DJ, 2009, J THORAC CARDIOV SUR, V137, P529, DOI 10.1016/j.jtcvs.2008.10.025; Limperopoulos C, 2000, J PEDIATR-US, V137, P638, DOI 10.1067/mpd.2000.109152; Limperopoulos C, 2010, CIRCULATION, V121, P26, DOI 10.1161/CIRCULATIONAHA.109.865568; Marino BS, 2012, CIRCULATION, V126, P1143, DOI 10.1161/CIR.0b013e318265ee8a; Masoller N, 2016, ULTRASOUND OBST GYN, V47, P65, DOI 10.1002/uog.14919; Masoller N, 2014, ULTRASOUND OBST GYN, V44, P182, DOI 10.1002/uog.13373; McQuillen PS, 2007, STROKE, V38, P736, DOI 10.1161/01.STR.0000247941.41234.90; Mebius MJ, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-4055; Mebius MJ, 2016, EARLY HUM DEV, V103, P199, DOI 10.1016/j.earlhumdev.2016.10.001; Miller SP, 2004, ANN THORAC SURG, V77, P1698, DOI 10.1016/j.athoracsur.2003.10.084; Mulkey SB, 2015, PEDIATR NEUROL, V52, P599, DOI 10.1016/j.pediatrneurol.2015.02.026; Mulkey SB, 2014, PEDIATR NEUROL, V51, P377, DOI 10.1016/j.pediatrneurol.2014.04.008; Nakajima Y, 2006, EARLY HUM DEV, V82, P53, DOI 10.1016/j.earlhumdev.2005.07.010; Ortinau C, 2012, PEDIATR CARDIOL, V33, P1138, DOI 10.1007/s00246-012-0269-9; Park IS, 2006, PEDIATR CARDIOL, V27, P569, DOI 10.1007/s00246-004-0730-5; Ringle ML, 2016, SEMIN PERINATOL, V40, P556, DOI 10.1053/j.semperi.2016.09.008; Salameh A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111945; Sethi V, 2013, PEDIATR RES, V73, P661, DOI 10.1038/pr.2013.29; Simons J, 2012, J THORAC CARDIOV SUR, V143, P118, DOI 10.1016/j.jtcvs.2011.09.007; Sood ED, 2013, J THORAC CARDIOV SUR, V145, P438, DOI 10.1016/j.jtcvs.2012.10.033; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; ter Horst HJ, 2010, EARLY HUM DEV, V86, P759, DOI 10.1016/j.earlhumdev.2010.08.028; Toet MC, 2005, EXP BRAIN RES, V165, P343, DOI 10.1007/s00221-005-2300-3; Verhagen EA, 2015, DEV MED CHILD NEUROL, V57, P449, DOI 10.1111/dmcn.12622; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; von Rhein M, 2015, J PEDIATR-US, V167, P1259, DOI 10.1016/j.jpeds.2015.07.006; Williams IA, 2012, ULTRASOUND OBST GYN, V40, P304, DOI 10.1002/uog.11144; Williams IA, 2013, AM HEART J, V165, P544, DOI 10.1016/j.ahj.2012.11.013; Yamamoto Y, 2013, ULTRASOUND OBST GYN, V42, P294, DOI 10.1002/uog.12448; Zeng S, 2015, ULTRASOUND OBST GYN, V46, P174, DOI 10.1002/uog.14677; Zeng S, 2015, ULTRASOUND OBST GYN, V45, P649, DOI 10.1002/uog.14798	53	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230414	10.1371/journal.pone.0230414	http://dx.doi.org/10.1371/journal.pone.0230414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210445	Green Published, gold			2022-12-26	WOS:000535307600025
J	Tahtisalo, HS; Hiltunen, TP; Kentt, T; Junttila, J; Oikarinen, L; Virolainen, J; Kontula, KK; Porthan, K				Tahtisalo, Heini Sanez; Hiltunen, Timo P.; Kentt, Tuomas; Junttila, Juhani; Oikarinen, Lasse; Virolainen, Juha; Kontula, Kimmo K.; Porthan, Kimmo			Effect of four classes of antihypertensive drugs on cardiac repolarization heterogeneity: A double-blind rotational study	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; T-WAVE MORPHOLOGY; QT INTERVAL; INTERLEAD HETEROGENEITY; PREDICTIVE-VALUE; INCREASED RISK; ALL-CAUSE; DEATH; POPULATION; HYPERTENSION	Background T-wave area dispersion (TW-Ad) is a novel electrocardiographic (ECG) repolarization marker associated with sudden cardiac death. However, limited data is available on the clinical correlates of TW-Ad. In addition, there are no previous studies on cardiovascular drug effects on TW-Ad. In this study, we examined the relation between TW-Ad and left ventricular mass. We also studied the effects of four commonly used antihypertensive drugs on TW-Ad. Methods A total of 242 moderately hypertensive males (age, 51 +/- 6 years; office systolic/diastolic blood pressure during placebo, 153 +/- 14/100 +/- 8 mmHg), participating in the GENRES study, were included. Left ventricular mass index was determined by transthoracic echocardiography. Antihypertensive four-week monotherapies (a diuretic, a beta-blocker, a calcium channel blocker, and an angiotensin receptor antagonist) were administered in a randomized rotational fashion. Four-week placebo periods preceded all monotherapies. The average value of measurements (over 1700 ECGs in total) from all available placebo periods served as a reference to which measurements during each drug period were compared. Results Lower, i.e. risk-associated TW-Ad values correlated with a higher left ventricular mass index (r = - 0.14, p = 0.03). Bisoprolol, a beta-blocker, elicited a positive change in TW-Ad (p = 1.9x10(-5)), but the three other drugs had no significant effect on TW-Ad. Conclusions Our results show that TW-Ad is correlated with left ventricular mass and can be modified favorably by the use of bisoprolol, although demonstration of any effects on clinical end-points requires long-term prospective studies. Altogether, our results suggest that TW-Ad is an ECG repolarization measure of left ventricular arrhythmogenic substrate.	[Tahtisalo, Heini Sanez; Hiltunen, Timo P.; Kontula, Kimmo K.; Porthan, Kimmo] Univ Helsinki, Dept Med, Helsinki, Finland; [Tahtisalo, Heini Sanez; Hiltunen, Timo P.; Kontula, Kimmo K.] Helsinki Univ Hosp, Helsinki, Finland; [Tahtisalo, Heini Sanez; Hiltunen, Timo P.; Kontula, Kimmo K.] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Helsinki, Finland; [Kentt, Tuomas; Junttila, Juhani] Oulu Univ Hosp, Med Res Ctr Oulu, Res Unit Internal Med, Oulu, Finland; [Kentt, Tuomas; Junttila, Juhani] Univ Oulu, Oulu, Finland; [Oikarinen, Lasse; Virolainen, Juha; Porthan, Kimmo] Univ Helsinki, Heart & Lung Ctr, Div Cardiol, Helsinki, Finland; [Oikarinen, Lasse; Virolainen, Juha; Porthan, Kimmo] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Porthan, Kimmo] Minerva Fdn, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oulu; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Hiltunen, TP (corresponding author), Univ Helsinki, Dept Med, Helsinki, Finland.; Hiltunen, TP (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.; Hiltunen, TP (corresponding author), Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Helsinki, Finland.	timo.hiltunen@hus.fi	Hiltunen, Timo P/B-9436-2008	Hiltunen, Timo P/0000-0001-7011-0422; Sanez Tahtisalo, Heini/0000-0001-6896-3135; Kentta, Tuomas/0000-0003-2943-7188	Sigrid Juselius Foundation [140318, 3/3]; Finnish Foundation for Cardiovascular Research [190416KK]	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research	KKK: Sigrid Juselius Foundation. Grant number 140318#3/3. https://sigridjuselius.fi/en/KKK: Finnish Foundation for Cardiovascular Research. Grant number 190416KK. http://www.sydantutkimussaatio.fi/en/foundation The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar B, 1999, MED BIOL ENG COMPUT, V37, P574, DOI 10.1007/BF02513351; Al-Gobari M, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-52; ALGRA A, 1991, CIRCULATION, V83, P1888, DOI 10.1161/01.CIR.83.6.1888; Aro AL, 2017, EUR HEART J, V38, P3017, DOI 10.1093/eurheartj/ehx331; Devereux RB, 2002, J HYPERTENS, V20, P1445, DOI 10.1097/00004872-200207000-00033; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Deyell MW, 2015, CIRC RES, V116, P1907, DOI 10.1161/CIRCRESAHA.116.304493; Elming H, 1998, EUR HEART J, V19, P1391, DOI 10.1053/euhj.1998.1094; Frommeyer G, 2016, NAT REV CARDIOL, V13, P36, DOI 10.1038/nrcardio.2015.110; Gardner RT, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.001359; Giudicessi JR, 2018, INT J CARDIOL, V270, P214, DOI 10.1016/j.ijcard.2018.05.100; Haider AW, 1998, J AM COLL CARDIOL, V32, P1454, DOI 10.1016/S0735-1097(98)00407-0; HARTZELL HC, 1988, PROG BIOPHYS MOL BIO, V52, P165, DOI 10.1016/0079-6107(88)90014-4; Hiltunen TP, 2007, AM J HYPERTENS, V20, P311, DOI 10.1016/j.amjhyper.2006.09.006; Ishikawa J, 2019, HYPERTENS RES, V42, P541, DOI 10.1038/s41440-018-0164-8; Kahan T, 2005, HEART, V91, P250, DOI 10.1136/hrt.2004.042473; KARJALAINEN J, 1994, J AM COLL CARDIOL, V23, P1547, DOI 10.1016/0735-1097(94)90654-8; Kentta TV, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.117.005762; Kezerashvili A, 2012, CURR CARDIOL REV, V8, P77, DOI 10.2174/157340312801215764; Klingbeil AU, 2003, AM J MED, V115, P41, DOI 10.1016/S0002-9343(03)00158-X; Lip GYH, 2017, EUROPACE, V19, P891, DOI 10.1093/europace/eux091; Malik M, 2000, J CARDIOVASC ELECTR, V11, P835, DOI 10.1111/j.1540-8167.2000.tb00061.x; MORGANROTH J, 1985, PREV MED, V14, P346, DOI 10.1016/0091-7435(85)90061-1; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Noseworthy PA, 2011, CIRC-CARDIOVASC GENE, V4, P305, DOI 10.1161/CIRCGENETICS.110.959049; Panikkath R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P441, DOI 10.1161/CIRCEP.110.960658; Porthan K, 2007, J HYPERTENS, V25, P1951, DOI 10.1097/HJH.0b013e328263088b; Porthan K, 2015, J HYPERTENS, V33, P1284, DOI 10.1097/HJH.0000000000000553; Porthan K, 2013, CIRC-ARRHYTHMIA ELEC, V6, P690, DOI 10.1161/CIRCEP.113.000356; Porthan K, 2009, HEART RHYTHM, V6, P1202, DOI 10.1016/j.hrthm.2009.05.006; Porthan K, 2009, ANN MED, V41, P29, DOI 10.1080/07853890802195211; Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067; Verrier RL, 2017, HEART RHYTHM, V14, P1466, DOI 10.1016/j.hrthm.2017.06.017; Wellens HJJ, 2014, EUR HEART J, V35, P1642, DOI 10.1093/eurheartj/ehu176; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230655	10.1371/journal.pone.0230655	http://dx.doi.org/10.1371/journal.pone.0230655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208439	Green Published, Green Submitted, gold			2022-12-26	WOS:000535305100032
J	Goto, Y; Ando, T; Izumi, H; Feng, XD; Arang, N; Gilardi, M; Wang, ZY; Ando, K; Gutkind, JS				Goto, Yusuke; Ando, Toshinori; Izumi, Hiroki; Feng, Xiaodong; Arang, Nadia; Gilardi, Mara; Wang, Zhiyong; Ando, Kazuyo; Gutkind, J. Silvio			Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK-YAP signaling axis	ONCOGENE			English	Article							PROTEIN-COUPLED RECEPTORS; ANDROGEN RECEPTOR; VERTEPORFIN; PROGRESSION; ACTIVATION; EXPRESSION; THERAPY	Prostate cancer (PCa) innervation contributes to the progression of PCa. However, the precise impact of innervation on PCa cells is still poorly understood. By focusing on muscarinic receptors, which are activated by the nerve-derived neurotransmitter acetylcholine, we show that muscarinic receptors 1 and 3 (m1 and m3) are highly expressed in PCa clinical specimens compared with all other cancer types, and that amplification or gain of their corresponding encoding genes (CHRM1 and CHRM3, respectively) represent a worse prognostic factor for PCa progression free survival. Moreover, m1 and m3 gene gain or amplification is frequent in castration-resistant PCa (CRPC) compared with hormone-sensitive PCa (HSPC) specimens. This was reflected in HSPC-derived cells, which show aberrantly high expression of m1 and m3 under androgen deprivation mimicking castration and androgen receptor inhibition. We also show that pharmacological activation of m1 and m3 signaling is sufficient to induce the castration-resistant growth of PCa cells. Mechanistically, we found that m1 and m3 stimulation induces YAP activation through FAK, whose encoding gene, PTK2 is frequently amplified in CRPC cases. Pharmacological inhibition of FAK and knockdown of YAP abolished m1 and m3-induced castration-resistant growth of PCa cells. Our findings provide novel therapeutic opportunities for muscarinic-signal-driven CRPC progression by targeting the FAK-YAP signaling axis.	[Goto, Yusuke; Ando, Toshinori; Izumi, Hiroki; Feng, Xiaodong; Arang, Nadia; Gilardi, Mara; Wang, Zhiyong; Ando, Kazuyo; Gutkind, J. Silvio] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92093 USA; [Ando, Toshinori] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Feng, Xiaodong] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu 610041, Peoples R China; [Ando, Kazuyo] Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Orthodont, Hiroshima, Japan	University of California System; University of California San Diego; Hiroshima University; Sichuan University; Hiroshima University	Gutkind, JS (corresponding author), Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92093 USA.	sgutkind@health.ucsd.edu	Gutkind, J. Silvio/J-1201-2016; Ando, Toshinori/AAG-4033-2021; Ando, Toshinori/AAA-6401-2021; Gilardi, Mara/AAP-4387-2020	Gutkind, J. Silvio/0000-0002-5150-4482; Ando, Toshinori/0000-0002-3141-8173; Ando, Toshinori/0000-0002-3141-8173; Arang, Nadia/0000-0002-8167-2188	JSPS Overseas Research Fellowships; Uehara Memorial Foundation Research Fellowship; 111 Project of MOE China [B14038]; National Natural Science Foundation China [81402230, 81672677]; FIRC-AIRC fellowship for abroad (Italian Foundation for cancer research);  [S10OD021831]	JSPS Overseas Research Fellowships; Uehara Memorial Foundation Research Fellowship(Uehara Memorial Foundation); 111 Project of MOE China; National Natural Science Foundation China(National Natural Science Foundation of China (NSFC)); FIRC-AIRC fellowship for abroad (Italian Foundation for cancer research); 	YG is supported by the JSPS Overseas Research Fellowships and the Uehara Memorial Foundation Research Fellowship. XF is supported by 111 Project of MOE (B14038) China, the National Natural Science Foundation (81402230, 81672677) China. MG is supported by FIRC-AIRC fellowship for abroad (Italian Foundation for cancer research). We thank La Jolla Institute Microscopy Core Facility for professional advice and guidance, in particular Zbigniew Mikulski. This work was supported by S10OD021831. YG initiated the study; YG and JSG designed the study and experiments; YG performed the genomic analyses; YG, TA, HI, NA, KA performed in vitro experiments, YG and MG performed immunofluorescence experiments, YG, NA and JSG prepared the manuscript, XF, ZW, NA and JSG provided advice and supervised the project. All authors discussed the results and reviewed the manuscript.	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Arnold JJ, 2004, AM J OPHTHALMOL, V137, P683, DOI 10.1016/j.ajo.2003.11.059; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Baig AM, 2017, ANTI-CANCER DRUG, V28, P75, DOI 10.1097/CAD.0000000000000432; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Bluemn EG, 2017, CANCER CELL, V32, P474, DOI 10.1016/j.ccell.2017.09.003; Cao X, 2006, ONCOGENE, V25, P3719, DOI 10.1038/sj.onc.1209408; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chlenski A, 2001, PROSTATE, V47, P66; Crawford ED, 2015, J UROLOGY, V194, P1537, DOI 10.1016/j.juro.2015.06.106; Daaka Y., 2004, SCI STKE, V2004, pre2, DOI [10.1126/stke.2162004re2, DOI 10.1126/STKE.2162004RE2]; Drake JM, 2013, P NATL ACAD SCI USA, V110, pE4762, DOI 10.1073/pnas.1319948110; Feng XD, 2019, CANCER CELL, V35, P457, DOI 10.1016/j.ccell.2019.01.009; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gibault F, 2016, CURR MED CHEM, V23, P1171, DOI 10.2174/0929867323666160316125048; Grytli HH, 2014, EUR UROL, V65, P635, DOI 10.1016/j.eururo.2013.01.007; GUTKIND JS, 1991, P NATL ACAD SCI USA, V88, P4703, DOI 10.1073/pnas.88.11.4703; Inoue A, 2019, CELL, V177, P1933, DOI 10.1016/j.cell.2019.04.044; Kaye JA, 2017, PHARMACOTHERAPY, V37, P673, DOI 10.1002/phar.1932; Konstantinou EK, 2017, SCI REP-UK, V7, DOI 10.1038/srep46581; Kuser-Abali G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9126; Lee WY, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.07.019; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Luthin GR, 1997, LIFE SCI, V60, P963, DOI 10.1016/S0024-3205(97)00035-0; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Mauffrey P, 2019, NATURE, V569, P672, DOI 10.1038/s41586-019-1219-y; Mendiratta P, 2009, J CLIN ONCOL, V27, P2022, DOI 10.1200/JCO.2008.17.2882; Navone NM, 1997, CLIN CANCER RES, V3, P2493; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Patel N, 2011, PM&R, V3, P633, DOI 10.1016/j.pmrj.2011.04.024; Rayford W, 1997, PROSTATE, V30, P160, DOI 10.1002/(SICI)1097-0045(19970215)30:3<160::AID-PROS3>3.0.CO;2-Q; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Schultze A, 2010, EXPERT OPIN INV DRUG, V19, P777, DOI 10.1517/13543784.2010.489548; Schwartz S, 2015, CANCER CELL, V27, P109, DOI 10.1016/j.ccell.2014.11.008; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Slack-Davis JK, 2009, MOL CANCER THER, V8, P2470, DOI 10.1158/1535-7163.MCT-09-0262; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Wang NT, 2015, CLIN CANCER RES, V21, P4676, DOI 10.1158/1078-0432.CCR-14-3163; Wu V, 2019, J BIOL CHEM, V294, P11062, DOI 10.1074/jbc.REV119.005601; Zahalka AH, 2017, SCIENCE, V358, P321, DOI 10.1126/science.aah5072; Zhang HB, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac5418; Zhang L, 2015, MOL CELL BIOL, V35, P1350, DOI 10.1128/MCB.00102-15	44	13	14	2	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	20					4014	4027		10.1038/s41388-020-1272-x	http://dx.doi.org/10.1038/s41388-020-1272-x		MAR 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LN3GC	32205868	Green Accepted			2022-12-26	WOS:000521527500002
J	Evansen, M; Li, YW; Malcom, J				Evansen, Megan; Li, Ya-Wei; Malcom, Jacob			Same law, diverging practice: Comparative analysis of Endangered Species Act consultations by two federal agencies	PLOS ONE			English	Article							ALLOCATION; RESOURCES	Evaluating how wildlife conservation laws are implemented is critical for safeguarding biodiversity. Two agencies, the U.S. Fish and Wildlife Service and National Marine Fisheries Service (FWS and NMFS; Services collectively), are responsible for implementing the U.S. Endangered Species Act (ESA), which requires federal protection for threatened and endangered species. FWS and NMFS' comparable role for terrestrial and marine taxa, respectively, provides the opportunity to examine how implementation of the same law varies between agencies. We analyzed how the Services implement a core component of the ESA, section 7 consultations, by objectively assessing the contents of >120 consultations on sea turtle species against the requirements in the Services' consultation handbook, supplemented with in-person observations from Service biologists. Our results showed that NMFS consultations were 1.40 times as likely to have higher completeness scores than FWS consultations given the standard in the handbook. Consultations tiered from an FWS programmatic consultation inherited higher quality scores of generally more thorough programmatic consultations, indicating that programmatic consultations could increase the quality of consultations while improving efficiency. Both agencies commonly neglected to account for the effects of previous consultations and the potential for compounded effects on species. From these results, we recommend actions that can improve quality of consultation, including the use of a single database to track and integrate previously authorized harm in new analyses and the careful but more widespread use of programmatic consultations. Our study reveals several critical shortfalls in the current process of conducting ESA section 7 consultations that the Services could address to better safeguard North America's most imperiled species.	[Evansen, Megan] Sustainable Dev & Conservat Biol Grad Program, College Pk, MD 20740 USA; [Evansen, Megan; Li, Ya-Wei; Malcom, Jacob] Defenders Wildlife, Ctr Conservat Innovat, Washington, DC 20036 USA; [Li, Ya-Wei] Environm Policy Innovat Ctr, Washington, DC USA		Evansen, M (corresponding author), Sustainable Dev & Conservat Biol Grad Program, College Pk, MD 20740 USA.; Evansen, M (corresponding author), Defenders Wildlife, Ctr Conservat Innovat, Washington, DC 20036 USA.	mevansen@defenders.org		Evansen, Meg/0000-0002-5734-5259				Beck LE, 2013, AGENCY PRACTICES JUD; Burnham K.P, 2002, PRACTICAL INFORM THE; Christensen R.H.B., 2015, ORDINAL REGRESSION M, P6; Christensen RHB., 2015, R PACKAGE VERSION, V28, P2015; Converse SJ, 2011, BIOL CONSERV, V144, P319, DOI 10.1016/j.biocon.2010.09.009; Gosnell H, 2001, NAT RESOUR J, V41, P561; Government of Manitoba, 2022, END SPEC EC ACT CCSM; Kleinbaum DG, 2005, LINEAR REGRESSION SE, V21, P22; Lowell N, 2016, BIOL CONSERV, V196, P53, DOI 10.1016/j.biocon.2016.02.003; Malcom JW, 2015, P NATL ACAD SCI USA, V112, P15844, DOI 10.1073/pnas.1516938112; Mazerolle M., 2013, R PACKAGE VERSION, V1, P35; McCullagh P, 1989, GEN LINEAR MODELS; National Marine Fisheries Service (NMFS), 2014, FY 2014 BUDG SUMM; National Marine Fisheries Service (NMFS), 2017, FY 2017 BUDG SUMM; Owen D., 2012, FLA LAW REV, V64, P141; Restani M, 2002, BIOSCIENCE, V52, P169, DOI 10.1641/0006-3568(2002)052[0169:FEBNAP]2.0.CO;2; Schwartz MW, 2008, ANNU REV ECOL EVOL S, V39, P279, DOI 10.1146/annurev.ecolsys.39.110707.173538; Team R.C, R LANG ENV STAT COMP; U.S. Fish and Wildlife Service, LIST SPEC SUMM BOXS; U.S. Fish and Wildlife Service (USFWS), 2012, FED REG, V77; U.S. Fish and Wildlife Service (USFWS), 2017, BUDG JUST PERF INF F; US Fish and Wildlife Service, 1998, END SPEC CONS HDB; USFWS (U.S. Fish and Wildlife Service), 2009, THREAT END SPEC SYST	23	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0230477	10.1371/journal.pone.0230477	http://dx.doi.org/10.1371/journal.pone.0230477			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196537	Green Published, gold, Green Submitted			2022-12-26	WOS:000535303100030
J	Menary, J; Hobbs, M; de Albuquerque, SM; Pacho, A; Drake, PMW; Prendiville, A; Ma, JKC; Fuller, SS				Menary, Jonathan; Hobbs, Matthew; de Albuquerque, Sara Mesquita; Pacho, Agata; Drake, Pascal M. W.; Prendiville, Alison; Ma, Julian K-C; Fuller, Sebastian S.			Shotguns vs Lasers: Identifying barriers and facilitators to scaling-up plant molecular farming for high-value health products	PLOS ONE			English	Article							LOCK-IN; DEFICIT MODEL; PHARMACEUTICALS; OPPORTUNITIES; ACCEPTANCE; EXPRESSION; SCIENCE; BIOTECHNOLOGY; NANOPARTICLES; TRAJECTORIES	Plant molecular farming (PMF) is a convenient and cost-effective way to produce high-value recombinant proteins that can be used in the production of a range of health products, from pharmaceutical therapeutics to cosmetic products. New plant breeding techniques (NPBTs) provide a means to enhance PMF systems more quickly and with greater precision than ever before. However, the feasibility, regulatory standing and social acceptability of both PMF and NPBTs are in question. This paper explores the perceptions of key stakeholders on two European Union (EU) Horizon 2020 programmes-Pharma-Factory and Newcotiana-towards the barriers and facilitators of PMF and NPBTs in Europe. One-on-one qualitative interviews were undertaken with N = 20 individuals involved in one or both of the two projects at 16 institutions in seven countries (Belgium, France, Germany, Italy, Israel, Spain and the UK). The findings indicate that the current EU regulatory environment and the perception of the public towards biotechnology are seen as the main barriers to scaling-up PMF and NPBTs. Competition from existing systems and the lack of plant-specific regulations likewise present challenges for PMF developing beyond its current niche. However, respondents felt that the communication of the benefits and purpose of NPBT PMF could provide a platform for improving the social acceptance of genetic modification. The importance of the media in this process was highlighted. This article also uses the multi-level perspective to explore the ways in which NPBTs are being legitimated by interested parties and the systemic factors that have shaped and are continuing to shape the development of PMF in Europe.	[Menary, Jonathan; Hobbs, Matthew; de Albuquerque, Sara Mesquita; Pacho, Agata; Drake, Pascal M. W.; Ma, Julian K-C; Fuller, Sebastian S.] St Georges Univ London, Inst Infect & Immun, London, England; [Prendiville, Alison] Univ Arts, London Coll Commun, London, England	St Georges University London; University of Arts London	Menary, J (corresponding author), St Georges Univ London, Inst Infect & Immun, London, England.	j.menary@lancaster.ac.uk	Fuller, Sebastian Suarez/W-4570-2019	Fuller, Sebastian Suarez/0000-0002-9284-6630; Drake, Pascal/0000-0002-6181-0600; Menary, Jonathan/0000-0003-0156-0619	Horizon 2020 grant: Pharma-Factory; Horizon 2020 grant: Newcotiana; Newcotiana; Pharma-Factory	Horizon 2020 grant: Pharma-Factory; Horizon 2020 grant: Newcotiana; Newcotiana; Pharma-Factory	This study was funded by two Horizon 2020 grants: Pharma-Factory (https://pharmafactory.org) and Newcotiana (https://newcotiana.org/).JM is funded by Newcotiana, JKCM and SSF by both grants and remaining authors by Pharma-Factory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arntzen C, 2015, PLANT BIOTECHNOL J, V13, P1013, DOI 10.1111/pbi.12460; ARTHUR WB, 1989, ECON J, V99, P116, DOI 10.2307/2234208; Besley JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175643; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Breithaupt H, 2004, EMBO REP, V5, P1031, DOI 10.1038/sj.embor.7400289; Budzianowski Jaromir, 2015, Przegl Lek, V72, P567; Buiatti M, 2013, GENES NUTR, V8, P255, DOI 10.1007/s12263-012-0316-4; Carroll D, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0812-0; Connor M, 2010, SCI COMMUN, V32, P514, DOI 10.1177/1075547009358919; Custers R, 2017, EMERG TOP LIFE SCI, V1, P221, DOI 10.1042/ETLS20170019; Dederer H.-G., 2016, CONT ISSUES ENV LAW, P139, DOI DOI 10.1007/978-4-431-55435-68; Dhama K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01803; Dolfsma W, 2009, TECHNOL FORECAST SOC, V76, P932, DOI 10.1016/j.techfore.2009.02.004; Duensing N, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00079; Dykman L, 2012, CHEM SOC REV, V41, P2256, DOI 10.1039/c1cs15166e; ECKERSTORFER MF, 2019, FRONT BIOENG BIOTECH, V7, DOI DOI 10.3389/FBIEE.2019.00026/FULI; Einsiedel E. F., 2005, AgBioForum, V8, P26; Eriksson D, 2016, FRONT PLANT SCI, V7, P1; Eriksson D, 2018, TRENDS BIOTECHNOL, V36, P1100, DOI 10.1016/j.tibtech.2018.05.001; European Commission, 2018, SUST BIOEC EUR STREN, DOI DOI 10.2777/478385; Faye L, 2010, PLANT BIOTECHNOL J, V8, P525, DOI 10.1111/j.1467-7652.2010.00521.x; Fischer R, 2013, CURR PHARM DESIGN, V19, P5471, DOI 10.2174/1381612811319310002; Fischer R, 2012, BIOTECHNOL ADV, V30, P434, DOI 10.1016/j.biotechadv.2011.08.007; Gaskell G, 2011, NAT BIOTECHNOL, V29, P113, DOI 10.1038/nbt.1771; Geels FW, 2007, RES POLICY, V36, P399, DOI 10.1016/j.respol.2007.01.003; Geels FW, 2010, RES POLICY, V39, P495, DOI 10.1016/j.respol.2010.01.022; Gerlach JQ, 2010, TRANSGENIC CROP PLANTS: VOL 2, P269, DOI 10.1007/978-3-642-04812-8_7; Hartley S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002453; Hartung F, 2014, PLANT J, V78, P742, DOI 10.1111/tpj.12413; He Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157034; HIATT A, 1989, NATURE, V342, P76, DOI 10.1038/342076a0; Horn ME, 2004, PLANT CELL REP, V22, P711, DOI 10.1007/s00299-004-0767-1; Jansing J, 2019, PLANT BIOTECHNOL J, V17, P350, DOI 10.1111/pbi.12981; Jiang L, 2018, MOL PHARMING APPL CH, P1, DOI DOI 10.1002/9781118801512.CH1; Knight A. J., 2006, AgBioForum, V9, P121; Lassoued R, 2019, TRANSGENIC RES, V28, P247, DOI 10.1007/s11248-019-00118-5; LIEBOWITZ SJ, 1995, J LAW ECON ORGAN, V11, P205; Lucht JM, 2015, VIRUSES-BASEL, V7, P4254, DOI 10.3390/v7082819; Ma JKC, 2005, EMBO REP, V6, P593, DOI 10.1038/sj.embor.7400470; Ma JKC, 2013, PLANT BIOTECHNOL J, V11, P1029, DOI 10.1111/pbi.12127; Malyska A, 2016, TRENDS BIOTECHNOL, V34, P530, DOI 10.1016/j.tibtech.2016.03.005; MASON HS, 1992, P NATL ACAD SCI USA, V89, P11745, DOI 10.1073/pnas.89.24.11745; Mason J., 2004, SAGE ENCY QUALITATIV, P518; Mason J., 1996, QUALITATIVE RES; MERCX S, 2017, FRONT PLANT SCI, V8, DOI DOI 10.3389/FIDS.2017.00403/FULL; Mirzaei H, 2017, CERAM INT, V43, P907, DOI 10.1016/j.ceramint.2016.10.051; Mitha F., 2019, DRUG DISCOV TODAY; Mohr Philip, 2007, Biotechnology Journal, V2, P1169, DOI 10.1002/biot.200700105; Moses T, 2017, J EXP BOT, V68, P4009, DOI 10.1093/jxb/erx268; Murad S, 2020, CURR OPIN BIOTECH, V61, P53, DOI 10.1016/j.copbio.2019.10.005; Myskja BK., 2015, KNOW YOUR FOOD FOOD, P95; Nevitt J., 2006, AgBioForum, V9, P104; Obembe OO, 2011, BIOTECHNOL ADV, V29, P210, DOI 10.1016/j.biotechadv.2010.11.004; Palys T., 2008, SAGE ENCY QUALITATIV, P697, DOI DOI 10.4135/9781412963909.N349; Paul M, 2011, HUM VACCINES, V7, P375, DOI 10.4161/HV.7.3.14456; Pei L, 2019, CURR OPIN BIOTECH, V56, P43, DOI 10.1016/j.copbio.2018.08.012; Pollock CJ, 2016, TRENDS BIOTECHNOL, V34, P604, DOI 10.1016/j.tibtech.2016.05.002; Ricroch AE, 2016, EMBO REP, V17, P1365, DOI 10.15252/embr.201643099; Ritchie J., 2010, QUALITATIVE RES PRAC; Rousseliere D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183213; Sainsbury F, 2014, CURR OPIN PLANT BIOL, V19, P1, DOI 10.1016/j.pbi.2014.02.003; Schaart JG, 2016, TRENDS PLANT SCI, V21, P438, DOI 10.1016/j.tplants.2015.11.006; Schenk MF, 2011, FOOD QUAL PREFER, V22, P83, DOI 10.1016/j.foodqual.2010.08.003; Schleissing S, 2019, TTN STUD SCH INST TE, V7, P9; SIJMONS PC, 1990, BIO-TECHNOL, V8, P217, DOI 10.1038/nbt0390-217; Simis MJ, 2016, PUBLIC UNDERST SCI, V25, P400, DOI 10.1177/0963662516629749; Sparrow P, 2013, CURR PHARM DESIGN, V19, P1; Spok A, 2008, TRENDS BIOTECHNOL, V26, P506, DOI 10.1016/j.tibtech.2008.05.007; Sprink T, 2016, PLANT CELL REP, V35, P1493, DOI 10.1007/s00299-016-1990-2; Srivastava A, 2009, FRAMEWORK ANAL QUALI, DOI DOI 10.1002/JIA2.25572; Stilgoe J, 2013, RES POLICY, V42, P1568, DOI 10.1016/j.respol.2013.05.008; Sturgis P, 2004, PUBLIC UNDERST SCI, V13, P55, DOI 10.1177/0963662504042690; Teh AYH, 2014, PLANT BIOTECHNOL J, V12, P300, DOI 10.1111/pbi.12137; Tomei J, 2016, LAND USE POLICY, V56, P320, DOI 10.1016/j.landusepol.2015.11.015; Tremblay R, 2010, BIOTECHNOL ADV, V28, P214, DOI 10.1016/j.biotechadv.2009.11.008; Tschofen M, 2016, ANNU REV ANAL CHEM, V9, P271, DOI 10.1146/annurev-anchem-071015-041706; Twyman Richard M, 2005, Expert Opin Emerg Drugs, V10, P185, DOI 10.1517/14728214.10.1.185; Twyman RM, 2003, TRENDS BIOTECHNOL, V21, P570, DOI 10.1016/j.tibtech.2003.10.002; van Dolleweerd CJ, 2014, J INFECT DIS, V210, P200, DOI 10.1093/infdis/jiu085; Vilella-Vila M., 2005, International Journal of Consumer Studies, V29, P108, DOI 10.1111/j.1470-6431.2004.00425.x; Vilella-Vila M, 2008, J SOCIO-ECON, V37, P2095, DOI DOI 10.1016/j.socec.2008.04.006; Waltz E, 2018, NAT BIOTECHNOL, V36, P6, DOI 10.1038/nbt0118-6b; Waltz E, 2016, NATURE, V532, P293, DOI 10.1038/nature.2016.19754; Wield D, 2010, J AGRAR CHANGE, V10, P342, DOI 10.1111/j.1471-0366.2010.00274.x; Wight AJ, 2018, NATURE, V563, P15, DOI 10.1038/d41586-018-07166-7; Xu JF, 2014, PHARM BIOPROCESS, V2, P499, DOI 10.4155/PBP.14.32; Yao J, 2015, INT J MOL SCI, V16, P28549, DOI 10.3390/ijms161226122; Yonekura-Sakakibara K, 2006, BIOTECHNOL LETT, V28, P1983, DOI 10.1007/s10529-006-9194-4; Zimny T, 2019, NEW BIOTECHNOL, V51, P49, DOI 10.1016/j.nbt.2019.02.003	89	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0229952	10.1371/journal.pone.0229952	http://dx.doi.org/10.1371/journal.pone.0229952			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9FU	32196508	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000535303100015
J	Bradley, MC; Yang, KT; Fernandez-del-Rio, L; Ngo, J; Ayer, A; Tsui, HS; Novales, NA; Stocker, R; Shirihai, OS; Barros, MH; Clarke, CF				Bradley, Michelle C.; Yang, Krista; Fernandez-del-Rio, Lucia; Ngo, Jennifer; Ayer, Anita; Tsui, Hui S.; Novales, Noelle Alexa; Stocker, Roland; Shirihai, Orian S.; Barros, Mario H.; Clarke, Catherine F.			COQ11 deletion mitigates respiratory deficiency caused by mutations in the gene encoding the coenzyme Q chaperone protein Coq10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquinone; mitochondrial metabolism; Saccharomyces cerevisiae; lipid; yeast; coenzyme Q; CoQ synthome; Coq10; Coq11	SACCHAROMYCES-CEREVISIAE; C-METHYLTRANSFERASE; ELECTRON-TRANSPORT; YEAST; MITOCHONDRIA; POLYPEPTIDE; COMPLEX; KINASE; MECHANISMS; SUPPLEMENTATION	Coenzyme Q (Q(n)) is a vital lipid component of the electron transport chain that functions in cellular energy metabolism and as a membrane antioxidant. In the yeast Saccharomyces cerevisiae, coq1?coq9 deletion mutants are respiratory-incompetent, sensitive to lipid peroxidation stress, and unable to synthesize Q(6). The yeast coq10 deletion mutant is also respiratory-deficient and sensitive to lipid peroxidation, yet it continues to produce Q(6) at an impaired rate. Thus, Coq10 is required for the function of Q(6) in respiration and as an antioxidant and is believed to chaperone Q(6) from its site of synthesis to the respiratory complexes. In several fungi, Coq10 is encoded as a fusion polypeptide with Coq11, a recently identified protein of unknown function required for efficient Q(6) biosynthesis. Because ?fused? proteins are often involved in similar biochemical pathways, here we examined the putative functional relationship between Coq10 and Coq11 in yeast. We used plate growth and Seahorse assays and LC-MS/MS analysis to show that COQ11 deletion rescues respiratory deficiency, sensitivity to lipid peroxidation, and decreased Q(6) biosynthesis of the coq10? mutant. Additionally, immunoblotting indicated that yeast coq11? mutants accumulate increased amounts of certain Coq polypeptides and display a stabilized CoQ synthome. These effects suggest that Coq11 modulates Q(6) biosynthesis and that its absence increases mitochondrial Q(6) content in the coq10?coq11? double mutant. This augmented mitochondrial Q(6) content counteracts the respiratory deficiency and lipid peroxidation sensitivity phenotypes of the coq10? mutant. This study further clarifies the intricate connection between Q(6) biosynthesis, trafficking, and function in mitochondrial metabolism.	[Bradley, Michelle C.; Yang, Krista; Fernandez-del-Rio, Lucia; Ngo, Jennifer; Tsui, Hui S.; Novales, Noelle Alexa; Clarke, Catherine F.] Univ Calif Los Angeles, Dept Chem & Biochem, Inst Mol Biol, Los Angeles, CA 90095 USA; [Ngo, Jennifer; Shirihai, Orian S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol & Med, Los Angeles, CA 90095 USA; [Ayer, Anita; Stocker, Roland] Victor Chang Cardiac Res Inst, Vasc Biol Div, Sydney, NSW 2010, Australia; [Ayer, Anita; Stocker, Roland] Univ New South Wales Med, St Vincents Clin Sch, Sydney, NSW 2050, Australia; [Barros, Mario H.] Univ Sao Paulo, Dept Microbiol, BR-05508900 Sao Paulo, Brazil	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Universidade de Sao Paulo	Clarke, CF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Inst Mol Biol, Los Angeles, CA 90095 USA.	cathy@chem.ucla.edu	del Rio, Lucia Fernandez/AAV-8233-2021; Stocker, Roland/AAV-4489-2021; Novales, Noelle Alexa/AAV-2010-2020; Barros, Mario H/B-8118-2012; Barros, Mario/Q-6358-2019	del Rio, Lucia Fernandez/0000-0001-5657-2700; Barros, Mario/0000-0003-2977-9815; Novales, Noelle Alexa/0000-0002-4903-2738; Ngo, Jennifer/0000-0002-5829-6866; Ayer, Anita/0000-0002-7073-2835	National Science Foundation [MCB-1330803]; National Institutes of Health [T32GM007185]; Ruth L. Kirschstein National Service; Whitcome Individual Predoctoral Fellowship; UCLA Summer Undergraduate Research Fellowship, Department of Chemistry and Biochemistry; Fundacao de Amparo a Pesquisa de Sao Paulo-FAPESP [2013/09482-8, 2013/07937-8]; Gates Millennium Scholars Fellowship; Eugene V. Cota Robles Fellowship	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitcome Individual Predoctoral Fellowship; UCLA Summer Undergraduate Research Fellowship, Department of Chemistry and Biochemistry; Fundacao de Amparo a Pesquisa de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Gates Millennium Scholars Fellowship; Eugene V. Cota Robles Fellowship	This work was supported by National Science Foundation Grant MCB-1330803 (to C. F. C.), National Institutes of Health Grant T32GM007185 (to H. S. T. and M. C. B.) Ruth L. Kirschstein National Service (to M. C. B. and H. S. T.), the Whitcome Individual Predoctoral Fellowship (to M. C. B.), UCLA Summer Undergraduate Research Fellowship, Department of Chemistry and Biochemistry (to K. Y.), Fundacao de Amparo a Pesquisa de Sao Paulo-FAPESP 2013/09482-8 and 2013/07937-8 (to M. H. B.), Gates Millennium Scholars Fellowship (to J. N.), and the Eugene V. Cota Robles Fellowship (to J. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcazar-Fabra M, 2018, ESSAYS BIOCHEM, V62, P377, DOI 10.1042/EBC20170107; Allan CM, 2015, J BIOL CHEM, V290, P7517, DOI 10.1074/jbc.M114.633131; Allan CM, 2013, BBA-MOL CELL BIOL L, V1831, P776, DOI 10.1016/j.bbalip.2012.12.007; Awad AM, 2018, ESSAYS BIOCHEM, V62, P361, DOI 10.1042/EBC20170106; Barkovich RJ, 1997, J BIOL CHEM, V272, P9182; Barros MH, 2017, MOL BIOL CELL, V28, P1426, DOI 10.1091/mbc.E16-11-0775; Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200; Brachmann CB, 1998, YEAST, V14, P115; CHEN WJ, 1987, CELL, V49, P651, DOI 10.1016/0092-8674(87)90541-1; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Cui TZ, 2009, FEBS J, V276, P748, DOI 10.1111/j.1742-4658.2008.06821.x; Desbats MA, 2015, J INHERIT METAB DIS, V38, P145, DOI 10.1007/s10545-014-9749-9; Eisenberg-Bord Michal, 2019, Contact (Thousand Oaks), V2, p2515256418825409, DOI 10.1177/2515256418825409; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; Fontanesi F, 2013, IUBMB LIFE, V65, P397, DOI 10.1002/iub.1156; FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Gonzalez-Hunt Claudia P, 2016, Curr Protoc Toxicol, V67, DOI 10.1002/0471140856.tx2011s67; Guaras A, 2016, CELL REP, V15, P197, DOI 10.1016/j.celrep.2016.03.009; Guo X, 2017, CELL REP, V18, P307, DOI 10.1016/j.celrep.2016.12.049; He CWH, 2014, BBA-MOL CELL BIOL L, V1841, P630, DOI 10.1016/j.bbalip.2013.12.017; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Hill S, 2012, FREE RADICAL BIO MED, V53, P893, DOI 10.1016/j.freeradbiomed.2012.06.004; Hill S, 2011, FREE RADICAL BIO MED, V50, P130, DOI 10.1016/j.freeradbiomed.2010.10.690; Hsieh EJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P19, DOI 10.1016/j.abb.2007.02.016; Kawamukai M, 2016, BIOSCI BIOTECH BIOCH, V80, P23, DOI 10.1080/09168451.2015.1065172; Kehrein K, 2015, ONCOTARGET, V6, P16806, DOI 10.18632/oncotarget.4783; Kopec J, 2011, ACTA CRYSTALLOGR F, V67, P1184, DOI 10.1107/S174430911102923X; Marbois B, 2005, J BIOL CHEM, V280, P20231, DOI 10.1074/jbc.M501315200; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582; Murley A, 2016, MOL CELL, V61, P648, DOI 10.1016/j.molcel.2016.01.031; Nguyen TPT, 2014, BBA-MOL CELL BIOL L, V1841, P1628, DOI 10.1016/j.bbalip.2014.08.007; OHASHI A, 1982, J BIOL CHEM, V257, P3042; Okada K, 1996, BBA-LIPID LIPID MET, V1302, P217, DOI 10.1016/0005-2760(96)00064-1; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Perocchi F, 2006, PLOS GENET, V2, P1612, DOI 10.1371/journal.pgen.0020170; PRYOR WA, 1990, FREE RADICAL BIO MED, V8, P541, DOI 10.1016/0891-5849(90)90153-A; READING DS, 1989, NATURE, V337, P655, DOI 10.1038/337655a0; Reidenbach AG, 2018, CELL CHEM BIOL, V25, P154, DOI 10.1016/j.chembiol.2017.11.001; Renaux A, 2018, NUCLEIC ACIDS RES, V46, P2699, DOI 10.1093/nar/gky092; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Santos Janine H, 2002, Methods Mol Biol, V197, P159, DOI 10.1385/1-59259-284-8:159; Santos-Ocana C, 2002, J BIOL CHEM, V277, P10973, DOI 10.1074/jbc.M112222200; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Scialo F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009; Shen Y, 2005, PROTEINS, V58, P747, DOI 10.1002/prot.20365; SIKORSKI RS, 1989, GENETICS, V122, P19; Stefely JA, 2017, TRENDS BIOCHEM SCI, V42, P824, DOI 10.1016/j.tibs.2017.06.008; Stefely JA, 2015, MOL CELL, V57, P83, DOI 10.1016/j.molcel.2014.11.002; Stoldt S, 2018, NAT CELL BIOL, V20, P528, DOI 10.1038/s41556-018-0090-7; Subramanian K, 2019, J CELL BIOL, V218, P1352, DOI 10.1083/jcb.201808044; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Tran UC, 2006, J BIOL CHEM, V281, P16401, DOI 10.1074/jbc.M513267200; Tsui HS, 2019, J LIPID RES, V60, P1293, DOI 10.1194/jlr.M093534; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; van den Bosch BJC, 2012, J MED GENET, V49, P10, DOI 10.1136/jmedgenet-2011-100466; Vogtle FN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00359-0; Wang Y, 2019, TRENDS ENDOCRIN MET, V30, P929, DOI 10.1016/j.tem.2019.08.009; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xie LTX, 2012, J BIOL CHEM, V287, P23571, DOI 10.1074/jbc.M112.360354; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z; Zhang TT, 2011, YEAST, V28, P795, DOI 10.1002/yea.1905	71	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6023	6042		10.1074/jbc.RA119.012420	http://dx.doi.org/10.1074/jbc.RA119.012420			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32205446	Green Published, hybrid			2022-12-26	WOS:000531417300015
J	Baldwin, MJ; Nagra, NS; Merritt, N; Rees, JL; Carr, AJ; Rangan, A; Thomas, M; Beard, DJ; Cooper, C; Kottam, L; Cook, JA				Baldwin, M. J.; Nagra, N. S.; Merritt, N.; Rees, J. L.; Carr, A. J.; Rangan, A.; Thomas, M.; Beard, D. J.; Cooper, C.; Kottam, L.; Cook, J. A.			The use of a patch to augment rotator cuff surgery - A survey of UK shoulder and elbow surgeons	PLOS ONE			English	Article							REPAIR	Background Rotator cuff tears are a common cause of shoulder pain and can result in prolonged periods of pain, disability and absence from work. Rotator cuff repair surgery is increasingly used in an attempt to resolve symptoms but has failure rates of around 40%. There is a pressing need to improve the outcome of rotator cuff repairs. Patch augmentation increasingly being used within the NHS in an attempt to reduce repair failures. The aim of this survey was to determine current UK practice and opinion relating to the factors that influence choice of patch, current patient selection and willingness to assist with generation of improved evidence. Methods An online survey was sent to the surgeon members of the British Elbow and Shoulder Society (BESS). Questions covered respondent demographics, experience with patches, indications for patch augmentation and willingness to be involved in a randomised trial of patch augmented rotator cuff surgery. Results The response rate was 105/550 (19%). 58% of respondents had used a patch to augment rotator cuff surgery. 70% of patch users had undertaken an augmented repair within the last 6 months. A wide surgical experience in augmentation was reported (ranging 1 to 200 implants used). However, most surgeons reported low volume usage, with a median of 5 rotator cuff augmentation procedures performed. At least 10 different products had been used. Most of the patches used were constructed from human decellularised dermis tissue, although porcine derived and synthetic based patches had also been used. Only 3-5% stated they would undertake an augmented repair for small tears across ages, whereas 28-40% and 19-59% would do so for large or massive tears respectively. When assessing patient suitability, patient age seemed relevant only for those with large and massive tears. Half of the surgeons reported an interest in taking part in a randomised controlled trial (RCT) evaluating the role of patch augmentation for rotator cuff surgery, with a further 22% of respondent's undecided. Conclusions A variety of patches have been used by surgeons to augment rotator cuff repair with a wide range of operator experience. There was substantial uncertainty about which patch to use and differing views on which patients were most suitable. There is a clear need for robust clinical evaluation and further research in this area.	[Baldwin, M. J.; Nagra, N. S.; Merritt, N.; Rees, J. L.; Carr, A. J.; Rangan, A.; Thomas, M.; Beard, D. J.; Cooper, C.; Cook, J. A.] Univ Oxford, Botnar Inst Musculoskeletal Sci, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Rangan, A.; Kottam, L.] South Tees Hosp NHS Fdn Trust, James Cook Univ Hosp, Middlesbrough, Cleveland, England	University of Oxford; James Cook University Hospital	Baldwin, MJ (corresponding author), Univ Oxford, Botnar Inst Musculoskeletal Sci, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.	matthew.baldwin@ndorms.ox.ac.uk	Cook, Jonathan/D-3648-2015	Cook, Jonathan/0000-0002-4156-6989; Baldwin, Mathew/0000-0002-8790-9975; Rees, Jonathan/0000-0003-1818-5800; Beard, David/0000-0001-7884-6389; Rangan, Amar/0000-0002-5452-8578	NIHR Health Technology Assessment Programme [15/103/03]; NIHR Oxford Biomedical Research Centre [NIHR-BRC-10 1215-20008]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; MRC [MR/R015651/1] Funding Source: UKRI	NIHR Health Technology Assessment Programme(National Institute for Health Research (NIHR)); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank all the BESS members who kindly completed this survey.PARCS is funded by the NIHR Health Technology Assessment Programme (15/103/03). JAC is partly funded by the NIHR Oxford Biomedical Research Centre (NIHR-BRC-10 1215-20008). The research was also supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funding body had no role in the design of the study and the collection, analysis and interpretation of data; in writing the manuscript; or in the decision to submit manuscripts for publication.	Barber FA, 2018, ARTHROSCOPY, V34, P38, DOI 10.1016/j.arthro.2017.07.013; Carr A, 2017, BONE JOINT J, V99B, P107, DOI 10.1302/0301-620X.99B1.BJJ-2016-0424.R1; Cook J., PARCS NUFFIELD DEP O; Ferguson DP, 2016, AM J SPORT MED, V44, P2984, DOI 10.1177/0363546515624463; Judge A, 2014, BONE JOINT J, V96B, P70, DOI 10.1302/0301-620X.96B1.32556; OZAKI J, 1986, CLIN ORTHOP RELAT R, P173; Rashid MS, 2017, ACTA ORTHOP, V88, P606, DOI 10.1080/17453674.2017.1370844; SHER JS, 1995, J BONE JOINT SURG AM, V77A, P10, DOI 10.2106/00004623-199501000-00002; Walton JR, 2007, J BONE JOINT SURG AM, V89A, P786, DOI 10.2106/JBJS.F.00315; Yamamoto A, 2010, J SHOULDER ELB SURG, V19, P116, DOI 10.1016/j.jse.2009.04.006	10	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230235	10.1371/journal.pone.0230235	http://dx.doi.org/10.1371/journal.pone.0230235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240199	Green Published, Green Submitted, gold			2022-12-26	WOS:000535945000021
J	Bohari, R; Hin, CJ; Matusop, A; Abdullah, MR; Ney, TG; Benjamin, S; Lim, LH				Bohari, Rezal; Hin, Chong Jin; Matusop, Asmad; Abdullah, Muhamad Rais; Ney, Teoh Guat; Benjamin, Seleena; Lim, Lee Han			Wide area spray of bacterial larvicide, Bacillus thuringiensis israelensis strain AM65-52, integrated in the national vector control program impacts dengue transmission in an urban township in Sibu district, Sarawak, Malaysia	PLOS ONE			English	Article							AEDES-AEGYPTI L.; ALBOPICTUS; MOSQUITO; POPULATIONS; CONTAINERS; RESISTANCE; COST; CITY; SITE	Several sites, Z-7L, Z-5 and Z-14, in Sibu district, Sarawak, Malaysia, experienced intense dengue transmission in 2014 that continued into 2015. A pilot study with Bacillus thuringiensis israelensis (Bti) to control Aedes aegypti (L.) and Ae. albopictus (Skuse) was evaluated in Z-7L, a densely populated site of 12 ha. Bti treatments were conducted weekly from epidemiology week (EW) 24/2015 for 4 weeks, followed by fortnight treatments for 2 months, in addition to the routine control activities. Bti was directly introduced into potable containers and the outdoor artificial and natural containers were treated via a wide area spray application method using a backpack mister. Aedes indices significantly reduced during the treatment and post treatment phases, compared to the control site, Z-5 (p<0.05). A 51 fold reduction in the incidence rate per 100,000 population (IR) was observed, with one case in 25 weeks (EW 29-52). In Z-5 and Z-14, control sites, a 6 fold reduction in the IR was observed from EW 29-52. However, almost every week there were dengue cases in Z-14 and until EW 44 in Z-5. In 2016, dengue cases resurfaced in Z-7L from EW 4. Intensive routine control activities were conducted, but the IR continued to escalate. The wide area Bti spray misting of the outdoor containers was then included from EW 27 on fortnight intervals. A 6 fold reduction in IR was observed in the Bti treatment phase (EW 32-52) with no successive weekly cases after EW 37. However, in the control sites, there were dengue cases throughout the year from EW 1-52, particularly in Z-14. We feel that the wide area Bti spray application method is an integral component in the control program, in conjunction with other control measures carried out, to suppress the vector population in outdoor cryptic containers and to interrupt the disease transmission.	[Bohari, Rezal; Abdullah, Muhamad Rais] Sibu Div Hlth Off, Sarawak, Malaysia; [Hin, Chong Jin; Matusop, Asmad] Sarawak State Hlth Dept, Sarawak, Malaysia; [Ney, Teoh Guat; Lim, Lee Han] Inst Med Res, Med Entomol Unit, Kuala Lumpur, Malaysia; [Benjamin, Seleena] Valent BioSci LLC, Kuala Lumpur, Malaysia	Kementerian Kesihatan Malaysia	Bohari, R (corresponding author), Sibu Div Hlth Off, Sarawak, Malaysia.	rezalbohari@gmail.com			Ministry of Health (MOH), Malaysia; Valent BioSciences LLC (VBC)	Ministry of Health (MOH), Malaysia; Valent BioSciences LLC (VBC)	The study was mainly funded by the Ministry of Health (MOH), Malaysia, in the form of authors' and staff salaries and travel expenses for field activities where relevant, except for one of the authors, Seleena Benjamin, whose salary and related expenses were supported by Valent BioSciences LLC (VBC). The field-laboratory equipment and materials for the study were supplied by the MOH Malaysia. The product, VectoBac WG, was purchased by the MOH Malaysia for the control of mosquito larvae and supplied to all the States in Malaysia. However, during the pilot project in 2015, VBC supported the supply of 3 back pack sprayers and the VectoBac WG product. In 2016 and after the product is from the MOH, Malaysia. The execution of the field work and collection of data were conducted by the MOH Malaysia staff who are from the Divisional Health Office, Sibu and the State Health Department, Kuching, Sarawak. The staff from the Institute For Medical Research, Kuala Lumpur, MOH Malaysia also participated in these activities. The study design, training of the field MOH Malaysia staff, data analysis and preparation of the manuscript were conducted by the MOH Malaysia staff in collaboration with VBC.	Amelia-Yap ZH, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2899-0; Ben-Dov E, 2014, TOXINS, V6, P1222, DOI 10.3390/toxins6041222; Benjamin S, 1999, J VECTOR ECOL, V24, P216; Centers for Disease Control and Prevention (CDC), MOSQ BORN TRANSM DEN; CHEONG W H, 1978, Asian Journal of Infectious Diseases, V2, P136; Institute for Public Health. National health and morbidity survey, 2011, NAT HLTH MORB SURV 2, V1; Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2; Jacups SP, 2013, AM J TROP MED HYG, V88, P490, DOI 10.4269/ajtmh.12-0385; Lam PHY, 2010, SE ASIAN J TROP MED, V41, P1071; Lau KW, 2015, WORLD ACAD SCI ENG T, V9; Lee H.L., 1990, Tropical Biomedicine, V7, P185; Lee H. L., 1992, Mosquito Borne Diseases Bulletin, V9, P9; Lee H. L., 1991, Tropical Biomedicine, V8, P157; Lee H. L., 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P601; Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1; Loke SR, 2010, TROP BIOMED, V27, P493; Lum LCS, 2008, AM J TROP MED HYG, V78, P862, DOI 10.4269/ajtmh.2008.78.862; Matusop A, 2015, 7 SAR HLTH DEP RES D; Mia MS, 2013, ASIAN PAC J TROP MED, V6, P462, DOI 10.1016/S1995-7645(13)60075-9; Miami-Dade County, 2017, MIAMI DADE COUNTY SO; Ministry of Health Malaysia, 2009, NAT DENG STRAT PLAN; Ministry of Health (MOH), 2014, GUID DENG CONTR VECT; Mudin RN, 2015, INT MED J MALAYS, V14, P5; Muhammad Azami Nor Azila, 2011, BMC Res Notes, V4, P216, DOI 10.1186/1756-0500-4-216; Nordin O, 2017, SE ASIAN J TROP MED, V48, P786; Packierisamy PR, 2015, AM J TROP MED HYG, V93, P1020, DOI 10.4269/ajtmh.14-0667; Pruszynski CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170079; Rosilawati R, 2017, INT MED J MALAYS, V16, P73; Rozilawati H, 2015, TROP BIOMED, V32, P49; Seleena P., 1998, Israel Journal of Entomology, V32, P25; Seleena P, 2001, J VECTOR ECOL, V26, P110; Shepard DS, 2012, AM J TROP MED HYG, V87, P796, DOI 10.4269/ajtmh.2012.12-0019; Stoddard PK, 2018, ACTA TROP, V187, P108, DOI 10.1016/j.actatropica.2018.07.031; Sun DB, 2014, J AM MOSQUITO CONTR, V30, P99, DOI 10.2987/13-6394.1; Tan AWA, 2012, SE ASIAN J TROP MED, V43, P296; Vezzani D, 2002, MEM I OSWALDO CRUZ, V97, P789, DOI 10.1590/S0074-02762002000600006; WHO, 2012, WORLD HEAL ORGAN, P1	37	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230910	10.1371/journal.pone.0230910	http://dx.doi.org/10.1371/journal.pone.0230910			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236146	Green Published, Green Submitted, gold			2022-12-26	WOS:000535938700039
J	Bolter, DR; Elliott, MC; Hawks, J; Berger, LR				Bolter, Debra R.; Elliott, Marina C.; Hawks, John; Berger, Lee R.			Immature remains and the first partial skeleton of a juvenile Homo naledi, a late Middle Pleistocene hominin from South Africa	PLOS ONE			English	Article							AUSTRALOPITHECUS-SEDIBA; PAN-PANISCUS; GROWTH; ERECTUS	Immature remains are critical for understanding maturational processes in hominin species as well as for interpreting changes in ontogenetic development in hominin evolution. The study of these subjects is hindered by the fact that associated juvenile remains are extremely rare in the hominin fossil record. Here we describe an assemblage of immature remains of Homo naledi recovered from the 2013-2014 excavation season. From this assemblage, we attribute 16 postcranial elements and a partial mandible with some dentition to a single juvenile Homo naledi individual. The find includes postcranial elements never before discovered as immature elements in the sub-equatorial early hominin fossil record, and contributes new data to the field of hominin ontogeny.	[Bolter, Debra R.; Elliott, Marina C.; Hawks, John; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Bolter, Debra R.; Elliott, Marina C.; Hawks, John; Berger, Lee R.] Univ Witwatersrand, Ctr Excellence PalaeoSci, Johannesburg, South Africa; [Bolter, Debra R.] Modesto Jr Coll, Dept Anthropol, Modesto, CA 95350 USA; [Hawks, John] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA	University of Witwatersrand; University of Witwatersrand; University of Wisconsin System; University of Wisconsin Madison	Bolter, DR (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa.; Bolter, DR (corresponding author), Univ Witwatersrand, Ctr Excellence PalaeoSci, Johannesburg, South Africa.; Bolter, DR (corresponding author), Modesto Jr Coll, Dept Anthropol, Modesto, CA 95350 USA.	bolterd@yosemite.edu	Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629; Bolter, Debra/0000-0003-4550-6913	National Geographic Society; Lyda Hill Foundation; South African National Research Foundation; Gauteng Provincial Government; Centre for Excellence in the Palaeosciences, University of the Witwatersrand; University of Wisconsin Madison; MJC Foundation	National Geographic Society(National Geographic Society); Lyda Hill Foundation; South African National Research Foundation(National Research Foundation - South Africa); Gauteng Provincial Government; Centre for Excellence in the Palaeosciences, University of the Witwatersrand; University of Wisconsin Madison; MJC Foundation	The National Geographic Society-LRB; The Lyda Hill Foundation-LRB; The South African National Research Foundation-LRB; The Gauteng Provincial Government-LRB. Centre for Excellence in the Palaeosciences, University of the Witwatersrand-LRB; University of Wisconsin Madison-JH; MJC Foundation-DRB.; We thank our colleagues for comments on early drafts of the paper. We appreciate the collegial dialogue of Ashley Kruger. We thank the University of the Witwatersrand and the Evolutionary Studies Institute for curating the material and the University Curator Bernhard Zipfel for assisting with access to the collections. We thank the South African Heritage Resource Agency and Cradle of Humankind UNESCO World Heritage Site Management Authority for granting the permits to work on the Rising Star site (excavation permit ID: 952); the Jacobs family and Lee R. Berger Foundation for Exploration for granting access to the Rising Star site; past and present exploration team members Pedro Boshoff, Mpume Hlope, Rick Hunter, Maropeng Ramalepa, Dirk van Rooyen, Mathabela Tsikoane and Steven Tucker; other excavators Elen Feuerriegel, K. Lindsay (Eaves) Hunter, Alia Gurtov, Hannah Morris and Becca Peixotto; as well as Wilma Lawrence, Bonita De Klerk, and Sonia Sequeira and Justin Mukanku for their assistance during all phases of the project. We thank the Centre for Excellence in PalaeoSciences.	Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; Argue D, 2017, J HUM EVOL, V107, P107, DOI 10.1016/j.jhevol.2017.02.006; Barker C., 2017, TAPHONOMY HUMAN REMA, P251, DOI DOI 10.1002/9781118953358.CH18; Bass W., 1971, SPECIAL PUBLICATION; Berger LR, 2017, ELIFE, V6, DOI 10.7554/eLife.24234; Berger LR, 2015, ELIFE, V4, DOI 10.7554/eLife.09560; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Bolter D, 2018, S AFR J SCI, V114, P37; Bolter D, 2011, PRIMATES PERSPECTIVE, P408; Bolter D, 2019, AM J PHYS ANTHR S, P168; Bolter DR, 2012, AM J PHYS ANTHROPOL, V147, P629, DOI 10.1002/ajpa.22025; Bolter DR, 2011, AM J PHYS ANTHROPOL, V145, P647, DOI 10.1002/ajpa.21517; BROWN F, 1985, NATURE, V316, P788, DOI 10.1038/316788a0; Cameron N, 2017, AM J PHYS ANTHROPOL, V163, P633, DOI 10.1002/ajpa.23234; Cofran Z, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0339; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Dean M. C., 2009, 1 HUMANS ORIGIN EARL, P101; Dembo M, 2015, P ROY SOC B-BIOL SCI, V282, P133, DOI 10.1098/rspb.2015.0943; Dirks PHGM, 2017, ELIFE, V6, DOI [10.7554/eLife.24231.001, 10.7554/eLife.24231]; Elliott MC, 2018, AM J PHYS ANTHROPOL, V165, P76; Eriksson P.G., 2006, GEOLOGY S AFRICA, P237; Feuerriegel EM, 2017, J HUM EVOL, V104, P155, DOI 10.1016/j.jhevol.2016.09.013; Gabunia L, 2000, J HUM EVOL, V38, P785, DOI 10.1006/jhev.1999.0383; Galloway A., 1997, FORENSIC TAPHONOMY P, P295; Garvin HM, 2017, J HUM EVOL, V111, P119, DOI 10.1016/j.jhevol.2017.06.010; Green DJ, 2012, SCIENCE, V338, P514, DOI 10.1126/science.1227123; Guatelli-Steinberg D, 2018, J HUM EVOL, V121, P40, DOI 10.1016/j.jhevol.2018.03.007; Gurka S, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.21; Harcourt-Smith WEH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9432; Hawks J, 2017, ELIFE, V6, DOI 10.7554/eLife.24232; Hoerr H, 1962, RADIOGRAPHIC ATLAS F; Kelley J, 2013, BLACKW COMPANION ANT, P97; Kivell TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9431; Kruger A, 2016, S AFR J SCI, V112, P103, DOI 10.17159/sajs.2016/20160032; Kruger T, 2017, GRAD TEXTS PHYS, P3, DOI 10.1007/978-3-319-44649-3_1; Laird MF, 2017, J HUM EVOL, V104, P100, DOI 10.1016/j.jhevol.2016.09.009; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Marchi D, 2017, J HUM EVOL, V104, P174, DOI 10.1016/j.jhevol.2016.09.005; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; Rosas A, 2017, SCIENCE, V357, P1282, DOI 10.1126/science.aan6463; Ruff Christopher B., 1993, P234; Scheuer L., 2000, DEV JUVENILE OSTEOLO; Schwartz GT, 2012, CURR ANTHROPOL, V53, pS395, DOI 10.1086/667591; Smith B. Holly, 1993, P195; Smith TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118118; Tanner JM, 2001, GOV OPPOS, V3rd, DOI DOI 10.1111/1477-7053.00052; VanSickle C, 2018, J HUM EVOL, V125, P122, DOI 10.1016/j.jhevol.2017.10.001; Walker A., 1993, NARIOKOTOME HOMO ERE; Williams SA, 2017, J HUM EVOL, V104, P136, DOI 10.1016/j.jhevol.2016.11.003; Zihlman AL, 2007, J ZOOL, V273, P63, DOI 10.1111/j.1469-7998.2007.00301.x; [No title captured]	51	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230440	10.1371/journal.pone.0230440	http://dx.doi.org/10.1371/journal.pone.0230440			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8IA	32236122	gold, Green Published			2022-12-26	WOS:000535938700019
J	Mikalova, L; Janeckova, K; Novakova, M; Strouhal, M; Cejkova, D; Harper, KN; Smajs, D				Mikalova, Lenka; Janeckova, Klara; Novakova, Marketa; Strouhal, Michal; Cejkova, Darina; Harper, Kristin N.; Smajs, David			Whole genome sequence of the Treponema pallidum subsp. endemicum strain Iraq B: A subpopulation of bejel treponemes contains full-length tprF and tprG genes similar to those present in T. p. subsp. pertenue strains	PLOS ONE			English	Article							ANTIGENIC VARIATION; SYPHILIS; DIVERSITY; REGIONS; NICHOLS; YAWS; CELL	Treponema pallidum subsp. endemicum (TEN) is the causative agent of endemic syphilis (bejel). Until now, only a single TEN strain, Bosnia A, has been completely sequenced. The only other laboratory TEN strain available, Iraq B, was isolated in Iraq in 1951 by researchers from the US Centers for Disease Control and Prevention. In this study, the complete genome of the Iraq B strain was amplified as overlapping PCR products and sequenced using the pooled segment genome sequencing method and Illumina sequencing. Total average genome sequencing coverage reached 3469x, with a total genome size of 1,137,653 bp. Compared to the genome sequence of Bosnia A, a set of 37 single nucleotide differences, 4 indels, 2 differences in the number of tandem repetitions, and 18 differences in the length of homopolymeric regions were found in the Iraq B genome. Moreover, the tprF and tprG genes that were previously found deleted in the genome of the TEN Bosnia A strain (spanning 2.3 kb in length) were present in a subpopulation of TEN Iraq B and Bosnia A microbes, and their sequence was highly similar to those found in T. p. subsp. pertenue strains, which cause the disease yaws. The genome sequence of TEN Iraq B revealed close genetic relatedness between both available bejel-causing laboratory strains (i.e., Iraq B and Bosnia A) and also genetic variability within the bejel treponemes comparable to that found within yaws- or syphilis-causing strains. In addition, genetic relatedness to TPE strains was demonstrated by the sequence of the tprF and tprG genes found in sub-populations of both TEN Iraq B and Bosnia A. The loss of the tprF and tprG genes in most TEN microbes suggest that TEN genomes have been evolving via the loss of genomic regions, a phenomenon previously found among the treponemes causing both syphilis and rabbit syphilis.	[Mikalova, Lenka; Janeckova, Klara; Novakova, Marketa; Strouhal, Michal; Smajs, David] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic; [Cejkova, Darina] Vet Res Inst, Dept Immunol, Brno, Czech Republic; [Harper, Kristin N.] Emory Univ, Dept Populat Biol Ecol & Evolut, Atlanta, GA 30322 USA; [Harper, Kristin N.] Harper Hlth & Sci Commun, Seattle, WA USA	Masaryk University Brno; Czech Veterinary Research Institute; Emory University	Smajs, D (corresponding author), Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic.	dsmajs@med.muni.cz	Nováková, Markéta/V-5436-2019; Janečková, Klára/AGZ-9436-2022; Janečková, Klára/AHA-0782-2022; Cejkova, Darina/AAA-5820-2022	Nováková, Markéta/0000-0001-8249-4494; Janečková, Klára/0000-0003-2755-927X; Cejkova, Darina/0000-0002-6989-6330; Pastekova, Lenka/0000-0003-4266-9952	Grant Agency of the Czech Republic [GA17-25455S, GC18-23521J, GJ17-25589Y]; Czech Ministry of Agriculture [RVO0518]; Faculty of Medicine, Masaryk University	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Czech Ministry of Agriculture(Ministry of Agriculture, Czech Republic); Faculty of Medicine, Masaryk University	This work was supported by the Grant Agency of the Czech Republic (GA17-25455S; GC18-23521J; gacr.cz) to DS and (GJ17-25589Y; gacr.cz) to MS. DC was supported by the grant RVO0518 of the Czech Ministry of Agriculture (eagri.cz). This work was also supported by funds from the Faculty of Medicine, Masaryk University (med.muni.cz), provided to junior researchers LM and MN. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial company Harper Health & Science Communications provided support in the form of salaries for author KNH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Antal GM, 2002, MICROBES INFECT, V4, P83, DOI 10.1016/S1286-4579(01)01513-1; Cejkova D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004110; Cejkova D, 2013, J MED MICROBIOL, V62, P196, DOI 10.1099/jmm.0.050658-0; Cejkova D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001471; Centurion-Lara A, 2004, MOL MICROBIOL, V52, P1579, DOI 10.1111/j.1365-2958.2004.04086.x; Centurion-Lara A, 1999, J EXP MED, V189, P647, DOI 10.1084/jem.189.4.647; Centurion-Lara A, 2000, INFECT IMMUN, V68, P824, DOI 10.1128/IAI.68.2.824-831.2000; Centurion-Lara A, 2000, J BACTERIOL, V182, P2332, DOI 10.1128/JB.182.8.2332-2335.2000; Centurion-Lara A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002222; ENGELKENS HJH, 1989, GENITOURIN MED, V65, P316; Fanella S, 2012, EMERG INFECT DIS, V18, P1002, DOI 10.3201/eid1806.111421; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Giacani L, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00333-14; Giacani L, 2014, CLIN MICROBIOL REV, V27, P89, DOI 10.1128/CMR.00070-13; Giacani L, 2012, J BACTERIOL, V194, P4208, DOI 10.1128/JB.00863-12; Giacani L, 2010, J IMMUNOL, V184, P3822, DOI 10.4049/jimmunol.0902788; Grange PA, 2016, SEX TRANSM DIS, V43, P517, DOI 10.1097/OLQ.0000000000000474; Grillova L, 2018, PLOS ONE, V13, DOI [10.1371/journalmone.0202619, DOI 10.1371/JOURNALMONE.0202619]; Harper KN, 2008, FEMS IMMUNOL MED MIC, V53, P322, DOI 10.1111/j.1574-695X.2008.00427.x; John St RK, 1984, HDB ENDEMIC TREPONEM; Kawahata T, 2019, EMERG INFECT DIS, V25, P1581, DOI 10.3201/eid2508.181690; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Knauf S, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0156-4; Kozlov AM, 2019, BIOINFORMATICS, V35, P4453, DOI 10.1093/bioinformatics/btz305; LaFond RE, 2003, J BACTERIOL, V185, P6262, DOI 10.1128/JB.185.21.6262-6268.2003; LaFond RE, 2006, INFECT IMMUN, V74, P6244, DOI 10.1128/IAI.00827-06; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; LIU D, 2019, PLOS NEGLECT TROP D, V131, DOI DOI 10.1371/JOURNAL.ONTD.0006855; LIU D, 2019, PLOS NEGLECT TROP D, V131, DOI DOI 10.1371/JOURNAL.POTD.0007621; Lumeij JT, 2013, VET MICROBIOL, V164, P190, DOI 10.1016/j.vetmic.2013.02.001; Mikalova L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005434; Mikalova L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-178; Mikalova L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015713; Mitja O, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002283; Morgan CA, 2002, J IMMUNOL, V169, P952, DOI 10.4049/jimmunol.169.2.952; Nechvatal L, 2014, INT J MED MICROBIOL, V304, P645, DOI 10.1016/j.ijmm.2014.04.007; Noda AA, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.02.006; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Petrosova H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074319; Pinto M, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.190; Radolf JD, 2018, CURR TOP MICROBIOL, V415, P1, DOI 10.1007/82_2017_44; Reid TB, 2014, INFECT IMMUN, V82, P4959, DOI 10.1128/IAI.02236-14; Saeed AF, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01462; Smajs D, 2002, GENOME RES, V12, P515, DOI 10.1101/gr.207302; Smajs D., 2016, FORUM IMMUN DIS THER, V7, P181, DOI DOI 10.1615/F0RUMIMMUNDISTHER.2017020184; Smajs D, 2018, INFECT GENET EVOL, V61, P92, DOI 10.1016/j.meegid.2018.03.015; Smajs D, 2012, INFECT GENET EVOL, V12, P191, DOI 10.1016/j.meegid.2011.12.001; Smajs D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020415; Staudova B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003261; Strouhal M, 2007, INFECT IMMUN, V75, P5859, DOI 10.1128/IAI.00709-07; Strouhal M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006867; Strouhal M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005894; TURNER T B, 1957, Monogr Ser World Health Organ, P3; Weinstock GM, 2000, RES MICROBIOL, V151, P151, DOI 10.1016/S0923-2508(00)00115-7; Zobanikova M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002172; Zobanikova M, 2012, STAND GENOMIC SCI, V7, P12, DOI 10.4056/sigs.2615838	56	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230926	10.1371/journal.pone.0230926	http://dx.doi.org/10.1371/journal.pone.0230926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236138	gold, Green Published			2022-12-26	WOS:000535938700042
J	Stennett, CA; Dyer, TV; He, X; Robinson, CK; Ravel, J; Ghanem, KG; Brotman, RM				Stennett, Christina A.; Dyer, Typhanye, V; He, Xin; Robinson, Courtney K.; Ravel, Jacques; Ghanem, Khalil G.; Brotman, Rebecca M.			A cross-sectional pilot study of birth mode and vaginal microbiota in reproductive-age women	PLOS ONE			English	Article							BACTERIAL-VAGINOSIS; CESAREAN-SECTION; RISK-FACTORS; OBESITY; DELIVERY; ASSOCIATION; CHILDHOOD; RATES; COLONIZATION; INFANTS	Recent studies suggest that birth mode (Cesarean section [C-section] or vaginal delivery) is an important event in the initial colonization of the human microbiome and may be associated with long-term health outcomes. We sought to determine the association between a woman's birth mode and her vaginal microbiota in adulthood. We re-contacted 144 adult women from two U.S. studies and administered a brief survey. Vaginal microbiota was characterized on a single sample by amplicon sequencing of the V3-V4 hypervariable regions of the 16S rRNA gene and clustered into community state types (CSTs). We evaluated the association between birth mode and a CST with low relative abundance of Lactobacillus spp. ("molecular bacterial vaginosis" [Molecular-BV]) compared to Lactobacillus-dominated CSTs in logistic regression modeling which adjusted for body mass index, a confounder in this analysis. Twenty-seven women (19%) reported C-section. Overall, C-section showed a non-significant trend towards increased odds of Molecular-BV (aOR = 1.22, 95% CI: 0.45, 3.32), and Prevotella bivia was the strongest single taxa associated with C-section. However, because the two archived studies had different inclusion criteria (interaction p = 0.048), we stratified the analysis by study site. In the study with a larger sample size (n = 88), women born by C-section had 3-fold higher odds of Molecular-BV compared to vaginally-delivered women (aOR = 3.55, p = 0.06, 95% CI: 0.97-13.02). No association was found in the smaller study (n = 56, aOR = 0.19, p = 0.14, 95% CI: 0.02-1.71). This pilot cross-sectional study suggests a possible association between C-section and Molecular-BV in adulthood. However, the analysis is limited by small sample size and lack of comparability in participant age and other characteristics between the study sites. Future longitudinal studies could recruit larger samples of women, address the temporal dynamics of vaginal microbiota, and explore other confounders, including maternal factors, breastfeeding history, and socioeconomic status, which may affect the relationship between birth mode and vaginal microbiota.	[Stennett, Christina A.; Brotman, Rebecca M.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Stennett, Christina A.; Robinson, Courtney K.; Ravel, Jacques; Brotman, Rebecca M.] Univ Maryland, Inst Genome Sci, Sch Med, Baltimore, MD 21201 USA; [Dyer, Typhanye, V; He, Xin] Univ Maryland, Dept Epidemiol & Biostat, Baltimore, MD 21201 USA; [Ravel, Jacques] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Ghanem, Khalil G.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University	Brotman, RM (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.; Brotman, RM (corresponding author), Univ Maryland, Inst Genome Sci, Sch Med, Baltimore, MD 21201 USA.	rbrotman@som.umaryland.edu	Brotman, Rebecca M/H-5442-2011; Penniman Dyer, Typhanye/N-1743-2014	Brotman, Rebecca M/0000-0001-8762-6214; Ravel, Jacques/0000-0002-0851-2233; He, Xin/0000-0002-9814-1666; Ghanem, Khalil/0000-0002-0033-302X; Penniman Dyer, Typhanye/0000-0002-8493-5772	National Institute of Allergy and Infectious Diseases (NIAID) [U01-AI070921]; NIAID [R01-AI089878, R01-AI119012]; National Institute on Aging [T32-AG000262]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institute of Allergy and Infectious Diseases (NIAID) U01-AI070921 (JR), NIAID R01-AI089878 (KGG), NIAID R01-AI119012 (RMB) and the National Institute on Aging T32-AG000262 (supporting CAS).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenhaim HA, 2011, J OBSTET GYNAECOL CA, V33, P443, DOI 10.1016/S1701-2163(16)34876-9; Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; [Anonymous], NATURE METHODS; [Anonymous], SPEC FAST CLUST FREE; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Berendzen Jodi A, 2013, Tenn Med, V106, P35; Biasucci G, 2010, EARLY HUM DEV, V86, pS13, DOI 10.1016/j.earlhumdev.2010.01.004; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; Decker E, 2010, PEDIATRICS, V125, pE1433, DOI 10.1542/peds.2009-2260; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Dominguez-Bello MG, 2016, NAT MED, V22, P250, DOI 10.1038/nm.4039; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; GOULD JB, 1989, NEW ENGL J MED, V321, P233, DOI 10.1056/NEJM198907273210406; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hickey RJ, 2015, MBIO, V6, DOI 10.1128/mBio.00097-15; HILL GB, 1995, CLIN INFECT DIS, V20, pS269, DOI 10.1093/clinids/20.Supplement_2.S269; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; Holm JB, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00029-19; Holzman C, 2001, AM J PUBLIC HEALTH, V91, P1664, DOI 10.2105/AJPH.91.10.1664; Huh SY, 2012, ARCH DIS CHILD, V97, P610, DOI 10.1136/archdischild-2011-301141; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Keag OE, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002494; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Kuhle S, 2015, OBES REV, V16, P295, DOI 10.1111/obr.12267; Linhares IM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.07.010; Liu CM, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-56, 10.1186/1471-2180-12-255]; Marrs T, 2013, PEDIAT ALLERG IMM-UK, V24, DOI 10.1111/pai.12064; Martin DH, 2012, AM J MED SCI, V343, P2, DOI 10.1097/MAJ.0b013e31823ea228; Matamoros S, 2013, TRENDS MICROBIOL, V21, P167, DOI 10.1016/j.tim.2012.12.001; McClelland RS, 2008, SEX TRANSM DIS, V35, P617, DOI 10.1097/OLQ.0b013e31816907fa; McKinnon LR, 2019, AIDS RES HUM RETROV, V35, P219, DOI [10.1089/aid.2018.0304, 10.1089/AID.2018.0304]; Mehta SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116894; MORRISON JA, 1994, AM J PUBLIC HEALTH, V84, P1761, DOI 10.2105/AJPH.84.11.1761; Mueller NT, 2017, INT J OBESITY, V41, P497, DOI 10.1038/ijo.2016.219; Murphy K, 2016, J INFECT DIS, V214, pS29, DOI 10.1093/infdis/jiw140; Onderdonk AB, 2016, CLIN MICROBIOL REV, V29, P223, DOI 10.1128/CMR.00075-15; Polos J, 2019, POP STUD-J DEMOG, V73, P353, DOI 10.1080/00324728.2019.1624810; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rautava S, 2012, NAT REV GASTRO HEPAT, V9, P565, DOI 10.1038/nrgastro.2012.144; Ravel J., 2018, KEYST C ROL GEN TRAC; Ravel J, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-29; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Sakwinska O, 2017, BENEF MICROBES, V8, P763, DOI 10.3920/BM2017.0064; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shin HD, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0126-1; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; Si J, 2017, CELL HOST MICROBE, V21, P97, DOI 10.1016/j.chom.2016.11.010; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Tuddenham S, 2019, SEX TRANSM INFECT, V95, pA263, DOI 10.1136/sextrans-2019-sti.662; WACHOLDER S, 1995, OCCUP ENVIRON MED, V52, P557, DOI 10.1136/oem.52.8.557; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	64	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0228574	10.1371/journal.pone.0228574	http://dx.doi.org/10.1371/journal.pone.0228574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8IA	32236123	Green Published, gold			2022-12-26	WOS:000535938700005
J	Rey-Cadilhac, L; Cariou, R; Ferlay, A; Jondreville, C; Delavaud, C; Faulconnier, Y; Alcouffe, S; Faure, P; Marchand, P; Le Bizec, B; Jurjanz, S; Lerch, S				Rey-Cadilhac, Lucille; Cariou, Ronan; Ferlay, Anne; Jondreville, Catherine; Delavaud, Carole; Faulconnier, Yannick; Alcouffe, Sebastien; Faure, Pascal; Marchand, Philippe; Le Bizec, Bruno; Jurjanz, Stefan; Lerch, Sylvain			Undernutrition combined with dietary mineral oil hastens depuration of stored dioxin and polychlorinated biphenyls in ewes. 1. Kinetics in blood, adipose tissue and faeces	PLOS ONE			English	Article							DIBENZO-P-DIOXINS; BODY-FAT; FEEDING LEVEL; METABOLISM; RUMINANTS; PREDICTION; EXCRETION; LIVER; MIREX; PCBS	Food safety crises involving persistent organic pollutants [POPs, e.g. dioxins, polychlorinated biphenyls (PCBs), organochlorine pesticides] lead to systematic slaughter of livestock to prevent their entry into the food chain. Therefore, there is a need to develop strategies to depurate livestock moderately contaminated with POPs in order to reduce such economic and social damages. This study aimed to test a POPs depuration strategy based on undernutrition (37% of energy requirements) combined with mineral oil (10% in total dry matter intake) in nine non-lactating ewes contaminated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and PCBs 126 and 153. In order to better understand the underlying mechanisms of the depuration process, POPs kinetics and body lipids dynamics were followed concomitantly over 57-day of depuration in POPs storage (adipose tissue, AT), central distribution (blood) and excretion (faeces) compartments. Faecal POPs concentrations in underfed and mineral oil supplemented ewes increased by 2.0 to 2.6-fold, but not proportionally to lipids concentration which increased by 6-fold, compared to the control ewes. Nonetheless, after 57 days of depuration in undernutrition and mineral oil supplementation, AT POPs concentrations were 1.5 to 1.6-fold higher while serum concentrations remained unchanged compared to the control ewes. This was concomitant with a decrease by 2.7-fold of the AT estimated lipids weight along the depuration period. This reduction of the volume of the storage compartment combined with the increase of POPs faecal excretion in underfed and mineral oil supplemented ewes led to a reduction by 1.5-fold of the PCB 126 AT burden, while no changes were observed for TCDD and PCB 153 burdens (vs. no change for PCB 126 and increases for TCDD and PCB 153 AT burdens in control ewes). The original approach of this study combining the fine description at once of POPs kinetic and of body lipids dynamic improved our understanding of POPs fate in the ruminant.	[Rey-Cadilhac, Lucille; Jondreville, Catherine; Jurjanz, Stefan; Lerch, Sylvain] Univ Lorraine, INRAE, UR AFPA, Nancy, France; [Rey-Cadilhac, Lucille; Ferlay, Anne; Delavaud, Carole; Faulconnier, Yannick] Univ Clermont Auvergne, UMR Herbivores, VetAgro Sup, INRAE, St Genes Champanelle, France; [Cariou, Ronan; Marchand, Philippe; Le Bizec, Bruno] INRAE, Oniris, LABERCA, Nantes, France; [Alcouffe, Sebastien; Faure, Pascal] INRAE, UE Herbipole, St Genes Champanelle, France; [Lerch, Sylvain] Agroscope, Ruminant Res Unit, Posieux, Switzerland	INRAE; Universite de Lorraine; INRAE; Universite Clermont Auvergne (UCA); VetAgro Sup; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Nantes Universite; INRAE; Swiss Federal Research Station Agroscope	Lerch, S (corresponding author), Univ Lorraine, INRAE, UR AFPA, Nancy, France.; Lerch, S (corresponding author), Agroscope, Ruminant Res Unit, Posieux, Switzerland.	sylvain.lerch@agroscope.admin.ch	Lerch, Sylvain/AAD-5727-2021; Cariou, Ronan/M-5549-2014	Lerch, Sylvain/0000-0003-0957-8012; Cariou, Ronan/0000-0002-4669-1834	"Conseil Regional de Lorraine" (Nancy, France); "Centre National Interprofessionnel de l'Economie Laitiere" (CNIEL, Paris, France)	"Conseil Regional de Lorraine" (Nancy, France)(Region Grand-Est); "Centre National Interprofessionnel de l'Economie Laitiere" (CNIEL, Paris, France)	This work was supported by the "Conseil Regional de Lorraine" (Nancy, France) under Grant "Universite/EPST-Region 2014" and by the "Centre National Interprofessionnel de l'Economie Laitiere" (CNIEL, Paris, France) to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antignac JP, 2006, ANAL BIOANAL CHEM, V384, P271, DOI 10.1007/s00216-005-0129-z; Atti N, 1999, ANN ZOOTECH, V48, P189, DOI 10.1051/animres:19990304; AUFRERE J, 1982, ANN ZOOTECH, V31, P111, DOI 10.1051/animres:19820202; Cariou R, 2010, ENVIRON POLLUT, V158, P941, DOI 10.1016/j.envpol.2009.09.010; Cavestany D, 2009, REPROD DOMEST ANIM, V44, P663, DOI 10.1111/j.1439-0531.2007.01044.x; Chilliard Y, 1998, REPROD NUTR DEV, V38, P131, DOI 10.1051/rnd:19980201; Delavaud C, 2007, BRIT J NUTR, V98, P106, DOI 10.1017/S0007114507704968; Faulconnier Y, 1999, PROD ANIM, V12, P287; Feil VJ, 2000, J AGR FOOD CHEM, V48, P6163, DOI 10.1021/jf0003092; Fernandez-Gonzalez R, 2015, CRIT REV FOOD SCI, V55, P1590, DOI 10.1080/10408398.2012.710279; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hoogenboom R, 2015, FOOD CONTROL, V50, P670, DOI 10.1016/j.foodcont.2014.10.010; Hoogenboom RLAP, 2015, CHEMOSPHERE, V122, P137, DOI 10.1016/j.chemosphere.2014.11.030; INRA, 2006, PREVALIM VERS PROF I; INRA, 2007, BES AN VAL AL TABL I; Inui H, 2014, INT J MOL SCI, V15, P14044, DOI 10.3390/ijms150814044; Jandacek RJ, 2005, AM J PHYSIOL-GASTR L, V288, pG292, DOI 10.1152/ajpgi.00285.2004; Jandacek RJ, 2001, LIPIDS, V36, P1289, DOI 10.1007/s11745-001-0844-z; Jandacek RJ, 2007, J NUTR BIOCHEM, V18, P163, DOI 10.1016/j.jnutbio.2006.12.001; JOHNSON DE, 1990, J NUTR, V120, P649, DOI 10.1093/jn/120.6.649; Lerch S, 2012, J DAIRY SCI, V95, P1956, DOI 10.3168/jds.2011-4575; Lerch S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230628; Lerch S, 2016, J AGR FOOD CHEM, V64, P1212, DOI 10.1021/acs.jafc.5b05817; LOMAX MA, 1983, BRIT J NUTR, V49, P481, DOI 10.1079/BJN19830057; Mackay D., 2006, HDB PHYS CHEM PROPER, V2; Moser GA, 1999, CHEMOSPHERE, V39, P1513, DOI 10.1016/S0045-6535(99)00219-2; ORTIGUES I, 1991, REPROD NUTR DEV, V31, P593, DOI 10.1051/rnd:19910601; POLIN D, 1989, POULTRY SCI, V68, P885, DOI 10.3382/ps.0680885; Richter W, 2001, J AGR FOOD CHEM, V49, P5857, DOI 10.1021/jf010859f; ROBELIN J, 1981, J LIPID RES, V22, P452; ROZMAN K, 1984, B ENVIRON CONTAM TOX, V32, P27, DOI 10.1007/BF01607461; ROZMAN K, 1982, J AGR FOOD CHEM, V30, P98, DOI 10.1021/jf00109a022; Rozman K. K., 1986, GASTROINTESTINAL TOX, P119; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; WIENER M, 1976, DRUG METAB DISPOS, V4, P281	35	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2020	15	3							e0230629	10.1371/journal.pone.0230629	http://dx.doi.org/10.1371/journal.pone.0230629			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HO	32231376	Green Published, gold			2022-12-26	WOS:000535937400015
J	Ricciardiello, F; Gang, Y; Palorini, R; Li, QX; Giampa, M; Zhao, FY; You, L; La Ferla, B; De Vitto, H; Guan, WF; Gu, J; Zhang, TP; Zhao, YP; Chiaradonna, F				Ricciardiello, Francesca; Gang, Yang; Palorini, Roberta; Li, Quanxiao; Giampa, Marco; Zhao, Fangyu; You, Lei; La Ferla, Barbara; De Vitto, Humberto; Guan, Wenfang; Gu, Jin; Zhang, Taiping; Zhao, Yupei; Chiaradonna, Ferdinando			Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulation	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; O-GLCNAC; GLCNACYLATION; CELLS	Different evidence has indicated metabolic rewiring as a necessity for pancreatic cancer (PC) growth, invasion, and chemotherapy resistance. A relevant role has been assigned to glucose metabolism. In particular, an enhanced flux through the Hexosamine Biosynthetic Pathway (HBP) has been tightly linked to PC development. Here, we show that enhancement of the HBP, through the upregulation of the enzyme Phosphoacetylglucosamine Mutase 3 (PGM3), is associated with the onset of gemcitabine (GEM) resistance in PC. Indeed, mRNA profiles of GEM sensitive and resistant patient-derived tumor xenografts (PDXs) indicate that PGM3 expression is specifically increased in GEM-resistant PDXs. Of note, PGM3 results also overexpressed in human PC tissues as compared to paired adjacent normal tissues and its higher expression in PC patients is associated with worse median overall survival (OS). Strikingly, genetic or pharmacological PGM3 inhibition reduces PC cell growth, migration, invasion, in vivo tumor growth and enhances GEM sensitivity. Thus, combined treatment between a specific inhibitor of PGM3, named FR054, and GEM results in a potent reduction of xenograft tumor growth without any obvious side effects in normal tissues. Mechanistically, PGM3 inhibition, reducing protein glycosylation, causes a sustained Unfolded Protein Response (UPR), a significant attenuation of the pro-tumorigenic Epidermal Growth Factor Receptor (EGFR)-Akt axis, and finally cell death. In conclusion this study identifies the HBP as a metabolic pathway involved in GEM resistance and provides a strong rationale for a PC therapy addressing the combined treatment with the PGM3 inhibitor and GEM.	[Ricciardiello, Francesca; Palorini, Roberta; Giampa, Marco; La Ferla, Barbara; De Vitto, Humberto; Chiaradonna, Ferdinando] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy; [Gang, Yang; Li, Quanxiao; Zhao, Fangyu; You, Lei; Zhang, Taiping; Zhao, Yupei] Chinese Acad Med Sci & Peking Union Med Coll, Dept Gen Surg, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Guan, Wenfang; Gu, Jin] Tsinghua Univ, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Guan, Wenfang; Gu, Jin] Tsinghua Univ, Bioinformat Div, Ctr Synthet & Syst Biol, BNRist, Beijing 100084, Peoples R China; [Guan, Wenfang; Gu, Jin] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [De Vitto, Humberto] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA	University of Milano-Bicocca; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Tsinghua University; Tsinghua University; Tsinghua University; University of Minnesota System	Chiaradonna, F (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy.; Zhang, TP; Zhao, YP (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Dept Gen Surg, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	tpingzhang@yahoo.com; zhao8028@263.net; ferdinando.chiaradonna@unimib.it	ricciardiello, francesca/AAO-3804-2020; CHIARADONNA, Ferdinando/K-4959-2016; La Ferla, Barbara/AAM-3452-2020	CHIARADONNA, Ferdinando/0000-0001-8529-2732; La Ferla, Barbara/0000-0002-4340-9717	MAECI (Executive Programme of Scientific and Technological Cooperation Italy-China) [CN19GR03]; Associazione Italiana per la Ricerca sul Cancro [15364]; Fondo individuale FFABBR_NAT 2017 (MIUR, Italy); Chinese Government [2018YFE0118600]; National Natural Science Foundation of China [81772639]; Natural Science Foundation of Beijing [7192157]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-001]; Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2018PT32014]; MIUR; National Brazilian Institution of Science (CAPES) [9281-13-4]; Italian Government [2018YFE0118600]	MAECI (Executive Programme of Scientific and Technological Cooperation Italy-China); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondo individuale FFABBR_NAT 2017 (MIUR, Italy); Chinese Government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); CAMS Innovation Fund for Medical Sciences (CIFMS); Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences; MIUR(Ministry of Education, Universities and Research (MIUR)); National Brazilian Institution of Science (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Italian Government	FC was supported by grants from MAECI (Executive Programme of Scientific and Technological Cooperation Italy-China 2019-2021, #CN19GR03), from Associazione Italiana per la Ricerca sul Cancro (A.I.R.C., IG2014 Id.15364) and Fondo individuale FFABBR_NAT 2017 (MIUR, Italy). TZ was supported by grants from Key Projects of International Scientific and Technological Innovation Cooperation Between Chinese and Italian Governments (2018YFE0118600), from the National Natural Science Foundation of China (No. 81772639), from Natural Science Foundation of Beijing (No. 7192157) and CAMS Innovation Fund for Medical Sciences (CIFMS) (No. 2016-I2M-1-001). YZ was supported by grants from Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (No. 2018PT32014). FR is supported by fellowship from MIUR. RP and HDV were supported by fellowship from MIUR and National Brazilian Institution of Science (CAPES 9281-13-4), respectively. We thank Neil Campbell for English editing.	ABBRUZZESE JL, 1991, J CLIN ONCOL, V9, P491, DOI 10.1200/JCO.1991.9.3.491; Akella NM, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0671-3; Amrutkar M, 2017, CANCERS, V9, DOI 10.3390/cancers9110157; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Avril T, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.72; Binenbaum Y, 2015, DRUG RESIST UPDATE, V23, P55, DOI 10.1016/j.drup.2015.10.002; Cavalcante LD, 2014, EUR J PHARMACOL, V741, P8, DOI [10.1010/j.ejphar.2014.07.041, 10.1016/j.ejphar.2014.07.041]; Chatham JC, 2010, CURR SIGNAL TRANSD T, V5, P49, DOI 10.2174/157436210790226492; Chen RR, 2017, SCI REP-UK, V7, DOI 10.1038/srep41463; Chiaradonna F, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7060053; Dauer P, 2018, MOL ONCOL, V12, P1498, DOI 10.1002/1878-0261.12322; de Queiroz RM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00116; Du YX, 2017, CANCER RES, V77, P2661, DOI 10.1158/0008-5472.CAN-16-2339; Fang B, 2001, EXP CELL RES, V263, P243, DOI 10.1006/excr.2000.5110; Feng MY, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0947-4; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Liu CF, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00415; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Lopez-Sambrooks C, 2016, NAT CHEM BIOL, V12, P1023, DOI 10.1038/nchembio.2194; Luo WH, 2019, CANCER MED-US, V8, P6403, DOI 10.1002/cam4.2384; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; Munkley J, 2019, ONCOL LETT, V17, P2569, DOI 10.3892/ol.2019.9885; Nagaraj NS, 2011, CLIN CANCER RES, V17, P483, DOI 10.1158/1078-0432.CCR-10-1670; Namba T, 2015, MAR DRUGS, V13, P2376, DOI 10.3390/md13042376; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Paiotta A, 2018, EUR J ORG CHEM, V2018, P1946, DOI 10.1002/ejoc.201800183; Palam LR, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.264; Qian WK, 2018, LIFE SCI, V208, P253, DOI 10.1016/j.lfs.2018.07.046; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Ricciardiello F, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0405-4; Rodrigues JG, 2018, CELL IMMUNOL, V333, P46, DOI 10.1016/j.cellimm.2018.03.007; Shukla SK, 2017, CANCER CELL, V32, P392, DOI 10.1016/j.ccell.2017.08.008; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stichelen SOV, 2012, AM J PHYSIOL-ENDOC M, V302, pE417, DOI 10.1152/ajpendo.00390.2011; Tadros S, 2017, CANCER RES, V77, P5503, DOI 10.1158/0008-5472.CAN-16-3062; Thakur PC, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1562-z; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Vaziri-Gohar A, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00617; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Yang G, 2019, SCI CHINA LIFE SCI, V62, P791, DOI 10.1007/s11427-018-9495-2; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	45	22	23	3	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	20					4103	4117		10.1038/s41388-020-1260-1	http://dx.doi.org/10.1038/s41388-020-1260-1		MAR 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LN3GC	32235891	Green Submitted			2022-12-26	WOS:000522606000001
J	Valencia, J; Alvaro-Meca, A; Troya, J; Gutierrez, J; Ramon, C; Rodriguez, A; Vazquez-Moron, S; Resino, S; Moreno, S; Ryan, P				Valencia, Jorge; Alvaro-Meca, Alejandro; Troya, Jesus; Gutierrez, Jorge; Ramon, Cristina; Rodriguez, Antonio; Vazquez-Moron, Sonia; Resino, Salvador; Moreno, Santiago; Ryan, Pablo			Gender-based vulnerability in women who inject drugs in a harm reduction setting	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; HIV RISK; SUBSTANCE-ABUSE; PREVENTION; HEALTH; USERS; HCV	Background and aims In comparison with men, women who use drugs (WWUD) have considerably more frequent and intense experiences with interpersonal violence, sexual abuse and trauma. The aim of this study was to identify issues related to gender-based vulnerability in a group of WWUD attended in a harm reduction facility in Madrid, Spain. Material and methods A cross-sectional study was conducted during a screening of blood borne infections. We included WWUD (smoked or injected heroin/cocaine) who were actively screened for HIV, HBV and HCV in a harm reduction setting in Madrid (Spain) from January to December 2017. WWUD were interviewed for gender-based abuse or violence using a face-to-face questionnaire by a trained interviewer. Aspects related to their social-epidemiological condition and gender-based vulnerability were collected. Results We included 109 women who were actively using drugs. The median age was 39 (IQR 3547) years, 84.4% were Spanish born, 22.9% were homeless, 43 (41.7%) had ever used injected drugs, 29 (26.6%) were currently using injected drugs, and 27.1% had mental health disorders. Aspects related to gender-based vulnerability were collected. Among those surveyed, they reported having ever suffered emotional or psychological damage (88%), having experienced at least one incident of serious physical injury by a male partner (71%), and having ever suffered sexual abuse (49%). In addition, 28% had ever exchanged sex for money/drugs. When compared to women that did not use injecting drugs, those who injected drugs had more frequently exchanged sex for money/drugs (55% vs 21%, p = 0.003). Conclusions A high proportion of WWUD suffer psychological or physical violence by partners denoting gender-based vulnerability. Interventions in harm reduction settings with a multidisciplinary and gender-based approach should be implemented.	[Valencia, Jorge] SERMAS, Harm Reduct Unit SMASD, Madrid, Spain; [Valencia, Jorge] SERMAS, Subdirecc Gen Adicc, Madrid, Spain; [Valencia, Jorge; Gutierrez, Jorge; Ramon, Cristina; Rodriguez, Antonio] Nongovt Org Madrid Posit, Madrid, Spain; [Alvaro-Meca, Alejandro] Rey Juan Carlos Univ, Unit Prevent Med & Publ Hlth, Madrid, Spain; [Troya, Jesus; Ryan, Pablo] Hosp Univ Infanta Leonor, Madrid, Spain; [Vazquez-Moron, Sonia] Fdn Estate Salud Infancia & Bienestar Social FCSA, Madrid, Spain; [Vazquez-Moron, Sonia; Resino, Salvador] Inst Hlth Carlos III, Natl Ctr Microbiol, Unit Viral Infect & Immun, Madrid, Spain; [Moreno, Santiago] Univ Alcala, Ramon y Cajal Hosp, Dept Infect Dis, IRYCIS, Madrid, Spain; [Ryan, Pablo] Complutense Madrid Univ UCM, Madrid, Spain; [Ryan, Pablo] Inst Invest Sanit Gregorio Maranon IiSGM, Madrid, Spain	Universidad Rey Juan Carlos; Hospital Universitario Infanta Leonor; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Universidad de Alcala	Valencia, J (corresponding author), SERMAS, Harm Reduct Unit SMASD, Madrid, Spain.; Valencia, J (corresponding author), SERMAS, Subdirecc Gen Adicc, Madrid, Spain.; Valencia, J (corresponding author), Nongovt Org Madrid Posit, Madrid, Spain.	jorge_vlr@yahoo.es	Vázquez-Morón, Sonia/H-7019-2013; RYAN, PABLO/GRF-3462-2022; Troya-García, Jesus/Y-9721-2019; Resino, Salvador/B-2430-2008; Ryan, Pablo/AAM-1924-2021	Vázquez-Morón, Sonia/0000-0002-0977-741X; RYAN, PABLO/0000-0002-4212-7419; Troya-García, Jesus/0000-0001-7323-114X; Resino, Salvador/0000-0001-8783-0450; Ryan, Pablo/0000-0002-4212-7419; Alvaro-Meca, Alejandro/0000-0003-1315-4386; valencia, jorge/0000-0002-0148-2422	Gilead Sciences; ViiV; Merck; Janssen; Abbott; BoehringerIngelheim; Bristol-Myers Squibb; Gilead; Glaxo Smith Kline; Janssen Cilag; Merck SharpDohme; Pfizer; Roche; Schering Plough; AbbVie	Gilead Sciences(Gilead Sciences); ViiV; Merck(Merck & Company); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Abbott(Abbott Laboratories); BoehringerIngelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Glaxo Smith Kline(GlaxoSmithKline); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck SharpDohme(Merck & Company); Pfizer(Pfizer); Roche(Roche Holding); Schering Plough(Merck & CompanySchering Plough Corporation); AbbVie(AbbVie)	JV has received research grants and honoraria for lectures from Gilead Sciences and travel grants from Gilead Sciences, ViiV, Merck and Janssen; SM has been involved in speaking activities and has received grants for research from Abbott, Boehringer&Ingelheim, Bristol-Myers Squibb, Gilead, Glaxo Smith Kline, Janssen Cilag, Merck Sharp&Dohme, Pfizer, Roche, and Schering Plough.; JT has received honoraria for talks from Gilead and Merck; PR has received grant/research support from Merck, Gilead, Janssen, AbbVie and ViiV. Other authors declare that they have no conflicts of interest.	Azim T, 2015, INT J DRUG POLICY, V26, pS16, DOI 10.1016/j.drugpo.2014.09.003; Bourgois P, 2004, HUM ORGAN, V63, P253, DOI 10.17730/humo.63.3.h1phxbhrb7m4mlv0; Boyd J, 2018, ADDICTION, V113, P2261, DOI 10.1111/add.14417; Caldentey C, 2017, ADICCIONES, V29, P172, DOI 10.20882/adicciones.738; Cascardi M, 2016, PSYCHOL VIOLENCE, V6, DOI 10.1037/vio0000013; Collazo-Vargas EM, 2018, P R HEALTH SCI J, V37, P88; Davis A, 2017, INT J STD AIDS, V28, P1397, DOI 10.1177/0956462417708678; Degenhardt L, 2017, LANCET GLOB HEALTH, V5, pE1192, DOI 10.1016/S2214-109X(17)30375-3; Doherty MC, 2000, AIDS, V14, P717, DOI 10.1097/00002030-200004140-00011; El-Bassel N, 2012, CURR OPIN HIV AIDS, V7, P326, DOI 10.1097/COH.0b013e3283536ab2; El-Bassel N, 2011, SUBST USE MISUSE, V46, P295, DOI 10.3109/10826084.2011.523296; Evans JL, 2003, J URBAN HEALTH, V80, P137, DOI 10.1093/jurban/jtg137; Fernandez-Montalvo J, 2011, ADICCIONES, V23, P5, DOI 10.20882/adicciones.161; Gilbert L, 2017, DRUG ALCOHOL REV, V36, P125, DOI 10.1111/dar.12437; Higgins JA, 2010, AM J PUBLIC HEALTH, V100, P435, DOI 10.2105/AJPH.2009.159723; Iversen J, 2015, JAIDS-J ACQ IMM DEF, V69, pS176, DOI 10.1097/QAI.0000000000000659; Lansky A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097596; Loeliger KB, 2016, ADDICT BEHAV, V53, P31, DOI 10.1016/j.addbeh.2015.09.013; MacRae R, 2000, AIDS CARE, V12, P505, DOI 10.1080/09540120050123909; Malinowska-Sempruch K, 2015, IMPACT DRUG POLICY W; Meyer JP, 2011, J WOMENS HEALTH, V20, P991, DOI 10.1089/jwh.2010.2328; Morris MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109282; Myers B., 2012, ADV PREVENTIVE MED, V2012, DOI https://doi.org/10.1155/2012/269123; Park JN, 2019, ADDICTION; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Sharma V, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018530; Stoicescu C, 2019, J URBAN HEALTH, V96, P477, DOI 10.1007/s11524-019-00352-6; Tirado-Munoz J, 2018, ARCH WOMEN MENT HLTH, V21, P259, DOI 10.1007/s00737-017-0800-3; Tracy D, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004988	29	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230886	10.1371/journal.pone.0230886	http://dx.doi.org/10.1371/journal.pone.0230886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8HE	32226042	gold, Green Published			2022-12-26	WOS:000535936400024
J	Amano, K; Okuzaki, D; Aikawa, T; Kogo, M				Amano, Katsuhiko; Okuzaki, Daisuke; Aikawa, Tomonao; Kogo, Mikihiko			Indian hedgehog in craniofacial neural crest cells links to skeletal malocclusion by regulating associated cartilage formation and gene expression	FASEB JOURNAL			English	Article						Indian hedgehog; mandibular angle cartilage; nasal cartilage; neural crest cell; RNA-Seq analysis	GROWTH-PLATE; TEMPOROMANDIBULAR-JOINT; CONDITIONAL DELETION; IHH; DIFFERENTIATION; MUTATIONS; ROLES	The frontal craniofacial skeleton derived from neural crest cells is vital for facial structure and masticatory functions. The exact role of Indian hedgehog (Ihh) in facial and masticatory development has not been fully explored. In this study, we generated craniofacial neural crest cells-specific Ihh deletion mice (Wnt1-Cre;Ihh(fl/fl);Tomato(fl/+)) and found the gradual dwarfism without perinatal lethality. Morphological and histological analyses revealed unambiguous craniofacial phenotypes in mutants, where we observed skeletal malocclusion accompanied by markedly hypoplastic nasomaxillary complex and reversed incisor occlusion. Both the replacement of nasal concha cartilage by turbinate bones and the endochondral ossification of nasal septum ethmoid bone were substantially delayed. We also observed hypoplastic mandibles in mutants where the mandibular ramus was unexpectedly the most affected. Both the condylar process and mandibular angle cartilages were distorted. However, dental examination showed no significant changes in teeth and dentition. Finally, a comprehensive RNA sequence analysis utilizing condylar cartilage identified Ihh-associated gene network including several cell cycle genes and 16 genes related to the extracellular matrix, sulfate transporters, transcription factors, receptors, a ciliogenesis factor, and an adhesion molecule. Our data provide direct in vivo evidence that Ihh plays crucial roles in midface and masticatory system formation, likely by activating key genes.	[Amano, Katsuhiko; Aikawa, Tomonao; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan; [Okuzaki, Daisuke] Osaka Univ, Microbial Dis Res Inst, Genome Informat Res Ctr, Suita, Osaka, Japan	Osaka University; Osaka University	Amano, K (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	k-tenno@dent.osaka-u.ac.jp	Okuzaki, Daisuke/AAN-5641-2020; Kogo, Mikihiko/ABD-7080-2020; Aikawa, Tomonao/AAV-2302-2021	Okuzaki, Daisuke/0000-0002-4552-783X; Kogo, Mikihiko/0000-0002-4556-2491; Aikawa, Tomonao/0000-0001-6906-6874	MEXT | Japan Society for the Promotion of Science (JSPS) [16K20572]; Takeda Medical Research Foundation	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Medical Research Foundation	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 16K20572; Takeda Medical Research Foundation	Abzhanov A, 2007, DEVELOPMENT, V134, P3133, DOI 10.1242/dev.002709; Amano K, 2015, J BONE MINER RES, V30, P2262, DOI 10.1002/jbmr.2582; Amano K, 2014, J BIOL CHEM, V289, P24898, DOI 10.1074/jbc.M114.570507; Bren-Mattison Y, 2011, DEV BIOL, V356, P486, DOI 10.1016/j.ydbio.2011.06.002; da Fontoura CSG, 2015, J DENT RES, V94, P913, DOI 10.1177/0022034515581643; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; Hellemans J, 2003, AM J HUM GENET, V72, P1040, DOI 10.1086/374318; Kurio N, 2018, MATRIX BIOL, V67, P15, DOI 10.1016/j.matbio.2018.02.011; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lewis AE, 2013, DEV BIOL, V379, P229, DOI 10.1016/j.ydbio.2013.04.026; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; Ochiai T, 2010, J DENT RES, V89, P349, DOI 10.1177/0022034510363078; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; Shibukawa Y, 2007, DEV DYNAM, V236, P426, DOI 10.1002/dvdy.21036; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Uribe LMM, 2015, ORTHOD CRANIOFAC RES, V18, P91, DOI 10.1111/ocr.12083; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Wei X, 2016, J DENT RES, V95, P1221, DOI 10.1177/0022034516651823; Yang L, 2016, CELL TISSUE RES, V364, P105, DOI 10.1007/s00441-015-2306-5; Young B, 2006, DEV BIOL, V299, P272, DOI 10.1016/j.ydbio.2006.07.028	20	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6791	6807		10.1096/fj.201903269R	http://dx.doi.org/10.1096/fj.201903269R		MAR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32223017	Bronze			2022-12-26	WOS:000522485600001
J	Lu, QX; Scott, PA; Vukmanic, EV; Kaplan, HJ; Dean, DC; Li, QT				Lu, Qingxian; Scott, Patrick A.; Vukmanic, Eric V.; Kaplan, Henry J.; Dean, Douglas C.; Li, Qiutang			Yap1 is required for maintenance of adult RPE differentiation	FASEB JOURNAL			English	Article						dedifferentiation; EMT; eye; knockout; RPE65; Wnt/beta-catenin	RETINAL-PIGMENT EPITHELIUM; HIPPO SIGNALING PATHWAY; TRANSGENIC SWINE MODEL; ORGAN SIZE CONTROL; BETA-CATENIN; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; ALPHA-CATENIN; PROTEIN RPE65; STEM-CELLS	Nuclear YAP1 plays a critical role in regulation of stem cell proliferation, tissue regeneration, and organ size in many types of epithelia. Due to rapid turnover of most epithelial cell types, the cytoplasmic function of YAP1 in epithelial cells has not been well studied. The retinal pigment epithelium (RPE) is a highly polarized epithelial cell type maintained at a senescence state, and offers an ideal cell model to study the active role of YAP1 in maintenance of the adult epithelial phenotype. Here, we show that the cytoplasmic function of YAP1 is essential to maintain adult RPE differentiation. Knockout of Yap1 in the adult mouse RPE caused cell depolarization and tight junction breakdown, and led to inhibition of RPE65 expression, diminishment of RPE pigments, and retraction of microvilli and basal infoldings. These changes in RPE further prompted the loss of adjacent photoreceptor outer segments and photoreceptor death, which eventually led to decline of visual function in older mice between 6 and 12 months of age. Furthermore, nuclear beta-catenin and its activity were significantly increased in mutant RPE. These results suggest that YAP1 plays an important role in active inhibition of Wnt/beta-catenin signaling, and is essential for downregulation of beta-catenin nuclear activity and prevention of dedifferentiation of adult RPE.	[Lu, Qingxian; Scott, Patrick A.; Vukmanic, Eric V.; Kaplan, Henry J.; Dean, Douglas C.; Li, Qiutang] Univ Louisville, Sch Med, Dept Ophthalmol & Visual Sci, 301 East Muhammad Ali Blvd, Louisville, KY 40202 USA	University of Louisville	Li, QT (corresponding author), Univ Louisville, Sch Med, Dept Ophthalmol & Visual Sci, 301 East Muhammad Ali Blvd, Louisville, KY 40202 USA.	q.li@louisville.edu			HHS | NIH | National Eye Institute (NEI) [EY027033]	HHS | NIH | National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	HHS | NIH | National Eye Institute (NEI), Grant/Award Number: EY027033	Asaoka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097365; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Burke JM, 2008, PROG RETIN EYE RES, V27, P579, DOI 10.1016/j.preteyeres.2008.08.002; Cabochette P, 2015, ELIFE, V4, DOI 10.7554/eLife.08488; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chen HC, 2012, LAB INVEST, V92, P676, DOI 10.1038/labinvest.2011.201; de Castro JPF, 2014, INVEST OPHTH VIS SCI, V55, P2460, DOI 10.1167/iovs.13-13724; Defoe DM, 2007, MOL VIS, V13, P273; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Elbediwy A, 2016, DEVELOPMENT, V143, P1674, DOI 10.1242/dev.133728; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Jiang Q, 2009, BIOCHEM BIOPH RES CO, V384, P114, DOI 10.1016/j.bbrc.2009.04.070; Kim JY, 2016, DEV BIOL, V419, P336, DOI 10.1016/j.ydbio.2016.09.001; Kodaka M, 2015, CELL MOL LIFE SCI, V72, P285, DOI 10.1007/s00018-014-1742-9; Lee Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04757-w; Liu YQ, 2009, INVEST OPHTH VIS SCI, V50, P5080, DOI 10.1167/iovs.08-2911; Mahoney JE, 2014, DEV CELL, V30, P137, DOI 10.1016/j.devcel.2014.06.003; Manes G, 1998, FEBS LETT, V423, P133, DOI 10.1016/S0014-5793(98)00081-7; Miesfeld JB, 2015, DEVELOPMENT, V142, P3021, DOI 10.1242/dev.119008; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nazari H, 2015, PROG RETIN EYE RES, V48, P1, DOI 10.1016/j.preteyeres.2015.06.004; Noel JM, 2012, EXP EYE RES, V97, P137, DOI 10.1016/j.exer.2011.12.018; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Robinson BS, 2011, CURR BIOL, V21, pR890, DOI 10.1016/j.cub.2011.09.019; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Sambandam SAT, 2015, J INVEST DERMATOL, V135, P1621, DOI 10.1038/jid.2015.42; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Scott PA, 2014, INVEST OPHTH VIS SCI, V55, P2452, DOI 10.1167/iovs.13-13723; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Ulsamer A, 2012, J BIOL CHEM, V287, P5164, DOI 10.1074/jbc.M111.322123; Umazume K, 2014, AM J PATHOL, V184, P1419, DOI 10.1016/j.ajpath.2014.01.022; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Wolf G, 2005, NUTR REV, V63, P97, DOI 10.1111/j.1753-4887.2005.tb00127.x; Yoshida K, 2004, ANAT EMBRYOL, V208, P145, DOI 10.1007/s00429-004-0382-5; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, J CELL SCI, V123, P4001, DOI 10.1242/jcs.069070; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao R, 2014, DEV CELL, V30, P151, DOI 10.1016/j.devcel.2014.06.004	54	2	2	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6757	6768		10.1096/fj.201903234R	http://dx.doi.org/10.1096/fj.201903234R		MAR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32223016	Green Accepted, Bronze			2022-12-26	WOS:000522486200001
J	Li, W; Liu, LL; Luo, ZZ; Han, CY; Wu, QH; Zhang, L; Tian, LS; Yuan, J; Zhang, T; Chen, ZW; Yang, TB; Feng, TJ; Zhang, M; Chen, XS				Li, Wu; Liu, Lan-lan; Luo, Zhen-zhou; Han, Chun-yan; Wu, Qiu-hong; Zhang, Li; Tian, Li-shan; Yuan, Jun; Zhang, Tao; Chen, Zhong-wei; Yang, Tu-bao; Feng, Tie-jian; Zhang, Min; Chen, Xiang-sheng			Associations of sexually transmitted infections and bacterial vaginosis with abnormal cervical cytology: A cross-sectional survey with 9090 community women in China	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; CHLAMYDIA-TRACHOMATIS; RISK; NEOPLASIA; CANCER; PERSISTENCE; DIAGNOSIS; COFACTOR; SYSTEM; HPV	Background Although it is well acknowledged that persistent infection with high-risk human papillomavirus types in genital sites plays a crucial role in the development of squamous cell cervical carcinoma, there is no unanimous consensus on the association between non-HPV sexually transmitted infections and abnormal cervical cytology. Methods In the present study, we evaluated cervical cytology status, sexually transmitted infections and bacterial vaginosis status, and collected social-demographic information among recruited participants to explore the association of STIs and bacterial vaginosis with abnormal cervical cytology. Results 9,090 women's specimens were successfully tested, with a total of 8,733 (96.1%) women had normal cytology and 357 (3.9%) women exhibited abnormal cytology. The prevalence of HPV, Chlamydia trachomatis, Neisseria gonorrhoeae, and bacterial vaginosis was significantly higher in the >= ASC-US group than the NILM group (P<0.05). Women with Neisseria gonorrhoeae infection (AOR = 5.30, 95% CIs = 1.30-21.51, P = 0.020) or bacterial vaginosis (AOR = 1.94, 95% CIs = 1.08-3.47, P = 0.026) exhibited an increased risk of abnormal cervical cytology after adjusted for carcinogenic HPV-positive status. Conclusions Our results demonstrated that Neisseria gonorrhoeae infection in genital sites and/or bacterial vaginosis may independently increase the risk for cervical cytology abnormalities after adjusted for carcinogenic HPV-positive status. Besides, these results improved our understanding of the etiology of abnormal cervical cytology and may be useful for the management of women with ASC-US cytology.	[Li, Wu; Liu, Lan-lan; Luo, Zhen-zhou; Wu, Qiu-hong; Zhang, Li; Tian, Li-shan; Yuan, Jun; Zhang, Tao; Chen, Zhong-wei; Zhang, Min] Shenzhen Nanshan Ctr Chron Dis Control, Shenzhen, Peoples R China; [Han, Chun-yan] Shenzhen Nanshan Matern & Child Healthcare Hosp, Shenzhen, Peoples R China; [Yang, Tu-bao] Cent South Univ, Dept Epidemiol & Hlth Stat, Xiangya Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Feng, Tie-jian] Shenzhen Ctr Chron Dis Control, Shenzhen, Peoples R China; [Chen, Xiang-sheng] Natl Ctr STD Control, Nanjing, Peoples R China	Central South University	Luo, ZZ (corresponding author), Shenzhen Nanshan Ctr Chron Dis Control, Shenzhen, Peoples R China.	paulluo9909@163.com		Li, Wu/0000-0003-3517-4425				Aoyama-Kikawa S, 2018, CANCER SCI, V109, P2003, DOI 10.1111/cas.13608; Arbyn M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008054.pub2; Biernat-Sudolska M, 2011, ADV MED SCI-POLAND, V56, P299, DOI 10.2478/v10039-011-0028-9; Cao SY, 2014, ARCH GYNECOL OBSTET, V290, P1059, DOI 10.1007/s00404-014-3365-7; Rodriguez AC, 2010, JNCI-J NATL CANCER I, V102, P315, DOI 10.1093/jnci/djq001; Chumduri C, 2013, CELL HOST MICROBE, V13, P746, DOI 10.1016/j.chom.2013.05.010; Cox JT, 2005, CLIN OBSTET GYNECOL, V48, P160, DOI 10.1097/01.grf.0000151571.91814.f3; de Abreu ALP, 2016, AM J CANCER RES, V6, P1371; Donders GGG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0086266; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gillet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045201; Hobbs MM, 2013, SEX TRANSM INFECT, V89, P434, DOI 10.1136/sextrans-2013-051057; Jensen KE, 2013, BRIT J CANCER, V108, P234, DOI 10.1038/bjc.2012.513; Jensen KE, 2014, SEX TRANSM INFECT, V90, P550, DOI 10.1136/sextrans-2013-051431; Kadhel P, 2012, HIV MED, V13, P79, DOI 10.1111/j.1468-1293.2011.00939.x; Kim HS, 2016, J GYNECOL ONCOL, V27, DOI 10.3802/jgo.2016.27.e49; Kinney WK, 1998, OBSTET GYNECOL, V91, P973, DOI 10.1016/S0029-7844(98)00080-5; La Vecchia C, 2014, EUR J CANCER PREV, V23, P110, DOI 10.1097/CEJ.0000000000000000; Landy R, 2016, CYTOPATHOLOGY, V27, P201, DOI 10.1111/cyt.12259; Lehtinen M, 2011, SEX TRANSM INFECT, V87, P372, DOI 10.1136/sti.2010.044354; Lukic A, 2006, ANTICANCER RES, V26, P4843; Luo ZZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196516; Nam KH, 2009, J GYNECOL ONCOL, V20, P39, DOI 10.3802/jgo.2009.20.1.39; O'Connell CM, 2016, MICROB CELL, V3, P390, DOI 10.15698/mic2016.09.525; Parthenis C, 2018, INT J INFECT DIS, V73, P72, DOI 10.1016/j.ijid.2018.06.001; Plummer M, 2003, CANCER CAUSE CONTROL, V14, P805, DOI 10.1023/B:CACO.0000003811.98261.3e; Safaeian M, 2010, JNCI-J NATL CANCER I, V102, P1794, DOI 10.1093/jnci/djq436; Samoff E, 2005, AM J EPIDEMIOL, V162, P668, DOI 10.1093/aje/kwi262; Sawaya GF, 2005, JAMA-J AM MED ASSOC, V294, P2210, DOI 10.1001/jama.294.17.2210; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Smith JS, 2002, JNCI-J NATL CANCER I, V94, P1604, DOI 10.1093/jnci/94.21.1604; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Suehiro TT, 2019, INT J GYNECOL CANCER, V29, P242, DOI 10.1136/ijgc-2018-000076; Unemo M, 2017, LANCET INFECT DIS, V17, pE235, DOI [10.1016/s1473-3099(17)30310-9, 10.1016/S1473-3099(17)30310-9]; Verstraelen H, 2009, EXPERT REV ANTI-INFE, V7, P1109, DOI [10.1586/eri.09.87, 10.1586/ERI.09.87]; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang J, 2019, HUM VACC IMMUNOTHER, V15, P2637, DOI [10.1080/21645515.2019.1596713, 10.1080/21645515.2019.1578598]; Yi X, 2014, AM J CLIN PATHOL, V141, P796, DOI 10.1309/AJCP9P2KJSXEKCJB; Yi X, 2011, AM J CLIN PATHOL, V136, P913, DOI 10.1309/AJCPWTZDT0Q7DOVI; You WZ, 2018, EXP THER MED, V15, P412, DOI 10.3892/etm.2017.5357; Zhang YR, 2016, ONCOTARGET, V7, P62411, DOI 10.18632/oncotarget.11498	41	4	5	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230712	10.1371/journal.pone.0230712	http://dx.doi.org/10.1371/journal.pone.0230712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214342	gold, Green Published			2022-12-26	WOS:000535934200042
J	Tochetto, C; Varela, APM; de Lima, DA; Loiko, MR; Scheffer, CM; Paim, WP; Cerva, C; Schmidt, C; Cibulski, SP; Ortiz, LC; Jacques, SMC; Franco, AC; Mayer, FQ; Roehe, PM				Tochetto, Caroline; Muterle Varela, Ana Paula; de Lima, Diane Alves; Loiko, Marcia Regina; Scheffer, Camila Mengue; Paim, Willian Pinto; Cerva, Cristine; Schmidt, Candice; Cibulski, Samuel Paulo; Ortiz, Lucia Cano; Callegari Jacques, Sidia Maria; Franco, Ana Claudia; Mayer, Fabiana Quoos; Roehe, Paulo Michel			Viral DNA genomes in sera of farrowing sows with or without stillbirths	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; RISK-FACTORS; FECAL VIROME; VIRUS; PIGS; SWINE; IDENTIFICATION; SEQUENCE; PIGLETS; VERSION	A study was conducted to investigate the serum virome of sows with and without stillbirths after farrowing. Sera from sows with at least one stillbirth or with normal litters were collected immediately after farrowing. Viral DNA was extracted from serum pools and submitted to high throughput sequencing. No differences in the proportion of virus-related reads were found in both groups (p > 0.05). A variety of viral DNA genomes were identified, mostly representative of three viral families: Anelloviridae, Circoviridae and Smacoviridae. Besides, a number of novel unclassified circular Rep-encoding single stranded DNA (CRESS DNA) viruses were also identified. These findings suggest that the presence of such viral genomes in sows' sera bears no correlation with stillbirths' occurrence; it seems likely that these constitute part of the normal serum microbiome of sows at farrowing.	[Tochetto, Caroline; Muterle Varela, Ana Paula; de Lima, Diane Alves; Loiko, Marcia Regina; Scheffer, Camila Mengue; Cerva, Cristine; Schmidt, Candice; Ortiz, Lucia Cano; Franco, Ana Claudia; Roehe, Paulo Michel] Univ Fed Rio Grande do Sul, Lab Virol, Dept Microbiol Imunol & Parasitol, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil; [Paim, Willian Pinto; Cibulski, Samuel Paulo] Univ Fed Rio Grande do Sul, Lab Virol, Fac Vet, Porto Alegre, RS, Brazil; [Cerva, Cristine; Mayer, Fabiana Quoos] Secretaria Estadual Agr Pecuaria & Desenvolviment, Lab Biol Mol, Ctr Pesquisa Saude Anim, Inst Pesquisas Vet Desiderio Finamor, Eldorado Do Sul, RS, Brazil; [Callegari Jacques, Sidia Maria] Univ Fed Rio Grande do Sul, Dept Estat, Inst Matemat & Estat, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Mayer, FQ (corresponding author), Secretaria Estadual Agr Pecuaria & Desenvolviment, Lab Biol Mol, Ctr Pesquisa Saude Anim, Inst Pesquisas Vet Desiderio Finamor, Eldorado Do Sul, RS, Brazil.	bimmayer@gmail.com	Franco, Ana Cláudia AC/N-4373-2015; ROEHE, PAULO MICHEL/K-1208-2012; MAYER, FABIANA QUOOS/AAV-2264-2020; Mayer, Fabiana Q/K-2279-2015; Loiko, Márcia Regina/AAH-9016-2019; Loiko, Márcia/GRN-8499-2022	ROEHE, PAULO MICHEL/0000-0002-2370-7661; MAYER, FABIANA QUOOS/0000-0002-9324-8536; Mayer, Fabiana Q/0000-0002-9324-8536; Loiko, Márcia Regina/0000-0002-0514-1078; Tochetto, Caroline/0000-0002-9804-6175; Cano-Ortiz, Lucia/0000-0003-0472-5159; Cibulski, Samuel/0000-0003-0503-8692	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [303432/2015-2]; CNPq [421104/2018-0]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CT was in receipt of a Master's' degree fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). - PMR is a research fellow 1A from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grant no 303432/2015-2. - This study was also supported by CNPq grant no 421104/2018-0.	Altan E, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00822-17; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Blome S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040086; Borges VF, 2005, PREV VET MED, V70, P165, DOI 10.1016/j.prevetmed.2005.03.003; BRASIL. Ministerio da Agricultura Pecuaria e Abastecimento, 2017, SIT SAN DOENC AN TER; Carocci M, 2012, VIRULENCE, V3, P351, DOI 10.4161/viru.20573; Cheung AK, 2014, GENOME ANNOUNC, V2; Cheung AK, 2015, ARCH VIROL, V160, P353, DOI 10.1007/s00705-014-2234-9; Cheung AK, 2013, ARCH VIROL, V158, P2157, DOI 10.1007/s00705-013-1701-z; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Higgins D G, 1994, Methods Mol Biol, V25, P307; Jeong J, 2018, TRANSBOUND EMERG DIS, V65, P1641, DOI 10.1111/tbed.12921; Kim AR, 2014, VIRUS GENES, V48, P81, DOI 10.1007/s11262-013-1003-2; Kirkwood R.N., 2012, DIS SWINE, P341; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lima DA, 2019, VIRUS RES, V261, P9, DOI 10.1016/j.virusres.2018.12.005; Lima DA, 2017, J GEN VIROL, V98, P690, DOI 10.1099/jgv.0.000711; Lucia T, 2002, PREV VET MED, V53, P285, DOI 10.1016/S0167-5877(01)00288-4; Maldonado J, 2005, VET J, V169, P454, DOI 10.1016/j.tvjl.2004.05.007; Martinez-Guino L, 2010, THERIOGENOLOGY, V74, P277, DOI 10.1016/j.theriogenology.2010.02.011; Masembe C, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-218; Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116; OIE World Organisation for Animal Health, 2019, WORLD AN HLTH INF DA; Oropeza-Moe M, 2017, PORCINE HEALTH MANAG, V3, DOI 10.1186/s40813-017-0072-3; Orozco BM, 1998, J BIOL CHEM, V273, P24448, DOI 10.1074/jbc.273.38.24448; Parras-Molto M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0507-3; Pensaert MB, 2004, VET MICROBIOL, V98, P175, DOI 10.1016/j.vetmic.2003.10.011; Ramos N, 2018, VET MICROBIOL, V224, P78, DOI 10.1016/j.vetmic.2018.08.029; Rocha DL, IDENTIFICACADO CIRCO; ROEHE PM, 1985, REV MICROBIOL, V16, P117; Rogers AJ, 2017, TRANSBOUND EMERG DIS, V64, P1877, DOI 10.1111/tbed.12586; Rosario K, 2012, ARCH VIROL, V157, P1851, DOI 10.1007/s00705-012-1391-y; Sachsenroder J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034631; Sambrook J., 2001, MOL CLONING LAB MANU; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Sikorski A, 2013, ARCH VIROL, V158, P283, DOI 10.1007/s00705-012-1470-0; Silva GS, 2015, TROP ANIM HEALTH PRO, V47, P445, DOI 10.1007/s11250-014-0745-8; Steel O, 2016, INFECT GENET EVOL, V43, P151, DOI 10.1016/j.meegid.2016.05.008; Teixeira TF, 2015, RES VET SCI, V101, P38, DOI 10.1016/j.rvsc.2015.05.016; Tochetto C, 2018, TRANSBOUND EMERG DIS, V65, P5, DOI 10.1111/tbed.12735; Vanderhaeghe C, 2013, ANIM REPROD SCI, V139, P76, DOI 10.1016/j.anireprosci.2013.03.007; Varsani A, 2018, ARCH VIROL, V163, P2005, DOI 10.1007/s00705-018-3820-z; Wolf VHG, 2008, GENET MOL RES, V7, P509, DOI 10.4238/vol7-2gmr440; Zhang B, 2014, J GEN VIROL, V95, P1603, DOI 10.1099/vir.0.063743-0	46	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230714	10.1371/journal.pone.0230714	http://dx.doi.org/10.1371/journal.pone.0230714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214388	Green Published, gold			2022-12-26	WOS:000535934200043
J	Marcos, A; Moreno, M; Orihuel, J; Ucha, M; de Paz, AM; Higuera-Matas, A; Capellan, R; Crego, AL; Martinez-Larranaga, MR; Ambrosio, E; Anadon, A				Marcos, Alberto; Moreno, Mario; Orihuel, Javier; Ucha, Marcos; de Paz, Ana Ma; Higuera-Matas, Alejandro; Capellan, Roberto; Crego, Antonio L.; Martinez-Larranaga, Maria-Rosa; Ambrosio, Emilio; Anadon, Arturo			The effects of combined intravenous cocaine and ethanol self-administration on the behavioral and amino acid profile of young adult rats	PLOS ONE			English	Article							PLASMA-CONCENTRATIONS; DRUG-ADDICTION; ALCOHOL; COCAETHYLENE; PHENYLALANINE; METABOLOMICS; ACQUISITION; HEROIN; MODELS; URINE	Under paradigms of combined intravenous cocaine and ethanol self-administration, the effects on behavior have been poorly explored. Numerous studies have found sex differences in amino acids profile and behavioral responses to each drug, yet few have focused on the interactions between cocaine and ethanol. The main objective of this work was to explore the acquisition and maintenance of intravenous self-administration behavior with a combination of cocaine and ethanol in male and female young adult rats. Likewise, the amino acids profile in blood plasma was quantified 48 hours after the last self-administration session. Male and female 52 days old Wistar rats were randomly assigned to one of 3 groups: i) saline control, ii) cocaine (1 mg/kg bodyweight/injection) and iii) cocaine and ethanol (1 mg + 133 mg/kg bodyweight/injection). After 24 self-administration sessions carried out on a fixed-ratio-1 schedule, with a limit of 15 doses per session, 14 plasma amino acids were quantified by mean Capillary Electrophoresis technique. The curve of cocaine and ethanol combined self-administration was similar to that associated with cocaine administration alone, with females acquiring self-administration criterion before males. The self-administration of cocaine and ethanol altered the plasma concentration and relative ratios of the amino acid L-Tyrosine. In our intravenous self-administration model, females appeared more vulnerable to acquire abusive consumption of the cocaine and ethanol combination, which altered plasma L-Tyrosine levels.	[Marcos, Alberto; Moreno, Mario; Orihuel, Javier; Ucha, Marcos; Higuera-Matas, Alejandro; Capellan, Roberto; Ambrosio, Emilio] Univ Nacl Educ Distancia, Sch Psychol, Psychobiol Dept, Madrid, Spain; [de Paz, Ana Ma] Univ Nacl Educ Distancia UNED, Fac Psicol, Dept Psicol Basica 1, Madrid, Spain; [Crego, Antonio L.] Univ Alcala, Fac Ciencias, Dept Quim Analit Quim Fis & Ingn Quim, Ctra Madrid Barcelona, Madrid, Spain; [Martinez-Larranaga, Maria-Rosa; Anadon, Arturo] Univ Complutense Madrid, Fac Vet Med, Dept Pharmacol & Toxicol, Madrid, Spain	Universidad Nacional de Educacion a Distancia (UNED); Universidad Nacional de Educacion a Distancia (UNED); Universidad de Alcala; Complutense University of Madrid	Ambrosio, E (corresponding author), Univ Nacl Educ Distancia, Sch Psychol, Psychobiol Dept, Madrid, Spain.	eambrosio@psi.uned.es	Ucha, Marcos/AAP-9978-2020; Orihuel, Javier/AGZ-0536-2022; Capellán Martín, Roberto/AAY-3988-2021; ANADON, ARTURO/L-2201-2014; de Paz Regidor, Ana/H-1167-2018; Higuera-Matas, Alejandro/E-6565-2013; Orihuel, Javier/J-3725-2016	Ucha, Marcos/0000-0002-2786-025X; Moreno Fernandez, Mario/0000-0003-3855-1812; ANADON, ARTURO/0000-0003-4021-0734; de Paz Regidor, Ana/0000-0002-3386-5532; Anadon, Arturo/0000-0002-0580-7204; Marcos, Alberto/0000-0001-7639-6943; Higuera-Matas, Alejandro/0000-0003-3438-9387; Orihuel, Javier/0000-0003-3033-6536	Ministerio de Sanidad, Servicios Sociales e Igualdad [RTA-RD16/017/0022]; Plan Nacional sobre Drogas [2016I073]; Ministerio de Ciencia e Innovacion [PSI2016-80541-P]; European Union [JUST-2017-AG-DRUG-806996/JUSTSO]	Ministerio de Sanidad, Servicios Sociales e Igualdad(Spanish Government); Plan Nacional sobre Drogas; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Union(European Commission)	This work was supported by: Ministerio de Sanidad, Servicios Sociales e Igualdad (Red de Trastornos Adictivos -Grant #RTA-RD16/017/0022 del Instituto de Salud Carlos III), https://sede.isciii.gob.es/anouncements_detail.jsp?pub=10523, EA, AHM, JO, RC; Plan Nacional sobre Drogas, (Grant #2016I073), http://www.pnsd.mscbs.gob.es/, EA, ALC, AM; Ministerio de Ciencia e Innovacion (Grant #PSI2016-80541-P), http://www.ciencia.gob.es/portal/site/MICINN, EA, AHM, JO, RC, MU, MM; European Union (Grant #: European Union, JUST-2017-AG-DRUG-806996/JUSTSO), https://www.eumadness.eu/, EA, AHM.	Altamura C, 1995, EUR NEUROPSYCHOPHARM, V5, P71, DOI 10.1016/0924-977X(95)00033-L; ALTAMURA CA, 1993, AM J PSYCHIAT, V150, P1731; Bell RL, 2017, NEUROPHARMACOLOGY, V122, P201, DOI 10.1016/j.neuropharm.2017.02.004; Bunney EB, 2000, J PHARMACOL EXP THER, V293, P383; CARROLL ME, 1993, PSYCHOPHARMACOLOGY, V110, P5, DOI 10.1007/BF02246944; Carroll ME, 1997, PSYCHOPHARMACOLOGY, V129, P206, DOI 10.1007/s002130050182; Crupp LA, 1981, PYCHOBIOLOGY AUSTIN, V9, P359, DOI [10.1016/0041-008x(92)90210-j, DOI 10.1016/0041-008X(92)90210-J]; DEAN RA, 1992, TOXICOL APPL PHARM, V117, P1, DOI 10.1016/0041-008X(92)90210-J; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; ERIKSSON T, 1980, J PHARM PHARMACOL, V32, P512, DOI 10.1111/j.2042-7158.1980.tb12983.x; FARRE M, 1993, J PHARMACOL EXP THER, V266, P1364; HAGMAN M, 1991, J PHARM PHARMACOL, V43, P625, DOI 10.1111/j.2042-7158.1991.tb03551.x; Hirayama M, 2016, J PARKINSON DIS, V6, P423, DOI 10.3233/JPD-150736; HUXTABLE RJ, 1983, NEUROCHEM INT, V5, P125, DOI 10.1016/0197-0186(83)90019-0; Hyytia P, 1996, PSYCHOPHARMACOLOGY, V125, P248, DOI 10.1007/BF02247335; IKEDA M, 1965, BIOCHEM BIOPH RES CO, V18, P482, DOI 10.1016/0006-291X(65)90778-3; Ikegami A, 2002, PHARMACOL BIOCHEM BE, V72, P787, DOI 10.1016/S0091-3057(02)00738-4; Ivanova T, 2003, J NEUROBIOL, V54, P638, DOI 10.1002/neu.10193; JATLOW P, 1991, LIFE SCI, V48, P1787, DOI 10.1016/0024-3205(91)90217-Y; Johnson ML, 2010, J NEUROENDOCRINOL, V22, P226, DOI 10.1111/j.1365-2826.2010.01964.x; Levasseur A., 2019, CURR OPIN ENDOCR MET, V8, P60, DOI [10.1016/j.coemr.2019.07.008, DOI 10.1016/J.COEMR.2019.07.008]; Lindholm S, 2001, BRAIN RES, V915, P176, DOI 10.1016/S0006-8993(01)02847-5; Liu YY, 2018, DRUG ALCOHOL DEPEN, V192, P16, DOI 10.1016/j.drugalcdep.2018.07.025; Lynch WJ, 1999, PSYCHOPHARMACOLOGY, V144, P77, DOI 10.1007/s002130050979; McCance-Katz EF, 1998, BIOL PSYCHIAT, V44, P250, DOI 10.1016/S0006-3223(97)00426-5; Nicholas PC, 2008, CHEM RES TOXICOL, V21, P408, DOI 10.1021/tx700324t; Lorenzo MP, 2013, ELECTROPHORESIS, V34, P1701, DOI 10.1002/elps.201200632; PEREZREYES M, 1992, LIFE SCI, V51, P553, DOI 10.1016/0024-3205(92)90224-D; RAFLA FK, 1979, J ANAL TOXICOL, V3, P59, DOI 10.1093/jat/3.2.59; Rounsaville BJ, 2003, DRUG ALCOHOL DEPEN, V70, P117, DOI 10.1016/S0376-8716(03)00033-4; Sanchez-Lopez E, 2017, J PHARM BIOMED ANAL, V140, P13; SCHECHTER MD, 1995, PHARMACOL BIOCHEM BE, V51, P549, DOI 10.1016/0091-3057(95)00053-Y; SHAW S, 1978, GASTROENTEROLOGY, V74, P677; SMITH SG, 1976, PHYSIOL PSYCHOL, V4, P91; TENNANT FS, 1985, AM J PSYCHIAT, V142, P1200; Wang L, 2016, BIOMARKERS, V21, P678, DOI 10.1080/1354750X.2016.1201530; WEISS F, 1993, J PHARMACOL EXP THER, V267, P250; Winger G, 2007, PSYCHOPHARMACOLOGY, V193, P587, DOI 10.1007/s00213-007-0809-9; Zaitsu K, 2016, DRUG METAB PHARMACOK, V31, P21, DOI 10.1016/j.dmpk.2015.10.002; Zaitsu K, 2014, ANAL BIOANAL CHEM, V406, P1339, DOI 10.1007/s00216-013-7234-1; Zavala M, 2001, REV NEUROLOGIA, V33, P401, DOI 10.33588/rn.3305.2001093	41	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0227044	10.1371/journal.pone.0227044	http://dx.doi.org/10.1371/journal.pone.0227044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GC	32203565	Green Published, gold			2022-12-26	WOS:000535303900002
J	Cho, MS; Park, CH; Lee, S; Park, HS				Cho, Min-Sun; Park, Chul Hwan; Lee, Sungsoo; Park, Heae Surng			Clinicopathological parameters for circulating tumor DNA shedding in surgically resected non-small cell lung cancer with EGFR or KRAS mutation	PLOS ONE			English	Article							OF-AMERICAN-PATHOLOGISTS; BLOOD-PLASMA; GEFITINIB; RESISTANCE; ORIGIN; RARE; IV	Background Circulating tumor DNA (ctDNA) is cell-free DNA that is released into peripheral blood by tumor cells. ctDNA harbors somatic mutations and mutant ctDNA obtained from blood can be used as a biomarker in advanced non-small cell lung cancer (NSCLC). In this study, we investigated the clinicopathological properties of tumors that shed ctDNA in surgically resected NSCLC patients. Methods Consecutive cases of NSCLC with matching surgically resected tissue specimens and peripheral or specimen blood samples were eligible for this study. EGFR and KRAS mutations in plasma ctDNA and formalin-fixed paraffin-embedded tissue were analyzed using peptide nucleic acid clamping-assisted method. The plasma and tissue results were compared according to clinicopathological features. Results Mutation analyses were available for 36 cases. EGFR and KRAS mutations were present in 41.7% (15/36) and 16.7% (6/36) of tissue samples, respectively. Among EGFR and KRASmutant tumors, plasma mutation detection sensitivity was 13.3% (2/15) for EGFR and 33.3% (2/6) for KRAS. The presence of ctDNA in plasma was significantly associated with higher pathological tumor stage (p = 0.028), nodal metastasis (p = 0.016), solid adenocarcinoma pattern (p = 0.003), tumor necrosis (p = 0.012), larger primary tumor diameter (p = 0.002) or volume (p = 0.002), and frequent mitosis (p = 0.018) in tissue specimens. All tumors larger than 4 cm in maximal diameter or 25 cm(3) in volume shed ctDNA in plasma. In subgroup analysis among EGFR mutated adenocarcinoma, ctDNA was significantly associated with nodal metastasis (p = 0.029), vascular invasion (p = 0.029), solid adenocarcinoma pattern (p = 0.010), and tumor necrosis (p = 0.010), high mitotic rate (p = 0.009), large pathological tumor size (p = 0.027), and large tumor volume on CT (p = 0.027). Conclusion We suggest that primary or total tumor burden, solid adenocarcinoma morphology, tumor necrosis, and frequent mitosis could predict ctDNA shedding in pulmonary adenocarcinoma.	[Cho, Min-Sun; Park, Heae Surng] Ewha Womans Univ, Coll Med, Dept Pathol, Seoul Hosp, Seoul, South Korea; [Park, Chul Hwan] Yonsei Univ, Gangnam Severance Hosp, Res Inst Radiol Sci, Dept Radiol,Coll Med, Seoul, South Korea; [Lee, Sungsoo] Yonsei Univ, Gangnam Severance Hosp, Dept Thorac & Cardiovasc Surg, Coll Med, Seoul, South Korea	Ewha Womans University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, HS (corresponding author), Ewha Womans Univ, Coll Med, Dept Pathol, Seoul Hosp, Seoul, South Korea.	turtle98p@naver.com		Park, Chul Hwan/0000-0002-0004-9475; Lee, Sungsoo/0000-0001-8998-9510	Ewha Womans University	Ewha Womans University	This study was supported by the Ewha Womans University Research Grant of 2019.	Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; Alsdorf WH, 2013, EXP MOL PATHOL, V94, P155, DOI 10.1016/j.yexmp.2012.09.016; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Chen KZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31985; Douillard JY, 2014, BRIT J CANCER, V110, P55, DOI 10.1038/bjc.2013.721; Guo NN, 2016, SCI REP-UK, V6, DOI 10.1038/srep33519; Han JY, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2678-2; Herbreteau G, 2019, J THORAC DIS, V11, pS113, DOI 10.21037/jtd.2018.12.18; Jahr S, 2001, CANCER RES, V61, P1659; Lee Y, 2018, THORAC CANCER, V9, P1104, DOI 10.1111/1759-7714.12793; Lindeman NI, 2018, ARCH PATHOL LAB MED, V142, P321, DOI 10.5858/arpa.2017-0388-CP; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Merker JD, 2018, J CLIN ONCOL, V36, P1631, DOI 10.1200/JCO.2017.76.8671; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Redig AJ, 2016, JAMA ONCOL, V2, P1240, DOI 10.1001/jamaoncol.2016.1304; Sacher AG, 2017, J THORAC ONCOL, V12, P1344, DOI 10.1016/j.jtho.2017.05.022; Schwarzenbach H, 2009, CLIN CANCER RES, V15, P1032, DOI 10.1158/1078-0432.CCR-08-1910; Stanta G, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00085; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Uchida J, 2015, CLIN CHEM, V61, P1191, DOI 10.1373/clinchem.2015.241414; Wan R, 2017, J THORAC ONCOL, V12, P1376, DOI 10.1016/j.jtho.2017.05.011; Yatabe Y, 2011, J CLIN ONCOL, V29, P2972, DOI 10.1200/JCO.2010.33.3906; Zhao X, 2013, RESPIRATION, V85, P119, DOI 10.1159/000338790	24	26	26	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0230622	10.1371/journal.pone.0230622	http://dx.doi.org/10.1371/journal.pone.0230622			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196518	gold, Green Published			2022-12-26	WOS:000535303100041
J	DeLeon, TT; Almquist, DR; Kipp, BR; Langlais, BT; Mangold, A; Winters, JL; Kosiorek, HE; Joseph, RW; Dronca, RS; Block, MS; McWilliams, RR; Kottschade, LA; Rumilla, KM; Voss, JS; Seetharam, M; Sekulic, A; Markovic, SN; Bryce, AH				DeLeon, Thomas T.; Almquist, Daniel R.; Kipp, Benjamin R.; Langlais, Blake T.; Mangold, Aaron; Winters, Jennifer L.; Kosiorek, Heidi E.; Joseph, Richard W.; Dronca, Roxana S.; Block, Matthew S.; McWilliams, Robert R.; Kottschade, Lisa A.; Rumilla, Kandelaria M.; Voss, Jesse S.; Seetharam, Mahesh; Sekulic, Aleksandar; Markovic, Svetomir N.; Bryce, Alan H.			Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations	PLOS ONE			English	Article							CUTANEOUS MELANOMA; BRAF; EXPRESSION; LANDSCAPE	Background CDKN2A and TP53 mutations are recurrent events in melanoma, occurring in 13.3% and 15.1% of cases respectively and are associated with poorer outcomes. It is unclear what effect CDKN2A and TP53 mutations have on the clinical outcomes of patients treated with checkpoint inhibitors. Methods All patients with cutaneous melanoma or melanoma of unknown primary who received checkpoint inhibitor therapy and underwent genomic profiling with the 50-gene Mayo Clinic solid tumor targeted cancer gene panel were included. Patients were stratified according to the presence or absence of mutations in BRAF, NRAS, CDKN2A, and TP53. Patients without mutations in any of these genes were termed quadruple wild type (Quad(WT)). Clinical outcomes including median time to progression (TTP), median overall survival (OS), 6-month and 12-month OS, 6-month and 12-month without progression, ORR and disease control rate (DCR) were analyzed according to the mutational status of CDKN2A, TP53 and Quad(WT). Results A total of 102 patients were included in this study of which 14 had mutations of CDKN2A (CDKN2A(mut)), 21 had TP53 mutations (TP53(mut)), and 12 were Quad(WT). TP53(mut), CDKN2A-(mut) and Quad(WT) mutational status did not impact clinical outcomes including median TTP, median OS, 6-month and 12-month OS, 6-month and 12-month without progression, ORR and DCR. There was a trend towards improved median TTP and DCR in CDKN2A(mut) cohort and a trend towards worsened median TTP in the Quad(WT) cohort. Conclusion Cell cycle regulators such as TP53 and CDKN2A do not appear to significantly alter clinical outcomes when immune checkpoint inhibitors are used.	[DeLeon, Thomas T.; Almquist, Daniel R.; Seetharam, Mahesh; Bryce, Alan H.] Mayo Clin Arizona, Dept Hematol & Oncol, Scottsdale, AZ 85259 USA; [Kipp, Benjamin R.; Winters, Jennifer L.; Rumilla, Kandelaria M.; Voss, Jesse S.] Mayo Clin Rochester, Dept Lab Med & Pathol, Rochester, MN USA; [Langlais, Blake T.; Kosiorek, Heidi E.] Mayo Clin Arizona, Dept Biostat, Scottsdale, AZ USA; [Mangold, Aaron; Sekulic, Aleksandar] Mayo Clin Arizona, Dept Dermatol, Scottsdale, AZ USA; [Joseph, Richard W.; Dronca, Roxana S.; Block, Matthew S.; McWilliams, Robert R.; Kottschade, Lisa A.; Markovic, Svetomir N.] Mayo Clin Rochester, Dept Hematol & Oncol, Rochester, MN USA; [Sekulic, Aleksandar] Mayo Clin Canc Ctr, Phoenix, AZ USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Bryce, AH (corresponding author), Mayo Clin Arizona, Dept Hematol & Oncol, Scottsdale, AZ 85259 USA.	Bryce.Alan@Mayo.edu	Bryce, Alan/W-1765-2019	Bryce, Alan/0000-0002-0206-3895; Mangold, Aaron/0000-0001-6873-1705				Bennett DC, 2016, PIGM CELL MELANOMA R, V29, P122, DOI 10.1111/pcmr.12422; Busch C, 2010, J INVEST DERMATOL, V130, P2514, DOI 10.1038/jid.2010.138; Carlino MS, 2014, BRIT J CANCER, V111, P292, DOI 10.1038/bjc.2014.287; Cullen SP, 2008, CELL DEATH DIFFER, V15, P251, DOI 10.1038/sj.cdd.4402244; Dixon H, 2002, CELL CYCLE, V1, P362, DOI 10.4161/cc.1.6.257; Dovey M, 2009, ZEBRAFISH, V6, P397, DOI 10.1089/zeb.2009.0606; Gallagher SJ, 2008, NEOPLASIA, V10, P1231, DOI 10.1593/neo.08702; Goel VK, 2009, ONCOGENE, V28, P2289, DOI 10.1038/onc.2009.95; Grafstrom E, 2005, CLIN CANCER RES, V11, P2991, DOI 10.1158/1078-0432.CCR-04-1731; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Iwadate Y, 2000, INT J ONCOL, V17, P501; Jakob JA, 2012, CANCER-AM CANCER SOC, V118, P4014, DOI 10.1002/cncr.26724; Johnson DB, 2015, CANCER IMMUNOL RES, V3, P288, DOI 10.1158/2326-6066.CIR-14-0207; Kato S, 2016, JNCI-J NATL CANCER I, V108, P5780, DOI [10.1200/JCO.2009.22.8239, DOI 10.1200/JCO.2009.22.8239]; Kim DW, 2017, CANCER-AM CANCER SOC, V123, P1372, DOI 10.1002/cncr.30463; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Rothberg BEG, 2009, J CLIN ONCOL, V27, P5772, DOI 10.1200/JCO.2009.22.8239; Rudolf K, 2010, NEOPLASMA, V57, P316, DOI 10.4149/neo_2010_04_316; Shain AH, 2015, NEW ENGL J MED, V373, P1926, DOI 10.1056/NEJMoa1502583; Viros A, 2014, NATURE, V511, P478, DOI 10.1038/nature13298; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yu H, 2009, AM J PATHOL, V174, P2367, DOI 10.2353/ajpath.2009.081057; Zhang J, 2017, CELL CYCLE, V16, P1193, DOI 10.1080/15384101.2017.1320005; Zhang TW, 2016, PIGM CELL MELANOMA R, V29, P266, DOI 10.1111/pcmr.12459	25	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0230306	10.1371/journal.pone.0230306	http://dx.doi.org/10.1371/journal.pone.0230306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196516	Green Published, gold			2022-12-26	WOS:000535303100026
J	Schaffer, AL; Pearson, SA; Perez-Concha, O; Dobbins, T; Ward, RL; van Leeuwen, MT; Rhee, JJ; Laaksonen, MA; Craigen, G; Vajdic, CM				Schaffer, Andrea L.; Pearson, Sallie-Anne; Perez-Concha, Oscar; Dobbins, Timothy; Ward, Robyn L.; van Leeuwen, Marina T.; Rhee, Joel J.; Laaksonen, Maarit A.; Craigen, Glynis; Vajdic, Claire M.			Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP)	PLOS ONE			English	Article							EMERGENCY PRESENTATION; PREVALENCE; PREDICTORS; CARCINOMA; OUTCOMES; FRAILTY; COHORT; POOR; CARE	Background Cancer of unknown primary (CUP) is a late-stage malignancy with poor prognosis, but we know little about what diagnostic tests and procedures people with CUP receive prior to diagnosis. The purpose of this study was to determine how health service utilisation prior to diagnosis for people with cancer-registry notified CUP differs from those notified with metastatic cancer of known primary. Methods We identified people with a cancer registry notification of CUP (n = 327) from the 45 and Up Study, a prospective cohort of 266,724 people >= 45 years in New South Wales, Australia, matched with up to three controls with a diagnosis of metastatic cancer of known primary (n = 977). Baseline questionnaire data were linked to population health data to identify all health service use, diagnostic tests, and procedures in the month of diagnosis and 3 months prior. We used conditional logistic regression to estimate adjusted odds ratios (ORs) and 95% confidence intervals (CIs). Results After adjusting for age and educational attainment, people with a cancer-registry notified CUP diagnosis were more likely to be an aged care resident (OR = 2.78, 95%CI 1.37-5.63), have an emergency department visit (OR = 1.65, 95%CI 1.23-2.21), serum tumor marker tests (OR = 1.51, 95%CI 1.12-2.04), or a cytology test without immunohistochemistry (OR = 2.01, 95%CI 1.47-2.76), and less likely to have a histopathology test without immunohistochemistry (OR = 0.43, 95%CI 0.31-0.59). Neither general practitioner, specialist, allied health practitioner or nurse consultations, hospitalisations, nor imaging procedures were associated with a CUP diagnosis. Conclusions The health service and diagnostic pathway to diagnosis differs markedly for people notified with CUP compared to those with metastatic cancer of known primary. While these differences may indicate missed opportunities for earlier detection and appropriate management, for some patients they may be clinically appropriate.	[Schaffer, Andrea L.; Pearson, Sallie-Anne; Perez-Concha, Oscar; van Leeuwen, Marina T.; Laaksonen, Maarit A.; Vajdic, Claire M.] UNSW Sydney, Ctr Big Data Res Hlth, Sydney, NSW, Australia; [Dobbins, Timothy] UNSW Sydney, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Ward, Robyn L.] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia; [Rhee, Joel J.] UNSW Sydney, Ctr Primary Hlth Care & Equ, Sydney, NSW, Australia; [Rhee, Joel J.] Univ Wollongong, Sch Med, Wollongong, NSW, Australia; [Craigen, Glynis] Canc Voices NSW, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; University of Wollongong	Schaffer, AL (corresponding author), UNSW Sydney, Ctr Big Data Res Hlth, Sydney, NSW, Australia.	andrea.schaffer@unsw.edu.au	Laaksonen, Maarit A/O-3467-2016; van Leeuwen, Marina T/AAQ-5339-2021; Dobbins, Timothy/AAS-1422-2020; Schaffer, Andrea L/Q-9121-2016; Perez-Concha, Oscar/AAX-9107-2021	Laaksonen, Maarit A/0000-0002-3676-0787; van Leeuwen, Marina T/0000-0002-1570-2852; Dobbins, Timothy/0000-0003-1841-9056; Schaffer, Andrea L/0000-0002-3701-4997; Perez-Concha, Oscar/0000-0002-8823-7090; Rhee, Joel/0000-0002-5233-2758	Cancer Institute of New South Wales (NSW) Epidemiology Linkage Program Grant [10/EPI/2-06]; National Health and Medical Research Council (NHMRC) Early Career Fellowship [1158763]	Cancer Institute of New South Wales (NSW) Epidemiology Linkage Program Grant; National Health and Medical Research Council (NHMRC) Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Cancer Institute of New South Wales (NSW) Epidemiology Linkage Program Grant (10/EPI/2-06). AS was supported by a National Health and Medical Research Council (NHMRC) Early Career Fellowship (1158763). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel GA, 2015, BRIT J CANCER, V112, pS129, DOI 10.1038/bjc.2015.52; Australian Institute of Health and Welfare, 2019, CANC DATA AUSTR; Australian Institute of Health and Welfare, 2019, CANC AUSTR 2019; Australian Institute of Health and Welfare, 2017, EM DEP CAR 2016 17 A; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Barbera L, 2010, CAN MED ASSOC J, V182, P563, DOI 10.1503/cmaj.091187; Bottle A, 2012, BRIT J CANCER, V107, P1213, DOI 10.1038/bjc.2012.320; Bradley CJ, 2008, JNCI-J NATL CANCER I, V100, P21, DOI 10.1093/jnci/djm271; Bradley CJ, 2003, J HEALTH CARE POOR U, V14, P503; Brewster DH, 2014, CANCER EPIDEMIOL, V38, P227, DOI 10.1016/j.canep.2014.03.010; Crawford SM, 2017, CLIN ONCOL-UK, V29, pE39, DOI 10.1016/j.clon.2016.09.011; Creighton N, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0537-3; Cretikos MA, 2009, EUROSURVEILLANCE, V14, P28; Cuthbertson CC, 2018, EPIDEMIOLOGY, V29, P556, DOI 10.1097/EDE.0000000000000833; Fizazi K, 2015, ANN ONCOL, V26, pV133, DOI 10.1093/annonc/mdv305; Gilbert T, 2018, LANCET, V391, P1775, DOI 10.1016/S0140-6736(18)30668-8; Handforth C, 2015, ANN ONCOL, V26, P1091, DOI 10.1093/annonc/mdu540; Jones W, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3083-1; Karapetis CS, 2017, INTERN MED J, V47, P408, DOI 10.1111/imj.13373; Kim CS, 2018, CURR ONCOL, V25, P307, DOI 10.3747/co.25.4003; Kim CS, 2015, ACTA ONCOL, V54, P1781, DOI 10.3109/0284186X.2015.1020965; Kojima G, 2015, J AM MED DIR ASSOC, V16, P940, DOI 10.1016/j.jamda.2015.06.025; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Mnatsakanyan E, 2014, CANCER CAUSE CONTROL, V25, P747, DOI 10.1007/s10552-014-0378-2; Murchie P, 2017, BRIT J CANCER, V116, P1148, DOI 10.1038/bjc.2017.71; National Cancer Registration and Analysis Service, 2016, ROUT DIAGN 2015 UPD; National Comprehensive Cancer Network (NCCN), 2018, NCCN CLIN PRACT GUID; National Institute for Health and Care Excellence, 2010, MET MAL DIS UNKN PRI; Pavlidis N, 2012, LANCET, V379, P1428, DOI 10.1016/S0140-6736(11)61178-1; Richardson DB, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2004.014472; Schroten-Loef C, 2018, EUR J CANCER, V101, P77, DOI 10.1016/j.ejca.2018.06.032; Shaw PHS, 2007, CLIN ONCOL-UK, V19, P87, DOI 10.1016/j.clon.2006.09.009; Smith-Gagen Julie, 2019, Cancer Rep Rev, V3, DOI 10.15761/CRR.1000187; Tan SYS, 2018, ASIA-PAC J CLIN ONCO, V14, pe512, DOI 10.1111/ajco.12815; Trevena JA, 2013, AUST HEALTH REV, V37, P649, DOI 10.1071/AH13092; Tsang C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-308; Urban D, 2013, BRIT J CANCER, V109, P1318, DOI 10.1038/bjc.2013.386; Vajdic CM, 2019, CANCER EPIDEMIOL, V61, P1, DOI 10.1016/j.canep.2019.05.001; Vajdic CM, 2019, CANCER EPIDEMIOL, V60, P156, DOI 10.1016/j.canep.2019.04.004; Vajdic CM, 2015, CANCER EPIDEMIOL, V39, P585, DOI 10.1016/j.canep.2015.02.006	40	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230373	10.1371/journal.pone.0230373	http://dx.doi.org/10.1371/journal.pone.0230373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191753	gold, Green Published			2022-12-26	WOS:000535302300041
J	Shibata, N; Ohoka, N; Tsuji, G; Demizu, Y; Miyawaza, K; Ui-Tei, K; Akiyama, T; Naito, M				Shibata, Norihito; Ohoka, Nobumichi; Tsuji, Genichiro; Demizu, Yosuke; Miyawaza, Keiji; Ui-Tei, Kumiko; Akiyama, Tetsu; Naito, Mikihiko			Deubiquitylase USP25 prevents degradation of BCR-ABL protein and ensures proliferation of Ph-positive leukemia cells	ONCOGENE			English	Article							IDENTIFICATION; INHIBITORS; TANKYRASE; FUSIONS; TARGET; GENES; HEAT-SHOCK-PROTEIN-90; BIOTINYLATION; OMACETAXINE; LINE	Fusion genes resulting from chromosomal rearrangements are frequently found in a variety of cancer cells. Some of these are known to be driver oncogenes, such as BCR-ABL in chronic myelogenous leukemia (CML). The products of such fusion genes are abnormal proteins that are ordinarily degraded in cells by a mechanism known as protein quality control. This suggests that the degradation of BCR-ABL protein is suppressed in CML cells to ensure their proliferative activity. Here, we show that ubiquitin-specific protease 25 (USP25) suppresses the degradation of BCR-ABL protein in cells harboring Philadelphia chromosome (Ph). USP25 was found proximal to BCR-ABL protein in cells. Depletion of USP25 using shRNA-mediated gene silencing increased the ubiquitylated BCR-ABL, and reduced the level of BCR-ABL protein. Accordingly, BCR-ABL-mediated signaling and cell proliferation were suppressed in BCR-ABL-positive leukemia cells by the depletion of USP25. We further found that pharmacological inhibition of USP25 induced rapid degradation of BCR-ABL protein in Ph-positive leukemia cells, regardless of their sensitivity to tyrosine kinase inhibitors. These results indicate that USP25 is a novel target for inducing the degradation of oncogenic BCR-ABL protein in Ph-positive leukemia cells. This could be an effective approach to overcome resistance to kinase inhibitors.	[Shibata, Norihito; Ohoka, Nobumichi; Naito, Mikihiko] Natl Inst Hlth Sci, Div Mol Target & Gene Therapy Prod, Kawasaki, Kanagawa 2109501, Japan; [Tsuji, Genichiro; Demizu, Yosuke] Natl Inst Hlth Sci, Div Organ Chem, Kawasaki, Kanagawa 2109501, Japan; [Miyawaza, Keiji] Univ Yamanashi, Grad Sch Med, Dept Biochem, Yamanashi 4093898, Japan; [Ui-Tei, Kumiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; [Ui-Tei, Kumiko] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Chiba 2778561, Japan; [Akiyama, Tetsu] Univ Tokyo, Inst Quantitat Biosci, Lab Mol & Genet Informat, Tokyo 1130032, Japan	National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; University of Yamanashi; University of Tokyo; University of Tokyo; University of Tokyo	Naito, M (corresponding author), Natl Inst Hlth Sci, Div Mol Target & Gene Therapy Prod, Kawasaki, Kanagawa 2109501, Japan.	miki-naito@nihs.go.jp	Demizu, Yosuke/AAE-2839-2022	Demizu, Yosuke/0000-0001-7521-4861; Ui-Tei, Kumiko/0000-0001-8695-9025; SHIBATA, NORIHITO/0000-0001-5792-8510	Japan Society for the Promotion of Science (KAKENHI) [18K07311, 16H05090, 18H05502]; Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development (AMED) [JP17cm0106522j0002]; Takeda Science Foundation	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported, in part, by the Japan Society for the Promotion of Science (KAKENHI Grant Numbers 18K07311 to NS, 16H05090 and 18H05502 to MN), by the Project for Cancer Research and Therapeutic Evolution (P-CREATE) (JP17cm0106522j0002 to NS) from the Japan Agency for Medical Research and Development (AMED), and by the Takeda Science Foundation (to NS).	Altun M, 2011, CHEM BIOL, V18, P1401, DOI 10.1016/j.chembiol.2011.08.018; Alvandi F, 2014, ONCOLOGIST, V19, P94, DOI 10.1634/theoncologist.2013-0077; Choi-Rhee E, 2004, PROTEIN SCI, V13, P3043, DOI 10.1110/ps.04911804; Cronan JE, 2005, J NUTR BIOCHEM, V16, P416, DOI 10.1016/j.jnutbio.2005.03.017; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; Demizu Y, 2016, BIOORG MED CHEM LETT, V26, P4865, DOI 10.1016/j.bmcl.2016.09.041; Deng SS, 2007, BREAST CANCER RES TR, V104, P21, DOI 10.1007/s10549-006-9393-7; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Gandhi V, 2014, CLIN CANCER RES, V20, P1735, DOI 10.1158/1078-0432.CCR-13-1283; Gelmini S, 2004, CANCER LETT, V216, P81, DOI 10.1016/j.canlet.2004.05.010; Gersch M, 2019, MOL CELL, V74, P436, DOI 10.1016/j.molcel.2019.02.030; Harrigan JA, 2018, NAT REV DRUG DISCOV, V17, P57, DOI 10.1038/nrd.2017.152; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Hochhaus A, 2017, NEW ENGL J MED, V376, P917, DOI 10.1056/NEJMoa1609324; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kawaguchi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45037; KISHI K, 1985, LEUKEMIA RES, V9, P381, DOI 10.1016/0145-2126(85)90060-8; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; Lai AC, 2016, ANGEW CHEM INT EDIT, V55, P807, DOI 10.1002/anie.201507634; Lawson AP, 2015, CANCER RES, V75, P5130, DOI 10.1158/0008-5472.CAN-15-1544; Li J, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-166; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Liu B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07510-5; Massimino M, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0805-1; Okabe S, 2010, EXP HEMATOL, V38, P765, DOI 10.1016/j.exphem.2010.04.017; Pal A, 2014, CANCER RES, V74, P4955, DOI 10.1158/0008-5472.CAN-14-1211; Peng C, 2007, CELL CYCLE, V6, P2227, DOI 10.4161/cc.6.18.4722; Peng C, 2007, BLOOD, V110, P678, DOI 10.1182/blood-2006-10-054098; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Reckel S, 2017, LEUKEMIA, V31, P1502, DOI 10.1038/leu.2017.36; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; RUDKIN GT, 1964, SCIENCE, V144, P1229, DOI 10.1126/science.144.3623.1229; Sauer F, 2019, MOL CELL, V74, P421, DOI 10.1016/j.molcel.2019.02.029; Shibata N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31913-5; Shibata N, 2017, CANCER SCI, V108, P1657, DOI 10.1111/cas.13284; Shimokawa K, 2017, ACS MED CHEM LETT, V8, P1042, DOI 10.1021/acsmedchemlett.7b00247; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tanno H, 2014, J BIOL CHEM, V289, P2415, DOI 10.1074/jbc.M113.528372; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tsukahara F, 2010, BLOOD, V116, P3582, DOI 10.1182/blood-2009-10-249623; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Wang WQ, 2015, CELL REP, V13, P524, DOI 10.1016/j.celrep.2015.09.014; Wrigley JD, 2017, ACS CHEM BIOL, V12, P3113, DOI 10.1021/acschembio.7b00334; Xu DC, 2017, GENE DEV, V31, P1024, DOI 10.1101/gad.300889.117	50	15	15	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	19					3867	3878		10.1038/s41388-020-1253-0	http://dx.doi.org/10.1038/s41388-020-1253-0		MAR 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LK4OF	32203161				2022-12-26	WOS:000519342000001
J	Basu, A; Shields, KE; Yap, MNF				Basu, Arnab; Shields, Kathryn E.; Yap, Mee-Ngan F.			The hibernating 100S complex is a target of ribosome-recycling factor and elongation factor G in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribosome; Staphylococcus aureus (S; aureus); GTPase; translation elongation factor; translation regulation; 100S ribosome; bacterial persistence; elongation factor G (EF-G); hibernation; ribosome-recycling factor (RRF)	PROMOTING FACTOR; ESCHERICHIA-COLI; EF-G; PSEUDOMONAS-AERUGINOSA; PROTEIN-SYNTHESIS; EXPRESSION; RRF; TRANSLATION; INITIATION; STABILITY	The formation of translationally inactive 70S dimers (called 100S ribosomes) by hibernation-promoting factor is a widespread survival strategy among bacteria. Ribosome dimerization is thought to be reversible, with the dissociation of the 100S complexes enabling ribosome recycling for participation in new rounds of translation. The precise pathway of 100S ribosome recycling has been unclear. We previously found that the heat-shock GTPase HflX in the human pathogen Staphylococcus aureus is a minor disassembly factor. Cells lacking hflX do not accumulate 100S ribosomes unless they are subjected to heat exposure, suggesting the existence of an alternative pathway during nonstressed conditions. Here, we provide biochemical and genetic evidence that two essential translation factors, ribosome-recycling factor (RRF) and GTPase elongation factor G (EF-G), synergistically split 100S ribosomes in a GTP-dependent but tRNA translocation-independent manner. We found that although HflX and the RRF/EF-G pair are functionally interchangeable, HflX is expressed at low levels and is dispensable under normal growth conditions. The bacterial RRF/EF-G pair was previously known to target only the post-termination 70S complexes; our results reveal a new role in the reversal of ribosome hibernation that is intimately linked to bacterial pathogenesis, persister formation, stress responses, and ribosome integrity.	[Basu, Arnab; Shields, Kathryn E.; Yap, Mee-Ngan F.] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Yap, Mee-Ngan F.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA	Saint Louis University; Northwestern University; Feinberg School of Medicine	Yap, MNF (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA.; Yap, MNF (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	frances.yap@northwestern.edu		Yap, Mee-Ngan F./0000-0003-4213-4050; Basu, Arnab/0000-0002-8048-8733	National Institutes of Health [GM121359]; Department of Defense Award [W81XWH-18-1-0122]; Northwestern University Faculty Start-up fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Award(United States Department of Defense); Northwestern University Faculty Start-up fund	This work was supported by National Institutes of Health Grant GM121359 (to M.-N. Y.), Department of Defense Award W81XWH-18-1-0122 (to M.-N. Y.), and the Northwestern University Faculty Start-up fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akanuma G, 2016, MICROBIOL-SGM, V162, P448, DOI 10.1099/mic.0.000234; Akiyama T, 2017, P NATL ACAD SCI USA, V114, P3204, DOI 10.1073/pnas.1700695114; Basu A, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00426-18; Basu A, 2017, P NATL ACAD SCI USA, V114, pE8165, DOI 10.1073/pnas.1709588114; Basu A, 2016, NUCLEIC ACIDS RES, V44, P4881, DOI 10.1093/nar/gkw180; Beckert B, 2018, NAT MICROBIOL, V3, P1115, DOI 10.1038/s41564-018-0237-0; Beckert B, 2017, EMBO J, V36, P2061, DOI 10.15252/embj.201696189; Boerema AP, 2018, NAT PLANTS, V4, P212, DOI 10.1038/s41477-018-0129-6; BRUCKNER R, 1992, GENE, V122, P187, DOI 10.1016/0378-1119(92)90048-T; Burroughs AM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081981; Caldas T, 2000, J BIOL CHEM, V275, P855, DOI 10.1074/jbc.275.2.855; Cerasi M, 2014, METALLOMICS, V6, P845, DOI 10.1039/c3mt00352c; Chen J, 2014, PLASMID, V76, P1, DOI 10.1016/j.plasmid.2014.08.001; Chen YW, 2017, NUCLEIC ACIDS RES, V45, P10168, DOI 10.1093/nar/gkx694; Coatham ML, 2016, NUCLEIC ACIDS RES, V44, P1952, DOI 10.1093/nar/gkv1524; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; Davis AR, 2014, P NATL ACAD SCI USA, V111, P15379, DOI 10.1073/pnas.1410356111; Dey S, 2018, J CELL BIOL, V217, P2519, DOI 10.1083/jcb.201711131; Dzyubak E, 2016, ANTIMICROB AGENTS CH, V60, P7178, DOI 10.1128/AAC.01806-16; Feaga HA, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00009-20; Franken LE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00718-x; Fu Z, 2016, STRUCTURE, V24, P2092, DOI 10.1016/j.str.2016.09.014; Fuller JR, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00019; Gohara DW, 2018, CURR GENET, V64, P753, DOI 10.1007/s00294-017-0796-2; Hirokawa G, 2004, MOL MICROBIOL, V54, P1011, DOI 10.1111/j.1365-2958.2004.04324.x; Hirokawa G, 2008, NUCLEIC ACIDS RES, V36, P6676, DOI 10.1093/nar/gkn647; Hood RD, 2016, P NATL ACAD SCI USA, V113, pE4867, DOI 10.1073/pnas.1524915113; Iwakura N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177972; Janosi L, 1998, EMBO J, V17, P1141, DOI 10.1093/emboj/17.4.1141; Keiler KC, 2015, NAT REV MICROBIOL, V13, P285, DOI 10.1038/nrmicro3438; Khusainov I, 2017, EMBO J, V36, P2073, DOI 10.15252/embj.201696105; Kline BC, 2015, J BACTERIOL, V197, P581, DOI 10.1128/JB.02223-14; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; Li YL, 2018, P NATL ACAD SCI USA, V115, P8191, DOI 10.1073/pnas.1804555115; Matzov D, 2019, FEBS J, V286, P3558, DOI 10.1111/febs.14968; Matzov D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00753-8; Mckay SL, 2015, ANTIMICROB AGENTS CH, V59, P6992, DOI 10.1128/AAC.01532-15; Medina LMP, 2019, MOL CELL PROTEOMICS, V18, P892, DOI 10.1074/mcp.RA118.001138; Michalik S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10059-w; Mohammad F, 2019, ELIFE, V8, DOI 10.7554/eLife.42591; Mohr D, 2000, EMBO J, V19, P3458, DOI 10.1093/emboj/19.13.3458; Moormeier DE, 2013, APPL ENVIRON MICROB, V79, P3413, DOI 10.1128/AEM.00395-13; Orelle C, 2015, NATURE, V524, P119, DOI 10.1038/nature14862; Polikanov YS, 2012, SCIENCE, V336, P915, DOI 10.1126/science.1218538; Prabhakar A, 2017, CELL REP, V20, P161, DOI 10.1016/j.celrep.2017.06.028; Prossliner T, 2018, ANNU REV GENET, V52, P321, DOI 10.1146/annurev-genet-120215-035130; Puri P, 2014, MOL MICROBIOL, V91, P394, DOI 10.1111/mmi.12468; Qin B, 2016, J MOL BIOL, V428, P3577, DOI 10.1016/j.jmb.2016.05.019; Raj VS, 2005, RNA, V11, P275, DOI 10.1261/rna.7201805; Rodnina MV, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032664; Savelsbergh A, 2000, J MOL BIOL, V300, P951, DOI 10.1006/jmbi.2000.3886; Shcherbakova K, 2015, GENES CELLS, V20, P789, DOI 10.1111/gtc.12273; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Trauner A, 2012, J BIOL CHEM, V287, P24053, DOI 10.1074/jbc.M112.364851; Trosch R, 2019, BIOL CHEM, V400, P879, DOI 10.1515/hsz-2018-0436; Ueta M, 2008, J BIOCHEM, V143, P425, DOI 10.1093/jb/mvm243; Ueta M, 2013, GENES CELLS, V18, P554, DOI 10.1111/gtc.12057; Ueta M, 2010, GENES CELLS, V15, P43, DOI 10.1111/j.1365-2443.2009.01364.x; Williamson KS, 2012, J BACTERIOL, V194, P2062, DOI 10.1128/JB.00022-12; Yamami T, 2005, MOL MICROBIOL, V55, P150, DOI 10.1111/j.1365-2958.2004.04387.x; Yamamoto H, 2016, P NATL ACAD SCI USA, V113, pE1180, DOI 10.1073/pnas.1524554113; Yoshida H, 2014, WIRES RNA, V5, P723, DOI 10.1002/wrna.1242; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016; Zhang LQ, 2006, ARCH BIOCHEM BIOPHYS, V450, P191, DOI 10.1016/j.abb.2006.03.029; Zhang YQ, 2015, NAT STRUCT MOL BIOL, V22, P906, DOI 10.1038/nsmb.3103; Zhou DJ, 2020, NAT STRUCT MOL BIOL, V27, P25, DOI 10.1038/s41594-019-0350-7	66	7	8	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6053	6063		10.1074/jbc.RA119.012307	http://dx.doi.org/10.1074/jbc.RA119.012307			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32209660	hybrid, Green Published			2022-12-26	WOS:000531417300017
J	Capron, A; Stewart, D; Hrywkiw, K; Allen, K; Feau, N; Bilodeau, G; Tanguay, P; Cusson, M; Hamelin, RC				Capron, Arnaud; Stewart, Don; Hrywkiw, Kelly; Allen, Kiah; Feau, Nicolas; Bilodeau, Guillaume; Tanguay, Philippe; Cusson, Michel; Hamelin, Richard C.			In Situ Processing and Efficient Environmental Detection (iSPEED) of tree pests and pathogens using point-of-use real-time PCR	PLOS ONE			English	Article							CLOSTRIDIUM-PERFRINGENS; PHYTOPHTHORA-RAMORUM; RAPID DETECTION; DNA; ASSAY; IDENTIFICATION; AMPLIFICATION; POLYMERASE; TREHALOSE; LAMP	Global trade and climate change are responsible for a surge in foreign invasive species and emerging pests and pathogens across the world. Early detection and surveillance activities are essential to monitor the environment and prevent or mitigate future ecosystem impacts. Molecular diagnostics by DNA testing has become an integral part of this process. However, for environmental applications, there is a need for cost-effective and efficient point-of-use DNA testing to obtain accurate results from remote sites in real-time. This requires the development of simple and fast sample processing and DNA extraction, room-temperature stable reagents and a portable instrument. We developed a point-of-use real-time Polymerase Chain Reaction system using a crude buffer-based DNA extraction protocol and lyophilized, pre-made, reactions for on-site applications. We demonstrate the use of this approach with pathogens and pests covering a broad spectrum of known undesirable forest enemies: the fungi Sphaerulina musiva, Cronartium ribicola and Cronartium comandrae, the oomycete Phytophthora ramorum and the insect Lymantria dispar. We obtained positive DNA identification from a variety of different tissues, including infected leaves, pathogen spores, or insect legs and antenna. The assays were accurate and yielded no false positive nor negative. The shelf-life of the lyophilized reactions was confirmed after one year at room temperature. Finally, successful tests conducted with portable thermocyclers and disposable instruments demonstrate the suitability of the method, named in Situ Processing and Efficient Environmental Detection (iSPEED), for field testing. This kit fits in a backpack and can be carried to remote locations for accurate and rapid detection of pests and pathogens.	[Capron, Arnaud; Hrywkiw, Kelly; Allen, Kiah; Feau, Nicolas; Hamelin, Richard C.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC, Canada; [Stewart, Don; Tanguay, Philippe; Cusson, Michel] Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Quebec City, PQ, Canada; [Bilodeau, Guillaume] Canadian Food Inspect Agcy, Ottawa, ON, Canada; [Cusson, Michel; Hamelin, Richard C.] Univ Laval, Inst Biol Integrat & Syst IBIS, Quebec City, PQ, Canada; [Hamelin, Richard C.] Univ Laval, Fac Foresterie & Geog, Dept Sci Bois & Foret, Quebec City, PQ, Canada	University of British Columbia; Natural Resources Canada; Canadian Forest Service; Canadian Food Inspection Agency; Laval University; Laval University	Hamelin, RC (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC, Canada.; Hamelin, RC (corresponding author), Univ Laval, Inst Biol Integrat & Syst IBIS, Quebec City, PQ, Canada.; Hamelin, RC (corresponding author), Univ Laval, Fac Foresterie & Geog, Dept Sci Bois & Foret, Quebec City, PQ, Canada.	richard.hamelin@ubc.ca	; Hamelin, Richard/F-7006-2010	Guillaume, Bilodeau/0000-0003-1766-229X; Hamelin, Richard/0000-0003-4006-532X	Genome Canada Large Scale Applied Research Program [10106]; Genome Canada Genomics Application Partnership Program [6102]	Genome Canada Large Scale Applied Research Program(Genome Canada); Genome Canada Genomics Application Partnership Program(Genome Canada)	RCH was funded by information Genome Canada Large Scale Applied Research Program #10106 and by a Genome Canada Genomics Application Partnership Program #6102.	Achuff PL, 2010, COSEWIC ASSESSMENT S; Albini S, 2008, VET MICROBIOL, V127, P179, DOI 10.1016/j.vetmic.2007.07.024; [Anonymous], 2016, COUNCIL EUROPEAN UNI; Becherer L, 2018, ANAL CHEM, V90, P4741, DOI 10.1021/acs.analchem.7b05371; BIER J. E., 1939, CANADIAN JOUR RES SECT C BOT SCI, V17, P195; Bilodeau GJ, 2014, PHYTOPATHOLOGY, V104, P733, DOI 10.1094/PHYTO-09-13-0263-R; Bilodeau P, 2019, J PEST SCI, V92, P71, DOI 10.1007/s10340-018-1001-1; Bonizzoni M, 2009, AM J TROP MED HYG, V81, P1030, DOI 10.4269/ajtmh.2009.09-0333; Brasier C, 2010, NATURE, V466, P824, DOI 10.1038/466824a; Chon JW, 2012, J MICROBIOL BIOTECHN, V22, P530, DOI 10.4014/jmb.1107.07064; CLEGG JS, 1965, COMP BIOCHEM PHYSIOL, V14, P135, DOI 10.1016/0010-406X(65)90014-9; Czank A, 1996, TRENDS GENET, V12, P457, DOI 10.1016/0168-9525(96)99992-8; de los Rios A, 2000, PREP BIOCHEM BIOTECH, V30, P145, DOI 10.1080/10826060008544953; Dhillon B, 2015, P NATL ACAD SCI USA, V112, P3451, DOI 10.1073/pnas.1424293112; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; EPPO, EPPO STAND PM 7 DIAG; Feau N, 2019, PLANT PATHOL, V68, P878, DOI 10.1111/ppa.13015; Feau N, 2018, PEERJ, V6, DOI 10.7717/peerj.4392; Feau N, 2016, GENOM DATA, V10, P85, DOI 10.1016/j.gdata.2016.09.013; Feau N, 2010, CAN J PLANT PATHOL, V32, P122, DOI 10.1080/07060661003740009; Fukushima H, 2007, APPL ENVIRON MICROB, V73, P92, DOI 10.1128/AEM.01772-06; Gagnon MC, 2017, PLANT DIS, V101, P666, DOI 10.1094/PDIS-11-16-1586-RE; Grunwald NJ, 2012, TRENDS MICROBIOL, V20, P131, DOI 10.1016/j.tim.2011.12.006; Gurjar AA, 2008, MOL CELL PROBE, V22, P90, DOI 10.1016/j.mcp.2007.08.001; Hamelin RC, 2020, EVOL APPL, V13, P95, DOI 10.1111/eva.12853; Harper SJ, 2010, PHYTOPATHOLOGY, V100, P1282, DOI 10.1094/PHYTO-06-10-0168; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herath P, 2016, BIOL INVASIONS, V18, P1147, DOI 10.1007/s10530-015-1051-8; HIGUCHI R, 1992, BIO-TECHNOL, V10, P413, DOI 10.1038/nbt0492-413; Hiratsuka Y., 1976, Forestry Technical Report, V83; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Joly DL, 2006, PLANT DIS, V90, P1552, DOI 10.1094/PD-90-1552A; Keena MA, 2007, ENVIRON ENTOMOL, V36, P11; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lamarche J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134265; Leslie JF, 2006, FUSARIUM LAB MANUAL; Liebhold A., 1989, Bulletin of the Entomological Society of America, V35, P20; Liu NW, 2017, SCI REP-UK, V7, DOI 10.1038/srep45601; Martin RR, 2000, ANNU REV PHYTOPATHOL, V38, P207, DOI 10.1146/annurev.phyto.38.1.207; McCartney HA, 2003, PEST MANAG SCI, V59, P129, DOI 10.1002/ps.575; MERCIER B, 1990, NUCLEIC ACIDS RES, V18, P5908, DOI 10.1093/nar/18.19.5908; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Montgomery ME, 1990, GYPSY MOTH RES REV 1, P13; Mori Y, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-3; PANACCIO M, 1993, NUCLEIC ACIDS RES, V21, P4656, DOI 10.1093/nar/21.19.4656; R Core Team, 2021, R LANGUAGE ENV STAT; Rizzo DM, 2002, PLANT DIS, V86, P205, DOI 10.1094/PDIS.2002.86.3.205; Roe AD, 2019, J PEST SCI, V92, P51, DOI 10.1007/s10340-018-1027-4; Russell JA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23641-7; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shannon KE, 2007, SCI TOTAL ENVIRON, V382, P121, DOI 10.1016/j.scitotenv.2007.02.039; Spiess AN, 2004, CLIN CHEM, V50, P1256, DOI 10.1373/clinchem.2004.031336; Stewart D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160878; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; USDA-APHIS, PHYT RAM; Valtonen M, 2019, BRIT J SPORT MED, V53, P1093, DOI 10.1136/bjsports-2018-100487; Vincelli P, 2008, PLANT DIS, V92, P660, DOI 10.1094/PDIS-92-5-0660; WETMUR JG, 1991, CRIT REV BIOCHEM MOL, V26, P227, DOI 10.3109/10409239109114069; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Willette DA, 2017, CONSERV BIOL, V31, P1076, DOI 10.1111/cobi.12888; Wise MG, 2005, APPL ENVIRON MICROB, V71, P3911, DOI 10.1128/AEM.71.7.3911-3916.2005; Zhang XA, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.134	62	8	8	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0226863	10.1371/journal.pone.0226863	http://dx.doi.org/10.1371/journal.pone.0226863			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240194	Green Submitted, gold, Green Published			2022-12-26	WOS:000535945000010
J	Lee, YH; Kawakami, K; HuangFu, WC; Liu, IH				Lee, Yen-Hua; Kawakami, Koichi; HuangFu, Wei-Chun; Liu, I-Hsuan			Chondroitin sulfate proteoglycan 4 regulates zebrafish body axis organization via Wnt/planar cell polarity pathway	PLOS ONE			English	Article							NG2 PROTEOGLYCAN; CONVERGENT EXTENSION; MELANOMA; PROTEIN; ACTIVATION; MOVEMENTS; GLYCOSAMINOGLYCAN; GASTRULATION; MIGRATION; RECEPTOR	Pericellular and extracellular proteoglycans play an important role in modulating morphogen gradients and signal transductions. Chondroitin sulfate proteoglycan 4 (Cspg4) is a membrane spanning proteoglycan expressed in immature progenitor cells and cancer cells. Cspg4 participates in cellular events such as proliferation, migration and signal transduction, and these events are generally important for embryo development. In this study, we characterized Cspg4 for its roles in zebrafish embryonic development. Our results demonstrated that cspg4 was maternally expressed from 0 to 3 hours post fertilization (hpf) and expressed in the anterior and posterior embryo end after 9 hpf. Knocking-down cspg4 resulted in a shorter anterior-posterior axis than control embryo, which could be rescued by co-injecting wnt11 mRNA suggesting that Cspg4 regulates body axis organization through modulating the Wnt/planar cell polarity signaling pathway. In addition, overexpressing cspg4 caused cyclopia. The Cspg4 transmembrane domain mutant embryo phenocopied the global overexpression of cspg4 mRNA and led to cyclopia with a very low penetrance. Our results demonstrated that the quantitatively and spatially accurate distribution of Cspg4 is critical for body axis and midline development during gastrulation.	[Lee, Yen-Hua; Liu, I-Hsuan] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Lee, Yen-Hua; Kawakami, Koichi] Natl Inst Genet, Lab Mol & Dev Biol, Mishima, Shizuoka, Japan; [Kawakami, Koichi] Grad Univ Adv Studies, Dept Genet, SOKENDAI, Mishima, Shizuoka, Japan; [HuangFu, Wei-Chun] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Canc Biol & Drug Discovery, Taipei, Taiwan; [Liu, I-Hsuan] Natl Taiwan Univ, Sch Vet Med, Taipei, Taiwan; [Liu, I-Hsuan] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan	National Taiwan University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Taipei Medical University; National Taiwan University; National Taiwan University	Liu, IH (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Liu, IH (corresponding author), Natl Taiwan Univ, Sch Vet Med, Taipei, Taiwan.; Liu, IH (corresponding author), Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan.	ihliu@ntu.edu.tw	Liu, I-Hsuan/D-9043-2017	Liu, I-Hsuan/0000-0002-4524-3263; Lee, Yen-Hua/0000-0001-8812-6094	Ministry of Science and Technology, Taiwan [105-2628-B-002-005-MY4, 105-2917-I-002-033]; Council of Agriculture, Taiwan [107AS-22.1.6-AD-U1(13), 108AS-21.1.7-AD-U1(14)]; National Taiwan University [107L7719, 108L7706]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Council of Agriculture, Taiwan; National Taiwan University(National Taiwan University)	This work was financially supported by Ministry of Science and Technology, Taiwan (105-2628-B-002-005-MY4 to I-Hsuan Liu and 105-2917-I-002-033 to Yen-Hua Lee), Council of Agriculture, Taiwan (107AS-22.1.6-AD-U1(13) and 108AS-21.1.7-AD-U1(14) to I-Hsuan Liu) and National Taiwan University (107L7719 and 108L7706 to I-Hsuan Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen F, 2019, NAT BIOTECHNOL, V37, P64, DOI 10.1038/nbt.4317; Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Burg MA, 1996, J BIOL CHEM, V271, P26110, DOI 10.1074/jbc.271.42.26110; Burg MA, 1997, EXP CELL RES, V235, P254, DOI 10.1006/excr.1997.3674; Campoli M, 2010, ADV CANCER RES, V109, P73, DOI 10.1016/B978-0-12-380890-5.00003-X; Chang NY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167644; Chang YC, 2013, AMINO ACIDS, V44, P615, DOI 10.1007/s00726-012-1386-8; Chatterjee N, 2008, J BIOL CHEM, V283, P8310, DOI 10.1074/jbc.M706074200; Costa C, 2013, TRANSL LUNG CANCER R, V2, P87, DOI 10.3978/j.issn.2218-6751.2013.02.05; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Goretzki L, 1999, J BIOL CHEM, V274, P16831, DOI 10.1074/jbc.274.24.16831; Grako KA, 1999, J CELL SCI, V112, P905; Gritsman K, 2000, DEVELOPMENT, V127, P921; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hill CS, 2018, CURR OPIN CELL BIOL, V51, P50, DOI 10.1016/j.ceb.2017.10.005; Hwangbo C, 2010, CANCER RES, V70, P1645, DOI 10.1158/0008-5472.CAN-09-2447; Iida J, 2007, BIOCHEM J, V403, P553, DOI 10.1042/BJ20061176; Izumikawa T, 2014, SCI REP-UK, V4, DOI 10.1038/srep03701; Izumikawa T, 2010, J BIOL CHEM, V285, P12190, DOI 10.1074/jbc.M110.100941; Kelly C, 2000, DEVELOPMENT, V127, P3899; Kozanoglu I, 2009, CYTOTHERAPY, V11, P527, DOI 10.1080/14653240902923153; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Montero JA, 2003, CURR BIOL, V13, P1279, DOI 10.1016/S0960-9822(03)00505-0; Morgan TH, 1895, J MORPHOL, P10; NISHIYAMA A, 1991, J CELL BIOL, V114, P359, DOI 10.1083/jcb.114.2.359; NISHIYAMA A, 1991, DEVELOPMENT, V111, P933; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Pluschke G, 1996, P NATL ACAD SCI USA, V93, P9710, DOI 10.1073/pnas.93.18.9710; Price MA, 2011, PIGM CELL MELANOMA R, V24, P1148, DOI 10.1111/j.1755-148X.2011.00929.x; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shih J, 1996, DEVELOPMENT, V122, P1313; Sisson BE, 2015, MECH DEVELOP, V138, P279, DOI 10.1016/j.mod.2015.10.001; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; STALLCUP WB, 1987, J NEUROSCI, V7, P2737; Sumner FB, 1903, ARCH ENTWICKLUNG ORG, V17, P92, DOI 10.1007/BF02161895; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wang XH, 2010, JNCI-J NATL CANCER I, V102, P1496, DOI 10.1093/jnci/djq343; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; White RJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30860.001, 10.7554/eLife.30860]; Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493; Yang JB, 2004, J CELL BIOL, V165, P881, DOI 10.1083/jcb.200403174; Yang JB, 2009, CANCER RES, V69, P7538, DOI 10.1158/0008-5472.CAN-08-4626; Ye ZD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3803; Zoeller JJ, 2009, J BIOL CHEM, V284, P11728, DOI 10.1074/jbc.M808991200	52	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230943	10.1371/journal.pone.0230943	http://dx.doi.org/10.1371/journal.pone.0230943			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240230	Green Published, Green Submitted, gold			2022-12-26	WOS:000535945000063
J	Ueda, M; Tanaka, T				Ueda, Masahiko; Tanaka, Toshiyuki			Linear algebraic structure of zero-determinant strategies in repeated games	PLOS ONE			English	Article							EXTORTION; EVOLUTION; COOPERATION; GENEROSITY	Zero-determinant (ZD) strategies, a recently found novel class of strategies in repeated games, has attracted much attention in evolutionary game theory. A ZD strategy unilaterally enforces a linear relation between average payoffs of players. Although existence and evolutional stability of ZD strategies have been studied in simple games, their mathematical properties have not been well-known yet. For example, what happens when more than one players employ ZD strategies have not been clarified. In this paper, we provide a general framework for investigating situations where more than one players employ ZD strategies in terms of linear algebra. First, we theoretically prove that a set of linear relations of average payoffs enforced by ZD strategies always has solutions, which implies that incompatible linear relations are impossible. Second, we prove that linear payoff relations are independent of each other under some conditions. These results hold for general games with public monitoring including perfect-monitoring games. Furthermore, we provide a simple example of a two-player game in which one player can simultaneously enforce two linear relations, that is, simultaneously control her and her opponent's average payoffs. All of these results elucidate general mathematical properties of ZD strategies.	[Ueda, Masahiko; Tanaka, Toshiyuki] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto, Japan	Kyoto University	Ueda, M (corresponding author), Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto, Japan.	ueda.masahiko.5r@kyoto-u.ac.jp	Ueda, Masahiko/D-1911-2018; Tanaka, Toshiyuki/C-2749-2011	Ueda, Masahiko/0000-0002-8168-0102; 	JSPS KAKENHI [JP18H06476, JP19K21542]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Numbers JP18H06476 and JP19K21542. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3193; Akin E., 2016, ERGODIC THEORY ADV D, P77; Akin E., 2015, GAMES, V6, P175, DOI [DOI 10.3390/G6030175), 10.3390/g6030175, DOI 10.3390/G6030175]; Al Daoud A, 2014, IEEE J SEL AREA COMM, V32, P2297, DOI 10.1109/JSAC.2014.141126; [Anonymous], 2012, LINEAR ALGEBRA GEOME; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Borkowski G, 2017, PLAN BATYMETRYCZNY J; Fudenberg D., 1991, GAME THEORY; Guo JL, 2014, ARXIV E PRINTS; Hao D, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.052803; He XF, 2016, IEEE SIGNAL PROC LET, V23, DOI 10.1109/LSP.2016.2517640; Hilbe C, 2013, PLOS ONE, V8, P1; Hilbe C, 2018, NAT HUM BEHAV, V2, P469, DOI 10.1038/s41562-018-0320-9; Hilbe C, 2017, P NATL ACAD SCI USA, V114, P4715, DOI 10.1073/pnas.1621239114; Hilbe C, 2015, GAME ECON BEHAV, V92, P41, DOI 10.1016/j.geb.2015.05.005; Hilbe C, 2014, P NATL ACAD SCI USA, V111, P16425, DOI 10.1073/pnas.1407887111; Hilbe C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4976; Hilbe C, 2013, P NATL ACAD SCI USA, V110, P6913, DOI 10.1073/pnas.1214834110; Ichinose G, 2018, J THEOR BIOL, V438, P61, DOI 10.1016/j.jtbi.2017.11.002; Mamiya A, 2019, J THEOR BIOL, V477, P63, DOI 10.1016/j.jtbi.2019.06.009; McAvoy A, 2016, P NATL ACAD SCI USA, V113, P3573, DOI 10.1073/pnas.1520163113; Murase Y, 2018, J THEOR BIOL, V449, P94, DOI 10.1016/j.jtbi.2018.04.027; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Press WH, 2012, P NATL ACAD SCI USA, V109, P10409, DOI 10.1073/pnas.1206569109; Rubinstein A., 1998, MODELING BOUNDED RAT; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Stewart AJ, 2013, P NATL ACAD SCI USA, V110, P15348, DOI 10.1073/pnas.1306246110; Stewart AJ, 2012, P NATL ACAD SCI USA, V109, P10134, DOI 10.1073/pnas.1208087109; Szolnoki A, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022804; von Neumann J., 1953, THEORY GAMES EC BEHA; Wang ZJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11125; Yang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10390; Zhang HQ, 2016, IEEE T WIREL COMMUN, V15, P2179, DOI 10.1109/TWC.2015.2499185	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230973	10.1371/journal.pone.0230973	http://dx.doi.org/10.1371/journal.pone.0230973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240215	Green Published, Green Submitted, gold			2022-12-26	WOS:000535945000067
J	Zaczek-Moczydlowska, MA; Young, GK; Trudgett, J; Plahe, C; Fleming, CC; Campbell, K; Hanlonm, RO				Zaczek-Moczydlowska, Maja A.; Young, Gillian K.; Trudgett, James; Plahe, Cali; Fleming, Colin C.; Campbell, Katrina; Hanlonm, Richard O.			Phage cocktail containing Podoviridae and Myoviridae bacteriophages inhibits the growth of Pectobacterium spp. under in vitro and in vivo conditions	PLOS ONE			English	Article							INFECTING PECTOBACTERIUM; BIOCONTROL; DIVERSITY; VIRUSES; DISEASE	Globally, there is a high economic burden caused by pre- and post-harvest losses in vegetables, fruits and ornamentals due to soft rot diseases. At present, the control methods for these diseases are limited, but there is some promise in developing biological control products for use in Integrated Pest Management. This study sought to formulate a phage cocktail which would be effective against soft rot Pectobacteriaceae species affecting potato (Solanum tuberosum L.), with potential methods of application in agricultural systems, including vacuum-infiltration and soil drench, also tested. Six bacteriophages were isolated and characterized using transmission electron microscopy, and tested against a range of Pectobacterium species that cause soft rot/blackleg of potato. Isolated bacteriophages of the family Podoviridae and Myoviridae were able to control isolates of the Pectobacterium species: Pectobacterium atrosepticum and Pectobacterium carotovorum subsp. carotovorum. Genomic analysis of three Podoviridae phages did not indicate host genes transcripts or proteins encoding toxin or antibiotic resistance genes. These bacteriophages were formulated as a phage cocktail and further experiments showed high activity in vitro and in vivo to suppress Pectobacterium growth, potentially indicating their efficacy in formulation as a microbial pest control agent to use in planta.	[Zaczek-Moczydlowska, Maja A.; Campbell, Katrina] Queens Univ, Sch Biol Sci, Inst Global Food Secur, Belfast, Antrim, North Ireland; [Young, Gillian K.; Fleming, Colin C.; Hanlonm, Richard O.] Agrifood & Biosci Inst, Sustainable Agrifood Sci Div, Belfast, Antrim, North Ireland; [Trudgett, James] Agrifood & Biosci Inst, Vet Sci Div, Belfast, Antrim, North Ireland; [Plahe, Cali; Fleming, Colin C.; Hanlonm, Richard O.] Queens Univ, Sch Biol Sci, Belfast, Antrim, North Ireland	Queens University Belfast; Agri-Food & Biosciences Institute; Agri-Food & Biosciences Institute; Queens University Belfast	Zaczek-Moczydlowska, MA (corresponding author), Queens Univ, Sch Biol Sci, Inst Global Food Secur, Belfast, Antrim, North Ireland.	mzaczekmoczydlowska01@qub.ac.uk	Campbell, Katrina/AAY-8103-2020	Campbell, Katrina/0000-0002-5994-2524; O'Hanlon, Richard/0000-0002-0595-0246	Department of Agriculture, Environment and Rural Affairs (DAERA) Northern Ireland	Department of Agriculture, Environment and Rural Affairs (DAERA) Northern Ireland	MAZM has been funded by Department of Agriculture, Environment and Rural Affairs (DAERA) Northern Ireland as a part of PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon ST, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00981; Ackermann HW, 2012, ARCH VIROL, V157, P1843, DOI 10.1007/s00705-012-1383-y; Adriaenssens EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033227; Alic S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01870; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Balogh B., 2006, CHARACTERIZATION USE; Balogh B, 2008, PLANT DIS, V92, P1048, DOI 10.1094/PDIS-92-7-1048; Blower TR, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03229-16; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Buttimer C, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11020045; Buttimer Colin, 2017, Front Microbiol, V8, P34, DOI 10.3389/fmicb.2017.00034; Carstens AB, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110621; Carstens AB, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz101; Charkowski AO, 2018, ANNU REV PHYTOPATHOL, V56, P269, DOI 10.1146/annurev-phyto-080417-045906; Charkowski AO, 2015, AM J POTATO RES, V92, P223, DOI 10.1007/s12230-015-9447-7; Czajkowski R, 2014, PLANT PATHOL, V63, P758, DOI 10.1111/ppa.12157; Czajkowski R, 2011, PLANT PATHOL, V60, P999, DOI 10.1111/j.1365-3059.2011.02470.x; Czajkowski R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183200; Czajkowski R, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnv230; Czajkowski R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119812; Day A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01654; De Boer SH, 2004, BLACKLEG POTATO, DOI [10.1094/PHI-I-2004-0712-01, DOI 10.1094/PHI-I-2004-0712-01]; Devaney R, 2016, AVIAN PATHOL, V45, P616, DOI 10.1080/03079457.2016.1193123; Devaux A, 2014, POTATO RES, V57, P185, DOI 10.1007/s11540-014-9265-1; Dupuis B, 2017, EUR J PLANT PATHOL, V147, P365, DOI 10.1007/s10658-016-1008-5; EAYRE CG, 1995, PLANT DIS, V79, P801, DOI 10.1094/PD-79-0801; Fillol-Salom A, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007888; Fortier LC, 2007, APPL ENVIRON MICROB, V73, P7358, DOI 10.1128/AEM.00582-07; Fujiwara A, 2011, APPL ENVIRON MICROB, V77, P4155, DOI 10.1128/AEM.02847-10; Gill JJ, 2003, APPL ENVIRON MICROB, V69, P2133, DOI 10.1128/AEM.69.4.2133-2138.2003; Hadizadeh I, 2019, PLANT PATHOL, V68, P297, DOI 10.1111/ppa.12956; Harper DR, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040177; Hirata H, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01625-15; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; Jones JB, 2007, ANNU REV PHYTOPATHOL, V45, P245, DOI 10.1146/annurev.phyto.45.062806.094411; Kabanova A, 2018, ARCH VIROL, V163, P1691, DOI 10.1007/s00705-018-3766-1; Kalischuk M, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00760-15; Kortright KE, 2019, CELL HOST MICROBE, V25, P219, DOI 10.1016/j.chom.2019.01.014; Lee DH, 2013, MICROBIOL-SGM, V159, P1487, DOI 10.1099/mic.0.067280-0; Lee J, 2017, J PLANT PATHOL, V99, P453; Lim JA, 2013, J MICROBIOL BIOTECHN, V23, P1147, DOI 10.4014/jmb.1304.04001; Malik DJ, 2017, ADV COLLOID INTERFAC, V249, P100, DOI 10.1016/j.cis.2017.05.014; Smolarska A, 2018, EUR J PLANT PATHOL, V150, P413, DOI 10.1007/s10658-017-1289-3; Soleimani-Delfan A, 2015, BRAZ J MICROBIOL, V46, P791, DOI 10.1590/S1517-838246320140498; Svircev A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050218; Toth IK, 2016, ROUTES BLACKLEG CONT; Xie YC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040189; Zaczek-Moczydlowska MA, 2019, EUR J PLANT PATHOL, V154, P635, DOI 10.1007/s10658-019-01687-1	48	19	19	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230842	10.1371/journal.pone.0230842	http://dx.doi.org/10.1371/journal.pone.0230842			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240203	Green Published, gold			2022-12-26	WOS:000535945000044
J	Martinez-Taboada, F; Redondo, JI				Martinez-Taboada, Fernando; Redondo, Jose Ignacio			The SIESTA (SEAAV Integrated evaluation sedation tool for anaesthesia) project: Initial development of a multifactorial sedation assessment tool for dogs	PLOS ONE			English	Article							MEDETOMIDINE; DEXMEDETOMIDINE; REVERSAL	Objective The aim of the study was to develop a multifactorial tool for assessment of sedation in dogs. Methods Following a modified Delphi method, thirty-eight veterinary anaesthetists were contacted to describe the following levels of awareness: no-sedation, light, moderate, profound sedation and excitation. The answers were summarized in descriptors for each level. A questionnaire was created with all the variables obtained from the descriptors. The questionnaire was returned to the panel of anaesthetists to be used before and after real sedations in conjunction with the previous 5-point categorical scale. Data obtained were analysed using the classification-tree and random-forest methods. Results Twenty-three anaesthetists (60%) replied with descriptions. The descriptors and study variables were grouped in categories: state-of-mind, posture, movements, stimuli-response, behaviour, response-to-restraint, muscle tone, physiological data, facial-expression, eye position, eyelids, pupils, vocalization and feasibility-to-perform-intended-procedure. The anaesthetists returned 205 completed questionnaires. The levels of awareness reported by the anaesthetists were: no sedation in 92, mild (26), moderate (37) and profound in 50 cases. The classification-tree detected 6 main classifying variables: change in posture, response-to-restraint, head-elevation, response-to-toe-pinching, response-to-name, and movements. The random-forest found that the following variables: change in posture, response-to-restraint, head-elevation, response-to-name, movements, posture, response-to-toe-pinching, demeanour, righting-reflex and response-to-handclap, were classified correctly in 100% awake, 62% mild, 70% moderate and 86% of profound sedation cases. Discussion and conclusion The questionnaire and methods developed here classified correctly the level of sedation in most cases. Further studies are needed to evaluate the validity of this tool in the clinical and research setting.	[Martinez-Taboada, Fernando] Univ Sydney, Fac Sci, Sch Vet Sci, Dept Vet Anaesthesia & Analgesia, Camperdown, NSW, Australia; [Redondo, Jose Ignacio] Univ CEU Cardenal Herrera, Fac Vet, Inst Ciencias Biomed, Dept Med & Cirugia Anim, Valencia, Spain	University of Sydney; Universidad CEU Cardenal Herrera	Martinez-Taboada, F (corresponding author), Univ Sydney, Fac Sci, Sch Vet Sci, Dept Vet Anaesthesia & Analgesia, Camperdown, NSW, Australia.	fer_m_taboada@hotmail.com		Redondo, Jose Ignacio/0000-0001-5377-9650; Martinez-Taboada, Fernando/0000-0002-0083-4764				Atkinson B, 2019, R PACKAGE VERSION 4; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 1984, CLASSIFICATION REGRE; Garcia Perez A., 2014, CUADERNOS ESTADISTIC, P298; Gomez-Villamandos RJ, 2006, J VET MED A, V53, P471, DOI 10.1111/j.1439-0442.2006.00859.x; Granholm M, 2007, VET REC, V160, P891, DOI 10.1136/vr.160.26.891; Grint NJ, 2009, J SMALL ANIM PRACT, V50, P62, DOI 10.1111/j.1748-5827.2008.00670.x; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hofmeister EH, 2010, JAVMA-J AM VET MED A, V237, P1155, DOI 10.2460/javma.237.10.1155; Kuusela E, 2000, J VET PHARMACOL THER, V23, P15, DOI 10.1046/j.1365-2885.2000.00245.x; Liaw A, 2016, R PACKAGE VERSION 4; Martinez-Martin P, 2010, J NEUROL SCI, V289, P7, DOI 10.1016/j.jns.2009.08.013; Merola I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150040; Newton Tim, 2013, SAAD Dig, V29, P88; Ringer SK, 2012, VET ANAESTH ANALG, V39, P1, DOI 10.1111/j.1467-2995.2011.00653.x; Sessler CN, 2004, CHEST, V126, P1727, DOI 10.1378/chest.126.6.1727; Thangaratinam S, 2005, OBSTET GYNAECOL, V7, P120, DOI 10.1576/toag.7.2.120.27071; Tranquilli WJ, VET ANESTHESIA ANALG; Varela-Ruiz Margarita, 2012, Investigación educ. médica, V1, P90; Wagner MC, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1027-2; YOUNG LE, 1990, J SMALL ANIM PRACT, V31, P554, DOI 10.1111/j.1748-5827.1990.tb00685.x	21	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230799	10.1371/journal.pone.0230799	http://dx.doi.org/10.1371/journal.pone.0230799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236148	gold, Green Published, Green Submitted			2022-12-26	WOS:000535938700031
J	Lin, SY; Lin, CL; Hsu, WH; Wang, IK; Lin, CC; Jeng, LB; Kao, CH				Lin, Shih-Yi; Lin, Cheng-Li; Hsu, Wu-Huei; Wang, I-Kuan; Lin, Cheng-Chieh; Jeng, Long-Bing; Kao, Chia-Hung			Risk of biliary tract disease in living liver donors: A population-based cohort study	PLOS ONE			English	Article							TRANSPLANTATION; DONATION; COMPLICATIONS; HEPATECTOMY; MORBIDITY; LOBE	Background & aims Whether living liver donors have a higher risk of biliary tract disease compared with nondonors remains unknown. Methods Data were collected from the Taiwan Longitudinal Health Insurance Database for the 20032011 period. The study cohort comprised 1,446 patients aged. 18 years who had served as living liver donors. The primary outcome was the incidence of biliary tract disease. Cox proportional hazards modeling was used to determine the hazard ratios. Results The incidence density rate of biliary tract disease was 13.9-fold higher in the liver donor (LD) cohort than in the non-LD cohort (10.2 vs. 0.71 per 1,000 person-years), with an adjusted hazard ratio (HR) of 14.2 (95% confidence interval [CI] = 7.73-26.1). Stratified by comorbidity, the relative risk of biliary tract disease was higher in the LD cohort than in the non-LD cohort for both patients with or without comorbidity. The incidence density rate of biliary tract disease was significantly higher in the first 3 years (13.5 per 1,000 person-years in the LD cohort). The highest adjusted HR of biliary tract disease for LD patients compared with the non-LD cohort was 22.4 (95% CI = 10.8-46.1) in the follow-up <= 3 years. Conclusion Living liver donors had a higher risk of biliary tract disease compared with non-donors.	[Lin, Shih-Yi; Hsu, Wu-Huei; Wang, I-Kuan; Lin, Cheng-Chieh; Jeng, Long-Bing; Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lin, Shih-Yi; Wang, I-Kuan] China Med Univ Hosp, Div Nephrol, Taichung, Taiwan; [Lin, Shih-Yi; Wang, I-Kuan] China Med Univ Hosp, Kidney Inst, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Hsu, Wu-Huei] China Med Univ Hosp, Div Pulm & Crit Care Med, Taichung, Taiwan; [Hsu, Wu-Huei] China Med Univ, Div Pulm & Crit Care Med, Taichung, Taiwan; [Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Jeng, Long-Bing] China Med Univ Hosp, Div Surg, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Ctr Augmented Intelligence Healthcare, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Ctr Augmented Intelligence Healthcare, Taichung, Taiwan.; Kao, CH (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	d10040@mail.cmuh.org.tw	Lin, Cheng-Chieh/P-2564-2015	Lin, Cheng-Chieh/0000-0002-9625-6216	Ministry of Health and Welfare, Taiwan [MOHW108-TDU-B-212-133004]; China Medical University Hospital [DMR-107-192, CMU107-ASIA-19]; Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 107-2321-B-039 -004-]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Ministry of Health and Welfare, Taiwan; China Medical University Hospital; Academia Sinica Stroke Biosignature Project; MOST Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This work was supported by grants from the Ministry of Health and Welfare, Taiwan (MOHW108-TDU-B-212-133004), China Medical University Hospital (DMR-107-192, CMU107-ASIA-19), Academia Sinica Stroke Biosignature Project (BM10701010021), MOST Clinical Trial Consortium for Stroke (MOST 107-2321-B-039 -004-), Tseng-Lien Lin Foundation, Taichung, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barr ML, 2006, TRANSPLANTATION, V81, P1373, DOI 10.1097/01.tp.0000216825.56841.cd; Broelsch CE, 2000, LIVER TRANSPLANT, V6, pS64, DOI 10.1053/jlts.2000.19015; Brown RS, 2003, NEW ENGL J MED, V348, P818, DOI 10.1056/NEJMsa021345; Chisuwa H, 2003, TRANSPLANTATION, V75, P1670, DOI 10.1097/01.TP.0000063939.81744.3E; Chuang YW, 2016, THROMB HAEMOSTASIS, V115, P439, DOI 10.1160/TH15-07-0600; Cotler SJ, 2001, LIVER TRANSPLANT, V7, P335, DOI 10.1053/jlts.2001.22755; Ghobrial RM, 2008, GASTROENTEROLOGY, V135, P468, DOI 10.1053/j.gastro.2008.04.018; Hashikura Y, 2009, TRANSPLANTATION, V88, P110, DOI 10.1097/TP.0b013e3181aaccb0; Lei JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061769; Nadalin S, 2004, LIVER TRANSPLANT, V10, P1024, DOI 10.1002/lt.20182; Rerknimitr R, 2002, GASTROINTEST ENDOSC, V55, P224, DOI 10.1067/mge.2002.120813; She WH, 2017, WORLD J GASTROENTERO, V23, P4270, DOI 10.3748/wjg.v23.i23.4270; SINGER PA, 1989, NEW ENGL J MED, V321, P620, DOI 10.1056/NEJM198908313210919; Stinton LM, 2012, GUT LIVER, V6, P172, DOI 10.5009/gnl.2012.6.2.172; Todo S, 2004, ANN SURG, V240, P451, DOI 10.1097/01.sla.0000137129.98894.42; Trotter JF, 2011, LIVER TRANSPLANT, V17, P409, DOI 10.1002/lt.22246; Trotter JF, 2001, LIVER TRANSPLANT, V7, P485, DOI 10.1053/jlts.2001.24646; Umeshita K, 2003, LANCET, V362, P687, DOI 10.1016/S0140-6736(03)14230-4; Unisa S, 2011, HPB, V13, P117, DOI 10.1111/j.1477-2574.2010.00255.x; Verdonk RC, 2006, SCAND J GASTROENTERO, V41, P89, DOI 10.1080/00365520600664375; Wang CC, 2016, HEART RHYTHM, V13, P416, DOI 10.1016/j.hrthm.2015.10.021; Yang HR, 2017, FORMOS J SURG, V50, P119, DOI 10.4103/fjs.fjs_42_17	22	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2020	15	3							e0230840	10.1371/journal.pone.0230840	http://dx.doi.org/10.1371/journal.pone.0230840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8HE	32226025	Green Published, gold			2022-12-26	WOS:000535936400021
J	Cheng, K; Xiao, TF; Chen, QF; Wang, YQ				Cheng, Ke; Xiao, Tianfeng; Chen, Qingfang; Wang, Yuanquan			Image segmentation using active contours with modified convolutional virtual electric field external force with an edge-stopping function	PLOS ONE			English	Article							GRADIENT VECTOR FLOW; AUTOMATIC INITIALIZATION; LEFT-VENTRICLE; SNAKES; DIFFUSION; FILTER; SHAPE	The gradient vector flow (GVF) is an effective external force to deform the active contours. However, it suffers from high computational cost. For efficiency, the virtual electric field (VEF) model has been proposed, which can be implemented in real time thanks to fast Fourier transform (FFT). The VEF model has large capture range and low computation cost, but it has the limitations of sensitivity to noise and leakage on weak edge. The recently proposed CONVEF (Convolutional Virtual Electric Field) model takes the VEF model as a convolutional operation and employed another convolution kernel to overcome the drawbacks of the VEF model. In this paper, we employ an edge stopping function similar to that in the anisotropic diffusion to further improve the CONVEF model, and the proposed model is referred to as MCONVEF (Modified CONVEF) model. In addition, a piecewise constant approximation algorithm is borrowed to accelerate the calculation of the MCONVEF model. The proposed MCONVEF model is compared with the GVF and VEF models, and the experimental results are presented to demonstrate its superiority in terms of noise robustness, weak edge preserving and deep concavity convergence.	[Cheng, Ke; Xiao, Tianfeng; Wang, Yuanquan] Jiangsu Univ Sci & Technol 1, Sch Comp, Zhenjiang, Jiangsu, Peoples R China; [Chen, Qingfang] Jiangsu Univ Sci & Technol 2, Sch Elect & Informat, Zhenjiang, Jiangsu, Peoples R China		Cheng, K (corresponding author), Jiangsu Univ Sci & Technol 1, Sch Comp, Zhenjiang, Jiangsu, Peoples R China.; Chen, QF (corresponding author), Jiangsu Univ Sci & Technol 2, Sch Elect & Informat, Zhenjiang, Jiangsu, Peoples R China.	chengke1972@just.edu.cn; rookiemary@just.edu.cn			Zhenjiang Bureau of Science and Technology [GY2017003]	Zhenjiang Bureau of Science and Technology	This research was funded by Zhenjiang Bureau of Science and Technology under grant number GY2017003 to KC.	Avendi MR, 2016, MED IMAGE ANAL, V30, P108, DOI 10.1016/j.media.2016.01.005; Boukerroui D, 2012, PATTERN RECOGN, V45, P626, DOI 10.1016/j.patcog.2011.07.007; Chen MQ, 2019, IEEE ACCESS, V7, P5438, DOI 10.1109/ACCESS.2018.2889744; Cheng JR, 2006, IEEE T IMAGE PROCESS, V15, P1563, DOI 10.1109/TIP.2006.871140; Durand F, 2002, ACM T GRAPHIC, V21, P257, DOI 10.1145/566570.566574; Han X, 2007, IET IMAGE PROCESS, V1, P48, DOI 10.1049/iet-ipr:20050225; Jaouen V, 2014, IEEE T IMAGE PROCESS, V23, P4773, DOI 10.1109/TIP.2014.2353854; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Keatmanee C, 2019, ULTRASONICS, V94, P438, DOI 10.1016/j.ultras.2017.12.008; Kirimasthong K, 2018, PATTERN ANAL APPL, V21, P491, DOI 10.1007/s10044-017-0627-6; Kirimasthong K, 2017, PATTERN ANAL APPL, V20, P239, DOI 10.1007/s10044-016-0556-9; Li CM, 2005, PATTERN RECOGN, V38, P1947, DOI 10.1016/j.patcog.2004.12.015; Liu Huafeng, 2019, IEEE J TRANSLATIONAL, V5, P1; Ning JF, 2007, PATTERN RECOGN LETT, V28, P58, DOI 10.1016/j.patrec.2006.06.014; Park HK, 2002, ELECTRON LETT, V38, P1500, DOI 10.1049/el:20021037; Qin LM, 2013, IEEE T CIRC SYST VID, V23, P883, DOI 10.1109/TCSVT.2013.2242554; Ray N, 2004, IEEE T MED IMAGING, V23, P1466, DOI 10.1109/TMI.2004.835603; Ren DW, 2013, PATTERN RECOGN LETT, V34, P219, DOI 10.1016/j.patrec.2012.09.017; Rodtook A, 2018, PATTERN RECOGN, V79, P172, DOI 10.1016/j.patcog.2018.01.032; Sum KW, 2007, PATTERN RECOGN, V40, P1635, DOI 10.1016/j.patcog.2006.11.006; Wang WJ, 2019, IEEE ACCESS, V7, P47918, DOI 10.1109/ACCESS.2019.2907564; Wang Y, 2008, ELECTRON LETT, V44, P105, DOI 10.1049/el:20081650; Wang YQ, 2013, SIGNAL PROCESS, V93, P2548, DOI 10.1016/j.sigpro.2013.02.020; Wang YQ, 2006, INT C PATT RECOG, P671; Wang YQ, 2013, COMPUT ELECTR ENG, V39, P1506, DOI 10.1016/j.compeleceng.2013.03.017; Wang YQ, 2010, IEEE SIGNAL PROC LET, V17, P875, DOI 10.1109/LSP.2010.2060482; Wang YQ, 2008, LECT NOTES ARTIF INT, V5351, P466, DOI 10.1007/978-3-540-89197-0_43; Wang YX, 2014, WORLD HLTH DIGEST, V9, P9, DOI DOI 10.1371/J0URNAL.P0NE.0096678; Wu YW, 2013, COMPUT VIS IMAGE UND, V117, P1421, DOI 10.1016/j.cviu.2013.05.003; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Xu CY, 1998, SIGNAL PROCESS, V71, P131, DOI 10.1016/S0165-1684(98)00140-6; Zhang ZY, 2020, INFORM SCIENCES, V506, P1, DOI 10.1016/j.ins.2019.08.003; Zhao F, 2015, APPL OPTICS, V54, P9809, DOI 10.1364/AO.54.009809; Zhou SJ, 2019, SIGNAL IMAGE VIDEO P, V13, P1131, DOI 10.1007/s11760-019-01456-x	34	0	0	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230581	10.1371/journal.pone.0230581	http://dx.doi.org/10.1371/journal.pone.0230581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214376	Green Published, gold			2022-12-26	WOS:000535934200033
J	Lopez-Garcia, G; Jerez, JM; Franco, L; Veredas, FJ				Lopez-Garcia, Guillermo; Jerez, Jose M.; Franco, Leonardo; Veredas, Francisco J.			Transfer learning with convolutional neural networks for cancer survival prediction using gene-expression data	PLOS ONE			English	Article							RNA-SEQ; DEEP; GENOME; RECURRENCE; SIGNATURE; KEGG	Precision medicine in oncology aims at obtaining data from heterogeneous sources to have a precise estimation of a given patient's state and prognosis. With the purpose of advancing to personalized medicine framework, accurate diagnoses allow prescription of more effective treatments adapted to the specificities of each individual case. In the last years, next-generation sequencing has impelled cancer research by providing physicians with an overwhelming amount of gene-expression data from RNA-seq high-throughput platforms. In this scenario, data mining and machine learning techniques have widely contribute to gene-expression data analysis by supplying computational models to supporting decision-making on real-world data. Nevertheless, existing public gene-expression databases are characterized by the unfavorable imbalance between the huge number of genes (in the order of tenths of thousands) and the small number of samples (in the order of a few hundreds) available. Despite diverse feature selection and extraction strategies have been traditionally applied to surpass derived over-fitting issues, the efficacy of standard machine learning pipelines is far from being satisfactory for the prediction of relevant clinical outcomes like follow-up endpoints or patient's survival. Using the public Pan-Cancer dataset, in this study we pre-train convolutional neural network architectures for survival prediction on a subset composed of thousands of gene-expression samples from thirty-one tumor types. The resulting architectures are subsequently fine-tuned to predict lung cancer progression-free interval. The application of convolutional networks to gene-expression data has many limitations, derived from the unstructured nature of these data. In this work we propose a methodology to rearrange RNA-seq data by transforming RNA-seq samples into gene-expression images, from which convolutional networks can extract high-level features. As an additional objective, we investigate whether leveraging the information extracted from other tumor-type samples contributes to the extraction of high-level features that improve lung cancer progression prediction, compared to other machine learning approaches.	[Lopez-Garcia, Guillermo; Jerez, Jose M.; Franco, Leonardo; Veredas, Francisco J.] Univ Malaga, Dept Lenguajes & Ciencias Comp, ETSI Informat, Malaga, Spain	Universidad de Malaga	Lopez-Garcia, G (corresponding author), Univ Malaga, Dept Lenguajes & Ciencias Comp, ETSI Informat, Malaga, Spain.	guilopgar@uma.es	Veredas, Francisco/L-1334-2014; Jerez, José/GYV-4500-2022; Jerez Aragones, Jose Manuel/L-1801-2014	Veredas, Francisco/0000-0003-0739-2505; Lopez-Garcia, Guillermo/0000-0001-5903-1483; Jerez Aragones, Jose Manuel/0000-0002-7858-2966	MINECO, Plan Nacional de I+D+I [TIN2017-88728-C2-1-R]; Grupo de Investigacion, Plan Andaluz de Investigacion, Desarrollo e Innovacion (PAIDI), Junta de Andalucia [TIC226]	MINECO, Plan Nacional de I+D+I; Grupo de Investigacion, Plan Andaluz de Investigacion, Desarrollo e Innovacion (PAIDI), Junta de Andalucia(Junta de Andalucia)	This work was supported by the project TIN2017-88728-C2-1-R, MINECO, Plan Nacional de I+D+I, and by the Grupo de Investigacion TIC226, Plan Andaluz de Investigacion, Desarrollo e Innovacion (PAIDI), Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Baesens B, 2005, J OPER RES SOC, V56, P1089, DOI 10.1057/palgrave.jors.2601990; Bashiri A, 2017, IRAN J PUBLIC HEALTH, V46, P165; Bederson BB, 2002, ACM T GRAPHIC, V21, P833, DOI 10.1145/571647.571649; Cancer Genome Atlas Research Network, 2013, Nat Genet, V45, P1113, DOI 10.1038/ng.2764; Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen HIH, 2018, BMC SYST BIOL, V12, DOI 10.1186/s12918-018-0642-2; Chen RP, 2020, BIOINFORMATICS, V36, P1476, DOI 10.1093/bioinformatics/btz769; Danaee P, 2016, BIOCOMPUT PAC SYM, V22, P219, DOI [10.1142/9789813207813_0022, DOI 10.1142/9789813207813_0022]; Demsar J, 2006, J MACH LEARN RES, V7, P1; Fioravanti D, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2033-5; Gao SW, 2016, JAMA ONCOL, V2, P37, DOI 10.1001/jamaoncol.2015.3413; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672, DOI 10.1145/3422622; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Ishwaran H, 2014, BIOSTATISTICS, V15, P757, DOI 10.1093/biostatistics/kxu010; JOHNSON B, 1991, VISUALIZATION 91, P284; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Kelley DR, 2016, GENOME RES, V26, P990, DOI 10.1101/gr.200535.115; Kingma Diederik P., 2013, ABS13126114 CORR; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1033; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Lopez-Garcia G., 2019, 2019 INT JOINT C NEU, P1; Lopez-Garcia G, 2019, LECT NOTES COMPUT SC, V11506, P912, DOI 10.1007/978-3-030-20521-8_74; Lyu B, 2018, P 2018 ACM INT; Ma S., 2018, CORRABS180405283; Miotto R, 2018, BRIEF BIOINFORM, V19, P1236, DOI 10.1093/bib/bbx044; Nair V., 2010, P 27 INT C INT C MAC, P807; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Povey S, 2001, HUM GENET, V109, P678, DOI 10.1007/s00439-001-0615-0; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Sevakula RK, 2019, IEEE ACM T COMPUT BI, V16, P2089, DOI 10.1109/TCBB.2018.2822803; Sharma A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47765-6; Simon N, 2011, J STAT SOFTW, V39, P1; Solin LJ, 2013, JNCI-J NATL CANCER I, V105, P701, DOI 10.1093/jnci/djt067; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Wang DL, 2017, BIOINFORMATICS, V33, P3909, DOI 10.1093/bioinformatics/btx496; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Way GP, 2018, BIOCOMPUT-PAC SYM, P80; Xiang A, 2000, COMPUT STAT DATA AN, V34, P243, DOI 10.1016/S0167-9473(99)00098-5; Xiao YW, 2018, COMPUT METH PROG BIO, V166, P99, DOI 10.1016/j.cmpb.2018.10.004; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yousefi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11817-6; Yu H, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5546-z; Zhang L, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00477; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]	55	30	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230536	10.1371/journal.pone.0230536	http://dx.doi.org/10.1371/journal.pone.0230536			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214348	Green Submitted, gold, Green Published			2022-12-26	WOS:000535934200030
J	Regal-McDonald, K; Somarathna, M; Lee, T; Litovsky, SH; Barnes, J; Peretik, JM; Traylor, JG; Orr, AW; Patel, RP				Regal-McDonald, Kellie; Somarathna, Maheshika; Lee, Timmy; Litovsky, Silvio H.; Barnes, Jarrod; Peretik, J. M.; Traylor, J. G., Jr.; Orr, A. Wayne; Patel, Rakesh P.			Assessment of ICAM-1 N-glycoforms in mouse and human models of endothelial dysfunction	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; ATHEROSCLEROTIC LESIONS; MONOCYTE ADHESION; SELECTIN-LIGAND; IMMUNE; EXPRESSION; GLYCOSYLATION; NEUTROPHILS; ACTIVATION; MICE	Endothelial dysfunction is a critical event in vascular inflammation characterized, in part, by elevated surface expression of adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1). ICAM-1 is heavily N-glycosylated, and like other surface proteins, it is largely presumed that fully processed, complex N-glycoforms are dominant. However, our recent studies suggest that hypoglycosylated or high mannose (HM)-ICAM-1 N-glycoforms are also expressed on the cell surface during endothelial dysfunction, and have higher affinity for monocyte adhesion and regulate outside-in endothelial signaling by different mechanisms. Whether different ICAM-1 N-glycoforms are expressed in vivo during disease is unknown. In this study, using the proximity ligation assay, we assessed the relative formation of high mannose, hybrid and complex alpha-2,6-sialyated N-glycoforms of ICAM-1 in human and mouse models of atherosclerosis, as well as in arteriovenous fistulas (AVF) of patients on hemodialysis. Our data demonstrates that ICAM-1 harboring HM or hybrid epitopes as well as ICAM-1 bearing alpha-2,6-sialylated epitopes are present in human and mouse atherosclerotic lesions. Further, HM-ICAM-1 positively associated with increased macrophage burden in lesions as assessed by CD68 staining, whereas alpha-2,6-sialylated ICAM-1 did not. Finally, both HM and alpha-2,6-sialylated ICAM-1 N-glycoforms were present in hemodialysis patients who had AVF maturation failure compared to successful AVF maturation. Collectively, these data provide evidence that HM-ICAM-1 N-glycoforms are present in vivo, and at levels similar to complex alpha-2,6-sialylated ICAM-1 underscoring the need to better understand their roles in modulating vascular inflammation.	[Regal-McDonald, Kellie; Litovsky, Silvio H.; Patel, Rakesh P.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Regal-McDonald, Kellie; Patel, Rakesh P.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Somarathna, Maheshika; Lee, Timmy] Univ Alabama Birmingham, Dept Med, Div Nephrol, Birmingham, AL 35294 USA; [Barnes, Jarrod] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Peretik, J. M.; Traylor, J. G., Jr.; Orr, A. Wayne] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol & Translat Pathobiol, Shreveport, LA 71105 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Patel, RP (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.; Patel, RP (corresponding author), Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA.	rakeshpatel@uabmc.edu	Orr, Anthony/P-8927-2015	Orr, Anthony/0000-0002-2377-213X; Patel, Rakesh/0000-0002-1526-4303	NIH [HL007918, HL098435, DK109789, R00HL131866]; US Department of Veterans Affairs; UAB Department of Pathology;  [NIHHL133497]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); UAB Department of Pathology; 	Funding for this study was received from NIH HL007918 (to KRM), NIH HL098435 (to AWO), NIHHL133497 (to AWO), NIH DK109789 (to TL), NIH R00HL131866 (to JB), US Department of Veterans Affairs (to TL) and UAB Department of Pathology (internal) funds (to RPP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ESSENTIALS GLYCOBIOL; Asano M, 2003, BLOOD, V102, P1678, DOI 10.1182/blood-2003-03-0836; Asif A, 2006, CLIN J AM SOC NEPHRO, V1, P332, DOI 10.2215/CJN.00850805; Bendjelloul F, 2000, CLIN EXP IMMUNOL, V119, P57, DOI 10.1046/j.1365-2249.2000.01090.x; Bloom JW, 1996, BIOCHEMISTRY-US, V35, P1856, DOI 10.1021/bi952354m; Bourdillon MC, 2000, ARTERIOSCL THROM VAS, V20, P2630, DOI 10.1161/01.ATV.20.12.2630; Chen PY, 2015, J CLIN INVEST, V125, P4514, DOI 10.1172/JCI82719; Chi Z, 2007, CELL ADHES MIGR, V1, P171, DOI 10.4161/cam.1.4.5321; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; DOUGHERTY GJ, 1988, EUR J IMMUNOL, V18, P35, DOI 10.1002/eji.1830180107; Etienne S, 1998, J IMMUNOL, V161, P5755; Fitts Michelle K, 2014, Open Urol Nephrol J, V7, P33; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Garcia-Vallejo JJ, 2006, J CELL PHYSIOL, V206, P203, DOI 10.1002/jcp.20458; Gerhardt T, 2015, CARDIOVASC RES, V107, P321, DOI 10.1093/cvr/cvv147; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Haverslag Rene, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P252, DOI 10.2174/187152908786786188; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Hou HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125956; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Iiyama K, 1999, CIRC RES, V85, P199, DOI 10.1161/01.RES.85.2.199; Jimenez D, 2005, J BIOL CHEM, V280, P5854, DOI 10.1074/jbc.M412104200; Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014; Kobata A, 2005, IMMUNOL CELL BIOL, V83, P429, DOI 10.1111/j.1440-1711.2005.01351.x; Kumar S, 2017, LAB INVEST, V97, P935, DOI 10.1038/labinvest.2017.47; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Li J, 2015, ARTERIOSCL THROM VAS, V35, P40, DOI 10.1161/ATVBAHA.114.303227; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Otto VI, 2004, J BIOL CHEM, V279, P35201, DOI 10.1074/jbc.M404947200; Patel SS, 1998, CIRCULATION, V97, P75, DOI 10.1161/01.CIR.97.1.75; POSTON RN, 1992, AM J PATHOL, V140, P665; Ramos TN, 2014, J IMMUNOL, V192, P4469, DOI 10.4049/jimmunol.1400135; Regal-McDonald K, 2019, AM J PHYSIOL-HEART C, V317, pH1028, DOI 10.1152/ajpheart.00306.2019; Saldova R, GLYCOBIOLOGY; Salmela K, 1999, TRANSPLANTATION, V67, P729, DOI 10.1097/00007890-199903150-00015; Scalia R, 1998, ARTERIOSCL THROM VAS, V18, P1093, DOI 10.1161/01.ATV.18.7.1093; Scott D.W., 2012, ARTERIOSCLER THROMB, V32; Scott DW, 2013, AM J PHYSIOL-CELL PH, V305, pC228, DOI 10.1152/ajpcell.00116.2013; Scott DW, 2013, GLYCOBIOLOGY, V23, P622, DOI 10.1093/glycob/cwt014; SELLAK H, 1994, BLOOD, V83, P2669; Sherman DG, 2001, NEUROLOGY, V57, P1428, DOI 10.1212/wnl.57.8.1428; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Sumagin R, 2007, AM J PHYSIOL-HEART C, V293, pH2786, DOI 10.1152/ajpheart.00720.2007; Vuorte J, 1999, J IMMUNOL, V162, P2353; Whitcup SM, 1999, CLIN IMMUNOL, V93, P107, DOI 10.1006/clim.1999.4775; Yuan K, 2008, INT J ONCOL, V32, P797; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	53	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230358	10.1371/journal.pone.0230358	http://dx.doi.org/10.1371/journal.pone.0230358			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208424	Green Published, gold			2022-12-26	WOS:000535305100015
J	Colomar, J; Baiget, E; Corbi, F; Munoz, J				Colomar, Joshua; Baiget, Ernest; Corbi, Francisco; Munoz, Joshua			Acute effects of in-step and wrist weights on change of direction speed, accuracy and stroke velocity in junior tennis players	PLOS ONE			English	Article							WEARABLE RESISTANCE; POWER SERVE; PERFORMANCE; RELIABILITY; ELITE	The main aim of this study was to investigate the acute effects of the use of a weighting set (Powerinstep (R)) on measures of stroke velocity (StV), accuracy and change of direction speed (CODS) in junior tennis players. A within-subjects design was used to evaluate seventeen (6 female and 11 male) tennis players (mean +/- SD; 16.5 +/- 1.3 years old; 1.75 +/- 8.4 m; 67.0 +/- 8.1 kg; 22.04 +/- 1.8 kg/m(2)) on StV of three specific tennis actions (serve, forehand and backhand) and CODS for the following conditions: wearing a 50, 100, 150, 200 g weight or no weight at all (baseline). No significant differences were found between conditions for forehand (F = 0.412; p = 0.799), backhand (F = 0.269; p = 0.897) and serve (F = 0.541; p = 0.706) velocity and forehand (F = 1.688; p = 0.161), backhand (F = 0.567; p = 0.687) and serve (F = 2.382; p = 0.059) accuracy and CODS (F = 0.416; p = 0.797). Small-to-moderate effect sizes (ES) negatively affecting StV when using 200 g compared to the baseline (ES = 0.48, 0.35 and 0.45) could be observed. Moderate (ES = -0.49) and trivial (ES = -0.14 and -0.16) ES for a higher accuracy score were noticed in serve, forehand and backhand 100 g compared to the baseline. Moreover, small ES (ES = 0.41) for improvement in 200 g CODS comparing to baseline conditions were found. These results indicate that the use of a weighting set does not significantly affect StV or CODS respectively. Notwithstanding, small-to-moderate changes show impact in accuracy and no variance in velocity production when using 100 g alongside faster execution in CODS when using 200 g.	[Colomar, Joshua; Munoz, Joshua] Univ Barcelona, Natl Inst Sport & Phys Educ INEFC, Barcelona, Spain; [Colomar, Joshua; Munoz, Joshua] Acad Sanchez Casal, Sports Sci Dept, Barcelona, Spain; [Baiget, Ernest] Cent Univ Catalonia, Sport Performance Anal Res Grp SPARG, Univ Vic, Vic, Spain; [Corbi, Francisco] Univ Lleida, Natl Inst Sport & Phys Educ INEFC, Lleida, Spain	University of Barcelona; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Universitat de Lleida	Colomar, J (corresponding author), Univ Barcelona, Natl Inst Sport & Phys Educ INEFC, Barcelona, Spain.; Colomar, J (corresponding author), Acad Sanchez Casal, Sports Sci Dept, Barcelona, Spain.	joshuacolomar@gmail.com	Baiget, Ernest/S-5414-2016; Corbi, Francisco/AAD-6815-2020	Baiget, Ernest/0000-0002-2059-2846; MUNOZ, JOSHUA/0000-0001-6220-6328	Universitat de Vic - Universitat Central de Catalunya; Powerinstep, SL	Universitat de Vic - Universitat Central de Catalunya; Powerinstep, SL	The research leading to these results has been conducted using funds from the agreement between the Universitat de Vic - Universitat Central de Catalunya and Powerinstep, SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen J.E., 1988, STAT POWER ANAL BEHA; DeRenne C, 2009, STRENGTH COND J, V31, P30, DOI 10.1519/SSC.0b013e31819d3396; Draper JA, 1985, AUST J SCI MED SPORT, V17, P15; ELLIOTT BC, 1995, J APPL BIOMECH, V11, P433, DOI 10.1123/jab.11.4.433; Fernandez-Fernandez J, 2009, STRENGTH COND J, V31, P15, DOI 10.1519/SSC.0b013e3181ada1cb; Genevois C, 2013, J STRENGTH COND RES, V27, P677, DOI 10.1519/JSC.0b013e31825c3290; Girard O, 2005, MED SCI SPORT EXER, V37, P1021, DOI 10.1249/01.mss.0000171619.99391.bb; Girard O, 2009, J STRENGTH COND RES, V23, P1867, DOI 10.1519/JSC.0b013e3181b3df89; Guillot A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143331; Hetzler RK, 2008, J STRENGTH COND RES, V22, P1969, DOI 10.1519/JSC.0b013e318185f36c; Hewit JK, 2013, J STRENGTH COND RES, V27, P69, DOI 10.1519/JSC.0b013e31824f202d; Hrysomallis C, 2012, J STRENGTH COND RES, V26, P299, DOI 10.1519/JSC.0b013e3182185186; Kovacs MS, 2006, BRIT J SPORT MED, V40, P381, DOI 10.1136/bjsm.2005.023309; Landlinger J, 2010, SPORT BIOMECH, V9, P280, DOI 10.1080/14763141.2010.535841; Macadam P, 2017, SPORTS MED, V47, P887, DOI 10.1007/s40279-016-0622-x; Macadam P, 2017, J STRENGTH COND RES, V31, P1297, DOI 10.1519/JSC.0000000000001596; Martin PE, 1985, MED SCI SPORTS EXERC, V18, P415; Antunez RM, 2012, J HUM KINET, V33, P45, DOI 10.2478/v10078-012-0043-3; Miller S, 2006, BRIT J SPORT MED, V40, P401, DOI 10.1136/bjsm.2005.023283; Pialoux V, 2015, PLOS ONE, V10, P1; Reid M, 2007, J SCI MED SPORT, V10, P1, DOI 10.1016/j.jsams.2006.05.011; Reid Machar, 2002, Sports Biomech, V1, P47, DOI 10.1080/14763140208522786; Reinold MM, 2018, SPORTS HEALTH, V10, P327, DOI 10.1177/1941738118779909; Ropret R, 1998, EUR J APPL PHYSIOL, V77, P547, DOI 10.1007/s004210050374; RUSKO H, 1987, EUR J APPL PHYSIOL O, V56, P412, DOI 10.1007/BF00417768; Simperingham K., 2014, J AUSTR STRENGTH CON, V22, P69; Sogut M, 2017, BALTIC J SPORTS HLTH, V1, P44; Stewart PF, 2014, SCAND J MED SCI SPOR, V24, P500, DOI 10.1111/sms.12019; van den Tillaar R, 2004, J STRENGTH COND RES, V18, P388; Whiteside D, 2014, J SCI MED SPORT, V17, P124, DOI 10.1016/j.jsams.2013.03.001; WILSON GJ, 1993, MED SCI SPORT EXER, V25, P1279	31	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2020	15	3							e0230631	10.1371/journal.pone.0230631	http://dx.doi.org/10.1371/journal.pone.0230631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GC	32203526	Green Published, gold			2022-12-26	WOS:000535303900031
J	Liu, JH; He, DH; Cheng, LJ; Huang, CK; Zhang, YQ; Rao, XJ; Kong, YF; Li, CH; Zhang, ZZ; Liu, JP; Jones, K; Napier, D; Lee, EY; Wang, C; Liu, XQ				Liu, Jinghui; He, Daheng; Cheng, Lijun; Huang, Changkun; Zhang, Yanquan; Rao, Xiongjian; Kong, Yifan; Li, Chaohao; Zhang, Zhuangzhuang; Liu, Jinpeng; Jones, Karrie; Napier, Dana; Lee, Eun Y.; Wang, Chi; Liu, Xiaoqi			p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer	ONCOGENE			English	Article							ANTITUMOR IMMUNITY; ANDROGEN RECEPTOR; PD-L1; EXPRESSION; MECHANISMS; DOCETAXEL	Blockade of programmed death-ligand 1 (PD-L1) by therapeutic antibodies has shown to be a promising strategy in cancer therapy, yet clinical response in many types of cancer, including prostate cancer (PCa), is limited. Tumor cells secrete PD-L1 through exosomes or splice variants, which has been described as a new mechanism for the resistance to PD-L1 blockade therapy in multiple cancers, including PCa. This suggests that cutting off the secretion or expression of PD-L1 might improve the response rate of PD-L1 blockade therapy in PCa treatment. Here we report that p300/CBP inhibition by a small molecule p300/CBP inhibitor dramatically enhanced the efficacy of PD-L1 blockade treatment in a syngeneic model of PCa by blocking both the intrinsic and IFN-gamma-induced PD-L1 expression. Mechanistically, p300/CBP could be recruited to the promoter of CD274 (encoding PD-L1) by the transcription factor IRF-1, which induced the acetylation of Histone H3 at CD274 promoter followed by the transcription of CD274. A485, a p300/CBP inhibitor, abrogated this process and cut off the secretion of exosomal PD-L1 by blocking the transcription of CD274, which combined with the anti-PD-L1 antibody to reactivate T cells function for tumor attack. This finding reports a new mechanism of how cancer cells regulate PD-L1 expression through epigenetic factors and provides a novel therapeutic approach to enhance the efficacy of immune checkpoint inhibitors treatment.	[Liu, Jinghui; Huang, Changkun; Zhang, Yanquan; Rao, Xiongjian; Kong, Yifan; Li, Chaohao; Zhang, Zhuangzhuang; Liu, Xiaoqi] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [He, Daheng; Liu, Jinpeng; Wang, Chi] Univ Kentucky, Dept Biostat, Lexington, KY 40536 USA; [Cheng, Lijun] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Jones, Karrie; Napier, Dana; Lee, Eun Y.; Wang, Chi; Liu, Xiaoqi] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Lee, Eun Y.] Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University System of Ohio; Ohio State University; University of Kentucky; University of Kentucky	Liu, XQ (corresponding author), Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA.; Liu, XQ (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA.	Xiaoqi.Liu@uky.edu	He, Daheng/AAR-1813-2021; Zhang, Yanquan/D-5615-2017	Zhang, Zhuangzhuang/0000-0003-2578-7375; Zhang, Yanquan/0000-0003-3527-9972	NIH [R01 CA157429, R01 CA192894, R01 CA196835, R01 CA196634]; Biospecimen Procurement and Translational Pathology, Biostatistics and Bioinformatics, Flow Cytometry and Immune Monitoring Shared Resources of the University of Kentucky Markey Cancer Center [P30CA177558]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biospecimen Procurement and Translational Pathology, Biostatistics and Bioinformatics, Flow Cytometry and Immune Monitoring Shared Resources of the University of Kentucky Markey Cancer Center	This work was supported by NIH grants R01 CA157429 (XL), R01 CA192894 (XL), R01 CA196835 (XL), and R01 CA196634 (XL). The work was also supported by Biospecimen Procurement and Translational Pathology, Biostatistics and Bioinformatics, Flow Cytometry and Immune Monitoring Shared Resources of the University of Kentucky Markey Cancer Center (P30CA177558). We thank Heather Russell-Simmons at Research Communications Office of Markey Cancer Center for proof-reading of the paper.	Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Calagua C, 2017, CLIN CANCER RES, V23, P6812, DOI 10.1158/1078-0432.CCR-17-0807; Chen G, 2018, NATURE, V560, P382, DOI 10.1038/s41586-018-0392-8; Chen LP, 2015, J CLIN INVEST, V125, P3384, DOI 10.1172/JCI80011; Claessens F, 2014, NAT REV UROL, V11, P712, DOI 10.1038/nrurol.2014.243; Coelho MA, 2017, IMMUNITY, V47, P1083, DOI 10.1016/j.immuni.2017.11.016; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Drazic A, 2016, BBA-PROTEINS PROTEOM, V1864, P1372, DOI 10.1016/j.bbapap.2016.06.007; Eckschlager T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071414; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Gevensleben H, 2016, CLIN CANCER RES, V22, P1969, DOI 10.1158/1078-0432.CCR-15-2042; Gong B, 2019, J EXP MED, V216, P982, DOI 10.1084/jem.20180870; Haeussler M, 2019, NUCLEIC ACIDS RES, V47, pD853, DOI 10.1093/nar/gky1095; Jin LY, 2017, CANCER RES, V77, P5564, DOI 10.1158/0008-5472.CAN-17-0314; Kaushik D, 2015, THER ADV UROL, V7, P388, DOI 10.1177/1756287215597637; Lasko LM, 2017, NATURE, V550, P128, DOI 10.1038/nature24028; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Li Y, 2016, COLD SPRING HARB PER, V6, P1; Liu JH, 2016, CHEMOSPHERE, V163, P14, DOI 10.1016/j.chemosphere.2016.08.002; Mahoney KM, 2019, CANCER IMMUNOL IMMUN, V68, P421, DOI 10.1007/s00262-018-2282-1; Martin AM, 2015, PROSTATE CANCER P D, V18, P325, DOI 10.1038/pcan.2015.39; Massari F, 2016, TARGET ONCOL, V11, P345, DOI 10.1007/s11523-015-0396-3; Michaelis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019705; Nebbioso A, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007362; Poggio M, 2019, CELL, V177, P414, DOI 10.1016/j.cell.2019.02.016; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Seruga B, 2011, NAT REV CLIN ONCOL, V8, P12, DOI 10.1038/nrclinonc.2010.136; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smithy JW, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0229-2; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Zhong J, 2014, CANCER RES, V74, P1870, DOI 10.1158/0008-5472.CAN-13-2485; Zhu HR, 2016, CELL REP, V16, P2829, DOI 10.1016/j.celrep.2016.08.032	35	44	44	2	16	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	19					3939	3951		10.1038/s41388-020-1270-z	http://dx.doi.org/10.1038/s41388-020-1270-z		MAR 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LK4OF	32203167	Green Accepted			2022-12-26	WOS:000520950900001
J	Robortella, DR; Calvet, AA; Amaral, LC; Fantin, RF; Guimaraes, LFF; Dias, MHF; de Brito, CFA; de Sousa, TN; Herzog, MM; Oliveira-Ferreira, J; Carvalho, LH				Robortella, Daniela Rocha; Calvet, Anderson Augusto; Amaral, Lara Cotta; Fantin, Raianna Farhat; Ferreira Guimaraes, Luiz Felipe; Franca Dias, Michelle Hallais; Alves de Brito, Cristiana Ferreira; de Sousa, Tais Nobrega; Herzog, Mariza Maia; Oliveira-Ferreira, Joseli; Carvalho, Luzia Helena			Prospective assessment of malaria infection in a semi-isolated Amazonian indigenous Yanomami community: Transmission heterogeneity and predominance of submicroscopic infection	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PLASMODIUM-MALARIAE; PARASITE; BRAZIL; BLOOD; FALCIPARUM; SAMPLES; HUMANS; TIME	In the Amazon basin, indigenous forest-dwelling communities typically suffer from a high burden of infectious diseases, including malaria. Difficulties in accessing these isolated ethnic groups, such as the semi-nomadic Yanomami, make official malaria data largely underestimated. In the current study, we longitudinally surveyed microscopic and submicroscopic malaria infection in four Yanomami villages of the Marari community in the northern-most region of the Brazilian Amazon. Malaria parasite species-specific PCR-based detection of ribosomal and non-ribosomal targets showed that approximately 75% to 80% of all malaria infections were submicroscopic, with the ratio of submicroscopic to microscopic infection remaining stable over the 4-month follow-up period. Although the prevalence of malaria infection fluctuated over time, microscopically-detectable parasitemia was only found in children and adolescents, presumably reflecting their higher susceptibility to malaria infection. As well as temporal variation, the prevalence of malaria infection differed significantly between villages (from 1% to 19%), demonstrating a marked heterogeneity at micro-scales. Over the study period, Plasmodium vivax was the most commonly detected malaria parasite species, followed by P. malariae, and much less frequently P. falciparum. Consecutive blood samples from 859 out of the 981 studied Yanomami showed that malaria parasites were detected in only 8% of the previously malaria-positive individuals, with most of them young children (median age 3 yrs). Overall, our results show that molecular tools are more sensitive for the identification of malaria infection among the Yanomami, which is characterized by heterogeneous transmission, a predominance of low-density infections, circulation of multiple malaria parasite species, and a higher susceptibility in young children. Our findings are important for the design and implementation of the new strategic interventions that will be required for the elimination of malaria from isolated indigenous populations in Latin America.	[Robortella, Daniela Rocha; Carvalho, Luzia Helena] Univ Fed Minas Gerais UFMG, Dept Parasitol, Belo Horizonte, MG, Brazil; [Robortella, Daniela Rocha; Amaral, Lara Cotta; Fantin, Raianna Farhat; Ferreira Guimaraes, Luiz Felipe; Franca Dias, Michelle Hallais; Alves de Brito, Cristiana Ferreira; de Sousa, Tais Nobrega; Carvalho, Luzia Helena] Inst Rene Rachou FIOCRUZ MINAS, Belo Horizonte, MG, Brazil; [Calvet, Anderson Augusto; Herzog, Mariza Maia; Oliveira-Ferreira, Joseli] Fundacao Oswaldo Cruz IOC FIOCRUZ, Inst Oswaldo Cruz, Rio De Janeiro, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Carvalho, LH (corresponding author), Univ Fed Minas Gerais UFMG, Dept Parasitol, Belo Horizonte, MG, Brazil.; Carvalho, LH (corresponding author), Inst Rene Rachou FIOCRUZ MINAS, Belo Horizonte, MG, Brazil.; Oliveira-Ferreira, J (corresponding author), Fundacao Oswaldo Cruz IOC FIOCRUZ, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.	lila@ioc.fiocruz.br; luzia.carvalho@fiocruz.br	de Sousa, Tais Nobrega/AAG-6225-2019; Carvalho, Luzia H/AAW-3461-2021; Oliveira-Ferreira, Joseli/E-7942-2014	de Sousa, Tais Nobrega/0000-0002-6874-9427; Fantin, Raianna/0000-0003-0184-8612; Franca Dias, Michelle Hallais/0000-0002-4325-8680; Oliveira-Ferreira, Joseli/0000-0002-6063-465X; Guimaraes, Luiz/0000-0002-6346-027X	CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; PAEF/FIOCRUZ [IOC-FIO-18-2-47]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [E-26/110.803/2013]; Yanomami Special Indigenous Sanitary District (DSEI-Y) for Air transport; CAPES; CNPq; Brazil-CAPES-Print from FIOCRUZ	CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PAEF/FIOCRUZ; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Yanomami Special Indigenous Sanitary District (DSEI-Y) for Air transport; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazil-CAPES-Print from FIOCRUZ	This work was supported by the CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - Finance code 001, PAEF/FIOCRUZ (IOC-FIO-18-2-47 by JOF), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ (E-26/110.803/2013 by JOF), Yanomami Special Indigenous Sanitary District (DSEI-Y) for Air transport (by JOF). CFAB, TNS, JOF and LHC are CNPq Research Productivity fellows. Scholarships were sponsored by CAPES (LFFG, LCA and MHFD) and CNPq (DRR and RFF). We also thank the financial support from the Program for Institutional Internationalization of the Higher Education Institutions and Research Institutions of Brazil-CAPES-Print from FIOCRUZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ACG, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2787-7; Amaral LC, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2781-3; [Anonymous], 2010, GUIA PRAT TRAT MAL B; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Collins WE, 2007, CLIN MICROBIOL REV, V20, P579, DOI 10.1128/CMR.00027-07; Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P21, DOI 10.1590/0074-0276140102; da Silva GB, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759053, 10.1590/s1678-9946201759053]; Demas A, 2011, J CLIN MICROBIOL, V49, P2411, DOI 10.1128/JCM.02603-10; Felger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045542; Grenfell P, 2008, T ROY SOC TROP MED H, V102, P645, DOI 10.1016/j.trstmh.2008.02.021; KROTOSKI WA, 1982, AM J TROP MED HYG, V31, P1291, DOI 10.4269/ajtmh.1982.31.1291; Lalremruata A, 2015, EBIOMEDICINE, V2, P1186, DOI 10.1016/j.ebiom.2015.07.033; Laserson KF, 1999, AM J TROP MED HYG, V60, P767, DOI 10.4269/ajtmh.1999.60.767; LASERSON KF, 1994, AM J TROP MED HYG, V50, P169, DOI 10.4269/ajtmh.1994.50.169; Leandro-Reguillo P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0806-0; Marcano TJ, 2004, MEM I OSWALDO CRUZ, V99, P369, DOI 10.1590/S0074-02762004000400005; Metzger WG, 2008, T ROY SOC TROP MED H, V102, P20, DOI 10.1016/j.trstmh.2007.08.007; Ministerio da Saude, 2009, MAN DIAGN LAB MAL; Ministry of Health of Brazil, 2018, MAL EP STAT BRAZ; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; Olsson ML, 1998, TRANSFUSION, V38, P168, DOI 10.1046/j.1537-2995.1998.38298193099.x; Mondolfi AEP, 2019, SCIENCE, V365, P766, DOI 10.1126/science.aay6003; PAYNE D, 1988, B WORLD HEALTH ORGAN, V66, P621; Recht J, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1925-6; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Sa D Ribeiro, 2005, Bull Soc Pathol Exot, V98, P28; Sa nchez-Ribas J, 2015, THESIS; Sanchez-Ribas J, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2517-6; Sanchez-Ribas J, 2015, MEM I OSWALDO CRUZ, V110, P760, DOI 10.1590/0074-02760150168; Shanks GD, 2016, TRAVEL MED INFECT DI, V14, P646, DOI 10.1016/j.tmaid.2016.08.003; Siqueira AM, 2016, AM J TROP MED HYG, V95, P87, DOI 10.4269/ajtmh.16-0204; Slater HC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09441-1; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Tavares FG, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311X00130819, 10.1590/0102-311x00130819]; Tedla M, 2019, PARASITE EPIDEM CONT, V6, DOI 10.1016/j.parepi.2019.e00107; Nguyen TN, 2018, LANCET INFECT DIS, V18, P565, DOI 10.1016/S1473-3099(18)30046-X; Vega CM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061051; WHO, 2019, WORLD MALARIA REPORT; WHO, 2018, WORLD MAL REP 2018; WHO, 2018, NUCL AC AMPL BAS DIA; World Health Organization, 2017, M REP WHO EV REV GRO; World Health Organization, 2016, WHO MAL TERM	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230643	10.1371/journal.pone.0230643	http://dx.doi.org/10.1371/journal.pone.0230643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191777	Green Published, gold			2022-12-26	WOS:000535302300064
J	Mamounis, KJ; Yukl, ET; Davidson, VL				Mamounis, Kyle J.; Yukl, Erik T.; Davidson, Victor L.			Roles of active-site residues in catalysis, substrate binding, cooperativity, and the reaction mechanism of the quinoprotein glycine oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; enzyme mechanism; enzyme kinetics; cooperativity; structure-function; quinone; oxidase; site-directed mutagenesis; acid-base chemistry; cysteine tryptophylquinone; GoxA; LodA-like protein	TRYPTOPHYLQUINONE; BIOGENESIS; ENZYME; GOXA	The quinoprotein glycine oxidase from the marine bacterium Pseudoalteromonas luteoviolacea (PlGoxA) uses a protein-derived cysteine tryptophylquinone (CTQ) cofactor to catalyze conversion of glycine to glyoxylate and ammonia. This homotetrameric enzyme exhibits strong cooperativity toward glycine binding. It is a good model for studying enzyme kinetics and cooperativity, specifically for being able to separate those aspects of protein function through directed mutagenesis. Variant proteins were generated with mutations in four active-site residues, Phe-316, His-583, Tyr-766, and His-767. Structures for glycine-soaked crystals were obtained for each. Different mutations had differential effects on k(cat) and K-0.5 for catalysis, K-0.5 for substrate binding, and the Hill coefficients describing the steady-state kinetics or substrate binding. Phe-316 and Tyr-766 variants retained catalytic activity, albeit with altered kinetics and cooperativity. Substitutions of His-583 revealed that it is essential for glycine binding, and the structure of H583C PlGoxA had no active-site glycine present in glycine-soaked crystals. The structure of H767A PlGoxA revealed a previously undetected reaction intermediate, a carbinolamine product-reduced CTQ adduct, and exhibited only negligible activity. The results of these experiments, as well as those with the native enzyme and previous variants, enabled construction of a detailed mechanism for the reductive half-reaction of glycine oxidation. This proposed mechanism includes three discrete reaction intermediates that are covalently bound to CTQ during the reaction, two of which have now been structurally characterized by X-ray crystallography.	[Mamounis, Kyle J.; Davidson, Victor L.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 6900 Lake Nona Blvd, Orlando, FL 32827 USA; [Yukl, Erik T.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	State University System of Florida; University of Central Florida; New Mexico State University	Davidson, VL (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	victor.davidson@ucf.edu		Davidson, Victor/0000-0002-1966-7302; Mamounis, Kyle/0000-0002-5489-0198	National Institutes of Health NIGMS Award [R35GM130173]	National Institutes of Health NIGMS Award	This work was supported by National Institutes of Health NIGMS Award R35GM130173 (to V. L. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreo-Vidal A, 2018, BIOCHEMISTRY-US, V57, P1155, DOI 10.1021/acs.biochem.8b00009; Avalos D, 2019, BIOCHEMISTRY-US, V58, P706, DOI 10.1021/acs.biochem.8b01145; Brazeau BJ, 2004, ARCH BIOCHEM BIOPHYS, V428, P22, DOI 10.1016/j.abb.2004.03.034; Campillo-Brocal JC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1455-y; Campillo-Brocal JC, 2013, MICROBIOLOGYOPEN, V2, P684, DOI 10.1002/mbo3.107; Davidson VL, 2018, BIOCHEMISTRY-US, V57, P3115, DOI 10.1021/acs.biochem.8b00123; Davidson VL, 2003, J AM CHEM SOC, V125, P3224, DOI 10.1021/ja0297133; EDSALL JT, 1980, FED PROC, V39, P226; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Jones LH, 2005, J BIOL CHEM, V280, P17392, DOI 10.1074/jbc.M500943200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klinman JP, 2014, CHEM REV, V114, P4343, DOI 10.1021/cr400475g; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Lucas-Elio P, 2005, BBA-GEN SUBJECTS, V1721, P193, DOI 10.1016/j.bbagen.2004.11.002; Ma ZX, 2019, BIOCHEMISTRY-US, V58, P2243, DOI 10.1021/acs.biochem.9b00104; Mamounis KJ, 2019, J BIOL CHEM, V294, P17463, DOI 10.1074/jbc.RA119.011255; Masgrau L, 2006, SCIENCE, V312, P237, DOI 10.1126/science.1126002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Okazaki S, 2013, J BIOCHEM, V154, P233, DOI 10.1093/jb/mvt070; Sehanobish E, 2016, J BIOL CHEM, V291, P23199, DOI 10.1074/jbc.M116.741835; Sehanobish E, 2016, BIOCHEMISTRY-US, V55, P2305, DOI 10.1021/acs.biochem.6b00274; Sehanobish E, 2015, ARCH BIOCHEM BIOPHYS, V579, P26, DOI 10.1016/j.abb.2015.05.013; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	26	1	1	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6472	6481		10.1074/jbc.RA120.013198	http://dx.doi.org/10.1074/jbc.RA120.013198			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32234764	hybrid, Green Published			2022-12-26	WOS:000537685000018
J	Rosana, ARR; Whitford, DS; Migur, A; Steglich, C; Kujat-Choy, SL; Hess, WR; Owttrim, GW				Rosana, Albert Remus R.; Whitford, Denise S.; Migur, Anzhela; Steglich, Claudia; Kujat-Choy, Sonya L.; Hess, Wolfgang R.; Owttrim, George W.			RNA helicase?regulated processing of the Synechocystis rimO?crhR operon results in differential cistron expression and accumulation of two sRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyanobacteria; post-transcriptional regulation; RNA processing; RNA helicase; stress response; cold-stress response; differential operon cistron expression; rimO?crhR dicistronic RNA; small noncoding regulatory RNA; Synechocystis CrhR RNA helicase	DEAD-BOX PROTEINS; MESSENGER-RNA; ESCHERICHIA-COLI; ANABAENA-VARIABILIS; GENE-EXPRESSION; HELICASE; TRANSCRIPTION; CLEAVAGE; ENZYME; STABILIZATION	The arrangement of functionally-related genes in operons is a fundamental element of how genetic information is organized in prokaryotes. This organization ensures coordinated gene expression by co-transcription. Often, however, alternative genetic responses to specific stress conditions demand the discoordination of operon expression. During cold temperature stress, accumulation of the gene encoding the sole Asp?Glu?Ala?Asp (DEAD)-box RNA helicase in Synechocystis sp. PCC 6803, crhR (slr0083), increases 15-fold. Here, we show that crhR is expressed from a dicistronic operon with the methylthiotransferase rimO/miaB (slr0082) gene, followed by rapid processing of the operon transcript into two monocistronic mRNAs. This cleavage event is required for and results in destabilization of the rimO transcript. Results from secondary structure modeling and analysis of RNase E cleavage of the rimO?crhR transcript in vitro suggested that CrhR plays a role in enhancing the rate of the processing in an auto-regulatory manner. Moreover, two putative small RNAs are generated from additional processing, degradation, or both of the rimO transcript. These results suggest a role for the bacterial RNA helicase CrhR in RNase E-dependent mRNA processing in Synechocystis and expand the known range of organisms possessing small RNAs derived from processing of mRNA transcripts.	[Rosana, Albert Remus R.; Whitford, Denise S.; Kujat-Choy, Sonya L.; Owttrim, George W.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Migur, Anzhela; Steglich, Claudia; Hess, Wolfgang R.] Univ Freiburg, Fac Biol, Schanzlestr 1, D-79104 Freiburg, Germany; [Hess, Wolfgang R.] Univ Freiburg, Freiburg Inst Adv Studies, Albertstr 19, D-79104 Freiburg, Germany	University of Alberta; University of Freiburg; University of Freiburg	Owttrim, GW (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	gowttrim@ualberta.ca	Whitford, Denise S./L-7126-2015; Rosana, Albert Remus/AAL-3288-2020	Whitford, Denise S./0000-0001-7551-4805; Rosana, Albert Remus/0000-0001-7847-7763; Hess, Wolfgang/0000-0002-5340-3423	Natural Sciences and Engineering Research Council of Canada (NSERC) [171319]; Baden-Wuerttemberg Foundation [BWST_NCRNA_008]; Federal Ministry of Education and Research (BMBF) Program RNAProNet Grant [031L0164B]; Deutsche Forschungsgemeinschaft (DFG) [STE 1119/4-2]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Baden-Wuerttemberg Foundation; Federal Ministry of Education and Research (BMBF) Program RNAProNet Grant(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Grant 171319 (to G. W. O.), Baden-Wuerttemberg Foundation Grant BWST_NCRNA_008 (to W. R. H.), Federal Ministry of Education and Research (BMBF) Program RNAProNet Grant 031L0164B (to W. R. H.), and Deutsche Forschungsgemeinschaft (DFG) Grant STE 1119/4-2 (to C. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Anton BP, 2008, P NATL ACAD SCI USA, V105, P1826, DOI 10.1073/pnas.0708608105; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Behler J, 2018, NAT MICROBIOL, V3, P367, DOI 10.1038/s41564-017-0103-5; Cam K, 1996, NUCLEIC ACIDS RES, V24, P3065, DOI 10.1093/nar/24.15.3065; Cameron JC, 2015, PHOTOSYNTH RES, V126, P171, DOI 10.1007/s11120-015-0076-2; Chamot D, 2000, J BACTERIOL, V182, P1251, DOI 10.1128/JB.182.5.1251-1256.2000; Chamot D, 2005, J BIOL CHEM, V280, P2036, DOI 10.1074/jbc.M409700200; Chamot D, 1999, J BACTERIOL, V181, P1728, DOI 10.1128/JB.181.6.1728-1732.1999; Chao YJ, 2017, MOL CELL, V65, P39, DOI 10.1016/j.molcel.2016.11.002; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; Charollais J, 2004, NUCLEIC ACIDS RES, V32, P2751, DOI 10.1093/nar/gkh603; Charollais J, 2003, MOL MICROBIOL, V48, P1253, DOI 10.1046/j.1365-2958.2003.03513.x; Conlon EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052137; Conway T, 2014, MBIO, V5, DOI 10.1128/mBio.01442-14; Dar D, 2018, MBIO, V9, DOI 10.1128/mBio.01730-18; Dar D, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007354; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Gao HC, 2006, J BACTERIOL, V188, P4560, DOI 10.1128/JB.01908-05; Gaubig LC, 2011, MICROBIOL-SGM, V157, P66, DOI 10.1099/mic.0.043802-0; Georg J, 2019, RNA BIOL, V16, P1205, DOI 10.1080/15476286.2019.1621622; Greene J M, 2001, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0406s45; Gulati A, 2001, J BIOSCIENCE, V26, P193, DOI 10.1007/BF02703643; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Horie Y, 2007, MOL GENET GENOMICS, V278, P331, DOI 10.1007/s00438-007-0254-9; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Imamura S, 2009, GENE REGUL SYST BIO, V3, P65; Iost I, 2013, BBA-GENE REGUL MECH, V1829, P866, DOI 10.1016/j.bbagrm.2013.01.012; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jager S, 2004, NUCLEIC ACIDS RES, V32, P386, DOI 10.1093/nar/gkh174; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Klahn S, 2015, P NATL ACAD SCI USA, V112, pE6243, DOI 10.1073/pnas.1508412112; Koo JT, 2004, MOL MICROBIOL, V52, P1813, DOI 10.1111/j.1365-2958.2004.04099.x; Kopf M, 2014, DNA RES, V21, P527, DOI 10.1093/dnares/dsu018; Kujat SL, 2000, PLANT PHYSIOL, V124, P703, DOI 10.1104/pp.124.2.703; Laing E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r46; LEE SJ, 1994, MOL MICROBIOL, V11, P833, DOI 10.1111/j.1365-2958.1994.tb00361.x; Lim HN, 2011, P NATL ACAD SCI USA, V108, P10626, DOI 10.1073/pnas.1105692108; Linder P, 2009, TRENDS PLANT SCI, V14, P344, DOI 10.1016/j.tplants.2009.03.007; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu J, 1999, INT J BIOCHEM CELL B, V31, P215, DOI 10.1016/S1357-2725(98)00142-3; Memon D, 2013, ANTON LEEUW INT J G, V103, P331, DOI 10.1007/s10482-012-9813-0; Mikami K, 2002, MOL MICROBIOL, V46, P905, DOI 10.1046/j.1365-2958.2002.03202.x; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Mohanty BK, 2010, NUCLEIC ACIDS RES, V38, P597, DOI 10.1093/nar/gkp997; Mossey P, 2013, PLASMID, V69, P72, DOI 10.1016/j.plasmid.2012.09.002; Nickel M, 2004, MOL GENET GENOMICS, V272, P98, DOI 10.1007/s00438-004-1038-0; Owttrim GW, 2013, RNA BIOL, V10, P96, DOI 10.4161/rna.22638; Owttrim GW, 2012, METHOD ENZYMOL, V511, P385, DOI 10.1016/B978-0-12-396546-2.00018-8; Papenfort K, 2013, CELL, V153, P426, DOI 10.1016/j.cell.2013.03.003; Pei GS, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0743-y; Pierrel F, 2004, J BIOL CHEM, V279, P47555, DOI 10.1074/jbc.M408562200; Polidoros AN, 2006, BIOTECHNIQUES, V41, P35, DOI 10.2144/000112205; Pratte BS, 2015, J BACTERIOL, V197, P1408, DOI 10.1128/JB.02609-14; Pratte BS, 2014, J BACTERIOL, V196, P3609, DOI 10.1128/JB.02045-14; Pratte BS, 2013, MOL MICROBIOL, V88, P413, DOI 10.1111/mmi.12197; Price MN, 2006, PLOS GENET, V2, P859, DOI 10.1371/journal.pgen.0020096; Prud'homme-Genereux A, 2004, MOL MICROBIOL, V54, P1409, DOI 10.1111/j.1365-2958.2004.04360.x; Qi QG, 2005, APPL ENVIRON MICROB, V71, P5678, DOI 10.1128/AEM.71.10.5678-5684.2005; Ritter SPA, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2019.129462; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rosana ARR, 2016, J BACTERIOL, V198, P2089, DOI 10.1128/JB.00267-16; Rosana ARR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048683; Rosana ARR, 2012, PLANT CELL PHYSIOL, V53, P646, DOI 10.1093/pcp/pcs020; SATO N, 1995, NUCLEIC ACIDS RES, V23, P2161; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sinetova MA, 2016, BBA-GEN SUBJECTS, V1860, P2391, DOI 10.1016/j.bbagen.2016.07.006; Smolke CD, 2000, APPL ENVIRON MICROB, V66, P5399, DOI 10.1128/AEM.66.12.5399-5405.2000; Suzuki I, 2001, MOL MICROBIOL, V40, P235, DOI 10.1046/j.1365-2958.2001.02379.x; Suzuki I, 2000, EMBO J, V19, P1327, DOI 10.1093/emboj/19.6.1327; Tarassova OS, 2014, J BACTERIOL, V196, P1560, DOI 10.1128/JB.01362-13; Ungerer JL, 2010, J BACTERIOL, V192, P3311, DOI 10.1128/JB.00278-10; Wang X, 2015, P NATL ACAD SCI USA, V112, P7581, DOI 10.1073/pnas.1424683112; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	76	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6372	6386		10.1074/jbc.RA120.013148	http://dx.doi.org/10.1074/jbc.RA120.013148			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32209657	Green Published, hybrid			2022-12-26	WOS:000537685000011
J	Neill, T; Chen, CG; Buraschi, S; Iozzo, RV				Neill, Thomas; Chen, Carolyn G.; Buraschi, Simone; Iozzo, Renato V.			Catabolic degradation of endothelial VEGFA via autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiogenesis; autophagy; endothelial cell; proteoglycan; cell signaling; AICAR; AMPK; HUVEC; Peg3; VEGFR2	GROWTH-FACTOR RECEPTOR; BREAST-CARCINOMA CELLS; IMPRINTED GENE PEG3; REGULATES AUTOPHAGY; TUMOR ANGIOGENESIS; IN-VITRO; DECORIN; CANCER; ENDOREPELLIN; INHIBITION	Extracellular matrix-evoked angiostasis and autophagy within the tumor microenvironment represent two critical, but unconnected, functions of the small leucine-rich proteoglycan, decorin. Acting as a partial agonist of vascular endothelial growth factor 2 (VEGFR2), soluble decorin signals via the energy sensing protein, AMP-activated protein kinase (AMPK), in the autophagic degradation of intracellular vascular endothelial growth factor A (VEGFA). Here, we discovered that soluble decorin evokes intracellular catabolism of endothelial VEGFA that is mechanistically independent of mTOR, but requires an autophagic regulator, paternally expressed gene 3 (PEG3). We found that administration of autophagic inhibitors such as chloroquine or bafilomycin A1, or depletion of autophagy-related 5 (ATG5), results in accumulation of intracellular VEGFA, indicating that VEGFA is a basal autophagic substrate. Mechanistically, decorin increased the VEGFA clearance rate by augmenting autophagic flux, a process that required RAB24 member RAS oncogene family (RAB24), a small GTPase that facilitates the disposal of autophagic compartments. We validated these findings by demonstrating the physiological relevance of this process in vivo. Mice starved for 48 h exhibited a sharp decrease in overall cardiac and aortic VEGFA that could be blocked by systemic chloroquine treatment. Thus, our findings reveal a unified mechanism for the metabolic control of endothelial VEGFA for autophagic clearance in response to decorin and canonical pro-autophagic stimuli. We posit that the VEGFR2/AMPK/PEG3 axis integrates the anti-angiogenic and pro-autophagic bioactivities of decorin as the molecular basis for tumorigenic suppression. These results support future therapeutic use of decorin as a next-generation protein therapy to combat cancer.	Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Sidney Kimmel Med Coll, Canc Cell Biol & Signaling Program, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Neill, T (corresponding author), Thomas Jefferson Univ, 1020 Locust St,Suite 336G Jefferson Alumni Hall, Philadelphia, PA 19107 USA.; Iozzo, RV (corresponding author), Thomas Jefferson Univ, 1020 Locust St,Suite 336 Jefferson Alumni Hall, Philadelphia, PA 19107 USA.	thomas.neill@jefferson.edu; renato.iozzo@jefferson.edu	Iozzo, Renato/AAS-1980-2020	Buraschi, Simone/0000-0002-4233-7627; Chen, Carolyn/0000-0003-4933-6544	National Institutes of Health [RO1 CA39481, RO1 CA47282, T32 AR052273]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants RO1 CA39481 and RO1 CA47282 (to R. V. I.) and T32 AR052273 (to C. G. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Apte RS, 2019, CELL, V176, P1248, DOI 10.1016/j.cell.2019.01.021; Ban HS, 2010, CANCER LETT, V296, P17, DOI 10.1016/j.canlet.2010.03.010; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Bi XL, 2012, CARCINOGENESIS, V33, P326, DOI 10.1093/carcin/bgr293; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Chen C, 2019, METHODS MOL BIOL, V1952, P157, DOI 10.1007/978-1-4939-9133-4_14; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Dodd KM, 2015, ONCOGENE, V34, P2239, DOI 10.1038/onc.2014.164; Douglass S, 2015, CONNECT TISSUE RES, V56, P381, DOI 10.3109/03008207.2015.1045297; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Ferrara N, 2016, NAT REV DRUG DISCOV, V15, P385, DOI 10.1038/nrd.2015.17; Fong TAT, 1999, CANCER RES, V59, P99; Francipane MG, 2013, ONCOTARGET, V4, P1948, DOI 10.18632/oncotarget.1310; Galluzzi L, 2017, NAT REV DRUG DISCOV, V16, P487, DOI 10.1038/nrd.2017.22; Garantziotis S, 2019, MATRIX BIOL, V78-79, P1, DOI 10.1016/j.matbio.2019.02.002; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Goldoni S, 2008, AM J PATHOL, V173, P844, DOI 10.2353/ajpath.2008.080275; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Goyal A, 2016, J BIOL CHEM, V291, P19245, DOI 10.1074/jbc.M116.740266; Goyal A, 2014, MATRIX BIOL, V34, P46, DOI 10.1016/j.matbio.2013.12.011; Goyal A, 2012, J BIOL CHEM, V287, P43543, DOI 10.1074/jbc.M112.401786; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Gubbiotti MA, 2020, SEMIN CANCER BIOL, V62, P1, DOI 10.1016/j.semcancer.2019.05.003; Gubbiotti MA, 2018, J BIOL CHEM, V293, P16940, DOI 10.1074/jbc.RA118.004563; Gubbiotti MA, 2016, MATRIX BIOL, V55, P7, DOI 10.1016/j.matbio.2016.09.009; Gubbiotti MA, 2015, MATRIX BIOL, V48, P6, DOI 10.1016/j.matbio.2015.10.002; Gubbiotti MA, 2015, MATRIX BIOL, V48, P14, DOI 10.1016/j.matbio.2015.09.001; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gurney MA, 2015, METHODS MOL BIOL, V1219, P187, DOI 10.1007/978-1-4939-1661-0_14; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Iozzo RV, 2018, MATRIX BIOL, V71-72, P1, DOI 10.1016/j.matbio.2018.03.023; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Jarvelainen H, 2015, MATRIX BIOL, V43, P15, DOI 10.1016/j.matbio.2015.01.023; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Jin LJ, 2014, BREAST CANCER RES TR, V146, P41, DOI 10.1007/s10549-014-2978-7; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Karamanos Nikos K, 2019, Matrix Biol, V75-76, P1, DOI 10.1016/j.matbio.2018.08.007; Karamanos NK, 2018, CHEM REV, V118, P9152, DOI 10.1021/acs.chemrev.8b00354; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kim J, 2013, AUTOPHAGY, V9, P1110, DOI 10.4161/auto.24877; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2011, AUTOPHAGY, V7, P1, DOI 10.4161/auto.7.1.14130; Kohda T, 2001, GENES CELLS, V6, P237, DOI 10.1046/j.1365-2443.2001.00412.x; Kuhajda FP, 2008, INT J OBESITY, V32, pS36, DOI 10.1038/ijo.2008.121; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Lee JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015394; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu Qingsong, 2009, Drug Discov Today Ther Strateg, V6, P47; Maegawa S, 2001, MOL CARCINOGEN, V31, P1, DOI 10.1002/mc.1034; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mendel DB, 2000, CLIN CANCER RES, V6, P4848; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1; Mongiat M, 2019, BIOCHEM SOC T, V47, P1543, DOI 10.1042/BST20190653; Moore BR, 2011, ANTIMICROB AGENTS CH, V55, P3899, DOI 10.1128/AAC.00067-11; Moreth K, 2012, CELL CYCLE, V11, P2084, DOI 10.4161/cc.20316; Moulis M, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6020014; Neill T, 2017, J BIOL CHEM, V292, P16211, DOI 10.1074/jbc.M116.769950; Neill T, 2016, ADV DRUG DELIVER REV, V97, P174, DOI 10.1016/j.addr.2015.10.016; Neill T, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975645; Neill T, 2015, BIOCHEMISTRY-US, V54, P4583, DOI 10.1021/acs.biochem.5b00653; Neill T, 2014, AM J PATHOL, V184, P2146, DOI 10.1016/j.ajpath.2014.05.010; Neill T, 2014, J BIOL CHEM, V289, P4952, DOI 10.1074/jbc.M113.512566; Neill T, 2013, AUTOPHAGY, V9, P1626, DOI 10.4161/auto.25881; Neill T, 2013, FEBS J, V280, P2353, DOI 10.1111/febs.12148; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Nye MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056325; Orillion A, 2018, CLIN CANCER RES, V24, P6383, DOI 10.1158/1078-0432.CCR-18-0980; Patel S, 1998, J BIOL CHEM, V273, P3121, DOI 10.1074/jbc.273.6.3121; Poluzzi C, 2014, J BIOL CHEM, V289, P16114, DOI 10.1074/jbc.M114.556530; Ricard-Blum S, 2019, MATRIX BIOL, V75-76, P170, DOI 10.1016/j.matbio.2017.11.005; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rimsa V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069538; Rosenbluth JM, 2009, AUTOPHAGY, V5, P114, DOI 10.4161/auto.5.1.7294; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Saleh AD, 2013, CELL CYCLE, V12, P1955, DOI 10.4161/cc.25016; Schaefer L, 2014, MATRIX BIOL, V35, P1, DOI 10.1016/j.matbio.2014.05.001; Simone BA, 2016, CELL CYCLE, V15, P2265, DOI 10.1080/15384101.2016.1160982; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Stjepanovic G, 2017, MOL CELL, V67, P528, DOI 10.1016/j.molcel.2017.07.003; Theocharis AD, 2015, BBA-REV CANCER, V1855, P276, DOI 10.1016/j.bbcan.2015.03.006; Torres A, 2017, J BIOL CHEM, V292, P5055, DOI 10.1074/jbc.M116.753632; Vigetti D, 2018, J BIOL CHEM, V293, P16951, DOI 10.1074/jbc.H118.006101; Xu W, 2015, GENE THER, V22, P247, DOI 10.1038/gt.2014.110; Yang F, 2013, J BIOL CHEM, V288, P6552, DOI 10.1074/jbc.M112.418335; Yang YF, 2015, HUM GENE THER, V26, P813, DOI 10.1089/hum.2015.098; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yla-Anttila Paivi, 2018, Small GTPases, V9, P57, DOI 10.1080/21541248.2017.1317699; Yla-Anttila P, 2015, AUTOPHAGY, V11, P1833, DOI 10.1080/15548627.2015.1086522; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	113	17	18	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6064	6079		10.1074/jbc.RA120.012593	http://dx.doi.org/10.1074/jbc.RA120.012593			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32209654	Green Published, hybrid			2022-12-26	WOS:000531417300018
J	Aida, S; Matsuda, Y; Shimono, K				Aida, Saori; Matsuda, Yusuke; Shimono, Koichi			Interaction of disparity size and depth structure on perceived numerosity in a three-dimensional space	PLOS ONE			English	Article							DISCRIMINATION; NUMBER; MAGNITUDE	The number of elements in two stereo-surfaces parallelly overlapped in depth is overestimated compared to that in a single flat surface, even when both have the same number of elements. Using stereoscopic pairs of elements, we evaluated two hypotheses on the overestimation: one that a higher-order process, forming a background surface, increases the number of perceived elements, and the other that the number of elements potentially occluded by the elements on a front surface is taken accounted for. The data from four experiments showed that (a) when binocular disparity between (or among) stereoscopic elements was small, the overestimation occurred for the stimuli we used-a two-surface-overlapping stimulus, where the likelihood for the process to operate was manipulated by changing the averaged luminance of each surface, a volumetric stimulus, where the likelihood for the background surface to be formed would decrease, and a two-non-overlapping-surface stimulus, where the surfaces in depth were not overlapped-, and (b) when binocular disparity was large, the overestimation occurred for the two-surfaces-overlapping stimulus, when the averaged luminance of the two surfaces were the same, and for the volumetric stimulus, but diminished for the surface-overlapping stimulus, when the averaged luminance differed between the surfaces and for the surfaces-non-overlapping stimulus. These results cannot be explained either hypothesis only. We explain the results by postulating that the sensory system processing disparities of elements interferes with that estimating the number of elements, resulting in an overestimation of the elements in a stereo-stimulus, and the disparity range within which the interference occurs may depend on the stimulus depth structure.	[Aida, Saori] Tokyo Univ Technol, Dept Comp Sci, Hachioji, Tokyo, Japan; [Matsuda, Yusuke; Shimono, Koichi] Tokyo Univ Marine Sci & Technol, Dept Logist & Informat Engn, Tokyo, Japan; [Aida, Saori] Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Yoshida, Japan; [Matsuda, Yusuke] Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi, Japan	Tokyo University of Technology; Tokyo University of Marine Science & Technology; Yamaguchi University; Toyohashi University of Technology	Aida, S (corresponding author), Tokyo Univ Technol, Dept Comp Sci, Hachioji, Tokyo, Japan.; Aida, S (corresponding author), Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Yoshida, Japan.	saori.aida.t@gmail.com	Aida, Saori/AAW-7957-2020	Aida, Saori/0000-0001-8233-6015; Matsuda, Yusuke/0000-0002-5982-3971	 [13J10777];  [17K18187];  [23330215];  [15H03463]	; ; ; 	This work was partly supported by Grants-in-Aid for Scientific Research, Grant-in-Aid for JSPS Fellows(13J10777) for SA; Grant-in-Aid for Young Scientists(B)(17K18187) for SA; Grant-in-Aid for Scientific Research(B)(23330215, 15H03463) for KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Aida S, 2018, P 21 CENT SCI HUM S, V6; Aida S, 2015, J VISION, V15, DOI 10.1167/15.9.23; Aida S, 2015, ATTEN PERCEPT PSYCHO, V77, P190, DOI 10.3758/s13414-014-0746-8; Anobile G, 2016, DEV PSYCHOL, V52, P1206, DOI 10.1037/dev0000155; Anobile G, 2015, J VISION, V15, DOI 10.1167/15.5.4; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Bell J, 2015, J VISION, V15, DOI 10.1167/15.2.18; BURGESS A, 1983, VISION RES, V23, P811, DOI 10.1016/0042-6989(83)90204-3; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; BURT P, 1980, SCIENCE, V208, P615, DOI 10.1126/science.7367885; Cantlon JF, 2009, TRENDS COGN SCI, V13, P83, DOI 10.1016/j.tics.2008.11.007; Dakin SC, 2011, P NATL ACAD SCI USA, V108, P19552, DOI 10.1073/pnas.1113195108; Durgin FH, 2008, CURR BIOL, V18, pR855, DOI 10.1016/j.cub.2008.07.053; Howard I. P., 2012, PERCEIVING DEPTH, V2; INDOW T, 1977, PERCEPT PSYCHOPHYS, V22, P265, DOI 10.3758/BF03199689; KAUFMAN EL, 1949, AM J PSYCHOL, V62, P498, DOI 10.2307/1418556; KRUEGER LE, 1972, PERCEPT PSYCHOPHYS, V11, P5, DOI 10.3758/BF03212674; KRUEGER LE, 1984, PERCEPT PSYCHOPHYS, V35, P536, DOI 10.3758/BF03205949; Matsuda Y, 2017, J VIS, V17, P151, DOI [10.1167/17.10.151, DOI 10.1167/17.10.151]; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Oyama T, 1978, BESSATSU SCI, V56, P31; Ross J, 2010, J VISION, V10, DOI 10.1167/10.2.10; Schutz AC, 2012, J VISION, V12, DOI 10.1167/12.12.9; Sun HC, 2018, J VISION, V18, DOI 10.1167/18.6.3; Tokita M, 2011, PSYCHON B REV, V18, P550, DOI 10.3758/s13423-011-0072-2; Tsirlin I, 2012, VISION RES, V54, P1, DOI 10.1016/j.visres.2011.11.013; Tsirlin I, 2008, J VISION, V8, DOI 10.1167/8.5.5	28	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0230847	10.1371/journal.pone.0230847	http://dx.doi.org/10.1371/journal.pone.0230847			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8KJ	32240209	gold, Green Published			2022-12-26	WOS:000535945000046
J	Su, SS; Yang, X; Su, Q; Zhao, Y				Su, Sisi; Yang, Xin; Su, Qing; Zhao, Yang			Prevalence and knowledge of heavy menstrual bleeding among gynecology outpatients by scanning a WeChat QR Code	PLOS ONE			English	Article							WOMEN; MENORRHAGIA; IMPACT	The aim of this study was to assess menstrual blood loss (MBL) and knowledge of heavy menstrual bleeding (HMB) among the gynecology outpatients at Peking University People's Hospital, by scanning a WeChat (a social media application software developed by Tencent) QR Code using a mobile phone or tablet. This survey was conducted among outpatients who were treated at the Gynecology Department of Peking University People's Hospital between September 2016 and November 2016. All participants filled up the questionnaires and scales through WeChat: general information questionnaire, Pictorial Blood Loss Assessment Chart (PBAC), Menorrhagia Multi-Attribute Quality-of-Life Scale (MMAS), and HMB knowledge questionnaire. Menstrual blood volume was assessed by the PBAC and self-assessment. Among the 1152 patients who filled out the survey, 77.4% (892/1152) had normal menstrual cycle (assessed by the patients), 15.6% (180/1152) patients described themselves as HMB, whereas the results from PBAC showed that 58.0% (668/1152) had HMB (PBAC >= 100). Among patients with PBAC >= 100, only 26.8% (179/668) patients reported HMB through self-assessment. Regarding its impact on daily life, the MMAS scores of HMB patients (PBAC >= 100) were significantly lower compared to those with normal blood loss (P<0.001). Regarding the awareness to HMB, 63.2% (728/1152) of the patients were not familiar with HMB. HMB is a common abnormal uterine bleeding and is frequently found among Chinese gynecology outpatients. HMB has major impacts on a woman's quality of life, affecting both physical and emotional health domains. Since women generally have low levels of awareness and understanding of HMB, they could assess their blood loss using the PBAC, which they can forward to their health care provider using a mobile phone or tablet and the WeChat platform. This tool may be effortlessly used by the health care providers and patients to easily share HMB-related data.	[Su, Sisi; Yang, Xin; Su, Qing; Zhao, Yang] Peking Univ, Dept Obstet & Gynecol, Peoples Hosp, Beijing, Peoples R China; [Su, Sisi] Fujian Nanan Hosp, Dept Obstet & Gynecol, Quanzhou, Fujian, Peoples R China	Peking University	Yang, X (corresponding author), Peking Univ, Dept Obstet & Gynecol, Peoples Hosp, Beijing, Peoples R China.	xinyang_2003@sina.com			National Key Technology RD Program [2015BAI13B06]	National Key Technology RD Program(National Key Technology R&D Program)	This study was supported by National Key Technology R&D Program (fund number: 2015BAI13B06).; This study was supported by National Key Technology R&D Program (fund number: 2015BAI13B06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahamondes Luis, 2015, F1000Prime Rep, V7, P33, DOI 10.12703/P7-33; Bitzer J, 2013, OPEN ACCESS J CONTR, V4, P21, DOI 10.2147/OAJC.S38993; Bonafede MM, 2014, CLINICOECONOMIC OUTC, V6, P423, DOI 10.2147/CEOR.S67888; Byles JE, 1997, FAM PRACT, V14, P249, DOI 10.1093/fampra/14.3.249; Cohen SL, 2014, JSLS-J SOC LAPAROEND, V18, DOI 10.4293/JSLS.2014.00096; Fraser I, 2009, EXP REV OBSTET GYNEC, V4, P179, DOI [10.1586/17474108.4.2.179, DOI 10.1586/17474108.4.2.179]; Fraser IS, 2015, INT J GYNECOL OBSTET, V128, P196, DOI 10.1016/j.ijgo.2014.09.027; Fraser IS, 2011, SEMIN REPROD MED, V29, P383, DOI 10.1055/s-0031-1287662; FRASER IS, 1984, AM J OBSTET GYNECOL, V149, P788, DOI 10.1016/0002-9378(84)90123-6; HALLBERG L, 1966, ACTA OBSTET GYN SCAN, V45, P320, DOI 10.3109/00016346609158455; Harlow SD, 2004, BJOG-INT J OBSTET GY, V111, P6, DOI 10.1111/j.1471-0528.2004.00012.x; HIGHAM JM, 1990, BRIT J OBSTET GYNAEC, V97, P734, DOI 10.1111/j.1471-0528.1990.tb16249.x; Hurskainen R, 2007, ACTA OBSTET GYN SCAN, V86, P749, DOI 10.1080/00016340701415400; Janssen CAH, 1998, EUR J OBSTET GYN R B, V78, P69, DOI 10.1016/S0301-2115(97)00275-3; Jocko JA, 2013, J OBSTET GYNAECOL CA, V35, P44, DOI 10.1016/S1701-2163(15)31047-1; Munro MG, 2017, BEST PRACT RES CL OB, V40, P3, DOI 10.1016/j.bpobgyn.2016.09.011; Munro MG, 2011, INT J GYNECOL OBSTET, V113, P3, DOI 10.1016/j.ijgo.2010.11.011; National Collaborating Center for Women's and Children Health, 2007, HEAV MENSTR BLEED CL; Nelson AL, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.04.023; NICE, 2007, HEAV MENSTR BLEED AS; Pattison H, 2011, BJOG-INT J OBSTET GY, V118, P1528, DOI 10.1111/j.1471-0528.2011.03057.x; Shaw RW, 1998, BRIT J OBSTET GYNAEC, V105, P1155, DOI 10.1111/j.1471-0528.1998.tb09968.x; Warrilow G, 2004, OBSTET GYNAECOL, V6, P88; Zakherah MS, 2011, GYNECOL OBSTET INVES, V71, P281, DOI 10.1159/000320336; ZANDER R, 1984, CLIN CHIM ACTA, V136, P83, DOI 10.1016/0009-8981(84)90250-X	25	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0229123	10.1371/journal.pone.0229123	http://dx.doi.org/10.1371/journal.pone.0229123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8KJ	32240178	Green Published, gold			2022-12-26	WOS:000535945000014
J	van Mastrigt, NM; Smeets, JBJ; van der Kooij, K				van Mastrigt, Nina M.; Smeets, Jeroen B. J.; van der Kooij, Katinka			Quantifying exploration in reward-based motor learning	PLOS ONE			English	Article							VARIABILITY; REINFORCEMENT; MODULATION	Exploration in reward-based motor learning is observable in experimental data as increased variability. In order to quantify exploration, we compare three methods for estimating other sources of variability: sensorimotor noise. We use a task in which participants could receive stochastic binary reward feedback following a target-directed weight shift. Participants first performed six baseline blocks without feedback, and next twenty blocks alternating with and without feedback. Variability was assessed based on trial-to-trial changes in movement endpoint. We estimated sensorimotor noise by the median squared trial-to-trial change in movement endpoint for trials in which no exploration is expected. We identified three types of such trials: trials in baseline blocks, trials in the blocks without feedback, and rewarded trials in the blocks with feedback. We estimated exploration by the median squared trial-to-trial change following non-rewarded trials minus sensorimotor noise. As expected, variability was larger following non-rewarded trials than following rewarded trials. This indicates that our reward-based weight-shifting task successfully induced exploration. Most importantly, our three estimates of sensorimotor noise differed: the estimate based on rewarded trials was significantly lower than the estimates based on the two types of trials without feedback. Consequently, the estimates of exploration also differed. We conclude that the quantification of exploration depends critically on the type of trials used to estimate sensorimotor noise. We recommend the use of variability following rewarded trials.	[van Mastrigt, Nina M.; Smeets, Jeroen B. J.; van der Kooij, Katinka] Vrije Univ Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van Mastrigt, NM (corresponding author), Vrije Univ Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands.	n.m.van.mastrigt@vu.nl	Smeets, Jeroen/B-4198-2008	Smeets, Jeroen/0000-0002-3794-0579; van Mastrigt, Nina/0000-0002-8531-9568; van der Kooij, Katinka/0000-0002-4190-7827	Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Toegepaste en Technische Wetenschappen (NWO-TTW); Open Technologie Programma (OTP) [15989]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Toegepaste en Technische Wetenschappen (NWO-TTW)(Netherlands Organization for Scientific Research (NWO)); Open Technologie Programma (OTP)	The research was funded by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Toegepaste en Technische Wetenschappen (NWO-TTW), by the Open Technologie Programma (OTP) grant 15989 awarded to Jeroen Smeets.	Abe M, 2011, CURR BIOL, V21, P557, DOI 10.1016/j.cub.2011.02.030; Bouman D, 2018, HUM MOVEMENT SCI, V57, P280, DOI 10.1016/j.humov.2017.09.006; Brielmann AA, 2015, J EXP PSYCHOL HUMAN, V41, P917, DOI 10.1037/a0039205; Cashaback JGA, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006839; Chen XL, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005503; Codol O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27378-1; Dhawale AK, 2019, CURR BIOL, V29, P3551, DOI 10.1016/j.cub.2019.08.052; Dhawale AK, 2017, ANNU REV NEUROSCI, V40, P479, DOI 10.1146/annurev-neuro-072116-031548; Galea JM, 2015, NAT NEUROSCI, V18, P597, DOI 10.1038/nn.3956; Hasson CJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00459; He K, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005023; Hickman R, 2015, DISTRIBUTION EUCLIDE; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; Lemons D. S., 2002, INTRO STOCHASTIC PRO; Manley H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086580; Manohar SG, 2015, CURR BIOL, V25, P1707, DOI 10.1016/j.cub.2015.05.038; Mehler DMA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180803; MILLER J, 1988, J EXP PSYCHOL HUMAN, V14, P539, DOI 10.1037/0096-1523.14.3.539; Nikooyan AA, 2015, J NEUROPHYSIOL, V113, P633, DOI 10.1152/jn.00032.2014; Pekny SE, 2015, J NEUROSCI, V35, P4015, DOI 10.1523/JNEUROSCI.3244-14.2015; Rousselet GA, 2018, REACTION TIMES OTHER, DOI [10.1101/383935, DOI 10.1101/383935]; Ryan RM, 2017, SELF-DETERMINATION THEORY: BASIC PSYCHOLOGICAL NEEDS IN MOTIVATION, DEVELOPMENT, AND WELLNESS, P1, DOI 10.1521/978.14625/28806; Shmuelof L, 2012, J NEUROSCI, V32, P14617, DOI 10.1523/JNEUROSCI.2184-12.2012; Sidarta A, 2018, J NEUROPHYSIOL, V120, P3275, DOI 10.1152/jn.00442.2018; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Takikawa Y, 2002, EXP BRAIN RES, V142, P284, DOI 10.1007/s00221-001-0928-1; Therrien AS, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0050-18.2018; Therrien AS, 2016, BRAIN, V139, P101, DOI 10.1093/brain/awv329; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Uehara S, 2019, J NEUROPHYSIOL, V122, P797, DOI 10.1152/jn.00390.2018; van Beers RJ, 2013, J NEUROPHYSIOL, V109, P969, DOI 10.1152/jn.00706.2012; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; van der Kooij K, 2016, EXP BRAIN RES, V234, P1441, DOI 10.1007/s00221-015-4540-1; van der Kooij K, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00294; van der Kooij K, 2019, J EXP PSYCHOL LEARN, V45, P71, DOI 10.1037/xlm0000573; van der Kooij K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193002; van der Kooij K, 2016, EUR J NEUROSCI, V44, P2708, DOI 10.1111/ejn.13355; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616	38	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2020	15	4							e0226789	10.1371/journal.pone.0226789	http://dx.doi.org/10.1371/journal.pone.0226789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8KJ	32240174	Green Published, Green Submitted, gold			2022-12-26	WOS:000535945000009
J	Li, Y; He, CL; Li, WX; Zhang, RX; Duan, Y				Li, Ya; He, Cheng-Lu; Li, Wen-Xing; Zhang, Rui-Xian; Duan, Yong			Transcriptome analysis reveals gender-specific differences in overall metabolic response of male and female patients in lung adenocarcinoma	PLOS ONE			English	Article							CANCER STATISTICS; ACID CERAMIDASE; CELL	Background Evidence from multiple studies suggests metabolic abnormalities play an important role in lung cancer. Lung adenocarcinoma (LUAD) is the most common subtype of lung cancer. The present study aimed to explore differences in the global metabolic response between male and female patients in LUAD and to identify the metabolic genes associated with lung cancer susceptibility. Methods Transcriptome and clinical LUAD data were acquired from The Cancer Genome Atlas (TCGA) database. Information on metabolic genes and metabolic subsystems were collected from the Recon3D human metabolic model. Two validation datasets (GSE68465 and GSE72094) were downloaded from the Gene Expression Omnibus (GEO) database. Differential expression analysis, gene set enrichment analysis and protein-protein interaction networks were used to identified key metabolic pathways and genes. Functional experiments were used to verify the effects of genes on proliferation, migration, and invasion in lung cancer cells in vitro. Results Samples of tumors and adjacent non-tumor tissue from both male and female patients exhibited distinct global patterns of gene expression. In addition, we found large differences in methionine and cysteine metabolism, pyruvate metabolism, cholesterol metabolism, nicotinamide adenine dinucleotide (NAD) metabolism, and nuclear transport between male and female LUAD patients. We identified 34 metabolic genes associated with lung cancer susceptibility in males and 15 in females. Most of the metabolic cancer-susceptibility genes had high prediction accuracy for lung cancer (AUC > 0.9). Furthermore, both bioinformatics analysis and experimental results showed that TAOK2 was down-regulated and ASAH1 was up-regulated in male tumor tissue and female tumor tissue in LUAD. Functional experiments showed that inhibiting ASAH1 suppressed the proliferation, migration, and invasion of lung cancer cells. Conclusions Metabolic cancer-susceptibility genes may be used alone or in combination as diagnostic markers for LUAD. Further studies are required to elucidate the functions of these genes in LUAD.	[Li, Ya; He, Cheng-Lu; Duan, Yong] Yunnan Key Lab Lab Med, Kunming, Yunnan, Peoples R China; [Li, Ya; He, Cheng-Lu; Duan, Yong] Yunnan Inst Lab Diag, Kunming, Yunnan, Peoples R China; [Li, Ya; He, Cheng-Lu; Duan, Yong] Kunming Med Univ, Dept Clin Lab, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Li, Wen-Xing] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Li, Wen-Xing] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Zhang, Rui-Xian] Yunnan Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China	Kunming Medical University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Duan, Y (corresponding author), Yunnan Key Lab Lab Med, Kunming, Yunnan, Peoples R China.; Duan, Y (corresponding author), Yunnan Inst Lab Diag, Kunming, Yunnan, Peoples R China.; Duan, Y (corresponding author), Kunming Med Univ, Dept Clin Lab, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China.	Duanyong7@139.com		Li, Wen-Xing/0000-0001-9984-8439	National Natural Science Foundation of China [81460325, 81760384]; Applied Basic Research in Yunnan Province [2015FB040]; Health Science and Technology Project in Yunnan province [:2017NS030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research in Yunnan Province; Health Science and Technology Project in Yunnan province	This work was supported by the National Natural Science Foundation of China (Grant No: 81460325 and 81760384), the Applied Basic Research in Yunnan Province (Grant No: 2015FB040). the Health Science and Technology Project in Yunnan province(Grant No:2017NS030). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach DH, 2018, MOL THER-NUCL ACIDS, V12, P817, DOI 10.1016/j.omtn.2018.07.016; Bertero T, 2019, CELL METAB, V29, P124, DOI 10.1016/j.cmet.2018.09.012; Brunk E, 2018, NAT BIOTECHNOL, V36, P272, DOI 10.1038/nbt.4072; Camacho L, 2013, J LIPID RES, V54, P1207, DOI 10.1194/jlr.M032375; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Graudenzi A, 2018, J BIOMED INFORM, V87, P37, DOI 10.1016/j.jbi.2018.09.010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Karam MB, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011628; Klobucar M, 2018, BIOCHEM BIOPH RES CO, V503, P843, DOI 10.1016/j.bbrc.2018.06.085; Koo CY, 2017, MOL CANCER THER, V16, P2410, DOI 10.1158/1535-7163.MCT-17-0077; Lacroix R, 2018, CANCER IMMUNOL IMMUN, V67, P1331, DOI 10.1007/s00262-018-2195-z; Leclerc J, 2019, ONCOGENE, V38, P1282, DOI 10.1038/s41388-018-0500-0; Lee J, 2018, JPN J CLIN ONCOL, V48, P920, DOI 10.1093/jjco/hyy115; Lee P, 2012, CLIN LUNG CANCER, V13, P52, DOI 10.1016/j.cllc.2011.05.001; Leithner K, 2018, P NATL ACAD SCI USA, V115, P6225, DOI 10.1073/pnas.1719871115; Li HJ, 2018, ONCOL LETT, V15, P2316, DOI 10.3892/ol.2017.7567; Lu DH, 2018, ONCOL LETT, V16, P3603, DOI 10.3892/ol.2018.9100; Molho-Pessach V, 2017, J DERMATOL SCI, V87, P123, DOI 10.1016/j.jdermsci.2017.03.018; Namani A, 2017, ONCOTARGET, V8, P69847, DOI 10.18632/oncotarget.19349; Piala AT, 2016, BIOORG MED CHEM LETT, V26, P3923, DOI 10.1016/j.bmcl.2016.07.016; Remon J, 2014, CLIN TRANSL ONCOL, V16, P517, DOI 10.1007/s12094-013-1137-7; Richter M, 2019, MOL PSYCHIATR, V24, P1329, DOI 10.1038/s41380-018-0025-5; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sanger N, 2015, MOL ONCOL, V9, P58, DOI 10.1016/j.molonc.2014.07.016; Sato T, 2018, MOL CELL ONCOL, V5, DOI 10.1080/23723556.2018.1472054; Schmidt CW, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP2093; Stoll G, 2015, ONCOTARGET, V6, P11894, DOI 10.18632/oncotarget.4180; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki Shuhei, 2018, Oncotarget, V9, P32667, DOI 10.18632/oncotarget.25994; Svensson RU, 2016, COLD SH Q B, V81, P93, DOI [10.1101/sqb.2016.81.030874, 10.1101/sqb.2016.81.030574]; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tang Q, 2018, ONCOL LETT, V16, P2344, DOI 10.3892/ol.2018.8882; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Zablocka-Slowinska KZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204173	37	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230796	10.1371/journal.pone.0230796	http://dx.doi.org/10.1371/journal.pone.0230796			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236130	Green Published, gold			2022-12-26	WOS:000535938700030
J	Uka, R; Britschgi, C; Krattli, A; Matter, C; Mihic, D; Okoniewski, MJ; Gualandi, M; Stupp, R; Cinelli, P; Dummer, R; Levesque, MP; Shakhova, O				Uka, Rexhep; Britschgi, Christian; Krattli, Anja; Matter, Claudia; Mihic, Daniela; Okoniewski, Michal J.; Gualandi, Marco; Stupp, Roger; Cinelli, Paolo; Dummer, Reinhard; Levesque, Mitchell P.; Shakhova, Olga			Temporal activation of WNT/beta-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth	ONCOGENE			English	Article							BETA-CATENIN; TRANSCRIPTION FACTOR; CUTANEOUS MELANOMA; MITF; CELL; PROGRESSION; IPILIMUMAB; IDENTIFICATION; MONOTHERAPY; VEMURAFENIB	Despite advances in the systemic treatment of patients with metastatic melanoma using immune checkpoint and tyrosine kinase inhibitors (TKI), the majority of stage IV melanoma patients eventually succumb to the disease. We have previously identified the transcription factor Sox10 as a crucial player in melanoma, yet the underlying molecular mechanisms mediating Sox10-dependent tumorigenesis remain largely uncharacterized. Here, we show that MEK and RAF inhibitors do not suppress levels of SOX10 protein in patient-derived cells in vitro, as well as in melanoma patients in vivo. In a search for pharmacological inhibitors of SOX10, we performed a mass spectrometry-based screen in human melanoma cells. Subsequent analysis revealed that SOX10 directly interacts with beta-catenin, which is a key mediator of canonical Wnt/beta-catenin signaling. We demonstrate that inhibitors of glycogen synthase kinase 3 alpha/beta (GSK3 alpha/beta) efficiently abrogate SOX10 protein in human melanoma cells in vitro and in melanoma mouse models in vivo. The mechanism of action of GSK3-mediated SOX10 suppression is transcription-independent and relies on the presence of a proteasome degradable form of beta-catenin. Taken together, we provide evidence that activation of canonical Wnt signaling has a profound effect on melanoma growth and is able to counteract Sox10-dependent melanoma maintenance both in vitro and in vivo.	[Uka, Rexhep; Britschgi, Christian; Krattli, Anja; Matter, Claudia; Gualandi, Marco; Stupp, Roger; Shakhova, Olga] Univ Zurich, Univ Hosp Zurich, Dept Med Oncol & Hematol, Wagistr 14, CH-8952 Schlieren, Switzerland; [Mihic, Daniela] Univ Zurich, Univ Hosp Zurich, Dept Surg Pathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland; [Okoniewski, Michal J.] Swiss Fed Inst Technol, Sci IT Serv ETH Zurich, Weinbergstr 11, CH-8092 Zurich, Switzerland; [Cinelli, Paolo] Univ Zurich, Univ Zurich Hosp, Dept Trauma Surg, Sternwartstr 1, CH-8091 Zurich, Switzerland; [Dummer, Reinhard; Levesque, Mitchell P.] Univ Zurich, Univ Zurich Hosp, Dept Dermatol, Wagistrasse 14, CH-8952 Schlieren, Switzerland; [Stupp, Roger] Northwestern Univ, Feinberg Sch Med, Ken & Ruth Davee Dept Neurol, Chicago, IL 60611 USA; [Stupp, Roger] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Lou & Jean Malnati Brain Tumor Inst, Chicago, IL 60611 USA	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Shakhova, O (corresponding author), Univ Zurich, Univ Hosp Zurich, Dept Med Oncol & Hematol, Wagistr 14, CH-8952 Schlieren, Switzerland.	olga.shakhova@usz.ch		Britschgi, Christian/0000-0001-8831-1564	Oncosuisse; Promedica UBS Stiftung; Krebsliga Zurich; Novartis Research Foundation	Oncosuisse; Promedica UBS Stiftung; Krebsliga Zurich; Novartis Research Foundation	This work was supported by Oncosuisse, Promedica UBS Stiftung, Krebsliga Zurich, and Novartis Research Foundation to OS. We thank A. Serra-Roma, C-L Yang, O. Engeler for helpful suggestions and scientific discussions. We thank Dr Lorenza Penengo (Institute of Molecular Cancer Research University of Zurich) for technical support and suggestions. We thank Dr Jelena Kuhn-Georgijevic from Functional Genomic Center Zurich for her support in RNA sequencing. We thank Dr Daniel Zingg from Institute of Anatomy University of Zurich for kindly providing with Mel888 and Mel501 human melanoma cell lines. We thank Axel Zani and Redi Leraj for helping drawing the cartoons. We thank Cindy Lee for helpful discussion and critically reading of the manuscript. Finally, we would like to thank the University Research Priority Program (URPP) in translational cancer research biobank for the melanoma cell lines that were generated from surplus biopsy material from consenting patients at the University of Zurich Hospital (EK.647/800).	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Anastas JN, 2014, J CLIN INVEST, V124, P2877, DOI 10.1172/JCI70156; Atkinson JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125028; Bachmann IM, 2005, CLIN CANCER RES, V11, P8606, DOI 10.1158/1078-0432.CCR-05-0011; Bastidas F, 2004, DEV DYNAM, V229, P109, DOI 10.1002/dvdy.10486; Biechele TL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002274; Biechele TL, 2010, CHEM BIOL, V17, P1177, DOI 10.1016/j.chembiol.2010.08.012; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Demunter A, 2002, MODERN PATHOL, V15, P454, DOI 10.1038/modpathol.3880546; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Dorsky RI, 2000, GENE DEV, V14, P158; Dummer R, 2015, ANN ONCOL, V26, pV126, DOI 10.1093/annonc/mdv297; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Grob JJ, 2015, LANCET ONCOL, V16, P1389, DOI 10.1016/S1470-2045(15)00087-X; Grossmann AH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003398; Kageshita T, 2001, BRIT J DERMATOL, V145, P210, DOI 10.1046/j.1365-2133.2001.04336.x; Kaur A, 2016, BRIT J CANCER, V115, P1273, DOI 10.1038/bjc.2016.332; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee M, 2000, J BIOL CHEM, V275, P37978, DOI 10.1074/jbc.M003816200; Leung AW, 2016, DEVELOPMENT, V143, P398, DOI 10.1242/dev.130849; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Long GV, 2018, J CLIN ONCOL, V36, P667, DOI 10.1200/JCO.2017.74.1025; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maelandsmo GM, 2003, CLIN CANCER RES, V9, P3383; Nonaka D, 2008, AM J SURG PATHOL, V32, P1291, DOI 10.1097/PAS.0b013e3181658c14; Omholt K, 2001, INT J CANCER, V92, P839, DOI 10.1002/ijc.1270; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Rehberg S, 2002, MOL CELL BIOL, V22, P5826, DOI 10.1128/MCB.22.16.5826-5834.2002; Reifenberger J, 2002, INT J CANCER, V100, P549, DOI 10.1002/ijc.10512; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Robertson AG, 2017, CANCER CELL, V32, P204, DOI 10.1016/j.ccell.2017.07.003; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; Tacha D, 2015, ARCH PATHOL LAB MED, V139, P530, DOI 10.5858/arpa.2014-0077-OA; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Vasilescu J, 2004, PROTEOMICS, V4, P3845, DOI 10.1002/pmic.200400856; Webster MR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004114; Wellbrock C, 2015, PIGM CELL MELANOMA R, V28, P390, DOI 10.1111/pcmr.12370; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhou DJ, 2014, TUMOR BIOL, V35, P9935, DOI 10.1007/s13277-014-1893-1; Zimmerman ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069593	52	12	16	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	20					4132	4154		10.1038/s41388-020-1267-7	http://dx.doi.org/10.1038/s41388-020-1267-7		APR 2020	23	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LN3GC	32238882	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000522804800002
J	Li, XH; Yang, ST; Han, L; Mao, KY; Yang, SY				Li, Xinhua; Yang, Shuting; Han, Lin; Mao, Keya; Yang, Shuying			Ciliary IFT80 is essential for intervertebral disc development and maintenance	FASEB JOURNAL			English	Article						annulus fibrosus; IFT80; intervertebral disc degeneration; nucleus pulposus; primary cilia	ENDOSCOPIC LUMBAR DISKECTOMY; PRIMARY CILIUM; ANNULUS FIBROSUS; HEDGEHOG; DEGENERATION; CELLS; CHONDROCYTES; EXPRESSION; MODELS; LENGTH	The intervertebral disc degeneration (IVDD)-related diseases occur in more than 90% of the population older than 50 years. Owing to the lack of understanding of the cellular mechanisms involved in IVDD formation effective treatment options are still unavailable. Primary cilia are microtubule-based organelles that play important roles in the organ development. Intraflagellar transport (IFT) proteins are essential for the assembly and bidirectional transport within the cilium. Role of cilia and IFT80 protein in intervertebral disc (IVD) development, maintenance, and degeneration are largely unknown. Using cilia-GFP mice, we found presence of cilia on growth plate (GP), cartilage endplate (EP) annulus fibrosus (AF), and nucleus pulposus (NP) with varying ciliary length. Cilia length in NP and AF during IVDD were significantly decreased. However, cilia numbers increased by 63% in AF during repair. Deletion of IFT80 in type II collagen-positive cells resulted in cilia loss in GP and EP, and disrupted IVD structure with disorganized and decreased GP, EP, and internal AF (IAF), and less compact and markedly decreased gel-like matrix in the NP. Deletion of IFT80 in type I collagen-positive cells led to a disorganized outer AF (OAF) with thinner, loosened, and disconnected fiber alignment. Mechanistic analyses showed that loss of IFT80 caused a significant increase in cell apoptosis in the IVD, and a marked decrease in expression of chondrogenic markers - type II collagen, sox9, aggrecan, and hedgehog (Hh) signaling components, including Gli1 and Patch1 in the IVD of IFT80(fl/fl); Col2-creERT mice, and Gli1 and Patch1 expression in the OAF of IFT80(fl/fl); Col1-creERT mice. Interestingly, Smoothened agonist-SAG rescued OAF cell proliferation and osteogenic differentiation. Our findings demonstrate that ciliary IFT80 is important for the maintenance of IVD cell organization and function through regulating the cell survival and Hh signaling.	[Li, Xinhua; Yang, Shuting; Yang, Shuying] Univ Penn, Sch Dent Med, Dept Basic & Translat Sci, 240 South 40th St,Levy 437, Philadelphia, PA 19104 USA; [Li, Xinhua] Tongji Univ, East Hosp, Sch Med, Dept Spinal Surg, Shanghai, Peoples R China; [Han, Lin] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Mao, Keya] Chinese PLA Gen Hosp 301 Hosp, Dept Orthoped, Beijing, Peoples R China; [Yang, Shuying] Univ Penn, Sch Med, Penn Ctr Musculoskeletal Disorders, Philadelphia, PA 19104 USA; [Yang, Shuying] Univ Penn, Sch Engn & Appl Sci, Sch Dent Med, Ctr Innovat & Precis Dent, Philadelphia, PA 19104 USA	University of Pennsylvania; Tongji University; Drexel University; University of Pennsylvania; University of Pennsylvania	Yang, SY (corresponding author), Univ Penn, Sch Dent Med, Dept Basic & Translat Sci, 240 South 40th St,Levy 437, Philadelphia, PA 19104 USA.	shuyingy@upenn.edu	Li, Xinhua/ABE-7575-2020	Yang, Shuying/0000-0002-7126-6901; Li, Xinhua/0000-0002-4387-3229	HHS\ NIH\ National Institute of Dental and Craniofacial Research (NIDCR) [DE023105]; HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR066101]; HHS \ NIH\ National Institute on Aging (NIA) [AG048388]	HHS\ NIH\ National Institute of Dental and Craniofacial Research (NIDCR); HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); HHS \ NIH\ National Institute on Aging (NIA)	HHS vertical bar NIH vertical bar National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: DE023105; HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR066101; HHS vertical bar NIH vertical bar National Institute on Aging (NIA), Grant/Award Number: AG048388	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; Alvarez-Satta M, 2019, AGEING RES REV, V52, P53, DOI 10.1016/j.arr.2019.04.004; Ballarin-Gonzalez B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056029; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Bedore J, 2016, J CELL COMMUN SIGNAL, V10, P137, DOI 10.1007/s12079-016-0329-7; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Challis RC, 2015, CURR BIOL, V25, P2503, DOI 10.1016/j.cub.2015.07.065; Chang CF, 2012, OSTEOARTHR CARTILAGE, V20, P152, DOI 10.1016/j.joca.2011.11.009; Chang CF, 2013, J ORTHOP RES, V31, P350, DOI 10.1002/jor.22237; Choi BKA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220056; Choksi SP, 2014, DEVELOPMENT, V141, P1427, DOI 10.1242/dev.074666; Cornils A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006325; Daly C, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5952165; Donnelly E, 2008, ANAT REC, V291, P1062, DOI 10.1002/ar.20665; Dummer Anneloes, 2016, Cilia, V5, P7, DOI 10.1186/s13630-016-0028-2; Gambassi S, 2017, J CELL PHYSIOL, V232, P3103, DOI 10.1002/jcp.25761; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Grimes DT, 2016, SCIENCE, V352, P1341, DOI 10.1126/science.aaf6419; Killion CH, 2017, MOL BIOL CELL, V28, P1862, DOI 10.1091/mbc.E17-02-0084; Li Q, 2017, ACTA BIOMATER, V54, P356, DOI 10.1016/j.actbio.2017.02.043; Li XH, 2016, J CLIN NEUROSCI, V33, P19, DOI 10.1016/j.jocn.2016.01.043; Li XH, 2016, INT J SURG, V27, P8, DOI 10.1016/j.ijsu.2016.01.034; Li YW, 2017, ELIFE, V6, DOI 10.7554/eLife.23279; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108239; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; McCann MR, 2016, J DEV BIOL, V4, DOI 10.3390/jdb4010003; MILLER JM, 1988, SYST BOT, V13, P173, DOI 10.1097/00007632-198802000-00008; Moriguchi Y, 2016, GLOB SPINE J, V6, P497, DOI 10.1055/s-0036-1571955; Nakamichi R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12503; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Noda K, 2016, P NATL ACAD SCI USA, V113, pE2589, DOI 10.1073/pnas.1519458113; Ponticos M, 2004, MATRIX BIOL, V22, P619, DOI 10.1016/j.matbio.2003.12.002; Raj P Prithvi, 2008, Pain Pract, V8, P18, DOI 10.1111/j.1533-2500.2007.00171.x; Rajesh Diviya, 2018, Curr Mol Biol Rep, V4, P173, DOI 10.1007/s40610-018-0107-9; Resnick A, 2007, BIOPHYS J, V93, P1380, DOI 10.1529/biophysj.107.105007; Risbud MV, 2011, CRIT REV EUKAR GENE, V21, P29, DOI 10.1615/CritRevEukarGeneExpr.v21.i1.30; Ruhlen R, 2014, OSTEOARTHR CARTILAGE, V22, P1071, DOI 10.1016/j.joca.2014.05.011; Seeger-Nukpezah T, 2012, CURR OPIN CELL BIOL, V24, P652, DOI 10.1016/j.ceb.2012.06.002; Shen X, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01450; Thorpe SD, 2017, J CELL PHYSIOL, V232, P2407, DOI 10.1002/jcp.25839; Tian ZZ, 2018, AM J PHYS MED REHAB, V97, P170, DOI 10.1097/PHM.0000000000000818; Tong W, 2017, TRANSL RES, V181, P49, DOI 10.1016/j.trsl.2016.11.008; Torre OM, 2018, FASEB J, V32, P4753, DOI 10.1096/fj.201701492R; Vergroesen PPA, 2015, OSTEOARTHR CARTILAGE, V23, P1057, DOI 10.1016/j.joca.2015.03.028; Vo NV, 2016, J ORTHOP RES, V34, P1289, DOI 10.1002/jor.23195; Wang CD, 2013, EXP CELL RES, V319, P623, DOI 10.1016/j.yexcr.2012.12.028; Wang SX, 2013, BBA-MOL BASIS DIS, V1832, P1582, DOI 10.1016/j.bbadis.2013.05.023; WHITE T L, 1990, Journal of Orthopaedic and Sports Physical Therapy, V12, P139; Yuan XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144773; Yuan X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11024; Zhang YJ, 2019, AM J PHYS MED REHAB, V98, P35, DOI 10.1097/PHM.0000000000001012; Zheng LW, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0022-y	53	16	16	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6741	6756		10.1096/fj.201902838R	http://dx.doi.org/10.1096/fj.201902838R		MAR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32227389	Bronze, Green Accepted			2022-12-26	WOS:000522486700001
J	Carmon, O; Laguerre, F; Riachy, L; Delestre-Delacour, C; Wang, QL; Tanguy, E; Jeandel, L; Cartier, D; Thahouly, T; Haeberle, AM; Fouillen, L; Rezazgui, O; Schapman, D; Haefele, A; Goumon, Y; Galas, L; Renard, PY; Alexandre, S; Vitale, N; Anouar, Y; Montero-Hadjadje, M				Carmon, Ophelie; Laguerre, Fanny; Riachy, Lina; Delestre-Delacour, Charlene; Wang, Qili; Tanguy, Emeline; Jeandel, Lydie; Cartier, Dorthe; Thahouly, Tamou; Haeberle, Anne-Marie; Fouillen, Laetitia; Rezazgui, Olivier; Schapman, Damien; Haefele, Alexandre; Goumon, Yannick; Galas, Ludovic; Renard, Pierre-Yves; Alexandre, Stephane; Vitale, Nicolas; Anouar, Youssef; Montero-Hadjadje, Maite			Chromogranin A preferential interaction with Golgi phosphatidic acid induces membrane deformation and contributes to secretory granule biogenesis	FASEB JOURNAL			English	Article						Golgi apparatus; membrane dynamics; organelle biogenesis; phospholipase D	DENSE-CORE VESICLES; PHOSPHOLIPASE D1; SECRETOGRANIN-II; PEPTIDE; LOCALIZATION; MECHANISMS; CATESTATIN; NETWORK; IDENTIFICATION; HYPERTENSION	Chromogranin A (CgA) is a key luminal actor of secretory granule biogenesis at the trans-Golgi network (TGN) level but the molecular mechanisms involved remain obscure. Here, we investigated the possibility that CgA acts synergistically with specific membrane lipids to trigger secretory granule formation. We show that CgA preferentially interacts with the anionic glycerophospholipid phosphatidic acid (PA). In accordance, bioinformatic analysis predicted a PA-binding domain (PABD) in CgA sequence that effectively bound PA (36:1) or PA (40:6) in membrane models. We identified PA (36:1) and PA (40:6) as predominant species in Golgi and granule membranes of secretory cells, and we found that CgA interaction with these PA species promotes artificial membrane deformation and remodeling. Furthermore, we demonstrated that disruption of either CgA PABD or phospholipase D (PLD) activity significantly alters secretory granule formation in secretory cells. Our findings show for the first time the ability of CgA to interact with PLD-generated PA, which allows membrane remodeling and curvature, key processes necessary to initiate secretory granule budding.	[Carmon, Ophelie; Laguerre, Fanny; Riachy, Lina; Delestre-Delacour, Charlene; Jeandel, Lydie; Cartier, Dorthe; Anouar, Youssef; Montero-Hadjadje, Maite] Normandie Univ, Inst Rech & Innovat Biomed Normandie, Lab Differenciat & Commun Neuronale & Neuroendocr, UNIROUEN,INSERM,U1239, F-76000 Rouen, France; [Wang, Qili; Tanguy, Emeline; Thahouly, Tamou; Haeberle, Anne-Marie; Goumon, Yannick; Vitale, Nicolas] Univ Strasbourg, CNRS, Inst Neurosci Cellulaires & Integrat, Strasbourg, France; [Fouillen, Laetitia] Univ Bordeaux, Lab Biogenese Membranaire, Plateforme Metabolome, UMR 5200,CNRS, Villenave Domon, France; [Rezazgui, Olivier; Haefele, Alexandre; Renard, Pierre-Yves] Normandie Univ, COBRA, UNIROUEN, INSA,Rouen CNRS,UMR 6014, Rouen, France; [Rezazgui, Olivier; Haefele, Alexandre; Renard, Pierre-Yves] FR 3038, Rouen, France; [Schapman, Damien; Galas, Ludovic] Normandie Univ, PRIMACEN, INSERM, UNIROUEN, Rouen, France; [Alexandre, Stephane] Normandie Univ, UNIROUEN, UMR 6270, Polymeres,Biopolymeres,Surfaces Lab,CNRS, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Montero-Hadjadje, M (corresponding author), Normandie Univ, Inst Rech & Innovat Biomed Normandie, Lab Differenciat & Commun Neuronale & Neuroendocr, UNIROUEN,INSERM,U1239, F-76000 Rouen, France.	maite.montero@univ-rouen.fr	Vitale, Nicolas/G-5967-2014; renard, pierre-yves/ABG-9624-2021; Anouar, Youssef/F-9683-2017; FOUILLEN, Laetitia/AAV-9710-2020	Vitale, Nicolas/0000-0002-4752-4907; renard, pierre-yves/0000-0001-9094-9778; FOUILLEN, Laetitia/0000-0002-1204-9296; Goumon, Yannick/0000-0003-4336-3437; Riachy, Lina/0000-0003-2543-3585; THAHOULY, Tamou/0000-0001-5980-6859; MONTERO, Maite/0000-0001-8859-893X	Fondation pour la Recherche Medicale (FRM) [DEI20151234424]; European Regional Development Fund (ERDF) [ERDF DO-IT2015]; Ministere de la Recherche et de l'Enseignement Superieur; European Union; Region Normandie; Agence Nationale de la Recherche (ANR) [ANR-11-INBS-0010]	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Regional Development Fund (ERDF)(European Commission); Ministere de la Recherche et de l'Enseignement Superieur; European Union(European Commission); Region Normandie(Region Normandie); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	Fondation pour la Recherche Medicale (FRM), Grant/Award Number: DEI20151234424; European Regional Development Fund (ERDF), Grant/Award Number: ERDF DO-IT2015 and ERDF PACT-CBS; Ministere de la Recherche et de l'Enseignement Superieur; European Union and Region Normandie; Agence Nationale de la Recherche (ANR), Grant/Award Number: ANR-11-INBS-0010	Abbineni PS, 2019, J GEN PHYSIOL, V151, P118, DOI 10.1085/jgp.201812182; Ammar MR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14778; Ammar MR, 2013, J NEUROSCI, V33, P19470, DOI 10.1523/JNEUROSCI.2283-13.2013; Anouar Y, 1998, J CLIN ENDOCR METAB, V83, P2944, DOI 10.1210/jc.83.8.2944; Aunis D, 2001, M S-MED SCI, V17, P418, DOI 10.4267/10608/1941; Bandyopadhyay GK, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00020; Benard M, 2015, BIOL CELL, V107, P419, DOI 10.1111/boc.201500004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blois A, 2006, REGUL PEPTIDES, V134, P30, DOI 10.1016/j.regpep.2005.11.003; BRAKS JAM, 1994, CELL, V78, P263, DOI 10.1016/0092-8674(94)90296-8; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; Chevalier A, 2013, CHEM-EUR J, V19, P1686, DOI 10.1002/chem.201203427; Cruz-Garcia D, 2013, EMBO J, V32, P1717, DOI 10.1038/emboj.2013.116; Cullis PR, 1997, BBA-REV BIOMEMBRANES, V1331, P187, DOI 10.1016/S0304-4157(97)00006-3; Delestre-Delacour C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05617-1; Dhanvantari S, 2002, BIOCHEMISTRY-US, V41, P52, DOI 10.1021/bi015698n; Dondossola E, 2010, CELL MOL LIFE SCI, V67, P2107, DOI 10.1007/s00018-010-0319-5; Duran JM, 2012, EMBO J, V31, P4535, DOI 10.1038/emboj.2012.317; Elias S, 2012, ENDOCRINOLOGY, V153, P4444, DOI 10.1210/en.2012-1436; Elias S, 2010, CELL MOL NEUROBIOL, V30, P1189, DOI 10.1007/s10571-010-9595-8; Freyberg Z, 2003, TRENDS CELL BIOL, V13, P540, DOI 10.1016/j.tcb.2003.08.004; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Galas L, 2018, CHEMOSENSORS, V6, DOI 10.3390/chemosensors6030040; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; Gondre-Lewis MC, 2006, J CELL SCI, V119, P1876, DOI 10.1242/jcs.02906; Gondre-Lewis MC, 2012, INT REV CEL MOL BIO, V299, P27, DOI 10.1016/B978-0-12-394310-1.00002-3; Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0306s07, 10.1002/0471143030.cb0309s10]; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Hummer BH, 2017, MOL BIOL CELL, V28, P3870, DOI 10.1091/mbc.E17-08-0491; Huston E, 2006, J CELL SCI, V119, P3799, DOI 10.1242/jcs.03106; Kang YK, 1997, FEBS LETT, V404, P87, DOI 10.1016/S0014-5793(97)00099-9; Kassas N, 2017, J BIOL CHEM, V292, P4266, DOI 10.1074/jbc.M116.742346; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Kiranmayi M, 2016, HYPERTENSION, V68, P334, DOI 10.1161/HYPERTENSIONAHA.116.06568; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Makowski Stefanie L., 2020, Advances in Biological Regulation, V75, P100661, DOI 10.1016/j.jbior.2019.100661; Miao R, 2019, J BIOL CHEM, V294, P6214, DOI 10.1074/jbc.RA118.006876; Montero-Hadjadje M, 2008, ACTA PHYSIOL, V192, P309, DOI 10.1111/j.1748-1716.2007.01806.x; Montero-Hadjadje M, 2002, CELL TISSUE RES, V310, P223, DOI 10.1007/s00441-002-0625-9; Montero-Hadjadje M, 2009, J BIOL CHEM, V284, P12420, DOI 10.1074/jbc.M805607200; Park SY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11324-4; Pasqua T, 2016, CELL TISSUE RES, V363, P693, DOI 10.1007/s00441-015-2316-3; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; Pomorski TG, 2016, PROG LIPID RES, V64, P69, DOI 10.1016/j.plipres.2016.08.003; Potocky M, 2014, NEW PHYTOL, V203, P483, DOI 10.1111/nph.12814; Rahajeng J, 2019, DEV CELL, V50, P573, DOI 10.1016/j.devcel.2019.05.038; Riebeling C, 2009, BBA-MOL CELL BIOL L, V1791, P876, DOI 10.1016/j.bbalip.2009.04.003; Sahu BS, 2012, J BIOL CHEM, V287, P43840, DOI 10.1074/jbc.M112.407916; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; Sugawara M, 2010, FASEB J, V24, P1737, DOI 10.1096/fj.09-142554; Surma MA, 2012, BBA-MOL CELL BIOL L, V1821, P1059, DOI 10.1016/j.bbalip.2011.12.008; Tanguy E, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020020; Tanguy E, 2016, J NEUROCHEM, V137, P904, DOI 10.1111/jnc.13577; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Vitale N, 2002, J CELL BIOL, V159, P79, DOI 10.1083/jcb.200203027; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Zhukovsky MA, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00291	60	6	8	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6769	6790		10.1096/fj.202000074R	http://dx.doi.org/10.1096/fj.202000074R		MAR 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32227388	Green Submitted, Bronze			2022-12-26	WOS:000522484500001
J	Song, W; Zhang, YB; Zhang, XJ; Gui, JF				Song, Wei; Zhang, YiBing; Zhang, XiaoJuan; Gui, JianFang			De novo transcriptome assembly of four organs of Collichthys lucidus and identification of genes involved in sex determination and reproduction	PLOS ONE			English	Article							PITUITARY-GONADAL AXIS; SPINYHEAD CROAKER; ADRENAL AXES; EXPRESSION; ZEBRAFISH; RECEPTOR; CATFISH; DIFFERENTIATION; IMPROVEMENT; PROFILES	The spinyhead croaker (Collichthys lucidus) is a commercially important fish species, which is mainly distributed in the coastal regions of China. However, little is known about the molecular regulatory mechanism underlying reproduction in C. lucidus. A de novo transcriptome assembly in brain, liver, ovary and testis tissues of C. lucidus was performed. Illumina sequencing generated 60,322,004, 57,044,284, 60,867,978 and 57,087,688 clean reads from brain, liver, ovary and testis tissues of C. lucidus, respectively. Totally, 131,168 unigenes with an average length of 644 bp and an N50 value of 1033 bp were assembled. In addition, 1288 genes were differentially expressed between ovary and testis, including 442 up-regulated and 846 down-regulated in ovary. Functional analysis revealed that the differentially expressed genes between ovary and testis were mainly involved in the function of sexual reproduction, sex differentiation, development of primary male sexual characteristics, female gamete generation, and male sex differentiation. A number of genes which might be involved in the regulation of reproduction and sex determination were found, including HYAL and SYCP3 and BMP15. Furthermore, 35,476 simple sequence repeats (SSRs) were identified in this transcriptome dataset, which would contribute to further genetic and mechanism researches. De novo transcriptome sequencing analysis of four organs of C. lucidus provides rich resources for understanding the mechanism of reproductive development of C. lucidus and further investigation of the molecular regulation of sex determination and reproduction of C. lucidus.	[Song, Wei; Zhang, YiBing; Zhang, XiaoJuan; Gui, JianFang] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China; [Song, Wei] Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS	Gui, JF (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China.	jfgui@ihb.ac.cn			Basic Research Fund for State-Level Nonprofit Research Institutes of ESCFRI, CAFS [Dong2018Z01]	Basic Research Fund for State-Level Nonprofit Research Institutes of ESCFRI, CAFS	This work was supported by the Basic Research Fund for State-Level Nonprofit Research Institutes of ESCFRI, CAFS(#Dong2018Z01). This funding body has no role in the design of the study, collection, analysis, interpretation of data or in writing the manuscript.	Chen W, 2017, CONSERV GENET RESOUR, V9, P573, DOI 10.1007/s12686-017-0725-1; Collins PM, 2001, BIOL REPROD, V65, P173, DOI 10.1095/biolreprod65.1.173; Couse JF, 2003, MOL ENDOCRINOL, V17, P1039, DOI 10.1210/me.2002-0398; Dranow DB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006323; Fang XL, 2018, J STEROID BIOCHEM, V182, P62, DOI 10.1016/j.jsbmb.2018.04.011; Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0; He Zhou-ting, 2011, Marine Fisheries, V33, P265; Hermann BP, 2007, MOL CELL ENDOCRINOL, V260, P100, DOI 10.1016/j.mce.2006.09.005; Hou LP, 2018, AQUAT TOXICOL, V201, P31, DOI 10.1016/j.aquatox.2018.05.019; [黄良敏 Huang Liangmin], 2010, [台湾海峡, Journal of Oceanography in Taiwan Strait], V29, P250; Laldinsangi C, 2018, GEN COMP ENDOCR, V266, P38, DOI 10.1016/j.ygcen.2018.04.004; Li HL, 2017, CELL BIOL INT, V41, P1379, DOI 10.1002/cbin.10869; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Liang YQ, 2015, CHEMOSPHERE, V128, P199, DOI 10.1016/j.chemosphere.2015.01.062; Lin QH, 2017, GENETICS, V207, P1007, DOI 10.1534/genetics.117.300274; Liu HB, 2015, ENVIRON BIOL FISH, V98, P165, DOI 10.1007/s10641-014-0246-7; Liu LW, 2017, META GENE, V13, P1, DOI 10.1016/j.mgene.2017.04.002; Lu JG, 2014, PHYSIOL GENOMICS, V46, P798, DOI 10.1152/physiolgenomics.00088.2014; Ma CY, 2010, J EXP MAR BIOL ECOL, V385, P14, DOI 10.1016/j.jembe.2010.01.015; Ma YB, 2012, AQUAT TOXICOL, V106, P173, DOI 10.1016/j.aquatox.2011.11.006; Meng XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128659; Mohindra V, 2012, MOL BIOL REP, V39, P5921, DOI 10.1007/s11033-011-1404-z; Sang C, 2015, GENET MOL RES, V14, P16050, DOI 10.4238/2015.December.7.18; Song N, 2014, ENVIRON BIOL FISH, V97, P69, DOI 10.1007/s10641-013-0124-8; Sundaray JK, 2016, AQUACULT INT, V24, P1089, DOI 10.1007/s10499-016-9973-4; Syrjanen JL, 2014, ELIFE, V3, DOI 10.7554/eLife.02963; Takahashi A, 2016, ENDOCRINOLOGY, V157, P3994, DOI 10.1210/en.2016-1356; Tan Q, 2009, MOL CELL ENDOCRINOL, V312, P72, DOI 10.1016/j.mce.2009.03.011; Teaniniuraitemoana V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-491; Tovo-Neto A, 2018, GEN COMP ENDOCR, V265, P230, DOI 10.1016/j.ygcen.2018.04.023; Uzbekova S, 2002, MOL REPROD DEV, V62, P47, DOI 10.1002/mrd.10065; Wang YQ, 2018, J APPL TOXICOL, V38, P308, DOI 10.1002/jat.3529; Wang ZP, 2017, J FISH BIOL, V91, P1407, DOI 10.1111/jfb.13459; Xu J, 2011, PLOS ONE, V6; Xu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021057; Yoon S, 2014, ANIM REPROD SCI, V150, P107, DOI 10.1016/j.anireprosci.2014.09.002; Yue HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127332; Yue ZH, 2018, COMP BIOCHEM PHYS C, V210, P30, DOI 10.1016/j.cbpc.2018.04.005; Zhang XN, 2018, COMP BIOCHEM PHYS C, V211, P41, DOI 10.1016/j.cbpc.2018.05.010; Zhou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116392; Zhuang P., 2006, FISHES YANGTZE ESTUA	41	5	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0230580	10.1371/journal.pone.0230580	http://dx.doi.org/10.1371/journal.pone.0230580			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218589	gold, Green Published, Green Submitted			2022-12-26	WOS:000535935400015
J	de Munter, L; Geraerds, AJLM; de Jongh, MAC; van der Vlegel, M; Steyerberg, EW; Haagsma, JA; Polinder, S				de Munter, Leonie; Geraerds, A. J. L. M.; de Jongh, Mariska A. C.; van der Vlegel, Marjolein; Steyerberg, Ewout W.; Haagsma, Juanita A.; Polinder, Suzanne			Prognostic factors for medical and productivity costs, and return to work after trauma	PLOS ONE			English	Article							HEALTH-CARE; INJURIES; PREDICTORS; DETERMINANTS; POPULATION; PREVALENCE; LIFE	Aim The aim of this study was to determine prognostic factors for medical and productivity costs, and return to work (RTW) during the first two years after trauma in a clinical trauma population. Methods This prospective multicentre observational study followed all adult trauma patients (>= 18 years) admitted to a hospital in Noord-Brabant, the Netherlands from August 2015 through November 2016. Health care consumption, productivity loss and return to work were measured in questionnaires at 1 week, 1, 3, 6, 12 and 24 months after injury. Data was linked with hospital registries. Prognostic factors for medical costs and productivity costs were analysed with log-linked gamma generalized linear models. Prognostic factors for RTW were assessed with Cox proportional hazards model. The predictive ability of the models was assessed with McFadden R-2 (explained variance) and c-statistics (discrimination). Results A total of 3785 trauma patients (39% of total study population) responded to at least one follow-up questionnaire. Mean medical costs per patient ((sic)9,710) and mean productivity costs per patient ((sic)9,000) varied widely. Prognostic factors for high medical costs were higher age, female gender, spine injury, lower extremity injury, severe head injury, high injury severity, comorbidities, and pre-injury health status. Productivity costs were highest in males, and in patients with spinal cord injury, high injury severity, longer length of stay at the hospital and patients admitted to the ICU. Prognostic factors for RTW were high educational level, male gender, low injury severity, shorter length of stay at the hospital and absence of comorbidity. Conclusions Productivity costs and RTW should be considered when assessing the economic impact of injury in addition to medical costs. Prognostic factors may assist in identifying high cost groups with potentially modifiable factors for targeted preventive interventions, hence reducing costs and increasing RTW rates.	[de Munter, Leonie; de Jongh, Mariska A. C.] ETZ Hosp Elisabeth TweeSteden Ziekenhuis, Dept Trauma TopCare, Tilburg, Netherlands; [Geraerds, A. J. L. M.; van der Vlegel, Marjolein; Steyerberg, Ewout W.; Haagsma, Juanita A.; Polinder, Suzanne] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [de Jongh, Mariska A. C.] Network Emergency Care Brabant, Brabant Trauma Registry, Tilburg, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands	Elisabeth-TweeSteden Ziekenhuis (ETZ); Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Munter, L (corresponding author), ETZ Hosp Elisabeth TweeSteden Ziekenhuis, Dept Trauma TopCare, Tilburg, Netherlands.	l.demunter@etz.nl		de Munter, Leonie/0000-0001-6573-2032; van der Vlegel, Marjolein/0000-0002-0217-9484	Dutch organization for health research and care innovation (ZonMW) section TopCare projects [80842009814226]	Dutch organization for health research and care innovation (ZonMW) section TopCare projects	This work was supported by a grant of the Dutch organization for health research and care innovation (ZonMW) section TopCare projects (grantnumber: 80842009814226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedzadeh-Kalahroudi M, 2017, CHIN J TRAUMATOL, V20, P67, DOI 10.1016/j.cjtee.2016.03.008; Berecki-Gisolf J, 2012, J OCCUP REHABIL, V22, P283, DOI 10.1007/s10926-011-9344-y; Bouwmans C, 2013, HANDLEIDING IMTA MED; Bouwmans C, 2013, GUIDELINE IMTA MED C; Bouwmans C, 2015, VALUE HEALTH, V18, P753, DOI 10.1016/j.jval.2015.05.009; Cancelliere C, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0113-z; CBS, WORK POP WORK TIM; CBS, BEROEPSBEVOLKING 201; Centraal Bureau voor de Statistiek, WERKZ BER DEELT; Clay FJ, 2010, J REHABIL MED, V42, P162, DOI 10.2340/16501977-0495; Collie A, 2019, ANN SURG, V269, P972, DOI 10.1097/SLA.0000000000002666; de Jongh MAC, 2017, INJURY PREV, V23, P59, DOI 10.1136/injuryprev-2016-042032; de Munter L, 2017, INJURY, V48, P221, DOI 10.1016/j.injury.2016.12.009; de Putter CE, 2012, J BONE JOINT SURG AM, V94A, DOI 10.2106/JBJS.K.00561; Elkerliek, STAND PRIJSL OV ZORG; Erasmus MC., PASSANTENPRIJSLIJST; Gennarelli TA, 2008, ABBREVIATED INJURY S; Geraerds AJLM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0227131; Hakkaart-van Roijen L, 2015, ZORGINSTITUUT NEDERL; Hartholt KA, 2011, J TRAUMA, V71, P748, DOI 10.1097/TA.0b013e3181f6f5e5; He YH, 2010, J OCCUP REHABIL, V20, P378, DOI 10.1007/s10926-010-9232-x; Hodgson CL, 2018, J CRIT CARE, V48, P21, DOI 10.1016/j.jcrc.2018.08.005; Howe EI, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01051; Kendrick D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-584; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; Landelijke Netwerk Acute Zorg (LNAZ), 2018, ANN REP DUTCH TRAUM; MacKenzie EJ, 2006, J TRAUMA, V61, P688, DOI 10.1097/01.ta.0000195985.56153.68; McClure RJ, 1996, ACCIDENT ANAL PREV, V28, P443, DOI 10.1016/0001-4575(96)00012-7; Meerding WJ, 2006, EUR J PUBLIC HEALTH, V16, P271, DOI 10.1093/eurpub/ckl006; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Nederlandse Zorgautoriteit, TAR EERST; Nederlandse Zorgautoriteit, BRCU 2015 BIJL 2 MED; Nederlandse Zorgautoriteit, NED ZORG ZORG; Polinder S, 2016, ACCIDENT ANAL PREV, V93, P92, DOI 10.1016/j.aap.2016.04.003; Polinder S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-531; Rivas, BIO IMPEDANTIEMETING; Scholten AC, 2015, ACCIDENT ANAL PREV, V81, P51, DOI 10.1016/j.aap.2015.04.022; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Steverink N, 2001, GERONTOLOGIST, V41, P236; Upatising B, 2015, TELEMED E-HEALTH, V21, P3, DOI 10.1089/tmj.2014.0021; Van Buuren S, 1999, 99054 TNOVGZPG; Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F; Waddell G., 2006, IS WORK GOOD YOUR HL; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Willenberg L, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-267; World Health Organization, 2014, INJ VIOL FACTS; Xu K., 2018, PUBLIC SPENDING HLTH; Zeelandcare, PASS PRIJSL DBC OVP	48	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230641	10.1371/journal.pone.0230641	http://dx.doi.org/10.1371/journal.pone.0230641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9HN	32210472	Green Published, Green Submitted, gold			2022-12-26	WOS:000535307600037
J	Pakhomov, SVS; Thuras, PD; Finzel, R; Eppel, J; Kotlyar, M				Pakhomov, Serguei V. S.; Thuras, Paul D.; Finzel, Raymond; Eppel, Jerika; Kotlyar, Michael			Using consumer-wearable technology for remote assessment of physiological response to stress in the naturalistic environment	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEART-RATE-VARIABILITY; PSYCHOLOGICAL STRESS; PHYSICAL-ACTIVITY; MENTAL STRESS; RISK-FACTORS; METAANALYSIS; REACTIVITY; WITHDRAWAL; COUNTRIES	Psychosocial stress is a major risk factor for morbidity and mortality related to a wide range of health conditions and has a significant negative impact on public health. Quantifying exposure to stress in the naturalistic environment can help to better understand its health effects and identify strategies for timely intervention. The objective of the current project was to develop and test the infrastructure and methods necessary for using wearable technology to quantify individual response to stressful situations and to determine if popular and accessible fitness trackers such as Fitbit (R) equipped with an optical heart rate (HR) monitor could be used to detect physiological response to psychosocial stress in everyday life. The participants in this study were University of Minnesota students (n = 18) that owned a Fitbit (R) tracker and had at least one upcoming examination. Continuous HR and activity measurements were obtained during a 7-day observation period containing examinations self-reported by the participants. Participants responded to six ecological momentary assessment surveys per day (similar to 2 hour intervals) to indicate occurrence of stressful events. We compared HR during stressful events (e.g., exams) to baseline HR during periods indicated as non-stressful using mixed effects modeling. Our results show that HR was elevated by 8.9 beats per minute during exams and by 3.2 beats per minute during non-exam stressors. These results are consistent with prior laboratory findings and indicate that consumer wearable fitness trackers could serve as a valuable source of information on exposure to psychosocial stressors encountered in the naturalistic environment.	[Pakhomov, Serguei V. S.; Finzel, Raymond] Univ Minnesota, Dept Pharmaceut Care & Hlth Syst, Coll Pharm, St Paul, MN USA; [Thuras, Paul D.; Kotlyar, Michael] Univ Minnesota, Dept Psychiat, St Paul, MN USA; [Eppel, Jerika; Kotlyar, Michael] Univ Minnesota, Dept Expt & Clin Pharmacol, Coll Pharm, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Pakhomov, SVS (corresponding author), Univ Minnesota, Dept Pharmaceut Care & Hlth Syst, Coll Pharm, St Paul, MN USA.	pakh0002@umn.edu		Kotlyar, Michael/0000-0002-3670-9930	University of Minnesota Clinical and Translational Science Institute [UL1TR002494]; National Center for Advancing Translational Sciences	University of Minnesota Clinical and Translational Science Institute; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The work presented in this paper was supported by the University of Minnesota Clinical and Translational Science Institute which is funded by a grant (UL1TR002494) from the National Center for Advancing Translational Sciences.	Abeare CA, 2017, J CLIN EXP NEUROPSYC, V39, P738, DOI 10.1080/13803395.2016.1259396; Airagnes G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196330; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; Campbell J, 2012, PSYCHONEUROENDOCRINO, V37, P1111, DOI 10.1016/j.psyneuen.2011.12.010; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Danielsen A, 2016, J BIOMED INFORM, V63, P184, DOI 10.1016/j.jbi.2016.08.016; Everson SA, 1997, BRIT MED J, V314, P553, DOI 10.1136/bmj.314.7080.553; Fatisson J, 2016, HEART INT, V11, pE32, DOI 10.5301/heartint.5000232; Fava GA, 2019, PSYCHONEUROENDOCRINO, V108, P94, DOI 10.1016/j.psyneuen.2019.05.028; Foley P, 2010, NEUROSCI BIOBEHAV R, V35, P91, DOI 10.1016/j.neubiorev.2010.01.010; Hackett RA, 2017, NAT REV ENDOCRINOL, V13, P547, DOI 10.1038/nrendo.2017.64; Han Kuem Sun, 2012, Exp Neurobiol, V21, P141, DOI 10.5607/en.2012.21.4.141; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hellhammer J, 2012, PSYCHONEUROENDOCRINO, V37, P119, DOI 10.1016/j.psyneuen.2011.05.012; Hyman SM, 2009, J SUBST ABUSE TREAT, V36, P400, DOI 10.1016/j.jsat.2008.08.005; JACOBS SC, 1994, AM HEART J, V128, P1170, DOI 10.1016/0002-8703(94)90748-X; Justice NJ, 2018, NEUROBIOL STRESS, V8, P127, DOI 10.1016/j.ynstr.2018.04.002; Kennedy AP, 2015, DRUG ALCOHOL DEPEN, V151, P159, DOI 10.1016/j.drugalcdep.2015.03.024; Kennedy DO, 2000, PSYCHOPHARMACOLOGY, V149, P63, DOI 10.1007/s002139900335; Kim Eui-Joong, 2007, Behav Sleep Med, V5, P256; Kim HG, 2018, PSYCHIAT INVEST, V15, P235, DOI 10.30773/pi.2017.08.17; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kivimaki M, 2018, NAT REV CARDIOL, V15, P215, DOI 10.1038/nrcardio.2017.189; Kop WJ, 2008, AM J CARDIOL, V101, P767, DOI 10.1016/j.amjcard.2007.11.006; Kotlyar M, 2006, PHARMACOL BIOCHEM BE, V83, P370, DOI 10.1016/j.pbb.2006.02.017; Kotlyar M, 2008, BIOL PSYCHOL, V77, P233, DOI 10.1016/j.biopsycho.2007.10.005; Kotlyar M, 2017, ADDICT BEHAV, V71, P18, DOI 10.1016/j.addbeh.2017.02.018; Kotlyar M, 2013, PSYCHOSOM MED, V75, P236, DOI 10.1097/PSY.0b013e3182898f6d; Kumar S, 2015, J AM MED INFORM ASSN, V22, P1137, DOI 10.1093/jamia/ocv056; Larson MR, 2001, PSYCHOSOM MED, V63, P493, DOI 10.1097/00006842-200105000-00020; Madsen IEH, 2017, PSYCHOL MED, V47, P1342, DOI [10.1017/S003329171600355X, 10.1017/s003329171600355x]; Marek-Spartz K., 2014, P 15 ANN C INT SPEEC; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2019, PSYCHONEUROENDOCRINO, V105, P36, DOI 10.1016/j.psyneuen.2018.09.011; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2; Pakhomov SVS, 2016, EXP CLIN PSYCHOPHARM, V24, P341, DOI 10.1037/pha0000089; Preston KL, 2017, PSYCHOPHARMACOLOGY, V234, P2631, DOI 10.1007/s00213-017-4663-0; Rahman Mahbubur, 2014, ACM BCB, V2014, P479; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Sala M, 2017, INT J EAT DISORDER, V50, P1413, DOI 10.1002/eat.22799; Sano A, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9410; Sano Akane, 2015, Int Conf Wearable Implant Body Sens Netw, V2015, DOI 10.1109/BSN.2015.7299420; Shcheslavskaya OV, 2010, PSYCHOSOM MED, V72, P128, DOI 10.1097/PSY.0b013e3181c94ca0; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Sinha R, 2001, PSYCHOPHARMACOLOGY, V158, P343, DOI 10.1007/s002130100917; Sinha R, 2013, BIOL PSYCHIAT, V73, P827, DOI 10.1016/j.biopsych.2013.01.032; Smyth A, 2016, CIRCULATION, V134, P1059, DOI 10.1161/CIRCULATIONAHA.116.023142; Sprint G, 2016, J BIOMED INFORM, V63, P54, DOI 10.1016/j.jbi.2016.07.020; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Torres OV, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.04.005; Trull TJ, 2009, PSYCHOL ASSESSMENT, V21, P457, DOI 10.1037/a0017653; Umematsu T, 2019, IEEE ENG MED BIO, P2186, DOI 10.1109/EMBC.2019.8856862; Vinkers CH, 2013, STRESS, V16, P520, DOI 10.3109/10253890.2013.807243; Wilbert-Lampen U, 2008, NEW ENGL J MED, V358, P475, DOI 10.1056/NEJMoa0707427	55	5	5	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0229942	10.1371/journal.pone.0229942	http://dx.doi.org/10.1371/journal.pone.0229942			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9HN	32210441	gold, Green Published			2022-12-26	WOS:000535307600013
J	Polanska, N; Ishemgulova, A; Volfova, V; Flegontov, P; Votypka, J; Yurchenko, V; Volf, P				Polanska, Nikola; Ishemgulova, Aygul; Volfova, Vera; Flegontov, Pavel; Votypka, Jan; Yurchenko, Vyacheslav; Volf, Petr			Sergentomyia schwetzi: Salivary gland transcriptome, proteome and enzymatic activities in two lineages adapted to different blood sources	PLOS ONE			English	Article							FLY LUTZOMYIA-LONGIPALPIS; PHLEBOTOMINE SANDFLIES DIPTERA; SAND FLIES; PROTEINS; VECTOR; EVOLUTION; BINDING; RNA; AYACUCHENSIS; PSYCHODIDAE	During the blood feeding, sand fly females inject saliva containing immunomodulatory and anti-haemostatic molecules into their vertebrate hosts. The saliva composition is species-specific, likely due to an adaptation to particular haemostatic pathways of their preferred host. Research on sand fly saliva is limited to the representatives of two best-studied genera, Phlebotomus and Lutzomyia. Although the members of the genus Sergentomyia are highly abundant in many areas in the Old World, their role in human disease transmission remains uncertain. Most Sergentomyia spp. preferentially attack various species of reptiles, but feeding on warm-blooded vertebrates, including humans and domestic animals, has been repeatedly described, especially for Sergentomyia schwetzi, of which salivary gland transcriptome and proteome is analyzed in the current study. Illumina RNA sequencing and de novo assembly of the reads and their annotation revealed 17,293 sequences homologous to other arthropods' proteins. In the sialome, all proteins typical for sand fly saliva were identified-antigen 5-related, lufaxin, yellow-related, PpSP15-like, D7-related, ParSP25-like, and silk proteins, as well as less frequent salivary proteins included 71kDa- like, ParSP80-like, SP16-like, and ParSP17- like proteins. Salivary enzymes include apyrase, hyaluronidase, endonuclease, amylase, lipase A2, adenosine deaminase, pyrophosphatase, 5'nucleotidase, and ribonuclease. Proteomics analysis of salivary glands identified 631 proteins, 81 of which are likely secreted into the saliva. We also compared two S. schwetzi lineages derived from the same origin. These lineages were adapted for over 40 generations for blood feeding either on mice (SM) or geckos (S-G), two vertebrate hosts with different haemostatic mechanisms. Altogether, 20 and 40 annotated salivary transcripts were up-regulated in the S-M and S-G lineage, respectively. Proteomic comparison revealed ten salivary proteins more abundant in the lineage S-M, whereas 66 salivary proteins were enriched in the lineage S-G. No difference between lineages was found for apyrase activity; contrarily the hyaluronidase activity was significantly higher in the lineage feeding on mice.	[Polanska, Nikola; Volfova, Vera; Votypka, Jan; Volf, Petr] Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic; [Ishemgulova, Aygul; Flegontov, Pavel; Yurchenko, Vyacheslav] Univ Ostrava, Fac Sci, Life Sci Res Ctr, Ostrava, Czech Republic; [Flegontov, Pavel; Yurchenko, Vyacheslav] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Budweis, Czech Republic; [Yurchenko, Vyacheslav] Sechenov Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia	Charles University Prague; University of Ostrava; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Sechenov First Moscow State Medical University	Polanska, N (corresponding author), Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic.	nikola.polanska@natur.cuni.cz	Volf, Petr/C-4300-2012; Polanská, Nikola/C-2119-2017; Votypka, Jan/C-5313-2012; Volfova, Vera/H-1055-2017; Yurchenko, Vyacheslav/E-4532-2013	Volf, Petr/0000-0003-1790-1123; Polanská, Nikola/0000-0002-5142-5880; Votypka, Jan/0000-0002-0552-9363; Volfova, Vera/0000-0002-7189-1483; Yurchenko, Vyacheslav/0000-0003-4765-3263	Czech Science Foundation (GACR) [17-10308S]; ERD funds "Centre for Research of Pathogenicity and Virulence of Parasites" [CZ.02.1.01/0.0/0.0/16_019/0000759]	Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); ERD funds "Centre for Research of Pathogenicity and Virulence of Parasites"	This work was supported by Czech Science Foundation (GACR project 17-10308S; PV, VY; https://gacr.cz/en/) and by ERD funds "Centre for Research of Pathogenicity and Virulence of Parasites" (CZ.02.1.01/0.0/0.0/16_019/0000759; PV; https://opvvv.msmt.cz/).The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeladhim M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004771; Abdeladhim M, 2014, INFECT GENET EVOL, V28, P691, DOI 10.1016/j.meegid.2014.07.028; Alkan C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005978; Andrews S., 2010, FASTQC QUALITY CONTR; Aransay AM, 2000, INSECT MOL BIOL, V9, P157, DOI 10.1046/j.1365-2583.2000.00168.x; Arca B, 2018, CURR OPIN INSECT SCI, V29, P102, DOI 10.1016/j.cois.2018.07.012; Arlinghaus FT, 2012, TOXICON, V60, P512, DOI 10.1016/j.toxicon.2012.03.001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ASHFORD RW, 1974, J MED ENTOMOL, V11, P605; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blanco A, 2017, MED BIOCH, P781, DOI [10.1016/B978-0-12-803550-4.00031-8, DOI 10.1016/B978-0-12-803550-4.00031-8]; Brown GD, 2018, NAT REV IMMUNOL, V18, P374, DOI 10.1038/s41577-018-0004-8; Bru C, 2005, NUCLEIC ACIDS RES, V33, pD212, DOI 10.1093/nar/gki034; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2009, P NATL ACAD SCI USA, V106, P3728, DOI 10.1073/pnas.0813190106; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Charlab R, 1999, P NATL ACAD SCI USA, V96, P15155, DOI 10.1073/pnas.96.26.15155; Charrel RN, 2006, EMERG INFECT DIS, V12, P1299, DOI 10.3201/eid1708.060345; Coutinho-Abreu IV, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00290; Coutinho-Abreu IV, 2010, J MED ENTOMOL, V47, P1146, DOI 10.1603/ME10072; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; de Moura TR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002242; DIDISHEIM P, 1959, J LAB CLIN MED, V53, P866; Dodds AW, 2007, IMMUNOBIOLOGY, V212, P233, DOI 10.1016/j.imbio.2006.11.009; Doolittle RF, 2011, J INNATE IMMUN, V3, P9, DOI 10.1159/000321005; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ferreira VP, 2016, SCI REP-UK, V6, DOI 10.1038/srep19300; Flegontov P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23704; Frost GI, 1997, ANAL BIOCHEM, V251, P263, DOI 10.1006/abio.1997.2262; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gebresilassie A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0807-4; Geevarghese G, 2005, J MED ENTOMOL, V42, P495, DOI 10.1603/0022-2585(2005)042[0495:DOCVFS]2.0.CO;2; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grace-Lema DM, 2015, SYST ENTOMOL, V40, P733, DOI 10.1111/syen.12135; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Isawa H, 2002, J BIOL CHEM, V277, P27651, DOI 10.1074/jbc.M203505200; Ishemgulova A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174165; Jablonka W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41848-0; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Kato H, 2015, BIOCHIMIE, V112, P49, DOI 10.1016/j.biochi.2015.02.011; Kato H, 2013, INFECT GENET EVOL, V13, P56, DOI 10.1016/j.meegid.2012.08.024; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kweku MA, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.5527; Lane R. P., 1993, P78; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lerner EA, 2007, PEPTIDES, V28, P1651, DOI 10.1016/j.peptides.2007.06.021; Lestinova T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005600; Lewis D.J., 1982, Bulletin of the British Museum (Natural History) Entomology, V45, P121; LEWIS DJ, 1987, ANN TROP MED PARASIT, V81, P173, DOI 10.1080/00034983.1987.11812109; LEWIS DJ, 1987, SYST ENTOMOL, V12, P163, DOI 10.1111/j.1365-3113.1987.tb00194.x; Lewis J.H, 1996, COMP HEMOSTASIS VERT, DOI [10.1007/978-1-4757-9768-8, DOI 10.1007/978-1-4757-9768-8]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maia C, 2016, PARASITE, V23, DOI 10.1051/parasite/2016062; Mans BJ, 2007, J BIOL CHEM, V282, P36626, DOI 10.1074/jbc.M706410200; Mans BJ, 2011, J INNATE IMMUN, V3, P41, DOI 10.1159/000321599; Marinotti O, 1996, COMP BIOCHEM PHYS B, V113, P675, DOI 10.1016/0305-0491(95)02035-7; Maroli M, 2013, MED VET ENTOMOL, V27, P123, DOI 10.1111/j.1365-2915.2012.01034.x; Martin-Martin I, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007006; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; R Core Team, 2021, R LANGUAGE ENV STAT; Ribeiro JMC, 2000, MED VET ENTOMOL, V14, P142, DOI 10.1046/j.1365-2915.2000.00227.x; Ribeiro JMC, 1998, J MED ENTOMOL, V35, P599, DOI 10.1093/jmedent/35.4.599; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Rohousova I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001660; Senghor MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014773; Sima M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166191; Siripattanapipong S, 2018, J MED ENTOMOL, V55, P1277, DOI 10.1093/jme/tjy069; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Sumova P, 2019, INSECT BIOCHEM MOLEC, V115, DOI 10.1016/j.ibmb.2019.103245; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; Vlkova M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002709; Volf P, 2011, J VECTOR ECOL, V36, pS1, DOI 10.1111/j.1948-7134.2011.00106.x; Volf P, 2000, MED VET ENTOMOL, V14, P251, DOI 10.1046/j.1365-2915.2000.00240.x; Volfova V, 2018, INSECT BIOCHEM MOLEC, V102, P67, DOI 10.1016/j.ibmb.2018.09.010; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xu XQ, 2011, J BIOL CHEM, V286, P32383, DOI 10.1074/jbc.M111.268904; Yared S, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02132; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Ye J, 2018, NUCLEIC ACIDS RES, V46, pW71, DOI 10.1093/nar/gky400	88	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230537	10.1371/journal.pone.0230537	http://dx.doi.org/10.1371/journal.pone.0230537			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208452	Green Submitted, gold, Green Published			2022-12-26	WOS:000535305100020
J	Seccia, R; Gammelli, D; Dominici, F; Romano, S; Landi, AC; Salvetti, M; Tacchella, A; Zaccaria, A; Crisanti, A; Grassi, F; Palagi, L				Seccia, Ruggiero; Gammelli, Daniele; Dominici, Fabio; Romano, Silvia; Landi, Anna Chiara; Salvetti, Marco; Tacchella, Andrea; Zaccaria, Andrea; Crisanti, Andrea; Grassi, Francesca; Palagi, Laura			Considering patient clinical history impacts performance of machine learning models in predicting course of multiple sclerosis	PLOS ONE			English	Article							LONG-TERM DISABILITY; NATURAL-HISTORY; ONSET	Multiple Sclerosis (MS) progresses at an unpredictable rate, but predictions on the disease course in each patient would be extremely useful to tailor therapy to the individual needs. We explore different machine learning (ML) approaches to predict whether a patient will shift from the initial Relapsing-Remitting (RR) to the Secondary Progressive (SP) form of the disease, using only "real world" data available in clinical routine. The clinical records of 1624 outpatients (207 in the SP phase) attending the MS service of Sant'Andrea hospital, Rome, Italy, were used. Predictions at 180, 360 or 720 days from the last visit were obtained considering either the data of the last available visit (Visit-Oriented setting), comparing four classical ML methods (Random Forest, Support Vector Machine, K-Nearest Neighbours and AdaBoost) or the whole clinical history of each patient (History-Oriented setting), using a Recurrent Neural Network model, specifically designed for historical data. Missing values were handled by removing either all clinical records presenting at least one missing parameter (Feature-saving approach) or the 3 clinical parameters which contained missing values (Record-saving approach). The performances of the classifiers were rated using common indicators, such as Recall (or Sensitivity) and Precision (or Positive predictive value). In the visit-oriented setting, the Record-saving approach yielded Recall values from 70% to 100%, but low Precision (5% to 10%), which however increased to 50% when considering only predictions for which the model returned a probability above a given "confidence threshold". For the History-oriented setting, both indicators increased as prediction time lengthened, reaching values of 67% (Recall) and 42% (Precision) at 720 days. We show how "real world" data can be effectively used to forecast the evolution of MS, leading to high Recall values and propose innovative approaches to improve Precision towards clinically useful values.	[Seccia, Ruggiero; Gammelli, Daniele; Dominici, Fabio; Palagi, Laura] Sapienza Univ Rome, Dept Comp Control & Management Engn Antonio Ruber, Rome, Italy; [Romano, Silvia; Landi, Anna Chiara; Salvetti, Marco] Sapienza Univ Rome, Dept Neurosci Mental Hlth & Sensory Organs, Rome, Italy; [Salvetti, Marco] IRCCS, Ist Neurol Mediterraneo Neuromed, Pozzilli, Italy; [Tacchella, Andrea; Zaccaria, Andrea] UOS Sapienza, Dept Phys, Ist Sistemi Complessi ISC, CNR, Rome, Italy; [Crisanti, Andrea] Sapienza Univ Rome, Dept Phys, Rome, Italy; [Grassi, Francesca] Sapienza Univ Rome, Dept Physiol & Pharmacol, Rome, Italy; [Gammelli, Daniele] Tech Univ Denmark, Lyngby, Denmark	Sapienza University Rome; Sapienza University Rome; IRCCS Neuromed; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome; Sapienza University Rome; Technical University of Denmark	Palagi, L (corresponding author), Sapienza Univ Rome, Dept Comp Control & Management Engn Antonio Ruber, Rome, Italy.; Grassi, F (corresponding author), Sapienza Univ Rome, Dept Physiol & Pharmacol, Rome, Italy.	francesca.grassi@uniroma1.it; palagi@diag.uniroma1.it	Crisanti, Andrea/C-1705-2016; Romano, Silvia/P-7984-2015; Grassi, Francesca/D-3963-2009; Salvetti, Marco/K-3836-2016	Crisanti, Andrea/0000-0002-9869-4420; Romano, Silvia/0000-0003-0499-8843; Grassi, Francesca/0000-0002-0169-8397; Seccia, Ruggiero/0000-0001-5292-1774; Crisanti, Andrea/0000-0002-2406-4426	project `MIME-BCI: Mindfulness Meditation training supported by Brain-Computer Interfaces"(2016) from Sapienza, University of Rome [PI1161550696379A]; Sapienza University of Rome; Italian Ministry of University and Research	project `MIME-BCI: Mindfulness Meditation training supported by Brain-Computer Interfaces"(2016) from Sapienza, University of Rome; Sapienza University of Rome; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	LP acknowledges partial support from the project `MIME-BCI: Mindfulness Meditation training supported by Brain-Computer Interfaces"(2016) (No PI1161550696379A) from Sapienza, University of Rome (www.uniroma1.it).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LP and RS acknowledge financial support from the Sapienza University of Rome (www.uniroma1.it) within the project "Network medicine-based machine learning and graph theory algorithms for precision oncology" (2019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript AT and AZ acknowledge financial support from the Italian Ministry of University and Research (www.miur.gov.it) within the project CRISIS LAB PNR 2011-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascherio A, 2014, JAMA NEUROL, V71, P306, DOI 10.1001/jamaneurol.2013.5993; Bejarano B, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-67; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; Bergamaschi R, 2015, EUR J NEUROL, V22, P981, DOI 10.1111/ene.12696; Bordi I, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/910321; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Briggs FBS, 2019, MULT SCLER RELAT DIS, V30, P9, DOI 10.1016/j.msard.2019.01.045; Bzdok Danilo, 2018, Nat Methods, V15, P233, DOI 10.1038/nmeth.4642; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Efron B, 1994, INTRO BOOTSTRAP; Farber RS, 2016, ANNU REV MED, V67, P309, DOI 10.1146/annurev-med-052814-023415; Ferreira D, 2014, J NEUROIMMUNOL, V274, P149, DOI 10.1016/j.jneuroim.2014.06.010; Fiorini S, 2015, IEEE ENG MED BIO, P4443, DOI 10.1109/EMBC.2015.7319381; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Gajofatto A, 2013, DIS MARKERS, V2013, P687, DOI 10.1155/2013/484959; Galea I, 2013, EUR J NEUROL, V20, P1107, DOI 10.1111/ene.12016; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Guillemin F, 2017, NEUROEPIDEMIOLOGY, V48, P179, DOI 10.1159/000479516; Howie, 2002, INTERPRETING PROBABI, DOI 10.1017/CBO9780511498480; Ion-Margineanu A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00398; Jokubaitis VG, 2016, ANN NEUROL, V80, P89, DOI 10.1002/ana.24682; Klotz L, 2019, THER ADV NEUROL DISO, V12, DOI 10.1177/1756286419836571; Kocevar G, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00478; Laakso SM, 2019, ACTA NEUROL SCAND, V140, P303, DOI 10.1111/ane.13145; Langer-Gould A, 2006, ARCH NEUROL-CHICAGO, V63, P1686, DOI 10.1001/archneur.63.12.1686; Lorscheider J, 2016, BRAIN, V139, P2395, DOI 10.1093/brain/aww173; Lynch CJ, 2018, NAT MED, P1; Manouchehrinia A, 2017, MULT SCLER J, V23, P1488, DOI 10.1177/1352458516681197; Marzullo A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00594; Matute-Blanch C, 2018, BRAIN, V141, DOI 10.1093/brain/awy021; Mellinger S, 2018, MULT SCLER RELAT DIS, V25, P212, DOI 10.1016/j.msard.2018.07.033; Muller HS, 2019, MAUERW KALENDER, P1; Obermeyer Z, 2017, NEW ENGL J MED, V377, P1209, DOI 10.1056/NEJMp1705348; Palagi L, 2019, J GLOBAL OPTIM, P1; Renoux C, 2011, NEUROL CLIN, V29, P293, DOI 10.1016/j.ncl.2011.01.006; Rio J, 2016, J NEUROL SCI, V361, P158, DOI 10.1016/j.jns.2015.12.043; Rotstein D, 2019, NAT REV NEUROL, V15, P287, DOI 10.1038/s41582-019-0170-8; Rzepinski L, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55060232; Saleem S, 2019, CUREUS J MED SCIENCE, V11, DOI 10.7759/cureus.5246; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Shalev-Shwartz S., 2014, UNDERSTANDING MACHIN, P410, DOI DOI 10.1017/CBO9781107298019; Stankiewicz JM, 2013, NEUROTHERAPEUTICS, V10, P77, DOI 10.1007/s13311-012-0172-3; Stewart T, 2017, MULT SCLER J, V23, P266, DOI 10.1177/1352458516643392; Tacchella Andrea, 2017, F1000Res, V6, P2172, DOI 10.12688/f1000research.13114.2; Urru SA, 2019, MULT SCLER, V22; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Wottschel V, 2015, NEUROIMAGE-CLIN, V7, P281, DOI 10.1016/j.nicl.2014.11.021; Yoo Y, 2016, LECT NOTES COMPUT SC, V10008, P86, DOI 10.1007/978-3-319-46976-8_10; Zhang HK, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2018.11.003; Zhao YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174866; Ziemssen T, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0639-7	52	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0230219	10.1371/journal.pone.0230219	http://dx.doi.org/10.1371/journal.pone.0230219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196512	Green Published, Green Submitted, gold			2022-12-26	WOS:000535303100021
J	Blanca, M; Puche, LV; Garrido-Arandia, M; Martin-Pedraza, L; Sahagun, AR; Lopez-Sanchez, JD; Galan, C; Marin, A; Villaba, M; Diaz-Perales, A; Somoza, ML				Blanca, Miguel; Puche, Laura Victorio; Garrido-Arandia, Maria; Martin-Pedraza, Laura; Sahagun, Alejandro Romero; Lopez-Sanchez, Jose Damian; Galan, Carmen; Marin, Antonio; Villaba, Mayte; Diaz-Perales, Araceli; Somoza, Maria Luisa			Pru p 9, a new allergen eliciting respiratory symptoms in subjects sensitized to peach tree pollen	PLOS ONE			English	Article							OCCUPATIONAL ALLERGY	Peach tree (PT) pollen sensitization is highly prevalent in subjects living in areas where this tree is widely cultivated. None of the allergens responsible for these sensitizations have been identified so far. Our aim was to identify the most relevant PT pollen allergens and analyze their capacity for inducing respiratory symptoms. We studied sixty-two individuals sensitized to PT pollen who developed symptoms after its exposure. The IgE binding profile on peach pollen extract by means of immunoblotting using sera from these subjects was analyzed. Protein extract was fractionated by anion-exchange chromatography and HPLC, fractions run in SDS-PAGE and proteins were identified from IgE-binding bands by mass spectrometry. Several allergenic proteins in the PT pollen extract were recognized by patients' IgE: a glucan endo-1,3-beta-glucosidase-like, a polygalacturonase, an UTP-glucose-1-phosphate uridylyltransferase and a PR-1a protein. This PR-1a protein is a novel allergen frequently recognized with a molecular mass of 18 kDa, named as Pru p 9 following the WHO-IUIS nomenclature. Skin Prick Test (SPT) performed with this allergen was positive in 41% of the PT pollen-sensitized clinical cases. Most of them had rhinitis or rhinoconjunctivitis, but a significant percentage experienced asthma with seasonal symptoms during the period of PT flowering. Nasal Provocation test (NPT) with Pru p 9 was positive in all cases with positive SPT to this new allergen eliciting nasal symptoms similar to those challenged with PT pollen. We demonstrate that PT pollen can induce sensitization and allergy in an exposed population, being Pru p 9 a relevant allergen responsible of respiratory symptoms. Considering the extensive peach worldwide production with a large number of people involved, our results add a great value for the diagnosis and management of subjects allergic to this pollen.	[Blanca, Miguel; Somoza, Maria Luisa] Hosp Univ Infanta Leonor, Allergy Serv, Madrid, Spain; [Puche, Laura Victorio] Hosp Gen Univ Morales Meseguer, Allergy Serv, Murcia, Spain; [Garrido-Arandia, Maria; Sahagun, Alejandro Romero; Diaz-Perales, Araceli] UPM INIA, Ctr Biotecnol & Genom Plantas, Madrid, Spain; [Martin-Pedraza, Laura; Villaba, Mayte] Univ Complutense Madrid, Fac Quim, Dept Bioquim & Biol Mol, Madrid, Spain; [Lopez-Sanchez, Jose Damian] Hosp Clin Univ Virgen Arrixaca, Allergy Serv, Murcia, Spain; [Galan, Carmen] Univ Cordoba, Dept Bot, Cordoba, Spain; [Marin, Antonio] Ctr Salud Blanca, Murcia, Spain	Hospital Universitario Infanta Leonor; Meseguer General University Hospital Morales; Universidad Politecnica de Madrid; Complutense University of Madrid; Hospital Clinico Universitario Virgen de la Arrixaca; Universidad de Cordoba	Somoza, ML (corresponding author), Hosp Univ Infanta Leonor, Allergy Serv, Madrid, Spain.	mlsomoza@yahoo.com	Martín-Pedraza, Laura/ADI-1395-2022; Garrido-Arandia, Maria/ABG-9760-2020; Díaz-Perales, Araceli/D-8433-2016	Díaz-Perales, Araceli/0000-0002-1093-3627; Victorio Puche, Laura/0000-0001-6612-1436; Somoza, Maria Luisa/0000-0002-0141-8914; Galan, Carmen/0000-0002-6849-1219; Garrido Arandia, Maria/0000-0001-6114-5754	Ministerio de Economia y Competitividad [PI17/00615, SAF2017-86483-R]; ISCIII - Fondo Europeo de Desarrollo Regional -FEDER for the Thematic Networks and Co-operative Research Centres: ARADyAL [RD16/0006/0014, RD16/0006/003, RD16/0006/0024]; Allerscreening Project [H2020-NMBP-X-KET-2017. 768641 Aller-Screening]; PE I+D+i 2013-2016 [PT17/0019]; ISCIII; ERDF	Ministerio de Economia y Competitividad(Spanish Government); ISCIII - Fondo Europeo de Desarrollo Regional -FEDER for the Thematic Networks and Co-operative Research Centres: ARADyAL; Allerscreening Project; PE I+D+i 2013-2016; ISCIII(Instituto de Salud Carlos III); ERDF(European Commission)	This work was supported by the grants PI17/00615 and SAF2017-86483-R from the Ministerio de Economia y Competitividad and ISCIII co-founded by Fondo Europeo de Desarrollo Regional -FEDER for the Thematic Networks and Co-operative Research Centres: ARADyAL (RD16/0006/0014, RD16/0006/003 and RD16/0006/0024). And also from Allerscreening Project (H2020-NMBP-X-KET-2017. 768641 Aller-Screening). The proteomic analysis was performed in the Proteomics Service of Complutense University of Madrid, a member of ProteoRed and is supported by grant PT17/0019, of the PE I+D+i 2013-2016, funded by ISCIII and ERDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, PROD PEACH NEC 2016; ASTWOOD JD, 1995, CLIN EXP ALLERGY, V25, P66, DOI 10.1111/j.1365-2222.1995.tb01004.x; Auge J, 2018, ALLERGY, V73, P1597, DOI 10.1111/all.13416; Boral D, 2004, ANN AGR ENV MED, V11, P45; Bousquet J, 2012, ALLERGY, V67, P18, DOI 10.1111/j.1398-9995.2011.02728.x; Chatzi L, 2005, CHEST, V127, P372, DOI 10.1378/chest.127.1.372; de Jong NW, 1998, ALLERGY, V53, P204, DOI 10.1111/j.1398-9995.1998.tb03872.x; Demir AU, 2002, ALLERGY, V57, P936, DOI 10.1034/j.1398-9995.2002.23277.x; Esch RE, 2009, MIDDLETONS ALLERGY P, V1, P509, DOI [10.1016/j.jbi.2012.09.002, DOI 10.1016/B978-0-323-05659-5.00032-2]; Faegri K, 2013, PRINCIPLES POLLINATI, P34; GAMSKY TE, 1992, AM REV RESPIR DIS, V145, P257, DOI 10.1164/ajrccm/145.2_Pt_1.257; Garcia BE, 2004, CLIN EXP ALLERGY, V34, P291, DOI 10.1111/j.1365-2222.2004.01871.x; Haroun-Diaz E, 2018, J ALLERGY CLIN IMMUN, V141, pAB243, DOI 10.1016/j.jaci.2017.12.772; Iraneta SG, 2005, INT ARCH ALLERGY IMM, V137, P265, DOI 10.1159/000086419; Javier F, 2015, ASIAN PAC J ALLERGY, V33, P196, DOI 10.12932/AP0542.33.3.2015; Jiang NN, 2015, IRAN J ALLERGY ASTHM, V14, P483; Larsen JN, 2004, ALLERGENS ALLERGEN I, P433; Lokas SB, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22047; Lopez S, 2010, CLIN EXP ALLERGY, V40, P1007, DOI 10.1111/j.1365-2222.2010.03492.x; Martin-Pedraza L, 2016, MOL NUTR FOOD RES, V60, P1172, DOI 10.1002/mnfr.201500782; Ojeda P, 2018, J INVEST ALLERG CLIN, V28, P151, DOI 10.18176/jiaci.0264; Patiwael JA, 2010, INT ARCH ALLERGY IMM, V152, P58, DOI 10.1159/000260084; Pawankar R, 2013, WORLD ALLERGY ORG WH; Perez-Calderon R, 2017, ALLERGY, V72, P1556, DOI 10.1111/all.13163; Rodriguez A, 2004, ALLERGY, V59, P364, DOI 10.1046/j.1398-9995.2003.00298.x; Saha B, 2017, J PROTEOMICS, V165, P1, DOI 10.1016/j.jprot.2017.05.021; Saha B, 2015, J PROTEOME RES, V14, P4823, DOI 10.1021/acs.jproteome.5b00657; Singh AB, 2003, ANN AGR ENV MED, V10, P131; van Toorenenbergen AW, 2000, INT ARCH ALLERGY IMM, V122, P246, DOI 10.1159/000024405; Puche LV, 2018, J ALLERGY CLIN IMMUN, V141, pAB31, DOI 10.1016/j.jaci.2017.12.099; Villalba M, 2014, METHODS, V66, P44, DOI 10.1016/j.ymeth.2013.07.038; Yabuhara Akihiko, 2004, Arerugi, V53, P494	32	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230010	10.1371/journal.pone.0230010	http://dx.doi.org/10.1371/journal.pone.0230010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191737	Green Published, gold			2022-12-26	WOS:000535302300022
J	Der, JB; Grint, D; Narh, CT; Bonsu, F; Grant, AD				Der, Joyce B.; Grint, Daniel; Narh, Clement T.; Bonsu, Frank; Grant, Alison D.			Where are patients missed in the tuberculosis diagnostic cascade? A prospective cohort study in Ghana	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; PRETREATMENT LOSS; FOLLOW-UP	Background Ghana's national prevalence survey showed higher than expected tuberculosis (TB) prevalence, indicating that many people with TB are not identified and treated. This study aimed to identify gaps in the TB diagnostic cascade prior to starting treatment. Methods A prospective cohort study was conducted in urban and rural health facilities in south-east Ghana. Consecutive patients routinely identified as needing a TB test were followed up for two months to find out if sputum was submitted and/or treatment started. The causal effect of health facility location on submitting sputum was assessed before risk factors were investigated using logistic regression. Results A total of 428 persons (mean age 48 years, 67.3% female) were recruited, 285 (66.6%) from urban and 143 (33.4%) from rural facilities. Of 410 (96%) individuals followed up, 290 (70.7%) submitted sputum, among which 27 (14.1%) had a positive result and started treatment. Among those who visited an urban facility, 245/267(91.8%) submitted sputum, compared to 45/143 (31.5%) who visited a rural facility. Participants recruited at the urban facility were far more likely to submit a sputum sample (odds ratio (OR) 24.24, 95%CI 13.84-42.51). After adjustment for confounding, there was still a strong association between attending the urban facility and submitting sputum (adjusted OR (aOR) 9.52, 95%CI 3.87-23.40). Travel distance of > 10 km to the laboratory was the strongest predictor of not submitting sputum (aOR 0.12, 95%CI 0.05-0.33). Conclusion The majority of presumptive TB patients attending a rural health facility did not submit sputum for testing, mainly due to the long travel distance to the laboratory. Bridging this gap in the diagnostic cascade may improve case detection.	[Der, Joyce B.; Grint, Daniel; Grant, Alison D.] London Sch Hyg & Trop Med, TB Ctr, London, England; [Der, Joyce B.; Narh, Clement T.] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Hohoe, Ghana; [Narh, Clement T.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Biostat Epidemiol & Informat, Mainz, Germany; [Bonsu, Frank] Ghana Hlth Serv, Dept Dis Control & Prevent, Natl TB Control Program, Accra, Ghana; [Grant, Alison D.] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Africa Hlth Res Inst, Durban, South Africa; [Grant, Alison D.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; Johannes Gutenberg University of Mainz; Ghana Health Service; Africa Health Research Institute; University of Kwazulu Natal; University of Witwatersrand	Der, JB (corresponding author), London Sch Hyg & Trop Med, TB Ctr, London, England.; Der, JB (corresponding author), Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Hohoe, Ghana.	joyce.der@lshtm.ac.uk	Narh, Clement/AAP-3097-2021	Narh, Clement/0000-0002-4025-5433; Grint, Daniel/0000-0001-8001-6544	Commonwealth Scholarship Commission; MRC [MR/R010161/1] Funding Source: UKRI	Commonwealth Scholarship Commission; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the staff of the Municipal Health Directorate, all participating health facilities, research assistants and all study participants for their cooperation and support. Thanks to the Commonwealth Scholarship Commission for granting JD a scholarship for her doctoral studies. The Commission had no involvement in any aspect of the study and manuscript.	Abebe G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013339; Afutu FK, 2012, T ROY SOC TROP MED H, V106, P511, DOI 10.1016/j.trstmh.2012.05.002; Ali SM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5222-2; Bogale S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2240-0; Chakrabartty Arupkumar, 2018, Indian J Tuberc, V65, P145, DOI 10.1016/j.ijtb.2017.08.032; CROOKS V, 1991, J GERONTOL, V46, pM139, DOI 10.1093/geronj/46.4.M139; Daftary A, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000515; De Schacht C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219470; Duko Bereket, 2019, Tuberc Res Treat, V2019, P5917537, DOI 10.1155/2019/5917537; Fry K., 2014, MEASURING EQUITY NAT; Ghana Health Service, 2018, KET S MUN HLTH DIR A; Ghana Health Service-National TB Control Program, 2015, GHAN NAT POP BAS TUB; Kidd R, 2009, UNDERSTANDING CHALLE; MacPherson P, 2014, B WORLD HEALTH ORGAN, V92, P126, DOI 10.2471/BLT.13.124800; Mhalu G, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4030-4; Mugauri H, 2018, INT J INFECT DIS, V76, P6, DOI 10.1016/j.ijid.2018.07.012; Murongazvombo AS, 2019, INT J INFECT DIS, V78, P113, DOI 10.1016/j.ijid.2018.10.013; Naidoo P, 2017, J INFECT DIS, V216, pS702, DOI 10.1093/infdis/jix335; National Tuberculosis Control Program, 2015, ANN REP NAT TB CONTR; National Tuberculosis Control Program, 2017, ANN REP NAT TB CONTR; Onyoh EF, 2018, INT J TUBERC LUNG D, V22, P378, DOI 10.5588/ijtld.17.0676; Osei E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1922-z; Padingani M, 2018, PAN AFR MED J, V31, DOI 10.11604/pamj.2018.31.196.15848; Pala Star, 2018, J Family Med Prim Care, V7, P942, DOI 10.4103/jfmpc.jfmpc_161_18; Quattrocchi A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019673; Saqib SE, 2018, AM J TROP MED HYG, V99, P143, DOI 10.4269/ajtmh.18-0001; Shewade HD, 2017, J EPIDEMIOL GLOB HEA, V7, P227, DOI 10.1016/j.jegh.2017.07.001; SHIFERAW MB, 2019, BMC HEALTH SERV RES, V19, P37583, DOI DOI 10.1186/S12913-; Van Rie A, 2008, TROP MED INT HEALTH, V13, P21, DOI 10.1111/j.1365-3156.2007.01971.x; WHO, 2019, GLOB TUB REP, P1; World Health Organization, 2015, WHOHISHSI20153; Yang Q, 2020, INT HEALTH, V12, P101, DOI 10.1093/inthealth/ihz036	32	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230604	10.1371/journal.pone.0230604	http://dx.doi.org/10.1371/journal.pone.0230604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191768	Green Published, Green Accepted, gold			2022-12-26	WOS:000535302300063
J	Sato, AY; Tsunoda, K; Mizuyama, R; Shimegi, S				Sato, Akinori Y.; Tsunoda, Keisuke; Mizuyama, Ryo; Shimegi, Satoshi			Serotonin improves behavioral contrast sensitivity of freely moving rats	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; VISUAL-CORTEX; NEURONS; PROJECTIONS; EXPRESSION; RESPONSES; MODULATION; FLUOXETINE; RECEPTORS; MOUSE	Serotonin (5-HT) is a neuromodulator secreted from serotonergic neurons located in the pons and upper brain stem in a behavioral context-dependent manner. The serotonergic axon terminals innervate almost the whole brain, causing modulatory actions on various brain functions including vision. Our previous study demonstrated the visual responses of neurons in the primary visual cortex (V1) of anesthetized monkeys were modulated by the activation of 5-HT receptors depending on the response magnitude, in which 5-HT2A receptor-selective agonists enhanced weak visual responses but not strong responses. This observation suggests that the activation of serotonergic receptors modulates neuronal visual information processing to improve the behavioral detectability of a stimulus. However, it remains unknown if 5-HT improves visual detectability at the behavioral level. To investigate this point, visual detectability was measured as contrast sensitivity (CS) in freely moving rats using a two-alternative forced-choice visual detection task (2AFC-VDT) combined with the staircase method. The grating contrast was decreased or increased step by step after a correct choice (hit) or incorrect choice (miss), respectively. CS was evaluated as an inverse value of the visual contrast threshold. The effect of the intraperitoneal administration of fluoxetine (FLX, 5 mg/kg), a selective serotonin reuptake inhibitor, on CS was tested. The CS of rats was significantly higher in FLX than control conditions, and the drug effect showed specificity for the spatial frequency (SF) of a grating stimulus, in which CS improvement was observed at optimal SF but not non-optimal high SF. Thus, we conclude that endogenously-secreted serotonin in the brain improves visual detectability, which may be mediated by vision-related neurons acquiring SF information of the visual stimulus.	[Sato, Akinori Y.; Tsunoda, Keisuke; Mizuyama, Ryo; Shimegi, Satoshi] Osaka Univ, Grad Sch Frontier Biosci, Lab Brain Informat Sci Sports, Toyonaka, Osaka, Japan; [Shimegi, Satoshi] Osaka Univ, Ctr Educ Liberal Arts & Sci, Lab Brain Informat Sci Sports, Toyonaka, Osaka, Japan; [Shimegi, Satoshi] Osaka Univ, Grad Sch Med, Lab Brain Informat Sci Sports, Toyonaka, Osaka, Japan	Osaka University; Osaka University; Osaka University	Shimegi, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Lab Brain Informat Sci Sports, Toyonaka, Osaka, Japan.; Shimegi, S (corresponding author), Osaka Univ, Ctr Educ Liberal Arts & Sci, Lab Brain Informat Sci Sports, Toyonaka, Osaka, Japan.; Shimegi, S (corresponding author), Osaka Univ, Grad Sch Med, Lab Brain Informat Sci Sports, Toyonaka, Osaka, Japan.	shimegi@celas.osaka-u.ac.jp		Tsunoda, Keisuke/0000-0002-1579-0549	KAKENHI [JP22500573, JP25282216, JP25560302, JP16H01869, JP17J08499]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI JP22500573, JP25282216, JP25560302, and JP16H01869 to S.S, and Grant-in-Aid for JSPS Fellows JP17J08499 to A.Y.S.	BENNETTCLARKE CA, 1993, P NATL ACAD SCI USA, V90, P153, DOI 10.1073/pnas.90.1.153; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CAMPBELL FW, 1969, J PHYSIOL-LONDON, V203, P223, DOI 10.1113/jphysiol.1969.sp008861; Celada P, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00025; Cooper J., 2003, BIOCH BASIS NEUROPHA; Dori I, 1996, EXP NEUROL, V138, P1, DOI 10.1006/exnr.1996.0041; Duxon MS, 1997, NEUROSCIENCE, V76, P323, DOI 10.1016/S0306-4522(96)00480-0; Hueletl-Soto ME, 2012, J SEX MED, V9, P1015, DOI 10.1111/j.1743-6109.2011.02339.x; Evrard A, 1999, EUR J NEUROSCI, V11, P3823, DOI 10.1046/j.1460-9568.1999.00800.x; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Histed MH, 2012, J NEUROPHYSIOL, V107, P758, DOI 10.1152/jn.00609.2011; Janusonis S, 2003, NEUROREPORT, V14, P459, DOI 10.1097/01.wnr.0000058959.85541.9a; KOH T, 1991, BRAIN RES BULL, V27, P675, DOI 10.1016/0361-9230(91)90044-K; KOHLER C, 1978, PHARMACOL BIOCHEM BE, V8, P223, DOI 10.1016/0091-3057(78)90309-X; Kursar JD, 1994, MOL CLONING FUNCTION, DOI [10.1016/0169-328x(94)90223-2, DOI 10.1016/0169-328X(94)90223-2]; Michaiel AM, 2019, CELL REP, V26, P3475, DOI 10.1016/j.celrep.2019.02.104; Miyamoto H, 2012, J NEUROSCI, V32, P14794, DOI 10.1523/JNEUROSCI.0793-12.2012; Miyazaki KW, 2012, J NEUROSCI, V32, P10451, DOI 10.1523/JNEUROSCI.0915-12.2012; Mizuyama R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168455; MONTAGNECLAVEL J, 1995, PAIN, V60, P303, DOI 10.1016/0304-3959(94)00129-3; Monti JM, 2011, SLEEP MED REV, V15, P269, DOI 10.1016/j.smrv.2010.11.003; Monti JM, 2010, SLEEP MED REV, V14, P319, DOI 10.1016/j.smrv.2009.10.003; OHEARN E, 1984, BRAIN RES BULL, V13, P709, DOI 10.1016/0361-9230(84)90232-6; Osredkar D, 2009, PERIOD BIOL, V111, P129; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peng L, 2014, CURR NEUROPHARMACOL, V12, P365, DOI 10.2174/1570159X12666140828221720; POMPEIANO M, 1994, MOL BRAIN RES, V23, P163, DOI 10.1016/0169-328X(94)90223-2; Portas CM, 2000, PROG NEUROBIOL, V60, P13, DOI 10.1016/S0301-0082(98)00097-5; Prouty EW, 2017, BRAIN RES, V1675, P28, DOI 10.1016/j.brainres.2017.08.031; Puig MV, 2011, MOL NEUROBIOL, V44, P449, DOI 10.1007/s12035-011-8214-0; ROWLAND NE, 1987, BRAIN RES BULL, V18, P501, DOI 10.1016/0361-9230(87)90115-8; Seillier L, 2017, J NEUROSCI, V37, P11390, DOI 10.1523/JNEUROSCI.1339-17.2017; Shimegi S, 2016, J PHYSIOL-PARIS, V110, P44, DOI 10.1016/j.jphysparis.2016.09.001; Soma S, 2018, BEHAV PROCESS, V157, P291, DOI 10.1016/j.beproc.2018.10.014; Soma S, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12060; Soma S, 2013, BEHAV BRAIN RES, V256, P362, DOI 10.1016/j.bbr.2013.08.022; Tsunoda K, 2019, PHYSIOL BEHAV, V199, P111, DOI 10.1016/j.physbeh.2018.11.014; Vertes RP, 1999, J COMP NEUROL, V407, P555; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; Watakabe A, 2009, CEREB CORTEX, V19, P1915, DOI 10.1093/cercor/bhn219; WATERHOUSE BD, 1986, J COMP NEUROL, V249, P460, DOI 10.1002/cne.902490403; WATERHOUSE BD, 1990, BRAIN RES, V514, P276, DOI 10.1016/0006-8993(90)91422-D	42	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230367	10.1371/journal.pone.0230367	http://dx.doi.org/10.1371/journal.pone.0230367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191757	Green Published, gold			2022-12-26	WOS:000535302300040
J	Wieghold, S; Nienhaus, L				Wieghold, Sarah; Nienhaus, Lea			Engineering 3D perovskites for photon interconversion applications	PLOS ONE			English	Review							TRIPLET-TRIPLET ANNIHILATION; LIGHT-EMITTING-DIODES; POWER UP-CONVERSION; HALIDE PEROVSKITES; SOLAR-CELLS; MOLECULAR-OXYGEN; CAPPING LIGANDS; THIN-FILMS; CSPBX3 X; NANOCRYSTALS	In this review, we highlight the current advancements in the field of triplet sensitization by three-dimensional (3D) perovskite nanocrystals and bulk films. First introduced in 2017, 3D perovskite sensitized upconversion (UC) is a young fast-evolving field due to the tunability of the underlying perovskite material. By tuning the perovskite bandgap, visible-to-ultraviolet, near-infrared-to-visible or green-to-blue UC has been realized, which depicts the broad applicability of this material. As this research field is still in its infancy, we hope to stimulate the field by highlighting the advantages of these perovskite nanocrystals and bulk films, as well as shedding light onto the current drawbacks. In particular, the keywords toxicity, reproducibility and stability must be addressed prior to commercialization of the technology. If successful, photon interconversion is a means to increase the achievable efficiency of photovoltaic cells beyond its current limits by increasing the window of useable wavelengths.	[Wieghold, Sarah; Nienhaus, Lea] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Nienhaus, L (corresponding author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.	lnienhaus@fsu.edu		Nienhaus, Lea/0000-0003-1412-412X	Florida State University	Florida State University	The authors thank Florida State University for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate A, 2017, JOULE, V1, P659, DOI 10.1016/j.joule.2017.09.007; Abdel-Shafi AA, 2005, J PHOTOCH PHOTOBIO A, V172, P170, DOI 10.1016/j.jphotochem.2004.12.006; Akkerman QA, 2018, NAT MATER, V17, P394, DOI 10.1038/s41563-018-0018-4; Akkerman QA, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2016.194; Akselrod GM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4646; Almeida G, 2019, SCIENCE, V364, P833, DOI 10.1126/science.aax5825; Amemori S, 2016, J AM CHEM SOC, V138, P8702, DOI 10.1021/jacs.6b04692; Brandt RE, 2017, CHEM MATER, V29, P4667, DOI 10.1021/acs.chemmater.6b05496; Chen YN, 2018, ADV MATER, V30, DOI 10.1002/adma.201703487; Cheng YY, 2010, PHYS CHEM CHEM PHYS, V12, P66, DOI 10.1039/b913243k; Cho HC, 2015, SCIENCE, V350, P1222, DOI 10.1126/science.aad1818; Correa-Baena JP, 2019, SCIENCE, V363, P627, DOI 10.1126/science.aah5065; Correa-Baena JP, 2018, JOULE, V2, P1410, DOI 10.1016/j.joule.2018.05.009; Correa-Baena JP, 2018, CHEM MATER, V30, P3734, DOI 10.1021/acs.chemmater.8b00676; Correa-Baena JP, 2017, SCIENCE, V358, P739, DOI 10.1126/science.aam6323; Dirin DN, 2014, J AM CHEM SOC, V136, P6550, DOI 10.1021/ja5006288; Dolzhnikov DS, 2015, SCIENCE, V347, P425, DOI 10.1126/science.1260501; Geva N, 2019, J PHYS CHEM LETT, V10, P3147, DOI 10.1021/acs.jpclett.9b01058; GREWER C, 1994, J PHYS CHEM-US, V98, P4230, DOI 10.1021/j100067a006; Haefele A, 2012, J PHYS CHEM LETT, V3, P299, DOI 10.1021/jz300012u; Han YY, 2019, J PHYS CHEM LETT, V10, P1457, DOI 10.1021/acs.jpclett.9b00597; Hao F, 2014, NAT PHOTONICS, V8, P489, DOI 10.1038/nphoton.2014.82; He S, 2019, J PHYS CHEM LETT, V10, P5036, DOI 10.1021/acs.jpclett.9b02106; Hill RBM, 2019, ACS APPL ENERG MATER, V2, P2402, DOI 10.1021/acsaem.9b00141; Huang ZY, 2017, J AM CHEM SOC, V139, P9412, DOI 10.1021/jacs.6b08783; Huang ZY, 2015, NANO LETT, V15, P5552, DOI 10.1021/acs.nanolett.5b02130; Im J, 2019, NPJ COMPUT MATER, V5, DOI 10.1038/s41524-019-0177-0; Imperiale CJ, 2019, J PHYS CHEM LETT, V10, P7463, DOI 10.1021/acs.jpclett.9b03115; Islangulov RR, 2007, J AM CHEM SOC, V129, P12652, DOI 10.1021/ja075014k; Islangulov RR, 2005, CHEM COMMUN, P3776, DOI 10.1039/b506575e; Jiang YZ, 2018, JOULE, V2, P1356, DOI 10.1016/j.joule.2018.05.004; Kafle TR, 2019, J AM CHEM SOC, V141, P11328, DOI 10.1021/jacs.9b05893; Kafle TR, 2017, ACS NANO, V11, P10184, DOI 10.1021/acsnano.7b04751; Khnayzer RS, 2012, CHEM COMMUN, V48, P209, DOI 10.1039/c1cc16015j; Kim J, 2009, ACCOUNTS CHEM RES, V42, P1037, DOI 10.1021/ar8002046; Kozlov DV, 2004, CHEM COMMUN, P2860, DOI 10.1039/b412681e; Krieg F, 2018, ACS ENERGY LETT, V3, P641, DOI 10.1021/acsenergylett.8b00035; Kroupa DM, 2018, ACS ENERGY LETT, V3, P2390, DOI 10.1021/acsenergylett.8b01528; Li FM, 2018, NANOSCALE, V10, P6318, DOI 10.1039/c8nr00758f; Li JX, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201901891; Loiudice A, 2019, J AM CHEM SOC, V141, P8254, DOI 10.1021/jacs.9b02061; Lu HP, 2019, J AM CHEM SOC, V141, P4919, DOI 10.1021/jacs.8b13562; Luo X, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13951-3; Luo X, 2019, J AM CHEM SOC, V141, P4186, DOI 10.1021/jacs.8b13180; Mase K, 2017, CHEM COMMUN, V53, P8261, DOI 10.1039/c7cc03087h; Meng FL, 2017, NANOSCALE, V9, P18535, DOI 10.1039/c7nr05416e; Meng L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07255-1; Menke SM, 2014, ENERG ENVIRON SCI, V7, P499, DOI 10.1039/c3ee42444h; Milstein TJ, 2019, NANO LETT, V19, P1931, DOI 10.1021/acs.nanolett.8b05104; Mir WJ, 2018, CHEM MATER, V30, P8170, DOI 10.1021/acs.chemmater.8b03066; Monguzzi A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195112; Nie WY, 2015, SCIENCE, V347, P522, DOI 10.1126/science.aaa0472; Nienhaus L, 2019, ACS ENERGY LETT, V4, P888, DOI 10.1021/acsenergylett.9b00283; Nienhaus L, 2018, WORL CON PHOTOVOLT E, P3698, DOI 10.1109/PVSC.2018.8547686; Nienhaus L, 2018, DALTON T, V47, P8509, DOI 10.1039/c8dt00419f; Nienhaus L, 2017, ACS NANO, V11, P7848, DOI 10.1021/acsnano.7b02024; Noel NK, 2014, ENERG ENVIRON SCI, V7, P3061, DOI 10.1039/c4ee01076k; Okumura K, 2019, CHEM LETT, V48, P1347, DOI 10.1246/cl.190473; Pan J, 2016, ADV MATER, V28, P8718, DOI 10.1002/adma.201600784; Pan J, 2015, J PHYS CHEM LETT, V6, P5027, DOI 10.1021/acs.jpclett.5b02460; Poindexter JR, 2018, IEEE J PHOTOVOLT, V8, P156, DOI 10.1109/JPHOTOV.2017.2775156; Poindexter JR, 2017, ACS NANO, V11, P7101, DOI 10.1021/acsnano.7b02734; Pun AB, 2019, CHEM SCI, V10, P3969, DOI 10.1039/c8sc03725f; Ravi VK, 2017, J PHYS CHEM LETT, V8, P4988, DOI 10.1021/acs.jpclett.7b02192; Saliba M, 2016, SCIENCE, V354, P206, DOI 10.1126/science.aah5557; Schulze TF, 2015, ENERG ENVIRON SCI, V8, P103, DOI 10.1039/c4ee02481h; Singh-Rachford TN, 2008, J PHYS CHEM A, V112, P3550, DOI 10.1021/jp7111878; Singh-Rachford TN, 2010, COORDIN CHEM REV, V254, P2560, DOI 10.1016/j.ccr.2010.01.003; Singh-Rachford TN, 2010, J PHYS CHEM LETT, V1, P195, DOI 10.1021/jz900170m; Singh-Rachford TN, 2009, INORG CHEM, V48, P2541, DOI 10.1021/ic802114d; Steirer KX, 2016, ACS ENERGY LETT, V1, P360, DOI 10.1021/acsenergylett.6b00196; Stoumpos CC, 2016, CHEM MATER, V28, P2852, DOI 10.1021/acs.chemmater.6b00847; Stranks SD, 2015, NAT NANOTECHNOL, V10, P391, DOI [10.1038/NNANO.2015.90, 10.1038/nnano.2015.90]; Sun SJ, 2019, JOULE, V3, P1437, DOI 10.1016/j.joule.2019.05.014; Tan ZK, 2014, NAT NANOTECHNOL, V9, P687, DOI [10.1038/nnano.2014.149, 10.1038/NNANO.2014.149]; Tao SX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10468-7; Trupke T, 2002, J APPL PHYS, V92, P4117, DOI 10.1063/1.1505677; Tsai HH, 2016, NATURE, V536, P312, DOI 10.1038/nature18306; VanOrman ZA, 2019, MRS COMMUN, V9, P924, DOI 10.1557/mrc.2019.115; Wheeler LM, 2018, J AM CHEM SOC, V140, P10504, DOI 10.1021/jacs.8b04984; Wieghold S, 2020, J PHYS CHEM LETT, V11, P601, DOI 10.1021/acs.jpclett.9b03596; Wieghold S, 2019, MATTER-US, V1, P705, DOI 10.1016/j.matt.2019.05.026; Wieghold S, 2019, J PHYS CHEM LETT, V10, P3806, DOI 10.1021/acs.jpclett.9b01526; Wieghold S, 2019, CHEM MATER, V31, P3712, DOI 10.1021/acs.chemmater.9b00650; Wieghold S, 2018, ACS APPL ENERG MATER, V1, P6801, DOI 10.1021/acsaem.8b00913; Wu MF, 2016, NAT PHOTONICS, V10, P31, DOI [10.1038/nphoton.2015.226, 10.1038/NPHOTON.2015.226]; Yoo JJ, 2019, ENERG ENVIRON SCI, V12, P2192, DOI 10.1039/c9ee00751b; Zhang TY, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700841; Zhao JZ, 2011, RSC ADV, V1, P937, DOI 10.1039/c1ra00469g; Zhou YY, 2019, ENERG ENVIRON SCI, V12, P1495, DOI 10.1039/c8ee03559h; Zhu XY, 2009, ACCOUNTS CHEM RES, V42, P1779, DOI 10.1021/ar800269u	91	8	8	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230299	10.1371/journal.pone.0230299	http://dx.doi.org/10.1371/journal.pone.0230299			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191735	gold, Green Published			2022-12-26	WOS:000535302300036
J	Choi, MS; Graves, MJ; Matoo, S; Storad, ZA; Idris, RAE; Weck, ML; Smith, ZB; Tyska, MJ; Crawley, SW				Choi, Myoung Soo; Graves, Maura J.; Matoo, Samaneh; Storad, Zachary A.; Idris, Rawnag A. El Sheikh; Weck, Meredith L.; Smith, Zachary B.; Tyska, Matthew J.; Crawley, Scott W.			The small EF-hand protein CALML4 functions as a critical myosin light chain within the intermicrovillar adhesion complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myosin; epithelial cell; intestinal epithelium; actin; calmodulin (CaM); cadherin; brush border; calmodulin-like protein 4 (CALML4); intermicrovillar adhesion complex (IMAC); Usher syndrome; intestine; protrusion; enterocyte	I USHER-SYNDROME; BRUSH-BORDER; INFANTILE HYPERINSULINISM; CONTIGUOUS GENE; VIIA GENE; DOMAIN; MUTATIONS; DEAFNESS; LOCALIZATION; ENTEROPATHY	Specialized transporting and sensory epithelial cells employ homologous protocadherin-based adhesion complexes to remodel their apical membrane protrusions into organized functional arrays. Within the intestine, the nutrient-transporting enterocytes utilize the intermicrovillar adhesion complex (IMAC) to assemble their apical microvilli into an ordered brush border. The IMAC bears remarkable homology to the Usher complex, whose disruption results in the sensory disorder type 1 Usher syndrome (USH1). However, the entire complement of proteins that comprise both the IMAC and Usher complex are not yet fully elucidated. Using a protein isolation strategy to recover the IMAC, we have identified the small EF-hand protein calmodulin-like protein 4 (CALML4) as an IMAC component. Consistent with this finding, we show that CALML4 exhibits marked enrichment at the distal tips of enterocyte microvilli, the site of IMAC function, and is a direct binding partner of the IMAC component myosin-7b. Moreover, distal tip enrichment of CALML4 is strictly dependent upon its association with myosin-7b, with CALML4 acting as a light chain for this myosin. We further show that genetic disruption of CALML4 within enterocytes results in brush border assembly defects that mirror the loss of other IMAC components and that CALML4 can also associate with the Usher complex component myosin-7a. Our study further defines the molecular composition and protein-protein interaction network of the IMAC and Usher complex and may also shed light on the etiology of the sensory disorder USH1H.	[Choi, Myoung Soo; Graves, Maura J.; Matoo, Samaneh; Storad, Zachary A.; Idris, Rawnag A. El Sheikh; Crawley, Scott W.] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA; [Weck, Meredith L.; Smith, Zachary B.; Tyska, Matthew J.] Vanderbilt Univ, Dept Cell & Dev Biol, Sch Med, Nashville, TN 37240 USA	University System of Ohio; University of Toledo; Vanderbilt University	Crawley, SW (corresponding author), Univ Toledo, Coll Nat Sci & Math, 2801 W Bancroft St, Toledo, OH 43606 USA.	william.crawley@utoledo.edu		Crawley, Scott William/0000-0002-4121-5353	National Science Foundation NOA-AGEP fellowship; FYSRE University of Toledo scholarship; URSCAP University of Toledo scholarship; National Institutes of Health [R15GM131382, DK075555, DK095811]; University of Toledo	National Science Foundation NOA-AGEP fellowship; FYSRE University of Toledo scholarship; URSCAP University of Toledo scholarship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Toledo	This work was supported by a National Science Foundation NOA-AGEP fellowship (to M. J. G.), FYSRE and URSCAP University of Toledo scholarships (to Z. A. S. and R. A. E.), University of Toledo start-up funds, and National Institutes of Health Grants R15GM131382 (to S. W. C.) and DK075555 and DK095811 (to M. J. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adato A, 1997, AM J HUM GENET, V61, P813, DOI 10.1086/514899; Ahmed ZM, 2009, CLIN GENET, V75, P86, DOI 10.1111/j.1399-0004.2008.01038.x; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Barr-Gillespie PG, 2015, MOL BIOL CELL, V26, P2727, DOI 10.1091/mbc.E14-04-0940; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Chaib H, 1997, HUM MOL GENET, V6, P27, DOI 10.1093/hmg/6.1.27; Crawley SW, 2016, DEV CELL, V36, P190, DOI 10.1016/j.devcel.2015.12.022; Crawley SW, 2014, J CELL BIOL, V207, P441, DOI 10.1083/jcb.201407015; Crawley SW, 2014, CELL, V157, P433, DOI 10.1016/j.cell.2014.01.067; Haithcock J, 2011, J BIOL CHEM, V286, P8819, DOI 10.1074/jbc.M110.163592; Heissler Sarah M, 2014, Bioarchitecture, V4, P169, DOI 10.1080/19490992.2015.1054092; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Hussain K, 2004, J PEDIATR ENDOCR MET, V17, P1613; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; Jaiganesh A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029280; Jaworek TJ, 2012, J HUM GENET, V57, P633, DOI 10.1038/jhg.2012.79; Lentz J, 2016, GENEREVIEWS; Li JC, 2017, P NATL ACAD SCI USA, V114, pE3776, DOI 10.1073/pnas.1702251114; Marjoram RJ, 2016, METHODS, V94, P19, DOI 10.1016/j.ymeth.2015.09.025; McConnell RE, 2011, AM J PHYSIOL-GASTR L, V300, pG914, DOI 10.1152/ajpgi.00005.2011; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; MILLER D, 1961, ANAL BIOCHEM, V2, P284, DOI 10.1016/S0003-2697(61)80014-6; Morgan CP, 2016, ELIFE, V5, DOI 10.7554/eLife.18312; Pan LF, 2012, PHYSIOLOGY, V27, P25, DOI 10.1152/physiol.00037.2011; Pangrsic T, 2015, P NATL ACAD SCI USA, V112, pE1028, DOI 10.1073/pnas.1416424112; PETERSON MD, 1993, J CELL SCI, V105, P445; Postema MM, 2018, CURR BIOL, V28, P2876, DOI 10.1016/j.cub.2018.07.022; Sahly I, 2012, J CELL BIOL, V199, P381, DOI 10.1083/jcb.201202012; Sakai T, 2015, J BIOL CHEM, V290, P17587, DOI 10.1074/jbc.M114.599365; Sauvanet C, 2015, ANNU REV CELL DEV BI, V31, P593, DOI 10.1146/annurev-cellbio-100814-125234; Schietroma C, 2017, J CELL BIOL, V216, P1849, DOI 10.1083/jcb.201612030; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Weck ML, 2016, CURR BIOL, V26, P2717, DOI 10.1016/j.cub.2016.08.014; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Yang Y, 2005, J BIOL CHEM, V280, P32061, DOI 10.1074/jbc.M506765200; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106; Yu IM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15864	43	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9281	9296		10.1074/jbc.RA120.012820	http://dx.doi.org/10.1074/jbc.RA120.012820			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32209652	Green Published, hybrid			2022-12-26	WOS:000552758600002
J	Jin, CM; Zhu, XB; Wu, H; Wang, YQ; Hu, X				Jin, Chengmeng; Zhu, Xiaobing; Wu, Hao; Wang, Yuqi; Hu, Xun			Perturbation of phosphoglycerate kinase 1 (PGK1) only marginally affects glycolysis in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycolysis; serine; lactic acid; cancer; Warburg effect; cellular metabolism; energy homeostasis; PGK1 forward reaction kinetics; phosphoglycerate kinase	AEROBIC GLYCOLYSIS; METABOLISM; P53; M2; INHIBITION; EXPRESSION; THERMODYNAMICS; METHYLGLYOXAL; CONTRIBUTES; MECHANISM	Phosphoglycerate kinase 1 (PGK1) plays important roles in glycolysis, yet its forward reaction kinetics are unknown, and its role especially in regulating cancer cell glycolysis is unclear. Here, we developed an enzyme assay to measure the kinetic parameters of the PGK1-catalyzed forward reaction. The K-m values for 1,3-bisphosphoglyceric acid (1,3-BPG, the forward reaction substrate) were 4.36 ?m (yeast PGK1) and 6.86 ?m (human PKG1). The K-m values for 3-phosphoglycerate (3-PG, the reverse reaction substrate and a serine precursor) were 146 ?m (yeast PGK1) and 186 ?m (human PGK1). The V-max of the forward reaction was about 3.5- and 5.8-fold higher than that of the reverse reaction for the human and yeast enzymes, respectively. Consistently, the intracellular steady-state concentrations of 3-PG were between 180 and 550 ?m in cancer cells, providing a basis for glycolysis to shuttle 3-PG to the serine synthesis pathway. Using siRNA-mediated PGK1-specific knockdown in five cancer cell lines derived from different tissues, along with titration of PGK1 in a cell-free glycolysis system, we found that the perturbation of PGK1 had no effect or only marginal effects on the glucose consumption and lactate generation. The PGK1 knockdown increased the concentrations of fructose 1,6-bisphosphate, dihydroxyacetone phosphate, glyceraldehyde 3-phosphate, and 1,3-BPG in nearly equal proportions, controlled by the kinetic and thermodynamic states of glycolysis. We conclude that perturbation of PGK1 in cancer cells insignificantly affects the conversion of glucose to lactate in glycolysis.	[Jin, Chengmeng; Zhu, Xiaobing; Wu, Hao; Wang, Yuqi; Hu, Xun] Zhejiang Univ, Sch Med, Affiliated Hosp 2,Zhejiang Prov Key Lab Mol Biol, Canc Inst,Key Lab Canc Intervent & Prevent,China, Hangzhou 310000, Peoples R China	Zhejiang University	Hu, X (corresponding author), 88 Jiefang Rd, Hangzhou 310000, Peoples R China.	huxun@zju.edu.cn			National Basic Research Program of China (973 Program) [2013CB911303]; National Natural Science Foundation of China [81470126]; Zhejiang Provincial Department of Sciences and Technologies [2018C03009]; Fundamental Research Funds for the Central Universities Grants [2017XZZX001-01, 2019FZJD009]; National Ministry of Education, China	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Department of Sciences and Technologies; Fundamental Research Funds for the Central Universities Grants; National Ministry of Education, China(Ministry of Education, China)	This work was supported in part by National Basic Research Program of China (973 Program) Grant 2013CB911303, National Natural Science Foundation of China Project Grant 81470126 and Key Project Grant 2018C03009 funded by Zhejiang Provincial Department of Sciences and Technologies, and Fundamental Research Funds for the Central Universities Grants 2017XZZX001-01 and 2019FZJD009, National Ministry of Education, China (to X. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad SS, 2013, INT J ONCOL, V43, P586, DOI 10.3892/ijo.2013.1971; Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Ai JZ, 2011, CELL PHYSIOL BIOCHEM, V27, P207, DOI 10.1159/000327946; Alberty Robert A, 2006, Methods Biochem Anal, V48, P1; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Berg KCG, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0691-y; Blanco R, 2009, HUM MUTAT, V30, P1199, DOI 10.1002/humu.21028; Bollong MJ, 2018, NATURE, V562, P600, DOI 10.1038/s41586-018-0622-0; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cascone T, 2018, CELL METAB, V27, P977, DOI 10.1016/j.cmet.2018.02.024; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chen XP, 2015, NAT CHEM BIOL, V11, P19, DOI 10.1038/nchembio.1657; Chiarelli LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032065; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Dang CV, 1999, MOL CELL BIOL, V19, P1; DeWaal D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02733-4; DONNOVAN L, 1975, THERMOCHIM ACTA, V11, P151, DOI 10.1016/0040-6031(75)80018-9; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fan J, 2015, ACS CHEM BIOL, V10, P510, DOI 10.1021/cb500683c; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Giachelli CM, 2003, J AM SOC NEPHROL, V14, pS300, DOI 10.1097/01.ASN.0000081663.52165.66; Gibon Y, 1997, ANAL BIOCHEM, V251, P153, DOI 10.1006/abio.1997.2283; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; HOPPESEYLER F, 1993, J VIROL, V67, P3111, DOI 10.1128/JVI.67.6.3111-3117.1993; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hu HG, 2017, HEPATOLOGY, V65, P515, DOI 10.1002/hep.28887; Hwang TL, 2006, PROTEOMICS, V6, P2259, DOI 10.1002/pmic.200500345; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; KACSER H, 1995, BIOCHEM SOC T, V23, P341, DOI 10.1042/bst0230341; KELETI T, 1972, BIOCHIM BIOPHYS ACTA, V268, P285, DOI 10.1016/0005-2744(72)90323-3; Kress S, 1998, J CANCER RES CLIN, V124, P315, DOI 10.1007/s004320050175; Li Xin, 2011, Database (Oxford), V2011, pbar005, DOI 10.1093/database/bar005; Li XJ, 2018, MOL CELL, V72, P650, DOI 10.1016/j.molcel.2018.09.007; Li XJ, 2016, MOL CELL, V61, P705, DOI 10.1016/j.molcel.2016.02.009; Liberti MV, 2017, CELL METAB, V26, P648, DOI 10.1016/j.cmet.2017.08.017; Locasale Jason W, 2018, Curr Opin Syst Biol, V8, P32, DOI 10.1016/j.coisb.2017.11.005; Lu S, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0336-6; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mendez E, 2008, BIOCHEM MOL BIOL EDU, V36, P116, DOI 10.1002/bmb.20157; Nakazawa MS, 2016, NAT REV CANCER, V16, P663, DOI 10.1038/nrc.2016.84; Passonneau J.V., 1993, ENZYMATIC ANAL PRACT; REKHARSKY MV, 1981, THERMOCHIM ACTA, V46, P89, DOI 10.1016/0040-6031(81)80234-1; RICHARD JP, 1993, BIOCHEM SOC T, V21, P549, DOI 10.1042/bst0210549; Shashni B, 2013, J DRUG TARGET, V21, P161, DOI 10.3109/1061186X.2012.736998; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; Shipanova IN, 1997, ARCH BIOCHEM BIOPHYS, V344, P29, DOI 10.1006/abbi.1997.0195; Tanner LB, 2018, CELL SYST, V7, P49, DOI 10.1016/j.cels.2018.06.003; Varga A, 2009, FEBS LETT, V583, P3660, DOI 10.1016/j.febslet.2009.10.048; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Xie JS, 2016, J BIOL CHEM, V291, P8987, DOI 10.1074/jbc.M115.704825; Xie JS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04927; YAGINUMA Y, 1991, CANCER RES, V51, P6506; Yan H, 2012, CNS NEUROSCI THER, V18, P729, DOI 10.1111/j.1755-5949.2012.00353.x; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Yang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08759-0; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Ying MF, 2019, J BIOL CHEM, V294, P9615, DOI 10.1074/jbc.RA119.007841; Yuan JY, 2018, DNA CELL BIOL, V37, P574, DOI 10.1089/dna.2018.4188; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhang W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08277-3; Zhang YJ, 2018, MOL CELL, V71, P201, DOI 10.1016/j.molcel.2018.06.023; Zhao YJ, 2018, TRANSL CANCER RES, V7, P231, DOI 10.21037/tcr.2018.02.14; Zhong XY, 2018, CELL REP, V24, P3207, DOI 10.1016/j.celrep.2018.08.066; Zieker D, 2010, INT J CANCER, V126, P1513, DOI 10.1002/ijc.24835	72	10	10	3	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6425	6446		10.1074/jbc.RA119.012312	http://dx.doi.org/10.1074/jbc.RA119.012312			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32217690	Green Published, hybrid			2022-12-26	WOS:000537685000015
J	Goydel, RS; Weber, J; Peng, HY; Qi, JP; Soden, J; Freeth, J; Park, H; Rader, C				Goydel, Rebecca S.; Weber, Justus; Peng, Haiyong; Qi, Junpeng; Soden, Jo; Freeth, Jim; Park, HaJeung; Rader, Christoph			Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; antigen; epitope mapping; X-ray crystallography; cancer therapy; affinity maturation; kringle domain; receptor tyrosine kinase (RTK) ROR2	COMPLEMENTARITY-DETERMINING REGIONS; TYROSINE KINASE GENES; PHAGE DISPLAY; RECEPTOR; EXPRESSION; GENERATION; FAMILY; DOMAIN; CRYSTALLOGRAPHY; SOFTWARE	Antibodies are widely used as cancer therapeutics, but their current use is limited by the low number of antigens restricted to cancer cells. A receptor tyrosine kinase, receptor tyrosine kinase-like orphan receptor 2 (ROR2), is normally expressed only during embryogenesis and is tightly down-regulated in postnatal healthy tissues. However, it is up-regulated in a diverse set of hematologic and solid malignancies, thus ROR2 represents a candidate antigen for antibody-based cancer therapy. Here we describe the affinity maturation and humanization of a rabbit mAb that binds human and mouse ROR2 but not human ROR1 or other human cell-surface antigens. Co-crystallization of the parental rabbit mAb in complex with the human ROR2 kringle domain (hROR2-Kr) guided affinity maturation by heavy-chain complementarity-determining region 3 (HCDR3)-focused mutagenesis and selection. The affinity-matured rabbit mAb was then humanized by complementarity-determining region (CDR) grafting and framework fine tuning and again co-crystallized with hROR2-Kr. We show that the affinity-matured and humanized mAb retains strong affinity and specificity to ROR2 and, following conversion to a T cell?engaging bispecific antibody, has potent cytotoxicity toward ROR2-expressing cells. We anticipate that this humanized affinity-matured mAb will find application for antibody-based cancer therapy of ROR2-expressing neoplasms.	[Goydel, Rebecca S.; Weber, Justus; Peng, Haiyong; Qi, Junpeng; Rader, Christoph] Scripps Res Inst, Dept Immunol & Microbiol, 130 Scripps Way 2C1, Jupiter, FL 33458 USA; [Soden, Jo; Freeth, Jim] Scripps Res Inst, Xray Crystallog Core, Jupiter, FL 33458 USA; [Park, HaJeung] Retrogenix Ltd, Chinley SK23 6FJ, High Peak, England; [Weber, Justus] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Versbacher Str 5, D-97078 Wurzburg, Germany	Scripps Research Institute; Scripps Research Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg	Rader, C (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, 130 Scripps Way 2C1, Jupiter, FL 33458 USA.	crader@scripps.edu	Qi, Junpeng/AAH-5525-2020	Weber, Justus/0000-0002-4919-952X; Rader, Christoph/0000-0001-9955-3454	National Institutes of Health [R01 CA174844, R01 CA181258, R01 CA204484, R21 CA229961]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by National Institutes of Health Grants R01 CA174844, R01 CA181258, R01 CA204484, and R21 CA229961 (to C. R.). This is manuscript no. 29916 from The Scripps Research Institute. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Al-Shawi R, 2001, DEV GENES EVOL, V211, P161, DOI 10.1007/s004270100140; Almagro JC, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01751; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Balakrishnan A, 2017, CLIN CANCER RES, V23, P3061, DOI 10.1158/1078-0432.CCR-16-2083; Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davda J, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0586-0; Debebe Z, 2015, PHARMACOL THERAPEUT, V150, P143, DOI 10.1016/j.pharmthera.2015.01.010; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Edris B, 2012, J PATHOL, V227, P223, DOI 10.1002/path.3986; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forrester WC, 2002, CELL MOL LIFE SCI, V59, P83, DOI 10.1007/s00018-002-8407-9; Freeth J, 2020, SLAS DISCOV, V25, P223, DOI 10.1177/2472555219897567; Frenquelli M, 2020, LEUKEMIA, V34, P257, DOI 10.1038/s41375-019-0486-9; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Hellmann I, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02490; Henry C, 2015, J CANCER RES CLIN, V141, P243, DOI 10.1007/s00432-014-1824-y; Hristodorov D, 2013, MOL BIOTECHNOL, V53, P326, DOI 10.1007/s12033-012-9531-x; Hudecek M, 2013, CLIN CANCER RES, V19, P3153, DOI 10.1158/1078-0432.CCR-13-0330; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Jones TD, 2016, MABS-AUSTIN, V8, P1, DOI 10.1080/19420862.2015.1114320; Lee CH, 2010, P NATL ACAD SCI USA, V107, P9567, DOI 10.1073/pnas.1001541107; Ma SSQ, 2017, VIRCHOWS ARCH, V470, P99, DOI 10.1007/s00428-016-2019-5; Mage RG, 2019, DEV COMP IMMUNOL, V92, P99, DOI 10.1016/j.dci.2018.10.003; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; McConnell AD, 2014, MABS-AUSTIN, V6, P1274, DOI 10.4161/mabs.29680; Menzen T, 2014, J PHARM SCI-US, V103, P445, DOI 10.1002/jps.23827; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Morioka K, 2009, CANCER SCI, V100, P1227, DOI 10.1111/j.1349-7006.2009.01165.x; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park H, 2005, J BIOL CHEM, V280, P13593, DOI 10.1074/jbc.M500768200; Peng H, 2017, J MOL BIOL, V429, P2954, DOI 10.1016/j.jmb.2017.08.003; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi JP, 2018, P NATL ACAD SCI USA, V115, pE5467, DOI 10.1073/pnas.1719905115; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; Rader C, 2000, J BIOL CHEM, V275, P13668, DOI 10.1074/jbc.275.18.13668; Rader Christoph, 2009, V525, P101, DOI 10.1007/978-1-59745-554-1_5; Rebagay G, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00034; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Robinson HR, 2018, BLOOD, V132, P521, DOI 10.1182/blood-2018-02-830992; Stahl SJ, 2010, J MOL BIOL, V397, P697, DOI 10.1016/j.jmb.2010.01.061; Stricker S, 2017, CURR TOP DEV BIOL, V123, P105, DOI 10.1016/bs.ctdb.2016.09.003; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang M, 2010, J STRUCT BIOL, V169, P349, DOI 10.1016/j.jsb.2009.09.011; Weber J, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.23; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Zhang YF, 2017, MABS-AUSTIN, V9, P419, DOI 10.1080/19420862.2017.1289302; ZHU ZP, 1995, INT J CANCER, V62, P319, DOI 10.1002/ijc.2910620315	54	16	15	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5995	6006		10.1074/jbc.RA120.012791	http://dx.doi.org/10.1074/jbc.RA120.012791			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32193207	hybrid, Green Published			2022-12-26	WOS:000531417300013
J	Pes, MP; Melo, AA; Stacke, RS; Zanella, R; Perini, CR; Silva, FMA; Guedes, JVC				Pes, Maiquel P.; Melo, Adriano A.; Stacke, Regina S.; Zanella, Renato; Perini, Clerison R.; Silva, Fabio M. A.; Carus Guedes, Jerson, V			Translocation of chlorantraniliprole and cyantraniliprole applied to corn as seed treatment and foliar spraying to control Spodoptera frugiperda (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							FALL ARMYWORM; INSECTICIDES; EFFICACY; MAIZE	The translocation of chemical insecticides in corn plants could enhance the control of Spodoptera frugiperda, based on their application form. Chlorantraniliprole and cyantraniliprole were applied via seed treatment and foliar spray in corn (VE and V3) to characterize the systemic action of both molecules in leaves that appeared after application. Bioassays with S. frugiperda and chemical quantification in LC-MS/MS confirmed the absorption and upward translocation of chlorantraniliprole and cyantraniliprole by xylem to new leaves. Both insecticides caused the mortality of larvae up to stage V6 (57.5 +/- 9.5% for chlorantraniliprole and 40 +/- 8.1% for cyantraniliprole), indicating the translocation of insecticides into leaves of corn plants when applied via seed treatment. However, the translocation of chlorantraniliprole and cyantraniliprole from sprayed leaves to new leaves was not observed, regardless of the stage of application plus the next first, second and third stages. An increased dosage of cyantraniliprole did not influence on its translocation in plant tissues, however, it influenced on the present amount of active ingredient. The application of chlorantraniliprole and cyantraniliprole in seed treatment is an important alternative for integrated pest management. The absorption and redistribution capacity of chlorantraniliprole and cyantraniliprole throughout the plant confer a prolonged residual action with satisfactory control of S. frugiperda.	[Pes, Maiquel P.; Melo, Adriano A.; Stacke, Regina S.; Perini, Clerison R.; Carus Guedes, Jerson, V] Univ Fed Santa Maria, Dept Crop Protect, Lab Integrated Pest Management, Santa Maria, RS, Brazil; [Zanella, Renato] Univ Fed Santa Maria, Dept Chem, Santa Maria, RS, Brazil; [Silva, Fabio M. A.] FMC Agr Solut, Paulinia, SP, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM)	Pes, MP (corresponding author), Univ Fed Santa Maria, Dept Crop Protect, Lab Integrated Pest Management, Santa Maria, RS, Brazil.	maiquelpizzuti@gmail.com	ZANELLA, RENATO/N-9682-2019; Melo, Adriano Arrué/M-5426-2014	ZANELLA, RENATO/0000-0002-5971-1785; Melo, Adriano Arrué/0000-0001-6868-4347; Pizzuti Pes, Maiquel/0000-0001-9444-2042	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FMC Agricultural Solutions; CAPES Foundation	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FMC Agricultural Solutions; CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the scholarship provided by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) to the first author, MP. The specific roles of this author is articulated in the author contributions section. FMC Agricultural Solutions also provided support for this study in the form of salaries for FMAS. Dupont and FMC Agricultural Solutions further supported this project with funding of research materials (technical and commercial products, pots for corn plants, corn seeds, and other research materials). The funder had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; We would like to thank the CAPES Foundation for the scholarship to the first author. Also, we thank Dominic Reisig, Ph.D from North Carolina State University for his critical and relevant contribution in the writing of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Adams A, 2016, J ECON ENTOMOL, V109, P2411, DOI 10.1093/jee/tow210; AGROFIT, 2019, REL PROD FORM; [Anonymous], JOINT FAO WHO M PEST; Barry JD, 2015, PEST MANAG SCI, V71, P395, DOI 10.1002/ps.3816; Bernardi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140130; Burtet LM, 2017, PEST MANAG SCI, V73, P2569, DOI 10.1002/ps.4660; Carvalho RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062268; Chen XiaoJun, 2015, Journal of Agricultural Science (Toronto), V7, P238, DOI 10.5539/jas.v7n12p238; CLOYD RA, 2011, FLORICULTURE ORNAMEN, V5, P1; Cruz I, 1999, INT J PEST MANAGE, V45, P293, DOI 10.1080/096708799227707; deBoer GJ, 2014, ACS SYM SER, V1171, P75; Ferreira DF, 2011, CIENC AGROTEC, V35, P1039, DOI 10.1590/S1413-70542011000600001; Foster SP, 2012, PEST MANAG SCI, V68, P629, DOI 10.1002/ps.2306; GREENE GL, 1976, J ECON ENTOMOL, V69, P487, DOI 10.1093/jee/69.4.487; (IRAC) Insect Resistance Action Committee, 2017, IRAC MOD ACT CLASS S; Jeanguenat A, 2013, PEST MANAG SCI, V69, P7, DOI 10.1002/ps.3406; Lahm GP, 2009, BIOORGAN MED CHEM, V17, P4127, DOI 10.1016/j.bmc.2009.01.018; Pihlstrom T, 2015, SANTE119452015 EUR C; Prestes OD, 2009, QUIM NOVA, V32, P1620, DOI 10.1590/S0100-40422009000600046; Schmidt-Jeffris RA, 2016, J ECON ENTOMOL, V109, P2479, DOI 10.1093/jee/tow219; Selby TP, 2017, PEST MANAG SCI, V73, P658, DOI 10.1002/ps.4308; Sidhu JK, 2014, FLA ENTOMOL, V97, P224, DOI 10.1653/024.097.0129; Silva PR, 2016, SUSCETIBILIDADE MILH; Thrash B, 2013, FLA ENTOMOL, V96, P724, DOI 10.1653/024.096.0304; Tomlin CDS, PESTICIDE MANUAL WOR, V1457, P20; Zhang Y, 2018, PEST MANAG SCI, V74, P1979, DOI 10.1002/ps.5037	27	21	22	7	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0229151	10.1371/journal.pone.0229151	http://dx.doi.org/10.1371/journal.pone.0229151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236101	gold, Green Published			2022-12-26	WOS:000535938700009
J	Sarma, H; Jabeen, I; Luies, SK; Uddin, MF; Ahmed, T; Bossert, TJ; Banwell, C				Sarma, Haribondhu; Jabeen, Ishrat; Luies, Sharmin Khan; Uddin, Md Fakhar; Ahmed, Tahmeed; Bossert, Thomas J.; Banwell, Cathy			Performance of volunteer community health workers in implementing home-fortification interventions in Bangladesh: A qualitative investigation	PLOS ONE			English	Article								Introduction BRAC, an international development organisation based in Bangladesh, uses female volunteer community health workers called Shasthya Shebika (SS), who receive small incentives to implement its home-fortification interventions at the community level. This paper examines the individual, community and BRAC work environment factors that exert an influence on the performance of SS. Methods This qualitative study was conducted between the period of June 2014 to December 2016 as part of a larger evaluation of BRAC's home-fortification programme. Data were collected through in-depth interviews, focus group discussions, and key informant interviews and analysed thematically. The participants were SS and their supervisors working for BRAC, caregivers of children aged 6-59 months, husbands of SS, village doctors, and Upazila Health and Family Planning Officers. Results Younger, better educated and more experienced SS with positive self-efficacy were perceived to have performed better than their peers. Social and community factors, such as community recognition of the SS's services, social and religious norms, family support, and household distance, also affected the performance of the SS. There were several challenges at the programme and organisational level that needed to be addressed, including appropriate recruitment, timely basic training and income-generation guidance for the SS. Conclusion BRAC's volunteer SS model faces challenges at individual, community, programme and organisational level. Importantly, BRAC's SS require a living wage to earn essential income for their family. Considering the current socio-cultural and economic context of Bangladesh, BRAC may need to revise the existing volunteer SS model to ensure that SS receive an adequate income so that they can devote themselves to implementing its home-fortification intervention.	[Sarma, Haribondhu; Banwell, Cathy] Australian Natl Univ, Coll Hlth & Med, Res Sch Populat Hlth, Acton, ACT, Australia; [Sarma, Haribondhu; Jabeen, Ishrat; Luies, Sharmin Khan; Uddin, Md Fakhar; Ahmed, Tahmeed] Icddr B, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Bossert, Thomas J.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Australian National University; International Centre for Diarrhoeal Disease Research (ICDDR); Harvard University; Harvard T.H. Chan School of Public Health	Sarma, H (corresponding author), Australian Natl Univ, Coll Hlth & Med, Res Sch Populat Hlth, Acton, ACT, Australia.; Sarma, H (corresponding author), Icddr B, Nutr & Clin Serv Div, Dhaka, Bangladesh.	haribondhu.sarma@anu.edu.au	Jabeen, Ishrat/AAD-1389-2022	Sarma, Haribondhu/0000-0003-1553-8498	Children's Investment Fund Foundation (CIFF) of UK	Children's Investment Fund Foundation (CIFF) of UK	Research for this article was founded by the Children's Investment Fund Foundation (CIFF) of UK. The views, opinions, assumptions, or any other information set out in this article are solely those of the authors and should not be attributed to CIFF or any person connected with CIFF.	Afsana K, 2012, MATERNAL AND PERINATAL HEALTH IN DEVELOPING COUNTRIES, P170, DOI 10.1079/9781845937454.0170; Ahmed M, 2016, AGR MECHANIZATION NO; Ahmed S., 2008, BRAC U J, VV, P39; Alam K, 2012, SOC SCI MED, V75, P511, DOI 10.1016/j.socscimed.2012.03.039; [Anonymous], GLOB HLTH WORKF ALL; Anyangwe Stella C E, 2007, Int J Environ Res Public Health, V4, P93, DOI 10.3390/ijerph2007040002; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; BRAC International, RAIS AW HEALTH LIF; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Cherrington A, 2008, DIABETES EDUCATOR, V34, P824, DOI 10.1177/0145721708323643; Cherrington A, 2010, ETHNIC DIS, V20, P189; Cometto G, 2018, LANCET GLOB HEALTH, V6, P1397, DOI 10.1016/S2214-109X(18)30482-0; Dieleman M., 2006, IMPROVING HLTH WORKE; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gerein N, 2006, REPROD HEALTH MATTER, V14, P40, DOI 10.1016/S0968-8080(06)27225-2; Gilroy K, 2006, MANAGEMENT SICK CHIL; Golden SD, 2012, HEALTH EDUC BEHAV, V39, P364, DOI 10.1177/1090198111418634; Gopalan SS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001557; Haggblade S, 2010, WORLD DEV, V38, P1429, DOI 10.1016/j.worlddev.2009.06.008; Hashima-E-Nasreen, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.7017; Kambarami RA, 2016, GLOB HEALTH-SCI PRAC, V4, P238, DOI 10.9745/GHSP-D-16-00003; Kawakatsu Y, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1117-4; Khan S H, 1998, Health Care Superv, V17, P37; Kok MC, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0001-3; Kok MC, 2014, HLTH POLICY PLAN, V30, P1, DOI [10.1093/heapol/czs111, DOI 10.1093/HEAPOL/CZS111]; Miyaguchi M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-383; Mukanga D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-121; Ndima SD, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0063-x; Perez LM, 2008, AM J PUBLIC HEALTH, V98, P11, DOI 10.2105/AJPH.2006.100842; Prata N, 2012, SOC SCI MED, V74, P1288, DOI 10.1016/j.socscimed.2011.11.035; Rashid SF, 2001, TROP MED INT HEALTH, V6, P249, DOI 10.1046/j.1365-3156.2001.00702.x; Razee H, 2012, SOC SCI MED, V75, P828, DOI 10.1016/j.socscimed.2012.04.013; Ritchie J, 2013, QUALITATIVE RES PRAC, P295, DOI [10.7748/nr2011.01.18.2.52.c8284, DOI 10.7748/NR2011.01.18.2.52.C8284]; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Sarma H, 2021, PUBLIC HEALTH NUTR, V24, pS23, DOI 10.1017/S1368980019003768; Sarma H, 2016, FOOD NUTR BULL, V37, P340, DOI 10.1177/0379572116645916; Scott K, 2010, AIDS CARE, V22, P1606, DOI 10.1080/09540121.2010.507751; Sikder M. J. U., 2017, MIGRATION DEV, V6, P253, DOI [10.1080/21632324.2016.1142752, DOI 10.1080/21632324.2016.1142752]; Smith Joanna, 2011, Nurse Res, V18, P52; Standing H, 2008, SOC SCI MED, V66, P2096, DOI 10.1016/j.socscimed.2008.01.046; Swider SM, 2002, PUBLIC HEALTH NURS, V19, P11, DOI 10.1046/j.1525-1446.2002.19003.x; Viswanathan K, 2012, J EPIDEMIOL COMMUN H, V66, P894, DOI 10.1136/jech-2011-200275; WHO, 2006, WORK TOG HLTH WORLD; Wiggins N, 1998, FINAL FULL REPORT NA, P11; World Health Organization, WORLD HLTH STAT 2016	46	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0230709	10.1371/journal.pone.0230709	http://dx.doi.org/10.1371/journal.pone.0230709			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR8IA	32236114	Green Published, gold, Green Submitted			2022-12-26	WOS:000535938700023
J	Wu, Y; Li, L; Li, MZ; Zhang, M; Sun, H; Sigrimis, N				Wu, Yong; Li, Li; Li, Minzan; Zhang, Man; Sun, Hong; Sigrimis, Nikolaos			Optimal fertigation for high yield and fruit quality of greenhouse strawberry	PLOS ONE			English	Article							X ANANASSA DUCH.; FERTILIZER MANAGEMENT; USE EFFICIENCY; CROP YIELD; CULTIVARS; GROWTH; ATTRIBUTES; PHOSPHORUS; POTASSIUM; SOIL	Nitrogen (N), phosphorus (P), potassium (K), and water are four crucial factors that have significant effects on strawberry yield and fruit quality. We used a 11 that involved 36 treatments with five levels of each of the four variables (N, P, and K fertilizers and water) to optimize fertilization and water combination for high yield and quality. Moreover, we used the SSC/TA ratio (the ratio of soluble solid content to titratable acid) as index of quality. Results showed that N fertilizer was the most important factor, followed by water and P fertilizer, and the N fertilizer had significant effect on yield and SSC/TA ratio. By contrast, the K fertilizer had significant effect only on yield. NxK fertilizer interacted significantly on yield, whereas the other interactions among the four factors had no significant effects on yield or SSC/TA ratio. The effects of the four factors on yield and SSC/TA ratio were ranked as N fertilizer > water > K fertilizer > P fertilizer and N fertilizer > P fertilizer > water > K fertilizer, respectively. The yield and SSC/TA ratio increased when NPK fertilizer and water increased, but then decreased when excessive NPK fertilizer and water were applied. The optimal fertilizer and water combination were 22.28-24.61 g plant(-1) Ca (NO3)(2).4H(2)O, 1.75-2.03 g plant(-1) NaH2PO4, 12.41-13.91 g plant(-1) K2SO4, and 12.00-13.05 L water plant(-1) for yields of more than 110 g plant(-1) and optimal SSC/TA ratio of 8.5-14.	[Wu, Yong; Li, Minzan; Zhang, Man; Sun, Hong] China Agr Univ, Key Lab Modern Precis Agr Syst Integrat Res, Minist Educ, Beijing, Peoples R China; [Li, Li] China Agr Univ, Key Lab Agr Informat Acquisit Technol, Minist Agr & Rural Areas, Beijing, Peoples R China; [Sigrimis, Nikolaos] Agr Univ Athens, Dept Agr Engn, Athens, Greece	China Agricultural University; China Agricultural University; Agricultural University of Athens	Li, MZ (corresponding author), China Agr Univ, Key Lab Modern Precis Agr Syst Integrat Res, Minist Educ, Beijing, Peoples R China.; Li, L (corresponding author), China Agr Univ, Key Lab Agr Informat Acquisit Technol, Minist Agr & Rural Areas, Beijing, Peoples R China.	lily@cau.edu.cn; limz@cau.edu.cn			National Key Research and Development Program [2016YED0201000-2016YED0201003]; NSFC [31971786]; Yunnan Academician Expert Workstation [20170907]	National Key Research and Development Program; NSFC(National Natural Science Foundation of China (NSFC)); Yunnan Academician Expert Workstation	This work was supported by the National Key Research and Development Program (Grant No. 2016YED0201000-2016YED0201003), NSFC Project (31971786), and Yunnan Academician Expert Workstation (Li Minzan, Grant No. 20170907).	Ahamed MS, 2018, COMPUT ELECTRON AGR, V150, P235, DOI 10.1016/j.compag.2018.04.025; Akhtar I, 2015, J ANIM PLANT SCI-PAK, V25, P669; Alavoine F., 1989, Acta Horticulturae, P449; Bottoms TG, 2008, THESIS; Cao F, 2015, SCI HORTIC-AMSTERDAM, V195, P183, DOI 10.1016/j.scienta.2015.09.018; Cardenosa V, 2015, J SCI FOOD AGR, V95, P2924, DOI 10.1002/jsfa.7034; Chelpinski P, 2010, J ELEMENTOL, V15, P251; Cordenunsi BR, 2003, FOOD CHEM, V83, P167, DOI 10.1016/S0308-8146(03)00059-1; Crisosto CH, 2004, POSTHARVEST BIOL TEC, V34, P237, DOI 10.1016/j.postharvbio.2004.06.003; Cronje RB, 2009, J PLANT NUTR, V32, P19, DOI 10.1080/01904160802530987; Deng X, 1998, ANN BOT-LONDON, V81, P67, DOI 10.1006/anbo.1997.0535; Dordas CA, 2008, IND CROP PROD, V27, P75, DOI 10.1016/j.indcrop.2007.07.020; Gallardo RK, 2015, AGRIBUSINESS, V31, P259, DOI 10.1002/agr.21396; Grant CA, 2001, CAN J PLANT SCI, V81, P211, DOI 10.4141/P00-093; Grant OM, 2010, ENVIRON EXP BOT, V68, P264, DOI 10.1016/j.envexpbot.2010.01.008; Gunness P, 2009, POSTHARVEST BIOL TEC, V52, P164, DOI 10.1016/j.postharvbio.2008.11.006; He Y, 2003, RENEW ENERG, V28, P1447, DOI 10.1016/S0960-1481(02)00223-9; Kafkas E, 2007, FOOD CHEM, V100, P1229, DOI 10.1016/j.foodchem.2005.12.005; Keutgen A, 2007, FOOD CHEM, V105, P1487, DOI 10.1016/j.foodchem.2007.05.033; Lado J, 2010, J SCI FOOD AGR, V90, P2268, DOI 10.1002/jsfa.4081; Li H, 2014, J PLANT NUTR SOIL SC, V177, P260, DOI 10.1002/jpln.201200654; Li H, 2011, ENVIRON EXP BOT, V71, P224, DOI 10.1016/j.envexpbot.2010.12.007; Li Y, 2017, 25TH ACM SIGSPATIAL INTERNATIONAL CONFERENCE ON ADVANCES IN GEOGRAPHIC INFORMATION SYSTEMS (ACM SIGSPATIAL GIS 2017), DOI 10.1145/3139958.3139971; Liu CH, 2018, POSTHARVEST BIOL TEC, V139, P47, DOI 10.1016/j.postharvbio.2018.01.016; Liu L, 2016, CATENA, V147, P686, DOI 10.1016/j.catena.2016.08.025; Lu YL, 2015, ENVIRON INT, V77, P5, DOI 10.1016/j.envint.2014.12.010; Martinez-Ferri E, 2016, AGR WATER MANAGE, V164, P73, DOI 10.1016/j.agwat.2015.08.014; MCARTHUR DAJ, 1988, SCI HORTIC-AMSTERDAM, V34, P33, DOI 10.1016/0304-4238(88)90073-8; Milosevic TM, 2018, SCI HORTIC-AMSTERDAM, V227, P48, DOI 10.1016/j.scienta.2017.09.013; Montero TM, 1996, SCI HORTIC-AMSTERDAM, V65, P239, DOI 10.1016/0304-4238(96)00892-8; Moor U, 2009, SCI HORTIC-AMSTERDAM, V119, P264, DOI 10.1016/j.scienta.2008.08.005; Oosterhuis DM, 2014, ADV AGRON, V126, P203, DOI 10.1016/B978-0-12-800132-5.00003-1; Pan JF, 2017, AGR WATER MANAGE, V184, P191, DOI 10.1016/j.agwat.2017.01.013; Pelayo-Zaldivar C, 2005, J FOOD QUALITY, V28, P78, DOI 10.1111/j.1745-4557.2005.00005.x; Perkins-Veazie P, 2016, INT J FRUIT SCI, V16, P220, DOI 10.1080/15538362.2016.1219289; Pettigrew WT, 2008, PHYSIOL PLANTARUM, V133, P670, DOI 10.1111/j.1399-3054.2008.01073.x; Pokhrel B, 2015, J AGR FOOD CHEM, V63, P5578, DOI 10.1021/acs.jafc.5b01366; Rutkowski KP, 2004, 5 INT STRAWB S, V708, P329; Sauer T, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR007729; Shao XF, 2013, POSTHARVEST BIOL TEC, V77, P94, DOI 10.1016/j.postharvbio.2012.11.010; Sonsteby A, 2009, SCI HORTIC-AMSTERDAM, V123, P204, DOI 10.1016/j.scienta.2009.08.009; Tsialtas IT, 2016, FIELD CROP RES, V193, P94, DOI 10.1016/j.fcr.2016.03.010; Tsialtas JT, 2005, J AGRON CROP SCI, V191, P330, DOI 10.1111/j.1439-037X.2005.00161.x; Ulrich D, 2017, ACTA HORTIC, V1156, P653, DOI 10.17660/ActaHortic.2017.1156.95; Ulrich D, 2016, J APPL BOT FOOD QUAL, V89, P223, DOI 10.5073/JABFQ.2016.089.029; Voca S, 2008, FOOD TECHNOL BIOTECH, V46, P292; Wang B, 2009, PEDOSPHERE, V19, P86, DOI 10.1016/S1002-0160(08)60087-9; Wang QL, 2010, INT J FOOD PROP, V13, P1234, DOI 10.1080/10942910903013415; Weber N, 2017, J SCI FOOD AGR, V97, P849, DOI 10.1002/jsfa.7806; Weissinger H., 2010, Ecofruit. 14th International Conference on Organic Fruit-Growing. Proceedings for the conference, Hohenheim, Germany, 22-24 February 2010, P243; Xing MK, 2018, INT J FOOD ENG, V14, DOI 10.1515/ijfe-2018-0111; Xu D, 2018, BIOSYST ENG, V171, P205, DOI 10.1016/j.biosystemseng.2018.05.002; Yuan YJ, 2018, POL J FOOD NUTR SCI, V68, P15, DOI 10.1515/pjfns-2017-0013; Zhang C, 2016, J FOOD ENG, V179, P11, DOI 10.1016/j.jfoodeng.2016.01.002; Zhang J, 2018, SCI TOTAL ENVIRON, V627, P361, DOI 10.1016/j.scitotenv.2018.01.090; Zhang XB, 2016, GEODERMA, V265, P176, DOI 10.1016/j.geoderma.2015.11.027; Zhou K, 2018, AGR WATER MANAGE, V210, P324, DOI 10.1016/j.agwat.2018.08.007	57	2	2	8	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2020	15	4							e0224588	10.1371/journal.pone.0224588	http://dx.doi.org/10.1371/journal.pone.0224588			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8IA	32236110	Green Published, gold, Green Submitted			2022-12-26	WOS:000535938700001
J	He, JC; McLaughlin, RP; van der Beek, L; Canisius, S; Wessels, L; Smid, M; Martens, JWM; Foekens, JA; Zhang, YH; van de Water, B				He, Jichao; McLaughlin, Ronan P.; van der Beek, Lambert; Canisius, Sander; Wessels, Lodewyk; Smid, Marcel; Martens, John W. M.; Foekens, John A.; Zhang, Yinghui; van de Water, Bob			Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progression	ONCOGENE			English	Article							GTPASE-ACTIVATING PROTEIN; COPY NUMBER VARIATION; SURVIVAL; MYC; LANDSCAPE; IMPACT; REGION	The genetically heterogeneous triple-negative breast cancer (TNBC) continues to be an intractable disease, due to lack of effective targeted therapies. Gene amplification is a major event in tumorigenesis. Genes with amplification-dependent expression are being explored as therapeutic targets for cancer treatment. In this study, we have applied Analytical Multi-scale Identification of Recurring Events analysis and transcript quantification in the TNBC genome across 222 TNBC tumors and identified 138 candidate genes with positive correlation in copy number gain (CNG) and gene expression. siRNA-based loss-of-function screen of the candidate genes has validated EGFR, MYC, ASAP1, IRF2BP2, and CCT5 genes as drivers promoting proliferation in different TNBC cells. MYC, ASAP1, IRF2BP2, and CCT5 display frequent CNG and concurrent expression over 2173 breast cancer tumors (cBioPortal dataset). More frequently are MYC and ASAP1 amplified in TNBC tumors (>30%, n = 320). In particular, high expression of ASAP1, the ADP-ribosylation factor GTPase-activating protein, is significantly related to poor metastatic relapse-free survival of TNBC patients (n = 257, bc-GenExMiner). Furthermore, we have revealed that silencing of ASAP1 modulates numerous cytokine and apoptosis signaling components, such as IL1B, TRAF1, AIFM2, and MAP3K11 that are clinically relevant to survival outcomes of TNBC patients. ASAP1 has been reported to promote invasion and metastasis in various cancer cells. Our findings that ASAP1 is an amplification-dependent TNBC driver gene promoting TNBC cell proliferation, functioning upstream apoptosis components, and correlating to clinical outcomes of TNBC patients, support ASAP1 as a potential actionable target for TNBC treatment.	[He, Jichao; McLaughlin, Ronan P.; van der Beek, Lambert; Zhang, Yinghui; van de Water, Bob] Leiden Univ, Div Drug Discovery & Safety, Leiden Acad Ctr Drug Res, NL-2300 RA Leiden, Netherlands; [Canisius, Sander; Wessels, Lodewyk] Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; [Smid, Marcel; Martens, John W. M.; Foekens, John A.] Erasmus MC, Dept Med Oncol & Canc Genom Netherlands, Erasmus MC Canc Inst, NL-3000 CA Rotterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	van de Water, B (corresponding author), Leiden Univ, Div Drug Discovery & Safety, Leiden Acad Ctr Drug Res, NL-2300 RA Leiden, Netherlands.	b.water@lacdr.leidenuniv.nl		Martens, John/0000-0002-3428-3366; Zhang, Yinghui/0000-0003-1635-0278	ERC Advanced grant Triple-BC [322737]; China Scholarship Council	ERC Advanced grant Triple-BC; China Scholarship Council(China Scholarship Council)	This work was supported by the ERC Advanced grant Triple-BC (grant no. 322737). JH was financially supported by the China Scholarship Council.	Andreopoulou E, 2017, BREAST CARE, V12, P21, DOI 10.1159/000455821; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Chaignat E, 2011, GENOME RES, V21, P106, DOI 10.1101/gr.112748.110; Chiu AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29992-5; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Ehlers JP, 2005, CLIN CANCER RES, V11, P3609, DOI 10.1158/1078-0432.CCR-04-1941; Fallah Y, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030053; Gamazon ER, 2015, BRIEF FUNCT GENOMICS, V14, P352, DOI 10.1093/bfgp/elv017; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; He JC, 2019, BREAST CANCER RES TR, V178, P263, DOI 10.1007/s10549-019-05380-z; Horiuchi D, 2012, J EXP MED, V209, P679, DOI 10.1084/jem.20111512; Hou T, 2014, INT J CLIN EXP PATHO, V7, P280; Jandu H, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2071-1; Jezequel P, 2012, BREAST CANCER RES TR, V131, P765, DOI 10.1007/s10549-011-1457-7; Jolly C, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1476-3; Kim MH, 2013, J CLIN INVEST, V123, P3211, DOI 10.1172/JCI65521; Kim Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13027-2; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krepischi ACV, 2012, EUR J CANCER, V48, pS134, DOI 10.1016/S0959-8049(12)71222-4; Kwok HF, 2015, AM J CANCER RES, V5, P52; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liang L, 2016, ONCOGENE, V35, P1475, DOI 10.1038/onc.2015.209; Lin D, 2008, CANCER RES, V68, P4352, DOI 10.1158/0008-5472.CAN-07-5237; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; Long J, 2018, AM J CANCER RES, V8, P778; Mazaki Y, 2001, MOL BIOL CELL, V12, P645, DOI 10.1091/mbc.12.3.645; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Muller T, 2010, ONCOGENE, V29, P2393, DOI 10.1038/onc.2010.6; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Rimawi MF, 2013, J CLIN ONCOL, V31, P1726, DOI 10.1200/JCO.2012.44.8027; Riquelme E, 2014, J THORAC ONCOL, V9, P998, DOI 10.1097/JTO.0000000000000202; Robertson AG, 2018, CANCER CELL, V33, P151, DOI 10.1016/j.ccell.2017.12.013; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; Sandhu V, 2016, CANCER RES, V76, P5092, DOI 10.1158/0008-5472.CAN-16-0658; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Schaub FX, 2018, CELL SYST, V6, P282, DOI 10.1016/j.cels.2018.03.003; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shi YQ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0850-9; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; van Dyk E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12159; van Dyk E, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt155; Ventura Elisa, 2018, Oncoscience, V5, P278, DOI 10.18632/oncoscience.467; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2013, HEPATOLOGY, V58, P706, DOI 10.1002/hep.26402; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Weisman PS, 2016, MODERN PATHOL, V29, P476, DOI 10.1038/modpathol.2016.39; Zhang T, 2018, ONCOL LETT, V15, P4432, DOI 10.3892/ol.2018.7834; Zhang YH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2883; Zhao ZM, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5290-4; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	54	12	14	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	20					4118	4131		10.1038/s41388-020-1279-3	http://dx.doi.org/10.1038/s41388-020-1279-3		MAR 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LN3GC	32235890	Green Published, hybrid			2022-12-26	WOS:000522606000002
J	Lauretti-Ferreira, F; Silva, PLD; Alcantara, NM; Silva, BF; Grabher, I; Souza, GO; Nakajima, E; Akamatsul, MA; Vasconcellos, SA; Abreu, PAE; Carvalho, E; Martine, EAL; Ho, PL; da Silva, JB				Lauretti-Ferreira, Fabiana; Silva, Paloma L. D.; Alcantara, Naiara M.; Silva, Bruna F.; Grabher, Isabele; Souza, Gisele O.; Nakajima, Erika; Akamatsul, Milena A.; Vasconcellos, Silvio A.; Abreu, Patricia A. E.; Carvalho, Eneas; Martine, Elizabeth A. L.; Ho, Paulo L.; da Silva, Josefa B.			New strategies for Leptospira vaccine development based on LPS removal	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; CROSS-PROTECTION; DENDRITIC CELLS; T-CELLS; STRAINS; LIPL32; CXCL16; CXCR6	Pathogenic spirochetes from genus Leptospira are etiologic agents of leptospirosis. Cellular vaccines against Leptospira infection often elicit mainly response against the LPS antigen of the serovars present in the formulation. There is no suitable protein candidate capable of replacing whole-cell vaccines, thus requiring new approaches on vaccine development to improve leptospirosis prevention. Our goal was to develop a whole-cell vaccine sorovar-independent based on LPS removal and conservation of protein antigens exposure, to evaluate the protective capacity of monovalent or bivalent vaccines against homologous and heterologous virulent Leptospira in hamster. Leptospire were subjected to heat inactivation, or to LPS extraction with butanol and in some cases further inactivation with formaldehyde. Hamsters were immunized and challenged with homologous or heterologous virulent serovars, blood and organs were collected from the survivors for bacterial quantification, chemokine evaluation, and analysis of sera antibody reactivity and cross-reactivity by Western blot. Immunization with either heated or low LPS vaccines with serovar Copenhageni or Canicola resulted in 100% protection of the animals challenged with homologous virulent bacteria. Notably, different from the whole-cell vaccine, the low LPS vaccines produced with serovar Canicola provided only partial protection in heterologous challenge with the virulent Copenhageni serovar. Immunization with bivalent formulation results in 100% protection of immunized animals challenged with virulent serovar Canicola. All vaccines produced were able to eliminate bacteria from the kidney of challenged animals. All the vaccines raised antibodies capable to recognize antigens of serovars not present in the vaccine formulation. Transcripts of IFN gamma, CXCL16, CCL5, CXCL10, CXCR6, and CCR5, increased in all immunized animals. Conclusion: Our results showed that bivalent vaccines with reduced LPS may be an interesting strategy for protection against heterologous virulent serovars. Besides the desirable multivalent protection, the low LPS vaccines are specially promising due to the expected lower reatogenicity.	[Lauretti-Ferreira, Fabiana; Akamatsul, Milena A.; Ho, Paulo L.] Butantan Inst, Bioind Div, Sao Paulo, Brazil; [Lauretti-Ferreira, Fabiana; Silva, Paloma L. D.; Alcantara, Naiara M.; Silva, Bruna F.; Grabher, Isabele; Abreu, Patricia A. E.; Carvalho, Eneas; da Silva, Josefa B.] Butantan Inst, Lab Bacteriol, Sao Paulo, Brazil; [Souza, Gisele O.; Vasconcellos, Silvio A.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Lab Bacterial Zoonosis, Sao Paulo, Brazil; [Nakajima, Erika; Martine, Elizabeth A. L.] Butantan Inst, Lab Proc Dev, Sao Paulo, Brazil	Instituto Butantan; Instituto Butantan; Universidade de Sao Paulo; Instituto Butantan	da Silva, JB (corresponding author), Butantan Inst, Lab Bacteriol, Sao Paulo, Brazil.	josefa.silva@butantan.gov.br	da Silva, Josefa Bezerra/I-3515-2015; Martins, Elizabeth AL/B-7135-2015	Martins, Elizabeth AL/0000-0002-2333-9379	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [473035/2013-8]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP; Fundacao Butantan (Brazil); Instituto Butantan-Secretaria da Saude do Estado de Sao Paulo; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Butantan (Brazil); Instituto Butantan-Secretaria da Saude do Estado de Sao Paulo; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (JBS grant 473035/2013-8), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP and Fundacao Butantan (Brazil). PLDS and IG received scholarships from Instituto Butantan-Secretaria da Saude do Estado de Sao Paulo. NMA and BFS received scholarships from CNPq.	Adler B, 2015, CURR TOP MICROBIOL, V387, P251, DOI 10.1007/978-3-662-45059-8_10; Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Braunersreuther V, 2010, J MOL CELL CARDIOL, V48, P789, DOI 10.1016/j.yjmcc.2009.07.029; Cagliero J, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00204; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Cameron CE, 2015, CURR TOP MICROBIOL, V387, P21, DOI 10.1007/978-3-662-45059-8_3; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; da Silva JB, 2012, MICROB PATHOGENESIS, V52, P206, DOI 10.1016/j.micpath.2012.01.002; Dellagostin OA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010158; Dellagostin OA, 2011, HUM VACCINES, V7, P1215, DOI 10.4161/hv.7.11.17944; Dias WO, 2013, HUM VACC IMMUNOTHER, V9, P339, DOI 10.4161/hv.22847; Domingos RH, 2017, IMMUNOBIOLOGY, V222, P1004, DOI 10.1016/j.imbio.2017.05.017; ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45; Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102; Feng CY, 2009, BRAZ J MED BIOL RES, V42, P796, DOI 10.1590/S0100-879X2009005000013; Glennie ND, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006349; Grassmann AA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00256; Haake DA, 2015, CURR TOP MICROBIOL, V387, P187, DOI 10.1007/978-3-662-45059-8_8; Haake DA, 2015, CURR TOP MICROBIOL, V387, P65, DOI 10.1007/978-3-662-45059-8_5; Ido Y, 1916, J EXP MED, V24, P471, DOI 10.1084/jem.24.5.471; KEMENES F, 1964, Z IMMUNITATSFORSCH, V127, P209; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; Lee LN, 2011, INFECT IMMUN, V79, P3328, DOI 10.1128/IAI.01133-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas DSD, 2011, VACCINE, V29, P3413, DOI 10.1016/j.vaccine.2011.02.084; Martins-Pinheiro M, 2016, MOL GENET GENOMICS, V291, P703, DOI 10.1007/s00438-015-1135-2; McKay PF, 2019, ELIFE, V8, DOI 10.7554/eLife.46149; McKay PF, 2004, EUR J IMMUNOL, V34, P1011, DOI 10.1002/eji.200324840; Picardeau M, 2017, NAT REV MICROBIOL, V15, P297, DOI 10.1038/nrmicro.2017.5; PLESKO I, 1970, ANN I PASTEUR PARIS, V119, P456; Riedel JH, 2012, J AM SOC NEPHROL, V23, P1987, DOI 10.1681/ASN.2012040394; Rookmaaker MB, 2007, AM J PHYSIOL-RENAL, V293, pF624, DOI 10.1152/ajprenal.00398.2006; Rosario LA, 2012, ADV CLIN EXP MED, V21, P581; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Shimaoka T, 2004, J BIOL CHEM, V279, P26807, DOI 10.1074/jbc.C400163200; Shimaoka T, 2003, J IMMUNOL, V171, P1647, DOI 10.4049/jimmunol.171.4.1647; Sonrier C, 2000, VACCINE, V19, P86, DOI 10.1016/S0264-410X(00)00129-8; Srikram A, 2011, J INFECT DIS, V203, P870, DOI 10.1093/infdis/jiq127; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Teixeira AF, 2019, VACCINE, V37, P3961, DOI 10.1016/j.vaccine.2019.05.087; Torgerson PR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004122; Tse SW, 2014, J INFECT DIS, V210, P1508, DOI 10.1093/infdis/jiu281; Verma R, 2013, HUM VACC IMMUNOTHER, V9, P763, DOI 10.4161/hv.23059; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; Wittel UA, 2015, PANCREATOLOGY, V15, P124, DOI 10.1016/j.pan.2015.01.004; Xia YF, 2013, HYPERTENSION, V62, P1129, DOI 10.1161/HYPERTENSIONAHA.113.01837; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	48	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2020	15	3							e0230460	10.1371/journal.pone.0230460	http://dx.doi.org/10.1371/journal.pone.0230460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GU	32218590	Green Submitted, gold, Green Published			2022-12-26	WOS:000535935400008
J	Wu, H; Wang, QM; Yu, KJ; Hu, XT; Ran, MX				Wu, Hao; Wang, Qiaomei; Yu, Kunjian; Hu, Xiaotao; Ran, Maoxia			A novel intelligent fault identification method based on random forests for HVDC transmission lines	PLOS ONE			English	Article							PROTECTION SCHEME	In order to remedy the current problem of having been buffeted by competing requirements for both protection sensitivity and quick reaction of High Voltage Direct Current (HVDC) transmission lines simultaneously, a new intelligent fault identification method based on Random Forests (RF) for HVDC transmission lines is proposed. S transform is implemented to extract fault current traveling wave of 8 frequencies and calculate the fluctuation index and energy sum ratio, in which the wave index is used to identify internal and external faults, and energy sum ratio is used to identify the positive and negative pole faults occurred on the transmission line. The intelligent fault identification model of RF is established, and the fault characteristic sample set of HVDC transmission lines is constructed by using multi-scale S transform fluctuation index and multi-scale S-transform energy sum ratio. Training and testing have been carried out to identify HVDC transmission line faults. According to theoretical researches and a large number of results of simulation experiments, the proposed intelligent fault identification method based on RF for HVDC transmission lines can effectively solve the problem of protection failure caused by inaccurate identification of traditional traveling wave wavefront or wavefront data loss. It can accurately and quickly realize the identification of internal and external faults and the selection of fault poles under different fault distances and transitional resistances, and has a strong ability to withstand transitional resistance and a strong ability to resist interference.	[Wu, Hao] Artificial Intelligence Key Lab Sichuan Prov, Zigong, Peoples R China; [Wu, Hao; Wang, Qiaomei; Yu, Kunjian; Hu, Xiaotao; Ran, Maoxia] Sichuan Univ Sci & Engn, Automat & Informat Engn, Zigong, Peoples R China	Sichuan University of Science & Engineering	Wu, H (corresponding author), Artificial Intelligence Key Lab Sichuan Prov, Zigong, Peoples R China.; Wu, H (corresponding author), Sichuan Univ Sci & Engn, Automat & Informat Engn, Zigong, Peoples R China.	wuhao801212@163.com			National Natural Science Foundation of China [11705122]; artificial intelligence key laboratory of Sichuan province Foundation [2017RYY02]; Project of Sichuan provincial science and Technology Department [2017JY0338, 2019YJ0477, 2018GZDZX0043]; Enterprise informatization and Internet of things measurement and control technology key laboratory project of Sichuan provincial university [2018WZY01]; Sichuan University of Science and Engineering talent introduction project [2017RCL53]; Project of Sichuan Provincial Academician (Expert) workstation of Sichuan University of Science and Engineering [2018YSGZZ04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); artificial intelligence key laboratory of Sichuan province Foundation; Project of Sichuan provincial science and Technology Department; Enterprise informatization and Internet of things measurement and control technology key laboratory project of Sichuan provincial university; Sichuan University of Science and Engineering talent introduction project; Project of Sichuan Provincial Academician (Expert) workstation of Sichuan University of Science and Engineering	This research was supported by National Natural Science Foundation of China (Grant Nos. 11705122), the artificial intelligence key laboratory of Sichuan province Foundation (2017RYY02), and the Project of Sichuan provincial science and Technology Department (Grant No. 2017JY0338, 2019YJ0477, 2018GZDZX0043),Enterprise informatization and Internet of things measurement and control technology key laboratory project of Sichuan provincial university (2018WZY01), Sichuan University of Science and Engineering talent introduction project (2017RCL53) and the Project of Sichuan Provincial Academician (Expert) workstation of Sichuan University of Science and Engineering (2018YSGZZ04). And the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; [陈仕龙 Chen Shilong], 2015, [电网技术, Power System Technology], V39, P989; Darwish HA, 2010, IEEE T POWER DELIVER, V25, P2174, DOI 10.1109/TPWRD.2009.2036401; Farshad M, 2019, INT J ELEC POWER, V104, P615, DOI 10.1016/j.ijepes.2018.07.044; Gao SP, 2015, INT J ELEC POWER, V65, P262, DOI 10.1016/j.ijepes.2014.10.013; Gao SP, 2016, IET GENER TRANSM DIS, V11, P1286; Gil M, 2017, IET GENER TRANSM DIS, V11, P2056, DOI 10.1049/iet-gtd.2016.1686; Guo Jianbo, 1998, Power System Technology, V22, P63; [李小鹏 Li Xiaopeng], 2018, [电网技术, Power System Technology], V42, P1251; [李小鹏 Li Xiaopeng], 2017, [电网技术, Power System Technology], V41, P617; Liu J, 2016, IET GENER TRANSM DIS, V10, P3597, DOI 10.1049/iet-gtd.2016.0408; [刘剑 Liu Jian], 2015, [电网技术, Power System Technology], V39, P1736; Luo SX, 2016, IEEE T POWER DELIVER, V31, P559, DOI 10.1109/TPWRD.2015.2461450; Shu Hongchun, 2011, Proceedings of the CSEE, V31, P96; Shu Hongchun, 2010, Proceedings of the CSEE, V30, P108; Song GB, 2015, IEEE T POWER DELIVER, V30, P599, DOI 10.1109/TPWRD.2014.2300183; [宋国兵 Song Guobing], 2012, [电力系统自动化, Automation of Electric Power Systems], V36, P123; Ventosa S, 2008, IEEE T SIGNAL PROCES, V56, P2771, DOI 10.1109/TSP.2008.917029; Wang G., 2006, AC DC POW TRANS 2006; Yadav Anamika, 2016, IET SCI MEAS TECHNOL, V11, P279; Yang YY, 2018, IEEJ T ELECTR ELECTR, V13, P732, DOI 10.1002/tee.22623; [杨亚宇 Yang Yayu], 2017, [中国电机工程学报, Proceedings of the Chinese Society of Electrical Engineering], V37, P4304; Zhang Bao-hui, 2010, POWER SYST PROTECT C, V38, P18; ZHANG Y, 2018, IEEE T POWER DELIVER, V35; Zhang Y, 2012, IEEE T POWER DELIVER, V27, P1583, DOI 10.1109/TPWRD.2012.2190528; [赵航 Zhao Hang], 2017, [中国电机工程学报, Proceedings of the Chinese Society of Electrical Engineering], V37, P6888	27	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2020	15	3							e0230717	10.1371/journal.pone.0230717	http://dx.doi.org/10.1371/journal.pone.0230717			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR8GI	32214364	Green Published, gold			2022-12-26	WOS:000535934200046
J	Kyrklund, M; Bildo, M; Akhi, R; Nissinen, AE; Pussinen, P; Horkko, S; Wang, CG				Kyrklund, Mikael; Bildo, Mika; Akhi, Ramin; Nissinen, Antti E.; Pussinen, Pirkko; Horkko, Sohvi; Wang, Chunguang			Humoral immune response to heat shock protein 60 of Aggregatibacter actinomycetemcomitans and cross-reactivity with malondialdehyde acetaldehyde-modified LDL	PLOS ONE			English	Article							SHOCK-PROTEIN 65; LOW-DENSITY-LIPOPROTEIN; NATURAL ANTIBODIES; ATHEROSCLEROSIS; ADDUCTS; HSP60; CELLS; IMMUNIZATION; ASSOCIATION; DISEASE	Atherosclerosis is a chronic inflammatory disease and major cause of mortality worldwide. One of the crucial steps for atherosclerotic plaque development is oxidation of low-density lipoprotein (LDL). Through the oxidation, highly immunogenic epitopes are created and the immune system is activated. Association between atherosclerosis and periodontal diseases is well documented, and one of the main oral pathogens common in periodontitis is Aggregatibacter actinomycetemcomitans (Aa). Heat shock protein 60 (HSP60) is an important virulence factor for Aa bacteria and a strong activator of the immune system. Cross-reactivity of HSP60 and oxidized LDL (OxLDL) antibodies could be a potential mechanism in the progression of atherosclerosis and one possible link between atherosclerosis and periodontitis. Human plasma samples from neonates and mothers were analyzed to determine if antibody titer to Aa-HSP60 protein is already present in newborns. Further objectives were to characterize antibody response in Aa-HSP60 immunized mice and to determine possible antibody cross-reaction with oxidized LDL. We demonstrated that newborns already have IgM antibody levels to Aa-HSP60. We also showed that in mice, Aa-HSP60 immunization provoked IgG and IgM antibody response not only to Aa-HSP60 but also to malondialdehyde acetaldehyde-modified LDL (MAA-LDL). Competition assay revealed that the antibodies were specific to Aa-HSP60 and cross-reacted with MAA-LDL. Our results suggest a possibility of molecular mimicry between Aa-HSP60 and MAA-LDL, making it intriguing to speculate on the role of HSP60 protein in atherosclerosis that manifests at young age.	[Kyrklund, Mikael; Bildo, Mika; Akhi, Ramin; Nissinen, Antti E.; Horkko, Sohvi; Wang, Chunguang] Univ Oulu, Res Unit Biomed Med Microbiol & Immunol, Fac Med, Oulu, Finland; [Kyrklund, Mikael; Akhi, Ramin; Nissinen, Antti E.; Horkko, Sohvi; Wang, Chunguang] Univ Hosp, Med Res Ctr, Oulu, Finland; [Kyrklund, Mikael; Akhi, Ramin; Nissinen, Antti E.; Horkko, Sohvi; Wang, Chunguang] Univ Hosp, Nordlab Oulu, Oulu, Finland; [Kyrklund, Mikael; Akhi, Ramin; Nissinen, Antti E.; Horkko, Sohvi; Wang, Chunguang] Univ Oulu, Oulu, Finland; [Pussinen, Pirkko] Univ Helsinki, Oral & Maxillofacial Dis, Helsinki, Finland; [Pussinen, Pirkko] Helsinki Univ Hosp, Helsinki, Finland; [Wang, Chunguang] Minerva Fdn, Inst Med Res, Helsinki, Finland	University of Oulu; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Wang, CG (corresponding author), Univ Oulu, Res Unit Biomed Med Microbiol & Immunol, Fac Med, Oulu, Finland.; Wang, CG (corresponding author), Univ Hosp, Med Res Ctr, Oulu, Finland.; Wang, CG (corresponding author), Univ Hosp, Nordlab Oulu, Oulu, Finland.; Wang, CG (corresponding author), Univ Oulu, Oulu, Finland.; Wang, CG (corresponding author), Minerva Fdn, Inst Med Res, Helsinki, Finland.	chunguang.wang@oulu.fi	Wang, Chunguang/AAE-7054-2020; Akhi, Ramin/GLU-5898-2022	Wang, Chunguang/0000-0001-5569-321X; Pussinen, Pirkko/0000-0003-3563-1876; Akhi, Ramin/0000-0003-1783-5330	Research Fund of the Medical Research Center, University of Oulu; Oulu University Hospital; Research Fund of Oulu University Hospital	Research Fund of the Medical Research Center, University of Oulu; Oulu University Hospital; Research Fund of Oulu University Hospital	This study was supported by the Research Fund of the Medical Research Center, University of Oulu and Oulu University Hospital, and Research Fund of Oulu University Hospital/special state support for research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afek A, 2000, J AUTOIMMUN, V14, P115, DOI 10.1006/jaut.1999.0351; Anderson DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107440; Antoniak DT, 2015, FREE RADICAL BIO MED, V89, P409, DOI 10.1016/j.freeradbiomed.2015.09.003; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bond AR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/379069; de Faire U, 2009, ANN NY ACAD SCI, V1173, P292, DOI 10.1111/j.1749-6632.2009.04748.x; Duryee MJ, 2010, FREE RADICAL BIO MED, V49, P1480, DOI 10.1016/j.freeradbiomed.2010.08.001; Frank S. A., 2002, IMMUNOLOGY EVOLUTION, P33; Grangeasse C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00500; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Hu YY, 2018, BIOCHEM BIOPH RES CO, V498, P701, DOI 10.1016/j.bbrc.2017.10.150; Karkhah A, 2016, CLIN EXP VACCINE RES, V5, P50, DOI 10.7774/cevr.2016.5.1.50; Kurita-Ochiai T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/595981; Kyrklund M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191216; Lu XJ, 2010, ATHEROSCLEROSIS, V212, P472, DOI 10.1016/j.atherosclerosis.2010.06.007; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Nilsson J, 2009, J INTERN MED, V266, P221, DOI 10.1111/j.1365-2796.2009.02150.x; Piconi S, 2009, FASEB J, V23, P1196, DOI 10.1096/fj.08-119578; Plomp R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02436; Schett G, 1999, CARDIOVASC RES, V42, P685, DOI 10.1016/S0008-6363(99)00012-7; Sun HG, 2014, ATHEROSCLEROSIS, V237, P853, DOI 10.1016/j.atherosclerosis.2014.10.012; Thiele GM, 2015, ARTHRITIS RHEUMATOL, V67, P645, DOI 10.1002/art.38969; Tsiantoulas D, 2014, CIRC RES, V114, P1743, DOI 10.1161/CIRCRESAHA.113.301145; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P2218, DOI 10.1016/j.jacc.2012.08.979; Turunen SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034910; Van Regenmortel MHV, 1998, J MOL RECOGNIT, V11, P163; Wang CG, 2016, IMMUNOL RES, V64, P699, DOI 10.1007/s12026-015-8781-7; Wang CG, 2013, INT IMMUNOL, V25, P575, DOI 10.1093/intimm/dxt022; Wick C, 2016, CELL STRESS CHAPERON, V21, P201, DOI 10.1007/s12192-015-0659-z; Wick G, 2014, NAT REV CARDIOL, V11, P516, DOI 10.1038/nrcardio.2014.91; Xu QB, 1999, CIRCULATION, V100, P1169, DOI 10.1161/01.CIR.100.11.1169; YOUNG RA, 1989, CELL, V59, P5, DOI 10.1016/0092-8674(89)90861-1	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2020	15	3							e0230682	10.1371/journal.pone.0230682	http://dx.doi.org/10.1371/journal.pone.0230682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9HN	32210456	Green Published, gold			2022-12-26	WOS:000535307600042
J	Hao, SJ; Wang, CY; Liu, SW; He, JX; Jiang, YF				Hao, Sijia; Wang, Chunyan; Liu, Siwen; He, Jiaxue; Jiang, Yanfang			HPV genotypic spectrum in Jilin province, China, where non-vaccine-covered HPV53 and 51 are prevalent, exhibits a bimodal age-specific pattern	PLOS ONE			English	Article							CROSS-PROTECTIVE EFFICACY; HUMAN-PAPILLOMAVIRUS HPV; CERVICAL-CANCER; GENITAL WARTS; INFECTION; WOMEN; INFLAMMATION; PREVENTION; DISEASE; BURDEN	Background Human papillomavirus (HPV), the most common sexually transmitted disease, is involved in a series of other diseases. The persistent infection of high-risk HPVs (HR-HPVs) is considered to be the causative agent of cervical cancer, and it is related to noncervical cancers. The present study aims to estimate the HPV prevalence and genotype distribution in Jilin province, China, to guide HPV-related cervical cancer screening and HPV vaccination. Methods From October 2017 to September 2019, 21,282 samples (634 male and 20,648 female) were collected for HPV infection detection using an HPV genotyping panel. The age-related HPV prevalence and morbidity of HPV-based disease and HPV prevalence associated with specific diseases were analyzed. Results A total of 7095 (34.4%) positive for HPV infection of 20648 women, and 164 (25.8%) positive of 634 men. The HPV prevalence among women exhibited a bimodal pattern, with a peak in young group and a second peak in old group, with increased severity of cervical lesions. HPV16 (7.8%), HPV52 (5.8%), HPV58 (5.0%), HPV53 (3.4%), and HPV51 (3.0%) were the most prevalent genotypes among women, and HPV6 (6.0%), HPV11 (5.7%), HPV16 (3.6%), HPV18 (2.7%), and HPV51 (3.0%) were prevalent among men. Non-vaccine-covered HPV53 and 51 were found in 6.3% of HPV infection and 8.9% of cervical cancer in Jilin province. Furthermore, 45.5% of females and 28.6% of males with genital warts were infected with HR-HPV genotypes. Conclusion The HPV genotypic spectrum in Jilin province, where non-vaccine-covered HPV53 and 51 were prevalent, exhibited an age- and cervical lesion-specific pattern, which provides guidance for HPV vaccination and cervical cancer screening. HPV infection in men and benign hyper-proliferative lesions should not be neglected.	[Hao, Sijia; Wang, Chunyan; Liu, Siwen; He, Jiaxue; Jiang, Yanfang] First Hosp Jilin Univ, Genet Diag Ctr, Key Lab Organ Regenerat & Transplantat, Minist Educ, Changchun, Peoples R China	Jilin University	Jiang, YF (corresponding author), First Hosp Jilin Univ, Genet Diag Ctr, Key Lab Organ Regenerat & Transplantat, Minist Educ, Changchun, Peoples R China.	yanfangjiang@hotmail.com		Jiang, Yanfang/0000-0002-2478-1521	National Natural Science Foundation of China [30972610, 81273240, 91742107, 81570002]; National Key Research and Development Program [2017YFC0910000, 2017YFD0501300]; Jilin Province Science and Technology Agency [20190101022JH, 2019J026, 20170622009JC, 2017C021, 2017J039, SXGJXX2017-8, JJKH20180197KJ, DBXM154-2018, 2018SCZWSZX-015]; State Key Laboratory of Kidney Diseases in PLA General Hospital [KF-01-147]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program; Jilin Province Science and Technology Agency; State Key Laboratory of Kidney Diseases in PLA General Hospital	YFJ National Natural Science Foundation of China (nos. 30972610, 81273240, 91742107, and 81570002) YFJ National Key Research and Development Program (nos. 2017YFC0910000 and 2017YFD0501300) YFJ Jilin Province Science and Technology Agency (nos. 20190101022JH, 2019J026, 20170622009JC, 2017C021, 2017J039, SXGJXX2017-8, JJKH20180197KJ, DBXM154-2018, and 2018SCZWSZX-015) YFJ the Fund of the State Key Laboratory of Kidney Diseases in PLA General Hospital (No.KF-01-147). Yes-Specify the role(s) played.	Acosta-Rios M P, 2017, J Med Life, V10, P237; Anic GM, 2011, J INFECT DIS, V204, P1886, DOI 10.1093/infdis/jir652; [Anonymous], 2016, Obstet Gynecol, V127, pe1, DOI 10.1097/AOG.0000000000001263; Arbyn M, 2014, J PATHOL, V234, P431, DOI 10.1002/path.4424; Benard VB, 2012, OBSTET GYNECOL, V120, P1117, DOI [10.1097/AOG.0b013e31826e4609, http://10.1097/AOG.0b013e31826e4609]; Boccardo E, 2010, CARCINOGENESIS, V31, P1905, DOI 10.1093/carcin/bgq176; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; Crow JM, 2012, NATURE, V486, pS12, DOI 10.1038/486S12a; Curry SJ, 2018, OBSTET GYNECOL SURV, V73, P689, DOI [10.1001/jama.2018.10897, 10.1097/01.ogx.0000549540.69362.81]; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Di Jiangli, 2015, Asian Pac J Cancer Prev, V16, P7401; Doorbar J, 2015, REV MED VIROL, V25, P2, DOI 10.1002/rmv.1822; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Gillison ML, 2008, CANCER-AM CANCER SOC, V113, P3036, DOI 10.1002/cncr.23764; Giorgi-Rossi P, 2012, INT J CANCER, V130, P1387, DOI 10.1002/ijc.26147; Gupta G, 2017, HUM VACC IMMUNOTHER, V13, P1421, DOI 10.1080/21645515.2017.1289301; Harden ME, 2017, MUTAT RES-REV MUTAT, V772, P3, DOI 10.1016/j.mrrev.2016.07.002; Jiang LB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210311; Kim JJ, 2018, JAMA-J AM MED ASSOC, V320, P706, DOI 10.1001/jama.2017.19872; Kim Min-Jeong, 2013, Obstet Gynecol Sci, V56, P110, DOI 10.5468/OGS.2013.56.2.110; Kovacic MB, 2008, HUM PATHOL, V39, P1088, DOI 10.1016/j.humpath.2007.12.002; Liu XX, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0708-8; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Plummer M, 2012, INT J CANCER, V130, P2638, DOI 10.1002/ijc.26250; Rinaldi S, 2011, CANCER EPIDEM BIOMAR, V20, P2532, DOI 10.1158/1055-9965.EPI-11-0753; Roura E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147029; Singh SM, 2015, INT J CLIN EXP PATHO, V8, P11901, DOI 10.5005/jp-journals-10005-1311; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Sun LL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-153; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; Woodhall S, 2008, SEX TRANSM INFECT, V84, P161, DOI 10.1136/sti.2007.029512; Zhao FH, 2012, INT J CANCER, V131, P2929, DOI 10.1002/ijc.27571; Zhao FH, 2012, CANCER EPIDEMIOL, V36, P384, DOI 10.1016/j.canep.2012.01.009; Zhong TY, 2017, J INFECT PUBLIC HEAL, V10, P783, DOI 10.1016/j.jiph.2017.01.011	39	10	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0230640	10.1371/journal.pone.0230640	http://dx.doi.org/10.1371/journal.pone.0230640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208459	Green Published, gold			2022-12-26	WOS:000535305100030
J	Sanaye, SV; Khandeparker, R; Rayadurga, AS; Shivaramu, MS; Kankonkar, H; Narvekar, J; Gauthankar, M				Sanaye, Sushant, V; Khandeparker, Rakhee; Rayadurga, Anantha Sreepada; Shivaramu, Mamatha S.; Kankonkar, Harshada; Narvekar, Jayu; Gauthankar, Mukund			Morphological and molecular evidence for first records and range extension of the Japanese seahorse, Hippocampus mohnikei (Bleeker 1853) in a bay-estuarine system of Goa, central west coast of India	PLOS ONE			English	Article							CHINESE MEDICINE MARKET; LIFE-HISTORY; TELEOSTEI SYNGNATHIDAE; DRIED SEAHORSES; MARINE FISH; CONSERVATION; MANDOVI; HABITAT; ZUARI; PHYLOGEOGRAPHY	Accurate information of taxonomy and geographic range of seahorse species (genus Hippocampus) is the first step in preparing threat assessments and designing effective conservation measures. Here, we report first records and a range extension of the Japanese seahorse, Hippocampus mohnikei (Bleeker, 1853) from the Mandovi estuarine ecosystem of Goa, central west coast of India (CWCI) based on morphological and molecular analyses. The morphometric and meristic traits, particularly short snout (29-35% head length), double cheek spine, low coronet, long tail (51.2-57.9% of standard length), 11 trunk rings, 37-39 tail rings, 15-16 dorsal and 12-14 fin rays observed in four collected specimens matched with the reported key diagnostic morphological criteria of vouchered specimens of H. mohnikei. The seahorse mitochondrial cytochrome oxidase subunit I (COI) and cytochrome b (Cyt b) genes were partially sequenced for conclusive genetic identification of the species under study. Molecular analysis showed that all four individuals clustered together suggesting a monophyletic lineage. Using the maximum similarity with GenBank database, maximum likelihood network and subsequent morphological analysis, the identity of the collected seahorse species was reconfirmed as H. mohnikei. With this new report, the geographic range of H. mohnikei extended significantly to the west from its previously known range. This new sighting of H. mohnikei could indicate a long-distance dispersal facilitated by the prevailing oceanic circulation in the IndoPacific region or increased habitat suitability in bay-estuarine systems of Goa, CWCI. Comparison of the pair-wise genetic distances (Kimura 2-parameter) based on COI and Cyt b sequences revealed that the specimens examined in this study are genetically closer to H. mohnikei populations from Vietnam and Thailand than they are to those in Japan and China. To test the hypothesis whether H. mohnikei are vagrants or previously unreported established population, long-term inter-annual sampling and analyses are warranted.	[Sanaye, Sushant, V; Khandeparker, Rakhee; Rayadurga, Anantha Sreepada; Shivaramu, Mamatha S.; Kankonkar, Harshada; Gauthankar, Mukund] CSIR Natl Inst Oceanog, Biol Oceanog Div, Aquaculture Lab, Panaji, Goa, India; [Narvekar, Jayu] CSIR Natl Inst Oceanog, Phys Oceanog Div, Panaji, Goa, India; [Shivaramu, Mamatha S.] CSIR Cent Food Technol Res Inst, Mysuru, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Rayadurga, AS (corresponding author), CSIR Natl Inst Oceanog, Biol Oceanog Div, Aquaculture Lab, Panaji, Goa, India.	sreepada@nio.org		Gauthankar, Mukund/0000-0002-2498-939X; Sreepada, Rayadurga/0000-0003-4589-3001				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1984, FISHES JAPANESE ARCH; Ansari ZA, 2003, ESTUAR COAST SHELF S, V56, P503, DOI 10.1016/S0272-7714(02)00201-9; ANSARI ZA, 1995, ESTUAR COAST SHELF S, V41, P593, DOI 10.1016/0272-7714(95)90029-2; Aylesworth L, 2016, J FISH BIOL, V88, P1620, DOI 10.1111/jfb.12908; Boehm JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116219; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bowen BW, 2001, EVOLUTION, V55, P1029, DOI 10.1554/0014-3820(2001)055[1029:POTTAR]2.0.CO;2; Caldwell IR, 2013, ENVIRON BIOL FISH, V96, P67, DOI 10.1007/s10641-012-0023-4; Casey SP, 2004, MOL PHYLOGENET EVOL, V30, P261, DOI 10.1016/j.ympev.2003.08.018; Chang CH, 2013, J FOOD DRUG ANAL, V21, P310, DOI 10.1016/j.jfda.2013.07.010; Choi YU, 2012, ICHTHYOL RES, V59, P235, DOI 10.1007/s10228-012-0285-z; Correia M, 2015, J FISH BIOL, V87, P679, DOI 10.1111/jfb.12748; Curtis JMR, 2006, J FISH BIOL, V68, P707, DOI 10.1111/j.0022-1112.2006.00952.x; Dalal SG, 2001, J PLANKTON RES, V23, P19, DOI 10.1093/plankt/23.1.19; Das P. B., 2017, International Journal for Research in Applied Science and Engineering Technology, V5, P1789; Fleminger A., 1986, UNESCO TECH PAP MAR, V49, P84; Foster SJ, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00429.x; Froese R, FISHBASE; Han SY, 2019, MAR BIODIVERS, V49, P263, DOI 10.1007/s12526-017-0792-2; Harasti D, 2017, J APPL ICHTHYOL, V33, P1018, DOI 10.1111/jai.13414; Harasti D., 2015, Marine Biodiversity Records, V8, pe49, DOI 10.1017/S1755267215000263; Harasti D, 2014, J FISH BIOL, V85, P1413, DOI 10.1111/jfb.12492; Hellyer CB, 2011, AQUAT CONSERV, V21, P582, DOI 10.1002/aqc.1217; Hou FX, 2018, MITOCHONDRIAL DNA A, V29, P107, DOI 10.1080/24701394.2016.1248430; JAGTAP TG, 1991, AQUAT BOT, V40, P379, DOI 10.1016/0304-3770(91)90082-G; Kanou K, 2001, ICHTHYOL RES, V48, P361, DOI 10.1007/s10228-001-8159-9; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krishnan TS, 2011, INDIAN J GEO-MAR SCI, V40, P642; Kuiter R. H., 2009, SEAHORSES THEIR RELA; Kumar R, 2007, INDIAN J EXP BIOL, V45, P992; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; KWAK S, 2008, KOREAN J ICHTHYOLOGY, V20, P112; Laksanawimol P, 2013, ACTA ICHTHYOL PISCAT, V43, P229, DOI 10.3750/AIP2013.43.3.07; Lim KKP, 2013, SINGAPORE BIODIVERSI, V2013, P68; Lourie S. A., 1999, SEAHORSES IDENTIFICA; Lourie S.A., 2003, 4 U BRIT COL FISH CT, V4, P1; Lourie S.A., 2004, GUIDE IDENTIFICATION; Lourie SA, 2005, MOL ECOL, V14, P1073, DOI 10.1111/j.1365-294X.2005.02464.x; Lourie SA, 2004, J BIOGEOGR, V31, P1975, DOI 10.1111/j.1365-2699.2004.01153.x; Lourie SA, 1999, BIOL J LINN SOC, V66, P231, DOI 10.1111/j.1095-8312.1999.tb01886.x; Lourie SA, 2016, ZOOTAXA, V4146, P1, DOI 10.11646/zootaxa.4146.1.1; Luzzatto DC, 2013, J FISH BIOL, V83, P677, DOI 10.1111/jfb.12196; Luzzatto Diego C., 2014, Marine Biodiversity Records, V7, pe71, DOI 10.1017/S1755267214000815; Madhupratap M, 2001, CURR SCI INDIA, V81, P355; Mahapatro Debasish, 2017, Marine Biodiversity Records, V10, DOI 10.1186/s41200-017-0108-z; Maree RC, 2000, S AFR J SCI, V96, P184; Martin-Smith KM, 2005, BIOL CONSERV, V123, P533, DOI 10.1016/j.biocon.2005.01.003; Murugan A, 2008, CURR SCI INDIA, V95, P253; Otsuka Yu, 2009, Journal of the School of Marine Science and Technology Tokai University, V7, P11; Padmavati G, 1996, INDIAN J MAR SCI, V25, P268; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Panithanarak T., 2019, BURAPHA SCI J, V24, P124; Pollom R., HIPPOCAMPUS MOHNIKEI, DOI [10.2305/IUCN.UK.20173.RLTS.T41005A54907304.en43, DOI 10.2305/IUCN.UK.20173.RLTS.T41005A54907304.EN43]; QASIM SZ, 1981, ESTUAR COAST SHELF S, V13, P557, DOI 10.1016/S0302-3524(81)80058-8; Qin G, 2018, BIOL OPEN, V7, DOI 10.1242/bio.032888; Qin G, 2017, ICES J MAR SCI, V74, P2170, DOI 10.1093/icesjms/fsx042; Saarman NP, 2010, CONSERV GENET, V11, P1989, DOI 10.1007/s10592-010-0092-x; Salin K. R., 2006, Aquaculture Asia Magazine, V11, P3; Scales H, 2010, PROG PHYS GEOG, V34, P443, DOI 10.1177/0309133310364928; SHETYE SR, 1991, DEEP-SEA RES, V38, P1517, DOI 10.1016/0198-0149(91)90087-V; Shetye SR, 1995, P INDIAN AS-EARTH, V104, P667; Shokri MR, 2009, AQUAT CONSERV, V19, P588, DOI 10.1002/aqc.1009; Short G, 2019, ZOOKEYS, P109, DOI 10.3897/zookeys.824.30921; Silveira RB, 2014, ZOOTAXA, V3861, P317, DOI 10.11646/zootaxa.3861.4.2; Sreepada RA, 2002, CURR SCI INDIA, V82, P377; Subburaman S, 2014, INDIAN J GEO-MAR SCI, V43, P408; Suda Yusuke, 2004, Journal of National Fisheries University, V52, P11; Teske PR, 2005, MAR ECOL PROG SER, V286, P249, DOI 10.3354/meps286249; Thangaraj M, 2007, J FISH BIOL, V70, P310, DOI 10.1111/j.1095-8649.2006.01278.x; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Wafar S., 1987, THESIS; Wang X, 2019, MITOCHONDRIAL DNA A, V30, P165, DOI 10.1080/24701394.2018.1467410; Wibowo K, 2017, NATURE KAGOSHIMA, V43, P71; Wong Nur Leena Wai Sin, 2017, Check List, V13, P993; Woodall LC, 2018, MAR BIOL, V165, DOI 10.1007/s00227-017-3274-y; Wyrtki K, 1961, NAGA REPORT; Yogeshkumar JS, 2012, INT J PLANT ANIM ENV, V2, P56; Zhang YH, 2016, ZOOTAXA, V4170, P384, DOI 10.11646/zootaxa.4170.2.11; Zhang YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105494	80	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2020	15	3							e0220420	10.1371/journal.pone.0220420	http://dx.doi.org/10.1371/journal.pone.0220420			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9GO	32208467	Green Submitted, Green Published, gold			2022-12-26	WOS:000535305100001
J	Song, PP; Kuryatov, A; Axelsen, PH				Song, Pingping; Kuryatov, Alexander; Axelsen, Paul H.			A new synthetic medium for the optimization of docosahexaenoic acid production in Crypthecodinium cohnii	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; GROWTH; ALGAE; TEMPERATURE; MICROALGAE; CULTURE; WATER	The heterotrophic microalgae Crypthecodinium cohnii was usually cultivated in complex medium containing glucose, yeast extract and sea salt. For the preparation of DHA with highest purity, a new defined medium without the yeast extract was developed. Different inoculated densities, C/N ratios, temperatures, culture volumes and glucose additions were investigated to optimize the algal growth rate and DHA production. The growth period in C. cohnii was shortened from 12-14 days to 7-8 days, the OD600 was enhanced from 2.0 to 3.0, the glucose consumption was accelerated and used up on day 3-4, and the DHA content in culture were increased from 10 to 45 nmoles/300 mu l batch. It was found that C. cohnii had optimal growth and DHA accumulation in 25 degrees C, 0.2 inoculated density, 5-10 C/N ratio, 5:1 air/culture volume ratio. This is the first time DHA production using C.cohnii has been optimized in synthetic medium. This allows preparation of uniformly radiolabeled C-13- and C-14-DHA.	[Song, Pingping] Guizhou Med Univ, Sch Biol Engn, Guiyang, Guizhou, Peoples R China; [Kuryatov, Alexander; Axelsen, Paul H.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Kuryatov, Alexander; Axelsen, Paul H.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Kuryatov, Alexander; Axelsen, Paul H.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	Guizhou Medical University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Song, PP (corresponding author), Guizhou Med Univ, Sch Biol Engn, Guiyang, Guizhou, Peoples R China.	songqian70@163.com			National Institutes of Health [AG057197]; Guizhou Science and Technology Foundation of China [TS [2017]-2843, TJ [2017] 1143, GY [2017] 5-6]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guizhou Science and Technology Foundation of China	This work was supported by National Institutes of Health AG057197 from Dr Paul H. Axelsen; Guizhou Science and Technology Foundation of China (No. TS [2017]-2843, TJ [2017] 1143, GY [2017] 5-6) from Dr Pingping Song.	Abdulrazaq M, 2017, NUTRITION, V39-40, P57, DOI 10.1016/j.nut.2016.12.003; Benavente-Valdes Juan Roberto, 2016, Biotechnol Rep (Amst), V10, P117, DOI 10.1016/j.btre.2016.04.001; Calder PC, 2016, ANN NUTR METAB, V69, P8, DOI 10.1159/000448262; Chi ZY, 2011, APPL BIOCHEM BIOTECH, V165, P442, DOI 10.1007/s12010-011-9263-6; de Swaaf ME, 1999, J BIOTECHNOL, V70, P185, DOI 10.1016/S0168-1656(99)00071-1; De Swaaf ME, 2003, BIOTECHNOL BIOENG, V81, P666, DOI 10.1002/bit.10513; Furman R, 2016, ACS CHEM NEUROSCI, V7, P367, DOI 10.1021/acschemneuro.5b00316; Harauma A, 2017, PROSTAG LEUKOTR ESS, V116, P9, DOI 10.1016/j.plefa.2016.11.002; Huerlimann R, 2010, BIOTECHNOL BIOENG, V107, P245, DOI 10.1002/bit.22809; Jiang Y, 2000, J AM OIL CHEM SOC, V77, P613, DOI 10.1007/s11746-000-0099-0; Lee JV, 2017, BIORESOURCE TECHNOL, V227, P142, DOI 10.1016/j.biortech.2016.12.050; Mendes A, 2009, J APPL PHYCOL, V21, P199, DOI 10.1007/s10811-008-9351-3; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mubarak M, 2015, ALGAL RES, V7, P117, DOI 10.1016/j.algal.2014.10.008; Nalley JO, 2018, ALGAL RES, V35, P500, DOI 10.1016/j.algal.2018.09.018; PAN JG, 1986, BIOTECHNOL LETT, V8, P715, DOI 10.1007/BF01032568; Ratledge C, 2001, LIPIDS, V36, P1241, DOI 10.1007/s11745-001-0838-x; Singh RN, 2012, RENEW SUST ENERG REV, V16, P2347, DOI 10.1016/j.rser.2012.01.026; Siriwardhana N, 2012, ADV FOOD NUTR RES, V65, P211, DOI 10.1016/B978-0-12-416003-3.00013-5; Sun GY, 2018, PROSTAG LEUKOTR ESS, V136, P3, DOI 10.1016/j.plefa.2017.03.006; TUTTLE R C, 1975, Phycologia, V14, P1, DOI 10.2216/i0031-8884-14-1-1.1; Udayan A, 2017, ALGAL GREEN CHEMISTRY: RECENT PROGRESS IN BIOTECHNOLOGY, P65, DOI 10.1016/B978-0-444-63784-0.00004-7; Ummalyma SB, 2018, WASTE BIOMASS VALORI, P1; Weiser MJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020099; Winwood RJ, 2013, OCL OILS FAT CROP LI, V20, DOI 10.1051/ocl/2013030; ZIBOH VA, 1970, J LIPID RES, V11, P346	26	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2020	15	3							e0229556	10.1371/journal.pone.0229556	http://dx.doi.org/10.1371/journal.pone.0229556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FU	32196504	Green Published, gold			2022-12-26	WOS:000535303100011
J	DeLeon, S; Webster, MS; DeVoogd, TJ; Dhondt, AA				DeLeon, Sara; Webster, Michael S.; DeVoogd, Timothy J.; Dhondt, Andre A.			Developmental polychlorinated biphenyl exposure influences adult zebra finch reproductive behaviour	PLOS ONE			English	Article							SWALLOWS TACHYCINETA-BICOLOR; SHOW DISTINCT PATTERNS; TREE SWALLOWS; TAENIOPYGIA-GUTTATA; PCB CONGENERS; HUDSON RIVER; ENDOCRINE DISRUPTION; SPERM COMPETITION; BRAIN-DEVELOPMENT; DENDRITIC GROWTH	Polychlorinated biphenyls (PCBs) are worldwide chemical pollutants that have been linked to disrupted reproduction and altered sexual behaviour in many organisms. However, the effect of developmental PCB-exposure on adult passerine reproductive behaviour remains unknown. A commercial PCB mixture (Aroclor 1242) or an estrogenic congener (PCB 52) were administered in sublethal amounts to nestling zebra finches (Taeniopygia guttata) in the laboratory to identify effects of developmental PCB-exposure on adult zebra finch reproductive parameters. Results indicate that although traditional measures of reproductive success are not altered by this PCB dosage, PCBs do alter sexual behaviours such as male song and nesting behaviour. Males treated with PCB 52 in the nest sang significantly fewer syllables than control males, while females treated with Aroclor 1242 in the nest showed the strongest song preferences. PCB treatment also caused an increase in the number of nesting attempts and abandoned nests in the Aroclor 1242 treatment relative to the PCB 52 treatment, and offspring with control fathers fledged significantly earlier than those with fathers treated with Aroclor 1242. Behavioural differences between males seem to best explain these reproductive effects, most notably aggression. These findings suggest that sublethal PCB-exposure during development can significantly alter key reproductive characteristics of adult zebra finches, likely reducing fitness in the wild.	[DeLeon, Sara; Dhondt, Andre A.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA; [DeLeon, Sara; Webster, Michael S.; Dhondt, Andre A.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA; [Webster, Michael S.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [DeVoogd, Timothy J.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	DeLeon, S (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.; DeLeon, S (corresponding author), Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA.	sd279@cornell.edu			State University of New York Fellowship; SLOAN Fellowship; Tibor T. Polgar Fellowship; National Sea Grant College Program of the U.S. Department of Commerce's National Oceanic and Atmospheric Administration [NA10OAR4170064]	State University of New York Fellowship; SLOAN Fellowship(Alfred P. Sloan Foundation); Tibor T. Polgar Fellowship; National Sea Grant College Program of the U.S. Department of Commerce's National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	S. DeLeon was supported by a State University of New York Fellowship (https://www.suny.edu/impact/research/suny-research-fellows/); a SLOAN Fellowship (https://sloan.org/fellowships/); and a Tibor T. Polgar Fellowship (https://www.hudsonriver.org/?x=polgar).This publication is a resulting product from project R/CTP-43 funded under award NA10OAR4170064 from the National Sea Grant College Program of the U.S. Department of Commerce's National Oceanic and Atmospheric Administration, to the Research Foundation of State University of New York on behalf of New York Sea Grant (https://seagrant.sunysb.edu/).The statements, findings, conclusions, views, and recommendations are those of the author(s) and do not necessarily reflect the views of any of those organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINSREGAN E, 1994, J NEUROBIOL, V25, P865, DOI 10.1002/neu.480250710; Airey DC, 2000, NEUROREPORT, V11, P2339, DOI 10.1097/00001756-200007140-00054; ALTMAN NH, 1979, LAB ANIM SCI, V29, P661; Alward BA, 2013, P NATL ACAD SCI USA, V110, P19573, DOI 10.1073/pnas.1311371110; Andersson Malte, 1994; Ball GF, 2002, FRONT NEUROENDOCRIN, V23, P137, DOI 10.1006/frne.2002.0230; Balthazart J, 2016, FRONT NEUROENDOCRIN, V41, P3, DOI 10.1016/j.yfrne.2016.03.003; Bell MR, 2014, CURR OPIN PHARMACOL, V19, P134, DOI 10.1016/j.coph.2014.09.020; Bernard DJ, 1999, ENDOCRINOLOGY, V140, P4633, DOI 10.1210/en.140.10.4633; BIRKHEAD TR, 1989, ANIM BEHAV, V38, P935, DOI 10.1016/S0003-3472(89)80135-6; BIRKHEAD TR, 1990, BEHAV ECOL SOCIOBIOL, V27, P315, DOI 10.1007/BF00164002; BIRKHEAD TR, 1988, NATURE, V334, P60, DOI 10.1038/334060a0; BIRKHEAD TR, 1988, ANIM BEHAV, V36, P1853, DOI 10.1016/S0003-3472(88)80133-7; Blocker TD, 2013, ACTA ETHOL, V16, P105, DOI 10.1007/s10211-012-0137-x; BOHNER J, 1983, ANIM BEHAV, V31, P231, DOI 10.1016/S0003-3472(83)80193-6; Bonefeld-Jorgensen EC, 2001, TOXICOLOGY, V158, P141, DOI 10.1016/S0300-483X(00)00368-1; Bowman RE, 2015, HORM BEHAV, V69, P89, DOI 10.1016/j.yhbeh.2014.12.007; BURLEY N, 1982, ANIM BEHAV, V30, P444, DOI 10.1016/S0003-3472(82)80055-9; Carpenter DO, 2010, PHYSIOL BEHAV, V99, P260, DOI 10.1016/j.physbeh.2009.09.001; CATCHPOLE CK, 1984, NATURE, V312, P563, DOI 10.1038/312563a0; Chen Z, 2013, NEUROSCIENCE, V239, P139, DOI 10.1016/j.neuroscience.2012.12.043; CLAYTON N, 1989, ANIM BEHAV, V38, P352, DOI 10.1016/S0003-3472(89)80096-X; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; COLLINS SA, 1994, BEHAV ECOL SOCIOBIOL, V35, P21, DOI 10.1007/s002650050065; Crisp TM, 1998, ENVIRON HEALTH PERSP, V106, P11, DOI 10.2307/3433911; Dauwe T, 2003, ARCH ENVIRON CON TOX, V44, P89, DOI 10.1007/s00244-002-1243-y; DeLeon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073471; DeVoogd TJ, 2004, BRAIN BEHAV EVOLUT, V63, P221, DOI 10.1159/000076783; DeVoogd TJ, 2001, HDB BEHAV NEUROBIOLO, V13; Dickerson SM, 2007, REV ENDOCR METAB DIS, V8, P143, DOI 10.1007/s11154-007-9048-y; EALES LA, 1985, ANIM BEHAV, V33, P1293, DOI 10.1016/S0003-3472(85)80189-5; Echols KR, 2004, ENVIRON SCI TECHNOL, V38, P6240, DOI 10.1021/es049785p; Eckbo N, 2019, ENVIRON POLLUT, V249, P191, DOI 10.1016/j.envpol.2019.01.025; Erickson MD, 2011, ENVIRON SCI POLLUT R, V18, P135, DOI 10.1007/s11356-010-0392-1; Fang ZQ, 2017, HORM BEHAV, V93, P151, DOI 10.1016/j.yhbeh.2017.05.014; Fanini D., 1990, Behav Pharmacol, V1, P505; Fernie K, 2003, J TOXICOL ENV HEAL A, V66, P2089, DOI 10.1080/15287390390211270; Fisher SA, 2006, ECOTOX ENVIRON SAFE, V63, P226, DOI 10.1016/j.ecoenv.2005.07.021; Fisher SA, 2001, ARCH ENVIRON CON TOX, V41, P215; Frame GM, 1997, FRESEN J ANAL CHEM, V357, P714, DOI 10.1007/s002160050238; Frye CA, 2012, J NEUROENDOCRINOL, V24, P144, DOI 10.1111/j.1365-2826.2011.02229.x; Fusani L, 2006, NEUROSCIENCE, V138, P939, DOI 10.1016/j.neuroscience.2005.08.041; Gillette R, 2017, HORM BEHAV, V87, P8, DOI 10.1016/j.yhbeh.2016.10.011; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; Gore AC, 2018, HORM BEHAV, V101, P3, DOI 10.1016/j.yhbeh.2017.09.001; Gorissen L, 2005, OECOLOGIA, V145, P504, DOI 10.1007/s00442-005-0091-7; Hallinger KK, 2010, AUK, V127, P156, DOI 10.1525/auk.2009.09058; Helberg M, 2005, ENVIRON POLLUT, V134, P475, DOI 10.1016/j.envpol.2004.09.006; HILL KM, 1991, BEHAV NEURAL BIOL, V56, P240, DOI 10.1016/0163-1047(91)90379-5; Holladay SD, 2000, ENVIRON HEALTH PERSP, V108, P463, DOI 10.2307/3454538; Hoogesteijn AL, 2005, ENVIRON TOXICOL CHEM, V24, P219, DOI 10.1897/03-632R.1; Hoogesteijn AL, 2003, THESIS; Hoogesteijn AL, 2008, ENVIRON TOXICOL CHEM, V27, P2071, DOI 10.1897/07-484.1; Hu DF, 2010, ATMOS ENVIRON, V44, P1550, DOI 10.1016/j.atmosenv.2010.01.006; Hwang L., 2011, REV ENV HLTH, V22, P313; Ingold DJ, 1996, J FIELD ORNITHOL, V67, P321; Iwaniuk AN, 2006, BEHAV BRAIN RES, V173, P1, DOI 10.1016/j.bbr.2006.05.026; JANSEN HT, 1993, REPROD TOXICOL, V7, P237, DOI 10.1016/0890-6238(93)90230-5; Kahn NW, 1998, AUK, V115, P1074; Kroodsma DE, 2001, ANIM BEHAV, V61, P1029, DOI 10.1006/anbe.2000.1676; Lauay C, 2005, J COMP NEUROL, V487, P119, DOI 10.1002/cne.20591; Lauay C, 2004, ANIM BEHAV, V68, P1249, DOI 10.1016/j.anbehav.2003.12.025; Lein PJ, 2007, ENVIRON HEALTH PERSP, V115, P556, DOI 10.1289/ehp.9773; Leon-Olea M, 2014, GEN COMP ENDOCR, V203, P158, DOI 10.1016/j.ygcen.2014.02.005; MacDougall-Shackleton SA, 2012, J ORNITHOL, V153, pS105, DOI 10.1007/s10336-011-0807-x; Markman S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001674; Maul JD, 2006, ENVIRON TOXICOL CHEM, V25, P1017, DOI 10.1897/05-309R.1; McCarty JP, 1999, ENVIRON TOXICOL CHEM, V18, P1433, DOI 10.1002/etc.5620180713; McCarty JP, 2000, AUK, V117, P987, DOI 10.1642/0004-8038(2000)117[0987:PEOPCO]2.0.CO;2; McCarty JP, 1999, AUK, V116, P55, DOI 10.2307/4089453; McCarty JP, 2002, J FIELD ORNITHOL, V73, P9, DOI 10.1648/0273-8570-73.1.9; MCCOY G, 1995, ARCH ENVIRON CON TOX, V28, P431; Millam JR, 2001, HORM BEHAV, V40, P542, DOI 10.1006/hbeh.2001.1724; Neigh AM, 2006, ENVIRON TOXICOL CHEM, V25, P1503, DOI 10.1897/05-046R.1; NIXDORFBERGWEILER BE, 1995, J NEUROBIOL, V27, P204, DOI 10.1002/neu.480270207; Nowicki S, 2004, ANN NY ACAD SCI, V1016, P704, DOI 10.1196/annals.1298.012; Nowicki S, 2002, J COMP PHYSIOL A, V188, P1003, DOI 10.1007/s00359-002-0361-3; Peters S, 2014, INTEGR COMP BIOL, V54, P555, DOI 10.1093/icb/icu020; Schantz SL, 1997, NEUROTOXICOLOGY, V18, P457; Secord AL, 1999, ENVIRON TOXICOL CHEM, V18, P2519, DOI 10.1002/etc.5620181119; Sherry DF, 2015, FRONT NEUROENDOCRIN, V37, P158, DOI 10.1016/j.yfrne.2014.11.008; Siikamaki P, 1998, ECOLOGY, V79, P1789, DOI 10.1890/0012-9658(1998)079[1789:LORSBF]2.0.CO;2; Soderstrom K, 2007, J NEUROSCI METH, V164, P116, DOI 10.1016/j.jneumeth.2007.04.007; Spencer KA, 2005, BEHAV ECOL SOCIOBIOL, V58, P423, DOI 10.1007/s00265-005-0927-5; Spencer KA, 2003, HORM BEHAV, V44, P132, DOI 10.1016/S0018-506X(03)00124-7; TRYPHONAS H, 1991, FUND APPL TOXICOL, V16, P773, DOI 10.1016/0272-0590(91)90163-X; Tyler CR, 1998, CRIT REV TOXICOL, V28, P319, DOI 10.1080/10408449891344236; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vyas A, 2009, HORM BEHAV, V55, P50, DOI 10.1016/j.yhbeh.2008.08.005; Waye A, 2011, J TOXICOL ENV HEAL B, V14, P270, DOI 10.1080/10937404.2011.578273; Wayman GA, 2012, ENVIRON HEALTH PERSP, V120, P997, DOI 10.1289/ehp.1104832; Zala SM, 2004, ANIM BEHAV, V68, P649, DOI 10.1016/j.anbehav.2004.01.005; ZANN RA, 1994, EMU, V94, P285, DOI 10.1071/MU9940285; Zann RA., 1996, ZEBRA FINCH SYNTHESI	95	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230283	10.1371/journal.pone.0230283	http://dx.doi.org/10.1371/journal.pone.0230283			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191759	Green Published, gold			2022-12-26	WOS:000535302300033
J	Heckman, CJ; Schut, C; Riley, M; Ehlers, A; Valdes-Rodriguez, R; Kupfer, J; Gieler, U; Stapleton, JL				Heckman, Carolyn J.; Schut, Christina; Riley, Mary; Ehlers, Anke; Valdes-Rodriguez, Rodrigo; Kupfer, Joerg; Gieler, Uwe; Stapleton, Jerod L.			Development and psychometrics of the English version of the Itch Cognitions Questionnaire	PLOS ONE			English	Article							ATOPIC-DERMATITIS; CHRONIC PRURITUS; VALIDATION; SCALE; PERSONALITY; REGRESSION; DISORDERS; STRESS; ADULTS; PAIN	Background The aim of this study was to validate the English version of the Itch Cognition Questionnaire in a sample of patients with chronic itch due to psoriasis or atopic dermatitis. An English-language version of an instrument assessing itch-related cognitions is needed since cognitions can contribute to a worsening of itch, and chronic itch is prevalent in English-speaking counties and internationally. Methods The German Itch Cognitions Questionnaire was translated into English, and cognitive interviewing was conducted to finalize item wording. Internal and test-retest reliability, item discrimination, responsiveness to change, and construct, convergent, and discriminant validity were assessed in a national sample of 137 individuals with chronic itch due to atopic dermatitis or psoriasis recruited online. Results Internal reliability was high with Cronbach's alphas of 0.93 for the Catastrophizing subscale and 0.88-0.90 for Coping. The Pearson's correlation assessing 1-month test-retest reliability for the Catastrophizing subscale was r = 0.62 and for the Coping subscale was r = 0.61. The corrected item-total correlation revealed that items were relatively consistent with the scores for the subscales (with correlations ranging from 0.58 to 0.79), indicating very good item discrimination. Results of factor analysis, convergent and discriminant, and responsiveness to change analyses provided evidence for validity. Conclusions This study showed good psychometric characteristics of the English version of the Itch Cognitions Questionnaire. We suggest that future studies investigate the use of the measure in clinical practice to assist with treatment planning and outcome assessment related to itch as well as address study limitations such as sampling and replication.	[Heckman, Carolyn J.; Riley, Mary] Rutgers Canc Inst New Jersey, Canc Prevent & Control, New Brunswick, NJ 08901 USA; [Schut, Christina; Kupfer, Joerg] Justus Liebig Univ Giessen, Inst Med Psychol, Giessen, Germany; [Ehlers, Anke] Univ Oxford, Dept Expt Psychol, Oxford, England; [Valdes-Rodriguez, Rodrigo] Univ Virginia, Dept Dermatol, Charlottesville, VA USA; [Gieler, Uwe] Justus Liebig Univ Giessen, Dept Dermatol, Giessen, Germany; [Stapleton, Jerod L.] Univ Kentucky, Dept Hlth Behav, Lexington, KY USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Justus Liebig University Giessen; University of Oxford; University of Virginia; Justus Liebig University Giessen; University of Kentucky	Heckman, CJ (corresponding author), Rutgers Canc Inst New Jersey, Canc Prevent & Control, New Brunswick, NJ 08901 USA.	ch842@rutgers.edu	Ehlers, Anke/G-8713-2014	Ehlers, Anke/0000-0002-8742-0192; Schut, Christina/0000-0001-5366-6285; heckman, carolyn/0000-0003-1016-3965	Pfizer [WI206759]; NIH [P30CA006927, P30CA072720]; Wellcome Trust [200796]	Pfizer(Pfizer); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)	Funding sources included Pfizer WI206759, NIH P30CA006927, and NIH P30CA072720. Anke Ehlers is funded by the Wellcome Trust 200796. The funders had no role in study design or data collection and analysis. Pfizer provided minimal edits on an earlier draft of the manuscript and approved submission to PlosOne.	Beck A.T., 1979, COGNITIVE THERAPY AN; Carr CW, 2014, JAMA DERMATOL, V150, P613, DOI 10.1001/jamadermatol.2013.7696; Clark DM, 1999, BEHAV RES THER, V37, pS5, DOI 10.1016/S0005-7967(99)00048-0; EHLERS A, 1995, J CONSULT CLIN PSYCH, V63, P624, DOI 10.1037/0022-006X.63.4.624; Ehlers A., 1993, VERHALTENSTHERAPIE, V3, P112; Elman S, 2010, BRIT J DERMATOL, V162, P587, DOI 10.1111/j.1365-2133.2009.09586.x; Evers AWM, 2019, EXP DERMATOL, V28, P1442, DOI 10.1111/exd.13992; FLOR H, 1988, J BEHAV MED, V11, P251, DOI 10.1007/BF00844431; Grob JJ, 1999, DERMATOLOGY, V199, P213, DOI 10.1159/000018250; Hermanns N, 1993, JB MED PSYCHOL; Huizinga J, 2012, J NURS MEAS, V20, P35, DOI 10.1891/1061-3749.20.1.35; Lavda AC, 2012, BRIT J DERMATOL, V167, P970, DOI 10.1111/j.1365-2133.2012.11183.x; Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004; Meni C, 2013, J EUR ACAD DERMATOL, V27, P1426, DOI 10.1111/jdv.12180; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; MORISKY DE, 2011, J CLIN EPIDEMIOL, V64, P8, DOI DOI 10.1016/J.JCLINEPI.2010.09.002; Morisky DE, 2011, J CLIN EPIDEMIOL, V64, P255, DOI 10.1016/j.jclinepi.2010.09.002; Ruiz MA, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-127; Schut C, 2016, EUR J PAIN, V20, P14, DOI 10.1002/ejp.751; Schut C, 2018, ACTA DERM-VENEREOL, V98, P32, DOI 10.2340/00015555-2767; Schut C, 2016, ACTA DERM-VENEREOL, V96, DOI 10.2340/00015555-2177; Schut C, 2015, EXP DERMATOL, V24, P148, DOI 10.1111/exd.12578; Schut C, 2014, ACTA DERM-VENEREOL, V94, P20, DOI 10.2340/00015555-1634; Stander S, 2017, J DTSCH DERMATOL GES, V15, P860, DOI 10.1111/ddg.13304; Ten Klooster PM, 2012, PATIENT EDUC COUNS, V87, P125, DOI 10.1016/j.pec.2011.07.017; Tsutsui J, 2003, VALIDATION JAPANESE; van Laarhoven AIM, 2018, PSYCHOL RES-PSYCH FO, V82, P876, DOI 10.1007/s00426-017-0878-2; van Laarhoven AIM, 2012, BRIT J DERMATOL, V167, P262, DOI 10.1111/j.1365-2133.2012.10933.x; van Os-Medendorp H, 2007, BRIT J DERMATOL, V156, P1235, DOI 10.1111/j.1365-2133.2007.07919.x; van Os-Medendorp H, 2006, J EUR ACAD DERMATOL, V20, P810, DOI 10.1111/j.1468-3083.2006.01647.x; Verhoeven EWM, 2008, ACTA DERM-VENEREOL, V88, P211, DOI 10.2340/00015555-0452	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230585	10.1371/journal.pone.0230585	http://dx.doi.org/10.1371/journal.pone.0230585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9FM	32191772	Green Published, gold			2022-12-26	WOS:000535302300062
J	Kidd-Weaver, A; Hepinstall-Cymerman, J; Welch, CN; Murray, MH; Adams, HC; Ellison, TJ; Yabsley, MJ; Hernandez, SM				Kidd-Weaver, Anjelika; Hepinstall-Cymerman, Jeffrey; Welch, Catharine N.; Murray, Maureen H.; Adams, Henry C.; Ellison, Taylor J.; Yabsley, Michael J.; Hernandez, Sonia M.			The movements of a recently urbanized wading bird reveal changes in season timing and length related to resource use	PLOS ONE			English	Article							ANIMAL MOVEMENT; WHITE IBISES; HADEDA IBIS; HABITAT; POPULATION; SELECTION; STRATEGIES; MIGRATION; PATTERNS; NOMADISM	The American White Ibis (Eudocimus albus) is a nomadic wading bird that is increasing the amount of time spent foraging in urban areas, relying on artificial wetlands and other anthropogenic resources year-round. In this study, we explore whether and how American White Ibis association with urban environments is predictive of variation in the timing and length of behavioral seasons. Other urbanized species exhibit altered annual cycles such as loss of migratory behavior and year-round breeding related to consistent resource abundance, often related to intentional and unintentional provisioning. To determine if these same patterns of behavior were also present in White Ibis, we used behavioral change point analysis to segment the tracks of 41 ibis equipped with GPS backpacks to identify the initiation and duration of four behavioral seasons (non-breeding, pre-breeding, breeding, post-breeding) the degree of urban association. We found that intraspecific variation in urban habitat use had strong carryover effects on the timing and duration of behavioral seasons. This study revealed ibis with higher use of urban habitats in non-breeding seasons had longer non-breeding seasons and shorter breeding seasons that began earlier in the year compared to ibis that primarily use wetland habitats. The timing and duration of seasons also varied with ibis age, such that ibis spent more time engaged in breeding-related seasons as they aged. Juvenile and subadult ibis, though considered to be reproductively immature, also exhibit behavioral shifts in relation to breeding seasons. The behavioral patterns found in this study provide evidence that ibis are adapting their annual cycles and seasonal behaviors to exploit urban resources. Future research is needed to identify the effect of interactions between ibis urban association and age on behavioral season expression.	[Kidd-Weaver, Anjelika; Hepinstall-Cymerman, Jeffrey; Welch, Catharine N.; Murray, Maureen H.; Adams, Henry C.; Ellison, Taylor J.; Yabsley, Michael J.; Hernandez, Sonia M.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Adams, Henry C.; Ellison, Taylor J.; Yabsley, Michael J.; Hernandez, Sonia M.] Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Athens, GA USA; [Kidd-Weaver, Anjelika] Clemson Univ, Dept Forestry & Environm Conservat, Clemson, SC USA; [Welch, Catharine N.] Florida Dept Environm Protect, Div Recreat & Pk, Okeechobee, FL USA; [Murray, Maureen H.] Davee Ctr Epidemiol & Endocrinol, Urban Wildlife Inst, Chicago, IL USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Clemson University	Hepinstall-Cymerman, J (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	jhepinstall@warnell.uga.edu		Hepinstall-Cymerman, Jeffrey/0000-0003-2087-850X; Yabsley, Michael/0000-0003-2452-5015	National Science Foundation EEID grant [DEB-1518611]; Georgia Ornithological Society	National Science Foundation EEID grant; Georgia Ornithological Society	Funding was provided by a National Science Foundation EEID grant, (DEB-1518611) and the Georgia Ornithological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 1993, WHITE IBIS WETLAND W; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birkett PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038363; Bokony V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036639; Casper RM, 2009, ANIM BEHAV, V78, P1477, DOI 10.1016/j.anbehav.2009.09.023; Duckworth GD, 2010, DIVERS DISTRIB, V16, P765, DOI 10.1111/j.1472-4642.2010.00683.x; Duckworth GD, 2014, ARDEA, V102, P21, DOI 10.5253/078.102.0104; Edelhoff H, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0086-5; ESRI, 2016, ARCGIS 10 6; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Ferguson SH, 2004, J ZOOL, V262, P125, DOI 10.1017/S0952836903004552; Firth JA, 2016, ECOL LETT, V19, P1324, DOI 10.1111/ele.12669; Flack A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500931; Frederick PC, 1996, CONSERV BIOL, V10, P203, DOI 10.1046/j.1523-1739.1996.10010203.x; Garstang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108736; Gawlik DE, 2002, ECOL MONOGR, V72, P329, DOI 10.1890/0012-9615(2002)072[0329:TEOPAO]2.0.CO;2; Gilbert NI, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0070-0; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Grund MD, 2002, J WILDLIFE MANAGE, V66, P123, DOI 10.2307/3802878; Gurarie E., 2013, BEHAV CHANGE POINT A, P1; Gurarie E., 2014, **DATA OBJECT**; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Heath JA, 2003, J FIELD ORNITHOL, V74, P187, DOI 10.1648/0273-8570-74.2.187; Heath JA, 2009, WHITE IBIS EUDOCIMUS; Hernandez SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164402; Herring G, 2008, J FIELD ORNITHOL, V79, P102, DOI 10.1111/j.1557-9263.2008.00151.x; Herring HK, 2011, WATERBIRDS, V34, P133, DOI 10.1675/063.034.0201; Hostetler JA, 2015, AUK, V132, P433, DOI 10.1642/AUK-14-211.1; Humphrey JS, 2014, J RAPTOR RES, V48, P289, DOI 10.3356/JRR-13-26.1; Johnston Richard F., 2001, P49; Kessel ST, 2014, MAR ECOL PROG SER, V514, P175, DOI 10.3354/meps10966; KUSHLAN JA, 1979, CONDOR, V81, P376, DOI 10.2307/1366963; Laver PN, 2018, MOV ECOL, V6, DOI 10.1186/s40462-018-0123-7; Lenz J, 2015, ECOGRAPHY, V38, P54, DOI 10.1111/ecog.00522; Gonzalez TM, 2017, ECOL MODEL, V360, P223, DOI 10.1016/j.ecolmodel.2017.07.006; Martin JM, 2011, LANDSCAPE URBAN PLAN, V102, P65, DOI 10.1016/j.landurbplan.2011.03.010; Martin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030108; McEvoy JF, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0048-3; Mingozzi T, 2016, J EXP MAR BIOL ECOL, V485, P8, DOI 10.1016/j.jembe.2016.08.007; Miranda AC, 2013, GLOBAL CHANGE BIOL, V19, P2634, DOI 10.1111/gcb.12258; Moller AP, 2015, CLIM RES, V66, P185, DOI 10.3354/cr01344; Mueller T, 2011, GLOBAL ECOL BIOGEOGR, V20, P683, DOI 10.1111/j.1466-8238.2010.00638.x; Murray MH, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0100; Nell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149572; Partecke J, 2007, ECOLOGY, V88, P882, DOI 10.1890/06-1105; Porlier M, 2012, J ANIM ECOL, V81, P1041, DOI 10.1111/j.1365-2656.2012.01996.x; Rees AM, 2008, BIPOLAR II DISORDER: MODELLING, MEASURING AND MANAGING, P141; Rose S, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00047; Roshier DA, 2008, OECOLOGIA, V156, P465, DOI 10.1007/s00442-008-0987-0; Scales J, 2011, BEHAV SYNDROMES BREA, P887; Scales KL, 2017, ECOGRAPHY, V40, P210, DOI 10.1111/ecog.02272; Shephard JM, 2015, J ORNITHOL, V156, P943, DOI 10.1007/s10336-015-1204-7; Singh NJ, 2012, ECOL APPL, V22, P2007, DOI 10.1890/12-0245.1; Smith ACM, 2013, POPUL ECOL, V55, P567, DOI 10.1007/s10144-013-0385-2; Team RC, 2016, R LANG ENV STAT COMP; Teitelbaum CS, 2019, TRENDS ECOL EVOL, V34, P569, DOI 10.1016/j.tree.2019.02.005; Teitelbaum CS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12793; USDA, 2012, 2012 CENS AGR COUNT; Varner DM, 2014, J WILDLIFE MANAGE, V78, P840, DOI 10.1002/jwmg.734; Wal EV, 2009, J WILDLIFE MANAGE, V73, P1189, DOI 10.2193/2008-137; Walden-Schreiner C, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-018-6463-3; Webber QMR, 2018, J ANIM ECOL, V87, P113, DOI 10.1111/1365-2656.12773; Welch C. N., 2016, URBAN LAND USE MOVEM; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001	64	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2020	15	3							e0230158	10.1371/journal.pone.0230158	http://dx.doi.org/10.1371/journal.pone.0230158			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ9FM	32191732	gold, Green Published			2022-12-26	WOS:000535302300027
